<SEC-DOCUMENT>0000200406-20-000050.txt : 20200724
<SEC-HEADER>0000200406-20-000050.hdr.sgml : 20200724
<ACCEPTANCE-DATETIME>20200724160436
ACCESSION NUMBER:		0000200406-20-000050
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		87
CONFORMED PERIOD OF REPORT:	20200628
FILED AS OF DATE:		20200724
DATE AS OF CHANGE:		20200724

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			JOHNSON & JOHNSON
		CENTRAL INDEX KEY:			0000200406
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				221024240
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-03215
		FILM NUMBER:		201046995

	BUSINESS ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
		BUSINESS PHONE:		732-524-2455

	MAIL ADDRESS:	
		STREET 1:		ONE JOHNSON & JOHNSON PLZ
		CITY:			NEW BRUNSWICK
		STATE:			NJ
		ZIP:			08933
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>jnj-20200628.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726,d:d4c2b9b2855142cd8f946cd473dea1c1--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2019-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2017-01-31" xmlns:jnj="http://www.jnj.com/20200628" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>jnj-20200628</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl80LTEtMS0xLTA_e5c13680-5697-406f-9b26-cac69da9272c">0000200406</ix:nonNumeric><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl81LTEtMS0xLTA_7d125377-cae8-4be8-b350-4675861f039e">1/3</ix:nonNumeric><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl85LTEtMS0xLTA_3b3ad76f-3c1f-446f-860b-2439794cd86d">2020</ix:nonNumeric><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl8xMC0xLTEtMS0w_8ccfc9b7-b7ef-488a-8cbf-aed334163a0e">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl8xMS0xLTEtMS0w_23e5e195-9316-4c45-83a2-33c06373df5f">FALSE</ix:nonNumeric><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfMi0xLTEtMS0w_cf9d42a9-4332-4a11-aa20-51db8a964d9c">334</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfMi0zLTEtMS0w_c1f441a3-1a1a-40ac-87ef-bdcd2cd7f3b2">226</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNS0xLTEtMS0w_2cb7f42c-5720-424b-8905-7f405538b199">1.00</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNS0zLTEtMS0w_4d126d35-d407-4f02-895a-026b38316372">1.00</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNi0xLTEtMS0w_af678560-ef04-4876-b0ca-a093f152100d">4,320,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNi0zLTEtMS0w_321ed6d1-c128-41f3-96a5-54297e2af6c8">4,320,000</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNy0xLTEtMS0w_0d9a45bf-fb59-444c-b672-0e1193fbde0c">3,119,843</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNy0zLTEtMS0w_9b7ab1d6-18e8-481b-961b-8d06cd186ccc">3,119,843</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfOC0xLTEtMS0w_e5c4a0fd-cf75-4d26-88a5-accb7f98a894">487,466</ix:nonFraction><ix:nonFraction unitRef="shares" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfOC0zLTEtMS0w_684d1f00-4053-474a-b955-6b9445a30672">487,336</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0xLTEtMS0w_8f4e2219-37cf-4543-9f72-eff03f50514d">114</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0yLTEtMS0w_57a26e82-65f3-4e3a-b4a3-cf4a618c1d26">68</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0zLTEtMS0w_5d271051-f39b-4ac3-bf95-eebaaaf9d2e3">106</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi00LTEtMS0w_94024b5f-a3f2-41b5-8c8d-15095ee52fea">44</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0xLTEtMS0w_487c49e9-5a2f-42f2-b9e6-45fcedb92449">1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0yLTEtMS0zMDYx_305337a0-69b8-4c19-9fbd-d7239ba604c7">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0zLTEtMS0w_23fcd304-92ea-436b-8ac2-e6682e7206ac">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy00LTEtMS0zMDY1_cdce0269-db5a-4d97-a914-12b8f74b0303">&#8212;</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0xLTEtMS0w_0516eccc-3f05-45ac-a964-9f1bf3a92836">55</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0yLTEtMS0w_b58d613e-4496-4f2a-8a19-d630aa47b5f7">111</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0zLTEtMS0w_1adb21ff-93b4-4600-b071-3dd4540cf408">34</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC00LTEtMS0w_91053ce1-7c78-4ef4-b646-5932358628d9">35</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0xLTEtMS0w_90ab002a-2df1-4dac-8c68-80b3943c1c54">10</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0yLTEtMS0w_d849313a-6b7b-4ff4-bf84-0e5b99f74a35">246</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0zLTEtMS0w_0ce537b6-d70b-4675-83f3-8c8a5d154d94">16</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS00LTEtMS0w_e218052f-58d5-47b8-a053-042eeee25e8d">39</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0xLTEtMS0w_79ede66f-8bfd-4482-905f-d9597a913d62">1.01</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0yLTEtMS0w_baae7d45-d914-45d9-8b7f-46081d64a3b5">1.96</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0zLTEtMS0w_d8a340a3-46b1-47d2-9a56-2b8bf9db405a">0.95</ix:nonFraction><ix:nonFraction unitRef="usdPerShare" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="2" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi00LTEtMS0w_86435025-a9d3-4677-8924-94cbe2ae041f">1.85</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82NC9mcmFnOjM1YjEyMGFiODRhZjQ5NzBiYTc5YTU4YmE2MmM5NGJkL3RhYmxlOmIwN2Y2M2NjYmQwMjQ1MDg4NjJiNTY3MzRiMTUyOTkwL3RhYmxlcmFuZ2U6YjA3ZjYzY2NiZDAyNDUwODg2MmI1NjczNGIxNTI5OTBfMC0xLTEtMS0w_a285c3a7-5ffe-463e-9e6f-7645adf16f2b">1.1</ix:nonFraction><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82NC9mcmFnOjM1YjEyMGFiODRhZjQ5NzBiYTc5YTU4YmE2MmM5NGJkL3RhYmxlOmIwN2Y2M2NjYmQwMjQ1MDg4NjJiNTY3MzRiMTUyOTkwL3RhYmxlcmFuZ2U6YjA3ZjYzY2NiZDAyNDUwODg2MmI1NjczNGIxNTI5OTBfMS0xLTEtMS0w_6f2e80cd-90e9-4bc8-9b40-0cb185cab1bb">2.2</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7d82f1709b994eacb901cda0b8414196_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNC0xLTEtMS0w_2c5b706d-5531-42a9-91b6-12e7b04ea99b">3.550</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i04fe5d0b9ade47e5981496ba5bbaed12_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNS0xLTEtMS0w_71939ce2-4e8d-4503-92fa-aa4309c5d6e1">2.450</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if8665aecb49944a58fbb92e84df3cc67_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNy0xLTEtMS0w_07f6949c-f237-430a-9b39-8ff283e2c52f">0.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i6e0e6b7104074202b4e5d369a606e4de_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfOC0xLTEtMS0w_db46e18d-34c0-4c70-99f5-0475433dbdb4">2.250</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id3a4040a4a9d496e941dd0a85aa89117_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfOS0xLTEtMS0w_5bd8b982-2277-42de-be2b-76cb38c0d5f9">6.730</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i83226f68d388482997387c732a694f0b_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTAtMS0xLTEtMA_c8853ff6-f668-486c-a233-3ab835ee3fe7">3.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ib7ea62f7202743edb0eb2e2ac6bdd8fc_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTEtMS0xLTEtMA_9af25301-3545-4218-b4ae-9e44d02e2947">2.050</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if1cca58000e94ac18ffc4da63ed491ee_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTItMS0xLTEtMA_fbe554d9-d19c-448b-9885-37941970e8af">0.650</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="id6b500b0012e4fffb964046db18b7ee9_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTMtMS0xLTEtMA_8a4eca45-92d2-4e51-8384-c901cbd3bc92">5.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ice6838c819764fd3b274d26aa88869fb_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTQtMS0xLTEtMA_ad8df626-0173-4708-bf9d-b7ab9506bd71">2.625</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ifa6388d8e4aa4d2ba5163676f80c3f61_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTUtMS0xLTEtMA_21e90df3-0ea4-4131-bb70-72b7ed61b4c1">2.450</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i55a1659d1528484386f3c1b96b56cd5b_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTYtMS0xLTEtMA_c85a9d6e-563a-44d4-b1a2-22edc705eb79">2.95</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ie6972f42d4f04331bdc3fa37a69b7170_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTctMS0xLTEtMA_3bfe5071-7e74-41a7-92f8-9e7566409091">2.900</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i29c4cbdbde9b4e11a996c3f6929a01ca_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTgtMS0xLTEtMA_b5685687-efe9-4c20-91cd-3fa89ef48294">1.150</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ica38f942e6f54e37b25a587ae66eb689_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTktMS0xLTEtMA_44ef4f3f-582a-443c-9bf6-ea348614311b">6.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="iddce8e7eb7d541908fa3346ff2ccc64d_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjAtMS0xLTEtMA_ad1535b6-6d76-4e0e-a175-e64282d77004">4.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="ia99bbdcc3d6f4e3a846ee43fffa0409c_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjEtMS0xLTEtMA_cf5aa255-ff1d-45fc-981d-c9ed70aa2a0a">4.375</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i7d75e926178641929b977bc0db3d772c_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjItMS0xLTEtMA_2107e504-bb2e-49d2-825e-34db09174c20">1.650</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if8d3f87a8a814ef3b7f7ceb44c1ed145_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjMtMS0xLTEtMA_4e741d77-895a-45eb-adc9-a5f922c07477">3.550</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="if1b09b47526a4eeba8c34cb6affc3050_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjQtMS0xLTEtMA_5592e5ad-a199-45e1-b9c9-e48c132259b3">5.950</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="idd21cfd6641847409da3807e3a428234_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjUtMS0xLTEtMA_4dc33df0-4c67-4ce3-97c0-6a56f8a7acb0">3.625</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i1abc4374a89f41bda84e861ad20017c5_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjYtMS0xLTEtMA_fee41b48-207a-48fc-8ebc-305b52379002">3.400</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0218ee4e0ffe4a1c9ae094465ceff9f3_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjctMS0xLTEtMA_d6dbb70f-d4be-4802-9be4-780caf66ba5e">5.850</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0e888a83818c4971ac6ee9c8f4183487_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjgtMS0xLTEtMA_3066b4d5-380e-490b-90f0-e827b905e35f">4.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i3b183eb71fa34ae282a8f6304ff5d4ed_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjktMS0xLTEtMA_ff0a1a9a-7cdd-4cfb-84db-15193ee24e46">4.850</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i672a40323bdb4457a31a3d077e38d562_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzAtMS0xLTEtMA_2a25afcd-20a1-4448-9ed2-cdb9476025ca">4.500</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i8e650bd7c2174e4989ca66001681ede2_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzEtMS0xLTEtMA_e848eaa3-41a5-46ba-85bb-e30b3746e836">3.700</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i5a9b919d33e6495ca7d583176e83bd1e_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzItMS0xLTEtMA_17960b55-4ae1-4a43-b125-9994c650cd6f">3.75</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="i0089df10475a41e29517b0bb7f6c056b_I20200628" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzMtMS0xLTEtMA_2fda793d-7aed-44eb-a58b-4e8b3e35aeb2">3.50</ix:nonFraction><ix:nonNumeric contextRef="i778843f60e324063b0b113788a8aaa4e_D20191230-20200628" format="ixt-sec:durwordsen" name="us-gaap:DebtInstrumentTerm" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RleHRyZWdpb246NTYzZjkyNWRmOGZjNGVmMTg4NjQwMDlhOTIwY2E4N2NfNzE0NjgyNTU4MDYxNA_ec35c33b-54a3-4719-8af8-006dc414c627">3 months, 21 days</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="jnj-20200628.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i972855702c8a4b18883e4284851151dd_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="iefb6241d9bf2428e94a47ac9ce454499_I20200720"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i56f124cb187a4df0b12cb443a129b124_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4250b233c8424335ac39cd07c8101199_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f5119916d654310ac75b5ef00226e3c_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28ce5a232c604b8bbf884d668b9f4e57_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24d9e08d937e4f179ddd650ddc14f39f_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73fd0a02b1154c3e9745a1263dc23b62_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefccab1bc61e4aac89cc6807ae4e1c54_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59a07beb3fc44f4287425a53a020e1d6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45078457294a49839d52d19d59d45e00_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if261e32787064849a30e8f746c585aa9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f156471cef4470986ef989b88c7640a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24cafb66e4484853bf4778ec14060e85_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i751605f69fa8470b949cd66a3de18cfb_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63412fd9538f4c419e57e8396e1e2450_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib519600bb19e47f6acf4f21be0fc6aaf_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5747648413fd46979174d12f0c200837_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic629a2a0279c40f7a8a22fbbbd206b62_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i946a5c53aec443718456445577b181c6_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37f2478bd1c94f8189108fa2df87fa35_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fd38c3886a84e65b754e209c671b4e3_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf51803037143adbd15041c11e9e51a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i246708123c874d65a705b8d658c14466_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0cde42ed21643029a65d234f94ce9ce_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3ae7c05de8449e4853379b1810a5cb4_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id93dcd19b8bf48879ab269ebebba20c7_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99963dbb725b4ce68efcd70e25e653e1_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b613a94dd42484783d6a12a1751f62a_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c0949379c4e4a58a6c9255f0e249053_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1edf2d8de4844dca95575354c2ff1e2_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e4c6a229a014b85a7a8b8c276c6ceb0_I20181230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49bf965261be49f3adf9b650ea02edfe_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i143de2467f00494d97e9051d438c9616_D20191230-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c16549172ea409986271df6c73e639c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64ccc08e02734c24a00e804f7b1912c9_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id939f17ab58546e792a3505ad59025d1_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4a1ace803e04933bfb1ecf684b3b69d_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ae5346cc81b4f27b4788b31c0e54a6f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc73eb3ded6942659b82f23e9f209d83_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc06a706e03b46438ac284c25745cad8_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bc60621d8554499a90278e03e0c6c2f_I20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99703a7240b24ff78c8ea755f087ee0a_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3cfcc9ed84c14ef99d0fa0093df15fc2_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9898c86a84104e428b5e32fc5072ca0a_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5317e81770cc465384ed2fda2daf0206_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dc0631cabd64cff92a35dc49719e5e8_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide8ee6042d8a44199c107aa75b895f4d_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb1af4e8ba9744f08026427afa0d3297_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae716e872a654f7d8eb4cdca336d0296_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b4629634a44afab44276b8c7cb5831_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad06a55c5b434327b4b129a23d14607a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2558fa0249654384927e35faad85b435_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc2e1511c074474db7b627c8d636f1f7_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2930efbd85243489088de50fb884ebf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic803db0b89c947539400ccc49f897abd_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i392345cf23fa442fa586318c28775403_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i182f09e72a12408fba69944468ed839b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a386510568948ef9401f50d743744af_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6147540408284062babe0382c2ed602f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i771189b421614759bcfeb81a969af79c_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9ac6becf67b448c872942fc733563e5_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if84c79837433431cbfe27e56a7471773_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02769757e5e740ba8d0918956fb4bebe_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e42ae0e28f84a3883a9d31defcc19c3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i890db46e47fd49d29bf0222d80de0e45_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib840e261052c4ea5ac6bd3f5620b9e0f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49811ec159eb4ac3bc3e2bbd99fe655b_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i440d6fd614824bcc9d8ddcc6388c5585_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05a3bd79ad904c7c8b977b55b1dfda9d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24f094cc45d4b64bcbc61338f27ef34_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab234b2a9db4b839ddaf49647f6f9f0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec571d4979a4ebba093f4d51dbf209d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i636d1fd3b5314b0cb1e7b53344d7a601_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i803140059c0440d58c12d070ec9ef9e4_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie56c599de2e24fc180918708256afa06_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4560dde64424b5eb34ac46f8e75831f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09bd4a7957314ad4806a70ff0309af9c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac20a877725e4f95bad00d306f8ef1bd_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ca06658d0fa40fd9124e23676ae5f16_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f752123964c43149dbce663ffb8dd1a_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9326dae4609548fba0848714a64d1794_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib201d398ebc14ebdb124f345bb48e79a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266b986790574bd58dd9c8410be41161_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib4796b3e074d44b8b27f9e3805365ef7_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32a304915e484dc482c62bb1f219c6ec_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07152e7d66cd425cbf3e240d1e56cec5_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e246117e68944788661db5d2b317e56_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i540760381d80440cad88a6dab18c3a11_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i808beb23831442638cf20b785a026f54_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i048d532d55964ba2af85ffcf6f324949_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fcaecf26704902b098af6c039a0f6f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45557044d86f4718ba2718ad7252be12_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dfa706123d84147824f6fd9464cff19_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b8d63c17e114b2e9b9a96275f1697e4_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccc7bf9a45e54601aca24b8cc9b8ea57_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e6c057229dc4bd7a12d48cbd4db8754_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icad4b86ea6694e5f9adc78bc100d29fc_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83d021f672be43748204f5d0a7908366_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idedeb1dfe09443a7b82d283ca7b15298_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9bc5029a28b4c25ac4f1670189d549e_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c9318d92354ba2a3360e24144f1b37_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad126eeedca04aedbf65bca596749ee3_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic563629e1c85446181090d0223f3a034_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34b771b7935f4c27a472b4058fc8a61a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">jnj:OtherReverseRepurchaseAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic66b3f5412794987b892ff0a6f28f018_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id60c2849846c43c7918fb9427719b8c3_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d30159c3fa949349d95c4d25158bbbd_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d6452213f4045a599c3f921fc70d80e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d98912977ba4917b953532514269c05_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d040c895d9a484983838bc608465de1_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4679f53893ef429da7ae2608c619ef95_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26f774541fbb4a11b90c5d2d53d5ac38_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13c392bf576441608a85b5f3084041ed_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf2600e49d414d4c9228f6fb5cf69b47_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21abfcc6203b49ce95faf424178935b8_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1cabbaf87184e1ea5605e3f3dfafa26_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife21e63962704b6ebd278d152e40a4eb_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae6e1bd14a034339920302779e0d2b6b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0fe3730cd7bd49aeb322782ed3670e1d_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia00a7be937144c12b2167fc98e13147c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia95278deee974881825cf0f9ce29d7a1_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8e5f7c3c0844f5af66ac2ad7955599_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4fa9e40d591048bda2fbd99d27df9044_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia36011f1be2b41518aa8989de6791c53_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a87256891cc4bf199c1a109a2537a60_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4870c94373034eb2bcd12dbc135d4626_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a31f41a5b6843ae9b894d9381f461e9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81fab23f82674c6980bc9c359eb28ba9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc37bc973c1b451387840c102be9a646_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3485e48ea0cc49a98aeb79cb18bc40b3_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2134273f7f24276bbcfc008eae7bd5f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie86818dd9c644e1d92aac548b679b5e8_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i892e47f9411246c698112667df4d52e9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c92433556884f33bec3fd9cc5547c56_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07512cb6822542c3aeca578fa5a030a2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8f099c74c285402fa0acf97d0bd56486_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c84c7aac7a8402b93fc4d50c3fb1b33_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50567b40671a4971ad917d310f56301a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icacf6978c8de4cd5adb37a3902bb8f2b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i738688db4eb94ba5b31c8ae44a9936bc_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1fc849891c249f9affbd772810f19cd_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic599954eed744eafbf6e49753e86ed68_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53cad7d01f364d4897d6a878c622734d_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie54b20ce4e0149e184e543ac46795d24_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee7cacef8bf14e17b0aeba908aae6c5a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f1ce70157c489995b6052930e4d920_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff6ffc8dbadf4318b62b6b49ffacd2ef_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2a9f041c1054b54b091f023e6d70707_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i594eec41b2c747798b5aac595a81b3cd_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b7150c261554f278bef9d5c04743f0e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i224d6ed1b3124fba9dee77b543600395_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib08f2638d7b846db950bf41478ecf12b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a589dd13dcd4d9ab04910f8be1fffaf_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i037b02ea1a8948fbb6e5f750e5b20a1e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a335dce7946400eb64a556c5e88d512_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibf95c2acf45c42e3bd3fa93ebe96b0a9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b8cdff3ed5419bbf4fe318b5605b78_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i401e6b8e8c924806a3e398ef7159815f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7ecdd57de4e4e4287dae9dc82bb4ca2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0601e6ae6921410ab7205bde53a6aba2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f239152a2141228348aa533720bf55_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i06101a865e8e4e8e82693744ec325c94_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37ccb3cc5bb040cba3430bd495d96186_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89c03926f30a4d13a7fa7a50e5afa527_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bf2ae2644d940ca9f392d4010b2fe3c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id07eeaf7cfbf4feb83e823bf4797e7e2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48ad5aba0d9742d3893f7a8373957913_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if10dd21b5f704d0abfea775170908a2e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic09551a2d2914e58b07c0faa2bdb5ca7_D20181231-20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if94dfff027b540c0aa481c801f7d039f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d82f1709b994eacb901cda0b8414196_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i04fe5d0b9ade47e5981496ba5bbaed12_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8665aecb49944a58fbb92e84df3cc67_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e0e6b7104074202b4e5d369a606e4de_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id3a4040a4a9d496e941dd0a85aa89117_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83226f68d388482997387c732a694f0b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7ea62f7202743edb0eb2e2ac6bdd8fc_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1cca58000e94ac18ffc4da63ed491ee_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6b500b0012e4fffb964046db18b7ee9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice6838c819764fd3b274d26aa88869fb_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa6388d8e4aa4d2ba5163676f80c3f61_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a1659d1528484386f3c1b96b56cd5b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6972f42d4f04331bdc3fa37a69b7170_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29c4cbdbde9b4e11a996c3f6929a01ca_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica38f942e6f54e37b25a587ae66eb689_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iddce8e7eb7d541908fa3346ff2ccc64d_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia99bbdcc3d6f4e3a846ee43fffa0409c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d75e926178641929b977bc0db3d772c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8d3f87a8a814ef3b7f7ceb44c1ed145_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1b09b47526a4eeba8c34cb6affc3050_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd21cfd6641847409da3807e3a428234_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1abc4374a89f41bda84e861ad20017c5_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0218ee4e0ffe4a1c9ae094465ceff9f3_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e888a83818c4971ac6ee9c8f4183487_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b183eb71fa34ae282a8f6304ff5d4ed_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672a40323bdb4457a31a3d077e38d562_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e650bd7c2174e4989ca66001681ede2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a9b919d33e6495ca7d583176e83bd1e_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0089df10475a41e29517b0bb7f6c056b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i778843f60e324063b0b113788a8aaa4e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1c7443736ae4f29bc57b7af183c277b_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jnj:AccruedTaxesOnIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27e026167a6740039f33d214df252c5f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief617abcc20648479b55e755c807413c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i752da11589284fda86e218b2a217edba_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3eb5537348114e3383db2050da995503_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f87318d318045a6ab036c942e910e82_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4556ab2a2fc4b759328bcaa7117d7f0_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70aedc4c48ed469a9776d7b4ca9dba52_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4b29a10c69e451f9cd0f65769fbc49e_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i76c2328f316b49948f37e4d51d76befd_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35b3b5367fed471a9262907b9c660c6b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe5bd9b8b1c4480ebc128d7538983d48_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b624b01490643e596a4c28527039518_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3d78226c4c54c9ca0d4cd83d95e2d73_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0bda8b685c44b2d86658936d3456c28_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94324367c9e54b678238a19050edb89c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83c49a3f745a40c8a5594ba2e9162d35_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b37abccd6c2406ab0e4786c66aea73a_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i412403fa25604c0eb6cb3612a92af406_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf7cb2cb2d84454889dc1978307aa501_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if72a15c285244bc3b010e33bfc90cde1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86aec8fde918479799b3d8999e4a92db_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0542775e36e242d1be3186249195e3ec_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3ebd2f992b4c62a96493401efcf524_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f06a464dd9742ea9682af70f69352eb_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40c2c1be7c9c4cdf8ed2ca776a685cec_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7fc53301bf44a03a86320a01d4c89b2_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e2c27311f954303936c62828d1203aa_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3241cc6119d45ba90518b03c7b76dde_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62f12565007d4fe4b8dd93b5e190e144_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5687f5838b614e4589f850bb1f5939c8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5df767d41f749ecb04e69b4d5853ccc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30eb63aff7fd481189b4f524a3f36f78_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8842b711d1844455848e9682cc4cceac_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a6b71be8d8141dab2ca5e6564f34d86_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f3fa93e7354cc6bf55b6b55246cce1_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d79693f595f4483a46180ef55b406d0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3749288c66d45cd8504ea939901383a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id5a61247d95c477381857604c8aed8c3_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie44840a7a12d4a59aa337501bb3c171a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3225a5919ff748b88fab0958b5dc1630_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccb687ba095a4752882b895461f25afc_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i416e1d239030434d91da317adc252268_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i217e8d94fe8343e7b9a36b46d7ff6f42_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6572c7d7c154078815d1d633a936600_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa2a865013ea455b9e5d8ff204f65c18_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3b8524a11f7463e8ceda09d321b1dcd_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8f472f6d184702a8de9d64eb4b3e33_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ab77cc2dfcf43e786584e6ae05cc727_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17319dbdd05e4674960f993b6cec2500_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d58945d2f9c49328b754ad12aee7c1d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fd4ce4d5bfd403ebdb1f23fc75bb9e7_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f5f12aff9364764b1862f5c138fb733_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00f88af71cc44acaa8ff9f73750b5cf6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a1fbdb565644530aefc8a04ee20b567_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3309bfb236f34376976fd1aae5a817b9_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4615adcb9f9c4c91bf219b6707943c12_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae6da712f0bc48308e8e5ba20cb5dda6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i676c5ca698d44f7bb1903045e7e0ec08_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67922ba98bf742f2b93e38317dd13f79_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3510f20d163437d9d386475e40596e5_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12139d83ab444d98a2b66446337fd19f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if362a6cd5d6b414ca2bb842004eef8f4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i238c4888cf1248d595768c38dab59641_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09e1792cc5c94bf6b0b2b40156599df0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9606d19598644104898d903b09806074_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id73f28649d29470cbd4b3ce23d75ffc8_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3ff780d0f74b38b1a6a69a052629ae_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41941d76be24820956011d29accd0d7_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ccb205116b4463884f94a7aa8ad4845_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd91babad94c42c5855b5b127b24d222_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i202c6ea421d34b83af4652977ad93e89_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic70ac4fab133415ab1c3c188c47b58ec_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie58a793be107479d9ac45bc6f91943be_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30a354f3a5aa42dbbb12c4091c197032_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6aedf491fd84a00ac5c03725947fa86_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib634d639ae9c49819dcc46f6d7dbaa22_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd25eb363984eb0abd80607dca205b4_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a0ff02b2a8546f7a5b1c62d388c8563_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72d4f321e7b44b50b09bdcb088bbe22a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8c5682649bb41e4afeb396ea67e339e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d51a74cecfc453496314405e25d87f9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70cff2202d7347afa5eb1607d57f14a6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia25dd344df8f4b6dafed16ebf59ddded_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabec2bb4211940caa377a2893b37a631_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11abb1995b224be4b48943c0dc5e5241_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e861771c7a249e8a7b1847d97087825_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i625a0328612340d3b2444593094ca6e6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e155080f5045fa8e60310a82f43852_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbdf2685c57d492f9ea918bb328f7c1f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5b2aa7ef11a4067b7913ca9a6049731_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd982433a2cc4b669204c6ff9a0df941_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic193be42f65642e5914f3b9a9fe4b1f7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f48c3e16a07411c939b255df38ab5ea_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i258519354ca34b0ea53867c6b0469e98_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21c482cfc9e440558a10a03ac6b0041e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc056e7edf5d4a879f07aabe7d8da1a4_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3094a6e0c0e5489ca31b150a28af16f7_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2493d378de5d441f8eed2a2813f2a10b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a9cc129087542a39b32ad178f8e7d1f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2e74d86ade443d79565d3d4db9806ee_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdff07e389d4a98a18843581742a126_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i617f22cd872049709ad264ec00aa4bbc_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ef4c7f60c8c4c179f5410a867c82c1f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7e1f856d6494507bf69cee1f35c925b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00a198b7e3724dfc8d0765ab1eb7c385_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ad5ba18e22b49c8b7d61dde83b71892_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i722753247dfe40609326df9c146077f6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee8e1d7d443b4b5c8fbff2c8140dd02d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i860d3da7dba846e9b34578282e68a159_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90605ed3fd3d4ce9b995899ac2960140_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i424fb644ea244b7da33323ed90262948_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb83db6bf2643a3beb8b071f017dd9e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i593eedd9b3554e4aabf346ef510aed2e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6756f2eb6504f6fbe424eaf7c67b1ee_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085528c026384b5c9822a2d0583767c9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5505f103f3741599a24e8ec3035a6da_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia111f6b65afb4bb78be8e74995a7f05f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d9bcb321c9e498f98febc66bd97be67_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iceb44ce996964b328d052671fe7e60e2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7a48b762e44344a5837c580cd3cbf5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94fb5529b7f24fdcb5216fd61202149a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i159cfea84a824beb9e343c1924836863_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20e61bae25d1431f95c16ee1a52b7698_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d9a2a75f7ec49fcb41600b16ed21ebb_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifabd48f69a75450fb39b1fcc14893a13_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ec93166231349a4a62144abaa88211c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9943abc01c244bfc976454f3930f0b53_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i865c1debd77c456ea62aaa4cee5f5098_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b12655dd4d549d791503b3d33bbc3bb_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e49fb04160848249e6b979e9e53d9de_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4958d04806e4a26989b410d7de289c3_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b73bb8b3a32402cabe464c9e85b926b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0a4733c057e4c91a422fa0925f0ae18_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id17f2144580042799de6fe20a0e39ccd_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebd5c6d65d444de181e96474c0ce96d7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie13d62f4906646048e8d258210540cc4_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69a768ae79db44808f989038a6762aa0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb74ce4d9f2a438ca8c55bce6a61f201_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if252bb07e5ce40b09ae6eef7a0bd8990_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2ffa593433846189cbe811f55d09e5d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e675afc2787431e8afb910310f97ada_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id409969f7fec4d07b24c2e6172c72cb2_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2968959d6568429a8880c28dcb335451_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i026f726665bd40f0ae400deeb330076e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8291c7e7f5074b05a4080989a7cdca7f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8bfd30da6154a89ad914f97e310482b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cbd731ae0314fdab64251ba569ebefd_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aaf80f3af504855ac58fed5a2bc812e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1439a394ab6846988867d4f1cf885731_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7fa5b3c2baa437496a6794409866f3c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3100b6a78517436fa32a8050740185a2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f27d0f078234139b5a188a530fdf0f4_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib615d062e3cc4937be3e2a60d7cb2915_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0beff2f10b94936b5d68d3d4b19ca88_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24c7d1c7078e4cbfad4062f370a3bfcd_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d6915ef71e9474593878dc7ff1d3c21_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i609cfa77c4914441937e2beddbb8131a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if72cc1f808a74f7a9d09c145562b9fe6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31b578e4ed884650a6403b04a4e0b789_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib262502572224ee39687f0f730b454e5_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80c887d315ba40298eef530b8f4ba42d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14201fb6ec904317a82f139c47f516d4_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d635955ff65456481154c2069841ae0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4102c5393e3e4404af8f3950fb3c1061_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab60464d3cb4430eb82579d017bef6f8_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11fc7443e78c45d6bf48c2a55810ae8c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17a8a56018f8486f8449896537768e16_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e861871c884f4680474af0cbc7e046_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40d8d8c184b744188f48cf36a41714c1_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia70fced883cc48efa3c30712ae539922_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57870f886e894fd8bbe4a13765b0df95_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781ae83699db4163b10fd85d372075b4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0afe68e69df24e9ebdf140bda8bafd0f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2caa6cea60a4de4bf1daf8484380ff9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c6b423472dc4d3aadf1c81dc48fc95d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68de92f3d1ce4ff98dbf3ea01899ba7f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd26991e9f7c4050a356609fa6aa6564_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5c47b91ea4f4a1a82f47eb2f2b05c3d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iedcc529eaf2d4f5e95ef455772dfe9d8_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c83bae4c94549c794523bba175150ad_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20db1fe43a544cd8bb1e84445a29fcf0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c6e046a80854e88a9f86f1695a5f3aa_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44e81356fdd54d65a78dac4fc0eda00e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie123409368b842cab55c01dc3d83661e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3e20f2e34a646dc856760483fc4ad2d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d4e3a4668ff480e9666f51b1628680a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d365fd404f94441a423bc83e35f9e37_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5f0cceba9a45adab7b92c8c0342bde_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1b199c2136c468f8a1e8ae983620d04_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7591b4f8a45d45e9adbb156f546300ed_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879dace13f494901b14e98c7595f7ce0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i451c8da9b5fa46f9becd1b7f4f4c2059_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b4f3715aad849fd85631a944342e87a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i81ae16fae08e4c16b6ba95255d7c70a5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f3face5d4a74567b928ba079035536f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4830a4c60c5480f8753cc4f6e6e0619_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ac0963e98b74865bd5c91872e42f462_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f34e03717784a4a8111609212e45149_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50c8b25757c84b7eba5a91969c95a1ff_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff1890bf78564da8b18b9b68921ec794_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40923251ff8c4dd2b498eed41e75b3df_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab98edb95934d548f9aab32a4017a85_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb58d996d2d340ac859eb5d48275ae50_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70777ca74a8f4c52bfcced79529e5a78_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia32c5586169343d1a69eec3e4c21fc0e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i016a755a6a094e0588480249a8a01013_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9fbe6cfac9849d8bf7baadf709ef1ca_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd032f631b7b483d84a771f14f2dd965_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i268e898503704282b1e644c2a204b27e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia30a1b9a326a4a0cbd7d5286285a5135_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6fe3b75e12074a2aa5073e4be2dc9f2c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590d4101caa4452e881c66c7cd378a8a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief29fa0003a342a9b72261c5a777f5d0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i92c5ae1bb6c844da97fbc887f5bda6e0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib56fd4104b864eaaae048a20df297cde_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i801fee3b508b48d7b1a571095a597b48_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94d1ee23a76c405bbf282ee929fb2018_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i372fe738f82d4d1aa79d1d22bb000b69_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6214365a5a6e4954a883f81d290094b5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c8d994f0ca943bc81943bb007e9399a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i317e0f05a6aa4f0ca7c59c511f3116df_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e6c9a032cef42779e88c9c4e9e74fdc_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae747a1c0cef4fb9a4aca0b3ba685a30_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d783195c6564387b12b4f45034f355b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4eb263dcded541a8aa2ced910f1cd8ff_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec7c2d99cde74ead89e90a32724d105d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic38012b16650436bae36d246ed2a8764_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a09f2ca879f43c2809e324c91ba6156_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff5b53cf06a84a3680777d7f2e8be88e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6c5cb1cb5ff547f0ad0d3363e354138b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5526426e0d0144459d16606be11f1e99_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23f20da385240978278a18b68c30b9f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1238641b920249c3aa20b57084128ec7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e7538e0459e41a980f744f172fed239_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6c7f0cce06545a092c974ebc7a8836f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c44c63fd2b14fbca695bf3112d4cfb9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28ce799db9f8497d8b627c203c959969_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e364c5e2e934b64bcfa4212283d45f6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c52dd3f3c3f4f1ab9080d8e927c9b9c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i441081885a084c1b9bcbf9be8a783fbe_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2ddd2fe68ae4f6da08c10e586b72d62_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9630c7bf786b44439a2c196398e924f8_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if804e1fb547a4207ab79bbd55dca0584_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19f9e20c45134d49a3c68d672c6cf4bd_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085ffcbbe09e4f149e82ba292414fe2f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8e06e959426468692abf98048c488a3_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1c0080e67a0463ebeb744e69d1860e6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icfad13b3e4b641f8823b1565bcc50f9a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7ace7a83ca7421399ad7ad9788512de_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02d9fc89b2fc448dbed4a48c9e578ce9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib543ea66309246278232bc6dc99b91d7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14ddf81148af49f8829e3a2f40ddb0ff_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i491add72dab6458988d768371a5f99f1_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica871b685f374f86882c4067f230ad66_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e9e1d0c2fca4315b63e1185226f0e3b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73bdd59bf0dd41a4a002312654599a0e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3101dfd757f24ebebe5d55676ba0b74f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc05ce35d84345148bfe86d926005942_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb65b67f0ca146a5a8fbf3d66409a1da_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i542b4161407e414194fdf6ed4d650599_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i936a7dd6706a4a36bbb3d4e462ea1915_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5736a09628a74942af5372765e9467a7_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04bf0c9bc6b546109f0c5c2b50e598ea_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i085118eba10e4519bb61e008118fee7e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bbccb018ffd4dc493cc91e90e401f8f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28e940beeb8e4e158a7e01a90398711b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c51ebb23e644f36a5bc98cb1b21b16b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b27e1d2c7f34ca595d359abf82ec68a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5a7d7ae1b647339fd559afaf42d469_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc1e91be376b420c80fdf945f74f19be_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdb38e3ece9f494b80986166616c8796_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id7d4a3441694425685b68ca60ff37697_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f6e2d7431db44d2a85a24ada1a8977f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ca587806fca4350a5892099573a24ed_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibcfa4ee807d44bb2ab00fe7d9ad30b84_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0acf6231882c4daf9707983397ea2171_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63596790121d4860a57507cabde319b5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i966890469adf4f7ab39dda3e8b42cce1_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice899dea89fe4582b37b2c8d67529df2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c56f0779bcb4802976ff987723bd905_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9851a937c384f21b0553db930e3ad00_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3d745559b8748329aee818ee4c2dffc_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i108362d021024b2bba503dce1ecd646e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca496862e9c406b80302245e8c996b7_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic080c2635078489b8837e0c15b529291_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd1737d9336f4ff499db39a6d78dd6af_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i82e70c787f7849f9b4e7eb17a1217ae8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3479c20afd6b47628f60faf7361db000_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7a4fa10b3864a2190a08faa6182e13c_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e34366acf8642948ee51937ea67737e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i644cb9fdf8ce4fc79443500fc969d197_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i037ad64a515043b49334f8fb421b33ac_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75e4158bcf404921b8195a9cad36a2cb_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2903af0eb1a74b4c8a4dd7ef23591531_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5659f85aa3624cc09864a84ecf854798_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb7726bd5ac44766aeafb59df236adb8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id719681b56d64604ab0267e1d3cfce80_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i057617a514dc4f72bdebb0e1ebe06b7e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic49dce02d6a342668ab35662fd1521e5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72eaf829d51c441fad147448cea308e8_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4aeb6f629da84fa689517fc2cf39b39a_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic34477da8fc847db9dbe086333871ef5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6225fbf007674bad9bb72edeec2ab93f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic62ccd20ee5b4d56a9e8161ca4b98d84_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6dcea95239d4c7c93cfb6aa0ad58cd2_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24408e76c0c24f55ba8d7876c31ed2af_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i951c881d588b402e80e0a08fabfcbb9d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41d577053e5b47e599467e7d5b2c1fc9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if46b85908413428cb65b67ada12835e7_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5d439ca53f48c7a5b9f80ea92d18b2_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if34599cdf8c34ab2a763c193d7f21c5e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i719c9077824048efa89c19d85df1c039_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie25872f3bae6482a86f7173fcb928c60_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfadb20ee8cf4b7ca29892f0e7ef9241_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28753b33f19b4472a4b3b9615d39bde2_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04834a7933574b9699e4470cca157b17_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i830efc8e5ef64f5d8bb67629c932302f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e8660da0ae049279be4908d645ac814_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61951583e0884a2b97857fcfd5143dfa_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea8c758499ee481a982e0844029f02c5_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9530070346e046928aaa20fbdb32b6be_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7f38204ba8470dbe88c6fbd6f163af_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43027bbce9224ae1864acee61096aaac_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7cfae47101947fbb19de601ee4d37cf_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21d4e243e3244926af114c5ac8d5622b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27f66ef65403479684878c39826affd8_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79a301cc9e4741a9acf742a4531b7ffa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3df852a1e1c9437cbefc5d5967937bd0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09753ee22db9438db02316fe99eab602_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab103ca2b6347f4bec8d5f5a68b902f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6131de48add44569afcbb5f13e616222_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1077c0d6182e42b8b4a449d5823797da_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61609c5ddc9d401f8c0a92c743695f8b_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29508d3dfad845269de0d3b934e5f72f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49489eb3476942d39146a7944e024129_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac621d3e8974b4290777cb0a715967d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i352af7e1cff64172939fb8676a18d694_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0d1afadaa0d41f1867dafdde83a550a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic461ce15080e4d46a58069a1bb325e45_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic08ba492d063467dada493b5225e27bf_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0065caf47fbc4cb98c76aafdc60d0caa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b7cf7e87b5048de9e83fc41fbba81d5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25729810182f492586a816b1ffe57aa7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib93b7593957c4146b7aa8d5210aeb960_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i901b7c058bc04f02aaadc04d05618104_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib82e302424784eb79d013cbeddc5714a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i882dff1fdab04b9cbffd9a0b66d09708_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaba1385624734a44a1f0995eb99a6a2f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i575b4d6c52db4ddd9a77241756d3bcf7_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia24b2dfc5933488685d4e8679f9858df_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic44276e5e39645adac5e0ec3c6d349a8_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36fbf025a3bd46258314eaf0c5fd03c9_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62837ac430c04475937229c201091a7b_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e94e3d16b6442b3bf8ae4d7e42763aa_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8482a9eacc9d4a16b903c3069e30606c_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3373b694e464e87b09c196866598a61_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18aae7095c214291953f8d5a7e83743d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b5abffa1631440c9c106f7646cee59f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1697845443b41b18f2e3fd65e94eff0_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib608a60c324249358f5c359cb804d50f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3fd8a707583422a985a694bde7e8369_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia53ba83708ab497da167bdf063b13001_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieeb64f7ebcf24e8eb4738e491a709ef6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3efc34904804bf392531b7e252380d0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e533e4df7574745be8a32f1d7f8b20d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia94c309ebefb41e0882e6e5f7db81fc6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f667109df48490a91c424f760c9163b_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6387e0464e874ecebf490a3e7a9ac5a9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i510fab0efb5c421e951697a2eaabf3a6_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6afb3e29007f4d8fbbe84b8aa64fe6c4_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idecf2a3bf83549faaface09de3d21842_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i513396c914d24f2ca5d1a3b179dbb137_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia88b31446b9949bb9dc52ab066f472a5_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95245826bf28466f88669de5c0eb29f9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0e846d3dd6246fdad7038aa4f8fc310_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea770061f1af4a23be59231dccaa6471_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7544a09dc2e443659a4749d9c524a033_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09d9e4292b9d49439e0ce7ef85bcd358_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id50251d99ca0478da493763fd6c20e76_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea17e937da204406896ee031cfe58c20_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1ce6b5f2cf0439c9d34f1a1e0c2ef86_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a7a9909054c412bb8414b6ad4b834fa_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed367815e324fed984862b7805db09b_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i780815182e5340ee9005439edb189dbd_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i40697a314e334705bf032c396d36a48f_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i215768a346504c6588118220125ee9e5_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8da67f7730324520a82f178539e2d723_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie05e097465d246e985c5a8a5836866ac_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cdc971d10a846eda0291042d8911094_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828cd0392f6a4f08b23a126fbc2fc210_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879c922e7e06439cbd2406e34a34569f_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieffb22b1734946ea874bf7ff0d96c59b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie38753485d6e4aa68503c096a70d147e_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ed428655a844057a0ad1aee8a48ddd6_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fd16a3299794c08b00e5e9af4b2f47b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023711733c384a55bc10c339faee9020_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f3e8b536cc4bd08b9add79f3cd22a3_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i990d3f55fb0d400fa30369f379908e85_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i875ab7cb24b5434fbef2a5fda9f740c0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f61c670043f4e00a54053474ec36a0d_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c910149219540038cfaa2070ca96ba0_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bebf8e1f4804892976ccad051fdb00c_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie452efdf003f4151a326a25ffbb9fc7a_D20181231-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-12-31</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-09</xbrli:startDate><xbrli:endDate>2020-07-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="chf"><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unit><xbrli:unit id="chfPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CHF</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i74a6f02cd81248429802bd3d52fdefc7_I20200709"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee3cf065b9ca46aa995976b921a5e5a4_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41d885ad0df54f67810fa0ea503cd065_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iccccb20c51044c9e9a84c5d3198c51c6_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89f3aa8637734074bb148409f97b74c1_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idcfe6f3194e6443e94a045dad55717d2_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e9061e1ace447648d5d732bae5eb9b7_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieafab643bde441f198c64b00b5b1e847_D20190401-20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb4d963c67ed4e88b28ef91289469a21_I20190401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic55b39bf44b4426e804766d6f7f475c9_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ff46a56cf074bac822b7e06872012bb_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="jpy"><xbrli:measure>iso4217:JPY</xbrli:measure></xbrli:unit><xbrli:context id="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-17</xbrli:startDate><xbrli:endDate>2019-01-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b0c726c6f4642738819e5d706d7e4e6_I20190116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if77e2506aa334aaab104d21008cc97f9_D20190401-20190630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2019-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a906710e47b4f588671a4492a187fc0_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic033ba1a92f34808934f4676de7a195b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd12eebc1fe4027b0210d330a2835b4_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claimant"><xbrli:measure>jnj:claimant</xbrli:measure></xbrli:unit><xbrli:context id="i582a2834e4fd4aff9b1bc95d88dffea5_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:AsrMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d8c3a0656d34fb5966cd9770c316551_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PinnacleAcetabularCupSystemMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i85df32700d11440b9f62c956e2be12e8_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PelvicMeshesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9a3f835f231472f99dfb7bb92dc9732_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RisperdalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea2331b0b13c42f9b906bf8c6741a1f2_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7cf6a6af023478299b61b15e7dc2e18_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TalcMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3d7dfc6628eb4c3e9f45d6d28b6c4239_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:InvokanaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50eec62d41b944978cdcf2b62bbde5d6_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PhysiomeshMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="patient"><xbrli:measure>jnj:patient</xbrli:measure></xbrli:unit><xbrli:context id="ib99b415ed1bd4de081616c1b0ba5adb9_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:DePuyASRU.S.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i70f14e4d505949438f899f930dceffd2_D20190930-20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-30</xbrli:startDate><xbrli:endDate>2019-12-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd1ca5d4c491437ba8eb090bb6173cdb_D20200101-20200131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b831b0b9e4744b890997d86490beb64_D20180701-20180731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-07-01</xbrli:startDate><xbrli:endDate>2018-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73c27ed443d4477a94166f5501e091cc_D20200601-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i843d961ffff941f780e135d0ac57ec95_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OpioidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a2d74fb903f4bf9bccd750be8be4662_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3071999c834c466fa7bf2ef272704338_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f5aae03f63f42a89d19ed1519e2f71b_I20191031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27b2c7dd82249fa8839a100c11d8cd0_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia605452b07814f9785dea5e1749593fb_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i502babb46275458897c6c348109c5035_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9acc37568ea42f9922fa2c92c7d50ea_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc9ce1c7b9de4d7c9bd370f431d114cf_D20200330-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i753470899d364d1599b1fb2ae589ae15_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee0f458f77f44dae9e9a9f498f732d53_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i924dea35cc4a4db3a0754750a03791e8_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4563a7367fd4e85a1f89eec3c0e1587_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i643a2ee9d94c46a1a5979059886f331c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia536875c9d1940f7b5044f50a10ec73f_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i966d76441bca4eeda5773245cb198ca5_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96475a51603a4e8e810595eccb66f241_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b9cec4fed09422f9f5c106fb3d09c7d_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87c5e8d39d9c4eaa85e56a1ce09a3918_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf1e8f0128234898a4c2745db86b0fdc_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91cdc9cf7fe24f6295e435d3967682d3_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39f8df2915ae4439892ff4f3cc7ccf0a_I20191229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i018045947632426a9bde5d53838f9afc_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb152c26aac84568b902e764916fb60c_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2020-06-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb137f18e4de4282a026c925fc22bbef_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ee00f42b2134d3796cbc180e878362c_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i006340b658e24cf8b366c83c9bbfff9d_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a038526da94ec5a15e091af7f02a84_I20200628"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000200406</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-28</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_1"></div><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">UNITED STATES </span></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%;">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center;margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;">Washington, D.C. 20549</span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%;">FORM <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY0_dda7052e-7742-48c4-9f51-e37a2418414b">10-Q</ix:nonNumeric> </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:6.199%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.295%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:83.506%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6NzdjYjdmNmYwZWM3NDJlYWFlZDM5NTlmYjhlNDkxMTkvdGFibGVyYW5nZTo3N2NiN2Y2ZjBlYzc0MmVhYWVkMzk1OWZiOGU0OTExOV8xLTAtMS0xLTA_fb0a794f-e9d0-4b75-b7a1-6328bf8f9dab">&#9745;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Quarterly Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">for the quarterly period ended <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8xMjI_0b2089c0-6b2c-4db5-bd4b-9909bb89036b">June 28, 2020</ix:nonNumeric> </span></div><div style="text-align:center;margin-top:6pt;"><span><br/></span></div><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">or</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:6.211%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:4.598%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:83.191%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:6pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ODA3Njk4YzkzZjg3NGMxZTljODUzZGY4ZjYxNTY5YTQvdGFibGVyYW5nZTo4MDc2OThjOTNmODc0YzFlOWM4NTNkZjhmNjE1NjlhNF8xLTAtMS0xLTA_103b8fa6-dca4-4db9-a53e-689bc77293d6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:12pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Transition Report Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934<br/>for the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to</span></td></tr></table></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Commission file number <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDU5_e3eacf2a-1b49-4d48-b85d-d67fdfaccefe">1-3215</ix:nonNumeric> </span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYw_954aca72-e769-4fce-ba42-343b46f917f3">Johnson &amp; Johnson</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:47.633%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.532%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:47.635%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="padding-left:2.25pt;padding-right:2.25pt;text-align:center;margin-bottom:1pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6YTQ2ZDI2ODg1MTg5NDcxMWFmZjI5MjU5OWYxODlmNzMvdGFibGVyYW5nZTphNDZkMjY4ODUxODk0NzExYWZmMjkyNTk5ZjE4OWY3M18wLTAtMS0xLTA_12b3f87f-7573-42ca-98ac-a0c9c92b9744">New Jersey</ix:nonNumeric></span></div></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6YTQ2ZDI2ODg1MTg5NDcxMWFmZjI5MjU5OWYxODlmNzMvdGFibGVyYW5nZTphNDZkMjY4ODUxODk0NzExYWZmMjkyNTk5ZjE4OWY3M18wLTItMS0xLTA_a845de14-9c47-47b4-978a-e1c47af31671">22-1024240</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(I.R.S. Employer<br/>Identification No.)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDcw_2b755b1e-b110-4e22-bcb7-76cfc4e1f5ce">One Johnson &amp; Johnson Plaza</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYx_c2a2a8c1-0825-411f-8bde-cabbca2924a2">New Brunswick</ix:nonNumeric>, <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV83MTQ2ODI1NTgyNjQw_3f768d96-28f5-451d-a0be-413122b61cc4">New Jersey</ix:nonNumeric> <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY2_efbf2067-dae4-4b1d-b861-5913da3cf2b8">08933</ix:nonNumeric> </span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Address of principal executive offices)</span></div><div style="text-align:center;margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Registrant&#8217;s telephone number, including area code (<ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY3_1fb7c172-04ca-45c6-99c3-2b7018f79d9c">732</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY4_1367a78b-4c1e-4d38-88f4-954c1403521d">524-0400</ix:nonNumeric> </span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYy_6f179e77-3585-4f3a-bf22-e0c3fe4847f5">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9744;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY5_a702d44f-154d-4b6e-904c-61e90d9bbf3b">Yes</ix:nonNumeric> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9744;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule&#160;12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.783%;"><tr><td style="width:1.0%;"></td><td style="width:11.897%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:34.102%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.380%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:39.540%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:2.081%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8wLTEtMS0xLTA_a125a8db-f7f5-46b2-9d1e-393b8bee6fc5">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9745;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accelerated filer </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-accelerated filer </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#9744;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Smaller reporting company </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8xLTQtMS0xLTA_7c66ba2f-c85c-42a8-9cb1-c90aa07dd791">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Emerging growth company </span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Arial Unicode MS',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8yLTItMS0xLTA_755f1766-44dd-424c-b5da-5a1e712b793e">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span><br/></span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">If&#160;an&#160;emerging&#160;growth&#160;company,&#160;indicated&#160;by&#160;check&#160;mark&#160;if&#160;the&#160;registrant&#160;has&#160;elected&#160;not&#160;to&#160;use&#160;the&#160;extended&#160;transition period&#160;for&#160;complying with&#160;any&#160;new&#160;or&#160;revised&#160;financial&#160;accounting&#160;standards&#160;provided pursuant&#160;to&#160;Section&#160;13(a)&#160;of&#160;the&#160;Exchange&#160;Act. &#9744;</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYz_97a8b715-7191-4d7d-8e5c-8f325efaa358">&#9744;</ix:nonNumeric></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Yes </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#9745;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> No</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">SECURITIES REGISTERED PURSUANT TO SECTION&#160;12(b) OF THE ACT</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%;"><tr><td style="width:1.0%;"></td><td style="width:40.898%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:11.909%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:41.193%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Title of each class</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trading Symbol</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTAtMS0xLTA_119f54bc-4174-4e7a-bdf5-3a6cfe5945f9">Common Stock, Par Value $1.00</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTEtMS0xLTA_d9f5edfc-f43e-40d9-a0b8-d36245e36957">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTItMS0xLTA_2322d36c-f5c1-455b-b8d4-401765e34624">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTAtMS0xLTA_4593f954-e21e-49dc-b47c-ce04bc1aad0c">0.250% Notes Due January 2022</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTEtMS0xLTA_72c76ac8-6817-4201-97ab-22041eba3552">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTItMS0xLTA_edb29f33-e6d6-44de-be90-5dad980dbe52">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTAtMS0xLTA_e15eab6c-f62d-478b-960c-1b489945fdf4">0.650% Notes Due May 2024</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTEtMS0xLTA_b7132aa1-c13e-41f7-b46a-813a7233baf1">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTItMS0xLTA_239f386e-11fc-47a6-9ed4-1e710fe26cd8">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTAtMS0xLTA_6d4074c7-fa8b-4f15-a522-0b4143977ca4">5.50% Notes Due November 2024</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTEtMS0xLTA_6ec5a5df-5af4-4776-b552-bce54446e509">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTItMS0xLTA_a338d604-facd-4b21-8adb-314504e088b7">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTAtMS0xLTA_e7b81e96-f2f8-48eb-8cad-919ee8a3acfc">1.150% Notes Due November 2028</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTEtMS0xLTA_1b487811-a259-47cb-9dd7-a63b30d44cb8">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTItMS0xLTA_c7bedbd9-701c-433b-a9e3-95339f6fd4b1">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTAtMS0xLTA_7e4b172f-d96c-49f3-b1d1-2b3d00aac39e">1.650% Notes Due May 2035</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTEtMS0xLTA_b4fa9817-9f9a-4f0a-83cb-a6d974206d69">JNJ</ix:nonNumeric></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonNumeric contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTItMS0xLTA_196b8777-64f1-4e37-8f81-6dd2d6462512">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Indicate the number of shares outstanding of each of the issuer&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On July 20, 2020, <ix:nonFraction unitRef="shares" contextRef="iefb6241d9bf2428e94a47ac9ce454499_I20200720" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8xOTk4_33f8569c-1650-47e9-a5bf-0a4e28df9316">2,632,823,475</ix:nonFraction> shares of Common Stock, $1.00 par value, were outstanding.</span></div><div style="text-indent:15.75pt;margin-top:6pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_4"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_10"></div><div style="margin-top:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;margin-top:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TABLE OF CONTENTS</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:84.257%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.017%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.700%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:2.826%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Page</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">No.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_16">Part I &#8212; Financial Information</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_19">Item&#160;1. Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_22">Consolidated Balance Sheets &#8212; June 28, 2020 and December 29, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_28">Consolidated Statements of Earnings for the Fiscal Second Quarter Ended June 28, 2020 and June 30, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_28">2</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_31">Consolidated Statements of Earnings for the Fiscal Six Months Ended June 28, 2020 and June 30, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_31">3</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_34">Consolidated Statements of Comprehensive Income for the Fiscal Second Quarter and Fiscal Six Months Ended June 28, 2020 and June 30, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_34">4</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_40">Consolidated Statements of Equity for the Fiscal Second Quarter and Fiscal Six Months Ended June 28, 2020 and June 30, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_40">5</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_46">Consolidated Statements of Cash Flows for the Fiscal Six Months Ended June 28, 2020 and June 30, 2019</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_46">7</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_49">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_49">8</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_100">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_100">47</a></span></div></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_103">Item&#160;2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_103">48</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_106">Item&#160;3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_106">66</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_109">Item&#160;4. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_109">66</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_112">Part II &#8212; Other Information</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_112">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_115">Item&#160;1 - Legal Proceedings</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_115">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_118">Item&#160;2 - Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_118">67</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_121">Item&#160;6 - Exhibits</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_121">68</a></span></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_124">Signatures</a></span></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:right;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_124">69</a></span></div></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:21pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;margin-top:8pt;margin-bottom:8pt;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS </span></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:18pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">This Quarterly Report on Form 10-Q </span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and Johnson &amp; Johnson's other publicly available documents contain </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8220;</span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">forward-looking statements</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8221;</span><span style="background-color:rgb(255,255,255, 0.0);color:#212121;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995.&#160;Management and representatives of Johnson &amp; Johnson and its subsidiaries (the Company) also may from time to time make forward-looking statements. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forward-looking statements do not relate strictly to historical or current facts and reflect management&#8217;s assumptions, views, plans, objectives and projections about the future. Forward-looking statements may be identified by the use of words such as &#8220;plans,&#8221; &#8220;expects,&#8221; &#8220;will,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; and other words of similar meaning in conjunction with, among other things: discussions of future operations, expected operating results, financial performance; impact of planned acquisitions and dispositions; impact and timing of restructuring initiatives including associated cost savings and other benefits; the Company's strategy for growth; product development activities; regulatory approvals; market position and expenditures.</span></div><div style="text-indent:18pt;margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Because forward-looking statements are based on current beliefs, expectations and assumptions regarding future events, they are subject to uncertainties, risks and changes that are difficult to predict and many of which are outside of the Company's control. Investors should realize that if underlying assumptions prove inaccurate, or known or unknown risks or uncertainties materialize, the Company&#8217;s actual results and financial condition could vary materially from expectations and projections expressed or implied in its forward-looking statements. Investors are therefore cautioned not to rely on these forward-looking statements. Risks and uncertainties include, but are not limited to:</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Product Development, Market Success and Competition</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges and uncertainties inherent in innovation and development of new and improved products and technologies on which the Company&#8217;s continued growth and success depend, including uncertainty of clinical outcomes, additional analysis of existing clinical data, obtaining regulatory approvals, health plan coverage and customer access, and initial and continued commercial success;  </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges to the Company&#8217;s ability to obtain and protect adequate patent and other intellectual property rights for new and existing products and technologies in the United States and other important markets;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact of patent expirations, typically followed by the introduction of competing biosimilars and generics and resulting revenue and market share losses;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increasingly aggressive and frequent challenges to the Company&#8217;s patents by competitors and others seeking to launch competing generic, biosimilar or other products and increased receptivity of courts, the United States Patent and Trademark Office and other decision makers to such challenges, potentially resulting in loss of market exclusivity and rapid decline in sales for the relevant product sooner than expected;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition in research and development of new and improved products, processes and technologies, which can result in product and process obsolescence;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition to reach agreement with third parties for collaboration, licensing, development and marketing agreements for products and technologies;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Competition based on cost-effectiveness, product performance, technological advances and patents attained by competitors; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Allegations that the Company&#8217;s products infringe the patents and other intellectual property rights of third parties, which could adversely affect the Company&#8217;s ability to sell the products in question and require the payment of money damages and future royalties.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Product Liability, Litigation and Regulatory Activity</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Product efficacy or safety concerns, whether or not based on scientific evidence, potentially resulting in product withdrawals, recalls, regulatory action on the part of the United States Food and Drug Administration (or international counterparts), declining sales, reputational damage, increased litigation expense and share price impact;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact, including declining sales and reputational damage, of significant litigation or government action adverse to the Company, including product liability claims and allegations related to pharmaceutical marketing practices and contracting strategies;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact of an adverse judgment or settlement and the adequacy of reserves related to legal proceedings, including patent litigation, product liability, personal injury claims, securities class actions, government investigations, employment and other legal proceedings;</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased scrutiny of the health care industry by government agencies and state attorneys general resulting in investigations and prosecutions, which carry the risk of significant civil and criminal penalties, including, but not limited to, debarment from government business; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Failure to meet compliance obligations in the McNEIL-PPC, Inc. Consent Decree or any other compliance agreements with governments or government agencies, which could result in significant sanctions;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Potential changes to applicable laws and regulations affecting United States&#160;and international operations, including relating to: approval of new products; licensing and patent rights; sales and promotion of health care products; access to, and reimbursement and pricing for, health care products and services; environmental protection and sourcing of raw materials;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Compliance with local regulations and laws that may restrict the Company&#8217;s ability to manufacture or sell its products in relevant markets including, requirements to comply with medical device reporting regulations and other requirements such as the European Union's Medical Devices Regulation;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes in domestic and international tax laws and regulations, including changes related to The Tax Cuts and Jobs Act in the United States, the Federal Act on Tax Reform and AHV Financing in Switzerland, increasing audit scrutiny by tax authorities around the world and exposures to additional tax liabilities potentially in excess of existing reserves; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Issuance of new or revised accounting standards by the Financial Accounting Standards Board and regulations by the Securities and Exchange Commission.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to the Company&#8217;s Strategic Initiatives and Healthcare Market Trends</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Pricing pressures resulting from trends toward health care cost containment, including the continued consolidation among health care providers and other market participants, trends toward managed care, the shift toward governments increasingly becoming the primary payers of health care expenses, significant new entrants to the health care markets seeking to reduce costs and government pressure on companies to voluntarily reduce costs and price increases;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Restricted spending patterns of individual, institutional and governmental purchasers of health care products and services due to economic hardship and budgetary constraints; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Challenges to the Company&#8217;s ability to realize its strategy for growth including through externally sourced innovations, such as development collaborations, strategic acquisitions, licensing and marketing agreements, and the potential heightened costs of any such external arrangements due to competitive pressures;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected strategic benefits and opportunities from any planned or completed acquisition or divestiture by the Company may not be realized or may take longer to realize than expected; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected benefits and opportunities related to past and ongoing restructuring actions may not be realized or may take longer to realize than expected.</span></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Economic Conditions, Financial Markets and Operating Internationally</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The risks associated with global operations, including the impact of global public health crises and pandemics, such as the outbreak of the novel coronavirus (COVID-19), on the Company and its customers and suppliers, including foreign governments in countries in which the Company operates.</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Impact of inflation and fluctuations in interest rates and currency exchange rates and the potential effect of such fluctuations on revenues, expenses and resulting margins;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Potential changes in export/import and trade laws, regulations and policies of the United States and other countries, including any increased trade restrictions or tariffs and potential drug reimportation legislation;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact on international operations from financial instability in international economies, sovereign risk, possible imposition of governmental controls and restrictive economic policies, and unstable international governments and legal systems; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Changes to global climate, extreme weather and natural disasters that could affect demand for the Company's products and services, cause disruptions in manufacturing and distribution networks, alter the availability of goods and services within the supply chain, and affect the overall design and integrity of the Company's products and operations; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The impact of armed conflicts and terrorist attacks in the United States and other parts of the world including social and economic disruptions and instability of financial and other markets; and</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span><br/></span></div></div><div style="margin-bottom:2pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Risks Related to Supply Chain and Operations </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Difficulties and delays in manufacturing, internally through third party providers or otherwise within the supply chain, that may lead to voluntary or involuntary business interruptions or shutdowns, product shortages, withdrawals or suspensions of products from the market, and potential regulatory action;</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Interruptions and breaches of the Company's information technology systems or those of the Company's vendors which, could result in reputational, competitive, operational or other business harm as well as financial costs and regulatory action; </span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Reliance on global supply chains and production and distribution processes that are complex and subject to increasing regulatory requirements that may adversely affect supply, sourcing and pricing of materials used in the Company&#8217;s products; and</span></div><div style="text-indent:-18pt;padding-left:18pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The potential that the expected benefits and opportunities related to restructuring actions contemplated for the global supply chain, including the Company's transaction with Jabil Inc., may not be realized or may take longer to realize than expected, including due to any required approvals from applicable regulatory authorities. Disruptions associated with the announced global supply chain actions may adversely affect supply and sourcing of materials used in the Company's products.</span></div><div style="text-indent:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Investors also should carefully read the Risk Factors described in Item 1A of the Company's Annual Report on Form 10-K for the fiscal year ended December 29, 2019, for a description of certain risks that could, among other things, cause the Company&#8217;s actual results to differ materially from those expressed in its forward-looking statements. Investors should understand that it is not possible to predict or identify all such factors and should not consider the risks described above to be a complete statement of all potential risks and uncertainties. The Company does not undertake to publicly update any forward-looking statement that may be made from time to time, whether as a result of new information or future events or developments.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><span><br/></span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Part&#160;I &#8212; FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_19"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;1 &#8212; FINANCIAL STATEMENTS</span></div><div style="text-align:center;"><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_22"></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions Except Share and Per Share Data)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%;"><tr><td style="width:1.0%;"></td><td style="width:68.518%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.540%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.222%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.540%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.780%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">ASSETS</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMy0yLTEtMS0w_5c690c6f-ac69-4a4b-887b-c0dd6084f938">11,174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMy00LTEtMS0w_e1af3349-436f-4fbe-94a6-b8163fe17db2">17,305</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Marketable securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNC0yLTEtMS0w_490ff0b3-1ede-45d9-a0a0-034a97af55d3">7,961</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNC00LTEtMS0w_ff51b132-0995-425b-98e9-b3ffb065eeb8">1,982</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $334 (2019, $226)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNS0yLTEtMS0w_6fe264ea-91d2-4b22-8e96-ea5551dfb523">14,645</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNS00LTEtMS0w_0492ec9e-28b2-4b95-ade2-11dccf6803d3">14,481</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inventories (Note 2)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNi0yLTEtMS0w_ef899a22-90b8-4c06-899e-7594f911b09d">9,424</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNi00LTEtMS0w_db70e9f0-e815-449a-b0bf-73c03af5f4c7">9,020</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Prepaid expenses and other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNy0yLTEtMS0w_79cb4233-fbd5-4c7c-b351-6b2bb4541d4e">2,588</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNy00LTEtMS0w_196e5985-8054-42d6-b775-59985e5b43cc">2,392</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets held for sale (Note 10)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOC0yLTEtMS0w_6da1bc09-7112-4a16-a7af-048cdc3733d1">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOC00LTEtMS0w_5c13af3c-7728-4fcf-a00a-8fc631d28b04">94</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOS0yLTEtMS0w_aa396c6f-084b-4492-81b3-6807f5c31804">45,892</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOS00LTEtMS0w_66f3c7b2-72a9-4c71-8aaa-38bf627a7cea">45,274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment at cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTAtMi0xLTEtMA_8559bcf0-3008-48e5-a2c5-f46ed1685d0e">44,056</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTAtNC0xLTEtMA_24e98b5f-8572-4d11-aaaf-7db4a7ec4c11">43,332</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTEtMi0xLTEtMA_b60effe6-df08-409f-b42b-02564f973be1">26,458</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTEtNC0xLTEtMA_c5126f0b-84c5-4dcb-b8c8-7e161f7996b2">25,674</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Property, plant and equipment, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTItMi0xLTEtMA_1144919c-1b97-4c41-9a5b-f1f578b52c4b">17,598</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTItNC0xLTEtMA_aac10e2a-87e6-4bec-8926-16086bdab646">17,658</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets, net (Note 3)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTMtMi0xLTEtMA_c13827ab-2596-49e3-849b-67bb6bd79e6b">47,413</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTMtNC0xLTEtMA_6b245543-769b-4317-a455-8a5ba660f627">47,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill (Note 3)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTQtMi0xLTEtMA_9d457ecd-849d-4a68-9e24-0d0e14bf6971">33,890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTQtNC0xLTEtMA_e2772ea9-c973-4085-98d4-c034ea3dce48">33,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTUtMi0xLTEtMA_50eba634-1385-4abd-8c34-13cb2e7f6b5b">7,805</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTUtNC0xLTEtMA_c925aec1-7462-440a-83b9-3352b92204e4">7,819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTYtMi0xLTEtMA_e9bd5345-314e-49e6-9a68-f8a08a2f3dc7">5,782</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTYtNC0xLTEtMA_3203ffc2-c384-48ea-a049-e6f7eaafc7c4">5,695</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTctMi0xLTEtMA_cc10d3fd-d1e8-4952-960d-c58c0bc03881">158,380</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTctNC0xLTEtMA_04edad4d-1136-41e1-9346-ea40242eb311">157,728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;margin-top:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Loans and notes payable</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjAtMi0xLTEtMA_5fa819e5-2f2e-4fe2-91db-9cdca38d940c">5,332</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjAtNC0xLTEtMA_88941fb6-b87c-418c-b4e5-6da41bdaf933">1,202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accounts payable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjEtMi0xLTEtMA_0407cf81-8c36-4d4f-8979-272d5795265d">6,765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjEtNC0xLTEtMA_9a47e807-bfeb-4395-ab7b-eb07bced94c2">8,544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjItMi0xLTEtMA_6229352f-8063-4224-9af5-56486772ad8d">8,940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjItNC0xLTEtMA_2c1b2003-22eb-4af4-ad64-54dfb2860698">9,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued rebates, returns and promotions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="jnj:AccruedRebatesReturnsAndPromotions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjMtMi0xLTEtMA_176d7797-efb0-4077-9e16-fd257d725369">11,790</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="jnj:AccruedRebatesReturnsAndPromotions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjMtNC0xLTEtMA_05e28e6c-3605-4441-891c-27d386464e0a">10,883</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued compensation and employee related obligations</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjQtMi0xLTEtMA_86b7360e-65dc-4bc5-a0d0-8959d8c65078">2,313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjQtNC0xLTEtMA_d9afc7bf-0e8b-4125-a22f-2499677cfd03">3,354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accrued taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjUtMi0xLTEtMA_1892edc3-6c45-4eb9-95d1-a1172545c46b">1,632</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjUtNC0xLTEtMA_3adc12ff-70a9-4a3d-9e52-e6c3428c4d93">2,266</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total current liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjYtMi0xLTEtMA_e4781dbe-7f5b-4939-9fba-80485fee88a4">36,772</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjYtNC0xLTEtMA_f56675a8-5f70-4df6-989b-c63ed8444e94">35,964</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term debt (Note 4)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjctMi0xLTEtMA_2e96982f-16b0-4b06-a2e3-439115bda7ce">25,062</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjctNC0xLTEtMA_8bf03b2a-6e1f-46c4-9266-06ec1a09dc4e">26,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Deferred taxes on income </span><span style="background-color:#cceeff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">(Note 5)</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjgtMi0xLTEtMA_9224ee5b-c4e0-4f59-9057-ec529de30f7d">5,532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjgtNC0xLTEtMA_93de453c-bd0b-462e-b70f-5789e97aa1c3">5,958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee related obligations (Note 6)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjktMi0xLTEtMA_3af7f786-e6f6-4098-a752-607a2aeee01d">10,411</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjktNC0xLTEtMA_d7cea31d-fdb8-450b-842e-143870f21abb">10,663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Long-term taxes payable (Note 5)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzAtMi0xLTEtMA_2658d454-d4d0-4141-ba8a-c3ffd66b7438">6,591</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccruedIncomeTaxesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzAtNC0xLTEtMA_9c7ebb23-dfe6-4c68-9e01-5b87330fed49">7,444</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzEtMi0xLTEtMA_4c0c3f18-88b6-4153-a2cf-a86f5bf7fef7">11,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzEtNC0xLTEtMA_810a739c-3a35-48d3-b2a8-93ff8d6f15ca">11,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzItMi0xLTEtMA_841fc65f-9271-4d08-b8da-87a44b358c4f">95,402</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzItNC0xLTEtMA_a0f57819-646d-4fca-90f5-3f73fe4a9eac">98,257</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Commitments and Contingencies (Note 11)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzMtMi0xLTEtMA_ca56f6a0-fbff-4ce6-920d-ac3aa8ffed84"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzMtNC0xLTEtMA_04467bdb-ae01-43e2-a1da-5b04c3fb844f"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common stock &#8212; par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzUtMi0xLTEtMA_655bca04-dbe9-41a6-8b2c-4c24d2a92507">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzUtNC0xLTEtMA_bae4f855-2423-4ab4-9bfe-3dc77a6ae026">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated other comprehensive income (loss) (Note 7)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzYtMi0xLTEtMA_51cb87d9-6621-4233-b036-e08822a3a24b">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzYtNC0xLTEtMA_a4101729-0dc6-44e3-899c-9c3b09591f19">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzctMi0xLTEtMA_30b0c9e6-e175-4d58-ac77-5780a2dc2d17">113,898</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzctNC0xLTEtMA_04660e34-5d7b-467b-a314-ce03b8b91633">110,659</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: common stock held in treasury, at cost (487,466,000 and 487,336,000 shares)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzgtMi0xLTEtMA_8024efd4-5f86-418a-a80a-3fb60945df4f">38,507</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzgtNC0xLTEtMA_61ee34dd-b995-4c3b-9bce-5b19d1396094">38,417</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzktMi0xLTEtMA_89031ae9-f824-410a-b6fd-8ee64eb4e7a4">62,978</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzktNC0xLTEtMA_948a8d68-979b-4765-903f-d24c9c6e773c">59,471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total liabilities and shareholders' equity</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNDAtMi0xLTEtMA_c78c3afb-3fcd-4140-8334-7b1ffe245948">158,380</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNDAtNC0xLTEtMA_6688f020-f176-4823-8cae-6b97eb337dc9">157,728</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars &amp; Shares in Millions Except Per Share Amounts)</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%;"><tr><td style="width:1.0%;"></td><td style="width:53.882%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.735%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.852%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.735%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.535%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.856%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales to customers (Note 9)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi0yLTEtMS0w_5617f0eb-55d4-4871-a258-304586281ff4">18,336</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi00LTEtMS0w_85aa4534-e996-45ea-bf37-97523bdb46ad">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi02LTEtMS0w_310dff66-66b7-4d89-8f15-f261fe77d690">20,562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi04LTEtMS0w_b00bfde3-bb4d-416f-b2dd-6e0a81abe9a6">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy0yLTEtMS0w_089cb98b-5dc8-4874-b5f5-0efb1578a0e9">6,579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy00LTEtMS0w_b7524c19-a8c2-4608-8df4-95cc25814c84">35.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy02LTEtMS0w_7b789937-b193-4766-aac6-5719bc403c9a">6,940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy04LTEtMS0w_e16c948c-68c6-4bcc-8d08-3f8b8300624e">33.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC0yLTEtMS0w_29221ffe-e066-44cf-b276-9521252d0058">11,757</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC00LTEtMS0w_81da7d7f-b66e-422c-8aad-a65fb63d6fec">64.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC02LTEtMS0w_e99c6c45-480b-44ec-87ff-cd8fea62c9c0">13,622</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC04LTEtMS0w_c8559410-572b-4d31-a57f-87ab24d0443e">66.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, marketing and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS0yLTEtMS0w_53329741-d499-4012-8adc-386ac930d793">4,993</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS00LTEtMS0w_010dffae-aae8-4272-8051-b9b23fb34b33">27.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS02LTEtMS0w_5c4026ae-1f93-4083-a100-88b8a5a37a65">5,546</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS04LTEtMS0w_3fb3b06e-97c3-480c-b8b6-1dc1f5b1f5c8">27.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi0yLTEtMS0w_773200ea-036f-4924-a9fd-1b8d111e86e2">2,707</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi00LTEtMS0w_d3ed1aed-821e-4d41-8353-9b9c58dc08d7">14.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi02LTEtMS0w_9987106a-caf9-457a-9a68-e945f2337bc8">2,666</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi04LTEtMS0w_55722f32-5876-48aa-a7fe-2b9a1293c428">13.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy0yLTEtMS0w_79336aef-776a-4cab-9660-b2f29951853b">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy00LTEtMS0w_ec25dfc2-ffb0-423b-bae3-5840f1215f22">0.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy02LTEtMS0w_1aac1d29-6b17-4a49-a800-bcdfbaac527c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" format="ixt:zerodash" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy04LTEtMS0w_a384ee3f-9dd0-4808-a0b5-b10b9b7d356c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC0yLTEtMS0w_8047cd08-a849-4421-bf00-f1f7a6566951">19</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC00LTEtMS0w_970f9cf8-313e-46c1-9a50-8d419116edd4">0.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC02LTEtMS0w_c3bca762-9538-4c4c-8558-5566fc59d497">88</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC04LTEtMS0w_cdde9a77-a94c-465d-82ec-13799491f892">0.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net of portion capitalized</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS0yLTEtMS0w_25c0b2f3-efc2-4ad8-aaab-490419f6d8d1">45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS00LTEtMS0w_19fd6527-b3f3-4c38-a70e-4b0043151553">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS02LTEtMS0w_b24c04b2-0840-42a6-a89c-2addd4e02a2f">83</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS04LTEtMS0w_5bee0eb1-eb61-4702-b18d-936f22c3e537">0.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtMi0xLTEtMA_01ed35b6-fab7-48e8-b468-d453a2b2d133">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtNC0xLTEtMA_961b40ac-ccb9-40cb-a67c-17b72bebf870">0.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtNi0xLTEtMA_1049d21a-2cd8-4847-ab45-ce9db7ba101e">1,683</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" sign="-" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtOC0xLTEtMA_7786f182-c36e-4074-99f5-15b73e11f315">8.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtMi0xLTEtMA_30c5ac00-d3f7-43c6-97bf-9e58dbd2463d">61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtNC0xLTEtMA_af28ec3f-fad1-4b43-a7b0-1c52e1d26293">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtNi0xLTEtMA_698bc347-7ad3-4294-b3e5-87d344ede006">57</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtOC0xLTEtMA_39ffd0d2-2d18-43ac-9955-f3f42ec026f3">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings before provision for taxes on income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItMi0xLTEtMA_55295df2-6725-4190-9171-11226e8ccc00">3,940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItNC0xLTEtMA_53972e12-7483-4600-b587-46c28608fe7e">21.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItNi0xLTEtMA_84bd3e64-3ff4-4fb6-a7c8-f4632b180401">7,041</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItOC0xLTEtMA_60c659d2-229f-4f57-8cc1-e269a5794c37">34.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtMi0xLTEtMA_68897aa0-7069-45c7-b9b4-e26c6d2c138e">314</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtNC0xLTEtMA_641ea0be-6670-4dd9-a4af-058d6a15bfce">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtNi0xLTEtMA_b4a6c11a-7657-42d3-a3bd-9bec26c54be3">1,434</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtOC0xLTEtMA_9530e260-320b-44d6-be8f-7b2032b38147">6.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtMi0xLTEtMA_b7c0a5ad-c816-450b-abbb-0f25c67b8ebe">3,626</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtNC0xLTEtMA_6d89b7e9-73fb-440c-8292-be37cc0da913">19.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtNi0xLTEtMA_cc891e39-cf0e-4764-a5b6-da1fc30f1380">5,607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtOC0xLTEtMA_adf93275-06d0-46e7-bc01-508067dd73ba">27.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS PER SHARE (Note 8)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTctMi0xLTEtMA_fd9beee5-2221-4fc4-9ae6-beb34ce2f00f">1.38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTctNi0xLTEtMA_45c99fc6-8b67-4aad-882e-baaf7fb83e34">2.11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTgtMi0xLTEtMA_b80f7416-e470-4c5b-9e46-080558e3cb3a">1.36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTgtNi0xLTEtMA_fc8b777f-bddd-40af-b268-da236efeb372">2.08</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">AVG. SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjEtMi0xLTEtMA_dab2d499-1706-4be0-9949-744abdcd1144">2,632.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjEtNi0xLTEtMA_dfdba21a-636d-4c9d-a786-55fd82e23898">2,652.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjItMi0xLTEtMA_28a9006a-0adf-4151-8ef7-32805e520bb0">2,665.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjItNi0xLTEtMA_e777322c-80b2-4eb4-ac8f-d9c7e90a4529">2,691.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars &amp; Shares in Millions Except Per Share Amounts)</span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_31"></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt;"><tr><td style="width:1.0pt;"></td><td style="width:283.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:48.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:48.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="21" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>to Sales</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales to customers (Note 9)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy0yLTEtMS0w_c53c3880-1b6a-4bc8-a755-b0ff31b7d1fb">39,027</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy00LTEtMS0w_0a233d19-6413-4ae3-b050-673ee7599d68">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy02LTEtMS0w_bb9bff66-9538-4ac9-92ef-9d77a56d06cb">40,583</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:SalesRevenueGoodsNetPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy04LTEtMS0w_818b0955-404a-443d-824c-1b53dca5d506">100.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of products sold</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC0yLTEtMS0w_c164fb1d-5a54-413d-ac54-5014c8ee15c7">13,641</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC00LTEtMS0w_c85585ea-8890-4196-87b6-c309adc15124">35.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC02LTEtMS0w_caea5706-42d2-429f-a3e4-6b4ddf9587b2">13,555</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:CostOfGoodsSoldPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC04LTEtMS0w_1ca67871-177e-4bb9-bdb5-66eefd39f2b8">33.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS0yLTEtMS0w_d0eb208d-230b-4b89-8f83-b6b3a418867a">25,386</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS00LTEtMS0w_f2dae28e-fa5f-48cc-abf7-4ca521c019eb">65.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS02LTEtMS0w_2ded5696-286a-4b24-a3b7-cc0f90dc15b8">27,028</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:GrossProfitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS04LTEtMS0w_c36db985-5c48-4937-8fa3-6202c7584432">66.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Selling, marketing and administrative expenses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi0yLTEtMS0w_d0ac0e98-ebfe-4869-9633-cc0b5c55a33e">10,196</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi00LTEtMS0w_9e298217-3484-4a07-baf0-ff3b32da7a47">26.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi02LTEtMS0w_47b53996-667b-4c74-b20a-9d3c55eea861">10,765</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:SellingGeneralAndAdministrativeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi04LTEtMS0w_a275bb56-9f39-4b8e-93d7-f73c96c1e596">26.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Research and development expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy0yLTEtMS0w_d4c8e23d-2112-4bd1-99fe-e90abaff7acd">5,287</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy00LTEtMS0w_cb9b2abc-937d-4290-bb94-32de37133c67">13.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy02LTEtMS0w_f6603427-0479-4c6f-9522-d2bdcaa4e84e">5,524</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy04LTEtMS0w_83e54922-d608-43df-bcde-e5eb6026e944">13.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">In-process research and development</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC0yLTEtMS0w_69036a5e-6b93-4ec0-b308-14b8e8cd7e6d">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC00LTEtMS0w_b1249f74-c61f-41a3-9610-77a3dc1a31df">0.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ResearchAndDevelopmentInProcess" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC02LTEtMS0w_95cdb791-1f1f-4e8f-927f-f9b05db3f323">890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:ResearchAndDevelopmentInProcessPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC04LTEtMS0w_71f02530-cd19-4c7c-bfa6-8fb7d00e9505">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS0yLTEtMS0w_924c3b7b-a3c2-49ea-81d9-6443ecf471eb">86</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS00LTEtMS0w_aa69df36-0524-4d3a-9d71-327921015f2b">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS02LTEtMS0w_a28f690d-3446-4626-826e-31ec48ad9db9">187</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" sign="-" name="jnj:InvestmentIncomeInterestPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS04LTEtMS0w_021297c2-305c-4590-9040-797acba0dc33">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest expense, net of portion capitalized</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtMi0xLTEtMA_df985ec4-13d3-49cc-bfe7-60a903f05ebd">70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtNC0xLTEtMA_217ec692-ee35-402f-b6ac-358657552448">0.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtNi0xLTEtMA_3d3e56be-d0e8-4cbf-9b61-6adc3484e44d">185</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:InterestExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtOC0xLTEtMA_f312079e-8e74-49fb-9408-87a9ec217644">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense, net</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtMi0xLTEtMA_c31cc2a7-9c81-4d95-9233-da52b250bdbd">655</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" sign="-" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtNC0xLTEtMA_65d2d633-35be-48cd-84b9-811cbe81c7f0">1.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtNi0xLTEtMA_94225e8a-5c4c-48b0-845b-0e6c5881bab8">1,705</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" sign="-" name="jnj:OtherNonOperatingIncomeExpensePercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtOC0xLTEtMA_f6c4f231-263f-45eb-b2c9-7b654dcfd113">4.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring (Note 12)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItMi0xLTEtMA_dfb430d0-6843-4f65-afbe-b282dc1fd592">119</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItNC0xLTEtMA_9734995d-d7b2-455f-9c0a-482178e43f97">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItNi0xLTEtMA_3abb953c-deaf-4175-bee4-8d7635bad6f2">93</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:Restructuringchargepercenttosales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItOC0xLTEtMA_5fb4c7e8-456c-4e51-8581-b91f41804b29">0.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Earnings before provision for taxes on income</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtMi0xLTEtMA_8e1f0f22-ec42-4cf5-87ef-6bfa6ff8e5c3">10,449</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtNC0xLTEtMA_e05c96e6-d41a-4570-b39d-6b766b60dd5e">26.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtNi0xLTEtMA_2de94825-f5bf-4a24-bc9e-2a59adec592c">11,463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtOC0xLTEtMA_3f90f9a8-f71a-454b-9368-8874a4204e74">28.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Provision for taxes on income (Note 5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtMi0xLTEtMA_ee32fcc5-e609-40fe-9fb9-f8463c03ce9a">1,027</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtNC0xLTEtMA_dcd24e78-2c9c-4530-964d-3979624fe140">2.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtNi0xLTEtMA_de316edf-2dab-4b98-85ad-6934a1d2777c">2,107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:IncomeTaxExpenseBenefitPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtOC0xLTEtMA_9a02aa38-b327-4449-9703-f104a2fba893">5.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtMi0xLTEtMA_a6997a8c-0b72-44e4-b6d7-cc626b290246">9,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtNC0xLTEtMA_96bc37df-0f13-4427-99f4-975121995385">24.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtNi0xLTEtMA_e2f6bdf4-3b47-41c7-b1cb-06f1c9c63858">9,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="jnj:NetIncomeAttributableToParentPercentToSales" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtOC0xLTEtMA_0a2a9c48-1a04-4298-98ac-3ba4c656d8be">23.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET EARNINGS PER SHARE (Note 8)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTgtMi0xLTEtMA_68b44b19-ad1d-440b-8ca7-a6b6aaaf6edf">3.58</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTgtNi0xLTEtMA_05ff431c-c68f-476d-bff2-54674f5cce38">3.52</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTktMi0xLTEtMA_09223f79-dbbb-48b3-8aaf-61a2baa953f6">3.53</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTktNi0xLTEtMA_b9d692e7-afdd-477a-87fc-520ab2c442eb">3.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">AVG. SHARES OUTSTANDING</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjItMi0xLTEtMA_f367731c-be9b-45ca-bf18-4a40caf40728">2,633.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjItNi0xLTEtMA_8c4eca8a-7053-4398-b1ab-73b950c13b57">2,656.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjMtMi0xLTEtMA_00034b60-a776-4051-908f-9c636f6bff1e">2,671.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjMtNi0xLTEtMA_186710df-15af-406e-97c2-e4423d4d79c0">2,697.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="27" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">See Notes to Consolidated Financial Statements</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%;"><tr><td style="width:1.0%;"></td><td style="width:42.558%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:10.794%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.976%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.794%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.976%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.088%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.829%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.385%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy0xLTEtMS0w_84f290af-ca56-4782-846b-fd0814c49111">3,626</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy0zLTEtMS0w_3693c4c0-3b3a-47a7-bff2-36c4564cde54">5,607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy01LTEtMS0w_97b7f3fd-e806-450d-9453-6d05135647e7">9,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy03LTEtMS0w_a2f18cb6-4573-481a-b2b8-650a7ff9b784">9,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign currency translation</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi0xLTEtMS0w_807dcac5-0320-4831-99ca-e4da36c9fb6b">556</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi0zLTEtMS0w_bb8d60b5-c5e7-41cf-a349-5c8b53cef26a">350</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi01LTEtMS0w_5d65aed9-b7c9-4107-8433-1c46c522deeb">963</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi03LTEtMS0w_d740f992-8973-4f38-9124-9cb95c8458e2">92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Unrealized holding gain (loss) arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS0xLTEtMS0w_54591684-d1ad-4900-a6ca-eeed435afdac">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS0zLTEtMS0w_1e4ef105-d3a2-4f8b-bc65-b743db7634c6">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS01LTEtMS0w_2a5add97-ad84-48f6-805c-3b59dd31c9f5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS03LTEtMS0w_0c6a9a0f-bb1d-42cc-8450-f11b90c55a80">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Reclassifications to earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtMS0xLTEtMA_7e0d9e6f-3bd0-4d37-8eee-ba523ca44e63">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtMy0xLTEtMA_d996fa6e-ddb8-40c0-babd-269941d58021">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtNS0xLTEtMA_28d13770-13b7-4744-8cab-5845188a2723">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtNy0xLTEtMA_3c7c7efb-f57e-4089-8870-fd86e01eaffd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItMS0xLTEtMA_5931ef17-a020-435e-907c-710ae9eda5ad">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItMy0xLTEtMA_b18fc638-df39-4240-9186-e65fbd7b1b1e">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItNS0xLTEtMA_d2e7e8d9-4eb4-4c21-a732-53d152f6976f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItNy0xLTEtMA_2c383fdb-c8b0-4943-897b-18a34f0773ff">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee benefit plans:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Prior service cost amortization during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtMS0xLTEtMA_596f4a8b-ed4a-4e62-a6ba-be57cd7f5b87">5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtMy0xLTEtMA_d3adbbec-6e98-4759-9baa-173fce313d3a">5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtNS0xLTEtMA_c8cc8897-7d3f-4165-aaee-d9290fcb910e">11</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtNy0xLTEtMA_d2fec453-5aac-4d07-b175-79900f161bbb">12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Gain (loss) amortization during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtMS0xLTEtMA_763a5771-039d-48a6-b56b-b6b2e13e3c8d">200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtMy0xLTEtMA_2a5dc9cf-e0cf-4a74-8416-9756a2e22810">142</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtNS0xLTEtMA_bfcb2369-07c0-4a31-929a-2b1419481713">401</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtNy0xLTEtMA_9cb142b2-221f-400d-bbf2-ce181d9439c8">318</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtMS0xLTEtMA_d9bac892-155d-4789-99eb-139c3390ce38">195</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtMy0xLTEtMA_dc9bfbd6-8459-4956-ba52-c8ea531a3705">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtNS0xLTEtMA_f7caf02d-8043-4e0c-a092-89ab96f29bc1">390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtNy0xLTEtMA_360778db-fafb-46c5-bc49-e3e23e373772">306</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives &amp; hedges:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Unrealized gain (loss) arising during period</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtMS0xLTEtMA_26cead28-b1ae-4a97-8883-ff89e6551791">21</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtMy0xLTEtMA_e8836f41-a815-4416-9d56-cb6f388d5fa8">86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtNS0xLTEtMA_ad3c6aa8-da3a-4667-9c0c-bdf32c2f5f57">853</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtNy0xLTEtMA_95e15ad4-e6af-4032-9d71-618a36a4a23f">216</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Reclassifications to earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItMS0xLTEtMA_feafcae9-d020-4dee-b23a-881d98a44d89">60</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItMy0xLTEtMA_1f289b46-4809-4f5c-b5e8-dd0c3b282d41">26</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItNS0xLTEtMA_5ebd2048-2aaa-42d7-b332-c74c9c780e39">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItNy0xLTEtMA_ca28add7-b8d5-4767-a1f4-d6a15b140c33">70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Net change</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtMS0xLTEtMA_e25c1188-690a-40e2-8d00-e2361388e5dd">39</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtMy0xLTEtMA_93556cd7-c155-4651-b4a4-fa4ee1904be9">60</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtNS0xLTEtMA_5d92d8be-6e70-467e-ba6a-b588d8357024">931</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtNy0xLTEtMA_fd1e8577-47a9-4a38-863a-051961f7d58b">146</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtMS0xLTEtMA_b38d8626-fd3a-49b7-8ac2-ce75c115f334">710</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtMy0xLTEtMA_fadc0a2e-03f6-471f-bfbb-b4bb0d94234c">548</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtNS0xLTEtMA_bebcfa26-cfa6-41e9-9db0-f00e9c87977d">358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtNy0xLTEtMA_75d0f380-2709-415c-b113-931dc029d6a0">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Comprehensive income </span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctMS0xLTEtMA_4effe271-7c4d-45e5-bc31-fa88fa613689">4,336</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctMy0xLTEtMA_d7ea1b77-4abe-425b-a52e-474537ee68c9">6,155</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctNS0xLTEtMA_d9352e02-7b64-488d-aeb5-7525221e4e9b">9,780</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctNy0xLTEtMA_c0e9b467-9012-4075-963f-0a15e47f1b58">9,609</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%;"><tr><td style="width:1.0%;"></td><td style="width:98.000%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The tax effects in other comprehensive income for the fiscal second quarter were as follows for 2020 and 2019, respectively: Foreign Currency Translation: $114 million and $106 million; Securities: $1 million for 2020, Employee Benefit Plans: $55 million and $34 million; Derivatives &amp; Hedges: $10 million and $16 million.</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The tax effects in other comprehensive income for the fiscal six months were as follows for 2020 and 2019, respectively: Foreign Currency Translation: $68 million and $44 million; Employee Benefit Plans: $111 million and $35 million; Derivatives &amp; Hedges: $246 million and $39 million.</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON&#160;&amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF EQUITY</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Second Quarter Ended June&#160;28, 2020 </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"></td><td style="width:37.207%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.985%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.985%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.922%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.132%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.137%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, March 29, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f5119916d654310ac75b5ef00226e3c_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS0xLTEtMS0w_6f0cce95-9c78-4fbc-848d-fed0398279b5">61,294</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28ce5a232c604b8bbf884d668b9f4e57_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS0zLTEtMS0w_6e735bc8-3400-4f19-a1fa-0f4e65fb476e">112,901</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i24d9e08d937e4f179ddd650ddc14f39f_I20200329" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS01LTEtMS0w_1a9b0fed-0524-411f-8999-f8b7a5ac6437">16,243</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73fd0a02b1154c3e9745a1263dc23b62_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS03LTEtMS0w_51673577-2c9d-4145-9754-50e8042e0697">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iefccab1bc61e4aac89cc6807ae4e1c54_I20200329" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS05LTEtMS0w_94eaf9f0-d25e-4b80-aceb-d177b975c40f">38,484</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMi0xLTEtMS0w_e8f8ca57-7065-4639-9abd-b51f9e8b094f">3,626</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMi0zLTEtMS0w_e6cd3b44-a7bf-4a16-b3a5-e1bc32b9f5b9">3,626</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash dividends paid ($1.01 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMy0xLTEtMS0w_e7634922-ae20-44b3-82f5-9e0f8c2d1808">2,659</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMy0zLTEtMS0w_9eb529ed-0fd2-435b-94d6-80559a4f776b">2,659</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC0xLTEtMS0w_c6be4e20-92d0-46cc-b0d4-55e34e89ddea">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC0zLTEtMS0w_c595e09f-edcb-492d-b8db-26434db10f14">29</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC05LTEtMS0w_ca09180d-cd64-4d14-951c-41125eb4e21a">683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNS0xLTEtMS0w_9c4030a9-fec9-45d0-8c77-64efae82c23f">706</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNS05LTEtMS0w_fdbeb193-eea5-43fd-b163-d515fbcbd90c">706</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNi0xLTEtMS0w_c0fb8a9b-30a5-4da2-844d-76e9ad87184d">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNi0zLTEtMS0w_ebade84a-c918-4918-a13c-5abfbf564efa">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNy0xLTEtMS0w_2c97015d-095d-4903-ba7a-259a3981c1a0">710</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i59a07beb3fc44f4287425a53a020e1d6_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNy01LTEtMS0w_00d5d091-25bd-4f7f-8bce-cded16903bd0">710</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 28, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC0xLTEtMS0w_0088db0d-fdd5-4901-b97a-ba7741b3f49d">62,978</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45078457294a49839d52d19d59d45e00_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC0zLTEtMS0w_3f3b269b-b488-48e5-8ca8-c13b442bed81">113,898</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if261e32787064849a30e8f746c585aa9_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC01LTEtMS0w_9c2d1ff0-e625-45e5-8e0f-66cc565998d5">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3f156471cef4470986ef989b88c7640a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC03LTEtMS0w_3ec41879-c65e-43eb-a44e-d767818b254e">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i24cafb66e4484853bf4778ec14060e85_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC05LTEtMS0w_dbda9ee7-c0ad-43f9-8ba7-769bde55c07e">38,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Six Months Ended June&#160;28, 2020</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%;"><tr><td style="width:1.0%;"></td><td style="width:37.207%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.985%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.985%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.922%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.132%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.708%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.137%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS0xLTEtMS0w_57156893-c884-40aa-bd73-cbeaecaa90ed">59,471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i751605f69fa8470b949cd66a3de18cfb_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS0zLTEtMS0w_249072d6-3020-44bf-ae36-0dd71eb67498">110,659</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS01LTEtMS0w_e9c0b60d-111d-4b75-966b-1ecded86417c">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63412fd9538f4c419e57e8396e1e2450_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS03LTEtMS0w_918d4709-078a-4bfa-a8ab-a7ba0ae0d9ae">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib519600bb19e47f6acf4f21be0fc6aaf_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS05LTEtMS0w_41c4d8dd-3cd3-4caf-89ce-5ab7d782b670">38,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMi0xLTEtMS0w_33259869-34de-4d78-9c90-011346e58e20">9,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMi0zLTEtMS0w_baf577ed-6140-41b9-ae25-babdab475d70">9,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash dividends paid ($1.96 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMy0xLTEtMS0w_e31e4ac4-e8bd-42e6-acd7-b402de8c7e86">5,164</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMy0zLTEtMS0w_a77fbb87-4c64-4b9b-bec4-ad7250e854cd">5,164</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC0xLTEtMS0w_7acb32a4-ca22-4eb4-b249-f4e405e6d013">1,307</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC0zLTEtMS0w_dd769c68-03f7-42c3-a5e2-e1d18cf12d57">1,020</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC05LTEtMS0w_2bdde0de-d4d7-400a-ba8e-bb618b9d55dd">2,327</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNS0xLTEtMS0w_e9076a89-f159-4206-9ddf-7656b982adc3">2,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNS05LTEtMS0w_6b3e3714-58c1-4c56-b9ff-8f6695881b82">2,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNi0xLTEtMS0w_82474df2-7c69-4453-9d91-72e1895e11ae">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628" decimals="-6" name="us-gaap:StockholdersEquityOther" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNi0zLTEtMS0w_0eeb6131-b4a4-4846-8f1b-57679026c4e7">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNy0xLTEtMS0w_767d9cbb-3cfc-405e-b85a-a09afd8ff0c4">358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNy01LTEtMS0w_c953c58f-9298-4d1b-997d-b79a49dd7158">358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 28, 2020</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC0xLTEtMS0w_4db05591-0b25-451a-9e8c-aa8ca320f3d7">62,978</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45078457294a49839d52d19d59d45e00_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC0zLTEtMS0w_a4f48c65-25bf-4b2f-815a-06d207e5637c">113,898</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if261e32787064849a30e8f746c585aa9_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC01LTEtMS0w_29d58327-e678-4005-a117-8d74e7deff74">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3f156471cef4470986ef989b88c7640a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC03LTEtMS0w_259371ad-40eb-4a2c-b43e-097fdfcbb18e">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i24cafb66e4484853bf4778ec14060e85_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC05LTEtMS0w_1098f2ee-3d6e-4b93-b93f-7c4665150628">38,507</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Second Quarter Ended June&#160;30, 2019 </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"></td><td style="width:37.085%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.882%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.029%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.979%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.176%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.181%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, March 31, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5747648413fd46979174d12f0c200837_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS0xLTEtMS0w_54d803ed-8f18-4696-9ebf-44a9823be7dd">58,955</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic629a2a0279c40f7a8a22fbbbd206b62_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS0zLTEtMS0w_f24e9820-3b76-48d4-a830-179d6fb96ede">106,650</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i946a5c53aec443718456445577b181c6_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS01LTEtMS0w_facf27a8-8ee7-4292-b618-9fcc93f714fa">15,517</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37f2478bd1c94f8189108fa2df87fa35_I20190331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS03LTEtMS0w_ea4a7941-f33a-4d3d-99d6-f37e46d0226a">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fd38c3886a84e65b754e209c671b4e3_I20190331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS05LTEtMS0w_d3fc8629-7527-4696-8ff7-e6ebdb2b571b">35,298</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMy0xLTEtMS0w_703b4b59-bf94-4b1f-9bb0-992e481d268a">5,607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMy0zLTEtMS0w_59d848cd-5dbd-4f22-9bcd-f01feb4bb5ca">5,607</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash dividends paid ($0.95 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNC0xLTEtMS0w_db4995ca-a9df-4540-86c5-1686c3749b6e">2,522</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNC0zLTEtMS0w_8f08ff58-737b-487e-9d9a-109fd1504fa2">2,522</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS0xLTEtMS0w_db041bfc-196f-4975-964f-5fa4036bd85f">683</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS0zLTEtMS0w_3973196a-558f-4b5a-bf5b-1d2fdd74ea6e">74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iddf51803037143adbd15041c11e9e51a_D20190401-20190630" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS05LTEtMS0w_374b99c0-0012-4de0-8d99-5b23c702a44e">609</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNi0xLTEtMS0w_ae718537-39eb-4754-9b5a-84da1b265b31">2,486</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="iddf51803037143adbd15041c11e9e51a_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNi05LTEtMS0w_b0bc6dad-e9de-48d5-ad21-1cea20d66e72">2,486</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOC0xLTEtMS0w_ecb3d6d7-7e64-4b4d-adef-f615be997d46">548</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i246708123c874d65a705b8d658c14466_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOC01LTEtMS0w_f593c83e-7b5a-4b13-ad85-7d99e0b22ef7">548</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS0xLTEtMS0w_2007c509-798a-405d-a31f-d16fc771ec28">60,785</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0cde42ed21643029a65d234f94ce9ce_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS0zLTEtMS0w_e02227fb-bce8-48e4-abef-553bf27cd8e6">109,809</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie3ae7c05de8449e4853379b1810a5cb4_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS01LTEtMS0w_ec9139ad-1692-4758-8aa9-904ccc69d613">14,969</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id93dcd19b8bf48879ab269ebebba20c7_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS03LTEtMS0w_1c436422-b902-48b0-8c74-62c50284253b">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS05LTEtMS0w_fd06c2af-2f5a-4748-9788-cdc5839781d3">37,175</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fiscal Six Months Ended June&#160;30, 2019</span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"></td><td style="width:37.085%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:7.882%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.029%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.979%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.176%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.717%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.181%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retained<br/>Earnings</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Accumulated<br/>Other<br/>Comprehensive<br/>Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Common Stock<br/>Issued Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Treasury<br/>Stock<br/>Amount</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, December 30, 2018</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS0xLTEtMS0w_8fdd3dd8-0186-4429-b9cb-01565870fcf3">59,752</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b613a94dd42484783d6a12a1751f62a_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS0zLTEtMS0w_ea3d2385-d2c8-486c-9db2-2c1bc928de28">106,216</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i8c0949379c4e4a58a6c9255f0e249053_I20181230" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS01LTEtMS0w_7e12b13d-51c9-4427-b9c1-35f0abfffe70">15,222</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if1edf2d8de4844dca95575354c2ff1e2_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS03LTEtMS0w_efe58edf-582c-42ce-bb83-9f4c2bd93a49">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i2e4c6a229a014b85a7a8b8c276c6ceb0_I20181230" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS05LTEtMS0w_6ad9875c-58e9-4c59-a0a4-e1dd969418e6">34,362</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMy0xLTEtMS0w_8e3431ac-8103-4905-b2e8-026b0c11eefa">9,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMy0zLTEtMS0w_5973a8af-9e97-40bd-945f-154ba797dcaa">9,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash dividends paid ($1.85 per share)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNC0xLTEtMS0w_301a1846-ec85-4b51-a3eb-9411d958b970">4,918</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNC0zLTEtMS0w_0d0e058e-010e-4a67-b871-f943bb49e458">4,918</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee compensation and stock option plans</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS0xLTEtMS0w_29ddd4da-2ffe-4f6e-aef4-575c953bc299">1,034</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS0zLTEtMS0w_cc00975b-04c4-4668-a9f9-0528f2a5dad0">845</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS05LTEtMS0w_6e24e8c2-6779-4c2b-aa9f-03f8ffe52c5d">1,879</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNi0xLTEtMS0w_45ae9a25-9af1-4937-8d4a-71a3242bd00a">4,692</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNi05LTEtMS0w_60f91adb-1937-4861-836d-130bf1bf6ffa">4,692</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other comprehensive income (loss), net of tax</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOC0xLTEtMS0w_8591b76f-d4ac-4725-aeca-cac7e4b1c2bc">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49bf965261be49f3adf9b650ea02edfe_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOC01LTEtMS0w_35f7823c-9c90-4f58-a228-2459f55be311">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Balance, June 30, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS0xLTEtMS0w_98074cc4-93a8-4606-85b5-3b14db2bad1f">60,785</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0cde42ed21643029a65d234f94ce9ce_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS0zLTEtMS0w_bd7eee6f-212c-494a-9e2d-0c2f98bc5117">109,809</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie3ae7c05de8449e4853379b1810a5cb4_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS01LTEtMS0w_2b6b6524-9ca8-4277-a26a-009f118f72bb">14,969</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id93dcd19b8bf48879ab269ebebba20c7_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS03LTEtMS0w_f7a3d3f0-c7f5-4289-ab32-aa666de5c974">3,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS05LTEtMS0w_833c74c2-34e0-4b5e-a443-fe462c611193">37,175</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">6</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_46"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JOHNSON &amp; JOHNSON AND SUBSIDIARIES</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(Unaudited; Dollars in Millions)</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%;"><tr><td style="width:1.0%;"></td><td style="width:75.419%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.557%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.558%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net earnings </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMy0yLTEtMS0w_95f35bf6-040a-4739-af6d-bf83124d8ae0">9,422</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMy00LTEtMS0w_30a729ac-264b-40b6-9d6c-648d9d0d0072">9,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Adjustments to reconcile net earnings to cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Depreciation and amortization of property and intangibles</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNS0yLTEtMS0w_0fd364a4-e11f-4c11-878b-dec9027a4729">3,473</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNS00LTEtMS0w_322d0961-1a8d-4e9f-a7ec-b1609286caae">3,466</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Stock based compensation</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNi0yLTEtMS0w_9f88987f-4f7b-4430-85ad-2a97fae0c8a2">589</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNi00LTEtMS0w_8f71da43-3158-4c38-8ff7-dffece667509">572</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset write-downs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfOS0yLTEtMS0w_629ae375-6ffd-47fd-8e79-e87f455a240d">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfOS00LTEtMS0w_63ea6883-847d-4cc6-8921-cd6d6b3c8375">989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;Contingent consideration reversal</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTAtMi0xLTEtMA_50ff46b9-5d8e-4780-91b4-5d5a31c13a73">983</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTAtNC0xLTEtMA_bd1942b3-5e82-4085-aab8-498ce691e8a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net gain on sale of assets/businesses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTEtMi0xLTEtMA_1cbd4ea2-76b8-4638-b2f3-2f109443fed3">60</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTEtNC0xLTEtMA_1b8bbaac-fff8-48e4-ae77-4f5cbfcc2ce1">2,079</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Deferred tax provision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTMtMi0xLTEtMA_2bc9c7a1-3530-45ca-a487-34d237515b64">428</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTMtNC0xLTEtMA_14d78a81-e963-44c5-aa16-6c3a9c29640a">694</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit losses and accounts receivable allowances </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTQtMi0xLTEtMA_8695a6a4-f3bb-4e63-aeac-49a10ceebd61">117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTQtNC0xLTEtMA_5127ab27-38e9-49df-a530-46bff1748311">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Changes in assets and liabilities, net of effects from acquisitions and divestitures:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in accounts receivable</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTYtMi0xLTEtMA_1f05b5cc-bab6-4528-b098-9d7fccf407ee">520</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTYtNC0xLTEtMA_cae4c8a2-aae0-42e0-acee-c1eac2a9584e">336</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in inventories</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTctMi0xLTEtMA_eb995bed-a9c7-48a3-b14d-250abf7640eb">637</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTctNC0xLTEtMA_1926a8ad-1d1a-4dc4-88c0-ba8950bfaae1">423</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in accounts payable and accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTgtMi0xLTEtMA_22c431b0-1ce8-4ac2-b651-b26d2f2b21fd">2,319</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTgtNC0xLTEtMA_a4b29e4e-dbd1-404b-ab81-a26d688f45f1">444</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Increase in other current and non-current assets</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTktMi0xLTEtMA_32fe740d-bc18-47df-bc3e-e36666b9c214">1,048</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTktNC0xLTEtMA_12323759-9db7-4e83-99bd-7fd6547abfe5">862</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:6.75pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in other current and non-current liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjAtMi0xLTEtMA_4ae01632-28c4-4b51-a934-1916f8b0f0e1">829</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjAtNC0xLTEtMA_2f6369f3-3faf-4a24-8565-c9f8ba2b34e0">55</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH FLOWS FROM OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjItMi0xLTEtMA_5b0b31d1-bebb-4169-95a0-de3946183437">6,810</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjItNC0xLTEtMA_f54decf5-a5b9-4e5b-9d70-c903f1ae41b8">9,491</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions to property, plant and equipment</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjUtMi0xLTEtMA_3d1989e4-79ce-4f62-acef-542cec9d9b2b">1,287</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjUtNC0xLTEtMA_91449192-d720-4115-a1e3-56ffbbf79b2f">1,493</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from the disposal of assets/businesses, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjYtMi0xLTEtMA_5db33d0b-9acc-4dce-98e7-08fdddd8c68b">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjYtNC0xLTEtMA_aea12a05-e238-41a8-8a17-80f517df61af">3,018</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisitions, net of cash acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjctMi0xLTEtMA_fa44baf6-d7f0-4427-bfa5-2feb5878c694">949</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjctNC0xLTEtMA_b4bd26e5-e2dc-422d-9fb0-ca39b370f172">5,346</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Purchases of investments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjgtMi0xLTEtMA_37c3a979-f540-4a3a-b84a-457362450354">8,551</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjgtNC0xLTEtMA_0dc49ca7-567c-4cd1-8002-b321a04805ae">1,517</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales of investments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjktMi0xLTEtMA_abf6a3b6-ac45-4b47-a173-529c24e29c7f">2,417</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjktNC0xLTEtMA_4f8f1a79-8c2d-44d5-a911-c2ffd494ff4a">2,132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from credit support agreements, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="jnj:Proceedsfromcreditsupportagreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzAtMi0xLTEtMA_a5bacd46-be43-4efb-beb8-bab73270811c">672</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="jnj:Proceedsfromcreditsupportagreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzAtNC0xLTEtMA_0217b9f8-af0c-41ce-9ec7-3cdb3da60d3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (primarily licenses and milestones)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzEtMi0xLTEtMA_89c05fec-b14b-46b8-a956-1f9f89d98437">492</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzEtNC0xLTEtMA_70806f53-65dc-43e7-9b95-bdd5786d3ac3">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH USED BY INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzMtMi0xLTEtMA_6473a3a1-3645-470d-adde-29a4579ea94d">8,103</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzMtNC0xLTEtMA_7634adc1-e766-4983-99fc-6fbbe43631e0">3,205</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH FLOWS FROM FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Dividends to shareholders</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzYtMi0xLTEtMA_6f4f7f2d-a84e-4a76-bf0b-3ba4fa128518">5,164</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsOfOrdinaryDividends" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzYtNC0xLTEtMA_7f2e5a18-cc4c-4f0b-9b9c-e5885ce0dcbe">4,918</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzctMi0xLTEtMA_4a344ca3-a74c-4d11-8fcb-5f331dac3d56">2,417</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzctNC0xLTEtMA_38d444d4-f2b1-455d-a341-21834d029bc0">4,692</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from short-term debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzgtMi0xLTEtMA_0afc60dc-5625-461c-a284-635381a92daa">2,717</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ProceedsFromShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzgtNC0xLTEtMA_831706c6-331a-49cf-b917-43c65eec9477">15</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayment of short-term debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzktMi0xLTEtMA_b840a07f-af0b-43bb-abee-0f6aa8d6d04a">17</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:RepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzktNC0xLTEtMA_7e124801-8870-4fc2-b8fe-6242b0e53583">12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDAtMi0xLTEtMA_960be49b-ce34-49aa-8ede-19d270ee6cd0">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDAtNC0xLTEtMA_c2f0e68b-a4b8-4714-89d9-89db89751198">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Repayment of long-term debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDEtMi0xLTEtMA_38fcbac2-fd50-4c97-a12f-307b293ff2cc">11</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDEtNC0xLTEtMA_ac6489b4-a59c-411b-b932-cb3b7f65dfce">1,005</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDItMi0xLTEtMA_c4e3fb07-0ca5-4446-aab8-3ff0129a8f15">708</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDItNC0xLTEtMA_af1df69f-7bd8-411d-b39a-ea743d85a311">463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDMtMi0xLTEtMA_46d7dfcc-e48d-4e38-8595-85d51c8dac6a">489</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDMtNC0xLTEtMA_6ff6d3d5-4081-45ab-a88a-7f401d7d94dd">98</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">NET CASH USED BY FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDUtMi0xLTEtMA_544e5f9b-28ac-4f15-978b-791971d08ada">4,672</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDUtNC0xLTEtMA_34d80a08-25b2-492b-823e-97996d78d341">10,050</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDctMi0xLTEtMA_d98dea68-dbae-46e0-b861-b83dc41ef361">166</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDctNC0xLTEtMA_64f930db-c290-476d-ac73-391c4d8d6d8f">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Decrease in cash and cash equivalents</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDgtMi0xLTEtMA_b53d701f-18d4-458a-bad9-a8ad20b0ac81">6,131</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDgtNC0xLTEtMA_eda02be2-f740-4bf1-b2e7-7b09cb27287f">3,731</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash and Cash equivalents, beginning of period</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDktMi0xLTEtMA_f4d432b9-c6c0-4121-a62d-c93f69dec64e">17,305</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDktNC0xLTEtMA_fa15552b-f76a-4257-90d9-7fb8e82b00ef">18,107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">CASH AND CASH EQUIVALENTS, END OF PERIOD</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTAtMi0xLTEtMA_0461260b-b0dc-4efa-87bf-c87994dccb27">11,174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTAtNC0xLTEtMA_32e68e23-96a7-4504-8ee5-e4554bf2c9ee">14,376</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of assets acquired</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTctMi0xLTEtMA_8787e170-e01a-436a-8747-421f6224680b">1,173</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTctNC0xLTEtMA_f58f8484-b8e4-4d41-ae74-17b131948073">6,744</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair value of liabilities assumed and noncontrolling interests</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTgtMi0xLTEtMA_3c2fcecb-a4f0-487d-8729-a33108e5d42d">224</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTgtNC0xLTEtMA_058cd010-7981-4eb3-b248-b333930fe9af">1,398</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash paid for acquisitions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTktMi0xLTEtMA_7fa46291-ffc4-40dc-bcc2-a83effc91604">949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTktNC0xLTEtMA_12960447-e521-4407-96e6-4d46b724e155">5,346</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Notes to Consolidated Financial Statements</span></div><div style="position:relative;width:100%;height:27pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">7</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_49"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_52"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> NOTE 1 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5Mw_76acbc8d-41ef-4912-8fda-6e154c66bab9" continuedAt="i86a5d32c1fc04e39827230c70a7b5f97" escape="true">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i86a5d32c1fc04e39827230c70a7b5f97"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5Ng_ee24c82b-99d5-4dc6-947c-d30387889b04" escape="true"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of June 28, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended June 28, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div></ix:nonNumeric><div style="margin-top:3pt;"><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5NA_9c8490ab-2e44-40a2-99ba-20fe2f99b6b4" escape="true"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal second quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal second quarter of 2020.</span></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5NQ_f9e5f431-24fa-4fa4-86ef-66db3f4c7c2a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">8</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_58"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 2 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RleHRyZWdpb246NzRjMTEwMTUzMDc3NDFmNDg2NTQ1NjdmMWEyOTk1YzVfMTYw_d75f2453-32fa-403c-a893-302ea12d4583" continuedAt="i6f7f4ee6618a4c9bb0a2ba596f7837ce" escape="true">INVENTORIES </ix:nonNumeric></span></div><ix:continuation id="i6f7f4ee6618a4c9bb0a2ba596f7837ce"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RleHRyZWdpb246NzRjMTEwMTUzMDc3NDFmNDg2NTQ1NjdmMWEyOTk1YzVfMTU2_a99d34f8-10cf-41d0-b9c5-5cbcfc9e479b" escape="true"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"></td><td style="width:50.996%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.736%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.722%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.736%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:21.410%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMS0yLTEtMS0w_4e7cc5db-ab8d-477f-a3c8-a92f95033820">1,303</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMS00LTEtMS0w_6cd08aad-b534-401e-85b7-7f0fa86c7db6">1,117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMi0yLTEtMS0w_5948822e-bf1e-4ddb-86fb-738b571e5a15">1,962</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMi00LTEtMS0w_35b1e664-c543-4fc2-a527-11f99746e4da">1,832</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMy0yLTEtMS0w_b3bd792d-f268-4961-b6aa-036df81cd389">6,159</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMy00LTEtMS0w_220aae5b-8391-4bb5-be38-2deac5c39fcf">6,071</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfNC0yLTEtMS0w_a983d8a9-8048-4270-9d55-2e469e9a8c12">9,424</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfNC00LTEtMS0w_411ab600-798d-4b4f-9e87-c3681d204ef4">9,020</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_61"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 3 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Ng_a4220c00-ed5b-49ae-bdac-95a5a391360b" continuedAt="i3ca00bd5eb12474482d49c76a63e41ef" escape="true">INTANGIBLE ASSETS AND GOODWILL</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3ca00bd5eb12474482d49c76a63e41ef" continuedAt="i43ed4a8abc1041a0a731086d5fb38ae9"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.</span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY0NQ_3be66799-b5a2-4201-9b08-02b41f5232f5" continuedAt="i8a5cf93adf9043c5b208269d36822b2a" escape="true"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"></td><td style="width:60.204%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.587%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.425%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.587%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.797%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMi0yLTEtMS0w_defbc938-2e61-4f71-a402-6c29dc5933fb">37,313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMi00LTEtMS0w_d68e1167-1fc1-44a6-86ed-5dae5bd1f07e">36,634</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMy0yLTEtMS0w_78d5d41c-9916-4f1b-9a4f-eb4f54cb84be">14,834</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMy00LTEtMS0w_370efe66-7f96-42bc-b8fa-dabdcb8b5c4c">13,154</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNC0yLTEtMS0w_484c6818-0e9f-42d3-acb1-03d0b13c90b9">22,479</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNC00LTEtMS0w_09e44294-8feb-4fe4-846e-8b4924ee13fd">23,480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c16549172ea409986271df6c73e639c_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNS0yLTEtMS0w_59db8f8d-0490-46d8-aafc-fc6d3016f8d4">22,272</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNS00LTEtMS0w_e32452d3-1e2a-4906-8676-3a173da278b2">22,056</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c16549172ea409986271df6c73e639c_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNi0yLTEtMS0w_274ae961-f289-4ecf-8833-c293269059ab">10,072</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNi00LTEtMS0w_d35531ca-7348-446c-84af-dbfc69cabb60">9,462</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c16549172ea409986271df6c73e639c_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNy0yLTEtMS0w_f10d9530-f4fa-445c-9e3b-0e8897e60833">12,200</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNy00LTEtMS0w_ca274029-3b9f-42d3-8e48-09693b1a1527">12,594</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id939f17ab58546e792a3505ad59025d1_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfOS0yLTEtMS0w_3d90864b-5a37-44ef-876c-213d699cf4d1">6,927</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4a1ace803e04933bfb1ecf684b3b69d_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfOS00LTEtMS0w_bc6065c4-c58e-43ff-aaa9-ff59fa464332">6,922</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ae5346cc81b4f27b4788b31c0e54a6f_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTAtMi0xLTEtMA_25c7993a-1658-4906-a670-2c153d46e68d">5,807</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc73eb3ded6942659b82f23e9f209d83_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTAtNC0xLTEtMA_489e121b-38d6-4362-8fb4-fc6fb7eaca81">4,647</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTEtMi0xLTEtMA_b147af95-1d6b-431b-b7b0-50cbbb798ca3">12,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTEtNC0xLTEtMA_0f12bc16-4a32-454b-91f7-7926d8bff657">11,569</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTItMi0xLTEtMA_60ab91b6-1f46-4028-887b-98661bd10d37">47,413</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTItNC0xLTEtMA_e7ac7649-0e21-429d-b774-7f12bb36ef29">47,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div></ix:nonNumeric><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"><ix:continuation id="i8a5cf93adf9043c5b208269d36822b2a" continuedAt="i99c979eb36ff4b0b984cde3b2eeffb1a">(1) </ix:continuation></sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"><ix:continuation id="i99c979eb36ff4b0b984cde3b2eeffb1a">In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $<ix:nonFraction unitRef="usd" contextRef="ifc06a706e03b46438ac284c25745cad8_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfNzgx_da33292a-04c6-40ce-bd4c-1988753a81a0">0.8</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i3bc60621d8554499a90278e03e0c6c2f_I20200329" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfNzg4_8fb8e9c7-ea9e-4e9c-8d2f-fbcdd6207347">0.4</ix:nonFraction> billion, respectively.</ix:continuation>  </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Mg_9f0bbc84-682b-4ac0-9df9-329d1f501eb5" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of June&#160;28, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"></td><td style="width:39.277%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.578%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.305%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.447%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.084%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.292%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.461%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.447%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.309%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99703a7240b24ff78c8ea755f087ee0a_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS0yLTEtMS0w_4cbdb2e7-856f-4b68-a39b-d1904c498be2">9,736</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3cfcc9ed84c14ef99d0fa0093df15fc2_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS00LTEtMS0w_327c54fc-8e7f-4998-bb46-9c8362eb0ab3">9,169</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9898c86a84104e428b5e32fc5072ca0a_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS02LTEtMS0w_3f9713e2-8287-46f7-b3f3-c6c7af3b9d4c">14,734</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS04LTEtMS0w_0a63d869-b234-459a-a1ce-f2aea697fda3">33,639</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi0yLTEtMS0w_cb50b218-aa8c-470f-82ec-af38b5298b61">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi00LTEtMS0w_aaa24b33-dc71-4f98-9229-7db3bf707521">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi02LTEtMS0w_dec7a63d-1f45-4059-a0d3-31d8760995e6">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi04LTEtMS0w_8d2094cd-7f89-4dd1-ab3f-70b2bfff281e">184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC0yLTEtMS0w_5fb4b41b-c7a2-4d6b-ac63-53fa861a2485">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC00LTEtMS0w_bb50340d-821c-4003-a9e8-bab2c5bbcb10">45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC02LTEtMS0w_c0524d9b-0d25-4ae6-b71d-81f711ffe22d">12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:GoodwillOtherIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC04LTEtMS0w_3a29a470-575b-48bf-bf22-42835a887ec7">67</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5317e81770cc465384ed2fda2daf0206_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS0yLTEtMS0w_34a0ab06-e7aa-4608-8a2a-9cf91344791e">9,746</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7dc0631cabd64cff92a35dc49719e5e8_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS00LTEtMS0w_49a73878-fe3f-4f29-a732-fa870af20c1e">9,215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ide8ee6042d8a44199c107aa75b895f4d_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS02LTEtMS0w_a0e98967-499b-4808-896f-bacdbdf30b3a">14,929</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS04LTEtMS0w_505bdf17-0d2e-4d3c-b83d-b9fac5e431bf">33,890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average amortization period for patents and trademarks is <ix:nonNumeric contextRef="ifb1af4e8ba9744f08026427afa0d3297_D20191230-20200628" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfOTUx_8a2e0f34-48af-48bf-b88b-394d0cbd1013">12</ix:nonNumeric> years. The weighted average amortization period for customer relationships and other intangible assets is <ix:nonNumeric contextRef="iae716e872a654f7d8eb4cdca336d0296_D20191230-20200628" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTA2MA_ab538735-908b-4d2f-aeb3-31b8d069faac">21</ix:nonNumeric> years. The amortization expense of amortizable intangible assets included in cost of products sold was $<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTE2Ng_ee8d4225-60e4-40a8-9b65-acd842c2d6cc">1.1</ix:nonFraction> billion for each of the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019. The amortization expense of amortizable intangible assets included in cost of products sold was $<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTI5NQ_68c66198-32cb-4f09-9203-1ac994142402">2.2</ix:nonFraction> billion for each of the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019. Intangible asset write-downs are included in Other (income) expense, net. </span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i43ed4a8abc1041a0a731086d5fb38ae9"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Mw_efba9bfa-166f-472d-b507-3abfbc95ac10" escape="true"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"></td><td style="width:17.628%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.214%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.008%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.008%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.833%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:17.010%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi0wLTEtMS0w_733600b6-1c11-473c-8e07-aa9a365f9417">4,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi0yLTEtMS0w_64f8d7f8-0d47-4361-ba87-d2dd497bec69">4,300</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi00LTEtMS0w_7d45ff37-0441-4874-85af-cc315be10dde">4,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi02LTEtMS0w_8225dae0-ad96-4c0d-9ccc-d2f53c1f1357">4,100</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi04LTEtMS0w_3fd88095-4f3f-4bb8-824d-d30111068b44">4,000</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 4 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkzOA_747c6866-fbf3-487f-b679-e6242dbfcb3a" continuedAt="iab86152c09694a1b94ab845bb42f4167" escape="true">FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="iab86152c09694a1b94ab845bb42f4167" continuedAt="i2a30517c057546b0a533e6433936a996"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges.  The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of June&#160;28, 2020, the total amount of cash collateral held by the Company under the credit support agreements (CSA) amounted to $<ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CollateralAlreadyPostedAggregateFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTY3Mg_fa44af25-9357-4c4a-8213-d5d4816a08b4">926</ix:nonFraction> million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of June&#160;28, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjI3MA_397bb4c0-3403-47d9-bdee-28afeaffca29">43.9</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="iad06a55c5b434327b4b129a23d14607a_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjI3OA_bd994d72-2483-4c44-bac7-c66528dd3def">22.2</ix:nonFraction>&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $<ix:nonFraction unitRef="usd" contextRef="i2558fa0249654384927e35faad85b435_I20191229" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjQzMw_207c3b81-faa3-4d10-94a8-5cc038313afa">45.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ibc2e1511c074474db7b627c8d636f1f7_I20191229" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjQ0MA_bfe92f46-5285-4ed8-ac23-da2b527215b8">20.1</ix:nonFraction> billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;28, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDU3MA_bc9edd37-06dd-4958-a51c-204239b812b9">636</ix:nonFraction>&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDgyOA_5112e55f-8061-4680-bbc3-64255f515811">next 12 months</ix:nonNumeric> as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:durmonth" name="us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDk4OQ_9021a216-9cbb-4e62-832c-fba2a098b9c9">18</ix:nonNumeric> months, excluding interest rate contracts and </span><span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">net investment hedge</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NzE_b9113c78-7596-46bf-a740-ce4f6531957c" continuedAt="i4aa2e380976244bc86ee6a87565bffff" escape="true">The following table is a summary of the activity related to derivatives and hedges for the fiscal second quarters ended in 2020 and 2019, net of tax:</ix:nonNumeric></span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i2a30517c057546b0a533e6433936a996" continuedAt="i5ffb9fb80ff1489a82c3307859e26528"><ix:continuation id="i4aa2e380976244bc86ee6a87565bffff" continuedAt="ia274ae8d55dd4f408eedd26e52424596"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:18.202%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.359%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.936%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.647%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.513%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.225%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.070%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.936%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.936%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.513%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.663%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMS0xLTEtMA_4f471c7f-2c6d-4031-b6ee-5e423fead76f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2930efbd85243489088de50fb884ebf_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMi0xLTEtMA_e96a2191-b407-4ace-965a-8907fcb49a4c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMy0xLTEtMA_5df75513-4fc9-422f-a47c-20b7c28f00b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic803db0b89c947539400ccc49f897abd_D20200330-20200628" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNC0xLTEtMA_2fb9c509-31cc-480c-9264-4c94bc597ac4">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNS0xLTEtMA_baaeea95-0a11-4af0-9a00-5bb86dcc70f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNi0xLTEtMA_89c41898-19f2-4365-a2fd-7232abdd80c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNy0xLTEtMA_076d8ec3-68f1-463e-87b4-111564611f2a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtOC0xLTEtMA_af0ef108-bc10-41ff-b1bc-3a22e87f0038">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtOS0xLTEtMA_5ec82462-90c2-459f-b525-ccd525662737">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMTAtMS0xLTA_2e601bb8-4c9a-427b-a34d-b2996de59e2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMS0xLTEtMA_bfc05ca0-5ee5-44ba-a2cc-a956baca9648">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2930efbd85243489088de50fb884ebf_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMi0xLTEtMA_35361224-b715-45eb-acf3-90bf3423b134">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMy0xLTEtMA_6f4bcbca-f9a3-4440-a45e-1aad99509f3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic803db0b89c947539400ccc49f897abd_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNC0xLTEtMA_79be0151-4bd0-44f3-a631-c96623ff2c37">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNS0xLTEtMA_aa547b69-872b-416f-95f7-1d17010745c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNi0xLTEtMA_fbe1338b-c85c-45a0-b989-a68e82aa0b6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNy0xLTEtMA_c08725c0-926b-4ae7-b2d6-001a50e734b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtOC0xLTEtMA_049f4e75-b883-4e43-b74d-1e8e05001931">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtOS0xLTEtMA_439d3233-affe-4a70-8dfb-aaf386566cdf">39</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMTAtMS0xLTA_2c864287-771e-400f-ad36-c29c5707ba86">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMS0xLTEtMA_201b88e9-942f-4d5d-bc7d-03deadd4e872">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMi0xLTEtMA_85407e40-6f40-4a95-82a2-7737f79e05ae">62</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMy0xLTEtMA_845a85e6-ab28-4d56-aeeb-af0a1ec60e0c">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNC0xLTEtMA_1f88069c-178d-4527-b507-0b4d17a6731a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNS0xLTEtMA_d414a315-90a8-4489-a06b-4d892bc9076f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNi0xLTEtMA_854db62d-829d-4410-b0d7-edd87b8a883f">14</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNy0xLTEtMA_03c59f61-c4da-485e-a388-0f91ca7bb5c0">101</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i392345cf23fa442fa586318c28775403_D20190401-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtOC0xLTEtMA_1581ae2e-c9cb-4772-8de0-1f85da242553">36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtOS0xLTEtMA_783a0265-236e-45c5-bd1f-cd0fcdbb5e26">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMTAtMS0xLTA_169a0783-5d37-4d21-b091-d3932fb34bb7">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMS0xLTEtMA_aa49cd9d-3b7e-421c-a09d-d5c4dbf7143f">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMi0xLTEtMA_fd0288f0-16a6-4b76-8158-c6969b63eb2f">128</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMy0xLTEtMA_f544b430-30bb-48f4-b1ee-436afaed5bd6">10</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNC0xLTEtMA_2bc972d8-3fbb-42a1-bf19-463359a2c327">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNS0xLTEtMA_9c6ce64f-923a-4951-9da2-d1e9323fa888">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNi0xLTEtMA_9bbbf799-7886-4af7-af23-ed7c05b2192f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNy0xLTEtMA_3dab226a-2b4c-40a5-b820-d4c9544ea60c">50</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i392345cf23fa442fa586318c28775403_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItOC0xLTEtMA_7cc15147-58e3-44ba-aaba-42cfff4f9ac7">18</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItOS0xLTEtMA_0acb034e-ff17-425a-b93f-91dce7a219dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMTAtMS0xLTA_17be1567-545e-4c9b-882e-7c8cbd2bfa88">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMS0xLTEtMA_18297f6f-3ac0-4187-802a-7e037179cddc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMi0xLTEtMA_25a09c8f-b9be-48b0-aeba-c390f49ad616">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMy0xLTEtMA_b8d092be-fcd2-4e43-b19d-a127e085db47">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNC0xLTEtMA_28073865-b918-4e50-ba69-0ac86265e259">83</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNS0xLTEtMA_acc2a0a8-0e13-4126-a2a4-3b0cba4040b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNi0xLTEtMA_f5c11c80-86ac-4785-8689-343381ab1f5e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span><ix:nonFraction unitRef="usd" contextRef="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630" xsi:nil="true" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNy0xLTEtMA_e1c8a45a-100a-44b0-bae7-93a2113891f5"></ix:nonFraction></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtOC0xLTEtMA_8b42477b-49b8-4fc4-a92c-21b54d96f83b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtOS0xLTEtMA_59ec5a4f-e123-4c3a-b4b2-f7584e16dc2c">64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMTAtMS0xLTA_07938156-f4b6-4be7-aeff-d7c40f256b3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMS0xLTEtMA_7ef75cd7-2c32-4146-ac7c-e0c18a719d40">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMi0xLTEtMA_b8377e44-6a5e-4b34-97ea-52b74f7902b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMy0xLTEtMA_a86f51d7-4d4f-40f9-92da-5297d0e01420">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNC0xLTEtMA_e9f35d1b-299f-4216-8d23-c29d1aabe3fa">100</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNS0xLTEtMA_066c1f85-ea81-4d9e-a55a-7a69d9d042eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNi0xLTEtMA_b879962f-bbe4-46e9-8e4c-a2f49d414f2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNy0xLTEtMA_c6143a61-6087-4791-b3c5-79ec92cc096d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctOC0xLTEtMA_356094b8-7838-49af-864b-3605e19f0ba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctOS0xLTEtMA_a70095e9-6865-44b2-a972-041a3d9f6ef5">82</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMTAtMS0xLTA_68a3b862-1456-4f38-a58e-3103f812b16a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i5ffb9fb80ff1489a82c3307859e26528" continuedAt="i4b206b0d13fc4286a6566d76a14ea7fe"><ix:continuation id="ia274ae8d55dd4f408eedd26e52424596" continuedAt="i21ce84e893b9429c9028eec4de6f5adc"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal six months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:17.593%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.402%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.982%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.272%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.272%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.272%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.111%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.272%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:5.692%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.272%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.860%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMS0xLTEtMA_946df260-313a-47d4-9b53-27508c7bdae8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMi0xLTEtMA_d35624b6-99f7-4933-86ae-9e531bac971f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMy0xLTEtMA_76a9f683-aea8-424f-97c2-ca6fa59d548f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNC0xLTEtMA_e4693348-f468-468f-9c72-a7e21b62b710">79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i182f09e72a12408fba69944468ed839b_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNS0xLTEtMA_058941c4-565e-4000-b062-92e2152eac9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNi0xLTEtMA_d363379e-5ec7-4b54-8b46-6d9acf56b19a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNy0xLTEtMA_0eac1eee-9125-4c7e-b336-bdaaa32f8830">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtOC0xLTEtMA_c584bb0f-92c8-4732-8f08-a82a10d4ecdf">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630" decimals="-6" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtOS0xLTEtMA_ed1dd248-ab54-42ed-81b6-cd146500a141">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMTAtMS0xLTA_4565e36a-396e-4c24-a436-d29919da26c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMS0xLTEtMA_a9b16e1a-2040-4bb4-b674-a9acb9a01859">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMi0xLTEtMA_20e84784-dae8-40b2-9e89-f1f4573dc6cd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMy0xLTEtMA_6ff667d5-ae73-478d-ae8c-6bb00d2372c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNC0xLTEtMA_ec71cac3-5329-457e-a5bc-d463586cc158">79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i182f09e72a12408fba69944468ed839b_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNS0xLTEtMA_eaaa49eb-20ab-4a3d-b57a-2293b0ca046f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNi0xLTEtMA_f9117411-146e-4f43-96b2-08e4e59008d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNy0xLTEtMA_25251512-c839-421d-8c87-da1d61743b34">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtOC0xLTEtMA_8aacf8dd-3118-4dd1-8abe-e2a6afe866e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtOS0xLTEtMA_d6dfb841-416f-4462-9d15-16e5f586a627">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMTAtMS0xLTA_0d023469-b5ad-4054-90fb-8ed5009882f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a386510568948ef9401f50d743744af_D20191230-20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMS0xLTEtMA_de8c89a6-bf6f-458a-92f7-1e8b3279617d">7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMi0xLTEtMA_e65ea5e5-c531-4736-94c0-72d99314c1d4">235</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMy0xLTEtMA_adda8f1a-b00a-484a-aa7c-b3c355f5ea63">108</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNC0xLTEtMA_f20ab9c2-b7b4-4bad-9739-51a17a33a169">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNS0xLTEtMA_c995a704-4d35-413b-a379-f1bbfa2c2c9f">2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNi0xLTEtMA_6ccf1991-416d-4a59-b323-2fb4c38ad668">35</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6147540408284062babe0382c2ed602f_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNy0xLTEtMA_e4a292d6-8e1e-41a6-b065-6f7e25fda8e6">136</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i771189b421614759bcfeb81a969af79c_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtOC0xLTEtMA_c46520b2-6912-40b0-9fea-b40672ab67c8">103</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtOS0xLTEtMA_110c0506-e26e-41af-a1df-9847f1c9373f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMTAtMS0xLTA_9be92306-3eda-4bda-9f01-b257e0ea8aea">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a386510568948ef9401f50d743744af_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMS0xLTEtMA_e2247b59-7e33-45d1-9ddd-32043d52cf6f">9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMi0xLTEtMA_02cd3f1e-a67f-491e-8400-3bcea760f308">174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMy0xLTEtMA_2e26870d-3568-4fbb-af3e-e1e1e34e27af">120</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNC0xLTEtMA_aac6f44d-706a-4b54-8f01-daff60de562a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNS0xLTEtMA_bcb1d053-6f93-4859-aa46-d70e1fe714a2">14</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNi0xLTEtMA_bfc2e2b0-4561-439a-9efe-99553a0f758d">6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i6147540408284062babe0382c2ed602f_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNy0xLTEtMA_6126e159-0000-4f06-acf6-6d47d52bc427">346</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i771189b421614759bcfeb81a969af79c_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItOC0xLTEtMA_bb5a54fa-6a34-4611-b31b-04b86255b923">92</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItOS0xLTEtMA_b4545d8d-ccff-4813-ba74-135ac7683ee2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMTAtMS0xLTA_2a8e5efe-900d-4317-8ace-5cbb2261b1c0">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMS0xLTEtMA_f193f343-fe6b-43a0-86b5-59770b059016">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMi0xLTEtMA_07d50628-090d-4553-a4bd-309ec95e7ed2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9ac6becf67b448c872942fc733563e5_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMy0xLTEtMA_f7267c79-6b9a-4078-b924-75b8795c86fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNC0xLTEtMA_615c43e0-2e4e-434c-be3d-56f2995ae780">181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if84c79837433431cbfe27e56a7471773_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNS0xLTEtMA_ed01d07d-24f7-4a9a-be32-44f0b0423f19">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNi0xLTEtMA_27f46052-cd63-410d-b745-b8f3e23f50e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNy0xLTEtMA_7b570ce3-ac5e-448d-849d-fcf44deb2129">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtOC0xLTEtMA_2ad3aa30-ea98-45f5-9b51-6b19e14b4ce6">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630" decimals="-6" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtOS0xLTEtMA_d2e40712-d791-4288-980c-a985c618673e">118</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMTAtMS0xLTA_27cce8ed-63b0-49a2-bf85-1721badfde9b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMS0xLTEtMA_afc8f492-1bf7-4000-b1c7-c499fe1fef32">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMi0xLTEtMA_7b191cf1-ac5f-4c4b-8f1c-de342dcaa285">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9ac6becf67b448c872942fc733563e5_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMy0xLTEtMA_44f67a09-f401-409b-af64-5f596e3a883e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNC0xLTEtMA_d3620e81-5e3d-4c21-b480-c7768ecc55e4">725</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if84c79837433431cbfe27e56a7471773_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNS0xLTEtMA_ebc3cb28-21ac-4599-92b5-f41628634ca2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNi0xLTEtMA_2af27858-026b-4366-94f6-8c24e4310b94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNy0xLTEtMA_172ed22b-fe77-44bf-9844-045c529d4a48">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctOC0xLTEtMA_fa6af805-ba3c-41b0-b7a7-fd7f99c59642">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctOS0xLTEtMA_c6161702-d937-4634-a697-f43eec7dc148">140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMTAtMS0xLTA_c7bf7804-1255-48c2-9489-c4d080fddc1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:28.555%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.823%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.789%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.969%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.789%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.992%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.935%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.700%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.648%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" xsi:nil="true" name="us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MTQ_14095e3a-d521-4644-a88b-8ef16f381972" escape="true"></ix:nonNumeric>The following table is the effect of derivatives not designated as hedging instruments for the fiscal second quarters and fiscal six months ended in 2020 and 2019: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MzQ_dce8ed8b-c3d8-4926-a65f-f6d8d2603e21" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:26.260%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.698%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:15.971%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.959%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.594%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.814%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.594%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:9.594%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.118%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.598%;"></td><td style="width:1.0%;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i02769757e5e740ba8d0918956fb4bebe_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC00LTEtMS0w_8e59ca3c-1ffd-4329-aac6-fca38e2038fc">24</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i0e42ae0e28f84a3883a9d31defcc19c3_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC02LTEtMS0w_5bb72b7e-fddb-440c-8e76-f65884f58a69">50</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i890db46e47fd49d29bf0222d80de0e45_D20191230-20200628" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC03LTEtMS0w_8715fed1-7473-4716-bcdc-27e1cdbb0fca">65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ib840e261052c4ea5ac6bd3f5620b9e0f_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC05LTEtMS0w_58a037bc-3edd-4628-8600-a8e6454cbae2">88</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="i4b206b0d13fc4286a6566d76a14ea7fe" continuedAt="id1ff604ce174451dad76718798665829"><ix:continuation id="i21ce84e893b9429c9028eec4de6f5adc"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal second quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:20.463%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.869%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.869%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.814%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.710%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.959%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.869%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.524%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.875%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy0yLTEtMS0w_28213c51-724c-424d-9d19-3cd712433381">95</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy00LTEtMS0w_ae59504b-93a2-4b95-98e3-ec3a3dd4bd83">57</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49811ec159eb4ac3bc3e2bbd99fe655b_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy04LTEtMS0w_83da79cf-43a0-4565-8e2a-0f1e4bde4c0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i440d6fd614824bcc9d8ddcc6388c5585_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy0xMC0xLTEtMA_712f4bde-3963-4b66-906b-f86c8febd0ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i05a3bd79ad904c7c8b977b55b1dfda9d_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC0yLTEtMS0w_60b221ef-f2fe-478f-8346-3ac63fac0dfc">186</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia24f094cc45d4b64bcbc61338f27ef34_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC00LTEtMS0w_ac1210dd-df04-4c61-88b6-dee0c0bc2932">57</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idab234b2a9db4b839ddaf49647f6f9f0_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC04LTEtMS0w_09c1c82e-d549-4a29-96b9-8648c6acd40b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ec571d4979a4ebba093f4d51dbf209d_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC0xMC0xLTEtMA_ee8bd351-035d-4a59-a7a4-bf1ea7005770">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal six months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:20.496%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.175%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.885%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.815%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:27.172%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.961%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.030%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.525%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.891%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC0yLTEtMS0w_8484eb70-4cb8-46b2-88fd-cb577fbadb52">48</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC00LTEtMS0w_81351b68-11ca-443c-8408-c9e267759875">14</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i636d1fd3b5314b0cb1e7b53344d7a601_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC04LTEtMS0w_dbdeac16-8d47-4359-ac31-4aad676c5e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i803140059c0440d58c12d070ec9ef9e4_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC0xMC0xLTEtMA_2cf55b3e-dade-4fee-ba0c-36ff56bb1e21">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie56c599de2e24fc180918708256afa06_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS0yLTEtMS0w_e95ba754-93ca-4401-b898-0a6a37bf6d91">641</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4560dde64424b5eb34ac46f8e75831f_D20181231-20190630" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS00LTEtMS0w_38f43369-4427-47cf-8d3c-9ff723c6da75">313</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09bd4a7957314ad4806a70ff0309af9c_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS04LTEtMS0w_f43216f6-4396-4bac-b063-c6da631ef2fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac20a877725e4f95bad00d306f8ef1bd_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS0xMC0xLTEtMA_8655cf98-e24d-4985-9dfa-8ac8ba79419c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:continuation><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NjY_83539a9f-077c-4f6b-b555-23ceb502dfef" escape="true"><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:25.071%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.983%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.532%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.835%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.349%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.539%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.869%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.835%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.869%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.539%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.579%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ca06658d0fa40fd9124e23676ae5f16_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi0yLTEtMS0w_f353330e-b7d9-404e-bc69-a4e5a1e28d6f">1,148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628" decimals="-6" name="us-gaap:EquityFairValueAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi00LTEtMS0w_ddaff9cd-6f32-449d-9d50-1ab0c3ae9fec">196</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628" decimals="-6" name="jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi02LTEtMS0w_0b30bae1-586f-492a-92b4-82d0dd16bf0d">144</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi04LTEtMS0w_3439184b-66b4-4cf5-9251-2b66b6d0700d">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi0xMC0xLTEtMA_53b33f55-e1a9-4737-b7a9-0d49e05ebd51">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f752123964c43149dbce663ffb8dd1a_I20191229" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC0yLTEtMS0w_a5d738a4-f866-4edd-9501-5fca14fa3a99">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:EquityFairValueAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC00LTEtMS0w_f54cc332-e240-4a40-82c7-e0e9c0fb64da">28</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628" decimals="-6" name="jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC02LTEtMS0w_69087957-a129-4d6b-9b6e-2d0e20c678e1">28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9326dae4609548fba0848714a64d1794_I20200628" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC04LTEtMS0w_34da7f4c-b5e1-4b29-af79-a0450281cca3">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9326dae4609548fba0848714a64d1794_I20200628" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC0xMC0xLTEtMA_7597df2f-97eb-438b-9bc4-ad05a8ac78b7">712</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For equity investments without readily determinable market values, $<ix:nonFraction unitRef="usd" contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="jnj:EquityFairValueAdjustmentImpairmentLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNjU1NA_9d03bd07-127e-4c45-84e5-65e0c2542672">39</ix:nonFraction> million of the decrease in the fair value reflected in net income were the result of impairments.  There were $<ix:nonFraction unitRef="usd" contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="jnj:EquityFairValueAdjustmentChangeInObservablePrice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDk0NzgwMjMzNzk4MA_31691568-f20d-4a59-9b77-60d358fa5cc9">11</ix:nonFraction> million of increase in fair value reflected in net income due to changes in observable prices.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="id1ff604ce174451dad76718798665829" continuedAt="i57ab9ba446cb4b90a65200ddb110c010"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#8217;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following three levels of inputs are used to measure fair value:</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 &#8212; Significant other observable inputs.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 &#8212; Significant unobservable inputs.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MTY_c0644d1c-1977-4e6b-9396-7886793e2c4b" continuedAt="i0fb072f0bdcc4e47a0a741dd45200f01" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of June&#160;28, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:47.329%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.345%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.302%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:5.004%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.345%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.545%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:13.950%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC0yLTEtMS0w_100db368-966c-4efb-ba8b-37dd4000b9fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i266b986790574bd58dd9c8410be41161_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC00LTEtMS0w_39b2f670-591d-4fc8-8b1b-fb7ab5e66c40">395</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC02LTEtMS0w_590eebdd-4ea2-438e-adfa-940a05487412">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC04LTEtMS0w_62084c8e-3dc3-4646-aa4e-8cdc86f3093a">395</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC0xMC0xLTEtMA_2934c65f-bbca-4595-979f-af5d46ae9474">209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32a304915e484dc482c62bb1f219c6ec_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS0yLTEtMS0w_8c202d31-ddeb-48a1-896f-48812cf89341">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i07152e7d66cd425cbf3e240d1e56cec5_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS00LTEtMS0w_f1d02d03-3d4f-4251-965c-c3f85aee39bc">1,126</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e246117e68944788661db5d2b317e56_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS02LTEtMS0w_05833ef3-7dab-4d59-8f8d-6ed1a3f0a003">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i540760381d80440cad88a6dab18c3a11_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS04LTEtMS0w_39b8eeba-cb4c-404c-a89f-a2e400c97131">1,126</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i808beb23831442638cf20b785a026f54_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS0xMC0xLTEtMA_07ea0cb3-02a1-4104-8086-2ecb1c46fa73">693</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy0yLTEtMS0w_fb782f06-c1eb-49c4-8f1c-9db374bff51c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy00LTEtMS0w_13a7ad8f-66f8-4dc1-9135-ca29a591a39a">1,521</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45557044d86f4718ba2718ad7252be12_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy02LTEtMS0w_ed8fe76b-149e-4bb0-b5db-45bb3f001fe0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy04LTEtMS0w_795fbe1a-e01f-4a9a-ba89-262b88a36e53">1,521</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1dfa706123d84147824f6fd9464cff19_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy0xMC0xLTEtMA_a225fdb1-22a3-437d-be04-fde43e016ded">902</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS0yLTEtMS0w_15458c7a-9fe5-4204-afaa-82f6d27c75f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i266b986790574bd58dd9c8410be41161_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS00LTEtMS0w_47e67144-b369-4b6d-b25e-3d71e74d3aae">260</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS02LTEtMS0w_7d25c782-c8b2-45a1-b0e9-dcac1813d516">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS04LTEtMS0w_702d79a7-74e0-4509-9a70-5e1fdf606fed">260</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS0xMC0xLTEtMA_b4ec8274-b95b-432c-a8ac-e50d3cec1534">426</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i32a304915e484dc482c62bb1f219c6ec_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtMi0xLTEtMA_22cfefed-ded8-415c-b130-e0b6202ac3d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i07152e7d66cd425cbf3e240d1e56cec5_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtNC0xLTEtMA_28fee5e1-0773-49a0-a644-57d320a59a3b">251</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e246117e68944788661db5d2b317e56_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtNi0xLTEtMA_5556f572-2411-4c36-a206-446883940505">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i540760381d80440cad88a6dab18c3a11_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtOC0xLTEtMA_12eabd59-0f84-4db6-8d77-e9e83a4f262d">251</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i808beb23831442638cf20b785a026f54_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtMTAtMS0xLTA_8dab137a-9ead-4f02-a658-8407d190d4e6">193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItMi0xLTEtMA_94c7e699-25d8-4049-bcb9-b30a6d361401">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItNC0xLTEtMA_e2b80da8-a3c4-45e4-9f59-c1ae9f5621c0">511</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45557044d86f4718ba2718ad7252be12_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItNi0xLTEtMA_3762f740-ae17-4eca-a696-e81b3b432b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItOC0xLTEtMA_aa33890d-2c4b-443a-8ced-d82c7522988e">511</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1dfa706123d84147824f6fd9464cff19_I20191229" decimals="-6" name="us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItMTAtMS0xLTA_834d887c-2754-498f-bdbf-5f968c188bc5">619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtMi0xLTEtMA_33ecf310-164a-4f92-8889-109c5df4778d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i266b986790574bd58dd9c8410be41161_I20200628" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtNC0xLTEtMA_5161cd7b-d0e3-42e5-bc6f-b3699f0be5bc">38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtNi0xLTEtMA_136cccad-ec4c-44a8-b80a-598be74c924a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtOC0xLTEtMA_d828a229-5bc0-4f44-aab6-f103429a754e">38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtMTAtMS0xLTA_f5cb1913-c3af-4c5f-85b5-887bec7c671e">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctMi0xLTEtMA_05762e50-bf66-42a5-b23a-11413339f292">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i266b986790574bd58dd9c8410be41161_I20200628" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctNC0xLTEtMA_487237e6-4615-4d7e-94e1-f37d330b5a1c">47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctNi0xLTEtMA_591099d8-ec65-44ea-9871-dea6a67f22e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctOC0xLTEtMA_8e27cd8f-7ac6-424c-99d2-d99f0108d6da">47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229" decimals="-6" name="us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctMTAtMS0xLTA_4dcc2615-586b-4ce0-87b0-eedd0b3b6595">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktMi0xLTEtMA_81421804-c13a-42e1-8f07-6f1094543b33">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktNC0xLTEtMA_d98cb18f-0014-41ca-b77f-1fdac7daf8ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45557044d86f4718ba2718ad7252be12_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktNi0xLTEtMA_96a07b43-068b-4ebc-a157-8cb8de920acc">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktOC0xLTEtMA_5ef6e38c-1551-4aca-93c8-af428807044c">1,488</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktMTAtMS0xLTA_8e83259f-e015-4747-b074-692b4b255f5c">1,148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtMi0xLTEtMA_973252d1-33d1-4894-a3d0-747e48563a43">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtNC0xLTEtMA_ea217821-a0e0-4aa9-a7ed-e9baf124cbe1">10,047</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45557044d86f4718ba2718ad7252be12_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtNi0xLTEtMA_831c2e20-7e27-4009-acb0-fbd500d39e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtOC0xLTEtMA_b64ac5c6-7cc9-4ce3-ab03-06641c610eeb">10,047</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtMTAtMS0xLTA_c576e6be-c32a-4523-9245-02496570916f">4,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45557044d86f4718ba2718ad7252be12_I20200628" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItNi0xLTEtMA_67a99e16-ce77-4c14-b2ee-503a145ce303">796</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItOC0xLTEtMA_0fe4940d-3736-4685-96fa-6919482485ee">796</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItMTAtMS0xLTA_ef0932a4-f927-4617-b5d3-25f1172939fe">1,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:42.005%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.992%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.198%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:6.187%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:22.418%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMi0yLTEtMS0w_06bccdea-30b3-4e16-8acc-7367a7706bf3">1,559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMi00LTEtMS0w_3eb7b36e-4248-4acd-bcac-15c3761e7a9d">925</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMy0yLTEtMS0w_127292a6-b651-4b17-b72e-cc6f29f724b5">1,437</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeAssetFairValueGrossLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMy00LTEtMS0w_382d09dd-0d01-4c8c-a4f8-79d34ab2ecf0">841</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNC0yLTEtMS0w_e1aa6c70-ac84-43b6-ad78-b00ef19f4017">122</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNC00LTEtMS0w_131ffe49-46e4-4725-89c3-137b48939142">84</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNi0yLTEtMS0w_d6186619-c517-4bac-8bad-aa823bb63b55">558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeFairValueOfDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNi00LTEtMS0w_39de75d1-e237-4cc8-bc69-f1b99582ac81">652</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNy0yLTEtMS0w_56246fa5-3267-45b0-ac47-947cee2ff437">510</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeLiabilityFairValueGrossAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNy00LTEtMS0w_70741ce8-334a-4f93-a9a0-16c3c08e84b9">586</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfOC0yLTEtMS0w_6e203bbc-e2c8-446c-bc88-2d0adf801086">48</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfOC00LTEtMS0w_3849d9b6-e830-489e-ac81-792206387dba">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><ix:continuation id="i57ab9ba446cb4b90a65200ddb110c010" continuedAt="id36885a76d554cf08ea552db8c33905a"><ix:continuation id="i0fb072f0bdcc4e47a0a741dd45200f01"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"></td><td style="width:40.369%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.410%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:24.706%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.406%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:24.709%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4250b233c8424335ac39cd07c8101199_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfMy0yLTEtMS0w_94cf6736-56a0-44ec-b625-6913293bb452">1,715</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfMy00LTEtMS0w_3a9fd38f-3d3b-4d92-a308-25e4c0592642">397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" sign="-" name="jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNC0yLTEtMS0w_e9e59692-68eb-41ea-bf6e-632fb9adffe7">938</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNC00LTEtMS0w_148ccafa-9e4e-4f4e-b718-b4f29e2a7c11">35</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNS0yLTEtMS0w_7577c303-a400-4d51-89c6-ea3333b64dd4">106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNS00LTEtMS0w_c3fadd52-7e6b-4f97-ba16-5add7c6d5283">1,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNi0yLTEtMS0w_326c4369-5678-45ce-8c3f-e4361d29f0ab">87</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNi00LTEtMS0w_2ede7979-fa91-4daa-b913-4ae9bef24d25">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNy0yLTEtMS0w_b8d50260-b243-40e0-9896-4c1bdd181936">796</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNy00LTEtMS0w_95754ad7-d9c5-47ed-97c5-a09617f45c8f">1,562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $<ix:nonFraction unitRef="usd" contextRef="i1b8d63c17e114b2e9b9a96275f1697e4_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODgyNw_9b014ee0-4479-47ae-b3ac-1218fd92773c">1,148</ix:nonFraction> million, which are classified as Level 1 and contingent consideration of $<ix:nonFraction unitRef="usd" contextRef="iccc7bf9a45e54601aca24b8cc9b8ea57_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODg5NQ_ed77f62b-3efa-44ee-87b6-59795b94f779">1,715</ix:nonFraction> million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $<ix:nonFraction unitRef="usd" contextRef="i3e6c057229dc4bd7a12d48cbd4db8754_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DerivativeAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODkzOQ_8a967939-1bb8-4e36-8633-ce890ccdf611">1</ix:nonFraction> million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Includes $<ix:nonFraction unitRef="usd" contextRef="icad4b86ea6694e5f9adc78bc100d29fc_I20200628" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTE3Ng_bb0e2b04-016d-40b5-a98c-fbe4ab0c2d1d">793</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i83d021f672be43748204f5d0a7908366_I20191229" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTE5MQ_8a023c64-c7da-4566-a4dc-ec95aaf303df">1,631</ix:nonFraction> million (primarily related to Auris Health), classified as non-current other liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.  Includes $<ix:nonFraction unitRef="usd" contextRef="idedeb1dfe09443a7b82d283ca7b15298_I20200628" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTMyNA_5c529c46-2ff8-4075-a03c-475b8d978641">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id9bc5029a28b4c25ac4f1670189d549e_I20191229" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTMzOQ_08e13cfa-4db2-4eca-aad7-4de389929589">84</ix:nonFraction> million classified as current liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company recorded a contingent consideration reversal of $<ix:nonFraction unitRef="usd" contextRef="i76c9318d92354ba2a3360e24144f1b37_D20191230-20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTYxNQ_696b593a-0661-485e-ae96-b0626b49fbbf">983</ix:nonFraction> million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The one-time reversal of the contingent consideration was recorded in Other income and expense. As of June 28, 2020, the estimated fair value of the remaining contingent consideration is $<ix:nonFraction unitRef="usd" contextRef="iad126eeedca04aedbf65bca596749ee3_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTkwOQ_b38763c9-7822-492d-a0b6-da50032e96eb">169</ix:nonFraction> million.  For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div></ix:continuation></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="id36885a76d554cf08ea552db8c33905a" continuedAt="i81b9fe0e80934af1a93414da72a06174"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MjU_40a4836a-d9de-4cfd-838d-923d2bf25b87" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of June&#160;28, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"></td><td style="width:21.308%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:8.827%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.631%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.481%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.827%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.454%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.578%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.153%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.282%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic563629e1c85446181090d0223f3a034_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS0xLTEtMS0w_b4b15ed5-6220-4091-8622-ae7122bbe98a">2,215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic563629e1c85446181090d0223f3a034_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS0zLTEtMS0w_215a864a-ae8d-4e81-9c4c-be115ad63e71">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic563629e1c85446181090d0223f3a034_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS01LTEtMS0w_149c15aa-51a4-4902-825b-7b8159662a36">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic563629e1c85446181090d0223f3a034_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS03LTEtMS0w_3d7569ab-532b-40b2-9c2b-1a4374360e53">2,215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic563629e1c85446181090d0223f3a034_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS05LTEtMS0w_1313b000-5c8f-4250-a40f-a9b2501d8a14">2,215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0xLTEtMS0w_3124ad44-7f40-4182-9989-7aeaa8b25ee2">655</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0zLTEtMS0w_31e1dd89-2e71-4f91-aad7-7f27a66b652c">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy01LTEtMS0w_16379a4e-03fe-4df6-86c2-4f5daa63a556">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy03LTEtMS0w_7587fdbd-12de-41f1-8c3a-33403c84821b">655</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy05LTEtMS0w_b396e89d-9ac0-4664-848b-d5c890d9cd92">225</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0xMS0xLTEtMA_c60cb6f6-e437-4c78-a6e4-899c5416a26c">430</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0xLTEtMS0w_1c39fdee-9682-48dd-bc74-60d79a6a9f0e">2,372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0zLTEtMS0w_beb785fa-daee-428f-92b8-5569eee4c2d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC01LTEtMS0w_818f1fe2-65ae-40f1-b17c-2423debe8d65">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC03LTEtMS0w_0fb7080c-c8b8-460f-aaf7-5b2f1b79a359">2,372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC05LTEtMS0w_c60a14a4-268d-4fb9-a12f-dad74c33ec7b">2,372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0xMS0xLTEtMA_b2edacd3-3a7c-4f84-98d2-73b01f89470f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS0xLTEtMS0w_999cb3d3-91bc-46ba-8002-8f2d1f8e1ff1">460</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS0zLTEtMS0w_7f95c150-27c2-4bbb-8881-a563136ba7aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS01LTEtMS0w_8a8029ef-e892-4257-93e6-e0eb7cf66a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS03LTEtMS0w_54a673fa-bc26-48d8-a5e1-24b52da49d0e">460</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS05LTEtMS0w_0f828305-3e75-430a-b7ac-cc1a1b9b3293">460</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0xLTEtMS0w_14f53788-ae99-42c7-b278-96f4f5bf12f5">1,279</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0zLTEtMS0w_11f3aca5-aaa5-4ca9-a24a-2d9f91d6d8d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi01LTEtMS0w_096e5133-0ffa-4616-a2f5-96ab51262550">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi03LTEtMS0w_93dbb1bc-a929-4e64-859a-f792159b1be6">1,279</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi05LTEtMS0w_cd9ec58a-06c1-4c48-9f16-cb1e35979f61">301</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0xMS0xLTEtMA_29ae692c-6a77-4dc7-99a4-f5dd86196ba7">978</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy0xLTEtMS0w_21dffcf4-12f0-4a2d-8511-dc28291f41ae">1,528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy0zLTEtMS0w_3ce9296e-9941-466a-8d0e-00398a375d34">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy01LTEtMS0w_79179af7-a8e9-481b-ac2d-701f7b230fd9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy03LTEtMS0w_019e4e79-5a0f-40c7-8f35-3ca1954d5ce5">1,528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy05LTEtMS0w_14e02c95-2d4c-4dda-81ef-f972293556ce">1,528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC0xLTEtMS0w_2c6df6d4-c1f7-4cae-817a-3ac3a7ae4a78">579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC0zLTEtMS0w_9ec869b0-6828-41eb-a925-904436ba3e6b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC01LTEtMS0w_a506cf08-a6d1-47a0-bdc1-42ef520e0eb2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628" decimals="-6" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC03LTEtMS0w_be0929cc-332e-4c1c-9514-1ee3628753b1">579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC05LTEtMS0w_7f8b4cba-bed1-48b9-863c-971d329f781f">579</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0xLTEtMS0w_b71c83ff-20d4-4bca-8617-3943123ef3df">9,088</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0zLTEtMS0w_5748726f-f857-44b3-9293-e4e9dc1b3f53">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS01LTEtMS0w_74309f7a-9982-433c-bfed-3e983c1eacd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:HeldToMaturitySecuritiesFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS03LTEtMS0w_65fad8cd-54bc-4d62-9f81-9c3e7b147d1f">9,088</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS05LTEtMS0w_9cb23aab-c414-4282-ae4f-a406c127aa26">7,680</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0xMS0xLTEtMA_fa4750be-c864-4ae2-bf6d-bb8c7c35a4bf">1,408</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMS0xLTEtMA_4c402a96-b733-4699-ace1-2ab153e25f6f">9,786</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMy0xLTEtMA_053c1eb4-15f1-416a-a7ba-7af3a2c0c38e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItNS0xLTEtMA_e6b841f5-dd95-488f-acb8-0ba6e257cab0">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItNy0xLTEtMA_75f3e5b5-d7a7-4190-9a79-23b799ea87c9">9,786</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItOS0xLTEtMA_69540ef6-a130-4f95-a72f-f60dc00fb1d2">3,480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMTEtMS0xLTA_edae7097-f3f2-4208-a560-ec418cc764b9">6,306</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMS0xLTEtMA_c93c032c-1ad6-46de-a13e-d14fe48c3106">255</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMy0xLTEtMA_54ed6e45-f59d-4155-b4ff-9b8a848acf03">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtNS0xLTEtMA_8b306f7f-86e9-4446-a3b2-c4fd304afe77">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtNy0xLTEtMA_9074c63c-6f0e-483f-a2cf-5386d7dcf72a">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtOS0xLTEtMA_56f24b52-a9c2-49b1-9c95-5de336877a7e">14</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMTEtMS0xLTA_5c8176ce-54d3-41f6-8df2-54bac9ec2552">242</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMS0xLTEtMA_77915a8e-1f03-4721-9c3d-f48a2835b695">10,046</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMy0xLTEtMA_feee407e-0766-435e-8554-82cbaaaf3c83">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtNS0xLTEtMA_3a983b32-8cf7-4ff8-b3a5-871b0a7c2c3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtNy0xLTEtMA_c4c1ba94-cf0e-4e81-a9ca-1fdf3fd230e2">10,047</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtOS0xLTEtMA_d3d740ee-dfda-4d88-988b-8f1504575816">3,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMTEtMS0xLTA_fcbf8917-b5f0-47cd-8aa4-442ed728889f">6,553</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMS0xLTEtMA_b7ec1de5-6aed-4faa-9ac5-1784d36fab5a">19,134</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMy0xLTEtMA_5ea677b9-5bb4-4f66-a0f2-343e057a4968">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:zerodash" name="jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtNS0xLTEtMA_3a813efb-4a4f-432c-b183-e764e5a52115">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtNy0xLTEtMA_b97adcb6-03f7-48db-8055-0796a620900b">19,135</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtOS0xLTEtMA_d80bb508-8191-4caa-8764-26430487ab9a">11,174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMTEtMS0xLTA_58fa441f-07a4-4b38-9444-3aa7104b4a31">7,961</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3Njk_7e708637-526d-4f2d-9560-72bbc8e33ecb" escape="true">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</ix:nonNumeric></span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NzA_2c83dabd-7db8-4a4f-98a2-7246f18226e0" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of June&#160;28, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"></td><td style="width:42.204%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.929%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:21.379%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.157%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:24.131%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMS0yLTEtMS0w_efc8ee45-1324-4edd-8b44-4f87ef0ecf6c">10,023</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMS00LTEtMS0w_89d60b65-9fbc-4bc7-9558-0cdf8b5f4071">10,024</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMi0yLTEtMS0w_761b23c4-a814-451e-85df-c93de50c74dd">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMi00LTEtMS0w_abb8acc9-cb17-4c77-8f48-c58af458b6df">23</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMy0yLTEtMS0w_39bfd52d-8e67-4003-b94a-0b5266a01537">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMy00LTEtMS0w_7673baaa-79ea-401b-920b-b8f90ccbcb6d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfNC0yLTEtMS0w_97c7679b-c66c-45db-a16b-2b2783d754bc">10,046</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfNC00LTEtMS0w_c427a5f8-e64a-481e-afd0-657b235b8f90">10,047</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i81b9fe0e80934af1a93414da72a06174"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NDI_6bbbd7fb-888a-4188-b2bb-d0ee1e36852a" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of June&#160;28, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:78.938%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.237%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.533%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.359%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d98912977ba4917b953532514269c05_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfNC0yLTEtMS0w_d6bf162a-1206-477d-afe8-3110f720f21a">5,332</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d040c895d9a484983838bc608465de1_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfNC00LTEtMS0w_d1faa05e-8805-4d9c-b023-cbef0e01da2c">5,388</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4679f53893ef429da7ae2608c619ef95_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfOC0yLTEtMS0w_9a433d65-0038-4fcf-a22a-167841e979b3">350</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26f774541fbb4a11b90c5d2d53d5ac38_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfOC00LTEtMS0w_cd2c709a-8b90-4ab6-9008-423ec54b7311">360</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.250% Notes due 2022 (1B Euro 1.1217)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i13c392bf576441608a85b5f3084041ed_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTAtMi0xLTEtMA_12998569-9472-4023-a792-10121fc4a275">1,121</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf2600e49d414d4c9228f6fb5cf69b47_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTAtNC0xLTEtMA_d1bd1d38-8248-4179-b526-54a26c7cc00b">1,131</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.25% Notes due 2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21abfcc6203b49ce95faf424178935b8_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTEtMi0xLTEtMA_2caf7da7-7428-4010-a09d-9fdc7eb67008">998</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie1cabbaf87184e1ea5605e3f3dfafa26_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTEtNC0xLTEtMA_67370e56-14e6-438f-ae09-45a3f60e267d">1,029</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.73% Debentures due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ife21e63962704b6ebd278d152e40a4eb_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTItMi0xLTEtMA_c3d08acf-594d-4a75-80ce-5e5bcd7c96bc">250</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae6e1bd14a034339920302779e0d2b6b_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTItNC0xLTEtMA_346ce14b-56a3-42e4-8dde-ba9570ffd3e5">302</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.375% Notes due 2023</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0fe3730cd7bd49aeb322782ed3670e1d_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTMtMi0xLTEtMA_ef36fd2e-d488-4e4a-905d-e319cb996f92">803</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia00a7be937144c12b2167fc98e13147c_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTMtNC0xLTEtMA_d853c58a-71f1-47a7-99cb-8c1accd8f8c5">891</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05% Notes due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia95278deee974881825cf0f9ce29d7a1_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTQtMi0xLTEtMA_7b26f393-0933-45b1-b8ea-e990bd8544f9">499</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9c8e5f7c3c0844f5af66ac2ad7955599_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTQtNC0xLTEtMA_caec4bad-f1ec-4672-995d-018a382703ab">523</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.650% Notes due 2024 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4fa9e40d591048bda2fbd99d27df9044_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTUtMi0xLTEtMA_50d6d157-8f45-43da-bfd1-6bac68d14013">839</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia36011f1be2b41518aa8989de6791c53_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTUtNC0xLTEtMA_1690f186-e591-45b7-b020-11b0084c8820">864</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.50% Notes due 2024 (500 MM GBP 1.2431)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a87256891cc4bf199c1a109a2537a60_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTYtMi0xLTEtMA_c8f2a897-2225-496b-a821-27ebc05d237e">618</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4870c94373034eb2bcd12dbc135d4626_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTYtNC0xLTEtMA_06f06338-4753-4446-adcb-6bcd476d0104">749</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.625% Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a31f41a5b6843ae9b894d9381f461e9_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTctMi0xLTEtMA_ee7cc4dd-0bed-43a3-8f6e-f65a118c6bca">748</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81fab23f82674c6980bc9c359eb28ba9_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTctNC0xLTEtMA_10ab4b6c-aaf7-4058-97af-832248526aba">813</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2026</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc37bc973c1b451387840c102be9a646_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTgtMi0xLTEtMA_e5d89bdf-a0c4-473d-916f-ab43b55e8b6c">1,993</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3485e48ea0cc49a98aeb79cb18bc40b3_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTgtNC0xLTEtMA_9098ece7-5c85-4629-8a48-ccfe5be9199d">2,179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.95% Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2134273f7f24276bbcfc008eae7bd5f_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTktMi0xLTEtMA_fff662b9-2e54-4538-85dd-f9f3dcc74651">997</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie86818dd9c644e1d92aac548b679b5e8_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTktNC0xLTEtMA_19e7c43b-fce4-4efc-b3d2-1c534a24155f">1,111</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.90%&#160;Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i892e47f9411246c698112667df4d52e9_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjAtMi0xLTEtMA_7ea014f2-8fb2-4912-9952-65fec162d238">1,494</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c92433556884f33bec3fd9cc5547c56_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjAtNC0xLTEtMA_2112801b-ac7f-4c31-9782-e5b1f87dbded">1,681</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.150% Notes due 2028 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i07512cb6822542c3aeca578fa5a030a2_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjEtMi0xLTEtMA_68f8ccb7-69aa-4c98-8407-731fa503b9e6">835</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8f099c74c285402fa0acf97d0bd56486_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjEtNC0xLTEtMA_1f90c1f2-5026-4cab-bb9e-9c846c6d5b18">917</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.95% Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7c84c7aac7a8402b93fc4d50c3fb1b33_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjItMi0xLTEtMA_2f3e0c5a-6121-4d2b-a29e-8e48e46c897f">297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i50567b40671a4971ad917d310f56301a_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjItNC0xLTEtMA_1335c27d-d4b5-4d2c-a1fc-9e94d89b7f4b">435</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.95% Debentures due 2033</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icacf6978c8de4cd5adb37a3902bb8f2b_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjMtMi0xLTEtMA_059e49d3-16b8-4235-9544-1051f1d17a35">498</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i738688db4eb94ba5b31c8ae44a9936bc_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjMtNC0xLTEtMA_ae849c55-07f9-4af9-b1af-dd2e292a6a59">689</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.375% Notes due 2033</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1fc849891c249f9affbd772810f19cd_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjQtMi0xLTEtMA_d886e646-3357-413c-a377-a6c483729ad8">856</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic599954eed744eafbf6e49753e86ed68_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjQtNC0xLTEtMA_de1da570-6b47-4073-a681-804a0b98f36b">1,127</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.650% Notes due 2035 (1.5B Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i53cad7d01f364d4897d6a878c622734d_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjUtMi0xLTEtMA_0d250929-9a4e-4172-82a4-ceb3994ffc03">1,667</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie54b20ce4e0149e184e543ac46795d24_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjUtNC0xLTEtMA_db04be91-8a51-4127-890e-f9d4b424603e">1,974</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.55% Notes due 2036</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee7cacef8bf14e17b0aeba908aae6c5a_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjYtMi0xLTEtMA_f7e098ed-4b83-49e7-98f3-a73ff1fecabc">989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29f1ce70157c489995b6052930e4d920_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjYtNC0xLTEtMA_e755c1c3-a7da-4d15-a800-1528f3058ee9">1,170</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.95% Notes due 2037</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff6ffc8dbadf4318b62b6b49ffacd2ef_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjctMi0xLTEtMA_8370e900-101d-4337-8335-bf98d3135b92">992</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib2a9f041c1054b54b091f023e6d70707_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjctNC0xLTEtMA_285e07c8-8c2d-4c79-9f2f-521ff240c222">1,531</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.625% Notes due 2037</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i594eec41b2c747798b5aac595a81b3cd_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjgtMi0xLTEtMA_57a9149f-1b8a-404f-ae25-2d0dced8d737">1,487</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b7150c261554f278bef9d5c04743f0e_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjgtNC0xLTEtMA_c1d0dfe4-7d9f-4d54-bbe8-3fb8b8c7865d">1,791</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.40%&#160;Notes due 2038</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i224d6ed1b3124fba9dee77b543600395_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjktMi0xLTEtMA_1c1ddcff-247c-4c6b-96fb-05cc83748b9b">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib08f2638d7b846db950bf41478ecf12b_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjktNC0xLTEtMA_ef48c382-bc16-4b87-8e80-3b4b1e0fbffa">1,168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.85% Debentures due 2038</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a589dd13dcd4d9ab04910f8be1fffaf_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzAtMi0xLTEtMA_5dc03d31-a057-42c1-b085-67b17ac002bb">696</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i037b02ea1a8948fbb6e5f750e5b20a1e_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzAtNC0xLTEtMA_c2ce0745-f23d-41bf-b022-c9ede74a7934">1,060</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Debentures due 2040</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a335dce7946400eb64a556c5e88d512_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzEtMi0xLTEtMA_df26bbae-7e3e-44fa-be63-7e26635657f6">539</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibf95c2acf45c42e3bd3fa93ebe96b0a9_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzEtNC0xLTEtMA_b31e24a8-4926-4e21-ac80-43cbb04e8e29">736</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.85% Notes due 2041</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80b8cdff3ed5419bbf4fe318b5605b78_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzItMi0xLTEtMA_78a6a0fc-7fba-4f6c-8cc2-9eeffd1df2d1">297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i401e6b8e8c924806a3e398ef7159815f_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzItNC0xLTEtMA_791ebb9e-c1d6-467f-826e-efd159ee777a">420</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Notes due 2043</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic7ecdd57de4e4e4287dae9dc82bb4ca2_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzMtMi0xLTEtMA_d63f1f05-e20a-493d-ad1c-81559d4b1222">495</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0601e6ae6921410ab7205bde53a6aba2_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzMtNC0xLTEtMA_f7c6a7d0-ab0e-4b9c-832c-676746a650e1">685</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.70% Notes due 2046</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70f239152a2141228348aa533720bf55_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzQtMi0xLTEtMA_831db107-0482-4bdc-a36d-5229329ccd2f">1,974</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i06101a865e8e4e8e82693744ec325c94_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzQtNC0xLTEtMA_de8800c0-2521-424c-bf85-d0ed8069b4bc">2,467</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.75% Notes due 2047</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37ccb3cc5bb040cba3430bd495d96186_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzUtMi0xLTEtMA_d933f524-2218-45ae-9834-40aa1175c87b">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i89c03926f30a4d13a7fa7a50e5afa527_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzUtNC0xLTEtMA_b581cab8-5336-4ded-b30c-3082ccef2549">1,255</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.50% Notes due 2048</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3bf2ae2644d940ca9f392d4010b2fe3c_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzYtMi0xLTEtMA_72b72ea3-61ac-485c-a07d-ed8538e32cc5">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id07eeaf7cfbf4feb83e823bf4797e7e2_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzYtNC0xLTEtMA_4c899dfe-24f5-4703-bb7b-b6b28dfbd9b4">923</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48ad5aba0d9742d3893f7a8373957913_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzctMi0xLTEtMA_82faf269-2e03-45ee-88a9-ec42f3d349df">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if10dd21b5f704d0abfea775170908a2e_I20200628" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzctNC0xLTEtMA_717a812f-477f-418e-a871-ed56d279548c">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d98912977ba4917b953532514269c05_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzgtMi0xLTEtMA_c23a3f2e-dc7e-4e96-9403-c3b2c60ca5cf">25,062</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d040c895d9a484983838bc608465de1_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzgtNC0xLTEtMA_5fc73dba-b2dd-4557-b4ac-85301dd01ac1">29,991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average effective interest rate on non-current debt is <ix:nonFraction unitRef="number" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE0NDA_318d4684-5ebd-4f67-b3af-41fe781a8ae7">3.24</ix:nonFraction>%.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The excess of the estimated fair value over the carrying value of debt was $<ix:nonFraction unitRef="usd" contextRef="ic09551a2d2914e58b07c0faa2bdb5ca7_D20181231-20191229" decimals="-8" format="ixt:numdotdecimal" name="jnj:ExcessOfFairValueOverCarryingValueOfDebt" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE1MjA_d42c79e2-55e6-4420-aeaf-10616c13bb95">3.0</ix:nonFraction> billion at December 29, 2019.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Current Debt balance as of June 28, 2020 includes $<ix:nonFraction unitRef="usd" contextRef="if94dfff027b540c0aa481c801f7d039f_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ShortTermBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkxOA_0b097de5-dbcf-4084-956b-5a8d525dbdce">2.7</ix:nonFraction>&#160;billion of commercial paper which has a weighted average interest rate of <ix:nonFraction unitRef="number" contextRef="if94dfff027b540c0aa481c801f7d039f_I20200628" decimals="4" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkzMg_69748555-dfb7-40f3-8c59-4decac05b062">0.15</ix:nonFraction>% and a weighted average maturity of 3.7 months.  There was no commercial paper as of December 29, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">18</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 5 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNzE0NjgyNTYwMDIwOA_f0369f14-a28e-44a9-a62d-e717673eacea" continuedAt="i7e8bb4a86aa9412da80b2e5d79d35d80" escape="true">INCOME TAXES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i7e8bb4a86aa9412da80b2e5d79d35d80"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The worldwide effective income tax rates for the fiscal six months of 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2019 were <ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMTE3_a0eb9983-1005-47cd-96c5-57b4dae62f77">9.8</ix:nonFraction>% an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d <ix:nonFraction unitRef="number" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMTI0_eabd8035-204d-4ca5-b0ea-3170bfb9c806">18.4</ix:nonFraction>%, respectively. In the third fiscal quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020.  More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the first fiscal quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $<ix:nonFraction unitRef="usd" contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNjUz_8e9bf03d-e0b5-4eab-bce1-3cd3d7e87279">0.3</ix:nonFraction> billion for the remeasurement of existing deferred tax liabilities offset by a related $<ix:nonFraction unitRef="usd" contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNzM1_d74bddf5-2f16-4fed-aef9-c772ce253dc9">0.2</ix:nonFraction> billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#8220;step-up&#8221;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up.  Consequently, the benefit recorded related to Swiss Tax reform in the first six months of fiscal 2020 was approximately $<ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfOTg5NTYwNDY2OTc1NA_56c238f0-a86c-48c9-b206-32a7f57d39e0">0.4</ix:nonFraction>&#160;billion, or <ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" name="jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfOTg5NTYwNDY2OTc2OA_463d9b88-5be7-4d20-bfe0-59be8fa2016c">3.8</ix:nonFraction>% benefit to the Company&#8217;s fiscal six months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">During the second fiscal quarter of 2020, the Company reversed some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions. This reserve reversal benefited the Company&#8217;s effective tax rate by approximately <ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjE5OTAyMzI2NjU3Mg_9e82eef7-8356-40c6-a360-d7198f278d13">1.0</ix:nonFraction>% for the first fiscal six months of fiscal 2020. In the first fiscal quarter of 2020, the Company reduced a contingent consideration liability related to the 2019 Auris Health acquisition that has benefited the year to date overall effective tax rate by approximately <ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjE5OTAyMzI2NjU3OA_39143735-45c4-405f-8fe7-e1a8689e4a98">1.0</ix:nonFraction>% (see Note 10 to the Consolidated Financial Statements for more details.) </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">  Additionally, the Company had less income in higher tax jurisdictions relative to lower tax jurisdictions as compared to the same period in the prior fiscal year primarily due to:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the accrual of additional legal costs, at the U.S. statutory rate, in the second fiscal quarter of 2020 (see Notes 9 and  11 to the Consolidated Financial Statements for more details)</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">               partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">  The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested during the first and second fiscal quarters.</span></div><div style="margin-bottom:8pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;28, 2020, the Company had approximately $<ix:nonFraction unitRef="usd" contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjI2OA_7ddf3bd9-c9f7-4443-904f-96117cf16ca2">3.1</ix:nonFraction> billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit and settlement of the related tax liabilities in the fiscal year 2020. As of June 28, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $<ix:nonFraction unitRef="usd" contextRef="ie1c7443736ae4f29bc57b7af183c277b_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjg1OQ_2040470a-4f6a-449a-b82b-bbfd6c937a63">0.2</ix:nonFraction> billion as a current liability on the &#8220;Accrued taxes on Income&#8221; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $<ix:nonFraction unitRef="usd" contextRef="i27e026167a6740039f33d214df252c5f_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="jnj:UnrecognizedTaxBenefitLiabilityPayment" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMzEzNw_1b91b18d-4145-41d4-89a6-fe0c70d8cb29">0.6</ix:nonFraction> billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement later in the fiscal year 2020. The completion of this tax audit may result in additional adjustments to the Company&#8217;s unrecognized tax benefit liability. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.</span></div></ix:continuation><div style="margin-bottom:8pt;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-bottom:8pt;"><span><br/></span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_76"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 6 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfOTQ1_519f93c1-58d9-44db-8bad-2744eed0ab27" continuedAt="ia5509f46ade94046990ef68353e3294a" escape="true">PENSIONS AND OTHER BENEFIT PLANS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia5509f46ade94046990ef68353e3294a"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of Net Periodic Benefit Cost</span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfNetBenefitCostsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfOTM4_6e075a8d-e13a-4ced-8b93-c822f1cd9115" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal second quarters and fiscal six months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"></td><td style="width:24.548%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.832%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.412%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0yLTEtMS0w_eb6158d7-d27b-4e92-8274-6ae6bdb813bf">323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy00LTEtMS0w_0539a262-aa89-4d94-8b92-134866ede38f">277</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy02LTEtMS0w_3c452da5-e850-432c-b80c-d11ea3dc17ad">72</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy04LTEtMS0w_dffb6222-b17f-4e5d-9ef1-608397bdb0d3">69</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xMC0xLTEtMA_d058e1b3-dc52-464f-8717-a09cfbde4936">649</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xMi0xLTEtMA_fffc8a7a-d1c5-44b0-8f72-48445dfca52c">553</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xNC0xLTEtMA_55f33c2f-2d75-41e7-a8a6-8c4beaf95a0f">144</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanServiceCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xNi0xLTEtMA_16ec573c-63a8-42b9-b280-8c78af60dc3a">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0yLTEtMS0w_dd16e8ea-cbaa-49e3-bdda-445a87a19df3">237</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC00LTEtMS0w_455d2d04-7257-435a-9793-4621f9a22fd6">274</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC02LTEtMS0w_49c58a31-27c5-43e4-80e9-33424d4a5f94">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC04LTEtMS0w_4dde5b18-7f96-442c-b2e4-1bcb5101f7ed">46</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xMC0xLTEtMA_139457ca-ebde-487d-86c7-f5ea5e6ced0a">477</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xMi0xLTEtMA_ba25794d-e883-4e67-9845-7741f22846fd">549</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xNC0xLTEtMA_5f7329c6-aa8d-48cd-89b5-e5355007f59a">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanInterestCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xNi0xLTEtMA_0ca6006c-c3e0-4503-a93b-641ec446a9da">92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0yLTEtMS0w_84fe1dea-d300-4629-b93c-f33f0b89a3c8">608</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS00LTEtMS0w_50332963-4b67-42ca-8632-086d672a06a2">581</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS02LTEtMS0w_8b637c03-41c0-417b-b88d-020dd3dedd1e">1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS04LTEtMS0w_99a659a0-5e49-472d-96f3-f9a02855ed22">1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xMC0xLTEtMA_1cdc60f9-6743-4531-a741-3106447f8696">1,222</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xMi0xLTEtMA_d1614fd8-82d7-46a5-aed7-613dde6193ca">1,164</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xNC0xLTEtMA_d28d3092-7e06-4117-92af-2bc157d6fc24">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xNi0xLTEtMA_e85c7331-a45e-4e01-b04a-56476301c23a">3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0yLTEtMS0w_997a947e-4281-412e-90db-6f88420392ce">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi00LTEtMS0w_845169a9-a62a-4341-bc36-1e4661dc9130">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi02LTEtMS0w_37c9e8ab-2d7d-4575-9ae8-e8131699d3c8">8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi04LTEtMS0w_c872e377-44f4-430b-bbe7-48bbab14ccef">8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xMC0xLTEtMA_1ccd8ca1-57b2-4b12-81ee-a8bb02c86a42">1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xMi0xLTEtMA_c7aea2c2-65b0-4c9e-8cc2-955c0670e476">2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xNC0xLTEtMA_485c4807-5d55-484a-879c-a8bb3076e472">16</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xNi0xLTEtMA_ef38d079-75ea-482f-a911-4da5f567dc4a">16</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0yLTEtMS0w_d9183811-1c74-4529-80c0-08bac3c563bf">222</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC00LTEtMS0w_4e4a15b4-224c-418a-ba0e-e9df6ca75360">146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC02LTEtMS0w_7b8c2918-38f3-444c-88dc-5d8c84b20267">35</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC04LTEtMS0w_364b9125-52ec-40f4-bdbb-7f3de350342a">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xMC0xLTEtMA_44366330-5f60-4d37-b5ea-78dabb0e6218">445</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xMi0xLTEtMA_f5165b57-02e9-4260-8317-9c7c6373fa1d">290</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xNC0xLTEtMA_3b74eaa5-ed3d-4f99-a8aa-25cffeaf7d39">71</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xNi0xLTEtMA_ef73fd80-2428-405a-a0ee-8087be9904e6">65</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0yLTEtMS0w_6438f098-d5c8-4d13-8689-0f2dbf2e5752">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS00LTEtMS0w_404d7d6f-17b8-47e4-9b35-2c4750ec99f1">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS02LTEtMS0w_30e334cc-68af-4565-a8e4-2562834fb9d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS04LTEtMS0w_ff1a578d-5f97-4d11-910b-52abbedb9fce">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xMC0xLTEtMA_a8ff9370-fd81-4813-be8c-74302161ada7">19</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" sign="-" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xMi0xLTEtMA_e753e7d4-a3f3-4db7-85b6-64baf8635bb6">7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xNC0xLTEtMA_3dbdd9c6-effa-4921-9c76-369ef15406f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xNi0xLTEtMA_f39a085e-7252-4e8f-8a54-38c96132480e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMi0xLTEtMA_e3ec0ad1-6f4f-43f2-88a3-4776356e3b83">175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtNC0xLTEtMA_dbfa3703-5f9a-4859-99ed-15a44a232ce6">125</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtNi0xLTEtMA_b12220a4-6837-403c-b14f-eb637095c884">131</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtOC0xLTEtMA_30e0d1e7-61a6-4160-90c8-55ed766a512b">139</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTAtMS0xLTA_e54426b4-34ac-491a-b269-2882386d0084">369</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTItMS0xLTA_ac7841f6-4428-4e0b-8c4e-fa203753575d">237</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTQtMS0xLTA_79a130a1-8e44-4f15-aee5-5d62a77eb129">262</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630" decimals="-6" name="us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTYtMS0xLTA_531ad1c1-f57e-4a9a-bc9e-e792c4de1f44">275</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company Contributions</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal six months ended June&#160;28, 2020, the Company contributed $<ix:nonFraction unitRef="usd" contextRef="i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfNjcy_d540d14a-37b3-4b62-8dbe-b23d559d2ab7">144</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f87318d318045a6ab036c942e910e82_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PensionContributions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfNjc5_d32b0a74-0123-44de-b9bb-52f3aa97f4c7">18</ix:nonFraction> million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.</span></div></ix:continuation><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_79"></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 7 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RleHRyZWdpb246NWE0OTgyN2IwOTQ4NGM3Mjg2ZDQzOGEwZGI3OGNjMDhfOTI1_46a7a402-64d0-4369-b35e-4edc18d19a7c" continuedAt="ia685de7e300b4903b83f227ae0f3138e" escape="true">ACCUMULATED OTHER COMPREHENSIVE INCOME</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ia685de7e300b4903b83f227ae0f3138e"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RleHRyZWdpb246NWE0OTgyN2IwOTQ4NGM3Mjg2ZDQzOGEwZGI3OGNjMDhfOTM2_3758c4ec-16d8-4066-be40-f810732e1240" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"></td><td style="width:33.874%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.014%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.762%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.846%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.819%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.406%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.547%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:16.091%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id4556ab2a2fc4b759328bcaa7117d7f0_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC0yLTEtMS0w_4b3b409d-b901-4583-b28b-11b748567b38">8,705</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70aedc4c48ed469a9776d7b4ca9dba52_I20191229" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC00LTEtMS0w_cf76c758-9086-4cde-b1e9-d0d15e6173a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="id4b29a10c69e451f9cd0f65769fbc49e_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC02LTEtMS0w_ad3bde08-e2c1-45d2-aee2-9a342de6ed10">6,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i76c2328f316b49948f37e4d51d76befd_I20191229" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC04LTEtMS0w_f14ffe00-84d8-4013-b26f-38d9451ff214">295</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC0xMC0xLTEtMA_1d1e39ae-28a7-4e96-9fee-db3837c4f65d">15,891</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i35b3b5367fed471a9262907b9c660c6b_D20191230-20200628" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS0yLTEtMS0w_c552416a-0951-450d-96b6-ba3b51eaedb3">963</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe5bd9b8b1c4480ebc128d7538983d48_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS00LTEtMS0w_4f9ac118-1464-4440-b3ad-a60ea76fd04d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4b624b01490643e596a4c28527039518_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS02LTEtMS0w_2d7653d4-3144-4fd0-b415-c8f3caaf2f23">390</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic3d78226c4c54c9ca0d4cd83d95e2d73_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS04LTEtMS0w_7fa6bb62-3267-44a7-8c91-9d83c56b381b">931</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS0xMC0xLTEtMA_8c50a203-9056-4d82-b946-70736c759777">358</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if0bda8b685c44b2d86658936d3456c28_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy0yLTEtMS0w_4ffa5fb0-a193-4a94-9a2d-3876c32e457b">9,668</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94324367c9e54b678238a19050edb89c_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy00LTEtMS0w_5e01c74b-2c44-4f9e-9ed7-121d8e72155a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i83c49a3f745a40c8a5594ba2e9162d35_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy02LTEtMS0w_f84a3e1b-0fcf-433c-ab98-90ff54db1993">6,501</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b37abccd6c2406ab0e4786c66aea73a_I20200628" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy04LTEtMS0w_3f76f158-d659-4a06-bf6d-838591079a84">636</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="if261e32787064849a30e8f746c585aa9_I20200628" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy0xMC0xLTEtMA_6625a6ff-2b74-4377-9844-43f8b38a23de">15,533</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Details on reclassifications out of Accumulated Other Comprehensive Income:</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Derivatives &amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">20</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 8 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfNzE0NjgyNTU4Mjc4NQ_4cb1d20e-719b-4c2c-9f4f-6f40e2829a33" continuedAt="icb1e5ebbb09e4c9989b3fdcd72de3e81" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="icb1e5ebbb09e4c9989b3fdcd72de3e81" continuedAt="i29acd8c6eda448dabb83bfeb2ab788ea"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfMTQ5MQ_5ae7ee63-1b77-4193-b009-d46bfe7e9807" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal second quarters and fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:47.425%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.805%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:10.500%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.380%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.074%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.518%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.632%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.518%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.348%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi0yLTEtMS0w_bc5ad01b-f12f-416a-8835-cd193a02224b">1.38</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi00LTEtMS0w_43c51887-71a1-420c-b266-40414f807a94">2.11</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi02LTEtMS0w_41b05959-cbaf-4dc8-8645-dc36af4f0b9a">3.58</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi04LTEtMS0w_5ee1b6ec-3da9-4515-b404-d785aa255ed6">3.52</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy0yLTEtMS0w_cb45382a-ecff-44d3-9991-7bd3a46e246c">2,632.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy00LTEtMS0w_19b97b1a-34b9-4999-9a52-7666e1772939">2,652.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy02LTEtMS0w_6d115cf9-919b-4294-bb63-ed9de8879f56">2,633.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy04LTEtMS0w_1f19aeb5-7be8-40af-9254-bfa908115e31">2,656.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC0yLTEtMS0w_efc8cb3b-d823-4910-a7d5-d564925bea5f">119.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC00LTEtMS0w_33b9a04c-17d4-49b8-a7f5-50c2137891c3">140.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC02LTEtMS0w_7ac52eb9-8235-4be2-8bd7-1cee84bde359">122.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC04LTEtMS0w_66bb7968-1980-48cf-b85d-3fb2223cb863">138.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS0yLTEtMS0w_fe9aaf4d-cee3-4934-a02f-5d9915159ceb">87.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS00LTEtMS0w_2b1e248f-90d4-4374-ab28-88420981b1a0">102.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS02LTEtMS0w_1277c420-b873-4cd6-ad53-adbc1e6111d2">85.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" name="jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS04LTEtMS0w_97454a1a-7a08-4730-8f11-21c5988e0ce7">99.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi0yLTEtMS0w_7d473082-5d92-40a6-a6cb-003c869b8b03">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi00LTEtMS0w_025d1b62-981c-4493-afc6-2e41922813cf">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi02LTEtMS0w_e725e164-5ee1-405c-b00f-29b166b58d5e">0.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi04LTEtMS0w_e6c489af-5c69-4a2c-9029-7db888f808ee">0.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy0yLTEtMS0w_ffcba19b-fec6-41de-aeeb-a43ea9881f35">2,665.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy00LTEtMS0w_9257d58c-0f63-493a-8d50-5660126b1ad4">2,691.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy02LTEtMS0w_024bef7b-33a9-46a5-862a-bce40945c808">2,671.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="shares" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy04LTEtMS0w_25168d77-b182-4180-887b-201222c00824">2,697.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC0yLTEtMS0w_22775eaf-511a-423a-879e-deb3cb511565">1.36</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC00LTEtMS0w_da31065d-5512-4f40-a8a5-f6af17888101">2.08</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC02LTEtMS0w_259fbb39-53e7-44d7-ba4b-140e5fd300e0">3.53</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usdPerShare" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC04LTEtMS0w_cda3624d-080b-4344-aec3-5507ffa2ea49">3.47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for both the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;28, 2020 excluded <ix:nonFraction unitRef="shares" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfNDg4_d08eaff0-f496-49e9-9fd3-1d98ef3a1e2a">20</ix:nonFraction> million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. </span></div></ix:continuation><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i29acd8c6eda448dabb83bfeb2ab788ea">The diluted net earnings per share calculation for both the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.  The diluted net earnings per share calculation for the fiscal six months ended June&#160;28, 2020 excluded <ix:nonFraction unitRef="shares" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfMjE5OTAyMzI1NzY4MQ_fc26d1ce-13ca-4704-a518-709373500dd9">15</ix:nonFraction>&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal six months ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value.</ix:continuation> </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:57.327%;"><tr><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.333%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:31.334%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">21</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 9 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU5NTE1Nw_11ce4304-9a1e-48e0-bf3c-6183fb20419e" continuedAt="ib2b854bc65104af493ba1187bd7abed9" escape="true">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ib2b854bc65104af493ba1187bd7abed9" continuedAt="ia20161dca9ca43dabc7b557333421b8f"><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="jnj:SalesBySegmentOfBusinessTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTYzOQ_2ff5c757-9a93-4268-a66d-22da096d13d4" continuedAt="ic39229b3db434aef955d728e73073452" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0yLTEtMS0w_52291eef-3e6f-4865-bbf3-c999ed37e87e">96</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i412403fa25604c0eb6cb3612a92af406_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS00LTEtMS0w_cf62f55a-e047-4ddf-9c79-e045c7e0d5f4">99</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS02LTEtMS0w_5ad4ae20-a75e-4fcd-8bbf-eef94fe0d4d3">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS04LTEtMS0w_0a81b3fa-bca1-4da3-9102-a71709c2a8b5">188</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibf7cb2cb2d84454889dc1978307aa501_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0xMC0xLTEtMA_33a686d6-2fb0-4fca-b135-28b646985088">186</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0xMi0xLTEtMA_27231483-3864-4e7b-a46d-fe7bc8ba8deb">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0yLTEtMS0w_7b1566d7-70b8-493b-a188-eac31a1b1446">260</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if72a15c285244bc3b010e33bfc90cde1_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi00LTEtMS0w_78f9a35f-d5f0-498a-a645-5f29000ef0bc">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi02LTEtMS0w_fcdcffec-4b4a-44db-9a97-645dae5eefe0">24.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86aec8fde918479799b3d8999e4a92db_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi04LTEtMS0w_c3fec96b-9aad-4a13-9040-a892c6dd0e38">529</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0xMC0xLTEtMA_ba9eaa73-4995-4abe-b9b3-77f69f7eb358">651</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0xMi0xLTEtMA_88dbbbe2-ac37-4347-8499-0ca7ee3f8342">18.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0542775e36e242d1be3186249195e3ec_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0yLTEtMS0w_58a5d42f-2435-40cf-a545-178e683b814e">356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f3ebd2f992b4c62a96493401efcf524_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy00LTEtMS0w_e6e02da0-c89f-45c7-9436-83fa73982524">443</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0542775e36e242d1be3186249195e3ec_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy02LTEtMS0w_c0cdf852-fd87-4556-9716-9a4cbe58a20f">19.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8f06a464dd9742ea9682af70f69352eb_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy04LTEtMS0w_422fe0ca-2da6-41f7-bd62-fc0ccda4bab3">717</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0xMC0xLTEtMA_3dc53366-7366-4139-b779-85bd7f52eb8d">837</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0xMi0xLTEtMA_5d5e92f7-de05-47f4-bbe2-34a0ead34993">14.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0yLTEtMS0w_0869cdc3-4cf5-4e39-8e07-15d760b5a6bc">170</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40c2c1be7c9c4cdf8ed2ca776a685cec_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS00LTEtMS0w_ffecbf53-da8e-4737-99fa-f20bfb82cb0b">155</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS02LTEtMS0w_07968346-a21e-44e3-962b-d12a13ae5d8f">9.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7fc53301bf44a03a86320a01d4c89b2_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS04LTEtMS0w_4f607c22-c889-4257-8029-9fde5968c0b4">346</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0xMC0xLTEtMA_cad12c65-ac37-48a6-84b1-7075ff021369">306</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0xMi0xLTEtMA_cf98395c-6f7e-45ca-af11-3126a07fca1b">12.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3e2c27311f954303936c62828d1203aa_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMi0xLTEtMA_8b72f2ee-01fc-41af-93bb-434b985844fd">227</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id3241cc6119d45ba90518b03c7b76dde_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtNC0xLTEtMA_7b143b60-dec6-438c-8c19-3d747b759758">234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3e2c27311f954303936c62828d1203aa_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtNi0xLTEtMA_c8cba314-c9a1-4320-9203-f6baf1e122c5">2.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62f12565007d4fe4b8dd93b5e190e144_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtOC0xLTEtMA_173fe8bb-046c-4287-8d34-a5e118eb350e">446</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMTAtMS0xLTA_23705609-9e9d-4c67-b8e5-5de5eaea319b">450</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMTItMS0xLTA_ae913ad6-c30f-48ae-be3b-552b9b05895e">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMi0xLTEtMA_28735b98-a2dc-4e34-b806-95c2ab77609d">397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5687f5838b614e4589f850bb1f5939c8_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtNC0xLTEtMA_a4f22991-4f55-45ea-8e52-8c80eedbc69c">389</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtNi0xLTEtMA_79dfd40a-c63e-4378-ac6e-9b830ff3507a">2.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5df767d41f749ecb04e69b4d5853ccc_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtOC0xLTEtMA_433ed4b1-343c-421b-af58-be5ab88bcc4e">792</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMTAtMS0xLTA_49cb5bf1-1407-47f0-85ec-7fc98cf6eabf">756</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMTItMS0xLTA_24dec06c-df43-426c-969e-8905da8f3530">4.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMi0xLTEtMA_06161bbc-8dc3-4d0e-ba72-fcfafb0fd195">627</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30eb63aff7fd481189b4f524a3f36f78_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtNC0xLTEtMA_765d3f75-a3e7-4547-bd5a-6ec7b6a85045">484</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtNi0xLTEtMA_38f71d37-d212-4caf-b922-a939b44f3c95">29.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8842b711d1844455848e9682cc4cceac_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtOC0xLTEtMA_b36f02c1-5b9b-4376-9bfb-fbcb94402bf0">1,316</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMTAtMS0xLTA_23300f39-b124-47c1-9a31-a93144a40423">991</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMTItMS0xLTA_dd69c275-4bf7-4532-bf4a-a344468501b5">32.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMi0xLTEtMA_04fd6b15-49a5-44df-9e6d-6df98b10e1d1">522</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1a6b71be8d8141dab2ca5e6564f34d86_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtNC0xLTEtMA_644a10ed-66ad-433e-b4fa-fb399a9ae334">580</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtNi0xLTEtMA_85f95dc5-7f2b-4f35-b823-2797659f7ca2">10.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86f3fa93e7354cc6bf55b6b55246cce1_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtOC0xLTEtMA_3d9a8f4a-8498-45e6-8047-5b49fa0a7854">1,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMTAtMS0xLTA_2cd86c93-59a3-4489-8f03-3b9cb41c0591">1,160</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMTItMS0xLTA_dd9a464b-30f9-476b-ae8c-02d65458a88b">1.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMi0xLTEtMA_6292e017-48b2-4a85-b802-230279a655e4">1,149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d79693f595f4483a46180ef55b406d0_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtNC0xLTEtMA_35afde7b-12a8-40b2-9e50-4d121c45c622">1,064</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtNi0xLTEtMA_304e68bf-346b-4c20-80d3-60446e346ca9">7.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3749288c66d45cd8504ea939901383a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtOC0xLTEtMA_7d87773d-1a6f-4175-ad29-1dbdb43bebd1">2,497</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id5a61247d95c477381857604c8aed8c3_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMTAtMS0xLTA_5f7b884c-f6ef-4490-9428-71170550b84f">2,151</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id5a61247d95c477381857604c8aed8c3_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMTItMS0xLTA_4fe25497-f6fa-4d2d-980a-e4240ea14c3a">16.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMi0xLTEtMA_bfdfa758-d3d9-4750-b8ee-39934e1bb8ae">536</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie44840a7a12d4a59aa337501bb3c171a_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctNC0xLTEtMA_d7962db0-defa-465e-b6d7-08f46e14a68c">663</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctNi0xLTEtMA_54b0d9e7-1e72-47a3-a107-e905827735aa">19.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3225a5919ff748b88fab0958b5dc1630_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctOC0xLTEtMA_425f0efa-2351-4841-a27d-3bc406ca0a49">1,195</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iccb687ba095a4752882b895461f25afc_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMTAtMS0xLTA_625f4376-a267-4375-a23e-02807b006289">1,251</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iccb687ba095a4752882b895461f25afc_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMTItMS0xLTA_d0f7cd35-d2c1-4849-8962-2643937c0af8">4.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMi0xLTEtMA_587dc9b5-4578-4ffe-b968-74a65db64b16">471</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i416e1d239030434d91da317adc252268_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtNC0xLTEtMA_f8de24d8-1903-40e3-b719-a5eb2986d32d">539</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtNi0xLTEtMA_180896c0-02fe-48c2-93ac-4d305c2edd2b">12.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i217e8d94fe8343e7b9a36b46d7ff6f42_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtOC0xLTEtMA_5018ab5c-375e-4f41-ad17-7b692d47fe0e">929</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMTAtMS0xLTA_14e0f448-eff0-4fc8-96bc-818c69d4d782">1,041</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMTItMS0xLTA_cfa28825-98fc-4132-9199-4515f87f28f8">10.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMi0xLTEtMA_a08f6c87-d3c9-4077-99fc-cb3e78df0a2d">1,007</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if6572c7d7c154078815d1d633a936600_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktNC0xLTEtMA_ef71eb54-aa8c-4f4c-b2e2-0742c0640fda">1,202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktNi0xLTEtMA_4922ff18-4d07-4a6e-8f5b-c793208b1844">16.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifa2a865013ea455b9e5d8ff204f65c18_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktOC0xLTEtMA_c3ad8dfb-36b3-43c6-b05a-55aa8acc3ccd">2,124</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMTAtMS0xLTA_40adc2d2-684d-47d0-9c50-e9f02f812ce5">2,292</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMTItMS0xLTA_eaa99ccf-e834-451e-8ae6-4429e9217e86">7.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMi0xLTEtMA_5c96d927-f43a-42f0-8676-fd66b6a65571">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3b8524a11f7463e8ceda09d321b1dcd_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtNC0xLTEtMA_816abc0e-247c-4a41-8c2e-ec1cbe313b97">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtNi0xLTEtMA_862b36fd-c61b-4d82-8664-14ddd1bbb137">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f8f472f6d184702a8de9d64eb4b3e33_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtOC0xLTEtMA_5d123521-8cbe-4ee9-96e8-31126bfce227">7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMTAtMS0xLTA_269c3b0b-58d1-4095-82cf-cd7b3774762d">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMTItMS0xLTA_68bafdcb-ae32-4b35-8123-850071990dc2">14.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMi0xLTEtMA_144fc52a-51a9-47be-af1a-d2ec841d699d">199</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ab77cc2dfcf43e786584e6ae05cc727_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItNC0xLTEtMA_b1cb158d-7431-4598-9e64-e4217821c0d4">250</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItNi0xLTEtMA_f0b4a319-aefd-4d35-970d-4ef32ea8bd24">20.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i17319dbdd05e4674960f993b6cec2500_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItOC0xLTEtMA_d768ecc6-0025-4dac-8cd8-56f75590ab76">427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMTAtMS0xLTA_790deb0d-0cda-43b7-8e70-b2a49db5125c">472</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMTItMS0xLTA_6bc9e578-a395-4b7e-9ba6-afa155785c97">9.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMi0xLTEtMA_84294b64-cca2-47b0-aa3e-577662438099">202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d58945d2f9c49328b754ad12aee7c1d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtNC0xLTEtMA_68aca18d-815b-49c9-a780-1c377bf1f465">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtNi0xLTEtMA_099e22da-de98-4d66-98f1-60f562952aef">20.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fd4ce4d5bfd403ebdb1f23fc75bb9e7_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtOC0xLTEtMA_89b78525-d959-43bb-8868-951f5ff5ab75">434</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMTAtMS0xLTA_30368f81-4b44-4993-8178-3148ae583bd7">478</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMTItMS0xLTA_fc8e1844-267c-41f1-9b10-a1eb902f902f">9.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMi0xLTEtMA_2a1d62d3-fc8f-421b-8a4d-bb95ba3c21e8">126</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f5f12aff9364764b1862f5c138fb733_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtNC0xLTEtMA_2ae859d5-0ef8-46d1-bd61-852d975bf4a2">132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtNi0xLTEtMA_bffd3ccf-5770-4a40-91c4-b5e2c22d41f2">4.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00f88af71cc44acaa8ff9f73750b5cf6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtOC0xLTEtMA_25d83a72-ce01-48da-bcae-3159fb1751c4">245</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMTAtMS0xLTA_c257e8db-13c7-47b6-a67c-2927f9757357">234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMTItMS0xLTA_eba817f1-c9a9-4415-9aa1-f0c9795a336a">4.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMi0xLTEtMA_251bc34e-905d-41d9-be6e-22e19ba36a08">59</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8a1fbdb565644530aefc8a04ee20b567_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtNC0xLTEtMA_d29b3bb2-5794-4f54-93d1-f02e0163ac38">61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtNi0xLTEtMA_0d6c1bd8-9269-4e47-9c81-ac7d5b73d1ef">2.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3309bfb236f34376976fd1aae5a817b9_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtOC0xLTEtMA_9b45578d-29d5-4549-8bed-62e643c9d59b">111</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMTAtMS0xLTA_c4cd7584-0aab-4ed4-a43b-83e18ac1d8e5">114</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMTItMS0xLTA_0a693958-ab3b-4911-8d7e-f67d5eb37af8">1.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMi0xLTEtMA_8d6b999d-b17b-4f0b-a71e-5170210b210e">185</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4615adcb9f9c4c91bf219b6707943c12_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctNC0xLTEtMA_a152492a-9950-4a62-8393-11aea9fb7675">193</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctNi0xLTEtMA_6840e418-b927-41e6-9214-06266669b84f">4.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae6da712f0bc48308e8e5ba20cb5dda6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctOC0xLTEtMA_e5cfc60e-8add-47ef-9062-9d9686bb566f">356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMTAtMS0xLTA_8b176e91-2b41-47c0-92e2-2ae36e32ffe2">348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMTItMS0xLTA_0cc793b0-344e-459c-988b-88bb258179be">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMi0xLTEtMA_d79e1d8c-4c8f-4913-ac4f-71679a41fea6">1,557</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i676c5ca698d44f7bb1903045e7e0ec08_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktNC0xLTEtMA_fa80d29b-0038-4aa6-9c5f-5e8bfbc4357f">1,537</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktNi0xLTEtMA_66f64d0b-4e51-4342-af19-fc7dc4d541fc">1.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i67922ba98bf742f2b93e38317dd13f79_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktOC0xLTEtMA_e114c99f-5294-4749-a7f4-79dc7678d6f9">3,297</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMTAtMS0xLTA_29751b30-4031-461a-a669-0b380f3d0055">2,975</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMTItMS0xLTA_8f6ac278-e794-4b54-8a23-144fddf13d0a">10.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3510f20d163437d9d386475e40596e5_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMi0xLTEtMA_88075864-3d59-4607-a1af-ebe500a7ce35">1,739</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12139d83ab444d98a2b66446337fd19f_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtNC0xLTEtMA_44a2adfa-4612-47bd-8034-1125259f051d">2,007</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia3510f20d163437d9d386475e40596e5_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtNi0xLTEtMA_41fdc287-32d2-40b4-afce-2885f830a0da">13.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if362a6cd5d6b414ca2bb842004eef8f4_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtOC0xLTEtMA_4416b641-0c6f-48fd-8363-7deb1f23ea5a">3,624</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i238c4888cf1248d595768c38dab59641_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMTAtMS0xLTA_b3e4ccc9-69eb-4fa2-999e-351593b6e855">3,887</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i238c4888cf1248d595768c38dab59641_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMTItMS0xLTA_f36455e1-987d-4572-84ec-670a4cd18986">6.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMi0xLTEtMA_a5cae14f-eb91-4614-9802-c05a61175755">3,296</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtNC0xLTEtMA_feced5f3-d60b-40da-9c37-3c93bd3215df">3,544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtNi0xLTEtMA_2c1a4be3-909c-4e93-9240-76413d3393d8">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtOC0xLTEtMA_4ad27cf2-56df-4f9e-8176-669f40bb74d2">6,921</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMTAtMS0xLTA_a68140af-250b-4110-822b-5ce1481e8354">6,862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMTItMS0xLTA_96dbf3f1-6225-47aa-be42-0565669edd00">0.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="ia20161dca9ca43dabc7b557333421b8f" continuedAt="ibace0003514d4decb7280d8401a92eb4"><ix:continuation id="ic39229b3db434aef955d728e73073452" continuedAt="i4116ba84856a43e2ba5c8bfca2d60aa7"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMi0xLTEtMA_a9cc70c9-4837-402f-b186-2e71f69ff846">2,362</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09e1792cc5c94bf6b0b2b40156599df0_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtNC0xLTEtMA_92c87a7f-d1ac-4533-be36-672b89902eef">2,379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtNi0xLTEtMA_e59507d7-acd5-4915-afcf-db698c733089">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9606d19598644104898d903b09806074_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtOC0xLTEtMA_a081850e-04cc-4bfc-800f-d32d8853d803">4,772</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id73f28649d29470cbd4b3ce23d75ffc8_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMTAtMS0xLTA_7307b9a5-4b98-41e4-a8b9-bb7c6f892fd6">4,542</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9606d19598644104898d903b09806074_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMTItMS0xLTA_bb652279-43b0-488d-928f-2b22faa66e33">5.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMi0xLTEtMA_80ed4a04-4ad8-40b2-8cdd-41b3675494d8">1,161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idd3ff780d0f74b38b1a6a69a052629ae_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctNC0xLTEtMA_d2fc65e8-90b2-4d07-9753-ebdfa9cb2cf0">1,087</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctNi0xLTEtMA_721ad56f-45a1-42dd-871b-fbb472f443eb">6.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia41941d76be24820956011d29accd0d7_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctOC0xLTEtMA_ce66b91c-54c6-47a4-9af8-f6eb6dc1e36d">2,389</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0ccb205116b4463884f94a7aa8ad4845_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMTAtMS0xLTA_01539c01-06f3-44bf-9d14-a002d13a5802">2,175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia41941d76be24820956011d29accd0d7_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMTItMS0xLTA_8ee768bb-cc8b-47fa-8032-3cb040c15e36">9.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd91babad94c42c5855b5b127b24d222_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMi0xLTEtMA_08bbffb8-607f-4dca-bd20-b12565878791">3,523</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i202c6ea421d34b83af4652977ad93e89_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtNC0xLTEtMA_4bfbe8f0-7af7-4943-89c5-fee332fcc2a7">3,466</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icd91babad94c42c5855b5b127b24d222_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtNi0xLTEtMA_d8932da1-f65c-4970-9f65-75af9b04ffae">1.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtOC0xLTEtMA_7909be6d-55d2-4549-9ca9-8fe2b6b485da">7,161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic70ac4fab133415ab1c3c188c47b58ec_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMTAtMS0xLTA_7d0328d1-cdeb-4e30-9e50-aa27913d0ded">6,717</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMTItMS0xLTA_b5b95d27-0da6-4d03-8cb8-c980de57c80c">6.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMi0xLTEtMA_64392d3f-1ef4-497d-a7d8-9487904e7ccd">593</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie58a793be107479d9ac45bc6f91943be_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtNC0xLTEtMA_73861d5f-8ab4-421b-8b70-2c3ea089a2e1">801</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtNi0xLTEtMA_7f33f406-7773-4bf6-8cd6-5b12829cf69b">25.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtOC0xLTEtMA_780c597d-37d2-4fb3-95ee-34cb5e93bf16">1,218</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30a354f3a5aa42dbbb12c4091c197032_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMTAtMS0xLTA_b54ba568-c343-47fa-8ebe-34558b3adaf0">1,575</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMTItMS0xLTA_9c986975-9c62-4101-ade2-a6b787799861">22.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6aedf491fd84a00ac5c03725947fa86_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMi0xLTEtMA_9da61c28-1ec5-473d-93fd-6d2a7653dfcd">133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib634d639ae9c49819dcc46f6d7dbaa22_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtNC0xLTEtMA_4dc294a4-baf4-4d15-a97d-f550d9257153">62</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtOC0xLTEtMA_4087d45e-d85d-4889-b1f8-77cdb7e5d62e">243</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6dd25eb363984eb0abd80607dca205b4_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMTAtMS0xLTA_bd95f8be-b127-4602-a732-e7afba9cd946">138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMTItMS0xLTA_9d47f355-96b0-4f6e-9c14-dfb2a5628aaf">75.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMi0xLTEtMA_e8234257-a88a-4646-8d9b-52fcb7d2f24c">208</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2a0ff02b2a8546f7a5b1c62d388c8563_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItNC0xLTEtMA_09ae5ce3-9b63-4873-9d6e-fc793a50d706">244</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItNi0xLTEtMA_4f048eed-ce1b-4640-8387-d6043ac1c5e6">14.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItOC0xLTEtMA_d66ecda2-07bc-4043-8549-b45f4ef603cb">464</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72d4f321e7b44b50b09bdcb088bbe22a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMTAtMS0xLTA_01880bb1-2a3f-4b7d-9fd5-f344a2bae4ca">496</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMTItMS0xLTA_e268b3a7-b170-47b1-9247-971c6c0d5d52">6.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMi0xLTEtMA_99799409-630a-42e9-99d8-667b1000c36a">935</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8c5682649bb41e4afeb396ea67e339e_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtNC0xLTEtMA_4309b47f-6c6a-4956-8a79-49ef18195d67">1,107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtNi0xLTEtMA_7bdeda05-bfa1-4669-9dd5-63bd54674560">15.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtOC0xLTEtMA_a16f4c11-a0d2-4967-991f-8b6ad745206e">1,925</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d51a74cecfc453496314405e25d87f9_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMTAtMS0xLTA_9ff8170e-deca-4438-bf9e-56573b0288b9">2,209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMTItMS0xLTA_df638e89-9339-4651-bf06-b632a2252e16">12.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMi0xLTEtMA_5d41c501-b8a4-4fc3-a07c-b71ddf64cc83">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70cff2202d7347afa5eb1607d57f14a6_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtNC0xLTEtMA_4c544762-4d5f-47f3-bb21-1ad317661be6">281</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtNi0xLTEtMA_1b43a2ad-25fa-48d4-a974-84236f8b807d">8.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtOC0xLTEtMA_1949d773-4ce4-4276-ad3b-df6479fad956">528</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia25dd344df8f4b6dafed16ebf59ddded_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMTAtMS0xLTA_42d71090-2eb6-4e8a-9989-22b2df6f89ac">544</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMTItMS0xLTA_b3a71b1b-9ef2-46f4-83d9-911e7d783ec5">2.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMi0xLTEtMA_eb5b1a5d-28dc-4564-aad5-78e4d306d1c8">289</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iabec2bb4211940caa377a2893b37a631_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtNC0xLTEtMA_99b4390e-6733-4671-af39-e47b6d766550">282</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtNi0xLTEtMA_3cb95523-9d31-4e9f-aa7f-75823ae7764e">2.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtOC0xLTEtMA_962d2af9-8ade-4995-a5b9-1958e76408f2">547</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i11abb1995b224be4b48943c0dc5e5241_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMTAtMS0xLTA_d98becd9-779b-4374-96f2-550c42b2c1f3">543</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMTItMS0xLTA_046fef59-31f8-40ac-a322-a7c113f52dcf">0.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMi0xLTEtMA_8ba4f8e9-2e0d-4da9-bfd1-37385299007b">546</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1e861771c7a249e8a7b1847d97087825_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctNC0xLTEtMA_6b8ead53-515f-43ec-96cb-a7a140a2b8af">563</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctNi0xLTEtMA_a6000c67-dd41-4f59-bf49-f2fb8030f35c">3.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctOC0xLTEtMA_310283e3-9896-46cd-9eab-0a7cd18d1bda">1,075</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i625a0328612340d3b2444593094ca6e6_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMTAtMS0xLTA_307c75dc-b9ce-4fd2-b824-cef1949f7654">1,087</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMTItMS0xLTA_3c78220a-90a1-4361-b6c7-71c52a99d215">1.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMi0xLTEtMA_7b587ecb-1668-4714-a4b1-406510684e65">1,138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18e155080f5045fa8e60310a82f43852_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktNC0xLTEtMA_7119b6fc-66df-4055-a3c0-a58aa6a7605d">1,058</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktNi0xLTEtMA_3ba14398-e50c-482a-8a5e-c1759d65efe8">7.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktOC0xLTEtMA_cfde3b9e-ea2b-4082-a38a-414852b6ad86">2,355</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icbdf2685c57d492f9ea918bb328f7c1f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMTAtMS0xLTA_217ed540-bb4e-4b3e-aff2-ec82add2f1d0">1,940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMTItMS0xLTA_6136e43f-c8e8-4b3c-b4c3-8f2a1aaad485">21.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMi0xLTEtMA_d3db8a7c-27fb-4526-b68c-9eb729ef678d">558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5b2aa7ef11a4067b7913ca9a6049731_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtNC0xLTEtMA_645779ab-9b80-42f8-a062-07ed01cd1d6b">499</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtNi0xLTEtMA_d8643015-9559-49fa-aaf7-89ca957e990b">11.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtOC0xLTEtMA_23baa023-74ee-4411-a9c3-76028cb02702">1,161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd982433a2cc4b669204c6ff9a0df941_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMTAtMS0xLTA_7b75b0c6-e19f-4697-a627-b572292dcba6">1,022</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMTItMS0xLTA_56ebc57f-f987-40f7-b1f5-61d68c03a0a4">13.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMi0xLTEtMA_3d91e9b1-e25f-4ab0-a523-b4275b02c74a">1,697</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic193be42f65642e5914f3b9a9fe4b1f7_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtNC0xLTEtMA_f190292b-a597-4ee1-a103-4d057e33abe0">1,558</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtNi0xLTEtMA_26e51f98-3b4b-4bd6-b9e7-667367b923c6">8.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtOC0xLTEtMA_fe688c68-43a4-469c-9ce4-0ac82cab07a3">3,516</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f48c3e16a07411c939b255df38ab5ea_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMTAtMS0xLTA_5588cb2a-4863-43cf-82f1-c4a20bb5ba31">2,963</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMTItMS0xLTA_d1aac234-1d54-4d0a-964d-340866f34d2e">18.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMi0xLTEtMA_87397b05-3db6-4944-b670-630e9b61680c">241</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i258519354ca34b0ea53867c6b0469e98_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtNC0xLTEtMA_ddc783d8-01a8-4d27-b08a-e96b2e1cedda">176</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtNi0xLTEtMA_a2f5f003-b11d-4ec5-855b-6c9a5f4873cc">36.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtOC0xLTEtMA_b2f09082-abc9-4f14-8892-adb5b0e7bd3f">428</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21c482cfc9e440558a10a03ac6b0041e_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMTAtMS0xLTA_9b031817-ca92-4776-8228-228233610f3f">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMTItMS0xLTA_2e9d7850-dade-4a8a-bfa0-f9cb74745255">24.4</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMi0xLTEtMA_bbe41ff1-f1b0-4f86-aafd-f5f5a4091ca4">101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc056e7edf5d4a879f07aabe7d8da1a4_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtNC0xLTEtMA_89f4aaec-d1e5-48f7-99ef-915a873d20f7">59</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtNi0xLTEtMA_a2f0ed68-6ca9-44e9-8ecb-18d2c6c9f268">71.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtOC0xLTEtMA_2e804b01-9b34-448a-b309-6c6e9e743009">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3094a6e0c0e5489ca31b150a28af16f7_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMTAtMS0xLTA_22af926f-2d5c-4af3-a807-2090d962b4e4">108</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMTItMS0xLTA_39054a59-3e99-44b2-9113-275903fa6bc6">94.0</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMi0xLTEtMA_d1abedc2-68c8-4828-9343-afb1f5e898a7">342</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2493d378de5d441f8eed2a2813f2a10b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtNC0xLTEtMA_ad421c7d-a81f-49bd-b0ac-704c032c4331">235</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtNi0xLTEtMA_98ed18ed-1200-479f-8fb6-c496083011f3">45.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtOC0xLTEtMA_fdb78288-702e-40e4-b958-f9ffe955d6f3">638</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9a9cc129087542a39b32ad178f8e7d1f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMTAtMS0xLTA_71199733-428d-4550-a34d-f3c4cadb0aff">452</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMTItMS0xLTA_d14757b8-4930-46ee-8615-c4607328164d">41.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMi0xLTEtMA_1e8081ee-77ad-4503-9528-689ae67279a7">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2e74d86ade443d79565d3d4db9806ee_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctNC0xLTEtMA_6242c03b-901f-4b7c-b397-f9ae992a0872">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctNi0xLTEtMA_5630a00f-b149-4491-8b78-08e0fb74a418">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctOC0xLTEtMA_dc62bcb3-b6d8-4671-8841-67ae4d3902dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cdff07e389d4a98a18843581742a126_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMTAtMS0xLTA_bc067640-2a13-4468-92de-dfb086183804">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMTItMS0xLTA_7e13a939-21e4-477d-9eb0-5cbd76617700">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMi0xLTEtMA_2aa061d8-ce78-4e9b-b990-3f4a4c23c35e">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i617f22cd872049709ad264ec00aa4bbc_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtNC0xLTEtMA_9555821a-f848-4029-aea2-d3bfadd72ba0">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtNi0xLTEtMA_5220399a-df70-4c42-b611-55a3f7446137">11.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtOC0xLTEtMA_560ee56a-09b3-44b5-960e-6ffc123693c8">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5ef4c7f60c8c4c179f5410a867c82c1f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMTAtMS0xLTA_a30a6f7f-cd37-40c6-802c-5a1e7d43ba3f">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMTItMS0xLTA_fe5ab0c8-1885-4dc6-b403-7c7fef4f2039">2.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMi0xLTEtMA_2e2eecc4-cc1f-4db0-8012-d9a91b551a81">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if7e1f856d6494507bf69cee1f35c925b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktNC0xLTEtMA_eabd4049-a13e-4fa1-a846-9968198af4ed">3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktNi0xLTEtMA_ca797ed8-3279-4299-90ce-4eeb4499483b">11.8</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktOC0xLTEtMA_c8387e44-9589-4baf-9e6a-63a0ea2c68d9">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00a198b7e3724dfc8d0765ab1eb7c385_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMTAtMS0xLTA_f076f8d7-ba0e-4b70-a2fa-e749371bf076">6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMTItMS0xLTA_b15c2027-6aa6-44df-ac98-c994f4a90ee4">2.7</ix:nonFraction></span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMi0xLTEtMA_164165ce-a28d-43ac-b99f-ef2476867995">416</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1ad5ba18e22b49c8b7d61dde83b71892_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItNC0xLTEtMA_0449dbe4-e93b-422f-9e40-49c5e35d52ec">387</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItNi0xLTEtMA_7d360882-da82-4b21-91b6-54a896a34cef">7.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i722753247dfe40609326df9c146077f6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItOC0xLTEtMA_33d8f1da-dbee-4ec8-980b-c06b97211fb5">852</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iee8e1d7d443b4b5c8fbff2c8140dd02d_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMTAtMS0xLTA_7473e5f8-425e-4e7a-8fb9-98bf308c9f6d">744</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i722753247dfe40609326df9c146077f6_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMTItMS0xLTA_2391b89c-3a54-4a9f-b0df-6ff6ffb041da">14.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMi0xLTEtMA_f0fec608-52db-461c-ad83-accc068853e4">463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i860d3da7dba846e9b34578282e68a159_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtNC0xLTEtMA_b2d9431f-6761-47ef-a519-ce3ad4ba8c44">475</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtNi0xLTEtMA_274d3b6b-27bb-4789-baf0-70ce5b2ccebb">2.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtOC0xLTEtMA_32562a5a-0170-453e-b7b7-009166218014">946</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i90605ed3fd3d4ce9b995899ac2960140_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMTAtMS0xLTA_dad5153a-0c11-438a-8d1b-c6c81c769111">964</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMTItMS0xLTA_0368a3c4-e7fe-4753-98b8-c63c6068e7d8">1.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i424fb644ea244b7da33323ed90262948_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMi0xLTEtMA_45ef4b2a-b2b5-46a1-b9a4-07a2b907e6b0">878</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifdb83db6bf2643a3beb8b071f017dd9e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtNC0xLTEtMA_a77bf17e-8094-44f0-98ab-9e2d8095bb23">862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i424fb644ea244b7da33323ed90262948_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtNi0xLTEtMA_7d17c6c1-ebcb-40be-802c-ce0520c9394c">1.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtOC0xLTEtMA_3c6bc719-dacf-4810-849c-fe2441a073e6">1,798</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i593eedd9b3554e4aabf346ef510aed2e_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMTAtMS0xLTA_1c3fe7e8-1f97-4e16-8b17-5b4a70d9c18a">1,708</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMTItMS0xLTA_d11d62d8-b16b-432b-8013-5c9ef41e401a">5.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMi0xLTEtMA_72fb24ca-cf95-4868-bf23-d1199ef2b8c6">10</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie6756f2eb6504f6fbe424eaf7c67b1ee_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtNC0xLTEtMA_0d8f90ec-90a7-4e8b-ab96-8c2ee88d042a">12</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtNi0xLTEtMA_404c0927-2756-426e-b929-47cf65fa8cf3">14.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtOC0xLTEtMA_67d7a1f3-edad-4404-bab2-a4c58f582930">22</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i085528c026384b5c9822a2d0583767c9_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMTAtMS0xLTA_d842fd8b-86f2-40f3-8cd1-7fc4c18e87ea">24</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMTItMS0xLTA_1ac7075d-91ea-4cd3-be6d-e2cdc80594ff">6.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMi0xLTEtMA_704a44fb-c41e-490a-a387-7b7faefcb8c0">246</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic5505f103f3741599a24e8ec3035a6da_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctNC0xLTEtMA_d0535380-38c7-4ada-b914-4eced2c5130e">198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctNi0xLTEtMA_cb932e6c-e872-4305-ac17-86e7ba009237">24.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctOC0xLTEtMA_9bee172c-6d17-455c-bb72-6c5aeb209d47">458</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia111f6b65afb4bb78be8e74995a7f05f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMTAtMS0xLTA_c5c75dc5-909e-42c4-8931-00a8ad303dea">397</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMTItMS0xLTA_122d76ae-924b-4dfd-a72e-466be89763e7">15.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMi0xLTEtMA_60e2ea63-6dd5-40c7-b971-e0e76fffd807">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d9bcb321c9e498f98febc66bd97be67_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtNC0xLTEtMA_d06a0742-4dc0-48e1-aac1-4a6782e90adc">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtNi0xLTEtMA_012ce4f1-94c3-4e95-bda4-ea6661beb0b5">22.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtOC0xLTEtMA_3c0a478a-bea0-4b68-8d5a-b35c94e147a8">480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iceb44ce996964b328d052671fe7e60e2_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMTAtMS0xLTA_cec1f053-eea5-48df-8549-664f8b1a65b9">421</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMTItMS0xLTA_cde2117d-e80e-4c50-9f35-ed9d0699ec60">14.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMi0xLTEtMA_2d06eeea-3c99-4496-9204-3c0b8ad6add1">379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d7a48b762e44344a5837c580cd3cbf5_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtNC0xLTEtMA_9da75d1d-96e2-4877-b865-5a85bbc3a511">344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtNi0xLTEtMA_64d54b86-3d5b-445f-b377-e622c6914b1d">10.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtOC0xLTEtMA_e40768c9-a0ba-41e8-82cf-7704dc9a264b">775</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94fb5529b7f24fdcb5216fd61202149a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMTAtMS0xLTA_c510263b-2949-43fa-bb55-816c8e54bf40">659</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMTItMS0xLTA_15b32dde-cb4e-48fd-9954-c8cb48177ea3">17.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMi0xLTEtMA_7afc3e2d-b81f-4201-b375-1b629af9e2c0">130</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i159cfea84a824beb9e343c1924836863_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtNC0xLTEtMA_d2b96dce-9393-4fb0-a15b-a404aeddbd1a">191</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtNi0xLTEtMA_ac51cd54-5765-4e86-89f2-819d4ce61efa">32.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtOC0xLTEtMA_f2a8f167-f66e-4389-b825-831206f2ba33">314</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i20e61bae25d1431f95c16ee1a52b7698_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMTAtMS0xLTA_a50bc115-71c5-40b2-aef8-3f264a926e9a">399</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMTItMS0xLTA_d8ea8740-3fae-42b9-9cf1-ed7edd20651b">21.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMi0xLTEtMA_4e6a5f75-0a4e-435b-bf0b-63c82d6767a8">510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d9a2a75f7ec49fcb41600b16ed21ebb_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItNC0xLTEtMA_d94244c2-c44f-481b-809f-711679ab3ddf">535</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItNi0xLTEtMA_fb651531-98c3-42a7-9d67-a1fc0d5d3127">4.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItOC0xLTEtMA_5a2ae8a3-7de9-4788-bedd-afabeae9a862">1,089</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifabd48f69a75450fb39b1fcc14893a13_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMTAtMS0xLTA_b3e949e4-9a58-4521-a064-e7082517d3ce">1,058</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMTItMS0xLTA_afd5af32-1537-4de4-b41e-20dc64146f43">2.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMi0xLTEtMA_cd99f876-b421-46dc-9cfe-2aadcf0e4102">25</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4ec93166231349a4a62144abaa88211c_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtNC0xLTEtMA_57e5cf98-facf-499a-8f63-ac9bf3f566b5">31</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtNi0xLTEtMA_7667c1ac-79fc-47cd-8e55-cec8975ef5e3">18.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtOC0xLTEtMA_96caf310-fd1a-4e9c-9ee3-77cdb45013c9">54</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9943abc01c244bfc976454f3930f0b53_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMTAtMS0xLTA_f3a91b69-1b17-4630-bbfe-75e15460ed30">61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMTItMS0xLTA_7aa09535-d6cd-4d71-9fa0-159c09e9673b">11.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMi0xLTEtMA_6624116b-54cc-4738-bad5-c4e5a0e4b399">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i865c1debd77c456ea62aaa4cee5f5098_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtNC0xLTEtMA_9b0b26a6-be05-4abc-8171-ab07f0458b79">86</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtNi0xLTEtMA_cd7a995b-ebb1-4a7f-ad67-978c5e1ed827">1.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtOC0xLTEtMA_497f5846-8ae2-4643-b7e7-781ffd8b3ef2">174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3b12655dd4d549d791503b3d33bbc3bb_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMTAtMS0xLTA_42498e42-b5f8-40c7-baed-f704c4e26287">168</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMTItMS0xLTA_2760895b-4de9-4059-89a5-b5dffabe2a00">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMi0xLTEtMA_26995051-4717-4af9-88fc-96994ee1f03b">113</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e49fb04160848249e6b979e9e53d9de_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtNC0xLTEtMA_2574f560-595e-4f32-88f6-fe2d5ced37bf">117</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtNi0xLTEtMA_4465b0c3-e8d2-4375-a7ef-da76df0a5d21">4.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id4958d04806e4a26989b410d7de289c3_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtOC0xLTEtMA_6d5a5728-b1f6-4b83-803a-ae79ac940a4f">229</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4b73bb8b3a32402cabe464c9e85b926b_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMTAtMS0xLTA_ce751549-f3ee-4369-ab86-9c4db1cd70ac">229</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id4958d04806e4a26989b410d7de289c3_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMTItMS0xLTA_0a372df8-91fd-477a-8a73-517e53ffca04">0.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="ibace0003514d4decb7280d8401a92eb4" continuedAt="ief1a1714e6ab43a5baf2038c41314117"><ix:continuation id="i4116ba84856a43e2ba5c8bfca2d60aa7" continuedAt="ie4004c9e8e5f48d78136a112ae560585"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMi0xLTEtMA_d1637490-032d-4ccd-b2ed-22be9913a025">778</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib0a4733c057e4c91a422fa0925f0ae18_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktNC0xLTEtMA_d9c76118-1453-411a-9f8a-6684a8d20b56">664</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktNi0xLTEtMA_e210b7c4-7a86-491d-a728-0c7913ec81b7">17.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktOC0xLTEtMA_fc7b5c66-b073-4f8c-a02e-751e44038b89">1,526</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id17f2144580042799de6fe20a0e39ccd_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMTAtMS0xLTA_c58c221f-3132-4b90-9845-c332ac3374c1">1,387</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMTItMS0xLTA_2534817e-1060-4229-b98a-d781e31cfc1f">10.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMi0xLTEtMA_97e783fa-4e12-4972-9c80-296ed61153cc">809</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iebd5c6d65d444de181e96474c0ce96d7_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtNC0xLTEtMA_3d14b312-1949-43e1-a963-307f737c5c2c">875</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtNi0xLTEtMA_6b302afe-cc05-4634-9043-9e69994794fe">7.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtOC0xLTEtMA_d1f16e4a-f596-405e-954b-e465d9ed2ba2">1,719</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie13d62f4906646048e8d258210540cc4_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMTAtMS0xLTA_acc51bc2-a4f2-43c3-9b86-2732227e6ab3">1,780</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMTItMS0xLTA_cf8dce6d-a17d-4a97-8caf-97f3738bd738">3.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMi0xLTEtMA_0008c15b-14b1-4f5b-b22c-d48bca84be19">1,587</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i69a768ae79db44808f989038a6762aa0_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtNC0xLTEtMA_a72b0303-6253-46f6-8429-6da227d33667">1,538</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtNi0xLTEtMA_e27f87f1-f32e-4ca3-b567-5a0aec02400a">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtOC0xLTEtMA_64e72a33-a268-4911-8902-8f925c44a25c">3,245</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb74ce4d9f2a438ca8c55bce6a61f201_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMTAtMS0xLTA_bd4ea470-71e4-4077-a4ad-81a9aecea0a8">3,167</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMTItMS0xLTA_6bddcae4-83fc-4c22-b880-69117936f710">2.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if252bb07e5ce40b09ae6eef7a0bd8990_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMi0xLTEtMA_693d5b03-4609-4aa6-ba89-ab57df7a177c">55</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2ffa593433846189cbe811f55d09e5d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtNC0xLTEtMA_4c53db2b-ab41-4caf-a743-51ee8ab077d1">15</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtOC0xLTEtMA_b7582c41-1a8e-49b6-8240-1285a65f52c1">107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e675afc2787431e8afb910310f97ada_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMTAtMS0xLTA_dcd152c8-21d3-4c0f-b1e6-2bff78262f82">112</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMTItMS0xLTA_d862367f-d169-4a2a-a620-ab1f2d7216ab">4.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMi0xLTEtMA_56523fde-492a-4ad0-9a87-83262c3260e5">94</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id409969f7fec4d07b24c2e6172c72cb2_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtNC0xLTEtMA_8f9cbe09-4023-424a-bf4c-82baf544b9b3">123</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtNi0xLTEtMA_fb9c4b84-61ba-4a13-a493-f9d395d71fed">23.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtOC0xLTEtMA_d27b2c09-34ec-4bcb-8bf6-7dee266d91df">212</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2968959d6568429a8880c28dcb335451_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMTAtMS0xLTA_5048a955-9138-47bb-83b7-3a90dfca8677">239</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMTItMS0xLTA_28717727-5251-4d01-ae73-3c88d1dc1156">11.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i026f726665bd40f0ae400deeb330076e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMi0xLTEtMA_b6844e35-2f34-4c0c-8cfd-f901d65fabf9">149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8291c7e7f5074b05a4080989a7cdca7f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtNC0xLTEtMA_ed8c2a4d-17e5-4093-8603-14e79f9ec889">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i026f726665bd40f0ae400deeb330076e_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtNi0xLTEtMA_956f1a0c-09a5-4c99-bda3-48e4d3aabe20">8.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtOC0xLTEtMA_4f205677-5b39-4a46-a4ec-6f9a9009e22d">320</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic8bfd30da6154a89ad914f97e310482b_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMTAtMS0xLTA_2eb35f36-7e8b-4d9b-82e5-f14e3b2ea1d4">351</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMTItMS0xLTA_30d725bc-a395-4e49-b77c-0cfbd5c60823">8.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMi0xLTEtMA_55ca2c80-d673-48a1-9e02-bdc2320592c6">576</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6cbd731ae0314fdab64251ba569ebefd_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctNC0xLTEtMA_14cb014c-833e-4189-9d4d-4cd0e8e3b1e5">506</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctNi0xLTEtMA_a94063cc-9a6c-4e3e-a17b-d27399dc456a">13.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctOC0xLTEtMA_80093015-0a5d-444b-854d-e0f1aac45740">1,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4aaf80f3af504855ac58fed5a2bc812e_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMTAtMS0xLTA_83336f1a-440c-45db-a3d8-64eea0bf37e3">989</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMTItMS0xLTA_e7a5ace5-fd1a-4fca-85a7-6c4a7e6e4387">13.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1439a394ab6846988867d4f1cf885731_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMi0xLTEtMA_0a54a856-6237-4770-b923-bf13ba339bc5">303</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7fa5b3c2baa437496a6794409866f3c_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtNC0xLTEtMA_e00937c2-2e4f-4b51-a26f-038f045c0891">312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1439a394ab6846988867d4f1cf885731_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtNi0xLTEtMA_9743cae4-94dc-4ccd-9a5a-8b174816dc4b">2.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtOC0xLTEtMA_d1b75f46-7184-4949-82b9-6993359a5341">642</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3100b6a78517436fa32a8050740185a2_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMTAtMS0xLTA_81915c83-912c-45c2-9be7-8b5bb4f929b3">619</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMTItMS0xLTA_c2211ee0-409e-4306-95fb-ddf7f1940d2a">3.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMi0xLTEtMA_68a881cc-1d01-4752-a1cd-b4af7b21e99c">879</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f27d0f078234139b5a188a530fdf0f4_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktNC0xLTEtMA_8da8d198-92c8-4658-a12e-97476410a8a2">818</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktNi0xLTEtMA_313cd1bb-bbe6-4f8e-b4ca-e741aa130766">7.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktOC0xLTEtMA_c5031111-a34a-4397-9aeb-f624e02a8f2d">1,762</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib615d062e3cc4937be3e2a60d7cb2915_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMTAtMS0xLTA_d5deb563-19ce-4472-a220-cfbff7de6363">1,608</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMTItMS0xLTA_bdb3dd8a-cbc8-4817-bd18-69f92c1714b2">9.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMi0xLTEtMA_c6e75d03-d1a0-4fd9-adad-612c837d0462">74</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0beff2f10b94936b5d68d3d4b19ca88_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtNC0xLTEtMA_b23a88ff-8456-40aa-8519-ec547d556f06">81</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtNi0xLTEtMA_10693c36-64cb-4cf1-9b71-b524742c9cbc">9.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtOC0xLTEtMA_d5e13f50-a4d9-4b66-8936-8f9f20b170d8">150</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24c7d1c7078e4cbfad4062f370a3bfcd_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMTAtMS0xLTA_6369bc2c-c102-4db6-81a5-7dddfff51257">158</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMTItMS0xLTA_57370c7b-93f7-4885-b630-600de1f72ae7">4.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMi0xLTEtMA_b89faf8c-80ac-4f33-8d4d-fee9868958c2">79</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d6915ef71e9474593878dc7ff1d3c21_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItNC0xLTEtMA_bd007990-7419-4093-b9eb-d6b08db79c55">101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItNi0xLTEtMA_9eb83373-2c88-47fc-a47b-95c6244eae78">21.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItOC0xLTEtMA_7753726d-8c75-4473-a9d2-01c9f3f3382c">173</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i609cfa77c4914441937e2beddbb8131a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMTAtMS0xLTA_7c608621-b2c3-453e-b261-dd3ef514ac72">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMTItMS0xLTA_8c3433fb-9227-47c7-95c7-64db96fc3de5">14.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMi0xLTEtMA_66a0ca31-98e2-4e28-b7c4-a8aa1fececfa">153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if72cc1f808a74f7a9d09c145562b9fe6_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtNC0xLTEtMA_30fb9d1a-dace-4797-99e2-dd75fb35db31">182</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtNi0xLTEtMA_c3cf1a39-8b36-4bad-9279-40eeb506b963">15.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtOC0xLTEtMA_46db8c24-0ffb-4301-a436-f192993b91da">323</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i31b578e4ed884650a6403b04a4e0b789_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMTAtMS0xLTA_fd60cea5-436d-4d92-a6e5-e57bcd2d9dfb">361</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMTItMS0xLTA_1801c089-2972-440c-b348-9df7b7a88d04">10.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib262502572224ee39687f0f730b454e5_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMi0xLTEtMA_e5846c8d-d730-4afe-b0c1-772a0bf76e22">75</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80c887d315ba40298eef530b8f4ba42d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtNC0xLTEtMA_f30ec6d7-8731-44ce-a961-6ee5dd891d9b">62</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib262502572224ee39687f0f730b454e5_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtNi0xLTEtMA_716e3dc0-354b-4105-87a5-679d80f06be3">21.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtOC0xLTEtMA_e849d29f-95b6-4b1a-8809-a7e257026a9e">150</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14201fb6ec904317a82f139c47f516d4_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMTAtMS0xLTA_fc328a64-4e1c-4728-a916-15f849e7e15b">128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMTItMS0xLTA_169339b7-26ed-4b49-9631-a2c192616502">16.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d635955ff65456481154c2069841ae0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMi0xLTEtMA_d101eb1e-fa6e-4bf1-b5a7-d7b0e38b884b">331</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4102c5393e3e4404af8f3950fb3c1061_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtNC0xLTEtMA_de720c05-758a-486e-88fd-b5d9a9749f49">340</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1d635955ff65456481154c2069841ae0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtNi0xLTEtMA_b43f3956-476c-4077-bd6c-39c9f5d4e31e">2.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtOC0xLTEtMA_69a39d9e-35ba-410a-b792-f28b9a8cde79">691</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iab60464d3cb4430eb82579d017bef6f8_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMTAtMS0xLTA_9fb12b2b-7963-490b-b4e7-66e55f4ab7c5">719</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMTItMS0xLTA_49474f39-cdff-4a6a-af31-3c6b9220de53">3.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMi0xLTEtMA_26427357-ed03-4746-9d2a-e813209fd5c9">406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i11fc7443e78c45d6bf48c2a55810ae8c_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctNC0xLTEtMA_ec46dea3-3f67-4468-80a2-b1ec449e5898">401</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctNi0xLTEtMA_9d1b2f5c-3b62-4ea3-bf43-92b720e2e7bc">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctOC0xLTEtMA_232d27c2-db86-49a6-aa3e-5e8a520a512b">841</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i17a8a56018f8486f8449896537768e16_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMTAtMS0xLTA_a7302c8b-5a50-47a9-a330-87d1eb2e45ea">847</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMTItMS0xLTA_0a98c34b-75e3-46af-a7dc-405dc3cc0201">0.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTItMS0xLTA_d0cd1b72-92e6-48bc-8851-1d8b4df6b881">1,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i98e861871c884f4680474af0cbc7e046_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTQtMS0xLTA_48a34c43-1e74-4d5b-a71c-0c15a93d2b69">1,013</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTYtMS0xLTA_3aae7222-ee7f-4a61-b7ee-812283cc7c5e">16.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTgtMS0xLTA_4af8cbf2-27d1-41cc-bbd1-376c2fd47a8d">2,356</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40d8d8c184b744188f48cf36a41714c1_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTEwLTEtMS0w_4b323112-fc40-4d03-bee3-9691e3d5ac89">1,975</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTEyLTEtMS0w_3c6dbc67-6677-4834-a362-20504a113f0f">19.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia70fced883cc48efa3c30712ae539922_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTItMS0xLTA_8587445f-a93f-4c07-8af1-b298746f66ca">1,609</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i57870f886e894fd8bbe4a13765b0df95_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTQtMS0xLTA_92fbd191-7f04-4592-a4fa-bcc8311e9ba9">1,684</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia70fced883cc48efa3c30712ae539922_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTYtMS0xLTA_876540ae-496c-4b39-9e73-1e902ccfd529">4.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i781ae83699db4163b10fd85d372075b4_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTgtMS0xLTA_5982dd07-cfd7-47f4-8037-100df951aabd">3,448</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0afe68e69df24e9ebdf140bda8bafd0f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTEwLTEtMS0w_cc000b71-3c8b-445f-a5c6-79b9eecdb35b">3,240</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i781ae83699db4163b10fd85d372075b4_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTEyLTEtMS0w_6272d50a-bd1e-4241-9343-73e4c23746c6">6.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTItMS0xLTA_001bff71-4bac-46d9-875e-5b37d4b72312">2,791</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic2caa6cea60a4de4bf1daf8484380ff9_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTQtMS0xLTA_85455991-ce96-4b7e-9afa-d61dc00c2e32">2,697</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTYtMS0xLTA_83e8338b-a36c-4353-aeb8-ae46f5d6f3e9">3.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTgtMS0xLTA_79c59fd3-fc6c-4d43-a711-a71f7d46360f">5,804</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c6b423472dc4d3aadf1c81dc48fc95d_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTEwLTEtMS0w_00298e07-255b-480c-b80e-5f25f689fb98">5,215</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTEyLTEtMS0w_deb154ed-731f-42a1-a250-2cd364ba2e6a">11.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTItMS0xLTA_673501e8-a14b-4079-a7fb-5c7892b4b35b">492</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i68de92f3d1ce4ff98dbf3ea01899ba7f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTQtMS0xLTA_35cb04b5-11a7-433b-b727-bbe8a270eb86">369</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTYtMS0xLTA_4b7502b4-8570-4f83-971d-bef134c99769">32.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTgtMS0xLTA_dd0102ea-25a0-47f9-9a75-4475c164ec7d">955</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibd26991e9f7c4050a356609fa6aa6564_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTEwLTEtMS0w_8efd83cf-19b5-480c-b34d-6b25d7842a0e">721</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTEyLTEtMS0w_e6a5fb52-ab7d-40a1-8147-45f973ada226">32.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTItMS0xLTA_a7947f86-4d89-4e6c-b38c-1ed6a90ae9f9">409</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib5c47b91ea4f4a1a82f47eb2f2b05c3d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTQtMS0xLTA_fb114a16-4b4f-453a-853d-fa7529fad705">405</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTYtMS0xLTA_46ce548c-192f-420f-a74c-03047d2dbefe">1.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTgtMS0xLTA_0da850d2-ff76-41aa-9d0d-1d4f491e7789">883</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iedcc529eaf2d4f5e95ef455772dfe9d8_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTEwLTEtMS0w_1af37062-404b-42ce-b956-b651293c2437">682</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTEyLTEtMS0w_584c9c02-4f5f-4216-823a-c1fccfac0e9f">29.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c83bae4c94549c794523bba175150ad_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTItMS0xLTA_d58f2dae-9218-4262-85d7-9d5b9f786980">901</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i20db1fe43a544cd8bb1e84445a29fcf0_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTQtMS0xLTA_ab9772e2-30b1-42ac-99c4-ce73429579a4">774</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i0c83bae4c94549c794523bba175150ad_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTYtMS0xLTA_d3e6dae8-883f-440e-9b14-bf876ec9c720">16.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTgtMS0xLTA_e2236f68-8f5d-4252-b516-d65761fe029a">1,838</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1c6e046a80854e88a9f86f1695a5f3aa_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTEwLTEtMS0w_36a10e90-f35c-464e-86d5-742b19f700ec">1,403</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTEyLTEtMS0w_0709f905-cf26-4c8d-a8c2-8942e6c13a08">31.0</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i44e81356fdd54d65a78dac4fc0eda00e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTItMS0xLTA_b542d036-0528-4527-a948-02c939a7955f">136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie123409368b842cab55c01dc3d83661e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTQtMS0xLTA_31bc8ba8-5bb0-4bdf-a8b9-a954faa40237">62</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib3e20f2e34a646dc856760483fc4ad2d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTgtMS0xLTM3Nw_04ac4539-3cf6-4e34-8405-d27f561f2437">255</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d4e3a4668ff480e9666f51b1628680a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTEwLTEtMS0zOTE_afc80f45-abf7-4bca-a645-ceb5e8d02596">120</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d365fd404f94441a423bc83e35f9e37_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTItMS0xLTA_5c7a358c-9b3b-4bfd-881b-734e9024b36d">33</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3a5f0cceba9a45adab7b92c8c0342bde_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTQtMS0xLTA_56df79fd-4096-45b3-9467-2e373252180f">7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1b199c2136c468f8a1e8ae983620d04_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTgtMS0xLTM3Nw_8769258c-bfee-47f4-a2cf-5ea1c8c7fb55">57</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7591b4f8a45d45e9adbb156f546300ed_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTEwLTEtMS0zOTE_c2188500-7a20-4050-b691-371f49b84c03">10</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i879dace13f494901b14e98c7595f7ce0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTItMS0xLTA_16afa138-e21d-4333-a0cd-fb32836d3eb6">170</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i451c8da9b5fa46f9becd1b7f4f4c2059_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTQtMS0xLTA_c135b96c-b6ac-4f84-b978-2bd1aa0a84ec">69</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2b4f3715aad849fd85631a944342e87a_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTgtMS0xLTM3Nw_0f66c03c-7329-49b5-9150-db3a0d1d71bf">313</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i81ae16fae08e4c16b6ba95255d7c70a5_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTEwLTEtMS0zOTE_42270f5e-df5a-4e99-8bdc-334c4856d1ad">130</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTItMS0xLTA_02b4e879-4cef-4e9c-8caa-90332627af8d">447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f3face5d4a74567b928ba079035536f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTQtMS0xLTA_0709d424-4ca0-4980-b5fd-c715acaf27f0">367</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTYtMS0xLTA_00a15cbf-6431-44a9-9fdb-218d2f745c50">21.5</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTgtMS0xLTA_dc04f04c-06dd-42e3-8436-df0048946fd3">879</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic4830a4c60c5480f8753cc4f6e6e0619_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTEwLTEtMS0w_735d5510-0633-42af-b852-5d806b03aad4">716</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTEyLTEtMS0w_cef46cba-1af9-451b-873d-934f359f091f">22.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTItMS0xLTA_3422cb43-349c-475f-a0bf-b02ec63c9871">502</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ac0963e98b74865bd5c91872e42f462_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTQtMS0xLTA_3204b611-e92f-4fdc-aa0a-1e216279cd20">463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTYtMS0xLTA_3687a29c-eeb0-4abb-b285-e9f3cc6bca8a">8.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTgtMS0xLTA_cc98058e-e807-4bd8-9c88-13123dd1a7b7">1,101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5f34e03717784a4a8111609212e45149_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTEwLTEtMS0w_22b27bbf-ff07-44af-b3fe-b45d13544054">898</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTEyLTEtMS0w_5838a33c-c608-4195-ba0d-8d5c29e685e3">22.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTItMS0xLTA_f8e2b01e-efc5-40c7-b5aa-c2740c70a0a4">949</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i50c8b25757c84b7eba5a91969c95a1ff_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTQtMS0xLTA_2f4277b8-ce96-44b2-a733-5260b044d823">831</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTYtMS0xLTA_a39b8117-1c02-4e68-bacc-8ba5b976dcf9">14.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTgtMS0xLTA_95fa801c-9579-4e5e-b82a-1f9bfa15b4f0">1,980</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff1890bf78564da8b18b9b68921ec794_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTEwLTEtMS0w_fa2215be-a12d-496e-b8ff-d4e17c14aac4">1,615</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTEyLTEtMS0w_74ca4309-0f6b-4c36-91fb-28f9e8bb02a6">22.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTItMS0xLTA_d74d1cfe-061c-480b-bc87-c3442f3ac607">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40923251ff8c4dd2b498eed41e75b3df_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTQtMS0xLTA_6f4f1db7-bce8-41c9-a839-45c7e7405d07">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTYtMS0xLTA_7942a095-1b02-4f0d-b976-156ef3f188fd">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTgtMS0xLTA_236d2fb0-029a-472b-b59c-618f56b71f0d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ab98edb95934d548f9aab32a4017a85_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTEwLTEtMS0w_10b02aca-5c62-4e1b-a9b4-a9329ebdd175">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTEyLTEtMS0w_5bc26530-e1c4-40ef-9811-3210e103b96a">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTItMS0xLTA_b58dd27e-9c14-4f83-ad12-4460d1bb43ed">98</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icb58d996d2d340ac859eb5d48275ae50_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTQtMS0xLTA_b38ef2ae-13d2-446b-a23f-4212f3552928">224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTYtMS0xLTA_d899042c-5825-46d0-92b8-aa3c65d19310">56.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTgtMS0xLTA_5e43fc57-f0c9-4f69-9cae-874afc5ce595">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70777ca74a8f4c52bfcced79529e5a78_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTEwLTEtMS0w_9758018c-84f6-4b6d-9095-07d657671454">487</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTEyLTEtMS0w_bb537a6c-f08b-430c-b6f3-a3f24474e0dc">57.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTItMS0xLTA_2fe530d8-0930-4175-be0c-d29179982ccd">98</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia32c5586169343d1a69eec3e4c21fc0e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTQtMS0xLTA_4d07e50b-05e5-4944-8bb3-816995172a78">224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTYtMS0xLTA_d57bccb6-d73d-4fc9-8949-6ac67483fc2c">56.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i016a755a6a094e0588480249a8a01013_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTgtMS0xLTA_4bae2b97-e336-44ab-9f97-3a40e743114e">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia9fbe6cfac9849d8bf7baadf709ef1ca_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTEwLTEtMS0w_092aa9f6-5078-42ee-80e6-70cd2e275197">487</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i016a755a6a094e0588480249a8a01013_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTEyLTEtMS0w_b078f297-a62f-4167-b213-6e36d29fe708">57.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTItMS0xLTA_f61e4a03-958b-453f-8bb2-a103e12709c2">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd032f631b7b483d84a771f14f2dd965_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTQtMS0xLTA_360b9699-ee61-4fb5-82ff-13f48207e54a">198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTYtMS0xLTA_f14b2a17-1e08-4d12-b847-ec570caa65f8">55.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i268e898503704282b1e644c2a204b27e_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTgtMS0xLTA_6c6c2336-fa59-4274-b0de-ec05fff8f6f8">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia30a1b9a326a4a0cbd7d5286285a5135_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTEwLTEtMS0w_ba97e924-b2f2-4fbb-ba78-a69537350e36">383</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i268e898503704282b1e644c2a204b27e_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTEyLTEtMS0w_aca54fd8-9cc5-41ad-9eb9-d21edb258ca3">40.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTItMS0xLTA_56a20906-95d4-4edf-bc19-99ddba4e4dd9">480</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6fe3b75e12074a2aa5073e4be2dc9f2c_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTQtMS0xLTA_0c36304e-c7c2-456e-aead-157319d0af26">500</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTYtMS0xLTA_2662c18b-cee5-4443-b9d3-5af6e49c718a">3.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTgtMS0xLTA_8351220a-16d7-4f50-958e-4bc2a15ee7c5">1,032</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i590d4101caa4452e881c66c7cd378a8a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTEwLTEtMS0w_63fc3f9a-65d9-432f-89ac-bafd997ff3d2">994</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTEyLTEtMS0w_01174223-ae75-4163-92d9-c7de80b9406e">3.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTItMS0xLTA_53300c69-ad63-449f-bac7-c1e509ccc659">568</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief29fa0003a342a9b72261c5a777f5d0_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTQtMS0xLTA_f9134252-7b65-4237-952a-6f4feb7ac9cc">698</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTYtMS0xLTA_19fb946e-979e-4902-b99b-3f3e65c75316">18.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTgtMS0xLTA_3dbbc490-933f-4cbb-955f-ca65d09f8638">1,258</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i92c5ae1bb6c844da97fbc887f5bda6e0_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTEwLTEtMS0w_469a7ae0-2569-442e-b2fd-08fbe38bf761">1,377</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTEyLTEtMS0w_6acfbe86-c2b3-4592-a951-9785a6a4cb63">8.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="ief1a1714e6ab43a5baf2038c41314117" continuedAt="i76bfeeb8a40f4f839330ceb241b599be"><ix:continuation id="ie4004c9e8e5f48d78136a112ae560585" continuedAt="icba9a42c561c4d4bac6084b7cc7fd1d6"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTItMS0xLTA_79053f87-71e3-4dbf-be7e-ed87aaf6c682">20</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib56fd4104b864eaaae048a20df297cde_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTQtMS0xLTA_d6873950-5822-429c-b20a-662d16cedd59">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTYtMS0xLTA_f32be62e-c564-46d9-abcd-fb06ee15e59f">22.9</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTgtMS0xLTA_85a18d90-e574-43da-bdb7-0b56ebd66f84">42</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i801fee3b508b48d7b1a571095a597b48_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTEwLTEtMS0w_496af60a-83b1-428a-80de-146f9aad8653">34</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTEyLTEtMS0w_f947134b-bd4a-4615-b334-e17860c6b7c8">21.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTItMS0xLTA_50f0f612-50ef-4409-834c-a4add1cecf5d">87</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94d1ee23a76c405bbf282ee929fb2018_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTQtMS0xLTA_b418c861-4e14-4ad4-a3c3-fd7a43432480">85</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTYtMS0xLTA_bfa75a85-38b3-43a8-8a05-5e66ac4a4a66">2.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTgtMS0xLTA_6dc45aa0-bd0a-45a7-94df-dc7e9c07f0d8">169</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i372fe738f82d4d1aa79d1d22bb000b69_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTEwLTEtMS0w_048af60c-8689-4cb4-8809-45103d657577">169</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTEyLTEtMS0w_2d8b94fb-85fb-4c62-8bb6-75ddaf0c8efd">0.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTItMS0xLTA_0451a298-8e80-49b2-8039-7735825e8a69">106</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6214365a5a6e4954a883f81d290094b5_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTQtMS0xLTA_ae7d1815-ebf8-484a-9140-d346af666a62">101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTYtMS0xLTA_9927a452-63c5-410b-ae57-8215d35369ef">5.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTgtMS0xLTA_2b80ec8b-dcf0-4334-8994-da031a5a1458">210</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9c8d994f0ca943bc81943bb007e9399a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTEwLTEtMS0w_3c98c458-3f58-4d06-83ee-59bffab06776">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTEyLTEtMS0w_a06b18aa-4738-4f74-b09e-5ded5e7c3ad6">3.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTItMS0xLTA_82848243-e838-47fe-8e00-6ab7b6172c39">545</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i317e0f05a6aa4f0ca7c59c511f3116df_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTQtMS0xLTA_0308a309-217e-4f40-9509-716aff728aa7">439</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTYtMS0xLTA_f37bc821-9fa0-44e9-973f-4e0a44da34b5">24.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTgtMS0xLTA_d7fff4c4-28c0-4761-9e46-197b554dbaed">1,031</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e6c9a032cef42779e88c9c4e9e74fdc_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTEwLTEtMS0w_4c0edb5f-2edd-455f-92f9-4b0f012acd38">869</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTEyLTEtMS0w_cbef2e18-0506-4bad-8a04-2e0d93acbbb3">18.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTItMS0xLTA_675ddc4c-6b93-4d5c-9cfe-54c2c717cf7b">243</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iae747a1c0cef4fb9a4aca0b3ba685a30_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTQtMS0xLTA_e1637e18-15a1-48af-bf6d-4d9ea5002a6e">251</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTYtMS0xLTA_6a208bdd-138c-42de-8630-0777eba24057">3.3</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTgtMS0xLTA_7cd03d09-d6a0-4d0b-8ba4-34d492b4e1f7">503</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d783195c6564387b12b4f45034f355b_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTEwLTEtMS0w_ac0c7865-be1e-4342-bb15-78c3044e9071">477</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTEyLTEtMS0w_e552ea11-12fd-4b3c-a1dc-73f07ad9ebe4">5.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTItMS0xLTA_1eee3897-a921-4aa0-84bf-6ba5a5cd798e">789</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4eb263dcded541a8aa2ced910f1cd8ff_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTQtMS0xLTA_74baea5a-3d8d-428a-a298-918bd83e9ed4">690</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTYtMS0xLTA_78ad57ee-b9f6-4275-94ad-065011d47a4f">14.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTgtMS0xLTA_b52cbec4-94fd-49e1-8827-919ff1c97c7e">1,534</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iec7c2d99cde74ead89e90a32724d105d_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTEwLTEtMS0w_29a6659a-e891-440b-9a15-2e7c52c8e154">1,346</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTEyLTEtMS0w_fe14cb74-209e-4b82-b610-1d1bc1ad3a79">13.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic38012b16650436bae36d246ed2a8764_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTItMS0xLTA_ac99dd6e-9fb9-4418-bf2c-6c0d1be8914b">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a09f2ca879f43c2809e324c91ba6156_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTQtMS0xLTA_7d2194cc-8254-41ee-8ed6-698514c2f9da">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ic38012b16650436bae36d246ed2a8764_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTYtMS0xLTA_d562e38c-9175-4df2-afdf-f7d0d3976aa3">26.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTgtMS0xLTA_41fc5b44-0515-4a44-8cbd-8553ae3a705b">485</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iff5b53cf06a84a3680777d7f2e8be88e_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTEwLTEtMS0w_dd0ca9dc-60d6-4206-a90e-dc4d21f8c3b0">375</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTEyLTEtMS0w_b95e5852-d10d-416f-a6f0-ac33d6bb04ed">29.3</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTItMS0xLTA_ac4769ae-e6f3-4a36-8a16-b56401ff096e">150</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6c5cb1cb5ff547f0ad0d3363e354138b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTQtMS0xLTA_f4ea7702-c329-4426-a004-f7b41aa4a8e9">146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTYtMS0xLTA_c173ba1f-f6d6-406d-b22b-11752caf652e">3.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5526426e0d0144459d16606be11f1e99_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTgtMS0xLTA_b3ca9cb5-02fb-42e5-b58c-42b4560833ee">310</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id23f20da385240978278a18b68c30b9f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTEwLTEtMS0w_7f212a3b-1344-4e8b-a520-c6b2569fdbf3">279</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5526426e0d0144459d16606be11f1e99_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTEyLTEtMS0w_9709df5f-64f6-42c8-8acc-42f37677af3d">11.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTItMS0xLTA_06f38079-8b2d-450c-b46c-0aaa2725da59">406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1238641b920249c3aa20b57084128ec7_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTQtMS0xLTA_54ad8a0a-4932-44cf-9fc2-975e8c058fc6">348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTYtMS0xLTA_3a8372b6-c16e-4298-b5d1-d623f31af928">16.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e7538e0459e41a980f744f172fed239_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTgtMS0xLTA_bff9158c-093a-42ac-b728-39a03d995638">795</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id6c7f0cce06545a092c974ebc7a8836f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTEwLTEtMS0w_a5cb0d7e-66f5-4340-8c89-80049890c7b3">654</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i9e7538e0459e41a980f744f172fed239_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTEyLTEtMS0w_ea66677a-3128-427f-9eaf-e8c8b0ac1a8c">21.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTItMS0xLTA_b26d133b-c873-48d5-bf49-b3839f60b4aa">254</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c44c63fd2b14fbca695bf3112d4cfb9_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTQtMS0xLTA_7fdfb915-1603-4fba-8095-59a80300d9cd">175</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTYtMS0xLTA_cf470858-e491-4e3d-af6d-99dad956da6d">44.5</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28ce799db9f8497d8b627c203c959969_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTgtMS0xLTA_2c41cf17-04fe-483d-8d46-a9caca80dabe">466</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e364c5e2e934b64bcfa4212283d45f6_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTEwLTEtMS0w_750c2a59-2fd3-4747-84b1-8033c021224e">351</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i28ce799db9f8497d8b627c203c959969_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTEyLTEtMS0w_d0cbb076-6947-4235-9438-33164c5a80dd">32.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTItMS0xLTA_deac1c2c-edf2-4796-a7d7-43ac304a9f1f">28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c52dd3f3c3f4f1ab9080d8e927c9b9c_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTQtMS0xLTA_86a3332d-beed-4ec5-b7c3-b91c6b18ad73">28</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTYtMS0xLTA_af9ec883-b19d-465b-88b6-98340a7124f1">4.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTgtMS0xLTA_8d70cd5b-0fa4-4996-905d-6a3f7f36d93e">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i441081885a084c1b9bcbf9be8a783fbe_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTEwLTEtMS0w_673cecc2-bf5c-4c0f-9e36-182009b8dd82">50</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTEyLTEtMS0w_01522ac8-36c0-4d0a-9fe6-e16cea1bd701">33.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTItMS0xLTA_efc19f92-eee7-49d5-a82f-c4454dcdd0ab">282</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia2ddd2fe68ae4f6da08c10e586b72d62_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTQtMS0xLTA_2e605d58-d7b9-487c-ba35-bc47043e0dfa">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTYtMS0xLTA_bf843a95-80ed-48ee-94b5-7535165e3699">39.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTgtMS0xLTA_9f88d830-84e6-40f8-bfea-e8c14efba9b5">532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9630c7bf786b44439a2c196398e924f8_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTEwLTEtMS0w_d7d4b475-6fb9-4553-8858-a04f9f1ec284">401</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTEyLTEtMS0w_bc252f32-a60e-4d78-989c-0ed8ac85da78">32.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTItMS0xLTA_9a68677c-5011-4931-970c-38bb335b73f3">37</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if804e1fb547a4207ab79bbd55dca0584_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTQtMS0xLTA_20c604a9-cb03-427b-ab33-79c006faf05f">61</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTYtMS0xLTA_9069e39b-180d-441d-8ff1-971b28aceffe">40.2</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTgtMS0xLTA_bbcb52f8-fee6-499b-b8f4-3072a9b9286b">81</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i19f9e20c45134d49a3c68d672c6cf4bd_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTEwLTEtMS0w_4b2cfe47-e897-4965-88ac-03d8d2373884">143</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTEyLTEtMS0w_ae25648a-d0a5-4c20-889b-8f5d2958fe49">43.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTItMS0xLTA_2685b39d-38d8-4a8c-82c5-9129149ded4d">64</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i085ffcbbe09e4f149e82ba292414fe2f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTQtMS0xLTA_bac74822-b9fe-48af-852a-0e6c10c8e228">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTYtMS0xLTA_ed254dd8-c40f-4659-a231-e9352c422cea">17.6</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTgtMS0xLTA_23717c57-3693-4ed4-a3f3-87737ad56efd">126</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia8e06e959426468692abf98048c488a3_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTEwLTEtMS0w_5b264727-5e00-40a9-b9f1-181c1227320f">149</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTEyLTEtMS0w_827cfc29-9472-4c6c-b4d4-57832d9b4d25">15.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTItMS0xLTA_b74273b4-3408-4769-b475-4029d82e6e85">101</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia1c0080e67a0463ebeb744e69d1860e6_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTQtMS0xLTA_117d14f5-4349-4241-aa5f-9ac2913618b9">140</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTYtMS0xLTA_0f3aa413-fae2-4096-a921-2d506daa6308">27.5</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTgtMS0xLTA_ab5b2dc7-021d-4580-bd83-df829351989c">207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icfad13b3e4b641f8823b1565bcc50f9a_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTEwLTEtMS0w_d08d3474-b45b-4c95-bd90-0029d42107c6">292</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTEyLTEtMS0w_ea690605-131e-449c-9e6c-e1a6c88146e9">29.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTItMS0xLTA_2a0a1597-530d-46a9-a0ad-db966c496b4e">837</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia7ace7a83ca7421399ad7ad9788512de_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTQtMS0xLTA_e00794b9-cda0-4bc6-a49b-baa8a3fa6ba9">902</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTYtMS0xLTA_fb7dcbb6-9a25-43b1-9153-1072c57a368b">7.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTgtMS0xLTA_1be4a5fc-6cd5-4840-a5a8-bfeb9897fb4a">1,643</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i02d9fc89b2fc448dbed4a48c9e578ce9_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTEwLTEtMS0w_d2d330a8-b7b7-4a72-9083-3551d0bb248e">1,849</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTEyLTEtMS0w_f520ed22-1dd5-4959-b412-c8636cbdf05d">11.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTItMS0xLTA_ae7140d1-6048-4419-9897-5e2168b9ebbf">347</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib543ea66309246278232bc6dc99b91d7_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTQtMS0xLTA_377db932-40ba-445f-a707-99ded7e62dce">373</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTYtMS0xLTA_2cd28be8-4a6a-4c84-aa57-81b14a98c519">7.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTgtMS0xLTA_8d4c1fb1-19ed-4b3d-b658-968534ccca1b">701</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i14ddf81148af49f8829e3a2f40ddb0ff_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTEwLTEtMS0w_bbaa4a59-37f4-44e3-8789-68846d248696">771</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTEyLTEtMS0w_847d8255-227a-47c8-bac8-629b38589885">9.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i491add72dab6458988d768371a5f99f1_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTItMS0xLTA_a6faa747-370b-4773-8241-75243c091aaa">1,184</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ica871b685f374f86882c4067f230ad66_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTQtMS0xLTA_66cd3d13-5ff2-496a-8b93-a19f2bba18a7">1,275</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i491add72dab6458988d768371a5f99f1_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTYtMS0xLTA_95c19365-6b9f-484c-b80e-1d52e77b4477">7.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTgtMS0xLTA_e7eecc25-60a8-4cac-a866-8015ff2ca185">2,344</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6e9e1d0c2fca4315b63e1185226f0e3b_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTEwLTEtMS0w_c02b8cdf-3575-4188-95e5-14c581f1e990">2,620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTEyLTEtMS0w_1c087563-a1a1-4113-92c0-51f5647ac381">10.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTItMS0xLTA_330b5f1f-de7b-4f4d-9350-d6079b52917b">559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i73bdd59bf0dd41a4a002312654599a0e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTQtMS0xLTA_d0723d2f-2fe9-4687-bbed-256e05aae2ff">549</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTYtMS0xLTA_553d208a-202c-41e1-87a7-74d9e4f4f17b">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTgtMS0xLTA_0b3dea01-bace-452c-9cb7-3b15ec6acbac">1,086</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3101dfd757f24ebebe5d55676ba0b74f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTEwLTEtMS0w_0809abb4-e9b0-4382-93b3-daeabc12ab0b">1,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTEyLTEtMS0w_c73959e0-0d3b-4e4f-a0b5-c2d313644a33">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc05ce35d84345148bfe86d926005942_D20200330-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTItMS0xLTA_081182e1-4942-419e-a0df-5d61c33bd8ee">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb65b67f0ca146a5a8fbf3d66409a1da_D20190401-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTQtMS0xLTA_0f4a7a99-a1c4-4b69-b1c5-99d6e27b3511">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="idc05ce35d84345148bfe86d926005942_D20200330-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTYtMS0xLTA_4dce2e22-7fae-48a2-8a9d-70911d8b3b2a">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i542b4161407e414194fdf6ed4d650599_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTgtMS0xLTA_91bdfa70-6cd1-4a68-84ac-b214a0d89bff">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i936a7dd6706a4a36bbb3d4e462ea1915_D20181231-20190630" decimals="-6" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTEwLTEtMS0w_c9619bb0-4329-46a4-9789-dc429bbc3506">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i542b4161407e414194fdf6ed4d650599_D20191230-20200628" decimals="3" format="ixt:zerodash" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTEyLTEtMS0w_2d3e6e74-65b9-4dda-82d9-24d56d0317f9">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5736a09628a74942af5372765e9467a7_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTItMS0xLTA_04874ec3-bb28-4604-9744-34c905b4085c">559</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i04bf0c9bc6b546109f0c5c2b50e598ea_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTQtMS0xLTA_391332ad-cacb-42ae-beba-0d93ea576d6e">549</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i5736a09628a74942af5372765e9467a7_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTYtMS0xLTA_3b351ece-bfdf-4e99-b578-c79a8d5338e1">1.7</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i085118eba10e4519bb61e008118fee7e_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTgtMS0xLTA_e078ae21-7c43-49a1-903d-22ccbaa9c804">1,086</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0bbccb018ffd4dc493cc91e90e401f8f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTEwLTEtMS0w_1ab15cae-7bd9-4b95-9ec2-538368e568fa">1,091</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i085118eba10e4519bb61e008118fee7e_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTEyLTEtMS0w_9d909528-62e0-4bbe-906f-df2c893e7f79">0.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTItMS0xLTA_279cdb0c-df2f-41da-9582-21ac7ca457a5">132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28e940beeb8e4e158a7e01a90398711b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTQtMS0xLTA_28dbd6b4-f2d1-4725-bbbb-d23c2ca0599f">132</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTYtMS0xLTA_4c3f4ac3-ccd7-429d-b5cb-7ac8323cce51">0.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTgtMS0xLTA_d05b9460-09f8-4d75-9cc6-cd1cc43ad621">249</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c51ebb23e644f36a5bc98cb1b21b16b_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTEwLTEtMS0w_a0f4d493-e05b-4827-b3ad-fcb445e0308b">286</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTEyLTEtMS0w_a141313e-9f2f-4fb1-ab50-093bd5479eae">13.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTItMS0xLTA_482a1816-abe2-43a2-9454-12480029aeaf">47</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5b27e1d2c7f34ca595d359abf82ec68a_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTQtMS0xLTA_9409d76a-f29e-480c-ab4c-5a24384fd410">43</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTYtMS0xLTA_7ddc1231-2f3c-4b9a-bc32-fb951c0ac58f">9.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTgtMS0xLTA_1f42a81b-1d39-43c8-8cb2-b2a539be0cd9">105</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b5a7d7ae1b647339fd559afaf42d469_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTEwLTEtMS0w_c183688d-fe86-4fb9-8755-b7cd523e3530">92</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTEyLTEtMS0w_09acca4a-4998-4d1c-956c-ecb704ae238b">14.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTItMS0xLTA_d059d844-de60-4be8-a110-8ba1dadf968b">179</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc1e91be376b420c80fdf945f74f19be_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTQtMS0xLTA_2f747f51-337f-4aed-912a-d51f74f5f6d1">177</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTYtMS0xLTA_1d15df2a-9f17-4ed5-874b-893f7f316949">1.6</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTgtMS0xLTA_42c09d05-7c44-4037-bcd4-67f7a1bef5b4">354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibdb38e3ece9f494b80986166616c8796_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTEwLTEtMS0w_760aae87-77f8-4987-bc9e-c8154068b25e">379</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTEyLTEtMS0w_1cbd8dbf-28dc-4a0c-b804-a09aa2ae5d07">6.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTItMS0xLTA_f7d458c6-f46f-4bd0-aaf8-9e1abd827e15">70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id7d4a3441694425685b68ca60ff37697_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTQtMS0xLTA_a2401477-6d08-4592-83d0-502574095c58">113</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTYtMS0xLTA_47056090-8a07-4fbb-bed2-7c3e8d0bcbc4">38.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTgtMS0xLTA_98e2f492-470d-4973-96a7-b2e5844d1d2c">146</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4f6e2d7431db44d2a85a24ada1a8977f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTEwLTEtMS0w_6435b4f8-69b2-4d15-be37-048383f68f04">261</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTEyLTEtMS0w_aa625d36-9266-4920-bc73-b3640f572531">44.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ca587806fca4350a5892099573a24ed_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTItMS0xLTA_708ebe56-4ff3-4220-a8f9-88b0e54aa447">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibcfa4ee807d44bb2ab00fe7d9ad30b84_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTQtMS0xLTA_7ea5befd-38a2-459c-8884-7003aa985cdf">70</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3ca587806fca4350a5892099573a24ed_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTYtMS0xLTA_a961b2f6-183f-47a6-8b14-12d94a911067">5.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0acf6231882c4daf9707983397ea2171_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTgtMS0xLTA_595a4755-cc0c-4b38-98de-c5d908cb7af3">145</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63596790121d4860a57507cabde319b5_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTEwLTEtMS0w_175589a1-96cd-4eaa-b4b4-69f5ce91c7b5">148</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0acf6231882c4daf9707983397ea2171_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTEyLTEtMS0w_d49d7e2f-f40e-4373-ad99-13cff8ddc604">2.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTItMS0xLTA_e4e69265-b231-4bde-9387-804cf039ae73">136</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i966890469adf4f7ab39dda3e8b42cce1_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTQtMS0xLTA_e9cd9581-3685-411f-886a-5abaa59eea20">183</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTYtMS0xLTA_472fdecd-7173-4d83-9c22-a9f0eb523335">25.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTgtMS0xLTA_70db9865-4eb2-4655-9fc3-8c84e869f2cd">291</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ice899dea89fe4582b37b2c8d67529df2_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTEwLTEtMS0w_c5d5ab5c-9655-4500-9083-8d9dc36de748">409</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTEyLTEtMS0w_042c5668-11d7-4e51-a2f5-11a9cadb2e83">28.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTItMS0xLTA_ebe5e38f-93af-4eab-8e22-79f1e60a8dd0">78</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2c56f0779bcb4802976ff987723bd905_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTQtMS0xLTA_f8e22b66-c7bc-40c7-a05f-8f67ebcf51a1">107</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTYtMS0xLTA_1355deeb-f32c-439c-a352-0698677dfd61">27.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id9851a937c384f21b0553db930e3ad00_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTgtMS0xLTA_1f21b001-d0df-453a-a8a2-41cf1fc7b690">163</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3d745559b8748329aee818ee4c2dffc_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTEwLTEtMS0w_7ce96ffb-6e73-4056-99b3-987c52028f57">211</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id9851a937c384f21b0553db930e3ad00_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTEyLTEtMS0w_9689a5fd-535d-41b2-9967-a87c970f150c">22.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTItMS0xLTA_571bc019-43aa-4144-9ab0-79fe9c60bd40">234</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i108362d021024b2bba503dce1ecd646e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTQtMS0xLTA_37cf22c3-b20d-4e0e-b8d8-536c2ee3da62">260</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTYtMS0xLTA_5485d70e-40db-45b9-90af-f8740c9e9f29">10.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTgtMS0xLTA_f2508bce-4991-453f-951d-a6046bbcdc5d">451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibca496862e9c406b80302245e8c996b7_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTEwLTEtMS0w_84147607-a2d6-42d3-98b2-c5c29db183d4">531</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTEyLTEtMS0w_be1570b1-865d-468d-ba87-99dd08087bb3">15.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTItMS0xLTA_7c753a95-a9d3-4085-a77b-76876bfc201a">312</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic080c2635078489b8837e0c15b529291_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTQtMS0xLTA_f66f67c1-882c-4349-9125-285f37c2670f">368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTYtMS0xLTA_f948877c-4aff-4f72-a790-00b47dcf385a">15.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibd1737d9336f4ff499db39a6d78dd6af_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTgtMS0xLTA_f7050fed-3ef8-449b-9334-43502cb771c9">614</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTEwLTEtMS0w_b9b8426a-2746-4c15-8497-52e216645f98">742</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTEyLTEtMS0w_82e87f6b-b8f4-4a9e-a942-57752e9220c3">17.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTItMS0xLTA_84e29bcc-2d5a-412a-b3fb-5f42d7341a26">6,120</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i82e70c787f7849f9b4e7eb17a1217ae8_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTQtMS0xLTA_4b21384a-3c03-4bd7-b4d1-af22e398863c">5,783</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTYtMS0xLTA_5424a854-7940-4d32-906c-e0d9dc6a8a65">5.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3479c20afd6b47628f60faf7361db000_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTgtMS0xLTA_60845c9e-edbe-440d-b9dd-b2ecb59f1ef3">12,181</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7a4fa10b3864a2190a08faa6182e13c_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTEwLTEtMS0w_9478304f-8162-4979-baf4-c918f639470e">11,365</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i3479c20afd6b47628f60faf7361db000_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTEyLTEtMS0w_27e89fbb-c7d7-4849-8ec6-3ae50b124bed">7.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7e34366acf8642948ee51937ea67737e_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTItMS0xLTA_fa2bb7c0-ed67-4891-8ec9-e1fca8119921">4,632</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i644cb9fdf8ce4fc79443500fc969d197_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTQtMS0xLTA_423d7ab5-867a-4779-b484-41a2aeda086a">4,746</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7e34366acf8642948ee51937ea67737e_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTYtMS0xLTA_4b6dc956-a73c-4eda-9a87-dfb87c831815">2.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTgtMS0xLTA_7cb67abb-df1a-4a02-9c07-be5d5ff288c2">9,705</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i037ad64a515043b49334f8fb421b33ac_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTEwLTEtMS0w_84249fb6-7bb0-4a5a-9ab7-7acaa6ea4571">9,408</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTEyLTEtMS0w_982a0b0a-2d2c-4dc7-9700-4661faae6068">3.2</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTItMS0xLTA_2a999314-2455-40aa-a636-6d4a6ffb535c">10,752</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i75e4158bcf404921b8195a9cad36a2cb_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTQtMS0xLTA_ec7061b1-b488-4789-b2a6-a20f5db4bacc">10,529</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTYtMS0xLTA_02812fe0-60a7-4443-92c6-295bcf0fc5c7">2.1</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTgtMS0xLTA_889bd469-2034-45cd-a51c-302db4a4b6b9">21,886</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTEwLTEtMS0w_b11892e5-833e-4e3e-b4cf-e98927b42a4b">20,773</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTEyLTEtMS0w_65ed20c0-8017-41e8-85c6-e3c3c740ec4f">5.4</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="margin-top:5pt;margin-bottom:5pt;"><ix:continuation id="i76bfeeb8a40f4f839330ceb241b599be" continuedAt="i17ee5824fc7745c8b9838664c5af00c2"><ix:continuation id="icba9a42c561c4d4bac6084b7cc7fd1d6" continuedAt="i6d28bed0442740478f88ad006be678be"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTItMS0xLTA_a6c1ee29-7fc3-4ee5-8846-7abba6a9af7d">255</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2903af0eb1a74b4c8a4dd7ef23591531_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTQtMS0xLTA_52abce03-b7d0-4368-a6bb-354dbaf19384">366</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTYtMS0xLTA_114749ae-c434-4d8b-8937-828025ee6792">30.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTgtMS0xLTA_dc7a9ae7-200c-4877-aad2-771a632b23fc">620</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5659f85aa3624cc09864a84ecf854798_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTEwLTEtMS0w_faab24de-80a5-4e61-87d1-19ed18df37f4">709</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTEyLTEtMS0w_a4f77ff2-a864-4b76-a1ef-eb4757caeb49">12.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTItMS0xLTA_31b5aaf8-ab1a-48ba-89b8-c7503b8e9a3a">335</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb7726bd5ac44766aeafb59df236adb8_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTQtMS0xLTA_917fd283-9b11-4baf-bf48-a19b67cb4a3c">385</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTYtMS0xLTA_9bc16f94-beb9-49fd-913b-d3f607ba0526">12.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTgtMS0xLTA_1a7ea303-2861-47ad-8126-f46c93f1a0f3">697</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id719681b56d64604ab0267e1d3cfce80_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTEwLTEtMS0w_e147d807-cae2-494c-9741-c07c2b0da9cd">774</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTEyLTEtMS0w_fb9535f9-ab14-4c7f-b485-1841c1ff6696">9.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTItMS0xLTA_a3022289-82dd-4cdb-9ea6-8ca551e58ff4">590</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i057617a514dc4f72bdebb0e1ebe06b7e_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTQtMS0xLTA_e0574d6b-bfc6-41b0-9c0a-a532cbba0d57">750</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTYtMS0xLTA_0f00e60f-a275-4f0a-8b6c-00ba914900ed">21.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTgtMS0xLTA_c2195f0d-2002-451d-9c57-0065f4d78b0c">1,317</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic49dce02d6a342668ab35662fd1521e5_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTEwLTEtMS0w_280ca02f-cf02-4dd9-ae44-526eff4500ce">1,482</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTEyLTEtMS0w_e015694b-a596-46e2-a0b2-c4217752eb94">11.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i72eaf829d51c441fad147448cea308e8_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTItMS0xLTA_5fd99c03-e55a-49cc-ab5c-c4e74e8fec67">869</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4aeb6f629da84fa689517fc2cf39b39a_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTQtMS0xLTA_969f1c6a-4f27-49a6-bb83-fb3811da01a9">1,331</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i72eaf829d51c441fad147448cea308e8_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTYtMS0xLTA_0422f091-a894-49ad-9d27-5391b68da095">34.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTgtMS0xLTA_ab98b3cb-eb3d-4fd1-aae8-0cb7263a61f5">2,119</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic34477da8fc847db9dbe086333871ef5_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTEwLTEtMS0w_f2408ae2-fa23-47e7-8724-4b6b88587b8e">2,649</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTEyLTEtMS0w_d960f6ac-fa6d-4dd5-8c14-923b5ce0b6d8">20.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTItMS0xLTA_4cd8468f-7811-491a-8ba3-f42299d78cb8">583</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6225fbf007674bad9bb72edeec2ab93f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTQtMS0xLTA_97ce73cf-aac8-4c00-8735-45c4f04ee0db">894</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTYtMS0xLTA_c65314e5-2b85-43db-9379-e46d24a40d83">34.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTgtMS0xLTA_a00e732e-b109-431e-aa58-d789233fe3a6">1,371</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic62ccd20ee5b4d56a9e8161ca4b98d84_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTEwLTEtMS0w_ecfef559-2c1a-49a1-b279-12af6ad04170">1,779</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTEyLTEtMS0w_1c1b6110-37b8-4638-aa5c-a24de4c1d8b1">22.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTItMS0xLTA_e723406f-bf0f-44a4-9cc2-010967a8be7f">1,451</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic6dcea95239d4c7c93cfb6aa0ad58cd2_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTQtMS0xLTA_0f972458-cec7-419a-892a-69a4c556f9ab">2,224</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTYtMS0xLTA_dbe27f14-d412-4d72-84c6-80ef9da36025">34.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTgtMS0xLTA_af712e70-30df-4851-9e5f-18814f08c866">3,489</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i24408e76c0c24f55ba8d7876c31ed2af_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTEwLTEtMS0w_e14b42db-54e5-45a0-9583-9b6ae59b83d9">4,428</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTEyLTEtMS0w_a8568188-8c2b-4cc1-8f64-686c5240beb7">21.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTItMS0xLTA_107775fd-33ae-42d6-a5cb-368d0a67fe66">137</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i951c881d588b402e80e0a08fabfcbb9d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTQtMS0xLTA_1e6c3832-fb00-4c98-8c41-6326951775e6">216</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTYtMS0xLTA_1322a695-8dd0-49a5-ae12-140b64677e1e">36.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTgtMS0xLTA_e77c6095-88e5-4295-a9c2-5f1afaa70470">343</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i41d577053e5b47e599467e7d5b2c1fc9_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTEwLTEtMS0w_5ccb6ce0-ca54-42e2-bf22-c6e716fd5e0a">429</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTEyLTEtMS0w_084632b9-2af9-4dc5-a110-35a0eaa3d62d">20.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if46b85908413428cb65b67ada12835e7_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTItMS0xLTA_686efdb5-94a3-409e-a73a-e976453ef036">88</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7d5d439ca53f48c7a5b9f80ea92d18b2_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTQtMS0xLTA_b0304298-e26e-413d-9a32-909d81b9855b">147</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if46b85908413428cb65b67ada12835e7_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTYtMS0xLTA_e99d64cc-d2f2-459f-9002-09b93d441600">39.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTgtMS0xLTA_e0bc6f2a-cf7a-47cc-a58f-f7b2ef31130d">220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if34599cdf8c34ab2a763c193d7f21c5e_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTEwLTEtMS0w_630606a6-cec6-481b-8db6-5ca3d1e06612">295</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTEyLTEtMS0w_530841c4-43d3-414a-b56b-02422627cd20">25.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTItMS0xLTA_c3476cc9-0958-4315-a385-c09c548efd25">226</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i719c9077824048efa89c19d85df1c039_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTQtMS0xLTA_719160c3-3487-40e9-b8e9-d7cf16832204">364</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTYtMS0xLTA_3e4c48f8-800c-4a1d-8793-fcbf6589734a">37.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTgtMS0xLTA_cbfaa74b-699b-4abe-9e2b-557eb1dcdb69">563</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie25872f3bae6482a86f7173fcb928c60_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTEwLTEtMS0w_146ee278-1c51-4c77-8dc7-9a009b4985d2">725</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTEyLTEtMS0w_80c6433a-41e5-4adf-ab1b-62c276e4e52b">22.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTItMS0xLTA_be326a9a-0f3b-4e21-a425-f0ae9bc23a1b">108</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idfadb20ee8cf4b7ca29892f0e7ef9241_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTQtMS0xLTA_19192b98-a6ff-4331-816e-9941bad35dc6">218</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTYtMS0xLTA_0aa2176c-52f7-4829-8d83-1261e66179fe">50.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTgtMS0xLTA_7c018e56-c2df-48d3-ba2b-3cd61a15b956">322</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i28753b33f19b4472a4b3b9615d39bde2_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTEwLTEtMS0w_94407ecd-c2d2-4375-adbf-da165ae6c52f">441</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTEyLTEtMS0w_e5ac3ef6-84b7-4901-8949-b847fd22ef78">27.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i04834a7933574b9699e4470cca157b17_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTItMS0xLTA_b052e720-4cc5-4b83-b4e9-0f08d7dfb90a">66</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i830efc8e5ef64f5d8bb67629c932302f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTQtMS0xLTA_0e134ee0-3250-4d4f-bef8-a106fc8165cd">153</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i04834a7933574b9699e4470cca157b17_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTYtMS0xLTA_892b8188-3b95-47d2-bf6c-e7b1603fdf03">56.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4e8660da0ae049279be4908d645ac814_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTgtMS0xLTA_39d72267-097f-4a95-9dfc-e31d6147a956">196</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61951583e0884a2b97857fcfd5143dfa_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTEwLTEtMS0w_9e0f3966-93f7-420d-8f33-6378b9548925">299</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4e8660da0ae049279be4908d645ac814_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTEyLTEtMS0w_484b52c0-fc1f-4580-a10f-3a01436c1891">34.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTItMS0xLTA_a28fdc75-090f-4dc6-8c6f-17d19005cd9e">174</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea8c758499ee481a982e0844029f02c5_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTQtMS0xLTA_eeb0a614-67a4-47c3-8e14-59d82ef2501c">372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTYtMS0xLTA_242355ef-5cd7-4da5-b266-45f4b104f731">53.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTgtMS0xLTA_cd95641d-ee95-4ec7-9447-668a2a3c07be">517</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9530070346e046928aaa20fbdb32b6be_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTEwLTEtMS0w_13df6bbd-08e5-4292-911e-e460419561e2">741</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTEyLTEtMS0w_4e23bbe8-a8d4-4e88-916a-bd1726b683b3">30.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTItMS0xLTA_7c8019e3-c629-42df-93b5-0944fe489b12">354</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8c7f38204ba8470dbe88c6fbd6f163af_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTQtMS0xLTA_a4ef6209-19ce-42b2-8d20-c71c5e4e6733">407</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTYtMS0xLTA_d67040ad-b494-4c28-be31-759e4613849a">12.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i43027bbce9224ae1864acee61096aaac_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTgtMS0xLTA_8ceff53e-2d32-4e64-9a9f-ef1ff8bdd45b">761</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib7cfae47101947fbb19de601ee4d37cf_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTEwLTEtMS0w_93e475ca-662e-42cf-9b15-b0dc2ea47417">824</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i43027bbce9224ae1864acee61096aaac_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTEyLTEtMS0w_25d3c71a-fc14-4f73-9961-d71f8abda8e2">7.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTItMS0xLTA_a19344b6-fb5f-4899-b5a7-cf61db6a8840">198</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21d4e243e3244926af114c5ac8d5622b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTQtMS0xLTA_2a0ede73-d7fd-4c06-b319-eee5218460f0">265</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTYtMS0xLTA_abe21fcf-ea7d-46b6-b976-378a2be03ff3">25.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTgtMS0xLTA_ba142d6b-10d9-4373-8b2b-c0edd160a232">445</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i27f66ef65403479684878c39826affd8_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTEwLTEtMS0w_80390f2c-d832-4bb6-ac16-afbd69238aff">533</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTEyLTEtMS0w_7c5be2bc-1fc9-4f1c-b323-8dd5908ca234">16.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTItMS0xLTA_7fb0c10e-623a-40a8-8618-559260f9443e">553</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i79a301cc9e4741a9acf742a4531b7ffa_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTQtMS0xLTA_28f04afb-8e47-416e-882f-db715d2be252">672</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTYtMS0xLTA_89a8b8d3-a697-43b6-a5fd-fb2d96c2d6a4">17.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTgtMS0xLTA_aeec3318-23c0-4286-b06b-eb71456b4bc7">1,207</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3df852a1e1c9437cbefc5d5967937bd0_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTEwLTEtMS0w_92d3bff2-faa1-4168-846d-1b817b7c387f">1,357</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTEyLTEtMS0w_ea92e4ad-21b9-4ec5-9866-5d20a9419762">11.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09753ee22db9438db02316fe99eab602_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTItMS0xLTA_2d4e7482-9ce8-4034-9ca1-5914d0861570">270</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ab103ca2b6347f4bec8d5f5a68b902f_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTQtMS0xLTA_c85f8348-c853-4d1e-b870-caf33190790e">490</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i09753ee22db9438db02316fe99eab602_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTYtMS0xLTA_a8414929-95b2-4bc2-ade2-70baee6f3788">45.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6131de48add44569afcbb5f13e616222_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTgtMS0xLTA_6fc7c326-566e-41cc-ba89-bae0240a0e83">693</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1077c0d6182e42b8b4a449d5823797da_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTEwLTEtMS0w_c50d972c-647e-49b8-83f4-c65d8946efa6">955</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6131de48add44569afcbb5f13e616222_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTEyLTEtMS0w_0e6b0471-be7f-48b0-844e-dfe80a101cb4">27.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTItMS0xLTA_895fd9e5-a5f4-4895-8eb9-86240d43786f">230</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i61609c5ddc9d401f8c0a92c743695f8b_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTQtMS0xLTA_7ec36a3c-0c56-4faa-981e-d84d1ee815d4">328</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTYtMS0xLTA_c9dd2ad8-2ce0-450f-b168-2ca41b0d3773">29.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTgtMS0xLTA_48612822-032b-4b6e-80f6-e23d9d6a04d4">510</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i29508d3dfad845269de0d3b934e5f72f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTEwLTEtMS0w_7aaeb717-1f58-4317-8657-e2cc5f1d2e86">651</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTEyLTEtMS0w_6ad8cf3c-90ec-4dff-9c20-0acc1e75243d">21.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTItMS0xLTA_b5e18e71-235f-4ddd-ae7a-30934ae6d276">499</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i49489eb3476942d39146a7944e024129_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTQtMS0xLTA_23c7013f-aeb0-4c7e-82d3-6c88f3d4e3f3">818</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTYtMS0xLTA_5096af3e-4dd1-454c-a0d2-55fa22318604">39.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTgtMS0xLTA_26183b48-a40f-45a5-919b-ee09441d8d09">1,202</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idac621d3e8974b4290777cb0a715967d_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTEwLTEtMS0w_c2384733-8585-4c8d-9307-17b0db16e737">1,606</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTEyLTEtMS0w_694d786f-f94c-4713-8538-9c4a3bbaba04">25.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTItMS0xLTA_56a074ea-0248-4391-864d-6a64d29d51ed">490</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i352af7e1cff64172939fb8676a18d694_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTQtMS0xLTA_af215ceb-8e3e-4e41-87a6-f172b5c6f34c">926</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTYtMS0xLTA_cf795686-2cdb-42f4-a790-87a5fbab4396">47.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTgtMS0xLTA_df8c9359-6484-46ce-8eb3-efe5ecd84715">1,334</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id0d1afadaa0d41f1867dafdde83a550a_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTEwLTEtMS0w_9c3154ce-47a2-4d22-a704-53b1392a01d6">1,927</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTEyLTEtMS0w_2565b7e7-dded-4b5c-a41a-954d56dc6ce9">30.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTItMS0xLTA_037bb65b-2566-4f76-aeca-a25659d9a9d5">1,060</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic461ce15080e4d46a58069a1bb325e45_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTQtMS0xLTA_764e6c2c-50c1-473f-a237-14e78d76cc9c">1,427</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTYtMS0xLTA_0e69ec18-f295-488e-a621-d3becc84b5fd">25.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTgtMS0xLTA_738d4a49-54f4-4755-b40c-4779104b3d15">2,317</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic08ba492d063467dada493b5225e27bf_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTEwLTEtMS0w_4afd9afa-81e9-4147-80d7-78df86339e3c">2,821</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTEyLTEtMS0w_31970a49-8f1a-4984-a262-ae36dbaeeb85">17.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTItMS0xLTA_f3716039-68cb-4b95-8204-843144080333">1,551</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0065caf47fbc4cb98c76aafdc60d0caa_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTQtMS0xLTA_0df4e22d-f4ab-48ed-ae99-8b45c66a5e4f">2,353</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTYtMS0xLTA_99ddf30c-6781-442b-b45a-11b5d979e282">34.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTgtMS0xLTA_e924e714-0aad-4e57-bdc9-abf92b9975dc">3,651</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b7cf7e87b5048de9e83fc41fbba81d5_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTEwLTEtMS0w_e542b2f4-795b-4e25-9a9b-0b0802532cf4">4,748</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTEyLTEtMS0w_9fcae315-3570-4aa6-8720-1c060da94b17">23.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTItMS0xLTA_17fe559e-93a7-40be-8937-4c9f1b3af424">277</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i25729810182f492586a816b1ffe57aa7_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTQtMS0xLTA_750a0ddc-c648-424b-b617-7ff78c7bdfa5">396</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTYtMS0xLTA_eb4a4e2c-b2e4-4e83-ae8a-da9028dfc37b">30.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTgtMS0xLTA_8ae3c75c-3730-4df3-a898-bedcecd9a137">658</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib93b7593957c4146b7aa8d5210aeb960_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTEwLTEtMS0w_c88abbc7-68e6-465d-9c10-5701004363bb">800</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTEyLTEtMS0w_7adeaa71-920d-4106-af2f-f7809c2a6041">17.7</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTItMS0xLTA_a0174741-a3fc-4964-ac16-980d08ed091d">498</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i901b7c058bc04f02aaadc04d05618104_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTQtMS0xLTA_569af246-77ea-4fd8-a3f5-8ee4b3c76582">633</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTYtMS0xLTA_ff415cd9-80ae-492b-8049-8b113e7aade2">21.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTgtMS0xLTA_7672b9b2-cd4b-4236-845d-7af18d7b77b7">1,065</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib82e302424784eb79d013cbeddc5714a_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTEwLTEtMS0w_b1f1aa00-368d-43a8-83f4-c59f93f566b8">1,209</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTEyLTEtMS0w_af6357c9-a891-45f5-9a18-46ec41c467d0">11.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTItMS0xLTA_5329bbdb-c98b-4dcf-a9d5-e45aea47aca1">775</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i882dff1fdab04b9cbffd9a0b66d09708_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTQtMS0xLTA_8217e05e-01f0-4eab-bf26-803fe80cb226">1,029</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTYtMS0xLTA_5f2de31b-c5b3-4c31-9c94-68904c732240">24.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTgtMS0xLTA_7e2dd662-0455-4254-b3fe-31bec17136c2">1,723</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaba1385624734a44a1f0995eb99a6a2f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTEwLTEtMS0w_43fb4997-3400-4207-8acc-38c9f3957b0d">2,009</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTEyLTEtMS0w_432c0dae-08ab-4ef1-bd6e-6abc473cd0dc">14.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTItMS0xLTA_9d845e36-d0d6-4772-b4bc-2da90fadec19">213</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i575b4d6c52db4ddd9a77241756d3bcf7_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTQtMS0xLTA_39ec297a-f7fe-44fc-ac99-76cd1a09a511">530</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTYtMS0xLTA_1adc66c8-1e81-4ca9-8a6f-bc82496b7652">59.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTgtMS0xLTA_5b0c8799-de67-46fa-b0cd-95fbc9b868fa">676</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia24b2dfc5933488685d4e8679f9858df_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTEwLTEtMS0w_40f49d35-7d0c-4239-b791-70df21968419">1,127</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTEyLTEtMS0w_d7263494-d648-4db3-9cd0-a066e51d596d">40.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTItMS0xLTA_817a99cc-eaf1-424f-827f-fa2e20955c43">562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic44276e5e39645adac5e0ec3c6d349a8_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTQtMS0xLTA_053ace77-dbbc-41d7-b8d8-08f01b6f9810">794</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTYtMS0xLTA_e0b26228-b4f0-4153-a351-ff9f1bbe5bd1">29.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTgtMS0xLTA_99f04c39-1dcb-4916-81c8-678944e3852e">1,252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i36fbf025a3bd46258314eaf0c5fd03c9_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTEwLTEtMS0w_c2849cf8-e256-485b-90ca-c86f7f5073fc">1,612</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTEyLTEtMS0w_fd17a4a6-bcf3-47a6-b617-66d31fd0ca36">22.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i62837ac430c04475937229c201091a7b_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTItMS0xLTA_ff40f326-8d2f-4df1-8410-024374cc13b3">775</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0e94e3d16b6442b3bf8ae4d7e42763aa_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTQtMS0xLTA_bd3b532b-a12e-4380-8629-af3c8fdaea04">1,325</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i62837ac430c04475937229c201091a7b_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTYtMS0xLTA_10f7eade-1e08-40b9-94bc-99934ea2b04a">41.5</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTgtMS0xLTA_9efaff92-1e7c-4684-a7c9-fe4acc91d465">1,928</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8482a9eacc9d4a16b903c3069e30606c_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTEwLTEtMS0w_744032cc-d13e-46d8-9c4c-478a264fb38b">2,739</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTEyLTEtMS0w_c7590a5a-5cde-408a-9e76-0058fe481f58">29.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic3373b694e464e87b09c196866598a61_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTItMS0xLTA_fe5c7947-fdc9-443d-8d57-3a43c9369fd7">248</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i18aae7095c214291953f8d5a7e83743d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTQtMS0xLTA_a73a1974-6c8f-4d85-ac67-375440a67fd6">461</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic3373b694e464e87b09c196866598a61_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTYtMS0xLTA_e455be54-9312-4dc4-a9fa-301aeda50bb0">46.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTgtMS0xLTA_ab495a41-f130-4c19-a17c-b11f71c1afe6">687</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6b5abffa1631440c9c106f7646cee59f_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTEwLTEtMS0w_cb642896-437e-43a6-a3ef-46469f9450e5">907</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTEyLTEtMS0w_0f2ae73e-4ffa-45f7-baa4-85a3906553ad">24.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTItMS0xLTA_54a10ecf-f49e-4852-97ba-ec8f1ec0af22">447</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id1697845443b41b18f2e3fd65e94eff0_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTQtMS0xLTA_85835625-7bdf-4702-be3b-bdc842165939">701</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTYtMS0xLTA_76ca00a9-fcd9-4b5f-bc74-c171e4c7e92d">36.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib608a60c324249358f5c359cb804d50f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTgtMS0xLTA_87c4d459-d71c-4b5b-b0f2-917a4c46d2ba">1,075</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia3fd8a707583422a985a694bde7e8369_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTEwLTEtMS0w_9f9d6bdd-0677-4c45-b3b4-e4d45ace2507">1,383</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib608a60c324249358f5c359cb804d50f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTEyLTEtMS0w_66b912a4-bfaf-439c-9af6-e4221bb3bf0a">22.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia53ba83708ab497da167bdf063b13001_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTItMS0xLTA_848c8416-4d0c-429d-9bd5-3a6112b41e02">695</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieeb64f7ebcf24e8eb4738e491a709ef6_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTQtMS0xLTA_3b544e6f-79b2-4b22-b2d5-ed2d9b532df9">1,161</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ia53ba83708ab497da167bdf063b13001_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTYtMS0xLTA_03fe8f44-a6fc-4588-8bac-bbb6719dec9d">40.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTgtMS0xLTA_867d0140-f625-4e81-9b3c-445616a73946">1,762</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie3efc34904804bf392531b7e252380d0_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTEwLTEtMS0w_f3196c13-c68f-442a-9299-32527835c509">2,290</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTEyLTEtMS0w_5b7d267e-204d-4a4d-8f26-060256cf285a">23.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTItMS0xLTA_0ace67b7-3c3e-4eeb-b8ae-f1801f8bfc5a">203</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2e533e4df7574745be8a32f1d7f8b20d_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTQtMS0xLTA_3d302e70-6c25-487f-b9cb-765a51e982ae">333</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTYtMS0xLTA_4b3b5e7c-345a-42c7-96dd-3da41cba1763">39.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTgtMS0xLTA_ecc04a0e-8f7d-4c53-aa05-72da4962da90">549</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia94c309ebefb41e0882e6e5f7db81fc6_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTEwLTEtMS0w_3fff379c-9fb2-48d2-8812-b84717495680">654</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTEyLTEtMS0w_82c82a11-e2df-4f36-bd47-931129f0da91">16.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f667109df48490a91c424f760c9163b_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTItMS0xLTA_94f40b00-2902-4a13-a3cd-b3f603de2ed5">352</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6387e0464e874ecebf490a3e7a9ac5a9_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTQtMS0xLTA_7617ffa6-268e-4738-bbec-f6cd407f1769">509</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i6f667109df48490a91c424f760c9163b_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTYtMS0xLTA_273a756e-7b39-4f0e-ad00-e706b2098167">30.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTgtMS0xLTA_c9d84d6f-9192-41e7-851e-d8328e5e0558">819</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i510fab0efb5c421e951697a2eaabf3a6_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTEwLTEtMS0w_98c4d2a3-22c8-4087-906c-22f9266e8d1b">1,011</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTEyLTEtMS0w_01d554ff-0dd8-4d8d-a2cf-142198151642">19.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTItMS0xLTA_bcb62cac-27b1-4cf1-8229-f8cc0f6e3b37">554</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6afb3e29007f4d8fbbe84b8aa64fe6c4_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTQtMS0xLTA_f591d68a-516f-4177-a8f9-e2d411fba16c">842</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTYtMS0xLTA_ad874646-f92d-4224-a893-a73ae80be5e6">34.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTgtMS0xLTA_d34e70c8-fadb-4042-a278-b9807953633c">1,368</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idecf2a3bf83549faaface09de3d21842_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTEwLTEtMS0w_5b696788-62c8-4336-9ee7-8d0b54a6801e">1,666</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTEyLTEtMS0w_1fb53583-5a4f-4dd5-bf31-284c11e3823d">17.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></ix:continuation></ix:continuation></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i17ee5824fc7745c8b9838664c5af00c2" continuedAt="ia2ddf3e4fe884bb8af7c8e9c467f2561"><ix:continuation id="i6d28bed0442740478f88ad006be678be"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"></td><td style="width:34.244%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.625%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.733%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.334%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.527%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.743%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTItMS0xLTA_8ebe3292-8174-4619-86fd-911951112527">45</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i513396c914d24f2ca5d1a3b179dbb137_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTQtMS0xLTA_8f513a17-778f-4446-a576-78bb33d11398">128</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTYtMS0xLTA_cec1402e-b041-44d3-b032-4ab1fd8d630a">64.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTgtMS0xLTA_94d5d930-ab1d-445e-87de-6e62b77afbf0">138</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia88b31446b9949bb9dc52ab066f472a5_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTEwLTEtMS0w_55142131-537b-45f8-ad58-9edb5c60e73f">253</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTEyLTEtMS0w_ff55a3a7-6d2d-46ae-a964-92e98ec8cee0">45.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTItMS0xLTA_1da22676-8db7-46ed-8676-9085e897de57">96</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i95245826bf28466f88669de5c0eb29f9_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTQtMS0xLTA_b950a840-52fd-44bb-91eb-95fb7e8ccedb">191</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTYtMS0xLTA_1bb12cef-4873-4cef-be2c-9e964fc3e773">49.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTgtMS0xLTA_f1096d34-c35a-4b08-8212-6caac09034f1">256</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie0e846d3dd6246fdad7038aa4f8fc310_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTEwLTEtMS0w_bd26ad9a-795d-478e-b165-324b657be7c6">371</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTEyLTEtMS0w_8af28693-a9cf-44a3-9317-9b118cae071b">31.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTItMS0xLTA_16ae42a2-9852-4724-b41d-ab416c834c06">141</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea770061f1af4a23be59231dccaa6471_D20190401-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTQtMS0xLTA_63cd4366-8064-402a-aa43-e33076a4f352">319</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTYtMS0xLTA_b9d10541-c6fb-4183-865b-7809cdafa3e6">55.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTgtMS0xLTA_cc987b0b-2422-41c7-a0c9-ab148f12c302">394</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7544a09dc2e443659a4749d9c524a033_D20181231-20190630" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTEwLTEtMS0w_1c1bde21-6f7f-4161-82f8-e1be56996ed3">624</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTEyLTEtMS0w_e2ad4828-303d-4fc3-a3f6-cb9d681d125b">36.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTItMS0xLTA_8eff7868-cb75-4527-84bd-a96dc44a4c35">1,862</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i09d9e4292b9d49439e0ce7ef85bcd358_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTQtMS0xLTA_92757c83-8830-4376-afce-db5b516793c4">3,083</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTYtMS0xLTA_76fd4eca-43fe-46a5-93d3-7c9087f3f56e">39.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTgtMS0xLTA_5193e9e7-c2a9-4a43-a945-6881654f93c1">4,760</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="id50251d99ca0478da493763fd6c20e76_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTEwLTEtMS0w_fa98ab1f-4863-4c99-a3c9-0ba8446aa7b3">6,192</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTEyLTEtMS0w_1d13159e-1ade-4555-843e-777dc05374d2">23.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iea17e937da204406896ee031cfe58c20_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTItMS0xLTA_0c80a076-0e32-4a5a-86c2-6169104c3c58">2,426</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ib1ce6b5f2cf0439c9d34f1a1e0c2ef86_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTQtMS0xLTA_346c146e-e9cf-4858-bab8-5cc69460ba64">3,406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iea17e937da204406896ee031cfe58c20_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTYtMS0xLTA_706f0b24-67f7-42cc-bc09-9f66faef6eb5">28.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTgtMS0xLTA_77897a2a-7617-4f94-9a9c-1914dd5aeba9">5,460</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5a7a9909054c412bb8414b6ad4b834fa_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTEwLTEtMS0w_59f115cd-0066-49b9-80ce-dfb25f64511e">6,756</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTEyLTEtMS0w_54c17e95-85a8-4b47-bf51-58d3b999c568">19.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTItMS0xLTA_65faf059-a8e2-43b1-9a5c-75cc6c6b72dd">4,288</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTQtMS0xLTA_2ee533f0-b785-4f8c-84dc-976a800b2c80">6,489</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTYtMS0xLTA_ea5ff982-9b76-4af3-907a-aef6a28335d4">33.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTgtMS0xLTA_d77d6a68-002f-475d-a326-d2c48da22b95">10,220</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTEwLTEtMS0w_b419b5ab-1041-4ee3-89d5-70b5c30720ba">12,948</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTEyLTEtMS0w_520d7924-c4b9-461d-8d3d-b221125b866f">21.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTItMS0xLTA_add4046b-bfee-471f-a8c8-a10b1b417cd5">9,539</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTQtMS0xLTA_537dd930-9b87-4ec3-a4c4-3077581138f8">10,403</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTYtMS0xLTA_69078547-c8de-427e-899b-0d76f1a4bd1d">8.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTgtMS0xLTA_20c6da60-e622-42bc-a32e-ef29d3083d31">20,238</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ed367815e324fed984862b7805db09b_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTEwLTEtMS0w_e47074cc-b7ac-4742-95d7-a6600549fff2">20,532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTEyLTEtMS0w_2c33c1c8-11a1-428a-ae06-3b1572f3a48a">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTItMS0xLTA_e7a6a242-1cde-4c1f-b764-c0f95dc31485">8,797</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i780815182e5340ee9005439edb189dbd_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTQtMS0xLTA_588d43af-16ae-4b35-9a2e-0ba7dca5cf71">10,159</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTYtMS0xLTA_e2717a44-8729-49b6-9dbc-e08ee1f6b7c0">13.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTgtMS0xLTA_f52e907d-8179-420c-84b6-d4f07affad4f">18,789</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i40697a314e334705bf032c396d36a48f_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTEwLTEtMS0w_c0211e9e-6622-46f1-9aac-81187b0278b2">20,051</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTEyLTEtMS0w_1f9fa158-2c7b-4168-bbbe-b37feec8d897">6.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTItMS0xLTA_5f649529-5d1b-4872-b0f3-a3cc2c30ed2f">18,336</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTQtMS0xLTA_422cc6dd-1838-4b8d-becf-5f3624dd00ef">20,562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTYtMS0xLTA_0d09e930-df00-4434-b31e-93d260bd7c97">10.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTgtMS0xLTA_1c1d32f5-08d7-4289-8813-2bf098ee97dc">39,027</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTEwLTEtMS0w_0924cfe3-8b7c-48ed-8c4b-528235721e9e">40,583</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesBySegmentOfBusiness" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTEyLTEtMS0w_eeeb8106-dfa0-4b72-bdeb-a16e66629d9a">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div></ix:continuation><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTA0MQ_d3b36199-6b03-490e-9c00-1a178bc62e4e" continuedAt="i4b4ccab6bf49435ba7237cef37fde79f" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"></td><td style="width:35.209%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.465%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.319%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.575%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.465%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.319%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.526%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.292%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0yLTEtMS0w_f4197afc-51d5-42aa-a83b-2c0580867359">32</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi00LTEtMS0w_e77d8ea1-f61d-4f15-a3e7-68406b9aeada">406</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi02LTEtMS0w_a61dc82d-0ccf-4221-b18a-9ab7145b24fa">92.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi04LTEtMS0w_013c8301-a405-4fdd-98f8-f041082d1238">802</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0xMC0xLTEtMA_489413d1-3475-4cfa-b9e0-134c65156c8b">1,147</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0xMi0xLTEtMA_02ea5dbe-2260-4d02-8c04-f4fa2f2cfddc">30.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0yLTEtMS0w_f48fb577-a9f0-4b35-898d-b4fac85b0b6e">4,514</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy00LTEtMS0w_d724b9af-a015-44e9-9d92-1dff76fcd81e">3,677</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628" decimals="3" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy02LTEtMS0w_a2c2fe6f-adf7-40c6-b63c-b7c1c3579fdc">22.8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy04LTEtMS0w_bc122246-e422-4821-b8bc-38fc2a8e6aab">8,348</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0xMC0xLTEtMA_a34e1db9-655d-4fae-ac55-6aace597e113">6,008</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="number" contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628" decimals="3" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0xMi0xLTEtMA_01d8370e-e2f0-4aaf-a5c7-68def287c4ea">38.9</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i215768a346504c6588118220125ee9e5_D20200330-20200628" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0yLTEtMS0w_74e0d6e0-dc25-4da5-a606-144a5dc01241">354</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i8da67f7730324520a82f178539e2d723_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC00LTEtMS0w_8a2fabaf-32ae-4d9a-99e3-cd274bcd5331">3,189</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:18pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC04LTEtMS0w_6968d2aa-086c-40f4-b58f-5235381958e2">1,671</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0xMC0xLTEtMA_61de4926-343d-4102-ae43-643a71cf939e">4,686</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0xMi0xLTEtMA_395ac4e1-f95c-4af9-9416-d1f6fb5670d9">64.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0yLTEtMS0w_55c5efd6-de2d-4107-8c37-ef329615b3c5">4,192</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie05e097465d246e985c5a8a5836866ac_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS00LTEtMS0w_4a29e0ee-8623-483b-8987-448abb394c22">7,272</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS02LTEtMS0w_8af04fb1-04d0-4d8b-98ce-3a827e2885c7">42.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS04LTEtMS0w_20de41dc-a947-4f35-9fa7-134d352e19ba">10,821</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2cdc971d10a846eda0291042d8911094_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0xMC0xLTEtMA_e815650d-2b5e-45d0-add7-fe845b9b2778">11,841</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0xMi0xLTEtMA_79939f8c-dda1-474f-b8b1-63fe3481c97b">8.6</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i828cd0392f6a4f08b23a126fbc2fc210_D20200330-20200628" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi0yLTEtMS0w_7da88ca5-4dfe-4dfd-8a51-0b986abfc96d">252</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i879c922e7e06439cbd2406e34a34569f_D20190401-20190630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi00LTEtMS0w_3531c8c2-f92e-424f-88a4-776078c596f6">231</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ieffb22b1734946ea874bf7ff0d96c59b_D20191230-20200628" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi04LTEtMS0w_4fe0006c-dcc2-4507-845d-02c34d5138e4">372</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie38753485d6e4aa68503c096a70d147e_D20181231-20190630" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi0xMC0xLTEtMA_da0e7128-f254-4bce-b3b1-c11bce221bb2">378</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0yLTEtMS0w_16f05155-98b6-407c-8615-d8375d2d0626">3,940</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy00LTEtMS0w_8e7174fa-cc12-44af-9862-50167a309a60">7,041</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy02LTEtMS0w_d2435414-7e39-4599-a713-a899d8b64575">44.0</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy04LTEtMS0w_6bc2dd8c-794b-4d87-9e06-4149dd30bde6">10,449</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0xMC0xLTEtMA_17a09ceb-831f-441e-be19-63ad49f5b740">11,463</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInOperatingIncomeLoss" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0xMi0xLTEtMA_6e26b575-f529-42c8-854f-114ceeaa5e3d">8.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i7ed428655a844057a0ad1aee8a48ddd6_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfEquityInvestments" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjEy_bb1ce62b-54ae-4e5a-a4a1-cf50f95eb7ff">0.3</ix:nonFraction> billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal six months of 2019. Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDk3Mg_052a064a-0974-469b-bf09-41880d759bbc">0.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2Mzk1Nw_9fecd883-beb3-44d5-a287-3223e5b67579">0.2</ix:nonFraction>&#160;billion in both the fiscal second quarters of 2020 and 2019, primarily talc related costs, respectively. Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2Mzk0Mw_a0d412c5-7be5-464a-991a-1e21c87c84ba">0.6</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAyOA_21652022-1961-43c5-8022-5100a08c7051">0.2</ix:nonFraction>&#160;billion in both the fiscal six months of 2020 and 2019, primarily talc related costs, respectively. Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMzg2_1e608bd2-57b1-4c20-8e72-5a8f8933381a"><ix:nonFraction unitRef="usd" contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMzg2_99e175aa-b81f-43fd-8ff8-6465fdcb9a0f">0.1</ix:nonFraction></ix:nonFraction> billion in both the fiscal second quarters of 2020 and 2019, respectively and $<ix:nonFraction unitRef="usd" contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjc0ODc3OTA3NTA1MQ_3d70b43b-7b27-4d59-b95b-e949b160f785"><ix:nonFraction unitRef="usd" contextRef="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjc0ODc3OTA3NTA1MQ_7225104c-9d81-4c9c-87fb-600f31b034ab">0.2</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal six months of 2020 and 2019, respectively. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes an in-process research and development expense of $<ix:nonFraction unitRef="usd" contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentInProcess" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNTIy_235bc119-e54c-410a-8c05-f674065a0163">0.9</ix:nonFraction> billion related to the Alios asset in the fiscal six months of 2019. Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNjI3_e6ae52a7-ad65-4501-8026-a14739e52b0c">0.4</ix:nonFraction> billion in the fiscal six months of 2019. Includes an unrealized gain on securities of $<ix:nonFraction unitRef="usd" contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzM1_6554d9a4-0806-4080-9982-447530fdc5b6">0.5</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIxOA_8b7192e3-3f7e-4b5f-aec3-adc980f22b72">0.2</ix:nonFraction>&#160;billion in the fiscal second quarter of 2020 and 2019, respectively. Includes an unrealized gain on securities of $<ix:nonFraction unitRef="usd" contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI1OTkxMw_35bed3d1-5d33-467e-ad51-d884681d2275">0.2</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI1OTkyNw_05399770-2628-4eb4-b3e0-c020f535a92a">0.3</ix:nonFraction>&#160;billion in the fiscal six months of 2020 and 2019, respectively. Additionally, the fiscal six months of 2019 includes a research and development expense of $<ix:nonFraction unitRef="usd" contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfOTQ4_106c3a36-edab-47cc-9977-5f29887bba0d">0.3</ix:nonFraction> billion for an upfront payment related to argenx. Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTAyNg_4edc1ebb-8e2c-4bbd-a915-b5e533c8d8ea"><ix:nonFraction unitRef="usd" contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTAyNg_50c94078-d123-46e0-8554-d3087319e1d4">0.8</ix:nonFraction></ix:nonFraction> billion in both the fiscal second quarters of 2020 and 2019. Includes amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIzMg_dc55dc8f-d853-4c54-88a0-5a4bcf3975b7"><ix:nonFraction unitRef="usd" contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIzMg_ea2a5787-2117-4a69-8623-f4b0b97fcee6">1.6</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal six months of 2020 and 2019. In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement.  Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. </span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes a contingent consideration reversal of $<ix:nonFraction unitRef="usd" contextRef="i7fd16a3299794c08b00e5e9af4b2f47b_D20191230-20200628" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTEzNA_77363621-fea9-4e55-9215-6a266b034f48">1.0</ix:nonFraction> billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. Includes a gain of $<ix:nonFraction unitRef="usd" contextRef="i023711733c384a55bc10c339faee9020_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk3MA_34bdcf7c-0e9c-4da0-a217-1957b0196d93"><ix:nonFraction unitRef="usd" contextRef="i73f3e8b536cc4bd08b9add79f3cd22a3_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk3MA_87377626-6e06-4caf-a87a-22f20c5cbbce">2.0</ix:nonFraction></ix:nonFraction>&#160;billion from the divestiture of the ASP business in the fiscal second quarter and six months of 2019. Includes litigation expense of $<ix:nonFraction unitRef="usd" contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTMwOA_3d063666-dd46-4406-b40d-5f33d47bf8bb">0.2</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:LitigationSettlementExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk4NQ_e7dcf54b-6154-41f1-a98d-80c35bffa6d1">0.3</ix:nonFraction>&#160;billion in the fiscal second quarter and fiscal six months of 2019, respectively. Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTM5MQ_86080261-d252-450e-aa53-259fd29a1667"><ix:nonFraction unitRef="usd" contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTM5MQ_b1a3800d-a9fb-4eb0-b178-4646b58beb68">0.1</ix:nonFraction></ix:nonFraction> billion and </span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="ia2ddf3e4fe884bb8af7c8e9c467f2561"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="i4b4ccab6bf49435ba7237cef37fde79f" continuedAt="i7bc855c884e94b95ae12f8f85918516d">amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i8da67f7730324520a82f178539e2d723_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTQyMg_6b6baede-2479-40b7-b9b3-241e03e771cd"><ix:nonFraction unitRef="usd" contextRef="i215768a346504c6588118220125ee9e5_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTQyMg_c365d577-e6d5-4f31-8d0e-73b94aa747df">0.2</ix:nonFraction></ix:nonFraction> billion in both the fiscal second quarters of 2020 and 2019.  Includes a restructuring related charge of $<ix:nonFraction unitRef="usd" contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk5OQ_1ec129eb-e386-4ed8-b94e-e108750f6cb4"><ix:nonFraction unitRef="usd" contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk5OQ_8424eeb4-2c9b-4de2-b916-de7278037480">0.2</ix:nonFraction></ix:nonFraction>&#160;billion and amortization expense of $<ix:nonFraction unitRef="usd" contextRef="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAxMw_3e4ad599-94aa-4f3f-9a8f-eeda4bf78954"><ix:nonFraction unitRef="usd" contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAxMw_7472c23c-810a-4e7c-8421-ad7364697b43">0.5</ix:nonFraction></ix:nonFraction>&#160;billion in both the fiscal six months of 2020 and 2019. </ix:continuation></span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"><ix:continuation id="i7bc855c884e94b95ae12f8f85918516d" continuedAt="id4d88b97348b4783bb863fa9e00130af">(4)</ix:continuation></sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="id4d88b97348b4783bb863fa9e00130af"> Amounts not allocated to segments include interest income/expense and general corporate income/expense.</ix:continuation> </span></div><div style="margin-bottom:10pt;"><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTYyMw_6fc8fe9d-24b8-47ab-89f6-5c0eca79832c" escape="true"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"></td><td style="width:31.138%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.094%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.510%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.343%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.821%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.094%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.821%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.510%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.529%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.353%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0yLTEtMS0w_50ea0f4d-bc1f-4ae2-bb13-e78a57f2ab6c">9,539</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi00LTEtMS0w_2f96254a-b2c9-4c45-8292-455a44a73582">10,403</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi02LTEtMS0w_8422f8f9-f3b8-44b1-8f3b-3d5a952140cc">8.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi04LTEtMS0w_01c82948-f376-4f3e-827a-b1b797e46070">20,238</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6ed367815e324fed984862b7805db09b_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0xMC0xLTEtMA_c5431aed-971b-413d-8423-5a4d44b41367">20,532</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0xMi0xLTEtMA_6672f30f-361d-48ae-9e1d-69487d352340">1.4</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0yLTEtMS0w_bba49baf-86ef-49f3-87a3-1455ab775a99">4,063</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i990d3f55fb0d400fa30369f379908e85_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy00LTEtMS0w_d0849c06-c668-4019-ac0d-d0665456eb76">4,733</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy02LTEtMS0w_b1b43ad1-28c7-4e93-bd04-09ef96068fc5">14.2</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy04LTEtMS0w_059371b7-419c-4053-8fb2-090dcbff29eb">8,890</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i875ab7cb24b5434fbef2a5fda9f740c0_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0xMC0xLTEtMA_4b564ba0-613f-4cbe-9c49-643f804ea826">9,342</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0xMi0xLTEtMA_a38d6de5-e53a-44d6-98fc-4c77c4575e69">4.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0yLTEtMS0w_f083b72c-5eab-49be-a12e-bdc18b031ae6">1,133</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i6f61c670043f4e00a54053474ec36a0d_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC00LTEtMS0w_abf0516a-ba55-4b29-9838-5c07ca97b8f9">1,455</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC02LTEtMS0w_81211108-5a22-4713-b71b-a3206f511b53">22.1</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC04LTEtMS0w_88d5f44a-c9cf-4053-ba8f-fc4e70b80935">2,635</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i0c910149219540038cfaa2070ca96ba0_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0xMC0xLTEtMA_b31561a0-f951-4f58-a899-857d3884582b">2,958</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0xMi0xLTEtMA_fc79b86d-c588-4001-909f-3e74727db149">10.9</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0yLTEtMS0w_b56fc922-f030-40ff-bc60-07ed2c5c788d">3,601</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2bebf8e1f4804892976ccad051fdb00c_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS00LTEtMS0w_ed096303-7395-430e-85bf-8c3e20520949">3,971</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS02LTEtMS0w_041a672f-3144-4063-a247-4c1fcbd5141f">9.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS04LTEtMS0w_c345d50b-a3e3-4753-a6c4-b8aff549f180">7,264</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ie452efdf003f4151a326a25ffbb9fc7a_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0xMC0xLTEtMA_64e2fdfd-7a6c-4910-b17c-293db9ba144d">7,751</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0xMi0xLTEtMA_bfe042fb-dcfd-4117-b597-917eeb35a300">6.3</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0yLTEtMS0w_ee38a593-a21f-40d8-ad91-dde6b3b552a1">18,336</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi00LTEtMS0w_975562b8-643d-478f-9fcc-85f386e21250">20,562</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi02LTEtMS0w_bd874cee-dfbb-47aa-9a66-e9b79b41fb8f">10.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi04LTEtMS0w_873f9877-f15a-4c4c-ae46-c347c69023b4">39,027</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0xMC0xLTEtMA_2c274155-cda9-4e03-915b-24645a04dcd1">40,583</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="number" contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" decimals="3" sign="-" name="jnj:PercentageChangeInSalesByGeographicArea" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0xMi0xLTEtMA_e64e5a94-6306-4481-b1c5-1fa3e73f40a3">3.8</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">28</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_91"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 10&#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNTEyMA_05c7e72e-c55c-4d21-8d30-ad2809160c54" continuedAt="i3887253cd2c647618ff5ddacdfc53f32" escape="true">BUSINESS COMBINATIONS AND DIVESTITURES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3887253cd2c647618ff5ddacdfc53f32" continuedAt="ic17871df744544aaa7148e09dbe95499"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subsequent to the quarter, on July 9, 2020, the Company sold <ix:nonFraction unitRef="shares" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE0Ng_c33b2e11-d1f2-48f6-a194-4bc3ba41140c">11.8</ix:nonFraction>&#160;million shares of Idorsia LTD (&#8220;Idorsia&#8221;), or its <ix:nonFraction unitRef="number" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE2MA_f3e37081-1693-4ad9-b0f3-a91cc5f74cdc">8.3</ix:nonFraction>% ownership in the company, via an accelerated bookbuild offering. The transaction resulted in gross proceeds of approximately CHF<ix:nonFraction unitRef="chf" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfOTg5NTYwNDY2NzY3OA_0ff7f8ad-4edd-4b83-ba41-4f9f623ef627">337</ix:nonFraction>&#160;million ($<ix:nonFraction unitRef="usd" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockConsiderationReceivedPerTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE2Nw_13522cdf-d204-4fc8-b48c-23bfade03f94">357</ix:nonFraction>&#160;million) based on a sales price of CHF <ix:nonFraction unitRef="chfPerShare" contextRef="i74a6f02cd81248429802bd3d52fdefc7_I20200709" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE4MQ_5fb72151-b58f-4a08-927a-44fbfc45aa01">28.55</ix:nonFraction>/share. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company currently has rights to at least an additional <ix:nonFraction unitRef="shares" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="-5" format="ixt:numdotdecimal" name="jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODIyMw_dbd47e55-a992-4921-82da-9038a72223bf">38.7</ix:nonFraction>&#160;million shares (or approximately <ix:nonFraction unitRef="number" contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709" decimals="2" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE4OQ_7e64f7ce-95ec-4187-9466-03f663e45844">20</ix:nonFraction>% of Idorsia equity) through a convertible loan with a principal amount of CHF <ix:nonFraction unitRef="chf" contextRef="iee3cf065b9ca46aa995976b921a5e5a4_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE5Ng_43930150-2d1d-49b0-9039-0b2b03ffed6f">445</ix:nonFraction>&#160;million (due June 2027). Idorsia also has access to an approximate CHF <ix:nonFraction unitRef="chf" contextRef="i41d885ad0df54f67810fa0ea503cd065_I20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODIwOQ_d8281438-e32f-4a3b-911c-b8372031f48a">243</ix:nonFraction>&#160;million credit facility with the Company. As of June 28, 2020, Idorsia has not made any draw-downs under the credit facility.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="iccccb20c51044c9e9a84c5d3198c51c6_D20200330-20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzEx_81b95061-00d3-4a68-8aa4-f6dde20aff3d">0.8</ix:nonFraction> billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="i89f3aa8637734074bb148409f97b74c1_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDMy_e56b2080-73fe-4a99-afeb-e115e822387d">0.8</ix:nonFraction> billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTA5OA_e3ccbbee-23dd-4c7c-b4aa-31b2f07fad6a">0.4</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTExNQ_3841a369-ed4e-4d30-b94e-96996f6abe62">0.2</ix:nonFraction> billion, other assets of $<ix:nonFraction unitRef="usd" contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTEzNQ_dc8977d7-abdd-42c6-8559-68ddabf63b97">0.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTE2NQ_f892aec2-a69d-4be3-998e-eb22614f31ae">0.3</ix:nonFraction> billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $<ix:nonFraction unitRef="usd" contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentsFairValueDisclosure" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTI2MQ_f64ac2b6-1f49-452d-a526-48ebae0d4ef1">0.4</ix:nonFraction> billion. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $<ix:nonFraction unitRef="usd" contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI1MQ_c769e1d5-48f5-4966-bee8-bdcd1f7d5f8d">2.8</ix:nonFraction>&#160;billion, consisting of $<ix:nonFraction unitRef="usd" contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationCash" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI2Nw_5fc3deb0-fb91-4075-a973-cb79fb6cf3d2">2.7</ix:nonFraction>&#160;billion of cash proceeds and $<ix:nonFraction unitRef="usd" contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401" decimals="-8" format="ixt:numdotdecimal" name="jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI4MQ_741075ec-83be-4c1f-aee3-44b9bcd424cb">0.1</ix:nonFraction>&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $<ix:nonFraction unitRef="usd" contextRef="i1e9061e1ace447648d5d732bae5eb9b7_D20190401-20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:GainLossOnSaleOfBusiness" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI5NQ_36f061e0-539d-4f4c-b917-39a0118aee81">2.0</ix:nonFraction>&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $<ix:nonFraction unitRef="usd" contextRef="ieafab643bde441f198c64b00b5b1e847_D20190401-20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTM2Mw_bc05e401-b012-40b5-a505-e01f689bc39b">3.4</ix:nonFraction> billion, net of cash acquired. Additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTQyOQ_3e0d3acf-3684-4db2-a0ea-657bb6fc1c05">2.35</ix:nonFraction> billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;D, for $<ix:nonFraction unitRef="usd" contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTk2MQ_491856df-6341-47f4-b9c0-98ff3ec00c2d">3.0</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTk3OA_b6e34338-0524-4272-aa85-22e5380c94fb">2.0</ix:nonFraction> billion, marketable securities of $<ix:nonFraction unitRef="usd" contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjAwNw_ebe60bcd-90ae-4db6-b1f6-2a5d7533de08">0.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjAzNw_69d2d2d0-fc7a-4faa-a825-efdea04a6d13">1.8</ix:nonFraction> billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  There were no valuation adjustments to the assets acquired but during the fiscal first quarter of 2020, the Company recorded Other income of approximately $<ix:nonFraction unitRef="usd" contextRef="ic55b39bf44b4426e804766d6f7f475c9_D20200330-20200628" decimals="-8" sign="-" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjM1OQ_f5d04ab0-0b2c-420c-8a97-93c5f5aee589">1.0</ix:nonFraction> billion for the reversal of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#8217;s current timelines. As of June 28, 2020, the fair value of the remaining contingent consideration is $<ix:nonFraction unitRef="usd" contextRef="i1ff46a56cf074bac822b7e06872012bb_I20200628" decimals="-7" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjY0Mg_20591bba-f455-4c86-9096-e4c0c17f1c7a">0.2</ix:nonFraction> billion. Further, the Company re-assessed the current value of the Auris IPR&amp;D assets in connection with the modified development timeline and determined the fair value still exceeds the carrying value. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#165;<ix:nonFraction unitRef="jpy" contextRef="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzA4Mg_327c173d-5dc0-4b2d-ac68-44f11d1a1e8f">230</ix:nonFraction> billion, which equates to approximately $<ix:nonFraction unitRef="usd" contextRef="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzExNw_37a739e9-14fb-4cd7-9ae6-5376785b5891">2.1</ix:nonFraction> billion, using the exchange rate of <ix:nonFraction unitRef="number" contextRef="i2b0c726c6f4642738819e5d706d7e4e6_I20190116" decimals="2" name="us-gaap:ForeignCurrencyExchangeRateTranslation1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzE0OA_3972ae75-4e4c-42d6-a2cc-285850ea1920">109.06</ix:nonFraction> Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $<ix:nonFraction unitRef="usd" contextRef="if77e2506aa334aaab104d21008cc97f9_D20190401-20190630" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzM1Mg_fc7862ba-6598-49c4-968a-af6170074c2e">0.3</ix:nonFraction> billion related to the Company's previously held equity investment in DR. CI:LABO. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $<ix:nonFraction unitRef="usd" contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc1MQ_30b98a5e-6ea5-496f-830e-5950347352e5">1.5</ix:nonFraction> billion, goodwill for $<ix:nonFraction unitRef="usd" contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc2OA_40cae521-bba3-48f7-9bd9-ac6112e8878d">1.2</ix:nonFraction> billion and liabilities assumed of $<ix:nonFraction unitRef="usd" contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc5OA_da7effcc-e18c-41ec-8b23-8c5cfcfdbbf0">0.4</ix:nonFraction> billion. The adjustments made since the date of acquisition were $<ix:nonFraction unitRef="usd" contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628" decimals="-8" format="ixt:numdotdecimal" name="jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzg1OQ_04e66b5e-3e61-4cf6-9441-044c8bef72dd">0.1</ix:nonFraction> billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of <ix:nonNumeric contextRef="ic033ba1a92f34808934f4676de7a195b_D20191230-20200628" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDEyMQ_11ad73bb-a342-4e9e-b1fa-091ccd5baedc">15.3</ix:nonNumeric> years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#8217;s leading manufacturing services providers for health care products and technology products.&#160;The Company is </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"><ix:continuation id="ic17871df744544aaa7148e09dbe95499">expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of June 28, 2020, the assets held for sale on the Consolidated Balance Sheet were $<ix:nonFraction unitRef="usd" contextRef="i8bd12eebc1fe4027b0210d330a2835b4_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDk0MA_55e9541e-c079-4858-8ca1-51f6f657efa4">0.1</ix:nonFraction> billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.</ix:continuation></span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_94"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 11 &#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfOTA0ODk_a9bacb67-807a-4233-b5ff-80d4145c3148" continuedAt="i3e74464ce6784ef39fe4218a3e48aa5b" escape="true">LEGAL PROCEEDINGS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3e74464ce6784ef39fe4218a3e48aa5b" continuedAt="i727eb9bd39ab4966836f48fc63f8166f"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation develops.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of June&#160;28, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">PRODUCT LIABILITY</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The most significant of these cases include: the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; pelvic meshes; RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; body powders containing talc, primarily JOHNSONS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder; INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; and ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh. As of June&#160;28, 2020, in the United States there were approximately <ix:nonFraction unitRef="claimant" contextRef="i582a2834e4fd4aff9b1bc95d88dffea5_I20200628" decimals="INF" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDQ2MA_78a82da5-b004-4949-8044-f33b6f19888c">800</ix:nonFraction> plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; <ix:nonFraction unitRef="claimant" contextRef="i1d8c3a0656d34fb5966cd9770c316551_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDYyNA_3d905839-ba90-46e3-972e-8ca05782fd16">8,600</ix:nonFraction> with respect to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; <ix:nonFraction unitRef="claimant" contextRef="i85df32700d11440b9f62c956e2be12e8_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDY4MA_f7b32dfb-46d7-488e-9cac-5c3aa6959553">15,600</ix:nonFraction> with respect to pelvic meshes; <ix:nonFraction unitRef="claimant" contextRef="ib9a3f835f231472f99dfb7bb92dc9732_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDcxNA_d060351c-28d0-474b-87d0-0cafe32aea25">10,600</ix:nonFraction> with respect to RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; <ix:nonFraction unitRef="claimant" contextRef="iea2331b0b13c42f9b906bf8c6741a1f2_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDc0NQ_ae592765-703e-4ba1-95e9-9b4b7496019c">21,000</ix:nonFraction> with respect to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; <ix:nonFraction unitRef="claimant" contextRef="ie7cf6a6af023478299b61b15e7dc2e18_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDc3NA_34339e24-29af-4843-af80-922e2ba8dcd2">20,600</ix:nonFraction> with respect to body powders containing talc; <ix:nonFraction unitRef="claimant" contextRef="i3d7dfc6628eb4c3e9f45d6d28b6c4239_I20200628" decimals="INF" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDgyMw_a14ee3e1-90a2-413f-a38f-a9d2e75ac7b5">300</ix:nonFraction> with respect to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">;</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and <ix:nonFraction unitRef="claimant" contextRef="i50eec62d41b944978cdcf2b62bbde5d6_I20200628" decimals="INF" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDg1OA_d84101ad-922e-4df3-a33e-b503dc635396">3,700</ix:nonFraction> with respect to ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i727eb9bd39ab4966836f48fc63f8166f" continuedAt="i41ad45a99edc43c7a2ffbcbd0dd6c2ca"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XL Acetabular System and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than <ix:nonFraction unitRef="patient" contextRef="ib99b415ed1bd4de081616c1b0ba5adb9_I20200628" decimals="0" format="ixt:numdotdecimal" name="jnj:Numberofpatientsinsettlement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjI0OA_339b52e6-7147-4a60-8e2f-0579e5fd8542">10,000</ix:nonFraction> claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#233;bec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of the Company's appeal to broaden the scope of participants. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip-related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp; Johnson (collectively, DePuy) relating to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System and the related settlement program.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants.  With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">s. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Along with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> lawsuits, there were a number of filings related to the PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch products.  In March 2019, the New Jersey Supreme Court entered an order consolidating all </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i41ad45a99edc43c7a2ffbcbd0dd6c2ca" continuedAt="i34722995638448eb9947c800cdd48bfd"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch cases as an MCL in Atlantic County Superior Court.  Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.  The Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh, PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch products. In September 2019, plaintiffs&#8217; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#8482; Polypropylene Hernia System cases.  The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have been transferred to an MCL in Atlantic County Superior Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson arising out of the use of RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $<ix:nonFraction unitRef="usd" contextRef="i70f14e4d505949438f899f930dceffd2_D20190930-20191229" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMTMyMzA_43ea2ece-a916-4ae6-9811-aa349bc44418">8</ix:nonFraction> billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $<ix:nonFraction unitRef="usd" contextRef="idd1ca5d4c491437ba8eb090bb6173cdb_D20200101-20200131" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMTMzMzU_abb4210f-ab1f-4267-9d01-8d76598afc47">6.8</ix:nonFraction> million by the trial judge. The Company will appeal the final judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury arising out of the use of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp; Johnson (J&amp;J); and JPI&#8217;s collaboration partner for XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;J announced an agreement in principle to the settle the XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Personal injury claims alleging that talc causes cancer have been made against Johnson &amp; Johnson Consumer Inc. and Johnson &amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#8217; attempt to limit the scope of testimony of certain of the Company&#8217;s witnesses.  With this ruling made, the court has now ordered case-specific discovery to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $<ix:nonFraction unitRef="usd" contextRef="i0b831b0b9e4744b890997d86490beb64_D20180701-20180731" decimals="-6" format="ixt:numdotdecimal" name="jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMjE5OTAyMzQxMjQzNw_d56395ca-547f-41c4-a776-16f5ad77cd23">4.7</ix:nonFraction>&#160;billion, reducing the overall award to $<ix:nonFraction unitRef="usd" contextRef="i73c27ed443d4477a94166f5501e091cc_D20200601-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMjE5OTAyMzQxMjQyMw_0b174caa-f67d-4842-a23a-503d83568970">2.1</ix:nonFraction>&#160;billion. The Company believes that it has strong grounds to seek further review and/or appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#8217;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual primarily for defense costs, and reserves for potential settlement of currently pending mesothelioma cases, in connection with product liability litigation associated with body powders containing talc.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, the Company&#8217;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).&#160; The Imerys Bankruptcy relates to Imerys&#8217; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).&#160; In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.&#160; Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.&#160; The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.&#160;&#160;The Company previously proposed to resolve Imerys' (and the Company&#8217;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i34722995638448eb9947c800cdd48bfd" continuedAt="if68d1f2c4a654df18a92a8897c0eab65"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">of all Talc Claims involving the Company's products, waiving the Company&#8217;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#8217; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction. The Bankruptcy Court will hold a hearing to consider approval of the Disclosure Statement on August 26, 2020 and the Company is disputing any indemnification objections and the scope of coverage in the reorganization plan. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and is in the process of responding to the complaint</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In February 2018, a securities class action lawsuit was filed against Johnson &amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder, and that purchasers of Johnson &amp; Johnson&#8217;s shares suffered losses as a result.  Plaintiffs are seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument.  The Court has not yet ruled in the books and records action.  In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In February 2020, the four cases were consolidated into a single action under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and the shareholders have until August 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp; Johnson Savings Plan against Johnson &amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp; Johnson stock as a Johnson &amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#8217; motion but granted leave to amend.  On June 15, 2020, Plaintiffs filed an amended complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#8217;s Consumer Legal Remedies Act relating to JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="if68d1f2c4a654df18a92a8897c0eab65" continuedAt="i208015eb33d34b6fadc43ec6a8fdf751"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents in response. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against a number of Johnson &amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson, arising out of the use of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">INTELLECTUAL PROPERTY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain subsidiaries of Johnson &amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#8217;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson &amp; Johnson in the United States District Court for the Southern District of New York alleging that Cordis&#8217;s sales of the CYPHER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and CYPHER SELECT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Although Johnson &amp; Johnson has since sold Cordis, it has retained liability for this case. After the trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases.  In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol&#8217;s motion for a new trial. In March 2019, the district court denied Medinol&#8217;s motion for a new trial. Medinol appealed, and in June 2020, the United States Court of Appeals for the Federal Circuit affirmed the district court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#8217;426); 8,273,132 (&#8217;132); 8,721,730 (&#8217;730)   and 9,492,280 (&#8217;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contact feature of the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#8217;132, &#8217;730 and &#8217;280 patents, based on the district court&#8217;s claim construction and reserving its right to appeal that construction, leaving only the &#8217;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#8217;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the &#8217;735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the &#8217;284 patent), are either invalid or not infringed by Ethicon&#8217;s ENSEAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#8217;735 patent, the &#8217;284 patent and United States Patent Nos. 8,323,310 (the &#8217;310 patent); 9,084,608; 9,241,759 (the &#8217;759 patent) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#8217;s favor.  In July 2020, Covidien filed a notice of appeal.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i208015eb33d34b6fadc43ec6a8fdf751" continuedAt="i309b35df1d724f09b4d4af5e661c1be4"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#8217;s RELIEVA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Spin and RELIEVEA SpinPlus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> products infringe U.S. Patent No. 9,011,412 (the &#8217;412 patent).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#8217;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Antibacterial Sutures and STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plus Antibacterial Sutures infringe plaintiffs&#8217; United States Patent Nos. 6,596,296 (the &#8217;296 patent) and 7,033,603 (the &#8217;603 patent) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT is seeking damages and an injunction.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking Inter Partes Review (IPR) of both asserted patents. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2020,the USPTO denied institution of the &#8217;296 patent IPR and granted institution of the &#8217;603 patent IPR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT dismissed the &#8217;603 patent from the suit and no longer accuses PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures or STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (&#8220;Intuitive&#8221;) filed a patent infringement suit against Auris Health, Inc. (&#8220;Auris&#8221;) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#8217;200 patent); 6,491,701 (&#8217;701 patent); 6,522,906 (&#8217;906 patent); 6,800,056 (&#8217;056 patent); 8,142,447 (&#8217;447 patent); 8,620,473 (&#8217;473 patent); 8,801,601 (&#8217;601 patent); and 9,452,276 (&#8217;276 patent) based on Auris&#8217; Monarch&#8482; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#8217;200, &#8217;056, &#8217;601 &#8217;701, &#8217;447, &#8217;276 and &#8217;906 patents.   Intuitive subsequently dropped the &#8217;200 and &#8217;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#8217;601 patent and denied review of the &#8217;056 patent.  In February and March 2020, the USPTO instituted review of the &#8217;200, &#8217;447, &#8217;701 and &#8217;906 patents and denied review of the &#8217;276 patent.   The district court trial is scheduled to begin in January 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, RSB Spine LLC (&#8220;RSB Spine&#8221;) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#8482; Spacer, ZERO-P</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Spacer, ZERO-P NATURAL&#8482; Plate, SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> LR Spacer and SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Virtual Surgical Planning Services and the TruMatch</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9, 292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Pharmaceutical</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i309b35df1d724f09b4d4af5e661c1be4" continuedAt="i66c2f250a2394c2d80f8a63879a8f9f1"><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,661,422 (the &#8217;422 patent).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#8217;s ANDS until the expiration of the &#8217;422 patent.  In November 2019, Apotex filed an appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;   </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">250 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the  &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, 500 mg, before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in April 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and InvaGen Pharmaceuticals Inc. (InvaGen) who filed ANDAs seeking approval to market generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of Bayer AG&#8217;s United States Patent No. 9,539,218 (&#8217;218) relating to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. JPI is the exclusive sublicensee of the asserted patent. The case against InvaGen has been stayed.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, JPI and Bayer AG entered into a settlement agreement with Taro. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">the &#8217;218 patent and United States Patent No. 7,157,456 relating</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Ltd. (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of United States Patent Nos. 7,700,645, 8,518,987, 7,126,015 and 7,595,408.  Janssen was </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i66c2f250a2394c2d80f8a63879a8f9f1" continuedAt="icad9b798a50f43eaab077af0859acbec"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">seeking an order enjoining Zydus from marketing its generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the relevant patents. In June 2020, Janssen entered into a settlement agreement with Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In April 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Marcan Pharmaceuticals Inc. (Marcan) in Canada in response to Marcan&#8217;s filing of an ANDS seeking approval to market a generic version of Prezista before the expiration of Canadian Patent No. 2,485,834 (the &#8217;834 patent).  Janssen was seeking an order enjoining Marcan from marketing its generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;834 patent. In May 2020, Janssen discontinued the action against Marcan.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR before expiration of MTPC&#8217;s United States Patent Nos. 7,943,582 (the &#8217;582 patent) and/or 8,513,202 (the &#8217;202 patent) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:  Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.;  Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories Ltd (DRL); Hetero USA, Inc., Hetero Labs Limited Unit V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).  These cases were consolidated into one action (Polymorph Main Action), which was scheduled for trial starting in June 2020 but is being rescheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of MTPC&#8217;s United States Patent No. 7,943,788 (the &#8217;788 patent), 8,222,219 (the &#8217;219 patent) and/or 8,785,403 (the &#8217;403 patent) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and/or&#160; INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:&#160; Sandoz, Zydus and Aurobindo. These cases were consolidated into one action (Compound Main Action), which was scheduled for trial in May 2020 but is being rescheduled.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;582 patent and &#8217;202 patent relating to INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent.  In March 2020, Janssen and MTPC initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent, &#8217;219 patent, &#8217;403 patent, &#8217;582 patent, and &#8217;202 patent.  These lawsuits have not been consolidated with the Main Actions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and MTPC entered into a settlement agreement with Aurobindo. In June 2020, Janssen and MTPC entered into a settlement agreement with Laurus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or, INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of United States Patent No. 7,094,781 (the &#8217;781 patent).  In the lawsuit, Actelion is seeking an order enjoining Zydus from marketing generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the patent. Trial is scheduled to commence in October 2020.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="icad9b798a50f43eaab077af0859acbec" continuedAt="icdcdcdbf5b314f90ae0b11472f6144d5"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, Actelion Pharmaceuticals Ltd. filed suit against Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited (Aurobindo).  Aurobindo filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;781 patent.  Actelion was seeking an order enjoining Defendants from marketing a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;781 patent. In July 2020, Actelion and Aurobindo entered into a settlement agreement.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,659,770 (the &#8217;770 patent). A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the &#8217;770 patent. A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&#174; 10 mg before the expiration of the &#8217;770 patent and Canadian Patent No. 2,621,273.  A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT&#174; before the expiration of the &#8217;770 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of United States Patent No. 9,439,906 (the &#8217;906 patent).  Trial is scheduled to begin in September 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#8217;906 patent. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of Canadian Patent Nos. 2,309,629 (the &#8217;629 patent) and 2,655,335 (the &#8217;335 patent).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Janssen subsequently discontinued the portion of the lawsuit relating to the &#8217;629 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#8217;s generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, if approved, would infringe claims of the &#8217;335 patent and that the claims of the &#8217;335 patent are not invalid for obviousness. Teva appealed the court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in response to Pharmascience's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;335 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trial is scheduled to begin in January 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the patent.</span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span><br/></span></div><ix:continuation id="icdcdcdbf5b314f90ae0b11472f6144d5" continuedAt="i68469b80ef8b4934833d04e81a245dd8"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">140 mg capsules</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">before expiration of Pharmacyclics&#8217;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">The trial is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting United States Patent No. 10,004,746.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sun to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Pharmacyclics and JBI amended their complaints against Cipla, and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232 and amended their complaint against Sun to further allege infringement of U.S. Patent No. 10,294,232.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Sandoz filed an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IPR Petition with</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the USPTO, seeking to invalidate United States Patent No. 9,795,604.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The IPR was instituted in September 2019, and a final written decision is expected by September 2020.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus, Sun and Sandoz asserting infringement of United States Patent No. 10,478,439.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2020, Pharmacyclics and JBI entered into a settlement agreement with Sun Pharmaceuticals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i68469b80ef8b4934833d04e81a245dd8" continuedAt="i6ab9b324f4044ff8a7a2963185241f62"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In December 2019, Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Limited (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">, 32 mg, before the expiration of U.S. Patent No. 8,309,126 (the &#8217;126 patent).  Actelion was seeking an order enjoining Zydus from marketing its generic version of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before the expiration of the &#8217;126 patent. In July 2020, Actelion entered into a settlement agreement with </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of Nippon Shinyaku&#8217;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GOVERNMENT PROCEEDINGS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Average Wholesale Price (AWP) Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;J AWP Defendants were ultimately dismissed. The J&amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp; Johnson and ALZA Corporation. All other cases have been resolved.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Opioid Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in 2014 and continuing to the present, Johnson &amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than <ix:nonFraction unitRef="claimant" contextRef="i843d961ffff941f780e135d0ac57ec95_I20191229" decimals="0" format="ixt:numdotdecimal" name="jnj:ProductLiabilityContingencyNumberOfClaimant" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjMzODI_6c1e653b-1212-4de8-8ee9-bfdd6f82afa8">2,900</ix:nonFraction> lawsuits related to the marketing of opioids, including DURAGESIC</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i6ab9b324f4044ff8a7a2963185241f62" continuedAt="i28580069b80f486cab765258694dc0c0"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.</span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp; Johnson and JPI in the amount of $<ix:nonFraction unitRef="usd" contextRef="i8a2d74fb903f4bf9bccd750be8be4662_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjYyMDI_5299bc01-3006-43e9-95c6-ae2579ec233f">572</ix:nonFraction> million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $<ix:nonFraction unitRef="usd" contextRef="i3071999c834c466fa7bf2ef272704338_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjYzMTY_52691751-22a0-4ab8-b686-a842d92a6897">465</ix:nonFraction> million. Johnson &amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#8217;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $<ix:nonFraction unitRef="usd" contextRef="i0f5aae03f63f42a89d19ed1519e2f71b_I20191031" decimals="-9" format="ixt:numdotdecimal" name="us-gaap:LossContingencyEstimateOfPossibleLoss" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjcxOTI_271d99b2-3c8d-4f5d-aa5e-c7bcc82fec8e">4</ix:nonFraction> billion as settlement of these lawsuits, subject to various conditions and an agreement being finalized.  This agreement in principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In August 2019, Johnson &amp; Johnson received a grand jury subpoena from the United States Attorney&#8217;s Office for the Eastern District of New York for documents related to the Company&#8217;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#8217; and distributors&#8217; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160; The Company is cooperating and producing documents in response to the various subpoenas and requests for information.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November 2019, a shareholder filed a derivative complaint against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> In re Johnson &amp; Johnson Opioid Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i28580069b80f486cab765258694dc0c0" continuedAt="ibd9a97e813be44d295200646f1217294"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#8482; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#8217; motion to dismiss with prejudice, unsealed the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> complaint, and denied the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators&#8217; request for leave to file a further amended complaint. The </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#8217;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#8217; request to file a third amended complaint. The relators&#8217; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2012, Johnson &amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $<ix:nonFraction unitRef="usd" contextRef="ib27b2c7dd82249fa8839a100c11d8cd0_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesAwardedValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNzE3Mzc_dce02ad8-5ca0-45e4-842e-088754ee308c">344</ix:nonFraction> million. The Company intends to appeal the decision. In April 2020, the Company settled the West Virginia case. In April 2020, the Court in California denied the Company's motion for a new trial. In June 2020, the Court denied the Attorney General's request for injunctive relief. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument will be heard in August  2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> (methoxsalen) and the Uvar Xts</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and Cellex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp; Johnson retains OCD&#8217;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#8217;s Office requested that Johnson &amp; Johnson produce certain documents, and Johnson &amp; Johnson is cooperating with those requests.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has filed a motion to dismiss certain of the claims in the Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forty-one states have commenced a joint investigation into the Company&#8217;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#8217;s Office for the Southern District of New York related to JPI&#8217;s contractual relationships with pharmacy benefit managers over the </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="ibd9a97e813be44d295200646f1217294" continuedAt="i06be0404f6df4a84b7ab33394db18583"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2016, Johnson &amp; Johnson and Janssen Products LP were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INTELENCE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> or SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#8217;s complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April and September 2017, Johnson &amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, OLYSIO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#8217;s investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp; Johnson to cooperate with these inquiries by producing the requested information.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GENERAL LITIGATION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp; Johnson's and JJCI&#8217;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i06be0404f6df4a84b7ab33394db18583" continuedAt="i0a842126c8c24ee2809ec5b0d6140016"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. </span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. Discovery is ongoing. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp; Johnson in connection with its investigation of whether Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160; TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on </span></div></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><ix:continuation id="i0a842126c8c24ee2809ec5b0d6140016"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#8217;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#174;. Several additional complaints were filed thereafter in Virginia and New Jersey.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry and seek damages. The Virginia cases have been transferred to the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry, and seek damages and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, a class action antitrust complaint was filed against Janssen R&amp;D Ireland (Janssen) and Johnson &amp; Johnson in the United States District Court for the Northern District of California.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, the Court granted in part and denied in part defendants&#8217; motions to dismiss.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plaintiffs filed an amended complaint in April 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#8217;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Johnson &amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</span></div></ix:continuation><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_97"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">NOTE 12&#8212; <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfOTg5NTYwNDY1MzQ0OA_07ec23d5-a810-4024-b9ba-3d68e2e0fb47" continuedAt="i0ce50908687646fca5cb799c1b02a481" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0ce50908687646fca5cb799c1b02a481"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal second quarter of 2020, the Company recorded a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="ia605452b07814f9785dea5e1749593fb_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfNzg1_8e7819c4-bcc7-4d7b-9231-5d3d6df8db57">115</ix:nonFraction> million, which is included on the following lines of the Consolidated Statement of Earnings, $<ix:nonFraction unitRef="usd" contextRef="i502babb46275458897c6c348109c5035_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfODcz_7d13d717-674a-4f71-9497-62beefaa4025">61</ix:nonFraction> million in restructuring, $<ix:nonFraction unitRef="usd" contextRef="id9acc37568ea42f9922fa2c92c7d50ea_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfODk0_0ade71a6-10eb-48a1-9dce-a685a34e9294">22</ix:nonFraction> million in cost of products sold and $<ix:nonFraction unitRef="usd" contextRef="ibc9ce1c7b9de4d7c9bd370f431d114cf_D20200330-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfOTI2_00c2a97e-f3d5-46ea-a628-7f382abd8619">32</ix:nonFraction> million in other (income) expense. In the first fiscal six months of 2020, the Company recorded a pre-tax charge of $<ix:nonFraction unitRef="usd" contextRef="i753470899d364d1599b1fb2ae589ae15_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQwOA_c4d68c34-9a37-41ef-ae6a-69c094070c18">233</ix:nonFraction>&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $<ix:nonFraction unitRef="usd" contextRef="iee0f458f77f44dae9e9a9f498f732d53_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQzOA_3cf77f0e-f55e-4f5a-966e-1f9451ec61ef">119</ix:nonFraction>&#160;million in restructuring, $<ix:nonFraction unitRef="usd" contextRef="i924dea35cc4a4db3a0754750a03791e8_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQ2OA_75bcb8d1-a78f-4e64-8c41-2b87a3428d9b">37</ix:nonFraction>&#160;million in cost of products sold and $<ix:nonFraction unitRef="usd" contextRef="ie4563a7367fd4e85a1f89eec3c0e1587_D20191230-20200628" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQ5OA_e8a825bd-c50c-4785-967d-c1441fa69cb7">77</ix:nonFraction>&#160;million in other (income) expense.Total project costs of approximately $<ix:nonFraction unitRef="usd" contextRef="i643a2ee9d94c46a1a5979059886f331c_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTI0NA_b565c3eb-1044-41f9-a611-91fbac1f86f8">1.1</ix:nonFraction> billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In total, the Company expects the Global Supply Chain actions to generate approximately $<ix:nonFraction unitRef="usd" contextRef="ia536875c9d1940f7b5044f50a10ec73f_I20200628" decimals="-8" format="ixt:numdotdecimal" name="jnj:RestructuringandRelatedCostExpectedFutureSavings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTQ3Mg_5e610240-6151-40bf-ad16-27a20dd96d71">0.6</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="i966d76441bca4eeda5773245cb198ca5_I20200628" decimals="-8" format="ixt:numdotdecimal" name="jnj:RestructuringandRelatedCostExpectedFutureSavings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTQ3OA_2372226b-0146-448e-8d4a-c2b30fbea9e1">0.8</ix:nonFraction> billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $<ix:nonFraction unitRef="usd" contextRef="ia536875c9d1940f7b5044f50a10ec73f_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTYzNQ_38f5ba07-d752-4d97-9be2-ac36f05d708e">1.9</ix:nonFraction> billion to $<ix:nonFraction unitRef="usd" contextRef="i966d76441bca4eeda5773245cb198ca5_I20200628" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY0MQ_d4e75ed4-e56e-4505-85ad-8067d3ecce74">2.3</ix:nonFraction> billion, over the <ix:nonNumeric contextRef="i96475a51603a4e8e810595eccb66f241_D20191230-20200628" format="ixt-sec:duryear" name="jnj:RestructuringandRelatedCostDurationofRestructuringPlan" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY1NA_0e9ca090-e9f4-4792-8666-e2c2eb98792f">4</ix:nonNumeric> to <ix:nonNumeric contextRef="i5b9cec4fed09422f9f5c106fb3d09c7d_D20191230-20200628" format="ixt-sec:duryear" name="jnj:RestructuringandRelatedCostDurationofRestructuringPlan" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY2MA_20a5ed9f-f233-4609-a707-029b0cc84bf6">5</ix:nonNumeric> year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjgyOA_15e667ff-0433-45a4-8b98-8ecdfcf3189c" escape="true"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the first fiscal six months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"></td><td style="width:32.703%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.372%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.981%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.372%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.500%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:13.072%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i87c5e8d39d9c4eaa85e56a1ce09a3918_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0xLTEtMS0w_98f43fa1-ec55-45e0-a9fc-e317692ec8ad">164</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idf1e8f0128234898a4c2745db86b0fdc_I20191229" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0yLTEtMS0w_20639d4d-ce6d-455a-98ea-2736faff0f3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i91cdc9cf7fe24f6295e435d3967682d3_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0zLTEtMS0w_bec97efd-1e9f-425a-abbc-eee14cae5784">16</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i39f8df2915ae4439892ff4f3cc7ccf0a_I20191229" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS01LTEtMS0w_fb571e30-ae3b-4faf-8828-766b18fa5298">180</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0xLTEtMS0w_cc324237-18c9-4793-b7af-ade9e3e69d54">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0yLTEtMS0w_06e1f585-633e-499a-b92b-b170ddc0cd06">27</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0zLTEtMS0w_56df930b-01c4-412e-a3f5-7eaab408d894">206</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC01LTEtMS0w_bff5f0a2-2e00-44c4-af73-489cd3b9f6c1">233</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0xLTEtMS0w_816d11a8-5e28-4dac-80d7-8645bc83b789">12</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0yLTEtMS0w_48408ae1-d97a-47a1-ba64-36cb8c21ab54">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0zLTEtMS0w_1c78bd4d-af43-4f66-b8a4-fab511a476e2">197</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS01LTEtMS0w_fa8cfa8b-2b19-485b-adb3-d640c9e23022">209</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0xLTEtMS0w_6a2a7ba9-877b-4690-a1d1-a21c141cb793">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0yLTEtMS0w_83d937fd-0320-4407-adc0-6e4cb531a910">27</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0zLTEtMS0w_61981996-f4ba-4658-9a96-0327f79cc9ec">17</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(<ix:nonFraction unitRef="usd" contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628" decimals="-6" name="us-gaap:RestructuringReserveSettledWithoutCash2" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi01LTEtMS0w_211e665f-2833-4401-bcc5-3ae1a2da05f1">44</ix:nonFraction>)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, June 28, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="ifb137f18e4de4282a026c925fc22bbef_I20200628" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0xLTEtMS0w_5a326ceb-ea9f-4144-8249-c00ecbed8bea">152</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i2ee00f42b2134d3796cbc180e878362c_I20200628" decimals="-6" format="ixt:zerodash" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0yLTEtMS0w_14674815-6099-4c3e-a04a-65e9d56f6694">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i006340b658e24cf8b366c83c9bbfff9d_I20200628" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0zLTEtMS0w_91126369-4cce-4402-b2b9-4d13c0510c2f">8</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><ix:nonFraction unitRef="usd" contextRef="i78a038526da94ec5a15e091af7f02a84_I20200628" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS01LTEtMS0w_bfff2c71-e453-4a58-86c4-61f42df4efb7">160</ix:nonFraction>&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next <ix:nonNumeric contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628" format="ixt-sec:duryear" name="jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjAxMw_2f07fa54-b289-4928-8869-dd03c09b566f">2</ix:nonNumeric> years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div></ix:nonNumeric></ix:continuation><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">46</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-indent:-54pt;padding-left:54pt;margin-top:9pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Item 1A.&#160;RISK FACTORS</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company faces a number of uncertainties and risks that are difficult to predict and many of which are outside of the Company's control.&#160;For a detailed discussion of the risks that affect our business, please refer to Part I, Item IA, &#8220;Risk Factors&#8221; in our Annual Report on Form 10-K for the fiscal year ended December 29, 2019.&#160;There have been no material changes to the risk factors as previously disclosed in the Company's Annual Report on Form 10-K, except as follows:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Global health crises and pandemics, such as the global outbreak of the novel coronavirus (COVID-19), could cause disruptions in our business.</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The recent global outbreak of COVID-19 could cause disruptions to the Company's business and have a negative impact on the Company's revenues and operating results. While the Company has robust business continuity plans in place across its global supply chain network to help mitigate the impact of COVID-19, these efforts may not completely prevent its business from being adversely affected. The extent to which COVID-19 impacts the Company's operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the outbreak and any prolonged restrictive measures implemented in order to control the spread of the disease. In particular, the continued global spread of COVID-19 could adversely impact the Company's operations, including, among other things, its manufacturing operations, supply chain, sales and marketing and clinical trial operations. Any of these factors could adversely affect the Company's business, operating results or financial condition.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">47</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-indent:-40.5pt;padding-left:40.5pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;2 &#8212; MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales to Customers</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Analysis of Consolidated Sales</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the first fiscal six months of 2020, worldwide sales were $39.0 billion, a total decrease of 3.8%, including an operational decline of 2.2% as compared to 2019 first fiscal six months sales of $40.6 billion. Currency fluctuations had a negative impact of 1.6% for the fiscal six months of 2020. In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on worldwide operational sales growth was a negative 0.5%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales by U.S. companies were $20.2 billion in the first fiscal six months of 2020, which represented a decrease of 1.4% as compared to the prior year. In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on the U.S. operational sales growth was a negative 0.6%.  Sales by international companies were $18.8 billion, a decrease of 6.3%, including operational decline of 2.9%, and a negative currency impact of 3.4% as compared to the fiscal six months sales of 2019. In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on the international operational sales growth was a negative 0.3%.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the first fiscal six months of 2020, sales by companies in Europe experienced a decline of 4.8%, which included an operational decline of 2.1% and a negative currency impact of 2.7%. Sales by companies in the Western Hemisphere, excluding the U.S., experienced a decline of 10.9%, which included an operational decline of 0.1%, and a negative currency impact of 10.8%. Sales by companies in the Asia-Pacific, Africa region experienced a decline of 6.3%, including an operational decline of 4.9% and a negative currency impact of 1.4%.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200628_g1.jpg" alt="jnj-20200628_g1.jpg" style="height:293px;width:324px;"/><img src="jnj-20200628_g2.jpg" alt="jnj-20200628_g2.jpg" style="height:293px;width:324px;"/></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal second quarter of 2020, worldwide sales were $18.3 billion, a total decrease of 10.8%, including an operational decline of 9.0% as compared to 2019 fiscal second quarter sales of $20.6 billion. Currency fluctuations had a negative impact of 1.8% for the fiscal second quarter of 2020.  In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on worldwide operational sales growth was a negative 0.2%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Sales by U.S. companies were $9.5 billion in the fiscal second quarter of 2020, which represented a decrease of 8.3% as compared to the prior year. In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on the U.S. operational sales growth was a negative 0.2%.  Sales by international companies were $8.8 billion, a decrease of 13.4%, including an operational decline of 9.6%, and a negative currency impact of 3.8% as compared to the fiscal second quarter sales of 2019. In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on the international operational sales growth was a negative 0.2%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal second quarter of 2020, sales by companies in Europe experienced a decline of 14.2%, which included an operational decline of 11.5% and a negative currency impact of 2.7%. Sales by companies in the Western Hemisphere, excluding the U.S., experienced a decline of 22.1%, which included an operational decline of 8.9%, and a negative currency impact of 13.2%. Sales by companies in the Asia-Pacific, Africa region experienced a decline of 9.3%, including an operational decline of 7.7% and a negative currency impact of 1.6%.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-indent:18pt;text-align:center;"><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200628_g3.jpg" alt="jnj-20200628_g3.jpg" style="height:293px;width:324px;"/><img src="jnj-20200628_g4.jpg" alt="jnj-20200628_g4.jpg" style="height:293px;width:324px;"/></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">Note: values may have been rounded</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="padding-left:180pt;"><span><br/></span></div><div style="padding-left:180pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Analysis of Sales by Business Segments</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Consumer Health* </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consumer Health segment sales in the first fiscal six months of 2020 were $6.9 billion, an increase of 0.9% as compared to the same period a year ago, including operational growth of 3.6% and a negative currency impact of 2.7%. U.S. Consumer Health segment sales increased by 10.8%.  International Consumer Health segment sales decreased by 6.8%, including an operational decline of 1.9% and a negative currency impact of 4.9%.  In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on the Consumer Health segment operational sales growth was negligible. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Consumer Health* Franchise Sales &#8212; Fiscal Six Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.492%;"><tr><td style="width:1.0%;"></td><td style="width:41.570%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.497%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.497%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.136%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.682%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.556%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.838%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,497&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty**</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women&#8217;s Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">434&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">478&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Consumer Health* Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Previously referred to as Consumer</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">** Previously referred to as Beauty</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consumer Health segment sales in the fiscal second quarter of 2020 were $3.3 billion, a decrease of 7.0% as compared to the same period a year ago, including an operational decline of 3.6% and a negative currency impact of 3.4%. U.S. Consumer Health segment sales increased by 1.3%. International Consumer Health segment sales decreased by 13.4%, including an operational decline of 7.4% and a negative currency impact of 6.0%. In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on the Consumer Health segment operational sales growth was a negative 0.2%. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Consumer Health* Franchise Sales &#8212; Fiscal Second Quarter Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.640%;"><tr><td style="width:1.0%;"></td><td style="width:42.259%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.480%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.480%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.516%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.667%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.555%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:7.823%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,064&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty**</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">389&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women&#8217;s Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Consumer Health* Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Previously referred to as Consumer</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">** Previously referred to as Beauty</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The OTC franchise achieved operational growth of 10.7% as compared to the prior year fiscal second quarter. Growth was primarily attributable to sales from TYLENOL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> driven by COVID-19 stocking demand, digestive health products and ZARBEES</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Naturals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Skin Health/Beauty franchise experienced an operational decline of 14.3% as compared to the prior year fiscal second quarter. The decline was primarily driven by COVID-19 related impacts in the U.S. and Asia Pacific region as well as reduced consumption impacting NEUTROGENA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and AVEENO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">products. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Oral Care franchise achieved operational growth of 6.3% as compared to the prior year fiscal second quarter primarily due to sales of LISTERINE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">mouthwash related to COVID-19 stocking demand primarily in the U.S. and promotional activity and new product innovation in Asia Pacific.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Baby Care franchise experienced an operational decline of 13.6% as compared to the prior year fiscal second quarter. The decline was primarily due to COVID-19 related impacts outside the U.S. and the Baby Center divestiture in the U.S. partially offset by strength in AVEENO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">baby. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Women&#8217;s Health franchise experienced an operational decline of 11.8% as compared to the prior year fiscal second quarter driven by COVID-19 impacts. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Wound Care/Other franchise experienced an operational decline of 2.1% as compared to the prior year fiscal second quarter driven by COVID-19 impacts.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pharmaceutical</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pharmaceutical segment sales in the first fiscal six months of 2020 were $21.9 billion, an increase of 5.4% as compared to the same period a year ago, with an operational increase of 7.0% and a negative currency impact of 1.6%. U.S. Pharmaceutical sales increased 7.2% as compared to the same period a year ago. International Pharmaceutical sales increased by 3.2%, including operational growth of 6.7% and a negative currency impact of 3.5%.  In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on the Pharmaceutical segment operational sales growth was negligible. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Pharmaceutical Therapeutic Area Sales** &#8212; Fiscal Six Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:47.557%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.619%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.849%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.702%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.117%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,963&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">452&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Immunology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,798&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,708&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/rilpivirine</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,089&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Infectious Diseases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,608&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">361&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,838&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,534&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,346&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Other Pulmonary Hypertension</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Pharmaceutical Sales</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,886&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Percentage greater than 100% or not meaningful</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">**Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Previously included in Other Oncology</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inclusive of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which was previously disclosed separately</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pharmaceutical segment sales in the fiscal second quarter of 2020 were $10.8 billion, an increase of 2.1% as compared to the same period a year ago, with an operational increase of 3.9% and a negative currency impact of 1.8%. U.S. Pharmaceutical sales increased 5.8% as compared to the same period a year ago. International Pharmaceutical sales decreased by 2.4%, including operational growth of 1.4% offset by a negative currency impact of 3.8%. In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on the Pharmaceutical segment operational sales growth was negligible.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Pharmaceutical Therapeutic Area Sales** &#8212; Fiscal Second Quarter Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:46.672%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.061%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:9.061%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.407%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.702%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:6.412%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,523&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">935&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">546&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Immunology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">878&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/rilpivirine</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">535&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Infectious Diseases</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,587&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,538&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/ INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">/</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">182&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Neuroscience</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">901&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">831&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">568&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other Oncology</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">282&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Other Pulmonary Hypertension</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(26.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">/ EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Pharmaceutical Sales</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">* Percentage greater than 100% or not meaningful</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">**Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Previously included in Other Oncology</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Inclusive of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">which was previously disclosed separately</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Immunology products achieved operational growth of 3.0% as compared to the same period a year ago driven by strong uptake of STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (ustekinumab) in Crohn's disease and Ulcerative Colitis, strength in TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(guselkumab) in Psoriasis, and U.S. immunology market growth. This was partially offset by COVID-19 related demand. Immunology was negatively impacted by lower sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(infliximab) due to increased discounts/rebates and biosimilar competition. </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The patents for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(infliximab)</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in certain countries in Europe expired in February 2015. Biosimilar versions of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> have been introduced in certain markets outside the United States, resulting in a reduction in sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> in those markets.  Additional biosimilar competition will likely result in a further reduction in REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> sales in markets outside the United States.&#160;In the United States, a biosimilar version of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> was introduced in 2016, and additional competitors continue to enter the market. Continued infliximab biosimilar competition in the U.S. market will result in a further reduction in U.S. sales of REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Infectious disease products achieved operational growth of 4.7% as compared to the same period a year ago primarily due to strong sales of SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in the U.S. and the launch uptake of </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">JULUCA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;. </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> This was partially offset by lower sales of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> due to increased competition, loss of exclusivity of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in certain countries outside the U.S. and the negative impact of COVID-19.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Neuroscience products achieved operational sales growth of 5.2% as compared to the same period a year ago. Paliperidone long-acting injectables growth was driven by strong sales of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (paliperidone palmitate) and INVEGA TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> from new patient starts and persistence. The growth was partially offset by cannibalization of RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(risperidone) and the negative impact of COVID-19. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Oncology products achieved strong operational sales growth of 5.7% as compared to the same period a year ago. Contributors to the growth were strong sales of DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (daratumumab) driven by patient uptake in all lines of therapy,  IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (ibrutinib) due to increased patient uptake globally and the continued global launch uptake of ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (apalutamide). The growth was partially offset by declining sales of  ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(abiraterone acetate) and VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(bortezomib) due to generic competition and a positive one-time adjustment for DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> sales in the fiscal second quarter of 2019 related to the completion of pricing and reimbursement discussions in certain European countries. In addition, Oncology products were negatively impacted by delayed diagnosis and reversal of the fiscal first quarter 2020 stocking related to COVID-19. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pulmonary Hypertension achieved operational sales growth of 15.0% as compared to the same period a year ago. Sales growth of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (macitentan) and UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (selexipag) were due to increased market penetration and market growth.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cardiovascular / Metabolism / Other products experienced an operational decline of 5.8% as compared to the same period a year ago. Sales growth of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (canagliflozin) were due to uptake in the European and Latin America regions and a one-time adjustment in 2020 to previous reserve estimates in the U.S. The growth of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(rivaroxaban) included a one-time adjustment in 2020 to previous reserve estimates in the U.S. partially offset by higher rebates and the negative impacts of COVID-19. Lower sales of PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/ EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(epoetin alfa) were due to biosimilar competition. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment sales in the first fiscal six months of 2020 were $10.2 billion, a decrease of 21.1% as compared to the same period a year ago, with an operational decline of 19.8% and a negative currency impact of 1.3%. U.S. Medical Devices sales decreased 23.1%. International Medical Devices sales decreased by 19.2%, including an operational decline of 16.8% and a negative currency impact of 2.4%. In the first fiscal six months of 2020, the net impact of acquisitions and divestitures on the Medical Devices segment operational sales growth was a negative 1.0% primarily due to the divestiture of the ASP business. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Medical Devices Franchise Sales* &#8212; Fiscal Six Months Ended</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:496.50pt;"><tr><td style="width:1.0pt;"></td><td style="width:228.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:55.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:54.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:43.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:42.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Advanced</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,009&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;General</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Hips</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">725&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Knees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">517&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Trauma</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Spine, Sports &amp; Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,606&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Contact Lenses/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,666&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Surgical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,482&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Medical Devices Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,948&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">*Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specialty Surgery which was previously disclosed separately</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Previously referred to as Spine &amp; Other</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment sales in the fiscal second quarter of 2020 were $4.3 billion, a decrease of 33.9% as compared to the same period a year ago, with an operational decline of 32.7% and a negative currency impact of 1.2%. U.S. Medical Devices sales decreased 39.6%. International Medical Devices sales decreased by 28.8%, including an operational decline of 26.4% and a negative currency impact of 2.4%. In the fiscal second quarter of 2020, the net impact of acquisitions and divestitures on the Medical Devices segment operational sales growth was a negative 0.2%. While results in the fiscal second quarter were net negatively impacted by COVID-19, primarily related to reduced procedures, the Company did see improvement throughout the quarter as countries and states began to gradually re-open. For example, sales in China returned to growth in the second quarter. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">However, the ultimate COVID-19 impact on Medical Devices fiscal year sales remains highly fluid and will continue to evolve with geographical re-openings and virus waves. </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Major Medical Devices Franchise Sales* &#8212; Fiscal Second Quarter Ended</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:507.75pt;"><tr><td style="width:1.0pt;"></td><td style="width:235.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:55.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:46.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:43.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:45.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Operations<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency<br/>Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,551&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,353&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Advanced</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,029&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;General</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Hips</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Knees</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(52.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Trauma</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">672&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;Spine, Sports &amp; Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">695&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Contact Lenses/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">842&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Surgical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">750&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Medical Devices Sales</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,288&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">*Certain prior year amounts have been reclassified to conform to current year presentation</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Specialty Surgery which was previously disclosed separately</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Previously referred to as Spine &amp; Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Surgery franchise experienced an operational sales decline of 32.2% as compared to the prior year fiscal second quarter. The operational decline in Advanced Surgery was primarily driven by the negative impact of COVID-19 and competitive pressures in the U.S. partially offset in Biosurgery which was positively impacted due to the recovery of an isolated supply disruption of SURGIFLO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in the prior year fiscal second quarter. The operational decline in General Surgery was primarily driven by the negative impact of COVID-19 and a one-time unfavorable prior period pricing adjustment in the U.S.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Orthopaedics franchise experienced an operational sales decline of 33.9% as compared to the prior year fiscal second quarter. The operational decline in hips was driven by the negative impact of COVID-19 partially offset by leadership position in the anterior approach. The operational decline in knees was driven by the negative impact of COVID-19. The operational decline in Trauma was driven by the negative impact of COVID-19. The operational decline in Spine, Sports &amp; Other was driven by the negative impact of COVID-19 partially offset by the uptake of the SYMPHONY</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Occipito-Cervico-Thoracic (OCT) System in Spine.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Vision franchise experienced an operational sales decline of 39.3% as compared to the prior year fiscal second quarter. The operational decline in Contact Lenses/Other was due to the negative impact of COVID-19. The Surgical operational decline was primarily driven by the negative impact of COVID-19 and competitive pressures in the U.S.     </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Interventional Solutions franchise experienced an operational sales decline of 20.5% as compared to the prior year fiscal second quarter driven by the negative impact of COVID-19 partially offset by strong growth in China.  </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ANALYSIS OF CONSOLIDATED EARNINGS BEFORE PROVISION FOR TAXES ON INCOME </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated earnings before provision for taxes on income for the first fiscal six months of 2020 was $10.4 billion representing 26.8% of sales as compared to $11.5 billion in the first fiscal six months of 2019, representing 28.2% of sales.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Consolidated earnings before provision for taxes on income for the fiscal second quarter of 2020 was $3.9 billion representing 21.5% of sales as compared to $7.0 billion in the fiscal second quarter of 2019, representing 34.2% of sales. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Cost of Products Sold </span></div><div style="text-align:center;"><img src="jnj-20200628_g5.jpg" alt="jnj-20200628_g5.jpg" style="height:165px;width:234px;"/><img src="jnj-20200628_g6.jpg" alt="jnj-20200628_g6.jpg" style="height:140px;width:234px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Six months Q2 2020 versus Fiscal Six months Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of products sold increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;">Medical Device idle capacity costs associated with COVID-19 related production slow downs and fixed cost deleveraging.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Establishment of incremental inventory reserves associated with the impact of COVID-19 in the Medical Devices business </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intangible asset amortization expense included in cost of products sold for each of the first fiscal six months of 2020 and 2019 was $2.2 billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q2 2020 versus Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cost of products sold increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;">Medical Device idle capacity costs associated with COVID-19 related production slow downs and fixed cost deleveraging. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.5pt;">Establishment of incremental inventory reserves associated with the impact of COVID-19 in the Medical Devices business </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The intangible asset amortization expense included in cost of products sold for each of the fiscal second quarters of 2020 and 2019 was $1.1 billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Selling, Marketing and Administrative Expenses</span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200628_g7.jpg" alt="jnj-20200628_g7.jpg" style="height:190px;width:250px;"/><img src="jnj-20200628_g8.jpg" alt="jnj-20200628_g8.jpg" style="height:155px;width:250px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Six Months Q2 2020 versus Fiscal Six Months Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Selling, Marketing and Administrative Expenses decreased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in the Pharmaceutical business </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the Consumer Health business</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Deleveraging in the Medical Devices business resulting from the COVID-19 impact on sales  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q2 2020 versus Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Selling, Marketing and Administrative Expenses increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Deleveraging in the Medical Devices business resulting from the COVID-19 impact on sales  </span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Expense leveraging in the Pharmaceutical business </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the Consumer Health business</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Research and Development Expense</span></div><div style="text-align:center;"><img src="jnj-20200628_g9.jpg" alt="jnj-20200628_g9.jpg" style="height:180px;width:254px;"/><img src="jnj-20200628_g10.jpg" alt="jnj-20200628_g10.jpg" style="height:150px;width:254px;"/></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">(Dollars in billions. Percentages in chart are as a percent to total sales)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Six Months Q2 2020 versus Fiscal Six Months Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and Development decreased slightly as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Higher upfront payments in the fiscal six months of 2019, primarily related to the argenx collaboration</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative COVID-19 impact on Medical Devices sales</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Increased investment in the Medical Devices business related to robotics and digital programs </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q2 2020 versus Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Research and Development increased as a percent to sales driven by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative COVID-19 impact on Medical Devices sales</span></div><div style="text-indent:-18pt;padding-left:36pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;padding-left:14.15pt;">Segment mix with a higher percentage of sales coming from the Pharmaceutical business</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">In-Process Research and Development (IPR&amp;D)</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal first quarter of 2019, the Company recorded an IPR&amp;D charge of $0.9 billion for the remaining intangible asset value related to the development program of AL-8176, an investigational drug for the treatment of Respiratory Syncytial Virus (RSV) and human metapneumovirus (hMPV) acquired with the 2014 acquisition of Alios Biopharma Inc. The impairment charge was based on additional information, including clinical data, which became available and led to the Company's decision to abandon the development of AL-8176. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Interest (Income) Expense</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Interest (Income) Expense in the first fiscal six months of 2020 was a net interest income of $16 million and was slightly higher than the $2 million in same period a year ago. This was primarily due to the positive effect of net investment hedging arrangements and certain cross currency swaps and a lower average debt balance with a lower average interest rate. This was partially offset by reduced interest income resulting from lower rates of interest earned on cash balances. Interest (Income) Expense in the fiscal second quarter of 2020 was a net interest expense of $26 million as compared to income of $5 million in </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the same period a year ago. This was primarily due to reduced interest income resulting from lower rates of interest earned on cash balances. The balance of cash, cash equivalents and current marketable securities was $19.1&#160;billion at the end of the fiscal second quarter of 2020 as compared to $15.3 billion at the end of the fiscal second quarter of 2019. The Company&#8217;s debt position was $30.4&#160;billion as of June 28, 2020 as compared to $29.4 billion the same period a year ago. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Other (Income) Expense, Net</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Fiscal Six Months Q2 2020 versus Fiscal Six Months Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income)&#160;expense, net for the first fiscal six months of 2020 was unfavorable by $1.1 billion as compared to the prior year primarily due to the following:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.377%;"><tr><td style="width:1.0%;"></td><td style="width:48.374%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.343%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.793%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.348%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.246%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Billions)(Income)/Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Litigation expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Acquisition and Integration related</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized (gains)/losses on securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity step-up gain related to DR. CI:LABO </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Divestiture Gains</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Restructuring related</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Other (Income) Expense, Net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2020 is primarily driven by a contingent consideration reversal of approximately $1.0 billion related to the timing of certain developmental milestones associated with the Auris Health acquisition.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2019 included the divestiture of ASP  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Q2 2020 versus Q2 2019</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Other (income)&#160;expense, net for the fiscal second quarter of 2020 was unfavorable by $1.7 billion as compared to the prior year primarily due to the following:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.377%;"><tr><td style="width:1.0%;"></td><td style="width:48.374%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.343%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.648%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:11.793%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.348%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:12.246%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-style:italic;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Billions)(Income)/Expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Litigation expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Acquisition and Integration related</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized (gains)/losses on securities</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Divestiture Gains</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Other (Income) Expense, Net</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">2019 included the divestiture of ASP  </span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Income before tax by segment of business for the first fiscal six months were as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:30.595%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.471%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.537%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.628%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income Before Tax</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent of Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">802&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,886&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,671&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,686&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,948&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,821&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expenses not allocated to segments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,449&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Income before tax by segment of business for the fiscal second quarters were as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"></td><td style="width:30.842%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.456%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.456%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.456%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.456%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.456%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:0.536%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:8.462%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income Before Tax</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent of Segment Sales</span></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(354)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,288&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">49.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expenses not allocated to segments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,041&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;border-bottom:3pt double #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amounts not allocated to segments include interest (income) expense and general corporate (income) expense. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Consumer Health Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consumer Health segment income before tax as a percent of sales in the first fiscal six months of 2020 was 11.6% versus 16.7% for the same period a year ago. The decrease in the income before tax as a percent of sales in the first fiscal six months of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Higher litigation expense of $0.6 billion in 2020 vs. $0.2 billion in 2019 (primarily associated with talc related costs) </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The first fiscal six months of 2019 included a gain of $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO </span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the fiscal six months of 2020</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Consumer Health segment income before tax as a percent of sales in the fiscal second quarter of 2020 was 1.0% versus 11.5% for the same period a year ago. The decrease in the income before tax as a percent of sales in the fiscal second quarter of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Higher litigation expense of $0.6 billion in 2020 vs. $0.2 billion in 2019 (primarily associated with talc related costs)</span></div><div style="text-indent:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Planned prioritization and reduced brand marketing expense in the fiscal second quarter of 2020</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Pharmaceutical Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Pharmaceutical segment income before tax as a percent of sales in the first fiscal six months  of 2020 was 38.1% versus 28.9% for the same period a year ago. The increase in the income before tax as a percent of sales for the first fiscal six months of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower litigation expense of $0.0 billion in 2020 vs. $0.4 billion in 2019 </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">An in-process research and development charge of $0.9 billion in the fiscal six months of 2019</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower research and development expense in 2020. The fiscal six months of 2019 included a $0.3 billion upfront payment to argenx</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in selling, marketing and administrative expense</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower unrealized gains on securities of $0.2 billion in the fiscal six months of 2020 vs. unrealized gains of $0.3 billion in the fiscal six months of 2019 </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Pharmaceutical segment income before tax as a percent of sales in the fiscal second quarter of 2020 was 42.0% versus 34.9% for the same period a year ago. The increase in the income before tax as a percent of sales for the fiscal second quarter of 2020 as compared to the prior year was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Unrealized gains on securities of $0.5 billion in Q2 2020 vs. $0.2 billion in Q2 2019 </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Leveraging in selling, marketing and administrative expense</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Favorable product mix</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Medical Devices Segment</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment income before tax as a percent of sales in the first fiscal six months of 2020 was 16.4% versus 36.2% for the same period a year ago. The decrease in the income before tax as a percent of sales for the first fiscal six months was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A gain of $2.0 billion related to the ASP divestiture recorded in the fiscal six months of 2019</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">COVID-19 period costs and fixed costs deleveraging and idle capacity charges in Cost of Products Sold in the fiscal six months of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative impact of COVID-19 on sales in the fiscal six months of 2020</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">   &#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A contingent consideration reversal of approximately $1.0 billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower litigation expense of $0.1 billion in 2020 vs. $0.3 billion in 2019 </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Medical Devices segment income before tax as a percent of sales in the fiscal second quarter of 2020 was (8.3)% versus 49.1% for the same period a year ago. The decrease in the income before tax as a percent of sales for the fiscal second quarter was primarily driven by the following:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">A gain of $2.0 billion related to the ASP divestiture recorded in the fiscal second quarter of 2019</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">COVID-19 period costs and fixed costs deleveraging and idle capacity charges in Cost of Products Sold in the fiscal second quarter of 2020</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">The negative impact of COVID-19 on sales in the fiscal second quarter of 2020 </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">   &#160;partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;">Lower litigation expense of $0.0 billion in Q2 2020 vs. $0.2 billion in Q2 2019 </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Restructuring</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the second quarter of 2018, the Company announced plans to implement actions across its global supply chain that are intended to enable the Company to focus resources and increase investments in critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio of the future, enhance agility and drive growth. The Company expects these supply chain actions will include expanding its use of strategic collaborations, and bolstering its initiatives to reduce complexity, improving cost-competitiveness, enhancing capabilities and optimizing its network.&#160;Discussions regarding specific future actions are ongoing and are subject to all relevant consultation requirements before they are finalized. In total, the Company expects these actions to generate approximately $0.6 to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 to $2.3 billion. In the first fiscal six months of 2020, the Company recorded a pre-tax charge of $233 million, which is included on the following lines of the Consolidated Statement of Earnings, $119 million in restructuring, $37 million in cost of products sold and $77 million in other (income) expense. In the fiscal second quarter of 2020, the Company recorded a pre-tax charge of $115 million, which is included on the following lines of the Consolidated Statement of Earnings, $61 million in restructuring, $22 million in cost of products sold and $32 million in other (income) expense. In the first fiscal six months of 2019, the Company recorded a pre-tax charge of $232 million, which is included on the following lines of the Consolidated Statement of Earnings, $93 million in restructuring, $61 million in cost of products sold and $78 million in other (income) expense. In the fiscal second quarter of 2019, the Company recorded a pre-tax charge of $142 million, which is included on the following lines of the Consolidated Statement of Earnings, $57 million in restructuring, $38 million in cost of products sold and $47 million in other (income) expense.  Restructuring charges of approximately $1.1 billion have been recorded since the restructuring was announced.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">See Note&#160;12 to the Consolidated Financial Statements for additional details related to the restructuring.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Provision for Taxes on Income</span></div><div><span><br/></span></div><div style="padding-right:2.25pt;margin-top:2.7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For discussion related to the fiscal six months of 2020 provision for taxes refer to Note&#160;5 to the Consolidated Financial Statements. </span></div><div style="padding-right:2.25pt;margin-top:2.7pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the second quarter of 2020, the Internal Revenue Service proposed regulations that may, if issued in their current form, limit the tax deductibility of the payments under the agreement in principle to settle opioid litigation that was accrued for in fiscal 2019 for $4.0 billion at an effective rate of 23.5% (for more information see Note 21 in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019). The financial impact of these regulations may be material to the Company&#8217;s financial results in the period in which they are finalized which could be later in fiscal 2020.</span></div><div style="margin-bottom:8pt;"><span><br/></span></div><div style="margin-bottom:8pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">LIQUIDITY AND CAPITAL RESOURCES </span></div><div><span><br/></span></div><div style="text-align:center;"><img src="jnj-20200628_g11.jpg" alt="jnj-20200628_g11.jpg" style="height:184px;width:193px;"/><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span><img src="jnj-20200628_g12.jpg" alt="jnj-20200628_g12.jpg" style="height:184px;width:200px;"/><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    </span><img src="jnj-20200628_g13.jpg" alt="jnj-20200628_g13.jpg" style="height:184px;width:193px;"/></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash Flows</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash and cash equivalents were $11.2&#160;billion at the end of the fiscal second quarter of 2020 as compared with $17.3&#160;billion at the end of fiscal year 2019. The primary sources and uses of cash that contributed to the $6.1&#160;billion decrease were:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.542%;"><tr><td style="width:1.0%;"></td><td style="width:20.464%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:75.536%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Q4 2019 Cash and cash equivalents balance</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">cash generated from operating activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net cash used by investing activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net cash used by financing activities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">effect of exchange rate and rounding</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Q2 2020 Cash and cash equivalents balance</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In addition, the Company had $8.0 billion in marketable securities at the end of the fiscal second quarter of 2020 and $2.0 billion at the end of fiscal year 2019.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Cash flow from operations of $6.8&#160;billion was the result of:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:18.524%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:77.476%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net Earnings</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">non-cash expenses and other adjustments primarily for depreciation and amortization, stock-based compensation and accounts receivable allowances and credit losses partially offset by the deferred tax provision and net gain on sale of assets/businesses  </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">decrease in accounts payable and accrued liabilities and other current and non-current liabilities</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">an increase in accounts receivable, inventories and other current and non-current assets</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">contingent consideration reversal (related to the timing of certain developmental milestones associated with the Auris Health acquisition)</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash Flow from operations</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Investing activities use of $8.1 billion of cash was primarily used for:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:18.524%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:77.476%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">primarily related to the acquisitions of bermekimab and related assets from XBiotech Inc. as well as the acquisition of all outstanding shares in Verb Surgical Inc.</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">additions to property, plant and equipment</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net purchases of investments</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">proceeds from credit support agreements, net</span></td></tr><tr><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">other (primarily licenses and milestones)</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used for investing activities</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financing activities use of $4.7 billion of cash was primarily used for: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.575%;"><tr><td style="width:1.0%;"></td><td style="width:18.524%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:77.476%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars In Billions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">dividends to shareholders </span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">repurchase of common stock</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">net proceeds from short and long term debt</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">proceeds from stock options exercised/employee withholding tax on stock awards, net</span></td></tr><tr><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;border-left:1pt solid #000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">other</span></td></tr><tr><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;border-left:1pt solid #000;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-bottom:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-bottom:1pt solid #000;padding-left:1pt;border-right:1pt solid #000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net cash used for financing activities</span></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has access to substantial sources of funds at numerous banks worldwide. In September 2019, the Company secured a new 364-day Credit Facility. Total credit available to the Company approximates $10&#160;billion, which expires on September&#160;10, 2020.  Interest charged on borrowings under the credit line agreement is based on either bids provided by banks, the prime rate, London Interbank Offered Rates (LIBOR), or other applicable market rates as allowed under the terms of the agreement, plus applicable margins. Commitment fees under the agreement are not material.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In the fiscal second quarter of 2020, the Company's notes payable and long-term debt was in excess of cash, cash equivalents and marketable securities.  As of June 28, 2020, the net debt position was $11.3 billion as compared to the prior year of $14.1 billion. Considering recent market conditions and the on-going COVID-19 crisis, the Company has re-evaluated its operating cash flows and liquidity profile and does not foresee any significant incremental risk. The Company anticipates that operating cash flows, the ability to raise funds from external sources, borrowing capacity from existing committed credit facilities and access to the commercial paper markets will continue to provide sufficient resources to fund operating needs, including the agreement in principle to settle opioid litigation to be potentially paid over the next two to three years. In addition, the Company monitors the global capital markets on an ongoing basis and from time to time may raise capital when market conditions are favorable. In the fiscal second quarter of 2020, the Company issued approximately $3.0 billion of commercial paper, with approximately $2.7 billion outstanding at quarter end,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">for additional liquidity at favorable interest rates. Additionally, as a result of the TCJA, the Company has access to its cash outside the U.S. at a significantly reduced cost.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal second quarter of 2020, the Company paid approximately $1.3 billion to the U.S. Treasury related to the normal estimated tax payment for the fiscal first and second quarters of 2020 and the current installment due on foreign undistributed </span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">earnings as part of the TCJA (see Note 8 to the Consolidated Financial Statements as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019).</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dividends</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 14, 2020, the Board of Directors declared a regular cash dividend of $1.01 per share, payable on June 9, 2020 to shareholders of record as of May 26, 2020. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On July 20, 2020, the Board of Directors declared a regular cash dividend of $1.01 per share, payable on September 8, 2020 to shareholders of record as of August 25, 2020. The Company expects to continue the practice of paying regular quarterly cash dividends.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OTHER INFORMATION</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">New Accounting Pronouncements</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Refer to Note 1 to the Consolidated Financial Statements for new accounting pronouncements.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Economic and Market Factors</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">COVID-19 considerations and business continuity </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has considered various internal and external factors in assessing the potential impact of COVID-19 on its business and financial results based upon information available at this time, as follows:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Operating Model: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has a diversified business model across the healthcare industry with flexibility designed into its manufacturing, research and development clinical operations and commercial capabilities. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Supply Chain: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continues to leverage its global manufacturing footprint and dual-source capabilities while closely monitoring and maintaining critical inventory at major distribution centers away from high-risk areas to ensure adequate and effective distribution. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Business Continuity: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The robust, active business continuity plans across the Company's network have been instrumental in preparing the Company for events like COVID-19 and the ability to meet the majority of patient and consumer needs remains uninterrupted.  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Workforce: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company has put procedures in place to protect its essential workforce in manufacturing, distribution, commercial and research operations while ensuring appropriate remote working protocols have been established for other employees  </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;padding-left:13.8pt;">Liquidity: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company's high-quality credit rating allows the Company superior access to the financial capital markets for the foreseeable future. In the fiscal second quarter of 2020, the Company issued approximately $3.0 billion of commercial paper, with approximately $2.7 billion outstanding at quarter end,</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">for additional liquidity at favorable interest rates.</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt;">Domestic and Foreign Legislation: </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company will continue to assess and evaluate the on-going global legislative efforts to combat the COVID-19 impact on economies and the sectors in which it participates. Currently, the recent legislative acts put in place are not expected to have a material impact on the Company&#8217;s operations. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement. Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. </span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:115%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company operates in certain countries where the economic conditions continue to present significant challenges. The Company continues to monitor these situations and take appropriate actions. Inflation rates and currency exchange rates continue to have an effect on worldwide economies and, consequently, on the way the Company operates. The Company has accounted for operations in Venezuela and Argentina as highly inflationary, as the prior three-year cumulative inflation rate surpassed 100%. This did not have a material impact on the Company's results in the period. In the face of increasing costs, the Company strives to maintain its profit margins through cost reduction programs, productivity improvements and periodic price increases.</span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the United Kingdom (U.K.) held a referendum in which voters approved an exit from the European Union (E.U.), commonly referred to as &#8220;Brexit&#8221; and on January 31, 2020, the U.K. formally exited the E.U. Given the lack of comparable precedent, it is unclear what the ultimate financial, trade, regulatory and legal implications the withdrawal of the U.K. from the E.U. will have. Brexit creates global political and economic uncertainty, which may cause, among other consequences, volatility in exchange rates and interest rates, additional cost containment by third-party payors and changes in regulations.&#160; However, the Company currently does not believe that these and other related effects will have a material impact on the Company&#8217;s consolidated financial position or operating results. As of June 28, 2020 and for the fiscal six months, the business of the Company&#8217;s U.K. subsidiaries represented less than 3% of both the Company&#8217;s consolidated assets and fiscal six months revenues, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Governments around the world consider various proposals to make changes to tax laws and regulations, which may include increasing or decreasing existing statutory tax rates. A change in statutory tax rate in any country would result in the revaluation of the Company&#8217;s deferred tax assets and liabilities related to that particular jurisdiction in the period in which the new tax law is enacted.&#160; This change would result in an expense or benefit recorded to the Company&#8217;s Consolidated Statement of Earnings.&#160; The Company closely monitors these proposals as they arise in the countries where it operates. Changes to the statutory tax rate may occur at any time, and any related expense or benefit recorded may be material to the fiscal quarter and year in which the law change is enacted. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company faces various worldwide health care changes that may continue to result in pricing pressures that include health care cost containment and government legislation relating to sales, promotions and reimbursement of health care products.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Changes in the behavior and spending patterns of purchasers of health care products and services, including delaying medical procedures, rationing prescription medications, reducing the frequency of physician visits and foregoing health care insurance coverage, may continue to impact the Company&#8217;s businesses.</span></div><div style="text-indent:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company also operates in an environment increasingly hostile to intellectual property rights. Firms have filed Abbreviated New Drug Applications or Biosimilar Biological Product Applications with the FDA, initiated Inter Partes Review proceedings in the United States Patent and Trademark Office, or otherwise challenged the coverage and/or validity of the Company's patents, seeking to market generic or biosimilar forms of many of the Company&#8217;s key pharmaceutical products prior to expiration of the applicable patents covering those products. In the event the Company is not successful in defending the patent claims challenged in these actions, generic or biosimilar versions of the products at issue may be introduced to the market, resulting in the potential for substantial market share and revenue losses for those products, and which may result in a non-cash impairment charge in any associated intangible asset. There is also a risk that one or more competitors could launch a generic or biosimilar version of the product at issue following regulatory approval even though one or more valid patents are in place. For further information, see the discussion on &#8220;Litigation Against Filers of Abbreviated New Drug Applications&#8221; in Note&#160;11 to the Consolidated Financial Statements.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">65</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;3 &#8212; QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There has been no material change in the Company&#8217;s assessment of its sensitivity to market risk since its presentation set forth in Item&#160;7A, &#8220;Quantitative and Qualitative Disclosures About Market Risk,&#8221; in its Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019.</span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_109"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;4 &#8212; CONTROLS AND PROCEDURES</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Disclosure controls and procedures. At the end of the period covered by this report, the Company evaluated the effectiveness of the design and operation of its disclosure controls and procedures. The Company&#8217;s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act is accumulated and communicated to the Company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Alex Gorsky, Chairman and Chief Executive Officer, and Joseph J. Wolk, Executive Vice President, Chief Financial Officer, reviewed and participated in this evaluation. Based on this evaluation, Messrs.&#160;Gorsky and Wolk concluded that, as of the end of the period covered by this report, the Company&#8217;s disclosure controls and procedures were effective.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Internal control. During the period covered by this report, there were no changes in the Company&#8217;s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. The Company has not experienced any material impact to its internal controls over financial reporting despite the fact that most of its employees are working remotely due to the COVID-19 pandemic. The Company proactively took actions to re-evaluate and refine its financial reporting process through additional monitoring controls to provide reasonable assurance that the financial results are reported accurately and timely. The Company continues to monitor and assess the effectiveness of the design and operation of its disclosure controls and procedures. </span></div><div style="margin-top:6pt;margin-bottom:6pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company is implementing a multi-year, enterprise-wide initiative to integrate, simplify and standardize processes and systems for the human resources, information technology, procurement, supply chain and finance functions. These are enhancements to support the growth of the Company&#8217;s financial shared service capabilities and standardize financial systems. This initiative is not in response to any identified deficiency or weakness in the Company&#8217;s internal control over financial reporting. In conjunction with this initiative, the Company has and will continue to align and streamline the design and operation of its financial control environment.</span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">66</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Part II &#8212; OTHER INFORMATION</span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_115"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;1 &#8212; LEGAL PROCEEDINGS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The information called for by this item is incorporated herein by reference to Note 11 included in Part&#160;I, Item&#160;1, Financial Statements (unaudited) &#8212; Notes to Consolidated Financial Statements.</span></div><div><span><br/></span></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_118"></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;2 &#8212; UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(c)&#160;Purchases of Equity Securities by the Issuer and Affiliated Purchasers.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table provides information with respect to Common Stock purchases by the Company during the fiscal second quarter of 2020. The repurchases below also include the stock-for-stock option exercises that settled in the fiscal second quarter.</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:497.25pt;"><tr><td style="width:1.0pt;"></td><td style="width:210.25pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:58.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:52.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:67.00pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:1.75pt;"></td><td style="width:1.0pt;"></td><td style="width:1.0pt;"></td><td style="width:84.25pt;"></td><td style="width:1.0pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Month Period</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total Number</span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">of Shares Purchased</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Avg. Price<br/>Per Share</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">March 30, 2020 through April 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">352,899&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.60&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">April 27, 2020 through May 24, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,474,619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150.35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">May 25, 2020 through June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">901,712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145.16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,729,230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:right;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"></span></span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="text-align:center;"><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;During the fiscal second quarter of 2020, the Company repurchased an aggregate of 4,729,230 shares of Johnson &amp; Johnson Common Stock in open-market transactions, all of which were purchased as part of a systematic plan to meet the needs of the Company&#8217;s compensation programs.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">67</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Item&#160;6 &#8212; EXHIBITS</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q2qexhibit311c.htm">Exhibit&#160;31.1 </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Executive Officer under Rule&#160;13a-14(a) of the Securities Exchange Act pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 &#8212; Filed with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q2qexhibit312c.htm">Exhibit&#160;31.2 </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Financial Officer under Rule&#160;13a-14(a) of the Securities Exchange Act pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002 &#8212; Filed with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q2qexhibit321c.htm">Exhibit&#160;32.1 </a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certification of Chief Executive Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 &#8212; Furnished with this document.</span></div><div style="text-indent:11.25pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;-sec-extract:exhibit;" href="a202010-q2qexhibit322c.htm">Exhibit&#160;32.2</a></span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Certification of Chief Financial Officer pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 &#8212; Furnished with this document.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Exhibit 101: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.269%;"><tr><td style="width:1.0%;"></td><td style="width:15.083%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:2.745%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:77.972%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.INS</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Instance Document - the instance document does not appear in the Interactive Data File because its                XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.SCH</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Schema</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.CAL</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Calculation Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.LAB</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Label Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.PRE</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Presentation Linkbase</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">EX-101.DEF</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Inline XBRL Taxonomy Extension Definition Document</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Exhibit 104:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cover Page Interactive Data File&#8211;&#8211;the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr></table></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;-sec-extract:summary;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">68</span></div></div></div><div id="id4c2b9b2855142cd8f946cd473dea1c1_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"><a style="background-color:rgb(255,255,255, 0.0);color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;" href="#id4c2b9b2855142cd8f946cd473dea1c1_10">Table of Contents</a></span></div></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span><br/></span></div><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SIGNATURES</span></div><div style="text-align:center;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.076%;"><tr><td style="width:1.0%;"></td><td style="width:50.560%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:45.440%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">JOHNSON &amp; JOHNSON<br/>(Registrant)&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="height:3pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: July 24, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By /s/ J. J. WOLK</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">J. J. WOLK</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Executive Vice President, Chief Financial Officer (Principal Financial Officer)&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Date: July 24, 2020</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">By /s/&#160;R. J. DECKER Jr.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R. J. DECKER Jr.</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Controller (Principal Accounting Officer)&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">69</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>a202010-q2qexhibit311c.htm
<DESCRIPTION>EXHIBIT 31.1 CEO CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i0780c1d43c64435c808aa5cf351aa7f7_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 31.1</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT </font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Alex Gorsky, certify that&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;</font></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June&#160;28, 2020 (the &#8220;report&#8221;) of Johnson &#38; Johnson (the &#34;Company&#34;)&#59; </font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4. The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Company and have&#58; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c)  Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d)  Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.  The Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.</font></div><div style="padding-left:288pt;"><font><br></font></div><div style="padding-left:288pt;"><font><br></font></div><div style="padding-left:288pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#47;s&#47; Alex Gorsky</font></div><div style="padding-left:288pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#7d7d7d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">__________________________</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Alex Gorsky</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Chief Executive Officer</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58;   July&#160;24, 2020</font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>a202010-q2qexhibit312c.htm
<DESCRIPTION>EXHIBIT 31.2 CFO CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i115302e1ead44fcf822c3735ee531bcb_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="text-align:right;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 31.2</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT </font></div><div style="text-align:center;"><font><br></font></div><div style="text-align:center;"><font><br></font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">I, Joseph J. Wolk, certify that&#58;</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160;</font></div><div style="text-indent:36pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">1. I have reviewed this Quarterly Report on Form 10-Q for the quarterly period ended June&#160;28, 2020 (the &#8220;report&#8221;) of Johnson &#38; Johnson (the &#34;Company&#34;)&#59; </font></div><div style="text-indent:36pt;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">4. The Company's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rule 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rule 13a-15(f) and 15d-15(f)) for the Company and have&#58; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">a)  Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">c)  Evaluated the effectiveness of the Company's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="text-indent:36pt;text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d)  Disclosed in this report any change in the Company's internal control over financial reporting that occurred during the Company's most recent fiscal quarter (the Company's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;5.  The Company's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Company's auditors and the audit committee of the Company's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(a)  All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Company's ability to record, process, summarize and report financial information&#59; and</font></div><div style="text-align:justify;"><font><br></font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(b)  Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company's internal control over financial reporting.</font></div><div style="padding-left:36pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font><br></font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#47;s&#47; Joseph J. Wolk</font></div><div style="text-indent:36pt;padding-left:252pt;text-align:justify;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">______________________________</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Joseph J. Wolk</font></div><div style="text-indent:36pt;padding-left:252pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Chief Financial Officer</font></div><div><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Date&#58; July&#160;24, 2020</font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>a202010-q2qexhibit321c.htm
<DESCRIPTION>EXHIBIT 32.1 CEO 906 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="i23864a85c9284718adef2d196bce162b_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-right:38.25pt;text-align:right;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 32.1</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</font></div><div style="padding-right:38.25pt;text-align:center;margin-top:18pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;The undersigned, Alex Gorsky, the Chief Executive Officer of Johnson &#38; Johnson, a New Jersey corporation (the &#8220;Company&#8221;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge&#58;</font></div><div style="padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.327%;"><tr><td style="width:1.0%;"></td><td style="width:1.927%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.237%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.109%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.767%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.764%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.764%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:40.062%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.170%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2020 (the&#8220;Report&#8221;) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934&#59; and</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="21" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Alex Gorsky</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Alex Gorsky&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Executive Officer&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Dated&#58;  July&#160;24, 2020</font></div><div style="padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;This certification is being furnished to the SEC with this Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section.</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11.25pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> &#160; </font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>a202010-q2qexhibit322c.htm
<DESCRIPTION>EXHIBIT 32.1 CFO 906 CERTIFICATION
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2020 Workiva -->
<title>Document</title></head><body><div id="iad81610b834b4511a8a178aece995100_1"></div><div style="min-height:42.75pt;width:100%;"><div><font><br></font></div></div><div style="padding-right:38.25pt;text-align:right;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Exhibit 32.2</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:18pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;The undersigned, Joseph J. Wolk, the Chief Financial Officer of Johnson &#38; Johnson, a New Jersey corporation (the &#8220;Company&#8221;), pursuant to 18 U.S.C. 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, hereby certifies that, to the best of my knowledge&#58;</font></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.327%;"><tr><td style="width:1.0%;"></td><td style="width:1.927%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:3.237%;"></td><td style="width:1.0%;"></td><td style="width:0.1%;"></td><td style="width:1.109%;"></td><td style="width:0.1%;"></td><td style="width:1.0%;"></td><td style="width:19.767%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.764%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:1.764%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:40.062%;"></td><td style="width:1.0%;"></td><td style="width:1.0%;"></td><td style="width:16.170%;"></td><td style="width:1.0%;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 28, 2020 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934&#59; and</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="21" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</font></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:justify;vertical-align:top;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-bottom:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#47;s&#47; Joseph J. Wolk</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Joseph J. Wolk&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="12" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Chief Financial Officer&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td></tr><tr><td colspan="24" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><font style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</font></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td><td colspan="3" style="display:none;"></td></tr></table></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;Dated&#58;  July&#160;24, 2020</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;margin-top:6pt;"><font><br></font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:justify;margin-top:6pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;This certification is being furnished to the SEC with this Report pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section.</font></div><div style="text-indent:-20.25pt;padding-left:22.5pt;padding-right:38.25pt;text-align:center;margin-top:11.25pt;"><font style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;"> &#160; </font></div><div><font><br></font></div><div style="position:relative;width:100%;height:42.75pt;"><div style="position:absolute;bottom:0;width:100%;"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>jnj-20200628.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:jnj="http://www.jnj.com/20200628" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.jnj.com/20200628">
  <xs:import namespace="http://fasb.org/srt/2019-01-31" schemaLocation="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2019-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2017-01-31" schemaLocation="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2019-01-31" schemaLocation="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200628_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200628_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200628_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="jnj-20200628_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.jnj.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEarnings" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings">
        <link:definition>1003004 - Statement - Consolidated Statements of Earnings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>1004005 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquity" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity">
        <link:definition>1005006 - Statement - Consolidated Statements of Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofEquityParenthetical" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical">
        <link:definition>1006007 - Statement - Consolidated Statements of Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2101101 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://www.jnj.com/role/Inventories">
        <link:definition>2103102 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://www.jnj.com/role/InventoriesTables">
        <link:definition>2304301 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://www.jnj.com/role/InventoriesDetails">
        <link:definition>2405401 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill">
        <link:definition>2106103 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>2307302 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails">
        <link:definition>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillGoodwillBySegmentDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails">
        <link:definition>2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillNarrativeDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails">
        <link:definition>2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails">
        <link:definition>2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.jnj.com/role/FairValueMeasurements">
        <link:definition>2112104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsPolicies" roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies">
        <link:definition>2213202 - Disclosure - Fair Value Measurements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.jnj.com/role/FairValueMeasurementsTables">
        <link:definition>2314303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2415406 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofDerivativeActivityDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails">
        <link:definition>2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails">
        <link:definition>2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails">
        <link:definition>2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails">
        <link:definition>2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails">
        <link:definition>2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails">
        <link:definition>2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails">
        <link:definition>2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails">
        <link:definition>2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.jnj.com/role/IncomeTaxes">
        <link:definition>2125105 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.jnj.com/role/IncomeTaxesDetails">
        <link:definition>2426416 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlans" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans">
        <link:definition>2127106 - Disclosure - Pensions and Other Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansTables" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables">
        <link:definition>2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
        <link:definition>2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PensionsandOtherBenefitPlansDetails" roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails">
        <link:definition>2430418 - Disclosure - Pensions and Other Benefit Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncome" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome">
        <link:definition>2131107 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables">
        <link:definition>2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShare" roleURI="http://www.jnj.com/role/EarningsPerShare">
        <link:definition>2134108 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareTables" roleURI="http://www.jnj.com/role/EarningsPerShareTables">
        <link:definition>2335306 - Disclosure - Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsPerShareDetails" roleURI="http://www.jnj.com/role/EarningsPerShareDetails">
        <link:definition>2436420 - Disclosure - Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreas" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas">
        <link:definition>2137109 - Disclosure - Segments of Business and Geographic Areas</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasTables" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables">
        <link:definition>2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails">
        <link:definition>2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails">
        <link:definition>2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails">
        <link:definition>2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandDivestitures" roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures">
        <link:definition>2142110 - Disclosure - Business Combinations and Divestitures</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsandDivestituresNarrativeDetails" roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails">
        <link:definition>2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedings" roleURI="http://www.jnj.com/role/LegalProceedings">
        <link:definition>2144111 - Disclosure - Legal Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LegalProceedingsDetails" roleURI="http://www.jnj.com/role/LegalProceedingsDetails">
        <link:definition>2445425 - Disclosure - Legal Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.jnj.com/role/Restructuring">
        <link:definition>2146112 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringTables" roleURI="http://www.jnj.com/role/RestructuringTables">
        <link:definition>2347308 - Disclosure - Restructuring (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringNarrativeDetails" roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails">
        <link:definition>2448426 - Disclosure - Restructuring - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringScheduleofRestructuringReserveDetails" roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails">
        <link:definition>2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="jnj_OtherReverseRepurchaseAgreementsMember" abstract="true" name="OtherReverseRepurchaseAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_StelaraMember" abstract="true" name="StelaraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" abstract="false" name="SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="jnj_RemicadeMember" abstract="true" name="RemicadeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EDURANTrilpivirineMember" abstract="true" name="EDURANTrilpivirineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherNonOperatingIncomeExpensePercentToSales" abstract="false" name="OtherNonOperatingIncomeExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_PelvicMeshesMember" abstract="false" name="PelvicMeshesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SalesBySegmentOfBusinessTableTextBlock" abstract="false" name="SalesBySegmentOfBusinessTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="jnj_AsrMember" abstract="false" name="AsrMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_Restructuringchargepercenttosales" abstract="false" name="Restructuringchargepercenttosales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A3.500Notesdue2048Member" abstract="true" name="A3.500Notesdue2048Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AssetWriteoffMember" abstract="true" name="AssetWriteoffMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" abstract="false" name="CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_IncomeTaxExpenseBenefitPercentToSales" abstract="false" name="IncomeTaxExpenseBenefitPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A2.625Notesdue2025Member" abstract="true" name="A2.625Notesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_WoundCareandOtherMember" abstract="true" name="WoundCareandOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SellingGeneralAndAdministrativeExpensePercentToSales" abstract="false" name="SellingGeneralAndAdministrativeExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" abstract="false" name="OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_TremfyaMember" abstract="true" name="TremfyaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" abstract="false" name="ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_AsiaPacificAfricaMember" abstract="true" name="AsiaPacificAfricaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.85Debenturesdue2038Member" abstract="true" name="A5.85Debenturesdue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A3.625Notesdue2037Member" abstract="true" name="A3.625Notesdue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IdorsiaLTDMember" abstract="true" name="IdorsiaLTDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" abstract="false" name="LossContingencyPreviousDamagesAwardedAndRevisedValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_ImmunologyMember" abstract="true" name="ImmunologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ExcessOfFairValueOverCarryingValueOfDebt" abstract="false" name="ExcessOfFairValueOverCarryingValueOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_GrossProfitPercentToSales" abstract="false" name="GrossProfitPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_VerbSurgicalInc.Member" abstract="true" name="VerbSurgicalInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.50Debenturesdue2040Member" abstract="true" name="A4.50Debenturesdue2040Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InvestmentIncomeInterestPercentToSales" abstract="false" name="InvestmentIncomeInterestPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_PercentageChangeInSalesByGeographicArea" abstract="false" name="PercentageChangeInSalesByGeographicArea" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_SalesRevenueGoodsNetPercentToSales" abstract="false" name="SalesRevenueGoodsNetPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_WesternHemisphereExcludingUSMember" abstract="true" name="WesternHemisphereExcludingUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IntangibleAssetsAndGoodwillTextualsAbstract" abstract="true" name="IntangibleAssetsAndGoodwillTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" abstract="false" name="CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_SupplyChainMember" abstract="true" name="SupplyChainMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_CONCERTAMethylphenidateMember" abstract="true" name="CONCERTAMethylphenidateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A1.150NotesDue2028Member" abstract="true" name="A1.150NotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" abstract="true" name="PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_NetIncomeAttributableToParentPercentToSales" abstract="false" name="NetIncomeAttributableToParentPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_OtherIncomeExpenseNetMember" abstract="true" name="OtherIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherOncologyMember" abstract="true" name="OtherOncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.05Notesdue2023Member" abstract="true" name="A2.05Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.70Notesdue2046Member" abstract="true" name="A3.70Notesdue2046Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" abstract="true" name="DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_OTHERNEUROSCIENCEMember" abstract="true" name="OTHERNEUROSCIENCEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ConsumerMember" abstract="true" name="ConsumerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" abstract="true" name="ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" abstract="true" name="INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.900Notesdue2028Member" abstract="true" name="A2.900Notesdue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PercentageChangeInOperatingIncomeLoss" abstract="false" name="PercentageChangeInOperatingIncomeLoss" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_LitigationSettlementByCompaniesDomain" abstract="true" name="LitigationSettlementByCompaniesDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OpioidMember" abstract="true" name="OpioidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BermekimabMember" abstract="true" name="BermekimabMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A6.73Debenturesdue2023Member" abstract="true" name="A6.73Debenturesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PharmaceuticalMember" abstract="true" name="PharmaceuticalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BeautyMember" abstract="true" name="BeautyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PurchasedInProcessResearchAndDevelopmentMember" abstract="true" name="PurchasedInProcessResearchAndDevelopmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A1.650NotesDue2035Member" abstract="true" name="A1.650NotesDue2035Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.95Notesdue2027Member" abstract="true" name="A2.95Notesdue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" abstract="false" name="EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_NotesDuePeriodFifteenMember" abstract="true" name="NotesDuePeriodFifteenMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LitigationSettlementByCompaniesAxis" abstract="true" name="LitigationSettlementByCompaniesAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="jnj_EquityInvestmentRollForward" abstract="true" name="EquityInvestmentRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_BabyPowderMember" abstract="true" name="BabyPowderMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentswithReadilyDeterminableValueMember" abstract="true" name="EquityInvestmentswithReadilyDeterminableValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_GENERALMember" abstract="true" name="GENERALMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" abstract="false" name="RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jnj_IncomeTaxTextualsAbstract" abstract="true" name="IncomeTaxTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_TRAUMAMember" abstract="true" name="TRAUMAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RestructuringandRelatedCostExpectedFutureSavings" abstract="false" name="RestructuringandRelatedCostExpectedFutureSavings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_PulmonaryHypertensionMember" abstract="true" name="PulmonaryHypertensionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OPSUMITMember" abstract="true" name="OPSUMITMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CostOfGoodsSoldPercentToSales" abstract="false" name="CostOfGoodsSoldPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_MedicalDevicesMember" abstract="true" name="MedicalDevicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_DARZALEXMember" abstract="true" name="DARZALEXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.75Notesdue2047Member" abstract="true" name="A3.75Notesdue2047Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.25Notesdue2022Member" abstract="true" name="A2.25Notesdue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" abstract="false" name="ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A4.85Notesdue2041Member" abstract="true" name="A4.85Notesdue2041Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_KNEESMember" abstract="true" name="KNEESMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityFairValueAdjustmentChangeInObservablePrice" abstract="false" name="EquityFairValueAdjustmentChangeInObservablePrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_DePuyASRU.S.Member" abstract="true" name="DePuyASRU.S.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OralCareMember" abstract="true" name="OralCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RestructuringandRelatedCostDurationofRestructuringPlan" abstract="false" name="RestructuringandRelatedCostDurationofRestructuringPlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="jnj_TalcMember" abstract="true" name="TalcMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" abstract="false" name="FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_ResearchAndDevelopmentInProcessPercentToSales" abstract="false" name="ResearchAndDevelopmentInProcessPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_A2.45Notesdue2021Member" abstract="true" name="A2.45Notesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OncologyMember" abstract="true" name="OncologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OtherMember" abstract="true" name="OtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SurgeryMember" abstract="true" name="SurgeryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PinnacleAcetabularCupSystemMember" abstract="false" name="PinnacleAcetabularCupSystemMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ProductLiabilityContingencyNumberOfClaimant" abstract="false" name="ProductLiabilityContingencyNumberOfClaimant" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jnj_OtherImmunologyMember" abstract="true" name="OtherImmunologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.55Notesdue2021Member" abstract="true" name="A3.55Notesdue2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_LegalProceedingTextualsAbstract" abstract="true" name="LegalProceedingTextualsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_OtherInfectiousDiseasesMember" abstract="true" name="OtherInfectiousDiseasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_RISPERDALCONSTAMember" abstract="true" name="RISPERDALCONSTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A2.45Notesdue2026Member" abstract="true" name="A2.45Notesdue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SimponiSimponiAriaMember" abstract="true" name="SimponiSimponiAriaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" abstract="true" name="EquityInvestmentswithoutReadilyDeterminableValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InvokanaMember" abstract="true" name="InvokanaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InfectiousDiseasesMember" abstract="true" name="InfectiousDiseasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PercentageChangeInSalesBySegmentOfBusiness" abstract="false" name="PercentageChangeInSalesBySegmentOfBusiness" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" abstract="false" name="FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" abstract="false" name="OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_EquityFairValueAdjustmentImpairmentLoss" abstract="false" name="EquityFairValueAdjustmentImpairmentLoss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_UnrecognizedTaxBenefitLiabilityPayment" abstract="false" name="UnrecognizedTaxBenefitLiabilityPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_UPTRAVIMember" abstract="true" name="UPTRAVIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" abstract="false" name="ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="jnj_XareltoMember" abstract="true" name="XareltoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" abstract="false" name="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_CardiovascularMetabolismOtherMember" abstract="true" name="CardiovascularMetabolismOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A0.650NotesDue2024Member" abstract="true" name="A0.650NotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AccruedRebatesReturnsAndPromotions" abstract="false" name="AccruedRebatesReturnsAndPromotions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A6.95Notesdue2029Member" abstract="true" name="A6.95Notesdue2029Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.50NotesDue2024Member" abstract="true" name="A5.50NotesDue2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InterestExpensePercentToSales" abstract="false" name="InterestExpensePercentToSales" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="jnj_WomensHealthMember" abstract="true" name="WomensHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_UNITEDSTATESExportsMember" abstract="true" name="UNITEDSTATESExportsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" abstract="false" name="EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_RisperdalMember" abstract="true" name="RisperdalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PROCRITEPREXMember" abstract="true" name="PROCRITEPREXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SURGICALMember" abstract="true" name="SURGICALMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OrthopaedicsMember" abstract="true" name="OrthopaedicsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_PatentsAndTrademarksMember" abstract="true" name="PatentsAndTrademarksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_BabyCareMember" abstract="true" name="BabyCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_VELCADEMember" abstract="true" name="VELCADEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A0.250NotesDue2022Member" abstract="true" name="A0.250NotesDue2022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" abstract="true" name="OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ERLEADAMember" abstract="true" name="ERLEADAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.95Debenturesdue2033Member" abstract="true" name="A4.95Debenturesdue2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A4.375Notesdue2033Member" abstract="true" name="A4.375Notesdue2033Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_SPINEOTHERMember" abstract="true" name="SPINEOTHERMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_OTCMember" abstract="true" name="OTCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="jnj_A3.400Notesdue2038Member" abstract="true" name="A3.400Notesdue2038Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_HIPSMember" abstract="true" name="HIPSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_VisionMember" abstract="true" name="VisionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AccruedTaxesOnIncomeMember" abstract="true" name="AccruedTaxesOnIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" abstract="false" name="CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_NeuroscienceMember" abstract="true" name="NeuroscienceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InterventionalSolutionsMember" abstract="true" name="InterventionalSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.55Notesdue2036Member" abstract="true" name="A3.55Notesdue2036Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_IMBRUVICAMember" abstract="true" name="IMBRUVICAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_Numberofpatientsinsettlement" abstract="false" name="Numberofpatientsinsettlement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="jnj_CONTACTLENSESOTHERMember" abstract="true" name="CONTACTLENSESOTHERMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A3.375Notesdue2023Member" abstract="true" name="A3.375Notesdue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_Proceedsfromcreditsupportagreements" abstract="false" name="Proceedsfromcreditsupportagreements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_AurisHealthMember" abstract="true" name="AurisHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_AdvancedSterilizationProductsMember" abstract="true" name="AdvancedSterilizationProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" abstract="false" name="FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_PhysiomeshMember" abstract="true" name="PhysiomeshMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_A5.95Notesdue2037Member" abstract="true" name="A5.95Notesdue2037Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_CizHoldingsCo.Ltd.Member" abstract="true" name="CizHoldingsCo.Ltd.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_INVOKANAINVOKAMETMember" abstract="true" name="INVOKANAINVOKAMETMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_InterestIncomeExpenseNetMember" abstract="true" name="InterestIncomeExpenseNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" abstract="false" name="FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="jnj_A4.50Notesdue2043Member" abstract="true" name="A4.50Notesdue2043Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ADVANCEDMember" abstract="true" name="ADVANCEDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="jnj_ZYTIGAMember" abstract="true" name="ZYTIGAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>jnj-20200628_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200628.xsd#Cover"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0caa2491-19cf-4ef7-a293-b4bf332a4a6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_LiabilitiesCurrent_0caa2491-19cf-4ef7-a293-b4bf332a4a6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_cf57543d-a099-4fa3-9495-b9454a172c4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_cf57543d-a099-4fa3-9495-b9454a172c4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bfbbc1eb-6c95-451a-bd98-3abdb59279aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bfbbc1eb-6c95-451a-bd98-3abdb59279aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_c4c52310-25f7-4832-bec2-bf37dfa51039" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_c4c52310-25f7-4832-bec2-bf37dfa51039" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4429277c-2faf-4522-9a38-8d51164f85e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_4429277c-2faf-4522-9a38-8d51164f85e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_4d027770-9e2d-4b3a-95a2-a1af3be98415" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_58b05f2f-c296-4b0f-9e9c-f957e8dfd267" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_4d027770-9e2d-4b3a-95a2-a1af3be98415" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_f3af411f-1d2c-48d2-abd3-4b57e1de0c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_us-gaap_ShortTermBorrowings_f3af411f-1d2c-48d2-abd3-4b57e1de0c0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_8c156a3d-6df2-4c8b-a6c3-1aca50a30063" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_us-gaap_AccountsPayableCurrent_8c156a3d-6df2-4c8b-a6c3-1aca50a30063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9a948f69-93a1-4ed2-99a7-960e6ca7634f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9a948f69-93a1-4ed2-99a7-960e6ca7634f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions_e180adcb-aa95-4f48-98f0-5deb248b8257" xlink:href="jnj-20200628.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_jnj_AccruedRebatesReturnsAndPromotions_e180adcb-aa95-4f48-98f0-5deb248b8257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_62da1c97-1e75-49fe-a878-5ee074c08b50" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_62da1c97-1e75-49fe-a878-5ee074c08b50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_71beb628-bd1f-4f80-8e3c-520e72e6c195" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_36e71af7-469d-42b7-83ad-65c6c1ddd697" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_71beb628-bd1f-4f80-8e3c-520e72e6c195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_afbb514a-f774-4344-9aee-6144d43a0b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ced4f4a0-b0ee-4ad9-b93f-0581f62e5e27" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afbb514a-f774-4344-9aee-6144d43a0b8d" xlink:to="loc_us-gaap_Liabilities_ced4f4a0-b0ee-4ad9-b93f-0581f62e5e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_38b037a6-41c9-4e6d-a7af-6956e031dba3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afbb514a-f774-4344-9aee-6144d43a0b8d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_38b037a6-41c9-4e6d-a7af-6956e031dba3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_966b017d-21d4-48f0-8746-a8c474c91d31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_afbb514a-f774-4344-9aee-6144d43a0b8d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_966b017d-21d4-48f0-8746-a8c474c91d31" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73209a18-8e23-4bad-989b-45d58d06ea36" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_73209a18-8e23-4bad-989b-45d58d06ea36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_90b0c024-3709-4285-b7f1-b63e894c86cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_90b0c024-3709-4285-b7f1-b63e894c86cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_936c78b9-3505-4c58-ab68-c4559bb67a9a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_936c78b9-3505-4c58-ab68-c4559bb67a9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a9be2aa2-79b8-4e61-aa2a-1e4c0433fb88" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_InventoryNet_a9be2aa2-79b8-4e61-aa2a-1e4c0433fb88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d3671b0-de83-444f-ae76-f4ac6951b743" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8d3671b0-de83-444f-ae76-f4ac6951b743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_0ed29a68-27d4-4c23-bf84-dd2b0a95396b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_d27b34f4-d260-4112-8a2d-2c24997d3b77" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_0ed29a68-27d4-4c23-bf84-dd2b0a95396b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2739fb35-992c-417a-b29a-007d5f353dee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_AssetsCurrent_2739fb35-992c-417a-b29a-007d5f353dee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_27ce1ea9-21d9-4ec7-8031-f1d91f3001b5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_27ce1ea9-21d9-4ec7-8031-f1d91f3001b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69b288a5-a820-412d-bc0a-c4785f9e934b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_69b288a5-a820-412d-bc0a-c4785f9e934b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0ae8d3d4-550a-4b5c-8520-713f55473903" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_Goodwill_0ae8d3d4-550a-4b5c-8520-713f55473903" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_21caf76a-3f37-4182-b501-937b9ed9299e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_21caf76a-3f37-4182-b501-937b9ed9299e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_cdf996e5-a3e5-4dd3-aae4-3842953e1a3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_910a2a23-b546-4044-9c0a-a06ab64c6601" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_cdf996e5-a3e5-4dd3-aae4-3842953e1a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb160494-11b1-4a05-a21f-d4dda728be2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c88ed682-9347-4a6a-8f88-ba51b2b468c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb160494-11b1-4a05-a21f-d4dda728be2e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_c88ed682-9347-4a6a-8f88-ba51b2b468c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_abd5c2a6-e645-4e38-8624-39de237fa38e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb160494-11b1-4a05-a21f-d4dda728be2e" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_abd5c2a6-e645-4e38-8624-39de237fa38e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_6ff9bbba-970a-4ade-b656-ae9e3e60287d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb160494-11b1-4a05-a21f-d4dda728be2e" xlink:to="loc_us-gaap_CommonStockValue_6ff9bbba-970a-4ade-b656-ae9e3e60287d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_014427dc-2009-4750-8301-c933ffe2abfe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cb160494-11b1-4a05-a21f-d4dda728be2e" xlink:to="loc_us-gaap_TreasuryStockValue_014427dc-2009-4750-8301-c933ffe2abfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_c1740c2e-d3bd-44f6-8c73-9566f878c1f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c46d6c65-6e5b-4b7e-9c01-e259152684bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c1740c2e-d3bd-44f6-8c73-9566f878c1f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c46d6c65-6e5b-4b7e-9c01-e259152684bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1473b478-759f-4c5a-9540-ceff40b0ddc1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_c1740c2e-d3bd-44f6-8c73-9566f878c1f8" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_1473b478-759f-4c5a-9540-ceff40b0ddc1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEarnings"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales_1e5f4b9c-b45b-4a24-9488-aa02300f2c59" xlink:href="jnj-20200628.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_59e58e70-3f7c-4e86-9460-4f0b1b4e34f5" xlink:href="jnj-20200628.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales_1e5f4b9c-b45b-4a24-9488-aa02300f2c59" xlink:to="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_59e58e70-3f7c-4e86-9460-4f0b1b4e34f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_43c46f3c-1449-4097-88ff-3a54088bd562" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales_1e5f4b9c-b45b-4a24-9488-aa02300f2c59" xlink:to="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_43c46f3c-1449-4097-88ff-3a54088bd562" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1c833f96-04e7-4a9d-a4ca-89651f55929c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ff3cb022-a2d3-4259-9d82-3052a3178442" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1c833f96-04e7-4a9d-a4ca-89651f55929c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ff3cb022-a2d3-4259-9d82-3052a3178442" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_28ce2af2-3882-4084-b835-67712647aa72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_1c833f96-04e7-4a9d-a4ca-89651f55929c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_28ce2af2-3882-4084-b835-67712647aa72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:href="jnj-20200628.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_a02cfd16-57b8-4599-a60e-8f26eaa0766e" xlink:href="jnj-20200628.xsd#jnj_GrossProfitPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_GrossProfitPercentToSales_a02cfd16-57b8-4599-a60e-8f26eaa0766e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_34cf21d8-e71f-4a13-8c9d-0113777fa62d" xlink:href="jnj-20200628.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_34cf21d8-e71f-4a13-8c9d-0113777fa62d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_1327a630-48ff-4d9b-8aca-1d3819c11a3a" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_1327a630-48ff-4d9b-8aca-1d3819c11a3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales_24c0a8c3-845c-453f-8850-5ce08f92f652" xlink:href="jnj-20200628.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_InvestmentIncomeInterestPercentToSales_24c0a8c3-845c-453f-8850-5ce08f92f652" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales_88859376-e43b-4f59-94f8-5df240375b91" xlink:href="jnj-20200628.xsd#jnj_InterestExpensePercentToSales"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_InterestExpensePercentToSales_88859376-e43b-4f59-94f8-5df240375b91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_c82cd931-82a9-4ef6-a020-f13b7c88b746" xlink:href="jnj-20200628.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_c82cd931-82a9-4ef6-a020-f13b7c88b746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales_06a472e1-e4c9-4b35-9aac-8b4a67b8d325" xlink:href="jnj-20200628.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_Restructuringchargepercenttosales_06a472e1-e4c9-4b35-9aac-8b4a67b8d325" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_1b60d8f2-7965-4483-8ad7-2e1ba6208dd9" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_da282d87-45cb-42a5-9fc4-6f3fc10c79bb" xlink:to="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_1b60d8f2-7965-4483-8ad7-2e1ba6208dd9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_5e204ced-6b21-454e-b245-8d84e00eee08" xlink:href="jnj-20200628.xsd#jnj_GrossProfitPercentToSales"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales_3681c6f3-73b1-44e0-a551-986f9d0ede56" xlink:href="jnj-20200628.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_GrossProfitPercentToSales_5e204ced-6b21-454e-b245-8d84e00eee08" xlink:to="loc_jnj_SalesRevenueGoodsNetPercentToSales_3681c6f3-73b1-44e0-a551-986f9d0ede56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales_76bbec53-0602-4f77-a61c-9b6428b2e9dd" xlink:href="jnj-20200628.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_jnj_GrossProfitPercentToSales_5e204ced-6b21-454e-b245-8d84e00eee08" xlink:to="loc_jnj_CostOfGoodsSoldPercentToSales_76bbec53-0602-4f77-a61c-9b6428b2e9dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b75dbe50-2be8-4a43-9a1f-19768252d6b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_e7939d71-0d6a-44ed-a594-0faf73353919" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b75dbe50-2be8-4a43-9a1f-19768252d6b4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_e7939d71-0d6a-44ed-a594-0faf73353919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e47b4b1c-fdc5-41b8-8be1-5dfcd8ba3f5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_b75dbe50-2be8-4a43-9a1f-19768252d6b4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_e47b4b1c-fdc5-41b8-8be1-5dfcd8ba3f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_f1563eaf-bc2c-45b1-be4a-1bed804383ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_GrossProfit_f1563eaf-bc2c-45b1-be4a-1bed804383ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5e395d02-46c4-4c60-aacb-1c62c981f2f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_5e395d02-46c4-4c60-aacb-1c62c981f2f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_4d94eef5-e6a9-4137-a98f-d9f2a6418ee4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_4d94eef5-e6a9-4137-a98f-d9f2a6418ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_e76aac98-5761-4e10-8ed4-744a893d3912" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_e76aac98-5761-4e10-8ed4-744a893d3912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_210f7c1c-99b2-4270-bcc1-240375c8e3a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_InvestmentIncomeInterest_210f7c1c-99b2-4270-bcc1-240375c8e3a7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_22a7dc13-2a5b-4edc-b591-61f629b5f963" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_InterestExpense_22a7dc13-2a5b-4edc-b591-61f629b5f963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_f466c74c-eb6a-423b-9ec8-09e869cd37a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_f466c74c-eb6a-423b-9ec8-09e869cd37a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_0d483237-903b-4673-8a01-376a759314f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_092086aa-aed5-4165-9730-f15de3723581" xlink:to="loc_us-gaap_RestructuringCharges_0d483237-903b-4673-8a01-376a759314f3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b4320a3a-f4a7-410a-9a36-3323db12be89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5d7a7278-d6f3-498a-aaa7-d1b8596cbf10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b4320a3a-f4a7-410a-9a36-3323db12be89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5d7a7278-d6f3-498a-aaa7-d1b8596cbf10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7fc21d8d-09d8-40ab-b2b7-a6e76c0d82f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_b4320a3a-f4a7-410a-9a36-3323db12be89" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_7fc21d8d-09d8-40ab-b2b7-a6e76c0d82f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d26933-ae54-49d3-af0c-0103c6692ad9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_954bfdfc-f1c9-43f3-9a92-0b47d5e9362f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d26933-ae54-49d3-af0c-0103c6692ad9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_954bfdfc-f1c9-43f3-9a92-0b47d5e9362f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4ee91fd3-ef76-41ae-9362-4dc833656ff9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d26933-ae54-49d3-af0c-0103c6692ad9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_4ee91fd3-ef76-41ae-9362-4dc833656ff9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9e0661e5-3841-4e3d-b34e-1ee85d713654" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d26933-ae54-49d3-af0c-0103c6692ad9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9e0661e5-3841-4e3d-b34e-1ee85d713654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_913f20a1-4454-4c6e-b6dd-54b0704b9484" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_77d26933-ae54-49d3-af0c-0103c6692ad9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_913f20a1-4454-4c6e-b6dd-54b0704b9484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_122da2fa-3bb8-44b3-8359-c775a22a79f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_3bd9ace6-83ed-4edb-ba15-8bd23d95d2c0" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_122da2fa-3bb8-44b3-8359-c775a22a79f1" xlink:to="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_3bd9ace6-83ed-4edb-ba15-8bd23d95d2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_01943735-4fb7-4d19-86d7-7e3069fa1a2c" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_122da2fa-3bb8-44b3-8359-c775a22a79f1" xlink:to="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_01943735-4fb7-4d19-86d7-7e3069fa1a2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_99e7e091-6200-4c0f-a2d7-1b7ec0988bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e8e3587b-dc34-431f-855d-88f7f3ed1c76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_99e7e091-6200-4c0f-a2d7-1b7ec0988bb4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_e8e3587b-dc34-431f-855d-88f7f3ed1c76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d8240647-973d-4cd4-bdd1-c7e52d492a5c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_99e7e091-6200-4c0f-a2d7-1b7ec0988bb4" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_d8240647-973d-4cd4-bdd1-c7e52d492a5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf2e01c7-5bba-4818-a5ac-6ecb7fe531ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d0bdce1d-aa83-4b3e-94c3-77acde672c3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf2e01c7-5bba-4818-a5ac-6ecb7fe531ee" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_d0bdce1d-aa83-4b3e-94c3-77acde672c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0941e7f3-84f6-4576-bc92-b8f5a252e7ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_cf2e01c7-5bba-4818-a5ac-6ecb7fe531ee" xlink:to="loc_us-gaap_NetIncomeLoss_0941e7f3-84f6-4576-bc92-b8f5a252e7ed" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquity"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a2af89e4-253a-477d-bcac-637a02fd852d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a2af89e4-253a-477d-bcac-637a02fd852d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6d6c4bc5-2a1d-4ba5-80a2-a4f467939f97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_6d6c4bc5-2a1d-4ba5-80a2-a4f467939f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_81380cce-6d2c-4693-81bd-adf4ad565b14" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_81380cce-6d2c-4693-81bd-adf4ad565b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_d00a9707-0b19-47b0-985e-47f64e9fd1d9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_d00a9707-0b19-47b0-985e-47f64e9fd1d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e6ee703b-b273-4f67-9510-ea3e2dcbd1fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_e6ee703b-b273-4f67-9510-ea3e2dcbd1fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c6cc3df-55e2-4cd0-b8b9-7576a3c6741f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9c6cc3df-55e2-4cd0-b8b9-7576a3c6741f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_c916e4cb-335e-479d-96d9-167e9d4d35a3" xlink:href="jnj-20200628.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_990e1f81-62ad-4551-b134-a6bbbb1e2db6" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_c916e4cb-335e-479d-96d9-167e9d4d35a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_26339f72-ae53-4195-9e1d-b7899dfcec57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_26339f72-ae53-4195-9e1d-b7899dfcec57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_36efac13-59a5-4482-bd38-91134b70480b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_36efac13-59a5-4482-bd38-91134b70480b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_1b240080-6fe9-4ec1-bd99-1b9bd82805bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_1b240080-6fe9-4ec1-bd99-1b9bd82805bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4caf6b05-0cfc-4d44-9531-4dd68a81f212" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_4caf6b05-0cfc-4d44-9531-4dd68a81f212" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_67656b01-9364-4c61-a172-3b2ee426ae54" xlink:href="jnj-20200628.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_67656b01-9364-4c61-a172-3b2ee426ae54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_b99f0838-602e-46a6-9971-995134d7a46e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_b99f0838-602e-46a6-9971-995134d7a46e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cedb3867-a88a-4a36-b11e-fd36e209898d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_cedb3867-a88a-4a36-b11e-fd36e209898d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_00176c16-46f1-49b0-b9d3-f0195b40b952" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_97a697ff-eb09-47fd-a66d-ba3044192200" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_00176c16-46f1-49b0-b9d3-f0195b40b952" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7e3fb9be-2fdc-4bc6-ae03-dcabdab775ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_NetIncomeLoss_7e3fb9be-2fdc-4bc6-ae03-dcabdab775ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2d8300f0-4103-41a5-8e5a-26d306143eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2d8300f0-4103-41a5-8e5a-26d306143eb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_28409252-36aa-41b3-a712-bcb57aa9ab34" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_ShareBasedCompensation_28409252-36aa-41b3-a712-bcb57aa9ab34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_9e5e2c84-db11-4131-a78b-9e7b1f477344" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_AssetImpairmentCharges_9e5e2c84-db11-4131-a78b-9e7b1f477344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_428d858d-dbbf-4a81-84ea-7885a708b69a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_428d858d-dbbf-4a81-84ea-7885a708b69a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_8e2400f6-73cb-4306-960b-5c4d4ef0795f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_8e2400f6-73cb-4306-960b-5c4d4ef0795f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1b6a1f10-fc3d-4313-8498-60b96f2ce50f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_1b6a1f10-fc3d-4313-8498-60b96f2ce50f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_437d9f0a-4647-4c6c-bd55-516fcf00cb95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_437d9f0a-4647-4c6c-bd55-516fcf00cb95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9c20f0f6-f085-4bfe-9038-b3c070510024" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_9c20f0f6-f085-4bfe-9038-b3c070510024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9c0f6621-01bb-411c-b5cf-60b8923f804d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9c0f6621-01bb-411c-b5cf-60b8923f804d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94269824-ea7b-45b0-8331-761b13c0cd07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_94269824-ea7b-45b0-8331-761b13c0cd07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_130d9ea5-4d59-42f0-b12a-edcd8af73db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_130d9ea5-4d59-42f0-b12a-edcd8af73db7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0b3525da-31ed-457f-a7fc-a0faf966fa69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9d58dce2-46a2-4458-b5b0-b007bd0c12e2" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_0b3525da-31ed-457f-a7fc-a0faf966fa69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_0c8d8b1b-4a93-4b93-bf38-d1fa2d8de2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_8c17b587-9537-4a84-b057-5f9e4aceba3a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_0c8d8b1b-4a93-4b93-bf38-d1fa2d8de2b0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_8c17b587-9537-4a84-b057-5f9e4aceba3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_d0fd72de-47b0-4d8d-bb6e-e0a40a93e211" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_0c8d8b1b-4a93-4b93-bf38-d1fa2d8de2b0" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_d0fd72de-47b0-4d8d-bb6e-e0a40a93e211" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc09dc99-e393-4d2d-a593-11f45da918e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e79cc40e-a5ce-42fa-a85b-e52f6666bd99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc09dc99-e393-4d2d-a593-11f45da918e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e79cc40e-a5ce-42fa-a85b-e52f6666bd99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_697e26d8-7b8b-4312-af5d-41531545e2b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc09dc99-e393-4d2d-a593-11f45da918e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_697e26d8-7b8b-4312-af5d-41531545e2b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bfafec51-ce69-4c14-b460-bdd694e30cf4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc09dc99-e393-4d2d-a593-11f45da918e9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bfafec51-ce69-4c14-b460-bdd694e30cf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f7b3d315-9673-4253-b9cd-f81ce11d4c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_cc09dc99-e393-4d2d-a593-11f45da918e9" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_f7b3d315-9673-4253-b9cd-f81ce11d4c6b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200628.xsd#Inventories"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dbff9e0c-85e2-434e-94a2-b8eabdac742c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_31ca6504-e89a-4c3a-bf20-67153d39f270" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dbff9e0c-85e2-434e-94a2-b8eabdac742c" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_31ca6504-e89a-4c3a-bf20-67153d39f270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cb11fc75-c595-4f1f-9c4e-66e6d395bbaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dbff9e0c-85e2-434e-94a2-b8eabdac742c" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cb11fc75-c595-4f1f-9c4e-66e6d395bbaf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f769be3e-80fa-428a-bac0-1b6dba88d098" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_dbff9e0c-85e2-434e-94a2-b8eabdac742c" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_f769be3e-80fa-428a-bac0-1b6dba88d098" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwill"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58045c09-1709-4471-baf1-a9940c3e4e7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d4b77b17-92ee-4297-a0d8-13faae5504a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58045c09-1709-4471-baf1-a9940c3e4e7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d4b77b17-92ee-4297-a0d8-13faae5504a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a99ca40c-c262-4da2-b580-53e340a8fc8d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_58045c09-1709-4471-baf1-a9940c3e4e7a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_a99ca40c-c262-4da2-b580-53e340a8fc8d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsPolicies"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_f3da0c40-b665-4966-b651-6fd3b4d19d6a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a4378f24-99ba-49ef-8ef0-af1f04e707ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_f3da0c40-b665-4966-b651-6fd3b4d19d6a" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a4378f24-99ba-49ef-8ef0-af1f04e707ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6e271881-f66a-40c7-a8cc-7d0c066aeb25" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeAssets_f3da0c40-b665-4966-b651-6fd3b4d19d6a" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_6e271881-f66a-40c7-a8cc-7d0c066aeb25" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_95128e06-e415-4bc1-8e8c-4731e66cc255" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_305d4e7d-d161-4b4d-8ae2-cc2d6364503a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_95128e06-e415-4bc1-8e8c-4731e66cc255" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_305d4e7d-d161-4b4d-8ae2-cc2d6364503a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_59f96331-43e2-4b65-97a1-8a520a0ab92e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DerivativeLiabilities_95128e06-e415-4bc1-8e8c-4731e66cc255" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_59f96331-43e2-4b65-97a1-8a520a0ab92e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_699e7161-601a-4c43-96bd-8af301b9f6ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_37a29162-af23-44c6-a9f9-b427604945a1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_699e7161-601a-4c43-96bd-8af301b9f6ed" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_37a29162-af23-44c6-a9f9-b427604945a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_f27f3899-c86a-442e-bf45-655577415596" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_699e7161-601a-4c43-96bd-8af301b9f6ed" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_f27f3899-c86a-442e-bf45-655577415596" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_088dcc29-44e8-44d1-b63f-776964a6a81c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_HeldToMaturitySecurities_699e7161-601a-4c43-96bd-8af301b9f6ed" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_088dcc29-44e8-44d1-b63f-776964a6a81c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_214e6d82-502f-43e9-9ac5-226878b261b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a80308d9-43bd-492f-a5d7-dddf9bc7790a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_214e6d82-502f-43e9-9ac5-226878b261b2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_a80308d9-43bd-492f-a5d7-dddf9bc7790a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c43257d2-2ed9-46e6-bded-bd941d98d00a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_214e6d82-502f-43e9-9ac5-226878b261b2" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_c43257d2-2ed9-46e6-bded-bd941d98d00a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_96e9b449-82cb-4224-a319-d98f86c74e71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_214e6d82-502f-43e9-9ac5-226878b261b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_96e9b449-82cb-4224-a319-d98f86c74e71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d524012-04f7-4118-86a3-6b37c95379db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_d3472ef4-9096-41a6-bc89-c6169c04d3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d524012-04f7-4118-86a3-6b37c95379db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_d3472ef4-9096-41a6-bc89-c6169c04d3ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bbe888d8-4bfd-447b-b16e-8130271eb556" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d524012-04f7-4118-86a3-6b37c95379db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_bbe888d8-4bfd-447b-b16e-8130271eb556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_2083d30a-ae0b-466e-a215-4404d8d8c8b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_1d524012-04f7-4118-86a3-6b37c95379db" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_2083d30a-ae0b-466e-a215-4404d8d8c8b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c22c53bb-c714-4041-b0c3-3118e932f7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6d3904c8-3eea-475c-bece-3a7b165a43ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c22c53bb-c714-4041-b0c3-3118e932f7c9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_6d3904c8-3eea-475c-bece-3a7b165a43ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_dc43caea-7dbc-4135-92e6-9b080ca41ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c22c53bb-c714-4041-b0c3-3118e932f7c9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_dc43caea-7dbc-4135-92e6-9b080ca41ab5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_2aefb022-3721-49cd-b2f2-cbdb110cb3fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_c22c53bb-c714-4041-b0c3-3118e932f7c9" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_2aefb022-3721-49cd-b2f2-cbdb110cb3fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlans"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_b5d3ac29-c434-420a-b5e0-858533c3a288" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_b5d3ac29-c434-420a-b5e0-858533c3a288" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_c9280e9f-a781-4f46-bd03-8a42b495e807" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_c9280e9f-a781-4f46-bd03-8a42b495e807" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_94df5a77-7073-4175-b8e0-f4d4ff53e6f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_94df5a77-7073-4175-b8e0-f4d4ff53e6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_05142044-1af7-4047-90b3-8c064d819edf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_05142044-1af7-4047-90b3-8c064d819edf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_50639895-8738-4e4f-b361-37c8d7508f9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_50639895-8738-4e4f-b361-37c8d7508f9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_683c693d-ee4e-4d02-8fa1-9a12d7e116b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_a328dd29-1ddd-4787-a768-2597a1f11c3b" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_683c693d-ee4e-4d02-8fa1-9a12d7e116b9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShare"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69308d34-fa5f-437a-aa1d-08b628603c09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eab5362f-ef24-43b3-9d0f-acb9f706db54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69308d34-fa5f-437a-aa1d-08b628603c09" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_eab5362f-ef24-43b3-9d0f-acb9f706db54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_ec6d0b15-2771-45ac-aceb-a73d6ead39ac" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69308d34-fa5f-437a-aa1d-08b628603c09" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_ec6d0b15-2771-45ac-aceb-a73d6ead39ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7e953997-b121-414a-974e-eb7ea97a76c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69308d34-fa5f-437a-aa1d-08b628603c09" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_7e953997-b121-414a-974e-eb7ea97a76c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_03165a1a-cd42-4881-b3f9-8584325a195d" xlink:href="jnj-20200628.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_69308d34-fa5f-437a-aa1d-08b628603c09" xlink:to="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_03165a1a-cd42-4881-b3f9-8584325a195d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestitures"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedings"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedingsDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200628.xsd#Restructuring"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringTables"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:calculationLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>jnj-20200628_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200628.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended" id="i53c3b669d9a84abba7144b3bc8c2dd9c_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ee4d912f-81f5-457b-80fb-94be4304eb30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentType_ee4d912f-81f5-457b-80fb-94be4304eb30" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_13e03329-8781-4571-90c9-e3cce5f94971" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentQuarterlyReport_13e03329-8781-4571-90c9-e3cce5f94971" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3c5d587e-d0af-4114-b219-60e485e660fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentPeriodEndDate_3c5d587e-d0af-4114-b219-60e485e660fb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_06729276-8c64-4ccd-b882-529191bf420e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentTransitionReport_06729276-8c64-4ccd-b882-529191bf420e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0fa1764a-d017-4be8-8c4a-a214e7697090" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityFileNumber_0fa1764a-d017-4be8-8c4a-a214e7697090" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c5e3539e-574d-4043-af01-1c2ff943ca93" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityRegistrantName_c5e3539e-574d-4043-af01-1c2ff943ca93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e8d6896a-3ede-42ee-940a-36ec251fe24b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e8d6896a-3ede-42ee-940a-36ec251fe24b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6fa6618b-4051-462e-b862-0313ed8d373a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityTaxIdentificationNumber_6fa6618b-4051-462e-b862-0313ed8d373a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b4c55654-4536-429e-b329-e2a44625051d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressAddressLine1_b4c55654-4536-429e-b329-e2a44625051d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1dd7f33c-87ec-474a-a1c0-0f4ce9262753" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressCityOrTown_1dd7f33c-87ec-474a-a1c0-0f4ce9262753" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_913d4655-2681-4fb4-84cd-7038ad3f885e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressStateOrProvince_913d4655-2681-4fb4-84cd-7038ad3f885e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d72b2d5f-ef2d-456d-a520-af1f97d90457" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressPostalZipCode_d72b2d5f-ef2d-456d-a520-af1f97d90457" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9942e2b1-bcab-4ff2-90f0-404b4464b3be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_CityAreaCode_9942e2b1-bcab-4ff2-90f0-404b4464b3be" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d612f209-1927-410e-a7a5-cc8e20ec0f79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_LocalPhoneNumber_d612f209-1927-410e-a7a5-cc8e20ec0f79" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_89084bfd-2dd9-4331-a4df-1066ee07ea91" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCurrentReportingStatus_89084bfd-2dd9-4331-a4df-1066ee07ea91" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f6c52de2-d399-46e1-8c08-0f96292e41e1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityInteractiveDataCurrent_f6c52de2-d399-46e1-8c08-0f96292e41e1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cd94e94d-baf6-4c1f-8806-d9bee41091e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityFilerCategory_cd94e94d-baf6-4c1f-8806-d9bee41091e2" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_96e52be6-fa5b-40ed-bc3f-063d46558b03" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntitySmallBusiness_96e52be6-fa5b-40ed-bc3f-063d46558b03" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d302a1a2-9487-4a8c-a69d-0c5b85a5cbdb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityEmergingGrowthCompany_d302a1a2-9487-4a8c-a69d-0c5b85a5cbdb" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f9966c57-e9c4-434e-a91d-a298b39b5ecd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityShellCompany_f9966c57-e9c4-434e-a91d-a298b39b5ecd" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_92f0593e-b34b-4508-b04a-4f9c312583ec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_Security12bTitle_92f0593e-b34b-4508-b04a-4f9c312583ec" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7cdb9605-5130-4b4b-a83f-28797e69ec20" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_TradingSymbol_7cdb9605-5130-4b4b-a83f-28797e69ec20" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_69812fc9-0e33-4899-af6d-028a588889a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_SecurityExchangeName_69812fc9-0e33-4899-af6d-028a588889a1" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_345cf95c-1c7b-4264-9983-f9bd7ec33752" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_345cf95c-1c7b-4264-9983-f9bd7ec33752" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f0720dfb-5bea-439e-9f5a-4779ad6c0493" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCentralIndexKey_f0720dfb-5bea-439e-9f5a-4779ad6c0493" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6140b6bf-ed4a-4e37-9070-3562d2a9998b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_CurrentFiscalYearEndDate_6140b6bf-ed4a-4e37-9070-3562d2a9998b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_35bf3c20-ae6c-4af8-a7a4-489bcc9fb43c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentFiscalYearFocus_35bf3c20-ae6c-4af8-a7a4-489bcc9fb43c" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6aec9ecc-6e73-4c19-84fb-07b14bad29a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6aec9ecc-6e73-4c19-84fb-07b14bad29a1" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d3b6d64b-9694-4a07-87d6-ff8c89527b6f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_AmendmentFlag_d3b6d64b-9694-4a07-87d6-ff8c89527b6f" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:to="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_59641486-4a19-48cd-bebf-bef9668119c5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:to="loc_us-gaap_ClassOfStockDomain_59641486-4a19-48cd-bebf-bef9668119c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:to="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_49e01285-d1c2-4acc-a7ea-7f9a799cd346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_us-gaap_CommonStockMember_49e01285-d1c2-4acc-a7ea-7f9a799cd346" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_3d01c5c7-2292-453d-8c06-771976062a69" xlink:href="jnj-20200628.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A0.250NotesDue2022Member_3d01c5c7-2292-453d-8c06-771976062a69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_e2e80acc-d4ff-430a-a0bc-2765bd785588" xlink:href="jnj-20200628.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A0.650NotesDue2024Member_e2e80acc-d4ff-430a-a0bc-2765bd785588" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_547d66b8-ae5b-4716-afc7-0a02e3b68b43" xlink:href="jnj-20200628.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A5.50NotesDue2024Member_547d66b8-ae5b-4716-afc7-0a02e3b68b43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_062a2ffb-ac8f-4a76-9912-bd006d4100f1" xlink:href="jnj-20200628.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A1.150NotesDue2028Member_062a2ffb-ac8f-4a76-9912-bd006d4100f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_add1d691-d7a9-4020-9c4f-176f35938ac0" xlink:href="jnj-20200628.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A1.650NotesDue2035Member_add1d691-d7a9-4020-9c4f-176f35938ac0" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="i87cc24bcc040403a9f11c20ec0c5ec84_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i5f81f009ef2e42c3950dc783aaa7904f_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEarnings"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended" id="i3a5fdf8c4811463fb04d8cbcbff95542_ConsolidatedStatementsofEarnings"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended" id="ie9eb8861339f4a88b27f3c6e975b3eba_ConsolidatedStatementsofComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquity"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended" id="i3fea26c775724b02999dc5a3c7db0375_ConsolidatedStatementsofEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ba4000-2dc1-498b-9c9b-56a3958a7ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ba4000-2dc1-498b-9c9b-56a3958a7ca9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d86681c9-119c-48ed-a03b-6406109c3fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_NetIncomeLoss_d86681c9-119c-48ed-a03b-6406109c3fa4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b547d995-3532-492b-b240-835ff28d2823" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_DividendsCommonStockCash_b547d995-3532-492b-b240-835ff28d2823" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_e3e1b9c3-17f6-42b7-a6ef-87a5b9332bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_e3e1b9c3-17f6-42b7-a6ef-87a5b9332bc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0f64a8ea-b59b-4334-af92-174f45df1fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0f64a8ea-b59b-4334-af92-174f45df1fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_820c8381-b5aa-496e-8a48-712cfa2ba84a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockholdersEquityOther_820c8381-b5aa-496e-8a48-712cfa2ba84a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6e64c559-cff4-4213-89fa-d2029ec312c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6e64c559-cff4-4213-89fa-d2029ec312c0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ca7c28c-6461-4daa-829a-aba9a834fed3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b5163b00-5c30-409c-9234-f7f1cdf3ee71_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:to="loc_us-gaap_EquityComponentDomain_b5163b00-5c30-409c-9234-f7f1cdf3ee71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:to="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3092184d-ba49-469c-9826-34169e8f892f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_RetainedEarningsMember_3092184d-ba49-469c-9826-34169e8f892f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8e5c159-2357-4438-8ab4-8979ffbe4111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8e5c159-2357-4438-8ab4-8979ffbe4111" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_671bebe8-ab62-4c2f-b271-1ecfbbcaf40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_CommonStockMember_671bebe8-ab62-4c2f-b271-1ecfbbcaf40a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ad645463-9c04-4d73-b368-0dd584c253dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_TreasuryStockMember_ad645463-9c04-4d73-b368-0dd584c253dc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended" id="i0be9448c97674f8c82d9856a559ed30c_ConsolidatedStatementsofEquityParenthetical"/>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i4d13b9ed5e8640a39158159c18422a8b_ConsolidatedStatementsofCashFlows">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93a77ce4-9d4c-4bb3-887b-5b4668618d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_NetIncomeLoss_93a77ce4-9d4c-4bb3-887b-5b4668618d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9ffa15f8-dc6e-4297-801f-19ae22644970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9ffa15f8-dc6e-4297-801f-19ae22644970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_83bd2bab-40cc-41f7-a909-641df18e9f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_ShareBasedCompensation_83bd2bab-40cc-41f7-a909-641df18e9f1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1c798e10-23fb-44af-8051-f7648e975835" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_AssetImpairmentCharges_1c798e10-23fb-44af-8051-f7648e975835" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ecd204e8-fdcc-4ea0-b903-92bc979c5f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ecd204e8-fdcc-4ea0-b903-92bc979c5f73" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_491a9768-dec5-451c-81df-6f35f606db0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_491a9768-dec5-451c-81df-6f35f606db0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bfcb6812-50d7-4588-9bc5-1c86b595d89d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bfcb6812-50d7-4588-9bc5-1c86b595d89d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_be8de7fb-2474-4497-98a3-5b5066ee5c09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_be8de7fb-2474-4497-98a3-5b5066ee5c09" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e418e84-87b5-4d24-82ce-e569f95d1431" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e418e84-87b5-4d24-82ce-e569f95d1431" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_40d360f7-f415-45ab-8f15-df15e2ca9417" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_40d360f7-f415-45ab-8f15-df15e2ca9417" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a7559df4-5b21-4e26-ba06-10375dbf13fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a7559df4-5b21-4e26-ba06-10375dbf13fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5768504f-8d1c-4547-924a-03cfff56d605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5768504f-8d1c-4547-924a-03cfff56d605" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b7239138-c47a-4a99-9cf2-4c1b7ee7651d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b7239138-c47a-4a99-9cf2-4c1b7ee7651d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7f9910f8-78b5-45c0-ba3f-8e6a1a08ac6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7f9910f8-78b5-45c0-ba3f-8e6a1a08ac6d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0cd28e4b-81a3-472f-98c6-a52ba40f4319" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0cd28e4b-81a3-472f-98c6-a52ba40f4319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a9a2593a-8647-40e2-93ee-6c472e15f033" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a9a2593a-8647-40e2-93ee-6c472e15f033" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_977676c4-eeac-4287-ab91-78bc38f72841" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_977676c4-eeac-4287-ab91-78bc38f72841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0b27f3f7-f599-4ac1-b272-1dda0c4c2dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0b27f3f7-f599-4ac1-b272-1dda0c4c2dd4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_3008a807-498f-4369-a89f-b37a35289df5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_3008a807-498f-4369-a89f-b37a35289df5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_a0d35e4f-d347-42d6-9060-d2d14df7b7e7" xlink:href="jnj-20200628.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_a0d35e4f-d347-42d6-9060-d2d14df7b7e7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fbcd91ed-1b0e-49f6-a1e9-5cf7c1e8bfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fbcd91ed-1b0e-49f6-a1e9-5cf7c1e8bfb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_254f3c4d-c7d2-400e-993c-8e81dd5e1de8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_254f3c4d-c7d2-400e-993c-8e81dd5e1de8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_545c8d75-21ca-49f2-b836-ed752cba1cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_545c8d75-21ca-49f2-b836-ed752cba1cf6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fd8c06ff-b7bc-4b46-a35d-becf3a98d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fd8c06ff-b7bc-4b46-a35d-becf3a98d61b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_0d9153f3-5dc8-4b93-9579-30d342b91a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_0d9153f3-5dc8-4b93-9579-30d342b91a0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_e22c31d9-6661-44e6-8e4d-30409bca667f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_e22c31d9-6661-44e6-8e4d-30409bca667f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8f348547-4076-47a6-b6d2-777f5d093261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8f348547-4076-47a6-b6d2-777f5d093261" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_86d5d8ca-350c-4bc0-b3eb-5719f71a17e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_86d5d8ca-350c-4bc0-b3eb-5719f71a17e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_eed0c200-bc42-4c63-8b91-07df3f8f9b66" xlink:href="jnj-20200628.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_eed0c200-bc42-4c63-8b91-07df3f8f9b66" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd22775-8678-4df4-b879-92ec81659310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd22775-8678-4df4-b879-92ec81659310" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ca5d4d6-e1ff-4309-b165-963245fdc0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ca5d4d6-e1ff-4309-b165-963245fdc0aa" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a69c6de4-80ca-4b39-9f56-f279e2298399" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a69c6de4-80ca-4b39-9f56-f279e2298399" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a111669-372e-44b5-81b5-851582afc3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a111669-372e-44b5-81b5-851582afc3ab" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10e06175-78f4-4c08-bcc6-cb8677fe5a33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10e06175-78f4-4c08-bcc6-cb8677fe5a33" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8725547a-c5c7-4fd6-827a-3198b190ef1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_c823dec0-d06f-47cb-85e1-b65d054335c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_c823dec0-d06f-47cb-85e1-b65d054335c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c5e57226-e0f2-47cc-b294-a1eb79335a69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c5e57226-e0f2-47cc-b294-a1eb79335a69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_4e3bf6e2-8e9a-4898-86be-5468c255eb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_4e3bf6e2-8e9a-4898-86be-5468c255eb0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_2015ea64-58ee-48c6-aaa8-21eb7dceba22" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:to="loc_jnj_AurisHealthMember_2015ea64-58ee-48c6-aaa8-21eb7dceba22" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="i72c981cb3ad940e0b5413baf97c91ed0_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="i85b92f8996a5473495cfed678b9913a6_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200628.xsd#Inventories"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended" id="i23bda86b2df340a3aeae680e67595248_Inventories"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended" id="i6b6ef56429aa42e39456ade9a79c603a_InventoriesTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended" id="ida30a7f44cfd4208859c83ff7244f9a9_InventoriesDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwill"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended" id="i6d98bed1138a458394c1a9efb6ead410_IntangibleAssetsandGoodwill"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended" id="i877b40abf8124bcfbcc42e1b80db4651_IntangibleAssetsandGoodwillTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended" id="ic82fe3ed03d6419d89d4ea854c435de6_IntangibleAssetsandGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:href="jnj-20200628.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41f89579-ef43-4626-abe2-318851df8386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41f89579-ef43-4626-abe2-318851df8386" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d936c92d-a45f-4733-9620-450cddff9698" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d936c92d-a45f-4733-9620-450cddff9698" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c77ffa2c-f533-4adb-8103-7a2aadfd1664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c77ffa2c-f533-4adb-8103-7a2aadfd1664" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e05e2584-90f0-4f0a-aac2-40f6fc835191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e05e2584-90f0-4f0a-aac2-40f6fc835191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e7b14a8-ca31-4219-a88c-2d87db1d62ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e7b14a8-ca31-4219-a88c-2d87db1d62ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:href="jnj-20200628.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:to="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_3bc557df-9437-4fab-9f18-ed1cbe426d3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:to="loc_us-gaap_SegmentDomain_3bc557df-9437-4fab-9f18-ed1cbe426d3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:to="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_d517ba7c-d283-4557-9d72-5230ea1b60af" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:to="loc_jnj_ConsumerMember_d517ba7c-d283-4557-9d72-5230ea1b60af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_db6e6a14-c49f-40b1-b57e-296332b82d11" xlink:href="jnj-20200628.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:to="loc_jnj_PatentsAndTrademarksMember_db6e6a14-c49f-40b1-b57e-296332b82d11" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_391036a2-f3c6-4f4d-8a2a-7e84f8f3d592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_391036a2-f3c6-4f4d-8a2a-7e84f8f3d592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_08d4a412-5174-4026-93ab-35ecfbda6517_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_08d4a412-5174-4026-93ab-35ecfbda6517_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_20699dc1-d4d3-440f-931f-6ba576d8d036" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:to="loc_us-gaap_TrademarksMember_20699dc1-d4d3-440f-931f-6ba576d8d036" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_55713e92-9ac2-4a3f-bdbb-bdb4ae98110e" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_55713e92-9ac2-4a3f-bdbb-bdb4ae98110e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended" id="iab62568cf66d4345902f73d9444022dd_IntangibleAssetsandGoodwillGoodwillBySegmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:to="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0375a39c-4fe2-4c38-9c9d-90f180ae0083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_Goodwill_0375a39c-4fe2-4c38-9c9d-90f180ae0083" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc3ef733-be96-49a3-a39c-a202196b114c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc3ef733-be96-49a3-a39c-a202196b114c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_d312b71f-0017-41a3-9fbf-6749878ce0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_d312b71f-0017-41a3-9fbf-6749878ce0b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_90b01b6f-ddb0-426c-a88f-82fb31313aad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ec009341-f3a4-4294-9d2a-c3c95037b654_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:to="loc_us-gaap_SegmentDomain_ec009341-f3a4-4294-9d2a-c3c95037b654_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:to="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_7670b3d0-e7fd-495a-afb1-9e1905f86c3d" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_ConsumerMember_7670b3d0-e7fd-495a-afb1-9e1905f86c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_3b95fb34-4e43-4f45-bbc0-5d1046b3058c" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_PharmaceuticalMember_3b95fb34-4e43-4f45-bbc0-5d1046b3058c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_3b704c98-9ed6-4ecc-88ab-793568f7094a" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_MedicalDevicesMember_3b704c98-9ed6-4ecc-88ab-793568f7094a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended" id="ifdf36cd9c61e45149580db77aaa108e7_IntangibleAssetsandGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7647f18f-0c25-4aa8-b711-7bb4705d0f97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7647f18f-0c25-4aa8-b711-7bb4705d0f97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:href="jnj-20200628.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:to="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_79db928e-8de3-4752-b35d-058e73029a01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_79db928e-8de3-4752-b35d-058e73029a01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dea342e2-c25b-46f4-b7a8-5c4f4777cdc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dea342e2-c25b-46f4-b7a8-5c4f4777cdc5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8c7d1d76-53a6-4aea-a8e4-382f271109df_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8c7d1d76-53a6-4aea-a8e4-382f271109df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_ba5b8ad3-9e9e-4b87-8e35-fd1915f2d001" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_ba5b8ad3-9e9e-4b87-8e35-fd1915f2d001" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67643bb8-b9b5-4972-966e-ac3f9f3c6d01_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_67643bb8-b9b5-4972-966e-ac3f9f3c6d01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_b1ae6f4f-d1b8-4582-b65a-04e708a438e2" xlink:href="jnj-20200628.xsd#jnj_BermekimabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:to="loc_jnj_BermekimabMember_b1ae6f4f-d1b8-4582-b65a-04e708a438e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_69902d67-fa62-4500-8f19-0bf5023b9500" xlink:href="jnj-20200628.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:to="loc_jnj_VerbSurgicalInc.Member_69902d67-fa62-4500-8f19-0bf5023b9500" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e7e91ed-37cc-4240-b65e-3f2acedd0eda_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_7e7e91ed-37cc-4240-b65e-3f2acedd0eda_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_b568eef9-1959-458a-b352-86ccd39d33bf" xlink:href="jnj-20200628.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:to="loc_jnj_PatentsAndTrademarksMember_b568eef9-1959-458a-b352-86ccd39d33bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b42e8ac1-92c6-4087-98db-bfe3047f70dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b42e8ac1-92c6-4087-98db-bfe3047f70dd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended" id="ie04cf72bcb884f95a7839edd69fe01d9_IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended" id="i81ae0bc9e3dd46469c462786aec9c685_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsPolicies"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended" id="ia6e472e1ade1477ca4c2c9ff2285c27d_FairValueMeasurementsPolicies"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended" id="ia9705a1d943d4f269f2ad49c330dfcc0_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="if4a0b4fdbc674772aadcab6d2bcc94c3_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_e974bc7f-b6cb-47a4-9a22-e061075a9a93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_e974bc7f-b6cb-47a4-9a22-e061075a9a93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_129a45ba-8516-448c-bf91-f304511e658e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_129a45ba-8516-448c-bf91-f304511e658e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6d9c086a-8aa7-49e1-a7a8-cc6be66a781b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6d9c086a-8aa7-49e1-a7a8-cc6be66a781b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7f042b5d-d4b2-4d36-a0dd-cb50d61a781a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7f042b5d-d4b2-4d36-a0dd-cb50d61a781a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ad4b0388-a754-44f4-94bd-958a91463b78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ad4b0388-a754-44f4-94bd-958a91463b78" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_d6c90888-cbec-44d6-bcac-a020ad0789ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_d6c90888-cbec-44d6-bcac-a020ad0789ed" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_757a14ac-05ec-4953-ae68-9e66d8e533d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_757a14ac-05ec-4953-ae68-9e66d8e533d3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_37016dcb-2641-45b8-b750-5d68ed8ff872" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_37016dcb-2641-45b8-b750-5d68ed8ff872" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_d753d766-5789-436e-977d-b6924de71a16" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_d753d766-5789-436e-977d-b6924de71a16" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cfafbd2d-06be-4af3-ae78-a01f88823443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cfafbd2d-06be-4af3-ae78-a01f88823443" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_4359d97a-27c4-4545-a023-a45b1ce14901" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_4359d97a-27c4-4545-a023-a45b1ce14901" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_b498a38a-6e39-42f3-9d65-2979c35bb31a" xlink:href="jnj-20200628.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_b498a38a-6e39-42f3-9d65-2979c35bb31a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_582938d6-7508-449c-a10e-4a2e9ad1adc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_ShortTermBorrowings_582938d6-7508-449c-a10e-4a2e9ad1adc4" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_6206984b-2b2f-4f99-92e3-c417eabb38c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_6206984b-2b2f-4f99-92e3-c417eabb38c2" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e7a4f048-39e2-409e-a30e-55b84121ee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DebtInstrumentTerm_e7a4f048-39e2-409e-a30e-55b84121ee4f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_cf32bf38-9d9b-47d3-b621-bca9b46e79d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_cf32bf38-9d9b-47d3-b621-bca9b46e79d6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_71ddf894-8181-4127-8f4f-31914741c811" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_71ddf894-8181-4127-8f4f-31914741c811" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_08a68572-accf-4488-aed3-aa72bc6fa911" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_08a68572-accf-4488-aed3-aa72bc6fa911" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_bb3cc816-feaf-4b9f-a232-02c1f2856db0" xlink:href="jnj-20200628.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_bb3cc816-feaf-4b9f-a232-02c1f2856db0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_e362327a-aac5-451e-8c54-88283c5a05a0" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0778c0d7-5609-4b0f-b98c-1513c34aef9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0778c0d7-5609-4b0f-b98c-1513c34aef9f" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_e1d1853e-7b45-4b85-868b-278bea5249c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquityFairValueAdjustment_e1d1853e-7b45-4b85-868b-278bea5249c7" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_21bebbe9-6be8-454e-9465-e235a499dcb8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_21bebbe9-6be8-454e-9465-e235a499dcb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_76f6bf0b-be76-4e64-ac8a-07714acb4c77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:to="loc_us-gaap_FairValueHedgingMember_76f6bf0b-be76-4e64-ac8a-07714acb4c77" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1bdd90c7-0eb6-4cd6-bfbd-e76178b61fbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:to="loc_us-gaap_CashFlowHedgingMember_1bdd90c7-0eb6-4cd6-bfbd-e76178b61fbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6522fc02-b775-4695-ad04-b5e8c173e170_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6522fc02-b775-4695-ad04-b5e8c173e170_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_acfa42ff-1553-4357-9d6e-a7e55554a5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_SalesMember_acfa42ff-1553-4357-9d6e-a7e55554a5d2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_151b2c81-9ddb-4dae-aff7-112d8a96e844" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_CostOfSalesMember_151b2c81-9ddb-4dae-aff7-112d8a96e844" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c46557a9-65b1-4ab4-b776-4afefad6add4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c46557a9-65b1-4ab4-b776-4afefad6add4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_688bc158-3a22-4a56-ad1c-b05b51272d71" xlink:href="jnj-20200628.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_688bc158-3a22-4a56-ad1c-b05b51272d71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_4fc08c73-2228-4654-becd-f63fbaec5010" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_4fc08c73-2228-4654-becd-f63fbaec5010" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9edb7cec-3592-4255-b7f3-299eb185ae20_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:to="loc_us-gaap_EquityComponentDomain_9edb7cec-3592-4255-b7f3-299eb185ae20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:to="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_20dc3f4c-7fc4-4297-a39d-d77944da80b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:to="loc_us-gaap_RetainedEarningsMember_20dc3f4c-7fc4-4297-a39d-d77944da80b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_6feb48ab-26fb-4b27-9750-9de76df5e476_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_6feb48ab-26fb-4b27-9750-9de76df5e476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_7e45e2ff-5030-4531-970f-7646e5ecefb8" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_7e45e2ff-5030-4531-970f-7646e5ecefb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_d6275e24-8e1a-4aaa-b969-a382c135c1df" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_d6275e24-8e1a-4aaa-b969-a382c135c1df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_56e7d3ad-4e18-48cc-afde-e28b5e56e879_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_56e7d3ad-4e18-48cc-afde-e28b5e56e879_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_599b86e2-8a2f-4430-b2af-1635319b3136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:to="loc_us-gaap_EquitySecuritiesMember_599b86e2-8a2f-4430-b2af-1635319b3136" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_51dc7ead-4222-41d6-9bdc-7586d01c6b5e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_51dc7ead-4222-41d6-9bdc-7586d01c6b5e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_57d43c2a-04fc-4fc6-b1d6-e30f4f22d2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:to="loc_us-gaap_EquitySecuritiesMember_57d43c2a-04fc-4fc6-b1d6-e30f4f22d2e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_260a0393-e5dd-4c18-9931-b97ab3390347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_260a0393-e5dd-4c18-9931-b97ab3390347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_52c487aa-58ba-42d9-a6ad-8d13d972d37d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_52c487aa-58ba-42d9-a6ad-8d13d972d37d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_1e834693-6913-4c16-8bc3-b82fd31b7d51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_InterestRateContractMember_1e834693-6913-4c16-8bc3-b82fd31b7d51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_017633bb-da9f-4d60-904b-dc12153944f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:to="loc_us-gaap_CommercialPaperMember_017633bb-da9f-4d60-904b-dc12153944f1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended" id="id5cc8b4d42834fecbe1154955684bdfe_FairValueMeasurementsSummaryofDerivativeActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_71ea6982-2ff4-43a2-97b0-41d66ef32fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_71ea6982-2ff4-43a2-97b0-41d66ef32fc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_1ce7b6a4-eba9-4d40-b9d0-6328b7b8a9df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_1ce7b6a4-eba9-4d40-b9d0-6328b7b8a9df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_0ae911c1-7782-46c0-b10d-a8e6ffabf138" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_0ae911c1-7782-46c0-b10d-a8e6ffabf138" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_9fde248a-3c8d-4c76-a3f8-ac166b689ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_9fde248a-3c8d-4c76-a3f8-ac166b689ba9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc1fb967-5375-4049-b034-20d731716e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc1fb967-5375-4049-b034-20d731716e8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:href="jnj-20200628.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6e27cd38-fcff-4b3f-a117-982efb4d9172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6e27cd38-fcff-4b3f-a117-982efb4d9172" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef620e5f-4fc0-41df-8ccf-18b300ce0361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef620e5f-4fc0-41df-8ccf-18b300ce0361" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_b5b4f20e-9598-40a5-9e7e-e4fbc70a9bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_b5b4f20e-9598-40a5-9e7e-e4fbc70a9bf0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_2b10276a-f61e-4456-b86e-c281ed673168_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:to="loc_us-gaap_HedgingRelationshipDomain_2b10276a-f61e-4456-b86e-c281ed673168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d28d32af-4e1e-4505-b36f-1af29fae5fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:to="loc_us-gaap_FairValueHedgingMember_d28d32af-4e1e-4505-b36f-1af29fae5fb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2e72cb46-209e-4b5b-b888-2706ddf82d60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:to="loc_us-gaap_CashFlowHedgingMember_2e72cb46-209e-4b5b-b888-2706ddf82d60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_63ac1c0e-9662-45c6-82eb-5442936a802c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_63ac1c0e-9662-45c6-82eb-5442936a802c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_2b503dcb-4a09-4076-a702-f675681a6659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_InterestRateContractMember_2b503dcb-4a09-4076-a702-f675681a6659" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f1e999d2-ddbb-4594-b780-4f7894371660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f1e999d2-ddbb-4594-b780-4f7894371660" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_869b5384-b6e7-4e78-8626-1f4f62b5e483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_869b5384-b6e7-4e78-8626-1f4f62b5e483" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_28b3ab42-ef0d-4524-9e68-3b599b6bb804" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_SalesMember_28b3ab42-ef0d-4524-9e68-3b599b6bb804" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0cb3dabf-d745-43b6-8c5f-f6d3f6da70f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_CostOfSalesMember_0cb3dabf-d745-43b6-8c5f-f6d3f6da70f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_686ba221-d3e9-4e22-9519-b0a192cf3d57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_686ba221-d3e9-4e22-9519-b0a192cf3d57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_f8e1e647-ff34-4c8a-a5c0-c79f1e89e599" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_f8e1e647-ff34-4c8a-a5c0-c79f1e89e599" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_8f3d932f-a103-4a85-98dc-9da0bc62c363" xlink:href="jnj-20200628.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_8f3d932f-a103-4a85-98dc-9da0bc62c363" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended" id="iae461a96b7d64cc4820c2c89ef2f5491_FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended" id="ibcc489c603474020b11e59497096f192_FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9dd3d99f-c619-41ff-9424-7ee49d6b1e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9dd3d99f-c619-41ff-9424-7ee49d6b1e05" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28a26bc9-8351-4d6c-8f87-3dfeb0c0ea8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28a26bc9-8351-4d6c-8f87-3dfeb0c0ea8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_85b7b647-c628-4207-bccd-a54afb5d44d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:to="loc_us-gaap_HedgingDesignationDomain_85b7b647-c628-4207-bccd-a54afb5d44d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_372fc4f0-c86f-4552-b667-159d42a80506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:to="loc_us-gaap_NondesignatedMember_372fc4f0-c86f-4552-b667-159d42a80506" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_02dd5c8a-54b9-49e3-837a-8e000774e66d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_02dd5c8a-54b9-49e3-837a-8e000774e66d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_258c950f-9e61-4f0c-90e3-dc0b96d069fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_258c950f-9e61-4f0c-90e3-dc0b96d069fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_6537d475-caa4-4bb8-a1a7-b079dcd0abb5" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_6537d475-caa4-4bb8-a1a7-b079dcd0abb5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended" id="i29fc98605a364c57888661df3b02a2ad_FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ecfea513-dd1a-40d8-88fe-ff38db456584" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ecfea513-dd1a-40d8-88fe-ff38db456584" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6f634b84-757e-46ea-ae96-5184b9a0f668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6f634b84-757e-46ea-ae96-5184b9a0f668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_4ff317c4-bae3-4bf9-8b3c-602f63a3229a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_4ff317c4-bae3-4bf9-8b3c-602f63a3229a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8748b952-7493-47ef-9f4e-a7a53685f99c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8748b952-7493-47ef-9f4e-a7a53685f99c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_226c9444-bea0-4220-b0c7-5662afc3723e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_226c9444-bea0-4220-b0c7-5662afc3723e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_46e851e3-5446-4137-9e12-cbeeb043a15e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_46e851e3-5446-4137-9e12-cbeeb043a15e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember_fea5cddf-b006-4032-b904-2862aed412a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:to="loc_us-gaap_SaleOfSubsidiaryGainLossMember_fea5cddf-b006-4032-b904-2862aed412a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_d895f132-fb22-4de4-bf9b-70482cc39a9c" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_d895f132-fb22-4de4-bf9b-70482cc39a9c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended" id="i16b3f05ab4334c64b214f93917f94a7e_FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7b150c75-0795-4310-8015-d0892daa7b29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7b150c75-0795-4310-8015-d0892daa7b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:to="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_ff0c9358-4ace-4957-9660-271989061df8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_ff0c9358-4ace-4957-9660-271989061df8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c544580c-07ed-4118-acb6-2696fef22e73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c544580c-07ed-4118-acb6-2696fef22e73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_4353ac06-42ac-470d-ae82-4cd244ccf5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_EquityFairValueAdjustment_4353ac06-42ac-470d-ae82-4cd244ccf5a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_76292c77-6495-4cbf-a799-197536b9248a" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_76292c77-6495-4cbf-a799-197536b9248a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_d3255a21-2ce1-467c-b8c9-30857f0b8821" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1728d100-b582-4df4-bf79-36eaf214f321" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_02e43783-3377-4f53-aa9b-1943bc8ce2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_02e43783-3377-4f53-aa9b-1943bc8ce2c4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_91722f87-964c-4eba-8431-e8e4e4f48552_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_91722f87-964c-4eba-8431-e8e4e4f48552_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_28aabae0-cf02-40e3-a9d2-6f15c3968170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:to="loc_us-gaap_EquitySecuritiesMember_28aabae0-cf02-40e3-a9d2-6f15c3968170" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_a661157b-1776-4d1c-a168-c9e266d39ec2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_a661157b-1776-4d1c-a168-c9e266d39ec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_3270c8d4-60bb-45fd-8d18-0b9824c13637" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_3270c8d4-60bb-45fd-8d18-0b9824c13637" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_411be1f5-75d4-4037-81ac-7fab2520efc1" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_411be1f5-75d4-4037-81ac-7fab2520efc1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i0ed4a49051424f70a027233e0e85f4d2_FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3623cb60-d089-406e-adc6-9f9f01063b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3623cb60-d089-406e-adc6-9f9f01063b1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_1d6aeb6e-f3aa-4c43-a17e-1a6758f41908" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_1d6aeb6e-f3aa-4c43-a17e-1a6758f41908" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_a548c716-51ec-495b-8934-df10e83e1de6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_a548c716-51ec-495b-8934-df10e83e1de6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_e76f84f9-536c-4321-afdc-008d60172c61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_e76f84f9-536c-4321-afdc-008d60172c61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_349149eb-bdbb-46cc-bf97-8a9bb6a881ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_349149eb-bdbb-46cc-bf97-8a9bb6a881ca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cbfec3ed-ae99-4a1d-8ce7-628d98d03543" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cbfec3ed-ae99-4a1d-8ce7-628d98d03543" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11306cec-20fc-4903-bbda-8f2cfb6a2c84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11306cec-20fc-4903-bbda-8f2cfb6a2c84" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_c5c9fe33-57c1-4917-8f1b-5754431d7294" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_c5c9fe33-57c1-4917-8f1b-5754431d7294" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2967587d-f65b-4338-a5b1-d1bf4be7c805" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2967587d-f65b-4338-a5b1-d1bf4be7c805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ecf2c5f3-1d73-4375-be1c-bed677699bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ecf2c5f3-1d73-4375-be1c-bed677699bb6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_bd11ebf8-3ace-4126-a0c4-e2d1d561740a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeAssets_bd11ebf8-3ace-4126-a0c4-e2d1d561740a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac77d73d-d8fd-4bd6-bfdf-58d0163b640c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac77d73d-d8fd-4bd6-bfdf-58d0163b640c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_7c45459a-8abe-4358-bd63-b3da88945477" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_7c45459a-8abe-4358-bd63-b3da88945477" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_bb769c37-000f-48ac-9630-157ca4c94c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeLiabilities_bb769c37-000f-48ac-9630-157ca4c94c32" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2329ef41-1e8f-4a60-936d-2ad0540da0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2329ef41-1e8f-4a60-936d-2ad0540da0f6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_9d416236-4b78-4e14-86f9-519e05519fb2" xlink:href="jnj-20200628.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_9d416236-4b78-4e14-86f9-519e05519fb2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ba64977a-c38b-452e-a9ce-8ab019bd89d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ba64977a-c38b-452e-a9ce-8ab019bd89d0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_79e13090-164b-4e94-8641-d74bd945b18e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_79e13090-164b-4e94-8641-d74bd945b18e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b50151b2-f587-48cf-b2c1-4ac89736093e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbe3a504-7c20-4d47-87f6-6402847b90e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbe3a504-7c20-4d47-87f6-6402847b90e0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d62db13-92aa-4a05-86c6-8045e1918db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d62db13-92aa-4a05-86c6-8045e1918db7" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e1557c64-81ea-43e4-92d9-195af07a3da5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e1557c64-81ea-43e4-92d9-195af07a3da5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c27f4f31-fa2e-4a05-925c-1741fbb307f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c27f4f31-fa2e-4a05-925c-1741fbb307f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_516daff4-67ee-4633-81dd-dd4824190910" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_516daff4-67ee-4633-81dd-dd4824190910" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_da112e50-0b27-4ca9-90ea-6496a0f5bbff" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:to="loc_jnj_AurisHealthMember_da112e50-0b27-4ca9-90ea-6496a0f5bbff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_68f01373-73a7-460c-be88-fb0f5448058d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_68f01373-73a7-460c-be88-fb0f5448058d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_5ceeb052-e54f-4371-9c29-95178bf92073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:to="loc_us-gaap_EquitySecuritiesMember_5ceeb052-e54f-4371-9c29-95178bf92073" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e3871abb-5bb1-4195-bdf6-aed1721ca191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_InterestRateContractMember_e3871abb-5bb1-4195-bdf6-aed1721ca191" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_366348b1-ab2b-49b3-b653-3076afd4c122" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_366348b1-ab2b-49b3-b653-3076afd4c122" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_5db88a9e-b829-4b3f-a165-3baeb38cccef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_5db88a9e-b829-4b3f-a165-3baeb38cccef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6c186392-0bb7-43a6-9319-845573d4953e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6c186392-0bb7-43a6-9319-845573d4953e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7d61926-f862-4d75-bac4-399c3dc5b882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7d61926-f862-4d75-bac4-399c3dc5b882" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_85c0cc31-893b-4118-9e99-881d59bffe0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_85c0cc31-893b-4118-9e99-881d59bffe0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_53f09140-8825-4f56-8495-152eae5aa144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_53f09140-8825-4f56-8495-152eae5aa144" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended" id="i339839de5d4c410eb2c6bc2150148219_FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_f86f47e5-ca70-41f2-860e-c47d35ce4abf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecurities_f86f47e5-ca70-41f2-860e-c47d35ce4abf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_4ff23887-03c0-4db7-b140-cef7fc6d0d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_4ff23887-03c0-4db7-b140-cef7fc6d0d8f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_1ba14c86-8f02-4ef9-82ce-96928b7e989b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_1ba14c86-8f02-4ef9-82ce-96928b7e989b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_1c14f2b1-935e-48c9-aac0-7f08e31620b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_1c14f2b1-935e-48c9-aac0-7f08e31620b1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eaeaca0a-39d8-4de5-ad76-2af42fc7c935" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eaeaca0a-39d8-4de5-ad76-2af42fc7c935" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_26ed6180-9caa-4773-b332-aaac5d79de62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_26ed6180-9caa-4773-b332-aaac5d79de62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_efcf4f89-d801-4881-b57d-986fcd7360ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_efcf4f89-d801-4881-b57d-986fcd7360ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d43dbf7e-cfc3-4716-86f4-ee6aff41b89b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d43dbf7e-cfc3-4716-86f4-ee6aff41b89b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d6feb6f-336a-4e36-afa5-8ac8934e8eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d6feb6f-336a-4e36-afa5-8ac8934e8eb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_f9bcb68c-55c5-4a33-bfa8-7f11ae8b7347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_f9bcb68c-55c5-4a33-bfa8-7f11ae8b7347" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_157f46bf-9c24-4005-8226-dd3dbfa1761b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_157f46bf-9c24-4005-8226-dd3dbfa1761b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_40c79746-e7b9-40ab-9a20-5bf017e59867" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_40c79746-e7b9-40ab-9a20-5bf017e59867" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_6f53cdc4-bec2-49a3-9274-65dc65d5b389" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_6f53cdc4-bec2-49a3-9274-65dc65d5b389" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_c4944242-b092-4961-b054-d87b61a3a34f" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_c4944242-b092-4961-b054-d87b61a3a34f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember_0facb313-68e1-4a62-9d51-aab26a152cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesMember_0facb313-68e1-4a62-9d51-aab26a152cdb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_10cae258-74c0-4b08-b748-c0730d69e703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_10cae258-74c0-4b08-b748-c0730d69e703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:to="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_b6a064c8-f8d7-415b-af9d-deec6451b8fe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_b6a064c8-f8d7-415b-af9d-deec6451b8fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_163cb549-45db-43b0-82ac-b1a917d9734f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_CashMember_163cb549-45db-43b0-82ac-b1a917d9734f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_1e9ad00b-25b8-443f-907a-6de61830805e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_1e9ad00b-25b8-443f-907a-6de61830805e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_eafa7c98-4126-4dca-a014-6a84effe88e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_eafa7c98-4126-4dca-a014-6a84effe88e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember_6760de06-8560-4eef-afb5-1da33d47ab19" xlink:href="jnj-20200628.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_jnj_OtherReverseRepurchaseAgreementsMember_6760de06-8560-4eef-afb5-1da33d47ab19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c2366568-5e02-4c03-b92e-d77efd640f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c2366568-5e02-4c03-b92e-d77efd640f9c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_3f0a3c49-2e66-4b19-8d68-ceaa0427656d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_MoneyMarketFundsMember_3f0a3c49-2e66-4b19-8d68-ceaa0427656d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_2ecb920e-a479-4a12-af5a-ada84cb7ce7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_BankTimeDepositsMember_2ecb920e-a479-4a12-af5a-ada84cb7ce7d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_5c27643f-53ae-44b6-809a-904005a955aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_5c27643f-53ae-44b6-809a-904005a955aa" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended" id="i9d54d30321164f10a2f489f0c60d1306_FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended" id="ifd817679c67544158f58285146375881_FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d9572242-e38a-42cb-991d-a2771a80f36f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:to="loc_us-gaap_ShortTermBorrowings_d9572242-e38a-42cb-991d-a2771a80f36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2bf91155-77d0-4601-8ca6-fe368c2692b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2bf91155-77d0-4601-8ca6-fe368c2692b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7fcb0da9-af0f-48fb-a614-7e33d9b51404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7fcb0da9-af0f-48fb-a614-7e33d9b51404" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:to="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4ee172e3-8d30-4f37-84ca-d605939a0c07_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4ee172e3-8d30-4f37-84ca-d605939a0c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2021Member_3d6a8cc7-d3c1-46ba-8b54-73987a05041b" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.55Notesdue2021Member_3d6a8cc7-d3c1-46ba-8b54-73987a05041b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member_dd3c0e03-39ad-4e3d-a784-b8475578e012" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.45Notesdue2021Member_dd3c0e03-39ad-4e3d-a784-b8475578e012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_a980ef7e-faa1-4a0a-a923-1fe27b8cbb0b" xlink:href="jnj-20200628.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A0.250NotesDue2022Member_a980ef7e-faa1-4a0a-a923-1fe27b8cbb0b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member_e7f17059-60ef-4554-bc35-e37e9143de46" xlink:href="jnj-20200628.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.25Notesdue2022Member_e7f17059-60ef-4554-bc35-e37e9143de46" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member_9a85b95a-c924-4123-af8b-eaf89356bd47" xlink:href="jnj-20200628.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A6.73Debenturesdue2023Member_9a85b95a-c924-4123-af8b-eaf89356bd47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member_817a1156-fc82-45ef-ad05-414c0eb0bd1a" xlink:href="jnj-20200628.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.375Notesdue2023Member_817a1156-fc82-45ef-ad05-414c0eb0bd1a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member_a10d3ead-00ce-47ae-9440-dd3289bf00c9" xlink:href="jnj-20200628.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.05Notesdue2023Member_a10d3ead-00ce-47ae-9440-dd3289bf00c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_dc1ba1c8-8ec7-42ed-aa24-1cadf4384454" xlink:href="jnj-20200628.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A0.650NotesDue2024Member_dc1ba1c8-8ec7-42ed-aa24-1cadf4384454" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_11ec8de7-ba73-4260-8d0f-97d550f1f9b5" xlink:href="jnj-20200628.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.50NotesDue2024Member_11ec8de7-ba73-4260-8d0f-97d550f1f9b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member_a88585b8-867c-434e-97d4-09184b1063f6" xlink:href="jnj-20200628.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.625Notesdue2025Member_a88585b8-867c-434e-97d4-09184b1063f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member_0cbb5993-5dc2-401a-bf43-47da066f773a" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.45Notesdue2026Member_0cbb5993-5dc2-401a-bf43-47da066f773a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member_86c240d9-cd77-4cc9-b057-95796b9f074c" xlink:href="jnj-20200628.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.95Notesdue2027Member_86c240d9-cd77-4cc9-b057-95796b9f074c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member_7f9ff884-90cf-4cee-b1b1-6a06fd2570c6" xlink:href="jnj-20200628.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.900Notesdue2028Member_7f9ff884-90cf-4cee-b1b1-6a06fd2570c6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_67a76e9a-5ca1-40ed-a876-7769c7874980" xlink:href="jnj-20200628.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A1.150NotesDue2028Member_67a76e9a-5ca1-40ed-a876-7769c7874980" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member_b97bcc14-2f02-4570-9cec-a327c3f611f5" xlink:href="jnj-20200628.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A6.95Notesdue2029Member_b97bcc14-2f02-4570-9cec-a327c3f611f5" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member_77b27f9f-e965-42be-8051-ba8ee2346957" xlink:href="jnj-20200628.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.95Debenturesdue2033Member_77b27f9f-e965-42be-8051-ba8ee2346957" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member_6e789396-c022-4627-a700-10a1960d7df0" xlink:href="jnj-20200628.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.375Notesdue2033Member_6e789396-c022-4627-a700-10a1960d7df0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_b5597e98-f452-497a-bc3e-6ff2ae347844" xlink:href="jnj-20200628.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A1.650NotesDue2035Member_b5597e98-f452-497a-bc3e-6ff2ae347844" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member_24d2e6be-0ade-4528-a270-c85f8317db82" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.55Notesdue2036Member_24d2e6be-0ade-4528-a270-c85f8317db82" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member_76243a17-f342-4c47-bc97-80ed2bb4adae" xlink:href="jnj-20200628.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.95Notesdue2037Member_76243a17-f342-4c47-bc97-80ed2bb4adae" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member_57c76e3b-52ae-4535-9a08-530af3bc2529" xlink:href="jnj-20200628.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.625Notesdue2037Member_57c76e3b-52ae-4535-9a08-530af3bc2529" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member_ea30faf1-9936-4dcc-9591-12303067255c" xlink:href="jnj-20200628.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.400Notesdue2038Member_ea30faf1-9936-4dcc-9591-12303067255c" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member_60b4bf2c-098a-4b18-ad0f-5a5781f3e570" xlink:href="jnj-20200628.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.85Debenturesdue2038Member_60b4bf2c-098a-4b18-ad0f-5a5781f3e570" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member_98c1916a-5a70-4b94-a90c-32b72c30d54f" xlink:href="jnj-20200628.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.50Debenturesdue2040Member_98c1916a-5a70-4b94-a90c-32b72c30d54f" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member_adc11ca8-119e-4c6b-a693-f62ac8f44394" xlink:href="jnj-20200628.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.85Notesdue2041Member_adc11ca8-119e-4c6b-a693-f62ac8f44394" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member_0e5880e4-cad1-4ce5-9a82-b9da83cc62cd" xlink:href="jnj-20200628.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.50Notesdue2043Member_0e5880e4-cad1-4ce5-9a82-b9da83cc62cd" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member_109b0c0f-a1c2-4a86-9882-ad6b422034f0" xlink:href="jnj-20200628.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.70Notesdue2046Member_109b0c0f-a1c2-4a86-9882-ad6b422034f0" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member_fc32e829-249d-4b6a-956b-35ff4d7b4c33" xlink:href="jnj-20200628.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.75Notesdue2047Member_fc32e829-249d-4b6a-956b-35ff4d7b4c33" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member_000a0582-4804-4124-8c76-3dc4ad76507e" xlink:href="jnj-20200628.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.500Notesdue2048Member_000a0582-4804-4124-8c76-3dc4ad76507e" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember_809e7dc6-9785-40f0-924a-c77943fb2db5" xlink:href="jnj-20200628.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_NotesDuePeriodFifteenMember_809e7dc6-9785-40f0-924a-c77943fb2db5" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9111828f-4255-4fbc-88d3-b76b1345ab46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9111828f-4255-4fbc-88d3-b76b1345ab46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3bccf5a8-acd4-4d4c-a39f-c1b643ed44fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3bccf5a8-acd4-4d4c-a39f-c1b643ed44fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9b01ad2-af49-4d82-be47-4ee628bb941d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9b01ad2-af49-4d82-be47-4ee628bb941d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended" id="ib3458e81e2ca4cf2a039783d1329bd2c_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended" id="i03e060778a2f455284f564f28f9fccaf_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:to="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_66c93340-4152-453c-8821-d72a747656d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_66c93340-4152-453c-8821-d72a747656d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_2c21448e-bc63-47f4-9377-ae8222622050" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_2c21448e-bc63-47f4-9377-ae8222622050" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_a751824c-e087-417f-9ec9-c42dae48de04" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_a751824c-e087-417f-9ec9-c42dae48de04" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_4042990d-b9cd-4701-a3f5-6e5ea401f1bc" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_4042990d-b9cd-4701-a3f5-6e5ea401f1bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_befd5cbd-a598-4580-8cf5-6203992808ce" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_befd5cbd-a598-4580-8cf5-6203992808ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_98dfb3d5-1b77-41fd-93ed-830f50bcf06d" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_98dfb3d5-1b77-41fd-93ed-830f50bcf06d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_29a15b5c-6c4b-47fa-ba65-99226bff568b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_29a15b5c-6c4b-47fa-ba65-99226bff568b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_e5856dcc-d99f-43f0-b60b-9734070f1c20" xlink:href="jnj-20200628.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_e5856dcc-d99f-43f0-b60b-9734070f1c20" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_39398d13-cd8a-42b7-8077-f12c270032e9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_39398d13-cd8a-42b7-8077-f12c270032e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_db886452-541a-40b9-bd4b-b05abcd8f7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_db886452-541a-40b9-bd4b-b05abcd8f7a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_30e4641e-ddb9-410d-ae52-81dfe33db95c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_30e4641e-ddb9-410d-ae52-81dfe33db95c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember_51c7d081-f030-4240-99bf-d2a0e2f2468f" xlink:href="jnj-20200628.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:to="loc_jnj_AccruedTaxesOnIncomeMember_51c7d081-f030-4240-99bf-d2a0e2f2468f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:to="loc_srt_RangeMember_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:to="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f03c0195-62ca-44fa-83ea-5c2997c432d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:to="loc_srt_MinimumMember_f03c0195-62ca-44fa-83ea-5c2997c432d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df2f7884-8cf6-471a-a68b-4bf21e799daf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:to="loc_srt_MaximumMember_df2f7884-8cf6-471a-a68b-4bf21e799daf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_5ec3609d-2370-45a2-9004-a99645f0e5aa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_5ec3609d-2370-45a2-9004-a99645f0e5aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9a0449e5-42b2-4e47-a5f5-bb0e1ca9957d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9a0449e5-42b2-4e47-a5f5-bb0e1ca9957d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlans"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended" id="i6065c593db4d42c4b83f25f6368c1c4a_PensionsandOtherBenefitPlans"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended" id="i76b5658b946844c7af3dd435e3d54520_PensionsandOtherBenefitPlansTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended" id="ia7e6755405a54f80b1c1795e0d455acc_PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:to="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_59113ab2-02e4-4cad-a4a1-178bd1ba816e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_59113ab2-02e4-4cad-a4a1-178bd1ba816e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_194fdd4c-5869-4464-9e12-0d96ad4e2372" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_194fdd4c-5869-4464-9e12-0d96ad4e2372" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_799b3379-697b-43c3-9f04-7e36ebdb2c66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_799b3379-697b-43c3-9f04-7e36ebdb2c66" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5dcdca9b-e084-4805-9882-ea92ac706fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5dcdca9b-e084-4805-9882-ea92ac706fe0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4079cbf3-303f-41b3-9f14-85b36c3e056b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4079cbf3-303f-41b3-9f14-85b36c3e056b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_bd878621-371a-42e6-a60a-714e0eee7a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_bd878621-371a-42e6-a60a-714e0eee7a1c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_db572040-4905-4fa2-9338-480019054df9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_db572040-4905-4fa2-9338-480019054df9" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_430e196f-3533-4ea8-84bc-617d82e7fe20_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_430e196f-3533-4ea8-84bc-617d82e7fe20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_dfeedb67-b9c3-48de-9cb0-3ebf6e5e937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_dfeedb67-b9c3-48de-9cb0-3ebf6e5e937b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f4beb09d-84e2-4b32-8fd6-c34a3374a38b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f4beb09d-84e2-4b32-8fd6-c34a3374a38b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended" id="i86e3749deb5942af8d9326058d8b501d_PensionsandOtherBenefitPlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_72192edc-7003-429c-b7cf-625b4d8c2f75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:to="loc_us-gaap_PensionContributions_72192edc-7003-429c-b7cf-625b4d8c2f75" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_92fbe8e3-a6a5-4135-a0c3-364debe3c21f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_92fbe8e3-a6a5-4135-a0c3-364debe3c21f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_60aba2e1-aa1f-42c6-b006-b554a23959f4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:to="loc_country_US_60aba2e1-aa1f-42c6-b006-b554a23959f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_88fd85da-b703-4fa9-a5cc-6be65d3050a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:to="loc_us-gaap_ForeignPlanMember_88fd85da-b703-4fa9-a5cc-6be65d3050a5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended" id="ibf581270ff3f4455bf47d5024c697c86_AccumulatedOtherComprehensiveIncome"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended" id="if6189d9203fe4217ae66f9c12ab60b9f_AccumulatedOtherComprehensiveIncomeTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ic5227a00fd8c458cb4d0c997432d612e_AccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d843cea1-04c9-4ac9-a0d2-beaac7868c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d843cea1-04c9-4ac9-a0d2-beaac7868c7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f891dbc-4413-459c-8875-878a26b51d71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f891dbc-4413-459c-8875-878a26b51d71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d461db7-e657-46ed-8775-65fe64c6a970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:to="loc_us-gaap_EquityComponentDomain_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:to="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4d5c2bb2-dc8d-4e33-8440-a8d823a10263" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4d5c2bb2-dc8d-4e33-8440-a8d823a10263" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ddc85968-769f-4ec0-b889-67439f3b0363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ddc85968-769f-4ec0-b889-67439f3b0363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_75b44ff8-41db-4119-8bda-fcfb5fdebbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_75b44ff8-41db-4119-8bda-fcfb5fdebbc4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_daa6c7f1-c901-4680-99a5-32285623befc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_daa6c7f1-c901-4680-99a5-32285623befc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a5e06c3-c96c-4515-ac4a-e0cfd75da4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a5e06c3-c96c-4515-ac4a-e0cfd75da4a7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShare"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended" id="i44a30c0d82fe4b71adf3fb0dd3b36460_EarningsPerShare"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended" id="i7f04d964452c40e7b29f425b529b9952_EarningsPerShareTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended" id="i1b837241c0864635a867e4b7cab007e5_EarningsPerShareDetails"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended" id="i5de719014bfb4ebca031c3fd952c5c2d_SegmentsofBusinessandGeographicAreas"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended" id="if9f49e5c50d242509531a041aa1b2a11_SegmentsofBusinessandGeographicAreasTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended" id="ib8a05c0bb46a4f688a6ee010eb30cb02_SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28ad9496-7261-4e7d-a5f0-a09f8fc61f99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28ad9496-7261-4e7d-a5f0-a09f8fc61f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_7430b488-3056-4ec0-927a-150db7822599" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:to="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_7430b488-3056-4ec0-927a-150db7822599" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6d977e24-e20a-48cb-86b0-b0f6996f490b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_6d977e24-e20a-48cb-86b0-b0f6996f490b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_e62265fa-408b-4196-b398-4933d734e55d" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_e62265fa-408b-4196-b398-4933d734e55d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5de7662-5765-43b0-8396-24f13f7b26c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b5de7662-5765-43b0-8396-24f13f7b26c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53c9c0ae-664e-4b0d-9d33-3cb794b5f4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53c9c0ae-664e-4b0d-9d33-3cb794b5f4e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d9f176cb-dde3-43af-b635-35b3a1d057eb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:to="loc_us-gaap_SegmentDomain_d9f176cb-dde3-43af-b635-35b3a1d057eb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:to="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_ca70143f-c321-408b-b4ed-b6672ab890da" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_ConsumerMember_ca70143f-c321-408b-b4ed-b6672ab890da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_a3df2838-aaf9-4db2-b0cf-3fbd12f13caa" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_PharmaceuticalMember_a3df2838-aaf9-4db2-b0cf-3fbd12f13caa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_2e5f4d1c-c027-42c3-86f0-38a0cbb6752f" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_MedicalDevicesMember_2e5f4d1c-c027-42c3-86f0-38a0cbb6752f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_1bf003de-69a0-41c6-8ed5-30aec7536002_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:to="loc_us-gaap_SubsegmentsDomain_1bf003de-69a0-41c6-8ed5-30aec7536002_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:to="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember_e3529f94-6c83-4931-b6d4-d55c166094b7" xlink:href="jnj-20200628.xsd#jnj_ImmunologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_ImmunologyMember_e3529f94-6c83-4931-b6d4-d55c166094b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember_989a7f37-fb29-42b1-b2bb-e920c62ba27c" xlink:href="jnj-20200628.xsd#jnj_InfectiousDiseasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_InfectiousDiseasesMember_989a7f37-fb29-42b1-b2bb-e920c62ba27c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember_8de0ff8c-1182-4b04-b85b-61b007c281c5" xlink:href="jnj-20200628.xsd#jnj_NeuroscienceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_NeuroscienceMember_8de0ff8c-1182-4b04-b85b-61b007c281c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember_1f23c5ca-d530-4b71-8ed7-241a80dd73fd" xlink:href="jnj-20200628.xsd#jnj_OncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_OncologyMember_1f23c5ca-d530-4b71-8ed7-241a80dd73fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember_f72918f4-9681-4fec-b72c-34949af6e87a" xlink:href="jnj-20200628.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_PulmonaryHypertensionMember_f72918f4-9681-4fec-b72c-34949af6e87a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember_e13a0e5f-4a28-42d3-b721-66d48e16691c" xlink:href="jnj-20200628.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_CardiovascularMetabolismOtherMember_e13a0e5f-4a28-42d3-b721-66d48e16691c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember_331033b9-e4c2-4e38-980d-3a51d1f48a11" xlink:href="jnj-20200628.xsd#jnj_InterventionalSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_InterventionalSolutionsMember_331033b9-e4c2-4e38-980d-3a51d1f48a11" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember_8a7e8434-1474-4643-9173-ffc80f0d7bd8" xlink:href="jnj-20200628.xsd#jnj_OrthopaedicsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_OrthopaedicsMember_8a7e8434-1474-4643-9173-ffc80f0d7bd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember_b7b1bfbd-64ff-4e26-94f6-166fa3e73ac2" xlink:href="jnj-20200628.xsd#jnj_SurgeryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_SurgeryMember_b7b1bfbd-64ff-4e26-94f6-166fa3e73ac2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember_87fc43c2-b02a-4f32-91b4-b245fd7621a4" xlink:href="jnj-20200628.xsd#jnj_VisionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_VisionMember_87fc43c2-b02a-4f32-91b4-b245fd7621a4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b7305f49-755c-4fd3-a787-d0ee1c15367b_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:to="loc_srt_ProductsAndServicesDomain_b7305f49-755c-4fd3-a787-d0ee1c15367b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:to="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember_e229fa82-262f-4af4-b62d-ab5ee0f1df6c" xlink:href="jnj-20200628.xsd#jnj_BabyCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_BabyCareMember_e229fa82-262f-4af4-b62d-ab5ee0f1df6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember_06b2a3de-e2db-496e-8392-2248f66fe451" xlink:href="jnj-20200628.xsd#jnj_BeautyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_BeautyMember_06b2a3de-e2db-496e-8392-2248f66fe451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember_24d2ce1f-49ff-40a6-b7e9-883095e9b734" xlink:href="jnj-20200628.xsd#jnj_OralCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OralCareMember_24d2ce1f-49ff-40a6-b7e9-883095e9b734" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember_2b5393de-ab96-4d03-8a51-c56ba845d708" xlink:href="jnj-20200628.xsd#jnj_OTCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OTCMember_2b5393de-ab96-4d03-8a51-c56ba845d708" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember_2d0d2b61-2fc7-4890-bff0-3ebdeda707d0" xlink:href="jnj-20200628.xsd#jnj_WomensHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_WomensHealthMember_2d0d2b61-2fc7-4890-bff0-3ebdeda707d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember_18941cd3-af6a-465f-a2c6-5be6e19cafa1" xlink:href="jnj-20200628.xsd#jnj_WoundCareandOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_WoundCareandOtherMember_18941cd3-af6a-465f-a2c6-5be6e19cafa1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember_55adf570-111a-483b-b232-ff4c50f6f1cf" xlink:href="jnj-20200628.xsd#jnj_RemicadeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_RemicadeMember_55adf570-111a-483b-b232-ff4c50f6f1cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember_4672c845-e10c-4d8a-8854-f27a8a489015" xlink:href="jnj-20200628.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SimponiSimponiAriaMember_4672c845-e10c-4d8a-8854-f27a8a489015" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember_155e2f05-a378-4fc4-b300-e8f8035dd8d5" xlink:href="jnj-20200628.xsd#jnj_StelaraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_StelaraMember_155e2f05-a378-4fc4-b300-e8f8035dd8d5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember_9be98ccd-51cf-49e9-8f3a-fc390ffaa651" xlink:href="jnj-20200628.xsd#jnj_TremfyaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_TremfyaMember_9be98ccd-51cf-49e9-8f3a-fc390ffaa651" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember_18028826-fe98-4ac3-86f3-691c0eeac787" xlink:href="jnj-20200628.xsd#jnj_OtherImmunologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherImmunologyMember_18028826-fe98-4ac3-86f3-691c0eeac787" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember_b3b41667-0ff5-4d1e-b302-67eba46fef77" xlink:href="jnj-20200628.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_EDURANTrilpivirineMember_b3b41667-0ff5-4d1e-b302-67eba46fef77" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_acd6ef72-660c-4f7c-b718-6f9c7f2d2ea5" xlink:href="jnj-20200628.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_acd6ef72-660c-4f7c-b718-6f9c7f2d2ea5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember_8480ebfc-f975-47a9-89a9-4bbeb19dc75c" xlink:href="jnj-20200628.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherInfectiousDiseasesMember_8480ebfc-f975-47a9-89a9-4bbeb19dc75c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember_94b395b4-ba3b-4592-9cbf-25646b015998" xlink:href="jnj-20200628.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_CONCERTAMethylphenidateMember_94b395b4-ba3b-4592-9cbf-25646b015998" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_76d5913a-8506-412d-9a46-9030bc39eaf9" xlink:href="jnj-20200628.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_76d5913a-8506-412d-9a46-9030bc39eaf9" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember_810d7219-8f3c-4073-af47-a90c0d4ce554" xlink:href="jnj-20200628.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_RISPERDALCONSTAMember_810d7219-8f3c-4073-af47-a90c0d4ce554" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember_266f11f0-be12-4288-a3b2-67c1b0094cb4" xlink:href="jnj-20200628.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OTHERNEUROSCIENCEMember_266f11f0-be12-4288-a3b2-67c1b0094cb4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember_3f31b03f-86bf-4a7e-a024-125e1ecbbb99" xlink:href="jnj-20200628.xsd#jnj_DARZALEXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_DARZALEXMember_3f31b03f-86bf-4a7e-a024-125e1ecbbb99" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember_25633192-038d-42ab-a39f-55e8d7edf794" xlink:href="jnj-20200628.xsd#jnj_ERLEADAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ERLEADAMember_25633192-038d-42ab-a39f-55e8d7edf794" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember_9da44a7c-9dd8-435c-818d-e8f61bf82265" xlink:href="jnj-20200628.xsd#jnj_IMBRUVICAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_IMBRUVICAMember_9da44a7c-9dd8-435c-818d-e8f61bf82265" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember_2c119687-ee50-40bb-ba96-8e2a431a3c68" xlink:href="jnj-20200628.xsd#jnj_VELCADEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_VELCADEMember_2c119687-ee50-40bb-ba96-8e2a431a3c68" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember_8f1e1953-000f-4a35-be17-d6e646fa9f16" xlink:href="jnj-20200628.xsd#jnj_ZYTIGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ZYTIGAMember_8f1e1953-000f-4a35-be17-d6e646fa9f16" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember_0fb85af3-9c57-4b6c-9909-cab4c347cac2" xlink:href="jnj-20200628.xsd#jnj_OtherOncologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherOncologyMember_0fb85af3-9c57-4b6c-9909-cab4c347cac2" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember_e20d477d-ed3c-48e6-82fa-c56453867d3c" xlink:href="jnj-20200628.xsd#jnj_OPSUMITMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OPSUMITMember_e20d477d-ed3c-48e6-82fa-c56453867d3c" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember_dbdd6d28-041b-4a4f-b1b4-d2fc19a2262f" xlink:href="jnj-20200628.xsd#jnj_UPTRAVIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_UPTRAVIMember_dbdd6d28-041b-4a4f-b1b4-d2fc19a2262f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_5e384ca7-cf2f-49c2-b914-4eddb5b2a8a5" xlink:href="jnj-20200628.xsd#jnj_XareltoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_XareltoMember_5e384ca7-cf2f-49c2-b914-4eddb5b2a8a5" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember_1d7819f1-3a7c-4717-9b4c-f74f574c9bea" xlink:href="jnj-20200628.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_INVOKANAINVOKAMETMember_1d7819f1-3a7c-4717-9b4c-f74f574c9bea" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember_a94c4ee7-de68-42ad-a66d-5f704e8d2486" xlink:href="jnj-20200628.xsd#jnj_PROCRITEPREXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_PROCRITEPREXMember_a94c4ee7-de68-42ad-a66d-5f704e8d2486" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember_d417e220-032a-46aa-b99b-c8dc2055cb6c" xlink:href="jnj-20200628.xsd#jnj_OtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherMember_d417e220-032a-46aa-b99b-c8dc2055cb6c" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember_7e0e5274-b387-48ac-a932-6f884580551e" xlink:href="jnj-20200628.xsd#jnj_HIPSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_HIPSMember_7e0e5274-b387-48ac-a932-6f884580551e" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember_f247fda2-a1cf-4f06-908e-e8565f0e7cce" xlink:href="jnj-20200628.xsd#jnj_KNEESMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_KNEESMember_f247fda2-a1cf-4f06-908e-e8565f0e7cce" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember_cb9e3485-226d-4caf-8020-809d4c172712" xlink:href="jnj-20200628.xsd#jnj_TRAUMAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_TRAUMAMember_cb9e3485-226d-4caf-8020-809d4c172712" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember_93f906c6-7add-454c-8319-5217c2c1eafd" xlink:href="jnj-20200628.xsd#jnj_SPINEOTHERMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SPINEOTHERMember_93f906c6-7add-454c-8319-5217c2c1eafd" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember_e5588fda-2670-4603-bf62-2bc46d6476b1" xlink:href="jnj-20200628.xsd#jnj_ADVANCEDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ADVANCEDMember_e5588fda-2670-4603-bf62-2bc46d6476b1" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember_bef6d2b7-f61a-472e-b9b6-b30d5dccf8de" xlink:href="jnj-20200628.xsd#jnj_GENERALMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_GENERALMember_bef6d2b7-f61a-472e-b9b6-b30d5dccf8de" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember_5ca1d9de-b6c0-4887-81e7-a8a5c1c1c7f2" xlink:href="jnj-20200628.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_CONTACTLENSESOTHERMember_5ca1d9de-b6c0-4887-81e7-a8a5c1c1c7f2" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember_71ad3a6e-bb58-4b50-bb5a-439d60ee9224" xlink:href="jnj-20200628.xsd#jnj_SURGICALMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SURGICALMember_71ad3a6e-bb58-4b50-bb5a-439d60ee9224" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:to="loc_srt_SegmentGeographicalDomain_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:to="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d9f61e25-5af4-43da-9d8c-3b2f6bf0c913" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_country_US_d9f61e25-5af4-43da-9d8c-3b2f6bf0c913" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember_cb285d0b-fe78-403f-832b-59445120b968" xlink:href="jnj-20200628.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_jnj_UNITEDSTATESExportsMember_cb285d0b-fe78-403f-832b-59445120b968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9a9ee6d2-885a-46fe-b2db-a174115db2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_us-gaap_NonUsMember_9a9ee6d2-885a-46fe-b2db-a174115db2b2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended" id="i5f170f922a5c49ddaf8443603843fffc_SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_897bf334-45d3-472d-9578-1b61925a42ad" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_897bf334-45d3-472d-9578-1b61925a42ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96b5514a-c44c-4a46-b8d8-fea8e0298fba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96b5514a-c44c-4a46-b8d8-fea8e0298fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_503d6b09-d791-440a-b347-bd360d366043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_OperatingIncomeLoss_503d6b09-d791-440a-b347-bd360d366043" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss_b0a58fa5-e335-46a3-a56a-120d5092682b" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_jnj_PercentageChangeInOperatingIncomeLoss_b0a58fa5-e335-46a3-a56a-120d5092682b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_36c96118-4f45-49d3-a9a4-bc2f3753211d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_36c96118-4f45-49d3-a9a4-bc2f3753211d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d96c3773-fde7-4441-bb19-71b7355877b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_AdjustmentForAmortization_d96c3773-fde7-4441-bb19-71b7355877b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_92b9eff7-649e-47f3-a376-358076568c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_92b9eff7-649e-47f3-a376-358076568c1e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d1b6891-288b-4135-9802-cd0db865118a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d1b6891-288b-4135-9802-cd0db865118a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_288bec59-a125-4582-9daa-e466d72890b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_288bec59-a125-4582-9daa-e466d72890b1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_0210ef65-e324-41fa-936f-cb9cd8e4f5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_RestructuringCharges_0210ef65-e324-41fa-936f-cb9cd8e4f5c9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_db82d8e8-f1c4-4c6d-a467-ed6537d81fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_LitigationSettlementExpense_db82d8e8-f1c4-4c6d-a467-ed6537d81fcd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities_eefa13af-12f0-43b6-ab65-7821683920c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_UnrealizedGainLossOnSecurities_eefa13af-12f0-43b6-ab65-7821683920c2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ba67ecee-2efc-47c9-8756-b492663318de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ba67ecee-2efc-47c9-8756-b492663318de" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4d0e8c2a-2236-43f8-8266-aefdf3f64765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4d0e8c2a-2236-43f8-8266-aefdf3f64765" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_a8bde2f8-d0a0-466c-bfc5-7922edb32207" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:to="loc_us-gaap_OtherIncomeMember_a8bde2f8-d0a0-466c-bfc5-7922edb32207" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_b92a7b2a-c359-4c50-90fb-7faa06822cf3" xlink:href="jnj-20200628.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_b92a7b2a-c359-4c50-90fb-7faa06822cf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7a7d6fca-c393-4256-8126-62fb12cb45d8_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:to="loc_srt_SegmentGeographicalDomain_7a7d6fca-c393-4256-8126-62fb12cb45d8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:to="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0f332966-deee-458b-9c92-3550e43dd494" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_country_US_0f332966-deee-458b-9c92-3550e43dd494" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_67155a69-dd73-4409-bb2f-f4657b28bb1c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_srt_EuropeMember_67155a69-dd73-4409-bb2f-f4657b28bb1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_08b02f7c-2d2d-4532-88a3-805ac16dea9e" xlink:href="jnj-20200628.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_08b02f7c-2d2d-4532-88a3-805ac16dea9e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_c925394d-0166-4e49-92bb-262538f2538e" xlink:href="jnj-20200628.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_jnj_AsiaPacificAfricaMember_c925394d-0166-4e49-92bb-262538f2538e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a52bd032-dfb1-4ba2-9989-77f7fd1b3676_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_a52bd032-dfb1-4ba2-9989-77f7fd1b3676_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_bb230d9c-23ad-430e-8341-e2dd64f9576f" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_bb230d9c-23ad-430e-8341-e2dd64f9576f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f0b16d5-2b05-47d6-a705-247c9c065b7f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5f0b16d5-2b05-47d6-a705-247c9c065b7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_2c9d99d8-4940-401c-9fc5-aace99509fd1" xlink:href="jnj-20200628.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_2c9d99d8-4940-401c-9fc5-aace99509fd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_5cd33bec-fdbc-47ee-9a4e-4701d7a553c1" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:to="loc_jnj_AurisHealthMember_5cd33bec-fdbc-47ee-9a4e-4701d7a553c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b39727dd-f33a-4869-81fb-f5c1c8c78a44_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:to="loc_srt_ConsolidationItemsDomain_b39727dd-f33a-4869-81fb-f5c1c8c78a44_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:to="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e8acf0ff-5fc2-419a-b252-8341a329294c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:to="loc_us-gaap_OperatingSegmentsMember_e8acf0ff-5fc2-419a-b252-8341a329294c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_53a4d45d-dc7c-4c27-9a7b-8978398a8560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:to="loc_us-gaap_CorporateNonSegmentMember_53a4d45d-dc7c-4c27-9a7b-8978398a8560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c3911ace-e654-4422-8755-520726bae56f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:to="loc_us-gaap_SegmentDomain_c3911ace-e654-4422-8755-520726bae56f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:to="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_f9acf6f0-da53-42be-9130-8604df306b40" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_ConsumerMember_f9acf6f0-da53-42be-9130-8604df306b40" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_c27301d5-53f0-4325-8a38-5445f59f43b7" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_PharmaceuticalMember_c27301d5-53f0-4325-8a38-5445f59f43b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_d431c764-ca66-42e5-84dd-9fb96fcab42d" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_MedicalDevicesMember_d431c764-ca66-42e5-84dd-9fb96fcab42d" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended" id="i4fa07a026f054b7a93bb778109ba379e_SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc32c2a-f735-4098-a025-09813dadb82d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc32c2a-f735-4098-a025-09813dadb82d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_3c7b44cc-a040-4f5b-853c-9809086f00e7" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_3c7b44cc-a040-4f5b-853c-9809086f00e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:to="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7886d37f-d361-46b5-9a2f-9b9e6024b36c_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:to="loc_srt_SegmentGeographicalDomain_7886d37f-d361-46b5-9a2f-9b9e6024b36c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:to="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3cc8c408-9904-428a-bfb8-ed99b6dd391b" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_country_US_3cc8c408-9904-428a-bfb8-ed99b6dd391b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_317f7588-4821-4a24-b264-14b40113ca15" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_srt_EuropeMember_317f7588-4821-4a24-b264-14b40113ca15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_aff16ce3-cd82-4764-aa81-8a8def4cabe3" xlink:href="jnj-20200628.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_aff16ce3-cd82-4764-aa81-8a8def4cabe3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_3da9a160-8b3d-4d85-b1b8-9a8825c2e677" xlink:href="jnj-20200628.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_jnj_AsiaPacificAfricaMember_3da9a160-8b3d-4d85-b1b8-9a8825c2e677" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestitures"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended" id="iafd45d06f1694e51baca4e3dfce33104_BusinessCombinationsandDivestitures"/>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended" id="i17f45f1786dc44679d24783075678875_BusinessCombinationsandDivestituresNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7ef685c2-02c6-4c0e-9b12-6739c0d8fa0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7ef685c2-02c6-4c0e-9b12-6739c0d8fa0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_766725d4-e2e7-4836-ab75-57ac21c90c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_766725d4-e2e7-4836-ab75-57ac21c90c0c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_e0575c63-17c4-4e3b-a3b8-963337eea230" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_e0575c63-17c4-4e3b-a3b8-963337eea230" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8d55cb31-7f83-4e38-9616-23194ab1e1d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8d55cb31-7f83-4e38-9616-23194ab1e1d7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_0b1d37b6-5902-4675-be6c-4a6359846a32" xlink:href="jnj-20200628.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_0b1d37b6-5902-4675-be6c-4a6359846a32" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_08f2a115-d2dd-4b5f-a091-0174cda2d2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_08f2a115-d2dd-4b5f-a091-0174cda2d2a9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d08b43eb-26e9-4228-ae6e-96aa711b38f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_LongTermDebt_d08b43eb-26e9-4228-ae6e-96aa711b38f3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b04ef9ae-a325-452a-a350-f157cbea690c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b04ef9ae-a325-452a-a350-f157cbea690c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eb11ca7-a2b4-4629-944b-94b0f139a153" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eb11ca7-a2b4-4629-944b-94b0f139a153" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3fac7b67-9fd5-422a-879c-7ece822d7f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3fac7b67-9fd5-422a-879c-7ece822d7f8c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1e92ce7-50af-4b2e-8676-1a9118f8f20a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_Goodwill_b1e92ce7-50af-4b2e-8676-1a9118f8f20a" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_44717a4c-3082-494c-962e-ad3f7dc4d575" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_44717a4c-3082-494c-962e-ad3f7dc4d575" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5016d6c9-95c0-4603-96bb-069e977333c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5016d6c9-95c0-4603-96bb-069e977333c7" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9ad4f614-99a1-4d19-a0ab-57f56f140687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9ad4f614-99a1-4d19-a0ab-57f56f140687" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_b692a410-b9e7-4484-b92d-35e2bae374be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_b692a410-b9e7-4484-b92d-35e2bae374be" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_f1e93963-e166-482c-8e8a-06c54f0898e1" xlink:href="jnj-20200628.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_f1e93963-e166-482c-8e8a-06c54f0898e1" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_25e97d9b-796f-48b8-a8eb-79c0ece3e4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_25e97d9b-796f-48b8-a8eb-79c0ece3e4bc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_f5e61097-2e39-4f45-86f9-dac09c4154f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_f5e61097-2e39-4f45-86f9-dac09c4154f6" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e0244f2a-eed8-4045-b474-eed14708d7de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e0244f2a-eed8-4045-b474-eed14708d7de" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_2a6223e3-09b1-4d9b-ad9a-f0ae81833d20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_2a6223e3-09b1-4d9b-ad9a-f0ae81833d20" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7fc9001e-a569-42d2-b7a3-4b6dc63f5a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7fc9001e-a569-42d2-b7a3-4b6dc63f5a5b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d713e81a-0e59-446f-95ec-7d0a1f5dc522" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d713e81a-0e59-446f-95ec-7d0a1f5dc522" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_54286414-dc5f-4731-af7f-2949254f6d29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_54286414-dc5f-4731-af7f-2949254f6d29" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_11f9ef60-f0f3-4780-868e-7f67b7042ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_11f9ef60-f0f3-4780-868e-7f67b7042ad0" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_a5255ecc-7d1c-4b20-852e-dddf7cfa3265" xlink:href="jnj-20200628.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_a5255ecc-7d1c-4b20-852e-dddf7cfa3265" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4a0db71c-0ef2-4356-93e1-9ab16d6c61f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4a0db71c-0ef2-4356-93e1-9ab16d6c61f3" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d65591e0-a1d2-4a41-94b8-555bee2de4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d65591e0-a1d2-4a41-94b8-555bee2de4dc" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_1c4a3b95-8ab9-4d20-90a8-81e754afc35b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_1c4a3b95-8ab9-4d20-90a8-81e754afc35b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_0e3b74aa-5e29-4ca9-8516-a3b235c4e636" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:to="loc_us-gaap_OtherIncomeMember_0e3b74aa-5e29-4ca9-8516-a3b235c4e636" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_df5d3a81-6a02-42e2-a791-a1d12155465b" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:to="loc_jnj_IdorsiaLTDMember_df5d3a81-6a02-42e2-a791-a1d12155465b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c59b5dce-c558-4876-9094-6cda5049a93f_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:to="loc_srt_RangeMember_c59b5dce-c558-4876-9094-6cda5049a93f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:to="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2524765d-62d0-44ca-abdf-6e58db8a6330" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:to="loc_srt_MinimumMember_2524765d-62d0-44ca-abdf-6e58db8a6330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d656573b-22ba-44f2-bc66-5a625344fbbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:to="loc_srt_MaximumMember_d656573b-22ba-44f2-bc66-5a625344fbbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_f6d9f583-13b8-4d39-84fd-425ad4c566e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_f6d9f583-13b8-4d39-84fd-425ad4c566e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_128da415-d5d3-4a4e-bd8f-dfdf0b328f43" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_SupplyChainMember_128da415-d5d3-4a4e-bd8f-dfdf0b328f43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_65bcf343-dc60-41c9-9ad4-5c1bd10853e3" xlink:href="jnj-20200628.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_65bcf343-dc60-41c9-9ad4-5c1bd10853e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_005ab70b-ab49-416f-befd-3b66bb0b2680" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_IdorsiaLTDMember_005ab70b-ab49-416f-befd-3b66bb0b2680" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_126680a4-650d-4d84-953b-2329c18225c9_default" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:to="loc_dei_EntityDomain_126680a4-650d-4d84-953b-2329c18225c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:to="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_d75fd8af-282f-4940-9ee7-d3608d5d0212" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:to="loc_jnj_IdorsiaLTDMember_d75fd8af-282f-4940-9ee7-d3608d5d0212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c15ce87-f08d-4be1-825a-b69323350c81_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c15ce87-f08d-4be1-825a-b69323350c81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_325bab94-184e-420d-b583-dadf2c38304b" xlink:href="jnj-20200628.xsd#jnj_BermekimabMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_BermekimabMember_325bab94-184e-420d-b583-dadf2c38304b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_38bbff04-00b1-4865-9b76-8924f983a4de" xlink:href="jnj-20200628.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_VerbSurgicalInc.Member_38bbff04-00b1-4865-9b76-8924f983a4de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_1b9cd84b-1e0a-4170-8ae8-576c3b087513" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_AurisHealthMember_1b9cd84b-1e0a-4170-8ae8-576c3b087513" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_824ee6b7-4f1a-46a6-84dd-345cb0d0b085" xlink:href="jnj-20200628.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_824ee6b7-4f1a-46a6-84dd-345cb0d0b085" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_46b08b03-225c-4522-981a-11ac1d126fcc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_46b08b03-225c-4522-981a-11ac1d126fcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e3cec6bc-d135-4bb5-940f-be824fd827e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:to="loc_us-gaap_ConvertibleDebtMember_e3cec6bc-d135-4bb5-940f-be824fd827e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_66959686-dc67-4cdf-a782-453a26bf4a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:to="loc_us-gaap_LineOfCreditMember_66959686-dc67-4cdf-a782-453a26bf4a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_a5b888fa-bd86-47fa-a444-3529443e6147_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:to="loc_us-gaap_CreditFacilityDomain_a5b888fa-bd86-47fa-a444-3529443e6147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:to="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_de11137c-96ef-45e9-a65a-1d7b41ec542b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_de11137c-96ef-45e9-a65a-1d7b41ec542b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_e98abd30-e248-49a5-aae1-81a3b1e5d720_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_e98abd30-e248-49a5-aae1-81a3b1e5d720_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_8306d22a-8ee0-45f7-ad2c-53bebdd6776c" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:to="loc_jnj_IdorsiaLTDMember_8306d22a-8ee0-45f7-ad2c-53bebdd6776c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_729e653b-8efc-43d8-ba70-0350bf1bee67_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_729e653b-8efc-43d8-ba70-0350bf1bee67_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0f988a21-0432-46e9-8d1b-6ff812ca77b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0f988a21-0432-46e9-8d1b-6ff812ca77b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6450ca59-a1a7-4a92-9317-18c34c6c7a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6450ca59-a1a7-4a92-9317-18c34c6c7a2e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_261316eb-830e-472f-8465-d85d88bb0894" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d55f20e5-b71b-421a-9cbd-abdad9b0babe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_261316eb-830e-472f-8465-d85d88bb0894" xlink:to="loc_us-gaap_SubsequentEventMember_d55f20e5-b71b-421a-9cbd-abdad9b0babe" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedings"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended" id="i1cc8a134380b4d428c17b034889a1959_LegalProceedings"/>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedingsDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended" id="ic6da540a928a400aa2e3b096ec6ee8b4_LegalProceedingsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:href="jnj-20200628.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:to="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_fe133ca2-94b8-4bfb-8ef9-9bbc9ebc07cf" xlink:href="jnj-20200628.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_fe133ca2-94b8-4bfb-8ef9-9bbc9ebc07cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement_30b93e12-c0c3-4fba-989c-ebe9bd9e1b7a" xlink:href="jnj-20200628.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_Numberofpatientsinsettlement_30b93e12-c0c3-4fba-989c-ebe9bd9e1b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_219757c6-3982-4864-96e7-762680ba0eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_219757c6-3982-4864-96e7-762680ba0eb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_aa5414a6-7457-43b0-8c2e-57bcb0ec481e" xlink:href="jnj-20200628.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_aa5414a6-7457-43b0-8c2e-57bcb0ec481e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6da5cc58-85c3-4fb4-817f-0f72f220e095" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6da5cc58-85c3-4fb4-817f-0f72f220e095" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:to="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_eef34dd1-6fea-4872-a685-c179ff84ba2f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:to="loc_us-gaap_SegmentDomain_eef34dd1-6fea-4872-a685-c179ff84ba2f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:to="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_cb1b6663-44d9-4d7b-a5eb-0fd91f465aac" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:to="loc_jnj_MedicalDevicesMember_cb1b6663-44d9-4d7b-a5eb-0fd91f465aac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_8dcb97db-833b-42e5-89fa-7600c816fd28_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:to="loc_srt_LitigationCaseTypeDomain_8dcb97db-833b-42e5-89fa-7600c816fd28_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:to="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member_45323b0c-dabd-478b-a731-0ee9df4a7661" xlink:href="jnj-20200628.xsd#jnj_DePuyASRU.S.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_DePuyASRU.S.Member_45323b0c-dabd-478b-a731-0ee9df4a7661" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_f469585a-221b-41b1-8de2-64ae1cc49a60" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_RisperdalMember_f469585a-221b-41b1-8de2-64ae1cc49a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember_32877245-8dad-4095-8774-9ffe0118e3ea" xlink:href="jnj-20200628.xsd#jnj_BabyPowderMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_BabyPowderMember_32877245-8dad-4095-8774-9ffe0118e3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_02b69a4e-80b4-455f-bf69-66839339be1c" xlink:href="jnj-20200628.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_02b69a4e-80b4-455f-bf69-66839339be1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_aeb6b01a-aecb-4875-b686-e4947a0e9836_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:to="loc_us-gaap_LitigationStatusDomain_aeb6b01a-aecb-4875-b686-e4947a0e9836_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:to="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b891b37b-28e2-459c-b27c-d36cbf8af21b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_SettledLitigationMember_b891b37b-28e2-459c-b27c-d36cbf8af21b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_19f31cb4-ada5-4af0-8bb9-bd11f6f1be65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_JudicialRulingMember_19f31cb4-ada5-4af0-8bb9-bd11f6f1be65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_7fd07691-9cfe-4f62-8ea6-b705804bc69f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_PendingLitigationMember_7fd07691-9cfe-4f62-8ea6-b705804bc69f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9f5039fb-6016-4702-81aa-72001d333e81_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:to="loc_srt_ProductsAndServicesDomain_9f5039fb-6016-4702-81aa-72001d333e81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:to="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember_6a5463c2-287d-40b7-a62e-2f293d9fe5f9" xlink:href="jnj-20200628.xsd#jnj_AsrMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_AsrMember_6a5463c2-287d-40b7-a62e-2f293d9fe5f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember_d3336c2e-1f93-4ae7-8f25-bff8682ef13a" xlink:href="jnj-20200628.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PinnacleAcetabularCupSystemMember_d3336c2e-1f93-4ae7-8f25-bff8682ef13a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember_f0a8b24a-dc8c-40c7-9ae9-1a41cef9daa1" xlink:href="jnj-20200628.xsd#jnj_PelvicMeshesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PelvicMeshesMember_f0a8b24a-dc8c-40c7-9ae9-1a41cef9daa1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_bd6e066c-a629-476f-ae26-1dddb48bed27" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_RisperdalMember_bd6e066c-a629-476f-ae26-1dddb48bed27" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_83254946-692d-4676-897f-f9a1426e0d1f" xlink:href="jnj-20200628.xsd#jnj_XareltoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_XareltoMember_83254946-692d-4676-897f-f9a1426e0d1f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember_a7873f2c-08ab-4014-9a18-05490026d712" xlink:href="jnj-20200628.xsd#jnj_TalcMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_TalcMember_a7873f2c-08ab-4014-9a18-05490026d712" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember_c38c1270-c46f-4f27-8295-2fbd085a80d6" xlink:href="jnj-20200628.xsd#jnj_InvokanaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_InvokanaMember_c38c1270-c46f-4f27-8295-2fbd085a80d6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember_f8e25d2d-c36c-4317-95b7-ad2ea954afb6" xlink:href="jnj-20200628.xsd#jnj_PhysiomeshMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PhysiomeshMember_f8e25d2d-c36c-4317-95b7-ad2ea954afb6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember_09df8106-cc9e-4aa9-b31a-f4d52327ebcd" xlink:href="jnj-20200628.xsd#jnj_OpioidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_OpioidMember_09df8106-cc9e-4aa9-b31a-f4d52327ebcd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_2bd54d57-9946-4e3a-a921-c82b5652eae7_default" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_2bd54d57-9946-4e3a-a921-c82b5652eae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_1730e759-52e7-4bff-8cb5-840a213ad152" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:to="loc_jnj_RisperdalMember_1730e759-52e7-4bff-8cb5-840a213ad152" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200628.xsd#Restructuring"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended" id="icb221befb0e148ad9b65e77303bf8a62_Restructuring"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringTables"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended" id="i4e4762107b1d40cab7c5fba9c7bc5e5a_RestructuringTables"/>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended" id="i0eb76bb215dc4c3eb7b3863a1c6706e4_RestructuringNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_97562f7a-8f89-43da-8370-dec354b996bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringCharges_97562f7a-8f89-43da-8370-dec354b996bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ee77f7d3-65f1-4358-89d3-9288f84668b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ee77f7d3-65f1-4358-89d3-9288f84668b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a5123e79-657a-4a30-966a-14a8ed4d56ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a5123e79-657a-4a30-966a-14a8ed4d56ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_3c02f677-225d-4aef-ade3-d5876fcafce5" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_3c02f677-225d-4aef-ade3-d5876fcafce5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_878e3b79-7ca6-4937-92ac-1e333c554c9b" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_878e3b79-7ca6-4937-92ac-1e333c554c9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_62dfce87-5b55-4301-96db-6c0f8ac3962b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_62dfce87-5b55-4301-96db-6c0f8ac3962b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_474ba678-f4e6-442d-9801-5c168f11f365" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:to="loc_jnj_SupplyChainMember_474ba678-f4e6-442d-9801-5c168f11f365" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9cbe79d3-51c0-46d1-a4f9-d9a920508a05_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:to="loc_us-gaap_SegmentDomain_9cbe79d3-51c0-46d1-a4f9-d9a920508a05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:to="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_91f8ae23-595c-43df-946d-97001dcff019" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:to="loc_jnj_MedicalDevicesMember_91f8ae23-595c-43df-946d-97001dcff019" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_3d45d8e4-829e-4bb7-886b-d63b8db68adf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:to="loc_us-gaap_RestructuringPlanDomain_3d45d8e4-829e-4bb7-886b-d63b8db68adf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:to="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_15beab2c-1c6c-4d5f-9adc-fa762444e930" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:to="loc_jnj_SupplyChainMember_15beab2c-1c6c-4d5f-9adc-fa762444e930" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_976a13e0-5148-4ebc-b19f-69aafbce12e7" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:to="loc_jnj_MedicalDevicesMember_976a13e0-5148-4ebc-b19f-69aafbce12e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_42a659f2-d315-44e7-a050-e446429ea003_default" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:to="loc_srt_RangeMember_42a659f2-d315-44e7-a050-e446429ea003_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:to="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_be0d3b9b-4229-4198-8184-046eb2013f87" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:to="loc_srt_MinimumMember_be0d3b9b-4229-4198-8184-046eb2013f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73fb41a7-e82a-4de5-bbc4-987b03ff5e2b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:to="loc_srt_MaximumMember_73fb41a7-e82a-4de5-bbc4-987b03ff5e2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_75675baa-2cf6-427a-b869-89eb415bde40_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_75675baa-2cf6-427a-b869-89eb415bde40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ef152160-699d-4bef-99d2-4b550eac5fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_us-gaap_RestructuringChargesMember_ef152160-699d-4bef-99d2-4b550eac5fd6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_140783f9-7a99-405f-ae54-8028aea912e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_us-gaap_CostOfSalesMember_140783f9-7a99-405f-ae54-8028aea912e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_9775f827-4c77-411a-8b7c-d4b1b649e388" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_9775f827-4c77-411a-8b7c-d4b1b649e388" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:definitionLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended" id="ib16319ca1cdf4afda2b7ff5a4cc3fcda_RestructuringScheduleofRestructuringReserveDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d071563a-7086-4646-a40f-36b5760928f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringReserve_d071563a-7086-4646-a40f-36b5760928f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b96eeed0-9767-419e-bb73-7c75f12420f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringCharges_b96eeed0-9767-419e-bb73-7c75f12420f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_c262f4b1-6cb7-4800-9a6b-c788da6aabf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_PaymentsForRestructuring_c262f4b1-6cb7-4800-9a6b-c788da6aabf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fcca2da3-d7ae-47ad-88c7-efcfbd852533" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fcca2da3-d7ae-47ad-88c7-efcfbd852533" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f776b909-0d7d-4647-b7ac-2a7012128f79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_9d95477c-2cef-4e96-af2d-9b208e2d0e9d" xlink:href="jnj-20200628.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:to="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_9d95477c-2cef-4e96-af2d-9b208e2d0e9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:to="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_a73d6a39-7edd-4d58-aedf-1696ff91cc90_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:to="loc_us-gaap_RestructuringPlanDomain_a73d6a39-7edd-4d58-aedf-1696ff91cc90_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:to="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_89504eb9-0feb-4150-8592-9ac0b812a9e6" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:to="loc_jnj_MedicalDevicesMember_89504eb9-0feb-4150-8592-9ac0b812a9e6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_6cde83b0-7b25-4265-98a6-01e5ae8c6b99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_6cde83b0-7b25-4265-98a6-01e5ae8c6b99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c8fd5144-63f0-4a0a-a4ae-c776b4de0392" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c8fd5144-63f0-4a0a-a4ae-c776b4de0392" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember_7f8169a5-7c69-4540-80bb-c0dd908964a1" xlink:href="jnj-20200628.xsd#jnj_AssetWriteoffMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_jnj_AssetWriteoffMember_7f8169a5-7c69-4540-80bb-c0dd908964a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_e95d8f18-41f0-4ec3-84e0-d5c9a70c7516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_us-gaap_OtherRestructuringMember_e95d8f18-41f0-4ec3-84e0-d5c9a70c7516" xlink:type="arc" order="2"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>jnj-20200628_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4e5f6030-3998-41da-a27b-de2d0f53921d_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_e4893a6d-6b18-4583-a2e0-4312ebc2786e_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_aca21f4c-a979-4788-9429-5bb4a62525db_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_282c06cd-3db5-4e63-9ae8-a4095a05b756_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant unobservable inputs Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_9ae5ae28-271c-405f-aef4-c49fef239e95_terseLabel_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI</link:label>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_label_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]</link:label>
    <link:label id="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_documentation_en-US" xlink:label="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:href="jnj-20200628.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:to="lab_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BabyPowderMember_23747d6a-d846-4aa9-81f4-0ed3af64c72a_terseLabel_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder</link:label>
    <link:label id="lab_jnj_BabyPowderMember_label_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder [Member]</link:label>
    <link:label id="lab_jnj_BabyPowderMember_documentation_en-US" xlink:label="lab_jnj_BabyPowderMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Powder [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember" xlink:href="jnj-20200628.xsd#jnj_BabyPowderMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BabyPowderMember" xlink:to="lab_jnj_BabyPowderMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_22eac509-94fd-4f01-a48a-65d1de627794_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration reversal</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_162580ef-f882-48f3-a8bb-bf4746728048_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_a6876904-c1a0-4809-b735-ddee3c2ea6d5_negatedTerseLabel_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reversal of contingent consideration</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_544dddb7-58af-4d16-9534-954e454d7dcd_terseLabel_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in estimated fair value (7)</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_label_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</link:label>
    <link:label id="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_documentation_en-US" xlink:label="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:href="jnj-20200628.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:to="lab_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_afce4918-3cf5-476e-8d36-6390f55a24c6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_5303cf3f-c0a7-4a89-92c0-d841ba64259d_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_6b93e17a-fd70-46f7-bc37-9b63a47c97d7_terseLabel_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period for activity</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_label_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Duration of Restructuring Plan</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_documentation_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Duration of Restructuring Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:to="lab_jnj_RestructuringandRelatedCostDurationofRestructuringPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_9e11ca54-ff46-4e24-b4b4-f6d01a287a94_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ConsumerMember_5da4f668-6778-43ac-8d06-78be62803eac_terseLabel_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Health*</link:label>
    <link:label id="lab_jnj_ConsumerMember_label_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer [Member]</link:label>
    <link:label id="lab_jnj_ConsumerMember_documentation_en-US" xlink:label="lab_jnj_ConsumerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ConsumerMember" xlink:to="lab_jnj_ConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DARZALEXMember_119672e2-4b87-48b6-98d9-8e2cde2d2a8b_terseLabel_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX&#174;</link:label>
    <link:label id="lab_jnj_DARZALEXMember_label_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX [Member]</link:label>
    <link:label id="lab_jnj_DARZALEXMember_documentation_en-US" xlink:label="lab_jnj_DARZALEXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DARZALEX [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember" xlink:href="jnj-20200628.xsd#jnj_DARZALEXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DARZALEXMember" xlink:to="lab_jnj_DARZALEXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_e11d16a9-af7f-4dae-870c-abfcc83c47d1_totalLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities - Carrying Amount</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecurities_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecurities" xlink:to="lab_us-gaap_HeldToMaturitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_183b202e-014d-4b8c-a16b-bcf3ac4bd761_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain from divestiture of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_3f886274-7a64-44ef-8c38-672455ba485c_terseLabel_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-U.S. sovereign securities(1)</link:label>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:to="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_21c3317a-1174-4729-a9e5-a2f296600c5a_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_caf08ed7-7dc8-4462-997b-31a9bc9b73f5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ADVANCEDMember_e291e535-ed2c-4e6a-9eb7-a6c5541c6fbc_terseLabel_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED</link:label>
    <link:label id="lab_jnj_ADVANCEDMember_label_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED [Member]</link:label>
    <link:label id="lab_jnj_ADVANCEDMember_documentation_en-US" xlink:label="lab_jnj_ADVANCEDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ADVANCED [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember" xlink:href="jnj-20200628.xsd#jnj_ADVANCEDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ADVANCEDMember" xlink:to="lab_jnj_ADVANCEDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_d06095a2-f63c-4f2f-b7dd-30b879ee9f3f_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_75c8b90d-dba4-4a25-ab29-7e83e7f4d5f0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_092a02f7-ad1a-47ff-8f3e-691b82b25358_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, related to acquisitions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_9354090d-d805-48c6-b4d9-f56c9c0ebf68_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanInterestCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Interest Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanInterestCost" xlink:to="lab_us-gaap_DefinedBenefitPlanInterestCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_5740cab0-5e9b-486f-b77e-13e80bee67bf_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments : Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Assets, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_71ddc9aa-0564-4c2d-b457-328a1e81af04_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_709299ea-7dbe-4f34-b268-95339f54448e_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Operating Income Loss</link:label>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_label_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change in Operating Income Loss</link:label>
    <link:label id="lab_jnj_PercentageChangeInOperatingIncomeLoss_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in operating income loss.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInOperatingIncomeLoss" xlink:to="lab_jnj_PercentageChangeInOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0b32fc2f-7ad9-49d5-9d28-3f53cadf3270_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards Recently Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_93bf1db3-6912-478e-9da8-ae834d642960_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_f9608da2-b0b5-4d6a-ad74-ccfaaca4e4db_totalLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:to="lab_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ded73e86-783f-4faa-b94b-36fb4e392b15_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_e357ee37-7fe7-4c42-9a54-dddc42972909_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfRestructuringDomain_label_en-US" xlink:label="lab_us-gaap_TypeOfRestructuringDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Restructuring [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRestructuringDomain" xlink:to="lab_us-gaap_TypeOfRestructuringDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_faf12369-17d9-46a9-85e5-402768d3069c_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected return on plan assets</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Expected Return (Loss) on Plan Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:to="lab_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_a65823b9-aa30-45f6-8c3f-c468b9153caf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_080d7515-f56b-49e4-a585-083537c5a7f5_terseLabel_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047</link:label>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_label_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047 [Member]</link:label>
    <link:label id="lab_jnj_A3.75Notesdue2047Member_documentation_en-US" xlink:label="lab_jnj_A3.75Notesdue2047Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.75% Notes due 2047 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member" xlink:href="jnj-20200628.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.75Notesdue2047Member" xlink:to="lab_jnj_A3.75Notesdue2047Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_2262d651-77bc-44bb-8097-22a37950b3d1_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesCurrent" xlink:to="lab_us-gaap_MarketableSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_62e03e1f-b05c-4333-a3c8-32cf54cf1a0c_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d345f16-14e0-46aa-944b-5e86f03004ae_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average shares outstanding &#8212; diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9add0a0a-1c08-4737-8d5f-576cb0fabfe1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_7292015c-c83b-49f3-8d71-9ea72ddb6fb6_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of net periodic benefit cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:to="lab_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_99189c25-7799-4463-bdc7-3c1542b27583_verboseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_e874925e-ea85-4244-9c4e-e74f26794aa6_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain" xlink:to="lab_us-gaap_ShortTermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_b080c241-c560-43f0-9e29-9481809d5e99_terseLabel_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES / OTHER</link:label>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_label_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES/OTHER [Member]</link:label>
    <link:label id="lab_jnj_CONTACTLENSESOTHERMember_documentation_en-US" xlink:label="lab_jnj_CONTACTLENSESOTHERMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONTACT LENSES/OTHER [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember" xlink:href="jnj-20200628.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CONTACTLENSESOTHERMember" xlink:to="lab_jnj_CONTACTLENSESOTHERMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_87c93c9a-c38c-4717-8a96-9a48e4feca68_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available for Sale Securities Maturities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_49be20dd-132d-48a2-997a-e4fd4e9fb33e_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_4fc74a62-d76c-4ed9-adb8-652fa2949483_negatedTerseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Unrecognized Loss</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:to="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_c2ce04fb-d457-4237-b1e8-5bd6ed35a7b4_negatedTerseLabel_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: shares which could be repurchased under treasury stock method</link:label>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_label_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Which Could Be Repurchased Under Treasury Stock Method</link:label>
    <link:label id="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_documentation_en-US" xlink:label="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:href="jnj-20200628.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:to="lab_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_7275c1a4-44da-4f1d-bf54-5ee089af9623_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_HIPSMember_b3560c3a-d2d4-4d84-b4da-96227e777a85_terseLabel_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS</link:label>
    <link:label id="lab_jnj_HIPSMember_label_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS [Member]</link:label>
    <link:label id="lab_jnj_HIPSMember_documentation_en-US" xlink:label="lab_jnj_HIPSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HIPS [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember" xlink:href="jnj-20200628.xsd#jnj_HIPSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_HIPSMember" xlink:to="lab_jnj_HIPSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_33485ce0-60c8-47b6-a4dc-8659f592ec42_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a36c70e3-e005-4933-a533-64f2273c711e_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_575f9159-50b3-4880-8061-60e9107fc230_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_43185c90-81b8-4347-8b30-7ac959457dd9_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign exchange contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_9df02f91-c9a2-4394-96f9-f186aa6f65e1_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_2c9416aa-1a3c-47d4-bcf6-25a0f4023579_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives &amp; Hedges</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a05ee0a6-ded5-4693-b0ed-1de89951ecfe_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_78412a79-5a13-4c87-b4df-4a8e18916c36_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_53ee480d-f382-4371-b8b0-5ffdf278d1c6_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_871aee70-87ec-4347-8a21-fb9f4360a82c_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_484351e7-c1c8-41d1-8641-9a6d036c6c83_negatedLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_d95b2ca8-57a8-4623-8f34-289ad84f873b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_681947d3-3998-47c7-b54e-aab09624eb71_verboseLabel_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due May 2035</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_4e8fcdf6-02d3-4fa4-93b5-a0bff39ec2c1_terseLabel_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes due 2035 (1.5B Euro 1.1217)</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_label_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due 2035 [Member]</link:label>
    <link:label id="lab_jnj_A1.650NotesDue2035Member_documentation_en-US" xlink:label="lab_jnj_A1.650NotesDue2035Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.650% Notes Due 2035 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member" xlink:href="jnj-20200628.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A1.650NotesDue2035Member" xlink:to="lab_jnj_A1.650NotesDue2035Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_bacc561f-98f6-426b-a6d3-f508a9457f47_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_d2e85c3f-978d-4a2b-9319-95ac98cc2183_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_46531d45-3243-4f7b-96c7-41c5390d9952_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_020de0ba-443b-45ad-9c75-856bb283efcf_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of basic net earnings per share to diluted net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_7cd804d3-aa2a-459f-b48d-4de356df1811_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_9f7d0d24-b8a9-4298-a802-9573014b4a81_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentRollForward_44765f72-fd3e-4beb-ab4d-44c186641e56_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:label id="lab_jnj_EquityInvestmentRollForward_label_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:label id="lab_jnj_EquityInvestmentRollForward_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investment [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentRollForward" xlink:to="lab_jnj_EquityInvestmentRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_646b72e4-64cb-4ba5-a447-5ff8801c297b_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages awarded</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesAwardedValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Awarded, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesAwardedValue" xlink:to="lab_us-gaap_LossContingencyDamagesAwardedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_be67d8ca-47ed-4f1b-a9c6-3a94be30e1e6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_4f9fe305-b08e-478b-8c60-c63e083549b9_terseLabel_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE</link:label>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_label_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE [Member]</link:label>
    <link:label id="lab_jnj_OTHERNEUROSCIENCEMember_documentation_en-US" xlink:label="lab_jnj_OTHERNEUROSCIENCEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER NEUROSCIENCE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember" xlink:href="jnj-20200628.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OTHERNEUROSCIENCEMember" xlink:to="lab_jnj_OTHERNEUROSCIENCEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignPlanMember_a60c5329-7116-4408-a3a7-d90047417811_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International retirement plans</link:label>
    <link:label id="lab_us-gaap_ForeignPlanMember_label_en-US" xlink:label="lab_us-gaap_ForeignPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignPlanMember" xlink:to="lab_us-gaap_ForeignPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_ffbc913e-a08a-43bd-9c55-5573c44144f6_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_2bb02e9c-b5c5-4584-8fd3-16da0a07d573_negatedLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed and noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_b45a5921-ee93-43ac-8645-114624be5a37_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_bebc8995-e45b-495e-8e60-99cbd1c38914_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term taxes payable (Note 5)</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Income Taxes, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_77fe23c7-44c3-4cc9-bb4f-fdf7bd4c4cf1_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_49d1f0a7-1736-4e2d-91c1-a53984eacaae_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_5136667c-0f0a-4f69-bb39-eb61a1d23d1d_terseLabel_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements, net</link:label>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_label_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements</link:label>
    <link:label id="lab_jnj_Proceedsfromcreditsupportagreements_documentation_en-US" xlink:label="lab_jnj_Proceedsfromcreditsupportagreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from credit support agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements" xlink:href="jnj-20200628.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Proceedsfromcreditsupportagreements" xlink:to="lab_jnj_Proceedsfromcreditsupportagreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_af79e17c-5526-47e0-a042-547d4b6fb2cd_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial assets and liabilities at fair value</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentDetailAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument Detail [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentDetailAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PhysiomeshMember_69c6e1a3-77f8-4baa-87c9-3df31eb7b9d7_terseLabel_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh</link:label>
    <link:label id="lab_jnj_PhysiomeshMember_label_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh [Member]</link:label>
    <link:label id="lab_jnj_PhysiomeshMember_documentation_en-US" xlink:label="lab_jnj_PhysiomeshMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Physiomesh [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember" xlink:href="jnj-20200628.xsd#jnj_PhysiomeshMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PhysiomeshMember" xlink:to="lab_jnj_PhysiomeshMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_1214f2a6-092a-42ff-b1fd-3b17fc603bb9_verboseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross currency interest rate swaps</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_2b722b87-1084-43d4-bd31-0d25a1558452_terseLabel_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_CrossCurrencyInterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cross Currency Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CrossCurrencyInterestRateContractMember" xlink:to="lab_us-gaap_CrossCurrencyInterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_7ccebf02-3e09-4ba1-b16b-2f7e2f0d12c1_terseLabel_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_label_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:label id="lab_jnj_Numberofpatientsinsettlement_documentation_en-US" xlink:label="lab_jnj_Numberofpatientsinsettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patients in settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement" xlink:href="jnj-20200628.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Numberofpatientsinsettlement" xlink:to="lab_jnj_Numberofpatientsinsettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a4fb861f-ef54-4196-b87e-7f46b1af80b4_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments of Business and Geographic Areas</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_bf8b9935-41cb-41f2-92fb-d5a9436d570a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable_6ebd6063-0c65-434b-824a-8ba531cfa828_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Table]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_45169d12-1681-4e53-b736-e446a3d94305_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by segment of business</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information, Revenue for Reportable Segment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:to="lab_us-gaap_SegmentReportingInformationRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_556e4682-86dd-422f-8fe0-2d6ec8f937d3_terseLabel_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029</link:label>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_label_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029 [Member]</link:label>
    <link:label id="lab_jnj_A6.95Notesdue2029Member_documentation_en-US" xlink:label="lab_jnj_A6.95Notesdue2029Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.95% Notes due 2029 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member" xlink:href="jnj-20200628.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A6.95Notesdue2029Member" xlink:to="lab_jnj_A6.95Notesdue2029Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_6e66f168-3cf9-4f7c-9e41-efea1c177291_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromShortTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromShortTermDebt" xlink:to="lab_us-gaap_ProceedsFromShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_07989d1c-75e7-4074-a70e-f8afce5fd17b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ff83c8f4-fa1d-422b-b3df-6a0a76ae5a75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_718ad9e9-fedc-49eb-984e-2dd339b93266_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8a6756a0-a415-4429-9b38-e9d58b725e10_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_4ea475e4-fed5-4de8-b390-9f6d041ec12d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_f5f34e60-4d32-4051-a84c-671294ee72ed_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies (Note 11)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_de31a1d7-d029-4a61-a3f3-b77f9255fd99_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_52ca3af7-c75d-40f0-bf63-ea226f2258e1_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_222a534f-8774-4798-b267-621a257eee76_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5cefc66a-13a0-4daa-a4c4-eb83557edcd0_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_820e44e8-fe88-444b-8905-01dd0287090b_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_c6163143-232a-4eee-972d-e427ee39a084_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with definite lives:</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InvokanaMember_69254dff-3f64-469d-90cb-81c69e73dd76_terseLabel_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana</link:label>
    <link:label id="lab_jnj_InvokanaMember_label_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana [Member]</link:label>
    <link:label id="lab_jnj_InvokanaMember_documentation_en-US" xlink:label="lab_jnj_InvokanaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invokana [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember" xlink:href="jnj-20200628.xsd#jnj_InvokanaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InvokanaMember" xlink:to="lab_jnj_InvokanaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_36f0dcd0-1584-4307-a9dc-e2e62ff95f7b_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with readily determinable value</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_label_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with Readily Determinable Value [Member]</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments with Readily Determinable Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:to="lab_jnj_EquityInvestmentswithReadilyDeterminableValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_0c4d101a-4cab-4a75-a773-8f191a4d1896_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_8c5c2cc6-8988-469b-bfd1-cf32f779d4bb_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_5bf2525e-1d5f-41ac-a0f8-d96af4b49a16_terseLabel_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S.</link:label>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_label_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S. [Member]</link:label>
    <link:label id="lab_jnj_WesternHemisphereExcludingUSMember_documentation_en-US" xlink:label="lab_jnj_WesternHemisphereExcludingUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Western Hemisphere, excluding U.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember" xlink:href="jnj-20200628.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WesternHemisphereExcludingUSMember" xlink:to="lab_jnj_WesternHemisphereExcludingUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_8cc6ecd1-cf4c-414e-804f-fff064cc93b5_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_2216bf25-f860-41f7-88ae-8141d957708f_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_1c0dc30f-6bcc-4c0c-8da8-38e61d2999ba_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_aa0b9309-5a08-4bf7-bcab-f352ab15f171_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_aa3aa127-7aab-4563-8d2b-a0609c427bd2_terseLabel_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_label_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021 [Member]</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2021Member_documentation_en-US" xlink:label="lab_jnj_A2.45Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.45Notesdue2021Member" xlink:to="lab_jnj_A2.45Notesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b8b8d62e-b2fc-4f4e-8093-30eb17225397_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_7d0a3b51-1e21-4ef5-8c4b-3670920c0501_terseLabel_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income percent to sales</link:label>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_label_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income Interest Percent To Sales</link:label>
    <link:label id="lab_jnj_InvestmentIncomeInterestPercentToSales_documentation_en-US" xlink:label="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment income interest percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales" xlink:href="jnj-20200628.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InvestmentIncomeInterestPercentToSales" xlink:to="lab_jnj_InvestmentIncomeInterestPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_39dae80e-d6f5-4261-808a-ee6d171b822b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_83db2e1d-2164-42d9-b6d0-67fea63808b8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales price per share (in CHF per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_c2d7d4b3-bd99-4ca3-affc-f11633fabdaa_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_6e55d253-f0ca-4071-b39b-7a92ff400342_terseLabel_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments made to intangible assets</link:label>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_label_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</link:label>
    <link:label id="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_documentation_en-US" xlink:label="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:href="jnj-20200628.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:to="lab_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_ebb40f9e-2ea0-44ca-be94-ed9b099394de_terseLabel_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net percent to sales</link:label>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_label_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Non Operating Income Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non operating income expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:href="jnj-20200628.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:to="lab_jnj_OtherNonOperatingIncomeExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_8cf65e77-f068-403e-be58-bc81f677802e_terseLabel_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_label_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice_documentation_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Change In Observable Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:to="lab_jnj_EquityFairValueAdjustmentChangeInObservablePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_aa4c25f9-0a05-41ba-a55f-00fd325b8e1e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_32ac0a93-7e89-4ad1-84d4-bb363fbd33ad_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock Amount</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SettledLitigationMember_6fbc0830-f6f0-44fe-8d33-9ab5ab301676_terseLabel_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">settled litigation</link:label>
    <link:label id="lab_us-gaap_SettledLitigationMember_label_en-US" xlink:label="lab_us-gaap_SettledLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SettledLitigationMember" xlink:to="lab_us-gaap_SettledLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BeautyMember_f0edf084-b222-4017-9375-f0f6e2d7e4b5_terseLabel_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care</link:label>
    <link:label id="lab_jnj_BeautyMember_label_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beauty [Member]</link:label>
    <link:label id="lab_jnj_BeautyMember_documentation_en-US" xlink:label="lab_jnj_BeautyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beauty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember" xlink:href="jnj-20200628.xsd#jnj_BeautyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BeautyMember" xlink:to="lab_jnj_BeautyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_135dc72b-0ad9-4605-879a-6bd40e3dba69_terseLabel_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net impact to tax rate due to change in contingent consideration liability</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_label_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_documentation_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:to="lab_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_3b27323c-b07d-47ec-a112-519fa473a506_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_62faa4dc-3b39-4d56-8b1f-e60b9b951fd9_verboseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement, Business Segments</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_ffbe7b27-0555-41cc-abc5-a46f89f725e7_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments : Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments in Hedges, Liabilities, at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:to="lab_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_23f6ad31-6639-4bd1-bbc3-279d830688fd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_37935675-590d-472e-8900-181ac34aa684_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_48d1b543-01dc-428f-8e59-77ae740ea526_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeAxis" xlink:to="lab_us-gaap_RetirementPlanTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_a1be7fd5-cad7-4c45-871f-b8335e35db6c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_edf689a0-3277-4265-b181-93f6fa32edda_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: common stock held in treasury, at cost (487,466,000 and 487,336,000 shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_0a6bc47e-e1de-4b50-b3ff-b65a09ec07a9_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_dd2a897d-459a-431c-904e-e7bd034d3930_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b0d8c346-b5a9-49e2-b077-0de985e66011_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_2496b1f9-7d00-48ce-9034-db378952fad4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Defined Benefit Plans Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:to="lab_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_a95a1a5d-5db0-45cf-b3da-4b41c7a715cf_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Asset Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_29edfcd8-1c2f-42d0-8510-204b781146b0_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis" xlink:to="lab_us-gaap_ShortTermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_dbd3a607-634f-4f06-96f8-538d93768d30_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by geographic area</link:label>
    <link:label id="lab_us-gaap_SegmentsGeographicalAreasAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments, Geographical Areas [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract" xlink:to="lab_us-gaap_SegmentsGeographicalAreasAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f5398202-257d-4eca-8d87-bf9c6980d404_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_fa33cd17-5e31-4290-9cdb-8223c2a5db75_terseLabel_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022</link:label>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_label_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022 [Member]</link:label>
    <link:label id="lab_jnj_A2.25Notesdue2022Member_documentation_en-US" xlink:label="lab_jnj_A2.25Notesdue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.25% Notes due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member" xlink:href="jnj-20200628.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.25Notesdue2022Member" xlink:to="lab_jnj_A2.25Notesdue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_a4e26775-6441-4520-ba77-8d65da2b9cf1_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_9a6e6d05-d0ce-453c-98c2-5b21acf9ba44_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Segment Operating Income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringChargesMember_f9f4c80e-a998-47d7-b813-6e7b439d2de9_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:label id="lab_us-gaap_RestructuringChargesMember_label_en-US" xlink:label="lab_us-gaap_RestructuringChargesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringChargesMember" xlink:to="lab_us-gaap_RestructuringChargesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_1e022d5c-29ea-4a51-a723-0acf8f627ae1_terseLabel_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023</link:label>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_label_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A3.375Notesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A3.375Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.375% Notes due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member" xlink:href="jnj-20200628.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.375Notesdue2023Member" xlink:to="lab_jnj_A3.375Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_eb6e8fb8-0555-4557-afe1-2d6066ce5e34_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill (Note 3)</link:label>
    <link:label id="lab_us-gaap_Goodwill_25b1451d-f25e-4711-8bb3-02d2b5e92c4c_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Beginning of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_4ffdafe4-3322-4dc8-8e17-dee1765d9191_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill End of Period</link:label>
    <link:label id="lab_us-gaap_Goodwill_ad87d262-90e7-4a54-9b9b-8af8ab86d5c5_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DePuyASRU.S.Member_1a1b09da-58b2-4978-af9d-07639bb8032e_terseLabel_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S.</link:label>
    <link:label id="lab_jnj_DePuyASRU.S.Member_label_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S. [Member]</link:label>
    <link:label id="lab_jnj_DePuyASRU.S.Member_documentation_en-US" xlink:label="lab_jnj_DePuyASRU.S.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DePuy ASR U.S. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member" xlink:href="jnj-20200628.xsd#jnj_DePuyASRU.S.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DePuyASRU.S.Member" xlink:to="lab_jnj_DePuyASRU.S.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_fb418438-8d22-42af-b4d9-12e09ee69d31_terseLabel_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174;</link:label>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_label_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]</link:label>
    <link:label id="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_documentation_en-US" xlink:label="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:href="jnj-20200628.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:to="lab_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b65034be-6502-48f1-8970-c92e0ceb0a1a_verboseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_759dd1d1-e197-4c09-9eec-925b05d42e9b_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_a3ea1925-cea3-4181-988f-c655fbc6c7d5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_fe9a4c07-ec1c-4bb2-a38c-917d233799cb_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8aa5b0d-bbf0-4647-8dbe-7f138dd9d4cf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c3335e60-9446-4677-ad3b-27f77701e038_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1fba58ca-c309-4273-9a5a-fc61a4b19873_netLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_110f0830-5409-47d5-b396-c740b1b14c8a_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_6dad042b-2ecb-40f1-9b1b-9b6c1a8a76b7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_656a7b69-590f-4edc-bda7-b944ddf2a61a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_c18c37c8-7473-4a55-9c16-2b19e9e46583_terseLabel_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_label_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development in process percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales_documentation_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">research and development in process percent to sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:to="lab_jnj_ResearchAndDevelopmentInProcessPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_15273f83-fa49-41aa-859f-79d7429e2787_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense (Excluding Acquired in Process Cost)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_18ab321b-45ce-4366-8fef-96b3b0cd9356_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_caf68bd4-0648-42fd-bd44-181789aa2ff4_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_030a9f97-ac3d-4a43-9696-5ecad6e0a230_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SupplyChainMember_fb917364-9f67-494c-8f81-b4b7ccd046b3_terseLabel_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain</link:label>
    <link:label id="lab_jnj_SupplyChainMember_label_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain [Member]</link:label>
    <link:label id="lab_jnj_SupplyChainMember_documentation_en-US" xlink:label="lab_jnj_SupplyChainMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supply Chain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SupplyChainMember" xlink:to="lab_jnj_SupplyChainMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_81fbf7d4-e79c-4f9e-9742-c73c0f3e61ab_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_9b6e0ba2-b356-4ca7-a28f-202f2af0b78a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives &amp; hedges:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_bdb04261-940c-4c3e-932d-76dacf40fe83_terseLabel_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033</link:label>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_label_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033 [Member]</link:label>
    <link:label id="lab_jnj_A4.375Notesdue2033Member_documentation_en-US" xlink:label="lab_jnj_A4.375Notesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.375% Notes due 2033 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member" xlink:href="jnj-20200628.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.375Notesdue2033Member" xlink:to="lab_jnj_A4.375Notesdue2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c454c073-0c23-45f0-bb0e-f4307a8c67f0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_f5c5699f-f9f0-46ce-a698-d7e6c7889859_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_da5b854d-4ee0-4f21-8299-8771cb01a669_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Support Agreement (CSA)</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetFairValueGrossLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:to="lab_us-gaap_DerivativeAssetFairValueGrossLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_dbf9606f-2a83-495d-88a9-b40a7754bb6f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_76df4e16-fc89-429b-b5b1-91ebaeebeabe_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_22ed8351-7334-40eb-811e-4c9742772f99_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_3c85b68b-b769-4781-99d6-e2e0a4d0531b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_8446ee9f-ccd4-4337-8e29-e0c7f5f12c93_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_551a1d2b-01c5-4ed2-8ed2-dddbf8d539f6_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities - Carrying Amount</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_da876288-3d25-4589-964c-0941605168e8_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in assets and liabilities, net of effects from acquisitions and divestitures:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e5a02c74-1610-4aa8-9bae-e9795a3af061_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_e3e85db9-bf1c-4300-b758-481df8183f81_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_6c69bf44-194f-4ee1-a5bb-3eb2e3b88e9c_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AVG. SHARES OUTSTANDING</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_70036220-7916-4c9b-82c7-475c8ded3e8d_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_21647745-0cc3-4b56-b0aa-33c6aa3a58bc_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted prices in active markets for identical assets and liabilities Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_a4c8b8f4-ccf8-4ba5-b50a-e0ba9f0ebd6f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of portion capitalized</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_770367ab-3905-4fa7-a7ec-912fd923d86c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_24a84820-cd25-4c7b-a78c-d4f9853b4993_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_e7411762-148c-4dfd-8de6-954863cd83fd_terseLabel_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previous damages awarded and revised</link:label>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_label_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Previous Damages Awarded And Revised, Value</link:label>
    <link:label id="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_documentation_en-US" xlink:label="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Previous Damages Awarded And Revised, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:href="jnj-20200628.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:to="lab_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_357fb8ab-7509-4d8a-942b-5ee4f2bf9c8c_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate on non-current debt</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bba9c8ae-3181-4006-ac44-dc4a011a9ec9_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_82d0bcde-3b84-42bf-af9c-5b998201ea6d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships and other intangible assets</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_e6b26017-ef16-4322-afcb-91fdac95be77_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage ownership before transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership before Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_bf968f41-cf4f-48c5-96b8-3d781e314d83_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Curtailments and settlements</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:to="lab_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_837f0838-b8bf-4478-abd3-9b6cd4f26085_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the disposal of assets/businesses, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfProductiveAssets_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:to="lab_us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a53c6355-562a-4441-bc61-49d8b7f06b1a_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $334 (2019, $226)</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_54083b82-86a8-4975-b83a-945c3cafbfc7_terseLabel_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular / Metabolism / Other</link:label>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_label_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular/Metabolism/Other [Member]</link:label>
    <link:label id="lab_jnj_CardiovascularMetabolismOtherMember_documentation_en-US" xlink:label="lab_jnj_CardiovascularMetabolismOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cardiovascular/Metabolism/Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember" xlink:href="jnj-20200628.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CardiovascularMetabolismOtherMember" xlink:to="lab_jnj_CardiovascularMetabolismOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_edc4b2d3-84d7-44d1-84af-32743fdba3e0_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_b86fe5d7-2e3b-4d35-849e-7418d7dac49b_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesMember" xlink:to="lab_us-gaap_EquitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_57b22f2c-8afe-4a2f-a873-24c6ef64aecd_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goods in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_01a696be-f19a-4ae0-a0b2-3bf7b3bf3e9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_1ecf877c-ec8a-4a24-b86e-72214720dd2e_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of equity investments</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfEquityInvestments_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Equity Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:to="lab_us-gaap_GainLossOnSaleOfEquityInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_d1d19aea-699f-44c4-b011-b614254688bf_negatedTerseLabel_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior service cost amortization during period</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_label_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_documentation_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:to="lab_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_178c6f55-a91f-49f3-b460-3c5a67507287_terseLabel_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding (Textuals)</link:label>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_label_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_LegalProceedingTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_LegalProceedingTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceeding Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract" xlink:href="jnj-20200628.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LegalProceedingTextualsAbstract" xlink:to="lab_jnj_LegalProceedingTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_0c344ecb-116f-46db-b979-add04a833ae2_terseLabel_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174;</link:label>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_label_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]</link:label>
    <link:label id="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_documentation_en-US" xlink:label="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:href="jnj-20200628.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:to="lab_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_309eac93-6519-4881-8918-490d9cfbdafb_verboseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_db73b945-40c0-409b-9d05-381837851847_verboseLabel_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued rebates, returns and promotions</link:label>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_label_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Rebates Returns And Promotions</link:label>
    <link:label id="lab_jnj_AccruedRebatesReturnsAndPromotions_documentation_en-US" xlink:label="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions" xlink:href="jnj-20200628.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AccruedRebatesReturnsAndPromotions" xlink:to="lab_jnj_AccruedRebatesReturnsAndPromotions" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_6835928a-eae8-475a-bb69-8f9373e26583_terseLabel_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development</link:label>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development [Member]</link:label>
    <link:label id="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember_documentation_en-US" xlink:label="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchased In-Process Research And Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:to="lab_jnj_PurchasedInProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1717777f-5ffe-4c62-a8f8-680b916a5636_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BabyCareMember_1bf85436-ef1b-434a-9a3a-35b3d3426c75_terseLabel_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care</link:label>
    <link:label id="lab_jnj_BabyCareMember_label_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care [Member]</link:label>
    <link:label id="lab_jnj_BabyCareMember_documentation_en-US" xlink:label="lab_jnj_BabyCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Baby Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember" xlink:href="jnj-20200628.xsd#jnj_BabyCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BabyCareMember" xlink:to="lab_jnj_BabyCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_9434cd97-c6b0-40bd-be4f-470e68a8e4b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_82088778-e900-4b9d-8cdf-a69b8c577145_terseLabel_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular Cup System</link:label>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_label_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular Cup System [Member]</link:label>
    <link:label id="lab_jnj_PinnacleAcetabularCupSystemMember_documentation_en-US" xlink:label="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pinnacle Acetabular cup system.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember" xlink:href="jnj-20200628.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PinnacleAcetabularCupSystemMember" xlink:to="lab_jnj_PinnacleAcetabularCupSystemMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_8dd53c0b-f5df-4f08-a820-5c06ee55c767_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3ff49efb-2113-4dec-9a52-f8e80232ec43_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_577cfe9a-71b9-490e-9632-cea48141d420_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_a5ad9ce3-fe31-4d4b-b26e-5322fdb212ae_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance</link:label>
    <link:label id="lab_us-gaap_EmployeeSeveranceMember_label_en-US" xlink:label="lab_us-gaap_EmployeeSeveranceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Severance [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeSeveranceMember" xlink:to="lab_us-gaap_EmployeeSeveranceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_1703a009-3e3e-4c1c-9ade-b08744687832_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_0d86b4d1-bc60-4526-8365-03e02ae3637b_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_61229d0d-f231-4619-9128-acee6e639e89_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_d10e48a7-3ce4-41c8-b248-afa273b0398d_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_330eebb6-bc93-410e-8fd4-541721720263_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_3c5de18f-55d4-4ea2-9a04-0e8d3dd43315_terseLabel_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040</link:label>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_label_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040 [Member]</link:label>
    <link:label id="lab_jnj_A4.50Debenturesdue2040Member_documentation_en-US" xlink:label="lab_jnj_A4.50Debenturesdue2040Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Debentures due 2040 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member" xlink:href="jnj-20200628.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.50Debenturesdue2040Member" xlink:to="lab_jnj_A4.50Debenturesdue2040Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_a039a539-af65-4d84-8585-e90d7d1b7f09_terseLabel_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_label_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036 [Member]</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2036Member_documentation_en-US" xlink:label="lab_jnj_A3.55Notesdue2036Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2036 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.55Notesdue2036Member" xlink:to="lab_jnj_A3.55Notesdue2036Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_7b595ca4-f994-4226-9c3d-e56cb8d9d536_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_7b53815d-d7e9-451f-b5b3-fce8f6af59fd_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par Value $1.00</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_045a146b-fe4d-43f5-ac83-6f27932d6810_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Issued Amount</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_c8e7a580-1b3a-4209-b82c-e264e340c0f0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TalcMember_3b7b250c-e387-43a9-9204-588ddffab5aa_terseLabel_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc</link:label>
    <link:label id="lab_jnj_TalcMember_label_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc [Member]</link:label>
    <link:label id="lab_jnj_TalcMember_documentation_en-US" xlink:label="lab_jnj_TalcMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Talc [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember" xlink:href="jnj-20200628.xsd#jnj_TalcMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TalcMember" xlink:to="lab_jnj_TalcMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_067d2701-c90d-4f33-b034-0ba4337fd6e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_b3a8233c-1a6b-44ac-8119-871f08f433bb_verboseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Proceedings</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_1149fe27-d9c7-4d64-96b7-f24f611fb7c4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee compensation and stock option plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnSecurities_1c701533-9793-4b92-8917-56fd0735a65a_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnSecurities_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnSecurities" xlink:to="lab_us-gaap_UnrealizedGainLossOnSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_8c8f49ff-a6a7-4c40-bc69-d05938a0d684_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Equity Securities</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesFvNi_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesFvNi" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesFvNi" xlink:to="lab_us-gaap_EquitySecuritiesFvNi" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_b48cf16e-a0e4-4fff-a5ad-6bc2a9cab8a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/(Loss) Recognized In Income on Derivative</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_4d0c652f-4e0f-40ea-87fd-7d83bd4db7fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_baecfe6f-099d-4883-a7dd-627284760d40_terseLabel_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038</link:label>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_label_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038 [Member]</link:label>
    <link:label id="lab_jnj_A5.85Debenturesdue2038Member_documentation_en-US" xlink:label="lab_jnj_A5.85Debenturesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.85% Debentures due 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member" xlink:href="jnj-20200628.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.85Debenturesdue2038Member" xlink:to="lab_jnj_A5.85Debenturesdue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_8f8243ab-38af-45f7-b74f-3ed3838b6321_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_a2a0f1eb-af6b-496f-a40a-eb3e3d3ae708_terseLabel_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SIMPONI / SIMPONI ARIA&#174;</link:label>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_label_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simponi/Simponi Aria [Member]</link:label>
    <link:label id="lab_jnj_SimponiSimponiAriaMember_documentation_en-US" xlink:label="lab_jnj_SimponiSimponiAriaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Simponi/Simponi Aria [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember" xlink:href="jnj-20200628.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SimponiSimponiAriaMember" xlink:to="lab_jnj_SimponiSimponiAriaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1124c3c7-89b9-4454-8ace-28b5fd614bd0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PelvicMeshesMember_61a663ad-3b3e-4908-b4e7-eac18da595ad_terseLabel_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Meshes</link:label>
    <link:label id="lab_jnj_PelvicMeshesMember_label_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic Meshes [Member]</link:label>
    <link:label id="lab_jnj_PelvicMeshesMember_documentation_en-US" xlink:label="lab_jnj_PelvicMeshesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pelvic meshes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember" xlink:href="jnj-20200628.xsd#jnj_PelvicMeshesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PelvicMeshesMember" xlink:to="lab_jnj_PelvicMeshesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_fd3e44d2-e6b6-4347-895c-ccf3694ea7b6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_e395b0bb-8ba0-424a-af0d-6e50d563643b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_0c89afa0-d7c4-4593-b1c8-77d2b72a760a_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_3916d023-f0ff-4c1f-83fc-5f1ae1f6b284_totalLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_XareltoMember_2fd3fe55-25cd-4895-92ac-1538e27547c2_terseLabel_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">XARELTO&#174;</link:label>
    <link:label id="lab_jnj_XareltoMember_label_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xarelto [Member]</link:label>
    <link:label id="lab_jnj_XareltoMember_documentation_en-US" xlink:label="lab_jnj_XareltoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Xarelto [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember" xlink:href="jnj-20200628.xsd#jnj_XareltoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_XareltoMember" xlink:to="lab_jnj_XareltoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_b70165a4-b1f6-480a-bb76-993c662a254a_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_1c276874-a9f0-4c60-9f2e-3ae011c4af34_terseLabel_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other reverse repurchase agreements</link:label>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_label_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reverse Repurchase Agreements [Member]</link:label>
    <link:label id="lab_jnj_OtherReverseRepurchaseAgreementsMember_documentation_en-US" xlink:label="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Reverse Repurchase Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember" xlink:href="jnj-20200628.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherReverseRepurchaseAgreementsMember" xlink:to="lab_jnj_OtherReverseRepurchaseAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_1d103e06-6c68-4758-9bce-16107bb9f638_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_349e335f-9791-4311-9f5b-31652bdc1381_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_39da3386-7554-4de9-83e0-42c4a5f043b0_terseLabel_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:label id="lab_us-gaap_InternalRevenueServiceIRSMember_label_en-US" xlink:label="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Revenue Service (IRS) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalRevenueServiceIRSMember" xlink:to="lab_us-gaap_InternalRevenueServiceIRSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_6229180c-e58b-4161-a6a8-853da1e4ef0b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_cb56e3b9-c6fb-4e1e-927e-07937dbd1951_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Derivative Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_dfe179ff-cddc-4669-ab55-aafdc6b15739_terseLabel_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_label_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026 [Member]</link:label>
    <link:label id="lab_jnj_A2.45Notesdue2026Member_documentation_en-US" xlink:label="lab_jnj_A2.45Notesdue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.45% Notes due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.45Notesdue2026Member" xlink:to="lab_jnj_A2.45Notesdue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_56604bf6-949d-4323-bb3e-8958bfdbcd1f_verboseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermBorrowings_b6ddab0a-82e6-442f-b5a5-b124b8401ae8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans and notes payable</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_06de08f0-1314-487f-903e-4d2248e72581_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Debt</link:label>
    <link:label id="lab_us-gaap_ShortTermBorrowings_label_en-US" xlink:label="lab_us-gaap_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermBorrowings" xlink:to="lab_us-gaap_ShortTermBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_9ef8195d-a972-4cc0-9fcb-e7570faa1f06_terseLabel_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043</link:label>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_label_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043 [Member]</link:label>
    <link:label id="lab_jnj_A4.50Notesdue2043Member_documentation_en-US" xlink:label="lab_jnj_A4.50Notesdue2043Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.50% Notes due 2043 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member" xlink:href="jnj-20200628.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.50Notesdue2043Member" xlink:to="lab_jnj_A4.50Notesdue2043Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_ed6a0ba8-326a-4707-a9bd-2edce210e075_terseLabel_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for taxes on income (Note 5)</link:label>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_label_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense Benefit Percent To Sales</link:label>
    <link:label id="lab_jnj_IncomeTaxExpenseBenefitPercentToSales_documentation_en-US" xlink:label="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense benefit percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:to="lab_jnj_IncomeTaxExpenseBenefitPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_8f748701-3067-4a37-9ae5-ebc94918cdfc_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_638205f0-ab85-46c6-a427-5f4f97f917f9_terseLabel_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers percent to sales</link:label>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_label_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Revenue Goods Net Percent To Sales</link:label>
    <link:label id="lab_jnj_SalesRevenueGoodsNetPercentToSales_documentation_en-US" xlink:label="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales revenue goods net percentage to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales" xlink:href="jnj-20200628.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SalesRevenueGoodsNetPercentToSales" xlink:to="lab_jnj_SalesRevenueGoodsNetPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_7b2d34ca-31fe-4d2a-89dc-d8f60f2449f6_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate debt securities(1)</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_592b3743-ce34-4338-ae6a-0abe30dfb339_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_1b4c58fc-b903-4354-b3ab-d10c62faa814_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_96489a1a-3390-4a5f-a192-8b57443cb023_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_b9c3bb48-7193-4dea-9096-e37c934c756b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to shareholders</link:label>
    <link:label id="lab_us-gaap_PaymentsOfOrdinaryDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfOrdinaryDividends" xlink:to="lab_us-gaap_PaymentsOfOrdinaryDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_0253154e-ac31-4371-b603-131d781b7140_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_f107a91a-fbe3-4204-a68d-14d1783b5eea_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales/ Purchases/Other</link:label>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_label_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</link:label>
    <link:label id="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:to="lab_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_1341cdee-ff80-49ee-86c1-ba2787a4ff5e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_b9072080-4c7b-4634-9182-f4667bf50c54_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities not Measured at Fair Value</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4ea7e2f4-cf51-46b9-a59f-81faa667ca80_terseLabel_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pensions and Other Benefit Plans</link:label>
    <link:label id="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension and Other Postretirement Benefits Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="lab_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_2ce00c14-a4dc-4805-b119-0c842e5fbd80_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Amount of the Hedged Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_b8cc01d8-027b-41ef-a07c-ed30d2910c83_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_f841f51e-a481-413f-a61e-b2db13cd229d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, current</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_123f855b-1dcb-4f8a-b2e8-e18879738d62_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Weighted-Average Useful Life</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_f497a5f7-35c2-4f52-a7bb-8507b841c8ab_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case Type</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_56b514d5-9fd3-4ca4-bc98-0f72dff8ecf8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage ownership after transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ZYTIGAMember_e960c438-0b4b-4159-8cea-53a86c4780c7_terseLabel_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA&#174; / abiraterone acetate</link:label>
    <link:label id="lab_jnj_ZYTIGAMember_label_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA [Member]</link:label>
    <link:label id="lab_jnj_ZYTIGAMember_documentation_en-US" xlink:label="lab_jnj_ZYTIGAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ZYTIGA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember" xlink:href="jnj-20200628.xsd#jnj_ZYTIGAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ZYTIGAMember" xlink:to="lab_jnj_ZYTIGAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_ea3f1d50-b192-486e-aab2-dc2e42f03d40_verboseLabel_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_label_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_documentation_en-US" xlink:label="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:href="jnj-20200628.xsd#jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:to="lab_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_09b8edc6-dc51-4312-9810-b5c6d5b3e06b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_74864902-4c21-4f17-9e3f-9f0d0f0f0fc4_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowances for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_221b2580-0d06-48ec-8c65-98f5fdf2f214_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_dadbdcc5-ee9b-4f93-86e6-301aafb0eb65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_67d047aa-7417-4440-bd28-cd356e59a8a8_terseLabel_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without readily determinable value</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_label_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without Readily Determinable Value [Member]</link:label>
    <link:label id="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_documentation_en-US" xlink:label="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Investments without Readily Determinable Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:to="lab_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_d3c4533e-c632-4b46-a8a1-cbc7db2e40e7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Support Agreement (CSA)</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:to="lab_us-gaap_DerivativeLiabilityFairValueGrossAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3013c8f5-e995-4e54-9166-9148b17a53f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_b711f472-c7aa-4b24-bf22-2745c5069417_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_771021c7-34ee-40f3-a591-e2511f4a97e3_terseLabel_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_label_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies [Axis]</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesAxis_documentation_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement by companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis" xlink:to="lab_jnj_LitigationSettlementByCompaniesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_d5d3de8c-dbbd-4938-96ee-f7015b809f25_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_50d7116c-0604-47a3-8209-3eecab9682ac_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PharmaceuticalMember_51f02e6b-bc73-4e83-a183-1dcee748d137_terseLabel_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PHARMACEUTICAL</link:label>
    <link:label id="lab_jnj_PharmaceuticalMember_label_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical [Member]</link:label>
    <link:label id="lab_jnj_PharmaceuticalMember_documentation_en-US" xlink:label="lab_jnj_PharmaceuticalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmaceutical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PharmaceuticalMember" xlink:to="lab_jnj_PharmaceuticalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_c8876047-4369-4579-b4a3-907942135e6b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_1e9ff1c3-5844-4cb6-ad7b-d81e94ec1c61_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:label id="lab_us-gaap_LossContingencyEstimateOfPossibleLoss_label_en-US" xlink:label="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Estimate of Possible Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:to="lab_us-gaap_LossContingencyEstimateOfPossibleLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_d598e082-0008-432a-b9c0-e9d695c08e29_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments : Liabilities</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_4e423dd4-e415-4463-9079-feb6dbb68e48_verboseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss) (Note 7)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_3fa3bd04-35f6-4880-adcb-76d9be8fdaf4_terseLabel_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc.</link:label>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_label_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc. [Member]</link:label>
    <link:label id="lab_jnj_VerbSurgicalInc.Member_documentation_en-US" xlink:label="lab_jnj_VerbSurgicalInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Verb Surgical Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member" xlink:href="jnj-20200628.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VerbSurgicalInc.Member" xlink:to="lab_jnj_VerbSurgicalInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_a84a873b-7550-4901-9365-63b33be2b8d1_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_b55cbaba-b0fa-4604-ae9c-6189a3aafde9_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_38b769bb-080c-4afb-b159-ca06519a9d17_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_6907cf31-64e4-4eea-8b35-03be52ea5030_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Geographic Area</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_label_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Geographic Area</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesByGeographicArea_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in sales by geographic area.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInSalesByGeographicArea" xlink:to="lab_jnj_PercentageChangeInSalesByGeographicArea" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SurgeryMember_ad18e004-7761-4874-9e4b-62b8cc78f00d_terseLabel_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery</link:label>
    <link:label id="lab_jnj_SurgeryMember_label_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:label id="lab_jnj_SurgeryMember_documentation_en-US" xlink:label="lab_jnj_SurgeryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Surgery [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember" xlink:href="jnj-20200628.xsd#jnj_SurgeryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SurgeryMember" xlink:to="lab_jnj_SurgeryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_fafede92-4dbb-4510-bcec-911d85f10311_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract" xlink:to="lab_us-gaap_LongTermDebtNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RemicadeMember_76c09c29-512f-405d-8cd9-8277ce759e9b_terseLabel_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REMICADE&#174;</link:label>
    <link:label id="lab_jnj_RemicadeMember_label_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remicade [Member]</link:label>
    <link:label id="lab_jnj_RemicadeMember_documentation_en-US" xlink:label="lab_jnj_RemicadeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remicade [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember" xlink:href="jnj-20200628.xsd#jnj_RemicadeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RemicadeMember" xlink:to="lab_jnj_RemicadeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_49b8ec86-7abb-449e-9686-b0fa5deadd4b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_341e7641-95a0-4b4c-b744-cf12a3ad558f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_af39a231-933f-40e7-a3e8-9405b4458b15_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_50caeaa5-6572-4123-9efd-b2ffcdf928b5_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TremfyaMember_05d430e6-d279-476f-97cb-40d016e4a306_terseLabel_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TREMFYA&#174;</link:label>
    <link:label id="lab_jnj_TremfyaMember_label_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tremfya [Member]</link:label>
    <link:label id="lab_jnj_TremfyaMember_documentation_en-US" xlink:label="lab_jnj_TremfyaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tremfaya</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember" xlink:href="jnj-20200628.xsd#jnj_TremfyaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TremfyaMember" xlink:to="lab_jnj_TremfyaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_dbbac44e-4838-4c88-94c5-f419e67a778b_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NeuroscienceMember_dae1ae15-17c1-45b9-99c3-1ecbb265583e_terseLabel_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience</link:label>
    <link:label id="lab_jnj_NeuroscienceMember_label_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:label id="lab_jnj_NeuroscienceMember_documentation_en-US" xlink:label="lab_jnj_NeuroscienceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Neuroscience [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember" xlink:href="jnj-20200628.xsd#jnj_NeuroscienceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NeuroscienceMember" xlink:to="lab_jnj_NeuroscienceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_6ce2cb7f-fd70-465b-a22c-fac0d5cb8f10_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityFairValueAdjustment_9f8a1665-2166-4db7-aefc-70c2997504b0_terseLabel_en-US" xlink:label="lab_us-gaap_EquityFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Fair Value Reflected in Net Income</link:label>
    <link:label id="lab_us-gaap_EquityFairValueAdjustment_label_en-US" xlink:label="lab_us-gaap_EquityFairValueAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityFairValueAdjustment" xlink:to="lab_us-gaap_EquityFairValueAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_8c4c54df-2ca6-409c-89be-b0caae51d89a_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_46a31073-feaa-4f38-b8b1-12fe56ed9100_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_e1a703e7-41d6-4e4b-b6a1-c4dd01f1c193_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service cost</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanServiceCost_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Service Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanServiceCost" xlink:to="lab_us-gaap_DefinedBenefitPlanServiceCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksMember_552ecd28-c42a-4d77-a94b-062ed4be5386_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks</link:label>
    <link:label id="lab_us-gaap_TrademarksMember_label_en-US" xlink:label="lab_us-gaap_TrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksMember" xlink:to="lab_us-gaap_TrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_f83d39e5-732a-42dc-b897-c67c6738bd44_terseLabel_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="lab_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_be95eff8-6ddd-46cb-8bb9-b5c79e1bc736_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativesFairValueLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativesFairValueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Fair Value [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesFairValueLineItems" xlink:to="lab_us-gaap_DerivativesFairValueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_36ac03fd-eee8-42e1-a142-8da5ffe84e43_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_95720894-501e-4547-9041-5be625c71932_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities - Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_0d5e1ca6-36cb-4778-a908-02ac2968ff54_verboseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VisionMember_10e2acbf-3102-4d14-9b46-6ba345255806_terseLabel_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision</link:label>
    <link:label id="lab_jnj_VisionMember_label_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision [Member]</link:label>
    <link:label id="lab_jnj_VisionMember_documentation_en-US" xlink:label="lab_jnj_VisionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vision[Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember" xlink:href="jnj-20200628.xsd#jnj_VisionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VisionMember" xlink:to="lab_jnj_VisionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_9978398f-61b8-4731-8c23-5f6246f49e44_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_313b25ba-46be-429d-8fee-611a4c0a4db6_verboseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_17b17b5a-0b9a-45e4-9b5d-59ab29be158b_terseLabel_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_label_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:label id="lab_jnj_AccruedTaxesOnIncomeMember_documentation_en-US" xlink:label="lab_jnj_AccruedTaxesOnIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Taxes On Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember" xlink:href="jnj-20200628.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AccruedTaxesOnIncomeMember" xlink:to="lab_jnj_AccruedTaxesOnIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_2fecbd02-1958-4ac8-857a-bfd8e67c8a46_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_6253db6a-5031-42c9-95e5-d66596c1d0fa_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:label id="lab_us-gaap_SalesMember_356dbeb1-3d55-4781-813f-6638fd780f3c_verboseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales to customers</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_9ff722c4-a5ee-442a-9afb-af086dbdd183_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_84a5911d-f780-4a51-8181-eb216d8c0e96_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a39225f0-65d2-4ff9-8bd4-65bc33d346eb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net earnings per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_2e5b8dbe-11a3-4f6f-b64c-59db7a76aa41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_acaac1a5-dda8-4dfe-87f2-4f4bf81e3829_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized holding gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_5d499348-6f6e-4145-af31-a76f0a7f4f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gains on equity investments</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_5b8b7918-65da-44a8-be69-bce126078441_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Net Periodic Benefit Cost</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Net Benefit Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2d6eaab5-15e5-49d8-8a0b-bde714f5b086_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_GENERALMember_cef659ab-90af-4ad1-bc69-69ba068a3d24_terseLabel_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL</link:label>
    <link:label id="lab_jnj_GENERALMember_label_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL [Member]</link:label>
    <link:label id="lab_jnj_GENERALMember_documentation_en-US" xlink:label="lab_jnj_GENERALMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GENERAL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember" xlink:href="jnj-20200628.xsd#jnj_GENERALMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_GENERALMember" xlink:to="lab_jnj_GENERALMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f5767710-cf03-46f7-bed7-40b0e7c6a210_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_0e42cc6b-2d44-426e-b2f0-4c1c472d6d1a_verboseLabel_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill (Textuals)</link:label>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_label_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:href="jnj-20200628.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:to="lab_jnj_IntangibleAssetsAndGoodwillTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInformationLineItems_1c31b357-fbec-4b9c-b1a4-4ac750fa8559_terseLabel_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:label id="lab_dei_EntityInformationLineItems_label_en-US" xlink:label="lab_dei_EntityInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_7c60c357-46c7-4690-b183-fe33aa26d821_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_aa204b5e-aba1-4b1e-afa8-41805a3d891c_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation expense</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementExpense_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementExpense" xlink:to="lab_us-gaap_LitigationSettlementExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_839f30a0-0a88-43fc-bccd-bc3d479face4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8ffc6a40-444b-40e7-a1b3-f65cda0da0d5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_527e03d2-4f5f-47f5-986d-3896d6838260_terseLabel_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.50% Notes due 2048</link:label>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_label_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Notes due 2048 [Member]</link:label>
    <link:label id="lab_jnj_A3.500Notesdue2048Member_documentation_en-US" xlink:label="lab_jnj_A3.500Notesdue2048Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.500% Notes due 2048 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member" xlink:href="jnj-20200628.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.500Notesdue2048Member" xlink:to="lab_jnj_A3.500Notesdue2048Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_348cc6f8-70f3-49a0-99ca-2c32a3d0c879_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_e2a16fec-2dab-470e-86aa-aaab5910125c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_106fe4cf-2ba4-4ad4-b548-436439cdce1b_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis" xlink:to="lab_us-gaap_RestructuringCostAndReserveAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_7336ba3c-f806-46f6-8c72-6eb671c8959f_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_2c2b9a6c-11a8-4476-b895-33215ff33bbc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_569dde9c-4280-4e81-8f0c-53c1292814dc_terseLabel_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_label_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:label id="lab_jnj_EquityFairValueAdjustmentImpairmentLoss_documentation_en-US" xlink:label="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Fair Value Adjustment, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:to="lab_jnj_EquityFairValueAdjustmentImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_7471afd9-47a7-4fba-82d5-14be86546f5e_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_4cb27a84-ffcd-4431-b86d-7e9acebdf766_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_12d8ece1-2063-401f-ad4c-b2074ef7d19b_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net earnings to cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_6382bf12-0dda-4254-b939-1f64a58615d4_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanSponsorLocationAxis_label_en-US" xlink:label="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Sponsor Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis" xlink:to="lab_us-gaap_RetirementPlanSponsorLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_53ca69aa-b62c-4369-b8ee-8f0cd6c88f2c_terseLabel_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_label_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:label id="lab_jnj_Restructuringchargepercenttosales_documentation_en-US" xlink:label="lab_jnj_Restructuringchargepercenttosales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charge percent to sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales" xlink:href="jnj-20200628.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_Restructuringchargepercenttosales" xlink:to="lab_jnj_Restructuringchargepercenttosales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_3cd344cc-0284-4fe3-ab64-b7c1c98538ec_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b125801f-236f-4e27-bc22-773540c10fa6_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED BY FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_964587d6-8202-489a-b519-0aa8c5faf962_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_48f37b10-e91c-4b6e-bd3a-37d04ea8e2e5_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_9aba76e4-7f24-44bf-93cc-3837492a69b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for taxes on income</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_7b846cd2-5727-4551-abe8-ae9a6a8b5bd3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net gain on sale of assets/businesses</link:label>
    <link:label id="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Sale of Assets and Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:to="lab_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SPINEOTHERMember_ea98626b-560c-40e3-a393-24d2a69caf7e_terseLabel_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE, SPORTS &amp; OTHER</link:label>
    <link:label id="lab_jnj_SPINEOTHERMember_label_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE &amp; OTHER [Member]</link:label>
    <link:label id="lab_jnj_SPINEOTHERMember_documentation_en-US" xlink:label="lab_jnj_SPINEOTHERMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPINE &amp; OTHER [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember" xlink:href="jnj-20200628.xsd#jnj_SPINEOTHERMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SPINEOTHERMember" xlink:to="lab_jnj_SPINEOTHERMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_c324beec-ee78-44ed-9908-2525448467ca_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Gross Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Fair Value, Gross Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_202afe7c-da3a-4f59-9804-d8e71037de5d_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1d0bcfbd-be75-4910-b49a-e6c11b9c2994_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_304b6e58-300b-4ee2-af35-10c3a59776ce_negatedTerseLabel_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) amortization during period</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_label_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</link:label>
    <link:label id="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_documentation_en-US" xlink:label="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:to="lab_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_b51c2a1c-fedf-4377-96c8-b1a7b56ff96f_terseLabel_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold percent to sales</link:label>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_label_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Percent To Sales</link:label>
    <link:label id="lab_jnj_CostOfGoodsSoldPercentToSales_documentation_en-US" xlink:label="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales" xlink:href="jnj-20200628.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CostOfGoodsSoldPercentToSales" xlink:to="lab_jnj_CostOfGoodsSoldPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_326761a9-3804-4144-98f8-eb8d7546e395_terseLabel_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts</link:label>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_label_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts [Member]</link:label>
    <link:label id="lab_jnj_AdvancedSterilizationProductsMember_documentation_en-US" xlink:label="lab_jnj_AdvancedSterilizationProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AdvancedSterilizationProducts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember" xlink:href="jnj-20200628.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AdvancedSterilizationProductsMember" xlink:to="lab_jnj_AdvancedSterilizationProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_ff591775-50a4-487b-95d3-27173256f99a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_effdd7a7-76e4-4ade-b69a-be6ae15597b3_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_c4d8f8cf-c381-455c-bf88-c23802b0f072_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee related obligations (Note 6)</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_e0ada751-5c9d-478c-96c5-3e8164110bd7_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net (Note 3)</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b797d67d-2a27-4dc5-aa86-494da1aeb086_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets - net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_44539ebf-d852-406e-ac21-4d6f5decb21f_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ImmunologyMember_af2fcd47-c8d8-4246-a8d1-537f8f4cb796_terseLabel_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology</link:label>
    <link:label id="lab_jnj_ImmunologyMember_label_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology [Member]</link:label>
    <link:label id="lab_jnj_ImmunologyMember_documentation_en-US" xlink:label="lab_jnj_ImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immunology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember" xlink:href="jnj-20200628.xsd#jnj_ImmunologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ImmunologyMember" xlink:to="lab_jnj_ImmunologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_5bd3e727-88c2-475d-b296-43f45cc0e686_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (primarily licenses and milestones)</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_a404c29b-0869-4a6b-a62f-d75e6a3fd965_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_782a66a4-f327-4747-ae76-72462269ab5a_terseLabel_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Already Posted, Aggregate Fair Value</link:label>
    <link:label id="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue_label_en-US" xlink:label="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collateral Already Posted, Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:to="lab_us-gaap_CollateralAlreadyPostedAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_8c6babc6-41da-46ee-a665-8eea8d81b042_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET EARNINGS PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d61d8a06-de3d-4778-9f3e-c59ecfda5120_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1b2ca9da-081c-4470-863f-f1274ca69dc5_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_4bcf6f9c-d6a2-4b54-9dc5-665a14fb0b12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis_f3a9ff2f-5094-4fe7-98e2-998d760d4614_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ea4dc981-a326-4917-a94a-a2602b06d2ca_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Investment Gain (Loss) Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="lab_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_dcaef8e3-aa5d-4182-9aef-069289c07bd6_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_520d0a78-9bcb-499c-8dd0-a19d6ed7c0fa_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_25de9030-753e-4932-a249-5aaf0c3a3e55_terseLabel_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="jnj-20200628.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_f13d9698-d3b5-4859-9238-3dae8664fedc_verboseLabel_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due November 2028</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_b649295e-bda0-4625-b266-34e68d6dab7e_terseLabel_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes due 2028 (750MM Euro 1.1217)</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_label_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due 2028 [Member]</link:label>
    <link:label id="lab_jnj_A1.150NotesDue2028Member_documentation_en-US" xlink:label="lab_jnj_A1.150NotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">1.150% Notes Due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member" xlink:href="jnj-20200628.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A1.150NotesDue2028Member" xlink:to="lab_jnj_A1.150NotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2dbc8c77-d78a-4049-92d3-bff7e1a8143d_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_93bfd621-9b4f-4440-9c30-731d0fbd568f_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities, Unrecognized Gain</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_779a68b4-a125-4179-84f3-8169e2b77e70_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_b0d76f9d-d655-4192-9911-ae742c86bfa5_verboseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible debt shares</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_261d6ead-0b40-45d8-8107-4afaf950dbed_terseLabel_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT&#174; / rilpivirine</link:label>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_label_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT/rilpivirine [Member]</link:label>
    <link:label id="lab_jnj_EDURANTrilpivirineMember_documentation_en-US" xlink:label="lab_jnj_EDURANTrilpivirineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EDURANT/rilpivirine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember" xlink:href="jnj-20200628.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EDURANTrilpivirineMember" xlink:to="lab_jnj_EDURANTrilpivirineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1_555b3eac-96ea-434a-b6de-299ccfabc88c_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange rate</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Exchange Rate, Translation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:to="lab_us-gaap_ForeignCurrencyExchangeRateTranslation1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_690be4af-7b90-469e-b1b3-bc3345a83046_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_d2a84fa1-4559-484b-b554-6e806f098dd5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_9497a281-e464-4eba-8cec-9ceeae184462_verboseLabel_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due May 2024</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_3109127b-c053-49a2-bfdc-af597e62f252_terseLabel_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes due 2024 (750MM Euro 1.1217)</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_label_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due 2024 [Member]</link:label>
    <link:label id="lab_jnj_A0.650NotesDue2024Member_documentation_en-US" xlink:label="lab_jnj_A0.650NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.650% Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member" xlink:href="jnj-20200628.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A0.650NotesDue2024Member" xlink:to="lab_jnj_A0.650NotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_12cecfcb-cf1c-4cb8-8168-3318685f3192_terseLabel_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of cash outlays for severance expected to be paid out</link:label>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_label_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</link:label>
    <link:label id="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_documentation_en-US" xlink:label="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:href="jnj-20200628.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:to="lab_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2563f1b0-b14e-4385-8806-bd5b3eb3dffc_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_62ad9e84-be8b-4fb5-8fdf-929602fd9009_totalLabel_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings before provision for taxes on income percent to sales</link:label>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_label_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Percent To Sales</link:label>
    <link:label id="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_documentation_en-US" xlink:label="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:href="jnj-20200628.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:to="lab_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_f2a34ba4-8554-496d-8824-990ffc8ecf45_terseLabel_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact to effective tax rate, percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_label_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</link:label>
    <link:label id="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_documentation_en-US" xlink:label="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:to="lab_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WomensHealthMember_476295e7-f6d7-4fa0-80b1-1dbff9e1618c_terseLabel_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health</link:label>
    <link:label id="lab_jnj_WomensHealthMember_label_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:label id="lab_jnj_WomensHealthMember_documentation_en-US" xlink:label="lab_jnj_WomensHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Women's Health [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember" xlink:href="jnj-20200628.xsd#jnj_WomensHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WomensHealthMember" xlink:to="lab_jnj_WomensHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_6b0c0e41-2e43-4e7f-95d7-5304e8cd233b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_6165d6e4-f1e0-486d-bfcd-b5614490a897_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_7516522a-c1f5-4ab8-879c-48baedbf8e5a_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IMBRUVICAMember_d9bdd19a-06a5-4a72-95ef-5e373df00d6c_terseLabel_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA&#174;</link:label>
    <link:label id="lab_jnj_IMBRUVICAMember_label_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA [Member]</link:label>
    <link:label id="lab_jnj_IMBRUVICAMember_documentation_en-US" xlink:label="lab_jnj_IMBRUVICAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">IMBRUVICA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember" xlink:href="jnj-20200628.xsd#jnj_IMBRUVICAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IMBRUVICAMember" xlink:to="lab_jnj_IMBRUVICAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_8816dbce-07b9-4b36-9071-41ba8e92b599_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:to="lab_us-gaap_DefinedBenefitPlanDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_18328ffa-4b58-4a0e-a6fc-71c10c78225c_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Profit by Segment of Business</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_4561211f-798c-4ef2-95e6-035911e810eb_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_9d28da71-c873-4d22-97b5-a452576355f2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_fde2a79a-add0-4f0f-92b2-be590babf443_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_37a51fd9-b62d-4994-b6ba-d2d9dbf6b41e_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestructuringMember_07f7f296-8405-4a71-b8fa-5ac5bbeb2054_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring</link:label>
    <link:label id="lab_us-gaap_OtherRestructuringMember_label_en-US" xlink:label="lab_us-gaap_OtherRestructuringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restructuring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestructuringMember" xlink:to="lab_us-gaap_OtherRestructuringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_df2133fc-a539-45cc-b80e-317c364e34c8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_555063a6-3940-4269-bb14-acf435eff12d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e0ba61eb-62b9-4bab-b422-4bcec0a0954a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OralCareMember_44ed6efb-0852-4745-bcf2-ae210b24cd4b_terseLabel_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC</link:label>
    <link:label id="lab_jnj_OralCareMember_label_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:label id="lab_jnj_OralCareMember_documentation_en-US" xlink:label="lab_jnj_OralCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oral Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember" xlink:href="jnj-20200628.xsd#jnj_OralCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OralCareMember" xlink:to="lab_jnj_OralCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_2199a8e1-4cb0-401b-8072-ad3e11ec3622_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_e45bebc4-51e4-46cd-bbc4-a323784010d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_3b7b850a-71d0-4f2f-bcb7-c1e1415236ad_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_ab1de11a-a56d-4469-ad21-e8229816ec9d_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OPSUMITMember_cc51372b-e499-4a8d-b3f1-fd1ff0063646_terseLabel_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT&#174;</link:label>
    <link:label id="lab_jnj_OPSUMITMember_label_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT [Member]</link:label>
    <link:label id="lab_jnj_OPSUMITMember_documentation_en-US" xlink:label="lab_jnj_OPSUMITMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPSUMIT [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember" xlink:href="jnj-20200628.xsd#jnj_OPSUMITMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OPSUMITMember" xlink:to="lab_jnj_OPSUMITMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_f92a7d4c-f1bf-4522-ac5b-69139f72b15f_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities - Estimated Fair Value</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesFairValue_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_6ffb84d4-2745-4aec-8e62-30d639378ac3_terseLabel_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_label_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:label id="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_documentation_en-US" xlink:label="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:href="jnj-20200628.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="lab_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_368b32bb-bbd3-4f42-8455-111072b337d1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_31ab30b2-4a67-41c9-8996-9661f5a4332e_verboseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_2af42454-4231-45d2-b4c0-ca1338da2c8e_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_416fc81e-fb9d-4670-8940-c3b8a099ec55_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:to="lab_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_b281661f-5dc3-4932-8a6d-3455e813b653_negatedLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities, Unrecognized Loss</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_1acccb85-a93e-4e8e-8f67-007f591af7e0_verboseLabel_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due January 2022</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_b94bdc2e-324c-4c5c-bcad-c993e0f4aa7c_terseLabel_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes due 2022 (1B Euro 1.1217)</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_label_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due 2022 [Member]</link:label>
    <link:label id="lab_jnj_A0.250NotesDue2022Member_documentation_en-US" xlink:label="lab_jnj_A0.250NotesDue2022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">0.250% Notes Due 2022 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member" xlink:href="jnj-20200628.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A0.250NotesDue2022Member" xlink:to="lab_jnj_A0.250NotesDue2022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_253f9202-6f3c-4315-a3e0-4729f6d72819_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ca527187-241e-4e01-ba22-44d8c2044e58_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_14116e58-6177-49f1-89d7-6c61f45e720e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_23e769d8-f532-4560-aaeb-aaf2ed7c4031_terseLabel_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.90%&#160;Notes due 2028</link:label>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_label_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% Notes due 2028 [Member]</link:label>
    <link:label id="lab_jnj_A2.900Notesdue2028Member_documentation_en-US" xlink:label="lab_jnj_A2.900Notesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.900% Notes due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member" xlink:href="jnj-20200628.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.900Notesdue2028Member" xlink:to="lab_jnj_A2.900Notesdue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_abafe1e2-f61c-4c9f-a7b3-83181c156f1b_terseLabel_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. Exports</link:label>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_label_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES Exports [Member]</link:label>
    <link:label id="lab_jnj_UNITEDSTATESExportsMember_documentation_en-US" xlink:label="lab_jnj_UNITEDSTATESExportsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES Exports [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember" xlink:href="jnj-20200628.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UNITEDSTATESExportsMember" xlink:to="lab_jnj_UNITEDSTATESExportsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserve_f0167777-7d1e-4b0c-a7af-37287f724351_periodStartLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve balance beginning</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_e7786226-f3d4-42f0-b134-26f844158265_periodEndLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserve balance ending</link:label>
    <link:label id="lab_us-gaap_RestructuringReserve_label_en-US" xlink:label="lab_us-gaap_RestructuringReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserve" xlink:to="lab_us-gaap_RestructuringReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_96e6cde9-d16b-4442-b03f-bce5fa2e0490_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AssetWriteoffMember_c9a7a484-34aa-4588-968b-042719af99eb_terseLabel_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off</link:label>
    <link:label id="lab_jnj_AssetWriteoffMember_label_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off [Member]</link:label>
    <link:label id="lab_jnj_AssetWriteoffMember_documentation_en-US" xlink:label="lab_jnj_AssetWriteoffMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Write-off [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember" xlink:href="jnj-20200628.xsd#jnj_AssetWriteoffMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AssetWriteoffMember" xlink:to="lab_jnj_AssetWriteoffMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_acbda683-4299-4fbd-8b5b-887d3d88c739_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges recorded to date</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Cost Incurred to Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_1d7b6573-c53b-4002-96d5-dd09edb4afbb_terseLabel_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Time deposits(1)</link:label>
    <link:label id="lab_us-gaap_BankTimeDepositsMember_label_en-US" xlink:label="lab_us-gaap_BankTimeDepositsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bank Time Deposits [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BankTimeDepositsMember" xlink:to="lab_us-gaap_BankTimeDepositsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3e76b305-d5f6-4c0b-9bc6-494be1b84026_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_4eac9531-7a0b-4a77-a22d-3dd6a146f7b3_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_53880b7e-1bcf-471c-b821-f840e074b357_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of previously held equity investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_EquityMethodInvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_78243656-dbd1-4c6e-991f-2265e3eee265_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lender Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis" xlink:to="lab_us-gaap_LineOfCreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_c381a3cd-20ff-44c1-8484-4f037735ac42_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitiesTable_137940c9-e5de-49db-bab3-4dd57819bbc8_terseLabel_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:label id="lab_dei_EntitiesTable_label_en-US" xlink:label="lab_dei_EntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_da7c72f2-ea74-40fe-ba97-ecc8ac19356e_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7a7a74ea-0183-4b1c-a5b1-7fdc9d23316e_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AsrMember_55efaa4f-1f74-4884-be0e-e62c43a87399_terseLabel_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR</link:label>
    <link:label id="lab_jnj_AsrMember_label_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR [Member]</link:label>
    <link:label id="lab_jnj_AsrMember_documentation_en-US" xlink:label="lab_jnj_AsrMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASR.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember" xlink:href="jnj-20200628.xsd#jnj_AsrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AsrMember" xlink:to="lab_jnj_AsrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0b889e79-c6b5-4efb-9804-dee3eb53a04c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IdorsiaLTDMember_58edbdc6-fb78-4f1f-a42c-c4167f2ab860_terseLabel_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia</link:label>
    <link:label id="lab_jnj_IdorsiaLTDMember_label_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia LTD [Member]</link:label>
    <link:label id="lab_jnj_IdorsiaLTDMember_documentation_en-US" xlink:label="lab_jnj_IdorsiaLTDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Idorsia LTD</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IdorsiaLTDMember" xlink:to="lab_jnj_IdorsiaLTDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_7ba9ecdf-69a3-434b-a167-725af01d13d7_terseLabel_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess of the estimated fair value over the carrying value of debt</link:label>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_label_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess Of Fair Value Over Carrying Value Of Debt</link:label>
    <link:label id="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt_documentation_en-US" xlink:label="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excess of fair value over carrying value of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:href="jnj-20200628.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:to="lab_jnj_ExcessOfFairValueOverCarryingValueOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_abe9f21c-88f1-45e7-88a6-2773e6448453_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_b820eb8b-5b9b-446c-b358-8051942fbf58_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivatives Recorded in Consolidated Balance Sheet</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Liabilities at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_GrossProfitPercentToSales_214dece4-e5c7-48c0-a4ee-14f53aeb04d7_totalLabel_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit percent to sales</link:label>
    <link:label id="lab_jnj_GrossProfitPercentToSales_label_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit Percent To Sales</link:label>
    <link:label id="lab_jnj_GrossProfitPercentToSales_documentation_en-US" xlink:label="lab_jnj_GrossProfitPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales" xlink:href="jnj-20200628.xsd#jnj_GrossProfitPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_GrossProfitPercentToSales" xlink:to="lab_jnj_GrossProfitPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_83cfed02-c52a-4c2e-bf0a-be5b00db9702_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_7e8eb70b-af5a-416e-b900-02258e4d3a54_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, marketing and administrative expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_4f662a4a-50b9-4fe9-bab0-3f87e7dae976_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Currency translation/Other</link:label>
    <link:label id="lab_us-gaap_GoodwillOtherIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Other Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillOtherIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillOtherIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_b94a6a22-8a21-4aee-bffa-2e8fc29249e5_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Liabilities</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_83672082-a17d-4f65-9c9a-9c6c74a295e3_terseLabel_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033</link:label>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_label_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033 [Member]</link:label>
    <link:label id="lab_jnj_A4.95Debenturesdue2033Member_documentation_en-US" xlink:label="lab_jnj_A4.95Debenturesdue2033Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.95% Debentures due 2033 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member" xlink:href="jnj-20200628.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.95Debenturesdue2033Member" xlink:to="lab_jnj_A4.95Debenturesdue2033Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_KNEESMember_4dabe79e-2432-42b4-9fd9-d69a69632774_terseLabel_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES</link:label>
    <link:label id="lab_jnj_KNEESMember_label_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES [Member]</link:label>
    <link:label id="lab_jnj_KNEESMember_documentation_en-US" xlink:label="lab_jnj_KNEESMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">KNEES [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember" xlink:href="jnj-20200628.xsd#jnj_KNEESMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_KNEESMember" xlink:to="lab_jnj_KNEESMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_13ca0b14-7905-45a3-85a3-e473e64b69ce_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_bcd3698f-b299-453b-93ee-baadcc608bc1_terseLabel_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling marketing and administrative expenses percent to sales</link:label>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_label_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling General And Administrative Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling general and administrative expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:href="jnj-20200628.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:to="lab_jnj_SellingGeneralAndAdministrativeExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_56af6847-c0b8-4639-a2f2-6c01d307a7b3_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_JudicialRulingMember_f4ef77bc-6b23-4f1a-ae43-9deb1c9dc10f_terseLabel_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling</link:label>
    <link:label id="lab_us-gaap_JudicialRulingMember_label_en-US" xlink:label="lab_us-gaap_JudicialRulingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Judicial Ruling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_JudicialRulingMember" xlink:to="lab_us-gaap_JudicialRulingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_ccfd107e-9f42-425b-98f1-b8ff2a81866e_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt (Note 4)</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_0f855262-5c16-468a-96c2-85cd914780cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Current Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_86c9782d-d34e-49a5-9e47-2ea39e618d72_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_50290f8e-1b1e-4734-a645-d2b4a9318a81_verboseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_89f2c8aa-e8d9-4afa-acb2-19d11dfa1aaa_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e3f1e1c3-de32-429c-906a-8fd5b2c511c8_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_bb4c4f91-0cc3-434f-b437-648a33ded5f3_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_833a3b05-2347-4bc6-88ba-6a9084258e12_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and employee related obligations</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_f0be7be5-2ea6-4625-be07-d7cfa7713e98_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant other observable inputs Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_736dd690-a10d-4c66-9f78-e1357c21ad3f_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_b098409d-9a25-4157-9196-e1adaedb0e3b_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials and supplies</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials and Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_399d018e-c022-41b8-b774-2c277153fcff_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements and Changes in Accounting Principles [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_0fa52948-d2dd-439a-b6a5-87e2de7184e8_verboseLabel_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax (Textuals)</link:label>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_label_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax (Textuals) [Abstract]</link:label>
    <link:label id="lab_jnj_IncomeTaxTextualsAbstract_documentation_en-US" xlink:label="lab_jnj_IncomeTaxTextualsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Textuals Abstract.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_IncomeTaxTextualsAbstract" xlink:to="lab_jnj_IncomeTaxTextualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_9059aef9-6bdd-4dc2-887e-8f36a2b677c6_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_d8d9d4b4-2bc8-404e-906c-7d6f45a9b310_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Maturity and Collection of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5b442fb6-4251-4bda-bfb4-ad1c4a330b88_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_1f038fc1-3ba6-4756-af1d-28ffbc8b1852_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effect of Derivatives not Designated as Hedging Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_d2c2d655-2e7d-4992-9097-0ad3c62a42e0_verboseLabel_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of designated derivatives</link:label>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_label_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Gain Loss On Statement Of Financial Performance Abstract</link:label>
    <link:label id="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_documentation_en-US" xlink:label="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments gain loss on statement of financial performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:href="jnj-20200628.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:to="lab_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_5e9d1b86-26c3-44cd-a6ce-327f931f9cdf_terseLabel_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency Number Of Claimants</link:label>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_label_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Liability Contingency Number Of Claimant</link:label>
    <link:label id="lab_jnj_ProductLiabilityContingencyNumberOfClaimant_documentation_en-US" xlink:label="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product liability contingency number of claimant.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:href="jnj-20200628.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:to="lab_jnj_ProductLiabilityContingencyNumberOfClaimant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_71b580a6-8dff-4419-9313-e44b2c3592c0_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentInProcess" xlink:to="lab_us-gaap_ResearchAndDevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0c368c0a-5abb-485a-9003-fceb2d3838b2_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND SHAREHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfSubsidiaryGainLossMember_b63d3c0e-018d-4635-9705-8afe63a17cd7_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Subsidiary Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_SaleOfSubsidiaryGainLossMember_label_en-US" xlink:label="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Subsidiary Gain (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:to="lab_us-gaap_SaleOfSubsidiaryGainLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_862208b5-197c-4756-8d87-b293bd8dad67_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9b9dd383-257b-4df1-b4e9-adc944b6b69e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Current Other Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_97cbab36-ca10-4f14-aa42-e6ef8f7951cd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_5b80db24-5917-470e-ace3-be3a5af547a3_verboseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_437a52bb-b140-440e-bde6-f6998b37ee67_terseLabel_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA&#174; / INVOKAMET&#174;</link:label>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_label_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA/INVOKAMET [Member]</link:label>
    <link:label id="lab_jnj_INVOKANAINVOKAMETMember_documentation_en-US" xlink:label="lab_jnj_INVOKANAINVOKAMETMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVOKANA/INVOKAMET [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember" xlink:href="jnj-20200628.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_INVOKANAINVOKAMETMember" xlink:to="lab_jnj_INVOKANAINVOKAMETMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_fbcaef5e-c5c2-410f-a871-b0bb41950375_terseLabel_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.40%&#160;Notes due 2038</link:label>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_label_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.400% Notes due 2038 [Member]</link:label>
    <link:label id="lab_jnj_A3.400Notesdue2038Member_documentation_en-US" xlink:label="lab_jnj_A3.400Notesdue2038Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.400% Notes due 2038 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member" xlink:href="jnj-20200628.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.400Notesdue2038Member" xlink:to="lab_jnj_A3.400Notesdue2038Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_15056f37-abe9-4a09-b4a4-45c2aa281269_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_10f07683-29ee-4f33-a530-2bfa7dcf840f_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH FLOWS FROM FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_7e72b3e3-0916-4620-aa9e-f7bdd760e549_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_33089cb3-f603-4821-bdb1-abae84a2a5ff_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_1470a491-ec04-4b1a-954b-bcdc0f068353_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_30830261-49e5-42ad-b1d1-923cd35afd5b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after five years through ten years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c66f7669-bc72-4e36-818e-d8f0da2a33d2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_938e3a12-890b-4b29-9238-341f43ece786_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_b7bb1e62-dd9e-477b-8853-51625e81b690_terseLabel_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023</link:label>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_label_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A2.05Notesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A2.05Notesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.05% Notes due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member" xlink:href="jnj-20200628.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.05Notesdue2023Member" xlink:to="lab_jnj_A2.05Notesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_VELCADEMember_62e3507a-b7b0-4d16-b675-9bfcb11cd5e3_terseLabel_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE&#174;</link:label>
    <link:label id="lab_jnj_VELCADEMember_label_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE [Member]</link:label>
    <link:label id="lab_jnj_VELCADEMember_documentation_en-US" xlink:label="lab_jnj_VELCADEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">VELCADE [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember" xlink:href="jnj-20200628.xsd#jnj_VELCADEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_VELCADEMember" xlink:to="lab_jnj_VELCADEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_d837f5c9-bbc6-4f9a-952a-a08e08783368_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_9df14361-5fa5-40ff-bd63-8e5c348d8d18_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability related to TRAF</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_57e73c25-5327-4403-8cb7-17913a0d0901_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Amortization Expense, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AurisHealthMember_af819d3b-fdb9-4068-b96b-e511493e4fdc_terseLabel_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health</link:label>
    <link:label id="lab_jnj_AurisHealthMember_label_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health [Member]</link:label>
    <link:label id="lab_jnj_AurisHealthMember_documentation_en-US" xlink:label="lab_jnj_AurisHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auris Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AurisHealthMember" xlink:to="lab_jnj_AurisHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ce83d3c4-9002-46f4-a0f1-3514af231300_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Fair Value Hierarchy</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7c1353a9-3f2d-49c2-8e0d-ce290d20f9e0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions to property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_8a7c8d9a-8c96-4cc2-acaa-0fbc8b501117_terseLabel_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities, Unrecognized Gain</link:label>
    <link:label id="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_label_en-US" xlink:label="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:to="lab_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_c0f1c7c3-8bdb-486c-a22a-981f4ad67d5e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_207ebcb6-f2fc-4ec9-a1b5-3ce92a6465d9_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_ae517490-c381-4cd2-9885-d7045f4cbf03_periodStartLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, beginning of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_6e4ffad6-0a3d-4f11-a183-64520a440557_periodEndLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, end of period</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_09efd617-2056-473a-a155-78306764e2a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_4e5feb2d-dfab-4afc-b703-eb88ded01921_terseLabel_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:label id="lab_us-gaap_RetirementPlanTypeDomain_label_en-US" xlink:label="lab_us-gaap_RetirementPlanTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plan Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetirementPlanTypeDomain" xlink:to="lab_us-gaap_RetirementPlanTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_3c139979-1b4c-4a96-9a2d-dc2c06c58480_terseLabel_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_label_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Due Period Fifteen Member</link:label>
    <link:label id="lab_jnj_NotesDuePeriodFifteenMember_documentation_en-US" xlink:label="lab_jnj_NotesDuePeriodFifteenMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes due period fifteen.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember" xlink:href="jnj-20200628.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NotesDuePeriodFifteenMember" xlink:to="lab_jnj_NotesDuePeriodFifteenMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_f53a2b4e-ad12-418a-9aa6-68fb2ee91a5e_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Assets and Liabilities at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_ce542105-b44c-496a-bf32-a549dd0ccc0c_terseLabel_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales By Segment Of Business</link:label>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_label_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales By Segment Of Business [Table Text Block]</link:label>
    <link:label id="lab_jnj_SalesBySegmentOfBusinessTableTextBlock_documentation_en-US" xlink:label="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales by segment of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:href="jnj-20200628.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:to="lab_jnj_SalesBySegmentOfBusinessTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_4c3e2a9e-7475-4a63-830b-9da4d8f97b24_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit losses and accounts receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_a931c8b0-f28d-4ce2-a3eb-0ce11014dc75_totalLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Net Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_d292b75c-8fd4-48d4-928e-012b9c23497f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_fe6cee47-2acb-4b17-acfb-ace6fde90a53_verboseLabel_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due November 2024</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_893fc69b-3f79-40ba-88c6-1cc60518afbc_terseLabel_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes due 2024 (500 MM GBP 1.2431)</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_label_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due 2024 [Member]</link:label>
    <link:label id="lab_jnj_A5.50NotesDue2024Member_documentation_en-US" xlink:label="lab_jnj_A5.50NotesDue2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.50% Notes Due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member" xlink:href="jnj-20200628.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.50NotesDue2024Member" xlink:to="lab_jnj_A5.50NotesDue2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_e3b9b31a-fbc8-4ebd-8e6c-3f78183e2772_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_3c312005-7598-4d59-858a-8163a5af4fb9_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_2d79b05f-76e7-4f00-95e5-18a1667855b3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Assets, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetsNoncurrent" xlink:to="lab_us-gaap_DerivativeAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_afc0177b-64d2-468d-afec-229df583348e_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit related to TRAF, percent</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_0354f416-99b5-4848-b69d-836cadf007e5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RisperdalMember_24a33935-0a36-4029-9995-bafcc5bc5515_terseLabel_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal</link:label>
    <link:label id="lab_jnj_RisperdalMember_label_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal [Member]</link:label>
    <link:label id="lab_jnj_RisperdalMember_documentation_en-US" xlink:label="lab_jnj_RisperdalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risperdal.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RisperdalMember" xlink:to="lab_jnj_RisperdalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionContributions_ef1bcce6-f52d-4bd0-80f5-155bb866ab0a_terseLabel_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution to pension plans</link:label>
    <link:label id="lab_us-gaap_PensionContributions_label_en-US" xlink:label="lab_us-gaap_PensionContributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Pension Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionContributions" xlink:to="lab_us-gaap_PensionContributions" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_be942890-8587-4d2c-b369-39d5c6aa3dac_terseLabel_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046</link:label>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_label_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046 [Member]</link:label>
    <link:label id="lab_jnj_A3.70Notesdue2046Member_documentation_en-US" xlink:label="lab_jnj_A3.70Notesdue2046Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.70% Notes due 2046 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member" xlink:href="jnj-20200628.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.70Notesdue2046Member" xlink:to="lab_jnj_A3.70Notesdue2046Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_c1ddd326-dd11-42f3-97dc-7ec097628e9f_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes on income (Note 5)</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_655b6424-e586-4800-a7a7-ad0f39e45a63_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash dividends paid (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_d3ede114-ec68-4dd7-a91a-e68991473b7c_verboseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S.</link:label>
    <link:label id="lab_country_US_763470e9-9a10-4f66-bd87-dce0fb18bd43_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_f10070eb-4708-4641-96bb-af69e7135b90_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_ddaec281-b31d-4b21-a99e-07f1ea08ab17_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e676a788-e571-46ca-abfb-60097c63439c_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_MedicalDevicesMember_31e524a8-bbd7-48b2-b395-ecf71d717d99_verboseLabel_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_2e6b51ac-de8c-4fcb-94f9-82e8b0a464bc_terseLabel_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MEDICAL DEVICES</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_label_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:label id="lab_jnj_MedicalDevicesMember_documentation_en-US" xlink:label="lab_jnj_MedicalDevicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Devices [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_MedicalDevicesMember" xlink:to="lab_jnj_MedicalDevicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_8ef5a3d9-887e-4bf9-b370-43bd9f934333_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_dbc58594-5cda-4826-8a06-fd90bae2176d_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsLineItems_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems" xlink:to="lab_us-gaap_CashAndCashEquivalentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_a6060410-e7d3-4efb-8dd1-452afd603a23_terseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Unrecognized Gain</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:to="lab_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c8d036a5-ecc2-42e5-9933-cfb745f926f5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_13701a66-b90f-4499-9700-75b58b02fedd_verboseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of foreign exchange contracts into earnings, period</link:label>
    <link:label id="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_label_en-US" xlink:label="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Reclassification of Cash Flow Hedge Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:to="lab_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a47fe9d1-9f7c-46af-9f8f-3bba5de90aaf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherOncologyMember_34fbdadc-871c-4d9f-9c2d-a7695230920e_terseLabel_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ONCOLOGY</link:label>
    <link:label id="lab_jnj_OtherOncologyMember_label_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Oncology [Member]</link:label>
    <link:label id="lab_jnj_OtherOncologyMember_documentation_en-US" xlink:label="lab_jnj_OtherOncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Oncology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember" xlink:href="jnj-20200628.xsd#jnj_OtherOncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherOncologyMember" xlink:to="lab_jnj_OtherOncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_99b8fedf-962f-4a4a-aa71-3f5839c3010d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_7d081b35-d836-41c3-b3ae-9e69abc09be6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_835ab8eb-4aff-4913-868e-9423a7c92413_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income on derivatives, after tax</link:label>
    <link:label id="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_label_en-US" xlink:label="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:to="lab_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3ad27f46-da26-47dd-8b0f-7edcbb3c8083_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_00958f2d-bb4a-4d33-a99a-32537266f136_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_0d3da2ec-41f4-4e6e-ac99-6791001a1c4d_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_aea01f28-bf7d-493c-b51a-456ce52e8d3a_terseLabel_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023</link:label>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_label_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023 [Member]</link:label>
    <link:label id="lab_jnj_A6.73Debenturesdue2023Member_documentation_en-US" xlink:label="lab_jnj_A6.73Debenturesdue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">6.73% Debentures due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member" xlink:href="jnj-20200628.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A6.73Debenturesdue2023Member" xlink:to="lab_jnj_A6.73Debenturesdue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_7e8b718b-a539-4210-9327-6b903a0a9651_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_2e6d3dbb-8722-429e-ac36-c1c5100f2880_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_127206a8-63ee-44e2-b8ff-c8c798953cf1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications to earnings</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_dc1dce7e-7f1f-48e2-81d0-8d2a2ca0647f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain/ (Loss) reclassified from Accumulated OCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_23028508-8341-40e2-ab46-56f26f3f7982_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_41110e36-5d7f-4916-9acd-f0ac96975591_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_d3a090ad-eb8f-4c18-a626-a1e2db419215_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ERLEADAMember_a192bdf8-311f-488b-999b-a74da712164f_terseLabel_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA [Member]</link:label>
    <link:label id="lab_jnj_ERLEADAMember_label_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA [Member]</link:label>
    <link:label id="lab_jnj_ERLEADAMember_documentation_en-US" xlink:label="lab_jnj_ERLEADAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ERLEADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember" xlink:href="jnj-20200628.xsd#jnj_ERLEADAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ERLEADAMember" xlink:to="lab_jnj_ERLEADAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c3dad686-12bc-426f-ad08-ad2f0545d774_verboseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets with indefinite lives:</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_5958f332-e907-4f8d-a5e0-38f804759b61_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_8388ba7a-a20e-40fc-8f67-81f533ccb78d_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_54e107ee-5e2f-426d-823b-556cdb90a068_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_d2151d11-0aed-422c-8190-15add0ad9527_terseLabel_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks</link:label>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_label_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:label id="lab_jnj_PatentsAndTrademarksMember_documentation_en-US" xlink:label="lab_jnj_PatentsAndTrademarksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Trademarks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember" xlink:href="jnj-20200628.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PatentsAndTrademarksMember" xlink:to="lab_jnj_PatentsAndTrademarksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_7d30ca7c-086d-4530-ad69-8a82b126f8d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring (Note 12)</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_55744f2b-52d1-407f-8d25-be60b6e003cc_verboseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_16afd61c-6add-4a44-9292-da7632d1559b_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_03ff062b-5e1c-4fe2-9ff9-cc29e23c27cc_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a592cd42-8788-4858-b71e-0d525f4178be_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH USED BY INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_cdfef0f6-abb5-4a2f-a663-08296adf6948_terseLabel_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037</link:label>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_label_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037 [Member]</link:label>
    <link:label id="lab_jnj_A3.625Notesdue2037Member_documentation_en-US" xlink:label="lab_jnj_A3.625Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.625% Notes due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member" xlink:href="jnj-20200628.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.625Notesdue2037Member" xlink:to="lab_jnj_A3.625Notesdue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherImmunologyMember_a051f4da-7635-4c46-975f-7f77b1a9957c_terseLabel_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER IMMUNOLOGY</link:label>
    <link:label id="lab_jnj_OtherImmunologyMember_label_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Immunology [Member]</link:label>
    <link:label id="lab_jnj_OtherImmunologyMember_documentation_en-US" xlink:label="lab_jnj_OtherImmunologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Immunology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember" xlink:href="jnj-20200628.xsd#jnj_OtherImmunologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherImmunologyMember" xlink:to="lab_jnj_OtherImmunologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_d21a3c5f-e379-4669-a21a-d708369711c9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisition cost</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_a1c19593-9c4e-46e6-b88f-2dab109ffe7a_terseLabel_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA&#174;</link:label>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_label_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA [Member]</link:label>
    <link:label id="lab_jnj_RISPERDALCONSTAMember_documentation_en-US" xlink:label="lab_jnj_RISPERDALCONSTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RISPERDAL CONSTA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember" xlink:href="jnj-20200628.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RISPERDALCONSTAMember" xlink:to="lab_jnj_RISPERDALCONSTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_1a8a4fc5-fc7f-4ed1-8f9b-cf1c12474c5a_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_BermekimabMember_3798fca3-1dcb-45e3-bcb2-94b1697fa4d9_terseLabel_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab</link:label>
    <link:label id="lab_jnj_BermekimabMember_label_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab [Member]</link:label>
    <link:label id="lab_jnj_BermekimabMember_documentation_en-US" xlink:label="lab_jnj_BermekimabMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">bermekimab [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember" xlink:href="jnj-20200628.xsd#jnj_BermekimabMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_BermekimabMember" xlink:to="lab_jnj_BermekimabMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_fa606dc7-2de4-4f2d-86e6-f0eadabab1fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_6c5ffcaf-9627-489d-81c9-d5c435c6ed87_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_82b56552-0e0b-4da6-aeb3-fc9cb59bf07f_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized gain (loss) arising during period</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_9742a85f-0e07-4ca4-9f0d-b7017a660f48_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_2a3a47d6-17e3-4186-8103-708f5e758116_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_a4c9690c-e65b-4d8d-abce-75c21aef9073_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of short-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfShortTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Short-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfShortTermDebt" xlink:to="lab_us-gaap_RepaymentsOfShortTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_83f37d1d-fab9-42c7-8830-107013296655_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_d7dd144f-6e03-417f-98a2-bf76abd49dc6_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_011588a2-570e-4ec1-94d3-15a62d7e782b_terseLabel_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest after sale</link:label>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_label_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</link:label>
    <link:label id="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_documentation_en-US" xlink:label="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:href="jnj-20200628.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:to="lab_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_59b29b1b-b26e-4871-948a-bcd2f432831f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e6393489-8036-430d-b0ae-5113e2369e1a_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_09f0a480-0770-4f51-a101-0ef58d4d366a_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_b97ffd1d-931b-4667-b580-48d85237a6c7_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8883c1f6-1605-4edf-811f-935b290f2827_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value per share</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_9032315e-b5ee-4e8c-ad14-3cbb9ceec6b0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:label id="lab_us-gaap_PaymentsForRestructuring_label_en-US" xlink:label="lab_us-gaap_PaymentsForRestructuring" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Restructuring</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRestructuring" xlink:to="lab_us-gaap_PaymentsForRestructuring" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_21d6ae14-3dfa-475b-b18e-ec09f651adce_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset write-downs</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterventionalSolutionsMember_f4a96e20-dc6a-4454-9023-e4a0df0e8e96_verboseLabel_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions</link:label>
    <link:label id="lab_jnj_InterventionalSolutionsMember_label_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions [Member]</link:label>
    <link:label id="lab_jnj_InterventionalSolutionsMember_documentation_en-US" xlink:label="lab_jnj_InterventionalSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember" xlink:href="jnj-20200628.xsd#jnj_InterventionalSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterventionalSolutionsMember" xlink:to="lab_jnj_InterventionalSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_351e1c89-706c-4da1-bf96-8a25a45646d6_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories (Note 2)</link:label>
    <link:label id="lab_us-gaap_InventoryNet_c4960a8b-3fb7-461d-9eb6-f4cea93f9190_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9ef54ee1-e5a3-474f-868a-01b4c41ec539_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5c2317ad-c7d6-4ad2-ac51-3f63f08a87d3_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_331c97da-ea01-4ffd-bf1c-a12a41009630_verboseLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prior service cost/(credit)</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Prior Service Cost (Credit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterestExpensePercentToSales_33c98dd9-052f-41c7-919f-e9eceed48b33_terseLabel_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net of portion capitalized percent to sales</link:label>
    <link:label id="lab_jnj_InterestExpensePercentToSales_label_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense Percent To Sales</link:label>
    <link:label id="lab_jnj_InterestExpensePercentToSales_documentation_en-US" xlink:label="lab_jnj_InterestExpensePercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales" xlink:href="jnj-20200628.xsd#jnj_InterestExpensePercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterestExpensePercentToSales" xlink:to="lab_jnj_InterestExpensePercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_7ccc05a0-4df6-40b2-b920-f0f50479c7ac_verboseLabel_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retirement Plans</link:label>
    <link:label id="lab_us-gaap_PensionPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PensionPlansDefinedBenefitMember" xlink:to="lab_us-gaap_PensionPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_bf862572-7deb-4fba-a2ae-ee8f3c2ee190_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="lab_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_dfd79c60-3c5b-4855-aa7e-f50dbbb4a06d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLenderDomain_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Lender [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain" xlink:to="lab_us-gaap_LineOfCreditFacilityLenderDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_1efd2043-27b3-4344-8959-cf3a2757ff0f_verboseLabel_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</link:label>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_label_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</link:label>
    <link:label id="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_documentation_en-US" xlink:label="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:href="jnj-20200628.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:to="lab_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0751deba-bc8c-40a3-af0b-4aa29d2763b7_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_c0c28ed5-27e4-4716-94b2-b7033939c32c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_e7a78a5a-e1fc-4657-ad3b-ea3c62058c23_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in other current and non-current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_98478aab-6500-4b00-a4d3-c20932cbf2b8_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_6050d20f-6444-449b-a436-97b9e62d8903_terseLabel_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027</link:label>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_label_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027 [Member]</link:label>
    <link:label id="lab_jnj_A2.95Notesdue2027Member_documentation_en-US" xlink:label="lab_jnj_A2.95Notesdue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.95% Notes due 2027 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member" xlink:href="jnj-20200628.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.95Notesdue2027Member" xlink:to="lab_jnj_A2.95Notesdue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashMember_9ac719f6-fa33-446e-9cdf-1dcbde0f05f2_terseLabel_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashMember_label_en-US" xlink:label="lab_us-gaap_CashMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashMember" xlink:to="lab_us-gaap_CashMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_f6c2e666-8cbb-42c0-9b3a-673ef34e30f1_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_1afdd2c5-a3c8-4509-971c-d552c94229a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6a56dfee-56c8-4576-bfe4-af87e8e4ffce_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OpioidMember_1fcfa430-a321-43dd-8ec2-d4ae124518c0_terseLabel_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid</link:label>
    <link:label id="lab_jnj_OpioidMember_label_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">opioid [Member]</link:label>
    <link:label id="lab_jnj_OpioidMember_documentation_en-US" xlink:label="lab_jnj_OpioidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Opioid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember" xlink:href="jnj-20200628.xsd#jnj_OpioidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OpioidMember" xlink:to="lab_jnj_OpioidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_1e186300-163b-44b5-a8e2-a06be30a8e60_verboseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_385b4896-fbc7-45a9-a486-c4e9d3294fc8_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of products sold</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_809b4ee4-1ca5-4031-82ae-d03654b6b820_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_1d696725-381c-4754-b487-14b5a710fc13_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_55d670d0-21b6-4f61-ae0e-aa56eedff54b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_055c2f1d-3a6a-4938-9d16-3ad072ed84ca_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_e756bed3-a993-4bf7-bf44-9c4c58d73290_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Worldwide effective income tax rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_a42168cc-c9b5-475f-b323-426b71b034d9_terseLabel_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041</link:label>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_label_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041 [Member]</link:label>
    <link:label id="lab_jnj_A4.85Notesdue2041Member_documentation_en-US" xlink:label="lab_jnj_A4.85Notesdue2041Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">4.85% Notes due 2041 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member" xlink:href="jnj-20200628.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A4.85Notesdue2041Member" xlink:to="lab_jnj_A4.85Notesdue2041Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_3347d25b-fbdc-4c1c-8e5a-0d342d716e9f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveSettledWithoutCash2_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve, Settled without Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:to="lab_us-gaap_RestructuringReserveSettledWithoutCash2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_26981a93-d078-408e-bd68-15f053ee3f23_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_eec5f73f-bd88-4c94-99b5-4faab263eabd_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherMember_ef267117-78fb-489d-bdc7-46538046d82c_terseLabel_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER PULMONARY HYPERTENSION</link:label>
    <link:label id="lab_jnj_OtherMember_label_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:label id="lab_jnj_OtherMember_documentation_en-US" xlink:label="lab_jnj_OtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember" xlink:href="jnj-20200628.xsd#jnj_OtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherMember" xlink:to="lab_jnj_OtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_e6edcda8-7d89-49c5-87f7-8f7c3ccb1b4a_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_9df6b56e-93d9-45fa-84c1-95b1c661f297_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock &#8212; par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_800292ec-adde-44ba-897d-c91f5c9a4e0f_terseLabel_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_afd627b1-0803-4a3e-b80d-a42a35c5cb0c_verboseLabel_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (income)/Interest expense, net</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_label_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member</link:label>
    <link:label id="lab_jnj_InterestIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_jnj_InterestIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income Expense Net Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember" xlink:href="jnj-20200628.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InterestIncomeExpenseNetMember" xlink:to="lab_jnj_InterestIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_8359bbe1-db16-4049-a56d-d6e58a8ec059_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_1cc45ca5-0132-4a48-8562-904a9950ae71_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal group consideration, cash</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_5dfbf6d2-85c0-469b-ba5f-3f3ad91706f3_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_RestructuringReserveRollForward_label_en-US" xlink:label="lab_us-gaap_RestructuringReserveRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Reserve [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringReserveRollForward" xlink:to="lab_us-gaap_RestructuringReserveRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_54062d75-4700-45fd-9c4e-e97a23a7119a_verboseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations and Divestitures</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_TRAUMAMember_348354b5-bb48-46c5-8715-b9e88825f8a8_terseLabel_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA</link:label>
    <link:label id="lab_jnj_TRAUMAMember_label_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA [Member]</link:label>
    <link:label id="lab_jnj_TRAUMAMember_documentation_en-US" xlink:label="lab_jnj_TRAUMAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TRAUMA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember" xlink:href="jnj-20200628.xsd#jnj_TRAUMAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_TRAUMAMember" xlink:to="lab_jnj_TRAUMAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_0b5a8fda-33bc-465e-a2dd-6a1331f8d2da_negatedLabel_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognized actuarial losses</link:label>
    <link:label id="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_label_en-US" xlink:label="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Benefit Plan, Amortization of Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:to="lab_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_72c0bc27-719b-47d5-a8db-7c0c957ee5d3_terseLabel_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (income) expense</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_42741a65-c4c5-4ba7-9ba3-319fbe779081_verboseLabel_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_label_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:label id="lab_jnj_OtherIncomeExpenseNetMember_documentation_en-US" xlink:label="lab_jnj_OtherIncomeExpenseNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income Expense Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherIncomeExpenseNetMember" xlink:to="lab_jnj_OtherIncomeExpenseNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_db58e027-161d-45dd-8e5e-00b43950881b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_a93b48ab-4f6c-459f-a30f-1a3c679069e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_41bbf46e-3ff7-4d9d-86bf-92e4071d57a9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_2f90daeb-dc2e-4b6d-a47b-0dd58b00ee96_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Basis</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_69449401-efc0-49db-a9f4-7d7e30ebe349_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_6edcc91e-d8ea-42dd-9e7f-2e46362b9258_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OncologyMember_5ce50bfd-f344-4fe5-ae4e-31dd7ea2c243_terseLabel_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology</link:label>
    <link:label id="lab_jnj_OncologyMember_label_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology [Member]</link:label>
    <link:label id="lab_jnj_OncologyMember_documentation_en-US" xlink:label="lab_jnj_OncologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Oncology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember" xlink:href="jnj-20200628.xsd#jnj_OncologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OncologyMember" xlink:to="lab_jnj_OncologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3f3386d2-17c5-4330-bc33-4c81df6dca0d_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potential shares exercisable under stock option plans</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesMember_ab000b04-605d-4cb4-9eac-49b843c2641d_terseLabel_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities</link:label>
    <link:label id="lab_us-gaap_HeldtomaturitySecuritiesMember_label_en-US" xlink:label="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-to-maturity Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HeldtomaturitySecuritiesMember" xlink:to="lab_us-gaap_HeldtomaturitySecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_23b18eec-425c-463f-a5d6-3bf8d7a21643_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring estimated cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OTCMember_8f7a02b8-d848-4085-b3f0-6d37ab342d08_terseLabel_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skin Health/Beauty</link:label>
    <link:label id="lab_jnj_OTCMember_label_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC [Member]</link:label>
    <link:label id="lab_jnj_OTCMember_documentation_en-US" xlink:label="lab_jnj_OTCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember" xlink:href="jnj-20200628.xsd#jnj_OTCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OTCMember" xlink:to="lab_jnj_OTCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_95ef195a-9d60-496e-923a-43e5860c604b_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_a475ba07-2efe-4b25-8a49-753203857b67_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_43c38672-ac5e-4944-ad35-887beaeaaee1_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2f06ed1e-4d69-4cea-b109-0ec604955fa2_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average shares outstanding &#8212; basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_4e0c9a0d-04f4-48f2-8db7-6fbd3b6cdbe3_terseLabel_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense percent to sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_label_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research And Development Expense Excluding Acquired In Process Cost Percent To Sales</link:label>
    <link:label id="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_documentation_en-US" xlink:label="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development expense excluding acquired in process cost percent to sales.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:to="lab_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_6a778350-396d-4ae1-9396-3757bbd08ff8_periodStartLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, beginning of period</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_46243986-a7ff-4c87-8302-80589cf1ff8d_periodEndLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying value, end of period</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesNoncurrent" xlink:to="lab_us-gaap_MarketableSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_e38e7f8a-2588-4f21-b9cf-a6660de23d5c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_457e9191-9ea4-4c4d-b0a6-133e09114720_terseLabel_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and current marketable securities, Estimated Fair Value</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_label_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, And Short-Term Investments, Estimated Fair Value</link:label>
    <link:label id="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_documentation_en-US" xlink:label="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:to="lab_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_33e46652-6a26-433c-9a53-d59a46e43ec7_terseLabel_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037</link:label>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_label_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037 [Member]</link:label>
    <link:label id="lab_jnj_A5.95Notesdue2037Member_documentation_en-US" xlink:label="lab_jnj_A5.95Notesdue2037Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">5.95% Notes due 2037 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member" xlink:href="jnj-20200628.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A5.95Notesdue2037Member" xlink:to="lab_jnj_A5.95Notesdue2037Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_677ccf0f-6d61-4c84-96ec-cd6784b73549_terseLabel_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment on unrecognized tax benefit liability</link:label>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_label_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit Liability, Payment</link:label>
    <link:label id="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment_documentation_en-US" xlink:label="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefit Liability, Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:href="jnj-20200628.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:to="lab_jnj_UnrecognizedTaxBenefitLiabilityPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_fdbd1ae7-466e-4dea-a87c-7dfa53f03e64_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_46429d72-a60b-4045-a4d9-3aacb04530c5_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense of amortizable intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_0ba4d09c-81a4-4c32-8a14-523a73390b6d_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments : Assets</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:to="lab_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_905a7641-0a9e-44c5-a21b-0a06c0afc469_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_52afa8b6-869a-4167-b972-a6304b2cbc96_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in other current and non-current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_37c4d190-b616-4661-ad30-4a6f8a95c922_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents and Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_983d401b-8776-439d-88b9-ac8906dd99b7_terseLabel_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:label id="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis_label_en-US" xlink:label="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Security Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="lab_us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_5bbe360f-ea01-4d84-8d79-10bd67bae923_terseLabel_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax benefit related to TRAF</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_label_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</link:label>
    <link:label id="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_documentation_en-US" xlink:label="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:to="lab_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_790d8737-f146-4e4e-9b96-3bed676e7f2b_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Convertible Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtMember" xlink:to="lab_us-gaap_ConvertibleDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A3.55Notesdue2021Member_60d959e0-1d0b-4097-bf1b-bade42c5f8e0_terseLabel_en-US" xlink:label="lab_jnj_A3.55Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2021 [Member]</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2021Member_label_en-US" xlink:label="lab_jnj_A3.55Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2021 [Member]</link:label>
    <link:label id="lab_jnj_A3.55Notesdue2021Member_documentation_en-US" xlink:label="lab_jnj_A3.55Notesdue2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3.55% Notes due 2021 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2021Member" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A3.55Notesdue2021Member" xlink:to="lab_jnj_A3.55Notesdue2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PROCRITEPREXMember_32a3e64b-d6e1-47db-9df5-fbd419bb8942_terseLabel_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT&#174; / EPREX&#174;</link:label>
    <link:label id="lab_jnj_PROCRITEPREXMember_label_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT/EPREX [Member]</link:label>
    <link:label id="lab_jnj_PROCRITEPREXMember_documentation_en-US" xlink:label="lab_jnj_PROCRITEPREXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROCRIT/EPREX [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember" xlink:href="jnj-20200628.xsd#jnj_PROCRITEPREXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PROCRITEPREXMember" xlink:to="lab_jnj_PROCRITEPREXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_deed5f25-f8fe-4e8f-bd74-c2d74c4e2c59_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_25ddd8cb-5e18-4279-bc26-2aa0f5e9d848_terseLabel_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum length of time for hedge exposure</link:label>
    <link:label id="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_label_en-US" xlink:label="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Length of Time, Foreign Currency Cash Flow Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:to="lab_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b3662ed6-8895-4473-893d-eeb38a805a6c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_bfe3e3c1-dd87-474e-8de1-9ce7215f1360_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_2136fbc8-9e7c-4abe-85f1-fd69b5fcd7f0_terseLabel_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_label_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Settlement By Companies [Domain]</link:label>
    <link:label id="lab_jnj_LitigationSettlementByCompaniesDomain_documentation_en-US" xlink:label="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation settlement by companies.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain" xlink:to="lab_jnj_LitigationSettlementByCompaniesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_94d9c0ed-04fb-4662-b4e3-91e7df437fc9_terseLabel_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA&#174; / methylphenidate</link:label>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_label_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA/Methylphenidate [Member]</link:label>
    <link:label id="lab_jnj_CONCERTAMethylphenidateMember_documentation_en-US" xlink:label="lab_jnj_CONCERTAMethylphenidateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CONCERTA/Methylphenidate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember" xlink:href="jnj-20200628.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CONCERTAMethylphenidateMember" xlink:to="lab_jnj_CONCERTAMethylphenidateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_e1c13025-52d9-46e7-9b16-a134496e44af_verboseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash or Part Noncash Acquisition, Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_StelaraMember_4d4fede1-bbc7-46c6-99ce-b8e78658313a_terseLabel_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STELARA&#174;</link:label>
    <link:label id="lab_jnj_StelaraMember_label_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stelara [Member]</link:label>
    <link:label id="lab_jnj_StelaraMember_documentation_en-US" xlink:label="lab_jnj_StelaraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stelara [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember" xlink:href="jnj-20200628.xsd#jnj_StelaraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_StelaraMember" xlink:to="lab_jnj_StelaraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_SURGICALMember_b0734fec-8148-4bab-bbe5-ee2d68bbe055_terseLabel_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL</link:label>
    <link:label id="lab_jnj_SURGICALMember_label_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL [Member]</link:label>
    <link:label id="lab_jnj_SURGICALMember_documentation_en-US" xlink:label="lab_jnj_SURGICALMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SURGICAL [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember" xlink:href="jnj-20200628.xsd#jnj_SURGICALMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_SURGICALMember" xlink:to="lab_jnj_SURGICALMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_c5ea0a5b-272c-4e40-b711-74c5261f6f3a_terseLabel_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables retained</link:label>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_label_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Receivables Retained</link:label>
    <link:label id="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_documentation_en-US" xlink:label="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Receivables Retained</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:href="jnj-20200628.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:to="lab_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0821ebba-ea72-4c67-8d4d-7b5c98625c29_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_0cb24083-8099-4f63-a994-44240ee1ed4a_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization of property and intangibles</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OrthopaedicsMember_129aed20-6035-4d0a-8e80-3bc93ffb2ba2_terseLabel_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics</link:label>
    <link:label id="lab_jnj_OrthopaedicsMember_label_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics [Member]</link:label>
    <link:label id="lab_jnj_OrthopaedicsMember_documentation_en-US" xlink:label="lab_jnj_OrthopaedicsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Orthopaedics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember" xlink:href="jnj-20200628.xsd#jnj_OrthopaedicsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OrthopaedicsMember" xlink:to="lab_jnj_OrthopaedicsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_644671dc-0092-4d83-acef-bc1c04c081c2_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross proceeds on sale</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received Per Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedPerTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_d211d47f-24e6-4a70-be84-a848f2ad17a8_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_612e0113-1291-4f80-a697-12b1e18dab37_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_58229710-b24b-45d0-a912-6c863bb66782_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_9adc75ee-de17-4772-941b-9a9917e3041d_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_57a12e42-509a-4a7c-a50b-60a9ad894542_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee benefit plans:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_InfectiousDiseasesMember_4c406b5c-1c9d-4719-920a-ebf468f353c2_terseLabel_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases</link:label>
    <link:label id="lab_jnj_InfectiousDiseasesMember_label_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases [Member]</link:label>
    <link:label id="lab_jnj_InfectiousDiseasesMember_documentation_en-US" xlink:label="lab_jnj_InfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Infectious Diseases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember" xlink:href="jnj-20200628.xsd#jnj_InfectiousDiseasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_InfectiousDiseasesMember" xlink:to="lab_jnj_InfectiousDiseasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_70b3bf33-b813-4423-b657-6b523834d5a4_terseLabel_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension</link:label>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_label_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension [Member]</link:label>
    <link:label id="lab_jnj_PulmonaryHypertensionMember_documentation_en-US" xlink:label="lab_jnj_PulmonaryHypertensionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pulmonary Hypertension [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember" xlink:href="jnj-20200628.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PulmonaryHypertensionMember" xlink:to="lab_jnj_PulmonaryHypertensionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_33097d27-bbd1-4415-a402-5c5bb96a39fd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Benefit Plans</link:label>
    <link:label id="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_label_en-US" xlink:label="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Postretirement Benefits Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:to="lab_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_088c8517-4879-47b0-bede-733a3f3f1f39_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_5c27545d-fd4f-4aef-af99-41c3b0a45e43_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_b2b9fe84-2191-4d03-bfbe-c5c84eb0a9be_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_11844b3e-6138-47b8-8d38-c1004c50f204_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_7818656a-2b01-495e-9e52-3c85be5b08ff_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d1b9eb37-e6e4-4917-b868-e9abc222f7b8_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_d28fe71a-3feb-4d56-b8b3-fd500afd1075_totalLabel_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net earnings percent to sales</link:label>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_label_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent Percent to Sales</link:label>
    <link:label id="lab_jnj_NetIncomeAttributableToParentPercentToSales_documentation_en-US" xlink:label="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Attributable to Parent Percent to Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales" xlink:href="jnj-20200628.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_NetIncomeAttributableToParentPercentToSales" xlink:to="lab_jnj_NetIncomeAttributableToParentPercentToSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_67ac0fa2-f206-4f8a-a052-f05c8c57471e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_label_en-US" xlink:label="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Investment Not Readily Marketable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:to="lab_us-gaap_OtherInvestmentNotReadilyMarketableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b4cdb9e9-4e57-4e4f-83ff-3cabf24b096d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET CASH FLOWS FROM OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_825956dc-e704-48ff-8331-c449d15616bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Activity Related to Equity Investments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_11f22bf1-5bcd-4ec1-8d07-a4db5d4bb1db_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_a8c8ee74-6726-4513-961a-1d16219bdd53_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIncomeMember_5cfca800-9fcf-484c-a23c-878fa43c149f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income</link:label>
    <link:label id="lab_us-gaap_OtherIncomeMember_label_en-US" xlink:label="lab_us-gaap_OtherIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIncomeMember" xlink:to="lab_us-gaap_OtherIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f414f063-8d1a-47ee-99ed-8e6a9d850b2d_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_63bb5fad-a8e7-4cf2-9693-28969d196c7f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_03ae2c2e-0a5a-4fc3-9649-aa3a9e39861c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_0196219e-d596-4504-946e-d9dd6b78c9c9_verboseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_61e4ed6c-38cb-466a-a263-dd012b472cad_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_b4964f98-67b7-45a8-b596-a67b807a4dfe_terseLabel_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent Change (as a percent)</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_label_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Change In Sales By Segment Of Business</link:label>
    <link:label id="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness_documentation_en-US" xlink:label="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage change in sales by segment of business.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:to="lab_jnj_PercentageChangeInSalesBySegmentOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_b4ab38ab-5ec5-43b6-9f9b-46420c1a9789_terseLabel_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625% Notes due 2025</link:label>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_label_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Notes due 2025 [Member]</link:label>
    <link:label id="lab_jnj_A2.625Notesdue2025Member_documentation_en-US" xlink:label="lab_jnj_A2.625Notesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2.625 Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member" xlink:href="jnj-20200628.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_A2.625Notesdue2025Member" xlink:to="lab_jnj_A2.625Notesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_dc8a39b5-3a37-474c-ac82-4fc466dc23e4_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_f83f6fc6-71c8-482e-832c-68e05c601a16_terseLabel_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:label id="lab_us-gaap_USTreasuryAndGovernmentMember_label_en-US" xlink:label="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Treasury and Government [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USTreasuryAndGovernmentMember" xlink:to="lab_us-gaap_USTreasuryAndGovernmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_c464d9c9-744c-400f-a3f5-32650a54a79e_terseLabel_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa</link:label>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_label_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa [Member]</link:label>
    <link:label id="lab_jnj_AsiaPacificAfricaMember_documentation_en-US" xlink:label="lab_jnj_AsiaPacificAfricaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific, Africa [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember" xlink:href="jnj-20200628.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_AsiaPacificAfricaMember" xlink:to="lab_jnj_AsiaPacificAfricaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_a12eb1c1-0ba7-4723-96b0-98972335c36c_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale (Note 10)</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_4dc542a3-d166-4e20-81f1-591cb2825f88_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_UPTRAVIMember_7a087f6a-4a62-4056-a807-d974d9dfaaa4_terseLabel_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI&#174;</link:label>
    <link:label id="lab_jnj_UPTRAVIMember_label_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI [Member]</link:label>
    <link:label id="lab_jnj_UPTRAVIMember_documentation_en-US" xlink:label="lab_jnj_UPTRAVIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UPTRAVI [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember" xlink:href="jnj-20200628.xsd#jnj_UPTRAVIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_UPTRAVIMember" xlink:to="lab_jnj_UPTRAVIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_6dbbe377-a427-44f3-a139-94b57e6ed5b8_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due after one year through five years</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e18aaa1c-6afc-4eaf-b038-ebc54407d95a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_WoundCareandOtherMember_eb274ead-b73b-469b-b5f7-d0042134b3e3_terseLabel_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care/Other</link:label>
    <link:label id="lab_jnj_WoundCareandOtherMember_label_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care and Other [Member]</link:label>
    <link:label id="lab_jnj_WoundCareandOtherMember_documentation_en-US" xlink:label="lab_jnj_WoundCareandOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Wound Care and Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember" xlink:href="jnj-20200628.xsd#jnj_WoundCareandOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_WoundCareandOtherMember" xlink:to="lab_jnj_WoundCareandOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_71cead86-d924-4ea8-a76d-fa7eec511323_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_15284810-9d8d-4f20-ab40-af26eb2eda6f_terseLabel_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. reverse repurchase agreements</link:label>
    <link:label id="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_label_en-US" xlink:label="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Securities Loaned or Sold under Agreements to Repurchase [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:to="lab_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_5bf2e41f-0ed1-4a15-8d15-e5377b8fb911_terseLabel_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER INFECTIOUS DISEASES</link:label>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_label_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Infectious Diseases [Member]</link:label>
    <link:label id="lab_jnj_OtherInfectiousDiseasesMember_documentation_en-US" xlink:label="lab_jnj_OtherInfectiousDiseasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Infectious Diseases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember" xlink:href="jnj-20200628.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_OtherInfectiousDiseasesMember" xlink:to="lab_jnj_OtherInfectiousDiseasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_dd062cd3-3b00-4abb-856a-8812e7405ab0_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_24879691-e80e-4738-89b1-9b53a1dd366a_terseLabel_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost savings expected</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_label_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Future Savings</link:label>
    <link:label id="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings_documentation_en-US" xlink:label="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Future Savings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:to="lab_jnj_RestructuringandRelatedCostExpectedFutureSavings" xlink:type="arc" order="1"/>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_b59ae83a-b3ee-41e3-993a-4f1dab542793_terseLabel_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd.</link:label>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_label_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd. [Member]</link:label>
    <link:label id="lab_jnj_CizHoldingsCo.Ltd.Member_documentation_en-US" xlink:label="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ci:z Holdings Co. Ltd. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member" xlink:href="jnj-20200628.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_jnj_CizHoldingsCo.Ltd.Member" xlink:to="lab_jnj_CizHoldingsCo.Ltd.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_81836a20-67b9-49e6-8a7b-2ebbc8dd4772_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_56dfc8ce-b12e-4286-89c7-b38cd30f2cb3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_e0f3d553-f62e-46f9-a2b7-5a4ad65d40e5_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_b7b05ec2-3f0d-4424-8733-715cf3d63799_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_c77701a9-70ba-495b-b506-afd35191dcb8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Gross Assets</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_cadf39c7-2f8f-4057-8196-80f2e44d3987_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_a9fe8ad7-3779-4dc6-bb4e-ebcdf58c3e6a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>jnj-20200628_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2020 Workiva-->
<!--r:d414555b-7c1a-48a1-a27c-a585d620943e,g:5870219b-e803-4fe6-8c77-36d969bcb726-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.jnj.com/role/Cover" xlink:type="simple" xlink:href="jnj-20200628.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7aa3b942-1192-4cb2-af9f-3abf783cc5a0" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7aa3b942-1192-4cb2-af9f-3abf783cc5a0" xlink:to="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:to="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_59641486-4a19-48cd-bebf-bef9668119c5" xlink:to="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_49e01285-d1c2-4acc-a7ea-7f9a799cd346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_us-gaap_CommonStockMember_49e01285-d1c2-4acc-a7ea-7f9a799cd346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_3d01c5c7-2292-453d-8c06-771976062a69" xlink:href="jnj-20200628.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A0.250NotesDue2022Member_3d01c5c7-2292-453d-8c06-771976062a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_e2e80acc-d4ff-430a-a0bc-2765bd785588" xlink:href="jnj-20200628.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A0.650NotesDue2024Member_e2e80acc-d4ff-430a-a0bc-2765bd785588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_547d66b8-ae5b-4716-afc7-0a02e3b68b43" xlink:href="jnj-20200628.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A5.50NotesDue2024Member_547d66b8-ae5b-4716-afc7-0a02e3b68b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_062a2ffb-ac8f-4a76-9912-bd006d4100f1" xlink:href="jnj-20200628.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A1.150NotesDue2028Member_062a2ffb-ac8f-4a76-9912-bd006d4100f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_add1d691-d7a9-4020-9c4f-176f35938ac0" xlink:href="jnj-20200628.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_3e0bf8b4-abdc-4ebb-b71c-7f339e5b294d" xlink:to="loc_jnj_A1.650NotesDue2035Member_add1d691-d7a9-4020-9c4f-176f35938ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_a33cd265-66bf-4a4a-bc25-bf38b3f61b47" xlink:to="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ee4d912f-81f5-457b-80fb-94be4304eb30" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentType_ee4d912f-81f5-457b-80fb-94be4304eb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_13e03329-8781-4571-90c9-e3cce5f94971" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentQuarterlyReport_13e03329-8781-4571-90c9-e3cce5f94971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3c5d587e-d0af-4114-b219-60e485e660fb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentPeriodEndDate_3c5d587e-d0af-4114-b219-60e485e660fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_06729276-8c64-4ccd-b882-529191bf420e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentTransitionReport_06729276-8c64-4ccd-b882-529191bf420e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_0fa1764a-d017-4be8-8c4a-a214e7697090" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityFileNumber_0fa1764a-d017-4be8-8c4a-a214e7697090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_c5e3539e-574d-4043-af01-1c2ff943ca93" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityRegistrantName_c5e3539e-574d-4043-af01-1c2ff943ca93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e8d6896a-3ede-42ee-940a-36ec251fe24b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e8d6896a-3ede-42ee-940a-36ec251fe24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6fa6618b-4051-462e-b862-0313ed8d373a" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityTaxIdentificationNumber_6fa6618b-4051-462e-b862-0313ed8d373a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b4c55654-4536-429e-b329-e2a44625051d" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressAddressLine1_b4c55654-4536-429e-b329-e2a44625051d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_1dd7f33c-87ec-474a-a1c0-0f4ce9262753" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressCityOrTown_1dd7f33c-87ec-474a-a1c0-0f4ce9262753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_913d4655-2681-4fb4-84cd-7038ad3f885e" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressStateOrProvince_913d4655-2681-4fb4-84cd-7038ad3f885e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d72b2d5f-ef2d-456d-a520-af1f97d90457" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityAddressPostalZipCode_d72b2d5f-ef2d-456d-a520-af1f97d90457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_9942e2b1-bcab-4ff2-90f0-404b4464b3be" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_CityAreaCode_9942e2b1-bcab-4ff2-90f0-404b4464b3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_d612f209-1927-410e-a7a5-cc8e20ec0f79" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_LocalPhoneNumber_d612f209-1927-410e-a7a5-cc8e20ec0f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_89084bfd-2dd9-4331-a4df-1066ee07ea91" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCurrentReportingStatus_89084bfd-2dd9-4331-a4df-1066ee07ea91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_f6c52de2-d399-46e1-8c08-0f96292e41e1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityInteractiveDataCurrent_f6c52de2-d399-46e1-8c08-0f96292e41e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_cd94e94d-baf6-4c1f-8806-d9bee41091e2" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityFilerCategory_cd94e94d-baf6-4c1f-8806-d9bee41091e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_96e52be6-fa5b-40ed-bc3f-063d46558b03" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntitySmallBusiness_96e52be6-fa5b-40ed-bc3f-063d46558b03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d302a1a2-9487-4a8c-a69d-0c5b85a5cbdb" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityEmergingGrowthCompany_d302a1a2-9487-4a8c-a69d-0c5b85a5cbdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_f9966c57-e9c4-434e-a91d-a298b39b5ecd" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityShellCompany_f9966c57-e9c4-434e-a91d-a298b39b5ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_92f0593e-b34b-4508-b04a-4f9c312583ec" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_Security12bTitle_92f0593e-b34b-4508-b04a-4f9c312583ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_7cdb9605-5130-4b4b-a83f-28797e69ec20" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_TradingSymbol_7cdb9605-5130-4b4b-a83f-28797e69ec20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_69812fc9-0e33-4899-af6d-028a588889a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_SecurityExchangeName_69812fc9-0e33-4899-af6d-028a588889a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_345cf95c-1c7b-4264-9983-f9bd7ec33752" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_345cf95c-1c7b-4264-9983-f9bd7ec33752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_f0720dfb-5bea-439e-9f5a-4779ad6c0493" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_EntityCentralIndexKey_f0720dfb-5bea-439e-9f5a-4779ad6c0493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6140b6bf-ed4a-4e37-9070-3562d2a9998b" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_CurrentFiscalYearEndDate_6140b6bf-ed4a-4e37-9070-3562d2a9998b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_35bf3c20-ae6c-4af8-a7a4-489bcc9fb43c" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentFiscalYearFocus_35bf3c20-ae6c-4af8-a7a4-489bcc9fb43c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_6aec9ecc-6e73-4c19-84fb-07b14bad29a1" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_6aec9ecc-6e73-4c19-84fb-07b14bad29a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d3b6d64b-9694-4a07-87d6-ff8c89527b6f" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_5449ac1a-c108-4b2d-b226-7139a9c4f0fa" xlink:to="loc_dei_AmendmentFlag_d3b6d64b-9694-4a07-87d6-ff8c89527b6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_57ade1c6-3085-4469-ba3f-28f78f94997d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57ade1c6-3085-4469-ba3f-28f78f94997d" xlink:to="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc79ec2c-23ff-4178-8426-af265c3e010a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bc79ec2c-23ff-4178-8426-af265c3e010a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_c3ec3708-5388-49ca-ab78-5c9e808bb485" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_c3ec3708-5388-49ca-ab78-5c9e808bb485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_4694b335-56a5-4ed0-83b4-f32da314fe23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_4694b335-56a5-4ed0-83b4-f32da314fe23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_af64fbb4-73cb-491d-8114-494aff3ea8dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_InventoryNet_af64fbb4-73cb-491d-8114-494aff3ea8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ea6f988a-8cd7-4f7c-af18-c9c72c770071" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ea6f988a-8cd7-4f7c-af18-c9c72c770071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_740016d8-1a1d-458b-a9cd-8787700705d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther_740016d8-1a1d-458b-a9cd-8787700705d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_eb83083f-8a22-4132-b4fb-18404055fd37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_8907e811-68fc-46f2-afd5-45c700777a2d" xlink:to="loc_us-gaap_AssetsCurrent_eb83083f-8a22-4132-b4fb-18404055fd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c6d0c2d4-e9c5-4398-b871-705a76b0d811" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c6d0c2d4-e9c5-4398-b871-705a76b0d811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_66884d3d-d75e-4235-a5c1-0a22fa921972" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_66884d3d-d75e-4235-a5c1-0a22fa921972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_39dcfbc5-1f31-476a-9120-d19aeb3a7c70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_39dcfbc5-1f31-476a-9120-d19aeb3a7c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ca01d309-cab1-471f-9d80-c9d0d1c9b924" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ca01d309-cab1-471f-9d80-c9d0d1c9b924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_11ee9eec-9a63-488b-ac9f-049a685c138f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_Goodwill_11ee9eec-9a63-488b-ac9f-049a685c138f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_bae487fc-f54b-45e4-8439-8c50edbb1080" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_bae487fc-f54b-45e4-8439-8c50edbb1080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_bbf0ceb2-fcee-4574-b047-156dbb07b6c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_bbf0ceb2-fcee-4574-b047-156dbb07b6c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c6b48de6-e5a4-48bf-80ca-6ea1094cfd2c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8b7144ca-47ae-44db-8651-1a8f68623b37" xlink:to="loc_us-gaap_Assets_c6b48de6-e5a4-48bf-80ca-6ea1094cfd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_57ade1c6-3085-4469-ba3f-28f78f94997d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_b6b6ec65-945f-497a-ae36-ece0fbe339e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_ShortTermBorrowings_b6b6ec65-945f-497a-ae36-ece0fbe339e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_6bc6bbe1-02af-4f0a-8138-f25d95cf0337" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_AccountsPayableCurrent_6bc6bbe1-02af-4f0a-8138-f25d95cf0337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_e3690d52-8cb8-43ab-b5a4-f62d4e03a99d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_e3690d52-8cb8-43ab-b5a4-f62d4e03a99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedRebatesReturnsAndPromotions_96f9fdfd-93fd-4f2b-a18a-63ac0d171d1e" xlink:href="jnj-20200628.xsd#jnj_AccruedRebatesReturnsAndPromotions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_jnj_AccruedRebatesReturnsAndPromotions_96f9fdfd-93fd-4f2b-a18a-63ac0d171d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ec4b0472-020a-445d-9520-e0f7f8da0b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_ec4b0472-020a-445d-9520-e0f7f8da0b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_3db1fa75-bf32-4284-af9a-96812bd90993" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_3db1fa75-bf32-4284-af9a-96812bd90993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_facacf9e-af38-42e6-b69a-71fd4b8ee3d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_fd6e478c-069d-4445-a37a-c5a007e972c1" xlink:to="loc_us-gaap_LiabilitiesCurrent_facacf9e-af38-42e6-b69a-71fd4b8ee3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_463d6fb1-121a-4cd8-968e-83c7e500e057" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_463d6fb1-121a-4cd8-968e-83c7e500e057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_45ba4ee8-4c3c-4063-8562-0b6c8687f4fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_45ba4ee8-4c3c-4063-8562-0b6c8687f4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_92c25134-f9cf-489c-8b83-8a9b7dc32c13" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent_92c25134-f9cf-489c-8b83-8a9b7dc32c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d0e88961-6ad5-46ef-bcc2-fddbbb514eaf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedIncomeTaxesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_AccruedIncomeTaxesNoncurrent_d0e88961-6ad5-46ef-bcc2-fddbbb514eaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_08a831c3-4f29-47c4-a14c-351d9f30853c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_08a831c3-4f29-47c4-a14c-351d9f30853c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_76bd5bdd-2518-4e49-b59f-bafdb8d9f649" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_Liabilities_76bd5bdd-2518-4e49-b59f-bafdb8d9f649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b62631e6-35fb-4039-a141-75e256517aba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b62631e6-35fb-4039-a141-75e256517aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_58d66b70-a72d-48ea-af00-40288d5e3201" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:to="loc_us-gaap_CommonStockValue_58d66b70-a72d-48ea-af00-40288d5e3201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f51f382-a9b9-4ec8-88ff-9c2bcffd7791" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_3f51f382-a9b9-4ec8-88ff-9c2bcffd7791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2ae8570-ae91-407f-b1dd-a4b0f839ab05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d2ae8570-ae91-407f-b1dd-a4b0f839ab05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8618374b-925d-4d9d-9bcc-0d361b17e49b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:to="loc_us-gaap_TreasuryStockValue_8618374b-925d-4d9d-9bcc-0d361b17e49b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7b8a16c3-57a9-4751-a786-5c17fa793b24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_374d3501-6945-47ea-a81e-55578b7fd63f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_7b8a16c3-57a9-4751-a786-5c17fa793b24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d8dd52d-d21b-46ab-9b33-7cf4fcf78833" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_6e49d57f-924f-45fa-89da-2dffd69e243b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7d8dd52d-d21b-46ab-9b33-7cf4fcf78833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_578f90a9-f397-4066-9d6b-0dbbcaef4f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_34c67dc3-c816-4e32-80b6-c302b87afad7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_578f90a9-f397-4066-9d6b-0dbbcaef4f73" xlink:to="loc_us-gaap_AssetsCurrentAbstract_34c67dc3-c816-4e32-80b6-c302b87afad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3db414a9-8776-4ebe-84c3-8d4fcf4d5d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_34c67dc3-c816-4e32-80b6-c302b87afad7" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3db414a9-8776-4ebe-84c3-8d4fcf4d5d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_578f90a9-f397-4066-9d6b-0dbbcaef4f73" xlink:to="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_75c4705f-88dd-41fd-927a-22c8af9d0f3e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_75c4705f-88dd-41fd-927a-22c8af9d0f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_729f569f-58be-4934-9bbb-67fb810f7178" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_729f569f-58be-4934-9bbb-67fb810f7178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_98f5d22d-55dc-4bb8-a770-c076c8ddcb65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:to="loc_us-gaap_CommonStockSharesIssued_98f5d22d-55dc-4bb8-a770-c076c8ddcb65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_16520862-bc26-4a36-9b2b-1f8fdc3ea453" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_12868cab-5f87-4b65-8019-0c3aea78503f" xlink:to="loc_us-gaap_TreasuryStockShares_16520862-bc26-4a36-9b2b-1f8fdc3ea453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEarnings"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEarnings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df3bef8a-9655-4e69-807a-15b6f4ec197d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_df3bef8a-9655-4e69-807a-15b6f4ec197d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesRevenueGoodsNetPercentToSales_812766e5-44b7-4974-9336-e6677468b972" xlink:href="jnj-20200628.xsd#jnj_SalesRevenueGoodsNetPercentToSales"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_SalesRevenueGoodsNetPercentToSales_812766e5-44b7-4974-9336-e6677468b972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ade31260-54dd-4deb-baa1-92631dacde7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ade31260-54dd-4deb-baa1-92631dacde7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CostOfGoodsSoldPercentToSales_b2d1cc15-b1bd-41ac-83fc-e946d74b2ba2" xlink:href="jnj-20200628.xsd#jnj_CostOfGoodsSoldPercentToSales"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_CostOfGoodsSoldPercentToSales_b2d1cc15-b1bd-41ac-83fc-e946d74b2ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3ee80247-dfce-4c5b-a959-6d6eb9254516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_GrossProfit_3ee80247-dfce-4c5b-a959-6d6eb9254516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GrossProfitPercentToSales_73254bb2-ab81-460e-ba39-7353c8386c0d" xlink:href="jnj-20200628.xsd#jnj_GrossProfitPercentToSales"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_GrossProfitPercentToSales_73254bb2-ab81-460e-ba39-7353c8386c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3c1b4cad-0068-4e78-9dc4-707112e5b5de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_3c1b4cad-0068-4e78-9dc4-707112e5b5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_34b274c2-3756-4e72-b3d7-e67563023086" xlink:href="jnj-20200628.xsd#jnj_SellingGeneralAndAdministrativeExpensePercentToSales"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_SellingGeneralAndAdministrativeExpensePercentToSales_34b274c2-3756-4e72-b3d7-e67563023086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ff64cde3-6cdf-4025-bc16-6e5d010fa0ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_ff64cde3-6cdf-4025-bc16-6e5d010fa0ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_19d72d74-f69f-461c-80e7-1359e59b576b" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales_19d72d74-f69f-461c-80e7-1359e59b576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_337404c5-962b-4621-b212-409a587776b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_337404c5-962b-4621-b212-409a587776b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_d201d731-24b5-4666-9c97-3c9f3956cbd3" xlink:href="jnj-20200628.xsd#jnj_ResearchAndDevelopmentInProcessPercentToSales"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_ResearchAndDevelopmentInProcessPercentToSales_d201d731-24b5-4666-9c97-3c9f3956cbd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c7629db5-e552-4950-ad98-eac38359c259" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c7629db5-e552-4950-ad98-eac38359c259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvestmentIncomeInterestPercentToSales_0f222762-f0c5-4233-8803-165bef34e23e" xlink:href="jnj-20200628.xsd#jnj_InvestmentIncomeInterestPercentToSales"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_InvestmentIncomeInterestPercentToSales_0f222762-f0c5-4233-8803-165bef34e23e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_e1fb61ab-3d83-475d-8e16-2941670be1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_InterestExpense_e1fb61ab-3d83-475d-8e16-2941670be1ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestExpensePercentToSales_85f10de6-729b-434c-8e69-9060f51a3786" xlink:href="jnj-20200628.xsd#jnj_InterestExpensePercentToSales"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_InterestExpensePercentToSales_85f10de6-729b-434c-8e69-9060f51a3786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_65f680ab-7d16-447d-9d16-3641674fe665" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_65f680ab-7d16-447d-9d16-3641674fe665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_ade91d3b-d693-47f2-b62f-83e678eab5cc" xlink:href="jnj-20200628.xsd#jnj_OtherNonOperatingIncomeExpensePercentToSales"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_OtherNonOperatingIncomeExpensePercentToSales_ade91d3b-d693-47f2-b62f-83e678eab5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_cab494b6-cbc0-4eb0-b64e-75bc1ec4d8c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_RestructuringCharges_cab494b6-cbc0-4eb0-b64e-75bc1ec4d8c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Restructuringchargepercenttosales_1ac0e47f-8a56-43f0-900e-16e154ece182" xlink:href="jnj-20200628.xsd#jnj_Restructuringchargepercenttosales"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_Restructuringchargepercenttosales_1ac0e47f-8a56-43f0-900e-16e154ece182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62edfe3d-480f-4623-90ce-6863cf481335" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_62edfe3d-480f-4623-90ce-6863cf481335" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_5b1d40c1-39e6-4335-85ba-1bbd80396ef2" xlink:href="jnj-20200628.xsd#jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales_5b1d40c1-39e6-4335-85ba-1bbd80396ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c19ab717-aad7-49c4-985a-efee7949ef9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c19ab717-aad7-49c4-985a-efee7949ef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_080f67ba-c3b5-42b5-9e5b-aebe436e24b8" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxExpenseBenefitPercentToSales"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_IncomeTaxExpenseBenefitPercentToSales_080f67ba-c3b5-42b5-9e5b-aebe436e24b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_47d98cbc-5898-4c59-82f0-b644043d8187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_NetIncomeLoss_47d98cbc-5898-4c59-82f0-b644043d8187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NetIncomeAttributableToParentPercentToSales_2329c92e-fb51-4050-abc4-f4460f5844ed" xlink:href="jnj-20200628.xsd#jnj_NetIncomeAttributableToParentPercentToSales"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_jnj_NetIncomeAttributableToParentPercentToSales_2329c92e-fb51-4050-abc4-f4460f5844ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_844555af-918f-4184-99ae-c4d3b80ffaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_EarningsPerShareAbstract_844555af-918f-4184-99ae-c4d3b80ffaa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b14dd10b-3f76-4d47-bbbb-7bea1a4aae60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_844555af-918f-4184-99ae-c4d3b80ffaa3" xlink:to="loc_us-gaap_EarningsPerShareBasic_b14dd10b-3f76-4d47-bbbb-7bea1a4aae60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_459438dd-6eb6-48dd-806c-2381bf4faf7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_844555af-918f-4184-99ae-c4d3b80ffaa3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_459438dd-6eb6-48dd-806c-2381bf4faf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_48bf86e3-af34-44bf-a3cf-fd4b2351c4ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_48bf86e3-af34-44bf-a3cf-fd4b2351c4ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b38436fa-2a2f-4e17-a833-ad7a9433a726" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_48bf86e3-af34-44bf-a3cf-fd4b2351c4ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b38436fa-2a2f-4e17-a833-ad7a9433a726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30a873e6-6990-4c67-90fb-47b44db77a9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_48bf86e3-af34-44bf-a3cf-fd4b2351c4ab" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_30a873e6-6990-4c67-90fb-47b44db77a9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2db00dce-f7bc-4e36-9495-686039582b4d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_65b5e6cd-71e4-48f0-876f-edf53aeba4ed" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2db00dce-f7bc-4e36-9495-686039582b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_274f957b-ef66-43c3-8f18-91036f3c11f5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_NetIncomeLoss_274f957b-ef66-43c3-8f18-91036f3c11f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_b97685d4-32cd-4ff2-aa01-57ebe7c97ad4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax_b97685d4-32cd-4ff2-aa01-57ebe7c97ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_6bf0a401-0a6e-4e09-bca4-ea52000561bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_6bf0a401-0a6e-4e09-bca4-ea52000561bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_76b29d2a-07a5-43c6-8c18-7b8a1c26ed44" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_6bf0a401-0a6e-4e09-bca4-ea52000561bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_76b29d2a-07a5-43c6-8c18-7b8a1c26ed44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_23484bba-8653-4723-876f-cbb04aed32e8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_6bf0a401-0a6e-4e09-bca4-ea52000561bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_23484bba-8653-4723-876f-cbb04aed32e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9758ce41-56a6-4a94-afad-19eda94593e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract_6bf0a401-0a6e-4e09-bca4-ea52000561bb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9758ce41-56a6-4a94-afad-19eda94593e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_41c84b0c-f84b-4346-ac00-6bbe436547c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_41c84b0c-f84b-4346-ac00-6bbe436547c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_6cde2e93-3e3f-4e0d-9653-0727799d6661" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_41c84b0c-f84b-4346-ac00-6bbe436547c6" xlink:to="loc_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax_6cde2e93-3e3f-4e0d-9653-0727799d6661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_fa8f0f7a-45be-4af8-b176-454e1474f5d8" xlink:href="jnj-20200628.xsd#jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_41c84b0c-f84b-4346-ac00-6bbe436547c6" xlink:to="loc_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax_fa8f0f7a-45be-4af8-b176-454e1474f5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9ff5f5ee-93b4-479b-990b-2ff3b9b6e5e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract_41c84b0c-f84b-4346-ac00-6bbe436547c6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_9ff5f5ee-93b4-479b-990b-2ff3b9b6e5e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_6e185c93-bc05-4c16-a742-3b69b9a1f805" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_69bf68f6-d28d-4e6a-90f9-434de68bcd04" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_6e185c93-bc05-4c16-a742-3b69b9a1f805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5dcbf8f1-9cd7-4e0f-be50-ab94daa64bdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_6e185c93-bc05-4c16-a742-3b69b9a1f805" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_5dcbf8f1-9cd7-4e0f-be50-ab94daa64bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4505fe6f-4808-4444-9438-c43b8aafaf71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_6e185c93-bc05-4c16-a742-3b69b9a1f805" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_4505fe6f-4808-4444-9438-c43b8aafaf71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4adcf9-f0b7-4e32-b911-f4a81cd17697" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract_6e185c93-bc05-4c16-a742-3b69b9a1f805" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_8e4adcf9-f0b7-4e32-b911-f4a81cd17697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b384a12-affe-4ac5-90bf-27a6dc2fb288" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0b384a12-affe-4ac5-90bf-27a6dc2fb288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_f350a12c-fab6-49b4-9487-cefd8f7f9236" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_f350a12c-fab6-49b4-9487-cefd8f7f9236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c284cfff-7d16-4411-8a6d-5ff4b87cec9d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_c284cfff-7d16-4411-8a6d-5ff4b87cec9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3e3d09bd-f619-450f-bcb5-fea0f9660455" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_3e3d09bd-f619-450f-bcb5-fea0f9660455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_6d3b4091-e8b3-45ec-8c31-8b1237483e6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_6d3b4091-e8b3-45ec-8c31-8b1237483e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_cb39b7c5-9d89-4d7a-9524-d8c30cac16ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_d8eef633-7d12-4f7a-9e56-6c4e0b6f123e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_cb39b7c5-9d89-4d7a-9524-d8c30cac16ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquity"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_4079cc55-343a-495e-a6a4-a4b6cf6ef475" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_4079cc55-343a-495e-a6a4-a4b6cf6ef475" xlink:to="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b5163b00-5c30-409c-9234-f7f1cdf3ee71" xlink:to="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_3092184d-ba49-469c-9826-34169e8f892f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_RetainedEarningsMember_3092184d-ba49-469c-9826-34169e8f892f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8e5c159-2357-4438-8ab4-8979ffbe4111" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8e5c159-2357-4438-8ab4-8979ffbe4111" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_671bebe8-ab62-4c2f-b271-1ecfbbcaf40a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_CommonStockMember_671bebe8-ab62-4c2f-b271-1ecfbbcaf40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_ad645463-9c04-4d73-b368-0dd584c253dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2b99ec1f-5029-4ae1-9cf7-c6aff1f00ee6" xlink:to="loc_us-gaap_TreasuryStockMember_ad645463-9c04-4d73-b368-0dd584c253dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_8bfd6bb0-f849-4dd5-99ee-891b8966311b" xlink:to="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ba4000-2dc1-498b-9c9b-56a3958a7ca9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_71ba4000-2dc1-498b-9c9b-56a3958a7ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d86681c9-119c-48ed-a03b-6406109c3fa4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_NetIncomeLoss_d86681c9-119c-48ed-a03b-6406109c3fa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_b547d995-3532-492b-b240-835ff28d2823" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_DividendsCommonStockCash_b547d995-3532-492b-b240-835ff28d2823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_e3e1b9c3-17f6-42b7-a6ef-87a5b9332bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued_e3e1b9c3-17f6-42b7-a6ef-87a5b9332bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0f64a8ea-b59b-4334-af92-174f45df1fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_0f64a8ea-b59b-4334-af92-174f45df1fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_820c8381-b5aa-496e-8a48-712cfa2ba84a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockholdersEquityOther_820c8381-b5aa-496e-8a48-712cfa2ba84a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6e64c559-cff4-4213-89fa-d2029ec312c0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6e64c559-cff4-4213-89fa-d2029ec312c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ca7c28c-6461-4daa-829a-aba9a834fed3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_4d9e84e7-ae95-4c05-986b-e528f2926a05" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4ca7c28c-6461-4daa-829a-aba9a834fed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofEquityParenthetical"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5013a6a0-62b6-450f-a385-2ec1885e9270" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_77168084-80c7-4ec2-b635-aa554dbffc65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5013a6a0-62b6-450f-a385-2ec1885e9270" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_77168084-80c7-4ec2-b635-aa554dbffc65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="jnj-20200628.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_534bba34-4d18-4a87-a68d-3beed1d08706" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_534bba34-4d18-4a87-a68d-3beed1d08706" xlink:to="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6d4769e5-ecff-4a3c-ad58-705f4bb0ec8c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_2015ea64-58ee-48c6-aaa8-21eb7dceba22" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_70969913-4e4d-4157-a0be-87527b9d1d42" xlink:to="loc_jnj_AurisHealthMember_2015ea64-58ee-48c6-aaa8-21eb7dceba22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_a60df978-c759-4536-ac7c-2ec16e69d080" xlink:to="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_93a77ce4-9d4c-4bb3-887b-5b4668618d38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_NetIncomeLoss_93a77ce4-9d4c-4bb3-887b-5b4668618d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9ffa15f8-dc6e-4297-801f-19ae22644970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9ffa15f8-dc6e-4297-801f-19ae22644970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_83bd2bab-40cc-41f7-a909-641df18e9f1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_ShareBasedCompensation_83bd2bab-40cc-41f7-a909-641df18e9f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_1c798e10-23fb-44af-8051-f7648e975835" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_AssetImpairmentCharges_1c798e10-23fb-44af-8051-f7648e975835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ecd204e8-fdcc-4ea0-b903-92bc979c5f73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_ecd204e8-fdcc-4ea0-b903-92bc979c5f73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_491a9768-dec5-451c-81df-6f35f606db0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges_491a9768-dec5-451c-81df-6f35f606db0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bfcb6812-50d7-4588-9bc5-1c86b595d89d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bfcb6812-50d7-4588-9bc5-1c86b595d89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_be8de7fb-2474-4497-98a3-5b5066ee5c09" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_848a107f-773d-44fb-ba6a-a0c62fdf202e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_be8de7fb-2474-4497-98a3-5b5066ee5c09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8065b87b-4ad1-4fa7-98f5-accacf6a52c9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e418e84-87b5-4d24-82ce-e569f95d1431" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1e418e84-87b5-4d24-82ce-e569f95d1431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_40d360f7-f415-45ab-8f15-df15e2ca9417" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_40d360f7-f415-45ab-8f15-df15e2ca9417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a7559df4-5b21-4e26-ba06-10375dbf13fa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_a7559df4-5b21-4e26-ba06-10375dbf13fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5768504f-8d1c-4547-924a-03cfff56d605" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_5768504f-8d1c-4547-924a-03cfff56d605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b7239138-c47a-4a99-9cf2-4c1b7ee7651d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_b7239138-c47a-4a99-9cf2-4c1b7ee7651d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7f9910f8-78b5-45c0-ba3f-8e6a1a08ac6d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_09e1ac9e-0139-47c9-9b2b-291822c414b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_7f9910f8-78b5-45c0-ba3f-8e6a1a08ac6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0cd28e4b-81a3-472f-98c6-a52ba40f4319" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_0cd28e4b-81a3-472f-98c6-a52ba40f4319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a9a2593a-8647-40e2-93ee-6c472e15f033" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_ProceedsFromSaleOfProductiveAssets_a9a2593a-8647-40e2-93ee-6c472e15f033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_977676c4-eeac-4287-ab91-78bc38f72841" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_977676c4-eeac-4287-ab91-78bc38f72841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_0b27f3f7-f599-4ac1-b272-1dda0c4c2dd4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_0b27f3f7-f599-4ac1-b272-1dda0c4c2dd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_3008a807-498f-4369-a89f-b37a35289df5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_3008a807-498f-4369-a89f-b37a35289df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Proceedsfromcreditsupportagreements_a0d35e4f-d347-42d6-9060-d2d14df7b7e7" xlink:href="jnj-20200628.xsd#jnj_Proceedsfromcreditsupportagreements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_jnj_Proceedsfromcreditsupportagreements_a0d35e4f-d347-42d6-9060-d2d14df7b7e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fbcd91ed-1b0e-49f6-a1e9-5cf7c1e8bfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_fbcd91ed-1b0e-49f6-a1e9-5cf7c1e8bfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_254f3c4d-c7d2-400e-993c-8e81dd5e1de8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf508a3d-83cc-47c2-81c9-64cb0f96b421" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_254f3c4d-c7d2-400e-993c-8e81dd5e1de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfOrdinaryDividends_545c8d75-21ca-49f2-b836-ed752cba1cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfOrdinaryDividends"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_PaymentsOfOrdinaryDividends_545c8d75-21ca-49f2-b836-ed752cba1cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fd8c06ff-b7bc-4b46-a35d-becf3a98d61b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_fd8c06ff-b7bc-4b46-a35d-becf3a98d61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromShortTermDebt_0d9153f3-5dc8-4b93-9579-30d342b91a0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromShortTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromShortTermDebt_0d9153f3-5dc8-4b93-9579-30d342b91a0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfShortTermDebt_e22c31d9-6661-44e6-8e4d-30409bca667f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfShortTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_RepaymentsOfShortTermDebt_e22c31d9-6661-44e6-8e4d-30409bca667f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8f348547-4076-47a6-b6d2-777f5d093261" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_8f348547-4076-47a6-b6d2-777f5d093261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_86d5d8ca-350c-4bc0-b3eb-5719f71a17e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_86d5d8ca-350c-4bc0-b3eb-5719f71a17e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_eed0c200-bc42-4c63-8b91-07df3f8f9b66" xlink:href="jnj-20200628.xsd#jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits_eed0c200-bc42-4c63-8b91-07df3f8f9b66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd22775-8678-4df4-b879-92ec81659310" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_bbd22775-8678-4df4-b879-92ec81659310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ca5d4d6-e1ff-4309-b165-963245fdc0aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_6b17e109-1230-470b-b635-4376498d28df" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1ca5d4d6-e1ff-4309-b165-963245fdc0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a69c6de4-80ca-4b39-9f56-f279e2298399" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_a69c6de4-80ca-4b39-9f56-f279e2298399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a111669-372e-44b5-81b5-851582afc3ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6a111669-372e-44b5-81b5-851582afc3ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10e06175-78f4-4c08-bcc6-cb8677fe5a33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_10e06175-78f4-4c08-bcc6-cb8677fe5a33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8725547a-c5c7-4fd6-827a-3198b190ef1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8725547a-c5c7-4fd6-827a-3198b190ef1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f180f9c-522a-4413-8d75-34f681284c7c" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_c823dec0-d06f-47cb-85e1-b65d054335c6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1_c823dec0-d06f-47cb-85e1-b65d054335c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c5e57226-e0f2-47cc-b294-a1eb79335a69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1_c5e57226-e0f2-47cc-b294-a1eb79335a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_4e3bf6e2-8e9a-4898-86be-5468c255eb0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract_79560f0b-8894-4ef7-a692-ceeeb34415f8" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1_4e3bf6e2-8e9a-4898-86be-5468c255eb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_606d57d4-a0ed-47c7-9840-6ad420198acf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f64a137a-3149-4d02-b1f8-5a2a09d5ec6f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_606d57d4-a0ed-47c7-9840-6ad420198acf" xlink:to="loc_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_f64a137a-3149-4d02-b1f8-5a2a09d5ec6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_47656af4-a06b-4bc3-983a-355784b6fc48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_a1b9bb96-8a78-4732-b694-93e05a3c56ba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47656af4-a06b-4bc3-983a-355784b6fc48" xlink:to="loc_us-gaap_UseOfEstimates_a1b9bb96-8a78-4732-b694-93e05a3c56ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1e3585d-13c9-4bcd-bb86-f8946d3b77ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47656af4-a06b-4bc3-983a-355784b6fc48" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_b1e3585d-13c9-4bcd-bb86-f8946d3b77ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a93f6822-c1a6-41f3-a296-4b96f062980b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_47656af4-a06b-4bc3-983a-355784b6fc48" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a93f6822-c1a6-41f3-a296-4b96f062980b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Inventories" xlink:type="simple" xlink:href="jnj-20200628.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_c0a039c4-4db7-4c79-b6bc-7ec85b91e8e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_da2c9039-c8fc-4998-b3c9-16d561ede15a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_c0a039c4-4db7-4c79-b6bc-7ec85b91e8e2" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_da2c9039-c8fc-4998-b3c9-16d561ede15a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_42db02e4-86ec-4fcd-81a0-65e2b6f93afd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_33214d7b-e4ac-42aa-adca-fe46c937bc7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_42db02e4-86ec-4fcd-81a0-65e2b6f93afd" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_33214d7b-e4ac-42aa-adca-fe46c937bc7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/InventoriesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8f3bf0a5-fb8f-4054-b22d-d181ddcabc10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_f486ed8d-2544-4c26-b071-af4d5c2f1c06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8f3bf0a5-fb8f-4054-b22d-d181ddcabc10" xlink:to="loc_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves_f486ed8d-2544-4c26-b071-af4d5c2f1c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a2689b68-34f9-4136-9817-224ac7eee430" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8f3bf0a5-fb8f-4054-b22d-d181ddcabc10" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_a2689b68-34f9-4136-9817-224ac7eee430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4b3410ee-06f9-494a-8b23-8405beb64505" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8f3bf0a5-fb8f-4054-b22d-d181ddcabc10" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4b3410ee-06f9-494a-8b23-8405beb64505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_324b95b0-379f-4297-8dfe-96ebced66c8b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8f3bf0a5-fb8f-4054-b22d-d181ddcabc10" xlink:to="loc_us-gaap_InventoryNet_324b95b0-379f-4297-8dfe-96ebced66c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_863531ad-9753-43a8-98bb-bde6118d6b8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6b7b45e9-15cb-465b-8664-d751a3fc2b26" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_863531ad-9753-43a8-98bb-bde6118d6b8c" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_6b7b45e9-15cb-465b-8664-d751a3fc2b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c60d0b4c-dda8-423e-8707-704656b7e7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_d1a8e642-eeff-4ff2-9ea2-ce3b86ca5536" xlink:href="jnj-20200628.xsd#jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c60d0b4c-dda8-423e-8707-704656b7e7c9" xlink:to="loc_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock_d1a8e642-eeff-4ff2-9ea2-ce3b86ca5536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_eb617264-f9c0-431c-bf07-8c15e16cabbe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c60d0b4c-dda8-423e-8707-704656b7e7c9" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_eb617264-f9c0-431c-bf07-8c15e16cabbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_eb66deb4-c74e-4422-af75-94f2f5f6634e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c60d0b4c-dda8-423e-8707-704656b7e7c9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_eb66deb4-c74e-4422-af75-94f2f5f6634e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb4e8379-75bf-4a27-bf64-bbd0f3391213" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:href="jnj-20200628.xsd#jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_bb4e8379-75bf-4a27-bf64-bbd0f3391213" xlink:to="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_3bc557df-9437-4fab-9f18-ed1cbe426d3d" xlink:to="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_d517ba7c-d283-4557-9d72-5230ea1b60af" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_dfd928dd-a05d-4f4c-a9de-955489bb3b96" xlink:to="loc_jnj_ConsumerMember_d517ba7c-d283-4557-9d72-5230ea1b60af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_0cc3aaad-9ffd-471a-81ac-5199ca3e7b72" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_db6e6a14-c49f-40b1-b57e-296332b82d11" xlink:href="jnj-20200628.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:to="loc_jnj_PatentsAndTrademarksMember_db6e6a14-c49f-40b1-b57e-296332b82d11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_391036a2-f3c6-4f4d-8a2a-7e84f8f3d592" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ec54349-0c17-4707-9e9d-0a9e18ae5c31" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_391036a2-f3c6-4f4d-8a2a-7e84f8f3d592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_08d4a412-5174-4026-93ab-35ecfbda6517" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksMember_20699dc1-d4d3-440f-931f-6ba576d8d036" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:to="loc_us-gaap_TrademarksMember_20699dc1-d4d3-440f-931f-6ba576d8d036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_55713e92-9ac2-4a3f-bdbb-bdb4ae98110e" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7edc7660-3adb-49c4-951e-2bfa0061abda" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_55713e92-9ac2-4a3f-bdbb-bdb4ae98110e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:href="jnj-20200628.xsd#jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_8f2d0e76-a6fa-4715-9d12-b3e9fdd193d5" xlink:to="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_7e332464-9bd6-4272-9fa0-20ee110730fb" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41f89579-ef43-4626-abe2-318851df8386" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_41f89579-ef43-4626-abe2-318851df8386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d936c92d-a45f-4733-9620-450cddff9698" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_d936c92d-a45f-4733-9620-450cddff9698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c77ffa2c-f533-4adb-8103-7a2aadfd1664" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_acf7a24f-c457-4a67-be8f-5bf6126e9d73" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c77ffa2c-f533-4adb-8103-7a2aadfd1664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_2a229a46-80bd-403c-a528-96f764e48d24" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e05e2584-90f0-4f0a-aac2-40f6fc835191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_e05e2584-90f0-4f0a-aac2-40f6fc835191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e7b14a8-ca31-4219-a88c-2d87db1d62ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_c0aa181d-47a5-4ab5-9005-5ecc684576ce" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_1e7b14a8-ca31-4219-a88c-2d87db1d62ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillGoodwillBySegmentDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3c9de30-5d1c-42ec-85e8-72d7d959ca0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e3c9de30-5d1c-42ec-85e8-72d7d959ca0a" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ec009341-f3a4-4294-9d2a-c3c95037b654" xlink:to="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_7670b3d0-e7fd-495a-afb1-9e1905f86c3d" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_ConsumerMember_7670b3d0-e7fd-495a-afb1-9e1905f86c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_3b95fb34-4e43-4f45-bbc0-5d1046b3058c" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_PharmaceuticalMember_3b95fb34-4e43-4f45-bbc0-5d1046b3058c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_3b704c98-9ed6-4ecc-88ab-793568f7094a" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_bf5c5a07-8c06-45de-9081-52ee584984e7" xlink:to="loc_jnj_MedicalDevicesMember_3b704c98-9ed6-4ecc-88ab-793568f7094a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_96e19b12-a1a1-4fa0-9120-31c34b68a853" xlink:to="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_ec219995-3ba9-4f7e-aea5-3427bf75f68b" xlink:to="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0375a39c-4fe2-4c38-9c9d-90f180ae0083" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_Goodwill_0375a39c-4fe2-4c38-9c9d-90f180ae0083" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc3ef733-be96-49a3-a39c-a202196b114c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_dc3ef733-be96-49a3-a39c-a202196b114c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillOtherIncreaseDecrease_d312b71f-0017-41a3-9fbf-6749878ce0b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillOtherIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_GoodwillOtherIncreaseDecrease_d312b71f-0017-41a3-9fbf-6749878ce0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_90b01b6f-ddb0-426c-a88f-82fb31313aad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_7033c358-33f6-45f0-9214-2a57df693478" xlink:to="loc_us-gaap_Goodwill_90b01b6f-ddb0-426c-a88f-82fb31313aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7aea3569-0f85-401d-a87c-941ee7d5788a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7aea3569-0f85-401d-a87c-941ee7d5788a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_8c7d1d76-53a6-4aea-a8e4-382f271109df" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_ba5b8ad3-9e9e-4b87-8e35-fd1915f2d001" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_16b922de-04f7-4417-8fa8-b5e5bb63ec99" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_ba5b8ad3-9e9e-4b87-8e35-fd1915f2d001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_67643bb8-b9b5-4972-966e-ac3f9f3c6d01" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_b1ae6f4f-d1b8-4582-b65a-04e708a438e2" xlink:href="jnj-20200628.xsd#jnj_BermekimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:to="loc_jnj_BermekimabMember_b1ae6f4f-d1b8-4582-b65a-04e708a438e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_69902d67-fa62-4500-8f19-0bf5023b9500" xlink:href="jnj-20200628.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_e6334045-6514-4cb0-b3b8-d2caa8cef66a" xlink:to="loc_jnj_VerbSurgicalInc.Member_69902d67-fa62-4500-8f19-0bf5023b9500" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_7e7e91ed-37cc-4240-b65e-3f2acedd0eda" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PatentsAndTrademarksMember_b568eef9-1959-458a-b352-86ccd39d33bf" xlink:href="jnj-20200628.xsd#jnj_PatentsAndTrademarksMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:to="loc_jnj_PatentsAndTrademarksMember_b568eef9-1959-458a-b352-86ccd39d33bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_b42e8ac1-92c6-4087-98db-bfe3047f70dd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9ae93504-f4ff-485d-b2bd-1fdfc498b1fd" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_b42e8ac1-92c6-4087-98db-bfe3047f70dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6506b0d0-afff-4cb0-9234-b3a07704634e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7647f18f-0c25-4aa8-b711-7bb4705d0f97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_7647f18f-0c25-4aa8-b711-7bb4705d0f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:href="jnj-20200628.xsd#jnj_IntangibleAssetsAndGoodwillTextualsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a5dc49db-cd12-490a-ba2d-0cdef3e5c38c" xlink:to="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_79db928e-8de3-4752-b35d-058e73029a01" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_79db928e-8de3-4752-b35d-058e73029a01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dea342e2-c25b-46f4-b7a8-5c4f4777cdc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IntangibleAssetsAndGoodwillTextualsAbstract_57320489-d366-4d03-8f50-57a014caf72c" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dea342e2-c25b-46f4-b7a8-5c4f4777cdc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b7717961-4fb7-4254-9592-a6335a82b5ef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b7717961-4fb7-4254-9592-a6335a82b5ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_99434691-4522-4270-9b99-1358e3a82a76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_99434691-4522-4270-9b99-1358e3a82a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e2132b7a-81ed-4da4-b124-c19ad209cc4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_e2132b7a-81ed-4da4-b124-c19ad209cc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_85ef8345-a429-4a73-ba7f-ed5ad607e4af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_85ef8345-a429-4a73-ba7f-ed5ad607e4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8b847436-ae2e-4ed2-8110-508a44181078" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_4596c115-d414-492f-ac9d-18cdc66ff54c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_8b847436-ae2e-4ed2-8110-508a44181078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a02bf0da-5599-4f25-a6e7-6161e755bf54" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_29d9c248-6949-4707-9a09-71920e1831ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a02bf0da-5599-4f25-a6e7-6161e755bf54" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_29d9c248-6949-4707-9a09-71920e1831ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsPolicies"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4d939b86-7d24-4a50-9dc8-69a04f646482" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7033175c-2ead-4266-ac21-7f6f171be5de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d939b86-7d24-4a50-9dc8-69a04f646482" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_7033175c-2ead-4266-ac21-7f6f171be5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4a5d2c3f-0204-4a0b-8196-98bc09caec37" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_4a5d2c3f-0204-4a0b-8196-98bc09caec37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_32ebec99-7d1d-4e7c-a82c-898b83af9a84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock_32ebec99-7d1d-4e7c-a82c-898b83af9a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_358a960f-6477-4adc-84bf-015f19d2664a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_358a960f-6477-4adc-84bf-015f19d2664a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_270fb250-70e7-40fa-b395-880ca727c329" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_270fb250-70e7-40fa-b395-880ca727c329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_33602cda-4537-4b07-99f0-c491cf70b65c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_33602cda-4537-4b07-99f0-c491cf70b65c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_6bab7867-2430-474e-8caf-2737aa48e5e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock_6bab7867-2430-474e-8caf-2737aa48e5e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8cbefd63-cc58-470a-8661-621f60471c96" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_8cbefd63-cc58-470a-8661-621f60471c96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_29c0af62-ff16-4209-b643-acc2d3445d56" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3af320a0-bb3c-4399-be69-d25267ce6036" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_29c0af62-ff16-4209-b643-acc2d3445d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_77b11d52-58c8-45e2-bd43-37822ecaa64e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_77b11d52-58c8-45e2-bd43-37822ecaa64e" xlink:to="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_21bebbe9-6be8-454e-9465-e235a499dcb8" xlink:to="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_76f6bf0b-be76-4e64-ac8a-07714acb4c77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:to="loc_us-gaap_FairValueHedgingMember_76f6bf0b-be76-4e64-ac8a-07714acb4c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_1bdd90c7-0eb6-4cd6-bfbd-e76178b61fbc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_7da64be3-9250-4026-bc29-428014d12ec8" xlink:to="loc_us-gaap_CashFlowHedgingMember_1bdd90c7-0eb6-4cd6-bfbd-e76178b61fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6522fc02-b775-4695-ad04-b5e8c173e170" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_acfa42ff-1553-4357-9d6e-a7e55554a5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_SalesMember_acfa42ff-1553-4357-9d6e-a7e55554a5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_151b2c81-9ddb-4dae-aff7-112d8a96e844" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_CostOfSalesMember_151b2c81-9ddb-4dae-aff7-112d8a96e844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c46557a9-65b1-4ab4-b776-4afefad6add4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_c46557a9-65b1-4ab4-b776-4afefad6add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_688bc158-3a22-4a56-ad1c-b05b51272d71" xlink:href="jnj-20200628.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_688bc158-3a22-4a56-ad1c-b05b51272d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_4fc08c73-2228-4654-becd-f63fbaec5010" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_092cb4a2-c744-478f-88d1-2d33f1931339" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_4fc08c73-2228-4654-becd-f63fbaec5010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_9edb7cec-3592-4255-b7f3-299eb185ae20" xlink:to="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_20dc3f4c-7fc4-4297-a39d-d77944da80b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_59050899-c7f5-48ea-8a85-d8b036c382e4" xlink:to="loc_us-gaap_RetainedEarningsMember_20dc3f4c-7fc4-4297-a39d-d77944da80b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_6feb48ab-26fb-4b27-9750-9de76df5e476" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_7e45e2ff-5030-4531-970f-7646e5ecefb8" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_7e45e2ff-5030-4531-970f-7646e5ecefb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_d6275e24-8e1a-4aaa-b969-a382c135c1df" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_c7097e3a-c16c-41e9-b7e3-5d1b0a6cee77" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_d6275e24-8e1a-4aaa-b969-a382c135c1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_56e7d3ad-4e18-48cc-afde-e28b5e56e879" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_599b86e2-8a2f-4430-b2af-1635319b3136" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_3702314e-6469-450b-91c2-d5e9a13176a8" xlink:to="loc_us-gaap_EquitySecuritiesMember_599b86e2-8a2f-4430-b2af-1635319b3136" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_51dc7ead-4222-41d6-9bdc-7586d01c6b5e" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_57d43c2a-04fc-4fc6-b1d6-e30f4f22d2e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_f76c38f2-ceb3-4ae1-9ebc-515f2bf28c1b" xlink:to="loc_us-gaap_EquitySecuritiesMember_57d43c2a-04fc-4fc6-b1d6-e30f4f22d2e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_101ae267-ea0b-49ce-ab93-ec11f7b2f9ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_260a0393-e5dd-4c18-9931-b97ab3390347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_ForeignExchangeContractMember_260a0393-e5dd-4c18-9931-b97ab3390347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_52c487aa-58ba-42d9-a6ad-8d13d972d37d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_52c487aa-58ba-42d9-a6ad-8d13d972d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_1e834693-6913-4c16-8bc3-b82fd31b7d51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_90e99641-df77-4aae-8d40-b7a5bfb8608f" xlink:to="loc_us-gaap_InterestRateContractMember_1e834693-6913-4c16-8bc3-b82fd31b7d51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeAxis_cceb1bf7-acc1-4e1a-ae9e-c36caaf2d55e" xlink:to="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_017633bb-da9f-4d60-904b-dc12153944f1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtTypeDomain_e30627ef-9c2d-42b4-8e65-ead995e9b72f" xlink:to="loc_us-gaap_CommercialPaperMember_017633bb-da9f-4d60-904b-dc12153944f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_e04cfef1-a3fc-4335-ba8e-506c8a27b224" xlink:to="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_e974bc7f-b6cb-47a4-9a22-e061075a9a93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_e974bc7f-b6cb-47a4-9a22-e061075a9a93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_129a45ba-8516-448c-bf91-f304511e658e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_129a45ba-8516-448c-bf91-f304511e658e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6d9c086a-8aa7-49e1-a7a8-cc6be66a781b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_6d9c086a-8aa7-49e1-a7a8-cc6be66a781b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_7f042b5d-d4b2-4d36-a0dd-cb50d61a781a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeNotionalAmount_7f042b5d-d4b2-4d36-a0dd-cb50d61a781a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ad4b0388-a754-44f4-94bd-958a91463b78" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax_ad4b0388-a754-44f4-94bd-958a91463b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_d6c90888-cbec-44d6-bcac-a020ad0789ed" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss_d6c90888-cbec-44d6-bcac-a020ad0789ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_757a14ac-05ec-4953-ae68-9e66d8e533d3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge_757a14ac-05ec-4953-ae68-9e66d8e533d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_37016dcb-2641-45b8-b750-5d68ed8ff872" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_37016dcb-2641-45b8-b750-5d68ed8ff872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_d753d766-5789-436e-977d-b6924de71a16" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentChangeInObservablePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_EquityFairValueAdjustmentChangeInObservablePrice_d753d766-5789-436e-977d-b6924de71a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cfafbd2d-06be-4af3-ae78-a01f88823443" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_cfafbd2d-06be-4af3-ae78-a01f88823443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_4359d97a-27c4-4545-a023-a45b1ce14901" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_4359d97a-27c4-4545-a023-a45b1ce14901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_b498a38a-6e39-42f3-9d65-2979c35bb31a" xlink:href="jnj-20200628.xsd#jnj_ExcessOfFairValueOverCarryingValueOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_ExcessOfFairValueOverCarryingValueOfDebt_b498a38a-6e39-42f3-9d65-2979c35bb31a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_582938d6-7508-449c-a10e-4a2e9ad1adc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_ShortTermBorrowings_582938d6-7508-449c-a10e-4a2e9ad1adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_6206984b-2b2f-4f99-92e3-c417eabb38c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_6206984b-2b2f-4f99-92e3-c417eabb38c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_e7a4f048-39e2-409e-a30e-55b84121ee4f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DebtInstrumentTerm_e7a4f048-39e2-409e-a30e-55b84121ee4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_cf32bf38-9d9b-47d3-b621-bca9b46e79d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_cf32bf38-9d9b-47d3-b621-bca9b46e79d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_71ddf894-8181-4127-8f4f-31914741c811" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_71ddf894-8181-4127-8f4f-31914741c811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_08a68572-accf-4488-aed3-aa72bc6fa911" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_08a68572-accf-4488-aed3-aa72bc6fa911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_bb3cc816-feaf-4b9f-a232-02c1f2856db0" xlink:href="jnj-20200628.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_bb3cc816-feaf-4b9f-a232-02c1f2856db0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityFairValueAdjustmentImpairmentLoss_e362327a-aac5-451e-8c54-88283c5a05a0" xlink:href="jnj-20200628.xsd#jnj_EquityFairValueAdjustmentImpairmentLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0778c0d7-5609-4b0f-b98c-1513c34aef9f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_0778c0d7-5609-4b0f-b98c-1513c34aef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_e1d1853e-7b45-4b85-868b-278bea5249c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_43bbf7f8-7dbe-4176-91d1-fa3b2cf723b9" xlink:to="loc_us-gaap_EquityFairValueAdjustment_e1d1853e-7b45-4b85-868b-278bea5249c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofDerivativeActivityDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b23cfa9d-a0e2-4f97-b23b-0325a1598048" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b23cfa9d-a0e2-4f97-b23b-0325a1598048" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_2b10276a-f61e-4456-b86e-c281ed673168" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_d28d32af-4e1e-4505-b36f-1af29fae5fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:to="loc_us-gaap_FairValueHedgingMember_d28d32af-4e1e-4505-b36f-1af29fae5fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_2e72cb46-209e-4b5b-b888-2706ddf82d60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d9011f8d-9360-4a86-a46c-1d191d7b8b70" xlink:to="loc_us-gaap_CashFlowHedgingMember_2e72cb46-209e-4b5b-b888-2706ddf82d60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_63ac1c0e-9662-45c6-82eb-5442936a802c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_2b503dcb-4a09-4076-a702-f675681a6659" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_InterestRateContractMember_2b503dcb-4a09-4076-a702-f675681a6659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_f1e999d2-ddbb-4594-b780-4f7894371660" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_ForeignExchangeContractMember_f1e999d2-ddbb-4594-b780-4f7894371660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_869b5384-b6e7-4e78-8626-1f4f62b5e483" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_389d803f-d59c-4eda-a01d-fc985f89e346" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_869b5384-b6e7-4e78-8626-1f4f62b5e483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a1f1e91-25a8-430a-9ddf-f1e79a1fd558" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_28b3ab42-ef0d-4524-9e68-3b599b6bb804" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_SalesMember_28b3ab42-ef0d-4524-9e68-3b599b6bb804" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_0cb3dabf-d745-43b6-8c5f-f6d3f6da70f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_CostOfSalesMember_0cb3dabf-d745-43b6-8c5f-f6d3f6da70f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_686ba221-d3e9-4e22-9519-b0a192cf3d57" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_686ba221-d3e9-4e22-9519-b0a192cf3d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_f8e1e647-ff34-4c8a-a5c0-c79f1e89e599" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_f8e1e647-ff34-4c8a-a5c0-c79f1e89e599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterestIncomeExpenseNetMember_8f3d932f-a103-4a85-98dc-9da0bc62c363" xlink:href="jnj-20200628.xsd#jnj_InterestIncomeExpenseNetMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6ddeedda-f801-4baf-a679-5b711e9e54d5" xlink:to="loc_jnj_InterestIncomeExpenseNetMember_8f3d932f-a103-4a85-98dc-9da0bc62c363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_83c02174-2905-44e1-9fcd-6ab8014ec5d8" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_71ea6982-2ff4-43a2-97b0-41d66ef32fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_71ea6982-2ff4-43a2-97b0-41d66ef32fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_1ce7b6a4-eba9-4d40-b9d0-6328b7b8a9df" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings_1ce7b6a4-eba9-4d40-b9d0-6328b7b8a9df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_0ae911c1-7782-46c0-b10d-a8e6ffabf138" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax_0ae911c1-7782-46c0-b10d-a8e6ffabf138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_9fde248a-3c8d-4c76-a3f8-ac166b689ba9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CollateralAlreadyPostedAggregateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_CollateralAlreadyPostedAggregateFairValue_9fde248a-3c8d-4c76-a3f8-ac166b689ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_cc1fb967-5375-4049-b034-20d731716e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeNotionalAmount_cc1fb967-5375-4049-b034-20d731716e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:href="jnj-20200628.xsd#jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6e27cd38-fcff-4b3f-a117-982efb4d9172" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract_0bfbfe63-298c-4638-9506-356eb43a85ca" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_6e27cd38-fcff-4b3f-a117-982efb4d9172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef620e5f-4fc0-41df-8ccf-18b300ce0361" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_ef620e5f-4fc0-41df-8ccf-18b300ce0361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_b5b4f20e-9598-40a5-9e7e-e4fbc70a9bf0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_519698a9-7594-4a92-8c66-960a7e846729" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_b5b4f20e-9598-40a5-9e7e-e4fbc70a9bf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7157a5c1-b6bd-4e2e-8c1d-61b40a32b97c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_de1750be-7fa9-4560-b218-7c326b908dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7157a5c1-b6bd-4e2e-8c1d-61b40a32b97c" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_de1750be-7fa9-4560-b218-7c326b908dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_99286459-656b-4893-886d-0f33f5c80d81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7157a5c1-b6bd-4e2e-8c1d-61b40a32b97c" xlink:to="loc_us-gaap_DerivativeLiabilities_99286459-656b-4893-886d-0f33f5c80d81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_86bc2f73-d3ab-45b3-b75a-9244154f011d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_86bc2f73-d3ab-45b3-b75a-9244154f011d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_85b7b647-c628-4207-bccd-a54afb5d44d4" xlink:to="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_372fc4f0-c86f-4552-b667-159d42a80506" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_fbe81bf8-1db2-4c6f-b301-ad22ddb54047" xlink:to="loc_us-gaap_NondesignatedMember_372fc4f0-c86f-4552-b667-159d42a80506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_02dd5c8a-54b9-49e3-837a-8e000774e66d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_258c950f-9e61-4f0c-90e3-dc0b96d069fc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e1c0807d-7227-4048-b252-bd78f331813a" xlink:to="loc_us-gaap_ForeignExchangeContractMember_258c950f-9e61-4f0c-90e3-dc0b96d069fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_28aa47e3-8b18-40eb-bd56-b533a3dbdc3d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_6537d475-caa4-4bb8-a1a7-b079dcd0abb5" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_251bd5ea-1c98-4ccc-888d-af78c1cc9cb2" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_6537d475-caa4-4bb8-a1a7-b079dcd0abb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_45b162aa-1607-4737-bc43-e53daa27c5ce" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9dd3d99f-c619-41ff-9424-7ee49d6b1e05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_9dd3d99f-c619-41ff-9424-7ee49d6b1e05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28a26bc9-8351-4d6c-8f87-3dfeb0c0ea8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_26240e85-51b8-4741-a809-9a6d7f7956ee" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_28a26bc9-8351-4d6c-8f87-3dfeb0c0ea8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1aafcbf1-2a27-47c1-a95e-666a210e1b99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1aafcbf1-2a27-47c1-a95e-666a210e1b99" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8748b952-7493-47ef-9f4e-a7a53685f99c" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_226c9444-bea0-4220-b0c7-5662afc3723e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_17ae0653-dd31-40f7-8274-40ff41d86d9c" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_226c9444-bea0-4220-b0c7-5662afc3723e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_46e851e3-5446-4137-9e12-cbeeb043a15e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfSubsidiaryGainLossMember_fea5cddf-b006-4032-b904-2862aed412a0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfSubsidiaryGainLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:to="loc_us-gaap_SaleOfSubsidiaryGainLossMember_fea5cddf-b006-4032-b904-2862aed412a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_d895f132-fb22-4de4-bf9b-70482cc39a9c" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cf4c1111-84b9-4829-9fa7-00217a8fe3b1" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_d895f132-fb22-4de4-bf9b-70482cc39a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_62520c4f-7799-47ac-a0d3-e7c1840c62a6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ecfea513-dd1a-40d8-88fe-ff38db456584" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_ecfea513-dd1a-40d8-88fe-ff38db456584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6f634b84-757e-46ea-ae96-5184b9a0f668" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred_6f634b84-757e-46ea-ae96-5184b9a0f668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_4ff317c4-bae3-4bf9-8b3c-602f63a3229a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_33a69166-0b47-4ded-9bb0-c8b6fa1aa887" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax_4ff317c4-bae3-4bf9-8b3c-602f63a3229a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_0966cf95-f53e-4ef0-a3e0-aaff1029cefb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_0966cf95-f53e-4ef0-a3e0-aaff1029cefb" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_91722f87-964c-4eba-8431-e8e4e4f48552" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_28aabae0-cf02-40e3-a9d2-6f15c3968170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_4c905958-109a-49de-8dde-3d59f13a0d99" xlink:to="loc_us-gaap_EquitySecuritiesMember_28aabae0-cf02-40e3-a9d2-6f15c3968170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableAxis_a661157b-1776-4d1c-a168-c9e266d39ec2" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_3270c8d4-60bb-45fd-8d18-0b9824c13637" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithReadilyDeterminableValueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:to="loc_jnj_EquityInvestmentswithReadilyDeterminableValueMember_3270c8d4-60bb-45fd-8d18-0b9824c13637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_411be1f5-75d4-4037-81ac-7fab2520efc1" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentswithoutReadilyDeterminableValueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableNameDomain_245b0c50-1097-4617-bfda-dbbf3a4028f6" xlink:to="loc_jnj_EquityInvestmentswithoutReadilyDeterminableValueMember_411be1f5-75d4-4037-81ac-7fab2520efc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherInvestmentNotReadilyMarketableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableTable_0534a688-9c22-4967-a2a8-3ba564a738a3" xlink:to="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7b150c75-0795-4310-8015-d0892daa7b29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_7b150c75-0795-4310-8015-d0892daa7b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherInvestmentNotReadilyMarketableLineItems_0642b9ba-b4d8-483b-b545-b0f59c7a07cc" xlink:to="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_ff0c9358-4ace-4957-9660-271989061df8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_ff0c9358-4ace-4957-9660-271989061df8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c544580c-07ed-4118-acb6-2696fef22e73" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c544580c-07ed-4118-acb6-2696fef22e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityFairValueAdjustment_4353ac06-42ac-470d-ae82-4cd244ccf5a3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityFairValueAdjustment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_EquityFairValueAdjustment_4353ac06-42ac-470d-ae82-4cd244ccf5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_76292c77-6495-4cbf-a799-197536b9248a" xlink:href="jnj-20200628.xsd#jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod_76292c77-6495-4cbf-a799-197536b9248a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesNoncurrent_d3255a21-2ce1-467c-b8c9-30857f0b8821" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_MarketableSecuritiesNoncurrent_d3255a21-2ce1-467c-b8c9-30857f0b8821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1728d100-b582-4df4-bf79-36eaf214f321" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_1728d100-b582-4df4-bf79-36eaf214f321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_02e43783-3377-4f53-aa9b-1943bc8ce2c4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_EquityInvestmentRollForward_8a738f4e-6907-4f53-a765-993bade5637b" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_02e43783-3377-4f53-aa9b-1943bc8ce2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eeeeec0d-658a-432b-a04e-816cb086fc80" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eeeeec0d-658a-432b-a04e-816cb086fc80" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e1557c64-81ea-43e4-92d9-195af07a3da5" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c27f4f31-fa2e-4a05-925c-1741fbb307f8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_c27f4f31-fa2e-4a05-925c-1741fbb307f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesMember_516daff4-67ee-4633-81dd-dd4824190910" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherCurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d00f6a92-d738-4177-b6f2-f9407d5a11ab" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesMember_516daff4-67ee-4633-81dd-dd4824190910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3e78f02d-2fd9-494f-8ce1-4b734cb3d2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_da112e50-0b27-4ca9-90ea-6496a0f5bbff" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4aa07205-f6cf-4b6e-9c09-6edda22d913e" xlink:to="loc_jnj_AurisHealthMember_da112e50-0b27-4ca9-90ea-6496a0f5bbff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_68f01373-73a7-460c-be88-fb0f5448058d" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesMember_5ceeb052-e54f-4371-9c29-95178bf92073" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_2f071406-dc35-40f3-9b2a-eccdeb97635d" xlink:to="loc_us-gaap_EquitySecuritiesMember_5ceeb052-e54f-4371-9c29-95178bf92073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4aeef45c-6feb-4e3c-9d36-edeb5ed77b48" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_e3871abb-5bb1-4195-bdf6-aed1721ca191" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_InterestRateContractMember_e3871abb-5bb1-4195-bdf6-aed1721ca191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_366348b1-ab2b-49b3-b653-3076afd4c122" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_366348b1-ab2b-49b3-b653-3076afd4c122" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CrossCurrencyInterestRateContractMember_5db88a9e-b829-4b3f-a165-3baeb38cccef" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CrossCurrencyInterestRateContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_57234603-aece-488d-afc1-5219b31fad8c" xlink:to="loc_us-gaap_CrossCurrencyInterestRateContractMember_5db88a9e-b829-4b3f-a165-3baeb38cccef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_6c186392-0bb7-43a6-9319-845573d4953e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d7d61926-f862-4d75-bac4-399c3dc5b882" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d7d61926-f862-4d75-bac4-399c3dc5b882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_85c0cc31-893b-4118-9e99-881d59bffe0f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_85c0cc31-893b-4118-9e99-881d59bffe0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_53f09140-8825-4f56-8495-152eae5aa144" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_061a82fd-2a95-4413-a2c0-8b4a1124fbc7" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_53f09140-8825-4f56-8495-152eae5aa144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativesFairValueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_0cde2fe6-88c9-4550-b9d1-0acb7bead061" xlink:to="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentDetailAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_3623cb60-d089-406e-adc6-9f9f01063b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeNotionalAmount_3623cb60-d089-406e-adc6-9f9f01063b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_1d6aeb6e-f3aa-4c43-a17e-1a6758f41908" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue_1d6aeb6e-f3aa-4c43-a17e-1a6758f41908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_a548c716-51ec-495b-8934-df10e83e1de6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue_a548c716-51ec-495b-8934-df10e83e1de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_e76f84f9-536c-4321-afdc-008d60172c61" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue_e76f84f9-536c-4321-afdc-008d60172c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_349149eb-bdbb-46cc-bf97-8a9bb6a881ca" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue_349149eb-bdbb-46cc-bf97-8a9bb6a881ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesFvNi_cbfec3ed-ae99-4a1d-8ce7-628d98d03543" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquitySecuritiesFvNi"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_EquitySecuritiesFvNi_cbfec3ed-ae99-4a1d-8ce7-628d98d03543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11306cec-20fc-4903-bbda-8f2cfb6a2c84" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_11306cec-20fc-4903-bbda-8f2cfb6a2c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetsNoncurrent_c5c9fe33-57c1-4917-8f1b-5754431d7294" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetsNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentDetailAbstract_29e87e49-b8e9-46d8-a066-b1b9d499dd10" xlink:to="loc_us-gaap_DerivativeAssetsNoncurrent_c5c9fe33-57c1-4917-8f1b-5754431d7294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2967587d-f65b-4338-a5b1-d1bf4be7c805" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_2967587d-f65b-4338-a5b1-d1bf4be7c805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ecf2c5f3-1d73-4375-be1c-bed677699bb6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssetFairValueGrossLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeAssetFairValueGrossLiability_ecf2c5f3-1d73-4375-be1c-bed677699bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_bd11ebf8-3ace-4126-a0c4-e2d1d561740a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeAssets_bd11ebf8-3ace-4126-a0c4-e2d1d561740a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac77d73d-d8fd-4bd6-bfdf-58d0163b640c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_ac77d73d-d8fd-4bd6-bfdf-58d0163b640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_7c45459a-8abe-4358-bd63-b3da88945477" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilityFairValueGrossAsset"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeLiabilityFairValueGrossAsset_7c45459a-8abe-4358-bd63-b3da88945477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_bb769c37-000f-48ac-9630-157ca4c94c32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_DerivativeLiabilities_bb769c37-000f-48ac-9630-157ca4c94c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2329ef41-1e8f-4a60-936d-2ad0540da0f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2329ef41-1e8f-4a60-936d-2ad0540da0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_9d416236-4b78-4e14-86f9-519e05519fb2" xlink:href="jnj-20200628.xsd#jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue_9d416236-4b78-4e14-86f9-519e05519fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ba64977a-c38b-452e-a9ce-8ab019bd89d0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_ba64977a-c38b-452e-a9ce-8ab019bd89d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_79e13090-164b-4e94-8641-d74bd945b18e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_79e13090-164b-4e94-8641-d74bd945b18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b50151b2-f587-48cf-b2c1-4ac89736093e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_b50151b2-f587-48cf-b2c1-4ac89736093e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbe3a504-7c20-4d47-87f6-6402847b90e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_fbe3a504-7c20-4d47-87f6-6402847b90e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d62db13-92aa-4a05-86c6-8045e1918db7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativesFairValueLineItems_fd053c15-ecdf-42fa-8181-6b4ce9517c1e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d62db13-92aa-4a05-86c6-8045e1918db7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_8370344f-3332-46dd-8fc6-24d343d25a7e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_8370344f-3332-46dd-8fc6-24d343d25a7e" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:to="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InformationByCategoryOfDebtSecurityAxis_c39e718c-6d6d-4eb7-a9c2-97c3c5f2e478" xlink:to="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldtomaturitySecuritiesMember_0facb313-68e1-4a62-9d51-aab26a152cdb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldtomaturitySecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:to="loc_us-gaap_HeldtomaturitySecuritiesMember_0facb313-68e1-4a62-9d51-aab26a152cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_10cae258-74c0-4b08-b748-c0730d69e703" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_afba7d75-21d2-4d14-a5f1-d15ade508f55" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_10cae258-74c0-4b08-b748-c0730d69e703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:to="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_b6a064c8-f8d7-415b-af9d-deec6451b8fe" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashMember_163cb549-45db-43b0-82ac-b1a917d9734f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_CashMember_163cb549-45db-43b0-82ac-b1a917d9734f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_1e9ad00b-25b8-443f-907a-6de61830805e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_1e9ad00b-25b8-443f-907a-6de61830805e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_eafa7c98-4126-4dca-a014-6a84effe88e7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember_eafa7c98-4126-4dca-a014-6a84effe88e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherReverseRepurchaseAgreementsMember_6760de06-8560-4eef-afb5-1da33d47ab19" xlink:href="jnj-20200628.xsd#jnj_OtherReverseRepurchaseAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_jnj_OtherReverseRepurchaseAgreementsMember_6760de06-8560-4eef-afb5-1da33d47ab19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_c2366568-5e02-4c03-b92e-d77efd640f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_c2366568-5e02-4c03-b92e-d77efd640f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_3f0a3c49-2e66-4b19-8d68-ceaa0427656d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_MoneyMarketFundsMember_3f0a3c49-2e66-4b19-8d68-ceaa0427656d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BankTimeDepositsMember_2ecb920e-a479-4a12-af5a-ada84cb7ce7d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BankTimeDepositsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_BankTimeDepositsMember_2ecb920e-a479-4a12-af5a-ada84cb7ce7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryAndGovernmentMember_5c27643f-53ae-44b6-809a-904005a955aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_USTreasuryAndGovernmentMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_8d8de489-5a90-41d9-8d43-4a68788dfb6b" xlink:to="loc_us-gaap_USTreasuryAndGovernmentMember_5c27643f-53ae-44b6-809a-904005a955aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTable_18b63ba8-8a98-461a-8c4c-373a2456ba0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesClassifiedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecurities_f86f47e5-ca70-41f2-860e-c47d35ce4abf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecurities_f86f47e5-ca70-41f2-860e-c47d35ce4abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_4ff23887-03c0-4db7-b140-cef7fc6d0d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain_4ff23887-03c0-4db7-b140-cef7fc6d0d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_1ba14c86-8f02-4ef9-82ce-96928b7e989b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss_1ba14c86-8f02-4ef9-82ce-96928b7e989b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HeldToMaturitySecuritiesFairValue_1c14f2b1-935e-48c9-aac0-7f08e31620b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_HeldToMaturitySecuritiesFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract_9c115b94-ec8d-45e9-b678-7a67847c694f" xlink:to="loc_us-gaap_HeldToMaturitySecuritiesFairValue_1c14f2b1-935e-48c9-aac0-7f08e31620b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eaeaca0a-39d8-4de5-ad76-2af42fc7c935" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_eaeaca0a-39d8-4de5-ad76-2af42fc7c935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_26ed6180-9caa-4773-b332-aaac5d79de62" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_26ed6180-9caa-4773-b332-aaac5d79de62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_efcf4f89-d801-4881-b57d-986fcd7360ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_efcf4f89-d801-4881-b57d-986fcd7360ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d43dbf7e-cfc3-4716-86f4-ee6aff41b89b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesAbstract_d1f2d84a-c5b5-4a9f-b270-9b479b215742" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d43dbf7e-cfc3-4716-86f4-ee6aff41b89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsLineItems_234cfdf7-944f-4133-83b4-f0d0b4effd1f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d6feb6f-336a-4e36-afa5-8ac8934e8eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5d6feb6f-336a-4e36-afa5-8ac8934e8eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesCurrent_f9bcb68c-55c5-4a33-bfa8-7f11ae8b7347" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MarketableSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_MarketableSecuritiesCurrent_f9bcb68c-55c5-4a33-bfa8-7f11ae8b7347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_157f46bf-9c24-4005-8226-dd3dbfa1761b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_157f46bf-9c24-4005-8226-dd3dbfa1761b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_40c79746-e7b9-40ab-9a20-5bf017e59867" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain_40c79746-e7b9-40ab-9a20-5bf017e59867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_6f53cdc4-bec2-49a3-9274-65dc65d5b389" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss_6f53cdc4-bec2-49a3-9274-65dc65d5b389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_c4944242-b092-4961-b054-d87b61a3a34f" xlink:href="jnj-20200628.xsd#jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract_3dfd4fdc-77d3-4d7c-a8aa-77bbd165ed06" xlink:to="loc_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue_c4944242-b092-4961-b054-d87b61a3a34f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_c0e0796d-d4cc-4d8c-9428-7a184efe5f58" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0e0796d-d4cc-4d8c-9428-7a184efe5f58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_23a9c3a8-20ec-4862-8e69-17b5d723350b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_23a9c3a8-20ec-4862-8e69-17b5d723350b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_aee78efc-2cfa-4d2d-9874-95de2e6fc785" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_aee78efc-2cfa-4d2d-9874-95de2e6fc785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7e17bdfd-0813-445c-9706-218464e9a35d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost_7e17bdfd-0813-445c-9706-218464e9a35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_7af02008-1fd6-4a24-bf29-75cf5c418dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_12bfce33-57a5-4dac-9a1c-ba2bf5ca5390" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_7af02008-1fd6-4a24-bf29-75cf5c418dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_c0e0796d-d4cc-4d8c-9428-7a184efe5f58" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4451b4b2-7531-455c-8c84-dc2967211fee" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_4451b4b2-7531-455c-8c84-dc2967211fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_14273fa7-e680-49f9-8575-672fbb8c948b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue_14273fa7-e680-49f9-8575-672fbb8c948b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_db5281b1-fa5c-4b2c-840f-df18118bd15f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue_db5281b1-fa5c-4b2c-840f-df18118bd15f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0414dd27-5777-43bd-bd30-87de9a9857c5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract_1fce1a07-5932-4a00-8b62-7e9fdd455feb" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0414dd27-5777-43bd-bd30-87de9a9857c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6210b51e-f3eb-413c-adfc-65eeb2204ff2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6210b51e-f3eb-413c-adfc-65eeb2204ff2" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:to="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4ee172e3-8d30-4f37-84ca-d605939a0c07" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2021Member_3d6a8cc7-d3c1-46ba-8b54-73987a05041b" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.55Notesdue2021Member_3d6a8cc7-d3c1-46ba-8b54-73987a05041b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2021Member_dd3c0e03-39ad-4e3d-a784-b8475578e012" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.45Notesdue2021Member_dd3c0e03-39ad-4e3d-a784-b8475578e012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.250NotesDue2022Member_a980ef7e-faa1-4a0a-a923-1fe27b8cbb0b" xlink:href="jnj-20200628.xsd#jnj_A0.250NotesDue2022Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A0.250NotesDue2022Member_a980ef7e-faa1-4a0a-a923-1fe27b8cbb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.25Notesdue2022Member_e7f17059-60ef-4554-bc35-e37e9143de46" xlink:href="jnj-20200628.xsd#jnj_A2.25Notesdue2022Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.25Notesdue2022Member_e7f17059-60ef-4554-bc35-e37e9143de46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.73Debenturesdue2023Member_9a85b95a-c924-4123-af8b-eaf89356bd47" xlink:href="jnj-20200628.xsd#jnj_A6.73Debenturesdue2023Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A6.73Debenturesdue2023Member_9a85b95a-c924-4123-af8b-eaf89356bd47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.375Notesdue2023Member_817a1156-fc82-45ef-ad05-414c0eb0bd1a" xlink:href="jnj-20200628.xsd#jnj_A3.375Notesdue2023Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.375Notesdue2023Member_817a1156-fc82-45ef-ad05-414c0eb0bd1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.05Notesdue2023Member_a10d3ead-00ce-47ae-9440-dd3289bf00c9" xlink:href="jnj-20200628.xsd#jnj_A2.05Notesdue2023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.05Notesdue2023Member_a10d3ead-00ce-47ae-9440-dd3289bf00c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A0.650NotesDue2024Member_dc1ba1c8-8ec7-42ed-aa24-1cadf4384454" xlink:href="jnj-20200628.xsd#jnj_A0.650NotesDue2024Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A0.650NotesDue2024Member_dc1ba1c8-8ec7-42ed-aa24-1cadf4384454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.50NotesDue2024Member_11ec8de7-ba73-4260-8d0f-97d550f1f9b5" xlink:href="jnj-20200628.xsd#jnj_A5.50NotesDue2024Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.50NotesDue2024Member_11ec8de7-ba73-4260-8d0f-97d550f1f9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.625Notesdue2025Member_a88585b8-867c-434e-97d4-09184b1063f6" xlink:href="jnj-20200628.xsd#jnj_A2.625Notesdue2025Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.625Notesdue2025Member_a88585b8-867c-434e-97d4-09184b1063f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.45Notesdue2026Member_0cbb5993-5dc2-401a-bf43-47da066f773a" xlink:href="jnj-20200628.xsd#jnj_A2.45Notesdue2026Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.45Notesdue2026Member_0cbb5993-5dc2-401a-bf43-47da066f773a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.95Notesdue2027Member_86c240d9-cd77-4cc9-b057-95796b9f074c" xlink:href="jnj-20200628.xsd#jnj_A2.95Notesdue2027Member"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.95Notesdue2027Member_86c240d9-cd77-4cc9-b057-95796b9f074c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A2.900Notesdue2028Member_7f9ff884-90cf-4cee-b1b1-6a06fd2570c6" xlink:href="jnj-20200628.xsd#jnj_A2.900Notesdue2028Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A2.900Notesdue2028Member_7f9ff884-90cf-4cee-b1b1-6a06fd2570c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.150NotesDue2028Member_67a76e9a-5ca1-40ed-a876-7769c7874980" xlink:href="jnj-20200628.xsd#jnj_A1.150NotesDue2028Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A1.150NotesDue2028Member_67a76e9a-5ca1-40ed-a876-7769c7874980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A6.95Notesdue2029Member_b97bcc14-2f02-4570-9cec-a327c3f611f5" xlink:href="jnj-20200628.xsd#jnj_A6.95Notesdue2029Member"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A6.95Notesdue2029Member_b97bcc14-2f02-4570-9cec-a327c3f611f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.95Debenturesdue2033Member_77b27f9f-e965-42be-8051-ba8ee2346957" xlink:href="jnj-20200628.xsd#jnj_A4.95Debenturesdue2033Member"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.95Debenturesdue2033Member_77b27f9f-e965-42be-8051-ba8ee2346957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.375Notesdue2033Member_6e789396-c022-4627-a700-10a1960d7df0" xlink:href="jnj-20200628.xsd#jnj_A4.375Notesdue2033Member"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.375Notesdue2033Member_6e789396-c022-4627-a700-10a1960d7df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A1.650NotesDue2035Member_b5597e98-f452-497a-bc3e-6ff2ae347844" xlink:href="jnj-20200628.xsd#jnj_A1.650NotesDue2035Member"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A1.650NotesDue2035Member_b5597e98-f452-497a-bc3e-6ff2ae347844" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.55Notesdue2036Member_24d2e6be-0ade-4528-a270-c85f8317db82" xlink:href="jnj-20200628.xsd#jnj_A3.55Notesdue2036Member"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.55Notesdue2036Member_24d2e6be-0ade-4528-a270-c85f8317db82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.95Notesdue2037Member_76243a17-f342-4c47-bc97-80ed2bb4adae" xlink:href="jnj-20200628.xsd#jnj_A5.95Notesdue2037Member"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.95Notesdue2037Member_76243a17-f342-4c47-bc97-80ed2bb4adae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.625Notesdue2037Member_57c76e3b-52ae-4535-9a08-530af3bc2529" xlink:href="jnj-20200628.xsd#jnj_A3.625Notesdue2037Member"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.625Notesdue2037Member_57c76e3b-52ae-4535-9a08-530af3bc2529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.400Notesdue2038Member_ea30faf1-9936-4dcc-9591-12303067255c" xlink:href="jnj-20200628.xsd#jnj_A3.400Notesdue2038Member"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.400Notesdue2038Member_ea30faf1-9936-4dcc-9591-12303067255c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A5.85Debenturesdue2038Member_60b4bf2c-098a-4b18-ad0f-5a5781f3e570" xlink:href="jnj-20200628.xsd#jnj_A5.85Debenturesdue2038Member"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A5.85Debenturesdue2038Member_60b4bf2c-098a-4b18-ad0f-5a5781f3e570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Debenturesdue2040Member_98c1916a-5a70-4b94-a90c-32b72c30d54f" xlink:href="jnj-20200628.xsd#jnj_A4.50Debenturesdue2040Member"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.50Debenturesdue2040Member_98c1916a-5a70-4b94-a90c-32b72c30d54f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.85Notesdue2041Member_adc11ca8-119e-4c6b-a693-f62ac8f44394" xlink:href="jnj-20200628.xsd#jnj_A4.85Notesdue2041Member"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.85Notesdue2041Member_adc11ca8-119e-4c6b-a693-f62ac8f44394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A4.50Notesdue2043Member_0e5880e4-cad1-4ce5-9a82-b9da83cc62cd" xlink:href="jnj-20200628.xsd#jnj_A4.50Notesdue2043Member"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A4.50Notesdue2043Member_0e5880e4-cad1-4ce5-9a82-b9da83cc62cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.70Notesdue2046Member_109b0c0f-a1c2-4a86-9882-ad6b422034f0" xlink:href="jnj-20200628.xsd#jnj_A3.70Notesdue2046Member"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.70Notesdue2046Member_109b0c0f-a1c2-4a86-9882-ad6b422034f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.75Notesdue2047Member_fc32e829-249d-4b6a-956b-35ff4d7b4c33" xlink:href="jnj-20200628.xsd#jnj_A3.75Notesdue2047Member"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.75Notesdue2047Member_fc32e829-249d-4b6a-956b-35ff4d7b4c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_A3.500Notesdue2048Member_000a0582-4804-4124-8c76-3dc4ad76507e" xlink:href="jnj-20200628.xsd#jnj_A3.500Notesdue2048Member"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_A3.500Notesdue2048Member_000a0582-4804-4124-8c76-3dc4ad76507e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NotesDuePeriodFifteenMember_809e7dc6-9785-40f0-924a-c77943fb2db5" xlink:href="jnj-20200628.xsd#jnj_NotesDuePeriodFifteenMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_dc4048b9-ee6a-48df-aca3-144739f1c074" xlink:to="loc_jnj_NotesDuePeriodFifteenMember_809e7dc6-9785-40f0-924a-c77943fb2db5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_9111828f-4255-4fbc-88d3-b76b1345ab46" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_48dce815-243a-42d1-895d-92a53f408643" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3bccf5a8-acd4-4d4c-a39f-c1b643ed44fd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_3bccf5a8-acd4-4d4c-a39f-c1b643ed44fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9b01ad2-af49-4d82-be47-4ee628bb941d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_4f3a1625-5527-4630-9d9c-d2ea4acb102e" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_e9b01ad2-af49-4d82-be47-4ee628bb941d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_0899521c-e59f-403c-b8e8-1b247a7e514c" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_26e0041a-697d-4bb3-b1e8-d3dd51a4fea5" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermBorrowings_d9572242-e38a-42cb-991d-a2771a80f36f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShortTermBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_d5d04022-0ee8-4a1c-a81a-3c518db33fe5" xlink:to="loc_us-gaap_ShortTermBorrowings_d9572242-e38a-42cb-991d-a2771a80f36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_2bf91155-77d0-4601-8ca6-fe368c2692b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongTermDebtNoncurrentAbstract_3c12d707-7829-4ad7-b314-67b5e1fb920c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_2bf91155-77d0-4601-8ca6-fe368c2692b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7fcb0da9-af0f-48fb-a614-7e33d9b51404" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_f3a5be9f-10a8-4894-959f-ae1dff5c9fb3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7fcb0da9-af0f-48fb-a614-7e33d9b51404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxes" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b1040dec-6600-4dc9-945b-e439f14ce868" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_fbc4d357-d4b9-45a0-b3a5-d5c18b18214e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b1040dec-6600-4dc9-945b-e439f14ce868" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_fbc4d357-d4b9-45a0-b3a5-d5c18b18214e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_3c87af41-2e6a-4002-b9be-9f5a6911e6be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_3c87af41-2e6a-4002-b9be-9f5a6911e6be" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_39398d13-cd8a-42b7-8077-f12c270032e9" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalRevenueServiceIRSMember_db886452-541a-40b9-bd4b-b05abcd8f7a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InternalRevenueServiceIRSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_14af284c-fbe3-42eb-9dac-89cece709aae" xlink:to="loc_us-gaap_InternalRevenueServiceIRSMember_db886452-541a-40b9-bd4b-b05abcd8f7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_30e4641e-ddb9-410d-ae52-81dfe33db95c" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AccruedTaxesOnIncomeMember_51c7d081-f030-4240-99bf-d2a0e2f2468f" xlink:href="jnj-20200628.xsd#jnj_AccruedTaxesOnIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c028599e-cd15-4c9c-9e6a-81b2a10b478b" xlink:to="loc_jnj_AccruedTaxesOnIncomeMember_51c7d081-f030-4240-99bf-d2a0e2f2468f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_b140eea4-8ed6-4633-b7e1-6e069d2f4dbc" xlink:to="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_f03c0195-62ca-44fa-83ea-5c2997c432d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:to="loc_srt_MinimumMember_f03c0195-62ca-44fa-83ea-5c2997c432d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_df2f7884-8cf6-471a-a68b-4bf21e799daf" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6adf9cd1-ea2f-4351-97f6-c5679c3ec40c" xlink:to="loc_srt_MaximumMember_df2f7884-8cf6-471a-a68b-4bf21e799daf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_9a0449e5-42b2-4e47-a5f5-bb0e1ca9957d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_5ec3609d-2370-45a2-9004-a99645f0e5aa" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_9a0449e5-42b2-4e47-a5f5-bb0e1ca9957d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_dabf8415-c75f-461a-82cd-0354cdde1caf" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:href="jnj-20200628.xsd#jnj_IncomeTaxTextualsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_cf78b71c-ceb4-4ac1-8a8e-128b695d55a8" xlink:to="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_66c93340-4152-453c-8821-d72a747656d6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_66c93340-4152-453c-8821-d72a747656d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_2c21448e-bc63-47f4-9377-ae8222622050" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset_2c21448e-bc63-47f4-9377-ae8222622050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_a751824c-e087-417f-9ec9-c42dae48de04" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit_a751824c-e087-417f-9ec9-c42dae48de04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_4042990d-b9cd-4701-a3f5-6e5ea401f1bc" xlink:href="jnj-20200628.xsd#jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent_4042990d-b9cd-4701-a3f5-6e5ea401f1bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_befd5cbd-a598-4580-8cf5-6203992808ce" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent_befd5cbd-a598-4580-8cf5-6203992808ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_98dfb3d5-1b77-41fd-93ed-830f50bcf06d" xlink:href="jnj-20200628.xsd#jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent_98dfb3d5-1b77-41fd-93ed-830f50bcf06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_29a15b5c-6c4b-47fa-ba65-99226bff568b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_29a15b5c-6c4b-47fa-ba65-99226bff568b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_e5856dcc-d99f-43f0-b60b-9734070f1c20" xlink:href="jnj-20200628.xsd#jnj_UnrecognizedTaxBenefitLiabilityPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_IncomeTaxTextualsAbstract_2843c212-e1db-4874-8cd6-20ba49480ffa" xlink:to="loc_jnj_UnrecognizedTaxBenefitLiabilityPayment_e5856dcc-d99f-43f0-b60b-9734070f1c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlans"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a28251ff-d21f-4b15-b1da-15dbc1f62a92" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4196baba-90df-42ca-af3d-f3a6fa215e93" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_a28251ff-d21f-4b15-b1da-15dbc1f62a92" xlink:to="loc_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_4196baba-90df-42ca-af3d-f3a6fa215e93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8b003891-641b-4900-8c30-596990f4ea70" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e7530cc5-42d6-4a6e-bf7d-c7e9c392bd0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfNetBenefitCostsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8b003891-641b-4900-8c30-596990f4ea70" xlink:to="loc_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock_e7530cc5-42d6-4a6e-bf7d-c7e9c392bd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_46b5cb0c-78f1-4b39-986a-39f99d899a69" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_46b5cb0c-78f1-4b39-986a-39f99d899a69" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:to="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeAxis_430e196f-3533-4ea8-84bc-617d82e7fe20" xlink:to="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionPlansDefinedBenefitMember_dfeedb67-b9c3-48de-9cb0-3ebf6e5e937b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionPlansDefinedBenefitMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:to="loc_us-gaap_PensionPlansDefinedBenefitMember_dfeedb67-b9c3-48de-9cb0-3ebf6e5e937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f4beb09d-84e2-4b32-8fd6-c34a3374a38b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanTypeDomain_9727e2d4-c7b1-4e3b-a017-268f9d27905b" xlink:to="loc_us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember_f4beb09d-84e2-4b32-8fd6-c34a3374a38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_ff3c9f2d-0d45-4840-8520-d82b1be01385" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_1280f0d9-2d30-4d1a-9462-aea392803323" xlink:to="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanServiceCost_59113ab2-02e4-4cad-a4a1-178bd1ba816e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanServiceCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanServiceCost_59113ab2-02e4-4cad-a4a1-178bd1ba816e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanInterestCost_194fdd4c-5869-4464-9e12-0d96ad4e2372" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanInterestCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanInterestCost_194fdd4c-5869-4464-9e12-0d96ad4e2372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_799b3379-697b-43c3-9f04-7e36ebdb2c66" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets_799b3379-697b-43c3-9f04-7e36ebdb2c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5dcdca9b-e084-4805-9882-ea92ac706fe0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit_5dcdca9b-e084-4805-9882-ea92ac706fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4079cbf3-303f-41b3-9f14-85b36c3e056b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses_4079cbf3-303f-41b3-9f14-85b36c3e056b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_bd878621-371a-42e6-a60a-714e0eee7a1c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1_bd878621-371a-42e6-a60a-714e0eee7a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_db572040-4905-4fa2-9338-480019054df9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract_927c6502-9189-4fe4-8ed0-fe1f6290903f" xlink:to="loc_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost_db572040-4905-4fa2-9338-480019054df9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#PensionsandOtherBenefitPlansDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6c730114-7488-47ac-bef3-c25bbcaceb60" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_6c730114-7488-47ac-bef3-c25bbcaceb60" xlink:to="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetirementPlanSponsorLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationAxis_92fbe8e3-a6a5-4135-a0c3-364debe3c21f" xlink:to="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_60aba2e1-aa1f-42c6-b006-b554a23959f4" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:to="loc_country_US_60aba2e1-aa1f-42c6-b006-b554a23959f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignPlanMember_88fd85da-b703-4fa9-a5cc-6be65d3050a5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RetirementPlanSponsorLocationDomain_68c9aaa2-0ded-4a22-bffb-a5ebf34413c9" xlink:to="loc_us-gaap_ForeignPlanMember_88fd85da-b703-4fa9-a5cc-6be65d3050a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DefinedBenefitPlanDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable_00fe9701-c9f9-4ad0-84df-160e9c4224f7" xlink:to="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PensionContributions_72192edc-7003-429c-b7cf-625b4d8c2f75" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PensionContributions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DefinedBenefitPlanDisclosureLineItems_d02662b6-498c-4f86-bdf3-7c354b1c5f7a" xlink:to="loc_us-gaap_PensionContributions_72192edc-7003-429c-b7cf-625b4d8c2f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c36762de-3a4b-4ae2-a584-86bc6ad81b0a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_cec03b51-b292-4cb1-ab60-83f0291df187" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c36762de-3a4b-4ae2-a584-86bc6ad81b0a" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_cec03b51-b292-4cb1-ab60-83f0291df187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_28a5c113-0401-4dc2-b180-6fd96fb63b0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5c3deb8f-37fd-4a48-b492-a1573166a2eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_28a5c113-0401-4dc2-b180-6fd96fb63b0d" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_5c3deb8f-37fd-4a48-b492-a1573166a2eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#AccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c3e332dd-063f-42b3-bc88-f6c97713fd89" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c3e332dd-063f-42b3-bc88-f6c97713fd89" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b1d00e7f-a4c8-4da3-9a9a-a329373f34a4" xlink:to="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4d5c2bb2-dc8d-4e33-8440-a8d823a10263" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_4d5c2bb2-dc8d-4e33-8440-a8d823a10263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ddc85968-769f-4ec0-b889-67439f3b0363" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_ddc85968-769f-4ec0-b889-67439f3b0363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_75b44ff8-41db-4119-8bda-fcfb5fdebbc4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_75b44ff8-41db-4119-8bda-fcfb5fdebbc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_daa6c7f1-c901-4680-99a5-32285623befc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_daa6c7f1-c901-4680-99a5-32285623befc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a5e06c3-c96c-4515-ac4a-e0cfd75da4a7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_6e212c67-b4ef-442a-b528-05933a2f9c47" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2a5e06c3-c96c-4515-ac4a-e0cfd75da4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_528645ec-6a5d-4069-ad45-a6e4f89fea7c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_0b63ee5f-3412-4385-a352-aee0c86f031a" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d843cea1-04c9-4ac9-a0d2-beaac7868c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d843cea1-04c9-4ac9-a0d2-beaac7868c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f891dbc-4413-459c-8875-878a26b51d71" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3f891dbc-4413-459c-8875-878a26b51d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d461db7-e657-46ed-8775-65fe64c6a970" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract_a1b1263c-238a-4d78-be54-5aec75beec9b" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d461db7-e657-46ed-8775-65fe64c6a970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShare" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShare"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_16564f80-afed-4933-b5c8-7f649d5250dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_7c5e9f22-27e4-4b28-9dd7-c8d71fad6e33" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_16564f80-afed-4933-b5c8-7f649d5250dc" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_7c5e9f22-27e4-4b28-9dd7-c8d71fad6e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f8776088-bd58-4cfe-9e2d-ff9a4688ee90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b7bce0bc-4bff-4c6f-b75a-17d5bf566753" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f8776088-bd58-4cfe-9e2d-ff9a4688ee90" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_b7bce0bc-4bff-4c6f-b75a-17d5bf566753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#EarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/EarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eba40c63-d34d-481d-8e2a-7245611ad262" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eba40c63-d34d-481d-8e2a-7245611ad262" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3390176a-2d57-404a-b700-9167d3555feb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_EarningsPerShareBasic_3390176a-2d57-404a-b700-9167d3555feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_93996ab7-66c0-461f-9ece-a330b70f08ad" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_93996ab7-66c0-461f-9ece-a330b70f08ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_15321f0a-cdb1-4baa-bba3-0a39914dd67d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_15321f0a-cdb1-4baa-bba3-0a39914dd67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_c2135525-d41b-49ec-ad34-9fdada768a35" xlink:href="jnj-20200628.xsd#jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod_c2135525-d41b-49ec-ad34-9fdada768a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_63105076-c3cf-471e-996c-b288ff6c83bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities_63105076-c3cf-471e-996c-b288ff6c83bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0437b9ea-bac6-42b5-be36-3463322cca38" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0437b9ea-bac6-42b5-be36-3463322cca38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_3ef22974-7c21-4204-97d2-55e8c5eb294b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_3ef22974-7c21-4204-97d2-55e8c5eb294b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_48480444-f596-42c6-bb35-7ecdf630184c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_c3dd97b2-2a08-41b2-a615-286b2fe9f86a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_48480444-f596-42c6-bb35-7ecdf630184c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreas"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bb3e0497-0988-4695-91f9-f1de9ff01fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_98fce168-faa5-4ba2-a6d7-05b6255d16b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bb3e0497-0988-4695-91f9-f1de9ff01fd0" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_98fce168-faa5-4ba2-a6d7-05b6255d16b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_34b2bd96-53eb-49b4-aeb4-acd1b76e062d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SalesBySegmentOfBusinessTableTextBlock_71122803-2d99-48f9-81b6-22d666012887" xlink:href="jnj-20200628.xsd#jnj_SalesBySegmentOfBusinessTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_34b2bd96-53eb-49b4-aeb4-acd1b76e062d" xlink:to="loc_jnj_SalesBySegmentOfBusinessTableTextBlock_71122803-2d99-48f9-81b6-22d666012887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bce7b51a-d316-48b7-b221-63c7f308e0d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_34b2bd96-53eb-49b4-aeb4-acd1b76e062d" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bce7b51a-d316-48b7-b221-63c7f308e0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ad43f5c0-1621-413b-b897-43b6f00c70f7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_34b2bd96-53eb-49b4-aeb4-acd1b76e062d" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock_ad43f5c0-1621-413b-b897-43b6f00c70f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_005fa1e0-a232-4ce5-8165-4214dc169220" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_005fa1e0-a232-4ce5-8165-4214dc169220" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_6d977e24-e20a-48cb-86b0-b0f6996f490b" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_e62265fa-408b-4196-b398-4933d734e55d" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_455cf9a2-8ce0-49de-9441-6bf72bed1dd0" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_e62265fa-408b-4196-b398-4933d734e55d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53c9c0ae-664e-4b0d-9d33-3cb794b5f4e3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b5de7662-5765-43b0-8396-24f13f7b26c7" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53c9c0ae-664e-4b0d-9d33-3cb794b5f4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d9f176cb-dde3-43af-b635-35b3a1d057eb" xlink:to="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_ca70143f-c321-408b-b4ed-b6672ab890da" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_ConsumerMember_ca70143f-c321-408b-b4ed-b6672ab890da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_a3df2838-aaf9-4db2-b0cf-3fbd12f13caa" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_PharmaceuticalMember_a3df2838-aaf9-4db2-b0cf-3fbd12f13caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_2e5f4d1c-c027-42c3-86f0-38a0cbb6752f" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2bd73b92-fa63-4127-bacf-88113c614f5f" xlink:to="loc_jnj_MedicalDevicesMember_2e5f4d1c-c027-42c3-86f0-38a0cbb6752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_1bf003de-69a0-41c6-8ed5-30aec7536002" xlink:to="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ImmunologyMember_e3529f94-6c83-4931-b6d4-d55c166094b7" xlink:href="jnj-20200628.xsd#jnj_ImmunologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_ImmunologyMember_e3529f94-6c83-4931-b6d4-d55c166094b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InfectiousDiseasesMember_989a7f37-fb29-42b1-b2bb-e920c62ba27c" xlink:href="jnj-20200628.xsd#jnj_InfectiousDiseasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_InfectiousDiseasesMember_989a7f37-fb29-42b1-b2bb-e920c62ba27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_NeuroscienceMember_8de0ff8c-1182-4b04-b85b-61b007c281c5" xlink:href="jnj-20200628.xsd#jnj_NeuroscienceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_NeuroscienceMember_8de0ff8c-1182-4b04-b85b-61b007c281c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OncologyMember_1f23c5ca-d530-4b71-8ed7-241a80dd73fd" xlink:href="jnj-20200628.xsd#jnj_OncologyMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_OncologyMember_1f23c5ca-d530-4b71-8ed7-241a80dd73fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PulmonaryHypertensionMember_f72918f4-9681-4fec-b72c-34949af6e87a" xlink:href="jnj-20200628.xsd#jnj_PulmonaryHypertensionMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_PulmonaryHypertensionMember_f72918f4-9681-4fec-b72c-34949af6e87a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CardiovascularMetabolismOtherMember_e13a0e5f-4a28-42d3-b721-66d48e16691c" xlink:href="jnj-20200628.xsd#jnj_CardiovascularMetabolismOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_CardiovascularMetabolismOtherMember_e13a0e5f-4a28-42d3-b721-66d48e16691c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InterventionalSolutionsMember_331033b9-e4c2-4e38-980d-3a51d1f48a11" xlink:href="jnj-20200628.xsd#jnj_InterventionalSolutionsMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_InterventionalSolutionsMember_331033b9-e4c2-4e38-980d-3a51d1f48a11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OrthopaedicsMember_8a7e8434-1474-4643-9173-ffc80f0d7bd8" xlink:href="jnj-20200628.xsd#jnj_OrthopaedicsMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_OrthopaedicsMember_8a7e8434-1474-4643-9173-ffc80f0d7bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SurgeryMember_b7b1bfbd-64ff-4e26-94f6-166fa3e73ac2" xlink:href="jnj-20200628.xsd#jnj_SurgeryMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_SurgeryMember_b7b1bfbd-64ff-4e26-94f6-166fa3e73ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VisionMember_87fc43c2-b02a-4f32-91b4-b245fd7621a4" xlink:href="jnj-20200628.xsd#jnj_VisionMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_7122d46e-459a-447e-b4b2-e82e48406ecf" xlink:to="loc_jnj_VisionMember_87fc43c2-b02a-4f32-91b4-b245fd7621a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_b7305f49-755c-4fd3-a787-d0ee1c15367b" xlink:to="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyCareMember_e229fa82-262f-4af4-b62d-ab5ee0f1df6c" xlink:href="jnj-20200628.xsd#jnj_BabyCareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_BabyCareMember_e229fa82-262f-4af4-b62d-ab5ee0f1df6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BeautyMember_06b2a3de-e2db-496e-8392-2248f66fe451" xlink:href="jnj-20200628.xsd#jnj_BeautyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_BeautyMember_06b2a3de-e2db-496e-8392-2248f66fe451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OralCareMember_24d2ce1f-49ff-40a6-b7e9-883095e9b734" xlink:href="jnj-20200628.xsd#jnj_OralCareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OralCareMember_24d2ce1f-49ff-40a6-b7e9-883095e9b734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTCMember_2b5393de-ab96-4d03-8a51-c56ba845d708" xlink:href="jnj-20200628.xsd#jnj_OTCMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OTCMember_2b5393de-ab96-4d03-8a51-c56ba845d708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WomensHealthMember_2d0d2b61-2fc7-4890-bff0-3ebdeda707d0" xlink:href="jnj-20200628.xsd#jnj_WomensHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_WomensHealthMember_2d0d2b61-2fc7-4890-bff0-3ebdeda707d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WoundCareandOtherMember_18941cd3-af6a-465f-a2c6-5be6e19cafa1" xlink:href="jnj-20200628.xsd#jnj_WoundCareandOtherMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_WoundCareandOtherMember_18941cd3-af6a-465f-a2c6-5be6e19cafa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RemicadeMember_55adf570-111a-483b-b232-ff4c50f6f1cf" xlink:href="jnj-20200628.xsd#jnj_RemicadeMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_RemicadeMember_55adf570-111a-483b-b232-ff4c50f6f1cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SimponiSimponiAriaMember_4672c845-e10c-4d8a-8854-f27a8a489015" xlink:href="jnj-20200628.xsd#jnj_SimponiSimponiAriaMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SimponiSimponiAriaMember_4672c845-e10c-4d8a-8854-f27a8a489015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_StelaraMember_155e2f05-a378-4fc4-b300-e8f8035dd8d5" xlink:href="jnj-20200628.xsd#jnj_StelaraMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_StelaraMember_155e2f05-a378-4fc4-b300-e8f8035dd8d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TremfyaMember_9be98ccd-51cf-49e9-8f3a-fc390ffaa651" xlink:href="jnj-20200628.xsd#jnj_TremfyaMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_TremfyaMember_9be98ccd-51cf-49e9-8f3a-fc390ffaa651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherImmunologyMember_18028826-fe98-4ac3-86f3-691c0eeac787" xlink:href="jnj-20200628.xsd#jnj_OtherImmunologyMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherImmunologyMember_18028826-fe98-4ac3-86f3-691c0eeac787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EDURANTrilpivirineMember_b3b41667-0ff5-4d1e-b302-67eba46fef77" xlink:href="jnj-20200628.xsd#jnj_EDURANTrilpivirineMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_EDURANTrilpivirineMember_b3b41667-0ff5-4d1e-b302-67eba46fef77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_acd6ef72-660c-4f7c-b718-6f9c7f2d2ea5" xlink:href="jnj-20200628.xsd#jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember_acd6ef72-660c-4f7c-b718-6f9c7f2d2ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherInfectiousDiseasesMember_8480ebfc-f975-47a9-89a9-4bbeb19dc75c" xlink:href="jnj-20200628.xsd#jnj_OtherInfectiousDiseasesMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherInfectiousDiseasesMember_8480ebfc-f975-47a9-89a9-4bbeb19dc75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONCERTAMethylphenidateMember_94b395b4-ba3b-4592-9cbf-25646b015998" xlink:href="jnj-20200628.xsd#jnj_CONCERTAMethylphenidateMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_CONCERTAMethylphenidateMember_94b395b4-ba3b-4592-9cbf-25646b015998" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_76d5913a-8506-412d-9a46-9030bc39eaf9" xlink:href="jnj-20200628.xsd#jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember_76d5913a-8506-412d-9a46-9030bc39eaf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RISPERDALCONSTAMember_810d7219-8f3c-4073-af47-a90c0d4ce554" xlink:href="jnj-20200628.xsd#jnj_RISPERDALCONSTAMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_RISPERDALCONSTAMember_810d7219-8f3c-4073-af47-a90c0d4ce554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OTHERNEUROSCIENCEMember_266f11f0-be12-4288-a3b2-67c1b0094cb4" xlink:href="jnj-20200628.xsd#jnj_OTHERNEUROSCIENCEMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OTHERNEUROSCIENCEMember_266f11f0-be12-4288-a3b2-67c1b0094cb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DARZALEXMember_3f31b03f-86bf-4a7e-a024-125e1ecbbb99" xlink:href="jnj-20200628.xsd#jnj_DARZALEXMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_DARZALEXMember_3f31b03f-86bf-4a7e-a024-125e1ecbbb99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ERLEADAMember_25633192-038d-42ab-a39f-55e8d7edf794" xlink:href="jnj-20200628.xsd#jnj_ERLEADAMember"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ERLEADAMember_25633192-038d-42ab-a39f-55e8d7edf794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IMBRUVICAMember_9da44a7c-9dd8-435c-818d-e8f61bf82265" xlink:href="jnj-20200628.xsd#jnj_IMBRUVICAMember"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_IMBRUVICAMember_9da44a7c-9dd8-435c-818d-e8f61bf82265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VELCADEMember_2c119687-ee50-40bb-ba96-8e2a431a3c68" xlink:href="jnj-20200628.xsd#jnj_VELCADEMember"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_VELCADEMember_2c119687-ee50-40bb-ba96-8e2a431a3c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ZYTIGAMember_8f1e1953-000f-4a35-be17-d6e646fa9f16" xlink:href="jnj-20200628.xsd#jnj_ZYTIGAMember"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ZYTIGAMember_8f1e1953-000f-4a35-be17-d6e646fa9f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherOncologyMember_0fb85af3-9c57-4b6c-9909-cab4c347cac2" xlink:href="jnj-20200628.xsd#jnj_OtherOncologyMember"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherOncologyMember_0fb85af3-9c57-4b6c-9909-cab4c347cac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OPSUMITMember_e20d477d-ed3c-48e6-82fa-c56453867d3c" xlink:href="jnj-20200628.xsd#jnj_OPSUMITMember"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OPSUMITMember_e20d477d-ed3c-48e6-82fa-c56453867d3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UPTRAVIMember_dbdd6d28-041b-4a4f-b1b4-d2fc19a2262f" xlink:href="jnj-20200628.xsd#jnj_UPTRAVIMember"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_UPTRAVIMember_dbdd6d28-041b-4a4f-b1b4-d2fc19a2262f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_5e384ca7-cf2f-49c2-b914-4eddb5b2a8a5" xlink:href="jnj-20200628.xsd#jnj_XareltoMember"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_XareltoMember_5e384ca7-cf2f-49c2-b914-4eddb5b2a8a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_INVOKANAINVOKAMETMember_1d7819f1-3a7c-4717-9b4c-f74f574c9bea" xlink:href="jnj-20200628.xsd#jnj_INVOKANAINVOKAMETMember"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_INVOKANAINVOKAMETMember_1d7819f1-3a7c-4717-9b4c-f74f574c9bea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PROCRITEPREXMember_a94c4ee7-de68-42ad-a66d-5f704e8d2486" xlink:href="jnj-20200628.xsd#jnj_PROCRITEPREXMember"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_PROCRITEPREXMember_a94c4ee7-de68-42ad-a66d-5f704e8d2486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherMember_d417e220-032a-46aa-b99b-c8dc2055cb6c" xlink:href="jnj-20200628.xsd#jnj_OtherMember"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_OtherMember_d417e220-032a-46aa-b99b-c8dc2055cb6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_HIPSMember_7e0e5274-b387-48ac-a932-6f884580551e" xlink:href="jnj-20200628.xsd#jnj_HIPSMember"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_HIPSMember_7e0e5274-b387-48ac-a932-6f884580551e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_KNEESMember_f247fda2-a1cf-4f06-908e-e8565f0e7cce" xlink:href="jnj-20200628.xsd#jnj_KNEESMember"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_KNEESMember_f247fda2-a1cf-4f06-908e-e8565f0e7cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TRAUMAMember_cb9e3485-226d-4caf-8020-809d4c172712" xlink:href="jnj-20200628.xsd#jnj_TRAUMAMember"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_TRAUMAMember_cb9e3485-226d-4caf-8020-809d4c172712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SPINEOTHERMember_93f906c6-7add-454c-8319-5217c2c1eafd" xlink:href="jnj-20200628.xsd#jnj_SPINEOTHERMember"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SPINEOTHERMember_93f906c6-7add-454c-8319-5217c2c1eafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ADVANCEDMember_e5588fda-2670-4603-bf62-2bc46d6476b1" xlink:href="jnj-20200628.xsd#jnj_ADVANCEDMember"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_ADVANCEDMember_e5588fda-2670-4603-bf62-2bc46d6476b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_GENERALMember_bef6d2b7-f61a-472e-b9b6-b30d5dccf8de" xlink:href="jnj-20200628.xsd#jnj_GENERALMember"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_GENERALMember_bef6d2b7-f61a-472e-b9b6-b30d5dccf8de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CONTACTLENSESOTHERMember_5ca1d9de-b6c0-4887-81e7-a8a5c1c1c7f2" xlink:href="jnj-20200628.xsd#jnj_CONTACTLENSESOTHERMember"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_CONTACTLENSESOTHERMember_5ca1d9de-b6c0-4887-81e7-a8a5c1c1c7f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SURGICALMember_71ad3a6e-bb58-4b50-bb5a-439d60ee9224" xlink:href="jnj-20200628.xsd#jnj_SURGICALMember"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_f59d65f7-5342-443a-8542-907cdc6166e3" xlink:to="loc_jnj_SURGICALMember_71ad3a6e-bb58-4b50-bb5a-439d60ee9224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ea88b3a3-c38e-450d-9b72-8ec47a5b95b8" xlink:to="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d9f61e25-5af4-43da-9d8c-3b2f6bf0c913" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_country_US_d9f61e25-5af4-43da-9d8c-3b2f6bf0c913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_UNITEDSTATESExportsMember_cb285d0b-fe78-403f-832b-59445120b968" xlink:href="jnj-20200628.xsd#jnj_UNITEDSTATESExportsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_jnj_UNITEDSTATESExportsMember_cb285d0b-fe78-403f-832b-59445120b968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_9a9ee6d2-885a-46fe-b2db-a174115db2b2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_ad8f6386-3a4d-4aee-ab7d-fbd3c46ab485" xlink:to="loc_us-gaap_NonUsMember_9a9ee6d2-885a-46fe-b2db-a174115db2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fbdf7214-3d1e-4529-b051-b5c37bb375b8" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationRevenueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_bf547d2a-b94d-4f28-adb0-22aa68bc36e1" xlink:to="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28ad9496-7261-4e7d-a5f0-a09f8fc61f99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28ad9496-7261-4e7d-a5f0-a09f8fc61f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_7430b488-3056-4ec0-927a-150db7822599" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesBySegmentOfBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationRevenueAbstract_5068610c-604f-4bff-b795-573311b199ea" xlink:to="loc_jnj_PercentageChangeInSalesBySegmentOfBusiness_7430b488-3056-4ec0-927a-150db7822599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_aecea2f9-d089-4729-8efc-ae4ed9c264db" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_aecea2f9-d089-4729-8efc-ae4ed9c264db" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8ef0def4-2769-4458-a12a-c7e8ae9ce0e5" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_a8bde2f8-d0a0-466c-bfc5-7922edb32207" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_fe0c7156-21d2-4f0e-b0be-9864a0b1ae5f" xlink:to="loc_us-gaap_OtherIncomeMember_a8bde2f8-d0a0-466c-bfc5-7922edb32207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_134a398c-0cbe-4ab0-ad17-5b43f31c2bd0" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_b92a7b2a-c359-4c50-90fb-7faa06822cf3" xlink:href="jnj-20200628.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_8f656206-d986-4d0e-a7d0-b9d70b0ef535" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_b92a7b2a-c359-4c50-90fb-7faa06822cf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7a7d6fca-c393-4256-8126-62fb12cb45d8" xlink:to="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0f332966-deee-458b-9c92-3550e43dd494" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_country_US_0f332966-deee-458b-9c92-3550e43dd494" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_67155a69-dd73-4409-bb2f-f4657b28bb1c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_srt_EuropeMember_67155a69-dd73-4409-bb2f-f4657b28bb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_08b02f7c-2d2d-4532-88a3-805ac16dea9e" xlink:href="jnj-20200628.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_08b02f7c-2d2d-4532-88a3-805ac16dea9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_c925394d-0166-4e49-92bb-262538f2538e" xlink:href="jnj-20200628.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8947e55e-1358-412d-b305-37d70be12d1d" xlink:to="loc_jnj_AsiaPacificAfricaMember_c925394d-0166-4e49-92bb-262538f2538e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_a52bd032-dfb1-4ba2-9989-77f7fd1b3676" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_bb230d9c-23ad-430e-8341-e2dd64f9576f" xlink:href="jnj-20200628.xsd#jnj_PurchasedInProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_1c93892a-6907-4a3c-b275-29e9112619fb" xlink:to="loc_jnj_PurchasedInProcessResearchAndDevelopmentMember_bb230d9c-23ad-430e-8341-e2dd64f9576f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_5f0b16d5-2b05-47d6-a705-247c9c065b7f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_2c9d99d8-4940-401c-9fc5-aace99509fd1" xlink:href="jnj-20200628.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_2c9d99d8-4940-401c-9fc5-aace99509fd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_5cd33bec-fdbc-47ee-9a4e-4701d7a553c1" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_c463c88c-7b1b-41ed-a299-f7069fc92647" xlink:to="loc_jnj_AurisHealthMember_5cd33bec-fdbc-47ee-9a4e-4701d7a553c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_b39727dd-f33a-4869-81fb-f5c1c8c78a44" xlink:to="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_e8acf0ff-5fc2-419a-b252-8341a329294c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:to="loc_us-gaap_OperatingSegmentsMember_e8acf0ff-5fc2-419a-b252-8341a329294c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_53a4d45d-dc7c-4c27-9a7b-8978398a8560" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_aa56fa3a-7b86-47b9-99ae-028f93927493" xlink:to="loc_us-gaap_CorporateNonSegmentMember_53a4d45d-dc7c-4c27-9a7b-8978398a8560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_c3911ace-e654-4422-8755-520726bae56f" xlink:to="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ConsumerMember_f9acf6f0-da53-42be-9130-8604df306b40" xlink:href="jnj-20200628.xsd#jnj_ConsumerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_ConsumerMember_f9acf6f0-da53-42be-9130-8604df306b40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PharmaceuticalMember_c27301d5-53f0-4325-8a38-5445f59f43b7" xlink:href="jnj-20200628.xsd#jnj_PharmaceuticalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_PharmaceuticalMember_c27301d5-53f0-4325-8a38-5445f59f43b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_d431c764-ca66-42e5-84dd-9fb96fcab42d" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_458cde45-a469-452b-9740-8cf2a55ffba1" xlink:to="loc_jnj_MedicalDevicesMember_d431c764-ca66-42e5-84dd-9fb96fcab42d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d3467303-855a-4fb6-8153-19973730aa35" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_897bf334-45d3-472d-9578-1b61925a42ad" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_897bf334-45d3-472d-9578-1b61925a42ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96b5514a-c44c-4a46-b8d8-fea8e0298fba" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_96b5514a-c44c-4a46-b8d8-fea8e0298fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_503d6b09-d791-440a-b347-bd360d366043" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_OperatingIncomeLoss_503d6b09-d791-440a-b347-bd360d366043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInOperatingIncomeLoss_b0a58fa5-e335-46a3-a56a-120d5092682b" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInOperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_jnj_PercentageChangeInOperatingIncomeLoss_b0a58fa5-e335-46a3-a56a-120d5092682b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_36c96118-4f45-49d3-a9a4-bc2f3753211d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_36c96118-4f45-49d3-a9a4-bc2f3753211d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_d96c3773-fde7-4441-bb19-71b7355877b9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_AdjustmentForAmortization_d96c3773-fde7-4441-bb19-71b7355877b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentInProcess_92b9eff7-649e-47f3-a376-358076568c1e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_ResearchAndDevelopmentInProcess_92b9eff7-649e-47f3-a376-358076568c1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d1b6891-288b-4135-9802-cd0db865118a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9d1b6891-288b-4135-9802-cd0db865118a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfEquityInvestments_288bec59-a125-4582-9daa-e466d72890b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfEquityInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_GainLossOnSaleOfEquityInvestments_288bec59-a125-4582-9daa-e466d72890b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_0210ef65-e324-41fa-936f-cb9cd8e4f5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_RestructuringCharges_0210ef65-e324-41fa-936f-cb9cd8e4f5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementExpense_db82d8e8-f1c4-4c6d-a467-ed6537d81fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationSettlementExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_LitigationSettlementExpense_db82d8e8-f1c4-4c6d-a467-ed6537d81fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnSecurities_eefa13af-12f0-43b6-ab65-7821683920c2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_UnrealizedGainLossOnSecurities_eefa13af-12f0-43b6-ab65-7821683920c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ba67ecee-2efc-47c9-8756-b492663318de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ba67ecee-2efc-47c9-8756-b492663318de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_4d0e8c2a-2236-43f8-8266-aefdf3f64765" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2657c8b9-6c0a-47a0-b115-bf7aa8c6a775" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_4d0e8c2a-2236-43f8-8266-aefdf3f64765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_48bbcb8b-8f8c-40d2-8862-929df91601bb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_48bbcb8b-8f8c-40d2-8862-929df91601bb" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:to="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_7886d37f-d361-46b5-9a2f-9b9e6024b36c" xlink:to="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_3cc8c408-9904-428a-bfb8-ed99b6dd391b" xlink:href="https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_country_US_3cc8c408-9904-428a-bfb8-ed99b6dd391b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_317f7588-4821-4a24-b264-14b40113ca15" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_srt_EuropeMember_317f7588-4821-4a24-b264-14b40113ca15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_WesternHemisphereExcludingUSMember_aff16ce3-cd82-4764-aa81-8a8def4cabe3" xlink:href="jnj-20200628.xsd#jnj_WesternHemisphereExcludingUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_jnj_WesternHemisphereExcludingUSMember_aff16ce3-cd82-4764-aa81-8a8def4cabe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsiaPacificAfricaMember_3da9a160-8b3d-4d85-b1b8-9a8825c2e677" xlink:href="jnj-20200628.xsd#jnj_AsiaPacificAfricaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_632de27b-46ac-4c55-87d8-3e6d6b9e252d" xlink:to="loc_jnj_AsiaPacificAfricaMember_3da9a160-8b3d-4d85-b1b8-9a8825c2e677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_dafc6291-3691-4994-a7ba-49f2b7a96628" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentsGeographicalAreasAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_26291d37-b1e7-4e99-aae1-f30dbff7e89e" xlink:to="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc32c2a-f735-4098-a025-09813dadb82d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fdc32c2a-f735-4098-a025-09813dadb82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PercentageChangeInSalesByGeographicArea_3c7b44cc-a040-4f5b-853c-9809086f00e7" xlink:href="jnj-20200628.xsd#jnj_PercentageChangeInSalesByGeographicArea"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentsGeographicalAreasAbstract_33232f54-33af-45a7-b84d-322998ce3197" xlink:to="loc_jnj_PercentageChangeInSalesByGeographicArea_3c7b44cc-a040-4f5b-853c-9809086f00e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestitures"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestitures" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_6eda9031-ec2f-4627-b966-99b21181ffb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_753a954f-4c01-4102-82fe-1802ce896170" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_6eda9031-ec2f-4627-b966-99b21181ffb8" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_753a954f-4c01-4102-82fe-1802ce896170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#BusinessCombinationsandDivestituresNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_564f38d6-c297-4c80-8c3d-7f9afd0b4254" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_564f38d6-c297-4c80-8c3d-7f9afd0b4254" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_1c4a3b95-8ab9-4d20-90a8-81e754afc35b" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIncomeMember_0e3b74aa-5e29-4ca9-8516-a3b235c4e636" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_5f854d64-7e74-4498-a96b-0e27bf9d4a32" xlink:to="loc_us-gaap_OtherIncomeMember_0e3b74aa-5e29-4ca9-8516-a3b235c4e636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_268328e8-8bd5-46e3-ad06-1f9bbf0b0f84" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_df5d3a81-6a02-42e2-a791-a1d12155465b" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_75bbbaeb-5247-4cf9-ba19-851cca839f7f" xlink:to="loc_jnj_IdorsiaLTDMember_df5d3a81-6a02-42e2-a791-a1d12155465b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c59b5dce-c558-4876-9094-6cda5049a93f" xlink:to="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2524765d-62d0-44ca-abdf-6e58db8a6330" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:to="loc_srt_MinimumMember_2524765d-62d0-44ca-abdf-6e58db8a6330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_d656573b-22ba-44f2-bc66-5a625344fbbd" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_33c2da98-81d2-47c3-952f-e2d6f3cf667a" xlink:to="loc_srt_MaximumMember_d656573b-22ba-44f2-bc66-5a625344fbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_b9477076-8d19-4bc0-98cc-b8ce5dcaaec5" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_f6d9f583-13b8-4d39-84fd-425ad4c566e2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_da0d7dab-f7c7-413a-8772-e20be3adfa21" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember_f6d9f583-13b8-4d39-84fd-425ad4c566e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_5c07f39a-21e1-4476-aba0-a8e6c1c4fa5a" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_128da415-d5d3-4a4e-bd8f-dfdf0b328f43" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_SupplyChainMember_128da415-d5d3-4a4e-bd8f-dfdf0b328f43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AdvancedSterilizationProductsMember_65bcf343-dc60-41c9-9ad4-5c1bd10853e3" xlink:href="jnj-20200628.xsd#jnj_AdvancedSterilizationProductsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_AdvancedSterilizationProductsMember_65bcf343-dc60-41c9-9ad4-5c1bd10853e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_005ab70b-ab49-416f-befd-3b66bb0b2680" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_e52573f0-b2df-48ce-8d6e-53fdb696ebbf" xlink:to="loc_jnj_IdorsiaLTDMember_005ab70b-ab49-416f-befd-3b66bb0b2680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:href="https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_126680a4-650d-4d84-953b-2329c18225c9" xlink:to="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_d75fd8af-282f-4940-9ee7-d3608d5d0212" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_582fce91-14bc-4cec-8779-03b297861be3" xlink:to="loc_jnj_IdorsiaLTDMember_d75fd8af-282f-4940-9ee7-d3608d5d0212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_2c15ce87-f08d-4be1-825a-b69323350c81" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BermekimabMember_325bab94-184e-420d-b583-dadf2c38304b" xlink:href="jnj-20200628.xsd#jnj_BermekimabMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_BermekimabMember_325bab94-184e-420d-b583-dadf2c38304b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_VerbSurgicalInc.Member_38bbff04-00b1-4865-9b76-8924f983a4de" xlink:href="jnj-20200628.xsd#jnj_VerbSurgicalInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_VerbSurgicalInc.Member_38bbff04-00b1-4865-9b76-8924f983a4de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AurisHealthMember_1b9cd84b-1e0a-4170-8ae8-576c3b087513" xlink:href="jnj-20200628.xsd#jnj_AurisHealthMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_AurisHealthMember_1b9cd84b-1e0a-4170-8ae8-576c3b087513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_CizHoldingsCo.Ltd.Member_824ee6b7-4f1a-46a6-84dd-345cb0d0b085" xlink:href="jnj-20200628.xsd#jnj_CizHoldingsCo.Ltd.Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_28c9a1d0-b383-4f38-9074-205c38c8fbe9" xlink:to="loc_jnj_CizHoldingsCo.Ltd.Member_824ee6b7-4f1a-46a6-84dd-345cb0d0b085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_46b08b03-225c-4522-981a-11ac1d126fcc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtMember_e3cec6bc-d135-4bb5-940f-be824fd827e0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ConvertibleDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:to="loc_us-gaap_ConvertibleDebtMember_e3cec6bc-d135-4bb5-940f-be824fd827e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_66959686-dc67-4cdf-a782-453a26bf4a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_13c1bf60-747d-443d-bd62-f0e32bc074eb" xlink:to="loc_us-gaap_LineOfCreditMember_66959686-dc67-4cdf-a782-453a26bf4a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_a5b888fa-bd86-47fa-a444-3529443e6147" xlink:to="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_de11137c-96ef-45e9-a65a-1d7b41ec542b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_4c9cff92-de33-4af3-8a5b-d997c2dbc2c7" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_de11137c-96ef-45e9-a65a-1d7b41ec542b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityAxis"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityLenderDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityAxis_e98abd30-e248-49a5-aae1-81a3b1e5d720" xlink:to="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_IdorsiaLTDMember_8306d22a-8ee0-45f7-ad2c-53bebdd6776c" xlink:href="jnj-20200628.xsd#jnj_IdorsiaLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLenderDomain_91873753-1aeb-4ba2-9078-50851a61534e" xlink:to="loc_jnj_IdorsiaLTDMember_8306d22a-8ee0-45f7-ad2c-53bebdd6776c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_0f988a21-0432-46e9-8d1b-6ff812ca77b1" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_729e653b-8efc-43d8-ba70-0350bf1bee67" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_0f988a21-0432-46e9-8d1b-6ff812ca77b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_6450ca59-a1a7-4a92-9317-18c34c6c7a2e" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_261316eb-830e-472f-8465-d85d88bb0894" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d55f20e5-b71b-421a-9cbd-abdad9b0babe" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_261316eb-830e-472f-8465-d85d88bb0894" xlink:to="loc_us-gaap_SubsequentEventMember_d55f20e5-b71b-421a-9cbd-abdad9b0babe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_63f148c2-7ee6-4cae-89b4-de4de44b3673" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7ef685c2-02c6-4c0e-9b12-6739c0d8fa0d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7ef685c2-02c6-4c0e-9b12-6739c0d8fa0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_766725d4-e2e7-4836-ab75-57ac21c90c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction_766725d4-e2e7-4836-ab75-57ac21c90c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_e0575c63-17c4-4e3b-a3b8-963337eea230" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedPerTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedPerTransaction_e0575c63-17c4-4e3b-a3b8-963337eea230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_8d55cb31-7f83-4e38-9616-23194ab1e1d7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_8d55cb31-7f83-4e38-9616-23194ab1e1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_0b1d37b6-5902-4675-be6c-4a6359846a32" xlink:href="jnj-20200628.xsd#jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares_0b1d37b6-5902-4675-be6c-4a6359846a32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_08f2a115-d2dd-4b5f-a091-0174cda2d2a9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_08f2a115-d2dd-4b5f-a091-0174cda2d2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_d08b43eb-26e9-4228-ae6e-96aa711b38f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_LongTermDebt_d08b43eb-26e9-4228-ae6e-96aa711b38f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b04ef9ae-a325-452a-a350-f157cbea690c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b04ef9ae-a325-452a-a350-f157cbea690c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eb11ca7-a2b4-4629-944b-94b0f139a153" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_1eb11ca7-a2b4-4629-944b-94b0f139a153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3fac7b67-9fd5-422a-879c-7ece822d7f8c" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_3fac7b67-9fd5-422a-879c-7ece822d7f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b1e92ce7-50af-4b2e-8676-1a9118f8f20a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_Goodwill_b1e92ce7-50af-4b2e-8676-1a9118f8f20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_44717a4c-3082-494c-962e-ad3f7dc4d575" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther_44717a4c-3082-494c-962e-ad3f7dc4d575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5016d6c9-95c0-4603-96bb-069e977333c7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_5016d6c9-95c0-4603-96bb-069e977333c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9ad4f614-99a1-4d19-a0ab-57f56f140687" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_9ad4f614-99a1-4d19-a0ab-57f56f140687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_b692a410-b9e7-4484-b92d-35e2bae374be" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationCash"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash_b692a410-b9e7-4484-b92d-35e2bae374be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_f1e93963-e166-482c-8e8a-06c54f0898e1" xlink:href="jnj-20200628.xsd#jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained_f1e93963-e166-482c-8e8a-06c54f0898e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_25e97d9b-796f-48b8-a8eb-79c0ece3e4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_25e97d9b-796f-48b8-a8eb-79c0ece3e4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_f5e61097-2e39-4f45-86f9-dac09c4154f6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EquityMethodInvestmentsFairValueDisclosure"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_EquityMethodInvestmentsFairValueDisclosure_f5e61097-2e39-4f45-86f9-dac09c4154f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e0244f2a-eed8-4045-b474-eed14708d7de" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_e0244f2a-eed8-4045-b474-eed14708d7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_2a6223e3-09b1-4d9b-ad9a-f0ae81833d20" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities_2a6223e3-09b1-4d9b-ad9a-f0ae81833d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7fc9001e-a569-42d2-b7a3-4b6dc63f5a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_7fc9001e-a569-42d2-b7a3-4b6dc63f5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d713e81a-0e59-446f-95ec-7d0a1f5dc522" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_d713e81a-0e59-446f-95ec-7d0a1f5dc522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_54286414-dc5f-4731-af7f-2949254f6d29" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ForeignCurrencyExchangeRateTranslation1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_ForeignCurrencyExchangeRateTranslation1_54286414-dc5f-4731-af7f-2949254f6d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_11f9ef60-f0f3-4780-868e-7f67b7042ad0" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_11f9ef60-f0f3-4780-868e-7f67b7042ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_a5255ecc-7d1c-4b20-852e-dddf7cfa3265" xlink:href="jnj-20200628.xsd#jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill_a5255ecc-7d1c-4b20-852e-dddf7cfa3265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4a0db71c-0ef2-4356-93e1-9ab16d6c61f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4a0db71c-0ef2-4356-93e1-9ab16d6c61f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d65591e0-a1d2-4a41-94b8-555bee2de4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_3c3f9f59-ae5c-498d-acdc-604fb65eed76" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent_d65591e0-a1d2-4a41-94b8-555bee2de4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedings" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedings"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/LegalProceedings" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93cd0eca-a20d-44d3-a7d5-49c7be7f50b7" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_670dedb6-d788-4919-9e7a-33b947ab5a97" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_93cd0eca-a20d-44d3-a7d5-49c7be7f50b7" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_670dedb6-d788-4919-9e7a-33b947ab5a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#LegalProceedingsDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/LegalProceedingsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb5bd293-5f7e-4bdd-a774-fd09c770e71f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_eb5bd293-5f7e-4bdd-a774-fd09c770e71f" xlink:to="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_eef34dd1-6fea-4872-a685-c179ff84ba2f" xlink:to="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_cb1b6663-44d9-4d7b-a5eb-0fd91f465aac" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a683b090-dcdf-448a-b2ce-f5012bdb33ab" xlink:to="loc_jnj_MedicalDevicesMember_cb1b6663-44d9-4d7b-a5eb-0fd91f465aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_8dcb97db-833b-42e5-89fa-7600c816fd28" xlink:to="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_DePuyASRU.S.Member_45323b0c-dabd-478b-a731-0ee9df4a7661" xlink:href="jnj-20200628.xsd#jnj_DePuyASRU.S.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_DePuyASRU.S.Member_45323b0c-dabd-478b-a731-0ee9df4a7661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_f469585a-221b-41b1-8de2-64ae1cc49a60" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_RisperdalMember_f469585a-221b-41b1-8de2-64ae1cc49a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_BabyPowderMember_32877245-8dad-4095-8774-9ffe0118e3ea" xlink:href="jnj-20200628.xsd#jnj_BabyPowderMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_BabyPowderMember_32877245-8dad-4095-8774-9ffe0118e3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_02b69a4e-80b4-455f-bf69-66839339be1c" xlink:href="jnj-20200628.xsd#jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_7af1d7f6-c031-43ba-90d1-3ca36236a954" xlink:to="loc_jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember_02b69a4e-80b4-455f-bf69-66839339be1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_aeb6b01a-aecb-4875-b686-e4947a0e9836" xlink:to="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SettledLitigationMember_b891b37b-28e2-459c-b27c-d36cbf8af21b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SettledLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_SettledLitigationMember_b891b37b-28e2-459c-b27c-d36cbf8af21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_JudicialRulingMember_19f31cb4-ada5-4af0-8bb9-bd11f6f1be65" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_JudicialRulingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_JudicialRulingMember_19f31cb4-ada5-4af0-8bb9-bd11f6f1be65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_7fd07691-9cfe-4f62-8ea6-b705804bc69f" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_78ad3fe6-7693-4b82-8ddd-e3abd3910707" xlink:to="loc_us-gaap_PendingLitigationMember_7fd07691-9cfe-4f62-8ea6-b705804bc69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_9f5039fb-6016-4702-81aa-72001d333e81" xlink:to="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AsrMember_6a5463c2-287d-40b7-a62e-2f293d9fe5f9" xlink:href="jnj-20200628.xsd#jnj_AsrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_AsrMember_6a5463c2-287d-40b7-a62e-2f293d9fe5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PinnacleAcetabularCupSystemMember_d3336c2e-1f93-4ae7-8f25-bff8682ef13a" xlink:href="jnj-20200628.xsd#jnj_PinnacleAcetabularCupSystemMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PinnacleAcetabularCupSystemMember_d3336c2e-1f93-4ae7-8f25-bff8682ef13a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PelvicMeshesMember_f0a8b24a-dc8c-40c7-9ae9-1a41cef9daa1" xlink:href="jnj-20200628.xsd#jnj_PelvicMeshesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PelvicMeshesMember_f0a8b24a-dc8c-40c7-9ae9-1a41cef9daa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_bd6e066c-a629-476f-ae26-1dddb48bed27" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_RisperdalMember_bd6e066c-a629-476f-ae26-1dddb48bed27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_XareltoMember_83254946-692d-4676-897f-f9a1426e0d1f" xlink:href="jnj-20200628.xsd#jnj_XareltoMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_XareltoMember_83254946-692d-4676-897f-f9a1426e0d1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_TalcMember_a7873f2c-08ab-4014-9a18-05490026d712" xlink:href="jnj-20200628.xsd#jnj_TalcMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_TalcMember_a7873f2c-08ab-4014-9a18-05490026d712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_InvokanaMember_c38c1270-c46f-4f27-8295-2fbd085a80d6" xlink:href="jnj-20200628.xsd#jnj_InvokanaMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_InvokanaMember_c38c1270-c46f-4f27-8295-2fbd085a80d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_PhysiomeshMember_f8e25d2d-c36c-4317-95b7-ad2ea954afb6" xlink:href="jnj-20200628.xsd#jnj_PhysiomeshMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_PhysiomeshMember_f8e25d2d-c36c-4317-95b7-ad2ea954afb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OpioidMember_09df8106-cc9e-4aa9-b31a-f4d52327ebcd" xlink:href="jnj-20200628.xsd#jnj_OpioidMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_432cd445-672d-4b98-8256-ba55bc1e22db" xlink:to="loc_jnj_OpioidMember_09df8106-cc9e-4aa9-b31a-f4d52327ebcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:href="jnj-20200628.xsd#jnj_LitigationSettlementByCompaniesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LitigationSettlementByCompaniesAxis_2bd54d57-9946-4e3a-a921-c82b5652eae7" xlink:to="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RisperdalMember_1730e759-52e7-4bff-8cb5-840a213ad152" xlink:href="jnj-20200628.xsd#jnj_RisperdalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LitigationSettlementByCompaniesDomain_28df15f1-c404-48b0-9611-273b444e44fa" xlink:to="loc_jnj_RisperdalMember_1730e759-52e7-4bff-8cb5-840a213ad152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_c7604e80-d340-4727-847a-ee27c4ae5a23" xlink:to="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:href="jnj-20200628.xsd#jnj_LegalProceedingTextualsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_93bbeae4-f225-41c8-8a01-b73359dac9af" xlink:to="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_fe133ca2-94b8-4bfb-8ef9-9bbc9ebc07cf" xlink:href="jnj-20200628.xsd#jnj_ProductLiabilityContingencyNumberOfClaimant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_ProductLiabilityContingencyNumberOfClaimant_fe133ca2-94b8-4bfb-8ef9-9bbc9ebc07cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_Numberofpatientsinsettlement_30b93e12-c0c3-4fba-989c-ebe9bd9e1b7a" xlink:href="jnj-20200628.xsd#jnj_Numberofpatientsinsettlement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_Numberofpatientsinsettlement_30b93e12-c0c3-4fba-989c-ebe9bd9e1b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesAwardedValue_219757c6-3982-4864-96e7-762680ba0eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyDamagesAwardedValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_us-gaap_LossContingencyDamagesAwardedValue_219757c6-3982-4864-96e7-762680ba0eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_aa5414a6-7457-43b0-8c2e-57bcb0ec481e" xlink:href="jnj-20200628.xsd#jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue_aa5414a6-7457-43b0-8c2e-57bcb0ec481e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6da5cc58-85c3-4fb4-817f-0f72f220e095" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LossContingencyEstimateOfPossibleLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_jnj_LegalProceedingTextualsAbstract_2dc530a0-793a-4553-8e61-9fa6b5ecb6a2" xlink:to="loc_us-gaap_LossContingencyEstimateOfPossibleLoss_6da5cc58-85c3-4fb4-817f-0f72f220e095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/Restructuring" xlink:type="simple" xlink:href="jnj-20200628.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02863d37-d4c4-49cb-837a-5818e69f6e95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_42c34333-5cb0-4967-bcd5-c5a7a239d115" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_02863d37-d4c4-49cb-837a-5818e69f6e95" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_42c34333-5cb0-4967-bcd5-c5a7a239d115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringTables" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringTables"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_73d88524-5cfb-4674-b24a-cccc5863d49d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_773d7a21-0bf3-4a96-bfea-5a8469703607" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_73d88524-5cfb-4674-b24a-cccc5863d49d" xlink:to="loc_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_773d7a21-0bf3-4a96-bfea-5a8469703607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6e7bfe0d-aee3-46ce-8a7a-05073900bd95" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_6e7bfe0d-aee3-46ce-8a7a-05073900bd95" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_62dfce87-5b55-4301-96db-6c0f8ac3962b" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_474ba678-f4e6-442d-9801-5c168f11f365" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_9df4bed1-d14b-4f18-8143-b0a9fa65fbbd" xlink:to="loc_jnj_SupplyChainMember_474ba678-f4e6-442d-9801-5c168f11f365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9cbe79d3-51c0-46d1-a4f9-d9a920508a05" xlink:to="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_91f8ae23-595c-43df-946d-97001dcff019" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_cc6f3ada-7df1-451a-ae20-9512bafeb774" xlink:to="loc_jnj_MedicalDevicesMember_91f8ae23-595c-43df-946d-97001dcff019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_3d45d8e4-829e-4bb7-886b-d63b8db68adf" xlink:to="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_SupplyChainMember_15beab2c-1c6c-4d5f-9adc-fa762444e930" xlink:href="jnj-20200628.xsd#jnj_SupplyChainMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:to="loc_jnj_SupplyChainMember_15beab2c-1c6c-4d5f-9adc-fa762444e930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_976a13e0-5148-4ebc-b19f-69aafbce12e7" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_3a60193a-462f-4e5f-b5b5-870991798a2d" xlink:to="loc_jnj_MedicalDevicesMember_976a13e0-5148-4ebc-b19f-69aafbce12e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_42a659f2-d315-44e7-a050-e446429ea003" xlink:to="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_be0d3b9b-4229-4198-8184-046eb2013f87" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:to="loc_srt_MinimumMember_be0d3b9b-4229-4198-8184-046eb2013f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_73fb41a7-e82a-4de5-bbc4-987b03ff5e2b" xlink:href="http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_4ba13f0d-7900-4b5f-98b7-67ac8d9b6ae3" xlink:to="loc_srt_MaximumMember_73fb41a7-e82a-4de5-bbc4-987b03ff5e2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_75675baa-2cf6-427a-b869-89eb415bde40" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringChargesMember_ef152160-699d-4bef-99d2-4b550eac5fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringChargesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_us-gaap_RestructuringChargesMember_ef152160-699d-4bef-99d2-4b550eac5fd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_140783f9-7a99-405f-ae54-8028aea912e6" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_us-gaap_CostOfSalesMember_140783f9-7a99-405f-ae54-8028aea912e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_OtherIncomeExpenseNetMember_9775f827-4c77-411a-8b7c-d4b1b649e388" xlink:href="jnj-20200628.xsd#jnj_OtherIncomeExpenseNetMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bf2cda0c-7772-4674-9534-a0bbcebd191a" xlink:to="loc_jnj_OtherIncomeExpenseNetMember_9775f827-4c77-411a-8b7c-d4b1b649e388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_9dabdeda-8b80-452f-a2b6-ce4a271ba44d" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_97562f7a-8f89-43da-8370-dec354b996bf" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringCharges_97562f7a-8f89-43da-8370-dec354b996bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ee77f7d3-65f1-4358-89d3-9288f84668b3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_ee77f7d3-65f1-4358-89d3-9288f84668b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a5123e79-657a-4a30-966a-14a8ed4d56ff" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedCostCostIncurredToDate1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1_a5123e79-657a-4a30-966a-14a8ed4d56ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_3c02f677-225d-4aef-ade3-d5876fcafce5" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostExpectedFutureSavings"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_jnj_RestructuringandRelatedCostExpectedFutureSavings_3c02f677-225d-4aef-ade3-d5876fcafce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_878e3b79-7ca6-4937-92ac-1e333c554c9b" xlink:href="jnj-20200628.xsd#jnj_RestructuringandRelatedCostDurationofRestructuringPlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_64b8168b-3e4e-4bf4-b334-719cd8c89b51" xlink:to="loc_jnj_RestructuringandRelatedCostDurationofRestructuringPlan_878e3b79-7ca6-4937-92ac-1e333c554c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="simple" xlink:href="jnj-20200628.xsd#RestructuringScheduleofRestructuringReserveDetails"/>
  <link:presentationLink xlink:role="http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f51c21eb-2933-46e8-be58-a74874c0509d" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringAndRelatedActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesAbstract_f51c21eb-2933-46e8-be58-a74874c0509d" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:to="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_a73d6a39-7edd-4d58-aedf-1696ff91cc90" xlink:to="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_MedicalDevicesMember_89504eb9-0feb-4150-8592-9ac0b812a9e6" xlink:href="jnj-20200628.xsd#jnj_MedicalDevicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_9682ea56-05ad-45d5-9838-1d2e8e7e9899" xlink:to="loc_jnj_MedicalDevicesMember_89504eb9-0feb-4150-8592-9ac0b812a9e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:to="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_TypeOfRestructuringDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveAxis_6cde83b0-7b25-4265-98a6-01e5ae8c6b99" xlink:to="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeSeveranceMember_c8fd5144-63f0-4a0a-a4ae-c776b4de0392" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeSeveranceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_us-gaap_EmployeeSeveranceMember_c8fd5144-63f0-4a0a-a4ae-c776b4de0392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_AssetWriteoffMember_7f8169a5-7c69-4540-80bb-c0dd908964a1" xlink:href="jnj-20200628.xsd#jnj_AssetWriteoffMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_jnj_AssetWriteoffMember_7f8169a5-7c69-4540-80bb-c0dd908964a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestructuringMember_e95d8f18-41f0-4ec3-84e0-d5c9a70c7516" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherRestructuringMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfRestructuringDomain_e3ea2131-b343-4a54-81d1-9e414b5f94f4" xlink:to="loc_us-gaap_OtherRestructuringMember_e95d8f18-41f0-4ec3-84e0-d5c9a70c7516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_7650af34-512d-4e6c-b6c5-b2de91bc7b86" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:to="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_d071563a-7086-4646-a40f-36b5760928f9" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringReserve_d071563a-7086-4646-a40f-36b5760928f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_b96eeed0-9767-419e-bb73-7c75f12420f3" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringCharges_b96eeed0-9767-419e-bb73-7c75f12420f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRestructuring_c262f4b1-6cb7-4800-9a6b-c788da6aabf2" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsForRestructuring"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_PaymentsForRestructuring_c262f4b1-6cb7-4800-9a6b-c788da6aabf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fcca2da3-d7ae-47ad-88c7-efcfbd852533" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserveSettledWithoutCash2"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringReserveSettledWithoutCash2_fcca2da3-d7ae-47ad-88c7-efcfbd852533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringReserve_f776b909-0d7d-4647-b7ac-2a7012128f79" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RestructuringReserve"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringReserveRollForward_e58467c8-45d9-490a-bd59-21b564def809" xlink:to="loc_us-gaap_RestructuringReserve_f776b909-0d7d-4647-b7ac-2a7012128f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_9d95477c-2cef-4e96-af2d-9b208e2d0e9d" xlink:href="jnj-20200628.xsd#jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_ebdd9bba-216d-4aa6-b75d-e5fe2c19103b" xlink:to="loc_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid_9d95477c-2cef-4e96-af2d-9b208e2d0e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>jnj-20200628_g1.jpg
<TEXT>
begin 644 jnj-20200628_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#FD:1X&T/Q%>:1X7\8V7C%KX^)VMI!%+<PV_V.(1VXD$T7F&4EI('V!XRLK
M'>?%;XR?"CX%>$9O'_QF^(FC^%M#M@QN=8UZ_2UMH0%9R7DD(50%5B22  #7
M,_L__MG?LC?M7W6J6/[,?[37@/X@S:)'$^L0^#?%5KJ+62REQ&TH@D8H&*.
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MQ\(;RY_9ZE^(WAGXQ"<:#KGASQ6(IHS$UJ6(M_LLGG(\=Y"\920ESO4JN%+
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MP;\-OV'OC+::K-\:_AO>-H.D_#ZW\(7-[?ZHT5Q)]CN+3$9CA*1.(Y9)I(A
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M2>3%+$HE*\+%)(Y#; *^H:C>TM);F.\DMHVFB5EBE9 60-C< >H!P,^N!Z4
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M^89_=NH+O3--OYX+F^TZ":2UD\RVDEA5FA?&-RDCY3@D9'K0!^$?_!;3XO\
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M^"</@*SDU3X\P_'^\\/W7PJB4+KEE=1:CKL[BXM#B2WCC@N+=I)9%5$$@+$
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M/%UWHFHPM'<V%O-#;VUM'*C &-V@M(YBA^9?/PP# J/T:HHH **** "BBB@
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M_&/X-LZ>+?@IJ'BA5FN)%\TJMI>K;$2&3[/<1HK0H1-%Y;[%993:_P""8/\
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MN ]U<16MU*\SQQ96%(>DD19E#B@#["HKXP_8Y_X+4_ 7]HK0OCKI7QE\-O\
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M%KX@T^?47FNKFRD3/G)%:6I8RIG#7";><@>8_LIK^Q#\<O\ @DJ?^"<>K_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P $O]=NOAM<^,CX>\1ZIJGQ,M+;[+<>8ZJ+5%M7ENAA/FD:.*-9&6,,Y#E
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M#P?\(?VI_ /B?5_"EC/>>)]*T'Q5:W=SI5O"^R:2XBC<O"J.=K%@,-P>:M?
MW]LW]D?]INVUZ]_9V_::\">.(?"R1/XEE\*^*K6^72EE$IC:X,,C"$,()B"^
M,^4_]TX_(O\ X(@QI'_P<T?MRK&@4$Z^<*,<GQ!:DG\ZX_\ X-D-1/ACQ?\
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M?E^=\&\2\/7EC</)1_F7O1_\"C=+T=GY'ZID?&G#/$5HX'$QE/\ E?NR_P#
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MA'LH9L"NS 9?C,TQD,+A8.=2;LDOZT2W;>B6K./,,PP658.>+Q<U"G!7;?\
M6K>R2U;T6IO?M>_MC?!W]B[X82?$;XK:J6FFW1Z)H5JZF[U2< ?NXE)X49!9
MS\J C/)4'\4OVV/^"BOQ_P#VW?$!'C?5O[)\+V\^_2_!^ES,+2#'W7E/!N)<
M?QOP,G:J D5P'[2'[2GQ;_:L^*-[\6?C%XC:^U"Y.RVMX\K;V$ )*V\$>3Y<
M:Y/')))9BS$D\%7]6\#>'.7\+T8XC$I5,4]Y;J'E"_XRW?2RT/Y)X[\2<QXJ
MK2PV&;IX5;1V<_.=OPCLNMWJ%%%%?I9^8A1110 4444 %%%% !1110 4444
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MYMW****_0S\Y"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *ZOX)_&SXE_L\?$O3/BU\)?$LVE:UI4V^">/E)$/WHI%Z21L.
M&0\$?@:Y2BLZU&EB*4J56*E&2:::NFGNFNQK1K5L-6C5I2<91:::=FFMFGT:
M/Z$/V#?VX?AW^W)\'HO'/AHQV&OZ>$@\5>'3+F33[DC[RYY:%\$H_< J<,K
M>X5_.5^R9^U)\1_V/_C5IGQD^'%V3):MY6J:8\A6'4[-B/,MY,=F !!P=K*K
M#E17] /[/GQZ^'?[3/PBT;XS_"_51<Z5K%L'",0);64<202J/NR(V5(Z<9!(
M()_DGQ%X&GPICE7PR;PU1^[_ ''OR-_C%O=>:;/Z^\-N/(<6X#ZOB6EBJ:][
M^^MN=+\));/R:1VE%%%?FI^FA1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)]C]T\%.)7A,RJ9-6E[E7WH>4XK5?]O17WQ7<^^:***_FH_IP**** "BBB@
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M8<$T%)W=)R@_D[K[HM(****_.3])"BBB@ HHHH **** "BBB@ HHHH ****
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M #0<?_ 97_\ ;C^FO G$.63XRA_+4C+_ ,"C;_VT****_#C]V"BBB@ HHHH
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MLZKE-_-V7WQBF%%%%?G)^DA1110 4444 %%%% !1110 4444 %%%% !1110
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M68 FV:Z$4Z_6*3:X_%:[0$$9!R#T-?BW6QX>^(GQ \(X_P"$3\<ZQI>W[O\
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M5/8C(RIY&1V()YZO2C*,X\T7H>;.$H2Y9+4****HD**** "OV"_X(&_LM_\
M"N?@1JO[2GB73MFJ^.9_L^CF1,-%I=NY&X=QYLP<GU6&(CK7YC?LC_LX^)OV
ML/VA/#?P.\,^9'_:UZ#J5ZBY%E9)\\\YSQ\L8; /WF*KU85_1'X(\&>'/AUX
M-TGP!X/TU+/2=$TZ&QTVTCZ0P1($1??"J.>]?B7C-Q)'"9;#**,O?JVE/R@G
MHO\ MZ2^Z+[G[GX*<-/%YG4SBM'W*5XP\YM:O_MV+^^2[&I1117\T'].A111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <
MG\6M/M(?#TOBN7<!IT+27#)&6)A').%!)QU^F:^5OB!\?]<\0[]-\*"33K,\
M&;=B>4?4?<'3A3G_ &L'%?:CHDB&.1 RL,,K#((]*^,_VFO@I-\*/&37^DVI
M&B:F[26#*.(&ZM"?3'5?5<=2#7Z#P/7P%;$/#XA7GO"^WFK=^J^?8_.>.\-C
MJ-!8K#.T-IVW\G?L]GYV[GFA))R37)_'OQ[KWPJ^!?C3XH>%?#_]K:IX;\)Z
MCJFFZ5M8_;9[>UDFCAPO)WL@7CGGBNLK)\>>,M#^'/@?6?B%XFDD73=!TFXU
M'4&BCWN(((FED*KW.U3@=Z_6*O\ "EK;1Z]O/Y'Y+2_BQTOJM._E\S\NOV#/
MCIHO_!1?Q_X!MM>_:E^(UI\39/ OC.?QK/I/BR[T_P#LJ^%_HW]GM:6D3K:?
M9_(:;$?ELLAC;S@[1JR_8/C#]GK]M;XX_LQ^#O@3XU_:3NO!VLFTN$^)'COP
MW#&NIZB87\N".U\HHENDZDRR2*0RB-8]O[Q]OQ/_ ,%5O^":_@GP_P#&31?V
MB_V"M2C\%^()O /B3Q]>G1-0:"UN%TJ32V\VQ,6/LTKQ:A*_R'RV,2 *F]F/
MUQ^RG_P4*73/^"5'A7]MG]KC54M;X:1<17TA6."36;F&[FM;?RE)5?-N/*1O
MX4!=F^6,$CXO+)>RKUL'C[J48W<U)J,XI0NWU4MKO?WI'VV:1]KAZ&-R^SC*
M5E!Q3E"3<[)=''>RV]V.A\M?\$YY_P!K#]CS_@KSXB_X)]^(OCCK?Q!\&?V-
M/>WLVK7<LR6T1LX[NWO%21W-O+NDC@<*VUC+D[L(1^K_ $ZU\(?L"_%?]D/P
MY\6-7^+OBC]H;P=XV^/GQS\01KJNF^#]7CU Z5;A<PZ9;E3Q;6MO$#),V/,,
M ^]MB6OHKQ#^U!\$/C/K/Q&_96^#'QBTJ_\ B9H7AJ^2ZT*VD<36<YB,8.X@
M(Y25XU<(Q*,0&VFO3R&5'!X%Q]HFI3DX1YKM)ZQAOO;5K=7/+S^-;&X^,O9M
M.,(J<N6R;6DIVMM?1/9V1\E^%?V_M*_;^_:P\5>";K]INQ^%OP'\!7:6*W5M
MXKBT;4_'FHL[*J1WC2)+%:XCD;;;LLA1H]Q!E C^_P#P=X9\#?#OPC'IWA.U
MM[#1[>$S^8DC2!E(W&5G)9I6(YW$LS<=217XL_\ !-[X*_";XD?\$C_VJ=(^
M('@73)?$_A:&^U*.ZO\ 3D^VV#VNFF>W"NPWQXFMI1@$=7!ZD5]6?\$?/BA\
M2O$7_!-CP?X2\97EW+;VFIW\6F7%TY+RV$=PPAB!/)CC<2A1G&%0  1K4<(5
M\5FN.ITJRO*K&51S_E2ERN-NB6EK==]6V:<8X?"93@:M6B[1HSC34/YFX<RE
M=;MZMWZ;:)(^H/''BVY\9^()-6E0QPJ/+M("<^7$"<#ZG))]R<8&!6/117[I
M3IPHTU""LEH?@E6K.M4<YN[844459 4444 %%%% !1110 4444 %%%% !111
M0!G^*/"WA_QKH<WAOQ/IXN;2?D@':\3C[LD;8.QQDX//4@@J64_,?Q:^#GB#
MX5ZD/M#&[TR>0BRU)(\*_?8XYV/CMG!P2"0#7U94&JZ5I>NZ9/HNN:?%=V=R
MFRXMI@2KK^&""#R&!!! (((!JJ=25*5X_-?UU)J4X58VE\GV_P"!_2/BJBO0
M?C5\"=4^&ET^M:*9;W0I7_=7+#,EL2>(YL#&<\!P K<?=)*CSZO3IU(U8\T3
MS*E.5*7+(***^M_^"2?[ EW^V#\:4\;^.M*8_#_PA=1SZTTJ?)J=R,-'8J>X
M/#28Z1\<&137GYQFV"R/+:F.Q4K0@KON^R7FWHO,]#)LHQN?9G2P.$C><W9=
MEW;\DM7Y'W'_ ,$0_P!B&;X!?!>7]H;Q_I9B\5>/;.-K&&:/#V&DY#Q)ZAIC
MME8?W5A& 0U?<U)'&D2"*) JJ %51@ >E+7\2Y]G6+XAS:KC\1\4WMT2V45Y
M)67X[G]R</Y)A.'<HI9?AE[L%:_5O=R?FW=^6VP4445Y![(4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6)\0_ 6@_$
MOPE=>$/$,.8;E/DE4?-#(/NR+Z$'\QD'@FMNBM*56I0JQJ4W:2=T^S1G5I4Z
M]*5.HKQDK-/JF? GQ&^'WB#X8^++GPEXC@VRPG,4R@[)XS]V13W!_0@@\@UR
MGB?PUH?C/PWJ'@_Q/IJ7FF:K8RV>HVDN=L\$J%)(S@@X96(X]:^[_CG\%-$^
M,OA@V%QLM]3M59M,O]O,;'JC>J-@9';@CI7Q;XG\,:YX-UVY\-^)-/>UO+60
MI+$X_(@]P>H(X(.:_<N&^(*.>X3EG958KWEW\UY/\'IVO^#\2\/5\@Q?-"[I
M2?NR[>3\UT[K7O;Y1N?^"4/[.TGB+0+.W\1>,O\ A!]$\.:KHW_"O[GQIJ<U
MF]M>RV,A@21KGS(K4?8MKVP)CE#KN ";6[OX_?\ !/[]D7]I[P?X<^'OQH^$
M8U'0/",7E^'-"T_7;_3;.Q78L8VP64\2':BA5+ E5)"X#'/LE%>PLLR^,)0]
ME&TK75DT[6LK/HK:+8\5YIF,IQG[:5XWL[M-7O=W75WU>Y\[? 7_ ()0?L _
MLR?%/3?C5\$/@"NB^)](69=.U-O$^J77D"6%X9,1W%U)&28Y'7)4D;CC!KJ_
MAG^PG^S!\(/VC_%'[6'@#X<BR\;^,(Y4UK4S?3.C>;(LDS)$S%(VD=%9BH!)
M!QC<V?7JCN[RSTZSFU+49Q%;V\9DGE/\*C^9/  [D@#DU5++<!248TZ,59W2
M44K2VNK+?I?<FKF6857*56M)W5FW)N\=[.[VOK;8^;_CO^P?^R6;_P 7>.5\
M'ZCI6I?$F 6OC'3/#WB&[L+/Q$JMO:2\@@D5'(+-EAM9S*P8L&DS#X9\,^'O
M!GAZR\)>$M%MM.TS3K9+>PL+.$1Q01(,*BJ.  !71^,_%5YXRU^76;E2B'Y+
M: ON$,0SM4'\220!EB3@9K*K]"R;)\+E=)RC!*I+XFDO6WI?7S=WU/SO.\ZQ
M6:UE&51NG'2*;?:U_6RMY))= HHHKVCPPHHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** &S0P7,$EK=6\<T,T92:&:,.DB$8*LIX8$=0:^>OCI^SU-
MX.\WQAX&@DFT8DM<VF2\FGGZGEXO1CDKT;/#O]#UN_#;X<^,OBOXRL_ O@/1
MWO=1OGVQQ*/E5?XG<GA4 Y8GC%1/$0PD)5Y245%7;;LK+OZ=^GWET\//&3C0
MC%R<G9)*[N^WF^W7[K?)W[*7[+OQ+_:^^,VF_!OX9669[IO-U+494)@TVT4C
MS+B4C^%00 .K,54<L*_H _9Q_9]^'O[+WP<T7X*_#.P\K3=(M]KSR*/-O)SS
M+<2D?>D=LD]AP!@  <G^QI^Q9\*OV-O!%YH_@?1;5=8UR=;KQ'JD,9'VB8#B
M.,')2%,MLC' +,0!NP/9*_F#Q%XZJ<5XU8?#-K#4W[J_FE_,_P HKHM=VTOZ
MG\-^ J?"6">(Q*3Q51>\_P"6._(OSD^KTV2;****_-3]."BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M@OCM\!]!^,VA88I:ZQ:H?L&H;>G?RWQR4)_$'D=P>]HKIPF+Q&!Q$:]"7+*.
MS_KIW1S8S!X;'X>5"O'FC+=?UU[,_/OQAX-\1^ M?G\,^*M,>UNX#\R..&'9
ME/1E/8BLNONWXK_!WP?\7]#_ +*\26NRXB!-EJ$( EMV/H>Z^JG@^QP1\@?%
MGX+^-/A!K!L?$-F9+21R+/4H5)AG'U_A;U4\_4<G]IX>XHPN=05.?NUENNC\
MX_Y;KS6I^(<1\*8O))NK3O.B]I=5Y2_SV?D]#D:\R^-?C;[9>?\ "%Z9+^YM
M9,W[@?ZR8?P?1.0>F6SUVJ:ZWXD^-AX*T+=9R@:C> I9 -S$.C3<>G1>F6.1
MG:PKQ/KUK].R++^>7UFHM%\/KW^73S]#\MS_ ##V<?JU-ZOXO)=OGU\O4***
M*^L/D0HHHH **** "O#/CM^UK<>"OVE_!?[(?@-M'M?%'C#3Y=1?6?$:N]G8
MVJ^:$"PQO&US-(\$BK&)(P-N=QR!7N=?,?\ P4)_X)Y^%OVU(+'Q/X5\8+X>
M^(?AJS TC5-Y,<D)=WCBG"?.B^8)"DJ\J2YP_0>+Q!+-89:Y9='FJ)Q?+>SE
M%-.48OHW&Z3Z=-;'N<.QRB>9J.92Y:;4ES6NHR::C*2ZQ4K-KKUTN7_V6_V@
M_P!I;Q3!\,U^,GAWP_JVC_$3P4FJV?BG0X9;.2RO!;1SM:W-NS2([,K,5DC9
M WEO^[7&*X;]G_\ ;;^,7[:.H_%75_A!XN\/>$[#P(2GAO2;_1C>7.HC;,5N
M+MFE79$QBQMB4%=Q!8[1N\L_X)2_MS?&71/&7A3]BK]H?PRT=IJ7A:*[^'^L
MR0"*06*VAN(4<K\LL+01MLD'S*R%&W'.SP_XA?!KQ%\6M4^+7[:W_!.U]5T#
MPCHE[<Z?K-E%J;1W&IQ21&2_FMHT4;+;8\<GDNQ;#%EVE5C7\UGQ/BIY5A,1
MA:DZJO-5*5W&K[M.+=FM6H-\[N]>:*N?IM/A;"0S;%X?%TZ=)VINE5LI4?>J
MR2NGHG-+D5EIRR=EN?I#^P+^U7>_MC_LY:?\8-9\,1Z1J0O9K#5+6V+&!IXM
MN9(2V6V,&4X))4Y7+;<GG/VU?VS==^!?Q+^''[/'PQL;&3Q;\2=?M[*/4-3B
M:6WTBTDN(X&N3$K(97RYV+N _=L3G@&+_@E-\:/ WQH_8XT6Y\#?#RR\+IX=
MNY=&U'2--#?9UNHUCE>6,N2["19DD)<LVYV!9B-QY/\ X*0?L5?&/XT_$[X>
M?M-_L[1V%]XJ\ :A#*VAZE=K M['#<K<PE)&PJLL@8$,0"'R""N&^LKXW-ZW
M!5'$X.;JU7&FY2BO>DKKG<5OS6OT3[).Q\E0P.34..*V&QL%1I1E448R?NQ=
MI<BD[VY;VZM=VU<UOAG^VC\0/!O[=FJ?L+?'N;3]2>[M%O/!7BNQLOLKW2M;
M^>8+B(,R;MHE4.FT%HL;?G&/J:OS2TM/B#^TM_P6NT/6M3\ C0+CP-I%O/XF
MLH-62^6Q$5JSA7FB4(6,MQ%$0N<$GG(('Z6UU<(YABL?2Q:J2<H4ZTX0<KI\
MJMH[ZOE;:N]=+/5''QAEV$R^K@W3BHSJ4*<ZBBTUS.^JMHN9).RTUNM&%%%%
M?7'QX4444 %%%>D?L[_LM_$_]H_Q MCX2TUK;2H90NI:[=1D6]L.X!_Y:/CH
MB\\C.T<CEQN.PF78:6(Q,U"$=V]%_P /V6[V1UX' XS,L5'#86#G.6B25W_P
MW=O1;LYCX8?"SQS\8O%]MX'^'VA2W]_<')"\)"G>21NB(.Y/L!DD _I=^RI^
MROX1_9F\%BPM!%>Z_?1J=:UG9S*W7RH\\K$IZ#J3\QYX&Y\!?V>OAS^SOX07
MPMX$TW][*%;4=4G -Q>R ?>=O09.%'RKDX&22>YK^9^.?$#$<22>$PEX89/Y
MSMUEV7:/S>MK?T_P'X=X;AF*QF+M/$M?*%^D>[[R^2TNV4445^:GZ<%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %5-=T'1?$VE3:'X@TR&\M+A=LUO.@96'^/H>H-6Z*J
M,I0DI1=FB91C.+C)73/B/]K3_@G/XWGU*Y^(7P6U*36;<(-_AZY8"XMT4?=@
M;A9%')VG#Y[NS$U\>ZCIVH:1?3:7JUC-:W-O(8Y[>XB*21N#@JRM@@CT-?L]
M7FOQX_9.^#'[0UN9?&_AWR=36/9!KFG,(KJ,=@6P1(!V5PP';%?L7"GBMB,!
M".%S6//36BG%>\EYK127GH_\3/QCBWPEPV83EB\IER5'JX2;Y6_)ZN+\M5_A
M1^4M%?1/QV_X)N_&KX6K-K7@51XMTA,MNT^$K>1+_M09);ZQECWP*^>;BWN+
M2=[6Z@>*6-BLD<BE65AP00>AK]TRK.LJSO#^VP-55(^6Z]5NGZI'X+FV29MD
M>(]CCJ,J<NEUH_1K1KT;&4445ZAY04444 %>6?$CX0?&:X^-=I\;?@W\5M+T
MQ_\ A'TTC6?#6OZ))<V>H1)/+-'+YD4T;Q2H99 IPPPYR.:]3HKGQ.%I8N"C
M.^C333:::\TT_ELUH]#IPN*JX2;E3MJFFFDTT_)IKY[IZJS/E_\ 9-_86UWP
MEK/@#XW?M!ZK:W7BKP7\-[/PSH&@6%FJ6^CQK R3&6422?:ISYLJ%U*QA7("
MGAJ3X1?L&?$?]F;PQX\^%?[/OQ7T6'PCXVN9KBTMO$6A2W%UH4LT0A<QM',J
MW*B,+M#A.47);YMWU#17D4>&<GH4Z<80:<+VES/F?-%1E=IZ\R23Z*RLE96]
MBMQ3G->K4E.::GRWCRIQ]V3E%*+3MRR;?=W=V[N_RCXO_P""7VCVW[$$'['W
MP9^+.H>'I%UN/5M3\030ECJUQ@B03I&ZXC(V;5!.WR(L[L$GV+3OA;\:O"?P
M9\._!_P)\7[2"[TG0+?3[[QGK.DO?7D[QQA&ECA,JH'.-P:1Y ">5?'/IE%;
MX?(<KPDW*A!P?)&G[LI+W(WLE9Z;[JTO,PQ'$&:XN"CB)J:YY5/>C%^_*UV[
MK7;9WCY'FO[-W[*WPO\ V8=$U&U\$I>7^KZ[>->^)O%&M3B?4-7N6))DFDP.
M[,0B@*"S'&68GTJBBO1PV%P^#H1HT(J,8[)?U\V^KU9YN*Q6)QM>5>O)RG+=
MO?\ I;)=%H@HHJ6RLKS4KN.PTZTEGGF<)%##&6=V/0 #DGV%;-I*[,$FW9$5
M3Z;IFI:S?PZ5H^GSW=U<2!(+:VB,DDC'HJJH))/H*^@_@C_P37^.'Q+\G5O'
M:IX1TM\,3J$9>\=?]F $%?\ MH5(]#7VI\"/V6/@[^SUIZIX&\.+)J+1[;G6
M[_$EW-ZC?@!%/]U H]03S7YUQ'XEY!DD73P\O;U>T7[J_P 4M5\E=]['Z1PU
MX8<09Y)5,1'V%'O)>\U_=AH_F[+M<^7/V8O^"9>O:]/!XQ_:'633K 8>'PY!
M+BXN.X\YU/[I?]D'?SR4(K[;\-^&O#_@_1+;PUX5T6VT_3[2,);6=I"(XXU]
M !^?N>:O45_/G$7%.<<38CVF,G[J^&"TC'T7?S=WYV/Z+X<X4R;A?#>SP4/>
M?Q3>LI>K[>2LO*X4445\X?2!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7$_%3]G/X*_&F!D^(OP^L+Z<KA=02/RKI/3$T>'P/0DCU%=M171AL7BL
M%657#S<)+9Q;3^]'/BL)A<;1='$4U.#W4DFON>A\6_%7_@DTS2O?_!;XC*JG
M)73?$2'Y?83Q*<^@!C^IKY_^(G[%W[2_PRWS:[\*]0NK9.?MFCJ+R/']X^5N
M9!_O 5^J5%?HN5>*_$^ 2AB.6M%?S*TO_ HV^]IGYMFWA)PMF#<\.I4)/^5W
MC_X#*_W)H_%V:&:WE:"XB9'1BKHZX*D=00>E-K]B/%?PR^''CI"GC7P#HVK!
MA@G4M,BF/X%U)%>8^+?^"?'[*7BPM*/AN=,F;_EKI.H30X^B;B@_[YK[S!>,
MN45++%8:<'_=:DOQY7^!\!C?!7.*5WA,3":_O*4'^',OQ/S%HK] M8_X)0?
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MVP\6>';S[1I^J645W8W'ELGFPR('1MK ,N58'! (SR!5VN+_ &;?^3=O /\
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M1HI9FP 2< $X )K@?^&L_P!G[_H?_P#RE7?_ ,:KI?B[_P DG\3_ /8NWO\
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M=[.YS8VDJ^#J4V[<T6K[VNFC\9**_5G_ (6!XN_Z"_\ Y+Q__$T?\+ \7?\
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MG:^,-3\3_%_5_"OQ+U#1O#5A:V_B&UBTG5KVU,R")GMKF,6UJ)?(>)&D63Y
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M_!KQ=\(_[9_L[_A*?#%_I']H?9_.^R_:;>2'S?+W+OV[]VW<N<8R,YK\YO\
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M&VJ,NY+,<DDDDUH4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
; %%%% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>jnj-20200628_g10.jpg
<TEXT>
begin 644 jnj-20200628_g10.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***\>_:1_;V_9._9-UK2O"_QO\
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M4!MIP3@T >IT45\_>*?^"K__  3$\$>)M1\%^,?^"@WP:TO5]'OYK+5=,O\
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M5_#U[9:3K",P-C<RP.D4X*\@H[*W'/R\5^/'_!(C]IWP?\*/CSX)_P""2_\
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MS_PUG^S]_P!#_P#^4J[_ /C5'_#6?[/W_0__ /E*N_\ XU1_8F=?] U3_P
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M']N9)_T%4_\ P./^9Z-17G/_  UG^S]_T/\ _P"4J[_^-4?\-9_L_?\ 0_\
M_E*N_P#XU1_8F=?] U3_ , E_D']N9)_T%4__ X_YG>V^BZ/9ZG<ZU::3;17
MEXL:WEW' JRSA 0@=@,L%!.,GC)QUI1I&DC5CKXTNW^W&W%N;WR%\XPAMWE[
M\;MNXD[<XR<UP/\ PUG^S]_T/_\ Y2KO_P"-4?\ #6?[/W_0_P#_ )2KO_XU
M1_8F=?\ 0-4_\ E_D']N9)_T%4__  ./^9Z-17G/_#6?[/W_ $/_ /Y2KO\
M^-4?\-9_L_?]#_\ ^4J[_P#C5']B9U_T#5/_  "7^0?VYDG_ $%4_P#P./\
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M]N/R[Q*^'"_]O_\ MA!1117Z@?E@4444 %%%% !1110 4444 %%%% !1110
M4444 ?;/[+?_ "07P]_UPF_]'R5W]<!^RW_R07P]_P!<)O\ T?)7?U_.N<?\
MC?$?]?)_^E,_I')?^1-AO^O</_24%%%%>:>F%%%% !1110 4444 %%%% !11
M10 4444 %%%% !7QI^U]_P EZU?_ *X6O_HA*^RZ^-/VOO\ DO6K_P#7"U_]
M$)7W/A__ ,CJ?_7M_P#I43X/Q#_Y$</^OB_])D>94445^QGXN%%%% !1110
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M)/?-?II^7'045S^F_#;0=&^&*?"?2+S4+?38M&.FPW"WS-=1Q&,Q[Q,V6\P
MY#G)SS1IWP^AT?X8)\,--\5:TB1:,=/AUJ2^,FH)^[*"?SF',PSNWD?>&<4
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M8(KX,_X<QS_\-'^5_P )7_Q;+_C[\WSA]OQN_P"/''K_ --NFWG&[BOT$HH
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MG33RGVL/:PG>G[VMM;Q<4U:_]^+6NS?:Q]N45\S?LP_M6^.[C_@G+\,OC?\
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M )"-Q_UW?^9K]$:_.[4O^0C<?]=W_F:_3/#GX\3_ -N?^W'Y=XE?#A?^W_\
MVP@HHHK]0/RP**** "BBB@ HHHH **** "BBB@ HHHH **** /MG]EO_ )(+
MX>_ZX3?^CY*[^N _9;_Y(+X>_P"N$W_H^2N_K^=<X_Y&^(_Z^3_]*9_2.2_\
MB;#?]>X?^DH****\T],**** "BBB@ HHHH **** "BBB@ HKPK5O^"FG[!.A
MZI<Z)J_[47ABWN[.X>"Z@DGDW1R(Q5E/R=001^%0?\/2/^"?/_1UGA7_ ,")
M/_B* /?**\#_ .'I'_!/G_HZSPK_ .!$G_Q%'_#TC_@GS_T=9X5_\")/_B*
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M^@FG_P"!Q_S#^P\[_P"@6I_X!+_([:BN)_X:5_9Z_P"BV^%?_![!_P#%4?\
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M>D?\$^?^CK/"O_@1)_\ $4?\/2/^"?/_ $=9X5_\")/_ (BOGCZ(]\HKP/\
MX>D?\$^?^CK/"O\ X$2?_$4?\/2/^"?/_1UGA7_P(D_^(H ]\HKP/_AZ1_P3
MY_Z.L\*_^!$G_P 11_P](_X)\_\ 1UGA7_P(D_\ B* /?**\#_X>D?\ !/G_
M *.L\*_^!$G_ ,11_P /2/\ @GS_ -'6>%?_  (D_P#B* /?*_.[4O\ D(W'
M_7=_YFOI7_AZ1_P3Y_Z.L\*_^!$G_P 17QC??M,_L[S7LTT?QO\ "I5I6*G^
MW(.03_O5^A\!8W!X.6(^L5(PORVYFE>W-M=GYSX@X'&XV.&^KTI3MSWY8MVO
MRVO9,[*BN)_X:5_9Z_Z+;X5_\'L'_P 51_PTK^SU_P!%M\*_^#V#_P"*K]&_
MMO)?^@FG_P"!Q_S/S7^P\[_Z!:G_ (!+_([:BN)_X:5_9Z_Z+;X5_P#![!_\
M51_PTK^SU_T6WPK_ .#V#_XJC^V\E_Z":?\ X''_ ##^P\[_ .@6I_X!+_([
M:BN)_P"&E?V>O^BV^%?_  >P?_%4?\-*_L]?]%M\*_\ @]@_^*H_MO)?^@FG
M_P"!Q_S#^P\[_P"@6I_X!+_([:BN)_X:5_9Z_P"BV^%?_![!_P#%4?\ #2O[
M/7_1;?"O_@]@_P#BJ/[;R7_H)I_^!Q_S#^P\[_Z!:G_@$O\ ([:BN)_X:5_9
MZ_Z+;X5_\'L'_P 51_PTK^SU_P!%M\*_^#V#_P"*H_MO)?\ H)I_^!Q_S#^P
M\[_Z!:G_ (!+_([:BN)_X:5_9Z_Z+;X5_P#![!_\51_PTK^SU_T6WPK_ .#V
M#_XJC^V\E_Z":?\ X''_ ##^P\[_ .@6I_X!+_([:BN)_P"&E?V>O^BV^%?_
M  >P?_%4?\-*_L]?]%M\*_\ @]@_^*H_MO)?^@FG_P"!Q_S#^P\[_P"@6I_X
M!+_([:BN)_X:5_9Z_P"BV^%?_![!_P#%4?\ #2O[/7_1;?"O_@]@_P#BJ/[;
MR7_H)I_^!Q_S#^P\[_Z!:G_@$O\ (_0_]EO_ )(+X>_ZX3?^CY*[^OE/X"?\
M%'_V%O!7PCT;PQXF_:>\*VU]:12BX@^V%]A,KL/F12#P0>#78?\ #TC_ ()\
M_P#1UGA7_P ")/\ XBOP7-9PJ9I7G!W3G)IK9KF>J/W_ "B$Z64X>$U9J$$T
M]&FHK1GOE%>!_P##TC_@GS_T=9X5_P# B3_XBC_AZ1_P3Y_Z.L\*_P#@1)_\
M17 >B>^45X'_ ,/2/^"?/_1UGA7_ ,")/_B*[;X)?M<_LV?M'ZI?:)\#?C#I
M'B:[TVW6>^@TV1F:&-FVAFRHX)XH ]&HHHH **** "BBB@ HHHH YB?X)_!F
MZG>YN?A'X8DDD<M)))H%N69B<DDE.23WIO\ PHSX)?\ 1'?"O_A/6W_Q%=31
M0!RW_"C/@E_T1WPK_P"$];?_ !%'_"C/@E_T1WPK_P"$];?_ !%=310!RW_"
MC/@E_P!$=\*_^$];?_$4?\*,^"7_ $1WPK_X3UM_\174T4 <M_PHSX)?]$=\
M*_\ A/6W_P 11_PHSX)?]$=\*_\ A/6W_P 174T4 <M_PHSX)?\ 1'?"O_A/
M6W_Q%'_"C/@E_P!$=\*_^$];?_$5U-% '+?\*,^"7_1'?"O_ (3UM_\ $4?\
M*,^"7_1'?"O_ (3UM_\ $5U-% '+?\*,^"7_ $1WPK_X3UM_\11_PHSX)?\
M1'?"O_A/6W_Q%=310!RW_"C/@E_T1WPK_P"$];?_ !%'_"C/@E_T1WPK_P"$
M];?_ !%=310!RW_"C/@E_P!$=\*_^$];?_$4?\*,^"7_ $1WPK_X3UM_\174
MT4 <M_PHSX)?]$=\*_\ A/6W_P 11_PHSX)?]$=\*_\ A/6W_P 174T4 <M_
MPHSX)?\ 1'?"O_A/6W_Q%'_"C/@E_P!$=\*_^$];?_$5U-% '+?\*,^"7_1'
M?"O_ (3UM_\ $4?\*,^"7_1'?"O_ (3UM_\ $5U-% '+?\*,^"7_ $1WPK_X
M3UM_\11_PHSX)?\ 1'?"O_A/6W_Q%=310!RW_"C/@E_T1WPK_P"$];?_ !%'
M_"C/@E_T1WPK_P"$];?_ !%=310!RW_"C/@E_P!$=\*_^$];?_$4?\*,^"7_
M $1WPK_X3UM_\174T4 <M_PHSX)?]$=\*_\ A/6W_P 11_PHSX)?]$=\*_\
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M<UB+8%V75WI\$\HP.!AY&X' H ],HHHH **** "BBB@ HHHH **** "BBB@
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<4 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>jnj-20200628_g11.jpg
<TEXT>
begin 644 jnj-20200628_g11.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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MS 'W_4&GZIIFK1//I6HP7*13R02/;S*X26-BCH2#PRL"I'4$$'D5^=/[>O\
MP7!US0_^",3?\%//^">WPOE\4Z?K=FEO)K>NW=K;IX)GENX]/+WEJ\IDNIX[
MN9(EAA5XR1YC/Y6#)R7_  :\?M%_M8?$_P#8%\$:)\2_V;]8O/"VI7_BG5KG
MXW:CXYL)_P"V-1FUV\FF5['>;L2--+,ID<8)C+9PPH _4JBLOQQXV\)?#7P7
MJ_Q%\?>(+72="T#3)]1UG5;V4)#9VD$;22S2,?NHB*S$]@#7YT>&?^#@OQE\
M6_V6_B-_P4'_ &?_ -@VZ\1_ +X9^)'TS5?$NI_$1-.\0ZE!%Y)N;ZRT@V$D
M3PQ)/&Y$MY"Y&X!=RLJ@'Z5D@#)-?'GQ#_X+U?\ !++X8ZA,?$O[2+R:':>,
MO^$3O_&VF>%-3N_#]KK?E&8V+:E#;M;-((QO8H[*J\LP )&+^UQ^W[:?M)_\
M$7O&W[8_[!OA*\\<Z/XL^&6O9N(M=M])N_#=N-,O5NKR43$YFLY8MK6\9+LP
MRA888_F]_P &F_[/?PV_:^_8<\:_ ;]IS]B_0?'WPUT[XP7/B&T\6>([VUG@
ML]<CTS3(4LUL6_?%C [N9O\ 5%6,; DXH _?JSO+34+2*_L+J.>">-9(9H7#
M)(C#(92.""""".M24RWM[>SMX[2T@2**) D44:A510,  #@ #M3Z "BBB@ H
MHHH *^0/^"_'_*&S]H3_ +)_-_Z.BKZ_KY _X+\?\H;/VA/^R?S?^CHJ /XP
MJ*** /W^_P"#3;_E*9^UW_V\?^GR>OW^K\ ?^#3;_E*9^UW_ -O'_I\GK]_J
M "BBB@ HHHH **** "OA7X6/^UA^U;^U]X__ &Z/V;O$?PT/@_11=?#+X<S>
M--/O[OSK73[P_P!LZA;-:3QH%N=4C:V));>FCP," QS]G?$KX>>'/BSX$U/X
M<>+I]6CTS5[8P7K:%XAO-*N_+)!(CN[&6*XA)Q@F.1202"<$@^>_LA?L*?LS
M_L'^ U^%O[+/A/7/#OAJ-I6MO#]YX[UG5;*U:24RR&"'4+N=("\C,[&,+N9V
M)R6.0#^<?]L3PW\</^#?_P#X+]>%OVM?%EKHPT/QAK;^++^'P7:3Q:;<Z5J,
M\L&KV$,<SNRM'NF9(RQ"%K=A@;<??W_!Y3%XB^)W_!,#X7_%/X8Z@VK^"T^)
MECJ.H7VFR^9;R07.F78L[HE>#$?,*J_3,Z#JPK[\_;(_X(Y_\$[_ /@H'XPL
M/'?[8?P2U;QOJ.E12QZ3]N^(_B"W@L4E*M(L%O;W\<,(8HF=B#.Q<]!7<^"/
MV ?V2O 7[*MS^Q%IOPKDU/X5W6G&P?P;XK\1:CK=NEH0NV"-]1N)Y8HT*J8T
M1U6)E#(%(!H ^??V$?B[_P $^OV_/^"8GP2_:K^.7A[X<>(+7X:^%]-:\O\
MQ?8V=P?!^O6=O#!<@-,";63SHE9/NF1?(< Y2OS4_: O==\(_P#![#X0U?XR
M3/#I%]J6E1^$9+IML3P3>%C;6XBW=CJ!E7 ZR[P.M?IC^RO_ ,&Z_P#P2=_8
M\^-<'Q]^$?[.]Q/K^GWJW>A#Q)XCO-2M=)G4DI+!!/(R&1"<I)()'0_,K*>:
M]/\ V\_^"3O[$/\ P4AO/#WB+]IOX8W-QXB\)N#X;\7>']8GTW5;!0_F>6MQ
M RED#_.JN&",2R;6)) /R,_X+VW%G-_P=/\ [&4=K/$[Q2_#A+E8V!*/_P )
MK?L V.AVLIP><$'H13_^#W*1;'XB_LLZG=ADMXU\4EYBIVC;-HQ;ZX!!Q[UY
MA_P5R^$7[-W[)/\ P<B_LB>"_A%=166CZ%>_#Z\\7ZIJGB";4;V2]'BZ[>:Y
MU&\NI))I9_LX@)>5R5B6)1A%11^ZW[?'_!-W]C[_ (*<?"O3_A=^UG\./[>L
M-*O3?:#J5AJ$EK>:=,R[6>">(@A77 9#N1L*2I*J0 ?C;_P=Y>)O#NH?\%$_
MV5/#EAKMG-J%C;FXO;**Y5I8(IM5M1%(Z@Y57\J3:3PWEMCH:[W_ (/@O^2
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M=>*-1M]/AT_2O&TM]/>7"QQV\<7BRS,CNS$!54 DL3@#DFOUU_9#_P""-_\
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M_P"">\/_  4Z_8%\9?LHV6OV^D:[?BWU'PEJUX&,-KJEK()8?-V@D1R /"[
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MWX$2_#>\O=?^'!TGPK?ZY;W^H06/_"5S;'O6MBT$4[2><?*BDE54\O+[RZ(
M>B?\'DFI:M\+_P!I_P#9^\6?#76[_P /ZCXDTO5$\07>B7\MJVHBWN;%8#-Y
M; 2%%E=0S9(4[<X  /\ @Z\U'5OAC_P4Z_9TUSX<:YJ&@7/BBPMF\1R:-?RV
MPU-H=4BBB>=8V E=8R(]S ML55SA5 ^BO^#K3_@EE^UW^W;HGP?^.?['WPV;
MQGJ?PYN-4MM?\-6EU&EW);W36DD,\*2.HE5'MG5U4E_WJ$*0K$>'_P#!8O\
M8*_X+1_\%3/VD/@C^U?H'_!.F'P]I'A'3HO-\'#XG:))JMCLO8[B0W<EQ=6\
M6^3!\N.+?L1 9'5W,<8!I_\ !ZQ<WWPX\/\ P&^(OP\U.\T'7=6U'7K'5=6T
M6\DM9[VWABLGBBF:)E,JHTDA0-G;YCXQN.>N_P"#K:6Z\+_\$?O@-\8?#&H7
M>F>*D\<Z!I0\0Z==R07C64_A_4IY;=I48,T;2V\+E22-T8/7-=3_ ,'0?_!/
MG]O[_@J!X1^"OAC]D']D36]9D\*OJFI>(IM3\6^'K!+-KN*T5+7]]J0,DJ&&
M3>4#1# VR/GC9_X+V_L3?M\_\%"_^"67P4_9D_9W_8TU^Y\9Z-XGTG6_%.FZ
MEXP\.VR:.MGI%]8O \KZELF=Y+I60PF1=B$L5;"T <Q^P_\ \$2O'/[;GP:_
M8Q_X*)?'#]O#X@V_B?P)X9\-:U:^%H%2?2QI=M'!+9VMI\Z26D\L4:-=7+M.
MTSS285%"*OE_PZ_;7\'?\%%_^"_'QQ^'O[:OPN\4?$WX3?!K2=;\/_#SX2Z/
MX&O/$>FQ7=KJ,&G3:M<Z=;Q2+)(_^DL)YD.PW$2J5,<>/UC_ ."67@#XL?"#
M_@GG\'_@E\<?A5J7@[Q5X&^'VD^'=:TC4M1L+HF>SLXH'ECEL;B>)HF9"5)<
M/@?,JU^5/QZ_X)O_ /!4;_@EC_P6Q\2?\%.?^"=G[-Y^,7@+XD:EJ%WXF\+:
M=J\-M<;-2E6>_P!/F5V#QC[6HN(9XTD1-D8<?*RL :W[#_[6O_!0W_@F7_P3
M;_;$N/CA\'_B%H_A3X3R->?LU:Q\3=$NHF6UO[N>RM;4?; 'DA@=K&80MR!-
M(GR@J!YU_P $G_V(?A;^UG_P1(^/?_!1?]H/7O$^O_'+7[3QC=P_%&7Q/=KJ
M]G%9::P2U6428>"1A-YT+ADECF,;@JJA?T_\?_L_?M3_ /!3[]A7XK_"/]LO
MX?:?\'U^)WA(:7X4^']MK,.LW'AR>/=+%J-_>0HB33/<B!C;192.*W4;VDD?
M9^?'_!-W]G__ (+(?L7_ /!.OXY?\$G_ !/_ ,$];K4]0U6S\12>$OB0?%EC
M_826M]IYAE0;9#-<RLZ%X(D4,SW(6;[.J,X -[_@R/\ ^3+OC'_V5"#_ --T
M-<O\;OB5J?[.O_!Z!X4U#PA.\$'Q)\+Z=H_BNWB^47L5QHS0('QU"RVEG)]8
M%KWW_@UC_8(_;F_X)W? WXA_"S]L3]G5O!Z>*?$,.N:-?MXHT^]=BL$<#6\D
M-K-(T387>"3TR"%(&?+_  5\"-3_ &XO^#NSQI\>O#EH;KP3^SCX>L(==UB-
M<P/JQTCR(+(./^6JW-S<.1_TX2 ]L@'[4T444 %%%% !1110 4444 %%%% !
M7R!_P7X_Y0V?M"?]D_F_]'15]?U\@?\ !?C_ )0V?M"?]D_F_P#1T5 '\85%
M%% '[_?\&FW_ "E,_:[_ .WC_P!/D]?O]7X _P#!IM_RE,_:[_[>/_3Y/7[_
M % !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %?E?\ \%!O^"''[7W[:G_!5KX=_P#!2WP_\:/AOX>3X6:AH$GASPK>6^H7
M!OHM)U634(C<S*B[&E>0JP12$& "Q&X_JA10!!I;ZG)IEN^M0017C0(;N*UF
M:2))=HW!&95+*#D E5)&"0.E3T44 %%%% !1110 4444 8/Q-T+QUXF\!ZEX
M?^&GCR'POK=Y (K'Q!-HZW_V#+#?*D#NB/($W;-Y**Y5F215,;<5^R'^QU\$
M_P!B;X6R_"_X+Z3='^T=6N-8\3^(=8N?M.J>(]6N&WW.HW]P0#/<2MR6P%4
M*BJBJH]3HH **** "BBB@ HHHH **** "BBB@ KY _X+\?\ *&S]H3_LG\W_
M *.BKZ_KY _X+\?\H;/VA/\ LG\W_HZ*@#^,*BBB@#]_O^#3;_E*9^UW_P!O
M'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H **** "BBB@ HHHH ****
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M=_\ ;Q_Z?)Z_?ZOP!_X--O\ E*9^UW_V\?\ I\GK]_J "BBB@ HHHH ****
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M5[?Q!HEGKUI%(D5]:1W$23+AU5U# ,.QP>15JBB@ HHHH **** "BBB@ KY
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M83:U<ZA)J27%P9;:65)RBV%NI=W:7+$.<!* /LVBBB@ HHHH **** "BBB@
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M*OK^OD#_ (+\?\H;/VA/^R?S?^CHJ /XPJ*** /W^_X--O\ E*9^UW_V\?\
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M[1SE%9P6& $%?-OB[_@LI^S_ .(OVWO ?[47_#M?]JJ3_A%OAGXG\/3ZE+\
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M^"@.H^#KE_B?I'@I_"MAK(U:X$*::TTDI0VX?RF;=++\Y7.'/HI !\H_&/\
M8[\)?\$I-4^.'[?WP<_;<UWX5_#7QC--XG^(GP[7PM8:K%<ZX^1YNCR76?LM
MW=2NL:Q-'.CR2HNPJL:)N?\ !O1^QM\8_P!E#]A>^\:_M*V5Y:_$KXT>.M2^
M(7C/3]14"YL)K_RQ%;S !0LOE1++(NU2DD\B$#;BOIO6?V/O@UXU^*6F_&'X
MKV^J^--8T'43?^&(?%6JR7.GZ'<\[9[6P&VUCG0,0ER8FG0$A9!DY]2H ***
M* "BBB@ HHHH **** /R+_X.2?\ DKOPY_[%BZ_]*17YGU^F'_!R3_R5WX<_
M]BQ=?^E(K\SZ_IOPB_Y)27_7R7Y1/Y<\8O\ DK8_]>H_G(****_43\J"BBB@
M HHHH **** "BBB@ HHHH *=#_K5_P!X4VG0_P"M7_>%88K_ '6I_A?Y'1A/
M][I_XE^9_15_P3!_Y,!^%?\ V*T?_HQZ]XKP?_@F#_R8#\*_^Q6C_P#1CU[Q
M7\-']X!7R!_P7X_Y0V?M"?\ 9/YO_1T5?7]?('_!?C_E#9^T)_V3^;_T=%0!
M_&%1110!^_W_  :;?\I3/VN_^WC_ -/D]?O]7X _\&FW_*4S]KO_ +>/_3Y/
M7[_4 %>$?\% OVQ/$G[$GPQ\-?%3PW\ O&/Q-.I>-;?1KOP?\/M'-_K5W#-:
M7<A>TMP1YC1M"DC D#RTD.1C->[U#=:=I]]/;7-[80S26<QFM))8@S02%&C+
MH3]UMCNN1SM=AT)H _,?6O\ @I=\)/$WCO5_B;XI_P"#<W]K+5O$&O+;KJ^K
M:M^SY9W4UR((_+BRTMRV-J848QP!Z5[1_P $N_VF? ?[1?[0WQ@'@O\ X)R^
M-OV>GT3PEX12\M?B%X!C\/:CKHEN=?*2+!$S1RP1;'5) =Q>652<*H'VM5>/
M2=*AU6;78=,MTOKFWB@N+Q85$LL4;2-'&SXRRJTLI52< R.1C<<@%BBBB@ K
MBOC5^T7\$/V=-+LM:^-_Q)TWPW:ZE<-!8SZB[*LTBKN*C /('-=K7YO_ /!R
M 2/@7\/"#@_\)-=\C_KV%=> PKQV.I89.W/*,;]N9I7_ !.3'XI8' U<2U?D
MC*5N_*F[?@?4_P#P\_\ V ?^CI_"_P#W_D_^(H_X>?\ [ /_ $=/X7_[_P G
M_P 17\ZWG2_\]6_[ZH\Z7_GJW_?5?LG_ !!;%?\ 0:O_  !__)'XM_Q&["_]
M 4O_  -?_(G]%/\ P\__ & ?^CI_"_\ W_D_^(H_X>?_ + /_1T_A?\ [_R?
M_$5_.MYTO_/5O^^J/.E_YZM_WU1_Q!;%?]!J_P# '_\ )!_Q&["_] 4O_ U_
M\B?T4_\ #S_]@'_HZ?PO_P!_Y/\ XBC_ (>?_L _]'3^%_\ O_)_\17\ZWG2
M_P#/5O\ OJCSI?\ GJW_ 'U1_P 06Q7_ $&K_P  ?_R0?\1NPO\ T!2_\#7_
M ,B?T4_\//\ ]@'_ *.G\+_]_P"3_P"(H_X>?_L _P#1T_A?_O\ R?\ Q%?S
MK>=+_P ]6_[ZH\Z7_GJW_?5'_$%L5_T&K_P!_P#R0?\ $;L+_P! 4O\ P-?_
M ")_13_P\_\ V ?^CI_"_P#W_D_^(H_X>?\ [ /_ $=/X7_[_P G_P 17\ZW
MG2_\]6_[ZH\Z7_GJW_?5'_$%L5_T&K_P!_\ R0?\1NPO_0%+_P #7_R)_13_
M ,//_P!@'_HZ?PO_ -_Y/_B*/^'G_P"P#_T=/X7_ ._\G_Q%?SK>=+_SU;_O
MJCSI?^>K?]]4?\06Q7_0:O\ P!__ "0?\1NPO_0%+_P-?_(G]%/_  \__8!_
MZ.G\+_\ ?^3_ .(H_P"'G_[ /_1T_A?_ +_R?_$5_.MYTO\ SU;_ +ZH\Z7_
M )ZM_P!]4?\ $%L5_P!!J_\  '_\D'_$;L+_ - 4O_ U_P#(G]%/_#S_ /8!
M_P"CI_"__?\ D_\ B*]3^$WQC^&'QV\'IX_^$/C2RU_1I+B2!-1L&)C,B'#+
MR!R#7\P?G2_\]6_[ZK]U_P#@@]S_ ,$_-,)_Z&;4O_0UKXOC'@>KPA3HSG75
M3VCDM(VMRV\WW/MN"^.Z7&-6M"%!T_9J+UES7YK^2['V71117PA]\?D7_P '
M)/\ R5WX<_\ 8L77_I2*_,^OTP_X.2?^2N_#G_L6+K_TI%?F?7]-^$7_ "2D
MO^ODORB?RYXQ?\E;'_KU'\Y!1117ZB?E04444 %%%% !1110 4444 %%%% !
M3H?]:O\ O"FTZ'_6K_O"L,5_NM3_  O\CHPG^]T_\2_,_HJ_X)@_\F _"O\
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ML?\ P!__ "1^$U%?NS_PX>_X)^?]"QXF_P#"D?\ ^)H_X</?\$_/^A8\3?\
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M_@GY_P!"QXF_\*1__B:/^'#W_!/S_H6/$W_A2/\ _$T?\1IPO_0$_P#P-?\
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M "BBB@ KY _X+\?\H;/VA/\ LG\W_HZ*OK^OD#_@OQ_RAL_:$_[)_-_Z.BH
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M_;E_9XL? 6F?%W5/['\">._#/C<Z[I7]LD QZ7J!ELK.2SN)<@1E5FB=LCS
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M+)&66*SNY9IGGW@(L.U5C9GD0F-7 /<J*\W_ &4_CIXK_:'^$K>/O'/P@O?
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MQ#LM!\:>'_VB_'NJ>(=%U3= VE:<[1>7?7+N D%L[+Y:2NP5Y"J*2Q KQ?\
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M,C @\@'D=JELK*STVSBT_3K2*WMX(PD,$,81(U P%51P !V% 'C7_!1KXD>
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M-\:?A!J7_!IE\'-/TWXH^'[FY/@#X9V"VMOJ\,DSW=DNE_;+=45BS2P['\Q
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M/_CW^U?^S)^RQIMEK/[2OQ^\(> ;/4IC%I]YXO\ $%OI\5Q(!DHCSLJLV.<
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MGC*SNETJ)RP62X,<A\E24;YFP/E/I7QI_P %?%5/^"T7_!-Q$4 #Q?X[  '
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M[5_#DWB+QWI]BFJZ>][>%+NV,\RB>$AE(D3*_,.>17[(44 ?DS_P4&TO5?\
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M0\4^*/#7@?PSJ/C7QGK]GI6CZ/837NJZIJ-RL-O9VT2&26:61R%1$169F)
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M_P#1CWQ _P#"BL?\*/\ B-Y_99_Z,>^('_A16/\ A0!^WU%?B#_Q&\_LL_\
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/W$?+T'K0!^%M%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>jnj-20200628_g12.jpg
<TEXT>
begin 644 jnj-20200628_g12.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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M5^(/_![S_P FL_ __LH&H_\ I"* //\ _@TV_P"4IG[7?_;Q_P"GR>OW^K\
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MBO88H3]HA:,K-$T2A=\;(\BOD?L#^W!_P58\ ?\ !.7P%\!_AB? T'BKQ_\
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M[T]+6=+>X$RW=O%L>.:1(V0G>&.,<''T!7\W?_!.#XU>)?@#_P '.O[6^O\
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M\$A4[9%*R(Z2+PRN,A6#HH!]$T444 %%%% !1110 4444 %?B#_P>\_\FL_
M_P#[*!J/_I"*_;ZOQ!_X/>?^36?@?_V4#4?_ $A% 'G_ /P:;?\ *4S]KO\
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M^":_B*[\<_LP_!:2W\2W=O);-XF\0:O/J-[!;N07A@:9BMNK8&[RE4O@!RP
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M_:%_90_X)O\ Q _:M_9E^,-SX4\4^ K2UO+6/^Q;"^M-066_M;=X[B.[@D;
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M^T+\9-8AU#Q3XO\  MGJ6NWL%G';I-<R*2S".,!$!]% % 'OU%%% !17PO\
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M?2JKF-+G=BXCA:&0;C;UM?\ !>'1O$.B_P#!RK^SW\*/A)\1=?\  =MX_O/
MLFLW?A'4GM6%]=^)+BUDOQ&#Y;7&Q(SN92&:,%@W.?9?VWO^"2'CG_@HY^WK
M\$?CS\(?^"=WBW]GWQGI_BR#5OV@_%^I:GI*Z08H)H)EELY+*ZD_M&]9TE"3
MQ1QL^]#/M(/E^+_\'#-YXUT__@YQ_9<O_AMHEAJ7B."'X?R:!IVJWK6UK=7J
M^*KPP133*CM%&T@56<(Q522%;&" 5?\ @MWX3T7_ (( _P#!4'X'_M>_L%ZC
MX@\-V/C#39;CQ_X=G\47VH1^(_L=W&MV+M[R:62?[1!<(K;V.)(Q*NV3YJ]M
M_P""[W[8WQ)_:$_X+-?LY_\ !(BQ\37]A\)M8\3>&+OXF:3IU[);?\)0M_J
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M5RL$.JVUS&B7=CYKD+#(_DV[H[D)N@"L5#ET^</^"E_[$G[=O_!;KP;^S/\
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M %%%% !1110 5^(/_![S_P FL_ __LH&H_\ I"*_;ZOQ!_X/>?\ DUGX'_\
M90-1_P#2$4 >?_\ !IM_RE,_:[_[>/\ T^3U^_U?@#_P:;?\I3/VN_\ MX_]
M/D]?O]0 4444 %%%% !1110 4444 %%%% !1110 445!'J>FRZE+H\6H0-=P
M01S3VJR@R1QR%U1V7.0K&.0 G@F-@/NG !/1110 45\T^/O^"O'[ ?PK\/\
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M K\0?^#WG_DUGX'_ /90-1_](17[?5^(/_![S_R:S\#_ /LH&H_^D(H \_\
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M#OB$2L+6>Z:U<O9BV,IE22.3$49D,B[-IW,47\__ /@LY_RMG?LN?]A#X?\
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MN]UOQ'87-OK-B-+N$D)AL;&)'MTMIF8395 [P#>6>-6_&_\ ;$_X)[?M/?\
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MZ+088K&YNHK[2[IAO2QN%M98&@(4+(P^6-UD5OU;_9#_ ."R'_!/+]NGX_\
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M2V@GOOBOKL%E#-.JO<2B&"4H@)R["-'<@9.U&/0$T ?JO1110 4444 %%%%
M!7X@_P#![S_R:S\#_P#LH&H_^D(K]OJ_$'_@]Y_Y-9^!_P#V4#4?_2$4 >?_
M /!IM_RE,_:[_P"WC_T^3U^_U?@#_P &FW_*4S]KO_MX_P#3Y/7[_4 %%%%
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M4 <_K?PH^&?B+X6W7P0UGP'I,W@^]T%]$N?#/V%%L7TYX3 UIY*@*(O*.S8
M %X%?&?PV_X-L_\ @C_\-/"_BCP/:_LTWNKZ+XJ9C<Z7KGC759XK ,RDFS(N
M%:VD(14,Z$3F,&,R%'=6^[** /FSP!_P2,_8#^%O[)OB/]AKP%\&;^R^%/BR
MZCGUSP=<^-M8O;>5EGCG81M=W<KVZN\:EQ"R;NIYYJ'X??\ !)/]CKP%\7O!
MWQHO-/\ &?BO4OAM%+'\,K'Q[\0M4URR\(B0*K&QAO9Y C;4C57?>R".,(5V
M+CZ9HH ^6?C/_P $6_\ @G%^T'^TU;_MD?%WX):YJWQ-LM0M;W3?%J_%#Q);
M3V$UM()+<VRP:@D=LL;@,B1*JJ>0!DT_]J/_ ((Q?\$Y?VTOC!IOQ\_:;^".
ML^*?%VC65M::/K,WQ,\16S6$,#%XE@2WU"-(2')D+(H9G8NQ+$D_4=% 'RO\
M?/\ @BO_ ,$X/VH?CMI?[3?QY^"FO>(O'NAPV,6B>)[CXI^)8KC3ULW\RV$'
MDZBBQ%)"T@*@$R.SG+LS'LOVW?\ @FM^QK_P43^%6F_"#]K;X1IXGT_0W,F@
M:B^I7$6HZ9(556>&\1Q,"P5-X9F60HI<,5&/=J* /G']@7_@E!^P_P#\$U-.
MOXOV5OA5+I^I:I:K:ZCXBUK5I]1U":V5]XMUFG9O)AWX<Q1!$9@&*E@#7$W7
M_!"G_@GW/X$N/@];Z!X]M? &J:HFI^)?AS:_%/6ET'7;U9A-Y]U9?:3&6:55
M=EC\M'9%+*=HQ]B44 >'?M"?\$Z/V4?VF-6^'_B'X@>"]3T[4OA387EI\-=2
M\&^)[[0I_#:W*VBR-:MI\T.PA+*!%!RH0,FW:[ V?V5?V!OV<OV/?$7BWX@?
M"[1-6U#QCX]O(KGQMX[\6Z]<:KK6M/$NR)9KJX9F$<:X5(DVQJ!PN>:]HHH
M^&_CW_P;F?\ !)G]HK]H2Z_:9\;?L]WNG^)=3U!K[7!X7\57VEVNIW+DF266
M*WE4([DDNT/EER69B69B?=/C7_P3B_8W^/WP0\$_LW^/O@]'!X)^'.M6NK>"
MM"\-ZK=Z.ND7EM:W%K;S026,L4L;1)=2LI5P0^U_O*#7N%% '@W[/O\ P3A_
M9J_9W^-^J?M-:1#XH\5?$C5=%31I/'7Q"\77FN:G;:6C;UL8);IV\B'=\Q"
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M8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *_$'_@]
MY_Y-9^!__90-1_\ 2$5^WU?B#_P>\_\ )K/P/_[*!J/_ *0B@#S_ /X--O\
ME*9^UW_V\?\ I\GK]_J_ '_@TV_Y2F?M=_\ ;Q_Z?)Z_?Z@ HHHH _/#_@IG
M^S%X:^+GC6]_9X^.'_!0;X3?#?X*_$;QQIGC#XF>$/$=W%8>)M=BLX;.$Z;#
M=37J1_8IFT^W9I/*\Q"I4,R*$KV[]C;XD^#_ (P?M8?$[Q'X*^.OPF\3Z/H'
M@OPUI'AKPY\*M;74%T#3?M&K-&;V:,",RSLAV1(%6)+8 *=QD?XW_:%U;]C7
MX9?\%+?C_<_';_@B7\9?VEM4UO4/#]Z?&&G_  %TSQ=9Z:?[&MH18VDMW=%4
MM@D*2C"QR>=-<(R;(XV;Z(_X)-^.?V9?&7QM^+B_LX?\$N/&7[,*6OA;PG_;
M&E^,?A59^$9->+7.O>5-%:6;-'*L8613.3N)DV$ 1J2 ?<-%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4450\4>*?#/@?PW?^,O&GB*QTC2-*LY+O5-5U.[2WMK.WC4M)++(Y"QHJ@D
MLQ  !)- %^BO&_V9?^"A?[#_ .V9KNJ^%_V6?VI?!GCG4]$C\W4]-T#6HY;B
M&+<$\[R\AFBW$+YB@IE@,\C/LE !17FWQK_;!_9A_9RUFV\.?&_XX>'_  YJ
M%W8/?QV%_>CSH[)&VR7LB+EH;5&X:XD"Q*>&<5Z#I&KZ3XATFUU_0-4M[ZQO
MK=+BRO;.=98;B%U#)(CJ2KJRD$,"00010!8HHHH **** "BBB@ HHHH *_$'
M_@]Y_P"36?@?_P!E U'_ -(17[?5^(/_  >\_P#)K/P/_P"R@:C_ .D(H \_
M_P"#3;_E*9^UW_V\?^GR>OW^K\ ?^#3;_E*9^UW_ -O'_I\GK]_J "BBN$^-
M'[1/@'X$:YX(\/\ C;3]?GG\?^+X/#>A-HOAZYOHXKR6.216N7A1A;0XB;,L
MF%7J2 "0 ?+?QV^ O[<?[>?[27CO1/AW^WKK'P'^&OPZUJTT&#3?AQHMM)K_
M (BO_P"SK2_EN[R]GR;6%!?)'%;HK!U4R-C>HKTW]C#5/C!\,/C%XR_8\^-_
M[2$7Q=U?PGX7T77++QK=Z';6.L16=[-?PQV.II:XA>1#9M)%,%C:5)GW)F,R
M2_(__!4CXL_\$R?&W[4_B'X8_$?Q)^U1X#^*WARRLK3Q1XF_9RTK7K274;.2
M!;BVCN9;&*6VO$$<V%=T9T^9 P"E1ZO_ ,$1_%W[ 5BGQ*^!7[#/PG^(^DRZ
M!'HNM^//%OQ8TF_MM=\2W^HMJ$<<EP^H(LTWEIIYPP B'G$(JG>6 /O.BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH *YKXJ_"3X<?&CPY#X2^*WAJVUK18-1@OYM(U ;[2ZE@;S(O/B/
MR3(D@24(X*[XT;&5%=+7F?[5/[8O[-7[$?P]L?BO^U3\5K+P;X<U'7K?1K76
M-0MIY(?MLZR-'&YAC?RE*Q2$R/M1=OS,.* /@7PGXK_X)T?M'?\ !Q/X.\3?
MLU?&;P=HOC7X3?##6++Q5IFB6IM9/&UY=HT<-G$PC2&\6QM_/N)'5W;]Y %#
M+%(8?U&K\[?VO/!/[//_  42_;W_ &5OBM^QMXO\,^,?%'PM^(3>(_&WQ%\$
MZA!?6FE>%X[25FL+N]MF9#)=7)MD@MBY<J]Q($$8D:OK?5/VX?V<=&_;1TS_
M ()_:CXQN4^)^K^"G\56&C#2;@POIJS21%S<!/*5MT4OR%LX0^J@@'QU_P &
M_P!XYOOVL]<_:Q_;B^(*K>ZOXW_:(U+PS8O<J'-OX=TFTMTT^R&>D<:7<H*\
M!F+,1EB:M?\ !NW\3=:@\$?M&?L7WM]+<Z/^S_\ M*>)_"?@HR.6^RZ&+R0V
MUH">=L;I<;1T5&10 %%9'_!*^_\ AO\ \$H?B-^U#^QU^U'\0-%\#:3'\7-1
M^)GP]UKQ/J,5E;:SX8U."$;[:24J)VM7M?)G5,LDCKD8=,]W_P $"OV;/B'\
M+_@A\6/VI/BYX2OM!U_]HOXW:_\ $.WT35;5H+RQTF[G)L8YXV^:.1E,D^UL
M,JW"A@&!% 'WE1110 4444 %%%% !1110 5^(/\ P>\_\FL_ _\ [*!J/_I"
M*_;ZOQ!_X/>?^36?@?\ ]E U'_TA% 'G_P#P:;?\I3/VN_\ MX_]/D]?O]7X
M _\ !IM_RE,_:[_[>/\ T^3U^_U !7B7[<GQA_;$^#7@;PYJ?[%W[,&D_%7Q
M#J_BB/3M2T;6/%1T>*PM&MYY3>-.89%"*\21D'',RXSTKVVO$?VYO@Q^U-\;
M_!/AGPO^R?\ MB77P6U>+Q7'+KOB&T\-V&JR7FF_9K@/:QP7L;(9#+Y#A@5(
M6-_O=* /!K?]H'_@NA::C<ZO:?\ !*;X+Q7=X$%W<Q_'S;).$!"!V&G9;:"0
M,],G%>G_ +#GQ+_X* _$;XS?$63]N+]D_P +_#*WL_#?AQ?"4_A?Q,FM1:LS
M3ZN;L/>"&)\Q8MOW##$?G;Q_KCGSC_AW+_P5(_Z3S_$#_P ,IX6_^1Z[_P#8
M8_9U_:0^ 'Q[^)<?[2'_  4 OOCC?:KX3\,'38=7\,V.DW>@Q1W.M[BT%BJQ
M-'.TGRR$;R;>13PBT ?4%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 445\O?M]?\%0? '[ GBS0/"GC+X9:MKKZ_ITEW#/I
MUY%$L0239M(?J2>>*TI4JM>HJ=.+E)Z))7;?9)&=6K2H4W4J248K5MNR2[MO
M8^H:*_-__B)!^!7_ $;SXF_\&UO_ (4?\1(/P*_Z-Y\3?^#:W_PKTO[ SW_H
M%J?^"Y?Y'F?ZP9#_ -!=+_P9#_,_2"BOS?\ ^(D'X%?]&\^)O_!M;_X4?\1(
M/P*_Z-Y\3?\ @VM_\*/[ SW_ *!:G_@N7^0?ZP9#_P!!=+_P9#_,_2"JNM:'
MHOB33)M$\1:1:W]E<+MGM+VW66*09SAD8$$9]17YT_\ $2#\"O\ HWGQ-_X-
MK?\ PH_XB0?@5_T;SXF_\&UO_A1_8&>_] M3_P %R_R#_6#(?^@NE_X,A_F?
MHMHFA:)X:TR+1?#FC6NGV< Q#:65NL448]%50 /P%*VBZ.VL+XA;2;8WZ6QM
MUOC OG"$L&,8?&X*6 .W.,@&OSH_XB0?@5_T;SXF_P#!M;_X4?\ $2#\"O\
MHWGQ-_X-K?\ PH_L#/?^@6I_X+E_D'^L&0_]!=+_ ,&0_P S]$]7\.>'M?DM
M9==T&RO7LK@7%DUW:I(;>4=)$+ [&'9A@U=K\W_^(D'X%?\ 1O/B;_P;6_\
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MU>QDWPWMI,@DBFC;NK(P8'N#0!LT444 %%%% !1110 4444 %?D7_P ')/\
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M0M6&IZ;;ZA;+-%'="":!9-C@@E4GDQQP2".0*WZ* .?_ .%3?"O_ *)IX?\
M_!-!_P#$57\)_!CX7^!/'>L_$CP9X)T[2]7\0:78:?J]SI]FD/VF"SDNI+<,
M$ R4:]N,$]GQVKXA^-,G[<7QS_;7^*W@2U_X*S:;^SSX4\&7&DP^"/"6C^#=
M!U"XU>QN-/AEEU*XN=2W/O-W]K@\E0OEBV4D8D5W]0_X)W_#;XL_#KX[_%&+
MXL_\%*F_:(N;SPGX6>T:;2-.L9/#Z+<ZX"#%IP$&V<GAO]83;L&X"4 ?6U%%
M% !1110 4444 %%%% !7FO[9WQGU;]G#]CWXK_M#Z#:)<7W@+X:Z[XBLH)%!
M626RT^>Y12#U!:(#\:]*KAOVG_@K9?M)?LT_$/\ 9UU+439V_C[P-JWARXNP
M"3 E]9RVK/QSP)2?PH ^ _V"OV>] ^)G_!LY>^'?B2/[5U7XJ?"?Q/XL\6ZY
M?'S+G4-8U$WEZ-0ED/+W".8&5SRI@C_NBOH/_@A;^TSXX_:__P""3'P3^/7Q
M+U2:_P!?U#PQ-IVKZC<N6EO9].O;C36N)&/+22&T\QF[LY/>OEG]ES]J;3OV
M;_\ @@QK?[(_Q8GATWX^?#GP7KGPU'PH$ZOK6H:^1<VVE0VEHO[ZZCNHY;2:
M.6)61HG9P2J,1[A^R7XF^!__  0I_P""7?[/'P _:_\ %\FB7U[>V7A=O[/T
MR>^3_A)-5EN;^>WS;J_[M)I+D>:?E(CR.6 H ]/_ ."R/PY^'_Q _P""6W[0
MD_CKP1I.LR:-\$O%FHZ/)J>GQSM8W<6CW4D5Q"7!,<BNBL'7!!4<U:_X(\?\
MHH/V;?\ LA_AC_TV6]0_\%C/'?@GP+_P2P_:'?QKXOTS2!JGP2\5Z=IG]IW\
M<'VN\FT>[CAMXMY'F2N[!51<LQ( %4?^"*/C?P9XU_X)0?L^'P=XMTS5O[+^
M$'A[3]3_ +-OXY_LEW%IT"2V\NPGRY48%61L,I&"!0!]1T444 %%%% !1110
M 4444 %?D7_P<D_\E=^'/_8L77_I2*_72OR+_P"#DG_DKOPY_P"Q8NO_ $I%
M?2\&_P#)5X+_ *^0_,^8XT_Y)+'?]>I_D?F?1117]CG\7!1110 4444 %%%%
M !1110 4444 %%%% !7T/_P2D_Y2"?"__L9H_P#T!Z^>*^A_^"4G_*03X7_]
MC-'_ .@/7Q?B'_R1F+](_P#I<3[;PY_Y+7!_XI?^D2/Z':***_D<_L(*_$'_
M (/>?^36?@?_ -E U'_TA%?M]7X@_P#![S_R:S\#_P#LH&H_^D(H \__ .#3
M;_E*9^UW_P!O'_I\GK]_J_ '_@TV_P"4IG[7?_;Q_P"GR>OW^H *\3_;O_;R
M^!__  3L^%.C_'?]HW4;JP\'WGBJWT75=6L[":[>P,\%P\4ODPJTD@,L2(0B
MD@2;L'%>V5G:[X1\-^)K_2=3U[2(KJ?0M1-_I,DN?]&N3!-;^:HSC/E3RKSG
M&_/4 @ _'+XT_MQ_\&F_[2'QT\2_M&_M :*OC#Q9XK%F-5U#6_A/XE?_ (]K
M=;>,H%LEVDQI&#USL%?2O_!$_P")/_!(;XA?&?XU+_P23^'B:)I-AX=\(IXV
MGL]$OM-MKBZ:?7C BVU[&D@D1 Y:0#:PDC Y0Y_0FLNS\%>%[#QIJ'Q$L]'C
MCUK5=,L].U"_!;?/;6LES);QD9QA'O+D@@9_>G).!@ U**** "BBO)_VT?VL
M/#W[%_P0G^-_B?PG>ZU:P:E;V9L;"=(Y"TK$!LOQ@8H ]8HK\Y?^(C+X+?\
M1N/BC_P:VW^%'_$1E\%O^C<?%'_@UMO\* /T:HK\Y?\ B(R^"W_1N/BC_P &
MMM_A1_Q$9?!;_HW'Q1_X-;;_  H _1JBOSE_XB,O@M_T;CXH_P#!K;?X4?\
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MBBBOY8/ZP"OQ!_X/>?\ DUGX'_\ 90-1_P#2$5^WU?B#_P 'O/\ R:S\#_\
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M_LE_!+2O!FE:G?F]U1;)Y9I[ZX(QYD]Q</)-,0,@;W;:"0,9K<^%7[-GP?\
M@OXW\6?$KP'H6HKX@\<2VK^*-8U?Q)?ZG<7@MED6WB#WL\IBBB$TNR*/;&OF
M-A1DT =W1110 53U[PYX>\4Z>=)\3Z%9:C:EPQMK^U2:,L.AVN",BKE% '+_
M /"D/@M_T2'PO_X(+;_XBC_A2'P6_P"B0^%__!!;?_$5U%% '+_\*0^"W_1(
M?"__ ((+;_XBC_A2'P6_Z)#X7_\ !!;?_$5U%% '+_\ "D/@M_T2'PO_ .""
MV_\ B*/^%(?!;_HD/A?_ ,$%M_\ $5U%% '+_P#"D/@M_P!$A\+_ /@@MO\
MXBC_ (4A\%O^B0^%_P#P06W_ ,17444 <O\ \*0^"W_1(?"__@@MO_B*/^%(
M?!;_ *)#X7_\$%M_\17444 <O_PI#X+?]$A\+_\ @@MO_B*/^%(?!;_HD/A?
M_P $%M_\17444 <O_P *0^"W_1(?"_\ X(+;_P"(H_X4A\%O^B0^%_\ P06W
M_P 17444 <O_ ,*0^"W_ $2'PO\ ^""V_P#B*/\ A2'P6_Z)#X7_ /!!;?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_$UQKWC#X(_$&]\%7'B&[G::;4K.!(WMWED;F21-TD.XY+)#&S$LS$@'WO\
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M2?"GA;0;^\U70O#6GV5UJ,OFZA<VEFD<ET_/S2,H!<\GDY/- 'RI_P $6O\
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MO/[+/_1CWQ _\**Q_P * /V^HK\0?^(WG]EG_HQ[X@?^%%8_X4?\1O/[+/\
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MO/[+/_1CWQ _\**Q_P * /V^HK\0?^(WG]EG_HQ[X@?^%%8_X4?\1O/[+/\
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C\-_@#XD\'3^#O$EUJ5S<ZYJ=O.EPDMN(@BB(9!!&<F@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>jnj-20200628_g13.jpg
<TEXT>
begin 644 jnj-20200628_g13.jpg
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M#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _
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M_P#'J/\ B$V_X*F?])=O_*AKG_QZOW^HH _ '_B$V_X*F?\ 27;_ ,J&N?\
MQZC_ (A-O^"IG_27;_RH:Y_\>K]_J* /P!_XA-O^"IG_ $EV_P#*AKG_ ,>H
M_P"(3;_@J9_TEV_\J&N?_'J_?ZB@#\ ?^(3;_@J9_P!)=O\ RH:Y_P#'J/\
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MY3^)_P#P4ZN/V1OV+_%G[8__  45_9NU3X-P>'-4%EIGA,>+--UZ^UYY(XS
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M_!1GXDV_QG_:/^"4[>,88(H)O$_AO6[C3;N\ACP$2X\E@DY50%5W4R*H"A@
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M44 ?O]_P:;?\I3/VN_\ MX_]/D]?O]7X _\ !IM_RE,_:[_[>/\ T^3U^_U
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MP7X_Y0V?M"?]D_F_]'14 ?QA4444 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^
M/_!IM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5\@?\%^/^4-G[0G_ &3^;_T=%7U_7R!_P7X_
MY0V?M"?]D_F_]'14 ?QA4444 ?O]_P &FW_*4S]KO_MX_P#3Y/7[_5^ /_!I
MM_RE,_:[_P"WC_T^3U^_U !1110 4444 %%%% !1110 4444 %%%% !1110
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MV$?A"OP(_92^&4?A3PLNIW&HMIRZG=WKRW4Y!EFDGNY99I&;:HRSG 50,
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MB_@A^SII=EK7QO\ B3IOANUU*X:"QGU%V59I%7<5& >0.:[6OS?_ .#D D?
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M+8K_ *#5_P" /_Y(/^(W87_H"E_X&O\ Y$_HI_X>?_L _P#1T_A?_O\ R?\
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M -(9^/=%%%?VJ?P\%%%% !1110 4444 %%%% !1110 4444 %?NS_P $'O\
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M_1T5 '\85%%% '[_ '_!IM_RE,_:[_[>/_3Y/7[_ %?@#_P:;?\ *4S]KO\
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MC?\ ##\Y'V71117X$?T(?D7_ ,')/_)7?AS_ -BQ=?\ I2*_,^OTP_X.2?\
MDKOPY_[%BZ_]*17YGU_3?A%_R2DO^ODORB?RYXQ?\E;'_KU'\Y!1117ZB?E0
M4444 %%%% !1110 4444 %%%% !3H?\ 6K_O"FTZ'_6K_O"L,5_NM3_"_P C
MHPG^]T_\2_,_HJ_X)@_\F _"O_L5H_\ T8]>\5X/_P $P?\ DP'X5_\ 8K1_
M^C'KWBOX:/[P"OD#_@OQ_P H;/VA/^R?S?\ HZ*OK^OD#_@OQ_RAL_:$_P"R
M?S?^CHJ /XPJ*** /W^_X--O^4IG[7?_ &\?^GR>OW^K\ ?^#3;_ )2F?M=_
M]O'_ *?)Z_?Z@ ILD,,KH\L2LT;;HRRY*G!&1Z'!(^A-.HH KWVK:7I84ZGJ
M5O;[\[//F5-V.N,GGK69HOCGP!K_ (PU+PKX?\1Z=>:UING6=SJMK:S*\T%M
M.]PMLTFWHK-!<[0>Z/\ C^0W[9K_ /!'RV_X*=?'2'_@I-^S]\1?BWXE:?0)
M?#]S%X(U_4[3PY8-I%N/[,@6S/D*AD1KL2H/G:\=&PT+%OI#_@BM>_\ !+^?
MXP_&6U_X)I?LY^)?AW:1^&_"3>+[;7O#VH:5'>2M<:]]G:*WO_WFY568-(IV
M,&C4<HV0#]!**** "OS?_P"#D'_DA7P\_P"QFN__ $F%?I!7YO\ _!R#_P D
M*^'G_8S7?_I,*]?(/^1[A/\ K[3_ /2D>1Q!_P B'%_]>JG_ *0S\>Z***_M
M4_AX**** "BBB@ HHHH **** "BBB@ HHHH *_=G_@@]_P H^],_[&;4O_0U
MK\)J_=G_ ((/?\H^],_[&;4O_0UK\0\:?]VP7K/\HG[IX(_[WC?\,/SD?9=%
M%%?@1_0A^1?_  <D_P#)7?AS_P!BQ=?^E(K\SZ_3#_@Y)_Y*[\.?^Q8NO_2D
M5^9]?TWX1?\ )*2_Z^2_*)_+GC%_R5L?^O4?SD%%%%?J)^5!1110 4444 %%
M%% !1110 4444 %.A_UJ_P"\*;3H?]:O^\*PQ7^ZU/\ "_R.C"?[W3_Q+\S^
MBK_@F#_R8#\*_P#L5H__ $8]>\5X/_P3!_Y,!^%?_8K1_P#HQZ]XK^&C^\ K
MY _X+\?\H;/VA/\ LG\W_HZ*OK^OD#_@OQ_RAL_:$_[)_-_Z.BH _C"HHHH
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M7_)*2_Z^2_*)_+GC%_R5L?\ KU'\Y!1117ZB?E04444 %%%% !1110 4444
M%%%% !3H?]:O^\*;3H?]:O\ O"L,5_NM3_"_R.C"?[W3_P 2_,_HJ_X)@_\
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M_P#/NU']GWO_ #[M1_;^1?\ 053_ /!D?\P_U?S[_H$J_P#@N?\ D0U^[/\
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M'_,/]7\^_P"@2K_X+G_D0T5-_9][_P ^[4?V?>_\^[4?V_D7_053_P#!D?\
M,/\ 5_/O^@2K_P""Y_Y$-%3?V?>_\^[4?V?>_P#/NU']OY%_T%4__!D?\P_U
M?S[_ *!*O_@N?^1#14W]GWO_ #[M1_9][_S[M1_;^1?]!5/_ ,&1_P P_P!7
M\^_Z!*O_ (+G_D0T5-_9][_S[M1_9][_ ,^[4?V_D7_053_\&1_S#_5_/O\
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M_P"B0^%__!!;?_$5U%% '+_\*0^"W_1(?"__ ((+;_XBC_A2'P6_Z)#X7_\
M!!;?_$5U%% '+_\ "D/@M_T2'PO_ .""V_\ B*/^%(?!;_HD/A?_ ,$%M_\
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MH'_3[^UL8XY[GG/[QU 9^?4F@#\N?C;K_P ,?@/_ ,%V?V&/@QXJ^,&@M?\
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M/0]=MY?#]VMR-4T1[6UCU33G:'=D!?+=U/*1"X &7Y_6^B@#\BO^"P7A2/\
M9Z_X-UOB];_M$>)](TSXM_&*_P!/\6>+]-N-1C6XN]<O=<TV:2PMT8AITL;6
M.&S3:#B"P5CC!-5_^"B=QK/BW_@FY^Q'^WO\ Y5\?^$_V=?&O@GQ;\0M,\)3
MB^D73+>RMA=3A(6.9+? #KC=&LS.P"H]?K[10!^9_P#P6!\1_![_ (*E?#']
MGK]FW]CCXL^'_'FN^)?CEX>\61WGA34X[W^PO#]G%<O>:Q<&(G[-%&DBQ#S-
MC/+,L2@N2 WX1?&/X2'_ (.BOBOI(^)_A_[3+^S)I>F1P_VQ#N:^BU2*26U
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M8AXG\)0WEOI.KQPQB86MU'LGMF<J6,3%8Y-H(^>%#G (/YU?\&\D,,/[4O\
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M!^%]%U^)K47NGWVIJIL#<L%MA=/]RT,S$"(3,GFDX3=7PE_P34^%'AC]BO\
M:S_X*"_&O]GWPZ-,^!.@ZU8/X:\.6"[-/.OZ=H\EUKL=I&/EB2*YE%N0@"AE
M\H8$  VO^"$7P@L?VL/^"(E[XH^.WDZYKW[2E]XRU;XE:C>1AFU&YO=0O; L
MY(/"V]O"JCH@4!0 HH _22BOA+_@VR_:=\<_M5?\$?\ X8>+_B;K4^IZ]X=%
M]X:OM2NG+27,=C<O%;,S'EF%K]G5F))9E+$Y-?=M !1110 5Y;\>?VX/V./V
M6M8L_#_[2O[4?@+P#?:A"9K"U\8>*K73GN8P<%HQ.Z[P#C.,XR/6O4J^=?\
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M/^\0LC+U!YQUS74U!JFE:9KFG3Z/K6FP7EI<QF.YM;J%9(Y4(P596!# ^AH
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MPH _;ZBOQ!_XC>?V6?\ HQ[X@?\ A16/^%'_ !&\_LL_]&/?$#_PHK'_  H
M_;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_P#1CWQ _P#"BL?\* /V^HK\
M0?\ B-Y_99_Z,>^('_A16/\ A1_Q&\_LL_\ 1CWQ _\ "BL?\* /V^HK\0?^
M(WG]EG_HQ[X@?^%%8_X4?\1O/[+/_1CWQ _\**Q_PH _;ZBOQ!_XC>?V6?\
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MPH _;ZBOQ!_XC>?V6?\ HQ[X@?\ A16/^%'_ !&\_LL_]&/?$#_PHK'_  H
M_;ZBOQ!_XC>?V6?^C'OB!_X45C_A1_Q&\_LL_P#1CWQ _P#"BL?\* /V^HK\
M0?\ B-Y_99_Z,>^('_A16/\ A1_Q&\_LL_\ 1CWQ _\ "BL?\* /V^HK\0?^
M(WG]EG_HQ[X@?^%%8_X4?\1O/[+/_1CWQ _\**Q_PH _;ZOD#_@OQ_RAL_:$
M_P"R?S?^CHJ^ /\ B-Y_99_Z,>^('_A16/\ A7B?_!1S_@[2_9X_;<_8=^)7
K[)_A;]DCQIH>H>.O#;Z;::MJ&N6DD-J[.C;W5!N(^7H/6@#\+:*** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>jnj-20200628_g2.jpg
<TEXT>
begin 644 jnj-20200628_g2.jpg
M_]C_X  02D9)1@ ! @$ 8 !@  #_[@ .061O8F4 90     !_]L 0P " 0$!
M 0$" 0$! @(" @($ P(" @(%! 0#! 8%!@8&!08&!@<)" 8'"0<&!@@+" D*
M"@H*"@8("PP+"@P)"@H*_]L 0P$" @(" @(% P,%"@<&!PH*"@H*"@H*"@H*
M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*_\  $0@"
M2@*( P$B  (1 0,1 ?_$ !\   $% 0$! 0$!           ! @,$!08'" D*
M"__$ +40  (! P,"! ,%!00$   !?0$" P $$042(3%!!A-180<B<10R@9&A
M""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V-S@Y.D-$149'2$E*4U15
M5E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>H
MJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KAXN/DY>;GZ.GJ\?+S]/7V
M]_CY^O_$ !\!  ,! 0$! 0$! 0$        ! @,$!08'" D*"__$ +41  (!
M @0$ P0'!00$  $"=P ! @,1! 4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P
M%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E
M9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6V
MM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#
M 0 "$0,1 #\ _?RBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#FD:1X&T/Q%>:1X7\8V7C%KX^)VMI!%+<PV_V.(1VXD$T7F&4EI('V!XRLK
M'>?%;XR?"CX%>$9O'_QF^(FC^%M#M@QN=8UZ_2UMH0%9R7DD(50%5B22  #7
M,_L__MG?LC?M7W6J6/[,?[37@/X@S:)'$^L0^#?%5KJ+62REQ&TH@D8H&*.
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MQ\(;RY_9ZE^(WAGXQ"<:#KGASQ6(IHS$UJ6(M_LLGG(\=Y"\920ESO4JN%+
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MP;\-OV'OC+::K-\:_AO>-H.D_#ZW\(7-[?ZHT5Q)]CN+3$9CA*1.(Y9)I(A
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M2>3%+$HE*\+%)(Y#; *^H:C>TM);F.\DMHVFB5EBE9 60-C< >H!P,^N!Z4
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M^89_=NH+O3--OYX+F^TZ":2UD\RVDEA5FA?&-RDCY3@D9'K0!^$?_!;3XO\
MPW/_  <E?L3^(]3\6V6FP:5;>&9M=CU6X6WDT@3ZW<2QK>(Y!MGV.K%9-I 8
M$\<U8^!OQ.^'6H_\'J_Q/UBS\<Z2]I>^&5TBSN1J$>R>_A\,Z7!):HV[#2K+
M!-&4'S!HV&,@BOW;HH _FL_X*C_L^? OP'\2?$O_  5R_P""2_[4P^&_QG\.
M?&"[T/QW\$+?6$.LR:\VL26$DVF6Z_O+F.YF4SM:F.2"6*28J0(W@K^C#X/:
MIX_USX2>%M:^*^B0Z9XIO/#EC/XETZV;,=KJ#VZ-<1(>ZK*74>PK0E\%>#9]
M6M-?G\):8]]8;_L-Z]A&9K?>27\M]N4W$DG!&23FM.@#\1_^"['_  7G_8CA
M_:6M?^"=GQ*T_P 5^,OA?X7U%+OXV6G@!K<OXAU"WE5X/#KS2SQ".U251)=M
M&2[-&MN-F)B/:?#G[3-A_P '&W_!)/\ :-^&G[,OP(NO!7A6UT>#PS\.].UE
MX(I[S7+&&+4EA(A<PP6X8:;$B@_*"[$X(5?U/HH _FL^*<&L_&__ (-F?V>O
M^"</@*SDU3X\P_'^\\/W7PJB4+KEE=1:CKL[BXM#B2WCC@N+=I)9%5$$@+$
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M/%UWHFHPM'<V%O-#;VUM'*C &-V@M(YBA^9?/PP# J/T:HHH **** "BBB@
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M+>,[SP_J/AVXUE=0#&"*"1+J*X6*,2PS),LD;!1F-E) )*@ O?'W]LO]DO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MKB%>?E20C<HY/ /<^M 'X^_\%5?^">__  3&_:X\,?"K]B/Q7?+^S-X]\/\
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MTRSCT_3;.*WMX4"0P01A$11T 4< >PJ6@ HHHH **** "BBB@ HHHH ****
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M^'WAO0?BGX$O4DS>>';MH[>6[LV<JIDC>TN+FWEB90DG&]"!MH _0ZBO%?\
M@G1^U[I7[>W[#WPT_:ZTK3XK-O&WAF*ZU*QMV+1VFH1LT%Y A/)2.YBF12>2
M%!/->U4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!\
M(_\ !RW\'O%GQI_X(K_&C0_!5I-<7VC6&G:\]M ,^9:V&I6UU=$X[);QS2?]
MLQ6+^R%\4/ =E_P;-^%_'&M^)]-TW2K/]EN>QN+ZZN4AA2>'2I;1D+,<;S,A
M3'5G.,9.*_0#5=*TO7=+N=#UO3H+RRO;=X+RTNH1)%/$ZE71U8$,K*2"#P02
M*^=_V!/V*?$O_!/:RUO]F_X9:[9:I\$WU:]UGP#87UU*NJ>$7NI_.FT=1L9+
MNR\V2::*9G2:,N8W6;(E4 _&7_@D#\3?AQHW_!J=^UQX7UCQ[HUIJ<>I^*$?
M3KK4XHYPUUHNG16P\MF#?O9%9(^/G965<D$#R+7/B/\ #Y/^#//1O K>-])_
MMN3X[R0)I']H1_:3(+V:X*^5G=D0D2=/ND'H17]0]% 'SE_P1_\ $OAWQ5_P
M2F_9NO\ PSKMIJ$$'P-\*V<\UE<+*L=Q!I-M#/"Q4D!XY4>-E/*LC X(-?F3
M_P '&]W_ ,(S_P %L_V(OBGJUI<KX>\$:WI/B'Q=JT=NSP:/I5KXFLGN+VX<
M#$,$:\M(Y"KD9(S7[AU!-IFFW$\ES/IT#R2P>3+(\*EGBR3L)(Y7)/'3DT ?
MBK^VC\,I_P#@I)_P="? +Q!^R_K=KXF\*_ WP=H6M?$?QCH5TEUIVDR6NJ7^
MHQV<D\19/.F#VJ+&"6/V@G 5'9>1^"_Q:^%TG_!ZC\3?$4?Q&T-M/U#PO%I-
MC?KJD1AN+Z/POI4+VJ/NVM*LL,L90'=OC9<9&*_<_P ->$O"O@S3O['\'^&=
M/TFT,A<VNFV4<$>X]6VH ,G Y]JT* /P<_X(D_&?X0P_\')W[:GB>?XH^'X]
M,U>'Q)-I6I2:Q"MO>1PZY;R2O%(6VR*L:.Y*D@(C-]T$UQ__  ;5?&7X2:+J
M_P#P46UK7/B9H-A:ZK#!JFFSWVJPPK<V22>(]]PA=ANC7[1 "PX!FC!^\,_T
M)T4 ?S)?\$AO@+XT_;&_X-O/VO?V6O@;=QZEX^G\>6.O6'A6SN%:]OK>R&E7
M9180=[^:+.:./C#2@*,GBNE_:J\?>&OC]_P;%?LN_L5_!/48O$_Q<U#XI6^B
M+\-=)E676X;NUDUA9TELP?-B",\.2ZJ )XV) 8&OZ2*R[3P3X,L/$4_C"P\(
MZ7!J]TFRYU2&PC6YE7CAI0NYAP.">PH _GW_ .#E'PWIG[-?PF_X)U?LU>._
M'FFS^(OAEHD=AXG_ -/1I(DM+?0+9KN09RL;O;3%78 -Y;XSM;'7_M^_%7X8
M7G_!WK^SMXKL_B-H4NEVGA?18+K4H]7A:WAEEBU1HD:0-M5G6> J"<L)HR,[
MAG][:* /Y]O^"ZO[*?[(OQ7^-/QG_;Y_9-_:EM?@M^TK\"==27QEX2OO$0L9
MO%'D6UN]MJ>EL&25+J2&2)!Y(=9)4\M@CL99/NC]KGXP_'3Q#_P;!>*_BO\
MMA:<=/\ B!KW[/*KXIBO;06\K7UY$D$;RQ87R9I#+$S1X79(Y7:N-H_0[5/!
M7@W7+BWO-:\):9>2VEU]IM);JPCD:&;C]ZA925?@?,.>!7@G[>G[$_B#_@H-
M'H/[/7Q5UVRT_P""5OJMEK7CK2;&XE;4O&$UK-YT&DR#8J6M@)4AFED5Y)92
MBQJL 4R. >5_\&W?PC\6_!;_ ((K? WPMXUM);>^U#1;_7$@E4@I;:CJ=W?6
MQ /0-;W$3_\  S7W%4.G:=I^CZ?!I.DV$-K:6L*PVMK;1!(X8U 5455P%4
M #@ 5-0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MS?V7[LO_  &5F_E=>9Z71117S1].%%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ/\ L$@KG^!EY)!K]-Z\T_:W^"$/Q\^!VK>#;>W5]4@C^V:(Y RMU&"54$]
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M]]U\!_\ !NYJ/F_LB>+M*S_J/B/<2]/[]A9#_P!DK[\K^-/$#F_USQO-_/\
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M2LZCE/[W9??%)A1117P!^A!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% 'BW_!0[X%?\-&?L9^/?AC:V?G:A)HCWVCH!EC>6I%Q"J^A
M=HQ']'/K7\\%?U$5_/5_P4A_9PD_9;_;$\8?#:TLS#I%Q?'5?#I"X4V-R3)&
MJ^HC8O#GUA-?OO@IG*3Q.5S>]JD?PC/_ -M_$_GSQQR5M8;-8+:].3^^4/\
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M_$^,Q57&XNIB*GQ3DY/U;NS^XL'A:6!P=/#4OAA%17I%67Y!1117.=(4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M']GWQ@FM>&]95Q#.8FBE@E1MLD$T;8:.5&!!4^Q!*E6/YD_\%]?BEXG\'?\
M!4_]B_3O']V]O\--.\<:;K$[7,A2T:]36;5;F63/RL8;<0MS]U97' <YPO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5[6W5FEH?.CH\;%)%*D'D$8(I*^@M0T31]67;JFEV]P.WG0AB/S'%8U]\)_
MM[D_V/Y+'^*"9E_3./TKRJ?$6'?QP:]+/_(]6KPWB%_#FGZW7^9XM17JMQ\"
M?##Y-MJE]&?1F1@/_'1523X!6I/[KQ/(!Z-: _\ LPKKCGF7/>37R9R2R+,E
MM%/YH\UHKT;_ (4!_P!3;_Y(?_;*DC^ 5H/];XFD/^[:@?\ LQJGG66K[?X/
M_(E9)F;^Q^*_S/-:*]6MO@5X7CP;G4KZ0^BNBC_T$_SK3L?A/X%L2&_L?SF'
M\4\K-^F<?I6,\_P,=KOY?YFT.'L?+XK+Y_Y'BZ(\C!(T+,3@ #)-;6D_#KQG
MK!'V;0IHT/\ RTN!Y:X]?FQG\*]HL-%T?2AC3-*M[?C_ )8PJN?R%6:\^MQ'
M-Z4H6]=?RL>C1X;IK6K4OZ*WXN_Y'G6B_ <#;+XAUK/K#:+_ .S-_A79Z%X1
M\.^&T T?2HHFQ@RD;G/_  (\UI45XV(S#&8K2I/3MLCVL-EV#PFM."OWW?WL
M****XSM"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH I:[XBT?PS:+?ZW>>1$\@C5_+9LL03C"@GH#63_ ,+:^'W_ $,'_DI+
M_P#$5G?'7_D4;;_L))_Z+DKR>OHLMRC#8S"JI-M.[VM_D?-YGG&*P6+=*"35
MEO?_ #1[;9_$_P #:A>16%IKF^6>18XD^S2C<Q. ,E<#DUOUX+X._P"1NTK_
M +"4'_HQ:]ZKCS; 4<!4C&FV[KK_ ,,CMRC'UL?3E*HDK/I?]6PHHHKR3UPH
MHHH **^0/V5/V@?C%_P4:^(_Q7\>>"_C%JW@#X7?#KXD:AX$\*6?A?3]/>_\
M1WNG"-;[5+J>]MK@+;F=_+MX85C.V%WE9_,5$]2\(^.O'O[,'A[Q3>_M@?&T
M>([*^^(D&G_#._BT*,:EJ-E<6%DL%D;2PB'VB\^UK?D^5&-R*9-D<8VH >VT
M5X'XJ_X*9_L=>!/A%XX^-/CGXA:GI&E_#35(=-^(-A?>$M2&I>'[J94:%;JS
M%N9XXY5DC,<Y3R) ZLLA4YK0\-?\%#OV3?$FO>/_  X_Q!O](N?AIX9'B7Q1
M_P )-X7U'2U&AD38U6U:[@C%[9$V\ZBXM_,0F/@D,A8 ]LHKQ+QQ_P %"/V9
M_A;X4\3^-/BMJ?BOPS8>#8M+F\2-J_P]UE9+.'49I8;.;8EJS/$\D$BF1 R1
MLI60HP*C6\>_MM_LV_#+XB^+/A-XU\::E:>(/!/@,>,_$>GQ^$=4G\C0C,\/
MVV-XK9DN4$D<BLL+2.NQBR@*2 #U>BOG+1_^"KO[$^NZOX9T6P\<>)3+XV\'
MCQ)X'<_#K6S'XFM/*AF>+37%H5U"Z1+B$O:VYDF4N5*;D<+UOP[_ &[OV:/B
MI\';/XV^"_&&HW&FWWB:X\-PZ3+X;OH=8&MV\DL<^EMIKPBZ2ZC,,Q>(Q@HD
M3RMB-2X /8**^>-1_P""J/[$6B>"K;QWK_Q0U*PM9OB.O@&[M;KP?JBW6F^)
M"R+_ &;>0BV+VDI#JZF4*DB$/&SJ03ZE\(?B_P"#_P!IKX-V?Q2^%>J>(-.T
MO6TN8K*ZU3PY<:7J-K)#/);R%K/48%DB=98G $L6" &PRD$@':T5\ ?L!_MG
M_$;XJ_\ !-?Q9\5?CU^VU#)\1H]5\7VMCJ%Q'H%E<:<-+U6_M+3R[5;18F,D
M=M$S>;')N+DKM!&/2?\ @F]^V#XE\5_\$WO@I^T%^U'\4-6\5^-OBAX=@O4A
ML_#L+7=_>R0/.\%K::;;)^[2.)W)*'8JEG< 9H ^MJ*\-\._\%&_V2O&?@_P
M[XK\$^/[W6+CQ7XEU+P[H?AJQ\/7IUF75]/2634+&2P:)9[::V2"5I1,B! %
MR?G3=Y%^UM^VI<^./AU^S)\??V/OCIJ$7A/XA?M(^'_#.M"UTJ.)=7TZ6XNX
M;RSN([RW^T6TD<]HT;*IB=661'ST !]GT5\)?M?_ /!236_%W[-?[8N@_ "Z
M\;>!/&/[/_AC4SI?B=_!TH2>]MM$BU+S!)=VDELB-]HB14<K,Z RQ@*R/7N?
M[*'[=/P3^.VN:7\!-/\ %FL3>/;7X>V/B*[AUCPM?V$6KV3"*&:_L;BX@CAO
MX%N)%1I;=G0-(F#A@: />J*** "BBB@ HHHH **** ,'XH?$[P/\&/A_JOQ2
M^)6M_P!FZ#HEJ;G4[[[-+-Y,0(!;9$K.W)'"J37SW_P^?_X)J?\ 1R7_ )9V
ML_\ R'74_P#!4#_E'_\ %3_L5I/_ $8E?SX5^N^'G &3\6Y95Q.,J5(RA/E7
M(XI6Y4];QEKKW/QWQ'\0LZX0S2CAL'3IRC.',^=2;OS-:<LXZ:=C]YO^'S__
M  34_P"CDO\ RSM9_P#D.OIC0]:TSQ)HMGXBT6Y\ZSO[6.YM)MC+YD3J&5L,
M 1D$'! /K7\P-?TP? __ )(KX/\ ^Q6T_P#])HZY?$;@?*>$*.&G@YSDZCDG
MSN+^%1M;EC'OYG5X;<=YOQC7Q,,;"G%4U%KD4E\3E>_-*7;R.HHHHK\L/U@*
M*** "BOB_P".WC[]IG6/^"M7AK]E#P=^UUXH\&>!M>^ NL>+KBRT;P_X?F>V
MU*SU2RM$837VG3OY)CNF+(3G<BD,HR#\Z_"7_@J/^U%\2OA3^SO\9/B5\4AI
M^GW/[6&N_#CQ5JOA30HCIGQ#T6QT_5GM]3MX1%-<!I9K2)%BM92))4=55MR(
MH!^K5%>&>%?^"CW[)7B[X2WGQCT_QUJEK8:?X]C\$7FD:MX3U&SUB+Q')+%%
M%I1TV>!;H7,AG@94\OE)5<X3+"KKW_!3C]C7PE\(-6^./C#XD:AI.@>'?'J^
M"O$LFH>%-1271=>:2&(65Y'Y!:VRUS;XFDQ"5FC82%74D ]]HKYRTS_@JQ^Q
MMJOB'3/!<.N>.(=?UNVUB?1?#EY\)?$5OJ.H+I<RPWBV]M)8K+/(CR1_ND5I
M-KAMNT,0SP?_ ,%9?V'/'=IX&U7PU\1M<ET_X@^(5\/:-J\O@/6(K*SUIKA[
M9-*O[E[41:=?-<1M$+:Y:.4L4^7;(C, ?2%%>+:W_P %!/V6/#_Q)'PQU#QW
M>&Y7X@6W@6?5H- O)=,M_$UQ%'+!I,EXD1A2X=98A@MM#R)&S"1@AE^*G[?'
M[+GP7U^XT;XA^/KFTMM.\2V/A[7-?AT.[GTK1]5O3$+6SO+V.)H+>5S/!D.X
M\O[1"9/+$J%@#V2BO'OBK^WA^S+\%-=;2OB/XUO;&RMO$UIX>U;Q(F@7DVD:
M3JET8A;VMY?1Q-!;.[3PKF1PJ--&KLAD0-G^*O\ @H_^Q[X)^'7Q,^*_BCXD
M:K::'\'-:&D_$JY;P-K+2Z'=&"&XQ) MH99(_)GAD\Z-'CVR [^M 'N-%>#6
MO[>?@B?]MWQ7^QA+X"\7)>>$? EAXCO=:A\'ZC<V]R+J2\"QQ-! XVJEC( [
M8$LK>5%O=66L[]F;]K3X"VG[)WP_^(&F_M'^*?BC9>,M1O['P?XBU;PY)_;G
MBFXCN;MGC2QMK6%_W203 GR$"0V_F2$ ,] 'T517AN@_\%&_V2O%_A'PYXI\
M%>/[W69_%OB34_#V@>'=-\/7CZO<:MIRS/J%DUD8A-#);+!*9?-5%0!?F_>1
M[O(OVN?VT;KQO\//V8OC]^Q]\=M0B\)?$+]H_P />&M9%KI4<2:QILT]W#=V
MEQ'>6_VFVDCGM&C95,3JRR(X/0 'V?1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <7\=?^11MO\ L))_
MZ+DKR>M;_@H1\9?B3\#O@QIGBSX7>)/[+U"X\3PVDUQ]CAGW0M;7+E=LR,H^
M:-#D#/'7DU\=?\/#?VPO^BO_ /EOZ?\ _(]?K'!_"F=9ODRQ&%]GR<S7O2DG
MIY*G)?B?D7&7%N1Y/G;PV*]IS\L7[L(M6?FZD7^!]@^#O^1NTK_L)0?^C%KW
MJOSK^"7[=G[57B_XS^$?"?B+XI_:-/U3Q/86E];_ -AV*>;#)<QHZ[E@#+E6
M(R"",\$5^BE?/\<9)F.28JC#%\EY1;7))RZ];QC^I]%P)GN6Y[A*U3!\]HR2
M?/%1=[=+2E^@4445\.?=A1110!\._LA?"3X]_P#!,3XG?%CX/1?L^^)?B%\*
M/'_Q0U+QSX#\5^")K*:ZT674S&]UI&H6EQ<0RJL<R,T-Q$)49'_>-&P KH/V
MW/A/^U;\8M2^"/[4G@/X22S7OP?^,47B2Y^%_P#:]JNI:CHDVG7.G73>89_L
MAU");N2:.$3>644IYQ=\5[G\&/VR?V;_ -H'XL>.O@5\*OB(U[XQ^&EQ:P^.
M/#=]HM[87>EFY1GMV:.[AB,B2(I97CW(05.?F7+OBK^V)^SG\%?C;X)_9O\
MB'\0FM_'7Q&BO9?!OA>PT:\O[O4([2,27$FVUAD\J-$)8O*44A7P3L; !\.?
MMS?L)_M,_M'^!_VMOC9\*?@AK)USXT>"O!WA3P9X%N]4TVSO+P:3<R3SZE=-
M+=+!$#]H,4:O+YH6V8E1YBJ/3OVB?V?_ (X^/OVZ?B3\9[W]C?4?&O@+Q)^Q
M^W@MM&O_ !!I$$>N:H=3O+N71G!OUDB,L%P(A.0L*NQ_>@#=7W%7G_[37[3O
MPA_9#^%,_P :?CEJVH6'AZVU"TLIKS3]$NKXI/=7"6\"NMO&YC5II8T\Q]J
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MCO&ED&VQF!DB21 Q3YB"2/LFB@ HHHH **** "BBB@ HHHH \&_X*@?\H_\
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M?0+WQOHGP*7Q+XM\=^%[V#1'US5#JMQI<DUO%)I^H1HMK+:%IH51!YMR@;"
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
@* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>jnj-20200628_g3.jpg
<TEXT>
begin 644 jnj-20200628_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "O$OB+_P %(/V%_A7X_P!2^%/C']IW
MPLOB;18C)KF@:9>-?WFEH.INHK59&M?^VH6OF?\ X.9OV\/BI^P+_P $N]7\
M9?!'7;C1_%?COQ19^#M(UZS8K/I8N8+FXGGB8<I+]GLYT1Q@HTBNI#**B_X-
M@/V;_!/P+_X)#?#WQUI.CQ#Q)\33>>)O%VLL@-QJ$\MW,EOO<_,P2V2)0"2
M2[#!=L@'VY\$_C[\#_VD_ L/Q-_9]^+OAOQKX>GD,<>L^%]9AOK?S!C=&7B9
M@KC(RAPPSR!7&_M._P#!0']B?]B^^TS2OVJ?VG_!O@6]UE=^EZ?K^M1Q7-S&
M&VF58<E_+# @R;=@/!.:_%/]H#XXZS_P20_X.M++2/@/<'2? 'QWU3PY'X^\
M'61V6%P=69;26Z,0^42QW>^\5P-P:25 =DC*?O[_ (*L_P#!'7_@G?\ %/\
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M+_P]/)*]N$N(C;S(RK=1R6SLLGRR[ H=7##U;1?^"C/C;X@_L@_ O]J3X-?
M31?$UU\<-4TBRL/#,?CYX?[--_&\I)N/L#><;6&*>2Y41J8Q;3;?-V?, ?55
M<3\>?VE/V?/V6_!1^(O[1_QK\+^!M#\SRDU/Q3K<-E%+)C(CC,K#S'/9%RQ[
M"NUC,AC4RJJN5&Y5;(![X.!G\J_GM_X(U_&#4O\ @N!_P< >//VPOVDY/[>\
M+?"OPY?ZG\*/"NI'S;/1$-]!:Z?L@;*;TA>6=G R;D+)P0N #]HO W_!2O\
M8,^(FO6GA?P]^U-X2AU'483+I=EK=\=,DOT !+6ZW@B-Q@$$^7NP#D\5Z_X-
M\8>%_B%X0TKQ]X(UVVU31=<TV#4-(U.RD#PW=K-&LD4T;#[R.C*P/<$5Q?[6
M'[*7P-_;6^ WB#]G']H?P/::[X:\16+P3PW$*F2UE*D1W,#D$PSQL=Z2+RK
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M_P#LW?LAR_ 'PUX+U.VUCXC7NK^-IM:26!+>]FRK.BF&"V2&?;&H/^M;')Y
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MX=\22:+XB\-SZH+Y(IA%'-'-#<"./S(WCE'WD5E977! #L ?7U%%% !1110
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MXC_$_P 8PV5O:WEU/<)%(X2"YEEBL+&U:5;:S3A4B +;G=SZIXF_9]/["_\
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M%KUI+?M+-(EI<S1[[H+Y4A>8'SECD4^!_P#! KX/?M&?L"_\%<?'/[ 'P/\
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M==8E3SEA D\LD$A0WS8/F?\ P7S_ &5_VB-/_P""-?[(?[2.D^'_ !KK5_\
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M!;X3Z=X4UO2;;XA:3J_Q \$^*I_L@\4Z';2-)/IUMJ"PS/IMQ(=FVXC577!
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MVY_VY]<U/XE:%:V6I>)K?6+"\N=6ACBN-/BU/6GENT=F :%%FA9I =JB122
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M ZT+'_@XU^',DN-2_9=UN%,CYH/$L,A]^#"O\Z_*2BMI>%/ K6F%:_[B5/\
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M&X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445\D_MU_\%=_@-^R&
MUUX$\(^5XT\=191]$T^Z MM.?_I[G (5A_SR7+\8;8"&KT\IR?,\\QBPN!I.
MI-]%T7=O9+S;2/,S?.<KR+!O%8^JJ<%U?5]DMV_))L^I_$_BGPSX)T"[\5^,
M?$-EI6EV,)EO=1U&Z2&"!!U9W<A5'N37P;^U?_P7P^"OPX^T^%?V8?#+>-]7
M3*#6[]7MM*A;U4<2W&".@$:G.0YK\W/VI_VXOVD/VQ-?_M7XS>/)9K"*4O8>
M'=/!@TZR]-D()W, <;W+/C@L17D=?T#PQX-8#"QC7SF?M9_R1;4%ZO24OERK
MU/YWXI\:LPQ<I4,EA[*'\\DG-^BUC'Y\S]#UW]H[]NO]JC]JJ\E/QB^+FHW6
MG22;DT"QD^S:=$,Y %O'A6([,^Y_5C7D5%%?L^#P6#R^@J.&IQA!;**27W(_
M%,9CL9F%=U\54E4F]W)MO[V%%%%=)RA1110 4444 %%%% !1110 4444 %%%
M% 'L'[-G[>7[5'[*%]$WP@^*U_!IL;9D\.ZBYNM.E&<D&"0E4)[M'L?_ &J_
M2+]E+_@O=\#_ (EO:^%/VE_#,G@;5Y2L?]M69:YTJ5SQENLMN"<<,'4<EI *
M_'VBOCN(> ^&N)4Y8FCRU']N'NR^?27_ &\F?9\.<?<3<,-1PU9RIK[$_>C\
MEO'_ +=:/Z=/#WB+P_XMT2U\2^%=<L]3TZ]B$MG?Z?<K-#.AZ,CH2K ^H-7*
M_G>_97_;I_:4_8ZUL7_P;\>RQZ;),)+[PWJ(,^G7?KNA)&QC@#?&4?'&['%?
MKE^PQ_P5N_9__:_2T\%>(IX_!OCJ0!/[ U*Y'D7[^MI.<"0G_GDVV3K@. 6K
M^=N+/#'/.&XRQ%']]07VHKWHK^]'6WJKKO8_H_A'Q2R+B:4</6_<5W]F3]V3
M_NRTOZ.S[7/J^BBBOS4_3@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(\=^/?!?PP\(W
MWCWXA^*++1M&TR S7VI:A<".*%!ZD]R<  <DD  D@5B_'CX]?"W]FOX9:A\6
M_B_XFBTO1]/3EV^:6XE(.R"%.LDK$$!1[DX )'X:_M_?\%#_ (J_MS^/C/J<
ML^C^#=-G;_A'O"L4Y,<8Y GGQQ+.0?O=$!*K@%BWW?!/ F8<7XJZ]RA%^].W
M_DL>\OP2U?1/X+CCCW+N#<+9_O,1)>["_P#Y-+M'\9/1=6O=_P#@H7_P6M\>
M?&B>\^%'[*6H7WAGPE\T-YXC7,.I:LO0["/FM83Z#$C#[Q4$I7P(S,[%W8DD
MY))Y)I**_J_(N'\JX<P2PN IJ,>K^U)]Y/J_P6R26A_(^?<0YMQ+CGBL?4<I
M=%]F*[16R7XO=MO4****]H\0**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *6.1XG$L3E64@JRG!!]:2B@#]!/^">7_  6Q\9?"!K'X1_M9
MWM[XB\+*5ALO%/S3:CI:] )NK74(]?\ 6J,XWX5!^L_@?QUX-^)GA.Q\=_#[
MQ-9:SHVIP":PU+3KA989D/&0R^A!!'4$$'!!%?S*5]#_ + __!1CXO\ [#/C
M';H\DFM>#=0N ^N^%+F<B.3H#/ QSY,X 'S 88 !@<*5_&..?"K"9K&>.RB*
MIU]W#:,_3I&7_DK>]M6?MG ?BSB\IE# YQ)U*&RGO.'KUE%?^!);722/WYHK
MA/V<_P!I'X1_M4_#*T^+'P:\3+J&FW)V3Q. EQ93@ M!/'DF.1<C(Y!!#*64
M@GNZ_FC$8>OA*\J-:+C.+LTU9IKHT?T]A\3A\70C6H24H25TT[II]4PHHHK$
MV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQF9XR>*Q4W.I-W;>[_K9):):+0****ZSD"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /7OV,OVT?BY^Q/\4XOB#\-[
M\SV%PR1^(/#MQ*1;:K;@GY' SM=<L4D RA/=2RM^[W[+W[4/PG_:Y^$]E\7/
MA'K7GVD_[N^L9L+<Z=<@ O;S(#\KKD<\A@0RD@@U_.'7MG["G[;GQ'_8>^,,
M/C[PHSWVB7Q2#Q1X=>7;'J-L#V[)*F24?L20<JS*?S#Q#\/\/Q1AGB\(E'%1
M6CV4TOLR\_Y7TV>FWZEX<^(>(X5Q2PF+;EA)O5;NFW]J/E_-'KNM=_Z%**Y7
MX)_&CX=_M"_##2?B]\*]>34=$UFV$MM,!AXVZ/%(O\$B,"K*>A!KJJ_DZM1J
MX>K*E5BXRBVFGHTUHTUW1_75&M2Q%&-6E)2C))IK5-/5-/LPHHHK,T"BBB@
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M "^04445Q'HA1110 4444 %%%% !1110 4444 %! (P1D'J*** /PT_X*_\
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MMAB>&:6+M[U*HO\ P&:L_P 5'[CX5HHHK^HS^50HHHH **** "BBB@ HHHH
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MA!@'@N":4VM:LIS_ !Y5]ZBF%%%%?F9^GA1110 4444 %%%% !1110 4444
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MLY?XJ?"CP_\ %/1Q:ZBH@O[="+#443+Q<D[&_O1DDG;V))&,G/S!XS\%^(O
M.NR>'O$UB89T&Z-@<I-&20)$;^)3@\]B"#@@@?8]8OC_ .'_ (;^).@'0/$E
ML3L)>SNXP/-M9" "R'T. &4\, .A"LNM*K*B]-5V_P C*K2C66NC[_YGQ[17
M0_$CX9^)/ACK?]DZ] &BERUE>Q ^5<H.I4]B,C*GD9'8@GGJ]*,HSCS1>AYL
MX2A+EDM0HHHJB0HHHH **** "OT7_P"#>[]G5O$OQ6\4?M-:WIY:T\-6/]D:
M)*Z_*;VX&Z9E/]Z. !3[70K\[;"PO=4OH=,TVTDGN+F58K>"%"SR.QPJJ!R2
M20 />OZ'?V$_V:;']DS]ESPM\&U@C&I6UD+KQ#-'@^=J,WSSG(^\%8^6I_N1
MK7Y7XN9^LIX:>#@_WF(?+_VXK.;^>D?^WC]8\'^'GF_$ZQDU^[PZYO\ M]W4
M%\M9?]NGKU%%%?R>?UP%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >>?$30#I>K?VC G[F[);C^%^X_'K^?I7/5ZMXBT:+7M(ETZ3
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MF_O,>0J#ECZ $C]._@M\%O OP&\"VW@/P'IWE01?/<W,@!FNYB!NED;NQQ]
M     *_.>.^.Z/#%'ZOA'?%26G:"?67Z1?J]+7_2N > :W%-;ZQBU;"Q>O>;
M7V8_K);;+6]G?!+X+?#O]GGX7Z1\(/A9H2:?HNC6PBMHA@O(W5Y9&P-\CL2S
M-W)/TKJZ**_EVM6JXBM*K5DY2DVVWJVWNV^[/ZIHT:.&HQI4HJ,8I)):)):)
M)=D%%%%9FH4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!@_$3X<>%OBAX;E\,^*K$2Q-\T,R\20/CAT;L?T/0Y%
M?'7QD^!WB[X-ZQ]GU:$W&G3.19:G$G[N4==K?W'QU4^^,CFON.J>O^']%\4Z
M1/H/B'3(;RSN$VS6\ZY5A_0CJ".0>17TW#_$N*R.IROWJ3WCV\X]G^#_ !/F
M.(N&,)GM+F7NU5M+OY2[K\5^#_/.BO:?CG^R-KW@IIO$OP[CFU/21EY;0#=<
M6H^@_P!8H]1R.XXW5X=JVK:?H&EW&M:JY6WMH]SA3AG/0(O7YF) ''&<G@$U
M^TY;F.$S>BJF%ES7TMU3[-='_2/Q#,\MQF3UW2Q<>6VM^C7=/JOZ9S/Q@\9_
M\([H?]@V$N+W4HB'(SF*W.0Q^K\J.O ?@94UY#5SQ#KM_P")M:N-=U-P9KB3
M<P7.U0!A57).%4 *!V %4Z_3LNP4<#AE#[3U?K_P-C\MS+'2QV)<_LK1>G^;
MW_ ****[SSPHHHH **** "N;^,GC'6/AU\(?%7Q!\.Z+_:6H:%X;OM0L=.P3
M]JFAMWD2+"\G<RA>.>:Z2L[QCXITGP-X1U7QKK[NMAH^FSWUZT2;F$,4;2.0
M.YVJ>.]95_X$O>Y='KVTW^6YMA_X\/=YM5IWUV^>Q^>_['7Q?TK]N+QGX-M]
M9_:&\<V_C]_"'BJ7Q7-IOB.YLO[.N_MFE_8FMK:-A;>1Y+2XC\M@^QO-#,BD
M?;/PYU_QA\*?V>K/7_VG/%UO)JV@:5*WB;7"D:I/Y3,//"Q#&70*P51DE@,;
MN*^$_P#@HK^PAX3T7XHZ5\<?V.;]/"NM2^#-=\971TF]:&WF&G/I[>9:&/'D
M2/'>R/\ *=C&-0 NXL>QT3X]_MS?'+]GCX(_%GP]^SD/B)$+6\O_ !'9OJ,-
MA%=ZE:7;065U*&8;U"QM<! H3S2C_P#+-!7Y9DV9XS),7B,)C:<I5X134X<T
MX5(_NH\[BKR<HWC*6[]Z=C]7SO*\'GN$PV+P-2,,/.33A4<(3IR7M9<BD[14
M)6E&*T2Y87ZB?L^_M"?&[XN_\%@-7\._$I;W1=.TGP5,FD^$FN3ML8)(;:XC
M\] =IN2LP,G7:Q*!BJ*:^_*_*;]G/XG_ +1>J_\ !8_4?%OB7X"1Z?XGUB.W
MM/%7AP:JCC1K%H+..2Z$@.)-L2I)M')WX[5^D/A+]I+X%^._BQK7P,\(?$O3
MK_Q9X=C+ZQHL#-YEN RJW) 5RK,JL%)*$@-@U[' V:4ZV%Q/MJKYI8BHHN=X
MN79)-+5):Q2O':R/%X[RJK1Q6&="DN6.&I.2IVE&/=MQ;T;>DF[2O>[N?&7[
M:'Q/_:2\#_\ !2/X+?"?4_CO>W/A?7M?T>_?0M*LQI]NI.I&)HI CL]PA"*<
M2NPR3@"OT%K\[_\ @HVRC_@K%^SL"PS]IT?C/_48DK]$*Z^%Y5/[8S2$I-J-
M5)7;=ER)V5V]-=NAQ\51IK)LJG&*BY4FW9*-WSM7=DE?3?J%%%%?:GQ 4444
M %%%*JLS!54DDX  ZT )7J_[+W[)/C_]I?Q#C38VT[P_:RA=3UV:+*)W,<0X
M\R3'8<#(+$9&?4/V5O\ @F_XH^(?V;QQ\<8[G1=$;$EOHXREY>KU&_/,"'W^
M<C. O#5]V^%?"GAOP1X?M?"GA'1;?3].LHA':V=K&%2-?IW)/))Y)))R37Y'
MQIXFX7*XRP>524ZVSGO&'ITE+\%UOL?L/!'A?B\UG'&9M%TZ&ZAM*?KUC'\7
MTMN8WP@^#7@#X&^#8?!'P\T5;6UC^:>9OFFNI,8,LK]68_D!P   *ZFBBOYU
MQ&(KXJO*M6DY3D[MMW;?FS^D</AZ&$H1HT8J,(JR25DEV2"BBBL38**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ KQ#]I[]B/P3^T!I;7.B:J_A[5UE,PFMH@;:ZEQ@&:(8R>2 Z
MD$;F.&SBO;Z*]#+,TQ^3XN.)P=1PFNJ_5/1KR9Y^:95E^<X26&QE-3@^C_1K
M5/S3/R6^-O[-WQ=_9^U;^S_B)X8>*VD<K::K:YDM+G_<D X/?:VUO45PE?LS
MKN@:'XHTF?0?$FCVU_8W*%+BTO(%DCD7T96!!KY<^-__  2T^'WB<3:U\%->
M?P]>MEAI=\S36;GT5N9(OK\X[!17[QPYXMX#%15'-H^SG_/%-P?JM7'\5YH_
M .)?!_,,))ULGE[6'\DFE->CT4OP?2S/@FBNY^,/[-_QF^!5X8/B-X)N;6V+
M[8=3@'FVDOIME7*@G^ZV&]0*X:OUS"XO"XZ@JV'FIP>SBTU]Z/Q[%X/%8&NZ
M.)IN$UNI)IKY,****Z#G"BBB@ JIK^A:1XIT*]\,^(+%+JPU&TDM;VVDSMFA
MD4HZ''."I(_&K=%*48R335TQQE*,DT[-'S]/_P $X_@@^MZ-:PZYXH_X1+2=
M#U'2_P#A"Y_%6H2VKP74EF_DH[7&^.W'V3#6X)20,N0 F&]VT'0=$\+:):>&
M_#>DVUAI]A;);V5E9PB.*") %5$50 J@   =,5;HKBPF6Y?@)2EAZ48.5KV5
MMDDEY)):):+L=N+S/,,?",<35E-1O:[ONVV_-MO5O5]SSW1_V5_@-H'Q[U']
MI[2? GE>.=6MOL^H:Y_:ETWFQ^7''M\EI3"OR11C(0'Y<]22:O@']D#]G[X9
M?'3Q!^T?X,\#"T\6^)TD75=0-Y*Z-YCJ\K)&S%$9W168@9)!Z9.?3**%EF6J
M2DJ,+J3FO=6DWO+;XGU>[&\TS-Q<77G9Q4'[SU@MH;_"ND=EV/'_ (C?L'?L
MO?%KXDV/Q?\ B'X'U74O$NEM"=,U>3QGJR2V9BD,L?D[+I1%MD)<;0,,2>M>
MM6%C#IME'86[S,D2[5:XN'E<CW=R68^Y)-345I0P."PM2=2C2C&4]9-12<GW
M;2U^9GB,?CL73A3KU93C#2*E)M179)O3Y!11174<@45W?P>_9K^-'QUO%A^'
M?@FYN+;=B75+@>3:1>N96PI(_NKEO:OK[X'_ /!+;X=^%/)UKXTZZ_B.]7#'
M3;,M#9(?0GB27Z_(#T*FOE,^XUX>X=3CB:MZB^Q'WI?-;+_MYH^MX?X(XCXD
M:EA:-J;^W+W8_)[R_P"W4SY"^"'[-?Q=_:"U;[!\//#+R6L<@6ZU:ZS':6W^
M])CD_P"RH+>U?=W[-/[ ?PL^ \UOXJU]AXC\2Q ,E_=P@06C^L$1S@C^^Q+<
M9&W.*]OT/0M$\,Z3!H/AS2+:PL;6,);6EG L<<2^BJH  JW7X'Q1XDYUQ I4
M*'[FB_LI^])?WI?HK+H[G]!<*^&>2</.->O^^KK7FDO=B_[L?U=WU5@HHHK\
MZ/TD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CNK2UOK9[.]MHYH9
M5*R12H&5U/4$'@BO%OBM_P $_/V;/BAYMY!X2;P]?R9/VWP\X@&?>$@Q'GKA
M03ZU[;17H9?FN9Y35]I@ZTJ;_NMJ_JMG\SSLQRG+,WI>RQM&-2/]Y)V]'NO5
M6/@+XD?\$J/C!H,TES\-?%VE:_;#)C@NB;.Y/MAMT9^I<?05X;X^_9R^.OPO
MWOXY^%>LV,,?W[O[(9;<?]MH]T?_ (]7ZWT5^CY;XO<0X5*.+A"LN]N67WKW
M?_)3\TS/P<X<Q;<L)4G1?:_/'[I>]_Y,?BW17Z\>*O@1\%/'#/)XM^$_AZ_D
M?[T]QI$)E_[[V[A^=>;^*?\ @G+^REXD+26O@B[TF1^LFEZK,O/LLC.@_!:^
MUP?C)D=6RQ-"I!^7+)?G%_@?#XSP6SVE=X;$4YKSYHO\I+\3\SZ*^_M4_P""
M3GP.GR=(\?\ BJV)Z">:VE _*%3^M<[J/_!(C1)6SI'QUNH!G@7/A]93C_@,
MZ5[M+Q2X-J?%6E'UA/\ 1,\&MX4\:T_AH1EZ3A^K1\1T5]L_\.AM._Z+W/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML;N:Y>%YHB8=D<VS[)'(/-0*$1&#+F_\$WO@7\:/AGX8^'/[/?[0_P#P2?\
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M[9>L^$M6/Q'L_"S>&X=>M?&.JV\9TEI#*;-[2*Y6UEB,C&0J\39?#_> (I^
M/V%/V>_AU#IL.EV/B2^.A>#KGPIX;N-;\9ZE>W.BZ-<& SVEK<2SF:+S/LML
M&EWF8BWB'F80  'RU^SS^T_^T1\?_P!F']D^ZU[]HW69?%?Q*^#=SXB\7>'O
M!6CZ>GB/Q%>"VL=NH)-<1BRT^QMY+B1Y2XB$DLEM$F_<87Z_]CC_ (*2?%'5
M/V O@A\9/C9\!OBA\2_%OC;P2MYX@UGX8> TN[?[3%(87>9(Y(T@>0KOV( O
M+;0H %>IZ?\ \$M/V+=#L_AI8>%_ /B#2(OA)HMSHO@DZ5\0=:@EM])N/+\[
M39YEN_-O+-C#"?(G:1/W8 &TL#Z-^S+^S%\&OV/_ (0:?\"/@%X>N]*\+Z5)
M*^GZ=>:U=WYM_,<L422ZED=8QG"QA@B  * * /C+6-7^,Y_X+\>.KWX%^#_#
ME[K5U^QSH)B@\::U<Z?!:EO$.H%6<6]K</(58C=%\F0"-Z]:7X _LM^/_P#@
MG-\)/@=_P3K\ ?M1ZOJ=\^C>+=:\1Z'X"T&T@US7;R6\AN/M5J][OM=-TNSE
MO90YF=#*[6L8,C2/"_U]I_['OP TK]J&^_;,L?#&JK\1]2\-Q^'[W76\7:HT
M4NF1S&=+7[&UR;4(LK,X B!#,Q!Y.:_QM_8O^ '[07Q6\)?&WXBZ#JX\3^"[
M6\L]'U70O%6H:7))97?EFXLKG['/$+JVD:&)FAEWH3&.,%@P!\A?L4?MY_'[
M]K71OV7O@9\4_BC+X>USXF? C7/&OC#Q=H5C:V]WKM_IUY96"65LKQ/% 76Y
MGO)O*0,/LZ!/+0N#V7CWXE_MC_L_^/OV2?A3X_\ VL[7QAJ?B?XOZOX5^)>H
M:-X:L+6W\0VL6DZM>VIF01,]M<QBVM1+Y#Q(TBR?(%(4>AZM_P $>_V#-2^"
M_@KX%VGPVU[3-+^&^K7.H^ -6T?Q]K%KK'AZ:X!6=;34H[H74,3IA#"LGE;5
M0;1L7'H%]^PG^R]J-M\-[6X\ WZ+\)=9EU?P&UOXLU.%K'4)4F2:[E:.Y4WL
MTJW%QYDER96D,\K.69V) /EG]G/PE\2M-_X*$?MUZSI/[1WB^"YTAO"KVK&P
MT>12[^%5EA9E:P/^H+8C"[0P4>:)6+,:W[&7[;/QS_:<T']E#X"?$;XPZAHV
ML?%+]FN\^(?C#QEIUK9P7VNZA;OIENMC;[H3#!G[=<74GE1A@+>,*44OGZX\
M/?L6_L\^%?B%\1?BIH/AS7(->^*\=O'X^OO^$XU=AJ0@MC:P[8VNBEL4@/EJ
M8%C( '/ QPOC/_@D_P#L/>-/@Q\//@5)\-];TO2?A*3_ ,*SU/0O'>KVFL>&
MD:/RGBM=3CNA>)&\8"-&92C*J9'R(5 /3/V6M#^,?A7X):5X0_:"^-6E_$/Q
MCI$]U::UXNTG28[%+XI<R>29+>(E(IU@,*RA JF17*JH(46?VE?C&_P"^!OB
M/XJV/AZ36=2TZR$7A_089 DFL:K/(MO86",Q #W%W+! I) #2@D@<UYWXK_8
M,^'4_P 0O@KXD^'*ZAX=M/@YJ&H7.FR67B[4E>:.[0"YAG@\PQZ@]S)\\US=
MM+)S,1NDG:5/2_B[\ _AG\<Y_#L_Q(LM6N#X4U^'6M$33?$^H:<D=]%_JI9%
MM)XEN I.0DP= >=N>: /SL_9/3Q-_P $^_\ @I_X6T;Q7\*O&?ACPI^T]X-C
MTGQ=K?B]-/2/5?B7IJ3W9U(?8[RX6)]0MI+H,AV%I8HP-V,+Z]=^ O&>K_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
+ "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>jnj-20200628_g4.jpg
<TEXT>
begin 644 jnj-20200628_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!&944N[
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M5FC!WPE@"5WJ-P!(R*9\<_VUOV3_ -F?7K?PM\>/C[X:\,ZG<:9)J8TW4=0
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M%^'Y\%>(_$6IVOB'Q7HOA^[F-OI-CI^HQL^J;79C"C6\=VKJ"$D^S[0NYVW
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ME8HWD/R\(I;H,UZ?7X8_$L ?\'O?P]P.O@^?/_A%:G7W=\0_^"PNL>(_CO\
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M]L2R^&]QX5T#Q9K.H+X2TF_E#W8T^UN&M!+<%24\QYH)WPGRA&09;!=O$/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MT5.?K%K_ -)DC^E+X=_M*_L\?%SRU^&'QS\):_))]V#2?$-O/+GT,:N6!]B
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !117R-^W=_P5[^ G[(#77@/PCY7C7QU%E'T33[L"VTY_\
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M6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK_A2XG(23H#/ QSY,X ^]]UP &!PI7\;XX\+<+FL9XW*4H5MW#:,_3I&3_\
M 6][:L_:>!?%;%Y5*&!S>3J4-E/>4/7K**_\"2VNK(_?^BN&_9W_ &COA%^U
M+\,K/XL?!GQ3'J6F70VS1G"SV4P +03QYS'(N1D'@@A@2I!/<U_-N(P]?"UY
M4:T7&<79IJS371H_IG#XBABZ$:U&2E"2NFG=-/JF%%%%8FP4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5YO\
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M4 %%%% !1110 4444 %%%% !5SP]X>UOQ7K5OX>\.Z;+=WMT^V""(<L<9)]
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M ^,.C_'?X3Z1\2=(V(UY!MO[96S]FN5XEC]>&R1GJI4]Z[*OST_X)H_M!_\
M"M_B@_PF\0WNS2/%4BK:EV^6"_ Q&?;S!^[/JWE^E?H77\A<:\.RX:SVIAXK
M]W+WH/\ NOIZQ=T_2_4_L?@CB2/$^04\3)_O8^[-?WEU])*TEZVZ!1117R1]
M>%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLOFM&^K3/Y(\2>'%P_Q')THVI5O?CV7\T?D]4NB:"BBBOOC\^"BBB@ HHHH
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MHPE9]I-6C^+1]'PAET<VXGPF%FKQE4C==XIWE^"9^RO3I1117\2']RA1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^7N\NIKZ[EOKEMTDTC/(?5
MB<FHZLZQ''%J]U%$@55N7"J!@ !CQ5:O[[C9Q5C_ #XE=2=PHHHIB"BBB@ H
MHHH **** "OT^_X-M[4OJ/QBO<C$<.@)C'/S'43_ .RU^8-?J#_P;<ZKI\=S
M\7]$; NI4T.=?]N-#?J?R+C_ +ZKX'Q0O_J-B[?W/_3D#]!\+.7_ %\P=_\
MIY_Z:F?J/1117\@G]CA1110 4444 %%%% !1110 4444 %%%% !1110 5\/_
M /!772?*\2>"-="?\?%C?0%O^N;PMC_R*:^X*^'_ /@KKJOF^)/ ^AA_^/>Q
MOIRO_71X5S_Y#K[_ ,,.?_73#\O:=_3DE^MC\]\4^3_4C$\V]X6]?:1_2Y\=
MT445_5I_)(5RGQ-^.?P:^"]O!<_%GXHZ%X=6ZD1+8:OJ<<#2EY%C!56()4,P
MW,!A1EF( )'5U^5/QV^/'Q#_ &5?VPOB5X4_:0\%3S:7X^^(6@:SHGC"2-G>
MVT?3M;M[R*.(A3YL*VT9C,2<K*@X.37S/$_$"X>PL*KCI)M<S3<8OE;CS6_F
M:45JDKW;TU^HX6X=_P!8L7.DI:P2ERII2DN9*7+?^6+<GHV[62UNOU(\-^*/
M#/C+1XO$/A#Q%8ZKI\XS!?:;=I/#(/\ 9="5/X&L_P"(/Q1^'GPJT^RU3XC>
M+['1X-1U.'3["2]FV_:+J4D1PH.K,V#P.P)Z"O/O@#X=_9V\$Z9XO_:+^#/C
M#1E\'^-&CUN^GT]D2QMI(862XGR"!'N"AI%(4JZN6Y) ^'_^"E'B;XC>._VA
M/@'\1_%5Q>:?HFO^*VD\+^&+A"C6EE%=V CNIT/*W,_F-(RG_5Q^5&0'60G#
M.N(ZV49*L5R*51M62=XV<U%3O_*[II;ZVZ-KHR3AFCG&>/"<\H4TG=R5I<R@
MYN%OYE9IO:ROU2?Z?UQWQ=_:%^!_P$LK:_\ C+\4]%\.)>,19IJE\L<D^,9V
M)]YP,C) (&1G&:[&OF/]OWP!^Q/X+^%/B_XL?M-^&-.U+5-;TR6VTN_U*'S[
M\3)"1!;6+ ;K8!L'Y-J[G9Y"=S$^SG.+Q."RZ=>@X)Q3=ZC:BDN]M?+IOOT?
MB9+A,+CLRIT*ZFU)I6II.3;?2^GGUVM;JOHCP9XV\'_$7PS:>,_ 7B>PUG2;
MZ/?9ZEIETLT,RY(.UT)!P001V((/(K4KX\_X(A:%X=T+]C#.B?$FUUZ>_P#$
MMS>ZC96K/_Q)I6BA3[(RN 0VV,2$@;29#M+#YF^PZ61YA4S;)Z&,G%1=2*DT
MG=*_9_U;9ZCS[+J>49S7P5.3DJ<G%-JS=NZ_J^ZT+OARZ^P^(;"]'_+&]B?@
M9Z.#7[+U^-'ARU^W>(;"RQ_KKV).N.K@5^R]?C?C5;VN![VJ?^V'[5X(<WLL
M?VO3_P#;PHHHK\,/W@**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /
MYG?C3X=_X1#XQ^+?"?EA?[+\37]IM'0>7<.F/_':YFO9/^"AOA:7P=^W-\6-
M&F@\O?X[U&[1,8PEQ.UPN/;;*,>U>-U_=^65_K66T:W\T(O[TF?P+F=#ZKF5
M>C_+.2^Z304445VG"%%%% !1110 4444 %?>_P#P;T>,QHO[7GB7P=<3A(];
M\"3M$A/WYX+JW91_W[:8_A7P17L/[ 7QM_X9Y_;&^'_Q3N+SR+*T\016VK2%
ML*ME<@V\['L=L<K-SW45\]Q9E\\UX:Q>%@KRE"5O5:K\4CZ/A#,893Q/A,5-
MVC&<;^C=F_N;/Z)Z***_B0_N4**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OST_X*I^)+;5OVA=/T*UGW?V5X:@CN%_N2R2RR8_[X:,_C7Z%U^2'[1GQ
M!/Q4^.?BGQXD_FPWVL2_8WSG-NA\N'_R&B5^L^#^7RQ'$-3%?9I0?WR=E^"D
M?D/C)F,<-P[3PB^*K-?=!7?XN)Q5%%%?TF?S*%?'7[77QJ_9S_:0^#7BOX)?
M%2^T2TUWPW\5-)TG4-)U.Y2"[BLCXAM(6O;=I"'5'LI&W2Q\*&D!('7[%K!\
M>?"_X??$^PATWQ]X2L]3B@O+:ZA^T1_,DMO.EQ$0PPP EC1BN<-C# @D'R<Y
MP.)S'!3H4I1M*,HM25T^96772SUO9]=.J]?)<?ALNQT*]6,FXRC).+LTXN[W
M6MUI:ZZ:]'^>?[$W[&GQ8\:_!GXT_"CX4?%Z[T?P-J'C^Q;X?^*+VQ-Q#J<5
ME<RM+<)%E4FCE1+52X!CD,>.0I%>:?\ !1+X#?M3_#;XQ_!_1/C+^U?+XUU+
M6M9EC\.:F^B+;G1I1<6:F0*&/F99XVP<?ZKWK]=%544(B@*!@ #@"EKY/$^'
MF7U\FC@HU91DK+F3GRV51U+>S4U%I7:C>[BK.[:/KL-XC9C0SJ6-G1C*+N^5
MQAS7=-4[^T<')-\J<K64G=629\U_%;]M]?V4?BM\)OV5_B!X3UGQ=KOBW3["
MTU'Q7:!8D:=I%M3.(L'S&:56D= 5V*ZD%L@5J6/[>G[&_P 5O'?C7]FWXC^(
M+31;S0;RXTS6-+\?00V=KJ:(2DC0M*Y26,XR VUROS!=O->]7&G:?=W,-[=6
M,,LUL2;>62(,T1(P2I/*Y'!Q5:[\+>&-0U--:O\ PY83WD6/*NYK-&E3'3#$
M9&/K7TKP.<PJRY,1%TW)6C*G>T.6SCS*2;=]>9W[,^96/R65*//AI*HHN\XU
M+7GS74N5Q:2MIRJW='R?_P $FOV:-0^!=I\4O&-E9W5IX6\5^,W'@:WOE=99
MM(M9+A;>Z*O\P65)1M+ %E0-C#*3]?T45U9/E=#)<MIX.C\,;_BW)Z=%=NRZ
M+0Y,YS7$9WF=3&UOBG;[DE%:]79*[ZO4Z#X3V;:A\4_#5@JEC/X@LXPH&2=T
MZ#^M?L)7Y3?L<>'_ /A)OVHO!&F[-WEZ[%=8Q_SP!G_]IU^K-?AOC/74LTPM
M'K&$G_X%*W_MI^\>"="4<JQ=;I*<5_X#&_\ [<%%%%?C!^V!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!^'W_!=?X?\ _"&?M_ZIKZ0;$\4^&]-U
M1<# 8K&;0D?C:G/O]:^.*_43_@XV^$TI_P"%;_'2SM\H/M>@ZC+CH>+BW7/O
MBZ/X5^7=?V3X>XY9AP=@YWNXQY'_ -N-Q_)(_BSQ%P#R_C3&4[64I<Z_[?2E
M^;84445]F?%!1110 4444 %%%% !1110!_0/_P $Q_VIH?VM/V0_#GCG4+T2
MZ_I$0T;Q0I;+?;;=5'FG_KK&8YO0&0CM7T#7X>?\$9?VV-._95_:)D\"?$#5
M/L_@_P >B&QO[B63$=A?*Q%M<MGA4R[QN> !(&)Q'BOW#K^._$'AN7#G$52$
M(VHU+SAVL]X_]NO2W:SZG]F^'?$T>)>&Z<YRO6IVA4[W6TO^WEK?O== HHHK
MX<^["BBB@ HHHH **** "BBB@ HHHH ***"0!DG '4T >1_MM?'!/@;\!=3U
M:QN535]64Z=HRYY$LBD-(/\ <3<V>FX*#UK\MZ]W_P""@?[05I\;_C.=*\,Z
MB+C0/#4;6>GRQME)YB09YAZ@L @(X*Q@CK7A%?U;X<<//(>'HRJQM5K>_+NE
M]F/R6K71MG\D^)7$:X@XCE&E*]*C[D>S?VI?-Z)]4DPHHHK[\_/0HHHH ***
M* "BBB@ HHHH ^AO^"8WAF37/VH;?5UA)71M%N[IGQPI91 /Q_?']:_1ZOCC
M_@DAX)\G0_%_Q'GAS]HNK?3;9\=/+4RR#\?,B_*OL>OY7\4L<L9Q?4@MJ<8P
M_#F?XR:/ZP\*< \%P=2F]ZLI3_'E7WJ*84445^=GZ0%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% 'R]_P6,^#[_%_]@'QDEE9F:]\,B#7[(!<[/LS
MYG;\+9[BOP8K^GW7]"TGQ1H5[X:UZR2YL=1M)+6]MI!\LL4BE'0^Q4D?C7\V
MO[1/P>U?]G[XZ>+/@MK>\S^&]=N+)97&#-$KGRI?H\91Q[,*_HKP4S:-3 XG
M+9/6$E->DE9_<TO_  (_F_QPRAT\?ALSBM)Q=.7K%WC]Z;_\!.,HHHK]R/P<
M**** "BBB@ HHHH **** "OV:_X(S?\ !1K2OC_\.++]FCXM>(@OCSPU9^5I
M5Q=R?-KFGQCY6#'[T\2C:Z_>9%$GS?O"OXRUH>$_%GB;P'XFL/&?@S7;K3-6
MTNZ2YT[4+*4QRV\R'*NK#D$$5\MQ?PMA.+,J>%JOEFM82_EE_D]FOU2/J^#N
M*\9PCFZQ5)<T'I./\T?T:W3^6S9_3Q17R!_P31_X*I?#[]L7PW9?#;XE:E::
M+\3;2WV7-A(1'#K6P<W%KVW$#<\/WEY*@J,CZ_K^/\WRC,,CQTL)C(.,X_<U
MT:?5/HS^R<GSG+L^P$,9@IJ<)?>GU371KJF%%%%>8>H%%%% !1110 4444 %
M%%% !7RO_P %&OVLO^%=^'I/@=X!U3;KNK6__$YN87^:QM&'W 1TDD'XA"3Q
MN4U[[\1?B3;>$X#INFLLNH2+P.HA']YO?T'XGCK\G?M'?LZV'QG$WBW2YDM_
M$H&YKJ0_)>X_AE]^P?MT.1C'WO N7Y<LXI8K,U^Z3NNSET<O[JW\W;I<_/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@&OO."^/,QX2K\CO4P\G[T+[?WH]GY;/KT:^ XWX RWB_#^T5J>(BO=G;?\
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M&*>%C'Z_*=.SC**LUZ[/S_R%BY2^H1A4NIQD[I]=-UY?YGT+1117K'D!110
M2< 4 %;G@OP+JWC*\V6ZF*U1OW]TR\+[#U;V_.MOP+\(;[5V34_$J/;6O58.
MDDOU_NC]?YUZA965IIUJEE86R10QKA(XUP *\#,LZA03IT-9=^B_S9]#EF25
M*[52OI'MU?\ DOZ\ROH'A_2_#6G)IFDVX2->68\LY_O,>YJ[117R$YRG)RD[
MMGV,(1IQ48JR04445)04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M,-K&%WW>O_ $5510B*  ,  < 4M%%><>D%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@GP&/&?B/3X_".J3^1H1F>'[;&\5LR7*"2.166%I'78Q90%) !ZO17SEH_\
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M>T;5Y? >L165GK37#VR:5?W+VHBTZ^:XC:(6URT<I8I\NV1&8 ^D**\6UO\
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MX,9W(1U(#?IEXS\7:)X!\):EXW\2-=+I^DV4EW>M8Z=/=S"*-2S%(8$>64@
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M=OI<JOH&GV$MI-Y]TL\5RD]G(JKY)C<.C&2-"S+^GM% 'R?X5\'_ +0OAO\
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M'B'6=0^W122WJ&:/R=0@55.)V99"8E&UG_4BB@ HHHH **** "BBB@ HHHH
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M]?X7<.9SPY@,13S&ER2G)->]&5TE;[+?XA1117YB?J(4444 ?E5\>"W[%O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
-10 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>jnj-20200628_g5.jpg
<TEXT>
begin 644 jnj-20200628_g5.jpg
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M$/Q>^(%S\1?!6I>"S9RW6BZS>QHFH:3=P7%Q"R(6AA-O."T012)7C8<^D?\
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MB#.JJ[[2:XKX'_!']JS0_P#@NE\5/VOO%'[*/B;3/AKXQ^$^D>%M'\3S^(=
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M^S+IEGJ_Q^^,6@>$X=1E:/3QK%^L;W3+C=Y:?><+E=Q (7<,XR*Z7P%X_P#
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MBBOZ0/YG"BBB@ HHHH **** "BBB@ HHHH **** "MSX8_\ )2?#W_8<M/\
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M44 %%%% !1110 4444 %%%% !7*_'+_DCGB?_L!W/_HLUU5<K\<O^2.>)_\
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ML<__ & Y_P#T9%7UM7XMQW_R/G_AC^I^W< _\B#_ +?E^@4445\8?;!1110
M4444 %%%% !1110 4444 %%%% !7*_'+_DCGB?\ [ =S_P"BS755ROQR_P"2
M.>)_^P'<_P#HLUV9=_R,*/\ BC^:./,?^1?6_P ,OR9\(T445_2!_,X4444
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M?^HK_P D_P#MSPVBO<O^'0_[,W_0_P#Q3_\ #CWO^-'_  Z'_9F_Z'_XI_\
MAQ[W_&C_ (B/_P!0O_D__P!H'_$-?^HK_P D_P#MSPVBO<O^'0_[,W_0_P#Q
M3_\ #CWO^-'_  Z'_9F_Z'_XI_\ AQ[W_&C_ (B/_P!0O_D__P!H'_$-?^HK
M_P D_P#MSPVBO<O^'0_[,W_0_P#Q3_\ #CWO^-'_  Z'_9F_Z'_XI_\ AQ[W
M_&C_ (B/_P!0O_D__P!H'_$-?^HK_P D_P#MSPVBO<O^'0_[,W_0_P#Q3_\
M#CWO^-'_  Z'_9F_Z'_XI_\ AQ[W_&C_ (B/_P!0O_D__P!H'_$-?^HK_P D
M_P#MSPVBO<O^'0_[,W_0_P#Q3_\ #CWO^-'_  Z'_9F_Z'_XI_\ AQ[W_&C_
M (B/_P!0O_D__P!H'_$-?^HK_P D_P#MSPVBO<O^'0_[,W_0_P#Q3_\ #CWO
M^-'_  Z'_9F_Z'_XI_\ AQ[W_&C_ (B/_P!0O_D__P!H'_$-?^HK_P D_P#M
MSPVMSX8_\E)\/?\ 8<M/_1R5ZM_PZ'_9F_Z'_P"*?_AQ[W_&C_AT/^S-_P!#
M_P#%/_PX][_C6=7Q#]K2E#ZMNFOC[_\ ;AI1\.?95HS^M7LT_@[?]OGU-17R
MS_PZ'_9F_P"A_P#BG_X<>]_QH_X=#_LS?]#_ /%/_P ./>_XU^:GZ<?4U%?+
M/_#H?]F;_H?_ (I_^''O?\:/^'0_[,W_ $/_ ,4__#CWO^- 'U-17RS_ ,.A
M_P!F;_H?_BG_ .''O?\ &C_AT/\ LS?]#_\ %/\ \./>_P"- 'U-17RS_P .
MA_V9O^A_^*?_ (<>]_QH_P"'0_[,W_0__%/_ ,./>_XT ?4U%?+/_#H?]F;_
M *'_ .*?_AQ[W_&C_AT/^S-_T/\ \4__  X][_C0!VW[=W_)-M(_[#B_^B9:
M^5Z]R_X=#_LS?]#_ /%/_P ./>_XT?\ #H?]F;_H?_BG_P"''O?\:^WR/C'^
MQ<O6%]ASV;=^:V_ERO\ ,^%SW@O^V\Q>*]OR725N6^R[\R_(\-HKW+_AT/\
MLS?]#_\ %/\ \./>_P"-'_#H?]F;_H?_ (I_^''O?\:]?_B(_P#U"_\ D_\
M]H>/_P 0U_ZBO_)/_MSPVBO<O^'0_P"S-_T/_P 4_P#PX][_ (T?\.A_V9O^
MA_\ BG_X<>]_QH_XB/\ ]0O_ )/_ /:!_P 0U_ZBO_)/_MSPVBO<O^'0_P"S
M-_T/_P 4_P#PX][_ (T?\.A_V9O^A_\ BG_X<>]_QH_XB/\ ]0O_ )/_ /:!
M_P 0U_ZBO_)/_MSPVBO<O^'0_P"S-_T/_P 4_P#PX][_ (T?\.A_V9O^A_\
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M (=#_LS?]#_\4_\ PX][_C7Q6?9O_;>/^L\G)HE:]]O.R_(^WR#)_P"P\O\
MJW/SZMWM;?RN_P SZFHKY9_X=#_LS?\ 0_\ Q3_\./>_XT?\.A_V9O\ H?\
MXI_^''O?\:\8]L^IJ*^6?^'0_P"S-_T/_P 4_P#PX][_ (T?\.A_V9O^A_\
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M!^#_  C?^,(_$ND>/9[70+.[L[9[M],MM-0+%!IV(VA0<R8(>1I275\[X,>
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MX_X*)^ /"^FZWX^UOP1XT^'OBF#Q+\-_B%X9$9OO#^J0D%9%20%)HV*IOB;
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
..**** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>jnj-20200628_g6.jpg
<TEXT>
begin 644 jnj-20200628_g6.jpg
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M .#_ ,?M.GUWX,>-H/$FE0;=FN:7!+)IUT&S@V]WL\BZ'RG)A=P,C.,C/8T
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MV@O^"-/PC\7?%75+G4-5TN#4="CU.[D+R75I8W]Q;6Q)/)*01QQ9/)\K)ZT
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M)1BKMDRE&$7*3LD6J*\Y_P"&L_V?O^A__P#*5=__ !JC_AK/]G[_ *'_ /\
M*5=__&J]+^Q,Z_Z!JG_@$O\ (\S^W,D_Z"J?_@<?\ST:BO.?^&L_V?O^A_\
M_*5=_P#QJC_AK/\ 9^_Z'_\ \I5W_P#&J/[$SK_H&J?^ 2_R#^W,D_Z"J?\
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M_P!#_P#^4J[_ /C5?%M%'_$/LE_Y^5/OC_\ (!_Q$7._^?=/[I?_ "9]I?\
M#6?[/W_0_P#_ )2KO_XU1_PUG^S]_P!#_P#^4J[_ /C5?%M%'_$/LE_Y^5/O
MC_\ (!_Q$7._^?=/[I?_ "9]I?\ #6?[/W_0_P#_ )2KO_XU1_PUG^S]_P!#
M_P#^4J[_ /C5?%M%'_$/LE_Y^5/OC_\ (!_Q$7._^?=/[I?_ "9]I?\ #6?[
M/W_0_P#_ )2KO_XU1_PUG^S]_P!#_P#^4J[_ /C5?%M%'_$/LE_Y^5/OC_\
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MK*2"/<5+36Y2:>Q-1112&>'_ +=W_)-M(_[#B_\ HF6OE>OJC]N[_DFVD?\
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M_;\OT"BBBOC#[8**** "BBB@ HHHH **** "BBB@ HHHH *Y7XY?\D<\3_\
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M6_@7Q%K4A>[U3P['*$LKJ1F^9A)MD=&8G,31$$KMKV[XS?!CX>_'_P"'M_\
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M **** "BBB@ HHHH **** "BBB@ KE?CE_R1SQ/_ -@.Y_\ 19KJJY7XY?\
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M%1144:%'#QY:<4EY?=^22]$D76KUL1+FJ2;?G]_YMOU;>X4445J9'L7[#_\
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M]ART_P#1R5ABO]UJ?X7^1T8/_>Z?^)?F??E%%%?S4?TX%%%% !1110 4444
M%%%% 'A_[=W_ "3;2/\ L.+_ .B9:^5Z^J/V[O\ DFVD?]AQ?_1,M?*]?MO
M_P#R3\/\4OS/PSCO_DHI_P"&/Y!1117UY\<%%%% !1110 4444 %%%% !111
M0 4444 >Q?L/_P#)8Y_^P'/_ .C(J^MJ^2?V'_\ DL<__8#G_P#1D5?6U?BW
M'?\ R/G_ (8_J?MW /\ R(/^WY?H%%%%?&'VP4444 %%%% !1110 4444 %%
M%% !1110 5ROQR_Y(YXG_P"P'<_^BS755ROQR_Y(YXG_ .P'<_\ HLUV9=_R
M,*/^*/YHX\Q_Y%];_#+\F?"-%%%?T@?S.%%%% !1110 4444 %%%% !1110
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MV'%_]$RU\KU^V\#_ /)/P_Q2_,_#.._^2BG_ (8_D%%%%?7GQP4444 %%%%
M!1110 4444 %%%% !1110![%^P__ ,ECG_[ <_\ Z,BKZVKY)_8?_P"2QS_]
M@.?_ -&15];5^+<=_P#(^?\ AC^I^W< _P#(@_[?E^@4445\8?;!1110 444
M4 %%%% !1110 4444 %%%% !7*_'+_DCGB?_ + =S_Z+-=57*_'+_DCGB?\
M[ =S_P"BS79EW_(PH_XH_FCCS'_D7UO\,OR9\(T445_2!_,X4444 %%%% !1
M110 4444 %%%% !1110 5N?#'_DI/A[_ +#EI_Z.2L.MSX8_\E)\/?\ 8<M/
M_1R5ABO]UJ?X7^1T8/\ WNG_ (E^9]^4445_-1_3@4444 %%%% !1110 444
M4 >'_MW?\DVTC_L.+_Z)EKY7KZH_;N_Y)MI'_8<7_P!$RU\KU^V\#_\ )/P_
MQ2_,_#.._P#DHI_X8_D%%%%?7GQP4444 %%%% !1110 4444 %%%% !1110!
M[%^P_P#\ECG_ .P'/_Z,BKZVKY)_8?\ ^2QS_P#8#G_]&15];5^+<=_\CY_X
M8_J?MW /_(@_[?E^@4445\8?;!1110 4444 %%%% !1110!Q/QM_:0^!G[.&
MEV.M_'+XEZ;X9M-2N&@L9]2=E6:15W%5P#R!S7G/_#TC_@GS_P!'6>%?_ B3
M_P"(KVKQ)X,\'^,H(K;Q?X4TW58X7+0QZE8QSK&Q&"5#@X..XK(_X49\$O\
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M/^%&?!+_ *([X5_\)ZV_^(H_XB#G7_/NG]TO_DP_XAUDG_/RI]\?_D#\VO\
MAI7]GK_HMOA7_P 'L'_Q5'_#2O[/7_1;?"O_ (/8/_BJ_27_ (49\$O^B.^%
M?_">MO\ XBC_ (49\$O^B.^%?_">MO\ XBC_ (B#G7_/NG]TO_DP_P"(=9)_
MS\J??'_Y _-K_AI7]GK_ *+;X5_\'L'_ ,56KX%_:F_9NT;QOHVL:E\=/"L=
MO::K;S7$G]MPG:BRJS' 8DX / YK]$/^%&?!+_HCOA7_ ,)ZV_\ B*/^%&?!
M+_HCOA7_ ,)ZV_\ B*BIQ]G%2FX.G3LU;:7_ ,D:4_#[)J52,U4J733WCT_[
M</+/^'I'_!/G_HZSPK_X$2?_ !%'_#TC_@GS_P!'6>%?_ B3_P"(KU/_ (49
M\$O^B.^%?_">MO\ XBC_ (49\$O^B.^%?_">MO\ XBOAS[H\L_X>D?\ !/G_
M *.L\*_^!$G_ ,11_P /2/\ @GS_ -'6>%?_  (D_P#B*]3_ .%&?!+_ *([
MX5_\)ZV_^(H_X49\$O\ HCOA7_PGK;_XB@#RS_AZ1_P3Y_Z.L\*_^!$G_P 1
M1_P](_X)\_\ 1UGA7_P(D_\ B*]3_P"%&?!+_HCOA7_PGK;_ .(H_P"%&?!+
M_HCOA7_PGK;_ .(H \L_X>D?\$^?^CK/"O\ X$2?_$4?\/2/^"?/_1UGA7_P
M(D_^(KU/_A1GP2_Z([X5_P#">MO_ (BC_A1GP2_Z([X5_P#">MO_ (B@#RS_
M (>D?\$^?^CK/"O_ ($2?_$4?\/2/^"?/_1UGA7_ ,")/_B*]3_X49\$O^B.
M^%?_  GK;_XBC_A1GP2_Z([X5_\ ">MO_B* /EC]K/\ X* ?L6_$SP1IVC^"
M/VD_"M[<0:J)I8_[0$>U/*=<YD"@\D<=>:\!_P"&E?V>O^BV^%?_  >P?_%5
M^DO_  HSX)?]$=\*_P#A/6W_ ,11_P *,^"7_1'?"O\ X3UM_P#$5]3E7%V9
M9/@UAJ,(.*;>J=]?22_(^4S;@_+,YQKQ-:<U)I+1QMIZQ?YGYM?\-*_L]?\
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MPK_X/8/_ (JC_AI7]GK_ *+;X5_\'L'_ ,57Z2_\*,^"7_1'?"O_ (3UM_\
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MQ/A_XP\4VJR,=#T/Q'#-<3I&"7>!0?\ 2$4 DM%O4#DG'- 'N5%%>,_M,?\
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M!KTBSO+34+2*_L+J.>">-9(9H7#)(C#(92.""""".M $E%%% !1110 4444
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MP?H]QX-^-NE^'["2ZO--T2=+M(]96WB#23Q0&]D>8(&95MXB%*[ROUI\5O\
M@IO^Q+\,O@FWQNTS]H/POXMM[RR\SPMH?@O6X-4U/Q+<LN8;+3[6W9Y;F>5L
M*$13C)+;55B #X<_X()^./%'[?\ ^P)\1_\ @GW^V3XLO/%R?!#XK'PCJ]W=
MS%W\1:%:3I-;65VQ):6)GMY;>13D2VRB)MP9\]3_ ,%F/V&/@Q>_%W]DF_\
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M4O'&)9H^C_X)K?\ !3#_ ()9?%;Q5I?[&O\ P3\^,FJ?$?7[F+4?$7B[5_\
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M@\:?#CQKIK>5?:/<VT\9N%CE'S;);<RHT9.QCL+ [!7<_L;VOPI_X*F?LN?
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MI5]&5@0P]B*?IVG:?I%C%I>DV$-K;6\82"WMX@D<:CHJJN  /05-10 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>jnj-20200628_g7.jpg
<TEXT>
begin 644 jnj-20200628_g7.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M  3I_9 \3_M0>)_#\FN7FG>18^&/#4$WER:UJ]U((;2T5L':&D8,[ $K&DC
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MW_VBOG.BC_4WAO\ Y\?^33_^2#_77B;_ )__ /DL/_D3Z,_X;^_ZI-_Y7O\
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MLR/D/)^]T^%: /WQ\+^*/#OC7P[9>+?"6LV^HZ9J-NL]E>VL@>.:-AD,"/\
M(J_7Y_\ _!&.X_:/8:M!LW?#)=_S:B6^2_XXL_7_ *:#[O0_>Z_H!0 4444
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M'GZO\S^G<-_NT/1?D%%%%8FX4444 %%%% !1110!\O?MY?\ ([Z'_P!@I_\
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M>OR3Q#_Y&5'_  ?JS]@\.?\ D65O\?\ [:@HHHK\^/T0**** "BBB@ HHHH
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M):ZWM!)ZIV:/INOCO]N#_E*3^QG_ -?GCO\ ]--K7O?@/XE_'C7_ -HKQO\
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M1117LGB!1110!V/[/O\ R6OPU_V%8Z^YZ^&/V??^2U^&O^PK'7W/7Y)XA_\
M(RH_X/U9^P>'/_(LK?X__;4%%%%?GQ^B!1110 4444 %%%% !1110 4444 %
M%%% !7DG[:O_ "11O^PK;_\ LU>MUY)^VK_R11O^PK;_ /LU>SP[_P CW#?X
MX_F>)Q)_R(<3_@?Y'R%1117]!G\[!1110 4444 %%%% !1110 4444 %%%%
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M_P#L%/\ ^C37A%?O?"G_ "3V']'^;/Y^XN_Y*/$>J_\ 24%%%%?0GS@4444
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M^1#B?\#_ "/D*BBBOZ#/YV"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M**ZS_AWG^WC_ -%U^%G_ (3&H?\ R11_P[S_ &\?^BZ_"S_PF-0_^2*_4O\
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M_?+_ .0.3HKK/^'>?[>/_1=?A9_X3&H?_)%'_#O/]O'_ *+K\+/_  F-0_\
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M4CZFHKY9_P"%3_\ !7+_ *.T^%G_ (0<O_Q='_"I_P#@KE_T=I\+/_"#E_\
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MV/Q1\)^'KZ-Y+F8W:VMY8Z//(S$/96UU=1W93'[RYM$<_+)(A /LSX3^,/\
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M>MU_PA6I_"O5?#RZD=@<P0:@NNW2P2'E5,L+(21N*#+5?_X)9_\ !3SX<_\
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MST?QK'X8_MZYMK>0L]Q<QJ;JW#7<S.7^TLS;2[,J9V%/!O W_!+#_@KKX$\
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F1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>jnj-20200628_g8.jpg
<TEXT>
begin 644 jnj-20200628_g8.jpg
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M#EW;"KN8[55<*.JH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ6%U/),9Y;=(6N;E+94A=W1)'VH/;_CY\:/VIOA_^T7\)/AQ\&?V5O\ A-/
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MC_B''_45_P"2?_;A_P 1*_ZA?_)__M#]&**_.>BC_B''_45_Y)_]N'_$2O\
MJ%_\G_\ M#]&**_.>BC_ (AQ_P!17_DG_P!N'_$2O^H7_P G_P#M#]&**_.>
MBC_B''_45_Y)_P#;A_Q$K_J%_P#)_P#[0_1BBOSGHH_XAQ_U%?\ DG_VX?\
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MY7O_ +11_J;Q)_SX_P#)H?\ R0?ZZ\,_\_\ _P EG_\ (GT917SG_P -_?\
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M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'Z!^!?^1(T;_L%6_\
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M1110 4444 %%%% !1110!^@?@7_D2-&_[!5O_P"BEK5K*\"_\B1HW_8*M_\
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M_P"2*-_V%;?_ -FKV>'?^1[AO\<?S/$XD_Y$.)_P/\CY"HHHK^@S^=@HHHH
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M\BRM_C_]M04445^?'Z(%%%% !1110 4444 %%%% !1110 4444 %>2?MJ_\
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MHH **** "BBB@ HHHH **** "BBB@#] _ O_ ")&C?\ 8*M__12UJUE>!?\
MD2-&_P"P5;_^BEK5K^:<1_'GZO\ ,_IW#?[M#T7Y!1116)N%%%% !1110 44
M44 ?+W[>7_([Z'_V"G_]&FO"*]W_ &\O^1WT/_L%/_Z-->$5^]\*?\D]A_1_
MFS^?N+O^2CQ'JO\ TE!1117T)\X%%%% !1110 4444 %%%% !1110 4444 %
M%%% '8_L^_\ ):_#7_85CK[GKX8_9]_Y+7X:_P"PK'7W/7Y)XA_\C*C_ (/U
M9^P>'/\ R+*W^/\ ]M04445^?'Z(%%%% !1110 4444 %%%% !1110 4444
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M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#] _ O_(D:-_V"K?\
M]%+6K65X%_Y$C1O^P5;_ /HI:U:_FG$?QY^K_,_IW#?[M#T7Y!1116)N%%%%
M !1110 4444 ?+W[>7_([Z'_ -@I_P#T::\(KW?]O+_D=]#_ .P4_P#Z-->$
M5^]\*?\ )/8?T?YL_G[B[_DH\1ZK_P!)04445]"?.!1110 4444 %%%% !11
M10 4444 %%%% !1110!V/[/O_):_#7_85CK[GKX8_9]_Y+7X:_["L=?<]?DG
MB'_R,J/^#]6?L'AS_P BRM_C_P#;4%%%%?GQ^B!1110 4444 %%%% !1110
M4444 %%%% !7DG[:O_)%&_["MO\ ^S5ZW7DG[:O_ "11O^PK;_\ LU>SP[_R
M/<-_CC^9XG$G_(AQ/^!_D?(5%%%?T&?SL%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110!^@?@7_D2-&_[!5O_ .BEK5K*\"_\B1HW_8*M_P#T4M:M
M?S3B/X\_5_F?T[AO]VAZ+\@HHHK$W"BBB@ HHHH **** /E[]O+_ )'?0_\
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M,_\ 1C7Q3_\ !?9?_)-?IE11_KEQ)_S_ /\ R6'_ ,B'^I7#/_/C_P FG_\
M)'YF[/VF?^C&OBG_ ."^R_\ DFC9^TS_ -&-?%/_ ,%]E_\ )-?IE11_KEQ)
M_P __P#R6'_R(?ZE<,_\^/\ R:?_ ,D?F;L_:9_Z,:^*?_@OLO\ Y)HV?M,_
M]&-?%/\ \%]E_P#)-?IE11_KEQ)_S_\ _)8?_(A_J5PS_P ^/_)I_P#R1^9N
MS]IG_HQKXI_^"^R_^2:-G[3/_1C7Q3_\%]E_\DU^F5%'^N7$G_/_ /\ )8?_
M "(?ZE<,_P#/C_R:?_R1^9NS]IG_ *,:^*?_ (+[+_Y)HV?M,_\ 1C7Q3_\
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M_P#P7V7_ ,DT;/VF?^C&OBG_ ."^R_\ DFOTRHH_URXD_P"?_P#Y+#_Y$/\
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M_:9_Z,:^*?\ X+[+_P"2:_3*BC_7+B3_ )__ /DL/_D0_P!2N&?^?'_DT_\
MY(_,W9^TS_T8U\4__!?9?_)-&S]IG_HQKXI_^"^R_P#DFOTRHH_URXD_Y_\
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MMS?LHV/[9?P4\:^7X+GM;F35)M=5;6;19+8$W,-XI8K"\0!+'<4*D.K,C*Q
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M_:(^!'B^#7?"7BS35OM&U.!2OF1DE61E;#1R(ZM&Z, R.C*0""*[2@ HHHH
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MV^+<_P"P1^SW^SMXRTS]I_5+&>'2? 'Q1M[71K'2;E8&D-U=7AG>.[MHT#3
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M117VC0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&_TS2+?3]3UJ;4;B&,++?7$4:23D?Q,L:J@)_P!E0/85:HHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
; **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>jnj-20200628_g9.jpg
<TEXT>
begin 644 jnj-20200628_g9.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_P"A_P#_ "E7?_QJOBVBC_B'V2_\_*GWQ_\ D _XB+G?_/NG]TO_ ),^TO\
MAK/]G[_H?_\ RE7?_P :H_X:S_9^_P"A_P#_ "E7?_QJOBVBC_B'V2_\_*GW
MQ_\ D _XB+G?_/NG]TO_ ),^TO\ AK/]G[_H?_\ RE7?_P :H_X:S_9^_P"A
M_P#_ "E7?_QJOBVBC_B'V2_\_*GWQ_\ D _XB+G?_/NG]TO_ ),^TO\ AK/]
MG[_H?_\ RE7?_P :H_X:S_9^_P"A_P#_ "E7?_QJOBVBC_B'V2_\_*GWQ_\
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M_P#;""BBBOU _+ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^V?V6_\
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M)XP_Y*.O_P!N_P#I$3]]X-_Y)K#_ /;W_I<@HHHKYD^G"BBB@ HHHH ****
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MC_KY/_TIG](Y+_R)L-_U[A_Z2@HHHKS3TPHHHH **** "BBB@ HHHH ****
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ME+7T+7X3QA_R4=?_ +=_](B?OO!O_)-8?_M[_P!+D%%%%?,GTX4444 %%%%
M!1110 5^=VI?\A&X_P"N[_S-?HC7YW:E_P A&X_Z[O\ S-?IGAS\>)_[<_\
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MNC>"_"$%Q\:?%$,QA@CL6WRMIJ.<%#=OYVXG#1V<<A;8TT+5Z_\ !S]K_P"
M7Q8UK1/!7@2_O;/_ (2#1)=2\%?VCHTME!KVG0,J23V)=0'1-T9V$*^QU<*4
M(:L[Q)^RMJ-U^QWX]^ .F^+?M'BKQ[X8U>+7?%=PFQK_ %B_M7B>Z<#)2,,R
M(D8)\N"*.)3A%KP#X*_!;XU>/?BC^R39ZG\*-<\*I^SYX$U&S^(%YJUDUO!]
MN?2H-,CL[.3E+Q7:)YC)"7B$6T%]YVU2EB<#4IPIPT:BK:NRYHQY4_[L6Y/N
M[O9"Y<+CZ=2=2>J<G?17?+*7-;KSS2BNRLMV?=%%%%?0'SH4444 ?;/[+?\
MR07P]_UPF_\ 1\E=_7 ?LM_\D%\/?]<)O_1\E=_7\ZYQ_P C?$?]?)_^E,_I
M')?^1-AO^O</_24%%%%>:>F%%%% !1110 4444 %%%% !1110 4444 %%%%
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M'J"*=12225D#;;NR#2]+TS0],M]%T73H+.SLX$@M+2UA6.*")%"JB*H 50
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M***\T],**** "BBB@ HHHH **** "BBB@ HHHH **** "OC3]K[_ )+UJ_\
MUPM?_1"5]EU\:?M??\EZU?\ ZX6O_HA*^Y\/_P#D=3_Z]O\ ]*B?!^(?_(CA
M_P!?%_Z3(\RHHHK]C/Q<**** "BBB@ HHHH **** "BBB@ HHHH **** /I/
M]@7_ )!WB?\ Z[VG\I:^A:^>OV!?^0=XG_Z[VG\I:^A:_">,/^2CK_\ ;O\
MZ1$_?>#?^2:P_P#V]_Z7(****^9/IPHHHH **** "BBB@ K\[M2_Y"-Q_P!=
MW_F:_1&OSNU+_D(W'_7=_P"9K],\.?CQ/_;G_MQ^7>)7PX7_ +?_ /;""BBB
MOU _+ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^V?V6_P#D@OA[_KA-
M_P"CY*[^N _9;_Y(+X>_ZX3?^CY*[^OYUSC_ )&^(_Z^3_\ 2F?TCDO_ ")L
M-_U[A_Z2@HHHKS3TPHHHH **** "BBB@ HHHH **** "BBB@ HHHH *^-/VO
MO^2]:O\ ]<+7_P!$)7V77QI^U]_R7K5_^N%K_P"B$K[GP_\ ^1U/_KV__2HG
MP?B'_P B.'_7Q?\ I,CS*BBBOV,_%PHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ^D_V!?^0=XG_Z[VG\I:^A:^>OV!?^0=XG_P"N]I_*6OH6OPGC#_DH
MZ_\ V[_Z1$_?>#?^2:P__;W_ *7(****^9/IPHHHH **** "BBB@ K\[M2_Y
M"-Q_UW?^9K]$:_.[4O\ D(W'_7=_YFOTSPY^/$_]N?\ MQ^7>)7PX7_M_P#]
ML(****_4#\L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#[9_9;_Y(+X>
M_P"N$W_H^2N_K@/V6_\ D@OA[_KA-_Z/DKOZ_G7./^1OB/\ KY/_ -*9_2.2
M_P#(FPW_ %[A_P"DH****\T],**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "OC3]K[_DO6K_]<+7_ -$)7V77QI^U]_R7K5_^N%K_ .B$K[GP_P#^1U/_
M *]O_P!*B?!^(?\ R(X?]?%_Z3(\RHHHK]C/Q<**** "BBB@ HHHH **** "
MBBB@ HHHH **** /I/\ 8%_Y!WB?_KO:?REKZ%KYZ_8%_P"0=XG_ .N]I_*6
MOH6OPGC#_DHZ_P#V[_Z1$_?>#?\ DFL/_P!O?^ER"BBBOF3Z<**** "BBB@
MHHHH *_.[4O^0C<?]=W_ )FOT1K\[M2_Y"-Q_P!=W_F:_3/#GX\3_P!N?^W'
MY=XE?#A?^W__ &P@HHHK]0/RP**** "BBB@ HHHH **** "BBB@ HHHH ***
M* /MG]EO_D@OA[_KA-_Z/DKOZX#]EO\ Y(+X>_ZX3?\ H^2N_K^=<X_Y&^(_
MZ^3_ /2F?TCDO_(FPW_7N'_I*"BBBO-/3"BBB@ HHHH **** "BBB@ HHHH
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M?^$QJ'_R11_P[S_;Q_Z+K\+/_"8U#_Y(H_XB#DO_ #[J?='_ .3#_B'6=_\
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MC4/_ )(H_P"(@Y+_ ,^ZGW1_^3#_ (AUG?\ S\I_?+_Y Y.BNL_X=Y_MX_\
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M0<E_Y]U/NC_\F'_$.L[_ .?E/[Y?_(')T5UG_#O/]O'_ *+K\+/_  F-0_\
MDBC_ (=Y_MX_]%U^%G_A,:A_\D4?\1!R7_GW4^Z/_P F'_$.L[_Y^4_OE_\
M(')T5UG_  [S_;Q_Z+K\+/\ PF-0_P#DBC_AWG^WC_T77X6?^$QJ'_R11_Q$
M')?^?=3[H_\ R8?\0ZSO_GY3^^7_ ,@?5O[+?_)!?#W_ %PF_P#1\E=_7R3X
M6_9^_P""JO@K0+?PQX9_:F^%EM8VBL+>#_A![A]@+%C\SR$GDD\FM#_A4_\
MP5R_Z.T^%G_A!R__ !=?E&/KPQ6.JUH;2E)J^]FV]3];R[#SPF7T:$]X1C%V
MVNDEH?4U%?+/_"I_^"N7_1VGPL_\(.7_ .+H_P"%3_\ !7+_ *.T^%G_ (0<
MO_Q=<AV'U-17RS_PJ?\ X*Y?]':?"S_P@Y?_ (NO2?V;O!O[:'AG6]2G_:A^
M,WA#Q/82VJ+I<'AOPZ]D\$V[+,[,3N!7C'K0!Z[1110 4444 %%%% !1110
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M)$/[-4 ?FU^T;^V-_P %1OV?_P#@I-^S_P#\$^C^T#\&=73XVZ;K=S<>+/\
MA2.HVYT@Z?:27&%MO^$A?SA(8]O,J;<Y^;%>]V6L_P#!3KP%%\8=+^+OQ2^%
M^I6WA_P98Z[\,O&F@_#"_L[>YGV:G]NLKZTEU6;<T;06#*8KA<I,QP"<+\U_
M\%&O^5D+]@O_ +%_QM_Z:[FOT/\ VA/^2!^./^Q/U/\ ])9* /AK_@E9^U%_
MP5<_X*4?L&>&/VU(?V@O@9X6O?$\^II9^%;CX):K>01&TOI[0"2Y7Q%$Y#F
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M/<1AB@E 9,+($3YL_8ZL=2TS_@Z _:^;Q)E7U+X0^$+KPX)>KV"V>G13%/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>jnj-20200628_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2017-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:jnj="http://www.jnj.com/20200628"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2019-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2019-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="jnj-20200628.xsd" xlink:type="simple"/>
    <context id="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i972855702c8a4b18883e4284851151dd_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iefb6241d9bf2428e94a47ac9ce454499_I20200720">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-07-20</instant>
        </period>
    </context>
    <context id="i56f124cb187a4df0b12cb443a129b124_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i4250b233c8424335ac39cd07c8101199_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7f5119916d654310ac75b5ef00226e3c_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i28ce5a232c604b8bbf884d668b9f4e57_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i24d9e08d937e4f179ddd650ddc14f39f_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i73fd0a02b1154c3e9745a1263dc23b62_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="iefccab1bc61e4aac89cc6807ae4e1c54_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i59a07beb3fc44f4287425a53a020e1d6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i45078457294a49839d52d19d59d45e00_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if261e32787064849a30e8f746c585aa9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3f156471cef4470986ef989b88c7640a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i24cafb66e4484853bf4778ec14060e85_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i751605f69fa8470b949cd66a3de18cfb_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i63412fd9538f4c419e57e8396e1e2450_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ib519600bb19e47f6acf4f21be0fc6aaf_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5747648413fd46979174d12f0c200837_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic629a2a0279c40f7a8a22fbbbd206b62_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i946a5c53aec443718456445577b181c6_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i37f2478bd1c94f8189108fa2df87fa35_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1fd38c3886a84e65b754e209c671b4e3_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iddf51803037143adbd15041c11e9e51a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i246708123c874d65a705b8d658c14466_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie0cde42ed21643029a65d234f94ce9ce_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ie3ae7c05de8449e4853379b1810a5cb4_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="id93dcd19b8bf48879ab269ebebba20c7_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-30</instant>
        </period>
    </context>
    <context id="i99963dbb725b4ce68efcd70e25e653e1_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i6b613a94dd42484783d6a12a1751f62a_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i8c0949379c4e4a58a6c9255f0e249053_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="if1edf2d8de4844dca95575354c2ff1e2_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i2e4c6a229a014b85a7a8b8c276c6ceb0_I20181230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-30</instant>
        </period>
    </context>
    <context id="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i49bf965261be49f3adf9b650ea02edfe_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i143de2467f00494d97e9051d438c9616_D20191230-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i2c16549172ea409986271df6c73e639c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i64ccc08e02734c24a00e804f7b1912c9_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="id939f17ab58546e792a3505ad59025d1_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib4a1ace803e04933bfb1ecf684b3b69d_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i9ae5346cc81b4f27b4788b31c0e54a6f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="icc73eb3ded6942659b82f23e9f209d83_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ifc06a706e03b46438ac284c25745cad8_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i3bc60621d8554499a90278e03e0c6c2f_I20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PurchasedInProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-29</instant>
        </period>
    </context>
    <context id="i99703a7240b24ff78c8ea755f087ee0a_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i3cfcc9ed84c14ef99d0fa0093df15fc2_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i9898c86a84104e428b5e32fc5072ca0a_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5317e81770cc465384ed2fda2daf0206_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7dc0631cabd64cff92a35dc49719e5e8_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ide8ee6042d8a44199c107aa75b895f4d_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ifb1af4e8ba9744f08026427afa0d3297_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">jnj:PatentsAndTrademarksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iae716e872a654f7d8eb4cdca336d0296_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id1b4629634a44afab44276b8c7cb5831_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iad06a55c5b434327b4b129a23d14607a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i2558fa0249654384927e35faad85b435_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ibc2e1511c074474db7b627c8d636f1f7_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if2930efbd85243489088de50fb884ebf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic803db0b89c947539400ccc49f897abd_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i392345cf23fa442fa586318c28775403_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i182f09e72a12408fba69944468ed839b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1a386510568948ef9401f50d743744af_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6147540408284062babe0382c2ed602f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i771189b421614759bcfeb81a969af79c_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if9ac6becf67b448c872942fc733563e5_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if84c79837433431cbfe27e56a7471773_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:InterestIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i02769757e5e740ba8d0918956fb4bebe_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0e42ae0e28f84a3883a9d31defcc19c3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i890db46e47fd49d29bf0222d80de0e45_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib840e261052c4ea5ac6bd3f5620b9e0f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i49811ec159eb4ac3bc3e2bbd99fe655b_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i440d6fd614824bcc9d8ddcc6388c5585_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i05a3bd79ad904c7c8b977b55b1dfda9d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia24f094cc45d4b64bcbc61338f27ef34_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idab234b2a9db4b839ddaf49647f6f9f0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4ec571d4979a4ebba093f4d51dbf209d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i636d1fd3b5314b0cb1e7b53344d7a601_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i803140059c0440d58c12d070ec9ef9e4_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SaleOfSubsidiaryGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie56c599de2e24fc180918708256afa06_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib4560dde64424b5eb34ac46f8e75831f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i09bd4a7957314ad4806a70ff0309af9c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iac20a877725e4f95bad00d306f8ef1bd_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5ca06658d0fa40fd9124e23676ae5f16_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i5f752123964c43149dbce663ffb8dd1a_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9326dae4609548fba0848714a64d1794_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:EquitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OtherInvestmentNotReadilyMarketableAxis">jnj:EquityInvestmentswithoutReadilyDeterminableValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib201d398ebc14ebdb124f345bb48e79a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i266b986790574bd58dd9c8410be41161_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib4796b3e074d44b8b27f9e3805365ef7_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i32a304915e484dc482c62bb1f219c6ec_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i07152e7d66cd425cbf3e240d1e56cec5_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i4e246117e68944788661db5d2b317e56_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i540760381d80440cad88a6dab18c3a11_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i808beb23831442638cf20b785a026f54_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i048d532d55964ba2af85ffcf6f324949_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i01fcaecf26704902b098af6c039a0f6f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i45557044d86f4718ba2718ad7252be12_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i1dfa706123d84147824f6fd9464cff19_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i1b8d63c17e114b2e9b9a96275f1697e4_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="iccc7bf9a45e54601aca24b8cc9b8ea57_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i3e6c057229dc4bd7a12d48cbd4db8754_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="icad4b86ea6694e5f9adc78bc100d29fc_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i83d021f672be43748204f5d0a7908366_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="idedeb1dfe09443a7b82d283ca7b15298_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id9bc5029a28b4c25ac4f1670189d549e_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i76c9318d92354ba2a3360e24144f1b37_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iad126eeedca04aedbf65bca596749ee3_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic563629e1c85446181090d0223f3a034_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ica9c1898e0614e26a7f94c1e754bcf74_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i34b771b7935f4c27a472b4058fc8a61a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i2b463dffff4f4aaeb587d2a343d0002e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">jnj:OtherReverseRepurchaseAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic66b3f5412794987b892ff0a6f28f018_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id60c2849846c43c7918fb9427719b8c3_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:BankTimeDepositsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3d30159c3fa949349d95c4d25158bbbd_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:HeldtomaturitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id54f7d8ddb0d4b40a0545418c41981bf_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:USTreasuryAndGovernmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i9d6452213f4045a599c3f921fc70d80e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iedf975dd84f14bb5b1f0231141b5cb43_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i9d98912977ba4917b953532514269c05_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i5d040c895d9a484983838bc608465de1_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i4679f53893ef429da7ae2608c619ef95_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i26f774541fbb4a11b90c5d2d53d5ac38_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i13c392bf576441608a85b5f3084041ed_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iaf2600e49d414d4c9228f6fb5cf69b47_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i21abfcc6203b49ce95faf424178935b8_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ie1cabbaf87184e1ea5605e3f3dfafa26_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ife21e63962704b6ebd278d152e40a4eb_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iae6e1bd14a034339920302779e0d2b6b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0fe3730cd7bd49aeb322782ed3670e1d_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ia00a7be937144c12b2167fc98e13147c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ia95278deee974881825cf0f9ce29d7a1_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i9c8e5f7c3c0844f5af66ac2ad7955599_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i4fa9e40d591048bda2fbd99d27df9044_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ia36011f1be2b41518aa8989de6791c53_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i8a87256891cc4bf199c1a109a2537a60_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i4870c94373034eb2bcd12dbc135d4626_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7a31f41a5b6843ae9b894d9381f461e9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i81fab23f82674c6980bc9c359eb28ba9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ibc37bc973c1b451387840c102be9a646_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3485e48ea0cc49a98aeb79cb18bc40b3_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic2134273f7f24276bbcfc008eae7bd5f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ie86818dd9c644e1d92aac548b679b5e8_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i892e47f9411246c698112667df4d52e9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0c92433556884f33bec3fd9cc5547c56_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i07512cb6822542c3aeca578fa5a030a2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i8f099c74c285402fa0acf97d0bd56486_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7c84c7aac7a8402b93fc4d50c3fb1b33_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i50567b40671a4971ad917d310f56301a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="icacf6978c8de4cd5adb37a3902bb8f2b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i738688db4eb94ba5b31c8ae44a9936bc_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib1fc849891c249f9affbd772810f19cd_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic599954eed744eafbf6e49753e86ed68_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i53cad7d01f364d4897d6a878c622734d_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ie54b20ce4e0149e184e543ac46795d24_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iee7cacef8bf14e17b0aeba908aae6c5a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i29f1ce70157c489995b6052930e4d920_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iff6ffc8dbadf4318b62b6b49ffacd2ef_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib2a9f041c1054b54b091f023e6d70707_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i594eec41b2c747798b5aac595a81b3cd_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i8b7150c261554f278bef9d5c04743f0e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i224d6ed1b3124fba9dee77b543600395_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib08f2638d7b846db950bf41478ecf12b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i9a589dd13dcd4d9ab04910f8be1fffaf_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i037b02ea1a8948fbb6e5f750e5b20a1e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i5a335dce7946400eb64a556c5e88d512_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ibf95c2acf45c42e3bd3fa93ebe96b0a9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i80b8cdff3ed5419bbf4fe318b5605b78_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i401e6b8e8c924806a3e398ef7159815f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic7ecdd57de4e4e4287dae9dc82bb4ca2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0601e6ae6921410ab7205bde53a6aba2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i70f239152a2141228348aa533720bf55_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i06101a865e8e4e8e82693744ec325c94_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i37ccb3cc5bb040cba3430bd495d96186_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i89c03926f30a4d13a7fa7a50e5afa527_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3bf2ae2644d940ca9f392d4010b2fe3c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id07eeaf7cfbf4feb83e823bf4797e7e2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i48ad5aba0d9742d3893f7a8373957913_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if10dd21b5f704d0abfea775170908a2e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:NotesDuePeriodFifteenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic09551a2d2914e58b07c0faa2bdb5ca7_D20181231-20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-12-29</endDate>
        </period>
    </context>
    <context id="if94dfff027b540c0aa481c801f7d039f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7d82f1709b994eacb901cda0b8414196_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i04fe5d0b9ade47e5981496ba5bbaed12_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if8665aecb49944a58fbb92e84df3cc67_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.250NotesDue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i6e0e6b7104074202b4e5d369a606e4de_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.25Notesdue2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id3a4040a4a9d496e941dd0a85aa89117_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.73Debenturesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i83226f68d388482997387c732a694f0b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.375Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib7ea62f7202743edb0eb2e2ac6bdd8fc_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.05Notesdue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if1cca58000e94ac18ffc4da63ed491ee_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A0.650NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="id6b500b0012e4fffb964046db18b7ee9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.50NotesDue2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ice6838c819764fd3b274d26aa88869fb_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.625Notesdue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ifa6388d8e4aa4d2ba5163676f80c3f61_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.45Notesdue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i55a1659d1528484386f3c1b96b56cd5b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.95Notesdue2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ie6972f42d4f04331bdc3fa37a69b7170_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A2.900Notesdue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i29c4cbdbde9b4e11a996c3f6929a01ca_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.150NotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ica38f942e6f54e37b25a587ae66eb689_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A6.95Notesdue2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iddce8e7eb7d541908fa3346ff2ccc64d_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.95Debenturesdue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ia99bbdcc3d6f4e3a846ee43fffa0409c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.375Notesdue2033Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7d75e926178641929b977bc0db3d772c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A1.650NotesDue2035Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if8d3f87a8a814ef3b7f7ceb44c1ed145_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.55Notesdue2036Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="if1b09b47526a4eeba8c34cb6affc3050_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.95Notesdue2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="idd21cfd6641847409da3807e3a428234_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.625Notesdue2037Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i1abc4374a89f41bda84e861ad20017c5_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.400Notesdue2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0218ee4e0ffe4a1c9ae094465ceff9f3_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A5.85Debenturesdue2038Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0e888a83818c4971ac6ee9c8f4183487_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Debenturesdue2040Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3b183eb71fa34ae282a8f6304ff5d4ed_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.85Notesdue2041Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i672a40323bdb4457a31a3d077e38d562_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A4.50Notesdue2043Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i8e650bd7c2174e4989ca66001681ede2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.70Notesdue2046Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i5a9b919d33e6495ca7d583176e83bd1e_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.75Notesdue2047Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i0089df10475a41e29517b0bb7f6c056b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">jnj:A3.500Notesdue2048Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i778843f60e324063b0b113788a8aaa4e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShortTermDebtTypeAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie1c7443736ae4f29bc57b7af183c277b_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">jnj:AccruedTaxesOnIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i27e026167a6740039f33d214df252c5f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:InternalRevenueServiceIRSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ief617abcc20648479b55e755c807413c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i752da11589284fda86e218b2a217edba_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:PensionPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3eb5537348114e3383db2050da995503_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanTypeAxis">us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2f87318d318045a6ab036c942e910e82_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RetirementPlanSponsorLocationAxis">us-gaap:ForeignPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id4556ab2a2fc4b759328bcaa7117d7f0_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i70aedc4c48ed469a9776d7b4ca9dba52_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="id4b29a10c69e451f9cd0f65769fbc49e_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i76c2328f316b49948f37e4d51d76befd_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i35b3b5367fed471a9262907b9c660c6b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibe5bd9b8b1c4480ebc128d7538983d48_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4b624b01490643e596a4c28527039518_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic3d78226c4c54c9ca0d4cd83d95e2d73_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if0bda8b685c44b2d86658936d3456c28_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i94324367c9e54b678238a19050edb89c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i83c49a3f745a40c8a5594ba2e9162d35_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i9b37abccd6c2406ab0e4786c66aea73a_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i412403fa25604c0eb6cb3612a92af406_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibf7cb2cb2d84454889dc1978307aa501_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if72a15c285244bc3b010e33bfc90cde1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i86aec8fde918479799b3d8999e4a92db_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0542775e36e242d1be3186249195e3ec_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5f3ebd2f992b4c62a96493401efcf524_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8f06a464dd9742ea9682af70f69352eb_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BabyCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i40c2c1be7c9c4cdf8ed2ca776a685cec_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie7fc53301bf44a03a86320a01d4c89b2_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3e2c27311f954303936c62828d1203aa_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id3241cc6119d45ba90518b03c7b76dde_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i62f12565007d4fe4b8dd93b5e190e144_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5687f5838b614e4589f850bb1f5939c8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic5df767d41f749ecb04e69b4d5853ccc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:BeautyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i30eb63aff7fd481189b4f524a3f36f78_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8842b711d1844455848e9682cc4cceac_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1a6b71be8d8141dab2ca5e6564f34d86_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i86f3fa93e7354cc6bf55b6b55246cce1_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6d79693f595f4483a46180ef55b406d0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie3749288c66d45cd8504ea939901383a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id5a61247d95c477381857604c8aed8c3_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OralCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie44840a7a12d4a59aa337501bb3c171a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3225a5919ff748b88fab0958b5dc1630_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iccb687ba095a4752882b895461f25afc_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i416e1d239030434d91da317adc252268_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i217e8d94fe8343e7b9a36b46d7ff6f42_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if6572c7d7c154078815d1d633a936600_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifa2a865013ea455b9e5d8ff204f65c18_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie3b8524a11f7463e8ceda09d321b1dcd_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0f8f472f6d184702a8de9d64eb4b3e33_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2ab77cc2dfcf43e786584e6ae05cc727_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i17319dbdd05e4674960f993b6cec2500_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9d58945d2f9c49328b754ad12aee7c1d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3fd4ce4d5bfd403ebdb1f23fc75bb9e7_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WomensHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6f5f12aff9364764b1862f5c138fb733_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i00f88af71cc44acaa8ff9f73750b5cf6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8a1fbdb565644530aefc8a04ee20b567_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3309bfb236f34376976fd1aae5a817b9_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4615adcb9f9c4c91bf219b6707943c12_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iae6da712f0bc48308e8e5ba20cb5dda6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:WoundCareandOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i676c5ca698d44f7bb1903045e7e0ec08_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i67922ba98bf742f2b93e38317dd13f79_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia3510f20d163437d9d386475e40596e5_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i12139d83ab444d98a2b66446337fd19f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if362a6cd5d6b414ca2bb842004eef8f4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i238c4888cf1248d595768c38dab59641_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i09e1792cc5c94bf6b0b2b40156599df0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9606d19598644104898d903b09806074_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id73f28649d29470cbd4b3ce23d75ffc8_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idd3ff780d0f74b38b1a6a69a052629ae_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia41941d76be24820956011d29accd0d7_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0ccb205116b4463884f94a7aa8ad4845_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icd91babad94c42c5855b5b127b24d222_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i202c6ea421d34b83af4652977ad93e89_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic70ac4fab133415ab1c3c188c47b58ec_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie58a793be107479d9ac45bc6f91943be_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i30a354f3a5aa42dbbb12c4091c197032_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib6aedf491fd84a00ac5c03725947fa86_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib634d639ae9c49819dcc46f6d7dbaa22_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6dd25eb363984eb0abd80607dca205b4_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:UNITEDSTATESExportsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2a0ff02b2a8546f7a5b1c62d388c8563_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i72d4f321e7b44b50b09bdcb088bbe22a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic8c5682649bb41e4afeb396ea67e339e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1d51a74cecfc453496314405e25d87f9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RemicadeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i70cff2202d7347afa5eb1607d57f14a6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia25dd344df8f4b6dafed16ebf59ddded_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iabec2bb4211940caa377a2893b37a631_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i11abb1995b224be4b48943c0dc5e5241_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1e861771c7a249e8a7b1847d97087825_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i625a0328612340d3b2444593094ca6e6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SimponiSimponiAriaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i18e155080f5045fa8e60310a82f43852_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="icbdf2685c57d492f9ea918bb328f7c1f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic5b2aa7ef11a4067b7913ca9a6049731_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="icd982433a2cc4b669204c6ff9a0df941_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic193be42f65642e5914f3b9a9fe4b1f7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9f48c3e16a07411c939b255df38ab5ea_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:StelaraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i258519354ca34b0ea53867c6b0469e98_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i21c482cfc9e440558a10a03ac6b0041e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibc056e7edf5d4a879f07aabe7d8da1a4_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3094a6e0c0e5489ca31b150a28af16f7_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2493d378de5d441f8eed2a2813f2a10b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9a9cc129087542a39b32ad178f8e7d1f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TremfyaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if2e74d86ade443d79565d3d4db9806ee_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2cdff07e389d4a98a18843581742a126_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i617f22cd872049709ad264ec00aa4bbc_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5ef4c7f60c8c4c179f5410a867c82c1f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if7e1f856d6494507bf69cee1f35c925b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i00a198b7e3724dfc8d0765ab1eb7c385_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherImmunologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:ImmunologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1ad5ba18e22b49c8b7d61dde83b71892_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i722753247dfe40609326df9c146077f6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iee8e1d7d443b4b5c8fbff2c8140dd02d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i860d3da7dba846e9b34578282e68a159_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i90605ed3fd3d4ce9b995899ac2960140_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i424fb644ea244b7da33323ed90262948_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifdb83db6bf2643a3beb8b071f017dd9e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i593eedd9b3554e4aabf346ef510aed2e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie6756f2eb6504f6fbe424eaf7c67b1ee_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i085528c026384b5c9822a2d0583767c9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic5505f103f3741599a24e8ec3035a6da_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia111f6b65afb4bb78be8e74995a7f05f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7d9bcb321c9e498f98febc66bd97be67_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iceb44ce996964b328d052671fe7e60e2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:EDURANTrilpivirineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7d7a48b762e44344a5837c580cd3cbf5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i94fb5529b7f24fdcb5216fd61202149a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i159cfea84a824beb9e343c1924836863_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i20e61bae25d1431f95c16ee1a52b7698_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3d9a2a75f7ec49fcb41600b16ed21ebb_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifabd48f69a75450fb39b1fcc14893a13_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4ec93166231349a4a62144abaa88211c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9943abc01c244bfc976454f3930f0b53_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i865c1debd77c456ea62aaa4cee5f5098_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3b12655dd4d549d791503b3d33bbc3bb_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2e49fb04160848249e6b979e9e53d9de_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id4958d04806e4a26989b410d7de289c3_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4b73bb8b3a32402cabe464c9e85b926b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherInfectiousDiseasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InfectiousDiseasesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib0a4733c057e4c91a422fa0925f0ae18_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id17f2144580042799de6fe20a0e39ccd_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iebd5c6d65d444de181e96474c0ce96d7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie13d62f4906646048e8d258210540cc4_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i69a768ae79db44808f989038a6762aa0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idb74ce4d9f2a438ca8c55bce6a61f201_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if252bb07e5ce40b09ae6eef7a0bd8990_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if2ffa593433846189cbe811f55d09e5d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4e675afc2787431e8afb910310f97ada_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id409969f7fec4d07b24c2e6172c72cb2_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2968959d6568429a8880c28dcb335451_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i026f726665bd40f0ae400deeb330076e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8291c7e7f5074b05a4080989a7cdca7f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic8bfd30da6154a89ad914f97e310482b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONCERTAMethylphenidateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6cbd731ae0314fdab64251ba569ebefd_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4aaf80f3af504855ac58fed5a2bc812e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1439a394ab6846988867d4f1cf885731_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie7fa5b3c2baa437496a6794409866f3c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3100b6a78517436fa32a8050740185a2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0f27d0f078234139b5a188a530fdf0f4_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib615d062e3cc4937be3e2a60d7cb2915_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie0beff2f10b94936b5d68d3d4b19ca88_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i24c7d1c7078e4cbfad4062f370a3bfcd_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5d6915ef71e9474593878dc7ff1d3c21_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i609cfa77c4914441937e2beddbb8131a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if72cc1f808a74f7a9d09c145562b9fe6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i31b578e4ed884650a6403b04a4e0b789_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RISPERDALCONSTAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib262502572224ee39687f0f730b454e5_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i80c887d315ba40298eef530b8f4ba42d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i14201fb6ec904317a82f139c47f516d4_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1d635955ff65456481154c2069841ae0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4102c5393e3e4404af8f3950fb3c1061_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iab60464d3cb4430eb82579d017bef6f8_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i11fc7443e78c45d6bf48c2a55810ae8c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i17a8a56018f8486f8449896537768e16_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OTHERNEUROSCIENCEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:NeuroscienceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i98e861871c884f4680474af0cbc7e046_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i40d8d8c184b744188f48cf36a41714c1_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia70fced883cc48efa3c30712ae539922_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i57870f886e894fd8bbe4a13765b0df95_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i781ae83699db4163b10fd85d372075b4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0afe68e69df24e9ebdf140bda8bafd0f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic2caa6cea60a4de4bf1daf8484380ff9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0c6b423472dc4d3aadf1c81dc48fc95d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i68de92f3d1ce4ff98dbf3ea01899ba7f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibd26991e9f7c4050a356609fa6aa6564_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib5c47b91ea4f4a1a82f47eb2f2b05c3d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iedcc529eaf2d4f5e95ef455772dfe9d8_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0c83bae4c94549c794523bba175150ad_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i20db1fe43a544cd8bb1e84445a29fcf0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1c6e046a80854e88a9f86f1695a5f3aa_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:DARZALEXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i44e81356fdd54d65a78dac4fc0eda00e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie123409368b842cab55c01dc3d83661e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib3e20f2e34a646dc856760483fc4ad2d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2d4e3a4668ff480e9666f51b1628680a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9d365fd404f94441a423bc83e35f9e37_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3a5f0cceba9a45adab7b92c8c0342bde_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id1b199c2136c468f8a1e8ae983620d04_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7591b4f8a45d45e9adbb156f546300ed_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i879dace13f494901b14e98c7595f7ce0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i451c8da9b5fa46f9becd1b7f4f4c2059_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2b4f3715aad849fd85631a944342e87a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i81ae16fae08e4c16b6ba95255d7c70a5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ERLEADAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5f3face5d4a74567b928ba079035536f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic4830a4c60c5480f8753cc4f6e6e0619_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9ac0963e98b74865bd5c91872e42f462_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5f34e03717784a4a8111609212e45149_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i50c8b25757c84b7eba5a91969c95a1ff_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iff1890bf78564da8b18b9b68921ec794_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:IMBRUVICAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i40923251ff8c4dd2b498eed41e75b3df_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3ab98edb95934d548f9aab32a4017a85_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="icb58d996d2d340ac859eb5d48275ae50_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i70777ca74a8f4c52bfcced79529e5a78_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia32c5586169343d1a69eec3e4c21fc0e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i016a755a6a094e0588480249a8a01013_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia9fbe6cfac9849d8bf7baadf709ef1ca_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:VELCADEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifd032f631b7b483d84a771f14f2dd965_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i268e898503704282b1e644c2a204b27e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia30a1b9a326a4a0cbd7d5286285a5135_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6fe3b75e12074a2aa5073e4be2dc9f2c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i590d4101caa4452e881c66c7cd378a8a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ief29fa0003a342a9b72261c5a777f5d0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i92c5ae1bb6c844da97fbc887f5bda6e0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ZYTIGAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib56fd4104b864eaaae048a20df297cde_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i801fee3b508b48d7b1a571095a597b48_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i94d1ee23a76c405bbf282ee929fb2018_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i372fe738f82d4d1aa79d1d22bb000b69_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6214365a5a6e4954a883f81d290094b5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9c8d994f0ca943bc81943bb007e9399a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherOncologyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OncologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i317e0f05a6aa4f0ca7c59c511f3116df_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2e6c9a032cef42779e88c9c4e9e74fdc_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iae747a1c0cef4fb9a4aca0b3ba685a30_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9d783195c6564387b12b4f45034f355b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4eb263dcded541a8aa2ced910f1cd8ff_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iec7c2d99cde74ead89e90a32724d105d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic38012b16650436bae36d246ed2a8764_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7a09f2ca879f43c2809e324c91ba6156_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iff5b53cf06a84a3680777d7f2e8be88e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6c5cb1cb5ff547f0ad0d3363e354138b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5526426e0d0144459d16606be11f1e99_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id23f20da385240978278a18b68c30b9f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1238641b920249c3aa20b57084128ec7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9e7538e0459e41a980f744f172fed239_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id6c7f0cce06545a092c974ebc7a8836f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OPSUMITMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8c44c63fd2b14fbca695bf3112d4cfb9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i28ce799db9f8497d8b627c203c959969_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2e364c5e2e934b64bcfa4212283d45f6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4c52dd3f3c3f4f1ab9080d8e927c9b9c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i441081885a084c1b9bcbf9be8a783fbe_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia2ddd2fe68ae4f6da08c10e586b72d62_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9630c7bf786b44439a2c196398e924f8_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:UPTRAVIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if804e1fb547a4207ab79bbd55dca0584_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i19f9e20c45134d49a3c68d672c6cf4bd_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i085ffcbbe09e4f149e82ba292414fe2f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia8e06e959426468692abf98048c488a3_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia1c0080e67a0463ebeb744e69d1860e6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="icfad13b3e4b641f8823b1565bcc50f9a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:PulmonaryHypertensionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia7ace7a83ca7421399ad7ad9788512de_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i02d9fc89b2fc448dbed4a48c9e578ce9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib543ea66309246278232bc6dc99b91d7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i14ddf81148af49f8829e3a2f40ddb0ff_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i491add72dab6458988d768371a5f99f1_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ica871b685f374f86882c4067f230ad66_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6e9e1d0c2fca4315b63e1185226f0e3b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i73bdd59bf0dd41a4a002312654599a0e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3101dfd757f24ebebe5d55676ba0b74f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idc05ce35d84345148bfe86d926005942_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idb65b67f0ca146a5a8fbf3d66409a1da_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i542b4161407e414194fdf6ed4d650599_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i936a7dd6706a4a36bbb3d4e462ea1915_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5736a09628a74942af5372765e9467a7_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i04bf0c9bc6b546109f0c5c2b50e598ea_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i085118eba10e4519bb61e008118fee7e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0bbccb018ffd4dc493cc91e90e401f8f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i28e940beeb8e4e158a7e01a90398711b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2c51ebb23e644f36a5bc98cb1b21b16b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5b27e1d2c7f34ca595d359abf82ec68a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9b5a7d7ae1b647339fd559afaf42d469_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idc1e91be376b420c80fdf945f74f19be_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibdb38e3ece9f494b80986166616c8796_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:INVOKANAINVOKAMETMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id7d4a3441694425685b68ca60ff37697_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4f6e2d7431db44d2a85a24ada1a8977f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3ca587806fca4350a5892099573a24ed_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibcfa4ee807d44bb2ab00fe7d9ad30b84_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0acf6231882c4daf9707983397ea2171_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i63596790121d4860a57507cabde319b5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i966890469adf4f7ab39dda3e8b42cce1_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ice899dea89fe4582b37b2c8d67529df2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PROCRITEPREXMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2c56f0779bcb4802976ff987723bd905_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id9851a937c384f21b0553db930e3ad00_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie3d745559b8748329aee818ee4c2dffc_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i108362d021024b2bba503dce1ecd646e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibca496862e9c406b80302245e8c996b7_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic080c2635078489b8837e0c15b529291_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibd1737d9336f4ff499db39a6d78dd6af_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:CardiovascularMetabolismOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i82e70c787f7849f9b4e7eb17a1217ae8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3479c20afd6b47628f60faf7361db000_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib7a4fa10b3864a2190a08faa6182e13c_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7e34366acf8642948ee51937ea67737e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i644cb9fdf8ce4fc79443500fc969d197_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i037ad64a515043b49334f8fb421b33ac_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i75e4158bcf404921b8195a9cad36a2cb_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2903af0eb1a74b4c8a4dd7ef23591531_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5659f85aa3624cc09864a84ecf854798_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idb7726bd5ac44766aeafb59df236adb8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id719681b56d64604ab0267e1d3cfce80_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i057617a514dc4f72bdebb0e1ebe06b7e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic49dce02d6a342668ab35662fd1521e5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:InterventionalSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i72eaf829d51c441fad147448cea308e8_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i4aeb6f629da84fa689517fc2cf39b39a_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic34477da8fc847db9dbe086333871ef5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6225fbf007674bad9bb72edeec2ab93f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic62ccd20ee5b4d56a9e8161ca4b98d84_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic6dcea95239d4c7c93cfb6aa0ad58cd2_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i24408e76c0c24f55ba8d7876c31ed2af_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i951c881d588b402e80e0a08fabfcbb9d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i41d577053e5b47e599467e7d5b2c1fc9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if46b85908413428cb65b67ada12835e7_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7d5d439ca53f48c7a5b9f80ea92d18b2_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="if34599cdf8c34ab2a763c193d7f21c5e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i719c9077824048efa89c19d85df1c039_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie25872f3bae6482a86f7173fcb928c60_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:HIPSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idfadb20ee8cf4b7ca29892f0e7ef9241_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i28753b33f19b4472a4b3b9615d39bde2_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i04834a7933574b9699e4470cca157b17_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i830efc8e5ef64f5d8bb67629c932302f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4e8660da0ae049279be4908d645ac814_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i61951583e0884a2b97857fcfd5143dfa_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iea8c758499ee481a982e0844029f02c5_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9530070346e046928aaa20fbdb32b6be_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:KNEESMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8c7f38204ba8470dbe88c6fbd6f163af_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i43027bbce9224ae1864acee61096aaac_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib7cfae47101947fbb19de601ee4d37cf_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i21d4e243e3244926af114c5ac8d5622b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i27f66ef65403479684878c39826affd8_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i79a301cc9e4741a9acf742a4531b7ffa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3df852a1e1c9437cbefc5d5967937bd0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TRAUMAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i09753ee22db9438db02316fe99eab602_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3ab103ca2b6347f4bec8d5f5a68b902f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6131de48add44569afcbb5f13e616222_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1077c0d6182e42b8b4a449d5823797da_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i61609c5ddc9d401f8c0a92c743695f8b_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i29508d3dfad845269de0d3b934e5f72f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i49489eb3476942d39146a7944e024129_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idac621d3e8974b4290777cb0a715967d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SPINEOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:OrthopaedicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i352af7e1cff64172939fb8676a18d694_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id0d1afadaa0d41f1867dafdde83a550a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic461ce15080e4d46a58069a1bb325e45_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic08ba492d063467dada493b5225e27bf_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0065caf47fbc4cb98c76aafdc60d0caa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6b7cf7e87b5048de9e83fc41fbba81d5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i25729810182f492586a816b1ffe57aa7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib93b7593957c4146b7aa8d5210aeb960_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i901b7c058bc04f02aaadc04d05618104_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib82e302424784eb79d013cbeddc5714a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i882dff1fdab04b9cbffd9a0b66d09708_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iaba1385624734a44a1f0995eb99a6a2f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:ADVANCEDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i575b4d6c52db4ddd9a77241756d3bcf7_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia24b2dfc5933488685d4e8679f9858df_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ic44276e5e39645adac5e0ec3c6d349a8_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i36fbf025a3bd46258314eaf0c5fd03c9_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i62837ac430c04475937229c201091a7b_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0e94e3d16b6442b3bf8ae4d7e42763aa_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8482a9eacc9d4a16b903c3069e30606c_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:GENERALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:SurgeryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic3373b694e464e87b09c196866598a61_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i18aae7095c214291953f8d5a7e83743d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6b5abffa1631440c9c106f7646cee59f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id1697845443b41b18f2e3fd65e94eff0_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib608a60c324249358f5c359cb804d50f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia3fd8a707583422a985a694bde7e8369_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ia53ba83708ab497da167bdf063b13001_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ieeb64f7ebcf24e8eb4738e491a709ef6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie3efc34904804bf392531b7e252380d0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2e533e4df7574745be8a32f1d7f8b20d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia94c309ebefb41e0882e6e5f7db81fc6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i6f667109df48490a91c424f760c9163b_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6387e0464e874ecebf490a3e7a9ac5a9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i510fab0efb5c421e951697a2eaabf3a6_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6afb3e29007f4d8fbbe84b8aa64fe6c4_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idecf2a3bf83549faaface09de3d21842_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:CONTACTLENSESOTHERMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i513396c914d24f2ca5d1a3b179dbb137_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia88b31446b9949bb9dc52ab066f472a5_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i95245826bf28466f88669de5c0eb29f9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie0e846d3dd6246fdad7038aa4f8fc310_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iea770061f1af4a23be59231dccaa6471_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i7544a09dc2e443659a4749d9c524a033_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:SURGICALMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">jnj:VisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i09d9e4292b9d49439e0ce7ef85bcd358_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id50251d99ca0478da493763fd6c20e76_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iea17e937da204406896ee031cfe58c20_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ib1ce6b5f2cf0439c9d34f1a1e0c2ef86_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5a7a9909054c412bb8414b6ad4b834fa_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6ed367815e324fed984862b7805db09b_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i780815182e5340ee9005439edb189dbd_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i40697a314e334705bf032c396d36a48f_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:PharmaceuticalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i215768a346504c6588118220125ee9e5_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8da67f7730324520a82f178539e2d723_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie05e097465d246e985c5a8a5836866ac_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2cdc971d10a846eda0291042d8911094_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i828cd0392f6a4f08b23a126fbc2fc210_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i879c922e7e06439cbd2406e34a34569f_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ieffb22b1734946ea874bf7ff0d96c59b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie38753485d6e4aa68503c096a70d147e_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7ed428655a844057a0ad1aee8a48ddd6_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:ConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i7fd16a3299794c08b00e5e9af4b2f47b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i023711733c384a55bc10c339faee9020_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i73f3e8b536cc4bd08b9add79f3cd22a3_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i990d3f55fb0d400fa30369f379908e85_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i875ab7cb24b5434fbef2a5fda9f740c0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i6f61c670043f4e00a54053474ec36a0d_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0c910149219540038cfaa2070ca96ba0_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:WesternHemisphereExcludingUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i2bebf8e1f4804892976ccad051fdb00c_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie452efdf003f4151a326a25ffbb9fc7a_D20181231-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">jnj:AsiaPacificAfricaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-31</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-09</startDate>
            <endDate>2020-07-09</endDate>
        </period>
    </context>
    <context id="i74a6f02cd81248429802bd3d52fdefc7_I20200709">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-09</instant>
        </period>
    </context>
    <context id="iee3cf065b9ca46aa995976b921a5e5a4_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LineOfCreditFacilityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:ConvertibleDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i41d885ad0df54f67810fa0ea503cd065_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">jnj:IdorsiaLTDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iccccb20c51044c9e9a84c5d3198c51c6_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i89f3aa8637734074bb148409f97b74c1_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:BermekimabMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i28266dc38c2e4216a3176ed95b4bbe08_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:VerbSurgicalInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="idcfe6f3194e6443e94a045dad55717d2_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="i1e9061e1ace447648d5d732bae5eb9b7_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:AdvancedSterilizationProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="ieafab643bde441f198c64b00b5b1e847_D20190401-20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-04-01</endDate>
        </period>
    </context>
    <context id="icb4d963c67ed4e88b28ef91289469a21_I20190401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-01</instant>
        </period>
    </context>
    <context id="ic55b39bf44b4426e804766d6f7f475c9_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i1ff46a56cf074bac822b7e06872012bb_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:AurisHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-17</startDate>
            <endDate>2019-01-17</endDate>
        </period>
    </context>
    <context id="i2b0c726c6f4642738819e5d706d7e4e6_I20190116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-16</instant>
        </period>
    </context>
    <context id="if77e2506aa334aaab104d21008cc97f9_D20190401-20190630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2019-06-30</endDate>
        </period>
    </context>
    <context id="i2a906710e47b4f588671a4492a187fc0_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ic033ba1a92f34808934f4676de7a195b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">jnj:CizHoldingsCo.Ltd.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i8bd12eebc1fe4027b0210d330a2835b4_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i582a2834e4fd4aff9b1bc95d88dffea5_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:AsrMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i1d8c3a0656d34fb5966cd9770c316551_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PinnacleAcetabularCupSystemMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i85df32700d11440b9f62c956e2be12e8_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PelvicMeshesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib9a3f835f231472f99dfb7bb92dc9732_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:RisperdalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="iea2331b0b13c42f9b906bf8c6741a1f2_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:XareltoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ie7cf6a6af023478299b61b15e7dc2e18_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:TalcMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i3d7dfc6628eb4c3e9f45d6d28b6c4239_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:InvokanaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i50eec62d41b944978cdcf2b62bbde5d6_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:PhysiomeshMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ib99b415ed1bd4de081616c1b0ba5adb9_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:DePuyASRU.S.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i70f14e4d505949438f899f930dceffd2_D20190930-20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-30</startDate>
            <endDate>2019-12-29</endDate>
        </period>
    </context>
    <context id="idd1ca5d4c491437ba8eb090bb6173cdb_D20200101-20200131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="i0b831b0b9e4744b890997d86490beb64_D20180701-20180731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-07-01</startDate>
            <endDate>2018-07-31</endDate>
        </period>
    </context>
    <context id="i73c27ed443d4477a94166f5501e091cc_D20200601-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:BabyPowderMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i843d961ffff941f780e135d0ac57ec95_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">jnj:OpioidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i8a2d74fb903f4bf9bccd750be8be4662_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i3071999c834c466fa7bf2ef272704338_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">jnj:OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:SettledLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i0f5aae03f63f42a89d19ed1519e2f71b_I20191031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-10-31</instant>
        </period>
    </context>
    <context id="ib27b2c7dd82249fa8839a100c11d8cd0_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:JudicialRulingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ia605452b07814f9785dea5e1749593fb_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i502babb46275458897c6c348109c5035_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="id9acc37568ea42f9922fa2c92c7d50ea_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ibc9ce1c7b9de4d7c9bd370f431d114cf_D20200330-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i753470899d364d1599b1fb2ae589ae15_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="iee0f458f77f44dae9e9a9f498f732d53_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:RestructuringChargesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i924dea35cc4a4db3a0754750a03791e8_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ie4563a7367fd4e85a1f89eec3c0e1587_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">jnj:OtherIncomeExpenseNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i643a2ee9d94c46a1a5979059886f331c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="ia536875c9d1940f7b5044f50a10ec73f_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i966d76441bca4eeda5773245cb198ca5_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i96475a51603a4e8e810595eccb66f241_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i5b9cec4fed09422f9f5c106fb3d09c7d_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:SupplyChainMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i87c5e8d39d9c4eaa85e56a1ce09a3918_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="idf1e8f0128234898a4c2745db86b0fdc_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i91cdc9cf7fe24f6295e435d3967682d3_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="i39f8df2915ae4439892ff4f3cc7ccf0a_I20191229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-29</instant>
        </period>
    </context>
    <context id="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i018045947632426a9bde5d53838f9afc_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="idb152c26aac84568b902e764916fb60c_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2020-06-28</endDate>
        </period>
    </context>
    <context id="ifb137f18e4de4282a026c925fc22bbef_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:EmployeeSeveranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i2ee00f42b2134d3796cbc180e878362c_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">jnj:AssetWriteoffMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i006340b658e24cf8b366c83c9bbfff9d_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringCostAndReserveAxis">us-gaap:OtherRestructuringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <context id="i78a038526da94ec5a15e091af7f02a84_I20200628">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000200406</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">jnj:MedicalDevicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-28</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="chf">
        <measure>iso4217:CHF</measure>
    </unit>
    <unit id="chfPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CHF</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="jpy">
        <measure>iso4217:JPY</measure>
    </unit>
    <unit id="claimant">
        <measure>jnj:claimant</measure>
    </unit>
    <unit id="patient">
        <measure>jnj:patient</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl80LTEtMS0xLTA_e5c13680-5697-406f-9b26-cac69da9272c">0000200406</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl81LTEtMS0xLTA_7d125377-cae8-4be8-b350-4675861f039e">--01-03</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl85LTEtMS0xLTA_3b3ad76f-3c1f-446f-860b-2439794cd86d">2020</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl8xMC0xLTEtMS0w_8ccfc9b7-b7ef-488a-8cbf-aed334163a0e">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83L2ZyYWc6ZDMyMDI2MTk0MWI1NGJlZjk1YTVhYTA5YTJlMWY0OTEvdGFibGU6Yzc4MTI0ZWMxNzljNDkyYzk2NzhiMjM4ZmU3NmVkZDYvdGFibGVyYW5nZTpjNzgxMjRlYzE3OWM0OTJjOTY3OGIyMzhmZTc2ZWRkNl8xMS0xLTEtMS0w_23e5e195-9316-4c45-83a2-33c06373df5f">false</dei:AmendmentFlag>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfMi0xLTEtMS0w_cf9d42a9-4332-4a11-aa20-51db8a964d9c"
      unitRef="usd">334000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfMi0zLTEtMS0w_c1f441a3-1a1a-40ac-87ef-bdcd2cd7f3b2"
      unitRef="usd">226000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNS0xLTEtMS0w_2cb7f42c-5720-424b-8905-7f405538b199"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNS0zLTEtMS0w_4d126d35-d407-4f02-895a-026b38316372"
      unitRef="usdPerShare">1.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNi0xLTEtMS0w_af678560-ef04-4876-b0ca-a093f152100d"
      unitRef="shares">4320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNi0zLTEtMS0w_321ed6d1-c128-41f3-96a5-54297e2af6c8"
      unitRef="shares">4320000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNy0xLTEtMS0w_0d9a45bf-fb59-444c-b672-0e1193fbde0c"
      unitRef="shares">3119843000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfNy0zLTEtMS0w_9b7ab1d6-18e8-481b-961b-8d06cd186ccc"
      unitRef="shares">3119843000</us-gaap:CommonStockSharesIssued>
    <us-gaap:TreasuryStockShares
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfOC0xLTEtMS0w_e5c4a0fd-cf75-4d26-88a5-accb7f98a894"
      unitRef="shares">487466000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yNS9mcmFnOjZmYTg2NGE5MzEzNDRiYjNhNzNmYzczZDE4NWU1ZjNhL3RhYmxlOmQwM2Y2YjgxMTgwMTQ4MTZhZjg0NzIzNTk4MWY4ZTFlL3RhYmxlcmFuZ2U6ZDAzZjZiODExODAxNDgxNmFmODQ3MjM1OTgxZjhlMWVfOC0zLTEtMS0w_684d1f00-4053-474a-b955-6b9445a30672"
      unitRef="shares">487336000</us-gaap:TreasuryStockShares>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0xLTEtMS0w_8f4e2219-37cf-4543-9f72-eff03f50514d"
      unitRef="usd">114000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0yLTEtMS0w_57a26e82-65f3-4e3a-b4a3-cf4a618c1d26"
      unitRef="usd">68000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi0zLTEtMS0w_5d271051-f39b-4ac3-bf95-eebaaaf9d2e3"
      unitRef="usd">106000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMi00LTEtMS0w_94024b5f-a3f2-41b5-8c8d-15095ee52fea"
      unitRef="usd">44000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0xLTEtMS0w_487c49e9-5a2f-42f2-b9e6-45fcedb92449"
      unitRef="usd">-1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0yLTEtMS0zMDYx_305337a0-69b8-4c19-9fbd-d7239ba604c7"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy0zLTEtMS0w_23fcd304-92ea-436b-8ac2-e6682e7206ac"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfMy00LTEtMS0zMDY1_cdce0269-db5a-4d97-a914-12b8f74b0303"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0xLTEtMS0w_0516eccc-3f05-45ac-a964-9f1bf3a92836"
      unitRef="usd">55000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0yLTEtMS0w_b58d613e-4496-4f2a-8a19-d630aa47b5f7"
      unitRef="usd">111000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC0zLTEtMS0w_1adb21ff-93b4-4600-b071-3dd4540cf408"
      unitRef="usd">34000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNC00LTEtMS0w_91053ce1-7c78-4ef4-b646-5932358628d9"
      unitRef="usd">35000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0xLTEtMS0w_90ab002a-2df1-4dac-8c68-80b3943c1c54"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0yLTEtMS0w_d849313a-6b7b-4ff4-bf84-0e5b99f74a35"
      unitRef="usd">246000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS0zLTEtMS0w_0ce537b6-d70b-4675-83f3-8c8a5d154d94"
      unitRef="usd">16000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNy9mcmFnOjFhNTA4ODM2NmE1ODQwNGViODcyNGZiNDhjOWMyNDRlL3RhYmxlOmViN2I2OWJiZjJjYTQ3MjBiM2FhMDMzYTY4MzZmMzIyL3RhYmxlcmFuZ2U6ZWI3YjY5YmJmMmNhNDcyMGIzYWEwMzNhNjgzNmYzMjJfNS00LTEtMS0w_e218052f-58d5-47b8-a053-042eeee25e8d"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0xLTEtMS0w_79ede66f-8bfd-4482-905f-d9597a913d62"
      unitRef="usdPerShare">1.01</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0yLTEtMS0w_baae7d45-d914-45d9-8b7f-46081d64a3b5"
      unitRef="usdPerShare">1.96</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi0zLTEtMS0w_d8a340a3-46b1-47d2-9a56-2b8bf9db405a"
      unitRef="usdPerShare">0.95</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80My9mcmFnOmQwMTg0N2M2ZTQwNzRlZjA5ZjA0NzAzZWI0NWJjYTQyL3RhYmxlOmZhZjFjNDI4ZjBjNDQ1MTFhYmY2ODVjZTY3ZTY3ZDVlL3RhYmxlcmFuZ2U6ZmFmMWM0MjhmMGM0NDUxMWFiZjY4NWNlNjdlNjdkNWVfMi00LTEtMS0w_86435025-a9d3-4677-8924-94cbe2ae041f"
      unitRef="usdPerShare">1.85</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82NC9mcmFnOjM1YjEyMGFiODRhZjQ5NzBiYTc5YTU4YmE2MmM5NGJkL3RhYmxlOmIwN2Y2M2NjYmQwMjQ1MDg4NjJiNTY3MzRiMTUyOTkwL3RhYmxlcmFuZ2U6YjA3ZjYzY2NiZDAyNDUwODg2MmI1NjczNGIxNTI5OTBfMC0xLTEtMS0w_a285c3a7-5ffe-463e-9e6f-7645adf16f2b"
      unitRef="usd">1100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82NC9mcmFnOjM1YjEyMGFiODRhZjQ5NzBiYTc5YTU4YmE2MmM5NGJkL3RhYmxlOmIwN2Y2M2NjYmQwMjQ1MDg4NjJiNTY3MzRiMTUyOTkwL3RhYmxlcmFuZ2U6YjA3ZjYzY2NiZDAyNDUwODg2MmI1NjczNGIxNTI5OTBfMS0xLTEtMS0w_6f2e80cd-90e9-4bc8-9b40-0cb185cab1bb"
      unitRef="usd">2200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7d82f1709b994eacb901cda0b8414196_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNC0xLTEtMS0w_2c5b706d-5531-42a9-91b6-12e7b04ea99b"
      unitRef="number">0.03550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i04fe5d0b9ade47e5981496ba5bbaed12_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNS0xLTEtMS0w_71939ce2-4e8d-4503-92fa-aa4309c5d6e1"
      unitRef="number">0.02450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8665aecb49944a58fbb92e84df3cc67_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfNy0xLTEtMS0w_07f6949c-f237-430a-9b39-8ff283e2c52f"
      unitRef="number">0.00250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i6e0e6b7104074202b4e5d369a606e4de_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfOC0xLTEtMS0w_db46e18d-34c0-4c70-99f5-0475433dbdb4"
      unitRef="number">0.02250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id3a4040a4a9d496e941dd0a85aa89117_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfOS0xLTEtMS0w_5bd8b982-2277-42de-be2b-76cb38c0d5f9"
      unitRef="number">0.06730</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i83226f68d388482997387c732a694f0b_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTAtMS0xLTEtMA_c8853ff6-f668-486c-a233-3ab835ee3fe7"
      unitRef="number">0.03375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ib7ea62f7202743edb0eb2e2ac6bdd8fc_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTEtMS0xLTEtMA_9af25301-3545-4218-b4ae-9e44d02e2947"
      unitRef="number">0.02050</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1cca58000e94ac18ffc4da63ed491ee_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTItMS0xLTEtMA_fbe554d9-d19c-448b-9885-37941970e8af"
      unitRef="number">0.00650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="id6b500b0012e4fffb964046db18b7ee9_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTMtMS0xLTEtMA_8a4eca45-92d2-4e51-8384-c901cbd3bc92"
      unitRef="number">0.05500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ice6838c819764fd3b274d26aa88869fb_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTQtMS0xLTEtMA_ad8df626-0173-4708-bf9d-b7ab9506bd71"
      unitRef="number">0.02625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ifa6388d8e4aa4d2ba5163676f80c3f61_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTUtMS0xLTEtMA_21e90df3-0ea4-4131-bb70-72b7ed61b4c1"
      unitRef="number">0.02450</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i55a1659d1528484386f3c1b96b56cd5b_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTYtMS0xLTEtMA_c85a9d6e-563a-44d4-b1a2-22edc705eb79"
      unitRef="number">0.0295</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie6972f42d4f04331bdc3fa37a69b7170_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTctMS0xLTEtMA_3bfe5071-7e74-41a7-92f8-9e7566409091"
      unitRef="number">0.02900</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i29c4cbdbde9b4e11a996c3f6929a01ca_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTgtMS0xLTEtMA_b5685687-efe9-4c20-91cd-3fa89ef48294"
      unitRef="number">0.01150</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ica38f942e6f54e37b25a587ae66eb689_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMTktMS0xLTEtMA_44ef4f3f-582a-443c-9bf6-ea348614311b"
      unitRef="number">0.06950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iddce8e7eb7d541908fa3346ff2ccc64d_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjAtMS0xLTEtMA_ad1535b6-6d76-4e0e-a175-e64282d77004"
      unitRef="number">0.04950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ia99bbdcc3d6f4e3a846ee43fffa0409c_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjEtMS0xLTEtMA_cf5aa255-ff1d-45fc-981d-c9ed70aa2a0a"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i7d75e926178641929b977bc0db3d772c_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjItMS0xLTEtMA_2107e504-bb2e-49d2-825e-34db09174c20"
      unitRef="number">0.01650</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if8d3f87a8a814ef3b7f7ceb44c1ed145_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjMtMS0xLTEtMA_4e741d77-895a-45eb-adc9-a5f922c07477"
      unitRef="number">0.03550</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="if1b09b47526a4eeba8c34cb6affc3050_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjQtMS0xLTEtMA_5592e5ad-a199-45e1-b9c9-e48c132259b3"
      unitRef="number">0.05950</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="idd21cfd6641847409da3807e3a428234_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjUtMS0xLTEtMA_4dc33df0-4c67-4ce3-97c0-6a56f8a7acb0"
      unitRef="number">0.03625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i1abc4374a89f41bda84e861ad20017c5_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjYtMS0xLTEtMA_fee41b48-207a-48fc-8ebc-305b52379002"
      unitRef="number">0.03400</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0218ee4e0ffe4a1c9ae094465ceff9f3_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjctMS0xLTEtMA_d6dbb70f-d4be-4802-9be4-780caf66ba5e"
      unitRef="number">0.05850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e888a83818c4971ac6ee9c8f4183487_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjgtMS0xLTEtMA_3066b4d5-380e-490b-90f0-e827b905e35f"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3b183eb71fa34ae282a8f6304ff5d4ed_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMjktMS0xLTEtMA_ff0a1a9a-7cdd-4cfb-84db-15193ee24e46"
      unitRef="number">0.04850</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i672a40323bdb4457a31a3d077e38d562_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzAtMS0xLTEtMA_2a25afcd-20a1-4448-9ed2-cdb9476025ca"
      unitRef="number">0.04500</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8e650bd7c2174e4989ca66001681ede2_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzEtMS0xLTEtMA_e848eaa3-41a5-46ba-85bb-e30b3746e836"
      unitRef="number">0.03700</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i5a9b919d33e6495ca7d583176e83bd1e_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzItMS0xLTEtMA_17960b55-4ae1-4a43-b125-9994c650cd6f"
      unitRef="number">0.0375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0089df10475a41e29517b0bb7f6c056b_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RhYmxlOjA2YWNhYTk3OTJhOTQ0Njg4YWZmOGFjMzI2YjIxNzdiL3RhYmxlcmFuZ2U6MDZhY2FhOTc5MmE5NDQ2ODhhZmY4YWMzMjZiMjE3N2JfMzMtMS0xLTEtMA_2fda793d-7aed-44eb-a58b-4e8b3e35aeb2"
      unitRef="number">0.0350</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentTerm
      contextRef="i778843f60e324063b0b113788a8aaa4e_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83MC9mcmFnOjU2M2Y5MjVkZjhmYzRlZjE4ODY0MDA5YTkyMGNhODdjL3RleHRyZWdpb246NTYzZjkyNWRmOGZjNGVmMTg4NjQwMDlhOTIwY2E4N2NfNzE0NjgyNTU4MDYxNA_ec35c33b-54a3-4719-8af8-006dc414c627">P3M21D</us-gaap:DebtInstrumentTerm>
    <dei:DocumentType
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY0_dda7052e-7742-48c4-9f51-e37a2418414b">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6NzdjYjdmNmYwZWM3NDJlYWFlZDM5NTlmYjhlNDkxMTkvdGFibGVyYW5nZTo3N2NiN2Y2ZjBlYzc0MmVhYWVkMzk1OWZiOGU0OTExOV8xLTAtMS0xLTA_fb0a794f-e9d0-4b75-b7a1-6328bf8f9dab">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8xMjI_0b2089c0-6b2c-4db5-bd4b-9909bb89036b">2020-06-28</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ODA3Njk4YzkzZjg3NGMxZTljODUzZGY4ZjYxNTY5YTQvdGFibGVyYW5nZTo4MDc2OThjOTNmODc0YzFlOWM4NTNkZjhmNjE1NjlhNF8xLTAtMS0xLTA_103b8fa6-dca4-4db9-a53e-689bc77293d6">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDU5_e3eacf2a-1b49-4d48-b85d-d67fdfaccefe">1-3215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYw_954aca72-e769-4fce-ba42-343b46f917f3">Johnson &amp; Johnson</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6YTQ2ZDI2ODg1MTg5NDcxMWFmZjI5MjU5OWYxODlmNzMvdGFibGVyYW5nZTphNDZkMjY4ODUxODk0NzExYWZmMjkyNTk5ZjE4OWY3M18wLTAtMS0xLTA_12b3f87f-7573-42ca-98ac-a0c9c92b9744">NJ</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6YTQ2ZDI2ODg1MTg5NDcxMWFmZjI5MjU5OWYxODlmNzMvdGFibGVyYW5nZTphNDZkMjY4ODUxODk0NzExYWZmMjkyNTk5ZjE4OWY3M18wLTItMS0xLTA_a845de14-9c47-47b4-978a-e1c47af31671">22-1024240</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDcw_2b755b1e-b110-4e22-bcb7-76cfc4e1f5ce">One Johnson &amp; Johnson Plaza</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYx_c2a2a8c1-0825-411f-8bde-cabbca2924a2">New Brunswick</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV83MTQ2ODI1NTgyNjQw_3f768d96-28f5-451d-a0be-413122b61cc4">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY2_efbf2067-dae4-4b1d-b861-5913da3cf2b8">08933</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY3_1fb7c172-04ca-45c6-99c3-2b7018f79d9c">732</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY4_1367a78b-4c1e-4d38-88f4-954c1403521d">524-0400</dei:LocalPhoneNumber>
    <dei:EntityCurrentReportingStatus
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYy_6f179e77-3585-4f3a-bf22-e0c3fe4847f5">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDY5_a702d44f-154d-4b6e-904c-61e90d9bbf3b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8wLTEtMS0xLTA_a125a8db-f7f5-46b2-9d1e-393b8bee6fc5">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8xLTQtMS0xLTA_7c66ba2f-c85c-42a8-9cb1-c90aa07dd791">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6ZWQyNzFkZGRhMTRkNDRkMTg4ZWUzM2NlNjQ4ZDY4NjEvdGFibGVyYW5nZTplZDI3MWRkZGExNGQ0NGQxODhlZTMzY2U2NDhkNjg2MV8yLTItMS0xLTA_755f1766-44dd-424c-b5da-5a1e712b793e">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8yMDYz_97a8b715-7191-4d7d-8e5c-8f325efaa358">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTAtMS0xLTA_119f54bc-4174-4e7a-bdf5-3a6cfe5945f9">Common Stock, Par Value $1.00</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTEtMS0xLTA_d9f5edfc-f43e-40d9-a0b8-d36245e36957">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i972855702c8a4b18883e4284851151dd_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8xLTItMS0xLTA_2322d36c-f5c1-455b-b8d4-401765e34624">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTAtMS0xLTA_4593f954-e21e-49dc-b47c-ce04bc1aad0c">0.250% Notes Due January 2022</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTEtMS0xLTA_72c76ac8-6817-4201-97ab-22041eba3552">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ie69874f5eb3741e8b3a01cc583f67093_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8yLTItMS0xLTA_edb29f33-e6d6-44de-be90-5dad980dbe52">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTAtMS0xLTA_e15eab6c-f62d-478b-960c-1b489945fdf4">0.650% Notes Due May 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTEtMS0xLTA_b7132aa1-c13e-41f7-b46a-813a7233baf1">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i41431b29b99e43f2b7ca1668c3a0701b_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml8zLTItMS0xLTA_239f386e-11fc-47a6-9ed4-1e710fe26cd8">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTAtMS0xLTA_6d4074c7-fa8b-4f15-a522-0b4143977ca4">5.50% Notes Due November 2024</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTEtMS0xLTA_6ec5a5df-5af4-4776-b552-bce54446e509">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="if5ff9ea58a5843a48f1380171cf7ec33_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml80LTItMS0xLTA_a338d604-facd-4b21-8adb-314504e088b7">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTAtMS0xLTA_e7b81e96-f2f8-48eb-8cad-919ee8a3acfc">1.150% Notes Due November 2028</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTEtMS0xLTA_1b487811-a259-47cb-9dd7-a63b30d44cb8">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9d358fb42f6e442d8d560259c53af35c_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml81LTItMS0xLTA_c7bedbd9-701c-433b-a9e3-95339f6fd4b1">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTAtMS0xLTA_7e4b172f-d96c-49f3-b1d1-2b3d00aac39e">1.650% Notes Due May 2035</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTEtMS0xLTA_b4fa9817-9f9a-4f0a-83cb-a6d974206d69">JNJ</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic856d158dae44bebac8f434b09054dc1_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGFibGU6MjA5NmY3NTIxZjRlNDg3MDhmYjFjMmVlNDZhY2E1ODIvdGFibGVyYW5nZToyMDk2Zjc1MjFmNGU0ODcwOGZiMWMyZWU0NmFjYTU4Ml82LTItMS0xLTA_196b8777-64f1-4e37-8f81-6dd2d6462512">NYSE</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="iefb6241d9bf2428e94a47ac9ce454499_I20200720"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8xL2ZyYWc6YjFiZDdjYTVhMTExNGNiYTg0YjkwMmQxNDA0MzVmZjEvdGV4dHJlZ2lvbjpiMWJkN2NhNWExMTE0Y2JhODRiOTAyZDE0MDQzNWZmMV8xOTk4_33f8569c-1650-47e9-a5bf-0a4e28df9316"
      unitRef="shares">2632823475</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMy0yLTEtMS0w_5c690c6f-ac69-4a4b-887b-c0dd6084f938"
      unitRef="usd">11174000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMy00LTEtMS0w_e1af3349-436f-4fbe-94a6-b8163fe17db2"
      unitRef="usd">17305000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNC0yLTEtMS0w_490ff0b3-1ede-45d9-a0a0-034a97af55d3"
      unitRef="usd">7961000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNC00LTEtMS0w_ff51b132-0995-425b-98e9-b3ffb065eeb8"
      unitRef="usd">1982000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNS0yLTEtMS0w_6fe264ea-91d2-4b22-8e96-ea5551dfb523"
      unitRef="usd">14645000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNS00LTEtMS0w_0492ec9e-28b2-4b95-ade2-11dccf6803d3"
      unitRef="usd">14481000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNi0yLTEtMS0w_ef899a22-90b8-4c06-899e-7594f911b09d"
      unitRef="usd">9424000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNi00LTEtMS0w_db70e9f0-e815-449a-b0bf-73c03af5f4c7"
      unitRef="usd">9020000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNy0yLTEtMS0w_79cb4233-fbd5-4c7c-b351-6b2bb4541d4e"
      unitRef="usd">2588000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNy00LTEtMS0w_196e5985-8054-42d6-b775-59985e5b43cc"
      unitRef="usd">2392000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOC0yLTEtMS0w_6da1bc09-7112-4a16-a7af-048cdc3733d1"
      unitRef="usd">100000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOC00LTEtMS0w_5c13af3c-7728-4fcf-a00a-8fc631d28b04"
      unitRef="usd">94000000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther>
    <us-gaap:AssetsCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOS0yLTEtMS0w_aa396c6f-084b-4492-81b3-6807f5c31804"
      unitRef="usd">45892000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfOS00LTEtMS0w_66f3c7b2-72a9-4c71-8aaa-38bf627a7cea"
      unitRef="usd">45274000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTAtMi0xLTEtMA_8559bcf0-3008-48e5-a2c5-f46ed1685d0e"
      unitRef="usd">44056000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTAtNC0xLTEtMA_24e98b5f-8572-4d11-aaaf-7db4a7ec4c11"
      unitRef="usd">43332000000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTEtMi0xLTEtMA_b60effe6-df08-409f-b42b-02564f973be1"
      unitRef="usd">26458000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTEtNC0xLTEtMA_c5126f0b-84c5-4dcb-b8c8-7e161f7996b2"
      unitRef="usd">25674000000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTItMi0xLTEtMA_1144919c-1b97-4c41-9a5b-f1f578b52c4b"
      unitRef="usd">17598000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTItNC0xLTEtMA_aac10e2a-87e6-4bec-8926-16086bdab646"
      unitRef="usd">17658000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTMtMi0xLTEtMA_c13827ab-2596-49e3-849b-67bb6bd79e6b"
      unitRef="usd">47413000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTMtNC0xLTEtMA_6b245543-769b-4317-a455-8a5ba660f627"
      unitRef="usd">47643000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTQtMi0xLTEtMA_9d457ecd-849d-4a68-9e24-0d0e14bf6971"
      unitRef="usd">33890000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTQtNC0xLTEtMA_e2772ea9-c973-4085-98d4-c034ea3dce48"
      unitRef="usd">33639000000</us-gaap:Goodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTUtMi0xLTEtMA_50eba634-1385-4abd-8c34-13cb2e7f6b5b"
      unitRef="usd">7805000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTUtNC0xLTEtMA_c925aec1-7462-440a-83b9-3352b92204e4"
      unitRef="usd">7819000000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTYtMi0xLTEtMA_e9bd5345-314e-49e6-9a68-f8a08a2f3dc7"
      unitRef="usd">5782000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTYtNC0xLTEtMA_3203ffc2-c384-48ea-a049-e6f7eaafc7c4"
      unitRef="usd">5695000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTctMi0xLTEtMA_cc10d3fd-d1e8-4952-960d-c58c0bc03881"
      unitRef="usd">158380000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMTctNC0xLTEtMA_04edad4d-1136-41e1-9346-ea40242eb311"
      unitRef="usd">157728000000</us-gaap:Assets>
    <us-gaap:ShortTermBorrowings
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjAtMi0xLTEtMA_5fa819e5-2f2e-4fe2-91db-9cdca38d940c"
      unitRef="usd">5332000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjAtNC0xLTEtMA_88941fb6-b87c-418c-b4e5-6da41bdaf933"
      unitRef="usd">1202000000</us-gaap:ShortTermBorrowings>
    <us-gaap:AccountsPayableCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjEtMi0xLTEtMA_0407cf81-8c36-4d4f-8979-272d5795265d"
      unitRef="usd">6765000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjEtNC0xLTEtMA_9a47e807-bfeb-4395-ab7b-eb07bced94c2"
      unitRef="usd">8544000000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjItMi0xLTEtMA_6229352f-8063-4224-9af5-56486772ad8d"
      unitRef="usd">8940000000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjItNC0xLTEtMA_2c1b2003-22eb-4af4-ad64-54dfb2860698"
      unitRef="usd">9715000000</us-gaap:AccruedLiabilitiesCurrent>
    <jnj:AccruedRebatesReturnsAndPromotions
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjMtMi0xLTEtMA_176d7797-efb0-4077-9e16-fd257d725369"
      unitRef="usd">11790000000</jnj:AccruedRebatesReturnsAndPromotions>
    <jnj:AccruedRebatesReturnsAndPromotions
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjMtNC0xLTEtMA_05e28e6c-3605-4441-891c-27d386464e0a"
      unitRef="usd">10883000000</jnj:AccruedRebatesReturnsAndPromotions>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjQtMi0xLTEtMA_86b7360e-65dc-4bc5-a0d0-8959d8c65078"
      unitRef="usd">2313000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjQtNC0xLTEtMA_d9afc7bf-0e8b-4125-a22f-2499677cfd03"
      unitRef="usd">3354000000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjUtMi0xLTEtMA_1892edc3-6c45-4eb9-95d1-a1172545c46b"
      unitRef="usd">1632000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjUtNC0xLTEtMA_3adc12ff-70a9-4a3d-9e52-e6c3428c4d93"
      unitRef="usd">2266000000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjYtMi0xLTEtMA_e4781dbe-7f5b-4939-9fba-80485fee88a4"
      unitRef="usd">36772000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjYtNC0xLTEtMA_f56675a8-5f70-4df6-989b-c63ed8444e94"
      unitRef="usd">35964000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjctMi0xLTEtMA_2e96982f-16b0-4b06-a2e3-439115bda7ce"
      unitRef="usd">25062000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjctNC0xLTEtMA_8bf03b2a-6e1f-46c4-9266-06ec1a09dc4e"
      unitRef="usd">26494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjgtMi0xLTEtMA_9224ee5b-c4e0-4f59-9057-ec529de30f7d"
      unitRef="usd">5532000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjgtNC0xLTEtMA_93de453c-bd0b-462e-b70f-5789e97aa1c3"
      unitRef="usd">5958000000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjktMi0xLTEtMA_3af7f786-e6f6-4098-a752-607a2aeee01d"
      unitRef="usd">10411000000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMjktNC0xLTEtMA_d7cea31d-fdb8-450b-842e-143870f21abb"
      unitRef="usd">10663000000</us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzAtMi0xLTEtMA_2658d454-d4d0-4141-ba8a-c3ffd66b7438"
      unitRef="usd">6591000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:AccruedIncomeTaxesNoncurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzAtNC0xLTEtMA_9c7ebb23-dfe6-4c68-9e01-5b87330fed49"
      unitRef="usd">7444000000</us-gaap:AccruedIncomeTaxesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzEtMi0xLTEtMA_4c0c3f18-88b6-4153-a2cf-a86f5bf7fef7"
      unitRef="usd">11034000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzEtNC0xLTEtMA_810a739c-3a35-48d3-b2a8-93ff8d6f15ca"
      unitRef="usd">11734000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzItMi0xLTEtMA_841fc65f-9271-4d08-b8da-87a44b358c4f"
      unitRef="usd">95402000000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzItNC0xLTEtMA_a0f57819-646d-4fca-90f5-3f73fe4a9eac"
      unitRef="usd">98257000000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzMtMi0xLTEtMA_ca56f6a0-fbff-4ce6-920d-ac3aa8ffed84"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzMtNC0xLTEtMA_04467bdb-ae01-43e2-a1da-5b04c3fb844f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzUtMi0xLTEtMA_655bca04-dbe9-41a6-8b2c-4c24d2a92507"
      unitRef="usd">3120000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzUtNC0xLTEtMA_bae4f855-2423-4ab4-9bfe-3dc77a6ae026"
      unitRef="usd">3120000000</us-gaap:CommonStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzYtMi0xLTEtMA_51cb87d9-6621-4233-b036-e08822a3a24b"
      unitRef="usd">-15533000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzYtNC0xLTEtMA_a4101729-0dc6-44e3-899c-9c3b09591f19"
      unitRef="usd">-15891000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzctMi0xLTEtMA_30b0c9e6-e175-4d58-ac77-5780a2dc2d17"
      unitRef="usd">113898000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzctNC0xLTEtMA_04660e34-5d7b-467b-a314-ce03b8b91633"
      unitRef="usd">110659000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzgtMi0xLTEtMA_8024efd4-5f86-418a-a80a-3fb60945df4f"
      unitRef="usd">38507000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzgtNC0xLTEtMA_61ee34dd-b995-4c3b-9bce-5b19d1396094"
      unitRef="usd">38417000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzktMi0xLTEtMA_89031ae9-f824-410a-b6fd-8ee64eb4e7a4"
      unitRef="usd">62978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfMzktNC0xLTEtMA_948a8d68-979b-4765-903f-d24c9c6e773c"
      unitRef="usd">59471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNDAtMi0xLTEtMA_c78c3afb-3fcd-4140-8334-7b1ffe245948"
      unitRef="usd">158380000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yMi9mcmFnOmM1ZWVhNmZiYjZkMjRiNTZhMDgyNjJhNmY3N2JiOTc1L3RhYmxlOmU3MDYyNzE0NmQxMzRkMDM4MDNkNzFhMWM1MTQzYzFiL3RhYmxlcmFuZ2U6ZTcwNjI3MTQ2ZDEzNGQwMzgwM2Q3MWExYzUxNDNjMWJfNDAtNC0xLTEtMA_6688f020-f176-4823-8cae-6b97eb337dc9"
      unitRef="usd">157728000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi0yLTEtMS0w_5617f0eb-55d4-4871-a258-304586281ff4"
      unitRef="usd">18336000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi00LTEtMS0w_85aa4534-e996-45ea-bf37-97523bdb46ad"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi02LTEtMS0w_310dff66-66b7-4d89-8f15-f261fe77d690"
      unitRef="usd">20562000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMi04LTEtMS0w_b00bfde3-bb4d-416f-b2dd-6e0a81abe9a6"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy0yLTEtMS0w_089cb98b-5dc8-4874-b5f5-0efb1578a0e9"
      unitRef="usd">6579000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy00LTEtMS0w_b7524c19-a8c2-4608-8df4-95cc25814c84"
      unitRef="number">0.359</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy02LTEtMS0w_7b789937-b193-4766-aac6-5719bc403c9a"
      unitRef="usd">6940000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMy04LTEtMS0w_e16c948c-68c6-4bcc-8d08-3f8b8300624e"
      unitRef="number">0.338</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:GrossProfit
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC0yLTEtMS0w_29221ffe-e066-44cf-b276-9521252d0058"
      unitRef="usd">11757000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC00LTEtMS0w_81da7d7f-b66e-422c-8aad-a65fb63d6fec"
      unitRef="number">0.641</jnj:GrossProfitPercentToSales>
    <us-gaap:GrossProfit
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC02LTEtMS0w_e99c6c45-480b-44ec-87ff-cd8fea62c9c0"
      unitRef="usd">13622000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNC04LTEtMS0w_c8559410-572b-4d31-a57f-87ab24d0443e"
      unitRef="number">0.662</jnj:GrossProfitPercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS0yLTEtMS0w_53329741-d499-4012-8adc-386ac930d793"
      unitRef="usd">4993000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS00LTEtMS0w_010dffae-aae8-4272-8051-b9b23fb34b33"
      unitRef="number">0.272</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS02LTEtMS0w_5c4026ae-1f93-4083-a100-88b8a5a37a65"
      unitRef="usd">5546000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNS04LTEtMS0w_3fb3b06e-97c3-480c-b8b6-1dc1f5b1f5c8"
      unitRef="number">0.270</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi0yLTEtMS0w_773200ea-036f-4924-a9fd-1b8d111e86e2"
      unitRef="usd">2707000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi00LTEtMS0w_d3ed1aed-821e-4d41-8353-9b9c58dc08d7"
      unitRef="number">0.148</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi02LTEtMS0w_9987106a-caf9-457a-9a68-e945f2337bc8"
      unitRef="usd">2666000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNi04LTEtMS0w_55722f32-5876-48aa-a7fe-2b9a1293c428"
      unitRef="number">0.130</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy0yLTEtMS0w_79336aef-776a-4cab-9660-b2f29951853b"
      unitRef="usd">6000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy00LTEtMS0w_ec25dfc2-ffb0-423b-bae3-5840f1215f22"
      unitRef="number">0.000</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy02LTEtMS0w_1aac1d29-6b17-4a49-a800-bcdfbaac527c"
      unitRef="usd">0</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfNy04LTEtMS0w_a384ee3f-9dd0-4808-a0b5-b10b9b7d356c"
      unitRef="number">0</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC0yLTEtMS0w_8047cd08-a849-4421-bf00-f1f7a6566951"
      unitRef="usd">19000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC00LTEtMS0w_970f9cf8-313e-46c1-9a50-8d419116edd4"
      unitRef="number">-0.001</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC02LTEtMS0w_c3bca762-9538-4c4c-8558-5566fc59d497"
      unitRef="usd">88000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOC04LTEtMS0w_cdde9a77-a94c-465d-82ec-13799491f892"
      unitRef="number">-0.004</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InterestExpense
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS0yLTEtMS0w_25c0b2f3-efc2-4ad8-aaab-490419f6d8d1"
      unitRef="usd">45000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS00LTEtMS0w_19fd6527-b3f3-4c38-a70e-4b0043151553"
      unitRef="number">0.003</jnj:InterestExpensePercentToSales>
    <us-gaap:InterestExpense
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS02LTEtMS0w_b24c04b2-0840-42a6-a89c-2addd4e02a2f"
      unitRef="usd">83000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfOS04LTEtMS0w_5bee0eb1-eb61-4702-b18d-936f22c3e537"
      unitRef="number">0.004</jnj:InterestExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtMi0xLTEtMA_01ed35b6-fab7-48e8-b468-d453a2b2d133"
      unitRef="usd">-24000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtNC0xLTEtMA_961b40ac-ccb9-40cb-a67c-17b72bebf870"
      unitRef="number">0.001</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtNi0xLTEtMA_1049d21a-2cd8-4847-ab45-ce9db7ba101e"
      unitRef="usd">1683000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTAtOC0xLTEtMA_7786f182-c36e-4074-99f5-15b73e11f315"
      unitRef="number">-0.082</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:RestructuringCharges
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtMi0xLTEtMA_30c5ac00-d3f7-43c6-97bf-9e58dbd2463d"
      unitRef="usd">61000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtNC0xLTEtMA_af28ec3f-fad1-4b43-a7b0-1c52e1d26293"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:RestructuringCharges
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtNi0xLTEtMA_698bc347-7ad3-4294-b3e5-87d344ede006"
      unitRef="usd">57000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTEtOC0xLTEtMA_39ffd0d2-2d18-43ac-9955-f3f42ec026f3"
      unitRef="number">0.002</jnj:Restructuringchargepercenttosales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItMi0xLTEtMA_55295df2-6725-4190-9171-11226e8ccc00"
      unitRef="usd">3940000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItNC0xLTEtMA_53972e12-7483-4600-b587-46c28608fe7e"
      unitRef="number">0.215</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItNi0xLTEtMA_84bd3e64-3ff4-4fb6-a7c8-f4632b180401"
      unitRef="usd">7041000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTItOC0xLTEtMA_60c659d2-229f-4f57-8cc1-e269a5794c37"
      unitRef="number">0.342</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtMi0xLTEtMA_68897aa0-7069-45c7-b9b4-e26c6d2c138e"
      unitRef="usd">314000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtNC0xLTEtMA_641ea0be-6670-4dd9-a4af-058d6a15bfce"
      unitRef="number">0.017</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtNi0xLTEtMA_b4a6c11a-7657-42d3-a3bd-9bec26c54be3"
      unitRef="usd">1434000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTMtOC0xLTEtMA_9530e260-320b-44d6-be8f-7b2032b38147"
      unitRef="number">0.069</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtMi0xLTEtMA_b7c0a5ad-c816-450b-abbb-0f25c67b8ebe"
      unitRef="usd">3626000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtNC0xLTEtMA_6d89b7e9-73fb-440c-8292-be37cc0da913"
      unitRef="number">0.198</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtNi0xLTEtMA_cc891e39-cf0e-4764-a5b6-da1fc30f1380"
      unitRef="usd">5607000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTQtOC0xLTEtMA_adf93275-06d0-46e7-bc01-508067dd73ba"
      unitRef="number">0.273</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTctMi0xLTEtMA_fd9beee5-2221-4fc4-9ae6-beb34ce2f00f"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTctNi0xLTEtMA_45c99fc6-8b67-4aad-882e-baaf7fb83e34"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTgtMi0xLTEtMA_b80f7416-e470-4c5b-9e46-080558e3cb3a"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMTgtNi0xLTEtMA_fc8b777f-bddd-40af-b268-da236efeb372"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjEtMi0xLTEtMA_dab2d499-1706-4be0-9949-744abdcd1144"
      unitRef="shares">2632900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjEtNi0xLTEtMA_dfdba21a-636d-4c9d-a786-55fd82e23898"
      unitRef="shares">2652500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjItMi0xLTEtMA_28a9006a-0adf-4151-8ef7-32805e520bb0"
      unitRef="shares">2665500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8yOC9mcmFnOjBlZTljMjZlMmJlMTQwMTFiMjM2Y2U3ODczOTI0Y2UyL3RhYmxlOmQ4MmU1MGY4ODY3MDQyOWQ4YjI0ODRhNWNiMWY2MmExL3RhYmxlcmFuZ2U6ZDgyZTUwZjg4NjcwNDI5ZDhiMjQ4NGE1Y2IxZjYyYTFfMjItNi0xLTEtMA_e777322c-80b2-4eb4-ac8f-d9c7e90a4529"
      unitRef="shares">2691700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy0yLTEtMS0w_c53c3880-1b6a-4bc8-a755-b0ff31b7d1fb"
      unitRef="usd">39027000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy00LTEtMS0w_0a233d19-6413-4ae3-b050-673ee7599d68"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy02LTEtMS0w_bb9bff66-9538-4ac9-92ef-9d77a56d06cb"
      unitRef="usd">40583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:SalesRevenueGoodsNetPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMy04LTEtMS0w_818b0955-404a-443d-824c-1b53dca5d506"
      unitRef="number">1.000</jnj:SalesRevenueGoodsNetPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC0yLTEtMS0w_c164fb1d-5a54-413d-ac54-5014c8ee15c7"
      unitRef="usd">13641000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC00LTEtMS0w_c85585ea-8890-4196-87b6-c309adc15124"
      unitRef="number">0.350</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC02LTEtMS0w_caea5706-42d2-429f-a3e4-6b4ddf9587b2"
      unitRef="usd">13555000000</us-gaap:CostOfGoodsAndServicesSold>
    <jnj:CostOfGoodsSoldPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNC04LTEtMS0w_1ca67871-177e-4bb9-bdb5-66eefd39f2b8"
      unitRef="number">0.334</jnj:CostOfGoodsSoldPercentToSales>
    <us-gaap:GrossProfit
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS0yLTEtMS0w_d0eb208d-230b-4b89-8f83-b6b3a418867a"
      unitRef="usd">25386000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS00LTEtMS0w_f2dae28e-fa5f-48cc-abf7-4ca521c019eb"
      unitRef="number">0.650</jnj:GrossProfitPercentToSales>
    <us-gaap:GrossProfit
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS02LTEtMS0w_2ded5696-286a-4b24-a3b7-cc0f90dc15b8"
      unitRef="usd">27028000000</us-gaap:GrossProfit>
    <jnj:GrossProfitPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNS04LTEtMS0w_c36db985-5c48-4937-8fa3-6202c7584432"
      unitRef="number">0.666</jnj:GrossProfitPercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi0yLTEtMS0w_d0ac0e98-ebfe-4869-9633-cc0b5c55a33e"
      unitRef="usd">10196000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi00LTEtMS0w_9e298217-3484-4a07-baf0-ff3b32da7a47"
      unitRef="number">0.261</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi02LTEtMS0w_47b53996-667b-4c74-b20a-9d3c55eea861"
      unitRef="usd">10765000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <jnj:SellingGeneralAndAdministrativeExpensePercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNi04LTEtMS0w_a275bb56-9f39-4b8e-93d7-f73c96c1e596"
      unitRef="number">0.265</jnj:SellingGeneralAndAdministrativeExpensePercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy0yLTEtMS0w_d4c8e23d-2112-4bd1-99fe-e90abaff7acd"
      unitRef="usd">5287000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy00LTEtMS0w_cb9b2abc-937d-4290-bb94-32de37133c67"
      unitRef="number">0.135</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy02LTEtMS0w_f6603427-0479-4c6f-9522-d2bdcaa4e84e"
      unitRef="usd">5524000000</us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost>
    <jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfNy04LTEtMS0w_83e54922-d608-43df-bcde-e5eb6026e944"
      unitRef="number">0.136</jnj:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC0yLTEtMS0w_69036a5e-6b93-4ec0-b308-14b8e8cd7e6d"
      unitRef="usd">6000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC00LTEtMS0w_b1249f74-c61f-41a3-9610-77a3dc1a31df"
      unitRef="number">0.000</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC02LTEtMS0w_95cdb791-1f1f-4e8f-927f-f9b05db3f323"
      unitRef="usd">890000000</us-gaap:ResearchAndDevelopmentInProcess>
    <jnj:ResearchAndDevelopmentInProcessPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOC04LTEtMS0w_71f02530-cd19-4c7c-bfa6-8fb7d00e9505"
      unitRef="number">0.022</jnj:ResearchAndDevelopmentInProcessPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS0yLTEtMS0w_924c3b7b-a3c2-49ea-81d9-6443ecf471eb"
      unitRef="usd">86000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS00LTEtMS0w_aa69df36-0524-4d3a-9d71-327921015f2b"
      unitRef="number">-0.002</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InvestmentIncomeInterest
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS02LTEtMS0w_a28f690d-3446-4626-826e-31ec48ad9db9"
      unitRef="usd">187000000</us-gaap:InvestmentIncomeInterest>
    <jnj:InvestmentIncomeInterestPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfOS04LTEtMS0w_021297c2-305c-4590-9040-797acba0dc33"
      unitRef="number">-0.005</jnj:InvestmentIncomeInterestPercentToSales>
    <us-gaap:InterestExpense
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtMi0xLTEtMA_df985ec4-13d3-49cc-bfe7-60a903f05ebd"
      unitRef="usd">70000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtNC0xLTEtMA_217ec692-ee35-402f-b6ac-358657552448"
      unitRef="number">0.002</jnj:InterestExpensePercentToSales>
    <us-gaap:InterestExpense
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtNi0xLTEtMA_3d3e56be-d0e8-4cbf-9b61-6adc3484e44d"
      unitRef="usd">185000000</us-gaap:InterestExpense>
    <jnj:InterestExpensePercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTAtOC0xLTEtMA_f312079e-8e74-49fb-9408-87a9ec217644"
      unitRef="number">0.005</jnj:InterestExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtMi0xLTEtMA_c31cc2a7-9c81-4d95-9233-da52b250bdbd"
      unitRef="usd">655000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtNC0xLTEtMA_65d2d633-35be-48cd-84b9-811cbe81c7f0"
      unitRef="number">-0.017</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtNi0xLTEtMA_94225e8a-5c4c-48b0-845b-0e6c5881bab8"
      unitRef="usd">1705000000</us-gaap:OtherNonoperatingIncomeExpense>
    <jnj:OtherNonOperatingIncomeExpensePercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTEtOC0xLTEtMA_f6c4f231-263f-45eb-b2c9-7b654dcfd113"
      unitRef="number">-0.042</jnj:OtherNonOperatingIncomeExpensePercentToSales>
    <us-gaap:RestructuringCharges
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItMi0xLTEtMA_dfb430d0-6843-4f65-afbe-b282dc1fd592"
      unitRef="usd">119000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItNC0xLTEtMA_9734995d-d7b2-455f-9c0a-482178e43f97"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:RestructuringCharges
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItNi0xLTEtMA_3abb953c-deaf-4175-bee4-8d7635bad6f2"
      unitRef="usd">93000000</us-gaap:RestructuringCharges>
    <jnj:Restructuringchargepercenttosales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTItOC0xLTEtMA_5fb4c7e8-456c-4e51-8581-b91f41804b29"
      unitRef="number">0.003</jnj:Restructuringchargepercenttosales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtMi0xLTEtMA_8e1f0f22-ec42-4cf5-87ef-6bfa6ff8e5c3"
      unitRef="usd">10449000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtNC0xLTEtMA_e05c96e6-d41a-4570-b39d-6b766b60dd5e"
      unitRef="number">0.268</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtNi0xLTEtMA_2de94825-f5bf-4a24-bc9e-2a59adec592c"
      unitRef="usd">11463000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTMtOC0xLTEtMA_3f90f9a8-f71a-454b-9368-8874a4204e74"
      unitRef="number">0.282</jnj:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtMi0xLTEtMA_ee32fcc5-e609-40fe-9fb9-f8463c03ce9a"
      unitRef="usd">1027000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtNC0xLTEtMA_dcd24e78-2c9c-4530-964d-3979624fe140"
      unitRef="number">0.027</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtNi0xLTEtMA_de316edf-2dab-4b98-85ad-6934a1d2777c"
      unitRef="usd">2107000000</us-gaap:IncomeTaxExpenseBenefit>
    <jnj:IncomeTaxExpenseBenefitPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTQtOC0xLTEtMA_9a02aa38-b327-4449-9703-f104a2fba893"
      unitRef="number">0.051</jnj:IncomeTaxExpenseBenefitPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtMi0xLTEtMA_a6997a8c-0b72-44e4-b6d7-cc626b290246"
      unitRef="usd">9422000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtNC0xLTEtMA_96bc37df-0f13-4427-99f4-975121995385"
      unitRef="number">0.241</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:NetIncomeLoss
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtNi0xLTEtMA_e2f6bdf4-3b47-41c7-b1cb-06f1c9c63858"
      unitRef="usd">9356000000</us-gaap:NetIncomeLoss>
    <jnj:NetIncomeAttributableToParentPercentToSales
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTUtOC0xLTEtMA_0a2a9c48-1a04-4298-98ac-3ba4c656d8be"
      unitRef="number">0.231</jnj:NetIncomeAttributableToParentPercentToSales>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTgtMi0xLTEtMA_68b44b19-ad1d-440b-8ca7-a6b6aaaf6edf"
      unitRef="usdPerShare">3.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTgtNi0xLTEtMA_05ff431c-c68f-476d-bff2-54674f5cce38"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTktMi0xLTEtMA_09223f79-dbbb-48b3-8aaf-61a2baa953f6"
      unitRef="usdPerShare">3.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMTktNi0xLTEtMA_b9d692e7-afdd-477a-87fc-520ab2c442eb"
      unitRef="usdPerShare">3.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjItMi0xLTEtMA_f367731c-be9b-45ca-bf18-4a40caf40728"
      unitRef="shares">2633300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjItNi0xLTEtMA_8c4eca8a-7053-4398-b1ab-73b950c13b57"
      unitRef="shares">2656700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjMtMi0xLTEtMA_00034b60-a776-4051-908f-9c636f6bff1e"
      unitRef="shares">2671000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zMS9mcmFnOjc1Zjk2ZTU3M2U0YzRiYjg5OGQ3MzE0Y2Y2MTVlYjY1L3RhYmxlOjQ3MjBjZDJiODI4NDQ0MzM4MDJjNDM2ZDFmYWJkNWM5L3RhYmxlcmFuZ2U6NDcyMGNkMmI4Mjg0NDQzMzgwMmM0MzZkMWZhYmQ1YzlfMjMtNi0xLTEtMA_186710df-15af-406e-97c2-e4423d4d79c0"
      unitRef="shares">2697000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy0xLTEtMS0w_84f290af-ca56-4782-846b-fd0814c49111"
      unitRef="usd">3626000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy0zLTEtMS0w_3693c4c0-3b3a-47a7-bff2-36c4564cde54"
      unitRef="usd">5607000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy01LTEtMS0w_97b7f3fd-e806-450d-9453-6d05135647e7"
      unitRef="usd">9422000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMy03LTEtMS0w_a2f18cb6-4573-481a-b2b8-650a7ff9b784"
      unitRef="usd">9356000000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi0xLTEtMS0w_807dcac5-0320-4831-99ca-e4da36c9fb6b"
      unitRef="usd">556000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi0zLTEtMS0w_bb8d60b5-c5e7-41cf-a349-5c8b53cef26a"
      unitRef="usd">350000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi01LTEtMS0w_5d65aed9-b7c9-4107-8433-1c46c522deeb"
      unitRef="usd">-963000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfNi03LTEtMS0w_d740f992-8973-4f38-9124-9cb95c8458e2"
      unitRef="usd">92000000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS0xLTEtMS0w_54591684-d1ad-4900-a6ca-eeed435afdac"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS0zLTEtMS0w_1e4ef105-d3a2-4f8b-bc65-b743db7634c6"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS01LTEtMS0w_2a5add97-ad84-48f6-805c-3b59dd31c9f5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfOS03LTEtMS0w_0c6a9a0f-bb1d-42cc-8450-f11b90c55a80"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtMS0xLTEtMA_7e0d9e6f-3bd0-4d37-8eee-ba523ca44e63"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtMy0xLTEtMA_d996fa6e-ddb8-40c0-babd-269941d58021"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtNS0xLTEtMA_28d13770-13b7-4744-8cab-5845188a2723"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTAtNy0xLTEtMA_3c7c7efb-f57e-4089-8870-fd86e01eaffd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItMS0xLTEtMA_5931ef17-a020-435e-907c-710ae9eda5ad"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItMy0xLTEtMA_b18fc638-df39-4240-9186-e65fbd7b1b1e"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItNS0xLTEtMA_d2e7e8d9-4eb4-4c21-a732-53d152f6976f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTItNy0xLTEtMA_2c383fdb-c8b0-4943-897b-18a34f0773ff"
      unitRef="usd">1000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtMS0xLTEtMA_596f4a8b-ed4a-4e62-a6ba-be57cd7f5b87"
      unitRef="usd">5000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtMy0xLTEtMA_d3adbbec-6e98-4759-9baa-173fce313d3a"
      unitRef="usd">5000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtNS0xLTEtMA_c8cc8897-7d3f-4165-aaee-d9290fcb910e"
      unitRef="usd">11000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTUtNy0xLTEtMA_d2fec453-5aac-4d07-b175-79900f161bbb"
      unitRef="usd">12000000</jnj:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtMS0xLTEtMA_763a5771-039d-48a6-b56b-b6b2e13e3c8d"
      unitRef="usd">-200000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtMy0xLTEtMA_2a5dc9cf-e0cf-4a74-8416-9756a2e22810"
      unitRef="usd">-142000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtNS0xLTEtMA_bfcb2369-07c0-4a31-929a-2b1419481713"
      unitRef="usd">-401000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTYtNy0xLTEtMA_9cb142b2-221f-400d-bbf2-ce181d9439c8"
      unitRef="usd">-318000000</jnj:OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtMS0xLTEtMA_d9bac892-155d-4789-99eb-139c3390ce38"
      unitRef="usd">-195000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtMy0xLTEtMA_dc9bfbd6-8459-4956-ba52-c8ea531a3705"
      unitRef="usd">-137000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtNS0xLTEtMA_f7caf02d-8043-4e0c-a092-89ab96f29bc1"
      unitRef="usd">-390000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMTgtNy0xLTEtMA_360778db-fafb-46c5-bc49-e3e23e373772"
      unitRef="usd">-306000000</us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtMS0xLTEtMA_26cead28-b1ae-4a97-8883-ff89e6551791"
      unitRef="usd">21000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtMy0xLTEtMA_e8836f41-a815-4416-9d56-cb6f388d5fa8"
      unitRef="usd">86000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtNS0xLTEtMA_ad3c6aa8-da3a-4667-9c0c-bdf32c2f5f57"
      unitRef="usd">853000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjEtNy0xLTEtMA_95e15ad4-e6af-4032-9d71-618a36a4a23f"
      unitRef="usd">-216000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItMS0xLTEtMA_feafcae9-d020-4dee-b23a-881d98a44d89"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItMy0xLTEtMA_1f289b46-4809-4f5c-b5e8-dd0c3b282d41"
      unitRef="usd">26000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItNS0xLTEtMA_5ebd2048-2aaa-42d7-b332-c74c9c780e39"
      unitRef="usd">-78000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjItNy0xLTEtMA_ca28add7-b8d5-4767-a1f4-d6a15b140c33"
      unitRef="usd">-70000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtMS0xLTEtMA_e25c1188-690a-40e2-8d00-e2361388e5dd"
      unitRef="usd">-39000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtMy0xLTEtMA_93556cd7-c155-4651-b4a4-fa4ee1904be9"
      unitRef="usd">60000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtNS0xLTEtMA_5d92d8be-6e70-467e-ba6a-b588d8357024"
      unitRef="usd">931000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjMtNy0xLTEtMA_fd1e8577-47a9-4a38-863a-051961f7d58b"
      unitRef="usd">-146000000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtMS0xLTEtMA_b38d8626-fd3a-49b7-8ac2-ce75c115f334"
      unitRef="usd">710000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtMy0xLTEtMA_fadc0a2e-03f6-471f-bfbb-b4bb0d94234c"
      unitRef="usd">548000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtNS0xLTEtMA_bebcfa26-cfa6-41e9-9db0-f00e9c87977d"
      unitRef="usd">358000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjUtNy0xLTEtMA_75d0f380-2709-415c-b113-931dc029d6a0"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctMS0xLTEtMA_4effe271-7c4d-45e5-bc31-fa88fa613689"
      unitRef="usd">4336000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctMy0xLTEtMA_d7ea1b77-4abe-425b-a52e-474537ee68c9"
      unitRef="usd">6155000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctNS0xLTEtMA_d9352e02-7b64-488d-aeb5-7525221e4e9b"
      unitRef="usd">9780000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV8zNC9mcmFnOmQwYWI4NzQ4ZDliZTRmNmFiY2FmY2Y5MmM4ZGQwYTNhL3RhYmxlOjRkNzJiMzUzOGM0ZDQyNTg4YzVlYjhmZGMwYmEwYWZiL3RhYmxlcmFuZ2U6NGQ3MmIzNTM4YzRkNDI1ODhjNWViOGZkYzBiYTBhZmJfMjctNy0xLTEtMA_c0e9b467-9012-4075-963f-0a15e47f1b58"
      unitRef="usd">9609000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f5119916d654310ac75b5ef00226e3c_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS0xLTEtMS0w_6f0cce95-9c78-4fbc-848d-fed0398279b5"
      unitRef="usd">61294000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i28ce5a232c604b8bbf884d668b9f4e57_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS0zLTEtMS0w_6e735bc8-3400-4f19-a1fa-0f4e65fb476e"
      unitRef="usd">112901000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24d9e08d937e4f179ddd650ddc14f39f_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS01LTEtMS0w_1a9b0fed-0524-411f-8999-f8b7a5ac6437"
      unitRef="usd">-16243000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i73fd0a02b1154c3e9745a1263dc23b62_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS03LTEtMS0w_51673577-2c9d-4145-9754-50e8042e0697"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iefccab1bc61e4aac89cc6807ae4e1c54_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMS05LTEtMS0w_94eaf9f0-d25e-4b80-aceb-d177b975c40f"
      unitRef="usd">-38484000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMi0xLTEtMS0w_e8f8ca57-7065-4639-9abd-b51f9e8b094f"
      unitRef="usd">3626000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMi0zLTEtMS0w_e6cd3b44-a7bf-4a16-b3a5-e1bc32b9f5b9"
      unitRef="usd">3626000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockCash
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMy0xLTEtMS0w_e7634922-ae20-44b3-82f5-9e0f8c2d1808"
      unitRef="usd">2659000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfMy0zLTEtMS0w_9eb529ed-0fd2-435b-94d6-80559a4f776b"
      unitRef="usd">2659000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC0xLTEtMS0w_c6be4e20-92d0-46cc-b0d4-55e34e89ddea"
      unitRef="usd">712000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC0zLTEtMS0w_c595e09f-edcb-492d-b8db-26434db10f14"
      unitRef="usd">29000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNC05LTEtMS0w_ca09180d-cd64-4d14-951c-41125eb4e21a"
      unitRef="usd">683000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNS0xLTEtMS0w_9c4030a9-fec9-45d0-8c77-64efae82c23f"
      unitRef="usd">706000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i39129aa4a79a4fa895d391c605e6d249_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNS05LTEtMS0w_fdbeb193-eea5-43fd-b163-d515fbcbd90c"
      unitRef="usd">706000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNi0xLTEtMS0w_c0fb8a9b-30a5-4da2-844d-76e9ad87184d"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ie25aecd64d04465a88c20bba1d3a20dc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNi0zLTEtMS0w_ebade84a-c918-4918-a13c-5abfbf564efa"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNy0xLTEtMS0w_2c97015d-095d-4903-ba7a-259a3981c1a0"
      unitRef="usd">710000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i59a07beb3fc44f4287425a53a020e1d6_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfNy01LTEtMS0w_00d5d091-25bd-4f7f-8bce-cded16903bd0"
      unitRef="usd">710000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC0xLTEtMS0w_0088db0d-fdd5-4901-b97a-ba7741b3f49d"
      unitRef="usd">62978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45078457294a49839d52d19d59d45e00_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC0zLTEtMS0w_3f3b269b-b488-48e5-8ca8-c13b442bed81"
      unitRef="usd">113898000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if261e32787064849a30e8f746c585aa9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC01LTEtMS0w_9c2d1ff0-e625-45e5-8e0f-66cc565998d5"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f156471cef4470986ef989b88c7640a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC03LTEtMS0w_3ec41879-c65e-43eb-a44e-d767818b254e"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24cafb66e4484853bf4778ec14060e85_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjA0NTZjOTliNjIyMTRmNzdhZDQxYmQ2NjRlYzBlNWUxL3RhYmxlcmFuZ2U6MDQ1NmM5OWI2MjIxNGY3N2FkNDFiZDY2NGVjMGU1ZTFfOC05LTEtMS0w_dbda9ee7-c0ad-43f9-8ba7-769bde55c07e"
      unitRef="usd">-38507000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS0xLTEtMS0w_57156893-c884-40aa-bd73-cbeaecaa90ed"
      unitRef="usd">59471000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i751605f69fa8470b949cd66a3de18cfb_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS0zLTEtMS0w_249072d6-3020-44bf-ae36-0dd71eb67498"
      unitRef="usd">110659000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS01LTEtMS0w_e9c0b60d-111d-4b75-966b-1ecded86417c"
      unitRef="usd">-15891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i63412fd9538f4c419e57e8396e1e2450_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS03LTEtMS0w_918d4709-078a-4bfa-a8ab-a7ba0ae0d9ae"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib519600bb19e47f6acf4f21be0fc6aaf_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMS05LTEtMS0w_41c4d8dd-3cd3-4caf-89ce-5ab7d782b670"
      unitRef="usd">-38417000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMi0xLTEtMS0w_33259869-34de-4d78-9c90-011346e58e20"
      unitRef="usd">9422000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMi0zLTEtMS0w_baf577ed-6140-41b9-ae25-babdab475d70"
      unitRef="usd">9422000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMy0xLTEtMS0w_e31e4ac4-e8bd-42e6-acd7-b402de8c7e86"
      unitRef="usd">5164000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfMy0zLTEtMS0w_a77fbb87-4c64-4b9b-bec4-ad7250e854cd"
      unitRef="usd">5164000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC0xLTEtMS0w_7acb32a4-ca22-4eb4-b249-f4e405e6d013"
      unitRef="usd">1307000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC0zLTEtMS0w_dd769c68-03f7-42c3-a5e2-e1d18cf12d57"
      unitRef="usd">-1020000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNC05LTEtMS0w_2bdde0de-d4d7-400a-ba8e-bb618b9d55dd"
      unitRef="usd">2327000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNS0xLTEtMS0w_e9076a89-f159-4206-9ddf-7656b982adc3"
      unitRef="usd">2417000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ica9a1bb6f4b242b58b60a4e92f4e8b5d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNS05LTEtMS0w_6b3e3714-58c1-4c56-b9ff-8f6695881b82"
      unitRef="usd">2417000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockholdersEquityOther
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNi0xLTEtMS0w_82474df2-7c69-4453-9d91-72e1895e11ae"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther
      contextRef="ic7256615712e418a96a13f35c9e623fc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNi0zLTEtMS0w_0eeb6131-b4a4-4846-8f1b-57679026c4e7"
      unitRef="usd">1000000</us-gaap:StockholdersEquityOther>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNy0xLTEtMS0w_767d9cbb-3cfc-405e-b85a-a09afd8ff0c4"
      unitRef="usd">358000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfNy01LTEtMS0w_c953c58f-9298-4d1b-997d-b79a49dd7158"
      unitRef="usd">358000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC0xLTEtMS0w_4db05591-0b25-451a-9e8c-aa8ca320f3d7"
      unitRef="usd">62978000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i45078457294a49839d52d19d59d45e00_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC0zLTEtMS0w_a4f48c65-25bf-4b2f-815a-06d207e5637c"
      unitRef="usd">113898000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if261e32787064849a30e8f746c585aa9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC01LTEtMS0w_29d58327-e678-4005-a117-8d74e7deff74"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3f156471cef4470986ef989b88c7640a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC03LTEtMS0w_259371ad-40eb-4a2c-b43e-097fdfcbb18e"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i24cafb66e4484853bf4778ec14060e85_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjI3OWJhYmI4NTY3ZjQ1NjNiY2I1N2YwN2RlODcyYjNmL3RhYmxlcmFuZ2U6Mjc5YmFiYjg1NjdmNDU2M2JjYjU3ZjA3ZGU4NzJiM2ZfOC05LTEtMS0w_1098f2ee-3d6e-4b93-b93f-7c4665150628"
      unitRef="usd">-38507000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5747648413fd46979174d12f0c200837_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS0xLTEtMS0w_54d803ed-8f18-4696-9ebf-44a9823be7dd"
      unitRef="usd">58955000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic629a2a0279c40f7a8a22fbbbd206b62_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS0zLTEtMS0w_f24e9820-3b76-48d4-a830-179d6fb96ede"
      unitRef="usd">106650000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i946a5c53aec443718456445577b181c6_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS01LTEtMS0w_facf27a8-8ee7-4292-b618-9fcc93f714fa"
      unitRef="usd">-15517000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i37f2478bd1c94f8189108fa2df87fa35_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS03LTEtMS0w_ea4a7941-f33a-4d3d-99d6-f37e46d0226a"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1fd38c3886a84e65b754e209c671b4e3_I20190331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMS05LTEtMS0w_d3fc8629-7527-4696-8ff7-e6ebdb2b571b"
      unitRef="usd">-35298000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMy0xLTEtMS0w_703b4b59-bf94-4b1f-9bb0-992e481d268a"
      unitRef="usd">5607000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfMy0zLTEtMS0w_59d848cd-5dbd-4f22-9bcd-f01feb4bb5ca"
      unitRef="usd">5607000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockCash
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNC0xLTEtMS0w_db4995ca-a9df-4540-86c5-1686c3749b6e"
      unitRef="usd">2522000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNC0zLTEtMS0w_8f08ff58-737b-487e-9d9a-109fd1504fa2"
      unitRef="usd">2522000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS0xLTEtMS0w_db041bfc-196f-4975-964f-5fa4036bd85f"
      unitRef="usd">683000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i70d08a07c24b4770b35a59d9a855f0b1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS0zLTEtMS0w_3973196a-558f-4b5a-bf5b-1d2fdd74ea6e"
      unitRef="usd">74000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="iddf51803037143adbd15041c11e9e51a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNS05LTEtMS0w_374b99c0-0012-4de0-8d99-5b23c702a44e"
      unitRef="usd">609000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNi0xLTEtMS0w_ae718537-39eb-4754-9b5a-84da1b265b31"
      unitRef="usd">2486000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="iddf51803037143adbd15041c11e9e51a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfNi05LTEtMS0w_b0bc6dad-e9de-48d5-ad21-1cea20d66e72"
      unitRef="usd">2486000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOC0xLTEtMS0w_ecb3d6d7-7e64-4b4d-adef-f615be997d46"
      unitRef="usd">548000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i246708123c874d65a705b8d658c14466_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOC01LTEtMS0w_f593c83e-7b5a-4b13-ad85-7d99e0b22ef7"
      unitRef="usd">548000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS0xLTEtMS0w_2007c509-798a-405d-a31f-d16fc771ec28"
      unitRef="usd">60785000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0cde42ed21643029a65d234f94ce9ce_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS0zLTEtMS0w_e02227fb-bce8-48e4-abef-553bf27cd8e6"
      unitRef="usd">109809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3ae7c05de8449e4853379b1810a5cb4_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS01LTEtMS0w_ec9139ad-1692-4758-8aa9-904ccc69d613"
      unitRef="usd">-14969000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id93dcd19b8bf48879ab269ebebba20c7_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS03LTEtMS0w_1c436422-b902-48b0-8c74-62c50284253b"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOjEyNGI5YzI2ZmQxMDRlODk4Njg5YTY3NzJjYzdkN2UxL3RhYmxlcmFuZ2U6MTI0YjljMjZmZDEwNGU4OTg2ODlhNjc3MmNjN2Q3ZTFfOS05LTEtMS0w_fd06c2af-2f5a-4748-9788-cdc5839781d3"
      unitRef="usd">-37175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS0xLTEtMS0w_8fdd3dd8-0186-4429-b9cb-01565870fcf3"
      unitRef="usd">59752000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6b613a94dd42484783d6a12a1751f62a_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS0zLTEtMS0w_ea3d2385-d2c8-486c-9db2-2c1bc928de28"
      unitRef="usd">106216000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8c0949379c4e4a58a6c9255f0e249053_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS01LTEtMS0w_7e12b13d-51c9-4427-b9c1-35f0abfffe70"
      unitRef="usd">-15222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if1edf2d8de4844dca95575354c2ff1e2_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS03LTEtMS0w_efe58edf-582c-42ce-bb83-9f4c2bd93a49"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e4c6a229a014b85a7a8b8c276c6ceb0_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMS05LTEtMS0w_6ad9875c-58e9-4c59-a0a4-e1dd969418e6"
      unitRef="usd">-34362000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMy0xLTEtMS0w_8e3431ac-8103-4905-b2e8-026b0c11eefa"
      unitRef="usd">9356000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfMy0zLTEtMS0w_5973a8af-9e97-40bd-945f-154ba797dcaa"
      unitRef="usd">9356000000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCommonStockCash
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNC0xLTEtMS0w_301a1846-ec85-4b51-a3eb-9411d958b970"
      unitRef="usd">4918000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNC0zLTEtMS0w_0d0e058e-010e-4a67-b871-f943bb49e458"
      unitRef="usd">4918000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS0xLTEtMS0w_29ddd4da-2ffe-4f6e-aef4-575c953bc299"
      unitRef="usd">1034000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i27d1d32f5e6b428486bb2757b27d94c2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS0zLTEtMS0w_cc00975b-04c4-4668-a9f9-0528f2a5dad0"
      unitRef="usd">-845000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued
      contextRef="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNS05LTEtMS0w_6e24e8c2-6779-4c2b-aa9f-03f8ffe52c5d"
      unitRef="usd">1879000000</us-gaap:StockIssuedDuringPeriodValueTreasuryStockReissued>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNi0xLTEtMS0w_45ae9a25-9af1-4937-8d4a-71a3242bd00a"
      unitRef="usd">4692000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i4acc8939fd2b4365853122268b0c9480_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfNi05LTEtMS0w_60f91adb-1937-4861-836d-130bf1bf6ffa"
      unitRef="usd">4692000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOC0xLTEtMS0w_8591b76f-d4ac-4725-aeca-cac7e4b1c2bc"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i49bf965261be49f3adf9b650ea02edfe_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOC01LTEtMS0w_35f7823c-9c90-4f58-a228-2459f55be311"
      unitRef="usd">253000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS0xLTEtMS0w_98074cc4-93a8-4606-85b5-3b14db2bad1f"
      unitRef="usd">60785000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie0cde42ed21643029a65d234f94ce9ce_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS0zLTEtMS0w_bd7eee6f-212c-494a-9e2d-0c2f98bc5117"
      unitRef="usd">109809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie3ae7c05de8449e4853379b1810a5cb4_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS01LTEtMS0w_2b6b6524-9ca8-4277-a26a-009f118f72bb"
      unitRef="usd">-14969000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id93dcd19b8bf48879ab269ebebba20c7_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS03LTEtMS0w_f7a3d3f0-c7f5-4289-ab32-aa666de5c974"
      unitRef="usd">3120000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7d01729708a4848b8e5f0a6d70e0c7f_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80MC9mcmFnOjBlOWM1NjE5OGZiYzQ2MTc5OTQyODQ4NThjMTI1ZWNkL3RhYmxlOmM0MjJkOGQ2MTBkZDRlNzE5ZTBiOGJlMjc4NWJlYjk4L3RhYmxlcmFuZ2U6YzQyMmQ4ZDYxMGRkNGU3MTllMGI4YmUyNzg1YmViOThfOS05LTEtMS0w_833c74c2-34e0-4b5e-a443-fe462c611193"
      unitRef="usd">-37175000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMy0yLTEtMS0w_95f35bf6-040a-4739-af6d-bf83124d8ae0"
      unitRef="usd">9422000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMy00LTEtMS0w_30a729ac-264b-40b6-9d6c-648d9d0d0072"
      unitRef="usd">9356000000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNS0yLTEtMS0w_0fd364a4-e11f-4c11-878b-dec9027a4729"
      unitRef="usd">3473000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNS00LTEtMS0w_322d0961-1a8d-4e9f-a7ec-b1609286caae"
      unitRef="usd">3466000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNi0yLTEtMS0w_9f88987f-4f7b-4430-85ad-2a97fae0c8a2"
      unitRef="usd">589000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNi00LTEtMS0w_8f71da43-3158-4c38-8ff7-dffece667509"
      unitRef="usd">572000000</us-gaap:ShareBasedCompensation>
    <us-gaap:AssetImpairmentCharges
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfOS0yLTEtMS0w_629ae375-6ffd-47fd-8e79-e87f455a240d"
      unitRef="usd">33000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfOS00LTEtMS0w_63ea6883-847d-4cc6-8921-cd6d6b3c8375"
      unitRef="usd">989000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTAtMi0xLTEtMA_50ff46b9-5d8e-4780-91b4-5d5a31c13a73"
      unitRef="usd">-983000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTAtNC0xLTEtMA_bd1942b3-5e82-4085-aab8-498ce691e8a2"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTEtMi0xLTEtMA_1cbd4ea2-76b8-4638-b2f3-2f109443fed3"
      unitRef="usd">60000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTEtNC0xLTEtMA_1b8bbaac-fff8-48e4-ae77-4f5cbfcc2ce1"
      unitRef="usd">2079000000</us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTMtMi0xLTEtMA_2bc9c7a1-3530-45ca-a487-34d237515b64"
      unitRef="usd">-428000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTMtNC0xLTEtMA_14d78a81-e963-44c5-aa16-6c3a9c29640a"
      unitRef="usd">-694000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTQtMi0xLTEtMA_8695a6a4-f3bb-4e63-aeac-49a10ceebd61"
      unitRef="usd">117000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTQtNC0xLTEtMA_5127ab27-38e9-49df-a530-46bff1748311"
      unitRef="usd">1000000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTYtMi0xLTEtMA_1f05b5cc-bab6-4528-b098-9d7fccf407ee"
      unitRef="usd">520000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTYtNC0xLTEtMA_cae4c8a2-aae0-42e0-acee-c1eac2a9584e"
      unitRef="usd">336000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTctMi0xLTEtMA_eb995bed-a9c7-48a3-b14d-250abf7640eb"
      unitRef="usd">637000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTctNC0xLTEtMA_1926a8ad-1d1a-4dc4-88c0-ba8950bfaae1"
      unitRef="usd">423000000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTgtMi0xLTEtMA_22c431b0-1ce8-4ac2-b651-b26d2f2b21fd"
      unitRef="usd">-2319000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTgtNC0xLTEtMA_a4b29e4e-dbd1-404b-ab81-a26d688f45f1"
      unitRef="usd">-444000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTktMi0xLTEtMA_32fe740d-bc18-47df-bc3e-e36666b9c214"
      unitRef="usd">1048000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMTktNC0xLTEtMA_12323759-9db7-4e83-99bd-7fd6547abfe5"
      unitRef="usd">862000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjAtMi0xLTEtMA_4ae01632-28c4-4b51-a934-1916f8b0f0e1"
      unitRef="usd">-829000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjAtNC0xLTEtMA_2f6369f3-3faf-4a24-8565-c9f8ba2b34e0"
      unitRef="usd">-55000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjItMi0xLTEtMA_5b0b31d1-bebb-4169-95a0-de3946183437"
      unitRef="usd">6810000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjItNC0xLTEtMA_f54decf5-a5b9-4e5b-9d70-c903f1ae41b8"
      unitRef="usd">9491000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjUtMi0xLTEtMA_3d1989e4-79ce-4f62-acef-542cec9d9b2b"
      unitRef="usd">1287000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjUtNC0xLTEtMA_91449192-d720-4115-a1e3-56ffbbf79b2f"
      unitRef="usd">1493000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjYtMi0xLTEtMA_5db33d0b-9acc-4dce-98e7-08fdddd8c68b"
      unitRef="usd">87000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:ProceedsFromSaleOfProductiveAssets
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjYtNC0xLTEtMA_aea12a05-e238-41a8-8a17-80f517df61af"
      unitRef="usd">3018000000</us-gaap:ProceedsFromSaleOfProductiveAssets>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjctMi0xLTEtMA_fa44baf6-d7f0-4427-bfa5-2feb5878c694"
      unitRef="usd">949000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjctNC0xLTEtMA_b4bd26e5-e2dc-422d-9fb0-ca39b370f172"
      unitRef="usd">5346000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjgtMi0xLTEtMA_37c3a979-f540-4a3a-b84a-457362450354"
      unitRef="usd">8551000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjgtNC0xLTEtMA_0dc49ca7-567c-4cd1-8002-b321a04805ae"
      unitRef="usd">1517000000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjktMi0xLTEtMA_abf6a3b6-ac45-4b47-a173-529c24e29c7f"
      unitRef="usd">2417000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMjktNC0xLTEtMA_4f8f1a79-8c2d-44d5-a911-c2ffd494ff4a"
      unitRef="usd">2132000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
    <jnj:Proceedsfromcreditsupportagreements
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzAtMi0xLTEtMA_a5bacd46-be43-4efb-beb8-bab73270811c"
      unitRef="usd">672000000</jnj:Proceedsfromcreditsupportagreements>
    <jnj:Proceedsfromcreditsupportagreements
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzAtNC0xLTEtMA_0217b9f8-af0c-41ce-9ec7-3cdb3da60d3d"
      unitRef="usd">0</jnj:Proceedsfromcreditsupportagreements>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzEtMi0xLTEtMA_89c05fec-b14b-46b8-a956-1f9f89d98437"
      unitRef="usd">492000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzEtNC0xLTEtMA_70806f53-65dc-43e7-9b95-bdd5786d3ac3"
      unitRef="usd">-1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzMtMi0xLTEtMA_6473a3a1-3645-470d-adde-29a4579ea94d"
      unitRef="usd">-8103000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzMtNC0xLTEtMA_7634adc1-e766-4983-99fc-6fbbe43631e0"
      unitRef="usd">-3205000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzYtMi0xLTEtMA_6f4f7f2d-a84e-4a76-bf0b-3ba4fa128518"
      unitRef="usd">5164000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsOfOrdinaryDividends
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzYtNC0xLTEtMA_7f2e5a18-cc4c-4f0b-9b9c-e5885ce0dcbe"
      unitRef="usd">4918000000</us-gaap:PaymentsOfOrdinaryDividends>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzctMi0xLTEtMA_4a344ca3-a74c-4d11-8fcb-5f331dac3d56"
      unitRef="usd">2417000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzctNC0xLTEtMA_38d444d4-f2b1-455d-a341-21834d029bc0"
      unitRef="usd">4692000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzgtMi0xLTEtMA_0afc60dc-5625-461c-a284-635381a92daa"
      unitRef="usd">2717000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:ProceedsFromShortTermDebt
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzgtNC0xLTEtMA_831706c6-331a-49cf-b917-43c65eec9477"
      unitRef="usd">15000000</us-gaap:ProceedsFromShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzktMi0xLTEtMA_b840a07f-af0b-43bb-abee-0f6aa8d6d04a"
      unitRef="usd">17000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:RepaymentsOfShortTermDebt
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfMzktNC0xLTEtMA_7e124801-8870-4fc2-b8fe-6242b0e53583"
      unitRef="usd">12000000</us-gaap:RepaymentsOfShortTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDAtMi0xLTEtMA_960be49b-ce34-49aa-8ede-19d270ee6cd0"
      unitRef="usd">1000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDAtNC0xLTEtMA_c2f0e68b-a4b8-4714-89d9-89db89751198"
      unitRef="usd">1000000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDEtMi0xLTEtMA_38fcbac2-fd50-4c97-a12f-307b293ff2cc"
      unitRef="usd">11000000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDEtNC0xLTEtMA_ac6489b4-a59c-411b-b932-cb3b7f65dfce"
      unitRef="usd">1005000000</us-gaap:RepaymentsOfLongTermDebt>
    <jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDItMi0xLTEtMA_c4e3fb07-0ca5-4446-aab8-3ff0129a8f15"
      unitRef="usd">708000000</jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits>
    <jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDItNC0xLTEtMA_af1df69f-7bd8-411d-b39a-ea743d85a311"
      unitRef="usd">463000000</jnj:ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDMtMi0xLTEtMA_46d7dfcc-e48d-4e38-8595-85d51c8dac6a"
      unitRef="usd">-489000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDMtNC0xLTEtMA_6ff6d3d5-4081-45ab-a88a-7f401d7d94dd"
      unitRef="usd">98000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDUtMi0xLTEtMA_544e5f9b-28ac-4f15-978b-791971d08ada"
      unitRef="usd">-4672000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDUtNC0xLTEtMA_34d80a08-25b2-492b-823e-97996d78d341"
      unitRef="usd">-10050000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDctMi0xLTEtMA_d98dea68-dbae-46e0-b861-b83dc41ef361"
      unitRef="usd">-166000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDctNC0xLTEtMA_64f930db-c290-476d-ac73-391c4d8d6d8f"
      unitRef="usd">33000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDgtMi0xLTEtMA_b53d701f-18d4-458a-bad9-a8ad20b0ac81"
      unitRef="usd">-6131000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDgtNC0xLTEtMA_eda02be2-f740-4bf1-b2e7-7b09cb27287f"
      unitRef="usd">-3731000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDktMi0xLTEtMA_f4d432b9-c6c0-4121-a62d-c93f69dec64e"
      unitRef="usd">17305000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNDktNC0xLTEtMA_fa15552b-f76a-4257-90d9-7fb8e82b00ef"
      unitRef="usd">18107000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTAtMi0xLTEtMA_0461260b-b0dc-4efa-87bf-c87994dccb27"
      unitRef="usd">11174000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTAtNC0xLTEtMA_32e68e23-96a7-4504-8ee5-e4554bf2c9ee"
      unitRef="usd">14376000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTctMi0xLTEtMA_8787e170-e01a-436a-8747-421f6224680b"
      unitRef="usd">1173000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTctNC0xLTEtMA_f58f8484-b8e4-4d41-ae74-17b131948073"
      unitRef="usd">6744000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTgtMi0xLTEtMA_3c2fcecb-a4f0-487d-8729-a33108e5d42d"
      unitRef="usd">224000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTgtNC0xLTEtMA_058cd010-7981-4eb3-b248-b333930fe9af"
      unitRef="usd">1398000000</us-gaap:NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTktMi0xLTEtMA_7fa46291-ffc4-40dc-bcc2-a83effc91604"
      unitRef="usd">949000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV80Ni9mcmFnOjBhOWM5MzFkMjBmNjQzMzFhMmUxMDIxOGIwNWExMDgxL3RhYmxlOmQzYmJkZDNkMDkzZTQ1ZTA4NTZlMWUxZjY1ODdmMjJjL3RhYmxlcmFuZ2U6ZDNiYmRkM2QwOTNlNDVlMDg1NmUxZTFmNjU4N2YyMmNfNTktNC0xLTEtMA_12960447-e521-4407-96e6-4d46b724e155"
      unitRef="usd">5346000000</us-gaap:NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1>
    <us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5Mw_76acbc8d-41ef-4912-8fda-6e154c66bab9">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp;amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The extent to which COVID-19 impacts the Company&#x2019;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of June 28, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the quarter ended June 28, 2020, the Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal second quarter of 2020 that impacted the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no new accounting standards adopted in the fiscal second quarter of 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain prior period amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5Ng_ee24c82b-99d5-4dc6-947c-d30387889b04">&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Use of Estimates &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The extent to which COVID-19 impacts the Company&#x2019;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of June 28, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#x2019;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#x2019;s consolidated financial statements as of and for the quarter ended June 28, 2020, the Company&#x2019;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#x2019;s consolidated financial statements in future reporting periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5NA_9c8490ab-2e44-40a2-99ba-20fe2f99b6b4">&lt;div style="margin-top:3pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;New Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal second quarter of 2020 that impacted the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;There were no new accounting standards adopted in the fiscal second quarter of 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81Mi9mcmFnOjQ0YzNkMjZhYmU4NTQyZDE4ZDJlNzAxZWZjYzU5NjI5L3RleHRyZWdpb246NDRjM2QyNmFiZTg1NDJkMThkMmU3MDFlZmNjNTk2MjlfNzE0NjgyNTU4NjU5NQ_f9e5f431-24fa-4fa4-86ef-66db3f4c7c2a">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;"&gt;Reclassification&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain prior period amounts have been reclassified to conform to current year presentation.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RleHRyZWdpb246NzRjMTEwMTUzMDc3NDFmNDg2NTQ1NjdmMWEyOTk1YzVfMTYw_d75f2453-32fa-403c-a893-302ea12d4583">INVENTORIES &lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:50.996%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.722%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.410%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goods in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Total inventories &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RleHRyZWdpb246NzRjMTEwMTUzMDc3NDFmNDg2NTQ1NjdmMWEyOTk1YzVfMTU2_a99d34f8-10cf-41d0-b9c5-5cbcfc9e479b">&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:50.996%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.722%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.736%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.410%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Raw materials and supplies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goods in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Total inventories &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,424&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMS0yLTEtMS0w_4e7cc5db-ab8d-477f-a3c8-a92f95033820"
      unitRef="usd">1303000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMS00LTEtMS0w_6cd08aad-b534-401e-85b7-7f0fa86c7db6"
      unitRef="usd">1117000000</us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMi0yLTEtMS0w_5948822e-bf1e-4ddb-86fb-738b571e5a15"
      unitRef="usd">1962000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMi00LTEtMS0w_35b1e664-c543-4fc2-a527-11f99746e4da"
      unitRef="usd">1832000000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMy0yLTEtMS0w_b3bd792d-f268-4961-b6aa-036df81cd389"
      unitRef="usd">6159000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfMy00LTEtMS0w_220aae5b-8391-4bb5-be38-2deac5c39fcf"
      unitRef="usd">6071000000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfNC0yLTEtMS0w_a983d8a9-8048-4270-9d55-2e469e9a8c12"
      unitRef="usd">9424000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV81OC9mcmFnOjc0YzExMDE1MzA3NzQxZjQ4NjU0NTY3ZjFhMjk5NWM1L3RhYmxlOmJjZDhjNDdmOGFlNzRmMzc5ZTFjOWM0OWY2YTRkMjJhL3RhYmxlcmFuZ2U6YmNkOGM0N2Y4YWU3NGYzNzllMWM5YzQ5ZjZhNGQyMmFfNC00LTEtMS0w_411ab600-798d-4b4f-9e87-c3681d204ef4"
      unitRef="usd">9020000000</us-gaap:InventoryNet>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Ng_a4220c00-ed5b-49ae-bdac-95a5a391360b">INTANGIBLE ASSETS AND GOODWILL&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:60.204%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.797%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles&#160;&#x2014; net*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Purchased in-process research and development &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets with indefinite lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*The majority is comprised of customer relationships&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Goodwill as of June&#160;28, 2020 was allocated by segment of business as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.277%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.578%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.305%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.084%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.292%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.309%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill, related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency translation/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average amortization period for patents and trademarks is 12 years. The weighted average amortization period for customer relationships and other intangible assets is 21 years. The amortization expense of amortizable intangible assets included in cost of products sold was $1.1 billion for each of the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019. The amortization expense of amortizable intangible assets included in cost of products sold was $2.2 billion for each of the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019. Intangible asset write-downs are included in Other (income) expense, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.628%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.214%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.008%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.008%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.010%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="margin-top:13pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$4,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY0NQ_3be66799-b5a2-4201-9b08-02b41f5232f5">&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:60.204%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.587%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.797%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with definite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37,313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,834&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Patents and trademarks &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles &#x2014; gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22,056&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Customer relationships and other intangibles&#160;&#x2014; net*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Intangible assets with indefinite lives:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Purchased in-process research and development &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets with indefinite lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total intangible assets &#x2014; net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*The majority is comprised of customer relationships&lt;/span&gt;&lt;/div&gt;(1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.</jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMi0yLTEtMS0w_defbc938-2e61-4f71-a402-6c29dc5933fb"
      unitRef="usd">37313000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMi00LTEtMS0w_d68e1167-1fc1-44a6-86ed-5dae5bd1f07e"
      unitRef="usd">36634000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMy0yLTEtMS0w_78d5d41c-9916-4f1b-9a4f-eb4f54cb84be"
      unitRef="usd">14834000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMy00LTEtMS0w_370efe66-7f96-42bc-b8fa-dabdcb8b5c4c"
      unitRef="usd">13154000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9d87b1387eeb4fd8bdbb82dc34fa8e98_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNC0yLTEtMS0w_484c6818-0e9f-42d3-acb1-03d0b13c90b9"
      unitRef="usd">22479000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2ed67d30efa2449d8c0345ac76f4e0fa_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNC00LTEtMS0w_09e44294-8feb-4fe4-846e-8b4924ee13fd"
      unitRef="usd">23480000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2c16549172ea409986271df6c73e639c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNS0yLTEtMS0w_59db8f8d-0490-46d8-aafc-fc6d3016f8d4"
      unitRef="usd">22272000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNS00LTEtMS0w_e32452d3-1e2a-4906-8676-3a173da278b2"
      unitRef="usd">22056000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2c16549172ea409986271df6c73e639c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNi0yLTEtMS0w_274ae961-f289-4ecf-8833-c293269059ab"
      unitRef="usd">10072000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNi00LTEtMS0w_d35531ca-7348-446c-84af-dbfc69cabb60"
      unitRef="usd">9462000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2c16549172ea409986271df6c73e639c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNy0yLTEtMS0w_f10d9530-f4fa-445c-9e3b-0e8897e60833"
      unitRef="usd">12200000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i64ccc08e02734c24a00e804f7b1912c9_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfNy00LTEtMS0w_ca274029-3b9f-42d3-8e48-09693b1a1527"
      unitRef="usd">12594000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="id939f17ab58546e792a3505ad59025d1_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfOS0yLTEtMS0w_3d90864b-5a37-44ef-876c-213d699cf4d1"
      unitRef="usd">6927000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib4a1ace803e04933bfb1ecf684b3b69d_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfOS00LTEtMS0w_bc6065c4-c58e-43ff-aaa9-ff59fa464332"
      unitRef="usd">6922000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i9ae5346cc81b4f27b4788b31c0e54a6f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTAtMi0xLTEtMA_25c7993a-1658-4906-a670-2c153d46e68d"
      unitRef="usd">5807000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="icc73eb3ded6942659b82f23e9f209d83_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTAtNC0xLTEtMA_489e121b-38d6-4362-8fb4-fc6fb7eaca81"
      unitRef="usd">4647000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTEtMi0xLTEtMA_b147af95-1d6b-431b-b7b0-50cbbb798ca3"
      unitRef="usd">12734000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTEtNC0xLTEtMA_0f12bc16-4a32-454b-91f7-7926d8bff657"
      unitRef="usd">11569000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTItMi0xLTEtMA_60ab91b6-1f46-4028-887b-98661bd10d37"
      unitRef="usd">47413000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmZhMzA4MTRiYWFhNzQzNDc4MzNjNDViNzY1ZDRmOGFiL3RhYmxlcmFuZ2U6ZmEzMDgxNGJhYWE3NDM0NzgzM2M0NWI3NjVkNGY4YWJfMTItNC0xLTEtMA_e7ac7649-0e21-429d-b774-7f12bb36ef29"
      unitRef="usd">47643000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ifc06a706e03b46438ac284c25745cad8_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfNzgx_da33292a-04c6-40ce-bd4c-1988753a81a0"
      unitRef="usd">800000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3bc60621d8554499a90278e03e0c6c2f_I20200329"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfNzg4_8fb8e9c7-ea9e-4e9c-8d2f-fbcdd6207347"
      unitRef="usd">400000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Mg_9f0bbc84-682b-4ac0-9df9-329d1f501eb5">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Goodwill as of June&#160;28, 2020 was allocated by segment of business as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:39.277%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.578%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.305%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.084%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.292%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.461%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.447%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.309%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pharmaceutical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Medical Devices&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill, related to acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency translation/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Goodwill at June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i99703a7240b24ff78c8ea755f087ee0a_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS0yLTEtMS0w_4cbdb2e7-856f-4b68-a39b-d1904c498be2"
      unitRef="usd">9736000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i3cfcc9ed84c14ef99d0fa0093df15fc2_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS00LTEtMS0w_327c54fc-8e7f-4998-bb46-9c8362eb0ab3"
      unitRef="usd">9169000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9898c86a84104e428b5e32fc5072ca0a_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS02LTEtMS0w_3f9713e2-8287-46f7-b3f3-c6c7af3b9d4c"
      unitRef="usd">14734000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMS04LTEtMS0w_0a63d869-b234-459a-a1ce-f2aea697fda3"
      unitRef="usd">33639000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi0yLTEtMS0w_cb50b218-aa8c-470f-82ec-af38b5298b61"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi00LTEtMS0w_aaa24b33-dc71-4f98-9229-7db3bf707521"
      unitRef="usd">1000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi02LTEtMS0w_dec7a63d-1f45-4059-a0d3-31d8760995e6"
      unitRef="usd">183000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfMi04LTEtMS0w_8d2094cd-7f89-4dd1-ab3f-70b2bfff281e"
      unitRef="usd">184000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC0yLTEtMS0w_5fb4b41b-c7a2-4d6b-ac63-53fa861a2485"
      unitRef="usd">10000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC00LTEtMS0w_bb50340d-821c-4003-a9e8-bab2c5bbcb10"
      unitRef="usd">45000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC02LTEtMS0w_c0524d9b-0d25-4ae6-b71d-81f711ffe22d"
      unitRef="usd">12000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:GoodwillOtherIncreaseDecrease
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNC04LTEtMS0w_3a29a470-575b-48bf-bf22-42835a887ec7"
      unitRef="usd">67000000</us-gaap:GoodwillOtherIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="i5317e81770cc465384ed2fda2daf0206_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS0yLTEtMS0w_34a0ab06-e7aa-4608-8a2a-9cf91344791e"
      unitRef="usd">9746000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7dc0631cabd64cff92a35dc49719e5e8_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS00LTEtMS0w_49a73878-fe3f-4f29-a732-fa870af20c1e"
      unitRef="usd">9215000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ide8ee6042d8a44199c107aa75b895f4d_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS02LTEtMS0w_a0e98967-499b-4808-896f-bacdbdf30b3a"
      unitRef="usd">14929000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmU2YmRlNzIxMTQ4MzQyNzI4ZWExMTE1YTQ5NDQ0MTY1L3RhYmxlcmFuZ2U6ZTZiZGU3MjExNDgzNDI3MjhlYTExMTVhNDk0NDQxNjVfNS04LTEtMS0w_505bdf17-0d2e-4d3c-b83d-b9fac5e431bf"
      unitRef="usd">33890000000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifb1af4e8ba9744f08026427afa0d3297_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfOTUx_8a2e0f34-48af-48bf-b88b-394d0cbd1013">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iae716e872a654f7d8eb4cdca336d0296_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTA2MA_ab538735-908b-4d2f-aeb3-31b8d069faac">P21Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTE2Ng_ee8d4225-60e4-40a8-9b65-acd842c2d6cc"
      unitRef="usd">1100000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTI5NQ_68c66198-32cb-4f09-9203-1ac994142402"
      unitRef="usd">2200000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RleHRyZWdpb246ZmIzZTQ4YTdlZWQzNDY2YjlhM2NlNmNmYTdkOWM3NjNfMTY2Mw_efba9bfa-166f-472d-b507-3abfbc95ac10">&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.628%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.214%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.008%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.008%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.833%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.010%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="margin-top:13pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$4,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,300&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,100&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi0wLTEtMS0w_733600b6-1c11-473c-8e07-aa9a365f9417"
      unitRef="usd">4500000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi0yLTEtMS0w_64f8d7f8-0d47-4361-ba87-d2dd497bec69"
      unitRef="usd">4300000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi00LTEtMS0w_7d45ff37-0441-4874-85af-cc315be10dde"
      unitRef="usd">4100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi02LTEtMS0w_8225dae0-ad96-4c0d-9ccc-d2f53c1f1357"
      unitRef="usd">4100000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82MS9mcmFnOmZiM2U0OGE3ZWVkMzQ2NmI5YTNjZTZjZmE3ZDljNzYzL3RhYmxlOmJhMjhmNDRhMDJiYTRmNGJhNzVhYTgxNjJjZmFmOGMzL3RhYmxlcmFuZ2U6YmEyOGY0NGEwMmJhNGY0YmE3NWFhODE2MmNmYWY4YzNfMi04LTEtMS0w_3fd88095-4f3f-4bb8-824d-d30111068b44"
      unitRef="usd">4000000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkzOA_747c6866-fbf3-487f-b679-e6242dbfcb3a">FAIR VALUE MEASUREMENTS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges.  The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of June&#160;28, 2020, the total amount of cash collateral held by the Company under the credit support agreements (CSA) amounted to $926 million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of June&#160;28, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $43.9&#160;billion and $22.2&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $45.3 billion and $20.1 billion, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June&#160;28, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $636&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts and &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;net investment hedge&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal second quarters ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.202%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.359%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.647%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.513%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.225%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.513%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.663%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal six months ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.593%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.402%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.982%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.111%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.860%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:12pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:28.555%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.823%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.969%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.789%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.935%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.700%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.648%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of derivatives not designated as hedging instruments for the fiscal second quarters and fiscal six months ended in 2020 and 2019: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:26.260%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.698%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.971%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.118%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.598%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain /(Loss) Recognized in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal second quarters ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.710%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.875%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated&lt;br/&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal six months ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.175%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.885%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.815%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.172%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.961%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.030%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.891%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.071%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.983%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.532%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.835%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.349%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.539%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.835%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.539%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.579%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Changes in Fair Value Reflected in Net Income &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Sales/ Purchases/Other &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non Current Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments with readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments without readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Recorded in Other Income/Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt;padding-left:36pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; (2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Other includes impact of currency&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For equity investments without readily determinable market values, $39 million of the decrease in the fair value reflected in net income were the result of impairments.  There were $11 million of increase in fair value reflected in net income due to changes in observable prices.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#x2019;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following three levels of inputs are used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 1 &#x2014; Quoted prices in active markets for identical assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 2 &#x2014; Significant other observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Level 3 &#x2014; Significant unobservable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s significant financial assets and liabilities measured at fair value as of June&#160;28, 2020 and December&#160;29, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:47.329%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.345%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.302%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.004%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.345%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.950%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;Total&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Equity investments &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Contingent consideration &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.005%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.198%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.187%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.418%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross to Net Derivative Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Summarized information about changes in liabilities for contingent consideration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.369%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.706%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.406%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.709%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Changes in estimated fair value &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(7) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;Includes $1 million of non-current other assets as of December&#160;29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3)     &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes cross currency interest rate swaps and interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (4)&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Classified as non-current other assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;Classified within cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;Includes $793 million and $1,631 million (primarily related to Auris Health), classified as non-current other liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.  Includes $3 million and $84 million classified as current liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (7)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal first quarter of 2020, the Company recorded a contingent consideration reversal of $983 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The one-time reversal of the contingent consideration was recorded in Other income and expense. As of June 28, 2020, the estimated fair value of the remaining contingent consideration is $169 million.  For additional details see Note 10 &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;t&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;o the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's cash, cash equivalents and current marketable securities as of June&#160;28, 2020 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.308%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.827%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.631%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.481%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.827%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.454%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.578%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.282%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash &amp;amp; Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Non-U.S. sovereign securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Corporate debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Time deposits&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Subtotal &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. Gov't securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other sovereign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;Subtotal available for sale debt&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The contractual maturities of the available for sale securities as of June&#160;28, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.204%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.929%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.379%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.157%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.131%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial Instruments not measured at Fair Value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following financial liabilities are held at carrying amount on the consolidated balance sheet as of June&#160;28, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:78.938%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.237%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.359%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.45% Notes due 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.250% Notes due 2022 (1B Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.25% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.73% Debentures due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.375% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.05% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.650% Notes due 2024 (750MM Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.50% Notes due 2024 (500 MM GBP 1.2431)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.625% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.45% Notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.95% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.90%&#160;Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.150% Notes due 2028 (750MM Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.95% Notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.95% Debentures due 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.375% Notes due 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.650% Notes due 2035 (1.5B Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.55% Notes due 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.95% Notes due 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.625% Notes due 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.40%&#160;Notes due 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.85% Debentures due 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.50% Debentures due 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.85% Notes due 2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.50% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.70% Notes due 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.75% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.50% Notes due 2048&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The weighted average effective interest rate on non-current debt is 3.24%.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The excess of the estimated fair value over the carrying value of debt was $3.0 billion at December 29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Current Debt balance as of June 28, 2020 includes $2.7&#160;billion of commercial paper which has a weighted average interest rate of 0.15% and a weighted average maturity of 3.7 months.  There was no commercial paper as of December 29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:CollateralAlreadyPostedAggregateFairValue
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTY3Mg_fa44af25-9357-4c4a-8213-d5d4816a08b4"
      unitRef="usd">926000000</us-gaap:CollateralAlreadyPostedAggregateFairValue>
    <us-gaap:DerivativeNotionalAmount
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjI3MA_397bb4c0-3403-47d9-bdee-28afeaffca29"
      unitRef="usd">43900000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="iad06a55c5b434327b4b129a23d14607a_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjI3OA_bd994d72-2483-4c44-bac7-c66528dd3def"
      unitRef="usd">22200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2558fa0249654384927e35faad85b435_I20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjQzMw_207c3b81-faa3-4d10-94a8-5cc038313afa"
      unitRef="usd">45300000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="ibc2e1511c074474db7b627c8d636f1f7_I20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMjQ0MA_bfe92f46-5285-4ed8-ac23-da2b527215b8"
      unitRef="usd">20100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDU3MA_bc9edd37-06dd-4958-a51c-204239b812b9"
      unitRef="usd">-636000000</us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax>
    <us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDgyOA_5112e55f-8061-4680-bbc3-64255f515811">next 12 months</us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss>
    <us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDk4OQ_9021a216-9cbb-4e62-832c-fba2a098b9c9">P18M</us-gaap:MaximumLengthOfTimeForeignCurrencyCashFlowHedge>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NzE_b9113c78-7596-46bf-a740-ce4f6531957c">The following table is a summary of the activity related to derivatives and hedges for the fiscal second quarters ended in 2020 and 2019, net of tax:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:18.202%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.359%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.647%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.513%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.225%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.070%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.936%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.513%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.663%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(62)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(101)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(128)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to derivatives and hedges for the fiscal six months ended in 2020 and 2019, net of tax:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:17.593%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.402%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.982%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.111%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.692%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.272%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.860%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Sales&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost of Products Sold&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;R&amp;amp;D Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (Income) Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (Income)  Expense&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;The effects of fair value, net investment and cash flow hedging:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on net investment hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain (Loss) on cash flow hedging relationship:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(35)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(136)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(103)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(120)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(346)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(92)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross currency interest rate swaps contracts:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal second quarters ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.463%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.710%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.524%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.875%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated&lt;br/&gt;OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(186)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is the effect of net investment hedges for the fiscal six months ended in 2020 and 2019&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:20.496%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.175%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.885%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.815%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:27.172%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.961%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.030%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.525%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.891%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Accumulated OCI&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From&lt;br/&gt;Accumulated OCI&lt;br/&gt;Into Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(48)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cross Currency interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMS0xLTEtMA_4f471c7f-2c6d-4031-b6ee-5e423fead76f"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="if2930efbd85243489088de50fb884ebf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMi0xLTEtMA_e96a2191-b407-4ace-965a-8907fcb49a4c"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMy0xLTEtMA_5df75513-4fc9-422f-a47c-20b7c28f00b7"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ic803db0b89c947539400ccc49f897abd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNC0xLTEtMA_2fb9c509-31cc-480c-9264-4c94bc597ac4"
      unitRef="usd">39000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNS0xLTEtMA_baaeea95-0a11-4af0-9a00-5bb86dcc70f0"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNi0xLTEtMA_89c41898-19f2-4365-a2fd-7232abdd80c3"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtNy0xLTEtMA_076d8ec3-68f1-463e-87b4-111564611f2a"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtOC0xLTEtMA_af0ef108-bc10-41ff-b1bc-3a22e87f0038"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtOS0xLTEtMA_5ec82462-90c2-459f-b525-ccd525662737"
      unitRef="usd">39000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTMtMTAtMS0xLTA_2e601bb8-4c9a-427b-a34d-b2996de59e2f"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i49d5622208c2453aa3b2ec9b491e6777_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMS0xLTEtMA_bfc05ca0-5ee5-44ba-a2cc-a956baca9648"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if2930efbd85243489088de50fb884ebf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMi0xLTEtMA_35361224-b715-45eb-acf3-90bf3423b134"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="id3e6ca8ab49e4b9db6ed69642c632250_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMy0xLTEtMA_6f4bcbca-f9a3-4440-a45e-1aad99509f3d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic803db0b89c947539400ccc49f897abd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNC0xLTEtMA_79be0151-4bd0-44f3-a631-c96623ff2c37"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ib50391dbdcc047d8a9a0fa959ed4e703_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNS0xLTEtMA_aa547b69-872b-416f-95f7-1d17010745c4"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ib8a6adee9d4345289e9aadeec183761c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNi0xLTEtMA_fbe1338b-c85c-45a0-b989-a68e82aa0b6b"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i708f3c73de914867a3a38ef4ce091aaa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtNy0xLTEtMA_c08725c0-926b-4ae7-b2d6-001a50e734b1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i92def947621b4a8083cdb65ee702dd1e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtOC0xLTEtMA_049f4e75-b883-4e43-b74d-1e8e05001931"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i672f43d13b1c42d9bdf08cd6bf6e830a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtOS0xLTEtMA_439d3233-affe-4a70-8dfb-aaf386566cdf"
      unitRef="usd">39000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic4f8c0e831aa47fca78a6fc21670d16a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTQtMTAtMS0xLTA_2c864287-771e-400f-ad36-c29c5707ba86"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMS0xLTEtMA_201b88e9-942f-4d5d-bc7d-03deadd4e872"
      unitRef="usd">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMi0xLTEtMA_85407e40-6f40-4a95-82a2-7737f79e05ae"
      unitRef="usd">-62000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMy0xLTEtMA_845a85e6-ab28-4d56-aeeb-af0a1ec60e0c"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNC0xLTEtMA_1f88069c-178d-4527-b507-0b4d17a6731a"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNS0xLTEtMA_d414a315-90a8-4489-a06b-4d892bc9076f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNi0xLTEtMA_854db62d-829d-4410-b0d7-edd87b8a883f"
      unitRef="usd">-14000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtNy0xLTEtMA_03c59f61-c4da-485e-a388-0f91ca7bb5c0"
      unitRef="usd">-101000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i392345cf23fa442fa586318c28775403_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtOC0xLTEtMA_1581ae2e-c9cb-4772-8de0-1f85da242553"
      unitRef="usd">36000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtOS0xLTEtMA_783a0265-236e-45c5-bd1f-cd0fcdbb5e26"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMTgtMTAtMS0xLTA_169a0783-5d37-4d21-b091-d3932fb34bb7"
      unitRef="usd">2000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie373716862d6408e8e773e5a6c8daa1e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMS0xLTEtMA_aa49cd9d-3b7e-421c-a09d-d5c4dbf7143f"
      unitRef="usd">-2000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i96ef6cebb37d4bf08bfe2eda2fc310a3_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMi0xLTEtMA_fd0288f0-16a6-4b76-8158-c6969b63eb2f"
      unitRef="usd">-128000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic2963d7236494e7b87b049a22c4a5e2f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMy0xLTEtMA_f544b430-30bb-48f4-b1ee-436afaed5bd6"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i1a5bdc0c3fa543358d481426f2c20454_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNC0xLTEtMA_2bc972d8-3fbb-42a1-bf19-463359a2c327"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i7ddf95ebc81444edabacdda4bc68fcb1_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNS0xLTEtMA_9c6ce64f-923a-4951-9da2-d1e9323fa888"
      unitRef="usd">22000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i210bca81d0b140acb2c261b2ff806ad9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNi0xLTEtMA_9bbbf799-7886-4af7-af23-ed7c05b2192f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ib10f5b79aaa249de99c4ff77ab3daca1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItNy0xLTEtMA_3dab226a-2b4c-40a5-b820-d4c9544ea60c"
      unitRef="usd">-50000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i392345cf23fa442fa586318c28775403_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItOC0xLTEtMA_7cc15147-58e3-44ba-aaba-42cfff4f9ac7"
      unitRef="usd">18000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ife6b2901a6b74177a9ff5e22f96ce8b0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItOS0xLTEtMA_0acb034e-ff17-425a-b93f-91dce7a219dc"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ia5b9b5cb00814f39b17c9efe02b26f7b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjItMTAtMS0xLTA_17be1567-545e-4c9b-882e-7c8cbd2bfa88"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMS0xLTEtMA_18297f6f-3ac0-4187-802a-7e037179cddc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMi0xLTEtMA_25a09c8f-b9be-48b0-aeba-c390f49ad616"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMy0xLTEtMA_b8d092be-fcd2-4e43-b19d-a127e085db47"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNC0xLTEtMA_28073865-b918-4e50-ba69-0ac86265e259"
      unitRef="usd">83000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNS0xLTEtMA_acc2a0a8-0e13-4126-a2a4-3b0cba4040b7"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNi0xLTEtMA_f5c11c80-86ac-4785-8689-343381ab1f5e"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtNy0xLTEtMA_e1c8a45a-100a-44b0-bae7-93a2113891f5"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtOC0xLTEtMA_8b42477b-49b8-4fc4-a92c-21b54d96f83b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtOS0xLTEtMA_59ec5a4f-e123-4c3a-b4b2-f7584e16dc2c"
      unitRef="usd">64000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjUtMTAtMS0xLTA_07938156-f4b6-4be7-aeff-d7c40f256b3d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6adefc338228408eb34e4a2d079034d0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMS0xLTEtMA_7ef75cd7-2c32-4146-ac7c-e0c18a719d40"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i38359dc9088e48f78819a412fb7bb8ff_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMi0xLTEtMA_b8377e44-6a5e-4b34-97ea-52b74f7902b9"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i53dc0a5a99fb411cac61cb2cc639ed5a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMy0xLTEtMA_a86f51d7-4d4f-40f9-92da-5297d0e01420"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i9a0b417f014440a2a644aa930c94bc42_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNC0xLTEtMA_e9f35d1b-299f-4216-8d23-c29d1aabe3fa"
      unitRef="usd">100000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="idc226d3190684ddcb7fea5efc1049edd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNS0xLTEtMA_066c1f85-ea81-4d9e-a55a-7a69d9d042eb"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4ce9a560e8dc4524bb57ac5caf2e422c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNi0xLTEtMA_b879962f-bbe4-46e9-8e4c-a2f49d414f2f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="idaf78e01bd9a40ac9ab7dcf9bedbe4f3_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctNy0xLTEtMA_c6143a61-6087-4791-b3c5-79ec92cc096d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i67f9fb646b914c93a7e48c50c027ff8d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctOC0xLTEtMA_356094b8-7838-49af-864b-3605e19f0ba5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i0c7ce27bac364ef9b21dfd520f2f7bb4_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctOS0xLTEtMA_a70095e9-6865-44b2-a972-041a3d9f6ef5"
      unitRef="usd">82000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i36aae441854049c791e8bc8a09e14e35_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjllMzlkMjY2MWQ3YzQyMzM4NjgxMWE2ODNjOGQ2NjI3L3RhYmxlcmFuZ2U6OWUzOWQyNjYxZDdjNDIzMzg2ODExYTY4M2M4ZDY2MjdfMjctMTAtMS0xLTA_68a3b862-1456-4f38-a58e-3103f812b16a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMS0xLTEtMA_946df260-313a-47d4-9b53-27508c7bdae8"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMi0xLTEtMA_d35624b6-99f7-4933-86ae-9e531bac971f"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMy0xLTEtMA_76a9f683-aea8-424f-97c2-ca6fa59d548f"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNC0xLTEtMA_e4693348-f468-468f-9c72-a7e21b62b710"
      unitRef="usd">79000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i182f09e72a12408fba69944468ed839b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNS0xLTEtMA_058941c4-565e-4000-b062-92e2152eac9c"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNi0xLTEtMA_d363379e-5ec7-4b54-8b46-6d9acf56b19a"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtNy0xLTEtMA_0eac1eee-9125-4c7e-b336-bdaaa32f8830"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtOC0xLTEtMA_c584bb0f-92c8-4732-8f08-a82a10d4ecdf"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtOS0xLTEtMA_ed1dd248-ab54-42ed-81b6-cd146500a141"
      unitRef="usd">78000000</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings
      contextRef="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTMtMTAtMS0xLTA_4565e36a-396e-4c24-a436-d29919da26c3"
      unitRef="usd">0</us-gaap:DerivativeExcludedComponentGainLossRecognizedInEarnings>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic1069bfc35014183ab9f9fdf6dcfed5b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMS0xLTEtMA_a9b16e1a-2040-4bb4-b674-a9acb9a01859"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ifd8a567d65dc43e2ac04facba2c1026c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMi0xLTEtMA_20e84784-dae8-40b2-9e89-f1f4573dc6cd"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i906c99c6de3c440fba141187cd930ef2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMy0xLTEtMA_6ff667d5-ae73-478d-ae8c-6bb00d2372c1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i7769755f6f774cfe8d620851ad216a16_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNC0xLTEtMA_ec71cac3-5329-457e-a5bc-d463586cc158"
      unitRef="usd">79000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i182f09e72a12408fba69944468ed839b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNS0xLTEtMA_eaaa49eb-20ab-4a3d-b57a-2293b0ca046f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6ec4fd4a2f1e4097be563e8f0f38002e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNi0xLTEtMA_f9117411-146e-4f43-96b2-08e4e59008d5"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i41c7225824274c148e6a8a7b4c03428b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtNy0xLTEtMA_25251512-c839-421d-8c87-da1d61743b34"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i9ec90df13b5a4758982253a047c812c6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtOC0xLTEtMA_8aacf8dd-3118-4dd1-8abe-e2a6afe866e1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i73bd80a928374cb7ab5ff788e0ad839a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtOS0xLTEtMA_d6dfb841-416f-4462-9d15-16e5f586a627"
      unitRef="usd">78000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="icc4696db1b7f47fbb11feb4abedabada_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTQtMTAtMS0xLTA_0d023469-b5ad-4054-90fb-8ed5009882f1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i1a386510568948ef9401f50d743744af_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMS0xLTEtMA_de8c89a6-bf6f-458a-92f7-1e8b3279617d"
      unitRef="usd">7000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMi0xLTEtMA_e65ea5e5-c531-4736-94c0-72d99314c1d4"
      unitRef="usd">-235000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMy0xLTEtMA_adda8f1a-b00a-484a-aa7c-b3c355f5ea63"
      unitRef="usd">-108000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNC0xLTEtMA_f20ab9c2-b7b4-4bad-9739-51a17a33a169"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNS0xLTEtMA_c995a704-4d35-413b-a379-f1bbfa2c2c9f"
      unitRef="usd">-2000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNi0xLTEtMA_6ccf1991-416d-4a59-b323-2fb4c38ad668"
      unitRef="usd">-35000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i6147540408284062babe0382c2ed602f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtNy0xLTEtMA_e4a292d6-8e1e-41a6-b065-6f7e25fda8e6"
      unitRef="usd">-136000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i771189b421614759bcfeb81a969af79c_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtOC0xLTEtMA_c46520b2-6912-40b0-9fea-b40672ab67c8"
      unitRef="usd">-103000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtOS0xLTEtMA_110c0506-e26e-41af-a1df-9847f1c9373f"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMTgtMTAtMS0xLTA_9be92306-3eda-4bda-9f01-b257e0ea8aea"
      unitRef="usd">8000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i1a386510568948ef9401f50d743744af_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMS0xLTEtMA_e2247b59-7e33-45d1-9ddd-32043d52cf6f"
      unitRef="usd">9000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic20861ff337f4b558b0230a07c21c9cf_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMi0xLTEtMA_02cd3f1e-a67f-491e-8400-3bcea760f308"
      unitRef="usd">174000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i751041c57207421492ee3bf6d4562ab2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMy0xLTEtMA_2e26870d-3568-4fbb-af3e-e1e1e34e27af"
      unitRef="usd">-120000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ifbb6c0af17f14a3483ffa391776b661f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNC0xLTEtMA_aac6f44d-706a-4b54-8f01-daff60de562a"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ie944f2ac2ecb4062a84abfad85ef6e56_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNS0xLTEtMA_bcb1d053-6f93-4859-aa46-d70e1fe714a2"
      unitRef="usd">-14000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i810459e8695041d8a1f6aec6987d5cad_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNi0xLTEtMA_bfc2e2b0-4561-439a-9efe-99553a0f758d"
      unitRef="usd">-6000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i6147540408284062babe0382c2ed602f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItNy0xLTEtMA_6126e159-0000-4f06-acf6-6d47d52bc427"
      unitRef="usd">-346000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i771189b421614759bcfeb81a969af79c_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItOC0xLTEtMA_bb5a54fa-6a34-4611-b31b-04b86255b923"
      unitRef="usd">-92000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ic8588f2797b64bfaac54842234c933f6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItOS0xLTEtMA_b4545d8d-ccff-4813-ba74-135ac7683ee2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i5bc871d010e84b72bb6b51383121686d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjItMTAtMS0xLTA_2a8e5efe-900d-4317-8ace-5cbb2261b1c0"
      unitRef="usd">10000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMS0xLTEtMA_f193f343-fe6b-43a0-86b5-59770b059016"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMi0xLTEtMA_07d50628-090d-4553-a4bd-309ec95e7ed2"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="if9ac6becf67b448c872942fc733563e5_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMy0xLTEtMA_f7267c79-6b9a-4078-b924-75b8795c86fc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNC0xLTEtMA_615c43e0-2e4e-434c-be3d-56f2995ae780"
      unitRef="usd">181000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="if84c79837433431cbfe27e56a7471773_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNS0xLTEtMA_ed01d07d-24f7-4a9a-be32-44f0b0423f19"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNi0xLTEtMA_27f46052-cd63-410d-b745-b8f3e23f50e5"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtNy0xLTEtMA_7b570ce3-ac5e-448d-849d-fcf44deb2129"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtOC0xLTEtMA_2ad3aa30-ea98-45f5-9b51-6b19e14b4ce6"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtOS0xLTEtMA_d2e40712-d791-4288-980c-a985c618673e"
      unitRef="usd">118000000</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjUtMTAtMS0xLTA_27cce8ed-63b0-49a2-bf85-1721badfde9b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i0913011070994b70a23fa4c40d1e873e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMS0xLTEtMA_afc8f492-1bf7-4000-b1c7-c499fe1fef32"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="iad3d1965309140cfb7ae0d25398daa17_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMi0xLTEtMA_7b191cf1-ac5f-4c4b-8f1c-de342dcaa285"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if9ac6becf67b448c872942fc733563e5_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMy0xLTEtMA_44f67a09-f401-409b-af64-5f596e3a883e"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i12e0441eb04b4331bdcd91124e9c4bdd_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNC0xLTEtMA_d3620e81-5e3d-4c21-b480-c7768ecc55e4"
      unitRef="usd">725000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="if84c79837433431cbfe27e56a7471773_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNS0xLTEtMA_ebc3cb28-21ac-4599-92b5-f41628634ca2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ib4cf792e34bb4a1a94b59e2df4691caa_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNi0xLTEtMA_2af27858-026b-4366-94f6-8c24e4310b94"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i4d3f23e490fd4f17a60a99864205374e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctNy0xLTEtMA_172ed22b-fe77-44bf-9844-045c529d4a48"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="iedef6d038b654f4c99bb6ec524ad249d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctOC0xLTEtMA_fa6af805-ba3c-41b0-b7a7-fd7f99c59642"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="i60b7ac6f6588437ea9cab06ef96da71a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctOS0xLTEtMA_c6161702-d937-4634-a697-f43eec7dc148"
      unitRef="usd">140000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax
      contextRef="ifd7e56691d954cb09f5967fec9bd5649_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmU2YjFkZDBkYmVkZDRiYjdhODIyODY1NmRlYTRhNDgwL3RhYmxlcmFuZ2U6ZTZiMWRkMGRiZWRkNGJiN2E4MjI4NjU2ZGVhNGE0ODBfMjctMTAtMS0xLTA_c7bf7804-1255-48c2-9489-c4d080fddc1c"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax>
    <us-gaap:ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MTQ_14095e3a-d521-4644-a88b-8ef16f381972"
      xsi:nil="true"/>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MzQ_dce8ed8b-c3d8-4926-a65f-f6d8d2603e21">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:26.260%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.698%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:15.971%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.959%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.814%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.594%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.118%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.598%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;br/&gt;Recognized In&lt;br/&gt;Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Location of Gain /(Loss) Recognized in Income on Derivative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign Exchange Contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other (income) expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(88)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i02769757e5e740ba8d0918956fb4bebe_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC00LTEtMS0w_8e59ca3c-1ffd-4329-aac6-fca38e2038fc"
      unitRef="usd">-24000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i0e42ae0e28f84a3883a9d31defcc19c3_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC02LTEtMS0w_5bb72b7e-fddb-440c-8e76-f65884f58a69"
      unitRef="usd">-50000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i890db46e47fd49d29bf0222d80de0e45_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC03LTEtMS0w_8715fed1-7473-4716-bcdc-27e1cdbb0fca"
      unitRef="usd">65000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib840e261052c4ea5ac6bd3f5620b9e0f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjE0MTZmOTA2YTViYzQ4NjZiNjZlZGVkOGFjM2RiYWQyL3RhYmxlcmFuZ2U6MTQxNmY5MDZhNWJjNDg2NmI2NmVkZWQ4YWMzZGJhZDJfNC05LTEtMS0w_58a037bc-3edd-4628-8600-a8e6454cbae2"
      unitRef="usd">-88000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy0yLTEtMS0w_28213c51-724c-424d-9d19-3cd712433381"
      unitRef="usd">-95000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy00LTEtMS0w_ae59504b-93a2-4b95-98e3-ec3a3dd4bd83"
      unitRef="usd">-57000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i49811ec159eb4ac3bc3e2bbd99fe655b_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy04LTEtMS0w_83da79cf-43a0-4565-8e2a-0f1e4bde4c0d"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i440d6fd614824bcc9d8ddcc6388c5585_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfMy0xMC0xLTEtMA_712f4bde-3963-4b66-906b-f86c8febd0ad"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i05a3bd79ad904c7c8b977b55b1dfda9d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC0yLTEtMS0w_60b221ef-f2fe-478f-8346-3ac63fac0dfc"
      unitRef="usd">-186000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ia24f094cc45d4b64bcbc61338f27ef34_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC00LTEtMS0w_ac1210dd-df04-4c61-88b6-dee0c0bc2932"
      unitRef="usd">-57000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="idab234b2a9db4b839ddaf49647f6f9f0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC04LTEtMS0w_09c1c82e-d549-4a29-96b9-8648c6acd40b"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i4ec571d4979a4ebba093f4d51dbf209d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjEyMDdmODk3YTBmMDQwYzE5YTY3OGEwYzk2Mzk2N2VjL3RhYmxlcmFuZ2U6MTIwN2Y4OTdhMGYwNDBjMTlhNjc4YTBjOTYzOTY3ZWNfNC0xMC0xLTEtMA_ee8bd351-035d-4a59-a7a4-bf1ea7005770"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC0yLTEtMS0w_8484eb70-4cb8-46b2-88fd-cb577fbadb52"
      unitRef="usd">-48000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC00LTEtMS0w_81351b68-11ca-443c-8408-c9e267759875"
      unitRef="usd">14000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i636d1fd3b5314b0cb1e7b53344d7a601_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC04LTEtMS0w_dbdeac16-8d47-4359-ac31-4aad676c5e9c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i803140059c0440d58c12d070ec9ef9e4_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNC0xMC0xLTEtMA_2cf55b3e-dade-4fee-ba0c-36ff56bb1e21"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ie56c599de2e24fc180918708256afa06_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS0yLTEtMS0w_e95ba754-93ca-4401-b898-0a6a37bf6d91"
      unitRef="usd">641000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax
      contextRef="ib4560dde64424b5eb34ac46f8e75831f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS00LTEtMS0w_38f43369-4427-47cf-8d3c-9ff723c6da75"
      unitRef="usd">313000000</us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="i09bd4a7957314ad4806a70ff0309af9c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS04LTEtMS0w_f43216f6-4396-4bac-b063-c6da631ef2fc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
      contextRef="iac20a877725e4f95bad00d306f8ef1bd_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjBmOThmZTJmMDFkOTQyMDE4MjJlOTVjODJmMjc0YjRkL3RhYmxlcmFuZ2U6MGY5OGZlMmYwMWQ5NDIwMTgyMmU5NWM4MmYyNzRiNGRfNS0xMC0xLTEtMA_8655cf98-e24d-4985-9dfa-8ac8ba79419c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred>
    <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NjY_83539a9f-077c-4f6b-b555-23ceb502dfef">&lt;div style="margin-bottom:7pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table is a summary of the activity related to equity investments:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:25.071%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.983%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.532%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.835%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:12.349%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.539%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.835%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.869%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.539%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.579%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Changes in Fair Value Reflected in Net Income &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;"&gt;Sales/ Purchases/Other &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non Current Other Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments with readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Equity Investments without readily determinable value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Recorded in Other Income/Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt;padding-left:36pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; (2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Other includes impact of currency&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i5ca06658d0fa40fd9124e23676ae5f16_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi0yLTEtMS0w_f353330e-b7d9-404e-bc69-a4e5a1e28d6f"
      unitRef="usd">1148000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:EquityFairValueAdjustment
      contextRef="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi00LTEtMS0w_ddaff9cd-6f32-449d-9d50-1ab0c3ae9fec"
      unitRef="usd">196000000</us-gaap:EquityFairValueAdjustment>
    <jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod
      contextRef="i4d8c558fb0b7472b87608a7e618b61c4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi02LTEtMS0w_0b30bae1-586f-492a-92b4-82d0dd16bf0d"
      unitRef="usd">144000000</jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod>
    <us-gaap:MarketableSecuritiesNoncurrent
      contextRef="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi04LTEtMS0w_3439184b-66b4-4cf5-9251-2b66b6d0700d"
      unitRef="usd">1488000000</us-gaap:MarketableSecuritiesNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i0ff0b776e3bc4e078f327bbba45fe15a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfMi0xMC0xLTEtMA_53b33f55-e1a9-4737-b7a9-0d49e05ebd51"
      unitRef="usd">1488000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i5f752123964c43149dbce663ffb8dd1a_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC0yLTEtMS0w_a5d738a4-f866-4edd-9501-5fca14fa3a99"
      unitRef="usd">712000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquityFairValueAdjustment
      contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC00LTEtMS0w_f54cc332-e240-4a40-82c7-e0e9c0fb64da"
      unitRef="usd">-28000000</us-gaap:EquityFairValueAdjustment>
    <jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod
      contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC02LTEtMS0w_69087957-a129-4d6b-9b6e-2d0e20c678e1"
      unitRef="usd">28000000</jnj:EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
      contextRef="i9326dae4609548fba0848714a64d1794_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC04LTEtMS0w_34da7f4c-b5e1-4b29-af79-a0450281cca3"
      unitRef="usd">712000000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i9326dae4609548fba0848714a64d1794_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjgzNzY4ZGZjMzYxZDQ2MGQ4NWFkNjZiMTRhOTEwMjEzL3RhYmxlcmFuZ2U6ODM3NjhkZmMzNjFkNDYwZDg1YWQ2NmIxNGE5MTAyMTNfNC0xMC0xLTEtMA_7597df2f-97eb-438b-9bc4-ad05a8ac78b7"
      unitRef="usd">712000000</us-gaap:OtherAssetsNoncurrent>
    <jnj:EquityFairValueAdjustmentImpairmentLoss
      contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNjU1NA_9d03bd07-127e-4c45-84e5-65e0c2542672"
      unitRef="usd">-39000000</jnj:EquityFairValueAdjustmentImpairmentLoss>
    <jnj:EquityFairValueAdjustmentChangeInObservablePrice
      contextRef="i069a576a3fad47e1b250efb6aa189c3a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNDk0NzgwMjMzNzk4MA_31691568-f20d-4a59-9b77-60d358fa5cc9"
      unitRef="usd">11000000</jnj:EquityFairValueAdjustmentChangeInObservablePrice>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MTY_c0644d1c-1977-4e6b-9396-7886793e2c4b">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company&#x2019;s significant financial assets and liabilities measured at fair value as of June&#160;28, 2020 and December&#160;29, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:47.329%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.345%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.302%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:5.004%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.345%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.545%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.950%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;"&gt;Total&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,521&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Interest rate contracts &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Forward foreign exchange contracts &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Investments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Equity investments &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Contingent consideration &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.005%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.992%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:19.198%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.187%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:22.418%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gross to Net Derivative Reconciliation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(841)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Gross Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Credit Support Agreement (CSA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(510)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(586)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Net Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Summarized information about changes in liabilities for contingent consideration is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:40.369%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.410%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.706%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.406%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.709%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Changes in estimated fair value &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(7) &lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(938)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;"&gt;Includes $1 million of non-current other assets as of December&#160;29, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3)     &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes cross currency interest rate swaps and interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (4)&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Classified as non-current other assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(5)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;Classified within cash equivalents and current marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:18pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(6)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;Includes $793 million and $1,631 million (primarily related to Auris Health), classified as non-current other liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.  Includes $3 million and $84 million classified as current liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;           (7)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal first quarter of 2020, the Company recorded a contingent consideration reversal of $983 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The one-time reversal of the contingent consideration was recorded in Other income and expense. As of June 28, 2020, the estimated fair value of the remaining contingent consideration is $169 million.  For additional details see Note 10 &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;t&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;o the Consolidated Financial Statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC0yLTEtMS0w_100db368-966c-4efb-ba8b-37dd4000b9fc"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i266b986790574bd58dd9c8410be41161_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC00LTEtMS0w_39b2f670-591d-4fc8-8b1b-fb7ab5e66c40"
      unitRef="usd">395000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC02LTEtMS0w_590eebdd-4ea2-438e-adfa-940a05487412"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC04LTEtMS0w_62084c8e-3dc3-4646-aa4e-8cdc86f3093a"
      unitRef="usd">395000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNC0xMC0xLTEtMA_2934c65f-bbca-4595-979f-af5d46ae9474"
      unitRef="usd">209000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i32a304915e484dc482c62bb1f219c6ec_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS0yLTEtMS0w_8c202d31-ddeb-48a1-896f-48812cf89341"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i07152e7d66cd425cbf3e240d1e56cec5_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS00LTEtMS0w_f1d02d03-3d4f-4251-965c-c3f85aee39bc"
      unitRef="usd">1126000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i4e246117e68944788661db5d2b317e56_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS02LTEtMS0w_05833ef3-7dab-4d59-8f8d-6ed1a3f0a003"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i540760381d80440cad88a6dab18c3a11_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS04LTEtMS0w_39b8eeba-cb4c-404c-a89f-a2e400c97131"
      unitRef="usd">1126000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i808beb23831442638cf20b785a026f54_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNS0xMC0xLTEtMA_07ea0cb3-02a1-4104-8086-2ecb1c46fa73"
      unitRef="usd">693000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy0yLTEtMS0w_fb782f06-c1eb-49c4-8f1c-9db374bff51c"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy00LTEtMS0w_13a7ad8f-66f8-4dc1-9135-ca29a591a39a"
      unitRef="usd">1521000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i45557044d86f4718ba2718ad7252be12_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy02LTEtMS0w_ed8fe76b-149e-4bb0-b5db-45bb3f001fe0"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy04LTEtMS0w_795fbe1a-e01f-4a9a-ba89-262b88a36e53"
      unitRef="usd">1521000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue
      contextRef="i1dfa706123d84147824f6fd9464cff19_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfNy0xMC0xLTEtMA_a225fdb1-22a3-437d-be04-fde43e016ded"
      unitRef="usd">902000000</us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS0yLTEtMS0w_15458c7a-9fe5-4204-afaa-82f6d27c75f9"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i266b986790574bd58dd9c8410be41161_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS00LTEtMS0w_47e67144-b369-4b6d-b25e-3d71e74d3aae"
      unitRef="usd">260000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS02LTEtMS0w_7d25c782-c8b2-45a1-b0e9-dcac1813d516"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS04LTEtMS0w_702d79a7-74e0-4509-9a70-5e1fdf606fed"
      unitRef="usd">260000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfOS0xMC0xLTEtMA_b4ec8274-b95b-432c-a8ac-e50d3cec1534"
      unitRef="usd">426000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i32a304915e484dc482c62bb1f219c6ec_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtMi0xLTEtMA_22cfefed-ded8-415c-b130-e0b6202ac3d1"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i07152e7d66cd425cbf3e240d1e56cec5_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtNC0xLTEtMA_28fee5e1-0773-49a0-a644-57d320a59a3b"
      unitRef="usd">251000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i4e246117e68944788661db5d2b317e56_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtNi0xLTEtMA_5556f572-2411-4c36-a206-446883940505"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i540760381d80440cad88a6dab18c3a11_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtOC0xLTEtMA_12eabd59-0f84-4db6-8d77-e9e83a4f262d"
      unitRef="usd">251000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i808beb23831442638cf20b785a026f54_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTAtMTAtMS0xLTA_8dab137a-9ead-4f02-a658-8407d190d4e6"
      unitRef="usd">193000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItMi0xLTEtMA_94c7e699-25d8-4049-bcb9-b30a6d361401"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItNC0xLTEtMA_e2b80da8-a3c4-45e4-9f59-c1ae9f5621c0"
      unitRef="usd">511000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i45557044d86f4718ba2718ad7252be12_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItNi0xLTEtMA_3762f740-ae17-4eca-a696-e81b3b432b13"
      unitRef="usd">0</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItOC0xLTEtMA_aa33890d-2c4b-443a-8ced-d82c7522988e"
      unitRef="usd">511000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
      contextRef="i1dfa706123d84147824f6fd9464cff19_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTItMTAtMS0xLTA_834d887c-2754-498f-bdbf-5f968c188bc5"
      unitRef="usd">619000000</us-gaap:DerivativeInstrumentsInHedgesLiabilitiesAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtMi0xLTEtMA_33ecf310-164a-4f92-8889-109c5df4778d"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="i266b986790574bd58dd9c8410be41161_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtNC0xLTEtMA_5161cd7b-d0e3-42e5-bc6f-b3699f0be5bc"
      unitRef="usd">38000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtNi0xLTEtMA_136cccad-ec4c-44a8-b80a-598be74c924a"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtOC0xLTEtMA_d828a229-5bc0-4f44-aab6-f103429a754e"
      unitRef="usd">38000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
      contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTUtMTAtMS0xLTA_f5cb1913-c3af-4c5f-85b5-887bec7c671e"
      unitRef="usd">23000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="ib201d398ebc14ebdb124f345bb48e79a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctMi0xLTEtMA_05762e50-bf66-42a5-b23a-11413339f292"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="i266b986790574bd58dd9c8410be41161_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctNC0xLTEtMA_487237e6-4615-4d7e-94e1-f37d330b5a1c"
      unitRef="usd">47000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="ib4796b3e074d44b8b27f9e3805365ef7_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctNi0xLTEtMA_591099d8-ec65-44ea-9871-dea6a67f22e0"
      unitRef="usd">0</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="id1b4629634a44afab44276b8c7cb5831_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctOC0xLTEtMA_8e27cd8f-7ac6-424c-99d2-d99f0108d6da"
      unitRef="usd">47000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
      contextRef="icdca07f5cbe24e8198c4af3fc1e4e4ed_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTctMTAtMS0xLTA_4dcc2615-586b-4ce0-87b0-eedd0b3b6595"
      unitRef="usd">33000000</us-gaap:ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktMi0xLTEtMA_81421804-c13a-42e1-8f07-6f1094543b33"
      unitRef="usd">1488000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktNC0xLTEtMA_d98cb18f-0014-41ca-b77f-1fdac7daf8ec"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i45557044d86f4718ba2718ad7252be12_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktNi0xLTEtMA_96a07b43-068b-4ebc-a157-8cb8de920acc"
      unitRef="usd">0</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktOC0xLTEtMA_5ef6e38c-1551-4aca-93c8-af428807044c"
      unitRef="usd">1488000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMTktMTAtMS0xLTA_8e83259f-e015-4747-b074-692b4b255f5c"
      unitRef="usd">1148000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i048d532d55964ba2af85ffcf6f324949_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtMi0xLTEtMA_973252d1-33d1-4894-a3d0-747e48563a43"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i01fcaecf26704902b098af6c039a0f6f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtNC0xLTEtMA_ea217821-a0e0-4aa9-a7ed-e9baf124cbe1"
      unitRef="usd">10047000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i45557044d86f4718ba2718ad7252be12_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtNi0xLTEtMA_831c2e20-7e27-4009-acb0-fbd500d39e03"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtOC0xLTEtMA_b64ac5c6-7cc9-4ce3-ab03-06641c610eeb"
      unitRef="usd">10047000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjAtMTAtMS0xLTA_c576e6be-c32a-4523-9245-02496570916f"
      unitRef="usd">4368000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i45557044d86f4718ba2718ad7252be12_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItNi0xLTEtMA_67a99e16-ce77-4c14-b2ee-503a145ce303"
      unitRef="usd">796000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItOC0xLTEtMA_0fe4940d-3736-4685-96fa-6919482485ee"
      unitRef="usd">796000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmJiOTUzYWYyZmE1NjQ0NzhiMzRjZjIzZDM3ZTgwZmNkL3RhYmxlcmFuZ2U6YmI5NTNhZjJmYTU2NDQ3OGIzNGNmMjNkMzdlODBmY2RfMjItMTAtMS0xLTA_ef0932a4-f927-4617-b5d3-25f1172939fe"
      unitRef="usd">1715000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMi0yLTEtMS0w_06bccdea-30b3-4e16-8acc-7367a7706bf3"
      unitRef="usd">1559000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMi00LTEtMS0w_3eb7b36e-4248-4acd-bcac-15c3761e7a9d"
      unitRef="usd">925000000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMy0yLTEtMS0w_127292a6-b651-4b17-b72e-cc6f29f724b5"
      unitRef="usd">1437000000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssetFairValueGrossLiability
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfMy00LTEtMS0w_382d09dd-0d01-4c8c-a4f8-79d34ab2ecf0"
      unitRef="usd">841000000</us-gaap:DerivativeAssetFairValueGrossLiability>
    <us-gaap:DerivativeAssets
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNC0yLTEtMS0w_e1aa6c70-ac84-43b6-ad78-b00ef19f4017"
      unitRef="usd">122000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNC00LTEtMS0w_131ffe49-46e4-4725-89c3-137b48939142"
      unitRef="usd">84000000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNi0yLTEtMS0w_d6186619-c517-4bac-8bad-aa823bb63b55"
      unitRef="usd">558000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeFairValueOfDerivativeLiability
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNi00LTEtMS0w_39de75d1-e237-4cc8-bc69-f1b99582ac81"
      unitRef="usd">652000000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNy0yLTEtMS0w_56246fa5-3267-45b0-ac47-947cee2ff437"
      unitRef="usd">510000000</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilityFairValueGrossAsset
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfNy00LTEtMS0w_70741ce8-334a-4f93-a9a0-16c3c08e84b9"
      unitRef="usd">586000000</us-gaap:DerivativeLiabilityFairValueGrossAsset>
    <us-gaap:DerivativeLiabilities
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfOC0yLTEtMS0w_6e203bbc-e2c8-446c-bc88-2d0adf801086"
      unitRef="usd">48000000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjJiMmM3ZTcwNzcxNzQwM2I4ZmZlOGNmYTgxZmM3NGRiL3RhYmxlcmFuZ2U6MmIyYzdlNzA3NzE3NDAzYjhmZmU4Y2ZhODFmYzc0ZGJfOC00LTEtMS0w_3849d9b6-e830-489e-ac81-792206387dba"
      unitRef="usd">66000000</us-gaap:DerivativeLiabilities>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i4250b233c8424335ac39cd07c8101199_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfMy0yLTEtMS0w_94cf6736-56a0-44ec-b625-6913293bb452"
      unitRef="usd">1715000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i99963dbb725b4ce68efcd70e25e653e1_I20181230"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfMy00LTEtMS0w_3a9fd38f-3d3b-4d92-a308-25e4c0592642"
      unitRef="usd">397000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNC0yLTEtMS0w_e9e59692-68eb-41ea-bf6e-632fb9adffe7"
      unitRef="usd">-938000000</jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue>
    <jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNC00LTEtMS0w_148ccafa-9e4e-4f4e-b718-b4f29e2a7c11"
      unitRef="usd">35000000</jnj:FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNS0yLTEtMS0w_7577c303-a400-4d51-89c6-ea3333b64dd4"
      unitRef="usd">106000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNS00LTEtMS0w_c3fadd52-7e6b-4f97-ba16-5add7c6d5283"
      unitRef="usd">1133000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNi0yLTEtMS0w_326c4369-5678-45ce-8c3f-e4361d29f0ab"
      unitRef="usd">87000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNi00LTEtMS0w_2ede7979-fa91-4daa-b913-4ae9bef24d25"
      unitRef="usd">3000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNy0yLTEtMS0w_b8d50260-b243-40e0-9896-4c1bdd181936"
      unitRef="usd">796000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i53f4e27a97c1484f9cee33fa33a3aeff_I20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmI3ZWZhNTE0MzI1NDQ0NmNiMTM2ODliYTAxZDI0N2QxL3RhYmxlcmFuZ2U6YjdlZmE1MTQzMjU0NDQ2Y2IxMzY4OWJhMDFkMjQ3ZDFfNy00LTEtMS0w_95754ad7-d9c5-47ed-97c5-a09617f45c8f"
      unitRef="usd">1562000000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:EquitySecuritiesFvNi
      contextRef="i1b8d63c17e114b2e9b9a96275f1697e4_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODgyNw_9b014ee0-4479-47ae-b3ac-1218fd92773c"
      unitRef="usd">1148000000</us-gaap:EquitySecuritiesFvNi>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iccc7bf9a45e54601aca24b8cc9b8ea57_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODg5NQ_ed77f62b-3efa-44ee-87b6-59795b94f779"
      unitRef="usd">1715000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:DerivativeAssetsNoncurrent
      contextRef="i3e6c057229dc4bd7a12d48cbd4db8754_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfODkzOQ_8a967939-1bb8-4e36-8633-ce890ccdf611"
      unitRef="usd">1000000</us-gaap:DerivativeAssetsNoncurrent>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icad4b86ea6694e5f9adc78bc100d29fc_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTE3Ng_bb0e2b04-016d-40b5-a98c-fbe4ab0c2d1d"
      unitRef="usd">793000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i83d021f672be43748204f5d0a7908366_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTE5MQ_8a023c64-c7da-4566-a4dc-ec95aaf303df"
      unitRef="usd">1631000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="idedeb1dfe09443a7b82d283ca7b15298_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTMyNA_5c529c46-2ff8-4075-a03c-475b8d978641"
      unitRef="usd">3000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="id9bc5029a28b4c25ac4f1670189d549e_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTMzOQ_08e13cfa-4db2-4eca-aad7-4de389929589"
      unitRef="usd">84000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i76c9318d92354ba2a3360e24144f1b37_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTYxNQ_696b593a-0661-485e-ae96-b0626b49fbbf"
      unitRef="usd">-983000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iad126eeedca04aedbf65bca596749ee3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfOTkwOQ_b38763c9-7822-492d-a0b6-da50032e96eb"
      unitRef="usd">169000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3MjU_40a4836a-d9de-4cfd-838d-923d2bf25b87">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company's cash, cash equivalents and current marketable securities as of June&#160;28, 2020 comprised:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.308%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.827%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.631%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.481%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.827%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.454%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.578%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.153%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.282%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrecognized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash &amp;amp; Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Non-U.S. sovereign securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;655&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other reverse repurchase agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Corporate debt securities&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Time deposits&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Subtotal &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Unrealized Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;U.S. Gov't securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,786&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other sovereign securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Corporate debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;Subtotal available for sale debt&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total cash, cash equivalents and current marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic563629e1c85446181090d0223f3a034_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS0xLTEtMS0w_b4b15ed5-6220-4091-8622-ae7122bbe98a"
      unitRef="usd">2215000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ic563629e1c85446181090d0223f3a034_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS0zLTEtMS0w_215a864a-ae8d-4e81-9c4c-be115ad63e71"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ic563629e1c85446181090d0223f3a034_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS01LTEtMS0w_149c15aa-51a4-4902-825b-7b8159662a36"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ic563629e1c85446181090d0223f3a034_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS03LTEtMS0w_3d7569ab-532b-40b2-9c2b-1a4374360e53"
      unitRef="usd">2215000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic563629e1c85446181090d0223f3a034_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMS05LTEtMS0w_1313b000-5c8f-4250-a40f-a9b2501d8a14"
      unitRef="usd">2215000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0xLTEtMS0w_3124ad44-7f40-4182-9989-7aeaa8b25ee2"
      unitRef="usd">655000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0zLTEtMS0w_31e1dd89-2e71-4f91-aad7-7f27a66b652c"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy01LTEtMS0w_16379a4e-03fe-4df6-86c2-4f5daa63a556"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy03LTEtMS0w_7587fdbd-12de-41f1-8c3a-33403c84821b"
      unitRef="usd">655000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy05LTEtMS0w_b396e89d-9ac0-4664-848b-d5c890d9cd92"
      unitRef="usd">225000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ica9c1898e0614e26a7f94c1e754bcf74_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMy0xMS0xLTEtMA_c60cb6f6-e437-4c78-a6e4-899c5416a26c"
      unitRef="usd">430000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0xLTEtMS0w_1c39fdee-9682-48dd-bc74-60d79a6a9f0e"
      unitRef="usd">2372000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0zLTEtMS0w_beb785fa-daee-428f-92b8-5569eee4c2d0"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC01LTEtMS0w_818f1fe2-65ae-40f1-b17c-2423debe8d65"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC03LTEtMS0w_0fb7080c-c8b8-460f-aaf7-5b2f1b79a359"
      unitRef="usd">2372000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC05LTEtMS0w_c60a14a4-268d-4fb9-a12f-dad74c33ec7b"
      unitRef="usd">2372000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i34b771b7935f4c27a472b4058fc8a61a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNC0xMS0xLTEtMA_b2edacd3-3a7c-4f84-98d2-73b01f89470f"
      unitRef="usd">0</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS0xLTEtMS0w_999cb3d3-91bc-46ba-8002-8f2d1f8e1ff1"
      unitRef="usd">460000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS0zLTEtMS0w_7f95c150-27c2-4bbb-8881-a563136ba7aa"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS01LTEtMS0w_8a8029ef-e892-4257-93e6-e0eb7cf66a85"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS03LTEtMS0w_54a673fa-bc26-48d8-a5e1-24b52da49d0e"
      unitRef="usd">460000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2b463dffff4f4aaeb587d2a343d0002e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNS05LTEtMS0w_0f828305-3e75-430a-b7ac-cc1a1b9b3293"
      unitRef="usd">460000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0xLTEtMS0w_14f53788-ae99-42c7-b278-96f4f5bf12f5"
      unitRef="usd">1279000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0zLTEtMS0w_11f3aca5-aaa5-4ca9-a24a-2d9f91d6d8d1"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi01LTEtMS0w_096e5133-0ffa-4616-a2f5-96ab51262550"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi03LTEtMS0w_93dbb1bc-a929-4e64-859a-f792159b1be6"
      unitRef="usd">1279000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi05LTEtMS0w_cd9ec58a-06c1-4c48-9f16-cb1e35979f61"
      unitRef="usd">301000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="ibb22c311b87d4a0889e5e77aef4a8e03_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNi0xMS0xLTEtMA_29ae692c-6a77-4dc7-99a4-f5dd86196ba7"
      unitRef="usd">978000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:HeldToMaturitySecurities
      contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy0xLTEtMS0w_21dffcf4-12f0-4a2d-8511-dc28291f41ae"
      unitRef="usd">1528000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy0zLTEtMS0w_3ce9296e-9941-466a-8d0e-00398a375d34"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy01LTEtMS0w_79179af7-a8e9-481b-ac2d-701f7b230fd9"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy03LTEtMS0w_019e4e79-5a0f-40c7-8f35-3ca1954d5ce5"
      unitRef="usd">1528000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ic66b3f5412794987b892ff0a6f28f018_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfNy05LTEtMS0w_14e02c95-2d4c-4dda-81ef-f972293556ce"
      unitRef="usd">1528000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC0xLTEtMS0w_2c6df6d4-c1f7-4cae-817a-3ac3a7ae4a78"
      unitRef="usd">579000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC0zLTEtMS0w_9ec869b0-6828-41eb-a925-904436ba3e6b"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC01LTEtMS0w_a506cf08-a6d1-47a0-bdc1-42ef520e0eb2"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC03LTEtMS0w_be0929cc-332e-4c1c-9514-1ee3628753b1"
      unitRef="usd">579000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id60c2849846c43c7918fb9427719b8c3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOC05LTEtMS0w_7f8b4cba-bed1-48b9-863c-971d329f781f"
      unitRef="usd">579000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:HeldToMaturitySecurities
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0xLTEtMS0w_b71c83ff-20d4-4bca-8617-3943123ef3df"
      unitRef="usd">9088000000</us-gaap:HeldToMaturitySecurities>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0zLTEtMS0w_5748726f-f857-44b3-9293-e4e9dc1b3f53"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain>
    <us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS01LTEtMS0w_74309f7a-9982-433c-bfed-3e983c1eacd7"
      unitRef="usd">0</us-gaap:HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss>
    <us-gaap:HeldToMaturitySecuritiesFairValue
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS03LTEtMS0w_65fad8cd-54bc-4d62-9f81-9c3e7b147d1f"
      unitRef="usd">9088000000</us-gaap:HeldToMaturitySecuritiesFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS05LTEtMS0w_9cb23aab-c414-4282-ae4f-a406c127aa26"
      unitRef="usd">7680000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i3d30159c3fa949349d95c4d25158bbbd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfOS0xMS0xLTEtMA_fa4750be-c864-4ae2-bf6d-bb8c7c35a4bf"
      unitRef="usd">1408000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMS0xLTEtMA_4c402a96-b733-4699-ace1-2ab153e25f6f"
      unitRef="usd">9786000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMy0xLTEtMA_053c1eb4-15f1-416a-a7ba-7af3a2c0c38e"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItNS0xLTEtMA_e6b841f5-dd95-488f-acb8-0ba6e257cab0"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItNy0xLTEtMA_75f3e5b5-d7a7-4190-9a79-23b799ea87c9"
      unitRef="usd">9786000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItOS0xLTEtMA_69540ef6-a130-4f95-a72f-f60dc00fb1d2"
      unitRef="usd">3480000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="id54f7d8ddb0d4b40a0545418c41981bf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTItMTEtMS0xLTA_edae7097-f3f2-4208-a560-ec418cc764b9"
      unitRef="usd">6306000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMS0xLTEtMA_c93c032c-1ad6-46de-a13e-d14fe48c3106"
      unitRef="usd">255000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMy0xLTEtMA_54ed6e45-f59d-4155-b4ff-9b8a848acf03"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtNS0xLTEtMA_8b306f7f-86e9-4446-a3b2-c4fd304afe77"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtNy0xLTEtMA_9074c63c-6f0e-483f-a2cf-5386d7dcf72a"
      unitRef="usd">256000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtOS0xLTEtMA_56f24b52-a9c2-49b1-9c95-5de336877a7e"
      unitRef="usd">14000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i9d6452213f4045a599c3f921fc70d80e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTQtMTEtMS0xLTA_5c8176ce-54d3-41f6-8df2-54bac9ec2552"
      unitRef="usd">242000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMS0xLTEtMA_77915a8e-1f03-4721-9c3d-f48a2835b695"
      unitRef="usd">10046000000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMy0xLTEtMA_feee407e-0766-435e-8554-82cbaaaf3c83"
      unitRef="usd">1000000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtNS0xLTEtMA_3a983b32-8cf7-4ff8-b3a5-871b0a7c2c3d"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtNy0xLTEtMA_c4c1ba94-cf0e-4e81-a9ca-1fdf3fd230e2"
      unitRef="usd">10047000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtOS0xLTEtMA_d3d740ee-dfda-4d88-988b-8f1504575816"
      unitRef="usd">3494000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="iedf975dd84f14bb5b1f0231141b5cb43_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTUtMTEtMS0xLTA_fcbf8917-b5f0-47cd-8aa4-442ed728889f"
      unitRef="usd">6553000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMS0xLTEtMA_b7ec1de5-6aed-4faa-9ac5-1784d36fab5a"
      unitRef="usd">19134000000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMy0xLTEtMA_5ea677b9-5bb4-4f66-a0f2-343e057a4968"
      unitRef="usd">1000000</jnj:CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain>
    <jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtNS0xLTEtMA_3a813efb-4a4f-432c-b183-e764e5a52115"
      unitRef="usd">0</jnj:CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss>
    <jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtNy0xLTEtMA_b97adcb6-03f7-48db-8055-0796a620900b"
      unitRef="usd">19135000000</jnj:CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtOS0xLTEtMA_d80bb508-8191-4caa-8764-26430487ab9a"
      unitRef="usd">11174000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:MarketableSecuritiesCurrent
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOmUwMjRmMzZmM2IxNTRkMzJiMDM4ZWU2YWE2MDE1OTgyL3RhYmxlcmFuZ2U6ZTAyNGYzNmYzYjE1NGQzMmIwMzhlZTZhYTYwMTU5ODJfMTYtMTEtMS0xLTA_58fa441f-07a4-4b38-9444-3aa7104b4a31"
      unitRef="usd">7961000000</us-gaap:MarketableSecuritiesCurrent>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3Njk_7e708637-526d-4f2d-9560-72bbc8e33ecb">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NzA_2c83dabd-7db8-4a4f-98a2-7246f18226e0">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The contractual maturities of the available for sale securities as of June&#160;28, 2020 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:42.204%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.929%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:21.379%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:2.157%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.131%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cost Basis&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after one year through five years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Due after five years through ten years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,046&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMS0yLTEtMS0w_efc8ee45-1324-4edd-8b44-4f87ef0ecf6c"
      unitRef="usd">10023000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMS00LTEtMS0w_89d60b65-9fbc-4bc7-9558-0cdf8b5f4071"
      unitRef="usd">10024000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMi0yLTEtMS0w_761b23c4-a814-451e-85df-c93de50c74dd"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMi00LTEtMS0w_abb8acc9-cb17-4c77-8f48-c58af458b6df"
      unitRef="usd">23000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMy0yLTEtMS0w_39bfd52d-8e67-4003-b94a-0b5266a01537"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfMy00LTEtMS0w_7673baaa-79ea-401b-920b-b8f90ccbcb6d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfNC0yLTEtMS0w_97c7679b-c66c-45db-a16b-2b2783d754bc"
      unitRef="usd">10046000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjMxMjI0Mjk3ZTM0MDQwNTM4ZWQ2NmY3ODhlZDY0Yjk3L3RhYmxlcmFuZ2U6MzEyMjQyOTdlMzQwNDA1MzhlZDY2Zjc4OGVkNjRiOTdfNC00LTEtMS0w_c427a5f8-e64a-481e-afd0-657b235b8f90"
      unitRef="usd">10047000000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE3NDI_6bbbd7fb-888a-4188-b2bb-d0ee1e36852a">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Financial Instruments not measured at Fair Value:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following financial liabilities are held at carrying amount on the consolidated balance sheet as of June&#160;28, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:78.938%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.237%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.533%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.359%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Estimated Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Financial Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.45% Notes due 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.250% Notes due 2022 (1B Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.25% Notes due 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.73% Debentures due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.375% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;891&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.05% Notes due 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.650% Notes due 2024 (750MM Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.50% Notes due 2024 (500 MM GBP 1.2431)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;618&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.625% Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.45% Notes due 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,993&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.95% Notes due 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.90%&#160;Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.150% Notes due 2028 (750MM Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.95% Notes due 2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.95% Debentures due 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.375% Notes due 2033&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.650% Notes due 2035 (1.5B Euro 1.1217)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.55% Notes due 2036&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.95% Notes due 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.625% Notes due 2037&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.40%&#160;Notes due 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.85% Debentures due 2038&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.50% Debentures due 2040&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.85% Notes due 2041&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.50% Notes due 2043&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.70% Notes due 2046&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,974&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.75% Notes due 2047&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.50% Notes due 2048&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Non-Current Debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29,991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:ShortTermBorrowings
      contextRef="i9d98912977ba4917b953532514269c05_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfNC0yLTEtMS0w_d6bf162a-1206-477d-afe8-3110f720f21a"
      unitRef="usd">5332000000</us-gaap:ShortTermBorrowings>
    <us-gaap:ShortTermBorrowings
      contextRef="i5d040c895d9a484983838bc608465de1_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfNC00LTEtMS0w_d1faa05e-8805-4d9c-b023-cbef0e01da2c"
      unitRef="usd">5388000000</us-gaap:ShortTermBorrowings>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4679f53893ef429da7ae2608c619ef95_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfOC0yLTEtMS0w_9a433d65-0038-4fcf-a22a-167841e979b3"
      unitRef="usd">350000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i26f774541fbb4a11b90c5d2d53d5ac38_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfOC00LTEtMS0w_cd2c709a-8b90-4ab6-9008-423ec54b7311"
      unitRef="usd">360000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i13c392bf576441608a85b5f3084041ed_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTAtMi0xLTEtMA_12998569-9472-4023-a792-10121fc4a275"
      unitRef="usd">1121000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iaf2600e49d414d4c9228f6fb5cf69b47_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTAtNC0xLTEtMA_d1bd1d38-8248-4179-b526-54a26c7cc00b"
      unitRef="usd">1131000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i21abfcc6203b49ce95faf424178935b8_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTEtMi0xLTEtMA_2caf7da7-7428-4010-a09d-9fdc7eb67008"
      unitRef="usd">998000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie1cabbaf87184e1ea5605e3f3dfafa26_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTEtNC0xLTEtMA_67370e56-14e6-438f-ae09-45a3f60e267d"
      unitRef="usd">1029000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ife21e63962704b6ebd278d152e40a4eb_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTItMi0xLTEtMA_c3d08acf-594d-4a75-80ce-5e5bcd7c96bc"
      unitRef="usd">250000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iae6e1bd14a034339920302779e0d2b6b_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTItNC0xLTEtMA_346ce14b-56a3-42e4-8dde-ba9570ffd3e5"
      unitRef="usd">302000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0fe3730cd7bd49aeb322782ed3670e1d_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTMtMi0xLTEtMA_ef36fd2e-d488-4e4a-905d-e319cb996f92"
      unitRef="usd">803000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia00a7be937144c12b2167fc98e13147c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTMtNC0xLTEtMA_d853c58a-71f1-47a7-99cb-8c1accd8f8c5"
      unitRef="usd">891000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia95278deee974881825cf0f9ce29d7a1_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTQtMi0xLTEtMA_7b26f393-0933-45b1-b8ea-e990bd8544f9"
      unitRef="usd">499000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9c8e5f7c3c0844f5af66ac2ad7955599_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTQtNC0xLTEtMA_caec4bad-f1ec-4672-995d-018a382703ab"
      unitRef="usd">523000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4fa9e40d591048bda2fbd99d27df9044_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTUtMi0xLTEtMA_50d6d157-8f45-43da-bfd1-6bac68d14013"
      unitRef="usd">839000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ia36011f1be2b41518aa8989de6791c53_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTUtNC0xLTEtMA_1690f186-e591-45b7-b020-11b0084c8820"
      unitRef="usd">864000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8a87256891cc4bf199c1a109a2537a60_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTYtMi0xLTEtMA_c8f2a897-2225-496b-a821-27ebc05d237e"
      unitRef="usd">618000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i4870c94373034eb2bcd12dbc135d4626_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTYtNC0xLTEtMA_06f06338-4753-4446-adcb-6bcd476d0104"
      unitRef="usd">749000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7a31f41a5b6843ae9b894d9381f461e9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTctMi0xLTEtMA_ee7cc4dd-0bed-43a3-8f6e-f65a118c6bca"
      unitRef="usd">748000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i81fab23f82674c6980bc9c359eb28ba9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTctNC0xLTEtMA_10ab4b6c-aaf7-4058-97af-832248526aba"
      unitRef="usd">813000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibc37bc973c1b451387840c102be9a646_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTgtMi0xLTEtMA_e5d89bdf-a0c4-473d-916f-ab43b55e8b6c"
      unitRef="usd">1993000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3485e48ea0cc49a98aeb79cb18bc40b3_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTgtNC0xLTEtMA_9098ece7-5c85-4629-8a48-ccfe5be9199d"
      unitRef="usd">2179000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic2134273f7f24276bbcfc008eae7bd5f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTktMi0xLTEtMA_fff662b9-2e54-4538-85dd-f9f3dcc74651"
      unitRef="usd">997000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie86818dd9c644e1d92aac548b679b5e8_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMTktNC0xLTEtMA_19e7c43b-fce4-4efc-b3d2-1c534a24155f"
      unitRef="usd">1111000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i892e47f9411246c698112667df4d52e9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjAtMi0xLTEtMA_7ea014f2-8fb2-4912-9952-65fec162d238"
      unitRef="usd">1494000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0c92433556884f33bec3fd9cc5547c56_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjAtNC0xLTEtMA_2112801b-ac7f-4c31-9782-e5b1f87dbded"
      unitRef="usd">1681000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i07512cb6822542c3aeca578fa5a030a2_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjEtMi0xLTEtMA_68f8ccb7-69aa-4c98-8407-731fa503b9e6"
      unitRef="usd">835000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8f099c74c285402fa0acf97d0bd56486_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjEtNC0xLTEtMA_1f90c1f2-5026-4cab-bb9e-9c846c6d5b18"
      unitRef="usd">917000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i7c84c7aac7a8402b93fc4d50c3fb1b33_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjItMi0xLTEtMA_2f3e0c5a-6121-4d2b-a29e-8e48e46c897f"
      unitRef="usd">297000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i50567b40671a4971ad917d310f56301a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjItNC0xLTEtMA_1335c27d-d4b5-4d2c-a1fc-9e94d89b7f4b"
      unitRef="usd">435000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="icacf6978c8de4cd5adb37a3902bb8f2b_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjMtMi0xLTEtMA_059e49d3-16b8-4235-9544-1051f1d17a35"
      unitRef="usd">498000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i738688db4eb94ba5b31c8ae44a9936bc_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjMtNC0xLTEtMA_ae849c55-07f9-4af9-b1af-dd2e292a6a59"
      unitRef="usd">689000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib1fc849891c249f9affbd772810f19cd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjQtMi0xLTEtMA_d886e646-3357-413c-a377-a6c483729ad8"
      unitRef="usd">856000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic599954eed744eafbf6e49753e86ed68_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjQtNC0xLTEtMA_de1da570-6b47-4073-a681-804a0b98f36b"
      unitRef="usd">1127000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i53cad7d01f364d4897d6a878c622734d_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjUtMi0xLTEtMA_0d250929-9a4e-4172-82a4-ceb3994ffc03"
      unitRef="usd">1667000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ie54b20ce4e0149e184e543ac46795d24_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjUtNC0xLTEtMA_db04be91-8a51-4127-890e-f9d4b424603e"
      unitRef="usd">1974000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iee7cacef8bf14e17b0aeba908aae6c5a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjYtMi0xLTEtMA_f7e098ed-4b83-49e7-98f3-a73ff1fecabc"
      unitRef="usd">989000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i29f1ce70157c489995b6052930e4d920_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjYtNC0xLTEtMA_e755c1c3-a7da-4d15-a800-1528f3058ee9"
      unitRef="usd">1170000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="iff6ffc8dbadf4318b62b6b49ffacd2ef_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjctMi0xLTEtMA_8370e900-101d-4337-8335-bf98d3135b92"
      unitRef="usd">992000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib2a9f041c1054b54b091f023e6d70707_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjctNC0xLTEtMA_285e07c8-8c2d-4c79-9f2f-521ff240c222"
      unitRef="usd">1531000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i594eec41b2c747798b5aac595a81b3cd_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjgtMi0xLTEtMA_57a9149f-1b8a-404f-ae25-2d0dced8d737"
      unitRef="usd">1487000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i8b7150c261554f278bef9d5c04743f0e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjgtNC0xLTEtMA_c1d0dfe4-7d9f-4d54-bbe8-3fb8b8c7865d"
      unitRef="usd">1791000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i224d6ed1b3124fba9dee77b543600395_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjktMi0xLTEtMA_1c1ddcff-247c-4c6b-96fb-05cc83748b9b"
      unitRef="usd">991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib08f2638d7b846db950bf41478ecf12b_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMjktNC0xLTEtMA_ef48c382-bc16-4b87-8e80-3b4b1e0fbffa"
      unitRef="usd">1168000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9a589dd13dcd4d9ab04910f8be1fffaf_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzAtMi0xLTEtMA_5dc03d31-a057-42c1-b085-67b17ac002bb"
      unitRef="usd">696000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i037b02ea1a8948fbb6e5f750e5b20a1e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzAtNC0xLTEtMA_c2ce0745-f23d-41bf-b022-c9ede74a7934"
      unitRef="usd">1060000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5a335dce7946400eb64a556c5e88d512_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzEtMi0xLTEtMA_df26bbae-7e3e-44fa-be63-7e26635657f6"
      unitRef="usd">539000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ibf95c2acf45c42e3bd3fa93ebe96b0a9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzEtNC0xLTEtMA_b31e24a8-4926-4e21-ac80-43cbb04e8e29"
      unitRef="usd">736000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i80b8cdff3ed5419bbf4fe318b5605b78_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzItMi0xLTEtMA_78a6a0fc-7fba-4f6c-8cc2-9eeffd1df2d1"
      unitRef="usd">297000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i401e6b8e8c924806a3e398ef7159815f_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzItNC0xLTEtMA_791ebb9e-c1d6-467f-826e-efd159ee777a"
      unitRef="usd">420000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ic7ecdd57de4e4e4287dae9dc82bb4ca2_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzMtMi0xLTEtMA_d63f1f05-e20a-493d-ad1c-81559d4b1222"
      unitRef="usd">495000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i0601e6ae6921410ab7205bde53a6aba2_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzMtNC0xLTEtMA_f7c6a7d0-ab0e-4b9c-832c-676746a650e1"
      unitRef="usd">685000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i70f239152a2141228348aa533720bf55_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzQtMi0xLTEtMA_831db107-0482-4bdc-a36d-5229329ccd2f"
      unitRef="usd">1974000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i06101a865e8e4e8e82693744ec325c94_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzQtNC0xLTEtMA_de8800c0-2521-424c-bf85-d0ed8069b4bc"
      unitRef="usd">2467000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i37ccb3cc5bb040cba3430bd495d96186_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzUtMi0xLTEtMA_d933f524-2218-45ae-9834-40aa1175c87b"
      unitRef="usd">991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i89c03926f30a4d13a7fa7a50e5afa527_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzUtNC0xLTEtMA_b581cab8-5336-4ded-b30c-3082ccef2549"
      unitRef="usd">1255000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i3bf2ae2644d940ca9f392d4010b2fe3c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzYtMi0xLTEtMA_72b72ea3-61ac-485c-a07d-ed8538e32cc5"
      unitRef="usd">742000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="id07eeaf7cfbf4feb83e823bf4797e7e2_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzYtNC0xLTEtMA_4c899dfe-24f5-4703-bb7b-b6b28dfbd9b4"
      unitRef="usd">923000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i48ad5aba0d9742d3893f7a8373957913_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzctMi0xLTEtMA_82faf269-2e03-45ee-88a9-ec42f3d349df"
      unitRef="usd">6000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="if10dd21b5f704d0abfea775170908a2e_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzctNC0xLTEtMA_717a812f-477f-418e-a871-ed56d279548c"
      unitRef="usd">10000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i9d98912977ba4917b953532514269c05_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzgtMi0xLTEtMA_c23a3f2e-dc7e-4e96-9403-c3b2c60ca5cf"
      unitRef="usd">25062000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i5d040c895d9a484983838bc608465de1_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RhYmxlOjI4NmZlYjJkZGUzZjQ4Y2JhZTQyNDM5YjUwZTQyMTEzL3RhYmxlcmFuZ2U6Mjg2ZmViMmRkZTNmNDhjYmFlNDI0MzliNTBlNDIxMTNfMzgtNC0xLTEtMA_5fc73dba-b2dd-4557-b4ac-85301dd01ac1"
      unitRef="usd">29991000000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE0NDA_318d4684-5ebd-4f67-b3af-41fe781a8ae7"
      unitRef="number">0.0324</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <jnj:ExcessOfFairValueOverCarryingValueOfDebt
      contextRef="ic09551a2d2914e58b07c0faa2bdb5ca7_D20181231-20191229"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfMTE1MjA_d42c79e2-55e6-4420-aeaf-10616c13bb95"
      unitRef="usd">3000000000.0</jnj:ExcessOfFairValueOverCarryingValueOfDebt>
    <us-gaap:ShortTermBorrowings
      contextRef="if94dfff027b540c0aa481c801f7d039f_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkxOA_0b097de5-dbcf-4084-956b-5a8d525dbdce"
      unitRef="usd">2700000000</us-gaap:ShortTermBorrowings>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="if94dfff027b540c0aa481c801f7d039f_I20200628"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV82Ny9mcmFnOjhlOTkxMzRlMDQyNjQ0MTk4NWMxMTgxMjA2YjZmZDM5L3RleHRyZWdpb246OGU5OTEzNGUwNDI2NDQxOTg1YzExODEyMDZiNmZkMzlfNzE0NjgyNTU5NjkzMg_69748555-dfb7-40f3-8c59-4decac05b062"
      unitRef="number">0.0015</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNzE0NjgyNTYwMDIwOA_f0369f14-a28e-44a9-a62d-e717673eacea">INCOME TAXES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The worldwide effective income tax rates for the fiscal six months of 2020 and &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;2019 were 9.8% an&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;d 18.4%, respectively. In the third fiscal quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020.  More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#x2019;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the first fiscal quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $0.3 billion for the remeasurement of existing deferred tax liabilities offset by a related $0.2 billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#x201c;step-up&#x201d;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up.  Consequently, the benefit recorded related to Swiss Tax reform in the first six months of fiscal 2020 was approximately $0.4&#160;billion, or 3.8% benefit to the Company&#x2019;s fiscal six months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;During the second fiscal quarter of 2020, the Company reversed some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions. This reserve reversal benefited the Company&#x2019;s effective tax rate by approximately 1.0% for the first fiscal six months of fiscal 2020. In the first fiscal quarter of 2020, the Company reduced a contingent consideration liability related to the 2019 Auris Health acquisition that has benefited the year to date overall effective tax rate by approximately 1.0% (see Note 10 to the Consolidated Financial Statements for more details.) &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;  Additionally, the Company had less income in higher tax jurisdictions relative to lower tax jurisdictions as compared to the same period in the prior fiscal year primarily due to:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the accrual of additional legal costs, at the U.S. statutory rate, in the second fiscal quarter of 2020 (see Notes 9 and  11 to the Consolidated Financial Statements for more details)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;               partially offset by:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-18pt;padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;&#x2022;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;"&gt;the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;  The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested during the first and second fiscal quarters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:8pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;As of June&#160;28, 2020, the Company had approximately $3.1 billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit and settlement of the related tax liabilities in the fiscal year 2020. As of June 28, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $0.2 billion as a current liability on the &#x201c;Accrued taxes on Income&#x201d; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $0.6 billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement later in the fiscal year 2020. The completion of this tax audit may result in additional adjustments to the Company&#x2019;s unrecognized tax benefit liability. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;"&gt;In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMTE3_a0eb9983-1005-47cd-96c5-57b4dae62f77"
      unitRef="number">0.098</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMTI0_eabd8035-204d-4ca5-b0ea-3170bfb9c806"
      unitRef="number">0.184</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset
      contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNjUz_8e9bf03d-e0b5-4eab-bce1-3cd3d7e87279"
      unitRef="usd">300000000</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset>
    <jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit
      contextRef="i143de2467f00494d97e9051d438c9616_D20191230-20200329"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfNzM1_d74bddf5-2f16-4fed-aef9-c772ce253dc9"
      unitRef="usd">200000000</jnj:FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfOTg5NTYwNDY2OTc1NA_56c238f0-a86c-48c9-b206-32a7f57d39e0"
      unitRef="usd">400000000</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset>
    <jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfOTg5NTYwNDY2OTc2OA_463d9b88-5be7-4d20-bfe0-59be8fa2016c"
      unitRef="number">0.038</jnj:FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent>
    <jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjE5OTAyMzI2NjU3Mg_9e82eef7-8356-40c6-a360-d7198f278d13"
      unitRef="number">0.010</jnj:EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent>
    <jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjE5OTAyMzI2NjU3OA_39143735-45c4-405f-8fe7-e1a8689e4a98"
      unitRef="number">0.010</jnj:EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i56f124cb187a4df0b12cb443a129b124_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjI2OA_7ddf3bd9-c9f7-4443-904f-96117cf16ca2"
      unitRef="usd">3100000000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie1c7443736ae4f29bc57b7af183c277b_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMjg1OQ_2040470a-4f6a-449a-b82b-bbfd6c937a63"
      unitRef="usd">200000000</us-gaap:UnrecognizedTaxBenefits>
    <jnj:UnrecognizedTaxBenefitLiabilityPayment
      contextRef="i27e026167a6740039f33d214df252c5f_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83My9mcmFnOjBjYzIyZTM1YTZlZDQwY2M4MWYzMDNmYTUzNzYyNDE1L3RleHRyZWdpb246MGNjMjJlMzVhNmVkNDBjYzgxZjMwM2ZhNTM3NjI0MTVfMzEzNw_1b91b18d-4145-41d4-89a6-fe0c70d8cb29"
      unitRef="usd">600000000</jnj:UnrecognizedTaxBenefitLiabilityPayment>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfOTQ1_519f93c1-58d9-44db-8bad-2744eed0ab27">PENSIONS AND OTHER BENEFIT PLANS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of Net Periodic Benefit Cost&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit retirement plans and other benefit plans for the fiscal second quarters and fiscal six months of 2020 and 2019 include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.548%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.832%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.412%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service cost/(credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Curtailments and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Company Contributions&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;For the fiscal six months ended June&#160;28, 2020, the Company contributed $144 million and $18 million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.&lt;/span&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:ScheduleOfNetBenefitCostsTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfOTM4_6e075a8d-e13a-4ced-8b93-c822f1cd9115">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Net periodic benefit costs for the Company&#x2019;s defined benefit retirement plans and other benefit plans for the fiscal second quarters and fiscal six months of 2020 and 2019 include the following components:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:24.548%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.832%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.407%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.537%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.412%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Retirement Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Benefit Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Service cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;144&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interest cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Expected return on plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(608)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(581)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,222)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1,164)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Amortization of prior service cost/(credit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Recognized actuarial losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;222&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Curtailments and settlements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net periodic benefit cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNetBenefitCostsTableTextBlock>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0yLTEtMS0w_eb6158d7-d27b-4e92-8274-6ae6bdb813bf"
      unitRef="usd">323000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy00LTEtMS0w_0539a262-aa89-4d94-8b92-134866ede38f"
      unitRef="usd">277000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy02LTEtMS0w_3c452da5-e850-432c-b80c-d11ea3dc17ad"
      unitRef="usd">72000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy04LTEtMS0w_dffb6222-b17f-4e5d-9ef1-608397bdb0d3"
      unitRef="usd">69000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xMC0xLTEtMA_d058e1b3-dc52-464f-8717-a09cfbde4936"
      unitRef="usd">649000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xMi0xLTEtMA_fffc8a7a-d1c5-44b0-8f72-48445dfca52c"
      unitRef="usd">553000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xNC0xLTEtMA_55f33c2f-2d75-41e7-a8a6-8c4beaf95a0f"
      unitRef="usd">144000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanServiceCost
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMy0xNi0xLTEtMA_16ec573c-63a8-42b9-b280-8c78af60dc3a"
      unitRef="usd">137000000</us-gaap:DefinedBenefitPlanServiceCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0yLTEtMS0w_dd16e8ea-cbaa-49e3-bdda-445a87a19df3"
      unitRef="usd">237000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC00LTEtMS0w_455d2d04-7257-435a-9793-4621f9a22fd6"
      unitRef="usd">274000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC02LTEtMS0w_49c58a31-27c5-43e4-80e9-33424d4a5f94"
      unitRef="usd">33000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC04LTEtMS0w_4dde5b18-7f96-442c-b2e4-1bcb5101f7ed"
      unitRef="usd">46000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xMC0xLTEtMA_139457ca-ebde-487d-86c7-f5ea5e6ced0a"
      unitRef="usd">477000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xMi0xLTEtMA_ba25794d-e883-4e67-9845-7741f22846fd"
      unitRef="usd">549000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xNC0xLTEtMA_5f7329c6-aa8d-48cd-89b5-e5355007f59a"
      unitRef="usd">66000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanInterestCost
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNC0xNi0xLTEtMA_0ca6006c-c3e0-4503-a93b-641ec446a9da"
      unitRef="usd">92000000</us-gaap:DefinedBenefitPlanInterestCost>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0yLTEtMS0w_84fe1dea-d300-4629-b93c-f33f0b89a3c8"
      unitRef="usd">608000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS00LTEtMS0w_50332963-4b67-42ca-8632-086d672a06a2"
      unitRef="usd">581000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS02LTEtMS0w_8b637c03-41c0-417b-b88d-020dd3dedd1e"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS04LTEtMS0w_99a659a0-5e49-472d-96f3-f9a02855ed22"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xMC0xLTEtMA_1cdc60f9-6743-4531-a741-3106447f8696"
      unitRef="usd">1222000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xMi0xLTEtMA_d1614fd8-82d7-46a5-aed7-613dde6193ca"
      unitRef="usd">1164000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xNC0xLTEtMA_d28d3092-7e06-4117-92af-2bc157d6fc24"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNS0xNi0xLTEtMA_e85c7331-a45e-4e01-b04a-56476301c23a"
      unitRef="usd">3000000</us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0yLTEtMS0w_997a947e-4281-412e-90db-6f88420392ce"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi00LTEtMS0w_845169a9-a62a-4341-bc36-1e4661dc9130"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi02LTEtMS0w_37c9e8ab-2d7d-4575-9ae8-e8131699d3c8"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi04LTEtMS0w_c872e377-44f4-430b-bbe7-48bbab14ccef"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xMC0xLTEtMA_1ccd8ca1-57b2-4b12-81ee-a8bb02c86a42"
      unitRef="usd">1000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xMi0xLTEtMA_c7aea2c2-65b0-4c9e-8cc2-955c0670e476"
      unitRef="usd">2000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xNC0xLTEtMA_485c4807-5d55-484a-879c-a8bb3076e472"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfNi0xNi0xLTEtMA_ef38d079-75ea-482f-a911-4da5f567dc4a"
      unitRef="usd">-16000000</us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0yLTEtMS0w_d9183811-1c74-4529-80c0-08bac3c563bf"
      unitRef="usd">-222000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC00LTEtMS0w_4e4a15b4-224c-418a-ba0e-e9df6ca75360"
      unitRef="usd">-146000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC02LTEtMS0w_7b8c2918-38f3-444c-88dc-5d8c84b20267"
      unitRef="usd">-35000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC04LTEtMS0w_364b9125-52ec-40f4-bdbb-7f3de350342a"
      unitRef="usd">-33000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xMC0xLTEtMA_44366330-5f60-4d37-b5ea-78dabb0e6218"
      unitRef="usd">-445000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xMi0xLTEtMA_f5165b57-02e9-4260-8317-9c7c6373fa1d"
      unitRef="usd">-290000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xNC0xLTEtMA_3b74eaa5-ed3d-4f99-a8aa-25cffeaf7d39"
      unitRef="usd">-71000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOC0xNi0xLTEtMA_ef73fd80-2428-405a-a0ee-8087be9904e6"
      unitRef="usd">-65000000</us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0yLTEtMS0w_6438f098-d5c8-4d13-8689-0f2dbf2e5752"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS00LTEtMS0w_404d7d6f-17b8-47e4-9b35-2c4750ec99f1"
      unitRef="usd">-8000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS02LTEtMS0w_30e334cc-68af-4565-a8e4-2562834fb9d4"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS04LTEtMS0w_ff1a578d-5f97-4d11-910b-52abbedb9fce"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xMC0xLTEtMA_a8ff9370-fd81-4813-be8c-74302161ada7"
      unitRef="usd">-19000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xMi0xLTEtMA_e753e7d4-a3f3-4db7-85b6-64baf8635bb6"
      unitRef="usd">-7000000</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xNC0xLTEtMA_3dbdd9c6-effa-4921-9c76-369ef15406f3"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfOS0xNi0xLTEtMA_f39a085e-7252-4e8f-8a54-38c96132480e"
      unitRef="usd">0</us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMi0xLTEtMA_e3ec0ad1-6f4f-43f2-88a3-4776356e3b83"
      unitRef="usd">175000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i4cb9b0f2fc3542a183d6fa7857403a0f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtNC0xLTEtMA_dbfa3703-5f9a-4859-99ed-15a44a232ce6"
      unitRef="usd">125000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ief617abcc20648479b55e755c807413c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtNi0xLTEtMA_b12220a4-6837-403c-b14f-eb637095c884"
      unitRef="usd">131000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="ia788f238ff9f48b89ba2b5931e10515c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtOC0xLTEtMA_30e0d1e7-61a6-4160-90c8-55ed766a512b"
      unitRef="usd">139000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i752da11589284fda86e218b2a217edba_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTAtMS0xLTA_e54426b4-34ac-491a-b269-2882386d0084"
      unitRef="usd">369000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i45af56a32be245b0a6f7abad28d5f974_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTItMS0xLTA_ac7841f6-4428-4e0b-8c4e-fa203753575d"
      unitRef="usd">237000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i3eb5537348114e3383db2050da995503_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTQtMS0xLTA_79a130a1-8e44-4f15-aee5-5d62a77eb129"
      unitRef="usd">262000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
      contextRef="i228ab82ff9094649978d94f86c2716d1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RhYmxlOmJhZjJkZGNiMTU2MzQzYTI5NTU4OWJiMTZiM2IwZjY4L3RhYmxlcmFuZ2U6YmFmMmRkY2IxNTYzNDNhMjk1NTg5YmIxNmIzYjBmNjhfMTAtMTYtMS0xLTA_531ad1c1-f57e-4a9a-bc9e-e792c4de1f44"
      unitRef="usd">275000000</us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost>
    <us-gaap:PensionContributions
      contextRef="i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfNjcy_d540d14a-37b3-4b62-8dbe-b23d559d2ab7"
      unitRef="usd">144000000</us-gaap:PensionContributions>
    <us-gaap:PensionContributions
      contextRef="i2f87318d318045a6ab036c942e910e82_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83Ni9mcmFnOjgyN2I2ZTI3ZWI1MDQ2NTk4NTdlZGQ3YjI5YmE0NjI5L3RleHRyZWdpb246ODI3YjZlMjdlYjUwNDY1OTg1N2VkZDdiMjliYTQ2MjlfNjc5_d32b0a74-0123-44de-b9bb-52f3aa97f4c7"
      unitRef="usd">18000000</us-gaap:PensionContributions>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RleHRyZWdpb246NWE0OTgyN2IwOTQ4NGM3Mjg2ZDQzOGEwZGI3OGNjMDhfOTI1_46a7a402-64d0-4369-b35e-4edc18d19a7c">ACCUMULATED OTHER COMPREHENSIVE INCOME&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of other comprehensive income (loss) consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.874%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.014%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.762%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.846%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.819%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.406%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.091%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Accumulated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Comprehensive&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&amp;amp; Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(963)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Details on reclassifications out of Accumulated Other Comprehensive Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Gain/(Loss) On Derivatives &amp;amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RleHRyZWdpb246NWE0OTgyN2IwOTQ4NGM3Mjg2ZDQzOGEwZGI3OGNjMDhfOTM2_3758c4ec-16d8-4066-be40-f810732e1240">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Components of other comprehensive income (loss) consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:33.874%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.014%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.762%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.846%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.819%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.406%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.547%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:16.091%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Employee&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Gain/(Loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total Accumulated&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Currency&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;On Derivatives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Other Comprehensive&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&amp;amp; Hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Income (Loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(295)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Net change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(963)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9,668)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6,501)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15,533)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4556ab2a2fc4b759328bcaa7117d7f0_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC0yLTEtMS0w_4b3b409d-b901-4583-b28b-11b748567b38"
      unitRef="usd">-8705000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i70aedc4c48ed469a9776d7b4ca9dba52_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC00LTEtMS0w_cf76c758-9086-4cde-b1e9-d0d15e6173a7"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id4b29a10c69e451f9cd0f65769fbc49e_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC02LTEtMS0w_ad3bde08-e2c1-45d2-aee2-9a342de6ed10"
      unitRef="usd">-6891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i76c2328f316b49948f37e4d51d76befd_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC04LTEtMS0w_f14ffe00-84d8-4013-b26f-38d9451ff214"
      unitRef="usd">-295000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9e6d7e0cb22d4abeb100ad0da8a3a5df_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNC0xMC0xLTEtMA_1d1e39ae-28a7-4e96-9fee-db3837c4f65d"
      unitRef="usd">-15891000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i35b3b5367fed471a9262907b9c660c6b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS0yLTEtMS0w_c552416a-0951-450d-96b6-ba3b51eaedb3"
      unitRef="usd">-963000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibe5bd9b8b1c4480ebc128d7538983d48_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS00LTEtMS0w_4f9ac118-1464-4440-b3ad-a60ea76fd04d"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4b624b01490643e596a4c28527039518_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS02LTEtMS0w_2d7653d4-3144-4fd0-b415-c8f3caaf2f23"
      unitRef="usd">390000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ic3d78226c4c54c9ca0d4cd83d95e2d73_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS04LTEtMS0w_7fa6bb62-3267-44a7-8c91-9d83c56b381b"
      unitRef="usd">931000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="id71720a3d5304f8a94c73716ab27569e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNS0xMC0xLTEtMA_8c50a203-9056-4d82-b946-70736c759777"
      unitRef="usd">358000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if0bda8b685c44b2d86658936d3456c28_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy0yLTEtMS0w_4ffa5fb0-a193-4a94-9a2d-3876c32e457b"
      unitRef="usd">-9668000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i94324367c9e54b678238a19050edb89c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy00LTEtMS0w_5e01c74b-2c44-4f9e-9ed7-121d8e72155a"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i83c49a3f745a40c8a5594ba2e9162d35_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy02LTEtMS0w_f84a3e1b-0fcf-433c-ab98-90ff54db1993"
      unitRef="usd">-6501000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b37abccd6c2406ab0e4786c66aea73a_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy04LTEtMS0w_3f76f158-d659-4a06-bf6d-838591079a84"
      unitRef="usd">636000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if261e32787064849a30e8f746c585aa9_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV83OS9mcmFnOjVhNDk4MjdiMDk0ODRjNzI4NmQ0MzhhMGRiNzhjYzA4L3RhYmxlOjA5MDY5ZTY5OTM3YTQ0YTBhNThkMDQ3YmFjMjAzNDFkL3RhYmxlcmFuZ2U6MDkwNjllNjk5MzdhNDRhMGE1OGQwNDdiYWMyMDM0MWRfNy0xMC0xLTEtMA_6625a6ff-2b74-4377-9844-43f8b38a23de"
      unitRef="usd">-15533000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfNzE0NjgyNTU4Mjc4NQ_4cb1d20e-719b-4c2c-9f4f-6f40e2829a33">EARNINGS PER SHARE&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal second quarters and fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:47.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.805%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.500%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.380%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.074%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.632%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.348%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Shares in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basic net earnings per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,632.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,652.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,633.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,656.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Potential shares exercisable under stock option plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;122.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: shares which could be repurchased under treasury stock method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(87.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(102.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(85.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(99.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Convertible debt shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,665.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,691.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,671.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,697.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The diluted net earnings per share calculation for both the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;28, 2020 excluded 20 million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. &lt;/span&gt;&lt;/div&gt;The diluted net earnings per share calculation for both the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.  The diluted net earnings per share calculation for the fiscal six months ended June&#160;28, 2020 excluded 15&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal six months ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfMTQ5MQ_5ae7ee63-1b77-4193-b009-d46bfe7e9807">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal second quarters and fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:47.425%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.805%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:10.500%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.380%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:11.074%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.632%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.518%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.348%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Shares in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Basic net earnings per share &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,632.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,652.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,633.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,656.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Potential shares exercisable under stock option plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;119.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;122.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Less: shares which could be repurchased under treasury stock method&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(87.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(102.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(85.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(99.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Convertible debt shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Average shares outstanding &#x2014; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,665.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,691.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,671.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,697.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Diluted net earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.53&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:EarningsPerShareBasic
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi0yLTEtMS0w_bc5ad01b-f12f-416a-8835-cd193a02224b"
      unitRef="usdPerShare">1.38</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi00LTEtMS0w_43c51887-71a1-420c-b266-40414f807a94"
      unitRef="usdPerShare">2.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi02LTEtMS0w_41b05959-cbaf-4dc8-8645-dc36af4f0b9a"
      unitRef="usdPerShare">3.58</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMi04LTEtMS0w_5ee1b6ec-3da9-4515-b404-d785aa255ed6"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy0yLTEtMS0w_cb45382a-ecff-44d3-9991-7bd3a46e246c"
      unitRef="shares">2632900000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy00LTEtMS0w_19b97b1a-34b9-4999-9a52-7666e1772939"
      unitRef="shares">2652500000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy02LTEtMS0w_6d115cf9-919b-4294-bb63-ed9de8879f56"
      unitRef="shares">2633300000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfMy04LTEtMS0w_1f19aeb5-7be8-40af-9254-bfa908115e31"
      unitRef="shares">2656700000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC0yLTEtMS0w_efc8cb3b-d823-4910-a7d5-d564925bea5f"
      unitRef="shares">119600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC00LTEtMS0w_33b9a04c-17d4-49b8-a7f5-50c2137891c3"
      unitRef="shares">140800000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC02LTEtMS0w_7ac52eb9-8235-4be2-8bd7-1cee84bde359"
      unitRef="shares">122600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNC04LTEtMS0w_66bb7968-1980-48cf-b85d-3fb2223cb863"
      unitRef="shares">138600000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS0yLTEtMS0w_fe9aaf4d-cee3-4934-a02f-5d9915159ceb"
      unitRef="shares">87500000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS00LTEtMS0w_2b1e248f-90d4-4374-ab28-88420981b1a0"
      unitRef="shares">102300000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS02LTEtMS0w_1277c420-b873-4cd6-ad53-adbc1e6111d2"
      unitRef="shares">85400000</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNS04LTEtMS0w_97454a1a-7a08-4730-8f11-21c5988e0ce7"
      unitRef="shares">99000000.0</jnj:SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi0yLTEtMS0w_7d473082-5d92-40a6-a6cb-003c869b8b03"
      unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi00LTEtMS0w_025d1b62-981c-4493-afc6-2e41922813cf"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi02LTEtMS0w_e725e164-5ee1-405c-b00f-29b166b58d5e"
      unitRef="shares">500000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNi04LTEtMS0w_e6c489af-5c69-4a2c-9029-7db888f808ee"
      unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToConversionOfDebtSecurities>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy0yLTEtMS0w_ffcba19b-fec6-41de-aeeb-a43ea9881f35"
      unitRef="shares">2665500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy00LTEtMS0w_9257d58c-0f63-493a-8d50-5660126b1ad4"
      unitRef="shares">2691700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy02LTEtMS0w_024bef7b-33a9-46a5-862a-bce40945c808"
      unitRef="shares">2671000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfNy04LTEtMS0w_25168d77-b182-4180-887b-201222c00824"
      unitRef="shares">2697000000.0</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC0yLTEtMS0w_22775eaf-511a-423a-879e-deb3cb511565"
      unitRef="usdPerShare">1.36</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC00LTEtMS0w_da31065d-5512-4f40-a8a5-f6af17888101"
      unitRef="usdPerShare">2.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC02LTEtMS0w_259fbb39-53e7-44d7-ba4b-140e5fd300e0"
      unitRef="usdPerShare">3.53</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RhYmxlOmI2Zjk5Y2RiMTQ3MjRiNDM4Mjk1OTUxNzAzNTI4N2RkL3RhYmxlcmFuZ2U6YjZmOTljZGIxNDcyNGI0MzgyOTU5NTE3MDM1Mjg3ZGRfOC04LTEtMS0w_cda3624d-080b-4344-aec3-5507ffa2ea49"
      unitRef="usdPerShare">3.47</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfNDg4_d08eaff0-f496-49e9-9fd3-1d98ef3a1e2a"
      unitRef="shares">20000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84Mi9mcmFnOjIyNDg3ZGE4ZDU0ODRhOTA4ZTZmYWM0YWQ3NDA0Y2FlL3RleHRyZWdpb246MjI0ODdkYThkNTQ4NGE5MDhlNmZhYzRhZDc0MDRjYWVfMjE5OTAyMzI1NzY4MQ_fc26d1ce-13ca-4704-a518-709373500dd9"
      unitRef="shares">15000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU5NTE1Nw_11ce4304-9a1e-48e0-bf3c-6183fb20419e">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY SEGMENT OF BUSINESS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Baby Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Skin Health/Beauty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Wound Care/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;TOTAL &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;* Previously referred to as Consumer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S. Exports&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SIMPONI / SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TREMFYA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;71.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER IMMUNOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Infectious Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;EDURANT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / rilpivirine&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / PREZCOBIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; /  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;                         &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;                     REZOLSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / SYMTUZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER INFECTIOUS DISEASES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONCERTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / methylphenidate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / XEPLION&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVEGA   TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / TREVICTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;RISPERDAL CONSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER NEUROSCIENCE&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ERLEADA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;VELCADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; / &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;abiraterone acetate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER ONCOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pulmonary Hypertension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER PULMONARY HYPERTENSION&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cardiovascular / Metabolism / Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;PROCRIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / EPREX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interventional Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;HIPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;KNEES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TRAUMA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SPINE, SPORTS &amp;amp; OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ADVANCED&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;GENERAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(59.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(46.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONTACT LENSES / OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SURGICAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(64.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(49.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;WORLDWIDE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.209%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.465%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.319%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.575%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.465%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.319%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Consumer Health &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(92.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Pharmaceutical&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Medical Devices&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:18pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(64.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment earnings before provision for taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Less: Expense not allocated to segments&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt; (4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Worldwide income before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal six months of 2019. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal second quarters of 2020 and 2019, primarily talc related costs, respectively. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, primarily talc related costs, respectively. Includes amortization expense of $0.1 billion in both the fiscal second quarters of 2020 and 2019, respectively and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal six months of 2019. Includes litigation expense of $0.4 billion in the fiscal six months of 2019. Includes an unrealized gain on securities of $0.5 billion and $0.2&#160;billion in the fiscal second quarter of 2020 and 2019, respectively. Includes an unrealized gain on securities of $0.2&#160;billion and $0.3&#160;billion in the fiscal six months of 2020 and 2019, respectively. Additionally, the fiscal six months of 2019 includes a research and development expense of $0.3 billion for an upfront payment related to argenx. Includes amortization expense of $0.8 billion in both the fiscal second quarters of 2020 and 2019. Includes amortization expense of $1.6&#160;billion in both the fiscal six months of 2020 and 2019. In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement.  Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Includes a contingent consideration reversal of $1.0 billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal second quarter and six months of 2019. Includes litigation expense of $0.2 billion and $0.3&#160;billion in the fiscal second quarter and fiscal six months of 2019, respectively. Includes a restructuring related charge of $0.1 billion and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;amortization expense of $0.2 billion in both the fiscal second quarters of 2020 and 2019.  Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.5&#160;billion in both the fiscal six months of 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(4)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Amounts not allocated to segments include interest income/expense and general corporate income/expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY GEOGRAPHIC AREA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.138%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.094%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.510%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.343%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.094%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.510%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.353%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Western Hemisphere, excluding U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia-Pacific, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <jnj:SalesBySegmentOfBusinessTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTYzOQ_2ff5c757-9a93-4268-a66d-22da096d13d4">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY SEGMENT OF BUSINESS &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Consumer Health*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Baby Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oral Care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;446&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;792&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;OTC&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;991&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;580&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,151&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Skin Health/Beauty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Women's Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;434&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Wound Care/Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;185&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;TOTAL &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Consumer Health&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,557&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,296&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;* Previously referred to as Consumer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Immunology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,389&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S. Exports&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;208&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;244&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SIMPONI / SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;544&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;289&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;543&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,963&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TREMFYA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;36.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.4%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;71.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;41.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER IMMUNOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.7&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Infectious Diseases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;EDURANT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / rilpivirine&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / PREZCOBIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; /  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;                         &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;                     REZOLSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / SYMTUZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(32.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER INFECTIOUS DISEASES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;117&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Neuroscience&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;17.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,526&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;809&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONCERTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / methylphenidate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / XEPLION&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVEGA   TRINZA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / TREVICTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;506&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;RISPERDAL CONSTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER NEUROSCIENCE&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Oncology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,356&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;19.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ERLEADA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;120&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;313&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;130&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;* &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;898&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;949&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;831&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;VELCADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(57.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt; / &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;abiraterone acetate&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;568&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,258&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER ONCOLOGY&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;87&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Pulmonary Hypertension&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;24.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;477&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;690&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;26.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;279&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;795&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;44.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;351&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;401&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER PULMONARY HYPERTENSION&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(43.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;64&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;149&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;292&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Cardiovascular / Metabolism / Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(0.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;&#160;PROCRIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt; / EPREX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(38.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(5.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;145&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(15.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL PHARMACEUTICAL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,120&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,632&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,529&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;21,886&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,773&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Interventional Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;697&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Orthopaedics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,331&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,649&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,224&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;HIPS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;343&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(20.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;KNEES&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(50.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;322&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(56.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(53.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;TRAUMA&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(7.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SPINE, SPORTS &amp;amp; OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;955&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;328&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;510&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Surgery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(47.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,927&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,427&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(25.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,551&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;ADVANCED&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;396&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;498&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;633&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(11.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;GENERAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;213&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(59.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;775&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(41.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,739&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(29.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Vision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(46.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(24.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(40.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;CONTACT LENSES / OTHER&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;654&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;352&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,368&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,666&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:34.244%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.625%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.733%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.334%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.527%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.743%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;&#160;&#160;&#160;&#160;&#160;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"&gt;SURGICAL&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(64.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(45.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(49.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;371&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(55.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(36.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;TOTAL MEDICAL DEVICES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(39.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(23.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(28.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;5,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(33.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;12,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(21.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;WORLDWIDE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(13.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,051&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;&#160;&#160;Worldwide  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;</jnj:SalesBySegmentOfBusinessTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0yLTEtMS0w_52291eef-3e6f-4865-bbf3-c999ed37e87e"
      unitRef="usd">96000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i412403fa25604c0eb6cb3612a92af406_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS00LTEtMS0w_cf62f55a-e047-4ddf-9c79-e045c7e0d5f4"
      unitRef="usd">99000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7c2121621b324738b75a2c633700cf1e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS02LTEtMS0w_5ad4ae20-a75e-4fcd-8bbf-eef94fe0d4d3"
      unitRef="number">-0.035</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS04LTEtMS0w_0a81b3fa-bca1-4da3-9102-a71709c2a8b5"
      unitRef="usd">188000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf7cb2cb2d84454889dc1978307aa501_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0xMC0xLTEtMA_33a686d6-2fb0-4fca-b135-28b646985088"
      unitRef="usd">186000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i77ed958b0e334f79ab35338ccd347fa7_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNS0xMi0xLTEtMA_27231483-3864-4e7b-a46d-fe7bc8ba8deb"
      unitRef="number">0.012</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0yLTEtMS0w_7b1566d7-70b8-493b-a188-eac31a1b1446"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if72a15c285244bc3b010e33bfc90cde1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi00LTEtMS0w_78f9a35f-d5f0-498a-a645-5f29000ef0bc"
      unitRef="usd">344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6c7cb4d175b749aeb37e01e6c303e01f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi02LTEtMS0w_fcdcffec-4b4a-44db-9a97-645dae5eefe0"
      unitRef="number">-0.243</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86aec8fde918479799b3d8999e4a92db_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi04LTEtMS0w_c3fec96b-9aad-4a13-9040-a892c6dd0e38"
      unitRef="usd">529000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0xMC0xLTEtMA_ba9eaa73-4995-4abe-b9b3-77f69f7eb358"
      unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i74d7df6cc55e4daf8ab5a7f9050e0357_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNi0xMi0xLTEtMA_88dbbbe2-ac37-4347-8499-0ca7ee3f8342"
      unitRef="number">-0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0542775e36e242d1be3186249195e3ec_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0yLTEtMS0w_58a5d42f-2435-40cf-a545-178e683b814e"
      unitRef="usd">356000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f3ebd2f992b4c62a96493401efcf524_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy00LTEtMS0w_e6e02da0-c89f-45c7-9436-83fa73982524"
      unitRef="usd">443000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0542775e36e242d1be3186249195e3ec_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy02LTEtMS0w_c0cdf852-fd87-4556-9716-9a4cbe58a20f"
      unitRef="number">-0.197</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f06a464dd9742ea9682af70f69352eb_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy04LTEtMS0w_422fe0ca-2da6-41f7-bd62-fc0ccda4bab3"
      unitRef="usd">717000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0xMC0xLTEtMA_3dc53366-7366-4139-b779-85bd7f52eb8d"
      unitRef="usd">837000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i79e9f2011bcb431386e85efba6efd3b4_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNy0xMi0xLTEtMA_5d5e92f7-de05-47f4-bbe2-34a0ead34993"
      unitRef="number">-0.143</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0yLTEtMS0w_0869cdc3-4cf5-4e39-8e07-15d760b5a6bc"
      unitRef="usd">170000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40c2c1be7c9c4cdf8ed2ca776a685cec_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS00LTEtMS0w_ffecbf53-da8e-4737-99fa-f20bfb82cb0b"
      unitRef="usd">155000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iacf341ff611b4f34b426298402d7caf2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS02LTEtMS0w_07968346-a21e-44e3-962b-d12a13ae5d8f"
      unitRef="number">0.097</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7fc53301bf44a03a86320a01d4c89b2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS04LTEtMS0w_4f607c22-c889-4257-8029-9fde5968c0b4"
      unitRef="usd">346000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0xMC0xLTEtMA_cad12c65-ac37-48a6-84b1-7075ff021369"
      unitRef="usd">306000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i144157d91cc342f8b08674e18b9362ba_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOS0xMi0xLTEtMA_cf98395c-6f7e-45ca-af11-3126a07fca1b"
      unitRef="number">0.129</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e2c27311f954303936c62828d1203aa_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMi0xLTEtMA_8b72f2ee-01fc-41af-93bb-434b985844fd"
      unitRef="usd">227000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3241cc6119d45ba90518b03c7b76dde_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtNC0xLTEtMA_7b143b60-dec6-438c-8c19-3d747b759758"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3e2c27311f954303936c62828d1203aa_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtNi0xLTEtMA_c8cba314-c9a1-4320-9203-f6baf1e122c5"
      unitRef="number">-0.028</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62f12565007d4fe4b8dd93b5e190e144_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtOC0xLTEtMA_173fe8bb-046c-4287-8d34-a5e118eb350e"
      unitRef="usd">446000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMTAtMS0xLTA_23705609-9e9d-4c67-b8e5-5de5eaea319b"
      unitRef="usd">450000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie73d2b3c29654564bf121b55d752f975_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAtMTItMS0xLTA_ae913ad6-c30f-48ae-be3b-552b9b05895e"
      unitRef="number">-0.008</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMi0xLTEtMA_28735b98-a2dc-4e34-b806-95c2ab77609d"
      unitRef="usd">397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5687f5838b614e4589f850bb1f5939c8_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtNC0xLTEtMA_a4f22991-4f55-45ea-8e52-8c80eedbc69c"
      unitRef="usd">389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7a410dc2cad446f188b84b3629d505ea_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtNi0xLTEtMA_79dfd40a-c63e-4378-ac6e-9b830ff3507a"
      unitRef="number">0.022</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5df767d41f749ecb04e69b4d5853ccc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtOC0xLTEtMA_433ed4b1-343c-421b-af58-be5ab88bcc4e"
      unitRef="usd">792000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMTAtMS0xLTA_49cb5bf1-1407-47f0-85ec-7fc98cf6eabf"
      unitRef="usd">756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idf7e24cc1e4b4e22bf6e355affbcec1e_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEtMTItMS0xLTA_24dec06c-df43-426c-969e-8905da8f3530"
      unitRef="number">0.048</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMi0xLTEtMA_06161bbc-8dc3-4d0e-ba72-fcfafb0fd195"
      unitRef="usd">627000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30eb63aff7fd481189b4f524a3f36f78_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtNC0xLTEtMA_765d3f75-a3e7-4547-bd5a-6ec7b6a85045"
      unitRef="usd">484000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if2b70b3e70ad4de9a9320d5ef7967e19_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtNi0xLTEtMA_38f71d37-d212-4caf-b922-a939b44f3c95"
      unitRef="number">0.296</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8842b711d1844455848e9682cc4cceac_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtOC0xLTEtMA_b36f02c1-5b9b-4376-9bfb-fbcb94402bf0"
      unitRef="usd">1316000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMTAtMS0xLTA_23300f39-b124-47c1-9a31-a93144a40423"
      unitRef="usd">991000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i18e2f9de622a499cb2331a3eb9e10dce_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMtMTItMS0xLTA_dd69c275-4bf7-4532-bf4a-a344468501b5"
      unitRef="number">0.328</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMi0xLTEtMA_04fd6b15-49a5-44df-9e6d-6df98b10e1d1"
      unitRef="usd">522000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1a6b71be8d8141dab2ca5e6564f34d86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtNC0xLTEtMA_644a10ed-66ad-433e-b4fa-fb399a9ae334"
      unitRef="usd">580000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2a3881b85da840c486ac4f924cef6a9e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtNi0xLTEtMA_85f95dc5-7f2b-4f35-b823-2797659f7ca2"
      unitRef="number">-0.101</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86f3fa93e7354cc6bf55b6b55246cce1_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtOC0xLTEtMA_3d9a8f4a-8498-45e6-8047-5b49fa0a7854"
      unitRef="usd">1181000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMTAtMS0xLTA_2cd86c93-59a3-4489-8f03-3b9cb41c0591"
      unitRef="usd">1160000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i37343b4add6c4977b1fd678a0566a09f_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQtMTItMS0xLTA_dd9a464b-30f9-476b-ae8c-02d65458a88b"
      unitRef="number">0.018</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMi0xLTEtMA_6292e017-48b2-4a85-b802-230279a655e4"
      unitRef="usd">1149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d79693f595f4483a46180ef55b406d0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtNC0xLTEtMA_35afde7b-12a8-40b2-9e50-4d121c45c622"
      unitRef="usd">1064000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i466a60ae96d046d5a57a24ab1d8896a0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtNi0xLTEtMA_304e68bf-346b-4c20-80d3-60446e346ca9"
      unitRef="number">0.079</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3749288c66d45cd8504ea939901383a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtOC0xLTEtMA_7d87773d-1a6f-4175-ad29-1dbdb43bebd1"
      unitRef="usd">2497000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id5a61247d95c477381857604c8aed8c3_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMTAtMS0xLTA_5f7b884c-f6ef-4490-9428-71170550b84f"
      unitRef="usd">2151000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id5a61247d95c477381857604c8aed8c3_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUtMTItMS0xLTA_4fe25497-f6fa-4d2d-980a-e4240ea14c3a"
      unitRef="number">0.161</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMi0xLTEtMA_bfdfa758-d3d9-4750-b8ee-39934e1bb8ae"
      unitRef="usd">536000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie44840a7a12d4a59aa337501bb3c171a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctNC0xLTEtMA_d7962db0-defa-465e-b6d7-08f46e14a68c"
      unitRef="usd">663000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie78da6f8e9954f93a4edc518f2b5326c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctNi0xLTEtMA_54b0d9e7-1e72-47a3-a107-e905827735aa"
      unitRef="number">-0.192</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3225a5919ff748b88fab0958b5dc1630_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctOC0xLTEtMA_425f0efa-2351-4841-a27d-3bc406ca0a49"
      unitRef="usd">1195000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iccb687ba095a4752882b895461f25afc_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMTAtMS0xLTA_625f4376-a267-4375-a23e-02807b006289"
      unitRef="usd">1251000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iccb687ba095a4752882b895461f25afc_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTctMTItMS0xLTA_d0f7cd35-d2c1-4849-8962-2643937c0af8"
      unitRef="number">-0.045</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMi0xLTEtMA_587dc9b5-4578-4ffe-b968-74a65db64b16"
      unitRef="usd">471000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i416e1d239030434d91da317adc252268_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtNC0xLTEtMA_f8de24d8-1903-40e3-b719-a5eb2986d32d"
      unitRef="usd">539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i43936290c33d4e4fa4c183ad59d42eeb_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtNi0xLTEtMA_180896c0-02fe-48c2-93ac-4d305c2edd2b"
      unitRef="number">-0.125</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i217e8d94fe8343e7b9a36b46d7ff6f42_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtOC0xLTEtMA_5018ab5c-375e-4f41-ad17-7b692d47fe0e"
      unitRef="usd">929000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMTAtMS0xLTA_14e0f448-eff0-4fc8-96bc-818c69d4d782"
      unitRef="usd">1041000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i647ec0331ecb4d6ea20c5e662e6ac526_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgtMTItMS0xLTA_cfa28825-98fc-4132-9199-4515f87f28f8"
      unitRef="number">-0.107</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMi0xLTEtMA_a08f6c87-d3c9-4077-99fc-cb3e78df0a2d"
      unitRef="usd">1007000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if6572c7d7c154078815d1d633a936600_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktNC0xLTEtMA_ef71eb54-aa8c-4f4c-b2e2-0742c0640fda"
      unitRef="usd">1202000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iaf8328f50bfb43e6875cf778d335f40f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktNi0xLTEtMA_4922ff18-4d07-4a6e-8f5b-c793208b1844"
      unitRef="number">-0.162</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifa2a865013ea455b9e5d8ff204f65c18_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktOC0xLTEtMA_c3ad8dfb-36b3-43c6-b05a-55aa8acc3ccd"
      unitRef="usd">2124000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMTAtMS0xLTA_40adc2d2-684d-47d0-9c50-e9f02f812ce5"
      unitRef="usd">2292000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia1b91c21f27a47c396e35b5f1b21a4ac_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTktMTItMS0xLTA_eaa99ccf-e834-451e-8ae6-4429e9217e86"
      unitRef="number">-0.073</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMi0xLTEtMA_5c96d927-f43a-42f0-8676-fd66b6a65571"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3b8524a11f7463e8ceda09d321b1dcd_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtNC0xLTEtMA_816abc0e-247c-4a41-8c2e-ec1cbe313b97"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6561c5a6eaa5435e85dab57807e85dff_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtNi0xLTEtMA_862b36fd-c61b-4d82-8664-14ddd1bbb137"
      unitRef="number">-0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f8f472f6d184702a8de9d64eb4b3e33_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtOC0xLTEtMA_5d123521-8cbe-4ee9-96e8-31126bfce227"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMTAtMS0xLTA_269c3b0b-58d1-4095-82cf-cd7b3774762d"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib85341e3bf2f400181aee65400bcdee0_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEtMTItMS0xLTA_68bafdcb-ae32-4b35-8123-850071990dc2"
      unitRef="number">0.143</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMi0xLTEtMA_144fc52a-51a9-47be-af1a-d2ec841d699d"
      unitRef="usd">199000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ab77cc2dfcf43e786584e6ae05cc727_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItNC0xLTEtMA_b1cb158d-7431-4598-9e64-e4217821c0d4"
      unitRef="usd">250000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifb5adbc418b94eecbd729b0280e9c5dc_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItNi0xLTEtMA_f0b4a319-aefd-4d35-970d-4ef32ea8bd24"
      unitRef="number">-0.204</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17319dbdd05e4674960f993b6cec2500_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItOC0xLTEtMA_d768ecc6-0025-4dac-8cd8-56f75590ab76"
      unitRef="usd">427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMTAtMS0xLTA_790deb0d-0cda-43b7-8e70-b2a49db5125c"
      unitRef="usd">472000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i516cc8edebeb44d988ba7b54674946bf_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjItMTItMS0xLTA_6bc9e578-a395-4b7e-9ba6-afa155785c97"
      unitRef="number">-0.096</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMi0xLTEtMA_84294b64-cca2-47b0-aa3e-577662438099"
      unitRef="usd">202000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d58945d2f9c49328b754ad12aee7c1d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtNC0xLTEtMA_68aca18d-815b-49c9-a780-1c377bf1f465"
      unitRef="usd">253000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib64d2641465c40a19e6e11f31431485b_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtNi0xLTEtMA_099e22da-de98-4d66-98f1-60f562952aef"
      unitRef="number">-0.201</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3fd4ce4d5bfd403ebdb1f23fc75bb9e7_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtOC0xLTEtMA_89b78525-d959-43bb-8868-951f5ff5ab75"
      unitRef="usd">434000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMTAtMS0xLTA_30368f81-4b44-4993-8178-3148ae583bd7"
      unitRef="usd">478000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie6099749bd3344dfbf839f3b37a59c72_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMtMTItMS0xLTA_fc8e1844-267c-41f1-9b10-a1eb902f902f"
      unitRef="number">-0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMi0xLTEtMA_2a1d62d3-fc8f-421b-8a4d-bb95ba3c21e8"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f5f12aff9364764b1862f5c138fb733_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtNC0xLTEtMA_2ae859d5-0ef8-46d1-bd61-852d975bf4a2"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if8c781b5ca524e09a6d17166156e0736_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtNi0xLTEtMA_bffd3ccf-5770-4a40-91c4-b5e2c22d41f2"
      unitRef="number">-0.047</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00f88af71cc44acaa8ff9f73750b5cf6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtOC0xLTEtMA_25d83a72-ce01-48da-bcae-3159fb1751c4"
      unitRef="usd">245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMTAtMS0xLTA_c257e8db-13c7-47b6-a67c-2927f9757357"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7d817c6ef01848bcb5c003374fe44ca5_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjUtMTItMS0xLTA_eba817f1-c9a9-4415-9aa1-f0c9795a336a"
      unitRef="number">0.047</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMi0xLTEtMA_251bc34e-905d-41d9-be6e-22e19ba36a08"
      unitRef="usd">59000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a1fbdb565644530aefc8a04ee20b567_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtNC0xLTEtMA_d29b3bb2-5794-4f54-93d1-f02e0163ac38"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i45370cd0533d437c8b5b1e66e268c3f2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtNi0xLTEtMA_0d6c1bd8-9269-4e47-9c81-ac7d5b73d1ef"
      unitRef="number">-0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3309bfb236f34376976fd1aae5a817b9_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtOC0xLTEtMA_9b45578d-29d5-4549-8bed-62e643c9d59b"
      unitRef="usd">111000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMTAtMS0xLTA_c4cd7584-0aab-4ed4-a43b-83e18ac1d8e5"
      unitRef="usd">114000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6bfe4bb01688477ab7b1ba114817c0ff_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjYtMTItMS0xLTA_0a693958-ab3b-4911-8d7e-f67d5eb37af8"
      unitRef="number">-0.019</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMi0xLTEtMA_8d6b999d-b17b-4f0b-a71e-5170210b210e"
      unitRef="usd">185000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4615adcb9f9c4c91bf219b6707943c12_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctNC0xLTEtMA_a152492a-9950-4a62-8393-11aea9fb7675"
      unitRef="usd">193000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i14857a7c1c6240d3903bf102595ec990_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctNi0xLTEtMA_6840e418-b927-41e6-9214-06266669b84f"
      unitRef="number">-0.040</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae6da712f0bc48308e8e5ba20cb5dda6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctOC0xLTEtMA_e5cfc60e-8add-47ef-9062-9d9686bb566f"
      unitRef="usd">356000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMTAtMS0xLTA_8b176e91-2b41-47c0-92e2-2ae36e32ffe2"
      unitRef="usd">348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib5b3591eccb9480f861f8d97df8a81bf_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjctMTItMS0xLTA_0cc793b0-344e-459c-988b-88bb258179be"
      unitRef="number">0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMi0xLTEtMA_d79e1d8c-4c8f-4913-ac4f-71679a41fea6"
      unitRef="usd">1557000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i676c5ca698d44f7bb1903045e7e0ec08_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktNC0xLTEtMA_fa80d29b-0038-4aa6-9c5f-5e8bfbc4357f"
      unitRef="usd">1537000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5ddde257d81b4b3ea500fc07d1eb3cca_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktNi0xLTEtMA_66f64d0b-4e51-4342-af19-fc7dc4d541fc"
      unitRef="number">0.013</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i67922ba98bf742f2b93e38317dd13f79_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktOC0xLTEtMA_e114c99f-5294-4749-a7f4-79dc7678d6f9"
      unitRef="usd">3297000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMTAtMS0xLTA_29751b30-4031-461a-a669-0b380f3d0055"
      unitRef="usd">2975000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iafb45df1b69d499797f802ae354f05f9_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjktMTItMS0xLTA_8f6ac278-e794-4b54-8a23-144fddf13d0a"
      unitRef="number">0.108</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3510f20d163437d9d386475e40596e5_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMi0xLTEtMA_88075864-3d59-4607-a1af-ebe500a7ce35"
      unitRef="usd">1739000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12139d83ab444d98a2b66446337fd19f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtNC0xLTEtMA_44a2adfa-4612-47bd-8034-1125259f051d"
      unitRef="usd">2007000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia3510f20d163437d9d386475e40596e5_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtNi0xLTEtMA_41fdc287-32d2-40b4-afce-2885f830a0da"
      unitRef="number">-0.134</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if362a6cd5d6b414ca2bb842004eef8f4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtOC0xLTEtMA_4416b641-0c6f-48fd-8363-7deb1f23ea5a"
      unitRef="usd">3624000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i238c4888cf1248d595768c38dab59641_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMTAtMS0xLTA_b3e4ccc9-69eb-4fa2-999e-351593b6e855"
      unitRef="usd">3887000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i238c4888cf1248d595768c38dab59641_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzAtMTItMS0xLTA_f36455e1-987d-4572-84ec-670a4cd18986"
      unitRef="number">-0.068</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMi0xLTEtMA_a5cae14f-eb91-4614-9802-c05a61175755"
      unitRef="usd">3296000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtNC0xLTEtMA_feced5f3-d60b-40da-9c37-3c93bd3215df"
      unitRef="usd">3544000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtNi0xLTEtMA_2c1a4be3-909c-4e93-9240-76413d3393d8"
      unitRef="number">-0.070</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtOC0xLTEtMA_4ad27cf2-56df-4f9e-8176-669f40bb74d2"
      unitRef="usd">6921000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMTAtMS0xLTA_a68140af-250b-4110-822b-5ce1481e8354"
      unitRef="usd">6862000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzEtMTItMS0xLTA_96dbf3f1-6225-47aa-be42-0565669edd00"
      unitRef="number">0.009</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMi0xLTEtMA_a9cc70c9-4837-402f-b186-2e71f69ff846"
      unitRef="usd">2362000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09e1792cc5c94bf6b0b2b40156599df0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtNC0xLTEtMA_92c87a7f-d1ac-4533-be36-672b89902eef"
      unitRef="usd">2379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i91d261f3713a4ca9b1aae601c9f71d07_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtNi0xLTEtMA_e59507d7-acd5-4915-afcf-db698c733089"
      unitRef="number">-0.007</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9606d19598644104898d903b09806074_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtOC0xLTEtMA_a081850e-04cc-4bfc-800f-d32d8853d803"
      unitRef="usd">4772000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id73f28649d29470cbd4b3ce23d75ffc8_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMTAtMS0xLTA_7307b9a5-4b98-41e4-a8b9-bb7c6f892fd6"
      unitRef="usd">4542000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9606d19598644104898d903b09806074_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzYtMTItMS0xLTA_bb652279-43b0-488d-928f-2b22faa66e33"
      unitRef="number">0.051</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMi0xLTEtMA_80ed4a04-4ad8-40b2-8cdd-41b3675494d8"
      unitRef="usd">1161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idd3ff780d0f74b38b1a6a69a052629ae_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctNC0xLTEtMA_d2fc65e8-90b2-4d07-9753-ebdfa9cb2cf0"
      unitRef="usd">1087000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i080d096b8a2940499720722fdf6ff8ce_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctNi0xLTEtMA_721ad56f-45a1-42dd-871b-fbb472f443eb"
      unitRef="number">0.068</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia41941d76be24820956011d29accd0d7_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctOC0xLTEtMA_ce66b91c-54c6-47a4-9af8-f6eb6dc1e36d"
      unitRef="usd">2389000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0ccb205116b4463884f94a7aa8ad4845_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMTAtMS0xLTA_01539c01-06f3-44bf-9d14-a002d13a5802"
      unitRef="usd">2175000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia41941d76be24820956011d29accd0d7_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzctMTItMS0xLTA_8ee768bb-cc8b-47fa-8032-3cb040c15e36"
      unitRef="number">0.098</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd91babad94c42c5855b5b127b24d222_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMi0xLTEtMA_08bbffb8-607f-4dca-bd20-b12565878791"
      unitRef="usd">3523000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i202c6ea421d34b83af4652977ad93e89_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtNC0xLTEtMA_4bfbe8f0-7af7-4943-89c5-fee332fcc2a7"
      unitRef="usd">3466000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icd91babad94c42c5855b5b127b24d222_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtNi0xLTEtMA_d8932da1-f65c-4970-9f65-75af9b04ffae"
      unitRef="number">0.016</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtOC0xLTEtMA_7909be6d-55d2-4549-9ca9-8fe2b6b485da"
      unitRef="usd">7161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic70ac4fab133415ab1c3c188c47b58ec_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMTAtMS0xLTA_7d0328d1-cdeb-4e30-9e50-aa27913d0ded"
      unitRef="usd">6717000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic511c59acd844f7f89a19cbc151a2e1c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMzgtMTItMS0xLTA_b5b95d27-0da6-4d03-8cb8-c980de57c80c"
      unitRef="number">0.066</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMi0xLTEtMA_64392d3f-1ef4-497d-a7d8-9487904e7ccd"
      unitRef="usd">593000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie58a793be107479d9ac45bc6f91943be_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtNC0xLTEtMA_73861d5f-8ab4-421b-8b70-2c3ea089a2e1"
      unitRef="usd">801000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie35acb66854643f4b8f8a2d3d3c34071_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtNi0xLTEtMA_7f33f406-7773-4bf6-8cd6-5b12829cf69b"
      unitRef="number">-0.258</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtOC0xLTEtMA_780c597d-37d2-4fb3-95ee-34cb5e93bf16"
      unitRef="usd">1218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30a354f3a5aa42dbbb12c4091c197032_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMTAtMS0xLTA_b54ba568-c343-47fa-8ebe-34558b3adaf0"
      unitRef="usd">1575000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if180a17c67724ed39b758654e92fc9b3_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDAtMTItMS0xLTA_9c986975-9c62-4101-ade2-a6b787799861"
      unitRef="number">-0.227</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6aedf491fd84a00ac5c03725947fa86_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMi0xLTEtMA_9da61c28-1ec5-473d-93fd-6d2a7653dfcd"
      unitRef="usd">133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib634d639ae9c49819dcc46f6d7dbaa22_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtNC0xLTEtMA_4dc294a4-baf4-4d15-a97d-f550d9257153"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtOC0xLTEtMA_4087d45e-d85d-4889-b1f8-77cdb7e5d62e"
      unitRef="usd">243000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6dd25eb363984eb0abd80607dca205b4_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMTAtMS0xLTA_bd95f8be-b127-4602-a732-e7afba9cd946"
      unitRef="usd">138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i78bfb2996a4e4ae4b08b1f83cea57332_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDEtMTItMS0xLTA_9d47f355-96b0-4f6e-9c14-dfb2a5628aaf"
      unitRef="number">0.757</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMi0xLTEtMA_e8234257-a88a-4646-8d9b-52fcb7d2f24c"
      unitRef="usd">208000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a0ff02b2a8546f7a5b1c62d388c8563_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItNC0xLTEtMA_09ae5ce3-9b63-4873-9d6e-fc793a50d706"
      unitRef="usd">244000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia380fa4023db43bdab25b34e59b434f2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItNi0xLTEtMA_4f048eed-ce1b-4640-8387-d6043ac1c5e6"
      unitRef="number">-0.145</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItOC0xLTEtMA_d66ecda2-07bc-4043-8549-b45f4ef603cb"
      unitRef="usd">464000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72d4f321e7b44b50b09bdcb088bbe22a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMTAtMS0xLTA_01880bb1-2a3f-4b7d-9fd5-f344a2bae4ca"
      unitRef="usd">496000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic2ca27512fab404bbc2b5a123f751327_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDItMTItMS0xLTA_e268b3a7-b170-47b1-9247-971c6c0d5d52"
      unitRef="number">-0.064</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMi0xLTEtMA_99799409-630a-42e9-99d8-667b1000c36a"
      unitRef="usd">935000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8c5682649bb41e4afeb396ea67e339e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtNC0xLTEtMA_4309b47f-6c6a-4956-8a79-49ef18195d67"
      unitRef="usd">1107000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i13159f17c36e4e349b63c92eb3a69fd9_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtNi0xLTEtMA_7bdeda05-bfa1-4669-9dd5-63bd54674560"
      unitRef="number">-0.155</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtOC0xLTEtMA_a16f4c11-a0d2-4967-991f-8b6ad745206e"
      unitRef="usd">1925000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d51a74cecfc453496314405e25d87f9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMTAtMS0xLTA_9ff8170e-deca-4438-bf9e-56573b0288b9"
      unitRef="usd">2209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2fe9c3e45b294f2296eb0d5baf6fec88_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDMtMTItMS0xLTA_df638e89-9339-4651-bf06-b632a2252e16"
      unitRef="number">-0.129</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMi0xLTEtMA_5d41c501-b8a4-4fc3-a07c-b71ddf64cc83"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70cff2202d7347afa5eb1607d57f14a6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtNC0xLTEtMA_4c544762-4d5f-47f3-bb21-1ad317661be6"
      unitRef="usd">281000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ida64e72af94e41a1b22ef3d7ace2c6a8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtNi0xLTEtMA_1b43a2ad-25fa-48d4-a974-84236f8b807d"
      unitRef="number">-0.087</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtOC0xLTEtMA_1949d773-4ce4-4276-ad3b-df6479fad956"
      unitRef="usd">528000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia25dd344df8f4b6dafed16ebf59ddded_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMTAtMS0xLTA_42d71090-2eb6-4e8a-9989-22b2df6f89ac"
      unitRef="usd">544000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i36ee6542e54541208b2f4f11037bfead_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDUtMTItMS0xLTA_b3a71b1b-9ef2-46f4-83d9-911e7d783ec5"
      unitRef="number">-0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMi0xLTEtMA_eb5b1a5d-28dc-4564-aad5-78e4d306d1c8"
      unitRef="usd">289000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iabec2bb4211940caa377a2893b37a631_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtNC0xLTEtMA_99b4390e-6733-4671-af39-e47b6d766550"
      unitRef="usd">282000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ieb41c9e9987345eba1589ae5eaaaf60c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtNi0xLTEtMA_3cb95523-9d31-4e9f-aa7f-75823ae7764e"
      unitRef="number">0.026</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtOC0xLTEtMA_962d2af9-8ade-4995-a5b9-1958e76408f2"
      unitRef="usd">547000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11abb1995b224be4b48943c0dc5e5241_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMTAtMS0xLTA_d98becd9-779b-4374-96f2-550c42b2c1f3"
      unitRef="usd">543000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i41e5d91599154dbb8bb79fbe81180644_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDYtMTItMS0xLTA_046fef59-31f8-40ac-a322-a7c113f52dcf"
      unitRef="number">0.008</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMi0xLTEtMA_8ba4f8e9-2e0d-4da9-bfd1-37385299007b"
      unitRef="usd">546000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1e861771c7a249e8a7b1847d97087825_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctNC0xLTEtMA_6b8ead53-515f-43ec-96cb-a7a140a2b8af"
      unitRef="usd">563000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2b5c1a46ec364fabb5b1749a9b206266_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctNi0xLTEtMA_a6000c67-dd41-4f59-bf49-f2fb8030f35c"
      unitRef="number">-0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctOC0xLTEtMA_310283e3-9896-46cd-9eab-0a7cd18d1bda"
      unitRef="usd">1075000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i625a0328612340d3b2444593094ca6e6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMTAtMS0xLTA_307c75dc-b9ce-4fd2-b824-cef1949f7654"
      unitRef="usd">1087000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie0c14b4cf0c742c2b83047ac45f55e32_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDctMTItMS0xLTA_3c78220a-90a1-4361-b6c7-71c52a99d215"
      unitRef="number">-0.011</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMi0xLTEtMA_7b587ecb-1668-4714-a4b1-406510684e65"
      unitRef="usd">1138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18e155080f5045fa8e60310a82f43852_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktNC0xLTEtMA_7119b6fc-66df-4055-a3c0-a58aa6a7605d"
      unitRef="usd">1058000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i734345fb43a944f7a1b79d0bf4294857_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktNi0xLTEtMA_3ba14398-e50c-482a-8a5e-c1759d65efe8"
      unitRef="number">0.075</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktOC0xLTEtMA_cfde3b9e-ea2b-4082-a38a-414852b6ad86"
      unitRef="usd">2355000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbdf2685c57d492f9ea918bb328f7c1f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMTAtMS0xLTA_217ed540-bb4e-4b3e-aff2-ec82add2f1d0"
      unitRef="usd">1940000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id62e66dd692e4baf8de1a3cae2b2c437_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNDktMTItMS0xLTA_6136e43f-c8e8-4b3c-b4c3-8f2a1aaad485"
      unitRef="number">0.214</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMi0xLTEtMA_d3db8a7c-27fb-4526-b68c-9eb729ef678d"
      unitRef="usd">558000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5b2aa7ef11a4067b7913ca9a6049731_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtNC0xLTEtMA_645779ab-9b80-42f8-a062-07ed01cd1d6b"
      unitRef="usd">499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iaf6199e647ba4fda84090559f0c7d47c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtNi0xLTEtMA_d8643015-9559-49fa-aaf7-89ca957e990b"
      unitRef="number">0.119</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtOC0xLTEtMA_23baa023-74ee-4411-a9c3-76028cb02702"
      unitRef="usd">1161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd982433a2cc4b669204c6ff9a0df941_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMTAtMS0xLTA_7b75b0c6-e19f-4697-a627-b572292dcba6"
      unitRef="usd">1022000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id8933a5902f04ee29faa9a017e88b82b_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTAtMTItMS0xLTA_56ebc57f-f987-40f7-b1f5-61d68c03a0a4"
      unitRef="number">0.136</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMi0xLTEtMA_3d91e9b1-e25f-4ab0-a523-b4275b02c74a"
      unitRef="usd">1697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic193be42f65642e5914f3b9a9fe4b1f7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtNC0xLTEtMA_f190292b-a597-4ee1-a103-4d057e33abe0"
      unitRef="usd">1558000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia068f084a3b045d5a5680a9cb631b562_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtNi0xLTEtMA_26e51f98-3b4b-4bd6-b9e7-667367b923c6"
      unitRef="number">0.089</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtOC0xLTEtMA_fe688c68-43a4-469c-9ce4-0ac82cab07a3"
      unitRef="usd">3516000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f48c3e16a07411c939b255df38ab5ea_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMTAtMS0xLTA_5588cb2a-4863-43cf-82f1-c4a20bb5ba31"
      unitRef="usd">2963000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3676df4cf12744d6bf14d47f19e2b71d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTEtMTItMS0xLTA_d1aac234-1d54-4d0a-964d-340866f34d2e"
      unitRef="number">0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMi0xLTEtMA_87397b05-3db6-4944-b670-630e9b61680c"
      unitRef="usd">241000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i258519354ca34b0ea53867c6b0469e98_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtNC0xLTEtMA_ddc783d8-01a8-4d27-b08a-e96b2e1cedda"
      unitRef="usd">176000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie6159dffe30d4dafa4f6443b8756a0db_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtNi0xLTEtMA_a2f5f003-b11d-4ec5-855b-6c9a5f4873cc"
      unitRef="number">0.367</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtOC0xLTEtMA_b2f09082-abc9-4f14-8892-adb5b0e7bd3f"
      unitRef="usd">428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21c482cfc9e440558a10a03ac6b0041e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMTAtMS0xLTA_9b031817-ca92-4776-8228-228233610f3f"
      unitRef="usd">344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4674e920e88745519030a1bc7ecc89e5_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTMtMTItMS0xLTA_2e9d7850-dade-4a8a-bfa0-f9cb74745255"
      unitRef="number">0.244</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMi0xLTEtMA_bbe41ff1-f1b0-4f86-aafd-f5f5a4091ca4"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc056e7edf5d4a879f07aabe7d8da1a4_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtNC0xLTEtMA_89f4aaec-d1e5-48f7-99ef-915a873d20f7"
      unitRef="usd">59000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i51ebbd4101ef460ca17e738ae321ede8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtNi0xLTEtMA_a2f0ed68-6ca9-44e9-8ecb-18d2c6c9f268"
      unitRef="number">0.710</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtOC0xLTEtMA_2e804b01-9b34-448a-b309-6c6e9e743009"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3094a6e0c0e5489ca31b150a28af16f7_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMTAtMS0xLTA_22af926f-2d5c-4af3-a807-2090d962b4e4"
      unitRef="usd">108000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9da2d1e7555d41b3953deff31d51c33a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTQtMTItMS0xLTA_39054a59-3e99-44b2-9113-275903fa6bc6"
      unitRef="number">0.940</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMi0xLTEtMA_d1abedc2-68c8-4828-9343-afb1f5e898a7"
      unitRef="usd">342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2493d378de5d441f8eed2a2813f2a10b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtNC0xLTEtMA_ad421c7d-a81f-49bd-b0ac-704c032c4331"
      unitRef="usd">235000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i164d2a1787a34c20aae0af6d09edafbf_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtNi0xLTEtMA_98ed18ed-1200-479f-8fb6-c496083011f3"
      unitRef="number">0.454</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtOC0xLTEtMA_fdb78288-702e-40e4-b958-f9ffe955d6f3"
      unitRef="usd">638000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9a9cc129087542a39b32ad178f8e7d1f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMTAtMS0xLTA_71199733-428d-4550-a34d-f3c4cadb0aff"
      unitRef="usd">452000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iee9d0b6e11204fc396c72ea8ffc5a3ee_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTUtMTItMS0xLTA_d14757b8-4930-46ee-8615-c4607328164d"
      unitRef="number">0.411</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMi0xLTEtMA_1e8081ee-77ad-4503-9528-689ae67279a7"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2e74d86ade443d79565d3d4db9806ee_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctNC0xLTEtMA_6242c03b-901f-4b7c-b397-f9ae992a0872"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifca089d4690f41469ff77c14f3be83e3_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctNi0xLTEtMA_5630a00f-b149-4491-8b78-08e0fb74a418"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctOC0xLTEtMA_dc62bcb3-b6d8-4671-8841-67ae4d3902dd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cdff07e389d4a98a18843581742a126_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMTAtMS0xLTA_bc067640-2a13-4468-92de-dfb086183804"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5d85cb9c973d4cd486c08d9144dfd3d8_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTctMTItMS0xLTA_7e13a939-21e4-477d-9eb0-5cbd76617700"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMi0xLTEtMA_2aa061d8-ce78-4e9b-b990-3f4a4c23c35e"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i617f22cd872049709ad264ec00aa4bbc_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtNC0xLTEtMA_9555821a-f848-4029-aea2-d3bfadd72ba0"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i97787dd4dffe4c9aad58e1f47b1d923c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtNi0xLTEtMA_5220399a-df70-4c42-b611-55a3f7446137"
      unitRef="number">0.118</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtOC0xLTEtMA_560ee56a-09b3-44b5-960e-6ffc123693c8"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5ef4c7f60c8c4c179f5410a867c82c1f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMTAtMS0xLTA_a30a6f7f-cd37-40c6-802c-5a1e7d43ba3f"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4a76048f57b04a7c9a1f367e0ba8eb36_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTgtMTItMS0xLTA_fe5ab0c8-1885-4dc6-b403-7c7fef4f2039"
      unitRef="number">0.027</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMi0xLTEtMA_2e2eecc4-cc1f-4db0-8012-d9a91b551a81"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if7e1f856d6494507bf69cee1f35c925b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktNC0xLTEtMA_eabd4049-a13e-4fa1-a846-9968198af4ed"
      unitRef="usd">3000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6c4ffc18f39c422aba6237a5812ecca6_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktNi0xLTEtMA_ca797ed8-3279-4299-90ce-4eeb4499483b"
      unitRef="number">0.118</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktOC0xLTEtMA_c8387e44-9589-4baf-9e6a-63a0ea2c68d9"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00a198b7e3724dfc8d0765ab1eb7c385_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMTAtMS0xLTA_f076f8d7-ba0e-4b70-a2fa-e749371bf076"
      unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i130ac8f5c9ea421c8fbbc0addd109b07_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNTktMTItMS0xLTA_b15c2027-6aa6-44df-ac98-c994f4a90ee4"
      unitRef="number">0.027</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMi0xLTEtMA_164165ce-a28d-43ac-b99f-ef2476867995"
      unitRef="usd">416000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ad5ba18e22b49c8b7d61dde83b71892_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItNC0xLTEtMA_0449dbe4-e93b-422f-9e40-49c5e35d52ec"
      unitRef="usd">387000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i83778742d1b2430a92a0a1a63865ba78_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItNi0xLTEtMA_7d360882-da82-4b21-91b6-54a896a34cef"
      unitRef="number">0.074</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i722753247dfe40609326df9c146077f6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItOC0xLTEtMA_33d8f1da-dbee-4ec8-980b-c06b97211fb5"
      unitRef="usd">852000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iee8e1d7d443b4b5c8fbff2c8140dd02d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMTAtMS0xLTA_7473e5f8-425e-4e7a-8fb9-98bf308c9f6d"
      unitRef="usd">744000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i722753247dfe40609326df9c146077f6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjItMTItMS0xLTA_2391b89c-3a54-4a9f-b0df-6ff6ffb041da"
      unitRef="number">0.145</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMi0xLTEtMA_f0fec608-52db-461c-ad83-accc068853e4"
      unitRef="usd">463000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i860d3da7dba846e9b34578282e68a159_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtNC0xLTEtMA_b2d9431f-6761-47ef-a519-ce3ad4ba8c44"
      unitRef="usd">475000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4b4a74afaa2341229ad237cd0066a224_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtNi0xLTEtMA_274d3b6b-27bb-4789-baf0-70ce5b2ccebb"
      unitRef="number">-0.025</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtOC0xLTEtMA_32562a5a-0170-453e-b7b7-009166218014"
      unitRef="usd">946000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i90605ed3fd3d4ce9b995899ac2960140_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMTAtMS0xLTA_dad5153a-0c11-438a-8d1b-c6c81c769111"
      unitRef="usd">964000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib58159f6df244fdb9511fefddccb341a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjMtMTItMS0xLTA_0368a3c4-e7fe-4753-98b8-c63c6068e7d8"
      unitRef="number">-0.018</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i424fb644ea244b7da33323ed90262948_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMi0xLTEtMA_45ef4b2a-b2b5-46a1-b9a4-07a2b907e6b0"
      unitRef="usd">878000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifdb83db6bf2643a3beb8b071f017dd9e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtNC0xLTEtMA_a77bf17e-8094-44f0-98ab-9e2d8095bb23"
      unitRef="usd">862000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i424fb644ea244b7da33323ed90262948_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtNi0xLTEtMA_7d17c6c1-ebcb-40be-802c-ce0520c9394c"
      unitRef="number">0.019</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtOC0xLTEtMA_3c6bc719-dacf-4810-849c-fe2441a073e6"
      unitRef="usd">1798000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i593eedd9b3554e4aabf346ef510aed2e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMTAtMS0xLTA_1c3fe7e8-1f97-4e16-8b17-5b4a70d9c18a"
      unitRef="usd">1708000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0f8ac49e2cba4216b2bcec88a9aed97b_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjQtMTItMS0xLTA_d11d62d8-b16b-432b-8013-5c9ef41e401a"
      unitRef="number">0.053</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMi0xLTEtMA_72fb24ca-cf95-4868-bf23-d1199ef2b8c6"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie6756f2eb6504f6fbe424eaf7c67b1ee_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtNC0xLTEtMA_0d8f90ec-90a7-4e8b-ab96-8c2ee88d042a"
      unitRef="usd">12000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icc35e0c70a0a45dcbbbe67a9691e94d2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtNi0xLTEtMA_404c0927-2756-426e-b929-47cf65fa8cf3"
      unitRef="number">-0.140</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtOC0xLTEtMA_67d7a1f3-edad-4404-bab2-a4c58f582930"
      unitRef="usd">22000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i085528c026384b5c9822a2d0583767c9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMTAtMS0xLTA_d842fd8b-86f2-40f3-8cd1-7fc4c18e87ea"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7d6a965fd8de42bcaa548849f23cd71f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjYtMTItMS0xLTA_1ac7075d-91ea-4cd3-be6d-e2cdc80594ff"
      unitRef="number">-0.069</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMi0xLTEtMA_704a44fb-c41e-490a-a387-7b7faefcb8c0"
      unitRef="usd">246000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5505f103f3741599a24e8ec3035a6da_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctNC0xLTEtMA_d0535380-38c7-4ada-b914-4eced2c5130e"
      unitRef="usd">198000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icc4fdb5dac2846608d2e9e168f15d4ac_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctNi0xLTEtMA_cb932e6c-e872-4305-ac17-86e7ba009237"
      unitRef="number">0.245</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctOC0xLTEtMA_9bee172c-6d17-455c-bb72-6c5aeb209d47"
      unitRef="usd">458000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia111f6b65afb4bb78be8e74995a7f05f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMTAtMS0xLTA_c5c75dc5-909e-42c4-8931-00a8ad303dea"
      unitRef="usd">397000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i18f8e6cb94f044c1a37879efd8f14993_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjctMTItMS0xLTA_122d76ae-924b-4dfd-a72e-466be89763e7"
      unitRef="number">0.154</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMi0xLTEtMA_60e2ea63-6dd5-40c7-b971-e0e76fffd807"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d9bcb321c9e498f98febc66bd97be67_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtNC0xLTEtMA_d06a0742-4dc0-48e1-aac1-4a6782e90adc"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9d59fd47ebf94263943190e9f801c84a_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtNi0xLTEtMA_012ce4f1-94c3-4e95-bda4-ea6661beb0b5"
      unitRef="number">0.222</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtOC0xLTEtMA_3c0a478a-bea0-4b68-8d5a-b35c94e147a8"
      unitRef="usd">480000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iceb44ce996964b328d052671fe7e60e2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMTAtMS0xLTA_cec1f053-eea5-48df-8549-664f8b1a65b9"
      unitRef="usd">421000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6467bbc32a3d47beb18f7bb276a6b8ca_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNjgtMTItMS0xLTA_cde2117d-e80e-4c50-9f35-ed9d0699ec60"
      unitRef="number">0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMi0xLTEtMA_2d06eeea-3c99-4496-9204-3c0b8ad6add1"
      unitRef="usd">379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d7a48b762e44344a5837c580cd3cbf5_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtNC0xLTEtMA_9da75d1d-96e2-4877-b865-5a85bbc3a511"
      unitRef="usd">344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4b9eb20a57fe4e44a52aba6238c4cc5f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtNi0xLTEtMA_64d54b86-3d5b-445f-b377-e622c6914b1d"
      unitRef="number">0.105</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtOC0xLTEtMA_e40768c9-a0ba-41e8-82cf-7704dc9a264b"
      unitRef="usd">775000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94fb5529b7f24fdcb5216fd61202149a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMTAtMS0xLTA_c510263b-2949-43fa-bb55-816c8e54bf40"
      unitRef="usd">659000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i297839c7d5c848b09e7768d7acad37c0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzAtMTItMS0xLTA_15b32dde-cb4e-48fd-9954-c8cb48177ea3"
      unitRef="number">0.177</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMi0xLTEtMA_7afc3e2d-b81f-4201-b375-1b629af9e2c0"
      unitRef="usd">130000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i159cfea84a824beb9e343c1924836863_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtNC0xLTEtMA_d2b96dce-9393-4fb0-a15b-a404aeddbd1a"
      unitRef="usd">191000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iae72a15ea30f464b9f7e76ce4dd81f7a_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtNi0xLTEtMA_ac51cd54-5765-4e86-89f2-819d4ce61efa"
      unitRef="number">-0.320</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtOC0xLTEtMA_f2a8f167-f66e-4389-b825-831206f2ba33"
      unitRef="usd">314000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20e61bae25d1431f95c16ee1a52b7698_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMTAtMS0xLTA_a50bc115-71c5-40b2-aef8-3f264a926e9a"
      unitRef="usd">399000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id500d5743ff949d9a15a0f2f8999fc28_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzEtMTItMS0xLTA_d8ea8740-3fae-42b9-9cf1-ed7edd20651b"
      unitRef="number">-0.214</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMi0xLTEtMA_4e6a5f75-0a4e-435b-bf0b-63c82d6767a8"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d9a2a75f7ec49fcb41600b16ed21ebb_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItNC0xLTEtMA_d94244c2-c44f-481b-809f-711679ab3ddf"
      unitRef="usd">535000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2c7be96871494eaeab44a8b9045720d4_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItNi0xLTEtMA_fb651531-98c3-42a7-9d67-a1fc0d5d3127"
      unitRef="number">-0.047</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItOC0xLTEtMA_5a2ae8a3-7de9-4788-bedd-afabeae9a862"
      unitRef="usd">1089000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifabd48f69a75450fb39b1fcc14893a13_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMTAtMS0xLTA_b3e949e4-9a58-4521-a064-e7082517d3ce"
      unitRef="usd">1058000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i981abfccd122472ea61c9ec18a45e97c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzItMTItMS0xLTA_afd5af32-1537-4de4-b41e-20dc64146f43"
      unitRef="number">0.029</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMi0xLTEtMA_cd99f876-b421-46dc-9cfe-2aadcf0e4102"
      unitRef="usd">25000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4ec93166231349a4a62144abaa88211c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtNC0xLTEtMA_57e5cf98-facf-499a-8f63-ac9bf3f566b5"
      unitRef="usd">31000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i75bbbd5a12d84abe995e3bc5d748be01_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtNi0xLTEtMA_7667c1ac-79fc-47cd-8e55-cec8975ef5e3"
      unitRef="number">-0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtOC0xLTEtMA_96caf310-fd1a-4e9c-9ee3-77cdb45013c9"
      unitRef="usd">54000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9943abc01c244bfc976454f3930f0b53_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMTAtMS0xLTA_f3a91b69-1b17-4630-bbfe-75e15460ed30"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6e96fd0ff7564836aed8ef12a4b8cf50_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzQtMTItMS0xLTA_7aa09535-d6cd-4d71-9fa0-159c09e9673b"
      unitRef="number">-0.112</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMi0xLTEtMA_6624116b-54cc-4738-bad5-c4e5a0e4b399"
      unitRef="usd">87000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i865c1debd77c456ea62aaa4cee5f5098_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtNC0xLTEtMA_9b0b26a6-be05-4abc-8171-ab07f0458b79"
      unitRef="usd">86000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idf71b6c187e74a80b51b5acab9a33ddf_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtNi0xLTEtMA_cd7a995b-ebb1-4a7f-ad67-978c5e1ed827"
      unitRef="number">0.010</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtOC0xLTEtMA_497f5846-8ae2-4643-b7e7-781ffd8b3ef2"
      unitRef="usd">174000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3b12655dd4d549d791503b3d33bbc3bb_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMTAtMS0xLTA_42498e42-b5f8-40c7-baed-f704c4e26287"
      unitRef="usd">168000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i58cbdc4d0e414b3c841e39575dd84f1f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzUtMTItMS0xLTA_2760895b-4de9-4059-89a5-b5dffabe2a00"
      unitRef="number">0.038</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMi0xLTEtMA_26995051-4717-4af9-88fc-96994ee1f03b"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e49fb04160848249e6b979e9e53d9de_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtNC0xLTEtMA_2574f560-595e-4f32-88f6-fe2d5ced37bf"
      unitRef="usd">117000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9cc3feda6b6944769f78fb69dd576dfb_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtNi0xLTEtMA_4465b0c3-e8d2-4375-a7ef-da76df0a5d21"
      unitRef="number">-0.042</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4958d04806e4a26989b410d7de289c3_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtOC0xLTEtMA_6d5a5728-b1f6-4b83-803a-ae79ac940a4f"
      unitRef="usd">229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b73bb8b3a32402cabe464c9e85b926b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMTAtMS0xLTA_ce751549-f3ee-4369-ab86-9c4db1cd70ac"
      unitRef="usd">229000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id4958d04806e4a26989b410d7de289c3_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzYtMTItMS0xLTA_0a372df8-91fd-477a-8a73-517e53ffca04"
      unitRef="number">-0.002</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMi0xLTEtMA_d1637490-032d-4ccd-b2ed-22be9913a025"
      unitRef="usd">778000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib0a4733c057e4c91a422fa0925f0ae18_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktNC0xLTEtMA_d9c76118-1453-411a-9f8a-6684a8d20b56"
      unitRef="usd">664000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6aa1a24e7fd246a9ad4b429c2035b1dd_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktNi0xLTEtMA_e210b7c4-7a86-491d-a728-0c7913ec81b7"
      unitRef="number">0.174</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktOC0xLTEtMA_fc7b5c66-b073-4f8c-a02e-751e44038b89"
      unitRef="usd">1526000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id17f2144580042799de6fe20a0e39ccd_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMTAtMS0xLTA_c58c221f-3132-4b90-9845-c332ac3374c1"
      unitRef="usd">1387000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i98af48c07bb1497597ea4d60530589f4_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfNzktMTItMS0xLTA_2534817e-1060-4229-b98a-d781e31cfc1f"
      unitRef="number">0.101</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMi0xLTEtMA_97e783fa-4e12-4972-9c80-296ed61153cc"
      unitRef="usd">809000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebd5c6d65d444de181e96474c0ce96d7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtNC0xLTEtMA_3d14b312-1949-43e1-a963-307f737c5c2c"
      unitRef="usd">875000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia8da94a37ad24e04977165e5a514f5bc_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtNi0xLTEtMA_6b302afe-cc05-4634-9043-9e69994794fe"
      unitRef="number">-0.076</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtOC0xLTEtMA_d1f16e4a-f596-405e-954b-e465d9ed2ba2"
      unitRef="usd">1719000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie13d62f4906646048e8d258210540cc4_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMTAtMS0xLTA_acc51bc2-a4f2-43c3-9b86-2732227e6ab3"
      unitRef="usd">1780000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id3ddce322cfb4ab1af656742fbbd751c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODAtMTItMS0xLTA_cf8dce6d-a17d-4a97-8caf-97f3738bd738"
      unitRef="number">-0.035</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMi0xLTEtMA_0008c15b-14b1-4f5b-b22c-d48bca84be19"
      unitRef="usd">1587000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69a768ae79db44808f989038a6762aa0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtNC0xLTEtMA_a72b0303-6253-46f6-8429-6da227d33667"
      unitRef="usd">1538000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ica80ee14e60d4446ae5eeb497b5a2522_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtNi0xLTEtMA_e27f87f1-f32e-4ca3-b567-5a0aec02400a"
      unitRef="number">0.032</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtOC0xLTEtMA_64e72a33-a268-4911-8902-8f925c44a25c"
      unitRef="usd">3245000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb74ce4d9f2a438ca8c55bce6a61f201_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMTAtMS0xLTA_bd4ea470-71e4-4077-a4ad-81a9aecea0a8"
      unitRef="usd">3167000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i360ea2a370c4476794a924f3117aa09d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODEtMTItMS0xLTA_6bddcae4-83fc-4c22-b880-69117936f710"
      unitRef="number">0.025</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if252bb07e5ce40b09ae6eef7a0bd8990_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMi0xLTEtMA_693d5b03-4609-4aa6-ba89-ab57df7a177c"
      unitRef="usd">55000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2ffa593433846189cbe811f55d09e5d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtNC0xLTEtMA_4c53db2b-ab41-4caf-a743-51ee8ab077d1"
      unitRef="usd">15000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtOC0xLTEtMA_b7582c41-1a8e-49b6-8240-1285a65f52c1"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e675afc2787431e8afb910310f97ada_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMTAtMS0xLTA_dcd152c8-21d3-4c0f-b1e6-2bff78262f82"
      unitRef="usd">112000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7bcb858920124c77b213cc64828f0faf_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODMtMTItMS0xLTA_d862367f-d169-4a2a-a620-ab1f2d7216ab"
      unitRef="number">-0.042</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMi0xLTEtMA_56523fde-492a-4ad0-9a87-83262c3260e5"
      unitRef="usd">94000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id409969f7fec4d07b24c2e6172c72cb2_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtNC0xLTEtMA_8f9cbe09-4023-424a-bf4c-82baf544b9b3"
      unitRef="usd">123000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib6a9bfed7d584c2eafd4a3e1dbd56700_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtNi0xLTEtMA_fb9c4b84-61ba-4a13-a493-f9d395d71fed"
      unitRef="number">-0.230</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtOC0xLTEtMA_d27b2c09-34ec-4bcb-8bf6-7dee266d91df"
      unitRef="usd">212000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2968959d6568429a8880c28dcb335451_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMTAtMS0xLTA_5048a955-9138-47bb-83b7-3a90dfca8677"
      unitRef="usd">239000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8289c5cbdca84db5a4c03c2011265dd4_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODQtMTItMS0xLTA_28717727-5251-4d01-ae73-3c88d1dc1156"
      unitRef="number">-0.110</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i026f726665bd40f0ae400deeb330076e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMi0xLTEtMA_b6844e35-2f34-4c0c-8cfd-f901d65fabf9"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8291c7e7f5074b05a4080989a7cdca7f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtNC0xLTEtMA_ed8c2a4d-17e5-4093-8603-14e79f9ec889"
      unitRef="usd">137000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i026f726665bd40f0ae400deeb330076e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtNi0xLTEtMA_956f1a0c-09a5-4c99-bda3-48e4d3aabe20"
      unitRef="number">0.087</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtOC0xLTEtMA_4f205677-5b39-4a46-a4ec-6f9a9009e22d"
      unitRef="usd">320000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic8bfd30da6154a89ad914f97e310482b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMTAtMS0xLTA_2eb35f36-7e8b-4d9b-82e5-f14e3b2ea1d4"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i01fc0df7a2da435594fd424bf4bf869f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODUtMTItMS0xLTA_30d725bc-a395-4e49-b77c-0cfbd5c60823"
      unitRef="number">-0.089</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMi0xLTEtMA_55ca2c80-d673-48a1-9e02-bdc2320592c6"
      unitRef="usd">576000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6cbd731ae0314fdab64251ba569ebefd_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctNC0xLTEtMA_14cb014c-833e-4189-9d4d-4cd0e8e3b1e5"
      unitRef="usd">506000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i30ef31089362407f9d8075a36f717fa8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctNi0xLTEtMA_a94063cc-9a6c-4e3e-a17b-d27399dc456a"
      unitRef="number">0.138</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctOC0xLTEtMA_80093015-0a5d-444b-854d-e0f1aac45740"
      unitRef="usd">1120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aaf80f3af504855ac58fed5a2bc812e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMTAtMS0xLTA_83336f1a-440c-45db-a3d8-64eea0bf37e3"
      unitRef="usd">989000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0518ed34f1744765bc4708fb0df1e31a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODctMTItMS0xLTA_e7a5ace5-fd1a-4fca-85a7-6c4a7e6e4387"
      unitRef="number">0.132</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1439a394ab6846988867d4f1cf885731_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMi0xLTEtMA_0a54a856-6237-4770-b923-bf13ba339bc5"
      unitRef="usd">303000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7fa5b3c2baa437496a6794409866f3c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtNC0xLTEtMA_e00937c2-2e4f-4b51-a26f-038f045c0891"
      unitRef="usd">312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1439a394ab6846988867d4f1cf885731_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtNi0xLTEtMA_9743cae4-94dc-4ccd-9a5a-8b174816dc4b"
      unitRef="number">-0.028</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtOC0xLTEtMA_d1b75f46-7184-4949-82b9-6993359a5341"
      unitRef="usd">642000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3100b6a78517436fa32a8050740185a2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMTAtMS0xLTA_81915c83-912c-45c2-9be7-8b5bb4f929b3"
      unitRef="usd">619000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ide4eb5ff9496490eafc2bcffafd0ead9_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODgtMTItMS0xLTA_c2211ee0-409e-4306-95fb-ddf7f1940d2a"
      unitRef="number">0.037</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMi0xLTEtMA_68a881cc-1d01-4752-a1cd-b4af7b21e99c"
      unitRef="usd">879000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f27d0f078234139b5a188a530fdf0f4_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktNC0xLTEtMA_8da8d198-92c8-4658-a12e-97476410a8a2"
      unitRef="usd">818000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3044a80b2f8b41c1a9fd634f601c5817_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktNi0xLTEtMA_313cd1bb-bbe6-4f8e-b4ca-e741aa130766"
      unitRef="number">0.075</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktOC0xLTEtMA_c5031111-a34a-4397-9aeb-f624e02a8f2d"
      unitRef="usd">1762000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib615d062e3cc4937be3e2a60d7cb2915_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMTAtMS0xLTA_d5deb563-19ce-4472-a220-cfbff7de6363"
      unitRef="usd">1608000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i70735e18020543e69ae701bb83f91ab0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfODktMTItMS0xLTA_bdb3dd8a-cbc8-4817-bd18-69f92c1714b2"
      unitRef="number">0.095</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMi0xLTEtMA_c6e75d03-d1a0-4fd9-adad-612c837d0462"
      unitRef="usd">74000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0beff2f10b94936b5d68d3d4b19ca88_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtNC0xLTEtMA_b23a88ff-8456-40aa-8519-ec547d556f06"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2771dc7965c64982affb211ea5d80aaf_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtNi0xLTEtMA_10693c36-64cb-4cf1-9b71-b524742c9cbc"
      unitRef="number">-0.093</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtOC0xLTEtMA_d5e13f50-a4d9-4b66-8936-8f9f20b170d8"
      unitRef="usd">150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24c7d1c7078e4cbfad4062f370a3bfcd_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMTAtMS0xLTA_6369bc2c-c102-4db6-81a5-7dddfff51257"
      unitRef="usd">158000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie17cb419d6ce4b64a774b57fda167ee6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTEtMTItMS0xLTA_57370c7b-93f7-4885-b630-600de1f72ae7"
      unitRef="number">-0.049</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMi0xLTEtMA_b89faf8c-80ac-4f33-8d4d-fee9868958c2"
      unitRef="usd">79000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d6915ef71e9474593878dc7ff1d3c21_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItNC0xLTEtMA_bd007990-7419-4093-b9eb-d6b08db79c55"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idbf0acd7699e4ce6a62fcd2b52e1a9fb_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItNi0xLTEtMA_9eb83373-2c88-47fc-a47b-95c6244eae78"
      unitRef="number">-0.212</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItOC0xLTEtMA_7753726d-8c75-4473-a9d2-01c9f3f3382c"
      unitRef="usd">173000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i609cfa77c4914441937e2beddbb8131a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMTAtMS0xLTA_7c608621-b2c3-453e-b261-dd3ef514ac72"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3966c1faf5274669b61cc55f55124f2c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTItMTItMS0xLTA_8c3433fb-9227-47c7-95c7-64db96fc3de5"
      unitRef="number">-0.149</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMi0xLTEtMA_66a0ca31-98e2-4e28-b7c4-a8aa1fececfa"
      unitRef="usd">153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if72cc1f808a74f7a9d09c145562b9fe6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtNC0xLTEtMA_30fb9d1a-dace-4797-99e2-dd75fb35db31"
      unitRef="usd">182000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i184a45b0e2ee43fd8c95e18957949321_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtNi0xLTEtMA_c3cf1a39-8b36-4bad-9279-40eeb506b963"
      unitRef="number">-0.159</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtOC0xLTEtMA_46db8c24-0ffb-4301-a436-f192993b91da"
      unitRef="usd">323000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i31b578e4ed884650a6403b04a4e0b789_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMTAtMS0xLTA_fd60cea5-436d-4d92-a6e5-e57bcd2d9dfb"
      unitRef="usd">361000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2b2280fc502c479ea94ad4d834e8f110_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTMtMTItMS0xLTA_1801c089-2972-440c-b348-9df7b7a88d04"
      unitRef="number">-0.105</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib262502572224ee39687f0f730b454e5_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMi0xLTEtMA_e5846c8d-d730-4afe-b0c1-772a0bf76e22"
      unitRef="usd">75000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i80c887d315ba40298eef530b8f4ba42d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtNC0xLTEtMA_f30ec6d7-8731-44ce-a961-6ee5dd891d9b"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib262502572224ee39687f0f730b454e5_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtNi0xLTEtMA_716e3dc0-354b-4105-87a5-679d80f06be3"
      unitRef="number">0.215</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtOC0xLTEtMA_e849d29f-95b6-4b1a-8809-a7e257026a9e"
      unitRef="usd">150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14201fb6ec904317a82f139c47f516d4_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMTAtMS0xLTA_fc328a64-4e1c-4728-a916-15f849e7e15b"
      unitRef="usd">128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i56752988cc69442c8423f60d576f3f9c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTUtMTItMS0xLTA_169339b7-26ed-4b49-9631-a2c192616502"
      unitRef="number">0.168</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d635955ff65456481154c2069841ae0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMi0xLTEtMA_d101eb1e-fa6e-4bf1-b5a7-d7b0e38b884b"
      unitRef="usd">331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4102c5393e3e4404af8f3950fb3c1061_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtNC0xLTEtMA_de720c05-758a-486e-88fd-b5d9a9749f49"
      unitRef="usd">340000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1d635955ff65456481154c2069841ae0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtNi0xLTEtMA_b43f3956-476c-4077-bd6c-39c9f5d4e31e"
      unitRef="number">-0.025</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtOC0xLTEtMA_69a39d9e-35ba-410a-b792-f28b9a8cde79"
      unitRef="usd">691000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab60464d3cb4430eb82579d017bef6f8_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMTAtMS0xLTA_9fb12b2b-7963-490b-b4e7-66e55f4ab7c5"
      unitRef="usd">719000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0493b1ac13db4ce6b05a87b6b5837bac_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTYtMTItMS0xLTA_49474f39-cdff-4a6a-af31-3c6b9220de53"
      unitRef="number">-0.039</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMi0xLTEtMA_26427357-ed03-4746-9d2a-e813209fd5c9"
      unitRef="usd">406000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i11fc7443e78c45d6bf48c2a55810ae8c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctNC0xLTEtMA_ec46dea3-3f67-4468-80a2-b1ec449e5898"
      unitRef="usd">401000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id9993b8c2f2445fa9f719a5335eb9189_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctNi0xLTEtMA_9d1b2f5c-3b62-4ea3-bf43-92b720e2e7bc"
      unitRef="number">0.012</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctOC0xLTEtMA_232d27c2-db86-49a6-aa3e-5e8a520a512b"
      unitRef="usd">841000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17a8a56018f8486f8449896537768e16_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMTAtMS0xLTA_a7302c8b-5a50-47a9-a330-87d1eb2e45ea"
      unitRef="usd">847000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8b41a207745f4e828e9ff6280a5cf326_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfOTctMTItMS0xLTA_0a98c34b-75e3-46af-a7dc-405dc3cc0201"
      unitRef="number">-0.007</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTItMS0xLTA_d0cd1b72-92e6-48bc-8851-1d8b4df6b881"
      unitRef="usd">1181000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i98e861871c884f4680474af0cbc7e046_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTQtMS0xLTA_48a34c43-1e74-4d5b-a71c-0c15a93d2b69"
      unitRef="usd">1013000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i579f3dd1b121423a9aaadcaf1d5cca7d_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTYtMS0xLTA_3aae7222-ee7f-4a61-b7ee-812283cc7c5e"
      unitRef="number">0.166</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTgtMS0xLTA_4af8cbf2-27d1-41cc-bbd1-376c2fd47a8d"
      unitRef="usd">2356000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40d8d8c184b744188f48cf36a41714c1_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTEwLTEtMS0w_4b323112-fc40-4d03-bee3-9691e3d5ac89"
      unitRef="usd">1975000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8bc81eeff6414723bc9d9963b115d44d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAwLTEyLTEtMS0w_3c6dbc67-6677-4834-a362-20504a113f0f"
      unitRef="number">0.193</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia70fced883cc48efa3c30712ae539922_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTItMS0xLTA_8587445f-a93f-4c07-8af1-b298746f66ca"
      unitRef="usd">1609000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57870f886e894fd8bbe4a13765b0df95_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTQtMS0xLTA_92fbd191-7f04-4592-a4fa-bcc8311e9ba9"
      unitRef="usd">1684000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia70fced883cc48efa3c30712ae539922_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTYtMS0xLTA_876540ae-496c-4b39-9e73-1e902ccfd529"
      unitRef="number">-0.044</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i781ae83699db4163b10fd85d372075b4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTgtMS0xLTA_5982dd07-cfd7-47f4-8037-100df951aabd"
      unitRef="usd">3448000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0afe68e69df24e9ebdf140bda8bafd0f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTEwLTEtMS0w_cc000b71-3c8b-445f-a5c6-79b9eecdb35b"
      unitRef="usd">3240000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i781ae83699db4163b10fd85d372075b4_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAxLTEyLTEtMS0w_6272d50a-bd1e-4241-9343-73e4c23746c6"
      unitRef="number">0.064</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTItMS0xLTA_001bff71-4bac-46d9-875e-5b37d4b72312"
      unitRef="usd">2791000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic2caa6cea60a4de4bf1daf8484380ff9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTQtMS0xLTA_85455991-ce96-4b7e-9afa-d61dc00c2e32"
      unitRef="usd">2697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id92b5e55b7f9482c9176ffbeb60e83ca_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTYtMS0xLTA_83e8338b-a36c-4353-aeb8-ae46f5d6f3e9"
      unitRef="number">0.035</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTgtMS0xLTA_79c59fd3-fc6c-4d43-a711-a71f7d46360f"
      unitRef="usd">5804000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c6b423472dc4d3aadf1c81dc48fc95d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTEwLTEtMS0w_00298e07-255b-480c-b80e-5f25f689fb98"
      unitRef="usd">5215000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i053e08ffb22b4c27aa751b148a3b4d1e_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTAyLTEyLTEtMS0w_deb154ed-731f-42a1-a250-2cd364ba2e6a"
      unitRef="number">0.113</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTItMS0xLTA_673501e8-a14b-4079-a7fb-5c7892b4b35b"
      unitRef="usd">492000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i68de92f3d1ce4ff98dbf3ea01899ba7f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTQtMS0xLTA_35cb04b5-11a7-433b-b727-bbe8a270eb86"
      unitRef="usd">369000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2dfcced4ef5a48a087b9f3753f38881e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTYtMS0xLTA_4b7502b4-8570-4f83-971d-bef134c99769"
      unitRef="number">0.329</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTgtMS0xLTA_dd0102ea-25a0-47f9-9a75-4475c164ec7d"
      unitRef="usd">955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd26991e9f7c4050a356609fa6aa6564_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTEwLTEtMS0w_8efd83cf-19b5-480c-b34d-6b25d7842a0e"
      unitRef="usd">721000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if5564bd8a6ea4c09984e5c1a1f2c7115_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA0LTEyLTEtMS0w_e6a5fb52-ab7d-40a1-8147-45f973ada226"
      unitRef="number">0.323</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTItMS0xLTA_a7947f86-4d89-4e6c-b38c-1ed6a90ae9f9"
      unitRef="usd">409000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5c47b91ea4f4a1a82f47eb2f2b05c3d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTQtMS0xLTA_fb114a16-4b4f-453a-853d-fa7529fad705"
      unitRef="usd">405000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i866decb978e348f6969e56e3ad85cc72_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTYtMS0xLTA_46ce548c-192f-420f-a74c-03047d2dbefe"
      unitRef="number">0.012</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTgtMS0xLTA_0da850d2-ff76-41aa-9d0d-1d4f491e7789"
      unitRef="usd">883000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iedcc529eaf2d4f5e95ef455772dfe9d8_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTEwLTEtMS0w_1af37062-404b-42ce-b956-b651293c2437"
      unitRef="usd">682000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if9c8b4c138cb40259709f04d6cf1befa_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA1LTEyLTEtMS0w_584c9c02-4f5f-4216-823a-c1fccfac0e9f"
      unitRef="number">0.296</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c83bae4c94549c794523bba175150ad_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTItMS0xLTA_d58f2dae-9218-4262-85d7-9d5b9f786980"
      unitRef="usd">901000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20db1fe43a544cd8bb1e84445a29fcf0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTQtMS0xLTA_ab9772e2-30b1-42ac-99c4-ce73429579a4"
      unitRef="usd">774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0c83bae4c94549c794523bba175150ad_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTYtMS0xLTA_d3e6dae8-883f-440e-9b14-bf876ec9c720"
      unitRef="number">0.163</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTgtMS0xLTA_e2236f68-8f5d-4252-b516-d65761fe029a"
      unitRef="usd">1838000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c6e046a80854e88a9f86f1695a5f3aa_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTEwLTEtMS0w_36a10e90-f35c-464e-86d5-742b19f700ec"
      unitRef="usd">1403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib1f9bf8f74ab4a0c8063e895b4c5af00_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA2LTEyLTEtMS0w_0709f905-cf26-4c8d-a8c2-8942e6c13a08"
      unitRef="number">0.310</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44e81356fdd54d65a78dac4fc0eda00e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTItMS0xLTA_b542d036-0528-4527-a948-02c939a7955f"
      unitRef="usd">136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie123409368b842cab55c01dc3d83661e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTQtMS0xLTA_31bc8ba8-5bb0-4bdf-a8b9-a954faa40237"
      unitRef="usd">62000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3e20f2e34a646dc856760483fc4ad2d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTgtMS0xLTM3Nw_04ac4539-3cf6-4e34-8405-d27f561f2437"
      unitRef="usd">255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d4e3a4668ff480e9666f51b1628680a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA4LTEwLTEtMS0zOTE_afc80f45-abf7-4bca-a645-ceb5e8d02596"
      unitRef="usd">120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d365fd404f94441a423bc83e35f9e37_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTItMS0xLTA_5c7a358c-9b3b-4bfd-881b-734e9024b36d"
      unitRef="usd">33000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3a5f0cceba9a45adab7b92c8c0342bde_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTQtMS0xLTA_56df79fd-4096-45b3-9467-2e373252180f"
      unitRef="usd">7000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1b199c2136c468f8a1e8ae983620d04_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTgtMS0xLTM3Nw_8769258c-bfee-47f4-a2cf-5ea1c8c7fb55"
      unitRef="usd">57000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7591b4f8a45d45e9adbb156f546300ed_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTA5LTEwLTEtMS0zOTE_c2188500-7a20-4050-b691-371f49b84c03"
      unitRef="usd">10000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i879dace13f494901b14e98c7595f7ce0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTItMS0xLTA_16afa138-e21d-4333-a0cd-fb32836d3eb6"
      unitRef="usd">170000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i451c8da9b5fa46f9becd1b7f4f4c2059_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTQtMS0xLTA_c135b96c-b6ac-4f84-b978-2bd1aa0a84ec"
      unitRef="usd">69000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2b4f3715aad849fd85631a944342e87a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTgtMS0xLTM3Nw_0f66c03c-7329-49b5-9150-db3a0d1d71bf"
      unitRef="usd">313000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i81ae16fae08e4c16b6ba95255d7c70a5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEwLTEwLTEtMS0zOTE_42270f5e-df5a-4e99-8bdc-334c4856d1ad"
      unitRef="usd">130000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTItMS0xLTA_02b4e879-4cef-4e9c-8caa-90332627af8d"
      unitRef="usd">447000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f3face5d4a74567b928ba079035536f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTQtMS0xLTA_0709d424-4ca0-4980-b5fd-c715acaf27f0"
      unitRef="usd">367000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7d6bb652c24648399b9c747033193c8a_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTYtMS0xLTA_00a15cbf-6431-44a9-9fdb-218d2f745c50"
      unitRef="number">0.215</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTgtMS0xLTA_dc04f04c-06dd-42e3-8436-df0048946fd3"
      unitRef="usd">879000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4830a4c60c5480f8753cc4f6e6e0619_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTEwLTEtMS0w_735d5510-0633-42af-b852-5d806b03aad4"
      unitRef="usd">716000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2c52b5d2044c4d318d98a1f88ca90f24_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEyLTEyLTEtMS0w_cef46cba-1af9-451b-873d-934f359f091f"
      unitRef="number">0.226</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTItMS0xLTA_3422cb43-349c-475f-a0bf-b02ec63c9871"
      unitRef="usd">502000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ac0963e98b74865bd5c91872e42f462_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTQtMS0xLTA_3204b611-e92f-4fdc-aa0a-1e216279cd20"
      unitRef="usd">463000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i00e512e017ad4fb59eb52dfd222677c8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTYtMS0xLTA_3687a29c-eeb0-4abb-b285-e9f3cc6bca8a"
      unitRef="number">0.083</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTgtMS0xLTA_cc98058e-e807-4bd8-9c88-13123dd1a7b7"
      unitRef="usd">1101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f34e03717784a4a8111609212e45149_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTEwLTEtMS0w_22b27bbf-ff07-44af-b3fe-b45d13544054"
      unitRef="usd">898000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic36febfed9d94dc59df03d626a007bcc_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTEzLTEyLTEtMS0w_5838a33c-c608-4195-ba0d-8d5c29e685e3"
      unitRef="number">0.226</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTItMS0xLTA_f8e2b01e-efc5-40c7-b5aa-c2740c70a0a4"
      unitRef="usd">949000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50c8b25757c84b7eba5a91969c95a1ff_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTQtMS0xLTA_2f4277b8-ce96-44b2-a733-5260b044d823"
      unitRef="usd">831000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia19fcd4868ad490f97a907d8fe74428f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTYtMS0xLTA_a39b8117-1c02-4e68-bacc-8ba5b976dcf9"
      unitRef="number">0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTgtMS0xLTA_95fa801c-9579-4e5e-b82a-1f9bfa15b4f0"
      unitRef="usd">1980000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff1890bf78564da8b18b9b68921ec794_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTEwLTEtMS0w_fa2215be-a12d-496e-b8ff-d4e17c14aac4"
      unitRef="usd">1615000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idac97fcd070e47e4a3a76006e88ee89e_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE0LTEyLTEtMS0w_74ca4309-0f6b-4c36-91fb-28f9e8bb02a6"
      unitRef="number">0.226</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTItMS0xLTA_d74d1cfe-061c-480b-bc87-c3442f3ac607"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40923251ff8c4dd2b498eed41e75b3df_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTQtMS0xLTA_6f4f1db7-bce8-41c9-a839-45c7e7405d07"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i46bd469176be4aeb8f6072308a707f51_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTYtMS0xLTA_7942a095-1b02-4f0d-b976-156ef3f188fd"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTgtMS0xLTA_236d2fb0-029a-472b-b59c-618f56b71f0d"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ab98edb95934d548f9aab32a4017a85_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTEwLTEtMS0w_10b02aca-5c62-4e1b-a9b4-a9329ebdd175"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if96d5b9798d546398c011106cc1f6dc8_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE2LTEyLTEtMS0w_5bc26530-e1c4-40ef-9811-3210e103b96a"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTItMS0xLTA_b58dd27e-9c14-4f83-ad12-4460d1bb43ed"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb58d996d2d340ac859eb5d48275ae50_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTQtMS0xLTA_b38ef2ae-13d2-446b-a23f-4212f3552928"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8d4283f7a1ec4df3888b3e3517865492_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTYtMS0xLTA_d899042c-5825-46d0-92b8-aa3c65d19310"
      unitRef="number">-0.561</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTgtMS0xLTA_5e43fc57-f0c9-4f69-9cae-874afc5ce595"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70777ca74a8f4c52bfcced79529e5a78_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTEwLTEtMS0w_9758018c-84f6-4b6d-9095-07d657671454"
      unitRef="usd">487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1df5aa6ea08c4fd1801e2e11fae63e13_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE3LTEyLTEtMS0w_bb537a6c-f08b-430c-b6f3-a3f24474e0dc"
      unitRef="number">-0.577</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTItMS0xLTA_2fe530d8-0930-4175-be0c-d29179982ccd"
      unitRef="usd">98000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia32c5586169343d1a69eec3e4c21fc0e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTQtMS0xLTA_4d07e50b-05e5-4944-8bb3-816995172a78"
      unitRef="usd">224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id0107b386b4c4f0e8f5c0cde1a516341_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTYtMS0xLTA_d57bccb6-d73d-4fc9-8949-6ac67483fc2c"
      unitRef="number">-0.561</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i016a755a6a094e0588480249a8a01013_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTgtMS0xLTA_4bae2b97-e336-44ab-9f97-3a40e743114e"
      unitRef="usd">206000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9fbe6cfac9849d8bf7baadf709ef1ca_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTEwLTEtMS0w_092aa9f6-5078-42ee-80e6-70cd2e275197"
      unitRef="usd">487000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i016a755a6a094e0588480249a8a01013_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTE4LTEyLTEtMS0w_b078f297-a62f-4167-b213-6e36d29fe708"
      unitRef="number">-0.577</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTItMS0xLTA_f61e4a03-958b-453f-8bb2-a103e12709c2"
      unitRef="usd">87000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd032f631b7b483d84a771f14f2dd965_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTQtMS0xLTA_360b9699-ee61-4fb5-82ff-13f48207e54a"
      unitRef="usd">198000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibe27d43603dd43d2acc49c20441934d8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTYtMS0xLTA_f14b2a17-1e08-4d12-b847-ec570caa65f8"
      unitRef="number">-0.556</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i268e898503704282b1e644c2a204b27e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTgtMS0xLTA_6c6c2336-fa59-4274-b0de-ec05fff8f6f8"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia30a1b9a326a4a0cbd7d5286285a5135_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTEwLTEtMS0w_ba97e924-b2f2-4fbb-ba78-a69537350e36"
      unitRef="usd">383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i268e898503704282b1e644c2a204b27e_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIwLTEyLTEtMS0w_aca54fd8-9cc5-41ad-9eb9-d21edb258ca3"
      unitRef="number">-0.409</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTItMS0xLTA_56a20906-95d4-4edf-bc19-99ddba4e4dd9"
      unitRef="usd">480000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6fe3b75e12074a2aa5073e4be2dc9f2c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTQtMS0xLTA_0c36304e-c7c2-456e-aead-157319d0af26"
      unitRef="usd">500000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i86dadb8fe5fb46b7b11039ff2da3cc7b_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTYtMS0xLTA_2662c18b-cee5-4443-b9d3-5af6e49c718a"
      unitRef="number">-0.039</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTgtMS0xLTA_8351220a-16d7-4f50-958e-4bc2a15ee7c5"
      unitRef="usd">1032000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i590d4101caa4452e881c66c7cd378a8a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTEwLTEtMS0w_63fc3f9a-65d9-432f-89ac-bafd997ff3d2"
      unitRef="usd">994000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ief5cadb3135a4604a717c020e80e798c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIxLTEyLTEtMS0w_01174223-ae75-4163-92d9-c7de80b9406e"
      unitRef="number">0.038</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTItMS0xLTA_53300c69-ad63-449f-bac7-c1e509ccc659"
      unitRef="usd">568000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief29fa0003a342a9b72261c5a777f5d0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTQtMS0xLTA_f9134252-7b65-4237-952a-6f4feb7ac9cc"
      unitRef="usd">698000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i93b7653f0d59459091ec7670de3a168d_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTYtMS0xLTA_19fb946e-979e-4902-b99b-3f3e65c75316"
      unitRef="number">-0.186</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTgtMS0xLTA_3dbbc490-933f-4cbb-955f-ca65d09f8638"
      unitRef="usd">1258000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i92c5ae1bb6c844da97fbc887f5bda6e0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTEwLTEtMS0w_469a7ae0-2569-442e-b2fd-08fbe38bf761"
      unitRef="usd">1377000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i590944fabb414f4d811f44cffa5ae7c5_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTIyLTEyLTEtMS0w_6acfbe86-c2b3-4592-a951-9785a6a4cb63"
      unitRef="number">-0.086</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTItMS0xLTA_79053f87-71e3-4dbf-be7e-ed87aaf6c682"
      unitRef="usd">20000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib56fd4104b864eaaae048a20df297cde_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTQtMS0xLTA_d6873950-5822-429c-b20a-662d16cedd59"
      unitRef="usd">16000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iefee0269632d4977a9cdbc10f6675106_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTYtMS0xLTA_f32be62e-c564-46d9-abcd-fb06ee15e59f"
      unitRef="number">0.229</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTgtMS0xLTA_85a18d90-e574-43da-bdb7-0b56ebd66f84"
      unitRef="usd">42000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i801fee3b508b48d7b1a571095a597b48_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTEwLTEtMS0w_496af60a-83b1-428a-80de-146f9aad8653"
      unitRef="usd">34000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i011838ccf0ec4135b0b8a79b6a6f57ec_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI1LTEyLTEtMS0w_f947134b-bd4a-4615-b334-e17860c6b7c8"
      unitRef="number">0.214</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTItMS0xLTA_50f0f612-50ef-4409-834c-a4add1cecf5d"
      unitRef="usd">87000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94d1ee23a76c405bbf282ee929fb2018_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTQtMS0xLTA_b418c861-4e14-4ad4-a3c3-fd7a43432480"
      unitRef="usd">85000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i709a9eaccd2a4c8aa71af6b19f8a9d5d_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTYtMS0xLTA_bfa75a85-38b3-43a8-8a05-5e66ac4a4a66"
      unitRef="number">0.022</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTgtMS0xLTA_6dc45aa0-bd0a-45a7-94df-dc7e9c07f0d8"
      unitRef="usd">169000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i372fe738f82d4d1aa79d1d22bb000b69_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTEwLTEtMS0w_048af60c-8689-4cb4-8809-45103d657577"
      unitRef="usd">169000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia4e976bf0deb40a4b91fd0887419c976_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI2LTEyLTEtMS0w_2d8b94fb-85fb-4c62-8bb6-75ddaf0c8efd"
      unitRef="number">-0.003</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTItMS0xLTA_0451a298-8e80-49b2-8039-7735825e8a69"
      unitRef="usd">106000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6214365a5a6e4954a883f81d290094b5_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTQtMS0xLTA_ae7d1815-ebf8-484a-9140-d346af666a62"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia98cd609efad4f55bd4205760779c72d_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTYtMS0xLTA_9927a452-63c5-410b-ae57-8215d35369ef"
      unitRef="number">0.055</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTgtMS0xLTA_2b80ec8b-dcf0-4334-8994-da031a5a1458"
      unitRef="usd">210000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9c8d994f0ca943bc81943bb007e9399a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTEwLTEtMS0w_3c98c458-3f58-4d06-83ee-59bffab06776"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i492ee4b2ddb149b4ae2a66f4a665eee3_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTI3LTEyLTEtMS0w_a06b18aa-4738-4f74-b09e-5ded5e7c3ad6"
      unitRef="number">0.034</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTItMS0xLTA_82848243-e838-47fe-8e00-6ab7b6172c39"
      unitRef="usd">545000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i317e0f05a6aa4f0ca7c59c511f3116df_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTQtMS0xLTA_0308a309-217e-4f40-9509-716aff728aa7"
      unitRef="usd">439000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i08a3511c83794d7e9043b0203e40bd1a_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTYtMS0xLTA_f37bc821-9fa0-44e9-973f-4e0a44da34b5"
      unitRef="number">0.242</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTgtMS0xLTA_d7fff4c4-28c0-4761-9e46-197b554dbaed"
      unitRef="usd">1031000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e6c9a032cef42779e88c9c4e9e74fdc_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTEwLTEtMS0w_4c0edb5f-2edd-455f-92f9-4b0f012acd38"
      unitRef="usd">869000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3ac005b9568e4b4ba126c6776a4280b1_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMwLTEyLTEtMS0w_cbef2e18-0506-4bad-8a04-2e0d93acbbb3"
      unitRef="number">0.187</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTItMS0xLTA_675ddc4c-6b93-4d5c-9cfe-54c2c717cf7b"
      unitRef="usd">243000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iae747a1c0cef4fb9a4aca0b3ba685a30_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTQtMS0xLTA_e1637e18-15a1-48af-bf6d-4d9ea5002a6e"
      unitRef="usd">251000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9f1883a4e7b84eb9b235553c3e3ed832_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTYtMS0xLTA_6a208bdd-138c-42de-8630-0777eba24057"
      unitRef="number">-0.033</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTgtMS0xLTA_7cd03d09-d6a0-4d0b-8ba4-34d492b4e1f7"
      unitRef="usd">503000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d783195c6564387b12b4f45034f355b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTEwLTEtMS0w_ac0c7865-be1e-4342-bb15-78c3044e9071"
      unitRef="usd">477000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6bb9c02db3dd41d0833c81added214b1_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMxLTEyLTEtMS0w_e552ea11-12fd-4b3c-a1dc-73f07ad9ebe4"
      unitRef="number">0.053</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTItMS0xLTA_1eee3897-a921-4aa0-84bf-6ba5a5cd798e"
      unitRef="usd">789000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4eb263dcded541a8aa2ced910f1cd8ff_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTQtMS0xLTA_74baea5a-3d8d-428a-a298-918bd83e9ed4"
      unitRef="usd">690000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i743245d46ea04dcc90f29475a7c57f31_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTYtMS0xLTA_78ad57ee-b9f6-4275-94ad-065011d47a4f"
      unitRef="number">0.142</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTgtMS0xLTA_b52cbec4-94fd-49e1-8827-919ff1c97c7e"
      unitRef="usd">1534000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iec7c2d99cde74ead89e90a32724d105d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTEwLTEtMS0w_29a6659a-e891-440b-9a15-2e7c52c8e154"
      unitRef="usd">1346000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i750f0f6d5b944c429552a944b3d3bb35_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTMyLTEyLTEtMS0w_fe14cb74-209e-4b82-b610-1d1bc1ad3a79"
      unitRef="number">0.139</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic38012b16650436bae36d246ed2a8764_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTItMS0xLTA_ac99dd6e-9fb9-4418-bf2c-6c0d1be8914b"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a09f2ca879f43c2809e324c91ba6156_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTQtMS0xLTA_7d2194cc-8254-41ee-8ed6-698514c2f9da"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic38012b16650436bae36d246ed2a8764_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTYtMS0xLTA_d562e38c-9175-4df2-afdf-f7d0d3976aa3"
      unitRef="number">0.261</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTgtMS0xLTA_41fc5b44-0515-4a44-8cbd-8553ae3a705b"
      unitRef="usd">485000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iff5b53cf06a84a3680777d7f2e8be88e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTEwLTEtMS0w_dd0ca9dc-60d6-4206-a90e-dc4d21f8c3b0"
      unitRef="usd">375000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i34d15aaedf104afbbe2f4cff270382da_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM0LTEyLTEtMS0w_b95e5852-d10d-416f-a6f0-ac33d6bb04ed"
      unitRef="number">0.293</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTItMS0xLTA_ac4769ae-e6f3-4a36-8a16-b56401ff096e"
      unitRef="usd">150000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6c5cb1cb5ff547f0ad0d3363e354138b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTQtMS0xLTA_f4ea7702-c329-4426-a004-f7b41aa4a8e9"
      unitRef="usd">146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i97aae7332fad40dbbee266460ff1d5c2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTYtMS0xLTA_c173ba1f-f6d6-406d-b22b-11752caf652e"
      unitRef="number">0.030</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5526426e0d0144459d16606be11f1e99_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTgtMS0xLTA_b3ca9cb5-02fb-42e5-b58c-42b4560833ee"
      unitRef="usd">310000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id23f20da385240978278a18b68c30b9f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTEwLTEtMS0w_7f212a3b-1344-4e8b-a520-c6b2569fdbf3"
      unitRef="usd">279000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5526426e0d0144459d16606be11f1e99_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM1LTEyLTEtMS0w_9709df5f-64f6-42c8-8acc-42f37677af3d"
      unitRef="number">0.112</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTItMS0xLTA_06f38079-8b2d-450c-b46c-0aaa2725da59"
      unitRef="usd">406000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1238641b920249c3aa20b57084128ec7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTQtMS0xLTA_54ad8a0a-4932-44cf-9fc2-975e8c058fc6"
      unitRef="usd">348000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5a6dbc5cc60342c8a5caa5ad29995922_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTYtMS0xLTA_3a8372b6-c16e-4298-b5d1-d623f31af928"
      unitRef="number">0.165</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e7538e0459e41a980f744f172fed239_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTgtMS0xLTA_bff9158c-093a-42ac-b728-39a03d995638"
      unitRef="usd">795000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id6c7f0cce06545a092c974ebc7a8836f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTEwLTEtMS0w_a5cb0d7e-66f5-4340-8c89-80049890c7b3"
      unitRef="usd">654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9e7538e0459e41a980f744f172fed239_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM2LTEyLTEtMS0w_ea66677a-3128-427f-9eaf-e8c8b0ac1a8c"
      unitRef="number">0.216</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTItMS0xLTA_b26d133b-c873-48d5-bf49-b3839f60b4aa"
      unitRef="usd">254000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c44c63fd2b14fbca695bf3112d4cfb9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTQtMS0xLTA_7fdfb915-1603-4fba-8095-59a80300d9cd"
      unitRef="usd">175000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i50fea254059341c38a3b9cab5cdfffb6_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTYtMS0xLTA_cf470858-e491-4e3d-af6d-99dad956da6d"
      unitRef="number">0.445</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28ce799db9f8497d8b627c203c959969_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTgtMS0xLTA_2c41cf17-04fe-483d-8d46-a9caca80dabe"
      unitRef="usd">466000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e364c5e2e934b64bcfa4212283d45f6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTEwLTEtMS0w_750c2a59-2fd3-4747-84b1-8033c021224e"
      unitRef="usd">351000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i28ce799db9f8497d8b627c203c959969_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM4LTEyLTEtMS0w_d0cbb076-6947-4235-9438-33164c5a80dd"
      unitRef="number">0.326</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTItMS0xLTA_deac1c2c-edf2-4796-a7d7-43ac304a9f1f"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c52dd3f3c3f4f1ab9080d8e927c9b9c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTQtMS0xLTA_86a3332d-beed-4ec5-b7c3-b91c6b18ad73"
      unitRef="usd">28000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia34dfdb6ea3242aebdc891580ac29ed8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTYtMS0xLTA_af9ec883-b19d-465b-88b6-98340a7124f1"
      unitRef="number">0.040</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTgtMS0xLTA_8d70cd5b-0fa4-4996-905d-6a3f7f36d93e"
      unitRef="usd">66000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i441081885a084c1b9bcbf9be8a783fbe_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTEwLTEtMS0w_673cecc2-bf5c-4c0f-9e36-182009b8dd82"
      unitRef="usd">50000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7ffb0701d90049dbbad29317cf5b8591_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTM5LTEyLTEtMS0w_01522ac8-36c0-4d0a-9fe6-e16cea1bd701"
      unitRef="number">0.336</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTItMS0xLTA_efc19f92-eee7-49d5-a82f-c4454dcdd0ab"
      unitRef="usd">282000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia2ddd2fe68ae4f6da08c10e586b72d62_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTQtMS0xLTA_2e605d58-d7b9-487c-ba35-bc47043e0dfa"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6a1a63c86aec4528b77a42c0cc294abc_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTYtMS0xLTA_bf843a95-80ed-48ee-94b5-7535165e3699"
      unitRef="number">0.390</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTgtMS0xLTA_9f88d830-84e6-40f8-bfea-e8c14efba9b5"
      unitRef="usd">532000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9630c7bf786b44439a2c196398e924f8_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTEwLTEtMS0w_d7d4b475-6fb9-4553-8858-a04f9f1ec284"
      unitRef="usd">401000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6b40761948364f62beb7d4848a0a70d6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQwLTEyLTEtMS0w_bc252f32-a60e-4d78-989c-0ed8ac85da78"
      unitRef="number">0.327</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTItMS0xLTA_9a68677c-5011-4931-970c-38bb335b73f3"
      unitRef="usd">37000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if804e1fb547a4207ab79bbd55dca0584_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTQtMS0xLTA_20c604a9-cb03-427b-ab33-79c006faf05f"
      unitRef="usd">61000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i37c6b77ce2064168959cbb3ea6475815_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTYtMS0xLTA_9069e39b-180d-441d-8ff1-971b28aceffe"
      unitRef="number">-0.402</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTgtMS0xLTA_bbcb52f8-fee6-499b-b8f4-3072a9b9286b"
      unitRef="usd">81000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i19f9e20c45134d49a3c68d672c6cf4bd_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTEwLTEtMS0w_4b2cfe47-e897-4965-88ac-03d8d2373884"
      unitRef="usd">143000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i03239282b74e4621bade57c1a09e88f0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQyLTEyLTEtMS0w_ae25648a-d0a5-4c20-889b-8f5d2958fe49"
      unitRef="number">-0.435</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTItMS0xLTA_2685b39d-38d8-4a8c-82c5-9129149ded4d"
      unitRef="usd">64000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i085ffcbbe09e4f149e82ba292414fe2f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTQtMS0xLTA_bac74822-b9fe-48af-852a-0e6c10c8e228"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibe07110bdf92488cbd5b2bdf7ddbe4d2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTYtMS0xLTA_ed254dd8-c40f-4659-a231-e9352c422cea"
      unitRef="number">-0.176</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTgtMS0xLTA_23717c57-3693-4ed4-a3f3-87737ad56efd"
      unitRef="usd">126000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8e06e959426468692abf98048c488a3_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTEwLTEtMS0w_5b264727-5e00-40a9-b9f1-181c1227320f"
      unitRef="usd">149000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibb375a3cfc904ebe9cba2f22ceea43ff_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQzLTEyLTEtMS0w_827cfc29-9472-4c6c-b4d4-57832d9b4d25"
      unitRef="number">-0.151</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTItMS0xLTA_b74273b4-3408-4769-b475-4029d82e6e85"
      unitRef="usd">101000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1c0080e67a0463ebeb744e69d1860e6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTQtMS0xLTA_117d14f5-4349-4241-aa5f-9ac2913618b9"
      unitRef="usd">140000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i48a40efcdf814f0998f707ba64bb5182_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTYtMS0xLTA_0f3aa413-fae2-4096-a921-2d506daa6308"
      unitRef="number">-0.275</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTgtMS0xLTA_ab5b2dc7-021d-4580-bd83-df829351989c"
      unitRef="usd">207000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icfad13b3e4b641f8823b1565bcc50f9a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTEwLTEtMS0w_d08d3474-b45b-4c95-bd90-0029d42107c6"
      unitRef="usd">292000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i260017b5e6754778ab61b0b94730f26d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ0LTEyLTEtMS0w_ea690605-131e-449c-9e6c-e1a6c88146e9"
      unitRef="number">-0.290</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTItMS0xLTA_2a0a1597-530d-46a9-a0ad-db966c496b4e"
      unitRef="usd">837000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia7ace7a83ca7421399ad7ad9788512de_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTQtMS0xLTA_e00794b9-cda0-4bc6-a49b-baa8a3fa6ba9"
      unitRef="usd">902000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i83c975d0be634a8d8c1b416113bbf12e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTYtMS0xLTA_fb7dcbb6-9a25-43b1-9153-1072c57a368b"
      unitRef="number">-0.072</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTgtMS0xLTA_1be4a5fc-6cd5-4840-a5a8-bfeb9897fb4a"
      unitRef="usd">1643000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i02d9fc89b2fc448dbed4a48c9e578ce9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTEwLTEtMS0w_d2d330a8-b7b7-4a72-9083-3551d0bb248e"
      unitRef="usd">1849000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4cc3c2230cb240ee9e9000ead9118f96_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ3LTEyLTEtMS0w_f520ed22-1dd5-4959-b412-c8636cbdf05d"
      unitRef="number">-0.111</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTItMS0xLTA_ae7140d1-6048-4419-9897-5e2168b9ebbf"
      unitRef="usd">347000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib543ea66309246278232bc6dc99b91d7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTQtMS0xLTA_377db932-40ba-445f-a707-99ded7e62dce"
      unitRef="usd">373000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7d7cb5abb35d47f8b4d58ccbf440bfb0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTYtMS0xLTA_2cd28be8-4a6a-4c84-aa57-81b14a98c519"
      unitRef="number">-0.070</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTgtMS0xLTA_8d4c1fb1-19ed-4b3d-b658-968534ccca1b"
      unitRef="usd">701000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i14ddf81148af49f8829e3a2f40ddb0ff_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTEwLTEtMS0w_bbaa4a59-37f4-44e3-8789-68846d248696"
      unitRef="usd">771000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i07397e34c62a4b6c81c1c5bf2914f5f8_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ4LTEyLTEtMS0w_847d8255-227a-47c8-bac8-629b38589885"
      unitRef="number">-0.091</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i491add72dab6458988d768371a5f99f1_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTItMS0xLTA_a6faa747-370b-4773-8241-75243c091aaa"
      unitRef="usd">1184000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ica871b685f374f86882c4067f230ad66_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTQtMS0xLTA_66cd3d13-5ff2-496a-8b93-a19f2bba18a7"
      unitRef="usd">1275000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i491add72dab6458988d768371a5f99f1_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTYtMS0xLTA_95c19365-6b9f-484c-b80e-1d52e77b4477"
      unitRef="number">-0.071</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTgtMS0xLTA_e7eecc25-60a8-4cac-a866-8015ff2ca185"
      unitRef="usd">2344000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6e9e1d0c2fca4315b63e1185226f0e3b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTEwLTEtMS0w_c02b8cdf-3575-4188-95e5-14c581f1e990"
      unitRef="usd">2620000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6a2fd211cbc84a83ba55b27c4445881c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTQ5LTEyLTEtMS0w_1c087563-a1a1-4113-92c0-51f5647ac381"
      unitRef="number">-0.105</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTItMS0xLTA_330b5f1f-de7b-4f4d-9350-d6079b52917b"
      unitRef="usd">559000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73bdd59bf0dd41a4a002312654599a0e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTQtMS0xLTA_d0723d2f-2fe9-4687-bbed-256e05aae2ff"
      unitRef="usd">549000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iddb03f14e11d45199b18929eeb3acf90_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTYtMS0xLTA_553d208a-202c-41e1-87a7-74d9e4f4f17b"
      unitRef="number">0.017</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTgtMS0xLTA_0b3dea01-bace-452c-9cb7-3b15ec6acbac"
      unitRef="usd">1086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3101dfd757f24ebebe5d55676ba0b74f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTEwLTEtMS0w_0809abb4-e9b0-4382-93b3-daeabc12ab0b"
      unitRef="usd">1091000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0899a2e4de5a4d7384aec18580e70be9_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUxLTEyLTEtMS0w_c73959e0-0d3b-4e4f-a0b5-c2d313644a33"
      unitRef="number">-0.005</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc05ce35d84345148bfe86d926005942_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTItMS0xLTA_081182e1-4942-419e-a0df-5d61c33bd8ee"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb65b67f0ca146a5a8fbf3d66409a1da_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTQtMS0xLTA_0f4a7a99-a1c4-4b69-b1c5-99d6e27b3511"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idc05ce35d84345148bfe86d926005942_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTYtMS0xLTA_4dce2e22-7fae-48a2-8a9d-70911d8b3b2a"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i542b4161407e414194fdf6ed4d650599_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTgtMS0xLTA_91bdfa70-6cd1-4a68-84ac-b214a0d89bff"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i936a7dd6706a4a36bbb3d4e462ea1915_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTEwLTEtMS0w_c9619bb0-4329-46a4-9789-dc429bbc3506"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i542b4161407e414194fdf6ed4d650599_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUyLTEyLTEtMS0w_2d3e6e74-65b9-4dda-82d9-24d56d0317f9"
      unitRef="number">0</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5736a09628a74942af5372765e9467a7_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTItMS0xLTA_04874ec3-bb28-4604-9744-34c905b4085c"
      unitRef="usd">559000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04bf0c9bc6b546109f0c5c2b50e598ea_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTQtMS0xLTA_391332ad-cacb-42ae-beba-0d93ea576d6e"
      unitRef="usd">549000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5736a09628a74942af5372765e9467a7_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTYtMS0xLTA_3b351ece-bfdf-4e99-b578-c79a8d5338e1"
      unitRef="number">0.017</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i085118eba10e4519bb61e008118fee7e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTgtMS0xLTA_e078ae21-7c43-49a1-903d-22ccbaa9c804"
      unitRef="usd">1086000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bbccb018ffd4dc493cc91e90e401f8f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTEwLTEtMS0w_1ab15cae-7bd9-4b95-9ec2-538368e568fa"
      unitRef="usd">1091000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i085118eba10e4519bb61e008118fee7e_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTUzLTEyLTEtMS0w_9d909528-62e0-4bbe-906f-df2c893e7f79"
      unitRef="number">-0.005</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTItMS0xLTA_279cdb0c-df2f-41da-9582-21ac7ca457a5"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28e940beeb8e4e158a7e01a90398711b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTQtMS0xLTA_28dbd6b4-f2d1-4725-bbbb-d23c2ca0599f"
      unitRef="usd">132000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib46cf7989f1f4339bdd2e3c4c3aa11b0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTYtMS0xLTA_4c3f4ac3-ccd7-429d-b5cb-7ac8323cce51"
      unitRef="number">-0.008</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTgtMS0xLTA_d05b9460-09f8-4d75-9cc6-cd1cc43ad621"
      unitRef="usd">249000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c51ebb23e644f36a5bc98cb1b21b16b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTEwLTEtMS0w_a0f4d493-e05b-4827-b3ad-fcb445e0308b"
      unitRef="usd">286000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i55b76bf7ed9f4421b5440e04435c35da_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU1LTEyLTEtMS0w_a141313e-9f2f-4fb1-ab50-093bd5479eae"
      unitRef="number">-0.130</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTItMS0xLTA_482a1816-abe2-43a2-9454-12480029aeaf"
      unitRef="usd">47000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5b27e1d2c7f34ca595d359abf82ec68a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTQtMS0xLTA_9409d76a-f29e-480c-ab4c-5a24384fd410"
      unitRef="usd">43000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i563c570542b34aefa534da7eddbf4ace_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTYtMS0xLTA_7ddc1231-2f3c-4b9a-bc32-fb951c0ac58f"
      unitRef="number">0.091</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTgtMS0xLTA_1f42a81b-1d39-43c8-8cb2-b2a539be0cd9"
      unitRef="usd">105000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b5a7d7ae1b647339fd559afaf42d469_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTEwLTEtMS0w_c183688d-fe86-4fb9-8755-b7cd523e3530"
      unitRef="usd">92000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia918684dd6e648c4ac8aa0138e1ebbf0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU2LTEyLTEtMS0w_09acca4a-4998-4d1c-956c-ecb704ae238b"
      unitRef="number">0.141</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTItMS0xLTA_d059d844-de60-4be8-a110-8ba1dadf968b"
      unitRef="usd">179000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc1e91be376b420c80fdf945f74f19be_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTQtMS0xLTA_2f747f51-337f-4aed-912a-d51f74f5f6d1"
      unitRef="usd">177000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if5ea966a50f748afa01e79b353b7e009_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTYtMS0xLTA_1d15df2a-9f17-4ed5-874b-893f7f316949"
      unitRef="number">0.016</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTgtMS0xLTA_42c09d05-7c44-4037-bcd4-67f7a1bef5b4"
      unitRef="usd">354000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibdb38e3ece9f494b80986166616c8796_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTEwLTEtMS0w_760aae87-77f8-4987-bc9e-c8154068b25e"
      unitRef="usd">379000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib87ef726304b42d69bc4ad332fa947e6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU3LTEyLTEtMS0w_1cbd8dbf-28dc-4a0c-b804-a09aa2ae5d07"
      unitRef="number">-0.064</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTItMS0xLTA_f7d458c6-f46f-4bd0-aaf8-9e1abd827e15"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id7d4a3441694425685b68ca60ff37697_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTQtMS0xLTA_a2401477-6d08-4592-83d0-502574095c58"
      unitRef="usd">113000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i23b645bcaa1d4dcb9537bf5144721392_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTYtMS0xLTA_47056090-8a07-4fbb-bed2-7c3e8d0bcbc4"
      unitRef="number">-0.383</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTgtMS0xLTA_98e2f492-470d-4973-96a7-b2e5844d1d2c"
      unitRef="usd">146000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f6e2d7431db44d2a85a24ada1a8977f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTEwLTEtMS0w_6435b4f8-69b2-4d15-be37-048383f68f04"
      unitRef="usd">261000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i694580410aca44ad9c1b5f19f6994518_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTU5LTEyLTEtMS0w_aa625d36-9266-4920-bc73-b3640f572531"
      unitRef="number">-0.441</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ca587806fca4350a5892099573a24ed_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTItMS0xLTA_708ebe56-4ff3-4220-a8f9-88b0e54aa447"
      unitRef="usd">66000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibcfa4ee807d44bb2ab00fe7d9ad30b84_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTQtMS0xLTA_7ea5befd-38a2-459c-8884-7003aa985cdf"
      unitRef="usd">70000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3ca587806fca4350a5892099573a24ed_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTYtMS0xLTA_a961b2f6-183f-47a6-8b14-12d94a911067"
      unitRef="number">-0.050</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0acf6231882c4daf9707983397ea2171_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTgtMS0xLTA_595a4755-cc0c-4b38-98de-c5d908cb7af3"
      unitRef="usd">145000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63596790121d4860a57507cabde319b5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTEwLTEtMS0w_175589a1-96cd-4eaa-b4b4-69f5ce91c7b5"
      unitRef="usd">148000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0acf6231882c4daf9707983397ea2171_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYwLTEyLTEtMS0w_d49d7e2f-f40e-4373-ad99-13cff8ddc604"
      unitRef="number">-0.022</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTItMS0xLTA_e4e69265-b231-4bde-9387-804cf039ae73"
      unitRef="usd">136000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i966890469adf4f7ab39dda3e8b42cce1_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTQtMS0xLTA_e9cd9581-3685-411f-886a-5abaa59eea20"
      unitRef="usd">183000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i05b2442c8107405782306ae9045cd3e9_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTYtMS0xLTA_472fdecd-7173-4d83-9c22-a9f0eb523335"
      unitRef="number">-0.256</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTgtMS0xLTA_70db9865-4eb2-4655-9fc3-8c84e869f2cd"
      unitRef="usd">291000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice899dea89fe4582b37b2c8d67529df2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTEwLTEtMS0w_c5d5ab5c-9655-4500-9083-8d9dc36de748"
      unitRef="usd">409000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie93efd752bc344138cae3f13bcc4edc2_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYxLTEyLTEtMS0w_042c5668-11d7-4e51-a2f5-11a9cadb2e83"
      unitRef="number">-0.289</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTItMS0xLTA_ebe5e38f-93af-4eab-8e22-79f1e60a8dd0"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2c56f0779bcb4802976ff987723bd905_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTQtMS0xLTA_f8e22b66-c7bc-40c7-a05f-8f67ebcf51a1"
      unitRef="usd">107000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibe9ec53573864e25a503963e5d3315e0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTYtMS0xLTA_1355deeb-f32c-439c-a352-0698677dfd61"
      unitRef="number">-0.277</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id9851a937c384f21b0553db930e3ad00_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTgtMS0xLTA_1f21b001-d0df-453a-a8a2-41cf1fc7b690"
      unitRef="usd">163000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3d745559b8748329aee818ee4c2dffc_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTEwLTEtMS0w_7ce96ffb-6e73-4056-99b3-987c52028f57"
      unitRef="usd">211000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id9851a937c384f21b0553db930e3ad00_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTYzLTEyLTEtMS0w_9689a5fd-535d-41b2-9967-a87c970f150c"
      unitRef="number">-0.229</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTItMS0xLTA_571bc019-43aa-4144-9ab0-79fe9c60bd40"
      unitRef="usd">234000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i108362d021024b2bba503dce1ecd646e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTQtMS0xLTA_37cf22c3-b20d-4e0e-b8d8-536c2ee3da62"
      unitRef="usd">260000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9d1693c23dea482d97485b4dda564e66_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTYtMS0xLTA_5485d70e-40db-45b9-90af-f8740c9e9f29"
      unitRef="number">-0.102</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTgtMS0xLTA_f2508bce-4991-453f-951d-a6046bbcdc5d"
      unitRef="usd">451000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibca496862e9c406b80302245e8c996b7_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTEwLTEtMS0w_84147607-a2d6-42d3-98b2-c5c29db183d4"
      unitRef="usd">531000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id4fa6d8ce0d5450c88d5c1783ecbdb6b_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY0LTEyLTEtMS0w_be1570b1-865d-468d-ba87-99dd08087bb3"
      unitRef="number">-0.150</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTItMS0xLTA_7c753a95-a9d3-4085-a77b-76876bfc201a"
      unitRef="usd">312000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic080c2635078489b8837e0c15b529291_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTQtMS0xLTA_f66f67c1-882c-4349-9125-285f37c2670f"
      unitRef="usd">368000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i58f9970305f943b4aba7a6d91cfcb156_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTYtMS0xLTA_f948877c-4aff-4f72-a790-00b47dcf385a"
      unitRef="number">-0.153</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd1737d9336f4ff499db39a6d78dd6af_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTgtMS0xLTA_f7050fed-3ef8-449b-9334-43502cb771c9"
      unitRef="usd">614000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTEwLTEtMS0w_b9b8426a-2746-4c15-8497-52e216645f98"
      unitRef="usd">742000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i20cbff5569f548cf97b4b5791f1533a2_D20181231-20190630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY1LTEyLTEtMS0w_82e87f6b-b8f4-4a9e-a942-57752e9220c3"
      unitRef="number">-0.173</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTItMS0xLTA_84e29bcc-2d5a-412a-b3fb-5f42d7341a26"
      unitRef="usd">6120000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i82e70c787f7849f9b4e7eb17a1217ae8_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTQtMS0xLTA_4b21384a-3c03-4bd7-b4d1-af22e398863c"
      unitRef="usd">5783000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iebe5528f339f4b28988fa920e8966d98_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTYtMS0xLTA_5424a854-7940-4d32-906c-e0d9dc6a8a65"
      unitRef="number">0.058</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3479c20afd6b47628f60faf7361db000_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTgtMS0xLTA_60845c9e-edbe-440d-b9dd-b2ecb59f1ef3"
      unitRef="usd">12181000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7a4fa10b3864a2190a08faa6182e13c_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTEwLTEtMS0w_9478304f-8162-4979-baf4-c918f639470e"
      unitRef="usd">11365000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3479c20afd6b47628f60faf7361db000_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY4LTEyLTEtMS0w_27e89fbb-c7d7-4849-8ec6-3ae50b124bed"
      unitRef="number">0.072</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7e34366acf8642948ee51937ea67737e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTItMS0xLTA_fa2bb7c0-ed67-4891-8ec9-e1fca8119921"
      unitRef="usd">4632000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i644cb9fdf8ce4fc79443500fc969d197_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTQtMS0xLTA_423d7ab5-867a-4779-b484-41a2aeda086a"
      unitRef="usd">4746000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7e34366acf8642948ee51937ea67737e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTYtMS0xLTA_4b6dc956-a73c-4eda-9a87-dfb87c831815"
      unitRef="number">-0.024</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTgtMS0xLTA_7cb67abb-df1a-4a02-9c07-be5d5ff288c2"
      unitRef="usd">9705000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i037ad64a515043b49334f8fb421b33ac_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTEwLTEtMS0w_84249fb6-7bb0-4a5a-9ab7-7acaa6ea4571"
      unitRef="usd">9408000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i91a2e883b7e24e0c97db0a1ee4c80a7c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTY5LTEyLTEtMS0w_982a0b0a-2d2c-4dc7-9700-4661faae6068"
      unitRef="number">0.032</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTItMS0xLTA_2a999314-2455-40aa-a636-6d4a6ffb535c"
      unitRef="usd">10752000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75e4158bcf404921b8195a9cad36a2cb_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTQtMS0xLTA_ec7061b1-b488-4789-b2a6-a20f5db4bacc"
      unitRef="usd">10529000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i38dcbd18640149a7885a01c44fe4b92e_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTYtMS0xLTA_02812fe0-60a7-4443-92c6-295bcf0fc5c7"
      unitRef="number">0.021</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTgtMS0xLTA_889bd469-2034-45cd-a51c-302db4a4b6b9"
      unitRef="usd">21886000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTEwLTEtMS0w_b11892e5-833e-4e3e-b4cf-e98927b42a4b"
      unitRef="usd">20773000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6af774e6ab2d42e2a681c31ca3cc535f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTcwLTEyLTEtMS0w_65ed20c0-8017-41e8-85c6-e3c3c740ec4f"
      unitRef="number">0.054</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTItMS0xLTA_a6c1ee29-7fc3-4ee5-8846-7abba6a9af7d"
      unitRef="usd">255000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2903af0eb1a74b4c8a4dd7ef23591531_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTQtMS0xLTA_52abce03-b7d0-4368-a6bb-354dbaf19384"
      unitRef="usd">366000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8d6b0a071dcb4da5aa7535659f645d01_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTYtMS0xLTA_114749ae-c434-4d8b-8937-828025ee6792"
      unitRef="number">-0.305</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTgtMS0xLTA_dc7a9ae7-200c-4877-aad2-771a632b23fc"
      unitRef="usd">620000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5659f85aa3624cc09864a84ecf854798_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTEwLTEtMS0w_faab24de-80a5-4e61-87d1-19ed18df37f4"
      unitRef="usd">709000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i5c0a9531a18d42589e331a0fdd5c03ed_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgyLTEyLTEtMS0w_a4f77ff2-a864-4b76-a1ef-eb4757caeb49"
      unitRef="number">-0.126</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTItMS0xLTA_31b5aaf8-ab1a-48ba-89b8-c7503b8e9a3a"
      unitRef="usd">335000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idb7726bd5ac44766aeafb59df236adb8_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTQtMS0xLTA_917fd283-9b11-4baf-bf48-a19b67cb4a3c"
      unitRef="usd">385000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i16367f76b853496fa1c997244fa7f7d1_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTYtMS0xLTA_9bc16f94-beb9-49fd-913b-d3f607ba0526"
      unitRef="number">-0.128</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTgtMS0xLTA_1a7ea303-2861-47ad-8126-f46c93f1a0f3"
      unitRef="usd">697000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id719681b56d64604ab0267e1d3cfce80_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTEwLTEtMS0w_e147d807-cae2-494c-9741-c07c2b0da9cd"
      unitRef="usd">774000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id91be1ecb0134eaa9f8df63ba4666682_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTgzLTEyLTEtMS0w_fb9535f9-ab14-4c7f-b485-1841c1ff6696"
      unitRef="number">-0.099</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTItMS0xLTA_a3022289-82dd-4cdb-9ea6-8ca551e58ff4"
      unitRef="usd">590000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i057617a514dc4f72bdebb0e1ebe06b7e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTQtMS0xLTA_e0574d6b-bfc6-41b0-9c0a-a532cbba0d57"
      unitRef="usd">750000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6d928d16aac54fbc8aa09a390324db12_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTYtMS0xLTA_0f00e60f-a275-4f0a-8b6c-00ba914900ed"
      unitRef="number">-0.215</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTgtMS0xLTA_c2195f0d-2002-451d-9c57-0065f4d78b0c"
      unitRef="usd">1317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic49dce02d6a342668ab35662fd1521e5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTEwLTEtMS0w_280ca02f-cf02-4dd9-ae44-526eff4500ce"
      unitRef="usd">1482000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9d9cf02433534a46b021068b7deb5ad6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg0LTEyLTEtMS0w_e015694b-a596-46e2-a0b2-c4217752eb94"
      unitRef="number">-0.112</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i72eaf829d51c441fad147448cea308e8_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTItMS0xLTA_5fd99c03-e55a-49cc-ab5c-c4e74e8fec67"
      unitRef="usd">869000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4aeb6f629da84fa689517fc2cf39b39a_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTQtMS0xLTA_969f1c6a-4f27-49a6-bb83-fb3811da01a9"
      unitRef="usd">1331000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i72eaf829d51c441fad147448cea308e8_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTYtMS0xLTA_0422f091-a894-49ad-9d27-5391b68da095"
      unitRef="number">-0.347</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTgtMS0xLTA_ab98b3cb-eb3d-4fd1-aae8-0cb7263a61f5"
      unitRef="usd">2119000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic34477da8fc847db9dbe086333871ef5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTEwLTEtMS0w_f2408ae2-fa23-47e7-8724-4b6b88587b8e"
      unitRef="usd">2649000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibbb2a5a2408e418aafee24598af57901_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg2LTEyLTEtMS0w_d960f6ac-fa6d-4dd5-8c14-923b5ce0b6d8"
      unitRef="number">-0.200</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTItMS0xLTA_4cd8468f-7811-491a-8ba3-f42299d78cb8"
      unitRef="usd">583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6225fbf007674bad9bb72edeec2ab93f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTQtMS0xLTA_97ce73cf-aac8-4c00-8735-45c4f04ee0db"
      unitRef="usd">894000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if72dba17ea6c4d5a9ed66dde61530d02_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTYtMS0xLTA_c65314e5-2b85-43db-9379-e46d24a40d83"
      unitRef="number">-0.348</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTgtMS0xLTA_a00e732e-b109-431e-aa58-d789233fe3a6"
      unitRef="usd">1371000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic62ccd20ee5b4d56a9e8161ca4b98d84_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTEwLTEtMS0w_ecfef559-2c1a-49a1-b279-12af6ad04170"
      unitRef="usd">1779000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ifd69e147535f4976b230bf11a9e9246a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg3LTEyLTEtMS0w_1c1b6110-37b8-4638-aa5c-a24de4c1d8b1"
      unitRef="number">-0.229</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTItMS0xLTA_e723406f-bf0f-44a4-9cc2-010967a8be7f"
      unitRef="usd">1451000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6dcea95239d4c7c93cfb6aa0ad58cd2_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTQtMS0xLTA_0f972458-cec7-419a-892a-69a4c556f9ab"
      unitRef="usd">2224000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icc684b1dc4254636b10af000ecc8b22a_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTYtMS0xLTA_dbe27f14-d412-4d72-84c6-80ef9da36025"
      unitRef="number">-0.347</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTgtMS0xLTA_af712e70-30df-4851-9e5f-18814f08c866"
      unitRef="usd">3489000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24408e76c0c24f55ba8d7876c31ed2af_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTEwLTEtMS0w_e14b42db-54e5-45a0-9583-9b6ae59b83d9"
      unitRef="usd">4428000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie644e17c95e747c0b6b7646c9c693fd2_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTg4LTEyLTEtMS0w_a8568188-8c2b-4cc1-8f64-686c5240beb7"
      unitRef="number">-0.212</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTItMS0xLTA_107775fd-33ae-42d6-a5cb-368d0a67fe66"
      unitRef="usd">137000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i951c881d588b402e80e0a08fabfcbb9d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTQtMS0xLTA_1e6c3832-fb00-4c98-8c41-6326951775e6"
      unitRef="usd">216000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i04516ef7baf44962908431f8097b6bc4_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTYtMS0xLTA_1322a695-8dd0-49a5-ae12-140b64677e1e"
      unitRef="number">-0.365</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTgtMS0xLTA_e77c6095-88e5-4295-a9c2-5f1afaa70470"
      unitRef="usd">343000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i41d577053e5b47e599467e7d5b2c1fc9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTEwLTEtMS0w_5ccb6ce0-ca54-42e2-bf22-c6e716fd5e0a"
      unitRef="usd">429000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib2272645a0bf45af860ccab8a526f27d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkwLTEyLTEtMS0w_084632b9-2af9-4dc5-a110-35a0eaa3d62d"
      unitRef="number">-0.201</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if46b85908413428cb65b67ada12835e7_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTItMS0xLTA_686efdb5-94a3-409e-a73a-e976453ef036"
      unitRef="usd">88000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7d5d439ca53f48c7a5b9f80ea92d18b2_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTQtMS0xLTA_b0304298-e26e-413d-9a32-909d81b9855b"
      unitRef="usd">147000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if46b85908413428cb65b67ada12835e7_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTYtMS0xLTA_e99d64cc-d2f2-459f-9002-09b93d441600"
      unitRef="number">-0.398</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTgtMS0xLTA_e0bc6f2a-cf7a-47cc-a58f-f7b2ef31130d"
      unitRef="usd">220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if34599cdf8c34ab2a763c193d7f21c5e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTEwLTEtMS0w_630606a6-cec6-481b-8db6-5ca3d1e06612"
      unitRef="usd">295000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i63aadf09d76f4022ac50cd53b7e2103d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkxLTEyLTEtMS0w_530841c4-43d3-414a-b56b-02422627cd20"
      unitRef="number">-0.254</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTItMS0xLTA_c3476cc9-0958-4315-a385-c09c548efd25"
      unitRef="usd">226000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i719c9077824048efa89c19d85df1c039_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTQtMS0xLTA_719160c3-3487-40e9-b8e9-d7cf16832204"
      unitRef="usd">364000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia177aca434fa4e00a391852ce7428a00_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTYtMS0xLTA_3e4c48f8-800c-4a1d-8793-fcbf6589734a"
      unitRef="number">-0.378</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTgtMS0xLTA_cbfaa74b-699b-4abe-9e2b-557eb1dcdb69"
      unitRef="usd">563000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie25872f3bae6482a86f7173fcb928c60_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTEwLTEtMS0w_146ee278-1c51-4c77-8dc7-9a009b4985d2"
      unitRef="usd">725000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i8e5606029dce40f4adaa4d1a0b2b63d1_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTkyLTEyLTEtMS0w_80c6433a-41e5-4adf-ab1b-62c276e4e52b"
      unitRef="number">-0.223</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTItMS0xLTA_be326a9a-0f3b-4e21-a425-f0ae9bc23a1b"
      unitRef="usd">108000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfadb20ee8cf4b7ca29892f0e7ef9241_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTQtMS0xLTA_19192b98-a6ff-4331-816e-9941bad35dc6"
      unitRef="usd">218000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i279a03bcd02b420eaf5adc4a8349b2d9_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTYtMS0xLTA_0aa2176c-52f7-4829-8d83-1261e66179fe"
      unitRef="number">-0.505</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTgtMS0xLTA_7c018e56-c2df-48d3-ba2b-3cd61a15b956"
      unitRef="usd">322000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28753b33f19b4472a4b3b9615d39bde2_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTEwLTEtMS0w_94407ecd-c2d2-4375-adbf-da165ae6c52f"
      unitRef="usd">441000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0c4c0d222766415ba91be469bcdb8b28_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk0LTEyLTEtMS0w_e5ac3ef6-84b7-4901-8949-b847fd22ef78"
      unitRef="number">-0.271</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i04834a7933574b9699e4470cca157b17_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTItMS0xLTA_b052e720-4cc5-4b83-b4e9-0f08d7dfb90a"
      unitRef="usd">66000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i830efc8e5ef64f5d8bb67629c932302f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTQtMS0xLTA_0e134ee0-3250-4d4f-bef8-a106fc8165cd"
      unitRef="usd">153000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i04834a7933574b9699e4470cca157b17_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTYtMS0xLTA_892b8188-3b95-47d2-bf6c-e7b1603fdf03"
      unitRef="number">-0.568</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e8660da0ae049279be4908d645ac814_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTgtMS0xLTA_39d72267-097f-4a95-9dfc-e31d6147a956"
      unitRef="usd">196000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61951583e0884a2b97857fcfd5143dfa_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTEwLTEtMS0w_9e0f3966-93f7-420d-8f33-6378b9548925"
      unitRef="usd">299000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4e8660da0ae049279be4908d645ac814_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk1LTEyLTEtMS0w_484b52c0-fc1f-4580-a10f-3a01436c1891"
      unitRef="number">-0.346</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTItMS0xLTA_a28fdc75-090f-4dc6-8c6f-17d19005cd9e"
      unitRef="usd">174000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea8c758499ee481a982e0844029f02c5_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTQtMS0xLTA_eeb0a614-67a4-47c3-8e14-59d82ef2501c"
      unitRef="usd">372000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibba821e5cfd6422ea6ccc9bbc524d038_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTYtMS0xLTA_242355ef-5cd7-4da5-b266-45f4b104f731"
      unitRef="number">-0.531</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTgtMS0xLTA_cd95641d-ee95-4ec7-9447-668a2a3c07be"
      unitRef="usd">517000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9530070346e046928aaa20fbdb32b6be_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTEwLTEtMS0w_13df6bbd-08e5-4292-911e-e460419561e2"
      unitRef="usd">741000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib3bcfc3c402a4817bfdab1c5364b679b_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk2LTEyLTEtMS0w_4e23bbe8-a8d4-4e88-916a-bd1726b683b3"
      unitRef="number">-0.301</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTItMS0xLTA_7c8019e3-c629-42df-93b5-0944fe489b12"
      unitRef="usd">354000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8c7f38204ba8470dbe88c6fbd6f163af_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTQtMS0xLTA_a4ef6209-19ce-42b2-8d20-c71c5e4e6733"
      unitRef="usd">407000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9d784ec2bc3647b3848e4ddcccb993ec_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTYtMS0xLTA_d67040ad-b494-4c28-be31-759e4613849a"
      unitRef="number">-0.129</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i43027bbce9224ae1864acee61096aaac_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTgtMS0xLTA_8ceff53e-2d32-4e64-9a9f-ef1ff8bdd45b"
      unitRef="usd">761000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7cfae47101947fbb19de601ee4d37cf_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTEwLTEtMS0w_93e475ca-662e-42cf-9b15-b0dc2ea47417"
      unitRef="usd">824000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i43027bbce9224ae1864acee61096aaac_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk4LTEyLTEtMS0w_25d3c71a-fc14-4f73-9961-d71f8abda8e2"
      unitRef="number">-0.076</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTItMS0xLTA_a19344b6-fb5f-4899-b5a7-cf61db6a8840"
      unitRef="usd">198000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i21d4e243e3244926af114c5ac8d5622b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTQtMS0xLTA_2a0ede73-d7fd-4c06-b319-eee5218460f0"
      unitRef="usd">265000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i4c41fef297fa4ba8ade251d8f91d3259_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTYtMS0xLTA_abe21fcf-ea7d-46b6-b976-378a2be03ff3"
      unitRef="number">-0.252</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTgtMS0xLTA_ba142d6b-10d9-4373-8b2b-c0edd160a232"
      unitRef="usd">445000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27f66ef65403479684878c39826affd8_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTEwLTEtMS0w_80390f2c-d832-4bb6-ac16-afbd69238aff"
      unitRef="usd">533000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icd855885341d47a0b45fe383f5290b8d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMTk5LTEyLTEtMS0w_7c5be2bc-1fc9-4f1c-b323-8dd5908ca234"
      unitRef="number">-0.165</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTItMS0xLTA_7fb0c10e-623a-40a8-8618-559260f9443e"
      unitRef="usd">553000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79a301cc9e4741a9acf742a4531b7ffa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTQtMS0xLTA_28f04afb-8e47-416e-882f-db715d2be252"
      unitRef="usd">672000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i00358fcd09f342c0af3eba4e8577cdc4_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTYtMS0xLTA_89a8b8d3-a697-43b6-a5fd-fb2d96c2d6a4"
      unitRef="number">-0.178</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTgtMS0xLTA_aeec3318-23c0-4286-b06b-eb71456b4bc7"
      unitRef="usd">1207000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3df852a1e1c9437cbefc5d5967937bd0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTEwLTEtMS0w_92d3bff2-faa1-4168-846d-1b817b7c387f"
      unitRef="usd">1357000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if9c820c667f9445aaccb95bd055a4b07_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAwLTEyLTEtMS0w_ea92e4ad-21b9-4ec5-9866-5d20a9419762"
      unitRef="number">-0.111</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09753ee22db9438db02316fe99eab602_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTItMS0xLTA_2d4e7482-9ce8-4034-9ca1-5914d0861570"
      unitRef="usd">270000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ab103ca2b6347f4bec8d5f5a68b902f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTQtMS0xLTA_c85f8348-c853-4d1e-b870-caf33190790e"
      unitRef="usd">490000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i09753ee22db9438db02316fe99eab602_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTYtMS0xLTA_a8414929-95b2-4bc2-ade2-70baee6f3788"
      unitRef="number">-0.450</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6131de48add44569afcbb5f13e616222_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTgtMS0xLTA_6fc7c326-566e-41cc-ba89-bae0240a0e83"
      unitRef="usd">693000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1077c0d6182e42b8b4a449d5823797da_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTEwLTEtMS0w_c50d972c-647e-49b8-83f4-c65d8946efa6"
      unitRef="usd">955000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6131de48add44569afcbb5f13e616222_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAyLTEyLTEtMS0w_0e6b0471-be7f-48b0-844e-dfe80a101cb4"
      unitRef="number">-0.274</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTItMS0xLTA_895fd9e5-a5f4-4895-8eb9-86240d43786f"
      unitRef="usd">230000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61609c5ddc9d401f8c0a92c743695f8b_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTQtMS0xLTA_7ec36a3c-0c56-4faa-981e-d84d1ee815d4"
      unitRef="usd">328000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i370776df86134ee684a4612ee7a2cfab_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTYtMS0xLTA_c9dd2ad8-2ce0-450f-b168-2ca41b0d3773"
      unitRef="number">-0.299</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTgtMS0xLTA_48612822-032b-4b6e-80f6-e23d9d6a04d4"
      unitRef="usd">510000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29508d3dfad845269de0d3b934e5f72f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTEwLTEtMS0w_7aaeb717-1f58-4317-8657-e2cc5f1d2e86"
      unitRef="usd">651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i94192c1b5aa34f1a8a44719b6a759231_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjAzLTEyLTEtMS0w_6ad8cf3c-90ec-4dff-9c20-0acc1e75243d"
      unitRef="number">-0.217</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTItMS0xLTA_b5e18e71-235f-4ddd-ae7a-30934ae6d276"
      unitRef="usd">499000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i49489eb3476942d39146a7944e024129_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTQtMS0xLTA_23c7013f-aeb0-4c7e-82d3-6c88f3d4e3f3"
      unitRef="usd">818000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id8f340c0ad0d465a9a705568fa552a3c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTYtMS0xLTA_5096af3e-4dd1-454c-a0d2-55fa22318604"
      unitRef="number">-0.390</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTgtMS0xLTA_26183b48-a40f-45a5-919b-ee09441d8d09"
      unitRef="usd">1202000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac621d3e8974b4290777cb0a715967d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTEwLTEtMS0w_c2384733-8585-4c8d-9307-17b0db16e737"
      unitRef="usd">1606000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6163129a38be49b68e051c945b1cd71a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA0LTEyLTEtMS0w_694d786f-f94c-4713-8538-9c4a3bbaba04"
      unitRef="number">-0.251</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTItMS0xLTA_56a074ea-0248-4391-864d-6a64d29d51ed"
      unitRef="usd">490000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i352af7e1cff64172939fb8676a18d694_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTQtMS0xLTA_af215ceb-8e3e-4e41-87a6-f172b5c6f34c"
      unitRef="usd">926000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i947ad6f0a47247c587f41e3df2327f4f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTYtMS0xLTA_cf795686-2cdb-42f4-a790-87a5fbab4396"
      unitRef="number">-0.470</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTgtMS0xLTA_df8c9359-6484-46ce-8eb3-efe5ecd84715"
      unitRef="usd">1334000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id0d1afadaa0d41f1867dafdde83a550a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTEwLTEtMS0w_9c3154ce-47a2-4d22-a704-53b1392a01d6"
      unitRef="usd">1927000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i148d29e0f460450b93f9bb80cbed9d2d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA2LTEyLTEtMS0w_2565b7e7-dded-4b5c-a41a-954d56dc6ce9"
      unitRef="number">-0.308</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTItMS0xLTA_037bb65b-2566-4f76-aeca-a25659d9a9d5"
      unitRef="usd">1060000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic461ce15080e4d46a58069a1bb325e45_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTQtMS0xLTA_764e6c2c-50c1-473f-a237-14e78d76cc9c"
      unitRef="usd">1427000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i377b5ddd4b7247c79f49a09b5083412f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTYtMS0xLTA_0e69ec18-f295-488e-a621-d3becc84b5fd"
      unitRef="number">-0.257</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTgtMS0xLTA_738d4a49-54f4-4755-b40c-4779104b3d15"
      unitRef="usd">2317000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic08ba492d063467dada493b5225e27bf_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTEwLTEtMS0w_4afd9afa-81e9-4147-80d7-78df86339e3c"
      unitRef="usd">2821000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i26d5bd9a4d6046e799eda0d91c3fcda9_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA3LTEyLTEtMS0w_31970a49-8f1a-4984-a262-ae36dbaeeb85"
      unitRef="number">-0.179</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTItMS0xLTA_f3716039-68cb-4b95-8204-843144080333"
      unitRef="usd">1551000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0065caf47fbc4cb98c76aafdc60d0caa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTQtMS0xLTA_0df4e22d-f4ab-48ed-ae99-8b45c66a5e4f"
      unitRef="usd">2353000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i859a1046989f4e1e9076aef974194ebf_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTYtMS0xLTA_99ddf30c-6781-442b-b45a-11b5d979e282"
      unitRef="number">-0.341</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTgtMS0xLTA_e924e714-0aad-4e57-bdc9-abf92b9975dc"
      unitRef="usd">3651000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b7cf7e87b5048de9e83fc41fbba81d5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTEwLTEtMS0w_e542b2f4-795b-4e25-9a9b-0b0802532cf4"
      unitRef="usd">4748000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia81aa9daf1554c0b81490dc1bfa6c36e_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjA4LTEyLTEtMS0w_9fcae315-3570-4aa6-8720-1c060da94b17"
      unitRef="number">-0.231</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTItMS0xLTA_17fe559e-93a7-40be-8937-4c9f1b3af424"
      unitRef="usd">277000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25729810182f492586a816b1ffe57aa7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTQtMS0xLTA_750a0ddc-c648-424b-b617-7ff78c7bdfa5"
      unitRef="usd">396000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ice887a7fe1424069bcb172ec14491bf2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTYtMS0xLTA_eb4a4e2c-b2e4-4e83-ae8a-da9028dfc37b"
      unitRef="number">-0.300</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTgtMS0xLTA_8ae3c75c-3730-4df3-a898-bedcecd9a137"
      unitRef="usd">658000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib93b7593957c4146b7aa8d5210aeb960_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTEwLTEtMS0w_c88abbc7-68e6-465d-9c10-5701004363bb"
      unitRef="usd">800000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i591db6891de849f78e3cefbc8ad7ef0d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEwLTEyLTEtMS0w_7adeaa71-920d-4106-af2f-f7809c2a6041"
      unitRef="number">-0.177</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTItMS0xLTA_a0174741-a3fc-4964-ac16-980d08ed091d"
      unitRef="usd">498000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i901b7c058bc04f02aaadc04d05618104_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTQtMS0xLTA_569af246-77ea-4fd8-a3f5-8ee4b3c76582"
      unitRef="usd">633000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i078fdcbfa964491badb3a3b22e32f99c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTYtMS0xLTA_ff415cd9-80ae-492b-8049-8b113e7aade2"
      unitRef="number">-0.212</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTgtMS0xLTA_7672b9b2-cd4b-4236-845d-7af18d7b77b7"
      unitRef="usd">1065000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib82e302424784eb79d013cbeddc5714a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTEwLTEtMS0w_b1f1aa00-368d-43a8-83f4-c59f93f566b8"
      unitRef="usd">1209000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if2bbcfb567754b3a9e531230e47cbe2c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjExLTEyLTEtMS0w_af6357c9-a891-45f5-9a18-46ec41c467d0"
      unitRef="number">-0.119</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTItMS0xLTA_5329bbdb-c98b-4dcf-a9d5-e45aea47aca1"
      unitRef="usd">775000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i882dff1fdab04b9cbffd9a0b66d09708_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTQtMS0xLTA_8217e05e-01f0-4eab-bf26-803fe80cb226"
      unitRef="usd">1029000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7f571e709cf14bb69fee729a8b5f19f6_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTYtMS0xLTA_5f2de31b-c5b3-4c31-9c94-68904c732240"
      unitRef="number">-0.246</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTgtMS0xLTA_7e2dd662-0455-4254-b3fe-31bec17136c2"
      unitRef="usd">1723000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaba1385624734a44a1f0995eb99a6a2f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTEwLTEtMS0w_43fb4997-3400-4207-8acc-38c9f3957b0d"
      unitRef="usd">2009000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic1657fa856994fa1b500fd37e53a246f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjEyLTEyLTEtMS0w_432c0dae-08ab-4ef1-bd6e-6abc473cd0dc"
      unitRef="number">-0.142</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTItMS0xLTA_9d845e36-d0d6-4772-b4bc-2da90fadec19"
      unitRef="usd">213000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i575b4d6c52db4ddd9a77241756d3bcf7_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTQtMS0xLTA_39ec297a-f7fe-44fc-ac99-76cd1a09a511"
      unitRef="usd">530000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ie7fb94e82966484e92f98870f546a0f6_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTYtMS0xLTA_1adc66c8-1e81-4ca9-8a6f-bc82496b7652"
      unitRef="number">-0.598</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTgtMS0xLTA_5b0c8799-de67-46fa-b0cd-95fbc9b868fa"
      unitRef="usd">676000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia24b2dfc5933488685d4e8679f9858df_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTEwLTEtMS0w_40f49d35-7d0c-4239-b791-70df21968419"
      unitRef="usd">1127000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i0e077085f86c4b7a99441830d46de7cc_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE0LTEyLTEtMS0w_d7263494-d648-4db3-9cd0-a066e51d596d"
      unitRef="number">-0.400</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTItMS0xLTA_817a99cc-eaf1-424f-827f-fa2e20955c43"
      unitRef="usd">562000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic44276e5e39645adac5e0ec3c6d349a8_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTQtMS0xLTA_053ace77-dbbc-41d7-b8d8-08f01b6f9810"
      unitRef="usd">794000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i16082ccf34e84094a92eccab1cdb16f0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTYtMS0xLTA_e0b26228-b4f0-4153-a351-ff9f1bbe5bd1"
      unitRef="number">-0.292</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTgtMS0xLTA_99f04c39-1dcb-4916-81c8-678944e3852e"
      unitRef="usd">1252000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36fbf025a3bd46258314eaf0c5fd03c9_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTEwLTEtMS0w_c2849cf8-e256-485b-90ca-c86f7f5073fc"
      unitRef="usd">1612000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib4c5f0c2072c4c6b886f7400eb5ea23f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE1LTEyLTEtMS0w_fd17a4a6-bcf3-47a6-b617-66d31fd0ca36"
      unitRef="number">-0.224</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i62837ac430c04475937229c201091a7b_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTItMS0xLTA_ff40f326-8d2f-4df1-8410-024374cc13b3"
      unitRef="usd">775000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e94e3d16b6442b3bf8ae4d7e42763aa_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTQtMS0xLTA_bd3b532b-a12e-4380-8629-af3c8fdaea04"
      unitRef="usd">1325000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i62837ac430c04475937229c201091a7b_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTYtMS0xLTA_10f7eade-1e08-40b9-94bc-99934ea2b04a"
      unitRef="number">-0.415</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTgtMS0xLTA_9efaff92-1e7c-4684-a7c9-fe4acc91d465"
      unitRef="usd">1928000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8482a9eacc9d4a16b903c3069e30606c_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTEwLTEtMS0w_744032cc-d13e-46d8-9c4c-478a264fb38b"
      unitRef="usd">2739000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i51c3dfacb74645cdac267e1e2249aaff_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE2LTEyLTEtMS0w_c7590a5a-5cde-408a-9e76-0058fe481f58"
      unitRef="number">-0.296</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic3373b694e464e87b09c196866598a61_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTItMS0xLTA_fe5c7947-fdc9-443d-8d57-3a43c9369fd7"
      unitRef="usd">248000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18aae7095c214291953f8d5a7e83743d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTQtMS0xLTA_a73a1974-6c8f-4d85-ac67-375440a67fd6"
      unitRef="usd">461000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic3373b694e464e87b09c196866598a61_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTYtMS0xLTA_e455be54-9312-4dc4-a9fa-301aeda50bb0"
      unitRef="number">-0.461</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTgtMS0xLTA_ab495a41-f130-4c19-a17c-b11f71c1afe6"
      unitRef="usd">687000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b5abffa1631440c9c106f7646cee59f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTEwLTEtMS0w_cb642896-437e-43a6-a3ef-46469f9450e5"
      unitRef="usd">907000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i512182672aa14bd39a13b0db9d81d0ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE4LTEyLTEtMS0w_0f2ae73e-4ffa-45f7-baa4-85a3906553ad"
      unitRef="number">-0.242</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTItMS0xLTA_54a10ecf-f49e-4852-97ba-ec8f1ec0af22"
      unitRef="usd">447000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1697845443b41b18f2e3fd65e94eff0_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTQtMS0xLTA_85835625-7bdf-4702-be3b-bdc842165939"
      unitRef="usd">701000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib80e37271ecf4f9d8a7d8fbf5f5a7acf_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTYtMS0xLTA_76ca00a9-fcd9-4b5f-bc74-c171e4c7e92d"
      unitRef="number">-0.361</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib608a60c324249358f5c359cb804d50f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTgtMS0xLTA_87c4d459-d71c-4b5b-b0f2-917a4c46d2ba"
      unitRef="usd">1075000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3fd8a707583422a985a694bde7e8369_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTEwLTEtMS0w_9f9d6bdd-0677-4c45-b3b4-e4d45ace2507"
      unitRef="usd">1383000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib608a60c324249358f5c359cb804d50f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjE5LTEyLTEtMS0w_66b912a4-bfaf-439c-9af6-e4221bb3bf0a"
      unitRef="number">-0.223</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia53ba83708ab497da167bdf063b13001_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTItMS0xLTA_848c8416-4d0c-429d-9bd5-3a6112b41e02"
      unitRef="usd">695000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ieeb64f7ebcf24e8eb4738e491a709ef6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTQtMS0xLTA_3b544e6f-79b2-4b22-b2d5-ed2d9b532df9"
      unitRef="usd">1161000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ia53ba83708ab497da167bdf063b13001_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTYtMS0xLTA_03fe8f44-a6fc-4588-8bac-bbb6719dec9d"
      unitRef="number">-0.401</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTgtMS0xLTA_867d0140-f625-4e81-9b3c-445616a73946"
      unitRef="usd">1762000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie3efc34904804bf392531b7e252380d0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTEwLTEtMS0w_f3196c13-c68f-442a-9299-32527835c509"
      unitRef="usd">2290000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1d973c80ca7b4bc2b2fd1fcc55ecc06f_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIwLTEyLTEtMS0w_5b7d267e-204d-4a4d-8f26-060256cf285a"
      unitRef="number">-0.230</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTItMS0xLTA_0ace67b7-3c3e-4eeb-b8ae-f1801f8bfc5a"
      unitRef="usd">203000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2e533e4df7574745be8a32f1d7f8b20d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTQtMS0xLTA_3d302e70-6c25-487f-b9cb-765a51e982ae"
      unitRef="usd">333000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="if89a82d170cc418791d5449b3fa4c283_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTYtMS0xLTA_4b3b5e7c-345a-42c7-96dd-3da41cba1763"
      unitRef="number">-0.390</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTgtMS0xLTA_ecc04a0e-8f7d-4c53-aa05-72da4962da90"
      unitRef="usd">549000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia94c309ebefb41e0882e6e5f7db81fc6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTEwLTEtMS0w_3fff379c-9fb2-48d2-8812-b84717495680"
      unitRef="usd">654000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="icf495c0650ac4b5caf5648a6780ccd5a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIyLTEyLTEtMS0w_82c82a11-e2df-4f36-bd47-931129f0da91"
      unitRef="number">-0.161</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f667109df48490a91c424f760c9163b_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTItMS0xLTA_94f40b00-2902-4a13-a3cd-b3f603de2ed5"
      unitRef="usd">352000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6387e0464e874ecebf490a3e7a9ac5a9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTQtMS0xLTA_7617ffa6-268e-4738-bbec-f6cd407f1769"
      unitRef="usd">509000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i6f667109df48490a91c424f760c9163b_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTYtMS0xLTA_273a756e-7b39-4f0e-ad00-e706b2098167"
      unitRef="number">-0.309</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTgtMS0xLTA_c9d84d6f-9192-41e7-851e-d8328e5e0558"
      unitRef="usd">819000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i510fab0efb5c421e951697a2eaabf3a6_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTEwLTEtMS0w_98c4d2a3-22c8-4087-906c-22f9266e8d1b"
      unitRef="usd">1011000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibafad8f4a0d7443e8dcf91d0e9cef4bd_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjIzLTEyLTEtMS0w_01d554ff-0dd8-4d8d-a2cf-142198151642"
      unitRef="number">-0.190</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTItMS0xLTA_bcb62cac-27b1-4cf1-8229-f8cc0f6e3b37"
      unitRef="usd">554000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6afb3e29007f4d8fbbe84b8aa64fe6c4_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTQtMS0xLTA_f591d68a-516f-4177-a8f9-e2d411fba16c"
      unitRef="usd">842000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib388f72d846e47e49a8d85d3f7460f0d_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTYtMS0xLTA_ad874646-f92d-4224-a893-a73ae80be5e6"
      unitRef="number">-0.341</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTgtMS0xLTA_d34e70c8-fadb-4042-a278-b9807953633c"
      unitRef="usd">1368000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idecf2a3bf83549faaface09de3d21842_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTEwLTEtMS0w_5b696788-62c8-4336-9ee7-8d0b54a6801e"
      unitRef="usd">1666000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i66fd7408e33f45cb80a1add2ee1ceb59_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI0LTEyLTEtMS0w_1fb53583-5a4f-4dd5-bf31-284c11e3823d"
      unitRef="number">-0.179</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTItMS0xLTA_8ebe3292-8174-4619-86fd-911951112527"
      unitRef="usd">45000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i513396c914d24f2ca5d1a3b179dbb137_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTQtMS0xLTA_8f513a17-778f-4446-a576-78bb33d11398"
      unitRef="usd">128000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="id3a234a09c774a82b137da6f6bf652bd_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTYtMS0xLTA_cec1402e-b041-44d3-b032-4ab1fd8d630a"
      unitRef="number">-0.646</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTgtMS0xLTA_94d5d930-ab1d-445e-87de-6e62b77afbf0"
      unitRef="usd">138000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia88b31446b9949bb9dc52ab066f472a5_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTEwLTEtMS0w_55142131-537b-45f8-ad58-9edb5c60e73f"
      unitRef="usd">253000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ib012b35bb6f44bb1b5d47710b8608d5d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI2LTEyLTEtMS0w_ff55a3a7-6d2d-46ae-a964-92e98ec8cee0"
      unitRef="number">-0.453</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTItMS0xLTA_1da22676-8db7-46ed-8676-9085e897de57"
      unitRef="usd">96000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i95245826bf28466f88669de5c0eb29f9_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTQtMS0xLTA_b950a840-52fd-44bb-91eb-95fb7e8ccedb"
      unitRef="usd">191000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3ab3c94025314e18be8bfa8c10fe49a7_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTYtMS0xLTA_1bb12cef-4873-4cef-be2c-9e964fc3e773"
      unitRef="number">-0.499</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTgtMS0xLTA_f1096d34-c35a-4b08-8212-6caac09034f1"
      unitRef="usd">256000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie0e846d3dd6246fdad7038aa4f8fc310_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTEwLTEtMS0w_bd26ad9a-795d-478e-b165-324b657be7c6"
      unitRef="usd">371000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1bb3625750f44c6e9321074e6541285c_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI3LTEyLTEtMS0w_8af28693-a9cf-44a3-9317-9b118cae071b"
      unitRef="number">-0.310</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTItMS0xLTA_16ae42a2-9852-4724-b41d-ab416c834c06"
      unitRef="usd">141000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea770061f1af4a23be59231dccaa6471_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTQtMS0xLTA_63cd4366-8064-402a-aa43-e33076a4f352"
      unitRef="usd">319000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i2cea0616240e49a1a3b579114b64732f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTYtMS0xLTA_b9d10541-c6fb-4183-865b-7809cdafa3e6"
      unitRef="number">-0.558</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTgtMS0xLTA_cc987b0b-2422-41c7-a0c9-ab148f12c302"
      unitRef="usd">394000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7544a09dc2e443659a4749d9c524a033_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTEwLTEtMS0w_1c1bde21-6f7f-4161-82f8-e1be56996ed3"
      unitRef="usd">624000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i12387d1e2dbb4a0b9e66794d1bcf4bb0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjI4LTEyLTEtMS0w_e2ad4828-303d-4fc3-a3f6-cb9d681d125b"
      unitRef="number">-0.368</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTItMS0xLTA_8eff7868-cb75-4527-84bd-a96dc44a4c35"
      unitRef="usd">1862000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i09d9e4292b9d49439e0ce7ef85bcd358_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTQtMS0xLTA_92757c83-8830-4376-afce-db5b516793c4"
      unitRef="usd">3083000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ibd3b956b9b5b4b46a25109d18ed37305_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTYtMS0xLTA_76fd4eca-43fe-46a5-93d3-7c9087f3f56e"
      unitRef="number">-0.396</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTgtMS0xLTA_5193e9e7-c2a9-4a43-a945-6881654f93c1"
      unitRef="usd">4760000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id50251d99ca0478da493763fd6c20e76_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTEwLTEtMS0w_fa98ab1f-4863-4c99-a3c9-0ba8446aa7b3"
      unitRef="usd">6192000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idf81954fe23f4430a26dfd9835b41bb6_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMxLTEyLTEtMS0w_1d13159e-1ade-4555-843e-777dc05374d2"
      unitRef="number">-0.231</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iea17e937da204406896ee031cfe58c20_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTItMS0xLTA_0c80a076-0e32-4a5a-86c2-6169104c3c58"
      unitRef="usd">2426000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1ce6b5f2cf0439c9d34f1a1e0c2ef86_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTQtMS0xLTA_346c146e-e9cf-4858-bab8-5cc69460ba64"
      unitRef="usd">3406000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="iea17e937da204406896ee031cfe58c20_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTYtMS0xLTA_706f0b24-67f7-42cc-bc09-9f66faef6eb5"
      unitRef="number">-0.288</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTgtMS0xLTA_77897a2a-7617-4f94-9a9c-1914dd5aeba9"
      unitRef="usd">5460000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5a7a9909054c412bb8414b6ad4b834fa_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTEwLTEtMS0w_59f115cd-0066-49b9-80ce-dfb25f64511e"
      unitRef="usd">6756000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9ccd3d4fe29f4557b03fdaeaa9cc9a0a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMyLTEyLTEtMS0w_54c17e95-85a8-4b47-bf51-58d3b999c568"
      unitRef="number">-0.192</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTItMS0xLTA_65faf059-a8e2-43b1-9a5c-75cc6c6b72dd"
      unitRef="usd">4288000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTQtMS0xLTA_2ee533f0-b785-4f8c-84dc-976a800b2c80"
      unitRef="usd">6489000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTYtMS0xLTA_ea5ff982-9b76-4af3-907a-aef6a28335d4"
      unitRef="number">-0.339</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTgtMS0xLTA_d77d6a68-002f-475d-a326-d2c48da22b95"
      unitRef="usd">10220000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTEwLTEtMS0w_b419b5ab-1041-4ee3-89d5-70b5c30720ba"
      unitRef="usd">12948000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjMzLTEyLTEtMS0w_520d7924-c4b9-461d-8d3d-b221125b866f"
      unitRef="number">-0.211</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTItMS0xLTA_add4046b-bfee-471f-a8c8-a10b1b417cd5"
      unitRef="usd">9539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTQtMS0xLTA_537dd930-9b87-4ec3-a4c4-3077581138f8"
      unitRef="usd">10403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTYtMS0xLTA_69078547-c8de-427e-899b-0d76f1a4bd1d"
      unitRef="number">-0.083</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTgtMS0xLTA_20c6da60-e622-42bc-a32e-ef29d3083d31"
      unitRef="usd">20238000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed367815e324fed984862b7805db09b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTEwLTEtMS0w_e47074cc-b7ac-4742-95d7-a6600549fff2"
      unitRef="usd">20532000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM2LTEyLTEtMS0w_2c33c1c8-11a1-428a-ae06-3b1572f3a48a"
      unitRef="number">-0.014</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTItMS0xLTA_e7a6a242-1cde-4c1f-b764-c0f95dc31485"
      unitRef="usd">8797000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i780815182e5340ee9005439edb189dbd_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTQtMS0xLTA_588d43af-16ae-4b35-9a2e-0ba7dca5cf71"
      unitRef="usd">10159000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="idc43230ec8164a09af1a04bab7c5e8d2_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTYtMS0xLTA_e2717a44-8729-49b6-9dbc-e08ee1f6b7c0"
      unitRef="number">-0.134</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTgtMS0xLTA_f52e907d-8179-420c-84b6-d4f07affad4f"
      unitRef="usd">18789000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i40697a314e334705bf032c396d36a48f_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTEwLTEtMS0w_c0211e9e-6622-46f1-9aac-81187b0278b2"
      unitRef="usd">20051000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="ic97118c2da164950abfae6ae9e23529d_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM3LTEyLTEtMS0w_1f9fa158-2c7b-4168-bbbe-b37feec8d897"
      unitRef="number">-0.063</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTItMS0xLTA_5f649529-5d1b-4872-b0f3-a3cc2c30ed2f"
      unitRef="usd">18336000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTQtMS0xLTA_422cc6dd-1838-4b8d-becf-5f3624dd00ef"
      unitRef="usd">20562000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTYtMS0xLTA_0d09e930-df00-4434-b31e-93d260bd7c97"
      unitRef="number">-0.108</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTgtMS0xLTA_1c1d32f5-08d7-4289-8813-2bf098ee97dc"
      unitRef="usd">39027000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTEwLTEtMS0w_0924cfe3-8b7c-48ed-8c4b-528235721e9e"
      unitRef="usd">40583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesBySegmentOfBusiness
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjA3ZmNiNTAzMGUyYzQyMWE4ZWUzMWM5ZjEzMTE3YTk1L3RhYmxlcmFuZ2U6MDdmY2I1MDMwZTJjNDIxYThlZTMxYzlmMTMxMTdhOTVfMjM4LTEyLTEtMS0w_eeeb8106-dfa0-4b72-bdeb-a16e66629d9a"
      unitRef="number">-0.038</jnj:PercentageChangeInSalesBySegmentOfBusiness>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTA0MQ_d3b36199-6b03-490e-9c00-1a178bc62e4e">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:35.209%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.465%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.319%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.575%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.465%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.319%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.526%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:6.292%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Consumer Health &lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(92.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(30.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Pharmaceutical&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;22.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;6,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Medical Devices&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(3)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(354)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:18pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(64.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Segment earnings before provision for taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,192&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Less: Expense not allocated to segments&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt; (4)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;231&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;378&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Worldwide income before tax&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;11,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;*Percentage greater than 100% or not meaningful&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal six months of 2019. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal second quarters of 2020 and 2019, primarily talc related costs, respectively. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, primarily talc related costs, respectively. Includes amortization expense of $0.1 billion in both the fiscal second quarters of 2020 and 2019, respectively and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal six months of 2019. Includes litigation expense of $0.4 billion in the fiscal six months of 2019. Includes an unrealized gain on securities of $0.5 billion and $0.2&#160;billion in the fiscal second quarter of 2020 and 2019, respectively. Includes an unrealized gain on securities of $0.2&#160;billion and $0.3&#160;billion in the fiscal six months of 2020 and 2019, respectively. Additionally, the fiscal six months of 2019 includes a research and development expense of $0.3 billion for an upfront payment related to argenx. Includes amortization expense of $0.8 billion in both the fiscal second quarters of 2020 and 2019. Includes amortization expense of $1.6&#160;billion in both the fiscal six months of 2020 and 2019. In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement.  Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Includes a contingent consideration reversal of $1.0 billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal second quarter and six months of 2019. Includes litigation expense of $0.2 billion and $0.3&#160;billion in the fiscal second quarter and fiscal six months of 2019, respectively. Includes a restructuring related charge of $0.1 billion and &lt;/span&gt;&lt;/div&gt;amortization expense of $0.2 billion in both the fiscal second quarters of 2020 and 2019.  Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.5&#160;billion in both the fiscal six months of 2020 and 2019. (4) Amounts not allocated to segments include interest income/expense and general corporate income/expense.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:OperatingIncomeLoss
      contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0yLTEtMS0w_f4197afc-51d5-42aa-a83b-2c0580867359"
      unitRef="usd">32000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi00LTEtMS0w_e77d8ea1-f61d-4f15-a3e7-68406b9aeada"
      unitRef="usd">406000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi02LTEtMS0w_a61dc82d-0ccf-4221-b18a-9ab7145b24fa"
      unitRef="number">-0.921</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi04LTEtMS0w_013c8301-a405-4fdd-98f8-f041082d1238"
      unitRef="usd">802000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0xMC0xLTEtMA_489413d1-3475-4cfa-b9e0-134c65156c8b"
      unitRef="usd">1147000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMi0xMi0xLTEtMA_02ea5dbe-2260-4d02-8c04-f4fa2f2cfddc"
      unitRef="number">-0.301</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0yLTEtMS0w_f48fb577-a9f0-4b35-898d-b4fac85b0b6e"
      unitRef="usd">4514000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy00LTEtMS0w_d724b9af-a015-44e9-9d92-1dff76fcd81e"
      unitRef="usd">3677000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy02LTEtMS0w_a2c2fe6f-adf7-40c6-b63c-b7c1c3579fdc"
      unitRef="number">0.228</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy04LTEtMS0w_bc122246-e422-4821-b8bc-38fc2a8e6aab"
      unitRef="usd">8348000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0xMC0xLTEtMA_a34e1db9-655d-4fae-ac55-6aace597e113"
      unitRef="usd">6008000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfMy0xMi0xLTEtMA_01d8370e-e2f0-4aaf-a5c7-68def287c4ea"
      unitRef="number">0.389</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i215768a346504c6588118220125ee9e5_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0yLTEtMS0w_74e0d6e0-dc25-4da5-a606-144a5dc01241"
      unitRef="usd">-354000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8da67f7730324520a82f178539e2d723_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC00LTEtMS0w_8a2fabaf-32ae-4d9a-99e3-cd274bcd5331"
      unitRef="usd">3189000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC04LTEtMS0w_6968d2aa-086c-40f4-b58f-5235381958e2"
      unitRef="usd">1671000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0xMC0xLTEtMA_61de4926-343d-4102-ae43-643a71cf939e"
      unitRef="usd">4686000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNC0xMi0xLTEtMA_395ac4e1-f95c-4af9-9416-d1f6fb5670d9"
      unitRef="number">-0.643</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0yLTEtMS0w_55c5efd6-de2d-4107-8c37-ef329615b3c5"
      unitRef="usd">4192000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie05e097465d246e985c5a8a5836866ac_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS00LTEtMS0w_4a29e0ee-8623-483b-8987-448abb394c22"
      unitRef="usd">7272000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="iaab0a1f9c5e74d1a8462947f5425c48f_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS02LTEtMS0w_8af04fb1-04d0-4d8b-98ce-3a827e2885c7"
      unitRef="number">-0.424</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS04LTEtMS0w_20de41dc-a947-4f35-9fa7-134d352e19ba"
      unitRef="usd">10821000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2cdc971d10a846eda0291042d8911094_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0xMC0xLTEtMA_e815650d-2b5e-45d0-add7-fe845b9b2778"
      unitRef="usd">11841000000</us-gaap:OperatingIncomeLoss>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i3fcb9509d611443789a8ce13dc161559_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNS0xMi0xLTEtMA_79939f8c-dda1-474f-b8b1-63fe3481c97b"
      unitRef="number">-0.086</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i828cd0392f6a4f08b23a126fbc2fc210_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi0yLTEtMS0w_7da88ca5-4dfe-4dfd-8a51-0b986abfc96d"
      unitRef="usd">252000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i879c922e7e06439cbd2406e34a34569f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi00LTEtMS0w_3531c8c2-f92e-424f-88a4-776078c596f6"
      unitRef="usd">231000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieffb22b1734946ea874bf7ff0d96c59b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi04LTEtMS0w_4fe0006c-dcc2-4507-845d-02c34d5138e4"
      unitRef="usd">372000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie38753485d6e4aa68503c096a70d147e_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNi0xMC0xLTEtMA_da0e7128-f254-4bce-b3b1-c11bce221bb2"
      unitRef="usd">378000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0yLTEtMS0w_16f05155-98b6-407c-8615-d8375d2d0626"
      unitRef="usd">3940000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy00LTEtMS0w_8e7174fa-cc12-44af-9862-50167a309a60"
      unitRef="usd">7041000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy02LTEtMS0w_d2435414-7e39-4599-a713-a899d8b64575"
      unitRef="number">-0.440</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy04LTEtMS0w_6bc2dd8c-794b-4d87-9e06-4149dd30bde6"
      unitRef="usd">10449000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0xMC0xLTEtMA_17a09ceb-831f-441e-be19-63ad49f5b740"
      unitRef="usd">11463000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <jnj:PercentageChangeInOperatingIncomeLoss
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjM5NWI2NjdhMzlkMjRlNDhiNjE2OTJkNWU5NzA4NWNhL3RhYmxlcmFuZ2U6Mzk1YjY2N2EzOWQyNGU0OGI2MTY5MmQ1ZTk3MDg1Y2FfNy0xMi0xLTEtMA_6e26b575-f529-42c8-854f-114ceeaa5e3d"
      unitRef="number">-0.088</jnj:PercentageChangeInOperatingIncomeLoss>
    <us-gaap:GainLossOnSaleOfEquityInvestments
      contextRef="i7ed428655a844057a0ad1aee8a48ddd6_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjEy_bb1ce62b-54ae-4e5a-a4a1-cf50f95eb7ff"
      unitRef="usd">300000000</us-gaap:GainLossOnSaleOfEquityInvestments>
    <us-gaap:LitigationSettlementExpense
      contextRef="ie10ee4ad8b8d4183b5d44ae81d9bfaa7_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDk3Mg_052a064a-0974-469b-bf09-41880d759bbc"
      unitRef="usd">600000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i038116ad19de45ebaa5935cddd492baa_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2Mzk1Nw_9fecd883-beb3-44d5-a287-3223e5b67579"
      unitRef="usd">200000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i914d5a3cdfa64ab8835b74b041c64d36_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2Mzk0Mw_a0d412c5-7be5-464a-991a-1e21c87c84ba"
      unitRef="usd">600000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i4bc1f1c42208428589d5048b1f9282ae_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAyOA_21652022-1961-43c5-8022-5100a08c7051"
      unitRef="usd">200000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:AdjustmentForAmortization
      contextRef="ia545a5bf4e984af2a8f3760dc3aa78f6_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMzg2_1e608bd2-57b1-4c20-8e72-5a8f8933381a"
      unitRef="usd">100000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i478d12a26a8b4c0aae766fd482798872_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMzg2_99e175aa-b81f-43fd-8ff8-6465fdcb9a0f"
      unitRef="usd">100000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i70d228f6bf5048b5b96b0dc82df039fc_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjc0ODc3OTA3NTA1MQ_3d70b43b-7b27-4d59-b95b-e949b160f785"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i165d0be7d7fe45d6ab970e86c306a184_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjc0ODc3OTA3NTA1MQ_7225104c-9d81-4c9c-87fb-600f31b034ab"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ResearchAndDevelopmentInProcess
      contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNTIy_235bc119-e54c-410a-8c05-f674065a0163"
      unitRef="usd">900000000</us-gaap:ResearchAndDevelopmentInProcess>
    <us-gaap:LitigationSettlementExpense
      contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNjI3_e6ae52a7-ad65-4501-8026-a14739e52b0c"
      unitRef="usd">400000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzM1_6554d9a4-0806-4080-9982-447530fdc5b6"
      unitRef="usd">500000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIxOA_8b7192e3-3f7e-4b5f-aec3-adc980f22b72"
      unitRef="usd">200000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI1OTkxMw_35bed3d1-5d33-467e-ad51-d884681d2275"
      unitRef="usd">200000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:UnrealizedGainLossOnSecurities
      contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI1OTkyNw_05399770-2628-4eb4-b3e0-c020f535a92a"
      unitRef="usd">300000000</us-gaap:UnrealizedGainLossOnSecurities>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6ab4dbfb907744079a8a7b75b5d75830_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfOTQ4_106c3a36-edab-47cc-9977-5f29887bba0d"
      unitRef="usd">300000000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AdjustmentForAmortization
      contextRef="i21aecfd8061b4238a1947055ea570d17_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTAyNg_4edc1ebb-8e2c-4bbd-a915-b5e533c8d8ea"
      unitRef="usd">800000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i0f62fe7cf6604123a8ad8c935d1c9b1e_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTAyNg_50c94078-d123-46e0-8554-d3087319e1d4"
      unitRef="usd">800000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i58e82ae5f77a4c3cb68b4e3103fb67c9_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIzMg_dc55dc8f-d853-4c54-88a0-5a4bcf3975b7"
      unitRef="usd">1600000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i87a1f8fd68134107b7cd0efab80b2b36_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMjE5OTAyMzI2MDIzMg_ea2a5787-2117-4a69-8623-f4b0b97fcee6"
      unitRef="usd">1600000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i7fd16a3299794c08b00e5e9af4b2f47b_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTEzNA_77363621-fea9-4e55-9215-6a266b034f48"
      unitRef="usd">-1000000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i023711733c384a55bc10c339faee9020_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk3MA_34bdcf7c-0e9c-4da0-a217-1957b0196d93"
      unitRef="usd">2000000000.0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i73f3e8b536cc4bd08b9add79f3cd22a3_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk3MA_87377626-6e06-4caf-a87a-22f20c5cbbce"
      unitRef="usd">2000000000.0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:LitigationSettlementExpense
      contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTMwOA_3d063666-dd46-4406-b40d-5f33d47bf8bb"
      unitRef="usd">200000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:LitigationSettlementExpense
      contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk4NQ_e7dcf54b-6154-41f1-a98d-80c35bffa6d1"
      unitRef="usd">300000000</us-gaap:LitigationSettlementExpense>
    <us-gaap:RestructuringCharges
      contextRef="i9b3e87e43b554055a825006b919ddb8e_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTM5MQ_86080261-d252-450e-aa53-259fd29a1667"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ic14113fe9bfc4f6d83351f4c65826a74_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTM5MQ_b1a3800d-a9fb-4eb0-b178-4646b58beb68"
      unitRef="usd">100000000</us-gaap:RestructuringCharges>
    <us-gaap:AdjustmentForAmortization
      contextRef="i8da67f7730324520a82f178539e2d723_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTQyMg_6b6baede-2479-40b7-b9b3-241e03e771cd"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i215768a346504c6588118220125ee9e5_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTQyMg_c365d577-e6d5-4f31-8d0e-73b94aa747df"
      unitRef="usd">200000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:RestructuringCharges
      contextRef="i08b3d0abde3f45e6b42bb15ab4604732_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk5OQ_1ec129eb-e386-4ed8-b94e-e108750f6cb4"
      unitRef="usd">200000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i44000fa4f1874e2cace44e764757fd8d_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4ODk5OQ_8424eeb4-2c9b-4de2-b916-de7278037480"
      unitRef="usd">200000000</us-gaap:RestructuringCharges>
    <us-gaap:AdjustmentForAmortization
      contextRef="i22bab0d3ab3f4a9cb40919789ead1d98_D20181231-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAxMw_3e4ad599-94aa-4f3f-9a8f-eeda4bf78954"
      unitRef="usd">500000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="i5d1ef020426c4336ac2b51aec1c3a62a_D20191230-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfNzE0NjgyNTU4OTAxMw_7472c23c-810a-4e7c-8421-ad7364697b43"
      unitRef="usd">500000000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RleHRyZWdpb246ZjNhMjE2ZDllOWUyNDYwYThmYmYzOWYyNWM5NmZiYzFfMTYyMw_6fc8fe9d-24b8-47ab-89f6-5c0eca79832c">&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;SALES BY GEOGRAPHIC AREA&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:31.138%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.094%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.510%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.343%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:9.094%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.821%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:8.510%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:0.529%;"/&gt;&lt;td style="width:0.1%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:7.353%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Second Quarter Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Fiscal Six Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent&lt;br/&gt;Change&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 28, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;June 30, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Percent Change&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;10,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;4,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(14.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;9,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(4.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Western Hemisphere, excluding U.S.&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;1,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;2,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asia-Pacific, Africa&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,601&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;3,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;7,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(6.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;18,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;20,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;39,027&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;40,583&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0yLTEtMS0w_50ea0f4d-bc1f-4ae2-bb13-e78a57f2ab6c"
      unitRef="usd">9539000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d6538c084484afdb541d4fc5fe67d6f_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi00LTEtMS0w_2f96254a-b2c9-4c45-8292-455a44a73582"
      unitRef="usd">10403000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i9736c59b7e3a4f0db63372b3557c5313_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi02LTEtMS0w_8422f8f9-f3b8-44b1-8f3b-3d5a952140cc"
      unitRef="number">-0.083</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi04LTEtMS0w_01c82948-f376-4f3e-827a-b1b797e46070"
      unitRef="usd">20238000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ed367815e324fed984862b7805db09b_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0xMC0xLTEtMA_c5431aed-971b-413d-8423-5a4d44b41367"
      unitRef="usd">20532000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i3d1ccc4a643b4308a5357aa7bd60641a_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMi0xMi0xLTEtMA_6672f30f-361d-48ae-9e1d-69487d352340"
      unitRef="number">-0.014</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0yLTEtMS0w_bba49baf-86ef-49f3-87a3-1455ab775a99"
      unitRef="usd">4063000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i990d3f55fb0d400fa30369f379908e85_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy00LTEtMS0w_d0849c06-c668-4019-ac0d-d0665456eb76"
      unitRef="usd">4733000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i63ecc9ac575b4a51b0bcb3c43e1301e3_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy02LTEtMS0w_b1b43ad1-28c7-4e93-bd04-09ef96068fc5"
      unitRef="number">-0.142</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy04LTEtMS0w_059371b7-419c-4053-8fb2-090dcbff29eb"
      unitRef="usd">8890000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i875ab7cb24b5434fbef2a5fda9f740c0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0xMC0xLTEtMA_4b564ba0-613f-4cbe-9c49-643f804ea826"
      unitRef="usd">9342000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i894143a8b7ec4a2a85d814c8e465e253_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfMy0xMi0xLTEtMA_a38d6de5-e53a-44d6-98fc-4c77c4575e69"
      unitRef="number">-0.048</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0yLTEtMS0w_f083b72c-5eab-49be-a12e-bdc18b031ae6"
      unitRef="usd">1133000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f61c670043f4e00a54053474ec36a0d_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC00LTEtMS0w_abf0516a-ba55-4b29-9838-5c07ca97b8f9"
      unitRef="usd">1455000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="iac74a95971d74353be6f1bd5868dc878_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC02LTEtMS0w_81211108-5a22-4713-b71b-a3206f511b53"
      unitRef="number">-0.221</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC04LTEtMS0w_88d5f44a-c9cf-4053-ba8f-fc4e70b80935"
      unitRef="usd">2635000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0c910149219540038cfaa2070ca96ba0_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0xMC0xLTEtMA_b31561a0-f951-4f58-a899-857d3884582b"
      unitRef="usd">2958000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i2d5e79aa2bdf420c98d424f30ec107f3_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNC0xMi0xLTEtMA_fc79b86d-c588-4001-909f-3e74727db149"
      unitRef="number">-0.109</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0yLTEtMS0w_b56fc922-f030-40ff-bc60-07ed2c5c788d"
      unitRef="usd">3601000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2bebf8e1f4804892976ccad051fdb00c_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS00LTEtMS0w_ed096303-7395-430e-85bf-8c3e20520949"
      unitRef="usd">3971000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="ief5e8f9039764ad5981eea4cfdde91a0_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS02LTEtMS0w_041a672f-3144-4063-a247-4c1fcbd5141f"
      unitRef="number">-0.093</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS04LTEtMS0w_c345d50b-a3e3-4753-a6c4-b8aff549f180"
      unitRef="usd">7264000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie452efdf003f4151a326a25ffbb9fc7a_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0xMC0xLTEtMA_64e2fdfd-7a6c-4910-b17c-293db9ba144d"
      unitRef="usd">7751000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="ifd870a3769c34240879fb75bc7524bd0_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNS0xMi0xLTEtMA_bfe042fb-dcfd-4117-b597-917eeb35a300"
      unitRef="number">-0.063</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0yLTEtMS0w_ee38a593-a21f-40d8-ad91-dde6b3b552a1"
      unitRef="usd">18336000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9e3c1b26c3cb4f528c42617194d2d912_D20190401-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi00LTEtMS0w_975562b8-643d-478f-9fcc-85f386e21250"
      unitRef="usd">20562000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i7a4c912478424448aac93f72bcf0275c_D20200330-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi02LTEtMS0w_bd874cee-dfbb-47aa-9a66-e9b79b41fb8f"
      unitRef="number">-0.108</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi04LTEtMS0w_873f9877-f15a-4c4c-ae46-c347c69023b4"
      unitRef="usd">39027000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf0a0e380cd74195a76fa4c172084591_D20181231-20190630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0xMC0xLTEtMA_2c274155-cda9-4e03-915b-24645a04dcd1"
      unitRef="usd">40583000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <jnj:PercentageChangeInSalesByGeographicArea
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV84NS9mcmFnOmYzYTIxNmQ5ZTllMjQ2MGE4ZmJmMzlmMjVjOTZmYmMxL3RhYmxlOjVkYzIwM2FjMmVjODQzYTlhOTE2MzU5YzM2YzA0MzRjL3RhYmxlcmFuZ2U6NWRjMjAzYWMyZWM4NDNhOWE5MTYzNTljMzZjMDQzNGNfNi0xMi0xLTEtMA_e64e5a94-6306-4481-b1c5-1fa3e73f40a3"
      unitRef="number">-0.038</jnj:PercentageChangeInSalesByGeographicArea>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNTEyMA_05c7e72e-c55c-4d21-8d30-ad2809160c54">BUSINESS COMBINATIONS AND DIVESTITURES&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Subsequent to the quarter, on July 9, 2020, the Company sold 11.8&#160;million shares of Idorsia LTD (&#x201c;Idorsia&#x201d;), or its 8.3% ownership in the company, via an accelerated bookbuild offering. The transaction resulted in gross proceeds of approximately CHF337&#160;million ($357&#160;million) based on a sales price of CHF 28.55/share. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;The Company currently has rights to at least an additional 38.7&#160;million shares (or approximately 20% of Idorsia equity) through a convertible loan with a principal amount of CHF 445&#160;million (due June 2027). Idorsia also has access to an approximate CHF 243&#160;million credit facility with the Company. As of June 28, 2020, Idorsia has not made any draw-downs under the credit facility.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $0.8 billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;amp;D, for $0.8 billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;amp;D, for $0.4 billion, goodwill for $0.2 billion, other assets of $0.2 billion and liabilities assumed of $0.3 billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $0.4 billion. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $2.8&#160;billion, consisting of $2.7&#160;billion of cash proceeds and $0.1&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $2.0&#160;billion.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $3.4 billion, net of cash acquired. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;amp;D, for $3.0 billion, goodwill for $2.0 billion, marketable securities of $0.2 billion and liabilities assumed of $1.8 billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  There were no valuation adjustments to the assets acquired but during the fiscal first quarter of 2020, the Company recorded Other income of approximately $1.0 billion for the reversal of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#x2019;s current timelines. As of June 28, 2020, the fair value of the remaining contingent consideration is $0.2 billion. Further, the Company re-assessed the current value of the Auris IPR&amp;amp;D assets in connection with the modified development timeline and determined the fair value still exceeds the carrying value. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#xa5;230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $1.5 billion, goodwill for $1.2 billion and liabilities assumed of $0.4 billion. The adjustments made since the date of acquisition were $0.1 billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of 15.3 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#x2019;s leading manufacturing services providers for health care products and technology products.&#160;The Company is &lt;/span&gt;&lt;/div&gt;expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of June 28, 2020, the assets held for sale on the Consolidated Balance Sheet were $0.1 billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE0Ng_c33b2e11-d1f2-48f6-a194-4bc3ba41140c"
      unitRef="shares">11800000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE2MA_f3e37081-1693-4ad9-b0f3-a91cc5f74cdc"
      unitRef="number">0.083</us-gaap:SaleOfStockPercentageOfOwnershipBeforeTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfOTg5NTYwNDY2NzY3OA_0ff7f8ad-4edd-4b83-ba41-4f9f623ef627"
      unitRef="chf">337000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedPerTransaction
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE2Nw_13522cdf-d204-4fc8-b48c-23bfade03f94"
      unitRef="usd">357000000</us-gaap:SaleOfStockConsiderationReceivedPerTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i74a6f02cd81248429802bd3d52fdefc7_I20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE4MQ_5fb72151-b58f-4a08-927a-44fbfc45aa01"
      unitRef="chfPerShare">28.55</us-gaap:SaleOfStockPricePerShare>
    <jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODIyMw_dbd47e55-a992-4921-82da-9038a72223bf"
      unitRef="shares">38700000</jnj:EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="ib96886311fb8454f8f7669fc957ab4f0_D20200709-20200709"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE4OQ_7e64f7ce-95ec-4187-9466-03f663e45844"
      unitRef="number">0.20</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:LongTermDebt
      contextRef="iee3cf065b9ca46aa995976b921a5e5a4_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODE5Ng_43930150-2d1d-49b0-9039-0b2b03ffed6f"
      unitRef="chf">445000000</us-gaap:LongTermDebt>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i41d885ad0df54f67810fa0ea503cd065_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODIwOQ_d8281438-e32f-4a3b-911c-b8372031f48a"
      unitRef="chf">243000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iccccb20c51044c9e9a84c5d3198c51c6_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzEx_81b95061-00d3-4a68-8aa4-f6dde20aff3d"
      unitRef="usd">800000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i89f3aa8637734074bb148409f97b74c1_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDMy_e56b2080-73fe-4a99-afeb-e115e822387d"
      unitRef="usd">800000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTA5OA_e3ccbbee-23dd-4c7c-b4aa-31b2f07fad6a"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTExNQ_3841a369-ed4e-4d30-b94e-96996f6abe62"
      unitRef="usd">200000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
      contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTEzNQ_dc8977d7-abdd-42c6-8559-68ddabf63b97"
      unitRef="usd">200000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTE2NQ_f892aec2-a69d-4be3-998e-eb22614f31ae"
      unitRef="usd">300000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:EquityMethodInvestmentsFairValueDisclosure
      contextRef="i28266dc38c2e4216a3176ed95b4bbe08_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTI2MQ_f64ac2b6-1f49-452d-a526-48ebae0d4ef1"
      unitRef="usd">400000000</us-gaap:EquityMethodInvestmentsFairValueDisclosure>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI1MQ_c769e1d5-48f5-4966-bee8-bdcd1f7d5f8d"
      unitRef="usd">2800000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationCash
      contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI2Nw_5fc3deb0-fb91-4075-a973-cb79fb6cf3d2"
      unitRef="usd">2700000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationCash>
    <jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained
      contextRef="idcfe6f3194e6443e94a045dad55717d2_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI4MQ_741075ec-83be-4c1f-aee3-44b9bcd424cb"
      unitRef="usd">100000000</jnj:DisposalGroupIncludingDiscontinuedOperationReceivablesRetained>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i1e9061e1ace447648d5d732bae5eb9b7_D20190401-20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNzE0NjgyNTU5ODI5NQ_36f061e0-539d-4f4c-b917-39a0118aee81"
      unitRef="usd">2000000000.0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ieafab643bde441f198c64b00b5b1e847_D20190401-20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTM2Mw_bc05e401-b012-40b5-a505-e01f689bc39b"
      unitRef="usd">3400000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTQyOQ_3e0d3acf-3684-4db2-a0ea-657bb6fc1c05"
      unitRef="usd">2350000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTk2MQ_491856df-6341-47f4-b9c0-98ff3ec00c2d"
      unitRef="usd">3000000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMTk3OA_b6e34338-0524-4272-aa85-22e5380c94fb"
      unitRef="usd">2000000000.0</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities
      contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjAwNw_ebe60bcd-90ae-4db6-b1f6-2a5d7533de08"
      unitRef="usd">200000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="icb4d963c67ed4e88b28ef91289469a21_I20190401"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjAzNw_69d2d2d0-fc7a-4faa-a825-efdea04a6d13"
      unitRef="usd">1800000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic55b39bf44b4426e804766d6f7f475c9_D20200330-20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjM1OQ_f5d04ab0-0b2c-420c-8a97-93c5f5aee589"
      unitRef="usd">-1000000000.0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1ff46a56cf074bac822b7e06872012bb_I20200628"
      decimals="-7"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMjY0Mg_20591bba-f455-4c86-9096-e4c0c17f1c7a"
      unitRef="usd">200000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzA4Mg_327c173d-5dc0-4b2d-ac68-44f11d1a1e8f"
      unitRef="jpy">230000000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i674b851e8dc64c7a806261c900c4ca68_D20190117-20190117"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzExNw_37a739e9-14fb-4cd7-9ae6-5376785b5891"
      unitRef="usd">2100000000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ForeignCurrencyExchangeRateTranslation1
      contextRef="i2b0c726c6f4642738819e5d706d7e4e6_I20190116"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzE0OA_3972ae75-4e4c-42d6-a2cc-285850ea1920"
      unitRef="number">109.06</us-gaap:ForeignCurrencyExchangeRateTranslation1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if77e2506aa334aaab104d21008cc97f9_D20190401-20190630"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzM1Mg_fc7862ba-6598-49c4-968a-af6170074c2e"
      unitRef="usd">300000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
      contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc1MQ_30b98a5e-6ea5-496f-830e-5950347352e5"
      unitRef="usd">1500000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill>
    <us-gaap:Goodwill
      contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc2OA_40cae521-bba3-48f7-9bd9-ac6112e8878d"
      unitRef="usd">1200000000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities
      contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzc5OA_da7effcc-e18c-41ec-8b23-8c5cfcfdbbf0"
      unitRef="usd">400000000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities>
    <jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill
      contextRef="i2a906710e47b4f588671a4492a187fc0_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfMzg1OQ_04e66b5e-3e61-4cf6-9441-044c8bef72dd"
      unitRef="usd">100000000</jnj:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ic033ba1a92f34808934f4676de7a195b_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDEyMQ_11ad73bb-a342-4e9e-b1fa-091ccd5baedc">P15Y3M18D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent
      contextRef="i8bd12eebc1fe4027b0210d330a2835b4_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85MS9mcmFnOjkzYzA3N2E5ZDRkOTQ0ZmU4MDU4NGVhY2Q2Mjc1YzI4L3RleHRyZWdpb246OTNjMDc3YTlkNGQ5NDRmZTgwNTg0ZWFjZDYyNzVjMjhfNDk0MA_55e9541e-c079-4858-8ca1-51f6f657efa4"
      unitRef="usd">100000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationInventoryCurrent>
    <us-gaap:LegalMattersAndContingenciesTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfOTA0ODk_a9bacb67-807a-4233-b5ff-80d4145c3148">LEGAL PROCEEDINGS&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation develops.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of June&#160;28, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;PRODUCT LIABILITY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The most significant of these cases include: the DePuy ASR&#x2122; XL Acetabular System and DePuy ASR&#x2122; Hip Resurfacing System; the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System; pelvic meshes; RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; body powders containing talc, primarily JOHNSONS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Baby Powder; INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; and ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Flexible Composite Mesh. As of June&#160;28, 2020, in the United States there were approximately 800 plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#x2122; XL Acetabular System and DePuy ASR&#x2122; Hip Resurfacing System; 8,600 with respect to the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System; 15,600 with respect to pelvic meshes; 10,600 with respect to RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; 21,000 with respect to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;; 20,600 with respect to body powders containing talc; 300 with respect to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;;&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and 3,700 with respect to ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Flexible Composite Mesh.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XL Acetabular System and DePuy ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp;amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#xe9;bec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of the Company's appeal to broaden the scope of participants. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Hip-related product liability litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp;amp; Johnson (collectively, DePuy) relating to the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Acetabular Cup System and the related settlement program.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp;amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants.  With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;s. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp;amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Along with ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; lawsuits, there were a number of filings related to the PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Mesh and PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Ventral Patch products.  In March 2019, the New Jersey Supreme Court entered an order consolidating all &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Ventral Patch cases as an MCL in Atlantic County Superior Court.  Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.  The Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Flexible Composite Mesh, PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Mesh and PROCEED&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Ventral Patch products. In September 2019, plaintiffs&#x2019; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#x2122; Polypropylene Hernia System cases.  The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have been transferred to an MCL in Atlantic County Superior Court.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson arising out of the use of RISPERDAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $8 billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $6.8 million by the trial judge. The Company will appeal the final judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury arising out of the use of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp;amp; Johnson (J&amp;amp;J); and JPI&#x2019;s collaboration partner for XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;amp;J announced an agreement in principle to the settle the XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; related product liability litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Personal injury claims alleging that talc causes cancer have been made against Johnson &amp;amp; Johnson Consumer Inc. and Johnson &amp;amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#x2019; attempt to limit the scope of testimony of certain of the Company&#x2019;s witnesses.  With this ruling made, the court has now ordered case-specific discovery to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $4.7&#160;billion, reducing the overall award to $2.1&#160;billion. The Company believes that it has strong grounds to seek further review and/or appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#x2019;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual primarily for defense costs, and reserves for potential settlement of currently pending mesothelioma cases, in connection with product liability litigation associated with body powders containing talc.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2019, the Company&#x2019;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).&#160; The Imerys Bankruptcy relates to Imerys&#x2019; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).&#160; In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.&#160; Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.&#160; The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.&#160;&#160;The Company previously proposed to resolve Imerys' (and the Company&#x2019;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;of all Talc Claims involving the Company's products, waiving the Company&#x2019;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#x2019; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction. The Bankruptcy Court will hold a hearing to consider approval of the Disclosure Statement on August 26, 2020 and the Company is disputing any indemnification objections and the scope of coverage in the reorganization plan. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and is in the process of responding to the complaint&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In February 2018, a securities class action lawsuit was filed against Johnson &amp;amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp;amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Baby Powder, and that purchasers of Johnson &amp;amp; Johnson&#x2019;s shares suffered losses as a result.  Plaintiffs are seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp;amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument.  The Court has not yet ruled in the books and records action.  In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp;amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Baby Powder, and that Johnson &amp;amp; Johnson has suffered damages as a result of those alleged breaches.  In February 2020, the four cases were consolidated into a single action under the caption &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;In re Johnson &amp;amp; Johnson Talc Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, and the shareholders have until August 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2020, a report was delivered to the Company&#x2019;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Board unanimously adopted the recommendations of the independent counsel&#x2019;s report.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp;amp; Johnson Savings Plan against Johnson &amp;amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp;amp; Johnson stock as a Johnson &amp;amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#x2019; motion but granted leave to amend.  On June 15, 2020, Plaintiffs filed an amended complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#x2019;s Consumer Legal Remedies Act relating to JOHNSON&#x2019;S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp;amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents in response. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Claims for personal injury have been made against a number of Johnson &amp;amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson, arising out of the use of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;INTELLECTUAL PROPERTY&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Certain subsidiaries of Johnson &amp;amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#x2019;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Medical Devices&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson &amp;amp; Johnson in the United States District Court for the Southern District of New York alleging that Cordis&#x2019;s sales of the CYPHER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; and CYPHER SELECT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#x2122;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Although Johnson &amp;amp; Johnson has since sold Cordis, it has retained liability for this case. After the trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases.  In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol&#x2019;s motion for a new trial. In March 2019, the district court denied Medinol&#x2019;s motion for a new trial. Medinol appealed, and in June 2020, the United States Court of Appeals for the Federal Circuit affirmed the district court&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#x2019;426); 8,273,132 (&#x2019;132); 8,721,730 (&#x2019;730)   and 9,492,280 (&#x2019;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;TM&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Contact feature of the ATTUNE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#x2019;132, &#x2019;730 and &#x2019;280 patents, based on the district court&#x2019;s claim construction and reserving its right to appeal that construction, leaving only the &#x2019;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#x2019;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the &#x2019;735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the &#x2019;284 patent), are either invalid or not infringed by Ethicon&#x2019;s ENSEAL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#x2019;735 patent, the &#x2019;284 patent and United States Patent Nos. 8,323,310 (the &#x2019;310 patent); 9,084,608; 9,241,759 (the &#x2019;759 patent) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#x2019;s favor.  In July 2020, Covidien filed a notice of appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#x2019;s RELIEVA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Spin and RELIEVEA SpinPlus&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; products infringe U.S. Patent No. 9,011,412 (the &#x2019;412 patent).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#x2019;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, MONOCRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures, STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Antibacterial Sutures and STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; MONOCRYL&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Plus Antibacterial Sutures infringe plaintiffs&#x2019; United States Patent Nos. 6,596,296 (the &#x2019;296 patent) and 7,033,603 (the &#x2019;603 patent) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UT is seeking damages and an injunction.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking Inter Partes Review (IPR) of both asserted patents. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2020,the USPTO denied institution of the &#x2019;296 patent IPR and granted institution of the &#x2019;603 patent IPR.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UT dismissed the &#x2019;603 patent from the suit and no longer accuses PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures or STRATAFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; PDS&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (&#x201c;Intuitive&#x201d;) filed a patent infringement suit against Auris Health, Inc. (&#x201c;Auris&#x201d;) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#x2019;200 patent); 6,491,701 (&#x2019;701 patent); 6,522,906 (&#x2019;906 patent); 6,800,056 (&#x2019;056 patent); 8,142,447 (&#x2019;447 patent); 8,620,473 (&#x2019;473 patent); 8,801,601 (&#x2019;601 patent); and 9,452,276 (&#x2019;276 patent) based on Auris&#x2019; Monarch&#x2122; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#x2019;200, &#x2019;056, &#x2019;601 &#x2019;701, &#x2019;447, &#x2019;276 and &#x2019;906 patents.   Intuitive subsequently dropped the &#x2019;200 and &#x2019;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#x2019;601 patent and denied review of the &#x2019;056 patent.  In February and March 2020, the USPTO instituted review of the &#x2019;200, &#x2019;447, &#x2019;701 and &#x2019;906 patents and denied review of the &#x2019;276 patent.   The district court trial is scheduled to begin in January 2021.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2019, RSB Spine LLC (&#x201c;RSB Spine&#x201d;) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#x2122; Spacer, ZERO-P&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Spacer, ZERO-P NATURAL&#x2122; Plate, SYNFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; LR Spacer and SYNFIX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;Virtual Surgical Planning Services and the TruMatch&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9, 292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Pharmaceutical&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp;amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of Canadian Patent No. 2,661,422 (the &#x2019;422 patent).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#x2019;s ANDS until the expiration of the &#x2019;422 patent.  In November 2019, Apotex filed an appeal.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent.  The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;   &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;250 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the  &#x2019;422 patent. The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#x2019;s filing of an ANDS seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, 500 mg, before the expiration of the &#x2019;422 patent.  The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent. The final hearing is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;422 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in April 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and InvaGen Pharmaceuticals Inc. (InvaGen) who filed ANDAs seeking approval to market generic versions of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before expiration of Bayer AG&#x2019;s United States Patent No. 9,539,218 (&#x2019;218) relating to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. JPI is the exclusive sublicensee of the asserted patent. The case against InvaGen has been stayed.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, JPI and Bayer AG entered into a settlement agreement with Taro. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; before expiration of &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;the &#x2019;218 patent and United States Patent No. 7,157,456 relating&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;to XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2020, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Ltd. (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of United States Patent Nos. 7,700,645, 8,518,987, 7,126,015 and 7,595,408.  Janssen was &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;seeking an order enjoining Zydus from marketing its generic version of PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the relevant patents. In June 2020, Janssen entered into a settlement agreement with Zydus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In April 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Marcan Pharmaceuticals Inc. (Marcan) in Canada in response to Marcan&#x2019;s filing of an ANDS seeking approval to market a generic version of Prezista before the expiration of Canadian Patent No. 2,485,834 (the &#x2019;834 patent).  Janssen was seeking an order enjoining Marcan from marketing its generic version of PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; before the expiration of the &#x2019;834 patent. In May 2020, Janssen discontinued the action against Marcan.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;/INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;/INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp;amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XR before expiration of MTPC&#x2019;s United States Patent Nos. 7,943,582 (the &#x2019;582 patent) and/or 8,513,202 (the &#x2019;202 patent) relating to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:  Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.;  Dr. Reddy&#x2019;s Laboratories, Inc. and Dr. Reddy&#x2019;s Laboratories Ltd (DRL); Hetero USA, Inc., Hetero Labs Limited Unit V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).  These cases were consolidated into one action (Polymorph Main Action), which was scheduled for trial starting in June 2020 but is being rescheduled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and/or INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before expiration of MTPC&#x2019;s United States Patent No. 7,943,788 (the &#x2019;788 patent), 8,222,219 (the &#x2019;219 patent) and/or 8,785,403 (the &#x2019;403 patent) relating to INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;and/or&#160; INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; XR Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:&#160; Sandoz, Zydus and Aurobindo. These cases were consolidated into one action (Compound Main Action), which was scheduled for trial in May 2020 but is being rescheduled.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before expiration of the &#x2019;582 patent and &#x2019;202 patent relating to INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before expiration of the &#x2019;788 patent.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before expiration of the &#x2019;788 patent.  In March 2020, Janssen and MTPC initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before expiration of the &#x2019;788 patent, &#x2019;219 patent, &#x2019;403 patent, &#x2019;582 patent, and &#x2019;202 patent.  These lawsuits have not been consolidated with the Main Actions.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, Janssen and MTPC entered into a settlement agreement with Aurobindo. In June 2020, Janssen and MTPC entered into a settlement agreement with Laurus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, INVOKAMET&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and/or, INVOKAMET XR&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of United States Patent No. 7,094,781 (the &#x2019;781 patent).  In the lawsuit, Actelion is seeking an order enjoining Zydus from marketing generic versions of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the patent. Trial is scheduled to commence in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2019, Actelion Pharmaceuticals Ltd. filed suit against Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited (Aurobindo).  Aurobindo filed an ANDA seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;781 patent.  Actelion was seeking an order enjoining Defendants from marketing a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;781 patent. In July 2020, Actelion and Aurobindo entered into a settlement agreement.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#x2019;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;  &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;10 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of Canadian Patent No. 2,659,770 (the &#x2019;770 patent). A final hearing has not yet been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#x2019;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;10 mg,&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the &#x2019;770 patent. A final hearing has not yet been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#x2019;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&#xae; 10 mg before the expiration of the &#x2019;770 patent and Canadian Patent No. 2,621,273.  A final hearing has not yet been scheduled.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT&#xae; before the expiration of the &#x2019;770 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of United States Patent No. 9,439,906 (the &#x2019;906 patent).  Trial is scheduled to begin in September 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#x2019;906 patent. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;906 patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of Canadian Patent Nos. 2,309,629 (the &#x2019;629 patent) and 2,655,335 (the &#x2019;335 patent).&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Janssen subsequently discontinued the portion of the lawsuit relating to the &#x2019;629 patent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#x2019;s generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, if approved, would infringe claims of the &#x2019;335 patent and that the claims of the &#x2019;335 patent are not invalid for obviousness. Teva appealed the court&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in response to Pharmascience's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the &#x2019;335 patent.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Trial is scheduled to begin in January 2022.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; before the expiration of the patent.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;140 mg capsules&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;before expiration of Pharmacyclics&#x2019;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus).&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;The trial is scheduled to begin in October 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting United States Patent No. 10,004,746.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In February 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sun to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2019, Pharmacyclics and JBI amended their complaints against Cipla, and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232 and amended their complaint against Sun to further allege infringement of U.S. Patent No. 10,294,232.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2019, Sandoz filed an&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;IPR Petition with&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;the USPTO, seeking to invalidate United States Patent No. 9,795,604.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The IPR was instituted in September 2019, and a final written decision is expected by September 2020.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus, Sun and Sandoz asserting infringement of United States Patent No. 10,478,439.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In May 2020, Pharmacyclics and JBI entered into a settlement agreement with Sun Pharmaceuticals.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;In December 2019, Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Limited (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt;, 32 mg, before the expiration of U.S. Patent No. 8,309,126 (the &#x2019;126 patent).  Actelion was seeking an order enjoining Zydus from marketing its generic version of TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"&gt; before the expiration of the &#x2019;126 patent. In July 2020, Actelion entered into a settlement agreement with &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"&gt;Zydus.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before expiration of Nippon Shinyaku&#x2019;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;before the expiration of the relevant patents.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;GOVERNMENT PROCEEDINGS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp;amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Average Wholesale Price (AWP) Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;amp;J AWP Defendants were ultimately dismissed. The J&amp;amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp;amp; Johnson and ALZA Corporation. All other cases have been resolved.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Opioid Litigation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in 2014 and continuing to the present, Johnson &amp;amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 2,900 lawsuits related to the marketing of opioids, including DURAGESIC&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, NUCYNTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and NUCYNTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp;amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp;amp; Johnson and JPI in the amount of $572 million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $465 million. Johnson &amp;amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp;amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp;amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#x2019;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $4 billion as settlement of these lawsuits, subject to various conditions and an agreement being finalized.  This agreement in principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; In August 2019, Johnson &amp;amp; Johnson received a grand jury subpoena from the United States Attorney&#x2019;s Office for the Eastern District of New York for documents related to the Company&#x2019;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#x2019; and distributors&#x2019; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp;amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160; The Company is cooperating and producing documents in response to the various subpoenas and requests for information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In November 2019, a shareholder filed a derivative complaint against Johnson &amp;amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp;amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp;amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt; In re Johnson &amp;amp; Johnson Opioid Stockholder Derivative Litigation&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2020, a report was delivered to the Company&#x2019;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Board unanimously adopted the recommendations of the independent counsel&#x2019;s report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;"&gt;Other&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp;amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#x2122; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#x2019; motion to dismiss with prejudice, unsealed the &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; complaint, and denied the &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; relators&#x2019; request for leave to file a further amended complaint. The &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#x2019;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#x2019; request to file a third amended complaint. The relators&#x2019; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In October 2012, Johnson &amp;amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp;amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp;amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp;amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp;amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $344 million. The Company intends to appeal the decision. In April 2020, the Company settled the West Virginia case. In April 2020, the Court in California denied the Company's motion for a new trial. In June 2020, the Court denied the Attorney General's request for injunctive relief. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument will be heard in August  2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp;amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; (methoxsalen) and the Uvar Xts&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; and Cellex&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt; Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp;amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp;amp; Johnson retains OCD&#x2019;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#x2019;s Office requested that Johnson &amp;amp; Johnson produce certain documents, and Johnson &amp;amp; Johnson is cooperating with those requests.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp;amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Baby Powder and JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp;amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has filed a motion to dismiss certain of the claims in the Amended Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Forty-one states have commenced a joint investigation into the Company&#x2019;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#x2019;s Office for the Southern District of New York related to JPI&#x2019;s contractual relationships with pharmacy benefit managers over the &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2016, Johnson &amp;amp; Johnson and Janssen Products LP were served with a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; and INTELENCE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; or SIMPONI ARIA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#x2019;s complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April and September 2017, Johnson &amp;amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, OLYSIO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, SIMPONI&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;, STELARA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;and ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2017, Johnson &amp;amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp;amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#x2019;s investigation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp;amp; Johnson do Brasil Ind&#xfa;stria e Com&#xe9;rcio de Produtos para Sa&#xfa;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp;amp; Johnson to cooperate with these inquiries by producing the requested information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;"&gt;GENERAL LITIGATION&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp;amp; Johnson and Johnson &amp;amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp;amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Baby Powder and JOHNSON'S&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp;amp; Johnson's and JJCI&#x2019;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp;amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp;amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp;amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  The complaint seeks damages and injunctive relief. Discovery is ongoing. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#x2019;s REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp;amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#x2019;s decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp;amp; Johnson in connection with its investigation of whether Janssen&#x2019;s REMICADE&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"&gt;In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp;amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&#160; TRACLEER&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#x2019;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC, and Johnson &amp;amp; Johnson (collectively, Janssen) were served with a &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;"&gt;qui tam&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt; to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In April 2019, Blue Cross &amp;amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp;amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#xae;. Several additional complaints were filed thereafter in Virginia and New Jersey.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"&gt; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt; &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in order to delay generic entry and seek damages. The Virginia cases have been transferred to the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp;amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae;&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;&#xae; &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;in order to delay generic entry, and seek damages and injunctive relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In May 2019, a class action antitrust complaint was filed against Janssen R&amp;amp;D Ireland (Janssen) and Johnson &amp;amp; Johnson in the United States District Court for the Northern District of California.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In March 2020, the Court granted in part and denied in part defendants&#x2019; motions to dismiss.&lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"&gt;  &lt;/span&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Plaintiffs filed an amended complaint in April 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#x2019;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In November 2019, Johnson &amp;amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp;amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp;amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;Johnson &amp;amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i582a2834e4fd4aff9b1bc95d88dffea5_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDQ2MA_78a82da5-b004-4949-8044-f33b6f19888c"
      unitRef="claimant">800</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i1d8c3a0656d34fb5966cd9770c316551_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDYyNA_3d905839-ba90-46e3-972e-8ca05782fd16"
      unitRef="claimant">8600</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i85df32700d11440b9f62c956e2be12e8_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDY4MA_f7b32dfb-46d7-488e-9cac-5c3aa6959553"
      unitRef="claimant">15600</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="ib9a3f835f231472f99dfb7bb92dc9732_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDcxNA_d060351c-28d0-474b-87d0-0cafe32aea25"
      unitRef="claimant">10600</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="iea2331b0b13c42f9b906bf8c6741a1f2_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDc0NQ_ae592765-703e-4ba1-95e9-9b4b7496019c"
      unitRef="claimant">21000</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="ie7cf6a6af023478299b61b15e7dc2e18_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDc3NA_34339e24-29af-4843-af80-922e2ba8dcd2"
      unitRef="claimant">20600</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i3d7dfc6628eb4c3e9f45d6d28b6c4239_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDgyMw_a14ee3e1-90a2-413f-a38f-a9d2e75ac7b5"
      unitRef="claimant">300</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i50eec62d41b944978cdcf2b62bbde5d6_I20200628"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNDg1OA_d84101ad-922e-4df3-a33e-b503dc635396"
      unitRef="claimant">3700</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <jnj:Numberofpatientsinsettlement
      contextRef="ib99b415ed1bd4de081616c1b0ba5adb9_I20200628"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjI0OA_339b52e6-7147-4a60-8e2f-0579e5fd8542"
      unitRef="patient">10000</jnj:Numberofpatientsinsettlement>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i70f14e4d505949438f899f930dceffd2_D20190930-20191229"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMTMyMzA_43ea2ece-a916-4ae6-9811-aa349bc44418"
      unitRef="usd">8000000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="idd1ca5d4c491437ba8eb090bb6173cdb_D20200101-20200131"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMTMzMzU_abb4210f-ab1f-4267-9d01-8d76598afc47"
      unitRef="usd">6800000</us-gaap:LossContingencyDamagesAwardedValue>
    <jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue
      contextRef="i0b831b0b9e4744b890997d86490beb64_D20180701-20180731"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMjE5OTAyMzQxMjQzNw_d56395ca-547f-41c4-a776-16f5ad77cd23"
      unitRef="usd">4700000000</jnj:LossContingencyPreviousDamagesAwardedAndRevisedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i73c27ed443d4477a94166f5501e091cc_D20200601-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfMjE5OTAyMzQxMjQyMw_0b174caa-f67d-4842-a23a-503d83568970"
      unitRef="usd">2100000000</us-gaap:LossContingencyDamagesAwardedValue>
    <jnj:ProductLiabilityContingencyNumberOfClaimant
      contextRef="i843d961ffff941f780e135d0ac57ec95_I20191229"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjMzODI_6c1e653b-1212-4de8-8ee9-bfdd6f82afa8"
      unitRef="claimant">2900</jnj:ProductLiabilityContingencyNumberOfClaimant>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i8a2d74fb903f4bf9bccd750be8be4662_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjYyMDI_5299bc01-3006-43e9-95c6-ae2579ec233f"
      unitRef="usd">572000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="i3071999c834c466fa7bf2ef272704338_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjYzMTY_52691751-22a0-4ab8-b686-a842d92a6897"
      unitRef="usd">465000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:LossContingencyEstimateOfPossibleLoss
      contextRef="i0f5aae03f63f42a89d19ed1519e2f71b_I20191031"
      decimals="-9"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNjcxOTI_271d99b2-3c8d-4f5d-aa5e-c7bcc82fec8e"
      unitRef="usd">4000000000</us-gaap:LossContingencyEstimateOfPossibleLoss>
    <us-gaap:LossContingencyDamagesAwardedValue
      contextRef="ib27b2c7dd82249fa8839a100c11d8cd0_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85NC9mcmFnOjM0ZDIxOWY2YWM5NjQ2YTg4ZWM2MDgzYWIzMDI5OGExL3RleHRyZWdpb246MzRkMjE5ZjZhYzk2NDZhODhlYzYwODNhYjMwMjk4YTFfNzE3Mzc_dce02ad8-5ca0-45e4-842e-088754ee308c"
      unitRef="usd">344000000</us-gaap:LossContingencyDamagesAwardedValue>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfOTg5NTYwNDY1MzQ0OA_07ec23d5-a810-4024-b9ba-3d68e2e0fb47">RESTRUCTURING&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal second quarter of 2020, the Company recorded a pre-tax charge of $115 million, which is included on the following lines of the Consolidated Statement of Earnings, $61 million in restructuring, $22 million in cost of products sold and $32 million in other (income) expense. In the first fiscal six months of 2020, the Company recorded a pre-tax charge of $233&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $119&#160;million in restructuring, $37&#160;million in cost of products sold and $77&#160;million in other (income) expense.Total project costs of approximately $1.1 billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the severance related reserves and the associated restructuring expenses through the first fiscal six months of 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.703%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.372%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.981%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.372%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.500%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.072%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Other&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reserve balance, December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current year activity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Charges  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Settled non cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Reserve balance, June 28, 2020&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt; Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="ia605452b07814f9785dea5e1749593fb_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfNzg1_8e7819c4-bcc7-4d7b-9231-5d3d6df8db57"
      unitRef="usd">115000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i502babb46275458897c6c348109c5035_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfODcz_7d13d717-674a-4f71-9497-62beefaa4025"
      unitRef="usd">61000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="id9acc37568ea42f9922fa2c92c7d50ea_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfODk0_0ade71a6-10eb-48a1-9dce-a685a34e9294"
      unitRef="usd">22000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ibc9ce1c7b9de4d7c9bd370f431d114cf_D20200330-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfOTI2_00c2a97e-f3d5-46ea-a628-7f382abd8619"
      unitRef="usd">32000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i753470899d364d1599b1fb2ae589ae15_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQwOA_c4d68c34-9a37-41ef-ae6a-69c094070c18"
      unitRef="usd">233000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iee0f458f77f44dae9e9a9f498f732d53_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQzOA_3cf77f0e-f55e-4f5a-966e-1f9451ec61ef"
      unitRef="usd">119000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i924dea35cc4a4db3a0754750a03791e8_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQ2OA_75bcb8d1-a78f-4e64-8c41-2b87a3428d9b"
      unitRef="usd">37000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie4563a7367fd4e85a1f89eec3c0e1587_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjE5OTAyMzI1ODQ5OA_e8a825bd-c50c-4785-967d-c1441fa69cb7"
      unitRef="usd">77000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostCostIncurredToDate1
      contextRef="i643a2ee9d94c46a1a5979059886f331c_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTI0NA_b565c3eb-1044-41f9-a611-91fbac1f86f8"
      unitRef="usd">1100000000</us-gaap:RestructuringAndRelatedCostCostIncurredToDate1>
    <jnj:RestructuringandRelatedCostExpectedFutureSavings
      contextRef="ia536875c9d1940f7b5044f50a10ec73f_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTQ3Mg_5e610240-6151-40bf-ad16-27a20dd96d71"
      unitRef="usd">600000000</jnj:RestructuringandRelatedCostExpectedFutureSavings>
    <jnj:RestructuringandRelatedCostExpectedFutureSavings
      contextRef="i966d76441bca4eeda5773245cb198ca5_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTQ3OA_2372226b-0146-448e-8d4a-c2b30fbea9e1"
      unitRef="usd">800000000</jnj:RestructuringandRelatedCostExpectedFutureSavings>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ia536875c9d1940f7b5044f50a10ec73f_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTYzNQ_38f5ba07-d752-4d97-9be2-ac36f05d708e"
      unitRef="usd">1900000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="i966d76441bca4eeda5773245cb198ca5_I20200628"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY0MQ_d4e75ed4-e56e-4505-85ad-8067d3ecce74"
      unitRef="usd">2300000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <jnj:RestructuringandRelatedCostDurationofRestructuringPlan
      contextRef="i96475a51603a4e8e810595eccb66f241_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY1NA_0e9ca090-e9f4-4792-8666-e2c2eb98792f">P4Y</jnj:RestructuringandRelatedCostDurationofRestructuringPlan>
    <jnj:RestructuringandRelatedCostDurationofRestructuringPlan
      contextRef="i5b9cec4fed09422f9f5c106fb3d09c7d_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMTY2MA_20a5ed9f-f233-4609-a707-029b0cc84bf6">P5Y</jnj:RestructuringandRelatedCostDurationofRestructuringPlan>
    <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjgyOA_15e667ff-0433-45a4-8b98-8ecdfcf3189c">&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The following table summarizes the severance related reserves and the associated restructuring expenses through the first fiscal six months of 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;margin-bottom:5pt;"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"&gt;&lt;tr&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:32.703%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.372%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.981%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.372%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.500%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;td style="width:13.072%;"/&gt;&lt;td style="width:1.0%;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(Dollars in Millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Severance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Asset Write-offs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;div style="text-align:center;"&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;"&gt;Other&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Reserve balance, December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;Current year activity:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Charges  &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Cash payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(12)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(197)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(209)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&#160;&#160;Settled non cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"&gt;&lt;span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;(44)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;td colspan="3" style="display:none;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;"&gt;Reserve balance, June 28, 2020&lt;/span&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"&gt;(1)&lt;/sup&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/&gt;&lt;td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"&gt;&lt;span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(1) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(2)&lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt; Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"&gt;(3) &lt;/sup&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"&gt;Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"&gt;The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
    <us-gaap:RestructuringReserve
      contextRef="i87c5e8d39d9c4eaa85e56a1ce09a3918_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0xLTEtMS0w_98f43fa1-ec55-45e0-a9fc-e317692ec8ad"
      unitRef="usd">164000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="idf1e8f0128234898a4c2745db86b0fdc_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0yLTEtMS0w_20639d4d-ce6d-455a-98ea-2736faff0f3a"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i91cdc9cf7fe24f6295e435d3967682d3_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS0zLTEtMS0w_bec97efd-1e9f-425a-abbc-eee14cae5784"
      unitRef="usd">16000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i39f8df2915ae4439892ff4f3cc7ccf0a_I20191229"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfMS01LTEtMS0w_fb571e30-ae3b-4faf-8828-766b18fa5298"
      unitRef="usd">180000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringCharges
      contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0xLTEtMS0w_cc324237-18c9-4793-b7af-ade9e3e69d54"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0yLTEtMS0w_06e1f585-633e-499a-b92b-b170ddc0cd06"
      unitRef="usd">27000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC0zLTEtMS0w_56df930b-01c4-412e-a3f5-7eaab408d894"
      unitRef="usd">206000000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNC01LTEtMS0w_bff5f0a2-2e00-44c4-af73-489cd3b9f6c1"
      unitRef="usd">233000000</us-gaap:RestructuringCharges>
    <us-gaap:PaymentsForRestructuring
      contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0xLTEtMS0w_816d11a8-5e28-4dac-80d7-8645bc83b789"
      unitRef="usd">12000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0yLTEtMS0w_48408ae1-d97a-47a1-ba64-36cb8c21ab54"
      unitRef="usd">0</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS0zLTEtMS0w_1c78bd4d-af43-4f66-b8a4-fab511a476e2"
      unitRef="usd">197000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:PaymentsForRestructuring
      contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNS01LTEtMS0w_fa8cfa8b-2b19-485b-adb3-d640c9e23022"
      unitRef="usd">209000000</us-gaap:PaymentsForRestructuring>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="ibc3b686e8f0940afb8bb0fc21856e1a4_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0xLTEtMS0w_6a2a7ba9-877b-4690-a1d1-a21c141cb793"
      unitRef="usd">0</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i018045947632426a9bde5d53838f9afc_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0yLTEtMS0w_83d937fd-0320-4407-adc0-6e4cb531a910"
      unitRef="usd">27000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="idb152c26aac84568b902e764916fb60c_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi0zLTEtMS0w_61981996-f4ba-4658-9a96-0327f79cc9ec"
      unitRef="usd">17000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserveSettledWithoutCash2
      contextRef="i80c55fa308da4315ab0777fba79fd61b_D20191230-20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfNi01LTEtMS0w_211e665f-2833-4401-bcc5-3ae1a2da05f1"
      unitRef="usd">44000000</us-gaap:RestructuringReserveSettledWithoutCash2>
    <us-gaap:RestructuringReserve
      contextRef="ifb137f18e4de4282a026c925fc22bbef_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0xLTEtMS0w_5a326ceb-ea9f-4144-8249-c00ecbed8bea"
      unitRef="usd">152000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i2ee00f42b2134d3796cbc180e878362c_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0yLTEtMS0w_14674815-6099-4c3e-a04a-65e9d56f6694"
      unitRef="usd">0</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i006340b658e24cf8b366c83c9bbfff9d_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS0zLTEtMS0w_91126369-4cce-4402-b2b9-4d13c0510c2f"
      unitRef="usd">8000000</us-gaap:RestructuringReserve>
    <us-gaap:RestructuringReserve
      contextRef="i78a038526da94ec5a15e091af7f02a84_I20200628"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RhYmxlOmIwZjMwZDQwZjE3ZTQ5NGI5ZDkyMzk0Y2VhMTc4MTVmL3RhYmxlcmFuZ2U6YjBmMzBkNDBmMTdlNDk0YjlkOTIzOTRjZWExNzgxNWZfOS01LTEtMS0w_bfff2c71-e453-4a58-86c4-61f42df4efb7"
      unitRef="usd">160000000</us-gaap:RestructuringReserve>
    <jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid
      contextRef="i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628"
      id="id3VybDovL2RvY3MudjEvZG9jOmQ0YzJiOWIyODU1MTQyY2Q4Zjk0NmNkNDczZGVhMWMxL3NlYzpkNGMyYjliMjg1NTE0MmNkOGY5NDZjZDQ3M2RlYTFjMV85Ny9mcmFnOjczN2QyMTQ3NTIyNzRiZGU4NGI3OWY4Yjk2YTI2MGFhL3RleHRyZWdpb246NzM3ZDIxNDc1MjI3NGJkZTg0Yjc5ZjhiOTZhMjYwYWFfMjAxMw_2f07fa54-b289-4928-8869-dd03c09b566f">P2Y</jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530264855256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 28,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-3215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Johnson & Johnson<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">22-1024240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One Johnson & Johnson Plaza<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New Brunswick<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08933<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">524-0400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,632,823,475<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000200406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--01-03<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, Par Value $1.00</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, Par Value $1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes Due January 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.250% Notes Due January 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes Due May 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">0.650% Notes Due May 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes Due November 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.50% Notes Due November 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes Due November 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.150% Notes Due November 2028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes Due May 2035</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">1.650% Notes Due May 2035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">JNJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 13<br> -Subsection a-13<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1-<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A0.250NotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A0.650NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A5.50NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A1.150NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=jnj_A1.650NotesDue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530341023592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 11,174<span></span>
</td>
<td class="nump">$ 17,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">7,961<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, trade, less allowances for doubtful accounts and credit losses $334 (2019, $226)</a></td>
<td class="nump">14,645<span></span>
</td>
<td class="nump">14,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories (Note 2)</a></td>
<td class="nump">9,424<span></span>
</td>
<td class="nump">9,020<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,588<span></span>
</td>
<td class="nump">2,392<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther', window );">Assets held for sale (Note 10)</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">94<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">45,892<span></span>
</td>
<td class="nump">45,274<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment at cost</a></td>
<td class="nump">44,056<span></span>
</td>
<td class="nump">43,332<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(26,458)<span></span>
</td>
<td class="num">(25,674)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">17,598<span></span>
</td>
<td class="nump">17,658<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net (Note 3)</a></td>
<td class="nump">47,413<span></span>
</td>
<td class="nump">47,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill (Note 3)</a></td>
<td class="nump">33,890<span></span>
</td>
<td class="nump">33,639<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred taxes on income (Note 5)</a></td>
<td class="nump">7,805<span></span>
</td>
<td class="nump">7,819<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">5,782<span></span>
</td>
<td class="nump">5,695<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">158,380<span></span>
</td>
<td class="nump">157,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Loans and notes payable</a></td>
<td class="nump">5,332<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">6,765<span></span>
</td>
<td class="nump">8,544<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">9,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_AccruedRebatesReturnsAndPromotions', window );">Accrued rebates, returns and promotions</a></td>
<td class="nump">11,790<span></span>
</td>
<td class="nump">10,883<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and employee related obligations</a></td>
<td class="nump">2,313<span></span>
</td>
<td class="nump">3,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Accrued taxes on income (Note 5)</a></td>
<td class="nump">1,632<span></span>
</td>
<td class="nump">2,266<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">36,772<span></span>
</td>
<td class="nump">35,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt (Note 4)</a></td>
<td class="nump">25,062<span></span>
</td>
<td class="nump">26,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred taxes on income (Note 5)</a></td>
<td class="nump">5,532<span></span>
</td>
<td class="nump">5,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent', window );">Employee related obligations (Note 6)</a></td>
<td class="nump">10,411<span></span>
</td>
<td class="nump">10,663<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesNoncurrent', window );">Long-term taxes payable (Note 5)</a></td>
<td class="nump">6,591<span></span>
</td>
<td class="nump">7,444<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">11,034<span></span>
</td>
<td class="nump">11,734<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">95,402<span></span>
</td>
<td class="nump">98,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies (Note 11)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock &#8212; par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)</a></td>
<td class="nump">3,120<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income (loss) (Note 7)</a></td>
<td class="num">(15,533)<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">113,898<span></span>
</td>
<td class="nump">110,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Less: common stock held in treasury, at cost (487,466,000 and 487,336,000 shares)</a></td>
<td class="nump">38,507<span></span>
</td>
<td class="nump">38,417<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">62,978<span></span>
</td>
<td class="nump">59,471<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders' equity</a></td>
<td class="nump">$ 158,380<span></span>
</td>
<td class="nump">$ 157,728<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_AccruedRebatesReturnsAndPromotions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_AccruedRebatesReturnsAndPromotions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4428-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=118952595&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6801-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=77912953&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=d3e31931-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.15(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530369701896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowances for doubtful accounts</a></td>
<td class="nump">$ 334<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders' equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value per share</a></td>
<td class="nump">$ 1.00<span></span>
</td>
<td class="nump">$ 1.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">4,320,000,000<span></span>
</td>
<td class="nump">4,320,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">3,119,843,000<span></span>
</td>
<td class="nump">3,119,843,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares</a></td>
<td class="nump">487,466,000<span></span>
</td>
<td class="nump">487,336,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118936363&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118955202&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530264222680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Earnings - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 18,336<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 39,027<span></span>
</td>
<td class="nump">$ 40,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesRevenueGoodsNetPercentToSales', window );">Sales to customers percent to sales</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of products sold</a></td>
<td class="nump">$ 6,579<span></span>
</td>
<td class="nump">$ 6,940<span></span>
</td>
<td class="nump">$ 13,641<span></span>
</td>
<td class="nump">$ 13,555<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CostOfGoodsSoldPercentToSales', window );">Cost of products sold percent to sales</a></td>
<td class="nump">35.90%<span></span>
</td>
<td class="nump">33.80%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.40%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">$ 11,757<span></span>
</td>
<td class="nump">$ 13,622<span></span>
</td>
<td class="nump">$ 25,386<span></span>
</td>
<td class="nump">$ 27,028<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_GrossProfitPercentToSales', window );">Gross profit percent to sales</a></td>
<td class="nump">64.10%<span></span>
</td>
<td class="nump">66.20%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">66.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, marketing and administrative expenses</a></td>
<td class="nump">$ 4,993<span></span>
</td>
<td class="nump">$ 5,546<span></span>
</td>
<td class="nump">$ 10,196<span></span>
</td>
<td class="nump">$ 10,765<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SellingGeneralAndAdministrativeExpensePercentToSales', window );">Selling marketing and administrative expenses percent to sales</a></td>
<td class="nump">27.20%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">26.10%<span></span>
</td>
<td class="nump">26.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost', window );">Research and development expense</a></td>
<td class="nump">$ 2,707<span></span>
</td>
<td class="nump">$ 2,666<span></span>
</td>
<td class="nump">$ 5,287<span></span>
</td>
<td class="nump">$ 5,524<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales', window );">Research and development expense percent to sales</a></td>
<td class="nump">14.80%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ResearchAndDevelopmentInProcessPercentToSales', window );">In-process research and development percent to sales</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">2.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="num">$ (19)<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
<td class="num">$ (86)<span></span>
</td>
<td class="num">$ (187)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InvestmentIncomeInterestPercentToSales', window );">Interest income percent to sales</a></td>
<td class="num">(0.10%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net of portion capitalized</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">$ 185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_InterestExpensePercentToSales', window );">Interest expense, net of portion capitalized percent to sales</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="nump">$ 24<span></span>
</td>
<td class="num">$ (1,683)<span></span>
</td>
<td class="num">$ (655)<span></span>
</td>
<td class="num">$ (1,705)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherNonOperatingIncomeExpensePercentToSales', window );">Other (income) expense, net percent to sales</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="num">(8.20%)<span></span>
</td>
<td class="num">(1.70%)<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring (Note 12)</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Restructuringchargepercenttosales', window );">Restructuring charge percent to sales</a></td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before provision for taxes on income</a></td>
<td class="nump">$ 3,940<span></span>
</td>
<td class="nump">$ 7,041<span></span>
</td>
<td class="nump">$ 10,449<span></span>
</td>
<td class="nump">$ 11,463<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales', window );">Earnings before provision for taxes on income percent to sales</a></td>
<td class="nump">21.50%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
<td class="nump">26.80%<span></span>
</td>
<td class="nump">28.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for taxes on income</a></td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="nump">$ 1,027<span></span>
</td>
<td class="nump">$ 2,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxExpenseBenefitPercentToSales', window );">Provision for taxes on income (Note 5)</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="nump">6.90%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">NET EARNINGS</a></td>
<td class="nump">$ 3,626<span></span>
</td>
<td class="nump">$ 5,607<span></span>
</td>
<td class="nump">$ 9,422<span></span>
</td>
<td class="nump">$ 9,356<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_NetIncomeAttributableToParentPercentToSales', window );">Net earnings percent to sales</a></td>
<td class="nump">19.80%<span></span>
</td>
<td class="nump">27.30%<span></span>
</td>
<td class="nump">24.10%<span></span>
</td>
<td class="nump">23.10%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>NET EARNINGS PER SHARE</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (per share)</a></td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 3.58<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (per share)</a></td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="nump">$ 3.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>AVG. SHARES OUTSTANDING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (shares)</a></td>
<td class="nump">2,632,900<span></span>
</td>
<td class="nump">2,652,500<span></span>
</td>
<td class="nump">2,633,300<span></span>
</td>
<td class="nump">2,656,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (shares)</a></td>
<td class="nump">2,665,500<span></span>
</td>
<td class="nump">2,691,700<span></span>
</td>
<td class="nump">2,671,000<span></span>
</td>
<td class="nump">2,697,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CostOfGoodsSoldPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of goods sold percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CostOfGoodsSoldPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_GrossProfitPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross profit percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_GrossProfitPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxExpenseBenefitPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income tax expense benefit percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeTaxExpenseBenefitPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InterestExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_InterestExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_InvestmentIncomeInterestPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investment income interest percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_InvestmentIncomeInterestPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_NetIncomeAttributableToParentPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income Attributable to Parent Percent to Sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_NetIncomeAttributableToParentPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherNonOperatingIncomeExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other non operating income expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherNonOperatingIncomeExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Research and development expense excluding acquired in process cost percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ResearchAndDevelopmentInProcessPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>research and development in process percent to sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ResearchAndDevelopmentInProcessPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Restructuringchargepercenttosales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring charge percent to sales</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Restructuringchargepercenttosales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesRevenueGoodsNetPercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales revenue goods net percentage to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SalesRevenueGoodsNetPercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SellingGeneralAndAdministrativeExpensePercentToSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Selling general and administrative expense percent to sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SellingGeneralAndAdministrativeExpensePercentToSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109238882&amp;loc=d3e38679-109324<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114775744&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68048583&amp;loc=d3e3636-108311<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530275970920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 3,626<span></span>
</td>
<td class="nump">$ 5,607<span></span>
</td>
<td class="nump">$ 9,422<span></span>
</td>
<td class="nump">$ 9,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax', window );">Foreign currency translation</a></td>
<td class="nump">556<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="num">(963)<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Securities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized holding gain (loss) arising during period</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax', window );">Reclassifications to earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Employee benefit plans:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax', window );">Prior service cost amortization during period</a></td>
<td class="num">(5)<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax', window );">Gain (loss) amortization during period</a></td>
<td class="nump">200<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">318<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax', window );">Net change</a></td>
<td class="nump">195<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="nump">306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Derivatives &amp; hedges:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="num">(216)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassifications to earnings</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax', window );">Net change</a></td>
<td class="num">(39)<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss)</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">4,336<span></span>
</td>
<td class="nump">6,155<span></span>
</td>
<td class="nump">9,780<span></span>
</td>
<td class="nump">9,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax', window );">Foreign Currency Translation</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax', window );">Securities</a></td>
<td class="num">(1)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax', window );">Employee Benefit Plans</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Derivatives &amp; Hedges</a></td>
<td class="num">$ (10)<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
<td class="nump">$ 246<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e557-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118948100&amp;loc=d3e30304-110892<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32022-110900<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27357-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL34724391-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e640-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530348255656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Equity - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
<th class="th"><div>Common Stock Issued Amount</div></th>
<th class="th"><div>Treasury Stock Amount</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 30, 2018</a></td>
<td class="nump">$ 59,752<span></span>
</td>
<td class="nump">$ 106,216<span></span>
</td>
<td class="num">$ (15,222)<span></span>
</td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="num">$ (34,362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">9,356<span></span>
</td>
<td class="nump">9,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(4,918)<span></span>
</td>
<td class="num">(4,918)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">1,034<span></span>
</td>
<td class="num">(845)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(4,692)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,692)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">60,785<span></span>
</td>
<td class="nump">109,809<span></span>
</td>
<td class="num">(14,969)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(37,175)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 31, 2019</a></td>
<td class="nump">58,955<span></span>
</td>
<td class="nump">106,650<span></span>
</td>
<td class="num">(15,517)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(35,298)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">5,607<span></span>
</td>
<td class="nump">5,607<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(2,522)<span></span>
</td>
<td class="num">(2,522)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(2,486)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,486)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 30, 2019</a></td>
<td class="nump">60,785<span></span>
</td>
<td class="nump">109,809<span></span>
</td>
<td class="num">(14,969)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(37,175)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Dec. 29, 2019</a></td>
<td class="nump">59,471<span></span>
</td>
<td class="nump">110,659<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">9,422<span></span>
</td>
<td class="nump">9,422<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(5,164)<span></span>
</td>
<td class="num">(5,164)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">1,307<span></span>
</td>
<td class="num">(1,020)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(2,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 28, 2020</a></td>
<td class="nump">62,978<span></span>
</td>
<td class="nump">113,898<span></span>
</td>
<td class="num">(15,533)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,507)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance at Mar. 29, 2020</a></td>
<td class="nump">61,294<span></span>
</td>
<td class="nump">112,901<span></span>
</td>
<td class="num">(16,243)<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="num">(38,484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">3,626<span></span>
</td>
<td class="nump">3,626<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Cash dividends paid</a></td>
<td class="num">(2,659)<span></span>
</td>
<td class="num">(2,659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued', window );">Employee compensation and stock option plans</a></td>
<td class="nump">712<span></span>
</td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">683<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Repurchase of common stock</a></td>
<td class="num">(706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(706)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income (loss), net of tax</a></td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance at Jun. 28, 2020</a></td>
<td class="nump">$ 62,978<span></span>
</td>
<td class="nump">$ 113,898<span></span>
</td>
<td class="num">$ (15,533)<span></span>
</td>
<td class="nump">$ 3,120<span></span>
</td>
<td class="num">$ (38,507)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530257330104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Equity (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Cash dividends paid (in dollars per share)</a></td>
<td class="nump">$ 1.01<span></span>
</td>
<td class="nump">$ 0.95<span></span>
</td>
<td class="nump">$ 1.96<span></span>
</td>
<td class="nump">$ 1.85<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530352588520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>CASH FLOWS FROM OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net earnings</a></td>
<td class="nump">$ 9,422<span></span>
</td>
<td class="nump">$ 9,356<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization of property and intangibles</a></td>
<td class="nump">3,473<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock based compensation</a></td>
<td class="nump">589<span></span>
</td>
<td class="nump">572<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset write-downs</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(983)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges', window );">Net gain on sale of assets/businesses</a></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(2,079)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred tax provision</a></td>
<td class="num">(428)<span></span>
</td>
<td class="num">(694)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit losses and accounts receivable allowances</a></td>
<td class="nump">117<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in assets and liabilities, net of effects from acquisitions and divestitures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Increase in accounts receivable</a></td>
<td class="num">(520)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Increase in inventories</a></td>
<td class="num">(637)<span></span>
</td>
<td class="num">(423)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Decrease in accounts payable and accrued liabilities</a></td>
<td class="num">(2,319)<span></span>
</td>
<td class="num">(444)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Increase in other current and non-current assets</a></td>
<td class="num">(1,048)<span></span>
</td>
<td class="num">(862)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Decrease in other current and non-current liabilities</a></td>
<td class="num">(829)<span></span>
</td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">NET CASH FLOWS FROM OPERATING ACTIVITIES</a></td>
<td class="nump">6,810<span></span>
</td>
<td class="nump">9,491<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>CASH FLOWS FROM INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Additions to property, plant and equipment</a></td>
<td class="num">(1,287)<span></span>
</td>
<td class="num">(1,493)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfProductiveAssets', window );">Proceeds from the disposal of assets/businesses, net</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">3,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="num">(949)<span></span>
</td>
<td class="num">(5,346)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(8,551)<span></span>
</td>
<td class="num">(1,517)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments', window );">Sales of investments</a></td>
<td class="nump">2,417<span></span>
</td>
<td class="nump">2,132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Proceedsfromcreditsupportagreements', window );">Proceeds from credit support agreements, net</a></td>
<td class="nump">672<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other (primarily licenses and milestones)</a></td>
<td class="num">(492)<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">NET CASH USED BY INVESTING ACTIVITIES</a></td>
<td class="num">(8,103)<span></span>
</td>
<td class="num">(3,205)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>CASH FLOWS FROM FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfOrdinaryDividends', window );">Dividends to shareholders</a></td>
<td class="num">(5,164)<span></span>
</td>
<td class="num">(4,918)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(2,417)<span></span>
</td>
<td class="num">(4,692)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromShortTermDebt', window );">Proceeds from short-term debt</a></td>
<td class="nump">2,717<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfShortTermDebt', window );">Repayment of short-term debt</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(11)<span></span>
</td>
<td class="num">(1,005)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits', window );">Proceeds from the exercise of stock options/employee withholding tax on stock awards, net</a></td>
<td class="nump">708<span></span>
</td>
<td class="nump">463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other</a></td>
<td class="num">(489)<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">NET CASH USED BY FINANCING ACTIVITIES</a></td>
<td class="num">(4,672)<span></span>
</td>
<td class="num">(10,050)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(166)<span></span>
</td>
<td class="nump">33<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Decrease in cash and cash equivalents</a></td>
<td class="num">(6,131)<span></span>
</td>
<td class="num">(3,731)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash equivalents, beginning of period</a></td>
<td class="nump">17,305<span></span>
</td>
<td class="nump">18,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and Cash equivalents, end of period</a></td>
<td class="nump">11,174<span></span>
</td>
<td class="nump">14,376<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract', window );"><strong>Acquisitions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1', window );">Fair value of assets acquired</a></td>
<td class="nump">1,173<span></span>
</td>
<td class="nump">6,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1', window );">Fair value of liabilities assumed and noncontrolling interests</a></td>
<td class="num">(224)<span></span>
</td>
<td class="num">(1,398)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1', window );">Net cash paid for acquisitions</a></td>
<td class="nump">949<span></span>
</td>
<td class="nump">$ 5,346<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net earnings to cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">$ (983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From The Exercise Of Stock Options And Excess Tax Benefits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Proceedsfromcreditsupportagreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from credit support agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Proceedsfromcreditsupportagreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfOrdinaryDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfOrdinaryDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=119407570&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfShortTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfShortTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254622808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">The accompanying unaudited interim consolidated financial statements and related notes should be read in conjunction with the audited Consolidated Financial Statements of Johnson &amp; Johnson and its subsidiaries (the Company) and related notes as contained in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. The unaudited interim financial statements include all adjustments (consisting only of normal recurring adjustments) and accruals necessary in the judgment of management for a fair statement of the results for the periods presented.<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Columns and rows within tables may not add due to rounding. Percentages have been calculated using actual, non-rounded figures.</span></div><div><span><br/></span></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of June 28, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended June 28, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal second quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal second quarter of 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254487736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">INVENTORIES <div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"/><td style="width:50.996%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.722%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:21.410%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,962&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,424&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530341368568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">INTANGIBLE ASSETS AND GOODWILL<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Intangible assets that have finite useful lives are amortized over their estimated useful lives. The latest annual impairment assessment of goodwill and indefinite lived intangible assets was completed in the fiscal fourth quarter of 2019. Future impairment tests for goodwill and indefinite lived intangible assets will be performed annually in the fiscal fourth quarter, or sooner, if warranted.</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"/><td style="width:60.204%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.425%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.797%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37,313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,834&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,479&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,072&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,594&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,922&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,807&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,569&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,413&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of June&#160;28, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"/><td style="width:39.277%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.578%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.084%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.292%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.309%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,746&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,929&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average amortization period for patents and trademarks is 12 years. The weighted average amortization period for customer relationships and other intangible assets is 21 years. The amortization expense of amortizable intangible assets included in cost of products sold was $1.1 billion for each of the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019. The amortization expense of amortizable intangible assets included in cost of products sold was $2.2 billion for each of the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019. Intangible asset write-downs are included in Other (income) expense, net. </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"/><td style="width:17.628%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.214%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.008%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.008%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.010%;"/><td style="width:1.0%;"/></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$4,500</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,300</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,000</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> See Note 10 to the Consolidated Financial Statements for additional details related to acquisitions and divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530255855656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">FAIR VALUE MEASUREMENTS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company uses forward foreign exchange contracts to manage its exposure to the variability of cash flows, primarily related to the foreign exchange rate changes of future intercompany product and third-party purchases of materials denominated in a foreign currency. The Company uses cross currency interest rate swaps to manage currency risk primarily related to borrowings. Both types of derivatives are designated as cash flow hedges. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Additionally, the Company uses interest rate swaps as an instrument to manage interest rate risk related to fixed rate borrowings.  These derivatives are designated as fair value hedges.  The Company uses cross currency interest rate swaps and forward foreign exchange contracts designated as net investment hedges.  Additionally, the Company uses forward foreign exchange contracts to offset its exposure to certain foreign currency assets and liabilities. These forward foreign exchange contracts are not designated as hedges, and therefore, changes in the fair values of these derivatives are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company does not enter into derivative financial instruments for trading or speculative purposes, or that contain credit risk related contingent features. The Company maintains credit support agreements (CSA) with certain derivative counterparties establishing collateral thresholds based on respective credit ratings and netting agreements. As of June&#160;28, 2020, the total amount of cash collateral held by the Company under the credit support agreements (CSA) amounted to $926 million, net. On an ongoing basis, the Company monitors counter-party credit ratings. The Company considers credit non-performance risk to be low, because the Company primarily enters into agreements with commercial institutions that have at least an investment grade credit rating.  Refer to the table on significant financial assets and liabilities measured at fair value contained in this footnote for receivables and payables with these commercial institutions. As of June&#160;28, 2020, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $43.9&#160;billion and $22.2&#160;billion, respectively.  As of December&#160;29, 2019, the Company had notional amounts outstanding for forward foreign exchange contracts and cross currency interest rate swaps of $45.3 billion and $20.1 billion, respectively.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">All derivative instruments are recorded on the balance sheet at fair value. Changes in the fair value of derivatives are recorded each period in current earnings or other comprehensive income, depending on whether the derivative is designated as part of a hedge transaction, and if so, the type of hedge transaction.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The designation as a cash flow hedge is made at the entrance date of the derivative contract. At inception, all derivatives are expected to be highly effective. Foreign exchange contracts designated as cash flow hedges are accounted for under the forward method and all gains/losses associated with these contracts will be recognized in the income statement when the hedged item impacts earnings. Changes in the fair value of these derivatives are recorded in accumulated other comprehensive income until the underlying transaction affects earnings and are then reclassified to earnings in the same account as the hedged transaction. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gains and losses associated with interest rate swaps and changes in fair value of hedged debt attributable to changes in interest rates are recorded to interest expense in the period in which they occur.  Gains and losses on net investment hedges are accounted for through the currency translation account within accumulated other comprehensive income. The portion excluded from effectiveness testing is recorded through interest (income) expense using the spot method. On an ongoing basis, the Company assesses whether each derivative continues to be highly effective in offsetting changes of hedged items. If and when a derivative is no longer expected to be highly effective, hedge accounting is discontinued. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company designated its Euro denominated notes issued in May 2016 with due dates ranging from 2022 to 2035 as a net investment hedge of the Company's investments in certain of its international subsidiaries that use the Euro as their functional currency in order to reduce the volatility caused by changes in exchange rates. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;28, 2020, the balance of deferred net gain on derivatives included in accumulated other comprehensive income was $636&#160;million after-tax. For additional information, see the Consolidated Statements of Comprehensive Income and Note 7. The Company expects that substantially all of the amounts related to forward foreign exchange contracts will be reclassified into earnings over the next 12 months as a result of transactions that are expected to occur over that period. The maximum length of time over which the Company is hedging transaction exposure is 18 months, excluding interest rate contracts and </span><span style="background-color:rgb(255,255,255, 0.0);color:#2c2c2c;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">net investment hedge</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracts. The amount ultimately realized in earnings may differ as foreign exchange rates change. Realized gains and losses are ultimately determined by actual exchange rates at maturity of the derivative.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal second quarters ended in 2020 and 2019, net of tax:</span></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.202%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.359%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.647%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.513%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.225%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.070%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.513%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.663%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(62)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(101)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(128)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal six months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.593%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.402%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.982%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.111%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.860%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(108)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(136)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(103)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(346)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">725&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="margin-top:5pt;margin-bottom:12pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:28.555%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.823%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.789%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.969%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.789%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.935%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.700%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.648%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:15pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of derivatives not designated as hedging instruments for the fiscal second quarters and fiscal six months ended in 2020 and 2019: </span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:26.260%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.698%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.971%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.118%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.598%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(88)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal second quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:20.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.710%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.875%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(95)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(186)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal six months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:20.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.175%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.885%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.815%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.172%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.961%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.030%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.891%;"/><td style="width:1.0%;"/></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">641&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span><br/></span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company holds equity investments with readily determinable fair values and equity investments without readily determinable fair values.  The Company has elected to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer.</span></div><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:25.071%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.983%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.532%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.835%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.349%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.539%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.835%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.539%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.579%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For equity investments without readily determinable market values, $39 million of the decrease in the fair value reflected in net income were the result of impairments.  There were $11 million of increase in fair value reflected in net income due to changes in observable prices.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value is the exit price that would be received to sell an asset or paid to transfer a liability. Fair value is a market-based measurement determined using assumptions that market participants would use in pricing an asset or liability. In accordance with ASC 820, a three-level hierarchy was established to prioritize the inputs used in measuring fair value. The levels within the hierarchy are described below with Level 1 inputs having the highest priority and Level 3 inputs having the lowest.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The fair value of a derivative financial instrument (i.e., forward foreign exchange contracts, interest rate contracts) is the aggregation by currency of all future cash flows discounted to its present value at the prevailing market interest rates and </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">subsequently converted to the U.S. Dollar at the current spot foreign exchange rate. The Company does not believe that fair values of these derivative instruments materially differ from the amounts that could be realized upon settlement or maturity, or that the changes in fair value will have a material effect on the Company&#8217;s results of operations, cash flows or financial position. The Company also holds equity investments which are classified as Level 1 and debt securities which are classified as Level 2. The Company holds acquisition related contingent liabilities based upon certain regulatory and commercial events, which are classified as Level 3, whose values are determined using discounted cash flow methodologies or similar techniques for which the determination of fair value requires significant judgment or estimations.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following three levels of inputs are used to measure fair value:</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 1 &#8212; Quoted prices in active markets for identical assets and liabilities.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 2 &#8212; Significant other observable inputs.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Level 3 &#8212; Significant unobservable inputs.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of June&#160;28, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:47.329%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.345%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.302%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.004%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.345%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.950%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">395&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">395&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,521&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,521&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">511&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">511&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.005%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.198%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.187%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:22.418%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,437)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(841)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(510)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(586)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"/><td style="width:40.369%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.410%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.706%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.406%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.709%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(938)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(87)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $1 million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Includes $793 million and $1,631 million (primarily related to Auris Health), classified as non-current other liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.  Includes $3 million and $84 million classified as current liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company recorded a contingent consideration reversal of $983 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The one-time reversal of the contingent consideration was recorded in Other income and expense. As of June 28, 2020, the estimated fair value of the remaining contingent consideration is $169 million.  For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of June&#160;28, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"/><td style="width:21.308%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.827%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.631%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.481%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.827%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.454%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.578%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.282%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">655&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">655&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">978&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">242&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,046&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,961&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the fiscal year ended December&#160;29, 2019 the carrying amount was the same as the estimated fair value.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of government securities and obligations and corporate debt securities was estimated using quoted broker prices and significant other observable inputs.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of June&#160;28, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"/><td style="width:42.204%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:1.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:21.379%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.157%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.131%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,023&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,024&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,046&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of June&#160;28, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:78.938%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.359%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,332&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">360&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.250% Notes due 2022 (1B Euro 1.1217)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.25% Notes due 2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">998&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,029&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.73% Debentures due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.375% Notes due 2023</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05% Notes due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">523&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.650% Notes due 2024 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">864&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.50% Notes due 2024 (500 MM GBP 1.2431)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">618&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.625% Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">813&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2026</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.95% Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">997&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.90%&#160;Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,681&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.150% Notes due 2028 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">835&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">917&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.95% Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.95% Debentures due 2033</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">689&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.375% Notes due 2033</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.650% Notes due 2035 (1.5B Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,667&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.55% Notes due 2036</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.95% Notes due 2037</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.625% Notes due 2037</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.40%&#160;Notes due 2038</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.85% Debentures due 2038</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">696&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Debentures due 2040</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.85% Notes due 2041</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">420&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Notes due 2043</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.70% Notes due 2046</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,467&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.75% Notes due 2047</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.50% Notes due 2048</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">923&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,062&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The weighted average effective interest rate on non-current debt is 3.24%.</span></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The excess of the estimated fair value over the carrying value of debt was $3.0 billion at December 29, 2019.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Current Debt balance as of June 28, 2020 includes $2.7&#160;billion of commercial paper which has a weighted average interest rate of 0.15% and a weighted average maturity of 3.7 months.  There was no commercial paper as of December 29, 2019.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Fair value of the non-current debt was estimated using market prices, which were corroborated by quoted broker prices and significant other observable inputs.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256116216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">INCOME TAXES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The worldwide effective income tax rates for the fiscal six months of 2020 and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">2019 were 9.8% an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">d 18.4%, respectively. In the third fiscal quarter of 2019, Switzerland enacted the Federal Act on Tax Reform and AHV Financing (TRAF), which became effective on January 1, 2020.  More information on the provisions of TRAF, including the step-up transitional provisions, can be found in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. During the first fiscal quarter of 2020, the final canton where the Company maintains significant operations enacted TRAF legislation and, accordingly, the Company recorded an estimated deferred tax benefit of approximately $0.3 billion for the remeasurement of existing deferred tax liabilities offset by a related $0.2 billion increase in U.S. GILTI deferred taxes. During the second fiscal quarter of 2020, the Company received rulings from the Swiss Federal and cantonal tax authorities in the remaining jurisdictions where it has significant operations. These rulings resulted in the Company revising its estimate on the tax basis adjustment (i.e., &#8220;step-up&#8221;) for its assets. As a result, the Company recorded additional deferred tax benefits in the second fiscal quarter of 2020 to recognize this step-up.  Consequently, the benefit recorded related to Swiss Tax reform in the first six months of fiscal 2020 was approximately $0.4&#160;billion, or 3.8% benefit to the Company&#8217;s fiscal six months effective tax rate, inclusive of the impact of U.S. GILTI deferred taxes. The Company does not expect to receive future rulings regarding the transitional provisions of TRAF.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">During the second fiscal quarter of 2020, the Company reversed some of its international unrecognized tax benefits due to the completion of several years of tax examinations in certain jurisdictions. This reserve reversal benefited the Company&#8217;s effective tax rate by approximately 1.0% for the first fiscal six months of fiscal 2020. In the first fiscal quarter of 2020, the Company reduced a contingent consideration liability related to the 2019 Auris Health acquisition that has benefited the year to date overall effective tax rate by approximately 1.0% (see Note 10 to the Consolidated Financial Statements for more details.) </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">  Additionally, the Company had less income in higher tax jurisdictions relative to lower tax jurisdictions as compared to the same period in the prior fiscal year primarily due to:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the 2019 divestiture gain related to Advanced Sterilization Products (ASP) which was primarily taxed in the U.S. </span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the accrual of additional legal costs, at the U.S. statutory rate, in the second fiscal quarter of 2020 (see Notes 9 and  11 to the Consolidated Financial Statements for more details)</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">               partially offset by:</span></div><div style="text-indent:-18pt;padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">&#8226;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;padding-left:14.5pt;">the reduced income in lower tax jurisdictions due to the ongoing COVID-19 pandemic.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">  The Company also generated additional tax benefits from stock-based compensation that were either exercised or vested during the first and second fiscal quarters.</span></div><div style="margin-bottom:8pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">As of June&#160;28, 2020, the Company had approximately $3.1 billion of liabilities from unrecognized tax benefits. The Company conducts business and files tax returns in numerous countries and currently has tax audits in progress in a number of jurisdictions. With respect to the United States, the IRS has completed its audit for the tax years through 2009 and is currently auditing the tax years 2010 through 2012. The Company currently expects completion of this audit and settlement of the related tax liabilities in the fiscal year 2020. As of June 28, 2020, the Company has classified unrecognized tax benefits and related interest of approximately $0.2 billion as a current liability on the &#8220;Accrued taxes on Income&#8221; line of the Consolidated Balance Sheet. This is the amount expected to be paid over the next 12 months with respect to the IRS audit. During the first fiscal quarter of 2020, the Company made a payment of approximately $0.6 billion to the U.S. Treasury with respect to the 2010-2012 tax audit in anticipation of a final settlement later in the fiscal year 2020. The completion of this tax audit may result in additional adjustments to the Company&#8217;s unrecognized tax benefit liability. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%;">In other major jurisdictions where the Company conducts business, the years that remain open to tax audit go back to the year 2006. The Company believes it is possible that tax audits may be completed over the next twelve months by taxing authorities in some jurisdictions outside of the United States. However, the Company is not able to provide a reasonably reliable estimate of the timing of any other future tax payments relating to uncertain tax positions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256594552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Pensions and Other Benefit Plans</a></td>
<td class="text">PENSIONS AND OTHER BENEFIT PLANS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of Net Periodic Benefit Cost</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal second quarters and fiscal six months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"/><td style="width:24.548%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.832%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.412%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">649&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(608)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(581)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,164)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The service cost component of net periodic benefit cost is presented in the same line items on the Consolidated Statement of Earnings where other employee compensation costs are reported. All other components of net periodic benefit cost are presented as part of Other (income) expense, net on the Consolidated Statement of Earnings.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Company Contributions</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">For the fiscal six months ended June&#160;28, 2020, the Company contributed $144 million and $18 million to its U.S. and international retirement plans, respectively. The Company plans to continue to fund its U.S. defined benefit plans to comply with the Pension Protection Act of 2006. International plans are funded in accordance with local regulations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for pension and other postretirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530352830136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">ACCUMULATED OTHER COMPREHENSIVE INCOME<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"/><td style="width:33.874%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.014%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.762%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.846%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.819%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.406%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.091%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,705)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(295)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(963)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">358&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,668)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,501)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,533)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Amounts in accumulated other comprehensive income are presented net of the related tax impact.  Foreign currency translation is not adjusted for income taxes where it relates to permanent investments in international subsidiaries.  For additional details on comprehensive income see the Consolidated Statements of Comprehensive Income. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Details on reclassifications out of Accumulated Other Comprehensive Income:</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Securities - reclassifications released to Other (income) expense, net.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Employee Benefit Plans - reclassifications are included in net periodic benefit cost. See Note 6 for additional details.</span></div><div style="padding-left:36pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Gain/(Loss) On Derivatives &amp; Hedges - reclassifications to earnings are recorded in the same account as the underlying transaction. See Note 4 for additional details.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256269416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings Per Share</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal second quarters and fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:47.425%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.805%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.500%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.380%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.074%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.632%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.348%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.52&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,632.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,652.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,633.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,656.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">119.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(87.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(102.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(99.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,665.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,691.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,671.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,697.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.08&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The diluted net earnings per share calculation for both the fiscal second quarters ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;28, 2020 excluded 20 million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal second quarter ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value. </span></div>The diluted net earnings per share calculation for both the fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019 included the dilutive effect of convertible debt that was offset by the related reduction in interest expense.  The diluted net earnings per share calculation for the fiscal six months ended June&#160;28, 2020 excluded 15&#160;million shares related to stock options, as the exercise price of these options was greater than their average market value. The diluted net earnings per share calculation for the fiscal six months ended June&#160;30, 2019 excluded an insignificant number of shares related to stock options, as the exercise price of these options was greater than their average market value.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256069624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segments of Business and Geographic Areas</a></td>
<td class="text">SEGMENTS OF BUSINESS AND GEOGRAPHIC AREAS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">186&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">346&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">446&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">389&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">627&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">522&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">580&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,064&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,497&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">663&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">929&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,041&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">199&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">472&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">434&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">478&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">114&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,557&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,887&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,362&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,772&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,542&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,389&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,523&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">801&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,575&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">464&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">496&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">935&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">281&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">282&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">543&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">546&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,355&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,022&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,963&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.7</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94.0</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">452&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.1%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">416&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">744&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">946&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">964&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">878&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,798&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,708&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">246&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">659&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">314&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">535&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,089&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,526&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">809&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">875&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,719&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,587&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,538&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">212&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">576&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">642&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,608&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">182&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">361&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">691&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">719&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,013&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,609&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,684&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,448&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">883&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">901&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,838&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">367&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">898&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">831&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,032&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">994&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">568&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.9</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">439&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.3)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">503&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,534&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,346&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">375&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">282&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.2)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.6)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,849&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">701&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">771&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">286&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">261&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">211&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,783&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,365&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,632&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,746&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,705&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,886&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">385&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">750&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,482&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,649&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">894&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,779&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">343&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">429&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">725&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">322&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">517&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">761&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">824&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">533&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">672&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">490&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,606&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">490&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">926&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,334&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,821&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,551&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,353&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">396&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">658&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">800&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,065&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,029&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,009&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">530&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(59.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">676&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">687&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">701&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">695&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">509&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">842&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,666&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(64.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(49.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,083&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,760&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,288&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,948&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,797&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,051&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"/><td style="width:35.209%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.465%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.319%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.575%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.465%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.319%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.292%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">802&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(354)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:18pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,671&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,686&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(64.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(42.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,821&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,041&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,449&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal six months of 2019. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal second quarters of 2020 and 2019, primarily talc related costs, respectively. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, primarily talc related costs, respectively. Includes amortization expense of $0.1 billion in both the fiscal second quarters of 2020 and 2019, respectively and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, respectively. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal six months of 2019. Includes litigation expense of $0.4 billion in the fiscal six months of 2019. Includes an unrealized gain on securities of $0.5 billion and $0.2&#160;billion in the fiscal second quarter of 2020 and 2019, respectively. Includes an unrealized gain on securities of $0.2&#160;billion and $0.3&#160;billion in the fiscal six months of 2020 and 2019, respectively. Additionally, the fiscal six months of 2019 includes a research and development expense of $0.3 billion for an upfront payment related to argenx. Includes amortization expense of $0.8 billion in both the fiscal second quarters of 2020 and 2019. Includes amortization expense of $1.6&#160;billion in both the fiscal six months of 2020 and 2019. In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement.  Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. </span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes a contingent consideration reversal of $1.0 billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal second quarter and six months of 2019. Includes litigation expense of $0.2 billion and $0.3&#160;billion in the fiscal second quarter and fiscal six months of 2019, respectively. Includes a restructuring related charge of $0.1 billion and </span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">amortization expense of $0.2 billion in both the fiscal second quarters of 2020 and 2019.  Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.5&#160;billion in both the fiscal six months of 2020 and 2019. </span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(4)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Amounts not allocated to segments include interest income/expense and general corporate income/expense. </span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"/><td style="width:31.138%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.094%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.510%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.343%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.094%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.510%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.353%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,063&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,733&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,958&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,601&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,971&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,264&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,751&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254649720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Divestitures<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Business Combinations and Divestitures</a></td>
<td class="text">BUSINESS COMBINATIONS AND DIVESTITURES<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Subsequent to the quarter, on July 9, 2020, the Company sold 11.8&#160;million shares of Idorsia LTD (&#8220;Idorsia&#8221;), or its 8.3% ownership in the company, via an accelerated bookbuild offering. The transaction resulted in gross proceeds of approximately CHF337&#160;million ($357&#160;million) based on a sales price of CHF 28.55/share. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">The Company currently has rights to at least an additional 38.7&#160;million shares (or approximately 20% of Idorsia equity) through a convertible loan with a principal amount of CHF 445&#160;million (due June 2027). Idorsia also has access to an approximate CHF 243&#160;million credit facility with the Company. As of June 28, 2020, Idorsia has not made any draw-downs under the credit facility.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company completed the acquisition of all rights to the investigational compound bermekimab, which has multiple dermatological indications, along with certain employees from XBiotech Inc., for a purchase price of $0.8 billion. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $0.8 billion. XBiotech may be eligible to receive additional payments upon the receipt of certain commercialization authorizations. The transaction was accounted for as a business combination and included in the Pharmaceutical segment. Additionally, the Company completed the acquisition of all outstanding shares in Verb Surgical Inc., a company with world-class robotics and data science capabilities, including those shares previously held by Verily. The transaction was accounted for as a business combination and included in the Medical Devices segment. The fair value of the acquisition was allocated primarily to non-amortizable intangible assets, primarily IPR&amp;D, for $0.4 billion, goodwill for $0.2 billion, other assets of $0.2 billion and liabilities assumed of $0.3 billion. The fair value of the Company's previously held equity investment in Verb Surgical Inc. was $0.4 billion. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company completed the divestiture of its ASP business to Fortive Corporation for an aggregate value of approximately $2.8&#160;billion, consisting of $2.7&#160;billion of cash proceeds and $0.1&#160;billion of retained net receivables.  The Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $2.0&#160;billion.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On April 1, 2019, the Company&#160;completed the acquisition of Auris Health, Inc. for approximately $3.4 billion, net of cash acquired. Additional contingent payments of up to $2.35 billion, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health was a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. The Company treated this transaction as a business combination and included it in the Medical Devices segment. The fair value of the acquisition was allocated primarily to amortizable and non-amortizable intangible assets, primarily IPR&amp;D, for $3.0 billion, goodwill for $2.0 billion, marketable securities of $0.2 billion and liabilities assumed of $1.8 billion, which includes the fair value of the contingent payments mentioned above. During the fiscal second quarter of 2020, the Company finalized the purchase price allocation.  There were no valuation adjustments to the assets acquired but during the fiscal first quarter of 2020, the Company recorded Other income of approximately $1.0 billion for the reversal of the contingent consideration related to the timing of certain developmental and commercial milestones, which are not expected to be met based on the Company&#8217;s current timelines. As of June 28, 2020, the fair value of the remaining contingent consideration is $0.2 billion. Further, the Company re-assessed the current value of the Auris IPR&amp;D assets in connection with the modified development timeline and determined the fair value still exceeds the carrying value. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">On January 17, 2019, the Company acquired DR. CI:LABO, a Japanese company focused on the marketing, development and distribution of a broad range of dermocosmetic, cosmetic and skincare products for a total purchase price of approximately &#165;230 billion, which equates to approximately $2.1 billion, using the exchange rate of 109.06 Japanese Yen to each U.S. Dollar on January 16, 2019. Additionally, in the fiscal first quarter of 2019, the Company recognized a pre-tax gain recorded in Other (income) expense, net, of approximately $0.3 billion related to the Company's previously held equity investment in DR. CI:LABO. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company treated this transaction as a business combination and included it in the Consumer Health segment. During the fiscal first quarter of 2020, the Company finalized the purchase price allocation. The fair value of the acquisition was allocated primarily to amortizable intangible assets for $1.5 billion, goodwill for $1.2 billion and liabilities assumed of $0.4 billion. The adjustments made since the date of acquisition were $0.1 billion to intangible assets, accrued liabilities, deferred taxes on income and property, plant and equipment with the offset to goodwill. The amortizable intangible assets were comprised of brand/trademarks and customer relationships with a weighted average life of 15.3 years. The goodwill is primarily attributable to synergies expected to arise from the business acquisition and is not expected to be deductible for tax purposes.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal third quarter of 2018, the Company accepted a binding offer to form a strategic collaboration with Jabil Inc., one of the world&#8217;s leading manufacturing services providers for health care products and technology products.&#160;The Company is </span></div>expanding a 12-year relationship with Jabil Inc. to produce a range of products within the Ethicon Endo-Surgery and DePuy Synthes businesses. This transaction includes the transfer of certain employees and manufacturing sites. The majority of the transfers were completed in 2019 with a minor amount remaining in 2020.&#160;As of June 28, 2020, the assets held for sale on the Consolidated Balance Sheet were $0.1 billion of inventory and property, plant and equipment, net. For additional details on the global supply chain restructuring see Note 12 to the Consolidated Financial Statements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530255994728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Legal Proceedings</a></td>
<td class="text">LEGAL PROCEEDINGS<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in various lawsuits and claims regarding product liability; intellectual property; commercial; supplier indemnification and other matters; governmental investigations; and other legal proceedings that arise from time to time in the ordinary course of their business. Due to the ongoing impacts of the COVID-19 pandemic, certain trials have been rescheduled or delayed.  The Company continues to monitor its legal proceedings as the situation develops.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company records accruals for loss contingencies associated with these legal matters when it is probable that a liability will be incurred, and the amount of the loss can be reasonably estimated. As of June&#160;28, 2020, the Company has determined that the liabilities associated with certain litigation matters are probable and can be reasonably estimated. The Company has accrued for these matters and will continue to monitor each related legal issue and adjust accruals as might be warranted based on new information and further developments in accordance with ASC 450-20-25. For these and other litigation and regulatory matters discussed below for which a loss is probable or reasonably possible, the Company is unable to estimate the possible loss or range of loss beyond the amounts already accrued. Amounts accrued for legal contingencies often result from a complex series of judgments about future events and uncertainties that rely heavily on estimates and assumptions including timing of related payments. The ability to make such estimates and judgments can be affected by various factors including, among other things, whether damages sought in the proceedings are unsubstantiated or indeterminate; scientific and legal discovery has not commenced or is not complete; proceedings are in early stages; matters present legal uncertainties; there are significant facts in dispute; procedural or jurisdictional issues; the uncertainty and unpredictability of the number of potential claims; or there are numerous parties involved. To the extent adverse verdicts have been rendered against the Company, the Company does not record an accrual until a loss is determined to be probable and can be reasonably estimated.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In the Company's opinion, based on its examination of these matters, its experience to date and discussions with counsel, the ultimate outcome of legal proceedings, net of liabilities accrued in the Company's balance sheet, is not expected to have a material adverse effect on the Company's financial position. However, the resolution of, or increase in accruals for, one or more of these matters in any reporting period may have a material adverse effect on the Company's results of operations and cash flows for that period.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">PRODUCT LIABILITY</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and certain of its subsidiaries are involved in numerous product liability claims and lawsuits involving multiple products. Claimants in these cases seek substantial compensatory and, where available, punitive damages. While the Company believes it has substantial defenses, it is not feasible to predict the ultimate outcome of litigation. From time to time, even if it has substantial defenses, the Company considers isolated settlements based on a variety of circumstances. The Company has established accruals for product liability claims and lawsuits in compliance with ASC 450-20 based on currently available information, which in some cases may be limited. The Company accrues an estimate of the legal defense costs needed to defend each matter when those costs are probable and can be reasonably estimated. For certain of these matters, the Company has accrued additional amounts such as estimated costs associated with settlements, damages and other losses. Product liability accruals can represent projected product liability for thousands of claims around the world, each in different litigation environments and with different fact patterns. Changes to the accruals may be required in the future as additional information becomes available.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The most significant of these cases include: the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; pelvic meshes; RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; body powders containing talc, primarily JOHNSONS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder; INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; and ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh. As of June&#160;28, 2020, in the United States there were approximately 800 plaintiffs with direct claims in pending lawsuits regarding injuries allegedly due to the DePuy ASR&#8482; XL Acetabular System and DePuy ASR&#8482; Hip Resurfacing System; 8,600 with respect to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System; 15,600 with respect to pelvic meshes; 10,600 with respect to RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; 21,000 with respect to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">; 20,600 with respect to body powders containing talc; 300 with respect to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">;</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and 3,700 with respect to ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2010, DePuy Orthopaedics, Inc. (DePuy) announced a worldwide voluntary recall of its ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XL Acetabular System and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip Resurfacing System used in hip replacement surgery. Claims for personal injury have been made against DePuy and Johnson &amp; Johnson. The number of pending lawsuits is expected to fluctuate as certain lawsuits are settled or dismissed and additional lawsuits are filed. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Ohio. Litigation has also been filed in countries outside of the United States, primarily in the United Kingdom, Canada, Australia, Ireland, Germany, India and Italy. In November 2013, DePuy reached an agreement with a Court-appointed committee of lawyers representing ASR Hip System plaintiffs to establish a program to settle claims with eligible ASR Hip patients in the United States who had surgery to replace their ASR Hips, known as revision surgery, as of August 31, 2013. DePuy reached additional agreements in February 2015 and March 2017, which further extended the settlement program to include ASR Hip patients who had revision surgeries after August 31, 2013 and prior to February 15, 2017. This settlement program has resolved more than 10,000 claims, therefore bringing to resolution significant ASR Hip litigation activity in the United States. However, lawsuits in the United States remain, and the settlement program does not address litigation outside of the United States. In Australia, a class action settlement was reached that resolved the claims of the majority of ASR Hip patients in that country. In Canada, the Company has reached agreements to settle two pending class actions which have been approved by the Qu&#233;bec Superior Court and the Supreme Court of British Columbia. The British Columbia order is currently the subject of the Company's appeal to broaden the scope of participants. The Company continues to receive information with respect to potential additional costs associated with this recall on a worldwide basis. The Company has established accruals for the costs associated with the United States settlement program and DePuy ASR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Hip-related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have also been made against DePuy Orthopaedics, Inc. and Johnson &amp; Johnson (collectively, DePuy) relating to the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System used in hip replacement surgery.  Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Northern District of Texas. Litigation has also been filed in some state courts and in countries outside of the United States.  Several adverse verdicts have been rendered against DePuy, one of which was reversed on appeal and remanded for retrial.  During the first quarter of 2019, DePuy established a United States settlement program to resolve these cases. As part of the settlement program, adverse verdicts have been settled. The Company has established an accrual for product liability litigation associated with the PINNACLE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Acetabular Cup System and the related settlement program.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Claims for personal injury have been made against Ethicon, Inc. (Ethicon) and Johnson &amp; Johnson arising out of Ethicon's pelvic mesh devices used to treat stress urinary incontinence and pelvic organ prolapse. The Company continues to receive information with respect to potential costs and additional cases. Cases filed in federal courts in the United States had been organized as a multi-district litigation (MDL) in the United States District Court for the Southern District of West Virginia. The MDL Court is remanding cases for trial to the jurisdictions where the case was originally filed and additional pelvic mesh lawsuits have been filed, and remain, outside of the MDL.  The Company has settled or otherwise resolved a majority of the United States cases and the estimated costs associated with these settlements and the remaining cases are reflected in the Company's accruals. In addition, class actions and individual personal injury cases or claims have been commenced in various countries outside of the United States, including claims and cases in the United Kingdom, the Netherlands, and class actions in Israel, Australia and Canada, seeking damages for alleged injury resulting from Ethicon's pelvic mesh devices.  In November 2019, the Federal Court of Australia issued a judgment regarding its findings with respect to liability in relation to the three Lead Applicants and generally in relation to the design, manufacture, pre and post-market assessments and testing, and supply and promotion of the devices in Australia used to treat stress urinary incontinence and pelvic organ prolapse. In March 2020, the Court entered damages awards to the three Lead Applicants.  With respect to other group members, there will be an individual case assessment process which will require proof of use and causally related loss.  The class actions in Canada are expected to be discontinued in 2020 as a result of a settlement of a group of cases. The Company has established accruals with respect to product liability litigation associated with Ethicon's pelvic mesh product</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">s. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Following a June 2016 worldwide market withdrawal of ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Flexible Composite Mesh, claims for personal injury have been made against Ethicon, Inc. and Johnson &amp; Johnson alleging personal injury arising out of the use of this hernia mesh device.&#160; Cases filed in federal courts in the United States have been organized as a multi-district litigation (MDL) in the United States District Court for the Northern District of Georgia. A multi-county litigation (MCL) has also been formed in New Jersey state court and assigned to Atlantic County for cases pending in New Jersey.  In addition to the matters in the MDL and MCL, there are additional lawsuits pending in the United States District Court for the Southern District of Ohio, which are part of the MDL for polypropylene mesh devices manufactured by C.R. Bard, Inc., and lawsuits pending outside the United States.   </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Along with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> lawsuits, there were a number of filings related to the PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch products.  In March 2019, the New Jersey Supreme Court entered an order consolidating all </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch cases as an MCL in Atlantic County Superior Court.  Additional cases have been filed in various federal and state courts in the US, and in jurisdictions outside the US.  The Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has established accruals with respect to product liability litigation associated with ETHICON PHYSIOMESH</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Flexible Composite Mesh, PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Mesh and PROCEED</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Ventral Patch products. In September 2019, plaintiffs&#8217; attorney filed an application with the New Jersey Supreme Court seeking centralized management of 107 PROLENE&#8482; Polypropylene Hernia System cases.  The New Jersey Supreme Court granted plaintiffs application in January 2020 and those cases have been transferred to an MCL in Atlantic County Superior Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson arising out of the use of RISPERDAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and related compounds, indicated for the treatment of schizophrenia, acute manic or mixed episodes associated with bipolar I disorder and irritability associated with autism. Lawsuits have been primarily filed in state courts in Pennsylvania, California, and Missouri. Other actions are pending in various courts in the United States and Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has successfully defended a number of these cases but there have been verdicts against the Company, including a recent verdict in October 2019 of $8 billion of punitive damages related to one single plaintiff which was subsequently reduced in January 2020 to $6.8 million by the trial judge. The Company will appeal the final judgment. The Company has settled or otherwise resolved many of the United States cases and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury arising out of the use of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, an oral anticoagulant, have been made against Janssen Pharmaceuticals, Inc. (JPI); Johnson &amp; Johnson (J&amp;J); and JPI&#8217;s collaboration partner for XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, Bayer AG and certain of its affiliates. Cases filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the Eastern District of Louisiana. In addition, cases have been filed in state courts across the United States. Many of these cases have been consolidated into a state mass tort litigation in Philadelphia, Pennsylvania and in a coordinated proceeding in Los Angeles, California. Class action lawsuits also have been filed in Canada. In March 2019, JPI and J&amp;J announced an agreement in principle to the settle the XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> cases in the United States; the settlement agreement was executed in May 2019, the settlement became final in December 2019, and the settlement was funded in January 2020.  This resolved the majority of cases pending in the United States. The Company has established accruals for its costs associated with the United States settlement program and XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> related product liability litigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Personal injury claims alleging that talc causes cancer have been made against Johnson &amp; Johnson Consumer Inc. and Johnson &amp; Johnson arising out of the use of body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  The number of pending personal injury lawsuits continues to increase, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. Lawsuits have been primarily filed in state courts in Missouri, New Jersey and California, and suits have also been filed outside the United States. The majority of cases are pending in federal court, organized into a multi-district litigation in the United States District Court for the District of New Jersey. In the multi-district litigation, the parties have sought to exclude experts, through Daubert motions.  In April 2020, the Court issued rulings that limit the scope of testimony, including some theories and testing methods, for certain plaintiff expert witnesses and denied  plaintiffs&#8217; attempt to limit the scope of testimony of certain of the Company&#8217;s witnesses.  With this ruling made, the court has now ordered case-specific discovery to proceed.  In talc cases that have previously gone to trial, the Company has obtained defense verdicts in a number of these cases but there have also been verdicts against the Company, many of which have been reversed on appeal.  Most recently, in June 2020, the Missouri Court of Appeals reversed in part and affirmed in part a July 2018 verdict of $4.7&#160;billion, reducing the overall award to $2.1&#160;billion. The Company believes that it has strong grounds to seek further review and/or appeal of this verdict, as well as other verdicts that it has appealed. Notwithstanding the Company&#8217;s confidence in the safety of its talc products, in certain circumstances the Company has and may settle cases.  The Company has established an accrual primarily for defense costs, and reserves for potential settlement of currently pending mesothelioma cases, in connection with product liability litigation associated with body powders containing talc.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, the Company&#8217;s talc supplier, Imerys Talc America, Inc. and two of its affiliates, Imerys Talc Vermont, Inc. and Imerys Talc Canada, Inc. (collectively, Imerys) filed a voluntary chapter 11 petition commencing a reorganization under the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (Imerys Bankruptcy).&#160; The Imerys Bankruptcy relates to Imerys&#8217; potential liability for personal injury from exposure to talcum powder sold by Imerys (Talc Claims).&#160; In its bankruptcy filing, Imerys noted certain claims it alleges it has against the Company for indemnification and rights to joint insurance proceeds.&#160; Based on such claims as well as indemnity and insurance claims the Company has against Imerys, the Company petitioned the United States District Court for the District of Delaware to establish federal jurisdiction of the state court talc lawsuits under the Bankruptcy Code.&#160; The Company's petition was denied and the state court talc lawsuits that have been removed to federal court on such basis have been remanded.&#160;&#160;The Company previously proposed to resolve Imerys' (and the Company&#8217;s) obligations arising out of the Talc Claims by agreeing to assume the defense of litigation </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">of all Talc Claims involving the Company's products, waiving the Company&#8217;s indemnification claims against Imerys, and lifting the automatic stay to enable the Talc Claims to proceed outside the bankruptcy forum with the Company agreeing to settle or pay any judgment against Imerys. In May 2020, Imerys and the asbestos claimants&#8217; committee filed their Plan of Reorganization and the Disclosure Statement related thereto agreeing to put its North American operations up for auction. The Bankruptcy Court will hold a hearing to consider approval of the Disclosure Statement on August 26, 2020 and the Company is disputing any indemnification objections and the scope of coverage in the reorganization plan. Additionally, in June 2020, Cyprus Mines Corporation and its parent filed an adversary proceeding against the Company as well as Imerys seeking a declaration of indemnity under certain contractual agreements.  The Company denies such indemnification is owed and is in the process of responding to the complaint</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In February 2018, a securities class action lawsuit was filed against Johnson &amp; Johnson and certain named officers in the United States District Court for the District of New Jersey, alleging that Johnson &amp; Johnson violated the federal securities laws by failing to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder, and that purchasers of Johnson &amp; Johnson&#8217;s shares suffered losses as a result.  Plaintiffs are seeking damages. In April 2019, the Company moved to dismiss the complaint and briefing on the motion was complete as of August 2019.  In December 2019, the Court denied, in part, the motion to dismiss.  In March 2020, Defendants answered the complaint. Discovery is underway.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, a shareholder filed a complaint initiating a summary proceeding in New Jersey state court for a books and records inspection. In August 2019, Johnson &amp; Johnson responded to the books and records complaint and filed a cross motion to dismiss. In September 2019, Plaintiff replied and the Court heard oral argument.  The Court has not yet ruled in the books and records action.  In October 2019, December 2019, and January 2020, four shareholders filed four separate derivative lawsuits against Johnson &amp; Johnson as the nominal defendant and its current directors and certain officers as defendants in the United States District Court for the District of New Jersey, alleging a breach of fiduciary duties related to the alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In February 2020, the four cases were consolidated into a single action under the caption </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">In re Johnson &amp; Johnson Talc Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and the shareholders have until August 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. </span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative lawsuits.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2019, two ERISA class action lawsuits were filed by participants in the Johnson &amp; Johnson Savings Plan against Johnson &amp; Johnson, its Pension and Benefits Committee, and certain named officers in the United States District Court for the District of New Jersey, alleging that the defendants breached their fiduciary duties by offering Johnson &amp; Johnson stock as a Johnson &amp; Johnson Savings Plan investment option when it was imprudent to do so because of failures to disclose alleged asbestos contamination in body powders containing talc, primarily JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Baby Powder.  Plaintiffs are seeking damages and injunctive relief. In September 2019, Defendants filed a motion to dismiss. In April 2020, the Court granted Defendants&#8217; motion but granted leave to amend.  On June 15, 2020, Plaintiffs filed an amended complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">A lawsuit is pending in the Superior Court of California for the County of San Diego alleging violations of California&#8217;s Consumer Legal Remedies Act relating to JOHNSON&#8217;S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder.  In that lawsuit, the plaintiffs allege that Johnson &amp; Johnson violated the CLRA by failing to provide required Proposition 65 warnings.  In July 2019, the Company filed a notice of removal to the United States District Court for the Southern District of California and plaintiffs filed a second amended complaint shortly thereafter.  In October 2019, the Company moved to dismiss the second amended complaint for failure to state a claim upon which relief may be granted.  In response to those motions, plaintiffs filed a third amended complaint.  In December 2019, the Company moved to dismiss the third amended complaint for failure to state a claim upon which relief may be granted.  In April 2020, the Court granted the motion to dismiss but granted leave to amend. In May 2020, plaintiffs filed a Fourth Amended Complaint but indicated that they would be filing a motion for leave to file a fifth amended complaint.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the Abtahi Law Group filed an action under Proposition 65 against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Inc. as well as a number of other alleged talcum powder manufacturers and distributors, including one California company.  In that action, the plaintiff alleges contamination of talcum powder products with unsafe levels of arsenic, hexavalent chromium and lead.  The plaintiff seeks civil penalties and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In addition, the Company has received preliminary inquiries and subpoenas to produce documents regarding these matters from Senator Murray, a member of the Senate Committee on Health, Education, Labor and Pensions, the Department of Justice, the </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Securities and Exchange Commission and the U.S. Congressional Subcommittee on Economic and Consumer Policy.  The Company is cooperating with government inquiries and continues to produce documents in response. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Claims for personal injury have been made against a number of Johnson &amp; Johnson companies, including Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson, arising out of the use of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, a prescription medication indicated to improve glycemic control in adults with Type 2 diabetes. Lawsuits filed in federal courts in the United States have been organized as a multi-district litigation in the United States District Court for the District of New Jersey. Cases have also been filed in state courts. Class action lawsuits have been filed in Canada. Product liability lawsuits continue to be filed, and the Company continues to receive information with respect to potential costs and the anticipated number of cases. The Company has settled or otherwise resolved many of the cases and claims in the United States and the costs associated with these settlements are reflected in the Company's accruals.</span></div><div style="margin-bottom:10pt;"><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">INTELLECTUAL PROPERTY</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain subsidiaries of Johnson &amp; Johnson are subject, from time to time, to legal proceedings and claims related to patent, trademark and other intellectual property matters arising out of their businesses. Many of these matters involve challenges to the coverage and/or validity of the patents on various products and allegations that certain of the Company&#8217;s products infringe the patents of third parties. Although these subsidiaries believe that they have substantial defenses to these challenges and allegations with respect to all significant patents, there can be no assurance as to the outcome of these matters. A loss in any of these cases could adversely affect the ability of these subsidiaries to sell their products, result in loss of sales due to loss of market exclusivity, require the payment of past damages and future royalties, and may result in a non-cash impairment charge for any associated intangible asset. The most significant of these matters are described below.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Medical Devices</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2013, Medinol Ltd. (Medinol) filed a patent infringement lawsuit against Cordis Corporation (Cordis) and Johnson &amp; Johnson in the United States District Court for the Southern District of New York alleging that Cordis&#8217;s sales of the CYPHER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and CYPHER SELECT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#8482;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> stents made in the United States since 2005 willfully infringed four of Medinol's patents directed to the geometry of articulated stents. Although Johnson &amp; Johnson has since sold Cordis, it has retained liability for this case. After the trial in January 2014, the district court dismissed the case, finding Medinol unreasonably delayed bringing its claims (the laches defense). In September 2014, the district court denied a motion by Medinol to vacate the judgment and grant it a new trial. Medinol appealed the decision to the United States Court of Appeals for the Federal Circuit. In March 2017, the United States Supreme Court held that the laches defense is not available in patent cases.  In April 2018, the United States Court of Appeals for the Federal Circuit remanded the case back to the district court to reconsider Medinol&#8217;s motion for a new trial. In March 2019, the district court denied Medinol&#8217;s motion for a new trial. Medinol appealed, and in June 2020, the United States Court of Appeals for the Federal Circuit affirmed the district court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2016, MedIdea, L.L.C. (MedIdea) filed a patent infringement lawsuit against DePuy Orthopaedics, Inc. in the United States District Court for the Northern District of Illinois alleging infringement by the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Knee System. In April 2017, MedIdea filed an amended complaint adding DePuy Synthes Products, Inc. and DePuy Synthes Sales, Inc. as named defendants (collectively, DePuy).  MedIdea alleges infringement of United States Patent Nos. 6,558,426 (&#8217;426); 8,273,132 (&#8217;132); 8,721,730 (&#8217;730)   and 9,492,280 (&#8217;280) relating to posterior stabilized knee systems. Specifically, MedIdea alleges that the SOFCAM</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">TM</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Contact feature of the ATTUNE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> posterior stabilized knee products infringes the patents-in-suit. MedIdea is seeking monetary damages and injunctive relief. In June 2017, the case was transferred to the United States District Court for the District of Massachusetts.  A claim construction hearing was held in October 2018, and a claim construction order was issued in November 2018. In December 2018, MedIdea stipulated to non-infringement of the &#8217;132, &#8217;730 and &#8217;280 patents, based on the district court&#8217;s claim construction and reserving its right to appeal that construction, leaving only the &#8217;426 patent at issue before the district court. In May 2019, DePuy filed a motion for summary judgment of non-infringement of the claims of the &#8217;426 patent. In November 2019, judgment was entered in favor of DePuy.  In December 2019, MedIdea filed a notice of appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2016, Ethicon Endo-Surgery, Inc. and Ethicon Endo-Surgery, LLC (now known as Ethicon LLC) sued Covidien, Inc. in the United States District Court for the District of Massachusetts seeking a declaration that United States Patent Nos. 6,585,735 (the &#8217;735 patent); 7,118,587; 7,473,253; 8,070,748 and 8,241,284 (the &#8217;284 patent), are either invalid or not infringed by Ethicon&#8217;s ENSEAL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> X1 Large Jaw Tissue Sealer product. In April 2017, Covidien LP, Covidien Sales LLC, and Covidien AG (collectively, Covidien) answered and counterclaimed, denying the allegations, asserting willful infringement of the &#8217;735 patent, the &#8217;284 patent and United States Patent Nos. 8,323,310 (the &#8217;310 patent); 9,084,608; 9,241,759 (the &#8217;759 patent) and 9,113,882, and seeking damages and an injunction. In June 2020, after a bench trial, the district court entered judgment in Ethicon&#8217;s favor.  In July 2020, Covidien filed a notice of appeal.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2016, Dr. Ford Albritton sued Acclarent, Inc. (Acclarent) in United States District Court for the Northern District of Texas alleging that Acclarent&#8217;s RELIEVA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Spin and RELIEVEA SpinPlus</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> products infringe U.S. Patent No. 9,011,412 (the &#8217;412 patent).  Dr. Albritton also alleges breach of contract, fraud and that he is the true owner of Acclarent&#8217;s U.S. Patent No. 8,414,473. Trial is scheduled to begin in March 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Board of Regents, The University of Texas System and TissueGen, Inc. (collectively, UT) filed a lawsuit in the United States District Court for the Western District of Texas against Ethicon, Inc. and Ethicon US, LLC alleging the manufacture and sale of VICRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures, STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Antibacterial Sutures and STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> MONOCRYL</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plus Antibacterial Sutures infringe plaintiffs&#8217; United States Patent Nos. 6,596,296 (the &#8217;296 patent) and 7,033,603 (the &#8217;603 patent) directed to implantable polymer drug releasing biodegradable fibers containing a therapeutic agent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT is seeking damages and an injunction.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Ethicon filed petitions with the United States Patent and Trademark Office (USPTO), seeking Inter Partes Review (IPR) of both asserted patents. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2020,the USPTO denied institution of the &#8217;296 patent IPR and granted institution of the &#8217;603 patent IPR.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UT dismissed the &#8217;603 patent from the suit and no longer accuses PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures or STRATAFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> PDS</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Plus Antibacterial Sutures of infringement. The previously scheduled district court trial has been postponed.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In August 2018, Intuitive Surgical, Inc. and Intuitive Surgical Operations, Inc. (&#8220;Intuitive&#8221;) filed a patent infringement suit against Auris Health, Inc. (&#8220;Auris&#8221;) in United States District Court for the District of Delaware.  In the suit, Intuitive alleges willful infringement of U.S. Patent Nos. 6,246,200 (&#8217;200 patent); 6,491,701 (&#8217;701 patent); 6,522,906 (&#8217;906 patent); 6,800,056 (&#8217;056 patent); 8,142,447 (&#8217;447 patent); 8,620,473 (&#8217;473 patent); 8,801,601 (&#8217;601 patent); and 9,452,276 (&#8217;276 patent) based on Auris&#8217; Monarch&#8482; Platform.  Auris filed IPR Petitions with the USPTO regarding the &#8217;200, &#8217;056, &#8217;601 &#8217;701, &#8217;447, &#8217;276 and &#8217;906 patents.   Intuitive subsequently dropped the &#8217;200 and &#8217;701 patents from the suit.  In December 2019, the USPTO instituted review of the &#8217;601 patent and denied review of the &#8217;056 patent.  In February and March 2020, the USPTO instituted review of the &#8217;200, &#8217;447, &#8217;701 and &#8217;906 patents and denied review of the &#8217;276 patent.   The district court trial is scheduled to begin in January 2021.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2019, RSB Spine LLC (&#8220;RSB Spine&#8221;) filed a patent infringement suit against DePuy Synthes, Inc. in United States District Court for the District of Delaware.  In October 2019, RSB Spine amended the complaint to change the named defendants to DePuy Synthes Sales, Inc. and DePuy Synthes Products, Inc.  In the suit, RSB Spine alleges willful infringement of United States Patent Nos. 6,984,234 and 9,713, 537 by one or more of the following products:  ZERO-P-VA&#8482; Spacer, ZERO-P</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Spacer, ZERO-P NATURAL&#8482; Plate, SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> LR Spacer and SYNFIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Evolution System.  RSB Spine seeks monetary damages and injunctive relief. In November 2019, the suit was consolidated for pre-trial purposes with other patent infringement suits brought by RSB Spine in the United States District Court for the District of Delaware against Life Spine, Inc., Medacta USA, Inc., Precision Spine, Inc., and Xtant Medical Holdings, Inc. In June 2020, the case was stayed pending IPR proceedings involving the asserted patents. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In March 2020, Osteoplastics, LLC filed a patent infringement suit against DePuy Synthes, Inc., DePuy Synthes Products, Inc., Medical Device Business Services, Inc., and Synthes, Inc. (collectively, DePuy Synthes)  in the United States District Court for the District of Delaware.  In the suit, Osteoplastics alleges willful infringement of U.S. Patent Nos. 8,781,557; 9,929,920; 9,330,206; 9,626,756; 9,672,617; 9,672,302; and 9,275,191 based on the PROPLAN CMF</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">Virtual Surgical Planning Services and the TruMatch</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> CMF Personalize Solutions.  In April 2020, Osteoplastics filed an amended complaint to substitute U.S. Patent No. 9, 292,920 for U.S. Patent No. 9,929,920.  Osteoplastics seeks monetary damages and injunctive relief. In June 2020, DePuy Synthes filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Pharmaceutical</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Litigation Against Filers of Abbreviated New Drug Applications (ANDAs)</span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following summarizes lawsuits pending against generic companies that have filed Abbreviated New Drug Applications (ANDAs) with the FDA or undertaken similar regulatory processes outside of the United States, seeking to market generic forms of products sold by various subsidiaries of Johnson &amp; Johnson prior to expiration of the applicable patents covering those products. These ANDAs typically include allegations of non-infringement and invalidity of the applicable patents. In the event the subsidiaries are not successful in an action, or the automatic statutory stay of the ANDAs expires before the United States District Court rulings are obtained, the third-party companies involved would have the ability, upon approval of the FDA, to introduce generic versions of their products to the market, resulting in the potential for substantial market share and revenue losses for the applicable products, and which may result in a non-cash impairment charge in any associated intangible asset. In addition, from time to time, subsidiaries may settle these types of actions and such settlements can involve the introduction of </span></div><div style="margin-bottom:12pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">generic versions of the products at issue to the market prior to the expiration of the relevant patents. The IPR process with the USPTO, created under the 2011 America Invents Act, is also being used at times by generic companies in conjunction with ANDAs and lawsuits, to challenge the applicable patents.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2017, Janssen initiated a Notice of Application under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) and the Minister of Health in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,661,422 (the &#8217;422 patent).  The final hearing concluded in May 2019.  In October 2019, the court issued an order prohibiting the Canadian Minister of Health from approving Apotex&#8217;s ANDS until the expiration of the &#8217;422 patent.  In November 2019, Apotex filed an appeal.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex in Canada in response to Apotex&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a film-coated generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) in Canada in response to Pharmascience&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;   </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">250 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the  &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience in Canada in response to Pharmascience&#8217;s filing of an ANDS seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, 500 mg, before the expiration of the &#8217;422 patent.  The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Dr. Reddy's Laboratories Ltd. and Dr. Reddy's Laboratories, Inc. (collectively, DRL) in Canada in response to DRL's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent. The final hearing is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen is seeking an order enjoining the defendants from marketing their generic versions of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;422 patent.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in April 2017, Janssen Pharmaceuticals, Inc. (JPI) and Bayer Pharma AG and Bayer Intellectual Property GmbH (collectively, Bayer) filed patent infringement lawsuits in the United States District Court for the District of Delaware against Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. (collectively, Taro) and InvaGen Pharmaceuticals Inc. (InvaGen) who filed ANDAs seeking approval to market generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of Bayer AG&#8217;s United States Patent No. 9,539,218 (&#8217;218) relating to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. JPI is the exclusive sublicensee of the asserted patent. The case against InvaGen has been stayed.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, JPI and Bayer AG entered into a settlement agreement with Taro. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In May 2020, JPI and Bayer AG filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against Unichem Inc. (a/k/a Unichem Laboratories, Ltd.) and Unichem Pharmaceuticals (USA), Inc.(collectively, Unichem) who filed an ANDA seeking approval to market a generic version of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before expiration of </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">the &#8217;218 patent and United States Patent No. 7,157,456 relating</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">to XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, JPI is seeking an order enjoining the defendants from marketing their generic versions of XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, Janssen Products, L.P. and Janssen Sciences Ireland Unlimited Company (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Ltd. (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of United States Patent Nos. 7,700,645, 8,518,987, 7,126,015 and 7,595,408.  Janssen was </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">seeking an order enjoining Zydus from marketing its generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the relevant patents. In June 2020, Janssen entered into a settlement agreement with Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In April 2020, Janssen initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Marcan Pharmaceuticals Inc. (Marcan) in Canada in response to Marcan&#8217;s filing of an ANDS seeking approval to market a generic version of Prezista before the expiration of Canadian Patent No. 2,485,834 (the &#8217;834 patent).  Janssen was seeking an order enjoining Marcan from marketing its generic version of PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> before the expiration of the &#8217;834 patent. In May 2020, Janssen discontinued the action against Marcan.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;">  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">/INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in July 2017, Janssen Pharmaceuticals, Inc., Janssen Research &amp; Development, LLC, Cilag GmbH International and Janssen Pharmaceutica NV (collectively, Janssen) and Mitsubishi Tanabe Pharma Corporation (MTPC) filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR before expiration of MTPC&#8217;s United States Patent Nos. 7,943,582 (the &#8217;582 patent) and/or 8,513,202 (the &#8217;202 patent) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR. Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:  Apotex Inc. and Apotex Corp. (Apotex); Aurobindo Pharma USA Inc. (Aurobindo); Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.; InvaGen Pharmaceuticals, Inc. (InvaGen); Prinston Pharmaceuticals Inc.;  Dr. Reddy&#8217;s Laboratories, Inc. and Dr. Reddy&#8217;s Laboratories Ltd (DRL); Hetero USA, Inc., Hetero Labs Limited Unit V and Hetero Labs Limited; MSN Laboratories Private Ltd. and MSN Pharmaceuticals, Inc. (MSN); Laurus Labs Ltd.; Indoco Remedies Ltd.; Zydus Pharmaceuticals (USA) Inc. (Zydus); Sandoz, Inc. (Sandoz); Teva Pharmaceuticals USA, Inc.; and Lupin Ltd. and Lupin Pharmaceuticals, Inc. (Lupin).  These cases were consolidated into one action (Polymorph Main Action), which was scheduled for trial starting in June 2020 but is being rescheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in July 2017, Janssen and MTPC filed patent infringement lawsuits in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of MTPC&#8217;s United States Patent No. 7,943,788 (the &#8217;788 patent), 8,222,219 (the &#8217;219 patent) and/or 8,785,403 (the &#8217;403 patent) relating to INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and/or&#160; INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> XR Janssen is the exclusive licensee of the asserted patents. The following generic companies were named as defendants:&#160; Sandoz, Zydus and Aurobindo. These cases were consolidated into one action (Compound Main Action), which was scheduled for trial in May 2020 but is being rescheduled.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, Janssen and MTPC filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;582 patent and &#8217;202 patent relating to INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against MSN, who filed ANDAs seeking approval to market generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent.  In October 2019, Janssen and MTPC initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against DRL, who filed an ANDA seeking approval to market a generic version of INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent.  In March 2020, Janssen and MTPC initiated patent infringement lawsuits in the United States District Court for the District of New Jersey against Aurobindo, who filed an ANDA seeking approval to market a generic version of INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before expiration of the &#8217;788 patent, &#8217;219 patent, &#8217;403 patent, &#8217;582 patent, and &#8217;202 patent.  These lawsuits have not been consolidated with the Main Actions.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and MTPC entered into a settlement agreement with Aurobindo. In June 2020, Janssen and MTPC entered into a settlement agreement with Laurus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen and MTPC are seeking an order enjoining the defendants from marketing their generic versions of INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and/or, INVOKAMET XR</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Actelion Pharmaceuticals Ltd (Actelion) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA) Inc. (Zydus) who filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of United States Patent No. 7,094,781 (the &#8217;781 patent).  In the lawsuit, Actelion is seeking an order enjoining Zydus from marketing generic versions of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the patent. Trial is scheduled to commence in October 2020.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2019, Actelion Pharmaceuticals Ltd. filed suit against Aurobindo Pharma USA Inc. and Aurobindo Pharma Limited (Aurobindo).  Aurobindo filed an ANDA seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;781 patent.  Actelion was seeking an order enjoining Defendants from marketing a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;781 patent. In July 2020, Actelion and Aurobindo entered into a settlement agreement.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen Inc. (Janssen) and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Sandoz Canada Inc. (Sandoz) in Canada in response to Sandoz&#8217;s filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;  </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of Canadian Patent No. 2,659,770 (the &#8217;770 patent). A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Apotex Inc. (Apotex) in Canada in response to Apotex&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">10 mg,</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the &#8217;770 patent. A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In July 2020, Janssen and Actelion initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against JAMP Pharma Corporation (JAMP) in Canada in response to JAMP&#8217;s filing of an ANDS seeking approval to market a generic version of OPSUMIT&#174; 10 mg before the expiration of the &#8217;770 patent and Canadian Patent No. 2,621,273.  A final hearing has not yet been scheduled.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these Canadian actions, Janssen and Actelion are seeking an order enjoining the defendants from marketing their generic versions of OPSUMIT&#174; before the expiration of the &#8217;770 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2018, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Teva Pharmaceuticals USA, Inc. (Teva), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of United States Patent No. 9,439,906 (the &#8217;906 patent).  Trial is scheduled to begin in September 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Mylan Laboratories Limited (Mylan), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.  In February 2020, Mylan filed a Petition for Inter Partes Review with the USPTO seeking to invalidate the &#8217;906 patent. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2019, Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc. (collectively, Janssen) initiated a patent infringement lawsuit in the United States District Courts for the Districts of New Jersey and Delaware against Pharmascience Inc., Mallinckrodt PLC and Specgx LLC (collectively, Pharmascience), who filed an ANDA seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;906 patent.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2018, Janssen Inc. and Janssen Pharmaceutica NV (collectively, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Teva Canada Limited (Teva) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in response to Teva's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of Canadian Patent Nos. 2,309,629 (the &#8217;629 patent) and 2,655,335 (the &#8217;335 patent).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Janssen subsequently discontinued the portion of the lawsuit relating to the &#8217;629 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">May 2020, the Canadian Federal Court issued a Public Judgment and Reasons declaring that Teva&#8217;s generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, if approved, would infringe claims of the &#8217;335 patent and that the claims of the &#8217;335 patent are not invalid for obviousness. Teva appealed the court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Janssen Inc. and Janssen Pharmaceutica NV (together, Janssen) initiated a Statement of Claim under Section 6 of the Patented Medicines (Notice of Compliance) Regulations against Pharmascience Inc. (Pharmascience) </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in response to Pharmascience's filing of an Abbreviated New Drug Submission (ANDS) seeking approval to market a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the &#8217;335 patent.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Trial is scheduled to begin in January 2022.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of these lawsuits, Janssen is seeking an order enjoining the defendant from marketing a generic version of INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> before the expiration of the patent.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">Beginning in January 2018, Pharmacyclics LLC (Pharmacyclics) and Janssen Biotech, Inc. (JBI) filed patent infringement lawsuits in the United States District Court for the District of Delaware against a number of generic companies who filed ANDAs seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">140 mg capsules</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">before expiration of Pharmacyclics&#8217;  United States Patent Nos. 8,008,309, 7,514,444, 8,697,711, 8,735,403, 8,957,079, 9,181,257, 8,754,091, 8,497,277, 8,925,015, 8,476,284, 8,754,090, 8,999,999, 9,125,889, 9,801,881, 9,801,883, 9,814,721, 9,795,604, 9,296,753, 9,540,382, 9,713,617 and/or 9,725,455 relating to IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">. JBI is the exclusive licensee of the asserted patents. The named defendants include the following generic companies: Cipla Limited and Cipla USA Inc. (Cipla); Sandoz Inc. and Lek Pharmaceuticals d.d. (Sandoz); Sun Pharma Global FZE and Sun Pharmaceutical Industries Limited (Sun); and Zydus Worldwide DMCC and Cadila Healthcare Limited (Zydus).</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">The trial is scheduled to begin in October 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Sun asserting United States Patent No. 10,004,746.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In January 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market a generic version of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> 70 mg before the expiration of U.S. Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753, 9,540,382, 9,713,617, 9,725,455, 10,106,548, and 10,125,140. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In February 2019, Pharmacyclics and JBI amended their complaints against Cipla and Sun to allege infringement of United States Patent Nos. 10,106,548, and 10,125,140.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen Pine Brook LLC and Natco Pharma Ltd. (Alvogen), who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, and 10,125,140.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, Pharmacyclics and JBI amended their complaint against Cipla to further allege infringement of United States Patent No. 10,016,435.  In June 2019, Pharmacyclics and JBI amended their complaint against Alvogen to further allege infringement of United States Patent No. 10,213,386.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2019, Pharmacyclics and JBI amended their complaints against Cipla, and Sandoz to further allege infringement of U.S. Patent Nos. 10,294,231 and 10,294,232 and amended their complaint against Sun to further allege infringement of U.S. Patent No. 10,294,232.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2019, Sandoz filed an</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">IPR Petition with</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">the USPTO, seeking to invalidate United States Patent No. 9,795,604.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The IPR was instituted in September 2019, and a final written decision is expected by September 2020.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Alvogen, Zydus, Sun and Sandoz asserting infringement of United States Patent No. 10,478,439.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI amended their complaint against Sandoz to further allege infringement of U.S. Patent No. 10,463,668.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Pharmacyclics and JBI filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Zydus, who filed an ANDA seeking approval to market generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> tablets, asserting infringement of United States Patent Nos. 7,514,444, 8,003,309, 8,476,284, 8,497,277, 8,697,711, 8,753,403, 8,754,090, 8,754,091, 8,952,015, 8,957,079, 9,181,257, 9,296,753,  9,655,857, 9,725,455, 10,010,507, 10,106,548, 10,125,140, 10,213,286 and 10,478,439.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2020, Pharmacyclics and JBI entered into a settlement agreement with Sun Pharmaceuticals.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In each of the lawsuits, Pharmacyclics and JBI are seeking an order enjoining the defendants from marketing generic versions of IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">In December 2019, Actelion Pharmaceuticals Ltd and Actelion Pharmaceuticals US, Inc. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against Zydus Pharmaceuticals (USA), Inc. and Cadila Healthcare Limited (collectively, Zydus), who filed an ANDA seeking approval to market a generic version of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;">, 32 mg, before the expiration of U.S. Patent No. 8,309,126 (the &#8217;126 patent).  Actelion was seeking an order enjoining Zydus from marketing its generic version of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:103%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:103%;"> before the expiration of the &#8217;126 patent. In July 2020, Actelion entered into a settlement agreement with </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:103%;">Zydus.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, Actelion Pharmaceuticals Ltd and Nippon Shinyaku Co., Ltd. initiated a patent infringement lawsuit in the United States District Court for the District of New Jersey against a number of generic companies who filed ANDAs seeking approval to market generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before expiration of Nippon Shinyaku&#8217;s United States Patent Nos. 7,205,302; 8,791,122; and 9,284,280 relating to UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  Actelion is the exclusive licensee of the asserted patents. The following generics are named defendants in the complaint: Alembic Pharmaceuticals Limited and Alembic Pharmaceuticals Inc. (Alembic); MSN Laboratories Private Limited and MSN Pharmaceuticals Inc. (MSN); Aizant Drug Research Solutions Private Limited (Aizant); VGYAAN Pharmaceuticals LLC (VGYAAN); and Zydus Pharmaceuticals (USA), Inc. and Zydus Worldwide DMCC (Zydus). In June 2020, the court entered a joint stipulation dismissing Aizant from suit.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Actelion and Nippon Shinyaku are seeking an order enjoining the defendants from marketing generic versions of UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">before the expiration of the relevant patents.</span></div><div><span><br/></span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GOVERNMENT PROCEEDINGS</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Like other companies in the pharmaceutical, consumer and medical devices industries, Johnson &amp; Johnson and certain of its subsidiaries are subject to extensive regulation by national, state and local government agencies in the United States and other countries in which they operate. As a result, interaction with government agencies is ongoing. The most significant litigation brought by, and investigations conducted by, government agencies are listed below. It is possible that criminal charges and substantial fines and/or civil penalties or damages could result from government investigations or litigation.</span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Average Wholesale Price (AWP) Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson and several of its pharmaceutical subsidiaries (the J&amp;J AWP Defendants), along with numerous other pharmaceutical companies, were named as defendants in a series of lawsuits in state and federal courts involving allegations that the pricing and marketing of certain pharmaceutical products amounted to fraudulent and otherwise actionable conduct because, among other things, the companies allegedly reported an inflated Average Wholesale Price (AWP) for the drugs at issue. Payors alleged that they used those AWPs in calculating provider reimbursement levels. The plaintiffs in these cases included three classes of private persons or entities that paid for any portion of the purchase of the drugs at issue based on AWP, and state government entities that made Medicaid payments for the drugs at issue based on AWP. Many of these cases, both federal actions and state actions removed to federal court, were consolidated for pre-trial purposes in a multi-district litigation in the United States District Court for the District of Massachusetts, where all claims against the J&amp;J AWP Defendants were ultimately dismissed. The J&amp;J AWP Defendants also prevailed in a case brought by the Commonwealth of Pennsylvania. Other AWP cases have been resolved through court order or settlement. The case brought by Illinois was settled after trial.  In New Jersey, a putative class action based upon AWP allegations is pending against Centocor, Inc. and Ortho Biotech Inc. (both now Janssen Biotech, Inc.), Johnson &amp; Johnson and ALZA Corporation. All other cases have been resolved.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Opioid Litigation</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in 2014 and continuing to the present, Johnson &amp; Johnson and Janssen Pharmaceuticals, Inc. (JPI), along with other pharmaceutical companies, have been named in more than 2,900 lawsuits related to the marketing of opioids, including DURAGESIC</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and NUCYNTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> ER.  The suits also raise allegations related to previously owned active pharmaceutical ingredient supplier subsidiaries, Tasmanian Alkaloids Pty, Ltd. and Noramco, Inc. (both subsidiaries were divested in 2016). The majority of the cases have been filed by state and local governments. Similar lawsuits have also been filed by private plaintiffs and organizations, including but not limited to the following: individual plaintiffs on behalf of children suffering from Neonatal Abstinence Syndrome; hospitals; and health insurers/payors. To date, complaints against pharmaceutical companies, including Johnson &amp; Johnson and JPI, have been filed by the state Attorneys General in Arkansas, Florida, Idaho, Illinois, Kentucky, Louisiana, Mississippi, Missouri, New Hampshire, New Jersey, New Mexico, New York, </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Ohio, Oklahoma, South Dakota, Texas, Washington and West Virginia. Complaints against the manufacturers also have been filed in state or federal court by city, county and local government agencies in the following states: Alabama, Arizona, Arkansas, California, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina; Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Washington, West Virginia and Wisconsin. The Government of Puerto Rico filed suit in Superior Court of San Juan. There are more than 370 cases pending in various state&#160;courts. There are over 2,700 federal cases coordinated in a federal Multi-District Litigation (MDL) pending in the U.S. District Court for the Northern District of Ohio (MDL No. 2804).&#160;In addition, the Province of British Columbia filed suit in Canada.  In October 2019, an anti-trust complaint was filed by private plaintiffs in federal court in Tennessee and is pending transfer to the MDL. These actions allege a variety of claims related to opioid marketing practices, including false advertising, unfair competition, public nuisance, consumer fraud violations, deceptive acts and practices, false claims and unjust enrichment. The suits generally seek penalties and/or injunctive and monetary relief and, in some of the suits, the plaintiffs are seeking joint and several liability among the defendants. An adverse judgment in any of these lawsuits could result in the imposition of large monetary penalties and significant damages including, punitive damages, cost of abatement, substantial fines, equitable remedies and other sanctions.</span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The trial in the matter filed by the Oklahoma Attorney General resulted in a judgment against Johnson &amp; Johnson and JPI in the amount of $572 million, subject to a final order to be issued by the court.&#160; The court issued a final judgment reducing the amount to $465 million. Johnson &amp; Johnson and JPI have appealed the judgment. The Company believes that it has strong grounds to overturn this judgment.&#160; In October 2019 Johnson &amp; Johnson and JPI announced a settlement of the first case set for trial in the MDL with two counties in Ohio. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson, JPI and other pharmaceutical companies have also received subpoenas or requests for information related to opioids marketing practices from the following state Attorneys General: Alaska, Indiana, Montana, New Hampshire, South Carolina, Tennessee, Texas and Washington. In September 2017, Johnson &amp; Johnson and JPI were contacted by the Texas and Colorado Attorney General&#8217;s Offices on behalf of approximately 38 states regarding a multi-state Attorney General investigation. In October 2019, the Company announced a proposed agreement in principle that would include the Company paying $4 billion as settlement of these lawsuits, subject to various conditions and an agreement being finalized.  This agreement in principle is not an admission of liability or wrong-doing and would resolve opioid lawsuits filed and future claims by states, cities and counties.  The Company cannot predict if or when the agreement will be finalized and individual cases are ongoing. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> In August 2019, Johnson &amp; Johnson received a grand jury subpoena from the United States Attorney&#8217;s Office for the Eastern District of New York for documents related to the Company&#8217;s anti-diversion policies and procedures and distribution of its opioid medications, in what the Company understands to be part of a broader investigation into manufacturers&#8217; and distributors&#8217; monitoring programs and reporting under the Controlled Substances Act.&#160; In September 2019, Johnson &amp; Johnson received subpoenas from the New York State Department of Financial Services (NYDFS) as part of an industry-wide inquiry into the effect of opioid prescriptions on New York health insurance premiums.&#160; The Company is cooperating and producing documents in response to the various subpoenas and requests for information.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In November 2019, a shareholder filed a derivative complaint against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the Superior Court of New Jersey.  The complaint alleges breaches of fiduciary duties related to the marketing of opioids, and that Johnson &amp; Johnson has suffered damages as a result of those alleged breaches.  In December 2019, two additional shareholders filed two separate derivative complaints making similar allegations against Johnson &amp; Johnson as the nominal defendant and certain current and former directors and officers as defendants in the United States District for the District of New Jersey. In April 2020,  the two federal cases were consolidated into a single action captioned</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;"> In re Johnson &amp; Johnson Opioid Stockholder Derivative Litigation</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">.  Pursuant to an agreed stipulation entered by the Court, the shareholders have until July 2020 to file a consolidated complaint or identify a previously filed complaint as the operative complaint. In July 2020, an additional shareholder filed a derivative complaint in the United States District Court for the District of New Jersey making similar allegations against the same defendants named in the consolidated action.  Pursuant to an order in the consolidated action, the newly-filed case will be consolidated into the consolidated action.</span></div><div><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2020, a report was delivered to the Company&#8217;s Board of Directors by independent counsel retained by the Board to investigate the allegations in the derivative lawsuits and in a series of shareholder letters that the Board received raising similar issues.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The independent counsel recommended that the Company reject the shareholder demands and take the steps that are necessary or appropriate to secure dismissal of the derivative litigation. </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Board unanimously adopted the recommendations of the independent counsel&#8217;s report.</span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration: underline;">Other</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In August 2012, DePuy Orthopaedics, Inc., DePuy, Inc. (now known as DePuy Synthes, Inc.), and Johnson &amp; Johnson Services, Inc. (collectively DePuy) received an informal request from the United States Attorney's Office for the District of Massachusetts and the Civil Division of the United States Department of Justice (the United States) for the production of materials relating to the DePuy ASR&#8482; XL Hip device. In July 2014, the United States notified the United States District Court for the District of Massachusetts that it had declined to intervene in a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> case filed pursuant to the False Claims Act against the companies. In February 2016, the district court granted the companies&#8217; motion to dismiss with prejudice, unsealed the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> complaint, and denied the </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators&#8217; request for leave to file a further amended complaint. The </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> relators appealed the case to the United States Court of Appeals for the First Circuit. In July 2017, the First Circuit affirmed the district court&#8217;s dismissal in part, reversed in part, and affirmed the decision to deny the relators&#8217; request to file a third amended complaint. The relators&#8217; remaining claims are now pending before the district court. In July 2020, the Court ordered the relators to complete discovery by August 2020.  </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2012, Johnson &amp; Johnson was contacted by the California Attorney General's office regarding a multi-state Attorney General investigation of the marketing of surgical mesh products for hernia and urogynecological purposes by Johnson &amp; Johnson's subsidiary, Ethicon, Inc. (Ethicon). In May 2016, California and Washington filed civil complaints against Johnson &amp; Johnson, Ethicon and Ethicon US, LLC alleging violations of their consumer protection statutes. Similar complaints were filed against the companies by the following states:  Kentucky, Mississippi, West Virginia and Oregon. In April 2019, Johnson &amp; Johnson and Ethicon settled the Washington case.  The California case started trial in July 2019 and concluded in September 2019. The trial date for the Kentucky case was scheduled for September 2019 but has been adjourned and no new trial date has been scheduled. The trial date for the Mississippi case is scheduled for April 2021. In October 2019, Johnson &amp; Johnson and Ethicon settled the multi-state investigation with 41 other states and the District of Columbia. In January 2020, the Court in California issued a statement of decision, finding in favor of the State of California, and awarded civil penalties in the amount of $344 million. The Company intends to appeal the decision. In April 2020, the Company settled the West Virginia case. In April 2020, the Court in California denied the Company's motion for a new trial. In June 2020, the Court denied the Attorney General's request for injunctive relief. In June 2020 the Court in Oregon denied the Company's motion to dismiss. Trial in Oregon is set for February 2022. The Attorney General of Mississippi filed a second amended complaint in April 2020 and the Company filed a motion to dismiss in May 2020. The motion to dismiss argument will be heard in August  2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In December 2012, Therakos, Inc. (Therakos), formerly a subsidiary of Johnson &amp; Johnson and part of the Ortho-Clinical Diagnostics, Inc. (OCD) franchise, received a letter from the civil division of the United States Attorney's Office for the Eastern District of Pennsylvania informing Therakos that the United States Attorney's Office was investigating the sales and marketing of Uvadex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> (methoxsalen) and the Uvar Xts</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> and Cellex</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:115%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;"> Systems during the period 2000 to the present. The United States Attorney's Office requested that OCD and Johnson &amp; Johnson preserve documents that could relate to the investigation. Therakos was subsequently acquired by an affiliate of Gores Capital Partners III, L.P. in January 2013, and OCD was divested in June 2014. Following the divestiture of OCD, Johnson &amp; Johnson retains OCD&#8217;s portion of any liability that may result from the investigation for activity that occurred prior to the sale of Therakos. In March 2014 and March 2016, the United States Attorney&#8217;s Office requested that Johnson &amp; Johnson produce certain documents, and Johnson &amp; Johnson is cooperating with those requests.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2014, the Mississippi Attorney General filed a complaint in Chancery Court of The First Judicial District of Hinds County, Mississippi against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI).&#160;The complaint alleges that defendants violated the Mississippi Consumer Protection Act by </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">failing to disclose alleged health risks associated with female consumers' use of talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Shower to Shower (a product divested in 2012) and seeks injunctive and monetary relief.  The matter is stayed pending interlocutory appeal of a December 2018 denial of Johnson &amp; Johnson and JJCI's motion for summary judgment. The Mississippi Supreme Court granted J&amp;J and JJCI's request to file an interlocutory appeal of the denial of the motion for summary judgment in late 2019. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In January 2020, the State of New Mexico filed a consumer protection case alleging that the Company deceptively marketed and sold its talcum powder products by making misrepresentations about the safety of the products and the presence of carcinogens, including asbestos.  The State of New Mexico filed an Amended Complaint in March 2020. The Company has filed a motion to dismiss certain of the claims in the Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Forty-one states have commenced a joint investigation into the Company&#8217;s marketing of its talcum powder products. At this time, the multi-state group has not asserted any claims against the Company. Several states have issued Civil Investigative Demands seeking documents and other information. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2016, Janssen Pharmaceuticals, Inc. (JPI) received a Civil Investigative Demand from the United States Attorney&#8217;s Office for the Southern District of New York related to JPI&#8217;s contractual relationships with pharmacy benefit managers over the </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">period from January 1, 2006 to the present with regard to certain of JPI's pharmaceutical products.  The demand was issued in connection with an investigation under the False Claims Act.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2016, Johnson &amp; Johnson and Janssen Products LP were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint pursuant to the False Claims Act filed in the United States District Court for the District of New Jersey alleging the off-label promotion of two HIV products, PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> and INTELENCE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, and anti-kickback violations in connection with the promotion of these products.&#160; The complaint was filed under seal in December 2012.&#160; The federal and state governments have declined to intervene, and the lawsuit is being prosecuted by the relators.&#160; </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2017, Janssen Biotech, Inc. received a Civil Investigative Demand from the United States Department of Justice regarding a False Claims Act investigation concerning management and advisory services provided to rheumatology and gastroenterology practices that purchased REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> or SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">. In August 2019, the Unites States Department of Justice notified Janssen Biotech, Inc. that it was closing the investigation. Subsequently, the United States District Court for the District of Massachusetts unsealed a qui tam False Claims Act complaint, which was served on the Company.  The Department of Justice had declined to intervene in the qui tam lawsuit in August 2019.  The Company has filed a motion to dismiss the relator&#8217;s complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April and September 2017, Johnson &amp; Johnson received subpoenas from the United States Attorney for the District of Massachusetts seeking documents broadly relating to pharmaceutical copayment support programs for DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, OLYSIO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, SIMPONI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">, STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">and ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160;The subpoenas also seek documents relating to&#160;Average Manufacturer Price and Best Price reporting to the Center for Medicare and Medicaid Services related to those products, as well as rebate payments to state Medicaid agencies. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2017, Johnson &amp; Johnson received a subpoena from the United States Attorney's Office for the District of Massachusetts seeking information regarding practices pertaining to the sterilization of DePuy Synthes, Inc. spinal implants at three hospitals in Boston as well as interactions of employees of Company subsidiaries with physicians at these hospitals. Johnson &amp; Johnson and DePuy Synthes, Inc. have produced documents in response to the subpoena and are fully cooperating with the government&#8217;s investigation.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In July 2018 the Public Prosecution Service in Rio de Janeiro and representatives from the Brazilian antitrust authority CADE inspected the offices of more than 30 companies including Johnson &amp; Johnson do Brasil Ind&#250;stria e Com&#233;rcio de Produtos para Sa&#250;de Ltda. The authorities appear to be investigating allegations of possible anti-competitive behavior and possible improper payments in the medical device industry.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We continue to actively respond to inquiries regarding the Foreign Corrupt Practices Act from the United States Department of Justice and the United States Securities and Exchange Commission. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">From time to time, the Company has received requests from a variety of United States Congressional Committees to produce information relevant to ongoing congressional inquiries. It is the policy of Johnson &amp; Johnson to cooperate with these inquiries by producing the requested information.</span></div><div style="margin-top:12pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration: underline;">GENERAL LITIGATION</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2014, two purported class actions were filed in federal court, one in the United States District Court for the Central District of California and one in the United States District Court for the Southern District of Illinois, against Johnson &amp; Johnson and Johnson &amp; Johnson Consumer Companies, Inc. (now known as Johnson &amp; Johnson Consumer Inc.) (JJCI) alleging violations of state consumer fraud statutes based on nondisclosure of alleged health risks associated with talc contained in JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Baby Powder and JOHNSON'S</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Shower to Shower (a product no longer sold by JJCI). Both cases seek injunctive relief and monetary damages; neither includes a claim for personal injuries. In October 2016, both cases were transferred to the United States District Court for the District Court of New Jersey as part of a newly created federal multi-district litigation. In July 2017, the district court granted Johnson &amp; Johnson's and JJCI&#8217;s motion to dismiss one of the cases.  In September 2018, the United States Court of Appeals for the Third Circuit affirmed this dismissal.  In September 2017, the plaintiff in the second case voluntarily dismissed the complaint.  In March 2018, the plaintiff in the second case refiled in Illinois State Court.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2014, United States Customs and Border Protection (US CBP) issued a Penalty Notice against Janssen Ortho LLC (Janssen Ortho), assessing penalties for the alleged improper classification of darunavir ethanolate (the active pharmaceutical ingredient in PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">) in connection with its importation into the United States. In October 2014, Janssen Ortho submitted a Petition for Relief in response to the Penalty Notice. In May 2015, US CBP issued an Amended Penalty Notice assessing substantial penalties and Janssen Ortho filed a Petition for Relief in July 2015. In May 2019, US CBP issued its Mitigation Decision and determined that Janssen Ortho had negligently misrepresented that darunavir ethanolate is entitled to duty free </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">treatment.  In June 2019, Janssen Ortho filed a Supplemental Petition for Relief. The Penalties Proceeding will be impacted by the related Classification Litigation pending in the United States Court of International Trade. The Classification Litigation will determine whether darunavir ethanolate was properly classified as exempt from duties upon importation into the United States. The trial in the Classification Litigation was held in July 2019. In February 2020, the Court ruled that darunavir ethanolate is eligible for duty free treatment. In April 2020, the United States filed a Notice of Appeal to the United States Court of Appeals for the Federal Circuit. </span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March and April 2015, over 30 putative class action complaints were filed by contact lens patients in a number of courts around the United States against Johnson &amp; Johnson Vision Care, Inc. (JJVCI) and other contact lens manufacturers, distributors, and retailers, alleging vertical and horizontal conspiracies to fix the retail prices of contact lenses. The complaints allege that the manufacturers reached agreements with each other and certain distributors and retailers concerning the prices at which some contact lenses could be sold to consumers. The plaintiffs are seeking damages and injunctive relief. All of the class action cases were transferred to the United States District Court for the Middle District of Florida in June 2015. The plaintiffs filed a consolidated class action complaint in November 2015. In December 2018, the district court granted the plaintiffs' motion for class certification. Defendants filed two motions for interlocutory appeal of class certification to the United States Court of Appeals for the Eleventh Circuit. Both motions were denied. Defendants' motions for summary judgment were denied in November 2019. The parties await a trial date. </span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2015, two third-party payors filed a purported class action in the United States District Court for the Eastern District of Louisiana against Janssen Research &amp; Development, LLC, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson &amp; Johnson (as well as certain Bayer entities), alleging that the defendants improperly marketed and promoted XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> as safer and more effective than less expensive alternative medications while failing to fully disclose its risks.  The complaint seeks damages.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In September 2017, Pfizer, Inc. (Pfizer) filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in United States District Court for the Eastern District of Pennsylvania.  Pfizer alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. Discovery is ongoing. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Beginning in September 2017, multiple purported class actions of direct and indirect purchasers were filed against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) alleging that Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting strategies violated federal and state antitrust and consumer laws and seeking damages and injunctive relief.  In November 2017, the cases were consolidated for pre-trial purposes in United States District Court for the Eastern District of Pennsylvania as In re Remicade Antitrust Litigation. Motions to dismiss were denied in both the direct and indirect purchaser cases.  A motion to compel arbitration of the direct purchaser case was denied by the district court. The United States Court of Appeals for the Third Circuit reversed the district court's ruling.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2018, Walgreen Co. and Kroger Co, filed an antitrust complaint against Johnson &amp; Johnson and Janssen Biotech, Inc. (collectively, Janssen) in the United States District Court for the Eastern District of Pennsylvania.  The complaint alleges that Janssen has violated federal antitrust laws through its contracting strategies for REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.  The complaint seeks damages and injunctive relief. In March 2019, summary judgment was granted in favor of Janssen. In February 2020, the United States Court of Appeals for the Third Circuit reversed the District Court&#8217;s decision.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2019, the United States Federal Trade Commission (FTC) issued a Civil Investigative Demand to Johnson &amp; Johnson in connection with its investigation of whether Janssen&#8217;s REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> contracting practices violate federal antitrust laws. The Company has produced documents and information responsive to the Civil Investigative Demand.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In October 2017, certain United States service members and their families brought a complaint against a number of pharmaceutical and medical devices companies, including Johnson &amp; Johnson and certain of its subsidiaries, alleging that the defendants violated the United States Anti-Terrorism Act.&#160; The complaint alleges that the defendants provided funding for terrorist organizations through their sales practices pursuant to pharmaceutical and medical device contracts with the Iraqi Ministry of Health. In January 2020, plaintiffs filed a Third Amended Complaint adding further plaintiffs to the lawsuit. In July 2020, the District Court dismissed the Third Amended Complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2018, two separate putative class actions were filed against Actelion Pharmaceutical Ltd., Actelion Pharmaceuticals US, Inc., and Actelion Clinical Research, Inc. (collectively Actelion) in United States District Court for the District of Maryland and United States District Court for the District of Columbia.&#160; The complaints allege that Actelion violated state and federal antitrust and unfair competition laws by allegedly refusing to supply generic pharmaceutical manufacturers with samples of TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.&#160; TRACLEER</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> is subject to a Risk Evaluation and Mitigation Strategy, which imposes restrictions on </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">distribution of the product.&#160; In January 2019, the plaintiffs dismissed the District of Columbia case and filed a consolidated complaint in the United States District Court for the District of Maryland.&#160; In October 2019, the Court granted Actelion&#8217;s motion to dismiss the amended complaint. Plaintiffs have appealed the decision.</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In December 2018, Janssen Biotech, Inc., Janssen Oncology, Inc, Janssen Research &amp; Development, LLC, and Johnson &amp; Johnson (collectively, Janssen) were served with a </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">qui tam</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> complaint filed on behalf of the United States, 28 states, and the District of Columbia.&#160; The complaint, which was filed in December 2017 in United States District Court for the Northern District of California, alleges that Janssen violated the federal False Claims Act and state law when providing pricing information for ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> to the government in connection with direct government sales and government-funded drug reimbursement programs.&#160; At this time, the federal and state governments have declined to intervene. The case has been transferred to United States District Court for the District of New Jersey. In September 2019, Janssen moved to dismiss the complaint. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In April 2019, Blue Cross &amp; Blue Shield of Louisiana and HMO Louisiana, Inc. filed a class action complaint against Janssen Biotech, Inc, Janssen Oncology, Inc, Janssen Research &amp; Development, LLC and BTG International Limited in the United States District Court for the Eastern District of Virginia on behalf of indirect purchasers of ZYTIGA&#174;. Several additional complaints were filed thereafter in Virginia and New Jersey.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The indirect purchaser complaints generally allege that the defendants violated the antitrust and consumer protections laws of several states and the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry and seek damages. The Virginia cases have been transferred to the United States District Court for the District of New Jersey and consolidated with the New Jersey case for pretrial purposes.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2020, a class action complaint was filed against Janssen Biotech Inc., Janssen Oncology, Inc., Janssen Research &amp; Development LLC and BTG International Limited in the United States District Court for the District of New Jersey, on behalf of direct purchasers of ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The direct purchaser complaint alleges that defendants violated the Sherman Act by pursuing patent litigation relating to ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;vertical-align:top;">&#174; </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in order to delay generic entry, and seek damages and injunctive relief. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In May 2019, a class action antitrust complaint was filed against Janssen R&amp;D Ireland (Janssen) and Johnson &amp; Johnson in the United States District Court for the Northern District of California.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The complaint alleges that Janssen violated federal and state antitrust and consumer protection laws by agreeing to exclusivity provisions in its agreements with Gilead concerning the development and marketing of combination antiretroviral therapies (cART) to treat HIV.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The complaint also alleges that Gilead entered into similar agreements with Bristol-Myers-Squibb and Japan Tobacco.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, the Court granted in part and denied in part defendants&#8217; motions to dismiss.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;">  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Plaintiffs filed an amended complaint in April 2020.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In October 2019, Innovative Health, LLC filed a complaint against Biosense Webster, Inc. (BWI) in the United States District Court for the Middle District of California.  The complaint alleges that certain of BWI&#8217;s&#160;business practices and contractual terms violate the antitrust laws of the United States and the State of California by restricting competition in the sale of High Density Mapping Catheters and Ultrasound Catheters. In January 2020, BWI filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In November 2019, Johnson &amp; Johnson received a demand for indemnification from Pfizer Inc., pursuant to the 2006 Stock and Asset Purchase Agreement between the Company and Pfizer.  Also in November 2019, Johnson &amp; Johnson, Inc. received a demand for indemnification from Sanofi Consumer Health, Inc., pursuant to the 2016 Asset Purchase Agreement between J&amp;J, Inc. and Sanofi.  In January 2020, Johnson &amp; Johnson received a demand for indemnification from Boehringer Ingelheim Pharmaceuticals, Inc., pursuant to the 2006 Asset Purchase Agreement among the Company, Pfizer, and Boehringer Ingelheim.  The notices seek indemnification for legal claims related to over-the-counter Zantac (ranitidine) products. Plaintiffs in the underlying actions allege that Zantac and other over-the-counter ranitidine medications contain unsafe levels of NDMA (N-nitrosodimethylamine) and can cause and/or have caused various cancers in patients using the products, and seek injunctive and monetary relief.</span></div><div><span><br/></span></div><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Johnson &amp; Johnson or its subsidiaries are also parties to a number of proceedings brought under the Comprehensive Environmental Response, Compensation, and Liability Act, commonly known as Superfund, and comparable state, local or foreign laws in which the primary relief sought is the cost of past and/or future remediation.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530343633880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring</a></td>
<td class="text">RESTRUCTURING<div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company announced plans to implement a series of actions across its Global Supply Chain that are intended to focus resources and increase investments in the critical capabilities, technologies and solutions necessary to manufacture and supply its product portfolio, enhance agility and drive growth. The Global Supply Chain actions will include expanding the use of strategic collaborations and bolstering initiatives to reduce complexity, improve cost-competitiveness, enhance capabilities and optimize the Supply Chain network. For additional details on the global supply chain restructuring strategic collaborations see Note 10 to the Consolidated Financial Statements. In the fiscal second quarter of 2020, the Company recorded a pre-tax charge of $115 million, which is included on the following lines of the Consolidated Statement of Earnings, $61 million in restructuring, $22 million in cost of products sold and $32 million in other (income) expense. In the first fiscal six months of 2020, the Company recorded a pre-tax charge of $233&#160;million, which is included on the following lines of the Consolidated Statement of Earnings, $119&#160;million in restructuring, $37&#160;million in cost of products sold and $77&#160;million in other (income) expense.Total project costs of approximately $1.1 billion have been recorded since the restructuring was announced. See the following table for additional details on the restructuring program. </span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In total, the Company expects the Global Supply Chain actions to generate approximately $0.6 billion to $0.8 billion in annual pre-tax cost savings that will be substantially delivered by 2022. The Company expects to record pre-tax restructuring charges of approximately $1.9 billion to $2.3 billion, over the 4 to 5 year period of this activity. These costs are associated with network optimizations, exit costs and accelerated depreciation and amortization.&#160; &#160;</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the first fiscal six months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"/><td style="width:32.703%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.372%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.981%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.372%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:1.500%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.072%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(197)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(209)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, June 28, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI http://asc.fasb.org/topic&amp;trid=2175745<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530258170536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Use of Estimates </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The extent to which COVID-19 impacts the Company&#8217;s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it will impact worldwide macroeconomic conditions including interest rates, employment rates and health insurance coverage, the speed of the anticipated recovery, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts COVID-19 as of June 28, 2020 and through the date of this report. The accounting matters assessed included, but were not limited to, the Company&#8217;s allowance for doubtful accounts and credit losses, inventory and related reserves, accrued rebates and associated reserves, and the carrying value of the goodwill and other long-lived assets. While there was not a material impact to the Company&#8217;s consolidated financial statements as of and for the quarter ended June 28, 2020, the Company&#8217;s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in material impacts to the Company&#8217;s consolidated financial statements in future reporting periods.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards Recently Adopted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-top:3pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">New Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company assesses the adoption impacts of recently issued accounting standards by the Financial Accounting Standards Board on the Company's financial statements as well as material updates to previous assessments, if any, from the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;29, 2019. There were no new material accounting standards issued in the fiscal second quarter of 2020 that impacted the Company.</span></div><div style="margin-top:3pt;"><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">There were no new accounting standards adopted in the fiscal second quarter of 2020.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassification</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;">Reclassification</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Certain prior period amounts have been reclassified to conform to current year presentation.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254558120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents, Policy</a></td>
<td class="text">The Company classifies all highly liquid investments with stated maturities of three months or less from date of purchase as cash equivalents and all highly liquid investments with stated maturities of greater than three months from the date of purchase as current marketable securities. Available for sale securities with stated maturities of greater than one year from the date of purchase are available to fund current operations and are classified as cash equivalents and current marketable securities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513485&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530372821912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Summary of Inventories</a></td>
<td class="text"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:78.070%;"><tr><td style="width:1.0%;"/><td style="width:50.996%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.722%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.736%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:21.410%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Raw materials and supplies</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goods in process</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,962&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,832&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,071&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Total inventories </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,424&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,020&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;"> </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">See Note 10 to the Consolidated Financial Statements for details on assets held for sale and the related divestitures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530353395336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:92.836%;"><tr><td style="width:1.0%;"/><td style="width:60.204%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.425%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.587%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.797%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with definite lives:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; gross</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37,313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36,634&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,834&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13,154&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Patents and trademarks &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,479&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles &#8212; gross</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22,056&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less accumulated amortization</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,072&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,462&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Customer relationships and other intangibles&#160;&#8212; net*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,200&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,594&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Intangible assets with indefinite lives:</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Trademarks</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,922&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Purchased in-process research and development </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,807&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,647&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets with indefinite lives</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,569&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total intangible assets &#8212; net</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,413&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*The majority is comprised of customer relationships</span></div>(1) In the fiscal first quarter of 2020, the Company completed the acquisition of bermekimab and certain related assets from XBiotech Inc., as well as the acquisition of all outstanding shares in Verb Surgical Inc., and recorded in-process research and development intangible assets of $0.8 billion and $0.4 billion, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Goodwill</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Goodwill as of June&#160;28, 2020 was allocated by segment of business as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:93.859%;"><tr><td style="width:1.0%;"/><td style="width:39.277%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.578%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.305%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.084%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.292%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.461%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.447%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.309%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pharmaceutical</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Medical Devices</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,734&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,639&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill, related to acquisitions</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency translation/Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">67&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Goodwill at June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,746&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14,929&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Intangible Asset Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The estimated amortization expense for approved products, before tax, for the five succeeding years is approximately:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:70.760%;"><tr><td style="width:1.0%;"/><td style="width:17.628%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.214%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.008%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.008%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.833%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:17.010%;"/><td style="width:1.0%;"/></tr><tr><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="margin-top:13pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">(Dollars in Millions)</span></div></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2021</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2022</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2023</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);text-decoration: underline;">2024</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$4,500</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,300</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,100</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,000</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530343675368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Summary of Derivative Activity</a></td>
<td class="text">The following table is a summary of the activity related to derivatives and hedges for the fiscal second quarters ended in 2020 and 2019, net of tax:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:18.202%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.359%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.647%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.513%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.225%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.070%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.936%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.513%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.663%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(62)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(101)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(128)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">83&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);"/></span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">100&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">82&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to derivatives and hedges for the fiscal six months ended in 2020 and 2019, net of tax:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:17.593%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.402%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.982%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.111%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:5.692%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.272%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.860%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Sales</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost of Products Sold</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">R&amp;D Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (Income) Expense</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (Income)  Expense</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">The effects of fair value, net investment and cash flow hedging:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on net investment hedging relationship:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in income on derivative amount excluded from effectiveness testing</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain (Loss) on cash flow hedging relationship:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(235)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(108)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(35)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(136)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(103)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:3pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(120)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(346)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross currency interest rate swaps contracts:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) reclassified from AOCI into income</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">118&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Amount of gain or (loss) recognized in AOCI</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">725&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal second quarters ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:20.463%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.710%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.524%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.875%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated<br/>OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(95)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(186)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div style="text-align:center;"><span><br/></span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is the effect of net investment hedges for the fiscal six months ended in 2020 and 2019</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:20.496%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.175%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.885%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.815%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:27.172%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.961%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.030%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.525%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.891%;"/><td style="width:1.0%;"/></tr><tr><td colspan="33" style="height:9pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Accumulated OCI</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income Into Income</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)                                                                                                                                                                                                                                  Reclassified From<br/>Accumulated OCI<br/>Into Income</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Debt</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(48)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cross Currency interest rate swaps</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">641&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest (income) expense</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock', window );">Schedule of Derivatives Recorded in Consolidated Balance Sheet</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Effect of Derivatives not Designated as Hedging Instruments</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:26.260%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.698%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:15.971%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.959%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.814%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:9.594%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.118%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.598%;"/><td style="width:1.0%;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)<br/>Recognized In<br/>Income on Derivative</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Location of Gain /(Loss) Recognized in Income on Derivative</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives Not Designated as Hedging Instruments</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign Exchange Contracts</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other (income) expense</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(88)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="display:none;"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Summary of Activity Related to Equity Investments</a></td>
<td class="text"><div style="margin-bottom:7pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table is a summary of the activity related to equity investments:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:25.071%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.983%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.532%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.835%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:12.349%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.539%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.835%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.869%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.539%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.579%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;border-top:1pt solid #ffffff;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Changes in Fair Value Reflected in Net Income </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;">Sales/ Purchases/Other </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non Current Other Assets</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments with readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Equity Investments without readily determinable value</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">712&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Recorded in Other Income/Expense</span></div><div style="text-indent:-36pt;padding-left:36pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;"> (2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Other includes impact of currency</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Financial Assets and Liabilities at Fair Value</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company&#8217;s significant financial assets and liabilities measured at fair value as of June&#160;28, 2020 and December&#160;29, 2019 were as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:47.329%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.345%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.302%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:5.004%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.345%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.545%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:13.950%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 1</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 2</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Level 3</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;">Total</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;vertical-align:top;">(1)</sup></div></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;border-top:1pt solid #000000;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">395&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">395&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)(3)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,521&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,521&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Interest rate contracts </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3) </sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">511&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">511&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Assets:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Forward foreign exchange contracts </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Investments:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Equity investments </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(4)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,488&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(5)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Contingent consideration </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(6)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:42.005%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.992%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:19.198%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:6.187%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:22.418%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gross to Net Derivative Reconciliation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,437)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(841)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Asset</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">84&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Gross Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">652&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Credit Support Agreement (CSA)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(510)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(586)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Net Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">48&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Summarized information about changes in liabilities for contingent consideration is as follows:</span></div><div style="text-align:center;margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:74.774%;"><tr><td style="width:1.0%;"/><td style="width:40.369%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.410%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.706%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.406%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.709%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Beginning Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,715&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Changes in estimated fair value </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(7) </sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(938)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Additions</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Payments</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(87)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Ending Balance</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">796&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><span><br/></span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">December 30, 2019 assets and liabilities are all classified as Level 2 with the exception of equity investments of $1,148 million, which are classified as Level 1 and contingent consideration of $1,715 million, classified as Level 3.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.43pt;">Includes $1 million of non-current other assets as of December&#160;29, 2019.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3)     </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes cross currency interest rate swaps and interest rate swaps.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (4)&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Classified as non-current other assets. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(5)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Classified within cash equivalents and current marketable securities.</span></div><div style="text-indent:-18pt;padding-left:18pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(6)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">&#160;Includes $793 million and $1,631 million (primarily related to Auris Health), classified as non-current other liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.  Includes $3 million and $84 million classified as current liabilities as of June&#160;28, 2020 and December&#160;29, 2019, respectively.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">           (7)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">    Ongoing fair value adjustment amounts are primarily recorded in Research and Development expense. </span></div><div style="padding-left:18pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">During the fiscal first quarter of 2020, the Company recorded a contingent consideration reversal of $983 million related to the timing of certain developmental milestones associated with the Auris Health acquisition. The one-time reversal of the contingent consideration was recorded in Other income and expense. As of June 28, 2020, the estimated fair value of the remaining contingent consideration is $169 million.  For additional details see Note 10 </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">t</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">o the Consolidated Financial Statements.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company's cash, cash equivalents and current marketable securities as of June&#160;28, 2020 comprised:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.849%;"><tr><td style="width:1.0%;"/><td style="width:21.308%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:8.827%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.631%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.481%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.827%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.454%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.578%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.153%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.282%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Gain</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrecognized Loss</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash &amp; Cash Equivalents</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Marketable Securities</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cash</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Non-U.S. sovereign securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">655&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">655&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">225&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">430&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other reverse repurchase agreements</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Corporate debt securities</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">301&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">978&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Money market funds</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Time deposits</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">579&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Subtotal </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,088&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,680&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Gain</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Unrealized Loss</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">U.S. Gov't securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,786&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other sovereign securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Corporate debt securities</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">242&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;Subtotal available for sale debt</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,046&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total cash, cash equivalents and current marketable securities</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,134&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19,135&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,961&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Held to maturity investments are reported at amortized cost and gains or losses are reported in earnings. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Available for sale debt securities are reported at fair value with unrealized gains and losses reported net of taxes in other comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Available for Sale Securities Maturities</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The contractual maturities of the available for sale securities as of June&#160;28, 2020 are as follows:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:76.426%;"><tr><td style="width:1.0%;"/><td style="width:42.204%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:1.929%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:21.379%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:2.157%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:24.131%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cost Basis</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fair Value</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due within one year</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,023&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,024&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after one year through five years</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">23&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Due after five years through ten years</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total debt securities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,046&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,047&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Financial Liabilities not Measured at Fair Value</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Financial Instruments not measured at Fair Value:</span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following financial liabilities are held at carrying amount on the consolidated balance sheet as of June&#160;28, 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:78.938%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.237%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.533%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.359%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Carrying Amount</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Estimated Fair Value</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Financial Liabilities</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,332&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,388&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2021</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">350&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">360&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.250% Notes due 2022 (1B Euro 1.1217)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,121&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.25% Notes due 2022</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">998&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,029&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.73% Debentures due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">302&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.375% Notes due 2023</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">803&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">891&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.05% Notes due 2023</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">523&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.650% Notes due 2024 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">839&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">864&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.50% Notes due 2024 (500 MM GBP 1.2431)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">618&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">749&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.625% Notes due 2025</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">813&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.45% Notes due 2026</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,993&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.95% Notes due 2027</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">997&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.90%&#160;Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,494&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,681&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.150% Notes due 2028 (750MM Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">835&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">917&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.95% Notes due 2029</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">435&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.95% Debentures due 2033</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">689&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.375% Notes due 2033</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">856&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.650% Notes due 2035 (1.5B Euro 1.1217)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,667&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.55% Notes due 2036</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.95% Notes due 2037</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">992&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.625% Notes due 2037</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.40%&#160;Notes due 2038</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.85% Debentures due 2038</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">696&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Debentures due 2040</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">736&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.85% Notes due 2041</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">420&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.50% Notes due 2043</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">495&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">685&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.70% Notes due 2046</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,974&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,467&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.75% Notes due 2047</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.50% Notes due 2048</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">923&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Non-Current Debt</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25,062&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29,991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13467-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash, cash equivalents, and investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative liabilities at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530340739192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock', window );">Components of Net Periodic Benefit Cost</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Net periodic benefit costs for the Company&#8217;s defined benefit retirement plans and other benefit plans for the fiscal second quarters and fiscal six months of 2020 and 2019 include the following components:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%;"><tr><td style="width:1.0%;"/><td style="width:24.548%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.832%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.407%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.537%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.412%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Retirement Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Benefit Plans</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Service cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">72&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">649&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">144&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interest cost</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">274&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">46&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Expected return on plan assets</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(608)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(581)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,222)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1,164)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Amortization of prior service cost/(credit)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Recognized actuarial losses</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">222&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">35&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">65&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Curtailments and settlements</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net periodic benefit cost</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">125&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">131&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">139&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">237&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">262&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNetBenefitCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNetBenefitCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530255929384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Components of Accumulated Other Comprehensive Income</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Components of other comprehensive income (loss) consist of the following:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.807%;"><tr><td style="width:1.0%;"/><td style="width:33.874%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.014%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.762%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.846%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.819%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.406%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.547%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:16.091%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Foreign</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Employee</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Gain/(Loss)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total Accumulated</span></td></tr><tr><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Currency</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Benefit</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">On Derivatives</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Other Comprehensive</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Translation</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Securities</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Plans</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&amp; Hedges</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Income (Loss)</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">December 29, 2019</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8,705)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(295)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,891)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Net change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(963)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">390&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">931&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">358&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9,668)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6,501)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">636&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15,533)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254601896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following is a reconciliation of basic net earnings per share to diluted net earnings per share for the fiscal second quarters and fiscal six months ended June&#160;28, 2020 and June&#160;30, 2019:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%;"><tr><td style="width:1.0%;"/><td style="width:47.425%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.805%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:10.500%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:1.380%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:11.074%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.632%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.518%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.348%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="9" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Shares in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Basic net earnings per share </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.38&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.11&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.58&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.52&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; basic</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,632.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,652.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,633.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,656.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Potential shares exercisable under stock option plans</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">119.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">122.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Less: shares which could be repurchased under treasury stock method</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(87.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(102.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(85.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(99.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Convertible debt shares</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Average shares outstanding &#8212; diluted</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,665.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,691.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,671.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,697.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Diluted net earnings per share</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.36&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.08&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.53&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254625464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SalesBySegmentOfBusinessTableTextBlock', window );">Sales By Segment Of Business</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY SEGMENT OF BUSINESS </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Consumer Health*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Baby Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">99&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">188&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">186&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">443&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oral Care</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">155&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">346&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">306&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">227&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">446&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">450&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">389&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">792&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">OTC</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">627&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">484&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,316&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">991&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">522&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">580&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,064&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,497&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,151&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Skin Health/Beauty</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">536&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">663&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,195&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">471&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">929&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,041&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,124&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Women's Health</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">199&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">250&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">472&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">434&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">478&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Wound Care/Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">111&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">114&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">185&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">193&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">TOTAL </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Consumer Health</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,557&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,537&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,297&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,007&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,887&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,296&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,921&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">* Previously referred to as Consumer</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:168pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Immunology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,362&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,772&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,542&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,389&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,523&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,717&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;REMICADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">593&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">801&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,575&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S. Exports</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">208&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">244&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">464&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">496&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">935&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,925&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SIMPONI / SIMPONI ARIA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">281&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">528&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">544&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">289&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">282&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">547&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">543&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">0.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">546&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,087&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">STELARA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,355&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,022&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,558&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,516&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,963&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TREMFYA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">241&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">176&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">36.7</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.4%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">59&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">71.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94.0</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">235&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45.4</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">638&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">452&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">41.1%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER IMMUNOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.8</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.7</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Infectious Diseases</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">416&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">852&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">744&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">475&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">946&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">964&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">878&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,798&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,708&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">EDURANT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / rilpivirine</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">246&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">458&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">397&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">421&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">PREZISTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / PREZCOBIX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> /  </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">                         </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">                     REZOLSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / SYMTUZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;text-decoration: underline;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">659&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(32.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">314&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">399&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">535&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,089&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,058&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER INFECTIOUS DISEASES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">25&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">54&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">86&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">168&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">117&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">229&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:50pt;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Neuroscience</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">778&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">664&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">17.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,526&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,387&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">809&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">875&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,719&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,780&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,587&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,538&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,245&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,167&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONCERTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / methylphenidate</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">55&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">15&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">112&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">94&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">123&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">212&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">239&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">320&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVEGA SUSTENNA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / XEPLION</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVEGA   TRINZA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / TREVICTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">576&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">506&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">989&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">303&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">642&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">619&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,608&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;RISPERDAL CONSTA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">74&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">158&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">79&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">173&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">182&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">323&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">361&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER NEUROSCIENCE</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">75&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">340&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">691&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">719&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">847&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:5pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Oncology</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,013&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,356&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,975&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">19.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,609&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,684&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,448&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,240&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,791&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,804&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,215&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">DARZALEX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">492&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">369&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">721&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">405&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">883&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">682&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">901&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,838&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">31.0&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ERLEADA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> </span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">62&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">120</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">57</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">170&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">69&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">313</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">130</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;* </span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">IMBRUVICA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">367&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.5&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">879&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">716&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">502&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">898&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">949&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">831&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,980&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,615&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">VELCADE</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">98&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">487&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(57.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ZYTIGA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;"> / </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">abiraterone acetate</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">480&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">500&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,032&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">994&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">568&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">698&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(18.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,258&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,377&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER ONCOLOGY</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.9</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">42&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">34&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">87&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">85&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">169&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">106&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.5</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">210&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Pulmonary Hypertension</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">545&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">439&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">24.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,031&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">243&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">251&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.3)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">503&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">477&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">690&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.2</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,534&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,346&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">13.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OPSUMIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">26.1</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">485&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">375&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">29.3&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">150&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.0</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">310&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">279&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">795&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;UPTRAVI</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">254&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">175&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">44.5</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">466&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">351&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">28&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4.0</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">50&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">33.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">282&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39.0</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">401&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER PULMONARY HYPERTENSION</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">37&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">61&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.2)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">81&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">143&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(43.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">64&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.6)</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">126&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">149&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">101&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">140&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.5)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">292&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Cardiovascular / Metabolism / Other</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">837&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">902&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,643&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,849&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">347&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">373&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">701&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">771&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,184&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,275&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,344&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">XARELTO</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">559&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.7&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,086&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,091&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">INVOKANA</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / INVOKAMET</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">132&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(0.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">249&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">286&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">47&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">43&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">105&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">92&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">14.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">179&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">177&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1.6&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">379&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">&#160;PROCRIT</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;"> / EPREX</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#174;</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">113&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(38.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">146&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">261&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">70&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(5.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">145&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">148&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">136&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">183&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">291&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">409&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">OTHER</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">78&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">107&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">163&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">211&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">234&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">260&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">531&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">312&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(15.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">614&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">742&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:9pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL PHARMACEUTICAL</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,120&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,783&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,181&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,365&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,632&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,746&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(2.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,705&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,408&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3.2&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,752&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,529&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2.1&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">21,886&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,773&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5.4&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:11pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Interventional Solutions</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">255&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">366&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">620&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">709&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">335&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">385&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">697&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">774&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">590&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">750&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,482&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Orthopaedics</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">869&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,331&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,119&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,649&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">894&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,779&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,451&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,224&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,428&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">HIPS</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">137&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">216&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">343&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">429&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(20.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">88&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">295&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">226&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">364&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(37.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">563&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">725&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">KNEES</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">108&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">218&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(50.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">322&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">441&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">66&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">153&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(56.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">196&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">299&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">174&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(53.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">517&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">741&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">TRAUMA</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">354&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">407&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">761&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">824&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(7.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">198&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">265&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">445&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">533&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">553&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">672&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,207&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,357&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SPINE, SPORTS &amp; OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">270&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">490&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">693&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">955&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">230&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">328&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">510&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">499&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">818&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,202&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,606&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Surgery</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">490&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">926&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(47.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,334&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,927&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,060&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,427&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(25.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,317&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,821&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,551&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,353&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,651&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,748&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;">&#160;&#160;&#160;&#160;&#160;</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">ADVANCED</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">277&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">396&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">658&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">800&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.7)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">498&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">633&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,065&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,209&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(11.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,029&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,723&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,009&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">GENERAL</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">213&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">530&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(59.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">676&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,127&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">794&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,612&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">775&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,325&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(41.5)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,928&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,739&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(29.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Vision</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">248&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">461&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(46.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">687&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">907&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(24.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">447&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">701&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,075&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,383&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">695&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,161&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(40.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,762&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,290&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">CONTACT LENSES / OTHER</span></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">203&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">333&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">549&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">654&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(16.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">352&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">509&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">819&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,011&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">554&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">842&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(34.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,368&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,666&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:24pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr></table><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.565%;"><tr><td style="width:1.0%;"/><td style="width:34.244%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.625%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.733%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.334%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.527%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.743%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;vertical-align:top;">&#160;&#160;&#160;&#160;&#160;</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration: underline;">SURGICAL</span></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">45&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">128&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(64.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">138&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">253&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(45.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">96&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">191&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(49.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">256&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">371&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(31.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">141&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">319&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(55.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">394&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">624&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(36.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:12pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">TOTAL MEDICAL DEVICES</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,862&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,083&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(39.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,760&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(23.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,426&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(28.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">5,460&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,756&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(19.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,288&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,489&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(33.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,220&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">12,948&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(21.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:8pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:9pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">WORLDWIDE</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;International</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,797&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,159&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(13.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,789&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,051&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;&#160;&#160;Worldwide  </span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Operating Profit by Segment of Business</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">EARNINGS BEFORE PROVISION FOR TAXES BY SEGMENT  </span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.710%;"><tr><td style="width:1.0%;"/><td style="width:35.209%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.465%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.319%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.575%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.465%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.319%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.526%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:6.292%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30,<br/>2019</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Consumer Health </span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">32&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">406&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(92.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">802&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,147&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(30.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Pharmaceutical</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,514&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,677&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">22.8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,348&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">6,008&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">38.9&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Medical Devices</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(3)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(354)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,189&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:18pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">*</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,671&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,686&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(64.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Segment earnings before provision for taxes</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,192&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,272&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(42.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,821&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,841&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.6)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Less: Expense not allocated to segments</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;"> (4)</sup></div></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">252&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">231&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">372&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">378&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Worldwide income before tax</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,940&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,041&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44.0)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,449&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">11,463&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">*Percentage greater than 100% or not meaningful</span></div><div><span><br/></span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(1)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> Includes a gain of $0.3 billion related to the Company's previously held equity investment in Ci:z Holdings Co., Ltd. (DR. CI: LABO) in the fiscal six months of 2019. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal second quarters of 2020 and 2019, primarily talc related costs, respectively. Includes litigation expense of $0.6&#160;billion and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, primarily talc related costs, respectively. Includes amortization expense of $0.1 billion in both the fiscal second quarters of 2020 and 2019, respectively and $0.2&#160;billion in both the fiscal six months of 2020 and 2019, respectively. </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">  </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(2) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes an in-process research and development expense of $0.9 billion related to the Alios asset in the fiscal six months of 2019. Includes litigation expense of $0.4 billion in the fiscal six months of 2019. Includes an unrealized gain on securities of $0.5 billion and $0.2&#160;billion in the fiscal second quarter of 2020 and 2019, respectively. Includes an unrealized gain on securities of $0.2&#160;billion and $0.3&#160;billion in the fiscal six months of 2020 and 2019, respectively. Additionally, the fiscal six months of 2019 includes a research and development expense of $0.3 billion for an upfront payment related to argenx. Includes amortization expense of $0.8 billion in both the fiscal second quarters of 2020 and 2019. Includes amortization expense of $1.6&#160;billion in both the fiscal six months of 2020 and 2019. In the fiscal second quarter and early in the third quarter of 2020, the Company entered into a series of contract manufacturing arrangements for vaccine production with third party contract manufacturing organizations. These arrangements provide the Company with future supplemental commercial capacity for vaccine production and potentially transferable rights to such production if capacity is not required. Amounts paid and contractually obligated to be paid to these contract manufacturing organizations are reflected in the prepaid expenses and other and the accrued liabilities accounts in the Company's consolidated balance sheet upon execution of each agreement.  Additionally, the Company has entered into certain vaccine development cost sharing arrangements with government related organizations. The costs associated with these arrangements have not been significant through the fiscal second quarter of 2020. </span><span style="background-color:rgb(255,255,255, 0.0);color:#ff0000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%;"> </span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:96%;"> </span></div><div style="margin-bottom:10pt;"><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">Includes a contingent consideration reversal of $1.0 billion in the fiscal six months of 2020 related to the timing of certain developmental milestones associated with the Auris Health acquisition. Includes a gain of $2.0&#160;billion from the divestiture of the ASP business in the fiscal second quarter and six months of 2019. Includes litigation expense of $0.2 billion and $0.3&#160;billion in the fiscal second quarter and fiscal six months of 2019, respectively. Includes a restructuring related charge of $0.1 billion and </span></div>amortization expense of $0.2 billion in both the fiscal second quarters of 2020 and 2019.  Includes a restructuring related charge of $0.2&#160;billion and amortization expense of $0.5&#160;billion in both the fiscal six months of 2020 and 2019. (4) Amounts not allocated to segments include interest income/expense and general corporate income/expense.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock', window );">Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas</a></td>
<td class="text"><div style="margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">SALES BY GEOGRAPHIC AREA</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.275%;"><tr><td style="width:1.0%;"/><td style="width:31.138%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.094%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.510%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.343%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:9.094%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.821%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:8.510%;"/><td style="width:1.0%;"/><td style="width:0.1%;"/><td style="width:0.529%;"/><td style="width:0.1%;"/><td style="width:1.0%;"/><td style="width:7.353%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Second Quarter Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="15" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Fiscal Six Months Ended</span></td><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent<br/>Change</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 28, 2020</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">June 30, 2019</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Percent Change</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">United States</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,539&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">10,403&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(8.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,238&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,532&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(1.4)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Europe</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,063&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">4,733&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(14.2)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8,890&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">9,342&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(4.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Western Hemisphere, excluding U.S.</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,133&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">1,455&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(22.1)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,635&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">2,958&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.9)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asia-Pacific, Africa</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,601&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">3,971&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(9.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,264&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">7,751&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(6.3)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">18,336&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">20,562&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(10.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">39,027&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">40,583&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3.8)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SalesBySegmentOfBusinessTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sales by segment of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SalesBySegmentOfBusinessTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e9038-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8721-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=115929826&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530254764424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 28, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesAbstract', window );"><strong>Restructuring and Related Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of Restructuring Reserve</a></td>
<td class="text"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The following table summarizes the severance related reserves and the associated restructuring expenses through the first fiscal six months of 2020:</span></div><div style="margin-top:5pt;margin-bottom:5pt;"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.052%;"><tr><td style="width:1.0%;"/><td style="width:32.703%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.372%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.981%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.372%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:1.500%;"/><td style="width:1.0%;"/><td style="width:1.0%;"/><td style="width:13.072%;"/><td style="width:1.0%;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:8pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(Dollars in Millions)</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Severance</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Asset Write-offs</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><div style="text-align:center;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;">Other</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;vertical-align:top;">(2)</sup></div></td><td colspan="3" style="background-color:rgb(255,255,255, 0.0);text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:rgb(255,255,255, 0.0);text-align:center;vertical-align:middle;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:700;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Total</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Reserve balance, December 29, 2019</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">164&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">16&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">180&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">Current year activity:</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Charges  </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">27&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">206&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">233&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Cash payments</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(12)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(197)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(209)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#cceeff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;&#160;&#160;Settled non cash </span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(27)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(17)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:top;padding-left:1pt;padding-right:1pt;"><span style="font-size:7pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(3)</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">(44)</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr><tr><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/><td colspan="3" style="display:none;"/></tr><tr><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="3" style="height:6pt;background-color:#cceeff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/></tr><tr><td colspan="3" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;">Reserve balance, June 28, 2020</span><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;vertical-align:top;">(1)</sup></div></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">$</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">152&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#8212;&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">8&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td><td colspan="3" style="background-color:#ffffff;text-align:left;vertical-align:bottom;padding-left:1pt;padding-right:1pt;"/><td colspan="2" style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-left:1pt;padding-right:0%;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">160&#160;</span></td><td style="padding-top:2px;padding-bottom:2px;background-color:#ffffff;text-align:right;vertical-align:bottom;padding-right:1pt;"><span style="font-size:10pt;font-weight:400;font-family:'Times New Roman',sans-serif;color:#000000;background-color:rgb(255,255,255, 0.0);">&#160;</span></td></tr></table></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(1) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Cash outlays for severance are expected to be substantially paid out over the next 2 years in accordance with the Company's plans and local laws. </span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(2)</sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;"> Other includes project expense such as salaries for employees supporting these initiatives and consulting expenses.</span></div><div><sup style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;vertical-align:top;">(3) </sup><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;">Relates to pension related actuarial losses associated with the transfer of employees to Jabil Inc. as part of the strategic collaboration.</span></div><div><span><br/></span></div><div><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The Company continuously reevaluates its severance reserves related to restructuring and the timing of payments due to the planned release of associates regarding several longer-term projects. The Company believes that the existing severance reserves are sufficient to cover the Global Supply Chain plans given the period over which the actions will take place. The Company will continue to assess and make adjustments as necessary if additional amounts become probable and estimable.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530258124728">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves', window );">Raw materials and supplies</a></td>
<td class="nump">$ 1,303<span></span>
</td>
<td class="nump">$ 1,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Goods in process</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">1,832<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">6,159<span></span>
</td>
<td class="nump">6,071<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventories</a></td>
<td class="nump">$ 9,424<span></span>
</td>
<td class="nump">$ 9,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116846819&amp;loc=d3e3927-108312<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530341008456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">$ 12,734<span></span>
</td>
<td class="nump">$ 11,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets - net</a></td>
<td class="nump">47,413<span></span>
</td>
<td class="nump">47,643<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember', window );">Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">6,927<span></span>
</td>
<td class="nump">6,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Intangible assets with indefinite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-Lived Intangible Assets</a></td>
<td class="nump">5,807<span></span>
</td>
<td class="nump">4,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember', window );">Patents And Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets with definite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">37,313<span></span>
</td>
<td class="nump">36,634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">14,834<span></span>
</td>
<td class="nump">13,154<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">22,479<span></span>
</td>
<td class="nump">23,480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Customer relationships and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Intangible assets with definite lives:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Finite-Lived Intangible Assets, Gross</a></td>
<td class="nump">22,272<span></span>
</td>
<td class="nump">22,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less accumulated amortization</a></td>
<td class="nump">10,072<span></span>
</td>
<td class="nump">9,462<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Finite-Lived Intangible Assets, Net</a></td>
<td class="nump">$ 12,200<span></span>
</td>
<td class="nump">$ 12,594<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530341032984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Goodwill By Segment (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">$ 33,639<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">33,890<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">9,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">9,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">9,169<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">45<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">9,215<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill Beginning of Period</a></td>
<td class="nump">14,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill, related to acquisitions</a></td>
<td class="nump">183<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillOtherIncreaseDecrease', window );">Currency translation/Other</a></td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill End of Period</a></td>
<td class="nump">$ 14,929<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillOtherIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=108376223&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillOtherIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530352813672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 12,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense of amortizable intangible assets</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="nump">$ 2,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember', window );">Patents And Trademarks</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted-Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Customer relationships and other intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract', window );"><strong>Intangible Assets and Goodwill (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Finite-Lived Intangible Assets, Weighted-Average Useful Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="nump">$ 5,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,647<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development | bermekimab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember', window );">Purchased In-Process Research And Development | Verb Surgical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived Intangible Assets (Excluding Goodwill)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IntangibleAssetsAndGoodwillTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Intangible Assets and Goodwill Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IntangibleAssetsAndGoodwillTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PatentsAndTrademarksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=jnj_PurchasedInProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530258049608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2020</a></td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2021</a></td>
<td class="nump">4,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2022</a></td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2023</a></td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2024</a></td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530257791272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">$ 1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax', window );">Accumulated other comprehensive income on derivatives, after tax</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss', window );">Reclassification of foreign exchange contracts into earnings, period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">next 12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge', window );">Maximum length of time for hedge exposure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gains on equity investments</a></td>
<td class="num">$ (2)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate on non-current debt</a></td>
<td class="nump">3.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ExcessOfFairValueOverCarryingValueOfDebt', window );">Excess of the estimated fair value over the carrying value of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 5,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">938<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember', window );">Commercial Paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollateralAlreadyPostedAggregateFairValue', window );">Collateral Already Posted, Aggregate Fair Value</a></td>
<td class="nump">$ 926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Asset, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember', window );">Equity Investments without readily determinable value | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityFairValueAdjustmentImpairmentLoss', window );">Equity, Fair Value Adjustment, Impairment Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityFairValueAdjustmentChangeInObservablePrice', window );">Equity, Fair Value Adjustment, Change In Observable Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Equity Securities without Readily Determinable Fair Value, Amount</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 712<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember', window );">Equity Investments with readily determinable value | Equity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Cost of Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Research and Development Expense [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Interest Income Expense Net Member | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging [Member] | Other (income) expense | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative, Excluded Component, Gain (Loss), Recognized in Earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Sales [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Cost of Sales [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Cost of Sales [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Research and Development Expense [Member] | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Research and Development Expense [Member] | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Income Expense Net Member | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Interest Income Expense Net Member | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">83<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Other (income) expense | Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging [Member] | Other (income) expense | Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityFairValueAdjustmentChangeInObservablePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity, Fair Value Adjustment, Change In Observable Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityFairValueAdjustmentChangeInObservablePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityFairValueAdjustmentImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity, Fair Value Adjustment, Impairment Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityFairValueAdjustmentImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ExcessOfFairValueOverCarryingValueOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of fair value over carrying value of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ExcessOfFairValueOverCarryingValueOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAlreadyPostedAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAlreadyPostedAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the transactions or other events that will result in the reclassification into earnings of gains or losses reported in accumulated other comprehensive income. May include the time period over which gains or losses will be reclassified to earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtTypeAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530262023896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Derivative Activity (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Gain/ (Loss) reclassified from Accumulated OCI into income</a></td>
<td class="nump">60<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="num">$ (70)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">853<span></span>
</td>
<td class="num">(216)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollateralAlreadyPostedAggregateFairValue', window );">Collateral Already Posted, Aggregate Fair Value</a></td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember', window );">Fair Value Hedging | Cross currency interest rate swaps | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings', window );">Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">39<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">79<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="num">(35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(50)<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="num">(346)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="num">(62)<span></span>
</td>
<td class="num">(101)<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="num">(136)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="num">(10)<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="num">(120)<span></span>
</td>
<td class="num">(92)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="num">(108)<span></span>
</td>
<td class="num">(103)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">22<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Forward foreign exchange contracts | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging | Cross currency interest rate swaps | Interest (income)/Interest expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax', window );">Unrealized gain (loss) arising during period</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="nump">725<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract', window );"><strong>Summary of designated derivatives</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="nump">$ 118<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative instruments gain loss on statement of financial performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollateralAlreadyPostedAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4H<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624258-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollateralAlreadyPostedAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061172-113977<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_InterestIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256937048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Carrying Amount of the Hedged Liability</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530257207784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Forward foreign exchange contracts | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Gain/(Loss) Recognized In Income on Derivative</a></td>
<td class="num">$ (24)<span></span>
</td>
<td class="num">$ (50)<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="num">$ (88)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530340910152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">$ (57)<span></span>
</td>
<td class="num">(48)<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember', window );">Sale of Subsidiary Gain (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember', window );">Other Income Expense Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred', window );">Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross Currency Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax', window );">Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax</a></td>
<td class="num">$ (186)<span></span>
</td>
<td class="num">$ (57)<span></span>
</td>
<td class="nump">$ 641<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=112277219&amp;loc=d3e80845-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (dd)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624171-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=d3e637-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CCC<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL109998896-113959<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109974929&amp;loc=SL110061190-113977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SaleOfSubsidiaryGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530275995736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Activity Related to Equity Investments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInvestmentNotReadilyMarketableLineItems', window );"><strong>Other Investment Not Readily Marketable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business Combination, Contingent Consideration, Liability</a></td>
<td class="nump">$ 796<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">5,782<span></span>
</td>
<td class="nump">$ 5,695<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Equity Investments with readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Carrying value, beginning of period</a></td>
<td class="nump">1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="nump">196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod', window );">Sales/ Purchases/Other</a></td>
<td class="nump">144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesNoncurrent', window );">Carrying value, end of period</a></td>
<td class="nump">1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember', window );">Equity Securities | Equity Investments without readily determinable value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentRollForward', window );"><strong>Equity Investment [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying value, beginning of period</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityFairValueAdjustment', window );">Changes in Fair Value Reflected in Net Income</a></td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod', window );">Sales/ Purchases/Other</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying value, end of period</a></td>
<td class="nump">712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Non Current Other Assets</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityInvestmentRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investment [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityInvestmentRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityFairValueAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityFairValueAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 321<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116654751&amp;loc=SL75117539-209714<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_EquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInvestmentNotReadilyMarketableAxis=jnj_EquityInvestmentswithoutReadilyDeterminableValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530264822760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
<th class="th"><div>Apr. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">$ 1,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">10,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,368<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total Gross Assets</a></td>
<td class="nump">1,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetFairValueGrossLiability', window );">Credit Support Agreement (CSA)</a></td>
<td class="num">(1,437)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(841)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Total Net Asset</a></td>
<td class="nump">122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Total Gross Liabilities</a></td>
<td class="nump">558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityFairValueGrossAsset', window );">Credit Support Agreement (CSA)</a></td>
<td class="num">(510)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(586)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Total Net Liabilities</a></td>
<td class="nump">48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">796<span></span>
</td>
<td class="nump">$ 1,562<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue', window );">Changes in estimated fair value (7)</a></td>
<td class="num">(938)<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Additions</a></td>
<td class="nump">106<span></span>
</td>
<td class="nump">1,133<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="num">(87)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">1,715<span></span>
</td>
<td class="nump">397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(983)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">1,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,148<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">1,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">902<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">619<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">10,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquitySecuritiesFvNi', window );">Available-for-sale Securities, Equity Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeAssetsNoncurrent', window );">Derivative Assets, Noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">251<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest Rate Contract | Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">43,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Quoted prices in active markets for identical assets and liabilities Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Significant other observable inputs Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">260<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">426<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign exchange contracts | Significant unobservable inputs Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue', window );">Derivatives designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue', window );">Derivatives designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue', window );">Derivatives not designated as hedging instruments : Assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue', window );">Derivatives not designated as hedging instruments : Liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember', window );">Cross currency interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative, Notional Amount</a></td>
<td class="nump">22,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Contingent consideration reversal</a></td>
<td class="num">(983)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">169<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other Noncurrent Liabilities | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">793<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember', window );">Other Current Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentDetailAbstract', window );"><strong>Financial assets and liabilities at fair value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetFairValueGrossLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetFairValueGrossLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118948506&amp;loc=SL51823488-111719<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentDetailAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentDetailAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=118260190&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityFairValueGrossAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226003-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityFairValueGrossAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesFvNi">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=99377092&amp;loc=SL75136599-209740<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesFvNi</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative assets not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109980867&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_CrossCurrencyInterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530257399256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">$ 10,047<span></span>
</td>
<td class="nump">$ 4,368<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">11,174<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">7,961<span></span>
</td>
<td class="nump">$ 1,982<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Total cash, cash equivalents and current marketable securities, Carrying Amount</a></td>
<td class="nump">19,134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain', window );">Total cash, cash equivalents and current marketable securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss', window );">Total cash, cash equivalents and current marketable securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue', window );">Total cash, cash equivalents and current marketable securities, Estimated Fair Value</a></td>
<td class="nump">19,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">9,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">9,088<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">7,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">1,408<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">2,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">2,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">2,215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Non-U.S. sovereign securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">655<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | U.S. reverse repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Other reverse repurchase agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Corporate debt securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">1,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember', window );">Held-to-maturity Securities | Time deposits(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract', window );"><strong>Debt Securities, Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecurities', window );">Held-to-maturity Securities - Carrying Amount</a></td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain', window );">Held-to-maturity Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss', window );">Held-to-maturity Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HeldToMaturitySecuritiesFairValue', window );">Held-to-maturity Securities - Estimated Fair Value</a></td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">579<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">10,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">10,047<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">3,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">6,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities | Corporate debt securities(1)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">242<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale Securities | US Treasury and Government [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAbstract', window );"><strong>Debt Securities, Available-for-sale [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Available-for-sale Securities - Carrying Amount</a></td>
<td class="nump">9,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Available-for-sale Securities, Unrecognized Gain</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Available-for-sale Securities, Unrecognized Loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale Securities - Estimated Fair Value</a></td>
<td class="nump">9,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract', window );"><strong>Debt Securities, Available-for-sale and Held-to-maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">3,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesCurrent', window );">Marketable securities</a></td>
<td class="nump">$ 6,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942338&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118954083&amp;loc=d3e26610-111562<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesClassifiedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesClassifiedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HeldToMaturitySecuritiesFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at amortized cost (held-to-maturity).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27232-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HeldToMaturitySecuritiesFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in marketable security, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118951113&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_HeldtomaturitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=jnj_OtherReverseRepurchaseAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=jnj_OtherReverseRepurchaseAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_BankTimeDepositsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_BankTimeDepositsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_USTreasuryAndGovernmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530341349912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Cost Basis</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Due within one year</a></td>
<td class="nump">$ 10,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost', window );">Due after one year through five years</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost', window );">Due after five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis', window );">Total debt securities</a></td>
<td class="nump">10,046<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">10,024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue', window );">Due after one year through five years</a></td>
<td class="nump">23<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue', window );">Due after five years through ten years</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate', window );">Total debt securities</a></td>
<td class="nump">$ 10,047<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth fiscal year through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27198-111563<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118939692&amp;loc=d3e27161-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=75019621&amp;loc=d3e62586-112803<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530252969704">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Dec. 29, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">$ 5,332<span></span>
</td>
<td class="nump">$ 1,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">25,062<span></span>
</td>
<td class="nump">$ 26,494<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">5,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">25,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermBorrowings', window );">Current Debt</a></td>
<td class="nump">5,388<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 29,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2021Member', window );">3.55% Notes due 2021 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member', window );">2.45% Notes due 2021 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 360<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1217)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1217) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member', window );">0.250% Notes due 2022 (1B Euro 1.1217) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,131<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member', window );">2.25% Notes due 2022 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,029<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">6.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member', window );">6.73% Debentures due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member', window );">3.375% Notes due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 891<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.05%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member', window );">2.05% Notes due 2023 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1217)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1217) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member', window );">0.650% Notes due 2024 (750MM Euro 1.1217) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2431)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2431) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member', window );">5.50% Notes due 2024 (500 MM GBP 1.2431) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 749<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 748<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member', window );">2.625% Notes due 2025 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.45%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member', window );">2.45% Notes due 2026 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 2,179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member', window );">2.95% Notes due 2027 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member', window );">2.90%&#160;Notes due 2028 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,681<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1217)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1217) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member', window );">1.150% Notes due 2028 (750MM Euro 1.1217) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 917<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">6.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member', window );">6.95% Notes due 2029 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member', window );">4.95% Debentures due 2033 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member', window );">4.375% Notes due 2033 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1217)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1217) | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member', window );">1.650% Notes due 2035 (1.5B Euro 1.1217) | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.55%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 989<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member', window );">3.55% Notes due 2036 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.95%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member', window );">5.95% Notes due 2037 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member', window );">3.625% Notes due 2037 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,791<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member', window );">3.40%&#160;Notes due 2038 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,168<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">5.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member', window );">5.85% Debentures due 2038 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member', window );">4.50% Debentures due 2040 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 736<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member', window );">4.85% Notes due 2041 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 495<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member', window );">4.50% Notes due 2043 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member', window );">3.70% Notes due 2046 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 2,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member', window );">3.75% Notes due 2047 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 1,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate (as a percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048 | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member', window );">3.50% Notes due 2048 | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">923<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember', window );">Other | Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember', window );">Other | Estimated Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrentAbstract', window );"><strong>Non-Current Debt</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Non-Current Debt</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A0.250NotesDue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.25Notesdue2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A6.73Debenturesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.375Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.05Notesdue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A0.650NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.50NotesDue2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.625Notesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.45Notesdue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.95Notesdue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A2.900Notesdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A1.150NotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A6.95Notesdue2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.95Debenturesdue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.375Notesdue2033Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A1.650NotesDue2035Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.55Notesdue2036Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.95Notesdue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.625Notesdue2037Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.400Notesdue2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A5.85Debenturesdue2038Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.50Debenturesdue2040Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.85Notesdue2041Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A4.50Notesdue2043Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.70Notesdue2046Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.75Notesdue2047Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_A3.500Notesdue2048Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=jnj_NotesDuePeriodFifteenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530343710504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Worldwide effective income tax rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
<td class="nump">18.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset', window );">Deferred tax benefit related to TRAF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit', window );">Deferred tax liability related to TRAF</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent', window );">Deferred tax benefit related to TRAF, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent', window );">Impact to effective tax rate, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent', window );">Net impact to tax rate due to change in contingent consideration liability</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember', window );">Accrued Taxes On Income [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember', window );">Internal Revenue Service (IRS) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_IncomeTaxTextualsAbstract', window );"><strong>Income Tax (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_UnrecognizedTaxBenefitLiabilityPayment', window );">Payment on unrecognized tax benefit liability</a></td>
<td class="nump">$ 0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_IncomeTaxTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income Tax Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_IncomeTaxTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_UnrecognizedTaxBenefitLiabilityPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Unrecognized Tax Benefit Liability, Payment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_UnrecognizedTaxBenefitLiabilityPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32698-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=116821951&amp;loc=SL37586934-109318<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=jnj_AccruedTaxesOnIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_InternalRevenueServiceIRSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530348291032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember', window );">Retirement Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">$ 649<span></span>
</td>
<td class="nump">$ 553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">237<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="nump">477<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(608)<span></span>
</td>
<td class="num">(581)<span></span>
</td>
<td class="num">(1,222)<span></span>
</td>
<td class="num">(1,164)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/(credit)</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">222<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">445<span></span>
</td>
<td class="nump">290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailments and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">19<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember', window );">Other Benefit Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract', window );"><strong>Components of net periodic benefit cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanServiceCost', window );">Service cost</a></td>
<td class="nump">72<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">144<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanInterestCost', window );">Interest cost</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets', window );">Expected return on plan assets</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit', window );">Amortization of prior service cost/(credit)</a></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses', window );">Recognized actuarial losses</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="nump">71<span></span>
</td>
<td class="nump">65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1', window );">Curtailments and settlements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost', window );">Net periodic benefit cost</a></td>
<td class="nump">$ 131<span></span>
</td>
<td class="nump">$ 139<span></span>
</td>
<td class="nump">$ 262<span></span>
</td>
<td class="nump">$ 275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanInterestCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost recognized for passage of time related to defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanInterestCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of net periodic benefit cost (credit) for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(7)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanServiceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118257860&amp;loc=d3e4179-114921<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e2709-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=118255775&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanServiceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_PensionPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanTypeAxis=us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530258104968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pensions and Other Benefit Plans (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember', window );">International retirement plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedBenefitPlanDisclosureLineItems', window );"><strong>Defined Benefit Plan Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionContributions', window );">Contribution to pension plans</a></td>
<td class="nump">$ 18<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedBenefitPlanDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedBenefitPlanDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionContributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionContributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetirementPlanSponsorLocationAxis=us-gaap_ForeignPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530464946712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="nump">$ 61,294<span></span>
</td>
<td class="nump">$ 58,955<span></span>
</td>
<td class="nump">$ 59,471<span></span>
</td>
<td class="nump">$ 59,752<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">62,978<span></span>
</td>
<td class="nump">60,785<span></span>
</td>
<td class="nump">62,978<span></span>
</td>
<td class="nump">60,785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Accumulated Foreign Currency Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,705)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(963)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">(9,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,668)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Accumulated Net Investment Gain (Loss) Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Accumulated Defined Benefit Plans Adjustment Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,891)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">(6,501)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,501)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(295)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">AOCI Attributable to Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract', window );"><strong>AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning Balance</a></td>
<td class="num">(16,243)<span></span>
</td>
<td class="num">(15,517)<span></span>
</td>
<td class="num">(15,891)<span></span>
</td>
<td class="num">(15,222)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Net change</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">548<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending Balance</a></td>
<td class="num">$ (15,533)<span></span>
</td>
<td class="num">$ (14,969)<span></span>
</td>
<td class="num">$ (15,533)<span></span>
</td>
<td class="num">$ (14,969)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=118951672&amp;loc=d3e1436-108581<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118930883&amp;loc=SL7669625-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=116874947&amp;loc=SL4590271-111686<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530276222120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings Per Share (Details) - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Reconciliation of basic net earnings per share to diluted net earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net earnings per share</a></td>
<td class="nump">$ 1.38<span></span>
</td>
<td class="nump">$ 2.11<span></span>
</td>
<td class="nump">$ 3.58<span></span>
</td>
<td class="nump">$ 3.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Average shares outstanding &#8212; basic</a></td>
<td class="nump">2,632,900<span></span>
</td>
<td class="nump">2,652,500<span></span>
</td>
<td class="nump">2,633,300<span></span>
</td>
<td class="nump">2,656,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Potential shares exercisable under stock option plans</a></td>
<td class="nump">119,600<span></span>
</td>
<td class="nump">140,800<span></span>
</td>
<td class="nump">122,600<span></span>
</td>
<td class="nump">138,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod', window );">Less: shares which could be repurchased under treasury stock method</a></td>
<td class="num">(87,500)<span></span>
</td>
<td class="num">(102,300)<span></span>
</td>
<td class="num">(85,400)<span></span>
</td>
<td class="num">(99,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities', window );">Convertible debt shares</a></td>
<td class="nump">500<span></span>
</td>
<td class="nump">700<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Average shares outstanding &#8212; diluted</a></td>
<td class="nump">2,665,500<span></span>
</td>
<td class="nump">2,691,700<span></span>
</td>
<td class="nump">2,671,000<span></span>
</td>
<td class="nump">2,697,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net earnings per share</a></td>
<td class="nump">$ 1.36<span></span>
</td>
<td class="nump">$ 2.08<span></span>
</td>
<td class="nump">$ 3.53<span></span>
</td>
<td class="nump">$ 3.47<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</a></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=117327953&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1252-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637391&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=116637232&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1930-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1500-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=117326831&amp;loc=d3e1448-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530182585784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Sales By Segment Of Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 18,336<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 39,027<span></span>
</td>
<td class="nump">$ 40,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(10.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 9,539<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
<td class="nump">$ 20,238<span></span>
</td>
<td class="nump">20,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(8.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 8,797<span></span>
</td>
<td class="nump">10,159<span></span>
</td>
<td class="nump">$ 18,789<span></span>
</td>
<td class="nump">20,051<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(13.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,296<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">$ 6,921<span></span>
</td>
<td class="nump">$ 6,862<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,557<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">3,297<span></span>
</td>
<td class="nump">$ 2,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,739<span></span>
</td>
<td class="nump">2,007<span></span>
</td>
<td class="nump">3,624<span></span>
</td>
<td class="nump">$ 3,887<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(13.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.80%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 356<span></span>
</td>
<td class="nump">443<span></span>
</td>
<td class="nump">717<span></span>
</td>
<td class="nump">$ 837<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(19.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.30%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
<td class="nump">$ 186<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Baby Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 260<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">$ 529<span></span>
</td>
<td class="nump">$ 651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(24.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18.70%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 397<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="nump">792<span></span>
</td>
<td class="nump">$ 756<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">155<span></span>
</td>
<td class="nump">346<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Oral Care | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 227<span></span>
</td>
<td class="nump">234<span></span>
</td>
<td class="nump">446<span></span>
</td>
<td class="nump">$ 450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.80%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,149<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
<td class="nump">2,497<span></span>
</td>
<td class="nump">$ 2,151<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 627<span></span>
</td>
<td class="nump">484<span></span>
</td>
<td class="nump">1,316<span></span>
</td>
<td class="nump">$ 991<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">29.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | OTC | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 522<span></span>
</td>
<td class="nump">580<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">$ 1,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(10.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,007<span></span>
</td>
<td class="nump">1,202<span></span>
</td>
<td class="nump">2,124<span></span>
</td>
<td class="nump">$ 2,292<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(16.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.30%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 536<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="nump">1,195<span></span>
</td>
<td class="nump">$ 1,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(19.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.50%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Skin Health/Beauty | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 471<span></span>
</td>
<td class="nump">539<span></span>
</td>
<td class="nump">929<span></span>
</td>
<td class="nump">$ 1,041<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.70%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 202<span></span>
</td>
<td class="nump">253<span></span>
</td>
<td class="nump">434<span></span>
</td>
<td class="nump">$ 478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(20.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.30%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Women's Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 199<span></span>
</td>
<td class="nump">250<span></span>
</td>
<td class="nump">427<span></span>
</td>
<td class="nump">$ 472<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(20.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.60%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 185<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="nump">356<span></span>
</td>
<td class="nump">$ 348<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">245<span></span>
</td>
<td class="nump">$ 234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health* | Wound Care/Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 59<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">111<span></span>
</td>
<td class="nump">$ 114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.90%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 10,752<span></span>
</td>
<td class="nump">10,529<span></span>
</td>
<td class="nump">$ 21,886<span></span>
</td>
<td class="nump">$ 20,773<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 6,120<span></span>
</td>
<td class="nump">5,783<span></span>
</td>
<td class="nump">$ 12,181<span></span>
</td>
<td class="nump">11,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 4,632<span></span>
</td>
<td class="nump">4,746<span></span>
</td>
<td class="nump">$ 9,705<span></span>
</td>
<td class="nump">9,408<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3,523<span></span>
</td>
<td class="nump">3,466<span></span>
</td>
<td class="nump">$ 7,161<span></span>
</td>
<td class="nump">6,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,362<span></span>
</td>
<td class="nump">2,379<span></span>
</td>
<td class="nump">$ 4,772<span></span>
</td>
<td class="nump">4,542<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,161<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">$ 2,389<span></span>
</td>
<td class="nump">2,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 935<span></span>
</td>
<td class="nump">1,107<span></span>
</td>
<td class="nump">$ 1,925<span></span>
</td>
<td class="nump">2,209<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(15.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 593<span></span>
</td>
<td class="nump">801<span></span>
</td>
<td class="nump">$ 1,218<span></span>
</td>
<td class="nump">1,575<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(25.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | U.S. Exports</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | REMICADE&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">244<span></span>
</td>
<td class="nump">$ 464<span></span>
</td>
<td class="nump">496<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(14.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 546<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="nump">1,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">281<span></span>
</td>
<td class="nump">$ 528<span></span>
</td>
<td class="nump">544<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(8.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | SIMPONI / SIMPONI ARIA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 289<span></span>
</td>
<td class="nump">282<span></span>
</td>
<td class="nump">$ 547<span></span>
</td>
<td class="nump">543<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,697<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
<td class="nump">$ 3,516<span></span>
</td>
<td class="nump">2,963<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,138<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
<td class="nump">$ 2,355<span></span>
</td>
<td class="nump">1,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | STELARA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 558<span></span>
</td>
<td class="nump">499<span></span>
</td>
<td class="nump">$ 1,161<span></span>
</td>
<td class="nump">1,022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 342<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="nump">$ 638<span></span>
</td>
<td class="nump">452<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">45.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 241<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">$ 428<span></span>
</td>
<td class="nump">344<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">36.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | TREMFYA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Immunology | OTHER IMMUNOLOGY | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">11.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 878<span></span>
</td>
<td class="nump">862<span></span>
</td>
<td class="nump">$ 1,798<span></span>
</td>
<td class="nump">1,708<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">387<span></span>
</td>
<td class="nump">$ 852<span></span>
</td>
<td class="nump">744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 463<span></span>
</td>
<td class="nump">475<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
<td class="nump">964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">210<span></span>
</td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">22.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(14.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | EDURANT&#174; / rilpivirine | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 246<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
<td class="nump">397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">24.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">535<span></span>
</td>
<td class="nump">$ 1,089<span></span>
</td>
<td class="nump">1,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 379<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="nump">$ 775<span></span>
</td>
<td class="nump">659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | PREZISTA&#174; / PREZCOBIX&#174; / REZOLSTA&#174; / SYMTUZA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 130<span></span>
</td>
<td class="nump">191<span></span>
</td>
<td class="nump">$ 314<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(32.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 113<span></span>
</td>
<td class="nump">117<span></span>
</td>
<td class="nump">$ 229<span></span>
</td>
<td class="nump">229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="nump">$ 54<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(18.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Infectious Diseases | OTHER INFECTIOUS DISEASES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">168<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,587<span></span>
</td>
<td class="nump">1,538<span></span>
</td>
<td class="nump">$ 3,245<span></span>
</td>
<td class="nump">3,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 778<span></span>
</td>
<td class="nump">664<span></span>
</td>
<td class="nump">$ 1,526<span></span>
</td>
<td class="nump">1,387<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">17.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 809<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="nump">$ 1,719<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 149<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 55<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="nump">$ 107<span></span>
</td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | CONCERTA&#174; / methylphenidate | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 94<span></span>
</td>
<td class="nump">123<span></span>
</td>
<td class="nump">$ 212<span></span>
</td>
<td class="nump">239<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(23.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">$ 1,762<span></span>
</td>
<td class="nump">1,608<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 576<span></span>
</td>
<td class="nump">506<span></span>
</td>
<td class="nump">$ 1,120<span></span>
</td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">13.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | INVEGA SUSTENNA&#174; / XEPLION&#174; / INVEGA TRINZA&#174; / TREVICTA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 303<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">$ 642<span></span>
</td>
<td class="nump">619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 153<span></span>
</td>
<td class="nump">182<span></span>
</td>
<td class="nump">$ 323<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(15.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">81<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(9.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | RISPERDAL CONSTA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">$ 173<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(21.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">401<span></span>
</td>
<td class="nump">$ 841<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">21.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Neuroscience | OTHER NEUROSCIENCE | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 331<span></span>
</td>
<td class="nump">340<span></span>
</td>
<td class="nump">$ 691<span></span>
</td>
<td class="nump">719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(2.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,791<span></span>
</td>
<td class="nump">2,697<span></span>
</td>
<td class="nump">$ 5,804<span></span>
</td>
<td class="nump">5,215<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,181<span></span>
</td>
<td class="nump">1,013<span></span>
</td>
<td class="nump">$ 2,356<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">16.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,609<span></span>
</td>
<td class="nump">1,684<span></span>
</td>
<td class="nump">$ 3,448<span></span>
</td>
<td class="nump">3,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(4.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 901<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="nump">$ 1,838<span></span>
</td>
<td class="nump">1,403<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">16.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 492<span></span>
</td>
<td class="nump">369<span></span>
</td>
<td class="nump">$ 955<span></span>
</td>
<td class="nump">721<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">32.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | DARZALEX&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 409<span></span>
</td>
<td class="nump">405<span></span>
</td>
<td class="nump">$ 883<span></span>
</td>
<td class="nump">682<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 170<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="nump">$ 313<span></span>
</td>
<td class="nump">130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA [Member] | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">136<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">255<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ERLEADA [Member] | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 949<span></span>
</td>
<td class="nump">831<span></span>
</td>
<td class="nump">$ 1,980<span></span>
</td>
<td class="nump">1,615<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">367<span></span>
</td>
<td class="nump">$ 879<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">21.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | IMBRUVICA&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 502<span></span>
</td>
<td class="nump">463<span></span>
</td>
<td class="nump">$ 1,101<span></span>
</td>
<td class="nump">898<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(56.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | VELCADE&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 98<span></span>
</td>
<td class="nump">224<span></span>
</td>
<td class="nump">$ 206<span></span>
</td>
<td class="nump">487<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(56.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 568<span></span>
</td>
<td class="nump">698<span></span>
</td>
<td class="nump">$ 1,258<span></span>
</td>
<td class="nump">1,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(18.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(55.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | ZYTIGA&#174; / abiraterone acetate | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 480<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">$ 1,032<span></span>
</td>
<td class="nump">994<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 106<span></span>
</td>
<td class="nump">101<span></span>
</td>
<td class="nump">$ 210<span></span>
</td>
<td class="nump">203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 20<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">22.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Oncology | OTHER ONCOLOGY | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 87<span></span>
</td>
<td class="nump">85<span></span>
</td>
<td class="nump">$ 169<span></span>
</td>
<td class="nump">169<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">2.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 789<span></span>
</td>
<td class="nump">690<span></span>
</td>
<td class="nump">$ 1,534<span></span>
</td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">14.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 545<span></span>
</td>
<td class="nump">439<span></span>
</td>
<td class="nump">$ 1,031<span></span>
</td>
<td class="nump">869<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">24.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 243<span></span>
</td>
<td class="nump">251<span></span>
</td>
<td class="nump">$ 503<span></span>
</td>
<td class="nump">477<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(3.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 406<span></span>
</td>
<td class="nump">348<span></span>
</td>
<td class="nump">$ 795<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">16.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">$ 485<span></span>
</td>
<td class="nump">375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">26.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OPSUMIT&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 150<span></span>
</td>
<td class="nump">146<span></span>
</td>
<td class="nump">$ 310<span></span>
</td>
<td class="nump">279<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 282<span></span>
</td>
<td class="nump">203<span></span>
</td>
<td class="nump">$ 532<span></span>
</td>
<td class="nump">401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">39.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">$ 466<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">44.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | UPTRAVI&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">28<span></span>
</td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 101<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="nump">$ 207<span></span>
</td>
<td class="nump">292<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(27.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 37<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">$ 81<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(40.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Pulmonary Hypertension | OTHER PULMONARY HYPERTENSION | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 64<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
<td class="nump">149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(17.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,184<span></span>
</td>
<td class="nump">1,275<span></span>
</td>
<td class="nump">$ 2,344<span></span>
</td>
<td class="nump">2,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 837<span></span>
</td>
<td class="nump">902<span></span>
</td>
<td class="nump">$ 1,643<span></span>
</td>
<td class="nump">1,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 347<span></span>
</td>
<td class="nump">373<span></span>
</td>
<td class="nump">$ 701<span></span>
</td>
<td class="nump">771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(7.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 559<span></span>
</td>
<td class="nump">549<span></span>
</td>
<td class="nump">$ 1,086<span></span>
</td>
<td class="nump">1,091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | XARELTO&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 179<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">379<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 132<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="nump">$ 249<span></span>
</td>
<td class="nump">286<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(0.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | INVOKANA&#174; / INVOKAMET&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">$ 105<span></span>
</td>
<td class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 136<span></span>
</td>
<td class="nump">183<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(25.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(28.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174; | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 70<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="nump">$ 146<span></span>
</td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(38.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | PROCRIT&#174; / EPREX&#174; | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">70<span></span>
</td>
<td class="nump">$ 145<span></span>
</td>
<td class="nump">148<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(5.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 312<span></span>
</td>
<td class="nump">368<span></span>
</td>
<td class="nump">$ 614<span></span>
</td>
<td class="nump">$ 742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(15.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.30%)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">$ 163<span></span>
</td>
<td class="nump">$ 211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(27.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL | Cardiovascular / Metabolism / Other | OTHER PULMONARY HYPERTENSION | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 234<span></span>
</td>
<td class="nump">260<span></span>
</td>
<td class="nump">$ 451<span></span>
</td>
<td class="nump">531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(10.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 4,288<span></span>
</td>
<td class="nump">6,489<span></span>
</td>
<td class="nump">$ 10,220<span></span>
</td>
<td class="nump">12,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(33.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
<td class="nump">$ 4,760<span></span>
</td>
<td class="nump">6,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(39.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 2,426<span></span>
</td>
<td class="nump">3,406<span></span>
</td>
<td class="nump">$ 5,460<span></span>
</td>
<td class="nump">6,756<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(28.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 590<span></span>
</td>
<td class="nump">750<span></span>
</td>
<td class="nump">$ 1,317<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(21.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 255<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="nump">$ 620<span></span>
</td>
<td class="nump">709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Interventional Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 335<span></span>
</td>
<td class="nump">385<span></span>
</td>
<td class="nump">$ 697<span></span>
</td>
<td class="nump">774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,451<span></span>
</td>
<td class="nump">2,224<span></span>
</td>
<td class="nump">$ 3,489<span></span>
</td>
<td class="nump">4,428<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(34.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 869<span></span>
</td>
<td class="nump">1,331<span></span>
</td>
<td class="nump">$ 2,119<span></span>
</td>
<td class="nump">2,649<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(34.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 583<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="nump">$ 1,371<span></span>
</td>
<td class="nump">1,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(34.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 226<span></span>
</td>
<td class="nump">364<span></span>
</td>
<td class="nump">$ 563<span></span>
</td>
<td class="nump">725<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(37.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 137<span></span>
</td>
<td class="nump">216<span></span>
</td>
<td class="nump">$ 343<span></span>
</td>
<td class="nump">429<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(36.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | HIPS | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 88<span></span>
</td>
<td class="nump">147<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="nump">295<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(39.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 174<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="nump">$ 517<span></span>
</td>
<td class="nump">741<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(53.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">218<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
<td class="nump">441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(50.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | KNEES | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 66<span></span>
</td>
<td class="nump">153<span></span>
</td>
<td class="nump">$ 196<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(56.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 553<span></span>
</td>
<td class="nump">672<span></span>
</td>
<td class="nump">$ 1,207<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(17.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 354<span></span>
</td>
<td class="nump">407<span></span>
</td>
<td class="nump">$ 761<span></span>
</td>
<td class="nump">824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(12.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | TRAUMA | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 198<span></span>
</td>
<td class="nump">265<span></span>
</td>
<td class="nump">$ 445<span></span>
</td>
<td class="nump">533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(25.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 499<span></span>
</td>
<td class="nump">818<span></span>
</td>
<td class="nump">$ 1,202<span></span>
</td>
<td class="nump">1,606<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(39.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 270<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="nump">$ 693<span></span>
</td>
<td class="nump">955<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(45.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Orthopaedics | SPINE, SPORTS &amp; OTHER | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 230<span></span>
</td>
<td class="nump">328<span></span>
</td>
<td class="nump">$ 510<span></span>
</td>
<td class="nump">651<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(29.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,551<span></span>
</td>
<td class="nump">2,353<span></span>
</td>
<td class="nump">$ 3,651<span></span>
</td>
<td class="nump">4,748<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(34.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
<td class="nump">1,927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(47.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 1,060<span></span>
</td>
<td class="nump">1,427<span></span>
</td>
<td class="nump">$ 2,317<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(25.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 775<span></span>
</td>
<td class="nump">1,029<span></span>
</td>
<td class="nump">$ 1,723<span></span>
</td>
<td class="nump">2,009<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(24.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 277<span></span>
</td>
<td class="nump">396<span></span>
</td>
<td class="nump">$ 658<span></span>
</td>
<td class="nump">800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.70%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | ADVANCED | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 498<span></span>
</td>
<td class="nump">633<span></span>
</td>
<td class="nump">$ 1,065<span></span>
</td>
<td class="nump">1,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(21.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 775<span></span>
</td>
<td class="nump">1,325<span></span>
</td>
<td class="nump">$ 1,928<span></span>
</td>
<td class="nump">2,739<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(41.50%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 213<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="nump">$ 676<span></span>
</td>
<td class="nump">1,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(59.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Surgery | GENERAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 562<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">$ 1,252<span></span>
</td>
<td class="nump">1,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(29.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 695<span></span>
</td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">$ 1,762<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(40.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 248<span></span>
</td>
<td class="nump">461<span></span>
</td>
<td class="nump">$ 687<span></span>
</td>
<td class="nump">907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(46.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 447<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="nump">$ 1,075<span></span>
</td>
<td class="nump">1,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(36.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 554<span></span>
</td>
<td class="nump">842<span></span>
</td>
<td class="nump">$ 1,368<span></span>
</td>
<td class="nump">1,666<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(34.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">333<span></span>
</td>
<td class="nump">$ 549<span></span>
</td>
<td class="nump">654<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(39.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | CONTACT LENSES / OTHER | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 352<span></span>
</td>
<td class="nump">509<span></span>
</td>
<td class="nump">$ 819<span></span>
</td>
<td class="nump">1,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(30.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 141<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="nump">$ 394<span></span>
</td>
<td class="nump">624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(55.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL | U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 45<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="nump">$ 138<span></span>
</td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(64.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">MEDICAL DEVICES | Vision | SURGICAL | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationRevenueAbstract', window );"><strong>Sales by segment of business</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="nump">$ 96<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="nump">$ 256<span></span>
</td>
<td class="nump">$ 371<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesBySegmentOfBusiness', window );">Percent Change (as a percent)</a></td>
<td class="num">(49.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesBySegmentOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by segment of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesBySegmentOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_BabyCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_BabyCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_BeautyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_BeautyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OralCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OralCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OTCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OTCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_WomensHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_WomensHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_WoundCareandOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_WoundCareandOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_ImmunologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_ImmunologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RemicadeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RemicadeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_UNITEDSTATESExportsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_UNITEDSTATESExportsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SimponiSimponiAriaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SimponiSimponiAriaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_StelaraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_StelaraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TremfyaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TremfyaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherImmunologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherImmunologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_InfectiousDiseasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_InfectiousDiseasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_EDURANTrilpivirineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_EDURANTrilpivirineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherInfectiousDiseasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherInfectiousDiseasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_NeuroscienceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_NeuroscienceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_CONCERTAMethylphenidateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_CONCERTAMethylphenidateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RISPERDALCONSTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RISPERDALCONSTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OTHERNEUROSCIENCEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OTHERNEUROSCIENCEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_OncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_OncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_DARZALEXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_DARZALEXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ERLEADAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ERLEADAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_IMBRUVICAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_IMBRUVICAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_VELCADEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_VELCADEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ZYTIGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ZYTIGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherOncologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherOncologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_PulmonaryHypertensionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_PulmonaryHypertensionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OPSUMITMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OPSUMITMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_UPTRAVIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_UPTRAVIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_CardiovascularMetabolismOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_CardiovascularMetabolismOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_XareltoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_XareltoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_INVOKANAINVOKAMETMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_INVOKANAINVOKAMETMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PROCRITEPREXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PROCRITEPREXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_InterventionalSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_InterventionalSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_OrthopaedicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_OrthopaedicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_HIPSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_HIPSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_KNEESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_KNEESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TRAUMAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TRAUMAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SPINEOTHERMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SPINEOTHERMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_SurgeryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_SurgeryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_ADVANCEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_ADVANCEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_GENERALMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_GENERALMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=jnj_VisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=jnj_VisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_CONTACTLENSESOTHERMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_CONTACTLENSESOTHERMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_SURGICALMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_SURGICALMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530256717784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,336<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 39,027<span></span>
</td>
<td class="nump">$ 40,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44.00%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Earnings before provision for taxes on income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,940<span></span>
</td>
<td class="nump">7,041<span></span>
</td>
<td class="nump">$ 10,449<span></span>
</td>
<td class="nump">11,463<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember', window );">Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,296<span></span>
</td>
<td class="nump">3,544<span></span>
</td>
<td class="nump">6,921<span></span>
</td>
<td class="nump">6,862<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember', window );">PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,752<span></span>
</td>
<td class="nump">10,529<span></span>
</td>
<td class="nump">21,886<span></span>
</td>
<td class="nump">20,773<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentInProcess', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,288<span></span>
</td>
<td class="nump">6,489<span></span>
</td>
<td class="nump">10,220<span></span>
</td>
<td class="nump">12,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationSettlementExpense', window );">Litigation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,192<span></span>
</td>
<td class="nump">7,272<span></span>
</td>
<td class="nump">$ 10,821<span></span>
</td>
<td class="nump">11,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(42.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.60%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
<td class="nump">406<span></span>
</td>
<td class="nump">$ 802<span></span>
</td>
<td class="nump">1,147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,514<span></span>
</td>
<td class="nump">3,677<span></span>
</td>
<td class="nump">$ 8,348<span></span>
</td>
<td class="nump">6,008<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="nump">$ 1,600<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnSecurities', window );">Unrealized Gain (Loss) on Securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(354)<span></span>
</td>
<td class="nump">3,189<span></span>
</td>
<td class="nump">$ 1,671<span></span>
</td>
<td class="nump">4,686<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInOperatingIncomeLoss', window );">Percentage Change in Operating Income Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(64.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate, Non-Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total Segment Operating Income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 252<span></span>
</td>
<td class="nump">231<span></span>
</td>
<td class="nump">372<span></span>
</td>
<td class="nump">378<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member', window );">Ci:z Holdings Co. Ltd. | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfEquityInvestments', window );">Gain on sale of equity investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,539<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
<td class="nump">$ 20,238<span></span>
</td>
<td class="nump">20,532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Consumer Health*</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,557<span></span>
</td>
<td class="nump">1,537<span></span>
</td>
<td class="nump">3,297<span></span>
</td>
<td class="nump">2,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | PHARMACEUTICAL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,120<span></span>
</td>
<td class="nump">5,783<span></span>
</td>
<td class="nump">12,181<span></span>
</td>
<td class="nump">11,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,862<span></span>
</td>
<td class="nump">3,083<span></span>
</td>
<td class="nump">$ 4,760<span></span>
</td>
<td class="nump">6,192<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,063<span></span>
</td>
<td class="nump">4,733<span></span>
</td>
<td class="nump">$ 8,890<span></span>
</td>
<td class="nump">9,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember', window );">Western Hemisphere, excluding U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,133<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">$ 2,635<span></span>
</td>
<td class="nump">2,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember', window );">Asia-Pacific, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales to customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,601<span></span>
</td>
<td class="nump">3,971<span></span>
</td>
<td class="nump">$ 7,264<span></span>
</td>
<td class="nump">7,751<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health | Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in operating income loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesByGeographicArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesByGeographicArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) recognized in the income statement on unsold other securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_ConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_PharmaceuticalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530272071320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 18,336<span></span>
</td>
<td class="nump">$ 20,562<span></span>
</td>
<td class="nump">$ 39,027<span></span>
</td>
<td class="nump">$ 40,583<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(10.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 9,539<span></span>
</td>
<td class="nump">10,403<span></span>
</td>
<td class="nump">$ 20,238<span></span>
</td>
<td class="nump">20,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(8.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.40%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 4,063<span></span>
</td>
<td class="nump">4,733<span></span>
</td>
<td class="nump">$ 8,890<span></span>
</td>
<td class="nump">9,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(14.20%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.80%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember', window );">Western Hemisphere, excluding U.S.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 1,133<span></span>
</td>
<td class="nump">1,455<span></span>
</td>
<td class="nump">$ 2,635<span></span>
</td>
<td class="nump">2,958<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(22.10%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.90%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember', window );">Asia-Pacific, Africa</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentsGeographicalAreasAbstract', window );"><strong>Sales by geographic area</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Sales</a></td>
<td class="nump">$ 3,601<span></span>
</td>
<td class="nump">$ 3,971<span></span>
</td>
<td class="nump">$ 7,264<span></span>
</td>
<td class="nump">$ 7,751<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_PercentageChangeInSalesByGeographicArea', window );">Percentage Change In Sales By Geographic Area</a></td>
<td class="num">(9.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_PercentageChangeInSalesByGeographicArea">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage change in sales by geographic area.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_PercentageChangeInSalesByGeographicArea</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130543-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=118956577&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentsGeographicalAreasAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentsGeographicalAreasAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_WesternHemisphereExcludingUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=jnj_AsiaPacificAfricaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530253184104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations and Divestitures - Narrative (Details)<br> SFr / shares in Units, shares in Millions, SFr in Millions, $ in Millions, &#165; in Billions</strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 09, 2020 </div>
<div>CHF (SFr) </div>
<div>SFr / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 17, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 17, 2019 </div>
<div>JPY (&#165;)</div>
</th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>CHF (SFr)</div>
</th>
<th class="th">
<div>Dec. 29, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Jan. 16, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 949<span></span>
</td>
<td class="nump">$ 5,346<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,890<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">796<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">$ 1,683<span></span>
</td>
<td class="nump">655<span></span>
</td>
<td class="nump">$ 1,705<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember', window );">bermekimab</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member', window );">Verb Surgical Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure', window );">Fair value of previously held equity investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember', window );">Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member', window );">Ci:z Holdings Co. Ltd.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities', window );">Liabilities assumed</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business acquisition cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,100<span></span>
</td>
<td class="nump">&#165; 230<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyExchangeRateTranslation1', window );">Foreign exchange rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109.06<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (income) expense, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill', window );">Adjustments made to intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Weighted average useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember', window );">AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain from divestiture of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-sale or Disposed of by Sale | Supply Chain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent', window );">Assets held for sale, current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember', window );">Discontinued Operations, Held-for-sale or Disposed of by Sale | AdvancedSterilizationProducts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal group consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash', window );">Disposal group consideration, cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained', window );">Receivables retained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Shares issued in transaction (in shares) | shares</a></td>
<td class="nump">11.8<span></span>
</td>
<td class="nump">11.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction', window );">Percentage ownership before transaction</a></td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction', window );">Gross proceeds on sale</a></td>
<td class="nump">$ 357<span></span>
</td>
<td class="nump">SFr 337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sales price per share (in CHF per share) | SFr / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 28.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares', window );">Ownership interest after sale | shares</a></td>
<td class="nump">38.7<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Percentage ownership after transaction</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia | Convertible Debt | Idorsia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term Debt | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember', window );">Idorsia | Idorsia | Line of Credit | Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Line of credit | SFr</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">SFr 243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember', window );">Other Income | Auris Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Reversal of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Receivables Retained</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of intangible assets, excluding goodwill, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=116869197&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2473-110228<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investments accounted under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 25<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117311354&amp;loc=d3e32014-111567<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyExchangeRateTranslation1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6897108&amp;loc=SL6897125-166521<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyExchangeRateTranslation1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=77989000&amp;loc=SL49117168-202975<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109500613&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=119400593&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=116634182&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedPerTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedPerTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_BermekimabMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_VerbSurgicalInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_AurisHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=jnj_CizHoldingsCo.Ltd.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_AdvancedSterilizationProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_SupplyChainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=jnj_SupplyChainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_ConvertibleDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=jnj_IdorsiaLTDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=jnj_IdorsiaLTDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530421823128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Legal Proceedings (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($) </div>
<div>claimant </div>
<div>patient</div>
</th>
<th class="th">
<div>Jan. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 31, 2018 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 29, 2019 </div>
<div>USD ($) </div>
<div>claimant</div>
</th>
<th class="th">
<div>Jun. 28, 2020 </div>
<div>USD ($) </div>
<div>claimant </div>
<div>patient</div>
</th>
<th class="th">
<div>Oct. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_AsrMember', window );">ASR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember', window );">Pinnacle Acetabular Cup System</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PelvicMeshesMember', window );">Pelvic Meshes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">15,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_RisperdalMember', window );">Risperdal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_XareltoMember', window );">XARELTO&#174;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_TalcMember', window );">Talc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">20,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_InvokanaMember', window );">Invokana</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_PhysiomeshMember', window );">Physiomesh</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=jnj_OpioidMember', window );">Opioid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_ProductLiabilityContingencyNumberOfClaimant', window );">Product Liability Contingency Number Of Claimants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember', window );">Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000.0<span></span>
</td>
<td class="nump">$ 344.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Pending Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyEstimateOfPossibleLoss', window );">Loss Contingency, Estimate of Possible Loss | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member', window );">DePuy ASR U.S. | settled litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_Numberofpatientsinsettlement', window );">Number of patients in settlement | patient</a></td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_BabyPowderMember', window );">Baby Powder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue', window );">Previous damages awarded and revised | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_BabyPowderMember', window );">Baby Powder | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="nump">$ 2,100.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember', window );">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI | settled litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 465.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember', window );">Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI | Judicial Ruling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_LegalProceedingTextualsAbstract', window );"><strong>Legal Proceeding (Textuals)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesAwardedValue', window );">Damages awarded | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 572.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LegalProceedingTextualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Proceeding Textuals Abstract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_LegalProceedingTextualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Previous Damages Awarded And Revised, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_Numberofpatientsinsettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of patients in settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_Numberofpatientsinsettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_ProductLiabilityContingencyNumberOfClaimant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product liability contingency number of claimant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_ProductLiabilityContingencyNumberOfClaimant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesAwardedValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of damages awarded to the plaintiff in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesAwardedValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyEstimateOfPossibleLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14435-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118942415&amp;loc=d3e14557-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=118943654&amp;loc=d3e12021-110248<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyEstimateOfPossibleLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_AsrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_AsrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PinnacleAcetabularCupSystemMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PelvicMeshesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PelvicMeshesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_RisperdalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_RisperdalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_XareltoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_XareltoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_TalcMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_TalcMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_InvokanaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_InvokanaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_PhysiomeshMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_PhysiomeshMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=jnj_OpioidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=jnj_OpioidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_JudicialRulingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_DePuyASRU.S.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_SettledLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_BabyPowderMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_BabyPowderMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530263266712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1', window );">Restructuring charges recorded to date</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Restructuring Charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">61<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Cost of products sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Other (income) expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring estimated cost</a></td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostExpectedFutureSavings', window );">Cost savings expected</a></td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember', window );">Supply Chain | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring estimated cost</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostExpectedFutureSavings', window );">Cost savings expected</a></td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Supply Chain | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan', window );">Period for activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Supply Chain | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Restructuring Cost and Reserve [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan', window );">Period for activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringandRelatedCostDurationofRestructuringPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Duration of Restructuring Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringandRelatedCostDurationofRestructuringPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringandRelatedCostExpectedFutureSavings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring and Related Cost, Expected Future Savings</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringandRelatedCostExpectedFutureSavings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostCostIncurredToDate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of costs incurred to date for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostCostIncurredToDate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_SupplyChainMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_RestructuringChargesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=jnj_OtherIncomeExpenseNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.2</span><table class="report" border="0" cellspacing="2" id="idm140530277234296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring - Schedule of Restructuring Reserve (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
<th class="th"><div>Jun. 28, 2020</div></th>
<th class="th"><div>Jun. 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 61<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
<td class="nump">$ 93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid', window );">Period of cash outlays for severance expected to be paid out</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 180<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(209)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(44)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Employee Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Asset Write-off</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember', window );">Medical Devices | Other Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveRollForward', window );"><strong>Restructuring Reserve [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance beginning</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">206<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments for Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(197)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveSettledWithoutCash2', window );">Restructuring Reserve, Settled without Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Reserve balance ending</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>jnj_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=118932676&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveSettledWithoutCash2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the reserve for full or partial settlement through consideration other than cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveSettledWithoutCash2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=jnj_MedicalDevicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_EmployeeSeveranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=jnj_AssetWriteoffMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=jnj_AssetWriteoffMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveAxis=us-gaap_OtherRestructuringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>82
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M?*&K#R^? OG(\F\ 4Q+Q&81:G2.H9ED^6%'N*+$LGDVX%4J)N-A<<!9PF1\
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M)I_@=&2:T,:44K%_4!RC; V'.PQQA%W3_=[A?BATCWO4<8\^S\VT;HXSCPY
MHB"X2N/HD/E#H7O,:<><]C+_QG-&-^IUG_H8;GI8MW04)\DA[='(*$H.8?V=
M+FE/J'NJ5DQHPF&)VL'E"$U4V_7;B9&U:YP+:; -NV&)!R4H&X#/EU*:MXGM
MQ=W1F_T'4$L#!!0    ( (^ ^%")SU0(RP<  -0H   8    >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&ULI5I=;^.X%?TKA+$%,D#&%DE]>9 $<"QU-@4F&\0S
MVX>B#XI,Q\+(DBO12=I?7TK62#9Y22K9E\22S[G4O3Z^/*1Y]5I6/^LM8QR]
M[?*BOIYL.=]_F<WJ=,MV23TM]ZP0[VS*:I=P<5D]S^I]Q9)U2]KE,^(X_FR7
M9,7DYJJ]]U#=7)4'GF<%>ZA0?=CMDNJ_MRPO7Z\G>/+KQF/VO.7-C=G-U3YY
M9BO&?^P?*G$UZZ.LLQTKZJPL4,4VUY,%_A)3OR&TB#\S]EJ?O$9-*D]E^;.Y
MN%M?3YSFB5C.4MZ$2,2_%[9D>=Y$$L_QGR[HI!^S(9Z^_A7][VWR(IFGI&;+
M,O]GMN;;ZTDX06NV20XY?RQ??V==0EX3+RWSNOV+7CNL,T'IH>;EKB.+)]AE
MQ?%_\M85XH0@XL $TA&(3' U!-H1Z-@1W([@CAW!ZPAMZK-C[FWAHH0G-U=5
M^8JJ!BVB-2_:ZK=L4:^L:(2RXI5X-Q,\?K,LB[K,LW7"V1JMN/@G5,!K5&Y0
MG%1%5CS7Z#/ZL8K0Q6^?4+U-*E:CK$#?M^6A3HIU?8E^:ZZ_97DN/OCZ:L;%
M4S6Q9VGW!+?')R":)Z#H6UGP;8WB8LW6 #\R\WT#?R:JT9>$_"K)+3$&_,>A
MF"(27B+B$ =XGN4(.G4:.IY#Z?RUT>,/CWY6#-KK@[;QJ";>79&6.S8H _UK
M\53S2GR__VV([O;1W3:ZJXF^2G(A)UYV2F<5J)]C#+^-T32^EQL<4NI?S5Y.
M/Q4511S/)^>H2$71N4."<U2LHES'"VF/.DO6ZY/UWIDLVK,J;8HJ;M;-NU#V
MYJ#8<::.\S=(IA\E1A\EQA\@GE72[ROI&R,MRYHW'6I?E>M#*KJ5:&%0Y[CU
ME<_1]X*Y)!P -'<=23<J"%/?Q9)N()3G>;!N@C[;X/W9CI*..2[UIG-8.18>
MG8:P<*SC:71C'<\URB;L"QD: WVMRKINRKC).%2N4/WT<.!)O6$)H*A/Y#ZC
MHHA'0ZEGQ0 J<$@(ZV7>ISD?G>8HF9C#^>X4PS*Q\/PI@65BX6EE8AW/-\H$
M.X,G<LR=6OA6X7PNA=&J?C(N7B)A=5"R%@8L:V:_QMPB]B;<>@V7M!O@; :9
MSZDD)0#E>:XDD@A 83&YRUH"88&O:3[XQ"#B,<485XM1>K,,2 *-<)9VHF9&
MLQ%]C<1C.]$S:XX,92;&4(^L9DF5;MOJKMF+6,+M6\/5E18L)('ZA]RP()3O
M*RI341X)96,$H3SB:C0VF$Q,_U+RXV1E'@.[FFEK:2-2K:RL1$4=71FM1$LK
M&PPV-COLN^*SF E2)F:$2E-DL):J Y;]-@"139,]2@Q PKFCT=/@M+'9:H[(
M>IRDS,-HK?<'>=$'>;&%1]2&>E[8P7ACL_.^*S@3%>5BR=^L"\&:J2;X,Y8]
M-P0*0UD^$$@1$#3<2=\Z3W3PW-AL.J5$QZG%'/+":6:93Z!>K$P79D9V)H&9
ML9WI*<SS8@Z^&YN-=U_,KIU?HH(=ES1EU6X7ILD^XTF>_0_< +K%JD]V/5E1
M*B:DLJ!43.#(>@+\?:@S48,EQV9S^IX*C-.:>3QG2C6=R<93EEI=Z6P\V++%
M5I[9/Y'!LQ.S9_^#;UF%+HY?UT]G=8;J1U2W?&)CNGT^%?,9^XJJ()CO2?J,
MP6"!HU$6&>PY,5M00]ZCA&0)[^@6?Q;>1:AK/)&-B:>!IF79F"XPYGE9!SM.
MK':<5X>4'ZIFQ7-Q7W*&,(&>ZI:HGMC'LI0 WQS(.E(Q6)XX8P TU^Q+DL%^
M$ZO]/DDVW2;5\[@9SQ)7VX6L/,W.P0?'B]_/.Z_D8+>)V6[WOYD\L4U9L687
MYB5K?U03EX@G;V*)+"[T[HE &]3R;N020 6.O!L9 2CLN*XB*0"&75^GJL&$
M$[/K?%<MQLG-8G.Q9KVUM!"IJQ6<941?LZ:,;<308LG)8,F)V9(_O%MBJF.F
M6)G[@*ULE[JRP@"4^FL*@"+8T5AT,EAT8G:HQL2[ENW!'=L<N)V 0!F9>;YF
M/SVR\(AFO-C"\]2Y^;R4@T$G9H-^'W]'\>+Q_N[^ZPHLF&J*J4_D'0$ Y?GR
M=E0$H.:NO'\>0RCJ^1K-##Z<F/WFO7!%[%=?&M5RS/'P7+>I9"&20#-713:B
M;CL^MA&I12YT\-KT:%9U/PJ?R@4]Q(]H]?OB,3:%'NPL-7NXVZ3.4G0A/IKC
M80/P^]O%"$[;SI1*VP=+ $6F6)XD 12=>E*L&$816(YT<)G4[#*C+#\T!R]L
M^1(H7_GK!Z#(U)$W50"4R(3*^4(H5].RZ<EA O-I@L6?7Z='L:S0'S^^K[XO
M[B,A(I-R!NM%S=:K4\[QB I<QF, [VPCG)*Y(]LK$.@13P9&<$1*96 ,1_0#
M1[/520>71<U.HI>0*7$/&%TL4=7$(> <!VKB$## CIHX&#%PM(D/OH>:?<^B
MX-FZ2;[Y_6G%4K%XX9FP /%;FA_6HB*;JMRA9;G;'WC2[K&<GFEZ$%^X55.Q
M2[38E0=X%[Q[@K.'=Y0<(P"&/37#V<DIK1T32ZSF>%R-TF;TXX&<_FY_!&_1
M'CR3[M_B+TL,W(_PE_AXP&X(?SSO]TVLZ+*B1CG;B*&<:2">M3H>H3M>\'+?
MGA%[*CDO=^W++4O6K&H XOU-*=Q4=]$,T!]DO/D_4$L#!!0    ( (^ ^% 7
MR!A!2 4  "47   8    >&PO=V]R:W-H965T<R]S:&5E=#4N>&ULK5C;;N,V
M$/T5PE@4N\ F$JF+K=0Q$%^ZNP72!DG3/A1]4"3:)E8279*VD_WZ4I=(%DG1
MZ;8OUL5G9G@.R9D1IT?*OO(MQ@(\YUG!KT=;(797CL.3+<YC?DEWN)#_K"G+
M8R$?V<;A.X;CM#+*,P>Y;NCD,2E&LVGU[H[-IG0O,E+@.P;X/L]C]C+'&3U>
MC^#H]<4]V6Q%^<*937?Q!C]@\;B[8_+):;VD),<%)[0 #*^O1S?P:H7\TJ!"
M_$[PD9_<@Y+*$Z5?RX<OZ?7(+4>$,YR(TD4L+P>\P%E6>I+C^+MQ.FICEH:G
M]Z_>?ZK(2S)/,<<+FOU!4K&]'DU&(,7K>)^)>WK\C!M"0>DOH1FO?L&QQH[1
M""1[+FC>&,L1Y*2HK_%S(\2)@?1C-D"- 5(-_ $#KS'PWAK!;PS\MT8(&H.*
MNE-SKX1;QB*>31D] E:BI;?RIE*_LI9ZD:)<* ^"R7^)M!.S!2TXS4@:"YR"
M!R$O<A4(#N@:+&@NU]ZV7!0'#+X4"<TQN "/#TOP_MT'\ Z0 MR2+)/SS:>.
MD(,I73I)$WA>!T8#@3UP2PNQY6!5I#@UV"_M]J'%WI$BM$J@5R7FR.KPYWUQ
M"=#D(T N<@WC6;S!W'-+<QB9Z/RWZ*OOCMX3PVN7A5?Y\P;\M2MA<"'\>?/$
M!9/[_"]+.+\-YU?A_(%PO\B,B&-6D&)C7$JU=5A9EZGO,/-"%$Z=P^G\Z* @
M=,=]T%('13Y"?=#* /*"+ER/8M!2#*R*_BJVF(&D)R6II7R?4<X_? 0%KN06
M\;-%TK"-%UHEE6E4)LE"YA#&<)&\ #E9!<_B,CV;)*Z]!:?J!:K".L8+7$5@
M'7,1A9XBL Z*D%G><4MW;%^P6!(E@F!^91%OTGJ;6,5[+&31S<@WF1.W-$OE
ML@0;672;F0(Q([Q\E\J0\K+#C%!3"IM/=#&4M;;0(5!15$<HFJ]L/GK\HY9_
M9.5_CY,LYIRL25(M& X$M6[0Z-P8%V<1R[.(E0W1XPG=KORY9S-/LHV+#3:6
M,/?\!!HPZ@P:("HUJY<^MY/2#JU[8I7O,OJ",7C"!5X3 7:93 &V_0%1YQM9
M=;N32U[VFY@=2()E6N,"Q#EE@GRK%LSYK='X[TD;J-*>QRQ-& A5=4V@@8P#
MNQH)/:L&GTY3PK\C[VGCD9V]REX'01^I]'60[VKT=9 ')P/TNYH-SQ=MR];Q
M]=%'V@0;0)Y:L@T@+]+VCP'D#I1LV-5L:"_:2SF#A[C\E.'@ASC?_0BV.-W8
M:PSL*C2TE^B3*O-=U07J911!56$=,PE5@0V80"W9!M %@D,*=V4;CO_?2M/X
MZXTCU+:. :3VBTL#:#Q161LP0S6G:RZ@O;LXLW$,38,7J01UD"K"TH")/"TU
M&*)!?VA:N_X!VAN(L]VND;E>W\=0FUH=%/@3E;H.\@)M;G40.EGV_8_(KJ%
M]H9B8>!L(HOT@N][GMIQ&U A#-0::$!%XXF:(DVHT(T&"'==!H)O^M!8O'YH
M_&;_T&C<]7(^]%7>!I"K;F #*%0GV8#Q_0'*7?.#[,U/][%A)&AJ-E1^.D;=
MON<A*RNDSZUK:I"]J6F;QGG3--Z53:.1I]Y5J"MS8<!XODK4T.=H'9S)43#
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MA[[RX_;,:@2G4!I#=F+(G PWY;X0SYPC=0DINVN2HV%4&6JZC2SVW1=[M??
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M%0B[LY:J),8NU0;K2@&A'E1R'(?A")>$B2!+O6VALE36AC,!"X5T799$/4V
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MDL9V%3\M[)\%E'.P^VLIS7[A!+I_5?8'4$L#!!0    ( (^ ^%"D#V\&7@@
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M 'Y?2:E?+\P-#J_#7/X74$L#!!0    ( (^ ^% F76 Y,08  &8/   8
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MR"74U6Z(UWV(FVT(Y/[6U;"RXI%LVI?]$\?6, C=+&BEI>?R/V;G5SFI7_;
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M@J?]'OVMYTY<=LS@C1*_\=R6RV 60(X%:X2]5X?WV/&9.+Q,">/_<&CWIE$
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M'DKK]GWPU_;VE77'])[X@L""1*EX)P'H]N72#JRJ_6N!"H3>'KY;TF,/M=M
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MR=E)#N'SM'/2)]_0 HB&)-'Z^?+Z['Q\,9B\4V_>H32@K$U9QUK*(\3"%SI
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M[B;+ (WYW2J_!?>$]&91E9N[)Q!@FU1]X:<[A(L.A?+V,*L:05Q9) "U G!
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M,UO=MV^:<BU_@8&8;\JEO%QD*;":"_#];0F2T+[A!@]_DO/R?P%02P,$%
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M(G3%A*8C%\W>"ZG]ZD[,Z8_Q]8^GHT_1W2>*"]3TVPLSK1BT&*O87LSM'6_
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MQ.LB#7$;P4G.&_!]Z5SL)FR@?U%>_@=02P,$%     @ CX#X4!R&7/6K @
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M;1N7M2@K)DBD+,VE*.0^V^+1E.5P'X0L_G3&("[1BDO=.=94+F232Y ; Q!
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MLZMIE8")[T=<.-V'GKW1CEZ ,-W3DXO&"]#Y5FLW++R!\1%?_0U02P,$%
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M-(N@Q#UOI7O0QX_8QS/V>(66-HQP['73"(K6.EWWQL2@%JJ;^4N?A[<8L-Z
M!=Z=H\#RCCN^7AI]!..U"<TO0JC!FL@)Y8ORZ R="K)SZ_?<**$.%K9HX+'B
M!N'J$]])M-?+Q)$#KY84/=BF V.O@$W@7BM767BO2BR_MD^(V,".G=AMV$7
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MP>#H0<([^%^.*EO1+1L5N:)+*0P=-0?ZZW(!*53*WR]8G \6Y\GB_!L6[]!
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M0.R,MLJ<K04U-,^4;(BRT<AF!ZXV#HUNF+"GN#0*=QGB3'XC]B",5 PT.5V
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MTN#-X89;O-M!V0#<7TMI7B;V^NC_%OE?4$L#!!0    ( (^ ^%#47E\?G@,
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M,8#G6R'TT\(<";HCX/)?4$L#!!0    ( (^ ^%!"3(8UE0,  $\.   9
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MICDW#W)W!_6$2H*QY+K\1;MJ;!@Z*,ZUD5D=;!ED3%1/^J->B+T @CL"2!U
M2MY5HI+E+35T.E9RAU0QVJ(5C7*J9;0EQT11E4>C[%=FX\ST7A@J-NR9 YII
M#48C*A+TJY3)CG&.?FZ;\U?T"!M;$(,^WH*AC.M/Z -B BWM9[O">NP:RZC
M=>,Z^[S*3CJR!V@IA4DU^BH22 [C73N39CKD;3IST@OX6RYN$!E]1L0CWM/C
M+?KXX5,/K-^LDE_"^AVPS2+\\R#MK]7#CJKDWQ[D08,\*)$'[R'/8<.$8&*#
MY!JM0#&9G%K/"BTHT8H=]S+U_<"/QN[+"1+#AL3P+!*?[3[CU$""C+3[Y7O.
M-#-=E:T@AWM,\&APFD?0\ AZ>2QRI4#$K\@H*K1E8G.[?Y@4U"D"P1&!(#R=
M/VSRA^<5P\JQOPSA46[?'T7>Z?2C)OVH?_IVI?,,%+H#RDWZ4X^\H@8RNK)P
ML=<ZAW=5Z=9P^XL6A7YP>LWPGH'AZXNWQMSGTE$\3%HBY(KJK<$.]D\7A=:F
ML'\E == A\48=!6C=3/<;V>KN]G#<K;X^O3G_6+V>Y_,6F_"PVM+N/4;W&\X
M%TOXV',B''2X+VYM!Y_G.Y=)^-B#< >1UH#P.PYTF81'1PP&PPX*K6'AZ%H2
MCHZ+07 ' =+:&NFWM24D+*8<W<(+BT'W'4I:CR+XRAHFK>V0?MNY5,/DA/$,
M0K_CKYNTWD/.\YZ+1$R.;0B/_ XJK0N1?A>Z3,8UV $'TD&A=2URWI'J?1G7
M0,%!/2+R?U-Q]\[X]HRP*6\R&L4R%Z8Z[C=OF]O2K+HCM,.KJ]:2*JL4C3BL
M;:AW$UH&JKJ]5!TCM^6-X5D:>_\HFZF]\8$J!MCO:RG-6Z=(T-PAI_\!4$L#
M!!0    ( (^ ^%!/9!+G'@0  !\1   9    >&PO=V]R:W-H965T<R]S:&5E
M=#,T+GAM;+U8WV_B.!#^5RRT#ZVT;>+P([0") IMKZOV5+7;W8?3/9AD(%:3
MF+.=TCW='W\3)TV !I?5:GF!Q,PWG_V-/3-FL!+R644 FKPF<:J&K4CKY;GC
MJ"""A*E3L804?YD+F3"-KW+AJ*4$%AI0$CN>Z_:<A/&T-1J8L7LY&HA,QSR%
M>TE4EB1,_KB 6*R&+=IZ&WC@BTCG \YHL&0+> 3]M+R7^.947D*>0*JX2(F$
M^; UIN?7G@$8BV\<5FKMF>1+F0GQG+_<A,.6F\\(8@AT[H+AUPM,((YS3SB/
M?TJGK8HS!ZX_OWF_,HO'Q<R8@HF(O_-01\-6OT5"F+,LU@]B]0>4"^KF_@(1
M*_-)5H6M[[=(D"DMDA*,,TAX6GRSUU*(-0#Z:09X)<#;!G1V -HEH+TO0Z<$
M=/9EZ): [KZ 7@GH[0OP2X!O@E6H:T(S99J-!E*LB,RMT5O^8.)KT!@1GN9;
M\5%+_)4C3H]N4LW2!9_%0,9*@5:$I2&Y%B)<\3@F)^1/)B7+MPLYFH)F/%;'
M./KT."5'GX[))\)3<H>6N*W4P-$XH]RO$Y3L%P6[MX.]3>Y$JB-%+M,0P@;\
MU([O6? .*E')X;W)<>%9'7[)TE/B]3\3S_7<AOE,]H"WW1Q.SYJ6\VOLE[_&
M?F6'WS&)[&<[V:_M\"D$;_!M]HU0M*N=V3;^VCO\7?&4:SBYQ:T7DO?;]*];
MM"<W&A+UMX6M4[%U#%MGYSG _%4PQCL8CRY?@S@+>;JHSL=QTY8OB'J&**\$
M+R/J^>W.P'E9WPE[65TW6-%N[ZRRVEAKMUIKUZKL!V?^Z"N\ZHSA0;?HVJNX
M>E9=QXF0FO_+3-V!5ZR@"HB8$U:.YY/@]7R8F4^3J@5-=T,)U]V4:])KD&O;
M:/K>R/.VC2X_,-K0PJ^T\*U:W#,-*:H]1K6_2A9B4X$-AT7D?N6X_]L#>E9Q
MG5D783^6G\EW4_PA/!F_@,1FACPIF&<QN>5S:,J(=C;JD1_ I$TDZM:ESK4Z
MFYAR"A);J-AL2!7Q9:&5T!&.?[ 1-VG7*BS][=&A7LWF'30^']!Y]., U1F?
MMNT'))-!A'UE/O&3>RD"4(H\@$*"(#+'9@HOV#TOL1?6-L8ZZ]/. 8H,K3,O
M[1ZJS)1,ZRFJVW?]K62WE]5U@U6GU_&;TQVM<S^U)_^?BB?YC\Q )O#,$S:S
MB5VG6^H?(KAU%J;] P7WJF1:#TA_5_FA=>JF]FSZL_'X!G)&'C.YX &+$1.<
MVEKL.@][[@'BXM4)V*.'BDO)M'%0WL7%6;N.8;E9F)NV(H'(4EWTO]5H=9L?
MFSOLUO@%/9_0AO$I/;\L[NJU^^*O ^SA%SQ5)(8Y4KFG/AYL6=S&BQ<MEN8R
M.!,::Z%YC !;$9D;X.]S(?3;2TY0_2<R^A]02P,$%     @ CX#X4#FWHF<Z
M @  M04  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&ULE91=;YLP%(;_
MBH5ZT4I;(.2KJ@A2TNRCDRI%C;I=3+MPX"18-3:S34GWZW=L",H66+0;\+'/
M>Y[S&NRHDNI%9P"&''(N]-S+C"GN?%\G&>14#V0! E=V4N748*CVOBX4T-2)
M<NZ'03#U<\J$%T=N;JWB2):&,P%K1729YU2]+8'+:NX-O>/$$]MGQD[X<530
M/6S /!=KA9'?5DE9#D(S*8B"W=Q;#.^6,YOO$KXRJ/3)F%@G6RE?;/"0SKW
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;-5<6V_;.!;^*X0Q"[1
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MP;@^EZO5N> =YV*C3T5>SAF*\@F9*-J'^O:>IOV VV5C'+PVSA76=OC;,O^
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M!K3SIFANX;7Q:*J&2W>+,ZOIE!/.9C>,:WAFHD:X1V9JC71%UL WF%'#%+5
M4 N8HN9KY@0W\(BYT@46P"5,E#1*\()9LL=,,)DCS'SWG4[1,B[,&85ZFDWA
M].0,3ASFG@M!%VC2T!)_QR+,&Z[C'=?X"ZX_:GD!\> <XBB./H%/CL.GF!-\
MZ."=X7MX2*JUTL6M=+&/U_VW=%-N<J&<>@9^7<^-U=2>OX_DZ+8YNCY'\D6.
M<6UHQQA2NIISR5SKGSO9+9=+NBA_ [Q W9S<<3;G@MOM9^KN4O5]*C?=Z^QR
MV$_#];Z$ASZ=RTZO=7I71-(6D1PM8L*TWA)?N*Y439RIH6R)<(O%DMKF*.7D
M@$XR^,#XT*7?_\ WW)L/]S;=,[WDTH# !8&BB\M> 'HW[SO#JI4?F;FR-(!^
M6=(3B=HYT/E"*?MFN"EL']WL+U!+ P04    " "/@/A0>/W &D(#  !P"0
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M)]0R_@(1*_M+MKFM6R-!JK1(<C"N(&$\^Z=/.1%[ /13#O!S@'\,:+X":.2
MQKD1FCF@>6Z$5@YHG0MHYX"VY3XCRS(]H9H.^E)LB336Z,TT[.>R:"28<:.L
MN98XRQ"G!S/*)/E.XQ3(/5"52D#9:$4NR1Q%'*8Q$!&1:12A$DSK3Q3[+=^
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M3K*_;'6.6"SQT^P>VDQ/_7C-<@[;!8?M2@[G-#OWYND"-<&PY.Y+LT*-G2)
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M&[&[+[+:-*]\WE=25NOFXXIG:O+:0/W]H:KD\Q=]@_U[R9?_ E!+ P04
M" "/@/A0<48\_2D(  #0/   &0   'AL+W=O<FMS:&5E=',O<VAE970T,RYX
M;6S%FU]3VS@0P+^*)G,/[4PAEBQ+5@>8H= _=W/<=4KI/73NP22">.K8J>U
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M&V;4C4';!?0]50IW@6T0OK^/7@!02P,$%     @ CX#X4-AOPYY(#@  ('H
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MDY]*(/:"8AD'"/P*>'K*V=4XT-*6H68GE"PPF"Q,H'<CHTR\^PZ$C044"SI
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M23:LPXH%#;H=AAT4FXF%RI(GT4W[[T?)CI=N34[#+K9(D>\]42:=[+5YM 4
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M"/8)SP#R^X8Q\?*2&:CNQV?_ U!+ P04    " "/@/A0&&*Q&@($  #C#0
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M:LSH^Y3C,Q<MBMYVJ27I2B74@KGQP[V ?:(K)U<MT)5C<WC99YUREJ*F[#-
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M(N$I<(&O-^R(\:A@#] \\ &RDG29I7@"0 ".*%4$V (<K@FMD);C:#@*M"2
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MZ$0E/M!)+5.5\M*=[+?N# L20&WM6ZD43EI]+Z@*I& 5IOER1+(7D 6:A[)
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M<_5N_3"8\04T@^>!9K" 9G 6: 8#T 79V+9@=<U$Q3_0,N'E RW2,JD;<UE
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M-CF;*N@+1J,O3'?JL&!7S:? /5JHT_;Z"ZJ#J2:63$FGGKV^>//JY%)?]1?
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MJZ%7">*#FX?XX 3QP64A/CA :2C#.XP:!R@-5'!XU!Z)4<E1N83X$47RR).
M/KC<T =-<,EH06G?6NW(DU5WZ@OH@YL&?8#N')'E!1#"S0.$< ((X;( (1Q
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M5<[T-,S#B_,T>01I(2VM%1_*<)7:<H*CN,BLZSR5_XVD7GYQ+>YEGN092.[
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MP?"5,[<RV&@2Z'E;R32)7]LHS2R&N*=9FELL04A\>\YB17O837LOR]D.XX,
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MNJ?<]EJ,T2/ODFJ.6,$Q[[A>E<O]PM/1Q-^@9R>0*U3F)T!EKE"9N['OF9W
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M)R@^;+T=#B3?9#L_"Z[N8)3]7!.L'"AMH*XO.9>O!VD'Q0;H^#]02P,$%
M  @ CX#X4!=CSHR"!   )!<  !D   !X;"]W;W)K<VAE971S+W-H965T-38N
M>&ULO5A;C^(V&/TK5K0/,U([B6VN(T!:+E6W*NUH1ML^5'WP)(98F\34-C C
M]<?7N4Q,2#!ABWB!V#G?[?C+B>/1GHMO,J14@;<X2N38"97:/+JN]$,:$_G
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MUR-=2I$?\^4#Q3?9.=:2*\7C[#($&H!(#?3S%>?J;9 &* ];9_\!4$L#!!0
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M5HTBJT:15:/(JE%DU?\IZY.UZ[_^I:"_YZVIN_=\-ORW<?4*4$L! A0#%
M  @ CX#X4 =!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " "/@/A0#5GDT^\    K @  $0
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M=#(N>&UL4$L! A0#%     @ CX#X4*M=-&^T @  A@<  !@
M ("!$A8  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (^
M^%")SU0(RP<  -0H   8              " @?P8  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " "/@/A0%\@804@%   E%P  &
M        @('](   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ CX#X4-<Z)$CS!0  7AT  !@              ("!>R8  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( (^ ^%#P*\H AP(  +<&   8
M              " @:0L  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " "/@/A0I ]O!EX(   :(P  &               @(%A+P  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ CX#X4"9=8#DQ!@
M9@\  !@              ("!]3<  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( (^ ^% + =NJHP(  '<%   9              " @5P^
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ CX#X4,72
M ?$D!@  30\  !D              ("!-D$  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " "/@/A0<<>C?ED7  "L4@  &0
M    @(&11P  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M (^ ^%#Y@B);M@@  -D6   9              " @2%?  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ CX#X4/, WNNE!   M@H  !D
M             ("!#F@  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " "/@/A0J1[.G1($   X"0  &0              @('J;   >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( (^ ^% [XC&*#P0
M $H*   9              " @3-Q  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ CX#X4&,I*@2@%   GC,  !D              ("!
M>74  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " "/@/A0
M8^SAP.L)  !(&P  &0              @(%0B@  >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( (^ ^%"N8<"=0"@  .*'   9
M      " @7*4  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ CX#X4"<=NUP4!P  #A$  !D              ("!Z;P  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " "/@/A0&3UU=7@%  !=#@
M&0              @($TQ   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( (^ ^% <AESUJP(  %\&   9              " @>/)  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ CX#X4-PTW@^G
M @  ?P4  !D              ("!Q<P  'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " "/@/A0N8?T75H$  ":"@  &0
M@(&CSP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (^
M^%#1AXF1Y@T  -DR   9              " @334  !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ CX#X4)GYH4V* P  T <  !D
M         ("!4>(  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
M    " "/@/A0-HD"=ND"   I!@  &0              @($2Y@  >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( (^ ^% HT?R.8@,  +('
M   9              " @3+I  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
M4$L! A0#%     @ CX#X4&(JS]CD%   EC,  !D              ("!R^P
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " "/@/A0$OP=
M?Y<$  "S"0  &0              @('F 0$ >&PO=V]R:W-H965T<R]S:&5E
M=#,P+GAM;%!+ 0(4 Q0    ( (^ ^% 7]%">;@(  #D&   9
M  " @;0& 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
MCX#X4-1>7Q^> P  #@X  !D              ("!60D! 'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " "/@/A00DR&-94#  !/#@  &0
M            @($N#0$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( (^ ^%!/9!+G'@0  !\1   9              " @?H0 0!X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ CX#X4#FWHF<Z @
MM04  !D              ("!3Q4! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " "/@/A0*WG9UI@+   W40  &0              @('
M%P$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( (^ ^%"Q
MD="X8 D  )A&   9              " @8\C 0!X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ CX#X4"L%6NMV @  @ 4  !D
M     ("!)BT! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (^ ^%!Q1CS]*0@  - \   9              "
M@?U$ 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ CX#X
M4#CE\>*8 @  ZP<  !D              ("!74T! 'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " "/@/A0V&_#GD@.   @>@  &0
M        @($L4 $ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( (^ ^% BU+51K0,  "8-   9              " @:M> 0!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ CX#X4)7 D(R4!   ^A,
M !D              ("!CV(! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " "/@/A0]XZ%VV$"   5!@  &0              @(%:9P$
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( (^ ^% "K87V
MQ00  "L7   9              " @?)I 0!X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ CX#X4!ABL1H"!   XPT  !D
M ("![FX! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " "/
M@/A00XP6H^$O   GJP$ &0              @($G<P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( (^ ^%!DF@(@,0H  .X\   9
M          " @3^C 0!X;"]W;W)K<VAE971S+W-H965T-3(N>&UL4$L! A0#
M%     @ CX#X4*/D\%A'!   MQ$  !D              ("!IZT! 'AL+W=O
M<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4    " "/@/A0!=_Y N,(  "K
M*P  &0              @($EL@$ >&PO=V]R:W-H965T<R]S:&5E=#4T+GAM
M;%!+ 0(4 Q0    ( (^ ^%",>-NKH@4   P=   9              " @3^[
M 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ CX#X4!=C
MSHR"!   )!<  !D              ("!&,$! 'AL+W=O<FMS:&5E=',O<VAE
M970U-BYX;6Q02P$"% ,4    " "/@/A0J S&L(\$  !X%0  &0
M    @('1Q0$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (
M (^ ^%!66ZC >P(  %@.   -              "  9?* 0!X;"]S='EL97,N
M>&UL4$L! A0#%     @ CX#X4)>*NQS     $P(   L              ( !
M/<T! %]R96QS+RYR96QS4$L! A0#%     @ CX#X4/.P%9]H!   !R8   \
M             ( !)LX! 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (^
M^%#S((MYZ0$  !(B   :              "  ;O2 0!X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (^ ^%"R:$G8U0$  +\A   3
M          "  =S4 0!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !! $$
*OA$  .+6 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1041</ContextCount>
  <ElementCount>395</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>183</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Earnings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEarnings</Role>
      <ShortName>Consolidated Statements of Earnings</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Statements of Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEquity</Role>
      <ShortName>Consolidated Statements of Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2106103 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2125105 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127106 - Disclosure - Pensions and Other Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlans</Role>
      <ShortName>Pensions and Other Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2131107 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2134108 - Disclosure - Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShare</Role>
      <ShortName>Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137109 - Disclosure - Segments of Business and Geographic Areas</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas</Role>
      <ShortName>Segments of Business and Geographic Areas</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2142110 - Disclosure - Business Combinations and Divestitures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/BusinessCombinationsandDivestitures</Role>
      <ShortName>Business Combinations and Divestitures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144111 - Disclosure - Legal Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/LegalProceedings</Role>
      <ShortName>Legal Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146112 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2213202 - Disclosure - Fair Value Measurements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsPolicies</Role>
      <ShortName>Fair Value Measurements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/Inventories</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2307302 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansTables</Role>
      <ShortName>Pensions and Other Benefit Plans (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/PensionsandOtherBenefitPlans</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2335306 - Disclosure - Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShareTables</Role>
      <ShortName>Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/EarningsPerShare</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables</Role>
      <ShortName>Segments of Business and Geographic Areas (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2347308 - Disclosure - Restructuring (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringTables</Role>
      <ShortName>Restructuring (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.jnj.com/role/Restructuring</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2405401 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/InventoriesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2408402 - Disclosure - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IntangibleAssetsandGoodwillTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Goodwill By Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails</Role>
      <ShortName>Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Derivative Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails</Role>
      <ShortName>Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails</Role>
      <ShortName>Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/IncomeTaxes</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails</Role>
      <ShortName>Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Pensions and Other Benefit Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails</Role>
      <ShortName>Pensions and Other Benefit Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/PensionsandOtherBenefitPlansTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2436420 - Disclosure - Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/EarningsPerShareDetails</Role>
      <ShortName>Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/EarningsPerShareTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails</Role>
      <ShortName>Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails</Role>
      <ShortName>Business Combinations and Divestitures - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Legal Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/LegalProceedingsDetails</Role>
      <ShortName>Legal Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.jnj.com/role/LegalProceedings</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2448426 - Disclosure - Restructuring - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringNarrativeDetails</Role>
      <ShortName>Restructuring - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="jnj-20200628.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails</Role>
      <ShortName>Restructuring - Schedule of Restructuring Reserve (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="jnj-20200628.htm">jnj-20200628.htm</File>
    <File>a202010-q2qexhibit311c.htm</File>
    <File>a202010-q2qexhibit312c.htm</File>
    <File>a202010-q2qexhibit321c.htm</File>
    <File>a202010-q2qexhibit322c.htm</File>
    <File>jnj-20200628.xsd</File>
    <File>jnj-20200628_cal.xml</File>
    <File>jnj-20200628_def.xml</File>
    <File>jnj-20200628_lab.xml</File>
    <File>jnj-20200628_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>jnj-20200628_g1.jpg</File>
    <File>jnj-20200628_g10.jpg</File>
    <File>jnj-20200628_g11.jpg</File>
    <File>jnj-20200628_g12.jpg</File>
    <File>jnj-20200628_g13.jpg</File>
    <File>jnj-20200628_g2.jpg</File>
    <File>jnj-20200628_g3.jpg</File>
    <File>jnj-20200628_g4.jpg</File>
    <File>jnj-20200628_g5.jpg</File>
    <File>jnj-20200628_g6.jpg</File>
    <File>jnj-20200628_g7.jpg</File>
    <File>jnj-20200628_g8.jpg</File>
    <File>jnj-20200628_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2017-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2019-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2019-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>88
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "jnj-20200628.htm": {
   "axisCustom": 0,
   "axisStandard": 39,
   "contextCount": 1041,
   "dts": {
    "calculationLink": {
     "local": [
      "jnj-20200628_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "jnj-20200628_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml",
      "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "jnj-20200628.htm"
     ]
    },
    "labelLink": {
     "local": [
      "jnj-20200628_lab.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "jnj-20200628_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml",
      "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "jnj-20200628.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd",
      "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd",
      "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd",
      "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 680,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2019-01-31": 62,
    "http://xbrl.sec.gov/dei/2019-01-31": 5,
    "total": 67
   },
   "keyCustom": 47,
   "keyStandard": 348,
   "memberCustom": 111,
   "memberStandard": 61,
   "nsprefix": "jnj",
   "nsuri": "http://www.jnj.com/20200628",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://www.jnj.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Inventories",
     "role": "http://www.jnj.com/role/Inventories",
     "shortName": "Inventories",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2106103 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Fair Value Measurements",
     "role": "http://www.jnj.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2125105 - Disclosure - Income Taxes",
     "role": "http://www.jnj.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127106 - Disclosure - Pensions and Other Benefit Plans",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlans",
     "shortName": "Pensions and Other Benefit Plans",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131107 - Disclosure - Accumulated Other Comprehensive Income",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome",
     "shortName": "Accumulated Other Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134108 - Disclosure - Earnings Per Share",
     "role": "http://www.jnj.com/role/EarningsPerShare",
     "shortName": "Earnings Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137109 - Disclosure - Segments of Business and Geographic Areas",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas",
     "shortName": "Segments of Business and Geographic Areas",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142110 - Disclosure - Business Combinations and Divestitures",
     "role": "http://www.jnj.com/role/BusinessCombinationsandDivestitures",
     "shortName": "Business Combinations and Divestitures",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144111 - Disclosure - Legal Proceedings",
     "role": "http://www.jnj.com/role/LegalProceedings",
     "shortName": "Legal Proceedings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Balance Sheets",
     "role": "http://www.jnj.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146112 - Disclosure - Restructuring",
     "role": "http://www.jnj.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UseOfEstimates",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2213202 - Disclosure - Fair Value Measurements (Policies)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsPolicies",
     "shortName": "Fair Value Measurements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Inventories (Tables)",
     "role": "http://www.jnj.com/role/InventoriesTables",
     "shortName": "Inventories (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2307302 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2328304 - Disclosure - Pensions and Other Benefit Plans (Tables)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansTables",
     "shortName": "Pensions and Other Benefit Plans (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332305 - Disclosure - Accumulated Other Comprehensive Income (Tables)",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables",
     "shortName": "Accumulated Other Comprehensive Income (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335306 - Disclosure - Earnings Per Share (Tables)",
     "role": "http://www.jnj.com/role/EarningsPerShareTables",
     "shortName": "Earnings Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:SalesBySegmentOfBusinessTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2338307 - Disclosure - Segments of Business and Geographic Areas (Tables)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables",
     "shortName": "Segments of Business and Geographic Areas (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "jnj:SalesBySegmentOfBusinessTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347308 - Disclosure - Restructuring (Tables)",
     "role": "http://www.jnj.com/role/RestructuringTables",
     "shortName": "Restructuring (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405401 - Disclosure - Inventories (Details)",
     "role": "http://www.jnj.com/role/InventoriesDetails",
     "shortName": "Inventories (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408402 - Disclosure - Intangible Assets and Goodwill (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
     "shortName": "Intangible Assets and Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "id939f17ab58546e792a3505ad59025d1_I20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i4250b233c8424335ac39cd07c8101199_I20191229",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Intangible Assets and Goodwill - Goodwill By Segment (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
     "shortName": "Intangible Assets and Goodwill - Goodwill By Segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "jnj:ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Intangible Assets and Goodwill - Narrative (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
     "shortName": "Intangible Assets and Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)",
     "role": "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails",
     "shortName": "Intangible Assets and Goodwill - Intangible Asset Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquitySecuritiesFvNi",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfReclassificationOfCashFlowHedgeGainLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - Fair Value Measurements - Summary of Derivative Activity (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
     "shortName": "Fair Value Measurements - Summary of Derivative Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails",
     "shortName": "Fair Value Measurements - Schedule of Derivatives Recorded in Consolidated Balance Sheet (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
     "shortName": "Fair Value Measurements - Schedule of Effect of Derivatives not Designated as Hedging Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i02769757e5e740ba8d0918956fb4bebe_D20200330-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Earnings",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
     "shortName": "Consolidated Statements of Earnings",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:SalesRevenueGoodsNetPercentToSales",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419410 - Disclosure - Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
     "shortName": "Fair Value Measurements - Schedule of Effect of Net Investment Hedges (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationContingentConsiderationLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420411 - Disclosure - Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails",
     "shortName": "Fair Value Measurements - Summary of Activity Related to Equity Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i5ca06658d0fa40fd9124e23676ae5f16_I20191229",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:MarketableSecuritiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421412 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Assets and Liabilities at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsInHedgesAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422413 - Disclosure - Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
     "shortName": "Fair Value Measurements - Cash, Cash Equivalents and Marketable Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423414 - Disclosure - Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails",
     "shortName": "Fair Value Measurements - Schedule of Available for Sale Securities Maturities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i56f124cb187a4df0b12cb443a129b124_I20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424415 - Disclosure - Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)",
     "role": "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails",
     "shortName": "Fair Value Measurements - Financial Liabilities not Measured at Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i9d98912977ba4917b953532514269c05_I20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ShortTermBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - Income Taxes (Details)",
     "role": "http://www.jnj.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
     "shortName": "Pensions and Other Benefit Plans - Components of Net Periodic Benefit Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNetBenefitCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "idb402f02d7d64973a1cab9ca48952a25_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedBenefitPlanServiceCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionContributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Pensions and Other Benefit Plans (Details)",
     "role": "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails",
     "shortName": "Pensions and Other Benefit Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i2ffdd5f1598a4f44af491294b283163f_D20191230-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionContributions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7f5119916d654310ac75b5ef00226e3c_I20200329",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "id4556ab2a2fc4b759328bcaa7117d7f0_I20191229",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Statements of Comprehensive Income",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareBasic",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436420 - Disclosure - Earnings Per Share (Details)",
     "role": "http://www.jnj.com/role/EarningsPerShareDetails",
     "shortName": "Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439421 - Disclosure - Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
     "shortName": "Segments of Business and Geographic Areas - Sales By Segment Of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:PercentageChangeInSalesBySegmentOfBusiness",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "jnj:PercentageChangeInSalesByGeographicArea",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440422 - Disclosure - Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
     "shortName": "Segments of Business and Geographic Areas - Operating Profit by Segment of Business (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "3",
      "lang": "en-US",
      "name": "jnj:PercentageChangeInOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441423 - Disclosure - Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)",
     "role": "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails",
     "shortName": "Segments of Business and Geographic Areas - Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443424 - Disclosure - Business Combinations and Divestitures - Narrative (Details)",
     "role": "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
     "shortName": "Business Combinations and Divestitures - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "iccccb20c51044c9e9a84c5d3198c51c6_D20200330-20200628",
      "decimals": "-8",
      "lang": "en-US",
      "name": "us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i582a2834e4fd4aff9b1bc95d88dffea5_I20200628",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "jnj:ProductLiabilityContingencyNumberOfClaimant",
      "reportCount": 1,
      "unitRef": "claimant",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Legal Proceedings (Details)",
     "role": "http://www.jnj.com/role/LegalProceedingsDetails",
     "shortName": "Legal Proceedings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i843d961ffff941f780e135d0ac57ec95_I20191229",
      "decimals": "0",
      "lang": "en-US",
      "name": "jnj:ProductLiabilityContingencyNumberOfClaimant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "claimant",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448426 - Disclosure - Restructuring - Narrative (Details)",
     "role": "http://www.jnj.com/role/RestructuringNarrativeDetails",
     "shortName": "Restructuring - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "ia605452b07814f9785dea5e1749593fb_D20200330-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i7a4c912478424448aac93f72bcf0275c_D20200330-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449427 - Disclosure - Restructuring - Schedule of Restructuring Reserve (Details)",
     "role": "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
     "shortName": "Restructuring - Schedule of Restructuring Reserve (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "lang": "en-US",
      "name": "jnj:RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i99963dbb725b4ce68efcd70e25e653e1_I20181230",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Statements of Equity",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
     "shortName": "Consolidated Statements of Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i6b613a94dd42484783d6a12a1751f62a_I20181230",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": null,
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Equity (Parenthetical)",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical",
     "shortName": "Consolidated Statements of Equity (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://www.jnj.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "jnj-20200628.htm",
      "contextRef": "i1fcf820672ea4d13a54b7bc90de199ce_D20191230-20200628",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 183,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States",
        "verboseLabel": "U.S."
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2017-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance",
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]"
       }
      }
     },
     "localname": "EntitiesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]"
       }
      }
     },
     "localname": "EntityInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "jnj_A0.250NotesDue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.250% Notes Due 2022 [Member]",
        "label": "0.250% Notes Due 2022 [Member]",
        "terseLabel": "0.250% Notes due 2022 (1B Euro 1.1217)",
        "verboseLabel": "0.250% Notes Due January 2022"
       }
      }
     },
     "localname": "A0.250NotesDue2022Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A0.650NotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "0.650% Notes Due 2024 [Member]",
        "label": "0.650% Notes Due 2024 [Member]",
        "terseLabel": "0.650% Notes due 2024 (750MM Euro 1.1217)",
        "verboseLabel": "0.650% Notes Due May 2024"
       }
      }
     },
     "localname": "A0.650NotesDue2024Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A1.150NotesDue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.150% Notes Due 2028 [Member]",
        "label": "1.150% Notes Due 2028 [Member]",
        "terseLabel": "1.150% Notes due 2028 (750MM Euro 1.1217)",
        "verboseLabel": "1.150% Notes Due November 2028"
       }
      }
     },
     "localname": "A1.150NotesDue2028Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A1.650NotesDue2035Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "1.650% Notes Due 2035 [Member]",
        "label": "1.650% Notes Due 2035 [Member]",
        "terseLabel": "1.650% Notes due 2035 (1.5B Euro 1.1217)",
        "verboseLabel": "1.650% Notes Due May 2035"
       }
      }
     },
     "localname": "A1.650NotesDue2035Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.05Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.05% Notes due 2023 [Member]",
        "label": "2.05% Notes due 2023 [Member]",
        "terseLabel": "2.05% Notes due 2023"
       }
      }
     },
     "localname": "A2.05Notesdue2023Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.25Notesdue2022Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.25% Notes due 2022 [Member]",
        "label": "2.25% Notes due 2022 [Member]",
        "terseLabel": "2.25% Notes due 2022"
       }
      }
     },
     "localname": "A2.25Notesdue2022Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.45Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.45% Notes due 2021 [Member]",
        "label": "2.45% Notes due 2021 [Member]",
        "terseLabel": "2.45% Notes due 2021"
       }
      }
     },
     "localname": "A2.45Notesdue2021Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.45Notesdue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.45% Notes due 2026 [Member]",
        "label": "2.45% Notes due 2026 [Member]",
        "terseLabel": "2.45% Notes due 2026"
       }
      }
     },
     "localname": "A2.45Notesdue2026Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.625Notesdue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.625 Notes due 2025 [Member]",
        "label": "2.625 Notes due 2025 [Member]",
        "terseLabel": "2.625% Notes due 2025"
       }
      }
     },
     "localname": "A2.625Notesdue2025Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.900Notesdue2028Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.900% Notes due 2028 [Member]",
        "label": "2.900% Notes due 2028 [Member]",
        "terseLabel": "2.90%\u00a0Notes due 2028"
       }
      }
     },
     "localname": "A2.900Notesdue2028Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A2.95Notesdue2027Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "2.95% Notes due 2027 [Member]",
        "label": "2.95% Notes due 2027 [Member]",
        "terseLabel": "2.95% Notes due 2027"
       }
      }
     },
     "localname": "A2.95Notesdue2027Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.375Notesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.375% Notes due 2023 [Member]",
        "label": "3.375% Notes due 2023 [Member]",
        "terseLabel": "3.375% Notes due 2023"
       }
      }
     },
     "localname": "A3.375Notesdue2023Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.400Notesdue2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.400% Notes due 2038 [Member]",
        "label": "3.400% Notes due 2038 [Member]",
        "terseLabel": "3.40%\u00a0Notes due 2038"
       }
      }
     },
     "localname": "A3.400Notesdue2038Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.500Notesdue2048Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.500% Notes due 2048 [Member]",
        "label": "3.500% Notes due 2048 [Member]",
        "terseLabel": "3.50% Notes due 2048"
       }
      }
     },
     "localname": "A3.500Notesdue2048Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.55Notesdue2021Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.55% Notes due 2021 [Member]",
        "label": "3.55% Notes due 2021 [Member]",
        "terseLabel": "3.55% Notes due 2021 [Member]"
       }
      }
     },
     "localname": "A3.55Notesdue2021Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.55Notesdue2036Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.55% Notes due 2036 [Member]",
        "label": "3.55% Notes due 2036 [Member]",
        "terseLabel": "3.55% Notes due 2036"
       }
      }
     },
     "localname": "A3.55Notesdue2036Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.625Notesdue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.625% Notes due 2037 [Member]",
        "label": "3.625% Notes due 2037 [Member]",
        "terseLabel": "3.625% Notes due 2037"
       }
      }
     },
     "localname": "A3.625Notesdue2037Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.70Notesdue2046Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.70% Notes due 2046 [Member]",
        "label": "3.70% Notes due 2046 [Member]",
        "terseLabel": "3.70% Notes due 2046"
       }
      }
     },
     "localname": "A3.70Notesdue2046Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A3.75Notesdue2047Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "3.75% Notes due 2047 [Member]",
        "label": "3.75% Notes due 2047 [Member]",
        "terseLabel": "3.75% Notes due 2047"
       }
      }
     },
     "localname": "A3.75Notesdue2047Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.375Notesdue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.375% Notes due 2033 [Member]",
        "label": "4.375% Notes due 2033 [Member]",
        "terseLabel": "4.375% Notes due 2033"
       }
      }
     },
     "localname": "A4.375Notesdue2033Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.50Debenturesdue2040Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Debentures due 2040 [Member]",
        "label": "4.50% Debentures due 2040 [Member]",
        "terseLabel": "4.50% Debentures due 2040"
       }
      }
     },
     "localname": "A4.50Debenturesdue2040Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.50Notesdue2043Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.50% Notes due 2043 [Member]",
        "label": "4.50% Notes due 2043 [Member]",
        "terseLabel": "4.50% Notes due 2043"
       }
      }
     },
     "localname": "A4.50Notesdue2043Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.85Notesdue2041Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.85% Notes due 2041 [Member]",
        "label": "4.85% Notes due 2041 [Member]",
        "terseLabel": "4.85% Notes due 2041"
       }
      }
     },
     "localname": "A4.85Notesdue2041Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A4.95Debenturesdue2033Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "4.95% Debentures due 2033 [Member]",
        "label": "4.95% Debentures due 2033 [Member]",
        "terseLabel": "4.95% Debentures due 2033"
       }
      }
     },
     "localname": "A4.95Debenturesdue2033Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.50NotesDue2024Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.50% Notes Due 2024 [Member]",
        "label": "5.50% Notes Due 2024 [Member]",
        "terseLabel": "5.50% Notes due 2024 (500 MM GBP 1.2431)",
        "verboseLabel": "5.50% Notes Due November 2024"
       }
      }
     },
     "localname": "A5.50NotesDue2024Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/Cover",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.85Debenturesdue2038Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.85% Debentures due 2038 [Member]",
        "label": "5.85% Debentures due 2038 [Member]",
        "terseLabel": "5.85% Debentures due 2038"
       }
      }
     },
     "localname": "A5.85Debenturesdue2038Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A5.95Notesdue2037Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "5.95% Notes due 2037 [Member]",
        "label": "5.95% Notes due 2037 [Member]",
        "terseLabel": "5.95% Notes due 2037"
       }
      }
     },
     "localname": "A5.95Notesdue2037Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A6.73Debenturesdue2023Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "6.73% Debentures due 2023 [Member]",
        "label": "6.73% Debentures due 2023 [Member]",
        "terseLabel": "6.73% Debentures due 2023"
       }
      }
     },
     "localname": "A6.73Debenturesdue2023Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_A6.95Notesdue2029Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "6.95% Notes due 2029 [Member]",
        "label": "6.95% Notes due 2029 [Member]",
        "terseLabel": "6.95% Notes due 2029"
       }
      }
     },
     "localname": "A6.95Notesdue2029Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ADVANCEDMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ADVANCED [Member]",
        "label": "ADVANCED [Member]",
        "terseLabel": "ADVANCED"
       }
      }
     },
     "localname": "ADVANCEDMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AccruedRebatesReturnsAndPromotions": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated obligations due within one year for rebates, returns and promotions. Reserves include such items related to Medicaid rebates, product returns due to expiration, product recalls, current portion of coupons and volume-based sales incentives programs.",
        "label": "Accrued Rebates Returns And Promotions",
        "verboseLabel": "Accrued rebates, returns and promotions"
       }
      }
     },
     "localname": "AccruedRebatesReturnsAndPromotions",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_AccruedTaxesOnIncomeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accrued Taxes On Income [Member]",
        "label": "Accrued Taxes On Income [Member]",
        "terseLabel": "Accrued Taxes On Income [Member]"
       }
      }
     },
     "localname": "AccruedTaxesOnIncomeMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AdvancedSterilizationProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "AdvancedSterilizationProducts [Member]",
        "label": "AdvancedSterilizationProducts [Member]",
        "terseLabel": "AdvancedSterilizationProducts"
       }
      }
     },
     "localname": "AdvancedSterilizationProductsMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AsiaPacificAfricaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asia-Pacific, Africa [Member]",
        "label": "Asia-Pacific, Africa [Member]",
        "terseLabel": "Asia-Pacific, Africa"
       }
      }
     },
     "localname": "AsiaPacificAfricaMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AsrMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ASR.",
        "label": "ASR [Member]",
        "terseLabel": "ASR"
       }
      }
     },
     "localname": "AsrMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AssetWriteoffMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset Write-off [Member]",
        "label": "Asset Write-off [Member]",
        "terseLabel": "Asset Write-off"
       }
      }
     },
     "localname": "AssetWriteoffMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_AurisHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Auris Health",
        "label": "Auris Health [Member]",
        "terseLabel": "Auris Health"
       }
      }
     },
     "localname": "AurisHealthMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BabyCareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Baby Care [Member]",
        "label": "Baby Care [Member]",
        "terseLabel": "Baby Care"
       }
      }
     },
     "localname": "BabyCareMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BabyPowderMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Baby Powder [Member]",
        "label": "Baby Powder [Member]",
        "terseLabel": "Baby Powder"
       }
      }
     },
     "localname": "BabyPowderMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BeautyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Beauty [Member]",
        "label": "Beauty [Member]",
        "terseLabel": "Oral Care"
       }
      }
     },
     "localname": "BeautyMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BermekimabMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "bermekimab [Member]",
        "label": "bermekimab [Member]",
        "terseLabel": "bermekimab"
       }
      }
     },
     "localname": "BermekimabMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Adjustments Made To Intangible Assets, Other than Goodwill",
        "terseLabel": "Adjustments made to intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAdjustmentsMadeToIntangibleAssetsOtherthanGoodwill",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CONCERTAMethylphenidateMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CONCERTA/Methylphenidate [Member]",
        "label": "CONCERTA/Methylphenidate [Member]",
        "terseLabel": "CONCERTA\u00ae / methylphenidate"
       }
      }
     },
     "localname": "CONCERTAMethylphenidateMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CONTACTLENSESOTHERMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "CONTACT LENSES/OTHER [Member]",
        "label": "CONTACT LENSES/OTHER [Member]",
        "terseLabel": "CONTACT LENSES / OTHER"
       }
      }
     },
     "localname": "CONTACTLENSESOTHERMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CardiovascularMetabolismOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cardiovascular/Metabolism/Other [Member]",
        "label": "Cardiovascular/Metabolism/Other [Member]",
        "terseLabel": "Cardiovascular / Metabolism / Other"
       }
      }
     },
     "localname": "CardiovascularMetabolismOtherMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss",
        "label": "Cash, Cash Equivalents, And Short-Term Investments, Accumulated Gross Unrealized Loss",
        "negatedTerseLabel": "Total cash, cash equivalents and current marketable securities, Unrecognized Loss"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsAccumulatedGrossUnrealizedLoss",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Short-term Investments, Estimated Fair Value",
        "label": "Cash, Cash Equivalents, And Short-Term Investments, Estimated Fair Value",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Estimated Fair Value"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestmentsEstimatedFairValue",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain",
        "label": "Cash, Cash Equivalents, and Short-term Investments, Accumulated Gross Unrealized Gain",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Unrecognized Gain"
       }
      }
     },
     "localname": "CashCashEquivalentsandShorttermInvestmentsAccumulatedGrossUnrealizedGain",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_CizHoldingsCo.Ltd.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ci:z Holdings Co. Ltd. [Member]",
        "label": "Ci:z Holdings Co. Ltd. [Member]",
        "terseLabel": "Ci:z Holdings Co. Ltd."
       }
      }
     },
     "localname": "CizHoldingsCo.Ltd.Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ConsumerMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Consumer.",
        "label": "Consumer [Member]",
        "terseLabel": "Consumer Health*"
       }
      }
     },
     "localname": "ConsumerMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_CostOfGoodsSoldPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_GrossProfitPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cost of goods sold percent to sales.",
        "label": "Cost Of Goods Sold Percent To Sales",
        "terseLabel": "Cost of products sold percent to sales"
       }
      }
     },
     "localname": "CostOfGoodsSoldPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_DARZALEXMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DARZALEX [Member]",
        "label": "DARZALEX [Member]",
        "terseLabel": "DARZALEX\u00ae"
       }
      }
     },
     "localname": "DARZALEXMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_DePuyASRU.S.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "DePuy ASR U.S. [Member]",
        "label": "DePuy ASR U.S. [Member]",
        "terseLabel": "DePuy ASR U.S."
       }
      }
     },
     "localname": "DePuyASRU.S.Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instruments gain loss on statement of financial performance.",
        "label": "Derivative Instruments Gain Loss On Statement Of Financial Performance Abstract",
        "verboseLabel": "Summary of designated derivatives"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossOnStatementOfFinancialPerformanceAbstract",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_DisposalGroupIncludingDiscontinuedOperationReceivablesRetained": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Receivables Retained",
        "label": "Disposal Group, Including Discontinued Operation, Receivables Retained",
        "terseLabel": "Receivables retained"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationReceivablesRetained",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EDURANTrilpivirineMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "EDURANT/rilpivirine [Member]",
        "label": "EDURANT/rilpivirine [Member]",
        "terseLabel": "EDURANT\u00ae / rilpivirine"
       }
      }
     },
     "localname": "EDURANTrilpivirineMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ERLEADAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ERLEADA",
        "label": "ERLEADA [Member]",
        "terseLabel": "ERLEADA [Member]"
       }
      }
     },
     "localname": "ERLEADAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Change In Contingent Consideration Liability, Percent",
        "terseLabel": "Net impact to tax rate due to change in contingent consideration liability"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInContingentConsiderationLiabilityPercent",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent",
        "label": "Effective Income Tax Rate Reconciliation, Increase (Decrease), Percent",
        "terseLabel": "Impact to effective tax rate, percent"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationIncreaseDecreasePercent",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_EquityFairValueAdjustmentChangeInObservablePrice": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity, Fair Value Adjustment, Change In Observable Price",
        "label": "Equity, Fair Value Adjustment, Change In Observable Price",
        "terseLabel": "Equity, Fair Value Adjustment, Change In Observable Price"
       }
      }
     },
     "localname": "EquityFairValueAdjustmentChangeInObservablePrice",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityFairValueAdjustmentImpairmentLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity, Fair Value Adjustment, Impairment Loss",
        "label": "Equity, Fair Value Adjustment, Impairment Loss",
        "terseLabel": "Equity, Fair Value Adjustment, Impairment Loss"
       }
      }
     },
     "localname": "EquityFairValueAdjustmentImpairmentLoss",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityInvestmentRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investment [Roll Forward]",
        "label": "Equity Investment [Roll Forward]",
        "terseLabel": "Equity Investment [Roll Forward]"
       }
      }
     },
     "localname": "EquityInvestmentRollForward",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period",
        "label": "Equity Investments, Increase (Decrease) from Acquisition (Sale) During Period",
        "terseLabel": "Sales/ Purchases/Other"
       }
      }
     },
     "localname": "EquityInvestmentsIncreaseDecreasefromAcquisitionSaleDuringPeriod",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_EquityInvestmentswithReadilyDeterminableValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments with Readily Determinable Value [Member]",
        "label": "Equity Investments with Readily Determinable Value [Member]",
        "terseLabel": "Equity Investments with readily determinable value"
       }
      }
     },
     "localname": "EquityInvestmentswithReadilyDeterminableValueMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EquityInvestmentswithoutReadilyDeterminableValueMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Investments without Readily Determinable Value [Member]",
        "label": "Equity Investments without Readily Determinable Value [Member]",
        "terseLabel": "Equity Investments without readily determinable value"
       }
      }
     },
     "localname": "EquityInvestmentswithoutReadilyDeterminableValueMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares",
        "label": "Equity Method Investment Retained After Disposal, Ownership Interest After Disposal, Shares",
        "terseLabel": "Ownership interest after sale"
       }
      }
     },
     "localname": "EquityMethodInvestmentRetainedAfterDisposalOwnershipInterestAfterDisposalShares",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jnj_ExcessOfFairValueOverCarryingValueOfDebt": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Excess of fair value over carrying value of debt.",
        "label": "Excess Of Fair Value Over Carrying Value Of Debt",
        "terseLabel": "Excess of the estimated fair value over the carrying value of debt"
       }
      }
     },
     "localname": "ExcessOfFairValueOverCarryingValueOfDebt",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Change In Estimated Fair Value",
        "negatedTerseLabel": "Reversal of contingent consideration",
        "terseLabel": "Changes in estimated fair value (7)"
       }
      }
     },
     "localname": "FairValueMeasurementwithUnobservableInputsReconciliationRecurringBasisChangeInEstimatedFairValue",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset",
        "label": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset",
        "terseLabel": "Deferred tax benefit related to TRAF"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingDeferredTaxAsset",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent",
        "label": "Federal Act On Tax Reform And AHV Financing, Deferred Tax Asset, Percent",
        "terseLabel": "Deferred tax benefit related to TRAF, percent"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingDeferredTaxAssetPercent",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)",
        "label": "Federal Act On Tax Reform And AHV Financing, GILTI Remeasurement, Income Tax Expense (Benefit)",
        "terseLabel": "Deferred tax liability related to TRAF"
       }
      }
     },
     "localname": "FederalActOnTaxReformAndAHVFinancingGILTIRemeasurementIncomeTaxExpenseBenefit",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived And Indefinite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_GENERALMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "GENERAL [Member]",
        "label": "GENERAL [Member]",
        "terseLabel": "GENERAL"
       }
      }
     },
     "localname": "GENERALMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_GrossProfitPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Gross profit percent to sales.",
        "label": "Gross Profit Percent To Sales",
        "totalLabel": "Gross profit percent to sales"
       }
      }
     },
     "localname": "GrossProfitPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_HIPSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "HIPS [Member]",
        "label": "HIPS [Member]",
        "terseLabel": "HIPS"
       }
      }
     },
     "localname": "HIPSMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IMBRUVICAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "IMBRUVICA [Member]",
        "label": "IMBRUVICA [Member]",
        "terseLabel": "IMBRUVICA\u00ae"
       }
      }
     },
     "localname": "IMBRUVICAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_INVEGASUSTENNAXEPLIONTRINZATREVICTAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]",
        "label": "INVEGA SUSTENNA/XEPLION/TRINZA/TREVICTA [Member]",
        "terseLabel": "INVEGA SUSTENNA\u00ae / XEPLION\u00ae / INVEGA TRINZA\u00ae / TREVICTA\u00ae"
       }
      }
     },
     "localname": "INVEGASUSTENNAXEPLIONTRINZATREVICTAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_INVOKANAINVOKAMETMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "INVOKANA/INVOKAMET [Member]",
        "label": "INVOKANA/INVOKAMET [Member]",
        "terseLabel": "INVOKANA\u00ae / INVOKAMET\u00ae"
       }
      }
     },
     "localname": "INVOKANAINVOKAMETMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IdorsiaLTDMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Idorsia LTD",
        "label": "Idorsia LTD [Member]",
        "terseLabel": "Idorsia"
       }
      }
     },
     "localname": "IdorsiaLTDMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ImmunologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Immunology [Member]",
        "label": "Immunology [Member]",
        "terseLabel": "Immunology"
       }
      }
     },
     "localname": "ImmunologyMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_NetIncomeAttributableToParentPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income loss from continuing operations before income taxes minority interest and income loss from equity method investments percent to sales.",
        "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Percent To Sales",
        "totalLabel": "Earnings before provision for taxes on income percent to sales"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_IncomeTaxExpenseBenefitPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_NetIncomeAttributableToParentPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income tax expense benefit percent to sales.",
        "label": "Income Tax Expense Benefit Percent To Sales",
        "terseLabel": "Provision for taxes on income (Note 5)"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_IncomeTaxTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Income Tax Textuals Abstract.",
        "label": "Income Tax (Textuals) [Abstract]",
        "verboseLabel": "Income Tax (Textuals)"
       }
      }
     },
     "localname": "IncomeTaxTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_InfectiousDiseasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Infectious Diseases [Member]",
        "label": "Infectious Diseases [Member]",
        "terseLabel": "Infectious Diseases"
       }
      }
     },
     "localname": "InfectiousDiseasesMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_IntangibleAssetsAndGoodwillTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible Assets and Goodwill Textuals Abstract.",
        "label": "Intangible Assets and Goodwill (Textuals) [Abstract]",
        "verboseLabel": "Intangible Assets and Goodwill (Textuals)"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_InterestExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest expense percent to sales.",
        "label": "Interest Expense Percent To Sales",
        "terseLabel": "Interest expense, net of portion capitalized percent to sales"
       }
      }
     },
     "localname": "InterestExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_InterestIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interest Income Expense Net Member.",
        "label": "Interest Income Expense Net Member",
        "terseLabel": "Interest Income Expense Net Member",
        "verboseLabel": "Interest (income)/Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNetMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_InterventionalSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Interventional Solutions [Member]",
        "label": "Interventional Solutions [Member]",
        "verboseLabel": "Interventional Solutions"
       }
      }
     },
     "localname": "InterventionalSolutionsMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_InvestmentIncomeInterestPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment income interest percent to sales.",
        "label": "Investment Income Interest Percent To Sales",
        "terseLabel": "Interest income percent to sales"
       }
      }
     },
     "localname": "InvestmentIncomeInterestPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_InvokanaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Invokana [Member]",
        "label": "Invokana [Member]",
        "terseLabel": "Invokana"
       }
      }
     },
     "localname": "InvokanaMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_KNEESMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "KNEES [Member]",
        "label": "KNEES [Member]",
        "terseLabel": "KNEES"
       }
      }
     },
     "localname": "KNEESMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_LegalProceedingTextualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Legal Proceeding Textuals Abstract.",
        "label": "Legal Proceeding (Textuals) [Abstract]",
        "terseLabel": "Legal Proceeding (Textuals)"
       }
      }
     },
     "localname": "LegalProceedingTextualsAbstract",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_LitigationSettlementByCompaniesAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation settlement by companies.",
        "label": "Litigation Settlement By Companies [Axis]",
        "terseLabel": "Litigation Settlement By Companies"
       }
      }
     },
     "localname": "LitigationSettlementByCompaniesAxis",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_LitigationSettlementByCompaniesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation settlement by companies.",
        "label": "Litigation Settlement By Companies [Domain]",
        "terseLabel": "Litigation Settlement By Companies"
       }
      }
     },
     "localname": "LitigationSettlementByCompaniesDomain",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_LossContingencyPreviousDamagesAwardedAndRevisedValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Loss Contingency, Previous Damages Awarded And Revised, Value",
        "label": "Loss Contingency, Previous Damages Awarded And Revised, Value",
        "terseLabel": "Previous damages awarded and revised"
       }
      }
     },
     "localname": "LossContingencyPreviousDamagesAwardedAndRevisedValue",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_MedicalDevicesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Medical Devices [Member]",
        "label": "Medical Devices [Member]",
        "terseLabel": "MEDICAL DEVICES",
        "verboseLabel": "Medical Devices"
       }
      }
     },
     "localname": "MedicalDevicesMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_NetIncomeAttributableToParentPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Net Income Attributable to Parent Percent to Sales",
        "label": "Net Income Attributable to Parent Percent to Sales",
        "totalLabel": "Net earnings percent to sales"
       }
      }
     },
     "localname": "NetIncomeAttributableToParentPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_NeuroscienceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Neuroscience [Member]",
        "label": "Neuroscience [Member]",
        "terseLabel": "Neuroscience"
       }
      }
     },
     "localname": "NeuroscienceMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_NotesDuePeriodFifteenMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Notes due period fifteen.",
        "label": "Notes Due Period Fifteen Member",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "NotesDuePeriodFifteenMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_Numberofpatientsinsettlement": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of patients in settlement",
        "label": "Number of patients in settlement",
        "terseLabel": "Number of patients in settlement"
       }
      }
     },
     "localname": "Numberofpatientsinsettlement",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "jnj_OPSUMITMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OPSUMIT [Member]",
        "label": "OPSUMIT [Member]",
        "terseLabel": "OPSUMIT\u00ae"
       }
      }
     },
     "localname": "OPSUMITMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OTCMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OTC [Member]",
        "label": "OTC [Member]",
        "terseLabel": "Skin Health/Beauty"
       }
      }
     },
     "localname": "OTCMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OTHERNEUROSCIENCEMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "OTHER NEUROSCIENCE [Member]",
        "label": "OTHER NEUROSCIENCE [Member]",
        "terseLabel": "OTHER NEUROSCIENCE"
       }
      }
     },
     "localname": "OTHERNEUROSCIENCEMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]",
        "label": "Oklahoma Attorney General VS. Johnson And Johnson And JPI [Member]",
        "terseLabel": "Oklahoma Attorney General vs. Johnson &amp; Johnson and JPI"
       }
      }
     },
     "localname": "OklahomaAttorneyGeneralVS.JohnsonAndJohnsonAndJPIMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oncology [Member]",
        "label": "Oncology [Member]",
        "terseLabel": "Oncology"
       }
      }
     },
     "localname": "OncologyMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OpioidMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Opioid",
        "label": "opioid [Member]",
        "terseLabel": "Opioid"
       }
      }
     },
     "localname": "OpioidMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OralCareMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Oral Care [Member]",
        "label": "Oral Care [Member]",
        "terseLabel": "OTC"
       }
      }
     },
     "localname": "OralCareMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OrthopaedicsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Orthopaedics [Member]",
        "label": "Orthopaedics [Member]",
        "terseLabel": "Orthopaedics"
       }
      }
     },
     "localname": "OrthopaedicsMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax",
        "label": "Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Net Prior Service Cost (Credit), Net of Amortization, Arising During Period, Net of Tax",
        "negatedTerseLabel": "Prior service cost amortization during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansNetPriorServiceCostCreditNetofAmortizationArisingDuringPeriodNetofTax",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax",
        "label": "Other Comprehensive (Income) Loss, Reclassification Adjustment from AOCI Pension and Other Postretirement Benefit Plans for Net Gain Loss, Net of Amortization, Net of Tax",
        "negatedTerseLabel": "Gain (loss) amortization during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentfromAOCIPensionandOtherPostretirementBenefitPlansforNetGainLossNetofAmortizationNetofTax",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_OtherImmunologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Immunology [Member]",
        "label": "Other Immunology [Member]",
        "terseLabel": "OTHER IMMUNOLOGY"
       }
      }
     },
     "localname": "OtherImmunologyMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherIncomeExpenseNetMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Income Expense Net [Member]",
        "label": "Other Income Expense Net [Member]",
        "terseLabel": "Other (income) expense",
        "verboseLabel": "Other Income Expense Net"
       }
      }
     },
     "localname": "OtherIncomeExpenseNetMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherInfectiousDiseasesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Infectious Diseases [Member]",
        "label": "Other Infectious Diseases [Member]",
        "terseLabel": "OTHER INFECTIOUS DISEASES"
       }
      }
     },
     "localname": "OtherInfectiousDiseasesMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other [Member]",
        "label": "Other [Member]",
        "terseLabel": "OTHER PULMONARY HYPERTENSION"
       }
      }
     },
     "localname": "OtherMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherNonOperatingIncomeExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other non operating income expense percent to sales.",
        "label": "Other Non Operating Income Expense Percent To Sales",
        "terseLabel": "Other (income) expense, net percent to sales"
       }
      }
     },
     "localname": "OtherNonOperatingIncomeExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_OtherOncologyMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Oncology [Member]",
        "label": "Other Oncology [Member]",
        "terseLabel": "OTHER ONCOLOGY"
       }
      }
     },
     "localname": "OtherOncologyMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_OtherReverseRepurchaseAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Other Reverse Repurchase Agreements [Member]",
        "label": "Other Reverse Repurchase Agreements [Member]",
        "terseLabel": "Other reverse repurchase agreements"
       }
      }
     },
     "localname": "OtherReverseRepurchaseAgreementsMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PREZISTAPREZCOBIXREZOLSTASYMTUZAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]",
        "label": "PREZISTA/PREZCOBIX/REZOLSTA/SYMTUZA [Member]",
        "terseLabel": "PREZISTA\u00ae / PREZCOBIX\u00ae / REZOLSTA\u00ae / SYMTUZA\u00ae"
       }
      }
     },
     "localname": "PREZISTAPREZCOBIXREZOLSTASYMTUZAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PROCRITEPREXMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "PROCRIT/EPREX [Member]",
        "label": "PROCRIT/EPREX [Member]",
        "terseLabel": "PROCRIT\u00ae / EPREX\u00ae"
       }
      }
     },
     "localname": "PROCRITEPREXMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PatentsAndTrademarksMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Patents And Trademarks [Member]",
        "label": "Patents And Trademarks [Member]",
        "terseLabel": "Patents And Trademarks"
       }
      }
     },
     "localname": "PatentsAndTrademarksMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PelvicMeshesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pelvic meshes.",
        "label": "Pelvic Meshes [Member]",
        "terseLabel": "Pelvic Meshes"
       }
      }
     },
     "localname": "PelvicMeshesMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PercentageChangeInOperatingIncomeLoss": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in operating income loss.",
        "label": "Percentage Change in Operating Income Loss",
        "terseLabel": "Percentage Change in Operating Income Loss"
       }
      }
     },
     "localname": "PercentageChangeInOperatingIncomeLoss",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PercentageChangeInSalesByGeographicArea": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in sales by geographic area.",
        "label": "Percentage Change In Sales By Geographic Area",
        "terseLabel": "Percentage Change In Sales By Geographic Area"
       }
      }
     },
     "localname": "PercentageChangeInSalesByGeographicArea",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PercentageChangeInSalesBySegmentOfBusiness": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage change in sales by segment of business.",
        "label": "Percentage Change In Sales By Segment Of Business",
        "terseLabel": "Percent Change (as a percent)"
       }
      }
     },
     "localname": "PercentageChangeInSalesBySegmentOfBusiness",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_PharmaceuticalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pharmaceutical.",
        "label": "Pharmaceutical [Member]",
        "terseLabel": "PHARMACEUTICAL"
       }
      }
     },
     "localname": "PharmaceuticalMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PhysiomeshMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Physiomesh [Member]",
        "label": "Physiomesh [Member]",
        "terseLabel": "Physiomesh"
       }
      }
     },
     "localname": "PhysiomeshMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PinnacleAcetabularCupSystemMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pinnacle Acetabular cup system.",
        "label": "Pinnacle Acetabular Cup System [Member]",
        "terseLabel": "Pinnacle Acetabular Cup System"
       }
      }
     },
     "localname": "PinnacleAcetabularCupSystemMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds From The Exercise Of Stock Options And Excess Tax Benefits",
        "label": "Proceeds From The Exercise Of Stock Options And Excess Tax Benefits",
        "verboseLabel": "Proceeds from the exercise of stock options/employee withholding tax on stock awards, net"
       }
      }
     },
     "localname": "ProceedsFromExerciseOfStockOptionsAndExcessTaxBenefits",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_Proceedsfromcreditsupportagreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Proceeds from credit support agreements",
        "label": "Proceeds from credit support agreements",
        "terseLabel": "Proceeds from credit support agreements, net"
       }
      }
     },
     "localname": "Proceedsfromcreditsupportagreements",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_ProductLiabilityContingencyNumberOfClaimant": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Product liability contingency number of claimant.",
        "label": "Product Liability Contingency Number Of Claimant",
        "terseLabel": "Product Liability Contingency Number Of Claimants"
       }
      }
     },
     "localname": "ProductLiabilityContingencyNumberOfClaimant",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "jnj_PulmonaryHypertensionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Pulmonary Hypertension [Member]",
        "label": "Pulmonary Hypertension [Member]",
        "terseLabel": "Pulmonary Hypertension"
       }
      }
     },
     "localname": "PulmonaryHypertensionMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_PurchasedInProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Purchased In-Process Research And Development [Member]",
        "label": "Purchased In-Process Research And Development [Member]",
        "terseLabel": "Purchased In-Process Research And Development"
       }
      }
     },
     "localname": "PurchasedInProcessResearchAndDevelopmentMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_RISPERDALCONSTAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "RISPERDAL CONSTA [Member]",
        "label": "RISPERDAL CONSTA [Member]",
        "terseLabel": "RISPERDAL CONSTA\u00ae"
       }
      }
     },
     "localname": "RISPERDALCONSTAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_RemicadeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Remicade [Member]",
        "label": "Remicade [Member]",
        "terseLabel": "REMICADE\u00ae"
       }
      }
     },
     "localname": "RemicadeMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Research and development expense excluding acquired in process cost percent to sales.",
        "label": "Research And Development Expense Excluding Acquired In Process Cost Percent To Sales",
        "terseLabel": "Research and development expense percent to sales"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCostPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_ResearchAndDevelopmentInProcessPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 8.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "research and development in process percent to sales",
        "label": "Research and development in process percent to sales",
        "terseLabel": "In-process research and development percent to sales"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcessPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid",
        "label": "Restructuring And Related Cost, Expected Period Of Cash Outlays For Severance Paid",
        "terseLabel": "Period of cash outlays for severance expected to be paid out"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedPeriodOfCashOutlaysForSeverancePaid",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jnj_RestructuringandRelatedCostDurationofRestructuringPlan": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and Related Cost, Duration of Restructuring Plan",
        "label": "Restructuring and Related Cost, Duration of Restructuring Plan",
        "terseLabel": "Period for activity"
       }
      }
     },
     "localname": "RestructuringandRelatedCostDurationofRestructuringPlan",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "jnj_RestructuringandRelatedCostExpectedFutureSavings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and Related Cost, Expected Future Savings",
        "label": "Restructuring and Related Cost, Expected Future Savings",
        "terseLabel": "Cost savings expected"
       }
      }
     },
     "localname": "RestructuringandRelatedCostExpectedFutureSavings",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_Restructuringchargepercenttosales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 7.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring charge percent to sales",
        "label": "Restructuring charge percent to sales",
        "terseLabel": "Restructuring charge percent to sales"
       }
      }
     },
     "localname": "Restructuringchargepercenttosales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_RisperdalMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risperdal.",
        "label": "Risperdal [Member]",
        "terseLabel": "Risperdal"
       }
      }
     },
     "localname": "RisperdalMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SPINEOTHERMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SPINE &amp; OTHER [Member]",
        "label": "SPINE &amp; OTHER [Member]",
        "terseLabel": "SPINE, SPORTS &amp; OTHER"
       }
      }
     },
     "localname": "SPINEOTHERMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SURGICALMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "SURGICAL [Member]",
        "label": "SURGICAL [Member]",
        "terseLabel": "SURGICAL"
       }
      }
     },
     "localname": "SURGICALMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SalesBySegmentOfBusinessTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales by segment of business.",
        "label": "Sales By Segment Of Business [Table Text Block]",
        "terseLabel": "Sales By Segment Of Business"
       }
      }
     },
     "localname": "SalesBySegmentOfBusinessTableTextBlock",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jnj_SalesRevenueGoodsNetPercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "jnj_GrossProfitPercentToSales",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sales revenue goods net percentage to sales.",
        "label": "Sales Revenue Goods Net Percent To Sales",
        "terseLabel": "Sales to customers percent to sales"
       }
      }
     },
     "localname": "SalesRevenueGoodsNetPercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]",
        "label": "Schedule of Finite and Indefinite-Lived Intangible Assets Excluding Goodwill by Major Class [Table Text Block]",
        "verboseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsExcludingGoodwillByMajorClassTableTextBlock",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "jnj_ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]",
        "label": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]",
        "terseLabel": "Schedule of Finite-Lived And Indefinite-Lived Intangible Assets By Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "jnj_SellingGeneralAndAdministrativeExpensePercentToSales": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "jnj_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsPercentToSales",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Selling general and administrative expense percent to sales.",
        "label": "Selling General And Administrative Expense Percent To Sales",
        "terseLabel": "Selling marketing and administrative expenses percent to sales"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensePercentToSales",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "percentItemType"
    },
    "jnj_SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": -1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Common stock assumed to be purchased using the proceeds that could be obtained upon exercise of potential shares exercisable under stock option plans, at the average market price during the period.",
        "label": "Shares Which Could Be Repurchased Under Treasury Stock Method",
        "negatedTerseLabel": "Less: shares which could be repurchased under treasury stock method"
       }
      }
     },
     "localname": "SharesWhichCouldBeRepurchasedUnderTreasuryStockMethod",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "jnj_SimponiSimponiAriaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Simponi/Simponi Aria [Member]",
        "label": "Simponi/Simponi Aria [Member]",
        "terseLabel": "SIMPONI / SIMPONI ARIA\u00ae"
       }
      }
     },
     "localname": "SimponiSimponiAriaMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_StelaraMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stelara [Member]",
        "label": "Stelara [Member]",
        "terseLabel": "STELARA\u00ae"
       }
      }
     },
     "localname": "StelaraMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SupplyChainMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Supply Chain",
        "label": "Supply Chain [Member]",
        "terseLabel": "Supply Chain"
       }
      }
     },
     "localname": "SupplyChainMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_SurgeryMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Surgery [Member]",
        "label": "Surgery [Member]",
        "terseLabel": "Surgery"
       }
      }
     },
     "localname": "SurgeryMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TRAUMAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "TRAUMA [Member]",
        "label": "TRAUMA [Member]",
        "terseLabel": "TRAUMA"
       }
      }
     },
     "localname": "TRAUMAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TalcMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Talc [Member]",
        "label": "Talc [Member]",
        "terseLabel": "Talc"
       }
      }
     },
     "localname": "TalcMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_TremfyaMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tremfaya",
        "label": "Tremfya [Member]",
        "terseLabel": "TREMFYA\u00ae"
       }
      }
     },
     "localname": "TremfyaMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UNITEDSTATESExportsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UNITED STATES Exports [Member]",
        "label": "UNITED STATES Exports [Member]",
        "terseLabel": "U.S. Exports"
       }
      }
     },
     "localname": "UNITEDSTATESExportsMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UPTRAVIMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "UPTRAVI [Member]",
        "label": "UPTRAVI [Member]",
        "terseLabel": "UPTRAVI\u00ae"
       }
      }
     },
     "localname": "UPTRAVIMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_UnrecognizedTaxBenefitLiabilityPayment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unrecognized Tax Benefit Liability, Payment",
        "label": "Unrecognized Tax Benefit Liability, Payment",
        "terseLabel": "Payment on unrecognized tax benefit liability"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitLiabilityPayment",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "jnj_VELCADEMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "VELCADE [Member]",
        "label": "VELCADE [Member]",
        "terseLabel": "VELCADE\u00ae"
       }
      }
     },
     "localname": "VELCADEMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_VerbSurgicalInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Verb Surgical Inc. [Member]",
        "label": "Verb Surgical Inc. [Member]",
        "terseLabel": "Verb Surgical Inc."
       }
      }
     },
     "localname": "VerbSurgicalInc.Member",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_VisionMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Vision[Member]",
        "label": "Vision [Member]",
        "terseLabel": "Vision"
       }
      }
     },
     "localname": "VisionMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WesternHemisphereExcludingUSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Western Hemisphere, excluding U.S. [Member]",
        "label": "Western Hemisphere, excluding U.S. [Member]",
        "terseLabel": "Western Hemisphere, excluding U.S."
       }
      }
     },
     "localname": "WesternHemisphereExcludingUSMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WomensHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Women's Health [Member]",
        "label": "Women's Health [Member]",
        "terseLabel": "Women's Health"
       }
      }
     },
     "localname": "WomensHealthMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_WoundCareandOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Wound Care and Other [Member]",
        "label": "Wound Care and Other [Member]",
        "terseLabel": "Wound Care/Other"
       }
      }
     },
     "localname": "WoundCareandOtherMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_XareltoMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Xarelto [Member]",
        "label": "Xarelto [Member]",
        "terseLabel": "XARELTO\u00ae"
       }
      }
     },
     "localname": "XareltoMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "jnj_ZYTIGAMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "ZYTIGA [Member]",
        "label": "ZYTIGA [Member]",
        "terseLabel": "ZYTIGA\u00ae / abiraterone acetate"
       }
      }
     },
     "localname": "ZYTIGAMember",
     "nsuri": "http://www.jnj.com/20200628",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case Type"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r168",
      "r271",
      "r273",
      "r432",
      "r433"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r169",
      "r271",
      "r274",
      "r434",
      "r441",
      "r442"
     ],
     "lang": {
      "en-US": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "verboseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r12",
      "r30",
      "r171",
      "r172",
      "r272"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, trade, less allowances for doubtful accounts and credit losses $334 (2019, $226)"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "auth_ref": [
      "r24",
      "r403",
      "r422"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.",
        "label": "Accrued Income Taxes, Current",
        "verboseLabel": "Accrued taxes on income (Note 5)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedIncomeTaxesNoncurrent": {
     "auth_ref": [
      "r26",
      "r403",
      "r422"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.",
        "label": "Accrued Income Taxes, Noncurrent",
        "terseLabel": "Long-term taxes payable (Note 5)"
       }
      }
     },
     "localname": "AccruedIncomeTaxesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "verboseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r76",
      "r82",
      "r85",
      "r288",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r46",
      "r226"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r82",
      "r92",
      "r331"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": {
     "auth_ref": [
      "r73",
      "r74",
      "r75",
      "r82",
      "r85"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.",
        "label": "AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]",
        "terseLabel": "Accumulated Net Investment Gain (Loss) Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r81",
      "r82"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "verboseLabel": "Accumulated other comprehensive income (loss) (Note 7)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r78",
      "r82",
      "r85",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income",
        "verboseLabel": "AOCI Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r70",
      "r82",
      "r85",
      "r332"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Accumulated Foreign Currency Adjustment Attributable to Parent"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Weighted average useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to reconcile net earnings to cash flows from operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r33",
      "r173",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Allowances for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r209",
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "verboseLabel": "Amortization expense of amortizable intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r146"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AociLossCashFlowHedgeCumulativeGainLossAfterTax": {
     "auth_ref": [
      "r79"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of accumulated gain (loss) on derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax",
        "negatedTerseLabel": "Accumulated other comprehensive income on derivatives, after tax"
       }
      }
     },
     "localname": "AociLossCashFlowHedgeCumulativeGainLossAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r121",
      "r223"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset write-downs"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r163",
      "r401",
      "r421"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets [Abstract]",
        "verboseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r14",
      "r15",
      "r62"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "verboseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther": {
     "auth_ref": [
      "r222"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current, Other",
        "terseLabel": "Assets held for sale (Note 10)"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrentOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r177"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Available-for-sale Securities, Unrecognized Gain"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r178"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Available-for-sale Securities, Unrecognized Loss"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r175",
      "r197"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Available-for-sale Securities - Carrying Amount"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale [Abstract]"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost": {
     "auth_ref": [
      "r182"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth fiscal year through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Amortized Cost",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue": {
     "auth_ref": [
      "r179",
      "r182",
      "r417"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in sixth through tenth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after Five Through Ten Years, Fair Value",
        "terseLabel": "Due after five years through ten years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": {
     "auth_ref": [
      "r181"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": {
     "auth_ref": [
      "r179",
      "r181",
      "r416"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Fair Value",
        "terseLabel": "Due after one year through five years"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Amortized Cost, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Cost Basis"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate": {
     "auth_ref": [
      "r179",
      "r183",
      "r418"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value",
        "totalLabel": "Total debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value [Abstract]",
        "terseLabel": "Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis": {
     "auth_ref": [
      "r179",
      "r183",
      "r418"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Amortized Cost",
        "totalLabel": "Total debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": {
     "auth_ref": [
      "r180"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r179",
      "r180",
      "r415"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.",
        "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofAvailableforSaleSecuritiesMaturitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r174",
      "r176",
      "r197"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Available-for-sale Securities",
        "verboseLabel": "Available-for-sale Securities - Estimated Fair Value"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-sale Securities [Member]",
        "terseLabel": "Available-for-sale Securities"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r343",
      "r349"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BankTimeDepositsMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Certificates of deposit (CD) or savings accounts with a fixed term or understanding the customer can only withdraw by giving advanced notice with a bank or other financial institution. A CD is a short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest.",
        "label": "Bank Time Deposits [Member]",
        "terseLabel": "Time deposits(1)"
       }
      }
     },
     "localname": "BankTimeDepositsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r321",
      "r322",
      "r324"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business acquisition cost"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r120",
      "r326"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Reversal of contingent consideration",
        "terseLabel": "Contingent consideration reversal"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r320",
      "r323",
      "r325"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration",
        "verboseLabel": "Business Combination, Contingent Consideration, Liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investments in debt and equity securities, including, but not limited to, held-to-maturity, trading and available-for-sale expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Marketable Securities",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed before one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities",
        "terseLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r318"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as reported on the statement of financial position (balance sheet).",
        "label": "Reported Value Measurement [Member]",
        "verboseLabel": "Carrying Amount"
       }
      }
     },
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r10",
      "r43",
      "r123"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and Cash Equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Cash and Cash Equivalents [Line Items]",
        "terseLabel": "Cash and Cash Equivalents [Line Items]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r124",
      "r129"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents, Policy"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r43"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "terseLabel": "Total cash, cash equivalents and current marketable securities, Carrying Amount"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r117",
      "r123",
      "r128"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and Cash equivalents, end of period",
        "periodStartLabel": "Cash and Cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r117",
      "r387"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Decrease in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging",
        "verboseLabel": "Cash Flow Hedging [Member]"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.",
        "label": "Cash [Member]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CollateralAlreadyPostedAggregateFairValue": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate fair value of assets that are already posted, at the end of the reporting period, as collateral for derivative instruments with credit-risk-related contingent features.",
        "label": "Collateral Already Posted, Aggregate Fair Value",
        "terseLabel": "Collateral Already Posted, Aggregate Fair Value"
       }
      }
     },
     "localname": "CollateralAlreadyPostedAggregateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial Paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r58",
      "r248",
      "r410",
      "r428"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and Contingencies (Note 11)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "auth_ref": [
      "r267"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "terseLabel": "Cash dividends paid (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareCashPaid",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquityParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock Issued Amount",
        "verboseLabel": "Common Stock, Par Value $1.00"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "verboseLabel": "Common stock, par value per share"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "verboseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r29"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "verboseLabel": "Common stock, shares issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "verboseLabel": "Common stock \u2014 par value $1.00 per share (authorized 4,320,000,000 shares; issued 3,119,843,000 shares)"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Retirement Benefits [Abstract]",
        "terseLabel": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r88",
      "r90",
      "r91"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r105"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "verboseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncome"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertibleDebtMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.",
        "label": "Convertible Debt [Member]",
        "terseLabel": "Convertible Debt"
       }
      }
     },
     "localname": "ConvertibleDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r279",
      "r300",
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate debt securities(1)"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r167"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate, Non-Segment"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Cost of products sold"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of products sold",
        "verboseLabel": "Cost of Sales [Member]"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CrossCurrencyInterestRateContractMember": {
     "auth_ref": [
      "r279",
      "r359"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to interest rates and foreign exchange rates.",
        "label": "Cross Currency Interest Rate Contract [Member]",
        "terseLabel": "Cross Currency Interest Rate Contract",
        "verboseLabel": "Cross currency interest rate swaps"
       }
      }
     },
     "localname": "CrossCurrencyInterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r22",
      "r24",
      "r25",
      "r402",
      "r404",
      "r419"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate (as a percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Long-term Debt, Type"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTerm": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Debt Instrument, Term",
        "terseLabel": "Term"
       }
      }
     },
     "localname": "DebtInstrumentTerm",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Available-for-sale and Held-to-maturity [Abstract]",
        "terseLabel": "Debt Securities, Available-for-sale and Held-to-maturity [Abstract]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAndHeldToMaturityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Schedule of Available for Sale Securities Maturities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r310"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred taxes on income (Note 5)"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r130",
      "r312",
      "r313"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "verboseLabel": "Deferred tax provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r305",
      "r310"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "verboseLabel": "Deferred taxes on income (Note 5)"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Defined Benefit Plan [Abstract]",
        "verboseLabel": "Components of net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPensionPlansAndDefinedBenefitPostretirementPlansDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfGainsLosses": {
     "auth_ref": [
      "r285",
      "r297",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Gain (Loss)",
        "negatedLabel": "Recognized actuarial losses"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfGainsLosses",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": {
     "auth_ref": [
      "r286",
      "r298",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.",
        "label": "Defined Benefit Plan, Amortization of Prior Service Cost (Credit)",
        "verboseLabel": "Amortization of prior service cost/(credit)"
       }
      }
     },
     "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Defined Benefit Plan Disclosure [Line Items]",
        "terseLabel": "Defined Benefit Plan Disclosure [Line Items]"
       }
      }
     },
     "localname": "DefinedBenefitPlanDisclosureLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": {
     "auth_ref": [
      "r284",
      "r296",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.",
        "label": "Defined Benefit Plan, Expected Return (Loss) on Plan Assets",
        "negatedLabel": "Expected return on plan assets"
       }
      }
     },
     "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanInterestCost": {
     "auth_ref": [
      "r278",
      "r283",
      "r295",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.",
        "label": "Defined Benefit Plan, Interest Cost",
        "verboseLabel": "Interest cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanInterestCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": {
     "auth_ref": [
      "r281",
      "r293",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)",
        "totalLabel": "Net periodic benefit cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanNetPeriodicBenefitCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1": {
     "auth_ref": [
      "r287",
      "r299"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in net periodic benefit (cost) credit from settlement and curtailment.",
        "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement and Curtailment",
        "negatedLabel": "Curtailments and settlements"
       }
      }
     },
     "localname": "DefinedBenefitPlanRecognizedNetGainLossDueToSettlementsAndCurtailments1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedBenefitPlanServiceCost": {
     "auth_ref": [
      "r277",
      "r282",
      "r294",
      "r300"
     ],
     "calculation": {
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cost for actuarial present value of benefits attributed to service rendered by employee for defined benefit plan.",
        "label": "Defined Benefit Plan, Service Cost",
        "verboseLabel": "Service cost"
       }
      }
     },
     "localname": "DefinedBenefitPlanServiceCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r121",
      "r161"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "verboseLabel": "Depreciation and amortization of property and intangibles"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetFairValueGrossLiability": {
     "auth_ref": [
      "r64",
      "r68",
      "r346"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of liability associated with financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Asset, Fair Value, Gross Liability",
        "negatedTerseLabel": "Credit Support Agreement (CSA)"
       }
      }
     },
     "localname": "DerivativeAssetFairValueGrossLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssets": {
     "auth_ref": [
      "r65",
      "r66",
      "r383"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset",
        "totalLabel": "Total Net Asset"
       }
      }
     },
     "localname": "DerivativeAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeAssetsNoncurrent": {
     "auth_ref": [
      "r65"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Asset, Noncurrent",
        "terseLabel": "Derivative Assets, Noncurrent",
        "verboseLabel": "Derivative Asset, Noncurrent"
       }
      }
     },
     "localname": "DerivativeAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeExcludedComponentGainLossRecognizedInEarnings": {
     "auth_ref": [
      "r352",
      "r368"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from excluded component of derivative hedge, recognized in earnings. Excludes recognition under systematic and rational method.",
        "label": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings",
        "terseLabel": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net",
        "verboseLabel": "Derivative, Excluded Component, Gain (Loss), Recognized in Earnings"
       }
      }
     },
     "localname": "DerivativeExcludedComponentGainLossRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r63",
      "r67",
      "r346",
      "r398"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Total Gross Assets"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "auth_ref": [
      "r63",
      "r67",
      "r346",
      "r398"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.",
        "label": "Derivative Liability, Fair Value, Gross Liability",
        "terseLabel": "Total Gross Liabilities"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Gain/(Loss) Recognized In Income on Derivative"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentDetailAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Derivative Instrument Detail [Abstract]",
        "verboseLabel": "Financial assets and liabilities at fair value"
       }
      }
     },
     "localname": "DerivativeInstrumentDetailAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r344",
      "r347",
      "r354",
      "r361"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r341",
      "r344",
      "r354"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r341",
      "r344",
      "r354",
      "r361",
      "r362",
      "r367",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred": {
     "auth_ref": [
      "r373"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The estimated value of gains (losses), net anticipated to be transferred in the future from accumulated other comprehensive income into earnings.",
        "label": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred",
        "terseLabel": "Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesAssetsAtFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative assets designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Assets, at Fair Value",
        "verboseLabel": "Derivatives designated as hedging instruments : Assets"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsInHedgesLiabilitiesAtFairValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate fair value of all derivative liabilities designated as hedging instruments. Includes instruments designated as cash flow hedges, fair value hedges, and hedges of net investments in foreign operations.",
        "label": "Derivative Instruments in Hedges, Liabilities, at Fair Value",
        "verboseLabel": "Derivatives designated as hedging instruments : Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsInHedgesLiabilitiesAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r65",
      "r66",
      "r383"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Carrying Amount of the Hedged Liability",
        "totalLabel": "Total Net Liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofDerivativesRecordedinConsolidatedBalanceSheetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityFairValueGrossAsset": {
     "auth_ref": [
      "r64",
      "r68",
      "r346"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DerivativeLiabilities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of asset associated with financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Liability, Fair Value, Gross Asset",
        "negatedTerseLabel": "Credit Support Agreement (CSA)"
       }
      }
     },
     "localname": "DerivativeLiabilityFairValueGrossAsset",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r336",
      "r338"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative, Notional Amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r134",
      "r335",
      "r337",
      "r338",
      "r341",
      "r342",
      "r350",
      "r354",
      "r365",
      "r366",
      "r370"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesFairValueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivatives, Fair Value [Line Items]",
        "terseLabel": "Derivatives, Fair Value [Line Items]"
       }
      }
     },
     "localname": "DerivativesFairValueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DescriptionOfReclassificationOfCashFlowHedgeGainLoss": {
     "auth_ref": [
      "r371"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the transactions or other events that will result in the reclassification into earnings of gains or losses reported in accumulated other comprehensive income. May include the time period over which gains or losses will be reclassified to earnings.",
        "label": "Description of Reclassification of Cash Flow Hedge Gain (Loss)",
        "verboseLabel": "Reclassification of foreign exchange contracts into earnings, period"
       }
      }
     },
     "localname": "DescriptionOfReclassificationOfCashFlowHedgeGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember": {
     "auth_ref": [
      "r3",
      "r4",
      "r5"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale or disposed of by sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale or Disposed of by Sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale or Disposed of by Sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldForSaleOrDisposedOfBySaleMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of currency on hand, demand deposits with banks or financial institutions, and  other kinds of accounts that have the general characteristics of demand deposits, held by a disposal group.",
        "label": "Disposal Group, Including Discontinued Operation, Cash",
        "terseLabel": "Disposal group consideration, cash"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal group consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationInventoryCurrent": {
     "auth_ref": [
      "r1",
      "r2",
      "r7",
      "r224",
      "r229"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount classified as inventory attributable to disposal group, expected to be disposed of within one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Inventory, Current",
        "terseLabel": "Assets held for sale, current"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationInventoryCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedTerseLabel": "Cash dividends paid"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]",
        "verboseLabel": "NET EARNINGS PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r136",
      "r140",
      "r143",
      "r144",
      "r145",
      "r148",
      "r412",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (per share)",
        "verboseLabel": "Basic net earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r136",
      "r140",
      "r143",
      "r144",
      "r145",
      "r148",
      "r412",
      "r431"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted net earnings per share",
        "verboseLabel": "Diluted (per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "verboseLabel": "Reconciliation of basic net earnings per share to diluted net earnings per share"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r149"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "verboseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r387"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "verboseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r133",
      "r306",
      "r307"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Worldwide effective income tax rate (as a percent)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "verboseLabel": "Accrued compensation and employee related obligations"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r409",
      "r429"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Employee-related Liabilities",
        "verboseLabel": "Employee related obligations (Note 6)"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeSeveranceMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.",
        "label": "Employee Severance [Member]",
        "terseLabel": "Employee Severance"
       }
      }
     },
     "localname": "EmployeeSeveranceMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityFairValueAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of addition (reduction) to the amount at which an instrument classified in shareholders' equity could be incurred (settled) in a current transaction between willing parties.",
        "label": "Equity, Fair Value Adjustment",
        "terseLabel": "Changes in Fair Value Reflected in Net Income"
       }
      }
     },
     "localname": "EquityFairValueAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value portion of investments accounted under the equity method.",
        "label": "Equity Method Investments, Fair Value Disclosure",
        "terseLabel": "Fair value of previously held equity investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesFvNi": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Equity Securities, FV-NI",
        "terseLabel": "Available-for-sale Securities, Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesFvNi",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquitySecuritiesMember": {
     "auth_ref": [
      "r18",
      "r23",
      "r191",
      "r407",
      "r420",
      "r440"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.",
        "label": "Equity Securities [Member]",
        "terseLabel": "Equity Securities"
       }
      }
     },
     "localname": "EquitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "auth_ref": [
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in equity security without readily determinable fair value.",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "periodEndLabel": "Carrying value, end of period",
        "periodStartLabel": "Carrying value, beginning of period",
        "terseLabel": "Equity Securities without Readily Determinable Fair Value, Amount"
       }
      }
     },
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured as an estimate of fair value.",
        "label": "Estimate of Fair Value Measurement [Member]",
        "terseLabel": "Estimated Fair Value"
       }
      }
     },
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r376"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class [Domain]"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r374",
      "r379"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class [Axis]"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r374",
      "r384",
      "r385"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "auth_ref": [
      "r374",
      "r384"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "verboseLabel": "Financial Liabilities not Measured at Fair Value"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r394"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "verboseLabel": "Fair Value, Hierarchy"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "auth_ref": [
      "r374",
      "r380"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by measurement basis.",
        "label": "Measurement Basis [Axis]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping, Disclosure Item Amounts"
       }
      }
     },
     "localname": "FairValueByMeasurementBasisAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value.",
        "label": "Fair Value Measurement [Domain]",
        "terseLabel": "Fair Value Measurement [Domain]"
       }
      }
     },
     "localname": "FairValueDisclosureItemAmountsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "verboseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging",
        "verboseLabel": "Fair Value Hedging [Member]"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r395"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "verboseLabel": "Quoted prices in active markets for identical assets and liabilities Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r396"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "verboseLabel": "Significant other observable inputs Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r279",
      "r280",
      "r300",
      "r375",
      "r397"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "verboseLabel": "Significant unobservable inputs Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r377"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "negatedTerseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r376"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Beginning Balance",
        "periodStartLabel": "Ending Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r343",
      "r350",
      "r367"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "terseLabel": "Financial Liabilities"
       }
      }
     },
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Finite-Lived Intangible Assets, Weighted-Average Useful Life"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "verboseLabel": "Less accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Next Twelve Months",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.",
        "label": "Finite-lived Intangible Assets Amortization Expense [Table Text Block]",
        "terseLabel": "Intangible Asset Amortization Expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r218"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.",
        "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillIntangibleAssetAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r210",
      "r213",
      "r216",
      "r220",
      "r399"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r216",
      "r399"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "verboseLabel": "Finite-Lived Intangible Assets, Gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r210",
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r216"
     ],
     "calculation": {
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Finite-Lived Intangible Assets, Net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "verboseLabel": "Intangible assets with definite lives:"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative assets not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Asset at Fair Value",
        "verboseLabel": "Derivatives not designated as hedging instruments : Assets"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of all foreign currency derivative liabilities not designated as hedging instruments.",
        "label": "Foreign Currency Derivative Instruments Not Designated as Hedging Instruments, Liability at Fair Value",
        "verboseLabel": "Derivatives not designated as hedging instruments : Liabilities"
       }
      }
     },
     "localname": "ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyExchangeRateTranslation1": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.",
        "label": "Foreign Currency Exchange Rate, Translation",
        "terseLabel": "Foreign exchange rate"
       }
      }
     },
     "localname": "ForeignCurrencyExchangeRateTranslation1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r279",
      "r358"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "verboseLabel": "Forward foreign exchange contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignPlanMember": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan, designed to provide retirement benefits, not determined as principal place of business. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Foreign Plan [Member]",
        "verboseLabel": "International retirement plans"
       }
      }
     },
     "localname": "ForeignPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r121",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "terseLabel": "Gain from divestiture of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfEquityInvestments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20% of the shares outstanding) and cannot exert significant influence.",
        "label": "Gain (Loss) on Sale of Equity Investments",
        "terseLabel": "Gain on sale of equity investments"
       }
      }
     },
     "localname": "GainLossOnSaleOfEquityInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSalesOfAssetsAndAssetImpairmentCharges": {
     "auth_ref": [
      "r121"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of gain (loss) from the difference between the sale price or salvage price and the book value of an asset that was sold or retired, and gain (loss) from the write down of assets from their carrying value to fair value.",
        "label": "Gain (Loss) on Sale of Assets and Asset Impairment Charges",
        "negatedTerseLabel": "Net gain on sale of assets/businesses"
       }
      }
     },
     "localname": "GainLossOnSalesOfAssetsAndAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r202",
      "r203"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill End of Period",
        "periodStartLabel": "Goodwill Beginning of Period",
        "terseLabel": "Goodwill (Note 3)",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r204"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill, related to acquisitions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r221"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "verboseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillOtherIncreaseDecrease": {
     "auth_ref": [
      "r205"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease), classified as other, of an asset representing the future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Other Increase (Decrease)",
        "terseLabel": "Currency translation/Other"
       }
      }
     },
     "localname": "GoodwillOtherIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r100"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r341",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_HeldToMaturitySecurities": {
     "auth_ref": [
      "r174",
      "r184"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity",
        "totalLabel": "Held-to-maturity Securities - Carrying Amount"
       }
      }
     },
     "localname": "HeldToMaturitySecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain": {
     "auth_ref": [
      "r186"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrecognized gain on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Gain",
        "terseLabel": "Held-to-maturity Securities, Unrecognized Gain"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss": {
     "auth_ref": [
      "r187"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of accumulated unrealized loss on investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Accumulated Unrecognized Loss",
        "negatedLabel": "Held-to-maturity Securities, Unrecognized Loss"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesClassifiedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Debt Securities, Held-to-maturity [Abstract]",
        "terseLabel": "Debt Securities, Held-to-maturity [Abstract]"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesClassifiedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HeldToMaturitySecuritiesFairValue": {
     "auth_ref": [
      "r185"
     ],
     "calculation": {
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_HeldToMaturitySecurities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at amortized cost (held-to-maturity).",
        "label": "Debt Securities, Held-to-maturity, Fair Value",
        "terseLabel": "Held-to-maturity Securities - Estimated Fair Value"
       }
      }
     },
     "localname": "HeldToMaturitySecuritiesFairValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HeldtomaturitySecuritiesMember": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Investments in debt securities classified as held-to-maturity.",
        "label": "Held-to-maturity Securities [Member]",
        "terseLabel": "Held-to-maturity Securities"
       }
      }
     },
     "localname": "HeldtomaturitySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r132"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "terseLabel": "Earnings before provision for taxes on income",
        "totalLabel": "Earnings before provision for taxes on income"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]",
        "verboseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]",
        "verboseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails",
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "verboseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r130",
      "r162",
      "r314"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for taxes on income"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "verboseLabel": "Decrease in accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Increase in accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Increase in inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "verboseLabel": "Changes in assets and liabilities, net of effects from acquisitions and divestitures:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Increase in other current and non-current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Decrease in other current and non-current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToConversionOfDebtSecurities": {
     "auth_ref": [
      "r142",
      "r147"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible debt securities using the if-converted method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities",
        "verboseLabel": "Convertible debt shares"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToConversionOfDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r141",
      "r147"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Potential shares exercisable under stock option plans"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r212",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "verboseLabel": "Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "verboseLabel": "Intangible assets with indefinite lives:"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r212",
      "r219"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Debt Security Category [Axis]",
        "terseLabel": "Debt Security Category [Axis]"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r208",
      "r214"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Total intangible assets - net",
        "verboseLabel": "Intangible assets, net (Note 3)"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "verboseLabel": "Intangible assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r94",
      "r160",
      "r391",
      "r392",
      "r413"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "terseLabel": "Interest expense, net of portion capitalized"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateContractMember": {
     "auth_ref": [
      "r279",
      "r357"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.",
        "label": "Interest Rate Contract [Member]",
        "terseLabel": "Interest Rate Contract"
       }
      }
     },
     "localname": "InterestRateContractMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InternalRevenueServiceIRSMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Designated tax department of the United States of America government entitled to levy and collect income taxes from the entity.",
        "label": "Internal Revenue Service (IRS) [Member]",
        "terseLabel": "Internal Revenue Service (IRS) [Member]"
       }
      }
     },
     "localname": "InternalRevenueServiceIRSMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Inventories"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r34",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "verboseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r11",
      "r61",
      "r199"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "totalLabel": "Total inventories",
        "verboseLabel": "Inventories (Note 2)"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": {
     "auth_ref": [
      "r36",
      "r37",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.",
        "label": "Inventory, Raw Materials and Supplies, Net of Reserves",
        "verboseLabel": "Raw materials and supplies"
       }
      }
     },
     "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r35",
      "r200"
     ],
     "calculation": {
      "http://www.jnj.com/role/InventoriesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "verboseLabel": "Goods in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r103",
      "r159"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "negatedTerseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r436",
      "r437",
      "r438",
      "r439"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_JudicialRulingMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Litigation outcome that occurs as a result of judicial intervention, supervision, or approval.",
        "label": "Judicial Ruling [Member]",
        "terseLabel": "Judicial Ruling"
       }
      }
     },
     "localname": "JudicialRulingMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.",
        "label": "Legal Matters and Contingencies [Text Block]",
        "verboseLabel": "Legal Proceedings"
       }
      }
     },
     "localname": "LegalMattersAndContingenciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedings"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r32",
      "r405",
      "r426"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "verboseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "verboseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityAxis": {
     "auth_ref": [
      "r49",
      "r131"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.",
        "label": "Lender Name [Axis]",
        "terseLabel": "Lender Name [Axis]"
       }
      }
     },
     "localname": "LineOfCreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLenderDomain": {
     "auth_ref": [
      "r49"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.",
        "label": "Line of Credit Facility, Lender [Domain]",
        "terseLabel": "Line of Credit Facility, Lender [Domain]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLenderDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r49"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LitigationSettlementExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of litigation expense, including but not limited to legal, forensic, accounting, and investigative fees.",
        "label": "Litigation Settlement, Expense",
        "terseLabel": "Litigation expense"
       }
      }
     },
     "localname": "LitigationSettlementExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r25",
      "r265",
      "r404",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Non-Current Debt",
        "verboseLabel": "Long-term debt (Note 4)"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Long-term Debt, Excluding Current Maturities [Abstract]",
        "terseLabel": "Non-Current Debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r56"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r56",
      "r263"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate on non-current debt"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r248",
      "r249",
      "r250",
      "r253",
      "r254",
      "r255",
      "r258",
      "r260",
      "r261"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "verboseLabel": "Product Liability Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesAwardedValue": {
     "auth_ref": [
      "r248",
      "r251",
      "r256"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of damages awarded to the plaintiff in the legal matter.",
        "label": "Loss Contingency, Damages Awarded, Value",
        "terseLabel": "Damages awarded"
       }
      }
     },
     "localname": "LossContingencyDamagesAwardedValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyEstimateOfPossibleLoss": {
     "auth_ref": [
      "r252",
      "r257",
      "r260"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.",
        "label": "Loss Contingency, Estimate of Possible Loss",
        "terseLabel": "Loss Contingency, Estimate of Possible Loss"
       }
      }
     },
     "localname": "LossContingencyEstimateOfPossibleLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesCurrent": {
     "auth_ref": [
      "r13",
      "r52"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as current.",
        "label": "Marketable Securities, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "MarketableSecuritiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MarketableSecuritiesNoncurrent": {
     "auth_ref": [
      "r44"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of investment in marketable security, classified as noncurrent.",
        "label": "Marketable Securities, Noncurrent",
        "periodEndLabel": "Carrying value, end of period",
        "periodStartLabel": "Carrying value, beginning of period"
       }
      }
     },
     "localname": "MarketableSecuritiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MaximumLengthOfTimeForeignCurrencyCashFlowHedge": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Maximum period of time the entity is hedging its exposure to variability in future cash flows for forecasted transactions, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Excludes forecasted transactions related to payment of variable interest on existing financial instruments.",
        "label": "Maximum Length of Time, Foreign Currency Cash Flow Hedge",
        "terseLabel": "Maximum length of time for hedge exposure"
       }
      }
     },
     "localname": "MaximumLengthOfTimeForeignCurrencyCashFlowHedge",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r9",
      "r327"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "verboseLabel": "Business Combinations and Divestitures"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestitures"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "NET CASH USED BY FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "NET CASH USED BY INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r117",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "NET CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "CASH FLOWS FROM OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r86",
      "r89",
      "r96",
      "r122",
      "r147",
      "r411",
      "r430"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "netLabel": "Net earnings",
        "terseLabel": "Net earnings",
        "totalLabel": "NET EARNINGS"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.",
        "label": "New Accounting Pronouncements and Changes in Accounting Principles [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "NewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards Recently Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "verboseLabel": "International"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net book value of a nonmonetary asset transferred or exchanged in connection with the acquisition of a business or asset in a noncash transaction. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. Nonmonetary assets and liabilities are assets and liabilities that will not result in cash receipts or cash payments in the future.",
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed)",
        "totalLabel": "Net cash paid for acquisitions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed) [Abstract]",
        "verboseLabel": "Acquisitions"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired",
        "verboseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1": {
     "auth_ref": [
      "r125",
      "r126",
      "r127"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The total amount of [all] liabilities that an Entity assumes in acquiring a business or in consideration for an asset received in a noncash (or part noncash) acquisition. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Noncash or Part Noncash Acquisition, Value of Liabilities Assumed",
        "negatedLabel": "Fair value of liabilities assumed and noncontrolling interests"
       }
      }
     },
     "localname": "NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Not Designated as Hedging Instrument"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofDerivativesnotDesignatedasHedgingInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "verboseLabel": "Total Segment Operating Income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r158",
      "r166"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Non Current Other Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Securities:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent [Abstract]",
        "terseLabel": "Employee benefit plans:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent [Abstract]",
        "terseLabel": "Derivatives &amp; hedges:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r69",
      "r79",
      "r386",
      "r388",
      "r389"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Foreign currency translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r74",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax",
        "totalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Derivatives &amp; Hedges"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r71",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Unrealized gain (loss) arising during period",
        "verboseLabel": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "auth_ref": [
      "r79",
      "r83"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "negatedTerseLabel": "Reclassifications to earnings",
        "verboseLabel": "Gain/ (Loss) reclassified from Accumulated OCI into income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax": {
     "auth_ref": [
      "r72",
      "r79",
      "r351",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and before adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments, after Tax",
        "verboseLabel": "Unrealized gain (loss) arising during period"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax": {
     "auth_ref": [
      "r72",
      "r79",
      "r351",
      "r356",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, before tax and adjustments, of gain (loss) from increase (decrease) in value of excluded component of derivative designated and qualifying as hedge. Adjustments include, but are not limited to, reclassifications for sale and settlement, and amounts recognized under systematic and rational method.",
        "label": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax",
        "terseLabel": "Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), before Adjustments and Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": {
     "auth_ref": [
      "r69",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r87",
      "r90",
      "r92",
      "r266"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Net change",
        "totalLabel": "Other comprehensive income (loss)",
        "verboseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss), net of tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": {
     "auth_ref": [
      "r77",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax",
        "negatedTotalLabel": "Net change"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax": {
     "auth_ref": [
      "r77",
      "r80",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, after reclassification adjustment, of tax (expense) benefit for (increase) decrease in accumulated other comprehensive income of defined benefit plan.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax",
        "terseLabel": "Employee Benefit Plans"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax": {
     "auth_ref": [
      "r79",
      "r83",
      "r84",
      "r190"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax",
        "negatedTerseLabel": "Reclassifications to earnings"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "auth_ref": [
      "r73",
      "r79"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax",
        "terseLabel": "Unrealized holding gain (loss) arising during period",
        "verboseLabel": "Unrealized gains on equity investments"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax": {
     "auth_ref": [
      "r74",
      "r80"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of tax expense (benefit) before reclassification adjustments of unrealized holding gain (loss) on available-for-sale securities.",
        "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax",
        "terseLabel": "Securities"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current liabilities.",
        "label": "Other Current Liabilities [Member]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIncomeMember": {
     "auth_ref": [
      "r363"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other revenue.",
        "label": "Other Income [Member]",
        "terseLabel": "Other Income"
       }
      }
     },
     "localname": "OtherIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "verboseLabel": "Customer relationships and other intangible assets"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableAxis": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Group of items that represent other investments not readily marketable, including description of investment, fair value, and value as measured by quoted value method.",
        "label": "Other Investment Not Readily Marketable [Axis]",
        "terseLabel": "Other Investment Not Readily Marketable [Axis]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Investment Not Readily Marketable [Line Items]",
        "terseLabel": "Other Investment Not Readily Marketable [Line Items]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableNameDomain": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Name of the investment category or actual investment title.",
        "label": "Other Investment Not Readily Marketable, Name [Domain]",
        "terseLabel": "Other Investment Not Readily Marketable, Name [Domain]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInvestmentNotReadilyMarketableTable": {
     "auth_ref": [
      "r400"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Description of the information about other investments not readily marketable, including, but not limited to, description of investment, fair value and value as measured by quoted price.",
        "label": "Other Investment Not Readily Marketable [Table]",
        "terseLabel": "Other Investment Not Readily Marketable [Table]"
       }
      }
     },
     "localname": "OtherInvestmentNotReadilyMarketableTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofActivityRelatedtoEquityInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other (income) expense, net",
        "terseLabel": "Other (income) expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": {
     "auth_ref": [
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.",
        "label": "Other Postretirement Benefits Plan [Member]",
        "verboseLabel": "Other Benefit Plans"
       }
      }
     },
     "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherRestructuringMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Restructuring and related activities classified as other.",
        "label": "Other Restructuring [Member]",
        "terseLabel": "Other Restructuring"
       }
      }
     },
     "localname": "OtherRestructuringMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r188"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r107",
      "r110",
      "r135"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Other (primarily licenses and milestones)"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRestructuring": {
     "auth_ref": [
      "r116",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.",
        "label": "Payments for Restructuring",
        "negatedTerseLabel": "Payments for Restructuring"
       }
      }
     },
     "localname": "PaymentsForRestructuring",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfOrdinaryDividends": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings.",
        "label": "Payments of Ordinary Dividends",
        "negatedLabel": "Dividends to shareholders"
       }
      }
     },
     "localname": "PaymentsOfOrdinaryDividends",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Acquisitions, net of cash acquired",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Additions to property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for pension and other postretirement benefits.",
        "label": "Pension and Other Postretirement Benefits Disclosure [Text Block]",
        "terseLabel": "Pensions and Other Benefit Plans"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlans"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PensionContributions": {
     "auth_ref": [
      "r118"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.",
        "label": "Payment for Pension Benefits",
        "terseLabel": "Contribution to pension plans"
       }
      }
     },
     "localname": "PensionContributions",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionPlansDefinedBenefitMember": {
     "auth_ref": [
      "r275",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.",
        "label": "Pension Plan [Member]",
        "verboseLabel": "Retirement Plans"
       }
      }
     },
     "localname": "PensionPlansDefinedBenefitMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Measured at fair value for financial reporting purposes.",
        "label": "Portion at Fair Value Measurement [Member]",
        "terseLabel": "Portion at Fair Value Measurement [Member]"
       }
      }
     },
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r14",
      "r41",
      "r42"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "verboseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassifications that affects the comparability of the financial statements.",
        "label": "Reclassification, Policy [Policy Text Block]",
        "terseLabel": "Reclassification"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r112",
      "r115",
      "r135"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.",
        "label": "Proceeds from Sale, Maturity and Collection of Investments",
        "verboseLabel": "Sales of investments"
       }
      }
     },
     "localname": "ProceedsFromSaleMaturityAndCollectionsOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfProductiveAssets": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Proceeds from Sale of Productive Assets",
        "verboseLabel": "Proceeds from the disposal of assets/businesses, net"
       }
      }
     },
     "localname": "ProceedsFromSaleOfProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromShortTermDebt": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash inflow from a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Proceeds from Short-term Debt",
        "verboseLabel": "Proceeds from short-term debt"
       }
      }
     },
     "localname": "ProceedsFromShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r45",
      "r225"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r19",
      "r20",
      "r227",
      "r427"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r98",
      "r196"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "verboseLabel": "Credit losses and accounts receivable allowances"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]",
        "terseLabel": "AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTaxAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfShortTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.",
        "label": "Repayments of Short-term Debt",
        "negatedLabel": "Repayment of short-term debt"
       }
      }
     },
     "localname": "RepaymentsOfShortTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r303",
      "r443"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost": {
     "auth_ref": [
      "r303"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.",
        "label": "Research and Development Expense (Excluding Acquired in Process Cost)",
        "terseLabel": "Research and development expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development Expense",
        "verboseLabel": "Research and Development Expense [Member]"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentInProcess": {
     "auth_ref": [],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.",
        "label": "Research and Development in Process",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentInProcess",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Restructuring and Related Activities [Abstract]",
        "terseLabel": "Restructuring and Related Activities [Abstract]"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostCostIncurredToDate1": {
     "auth_ref": [
      "r232",
      "r235",
      "r242",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of costs incurred to date for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Cost Incurred to Date",
        "terseLabel": "Restructuring charges recorded to date"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostCostIncurredToDate1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r232",
      "r235",
      "r242",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring estimated cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r121",
      "r231",
      "r238",
      "r244"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring (Note 12)",
        "verboseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringChargesMember": {
     "auth_ref": [
      "r234",
      "r238",
      "r245"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about restructuring charges have been included.",
        "label": "Restructuring Charges [Member]",
        "terseLabel": "Restructuring Charges"
       }
      }
     },
     "localname": "RestructuringChargesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCostAndReserveAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of restructuring cost.",
        "label": "Restructuring Type [Axis]",
        "terseLabel": "Restructuring Type [Axis]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Restructuring Cost and Reserve [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Restructuring Plan [Domain]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringReserve": {
     "auth_ref": [
      "r233",
      "r240"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.",
        "label": "Restructuring Reserve",
        "periodEndLabel": "Reserve balance ending",
        "periodStartLabel": "Reserve balance beginning"
       }
      }
     },
     "localname": "RestructuringReserve",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringReserveRollForward": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Restructuring Reserve [Roll Forward]",
        "terseLabel": "Restructuring Reserve [Roll Forward]"
       }
      }
     },
     "localname": "RestructuringReserveRollForward",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringReserveSettledWithoutCash2": {
     "auth_ref": [
      "r231",
      "r239"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.",
        "label": "Restructuring Reserve, Settled without Cash",
        "negatedTerseLabel": "Restructuring Reserve, Settled without Cash"
       }
      }
     },
     "localname": "RestructuringReserveSettledWithoutCash2",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r31",
      "r267",
      "r425"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "verboseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationAxis": {
     "auth_ref": [
      "r290",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Axis]",
        "terseLabel": "Retirement Plan Sponsor Location [Axis]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanSponsorLocationDomain": {
     "auth_ref": [
      "r290",
      "r292"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Location of employer sponsoring plan designed to provide retirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans.",
        "label": "Retirement Plan Sponsor Location [Domain]",
        "terseLabel": "Retirement Plan Sponsor Location [Domain]"
       }
      }
     },
     "localname": "RetirementPlanSponsorLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetirementPlanTypeAxis": {
     "auth_ref": [
      "r275",
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Axis]",
        "terseLabel": "Retirement Plan Type [Axis]"
       }
      }
     },
     "localname": "RetirementPlanTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RetirementPlanTypeDomain": {
     "auth_ref": [
      "r275",
      "r276",
      "r289",
      "r290",
      "r301"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.",
        "label": "Retirement Plan Type [Domain]",
        "terseLabel": "Retirement Plan Type [Domain]"
       }
      }
     },
     "localname": "RetirementPlanTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r270",
      "r271"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "netLabel": "Sales",
        "terseLabel": "Sales to customers",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedPerTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.",
        "label": "Sale of Stock, Consideration Received Per Transaction",
        "terseLabel": "Gross proceeds on sale"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedPerTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Percentage ownership after transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company before stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership before Transaction",
        "terseLabel": "Percentage ownership before transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipBeforeTransaction",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sales price per share (in CHF per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SaleOfSubsidiaryGainLossMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption in which reported facts about gain (loss) from sale of equity interest in subsidiary have been included.",
        "label": "Sale of Subsidiary Gain (Loss) [Member]",
        "terseLabel": "Sale of Subsidiary Gain (Loss)"
       }
      }
     },
     "localname": "SaleOfSubsidiaryGainLossMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsScheduleofEffectofNetInvestmentHedgesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SalesMember": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business.",
        "label": "Sales [Member]",
        "terseLabel": "Sales [Member]",
        "verboseLabel": "Sales to customers"
       }
      }
     },
     "localname": "SalesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.jnj.com/role/FairValueMeasurementsSummaryofDerivativeActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r82"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Components of Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.",
        "label": "Schedule of Available-for-sale Securities Reconciliation [Table Text Block]",
        "terseLabel": "Summary of Activity Related to Equity Investments"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r316",
      "r317"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of cash and cash equivalent balances. This table excludes restricted cash balances.",
        "label": "Schedule of Cash and Cash Equivalents [Table]",
        "terseLabel": "Schedule of Cash and Cash Equivalents [Table]"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash, cash equivalents, and investments.",
        "label": "Cash, Cash Equivalents and Investments [Table Text Block]",
        "terseLabel": "Marketable Securities"
       }
      }
     },
     "localname": "ScheduleOfCashCashEquivalentsAndShortTermInvestmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": {
     "auth_ref": [
      "r289",
      "r290",
      "r291",
      "r292",
      "r300"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans.  Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Defined Benefit Plans Disclosures [Table]",
        "terseLabel": "Schedule of Defined Benefit Plans Disclosures [Table]"
       }
      }
     },
     "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansComponentsofNetPeriodicBenefitCostDetails",
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r344",
      "r354",
      "r362"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "verboseLabel": "Summary of Derivative Activity"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "verboseLabel": "Financial Assets and Liabilities at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative liabilities at fair value.",
        "label": "Schedule of Derivative Liabilities at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivatives Recorded in Consolidated Balance Sheet"
       }
      }
     },
     "localname": "ScheduleOfDerivativeLiabilitiesAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r147"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "verboseLabel": "Reconciliation of Basic Net Earnings per Share to Diluted Net Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/EarningsPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r210",
      "r215"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets by Major Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r206",
      "r207"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r16",
      "r38",
      "r39",
      "r40"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "verboseLabel": "Summary of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/InventoriesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNetBenefitCostsTableTextBlock": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the components of net benefit costs for pension plans and/or other employee benefit plans including service cost, interest cost, expected return on plan assets, gain (loss), prior service cost or credit, transition asset or obligation, and gain (loss) recognized due to settlements or curtailments.",
        "label": "Schedule of Net Benefit Costs [Table Text Block]",
        "verboseLabel": "Components of Net Periodic Benefit Cost"
       }
      }
     },
     "localname": "ScheduleOfNetBenefitCostsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/PensionsandOtherBenefitPlansTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r353",
      "r355"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Effect of Derivatives not Designated as Hedging Instruments"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r236",
      "r237",
      "r241"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": {
     "auth_ref": [
      "r233",
      "r243"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.",
        "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]",
        "terseLabel": "Schedule of Restructuring Reserve"
       }
      }
     },
     "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": {
     "auth_ref": [
      "r99",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers and Long-Lived Assets, by Geographical Areas"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r93",
      "r95",
      "r169"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r157",
      "r163",
      "r164",
      "r165",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r157",
      "r163",
      "r164",
      "r165",
      "r206"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "verboseLabel": "Operating Profit by Segment of Business"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember": {
     "auth_ref": [
      "r408"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount of securities that an institution sells and agrees to repurchase at a specified date for a specified price, net of any reductions or offsets.",
        "label": "Securities Loaned or Sold under Agreements to Repurchase [Member]",
        "terseLabel": "U.S. reverse repurchase agreements"
       }
      }
     },
     "localname": "SecuritiesLoanedOrSoldUnderAgreementsToRepurchaseMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]",
        "verboseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r170"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "verboseLabel": "Segments of Business and Geographic Areas"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreas"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingInformationRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segment Reporting Information, Revenue for Reportable Segment [Abstract]",
        "verboseLabel": "Sales by segment of business"
       }
      }
     },
     "localname": "SegmentReportingInformationRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentsGeographicalAreasAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Segments, Geographical Areas [Abstract]",
        "verboseLabel": "Sales by geographic area"
       }
      }
     },
     "localname": "SegmentsGeographicalAreasAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasScheduleofRevenuefromExternalCustomersandLongLivedAssetsbyGeographicalAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r102",
      "r198"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, marketing and administrative expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SettledLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Agreement reached between parties in a litigation that occurs without judicial intervention, supervision or approval.",
        "label": "Settled Litigation [Member]",
        "terseLabel": "settled litigation"
       }
      }
     },
     "localname": "SettledLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/LegalProceedingsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermBorrowings": {
     "auth_ref": [
      "r21",
      "r402",
      "r423"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.",
        "label": "Short-term Debt",
        "terseLabel": "Current Debt",
        "verboseLabel": "Loans and notes payable"
       }
      }
     },
     "localname": "ShortTermBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/FairValueMeasurementsFinancialLiabilitiesnotMeasuredatFairValueDetails",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by type of short-term debt arrangement.",
        "label": "Short-term Debt, Type [Axis]",
        "terseLabel": "Short-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "ShortTermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShortTermDebtTypeDomain": {
     "auth_ref": [
      "r48"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.",
        "label": "Short-term Debt, Type [Domain]",
        "terseLabel": "Short-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "ShortTermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SovereignDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Debt security issued by foreign government (not within the country of domicile of the entity).",
        "label": "Sovereign Debt Securities [Member]",
        "terseLabel": "Non-U.S. sovereign securities(1)"
       }
      }
     },
     "localname": "SovereignDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r6",
      "r163",
      "r206",
      "r230",
      "r235",
      "r246",
      "r432"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]",
        "verboseLabel": "Statement, Business Segments"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails",
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillGoodwillBySegmentDetails",
      "http://www.jnj.com/role/LegalProceedingsDetails",
      "http://www.jnj.com/role/RestructuringNarrativeDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails",
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r60",
      "r266"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity",
      "http://www.jnj.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueTreasuryStockReissued": {
     "auth_ref": [
      "r28",
      "r29",
      "r266",
      "r267",
      "r268"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Value of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Value, Treasury Stock Reissued",
        "terseLabel": "Employee compensation and stock option plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders' equity:",
        "verboseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r328",
      "r329",
      "r334"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/AccumulatedOtherComprehensiveIncomeDetails",
      "http://www.jnj.com/role/ConsolidatedBalanceSheets",
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityOther": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.",
        "label": "Stockholders' Equity, Other",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "StockholdersEquityOther",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasSalesBySegmentOfBusinessDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/BusinessCombinationsandDivestituresNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TrademarksMember": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.",
        "label": "Trademarks [Member]",
        "terseLabel": "Trademarks"
       }
      }
     },
     "localname": "TrademarksMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IntangibleAssetsandGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r59",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock Amount"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r59",
      "r268"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "verboseLabel": "Treasury stock, shares"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r59",
      "r268",
      "r269"
     ],
     "calculation": {
      "http://www.jnj.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "verboseLabel": "Less: common stock held in treasury, at cost (487,466,000 and 487,336,000 shares)"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r266",
      "r267",
      "r268"
     ],
     "crdr": "debit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfRestructuringDomain": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Identification of the types of restructuring costs.",
        "label": "Type of Restructuring [Domain]",
        "terseLabel": "Type of Restructuring [Domain]"
       }
      }
     },
     "localname": "TypeOfRestructuringDomain",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/RestructuringScheduleofRestructuringReserveDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USTreasuryAndGovernmentMember": {
     "auth_ref": [
      "r279",
      "r406",
      "r435"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Treasury and Government [Member]",
        "terseLabel": "US Treasury and Government [Member]"
       }
      }
     },
     "localname": "USTreasuryAndGovernmentMember",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/FairValueMeasurementsCashCashEquivalentsandMarketableSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnSecurities": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrealized gain (loss) recognized in the income statement on unsold other securities.",
        "label": "Unrealized Gain (Loss) on Securities",
        "terseLabel": "Unrealized Gain (Loss) on Securities"
       }
      }
     },
     "localname": "UnrealizedGainLossOnSecurities",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SegmentsofBusinessandGeographicAreasOperatingProfitbySegmentofBusinessDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r304",
      "r309"
     ],
     "crdr": "credit",
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156"
     ],
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r139",
      "r145"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (shares)",
        "totalLabel": "Average shares outstanding \u2014 diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-US": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "verboseLabel": "AVG. SHARES OUTSTANDING"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r138",
      "r145"
     ],
     "calculation": {
      "http://www.jnj.com/role/EarningsPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-US": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (shares)",
        "verboseLabel": "Average shares outstanding \u2014 basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2019-01-31",
     "presentation": [
      "http://www.jnj.com/role/ConsolidatedStatementsofEarnings",
      "http://www.jnj.com/role/EarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1505-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1500-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=SL5780133-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(12))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27232-111563"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=SL6284393-111563"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=116654751&loc=SL75117539-209714"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=77912953&loc=d3e400-110220"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2473-110228"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.P.4)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(c))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "http://asc.fasb.org/topic&trid=2175745"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4852-112606"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "712",
   "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(j)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2410-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2417-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2439-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(4)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(5)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(7)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e2709-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e31931-109318"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116869197&loc=d3e4845-128472"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4590271-111686"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998890-113959"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CCC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(6)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624186-113959"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624258-113959"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=116861445&loc=SL5629052-113961"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061172-113977"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109974929&loc=SL110061190-113977"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80845-113994"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=99377092&loc=SL75136599-209740"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=d3e13220-108610"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13467-108611"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13476-108611"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118948100&loc=d3e30304-110892"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32022-110900"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=SL51823488-111719"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "820",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=35710923&loc=d3e45360-110995"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6)(a)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.13(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Subparagraph": "b.",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6477933&loc=d3e60009-112784"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.15(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=117420044&loc=d3e19393-158473"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12(2)(i))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12C(1)(a))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r444": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r445": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r446": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-13"
  },
  "r447": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1-"
  },
  "r448": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r449": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.2)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226003-175313"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(dd)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e640-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e689-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724391-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=118951672&loc=d3e1436-108581"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-03(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868656-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>89
<FILENAME>0000200406-20-000050-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000200406-20-000050-xbrl.zip
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MK?(,^Q.=93KIU1_]JDOQZ=^\<>\ G?P'4$L#!!0    ( (^ ^%#+WVR0Z0<
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MN3U'Q5H4$@8 EP("7'?&^1-RD[!8JIE9(*]D%<;M$^\T7*RLH<<L/'G@ZC<
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MC;;&*; ]%9&E78[<FUO6Y0;0M6D9'HZYCA80 6(%#X04^=Q*Z:9N[6IQ:')
M\4"_8[J6UCER_U .:%+H"8!JG/2'H=*1<\ E>&/*H.@2>$4)3>Q"L"9(7CTF
ML6#$1)+YALKM41F"+P=3+@O'*S9D%,=(L<04DVWNITH0[RVXT=]NSIL<]E 1
MU&9\:A:H(O]XQ]NP-U]:D\T[XT^G_RQ89+1N.9&? /CCH6,[^ :?;> 36;GU
M(7H8:IO#E,F/*UF'T0X,9I53A6&A;1S7E&K56*I,CAKVP Q-F!#URY,)?X:P
MLHP!/S#)/:/2.^P0R.U\[:8X*Y9>''L?$FZ6"FXYR,&5(D?.;M E<<ZQO[TE
M66Z#[]E7_ND\+)&YS='A[EN,KPIUN[Y=Z-38SEL0=R86+:!=63&&);!UP*W(
MPV)G!TV_F^_!*8YL+U?:+-73/4!+:2KRG.@A&0<*LFP?1P+>N+I'0".XSUAN
MQ?\VSUPL&/JC$'#6K9(B"]W6^'B;S<7_*;D=V<W$N42R J<%\,'AJ]W:A8(0
MS5+IEDG]C/BME2Z?O#CQ<FF7.SE;G$7LA)$R!?>[X0WLPB-4-+0DE_MX*G,T
M6&K[X@HH=K)IH)FF2%-L'_XD-X:2L#<>UOSOB.=18"2P&('0Q1JKM8*(D:,6
MQ-R=49;@J'@)$=E4R2E9'<GXN#QJU24;43J1:DXHG27*\P^_ SU Y7.4M/:H
M _&EWD1O>BO]Z1SPS@RV.JTO>>*W-VWO;^A/GO6,N]Y[W_A8)^+9SE\H_/:W
M?Y\U3_LR*1]!QQ=$Q)Z/M)\(BMGEDOFO?4[[E;UAOX!D^J3T52'GY6OD$_\:
M^>,*IOQ'9UU_FCJE]:^P[GV?=;"Y)@^,DD5.O4#EN4J[C9T_Y/+71*]D=4S5
M )G;;97'$.DNES,^-W?[_S(?D&V5;NW/'-7]MW?N*\"SOP!02P,$%     @
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MWE"[VC0<15#2N:R0@$VBMA[HA"29(%_)X[;=Q FEE$-.943<JTG"IY%7<7G
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M3$.8A J%.,IJF 0!X#)D3P+$(R)&""+2[XS&+"*1JYXC04__M*!PAIHU#5+
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M)S0@"KHMMZM^T<A:6KV2C/ U?"K5R[F& -:#.UZS:]J JUN!#_X#4$L#!!0
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MY>BW5W2Y6?5.&VOEX97$Q3?ZF53O^1I*6/^XWS6_9NVWNA&X_Q=02P,$%
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MWW_RYJO^0)F>_3BI50[G/^K]6QI9IA,^>_LWQT^E_>O.Q#9NV9F8G"!4ZS$
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MH40,0P!7DCA%$>?K@\G?%"C^*BAY/)N=K!%R.82<G@LDIA:$0&UH%%2J /!
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M3*L?_O=$/U<_(^3H4&_.+I89G\HQ3@ZE/L3IX>3PQ>SZR?7GL0_4(B;7XI-
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M^V0V!8KOE62!/A@E<G%=NXN#8H)?&?LL.AE?G\F:E=KZL!.E3@"5L820@@_
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M%&_%FF #KY 3+Y&M%^/7*;B*UH9<7(96,4=Q-E,?69>D$HY(S2QQP%Z LH&
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M@IS[F6;VJ>9$WQ($!,,90RA V&MYT54_@FUH2Y\]/X_'D9_WJE0-AWI!D8Q
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M&%.*V%O?9 QC*-: 7"4&)JEQT/AGJ6_/-1YS],Z@L14X%QK#WLXU(%>)XED
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M>0#FO(1V[NDQ1F[J=<%.J< RB5!*-8 ,4&X[\,X;_3SO89") 15)+:$ KP6
M*J.PB?<AS;::K?VV/L^;.L:*@FLJESD!RF0AF3I1T2=2+QNL[6_U\[QEO24?
MB^O*K&O9!1<4F=AQ(.< ]%(W6&\_Y)'$_]O=T2?KM_.[_[S^^;_]1K[^\MNO
M_WK]Z$-BP6_#KW_?7\5UL_2/?N$MMY'&I4N6T"H3=&40 ?<9V3IRQ;[#RXXC
MTP\ITWMV1[0BO.0HE1P:$D=?/RGIOOY*_[%#[MZI^<CT 0']A_U]!2OIHX'9
M-=L(A"!L?1/FCQ?D;QSBCDP_J$QO8=,Z^I@YAQ)VX)%2C7DV@)3U;7\ F_Y[
MSI&.7F\:,J1SMJ&.8@!S# E)Q:O[5!_B^H!')$>O3Z)5OV;*UC MM4.(+";P
M'%T%QOH/[=#G[^CUA;#59^5!57%<5=P%1$L;,ZIW2PO:X>SQZ/6%^'4X-_(Z
M1 PAU4BDL'0NO8%KW7X6YVMIZ!ZF+#A'G8(5W"!G4P_5LG9MC3)T;M_*XK4T
M=--;'F?+TJ#WE:,7W.G5&&60SJ4E%-]^"OO+:>B._LK ;E&:#^G05CH0[3A&
M2Z_8:FP_F^3%-'3/6^86DM38\7K04U.\P@0@"^F%XM1E_6.9?O;=]W_Z]C_D
MDLI3M7D/9X&$CAQ+G$)7DR1BK#.M67:^RK(WX*RCS8?RFUZS)*\)Q&N1A+I2
M9$8T0"9)O,:%;<!O1YM/Y<(.,.=:--,(IBO["J8T>N\T:^0.7'BT^5#>S-E<
MI5ZU<@:.PN%CN,>HV(N7'<[?WLQY\0N(]*8BO=8P-4N98X**L^K*21YA391[
M[@^>1Z3;$VCZX%AA'3LF\!RZ6%.SUK6D<H,A^Q/H$>G^*#J:F;<2<37!Q['$
M2754$U F)]@?18](MV=2LT&@U0T:PNA#:Y&U^9<P(VU--F#25Q?.3;U-AUL(
M8^OL8-.X6^H0*>)(:]G;@!-?73@W3?,= %&78# F3"LZ= X8QC96O/ =7OD=
MX=S2\Q.N ^<YK%B#1%0AG[1^WFMX^ZE![=OFJ9<7SBV,4P#KB)PJ"<"C<2'H
M-:GP7(N/P0:,\_,M6W_]R>=?_JN*.:?.#P4UQFI$=5$9*9065.+'-G^:ILJ^
M :@=]3] _3?=5;<VVP"4HKG^G#2*F2@)MI%M[E(!?=2_O_IO0&98R_Z<!?MU
M!#D#F6',F([:K*;Q!LA\U/\$]=]SWPY7J?9%^[5#(].!.J:XU$8=8V["_1_J
M /[?[[17M\%-+>\<'3J;8$\@FX+**_R&</-*NL-)[;'!DVQP4Z? +N)9V.?(
ME8.;&!9S_*&C<"U]ER1P;/ @&]P0";+#B@%V-6'O(-IDCFZ5N\]LU3 VB03'
M!H^QP2W90.J<8@(=4B!*D<Z5L%G,E13DQVDY&V2#(\T'\GIEN]H94X,"%"G$
M:X%V0L]JI?,FO'ZD^3R&IL!11FE7[364!'$1\"I%FX[NNU1^'6D^CVNC(<V6
M724&4!,:.>OL:<J-;.S2C.E(\WFLV29+Z6I>FD(K(8GB!D(=6)OS)JSYE#N2
MG[?9?_OTW;M?SF=O2_XWM2%-<;W*(,@2=)HT)FY98D9R@],K_\C_R<Q<#*QX
M:VV. 155KBZG,'CM!TK::!-F/O)_@/SO>+5-$[OVGI458#8![<JCHG=6C[8)
MEQ_Y;R__F]Z>+\J7R;WCA*5[YE@NN-X@5IQ:SQN4XX.7" '42Z118.2 1"?5
M,4=CX[[(IYVV$L<'+Y$&(&B,XE(DKOFCDU<6X$)^/5$WJK!_&C@^V,X'-\2"
M41DK4H]"!-*4)^%,2\<*W5/VCP7'!YOYX)9\H"IT]:M>RA_0VM4:SHQ5#1MX
MZ3OT(#[:?"BSAY!-)%B9-8"J,+6U7 .4QEF:X0;,?K3Y4([6KI;6;8E1EC:G
MIHM6PSY@!4O6#3CZ:/.A;,O82YFEPU@9;W C$6DEU;4W';K#$^NCS8?R)ON\
M!BLWM;523NT$%."^H%.9>]@&O/DZUS'OO_CH=[_]Z*'ZO^D<VF9V:@56[H)9
M7(/(QEJ;1];1Y0'GT$?_>^C_IO/G7MI4M>#60*+2 +&(40N/A2FV 3<?_3]%
M_S>PN4Y+"9AU_?HP4[6RQR@U%@7U]=<V8/.C_V?H_Q;^!X.:D8UGRL5 XM&P
M.B57[PT?\!;]B?<NCS;"/4&@58=HT*,W &Y#LE:PZQ+><;2F^P>!8X3-C'!/
M(C G1"+LL!PQI2A@1J>>V+@HG;XHQPBO$0W:S#$B!T+I,'D0T"3K3-?FD$[[
M1X-CA-V,<,^;]=*1TKQP=FA6)'NH0!#.:;Y%O_0CSJ=R^V3II9IQP(0J+)83
MF@#VJC-SA\'81YQ/9>EDHU9LC)D,@"+7M2JJ%T0!+7,#EC[B?"K?=D_")C6J
M,?1I&FGHR&-RGTNC&_#M$>=CF9,G]HC67)<XR;4L'8X,YA =3YB-O=6]S+]+
MF_^B\;[\_)-/WWWV_M?OOG@BVG;16KK)U4L-9H+&=1B=*(.4'U$C>3RPCP=N
MZM)=>_4 $O<%T(/E&E*%67N,.EK;83KD\<"3/' #J-<RIQ4?E5I 4U(0 ':D
MUB=/?T!MY/' 1AZX)0_TN4PP5F)=&P)$#%H>&+5%3&F6HOOG@3TO8U[<#/<$
M@X4^A0W=C7W1?Y(5X683^F!,.F]5CAE>)R$PU*7]JBC2(:O0@J-968=,Y,5$
M^R>$8X8]S7#'FQ7&0GXU3'$";(,]BG?EQ4R8LSW@.?LQPXYFN"4S.&6'LMC(
MB\- 89D%<5 *8I.^0VWK$>B3.1X8B$,[S,'0O'.%12T,$*5!;3M,]CD"?3);
MKZ#9EPZET]664 =%P>NU &HUGU4V8.LCT"?SKHN-5KW_W^Q]>5,;R9;O5ZE@
MYMWICJ#HW!?[CB-H@]WT,\)M</OA?SIR!6$A<;78QI_^G:PJ+6PVV("JY.J9
M:R35EI5YEM\Y>9:@M&26D=0G33J+C,0ID,4W .^V!+K*&%0S:;R(R#!)F'1<
MR<AP  .-4 (?8P,PZ&/NW3PV:7Z5^?8GPZ,P/%]%Y$G! (HR8!>C8%@2376T
M2DAAL/( 1AN /%NR7#V\B9GR1 <4F4",(ZMIU-8JY&SPVI,5R#ULR;*)*!-Y
M;&)J;HH\PQ&#H/0F>A\4-9RC-@#CIR?+)<5$2,N]]\P6V%+JR+1!VG*D*,-D
M!;#EPSC[?S[Z7 [(=$Q@%S"0(PK,,V&X0D(;;"TE/+ FU(MNZ7.%T281GENO
M#?. -D606@</&EYC1Z/S1C<?;;;TV638Z9"RAFGB03*R!#D]?*.6$Y">1-IV
M,[^ESZ7B3\5!F:>*Y@J09\!!(RE,B%HRK%FP3<"?][!T2Z/+1F)"H +N3$RE
M-AUS5BL'- .VM!/((V<:7ZYAM6EF.3C-*&R,]B9BSIE#5F&FD7?81B,<%:$!
M..WGIIEE])-+A7UE4-)RQ)0/.B@ ]0S'U& +>]X [/0ST\Q2\(P+2DDC8\",
MP!IJZRR6)#C,F 9AT]8<:#S,OM7\W1RJL+GU]V;G^?;6*@(SPB71"@/KD0@V
M)U<"Y*2P.,; I3&R <"L)?[F$_]R$";7V%NAX-^@F(Y2!>H"6"C*>!DB:O>=
M6^)_).)?1@L,3:WDFFHN 2 S0,[&*,\)1B98+9I0!ZPE_A4@_N74&9,J>F>C
MT:) ^<9;:J@E)% 2M6Y"CE#K8U\A+E@.^-<(6^D05]8A%A$QQGCXY!$7(/G1
M"H2#MES0)"Y84K5>8JV+E@LI.0,UH .G"?,'EHJCDA7HA==R0<.X8!GF@ +L
M@P@C+'4&ME)[A&D*P/:.2\Q6(-BUY8)&<<%2[ (9@=B#1-I%S*P5.H8@B38J
M%9_4433 +F@I<R6QNE+$QXBC-Q8QJ\%VC5X;9(7P2$ND&H#56\I<2?SLL. R
M&L6%UBP:;#E"T5,),-H0)F(#\'-+F2N):8TUF )= J:EJ7BNP1%IS8/5V@C3
MB+)8+66N),X,,EK-@B):" ;VEB91*R51Y$P8U B<^0B;+U^GCY?;G>TWFZ]^
M9DNND4B62VZ9%XX3#W\]H%@I"<.2"T^MBVW(24O[*YM[A@*28*SQJ(1C5AI
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M*L8;2LN'R$BF; .CKP2G?O^=R095WWOMUX>L-SA[D#N3#:3N*3O[)PC!6*7
MP ??+"RKZ18",6F&H\'P_+HMPV0D#)]7)S02HI61;N_?_77>^?+BP_N7;^":
M-S"6-Q]V#X[8^W=OO^R23J]S N/<.F2=V36S2+?>^ZT=NOON#5R;GO47@O]]
MWMLZ[KT_V/UR2-Z2SM;QA\[)$8$Q?GIUL#V/=,.$&^5M'F7:6!26Y-KCD%--
MK;(AB.CXVK-7UZNQ.F>6-C8Y^Y(9]M/,Y0,(J,W+!)O]=+/Z8!3*[E23H=7L
MC6*<SG5V4LL\#\4\/\-</@"5[M]D%+>4V@AX?V.5F!+6%\L[;3O>POIOP7J
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M6@18=W&[ZCI"74* "_Z]0<RVS; /JSE*8?1%\L*+;HJ#S_;AN8 "_YJ8X1A
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MTM.Y,WW!#5IYMIXN&!%PP>E@NKN^*._G=RKCA K)6;Y0]]1. .;- %$R-(L
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MDMBO6VK"CX,>"#0S[!8;CI=N4&W,56ZWUK"IZ5"O9[LWE9&2W*5%_FNY)Y'
M7T&#L%Q=8(F)Z26N F@SGLRR>A9I)UF^8.D> P5<)=YK#>?,3PH7%_! '[C
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MM4!:JJ,7<UQ%NP^AN#@3_EKBQT5O_VWC+[IL:<V]EH[RM1,QT)VTRJ9P"6N
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MAZ,&1\&=]B;E'C^EB$&W530P#^L3/9]=6&KK%@9DOO(JDX%XECFD.K-*N&C
M.>=!%%-/;5;11-KI"HG!,TPG0+(M/)?T,ZZA3KX3YF;.SX*RJ"33X'EAG0B\
M8$Z3!,(3(CB55$I>ZV0L+XV<0\XMQP&*"NX.:)OY/3T3@0C/@!A1I\4[!<[8
M *S,O2@288[E3M<@V9!L2+;%[[9'!7>?F)O;0>]3(LE32%Y1$)HP\-1$L%QE
MQ@)/DNLO>SJ1<ZUP=ZYWFN?!Y#B-JN_.DSS_?<7IB>&SM;(@"_%N?A8[NQ#)
MS:S:'PZ&IZDNM#UX>QY&0\U\<V.R=[0UV>N1#XU!V?J=T!2Y]*I,(:]!F&3
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M]QYNV-HU2/]L2T1E=2SGP_J+]]-D%K7$%<.-K.?K>2^Q4]9J9P(0KUFQGDF
M5U%#"(HISRQA0G6Z=D,P#$9B3@?F="S>2WR)MJW)9-3S9Q/G^^EH^-*-RH(!
MUPUW(]]\[0?E ]<Q \F4%_*5Q8.U693%@Z2LC)KD1G:Z3"QEX;!>X/N_MC$/
M=2[JW)7TD:/.O1/MY[(A6%8^%KQS+S0(&C1X&CP0E6FP0178FUKG<JD0]ZAS
M4><NW#...G>!Y)OSCQ/'G W" '5$@&#6@#7UF;B^C)R2*AI?[X7CJ'/OJ'._
MXAL_/F^7+>U\F @A-@6;@DW!IMQ'4S .>*<XX,N=5]7ACUNO=J:[*<SM=E,L
M0SWCH*[NR@?'#L<.QP['KNUCUZXMFFI3RQ7HQZ=NW MM2T=]N$VU[1J<>PVT
MW"6K<'4<CF?C^#*-#H_=*-UO=)U]'E2YJ,-Y<;GF2;KT,1)T,7Z#B_'M?!*1
M,EX(3RVX2",(03R8X#0XY95S+M=;$CI=OBF746YK[7-P6X#YAS?2*ZIT6C!V
M:*+11-^[B;YC8!!-]$),]%S^ Y$Y"TX#!&4R"*TB^)P92*&TR+(L.;EI3/0R
MTGS11*.);NW8M2NTL2+.B.U>_VR28ML\<ICWB7F?*^>.F#Y+J'9NI';^F'=(
M$,L8S]I"]-Z#,)Z#<2Z#HHYYYZSD635J!PO58NCE48=>6C!V:*312*^<0P*-
M].V,])Q+PMNH+$L:7(X1A-8.C,X!)"/.LR $2[XVTF(9M8K02*.1;NW8?5MF
MN6I/,BHV!9N"3<&F8&;Y$@S&UG]?;)YGDQ]6!Z^/#H^V]K=W]U^@]5_%P43E
MAF.'8X=CAV/7NB N9I1C@>.5\Y".:V?E^)XK-<H;5+#YM>F$%+=*1[NW:;\I
M*W&0&R?J^.!L,IZX0=VS5S.\L,+--[A3W^W.QSPS5UK7&5X^60]"!@<^4P/"
M"1)<%D274>RR#<7YYC+"GICDA4E>.'9HV)9IV.Y:F@T-6UL,VUR<T 21@C,.
M-)$<!+<&/'4>-/=6DD"YE[HQ;%+AP4[K!D<T; ^_\,7L9:Q@N"X*H05+W^EL
MNR844"/<2"/L74GX)80+KP@XK14((BE88C+4E5U55CYGFAJ-H.DFP70B=(X_
M9N=XF\8.3=LZ+7[1M-V3:9M;_E)3C!:)&:ATN9@VE<#JP" )P7@44=M &M-F
M-9JV=<,CFK:E9<I^^2HM2+7#AF'#L&'8L'8U[(ND9?I.]NJK3:_/A$BC=;%?
MARE5=?GG<3495L^&@_&PWXNNZ.?J>6_@!J'G^M7AI/S#2;GM\3=HE-@;G_;=
MQUH IJ_,('SK%]_:S.KOFZ-(RG]C[WWW/^7'Q4>NS\3IA.K^QX^^[UZ.T,7G
M_O;%RP=E..[54OV'4>J[2>]]>O)G+TZ.RY0LZ]'I@R[8N2.]\^5/.E^F3EEX
M/9D^7&3^*SK?=@M_J7._/'NO3OEO?E*^\L3U>X,$TWNFK&D\O]IQ\S_KVSI?
M38K O/7,2$D%"]%D*U2(0O.8' WT=RXZ%Q\Z'LT(]3:!'R7W![A<>N('U__3
M?1QWOK_282>] 7PV"M<Z]ZX]F//B>K 9\+**'XY<,U>JTJXTJM]6-]ZM7J.K
MXU'M[OC'UT>=EG7Q4?TH5\-<\W5RCE'7_=*46N5GY*>#'_</#_:K?[F3TR?5
MQ5];^]O5X>NGA[O;NUNO=G<._Y) *W>_SP[*#?Z\N[UUM%-N\:C\9V]G_^BP
M.GA>/3O8>_EJY\>=_</=_^Y4N_OE[YWUN?'O7@_<6>P5B?"DVA[V^VXTKGJ#
M:J_7[Y?'9/SO&]SIB1N]+6BKY5G-M.F?4P,RM36-';SLB^&H/(-U/_3=Z3C]
M</'+DPM#VALT+6X^]+E$*Y>98M/:34%E0\ZI>IQ^_Y2JF^=4_<Q3=?YB ;"4
MYJ]?_]L/__V+9%-;<<L/DTWZ=R]:K6[YV;5K<GG5W';\OM)DP^R"FLR-_,8/
M?\7[U(8UI,4%VK<OT)[WZK!%=5B$R"!6OYRY4;FY:J=HD6_)%5G,L@4GT8I.
MHMZ':J]<ZGB\M ET4QRM9D1CO6;+3V>#5#&S4=791X\G++6&@\A)/8C4XB"N
M\"#BD[@&@_C%)_$KQK&=[NE5>FN[MF"OPF3=3Y,J3>L,5HO=L8)5,N^\E6=U
ML@7/QO&S5$'M1+"4"6T$$T(8YX+E63,?,F%:ACI5D!'"_RH+7MT@5;#,ZMU!
M&)ZDGX?C<6L2 ?>?31,!3W[Y\\VONV+_4_GN[7[OMZ-7)_LGSWMOV/.3-^R-
MW#O9$[^]*.\YVC^>)0*^^F._M&WOT^M/!R_V2/GNC_M';\6;3W7"X/');R_V
M_GQSLE.^][?>M43 .L'P9/?3_M%>>7_YGNU=>K!]_&[_U__V#E[\]L>;3T][
M;XZ>'O]V\E/>^SA- CPD?_YN1&:6N S!205EY!@8H3SD2 P505A*::?+-Q13
MN =NO?; X0;A^Z&>33Q0SU3@P8LLF0F"*:JI%9'%@L/SO3]$D+](D$;J+8EZ
MGRZIQY7E000"W'-7J.?T^;%%7 4AE0@Q2='IR@U%<.?O>E /=2[JW'LC_EUW
M>R+QET1\>DE\J[W./$=(AA2=*TD$*R0'%8FDO#!?)]WIV@W!\*2Z]2 ^ZMQ[
MIMY=-P(B]99$/7Y)/<<R-<'7P-,<A*$.//,&E"1.YVR]-J*F7@$@4F]9V\2H
M_-+^BB6'=; MV!9LRZJV!8-@-Z7UP>0XC4I?G9R.TG$:C'OO4]5K%$;U7;]H
MC']O5(,TJ3/Z)^Y#:Z4L7A^O_]BNWZ[2<ZO NN?#4;G8H IGHU$:A(_59%2^
ML]_L>?I+M&'%G-;$P*\NA1O+]6S><)VOC*>C_&PZR$?U&)\W;VL0CV8C_L+U
M!O4J^FDJJ^_T*H6^&X][N0S*Q7O=!UQAWV"%?5E$IXF?$QV#"Q((9Z2LL#D%
M:X.#)*+C*MCLE>]TY5+6UUA"9XE+ .1E:Z+GR,NV\W(6>??>1$6\A""3!D%#
M!L>%!1F,ESRDS)3K=+G$DF/(R\?#R^^6&WP>EZXJOR$YVT_.601;1B5=BA:\
M#K:0DV@P@G.@0:@@&8NI/M?<JNN'\/P;H8G07#]H+C=TC:AL.RIG8>\RR"1;
MR\#8.NR=N8':)0,V>%N$II FL8+*963ZK#TN[Q3S7J[/&MN";<&VK&I;, YT
M4UH?IG VZDUZ:?Q#:Q4N7A^O_]BNC]D[M].=YS]?#T:IW,VG%*OC8;]N=O6V
MK*:F:3R5&_7&];_%@K[RG]-RV>%?5T7"W/![\DK>0]C[AE[)V3SX\7P:7*RI
M#P8SP[=U/ANVF\GPLID+^VERD'%Y?;/E]<'A7,Q;UBX3901$ZB((2P@X5<>\
M4XJ"2Y>C"YWN]=7UO?HAUSZ9_*'SKA"3*QSL1C@N%XZS #=-(F5*)$3N&(AL
M//B@)'@M>/1:<1%4ITMQNPT2$@FY\*W5G])H&-WX&+G93F[.PMO,R3*)K087
MB[(4)BLP1 ;@7MH8.0TVRYH"AE'V!.F)]$1Z/F"<&SFY7$[.8MLD*&<=R> ]
M+8MO%@*4H260*?66!"F=(:@OEQ':QHC3W_II/T]J:8ZCNZA#BMN0VK\-Z2XZ
MNC8%U[*:XKNS\:0^=/#Y:'BR=?!L]_EP=%BLP$&>V0PT$+>I^7&T51N'BZ.]
M=2+1)I6+=HX$1.0:3$H)O).,!R=$4GR94GKM<Z >.J"( &VEJQ8!NE( _7@)
MT&AM63>I!#%Z X($4MCI(S!EK:!1&L(H A0!B@!MKR<7 ;IL@.[/%"@S9<"U
M)D"YUR"T$&""\R"-D-08QS1#!8H 18 NL=XF K3U )TI4!YTT"E[R%*GHD"-
M!6,*3W,T*A&:7,X1 ;H\7V\[S\):I;=BTO-=G.GU&5[AV W>)DQE7K]4YMK4
M;KUWO7Y]QOW4HLZ%42^-+EK66UG6W7GGN+2<IDPU.%(7[.(R@24Z@*;$)9MB
MG8:"R<N87/)(P-C&Y&7$X:)Q.%MH>&IR4-Q S-Q",7@$+#4*DI+91^VIIPG3
M29")R,2V.KF1E LDY9Q/.[*DDXD%DLD+$(%1<)HSD#Q2R;*R6F5,4$9>(B_;
MD*",9%PT&6<:D@5N>(X>@O%E26T%KPMO>:#&<9&)UCQGU) /7VWK,9R,@VW!
MMF!;L$;-\FF]<W+:'WY,J?)ID')O4IWVRW?>KO+6<NNYX?7Q^H_C^KBCZRY!
MZ)>CWG!4E:][WPNI]-]X4KF38;G-3TURT')*;JUW>MB2X]3G:^EW@W=_NXY^
M6?_#<. &L7G7RS+PHS3IC5*]@'YZ;NU>UL:N+*:;.7)X/D6>E3<^&Z78JU?9
MP[PU-U>^O#5XB"OQ&Z_$7U\-;JLLG/&0HG @DF+@E'?@D]0AZBR]T9VNQ!,"
M,-D6:;J@Z#;2=+5I.K<-C+OH?0J@DC4@M+1@O7- -<\A<<K+&Y"F2%.DZ2+B
MXDC3-:#I7/P\F!",L1ITY!D$51*<2PFB99;DX"TE=:;1]3 1XA1Q^LAQ>F]A
M<\3I:N-T3IRRG(*0'*1S 40D&CS5$K2UA&2JJ/>^X'3!B>QKCU.,@]W%8_QB
M_F"&I;N*,>MJ83N:OF9'_GKC<)YN'/YF2Y.'HV(O+NI+7C,O:$MN94O>7"D8
MILH"36L*A-L(97XH\%)Y\,JS1'GBP=1[HL@R#N5>^Q2NAXZ!(F!;N34* ;MV
M@)W+D'4R!ALR)%)^"*<%&$$56"V58XDQ0^NBO6(9)](B8!&P[1B[Y?J3$;#K
M!M@YY[+/P3.N+! =2 $LIV"9=< \%<4*FV*+>:=;["\"%@&+@%V(AQD!NW:
MG2E8&PI)F6? &"T*EI (WF<&(959$:W@-IA.EU.#@,5B9*U_*^:!M[L8V7I'
M?EM?BVQJ>+>^:GAQ'_4=;>S;>3=\M&4*&<N 2AFAC+D%:Y,'6HPKYY:$HL\Z
MW2+.L. GYLD@+9?AAD=:MHR6<PDPP?KLHZJ/O[,@K%3- 4<03'*24\<UD866
M7",MD99(RV7XU)&6[:+EG(,\Z^#*DB&"(8*#2"2 (T5J&NN\59E9'VBG6T0F
MTA)IB;1<AH,<:=DR6LX=OZ&(UB;Z,O>R!Z&"!!^$A<03XXEKKC4KM"0*:?G
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MGKS5Q5=AP@#:PY9A^B+T&\A?(_\@(O=OROV]>1=J8C)0:@PH2XHL)HF!B81
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M3%!0)4&A)"@\7.D3K07SUDK*+;@@5(@N;_U1'@1G@33;?SF/ND1)S&/7[_0
M'YS\GGX['_OKNS>[SSOM3WO\S=&O]>%OOW<.3ART7_W>>7WR#F[N^J7?OS@X
M3?>Q^_KCP6_/TYA?LH.C3N?@MWUX??KRHOWI+7E]^G=]>'0<#Z83%%3TGGFO
M4%I(@0"H1E8[F_[D@BN)HXML8XOKEN2W^]>7,(D2)K&N81(SP*2P@C"CP7N@
MH$ JYH4AU!#)2134%)A<49B<2E PS%.F./+4Y00%X9#VEB+JB'6:*A]R'A?!
MHD7)[3J/!2<+3JXK3LX23J8<UJ"9U X"&*Z,2,].[JL:*&C,V>>!LH23K09B
M3A(49"#4$N81)TYG8BDSL22(Y0!"&V,,$B?$3,)$;Q/+$DY6L'(-L7(&J(PD
M^$A](A:)48)W1G,N.>/@:$S?T<(I5Q0A)PD*(0:NTBHCKJA#0%U UBJ&=$R+
M;+UF!G1)4"@H^=10<A9&20,X82C5!A.PBAMIE%6.2N&$"Q871KGJ>#E)4!#&
M:R6Y2W@9$J-T7".##:! O-=" VF*!#!H,5$896FU\ 0/+:T69I7]=AA6X6N1
M2*5&XWQL&I<L?QR8PLY+(#HI:Q$-."(I5L U:<HN9V4]AZ9':6$G)9B+SIU%
MYUY,;P\&!HP8AQ3!#&4G';(T*(2IL#AWJPK1;&SI%N.+\'JO?=G.4IEV_5"/
M2D\\HY$'88$J4,):*KE,+UXG2[^@WI*@WF2WCVO)C#(1Z: E FP]TL C(ARL
MD5IZ9PKJ%=1[<JA7ZG$7$2\B7D2\B'@1\:<HXNN5N+"(2=PQ@^/*U^]K'[I^
M4)V9VE<__(ML*EZ=A7XU.#;]<,LUO_K;9,O6;GR1GK?=R]4>98 UNV99#(HY
M.H,YVIYN:<HP,42!0,$ICL!R@@P+-MFDA'C-E=4YE I:FMSN@+:B^UY+SF%*
MC, *@=\B'7 %_.8#?A-?'/8X8*X"P@0'!$9(9)4D*&I@UN8RYUP5\"O@]X3
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MI0,@F98/010T%X2*B -UP6FO+;4YCIFJ4M*CQ#$70'Q$5UD!Q <#Q"E7F28
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M2<VD8T9+C2*'1+4-,\@J, BX9(("QXPGJJU:G-_.+BB9ZL6A_<0A\%')=H'
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MT=2;IKJ37$CMN[5WY10,7#\,G //+D#W,$ WQ:$5(Q(+)Q!CQ"#0+B*KB43
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MPSM*ZCYP28YO+!@AR.I4HV]R_]FB<O]_&Y=\W.[Z_>[0=-_6"?9&+:"6KAH
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ME!0&4N0Y.AY=QK&O'B#12_5LN8_@G _)(,#A,HXJDK1S!%=OAAC'';$A6R8
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MG-QD]7EA!AZZ;G/WZ.SVT?'1T6"(,N+=,$V7NS\\__/9CYV3+M+W;'S/O4'
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MKF^?BJ<'QE/F5M"4?322@P!CJ3$Q29J],9!\KGA:+3QUS_&4K'*<68024$W
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M"5\0&WC1,+E1VDZ3OW]))4WJL_C^>.+1OC9IV9<L0_Z8/Z3O<Z R.$ID2I(
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M4&4#8=I$ I)KXB75A'J(3#NE!5MJJIC*L\JSN_N5QIBM3#X@Q0!PU8B%Q.C
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M@%8,G*LHRCDM S$&KW-R,N7 ** 6%JL2MN8HFPLN& )W)0DP34P08%P1%&)
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M8)P+V<1(!&.&0(R,&.<32=PIEY-1*E5C?N58NSGVX#X,E5AM(];,$A95S-X
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MKD>.J^:]"M1EIC,#)\"(G)VP3&OE%6IC#YXZKV*L51B;B_*1BVN\#9QX[8&
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M*?%JCZ\<:S7''MP-O1*K9<2:=S_GSB396+$HC00$T\2XD(@,WG.NF&>!E@!
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MW&Q**6_^_8LWTTWVI1\-%_>\]XNE,K&IC5U,E:WZPH/;6&6V:2U?4)6M6,C
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M&J7Q:-&.D&L>_N3%9,?IY:UVMC_>=V[5R)&KY>ZX7I$C[W"J309'E9(FTNR
MYF@9A\2%TLHEF9EZ^_+_L7?N36T=V:+_*BK..?<F56ZF'ZM?F5-4.<;)>&K
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MU*MK^F5+'%\^X**^38]'L6R?MW5HY6E?M!F<IG \[/^G?EMM2#B[_LRRG;M
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MA<ME$Y;9'KNQQ.'\NN-T4FZQWO!=3;GNL]M<9%REE&)P%%R*/BOI@Y-6Z:+
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M>3^>(%TUL(-27F0)K!AO8(WVQO*<J5.9FTR9P?AU1T#>;OW+6<PY9"",9TK
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M0\(5" IE8KVMSD3VA&ET)B('D8./PT%,*%BB^[!=7\%D!\!RT?MJ&H$7AE@
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MUOM-$&W;AS8;3))9!Q&H*9M%NJR4"]Q%;:64UB+:UHJVEB(<7 K@7229I4!
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M2*Z<+V@S# ]*=%03WFXW\0U=3!3Z3;9<6O@@=)$/6@3F03)AM $:&.4^6:<
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MQ-X*#^X!%2] ;B6 5&+C)39^3>G-D'/B=,Z%LUQSHQG\ZV#V:"Y%B*2 ;UG
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MO)0M5:^OSCYS]W20%S;&Z)XQM=:K/\'+A1O-\K(U7 FOMYC!T]6KVC5!\_2
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M7!P,9Q(@?? 2)X.DXF %"D:0!8,=,0)V/%=)2R,!AR\HO;J 5)!8D/C,D?@
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M5Q42%A(NA^SN<H*?DY0[3+C!DK,HC+3<4RVHP@SLBMN0L#!OWLR;+#C1H*0
M#848J<^P"L \3@3R.C%O;:*)@M''#"Z\*[PKO+O*.\^"TI1*S[W@WGB+ _<!
MC#XC(DRNNQ_=5WCW\+R;+"BI9*7+)W(P*A78>%8A[0U!!D3FA71,$P=.+KL:
M(BV\*[PKO&L%113%E@7!,$_:&NX54R2GNRLAS?55_@OO%LN[Z74A[07.YS C
M@X5$/&B*G.$2*:Q8SLXT2BFP\,35TVD*\1YZ96A\5 #T<OS!!KWRT>7\:-G\
M=]=ID@^YJ\;GVRU;UDG9^%<V_CW<TF?"+ECMI!:><T>#EE)HPV1@7$A/=<ZX
M^<&*9\FX66++ZFQZXU]*5B2'D26&Y6.0.3*6!L2TDI[1R(7*GN0+*:]:5B7=
MIB0G/F\WTG!&.9/*FRBXDTI3IF$B88%C<-KXFTE9-OXM*QLG*ZDB8N(5=XCZ
M>E7!1&1B4(A0$G14E AAR\:_@LCGA\B[6).:>6XL2XH+R['75@C#G<UG.DL:
MF"C6Y%,GYF0=-FEN620.X>03XHQY9)W).Z=3$CPX8@S+&_\$+LG;!97/ I5W
ML28=4]9Y'\#)YEA:AR-76GHI;;2*V9M)62CX^!2<K,Z"KI.)"(V"% 9\:BR1
M2S(@S;0P!"MC-0<*,EELQ@+"9P/".T4@J2214:45EEQG\Q%'#1:D]$(+:TVQ
M&9\Z+:?7=J6DPLJ4$'4*_&RF%#(Z>]PL:<>TI2S$>L^?8'/>M;'RM*S7_7ZM
M1_+&Z#3Y48<V3X_A7KX^77[X%!O_<KU?-ZX</3_[B+=LS.P3W/K!?]"!]4GU
MH\-(":V)MWD,;1G4A>3MY$RFJEO7[_?3^1GPD;HTJNW%"E[MYZJOH>K$0=5-
M%7R\ZL7AM0/[K6H=G\!X6Z^JT?F*E1^=O5,-)B7-JU:_ZG0'E0U'I_U\)3!H
M?!?X$GC*K] *N/%@]-W]:M"M3B* J@-WAX]^ 9(<QU'[6QDMG?J;;;OJG[I^
M*[1LKQ7[PW94>?B-W@UQ8%OM?@6-N/8A^S'6S_2JV^EWVZU0/]C> /X:W@X>
M>29YI1IFKZQ7-XC_28Z-K4DG]:)OVWZ_E6!6YRZ$%T]KP4\=Y%5=<^C#J%]>
M7GGRR]BIM3*35YFP;)TR=3I=M=NI)C7<*W1-+\&XC;:?)T5WU#V_#$?8/ZOX
M[03Z*+[(4VA]=?IG?#!C-3J]IZH+H5_;.9DDK=IV@ Z""9Q9 K.[U0TM7[G1
MY;[;!X[LP1<VNX-8R1H25V?R"O7@I1$V=5!.-5U\_-HNA6$6;:\#SSOL7OA$
MMS?JWLRSOLT$]SY#O[+]^C5X\-AKG\$U0S@/#86I/N>WZ_.L&+.EU^J<UJV9
ME4*W7U_]LB8Y/,QO7UMA< B= L\\>GY.UY48RN>Z*ZT#%)\.XF\CDP1/?\7L
M-5>KDR^YS*=29(9].?5G?JZAB<P]=<91+03AU >=#%CX@2NP]RSQY*.F:^.+
M#GN3\?\I(M>+]C.R";KBI6U_M6?]M5]G>NRXU4&7Q'"E=W^V"U.:7Q?6$@]Y
MM-=C[^5H5+>&.5SVZ36Z.NQEU^Y_?BSU7!MN/UNH0ZL$ACM8*/_ZU6Y<-Z2>
MMD72W-W?KG0U6D*L_C5CBL^ZQ"3YI"F6BD;+ V%6<*><-SA$8HR_/F-YUM/=
M'I'TK]C;.P2:[L.7_]X&[_=Q75;>:(U=UIVSYM8G]N'U-O^P]2Z[K(>[^YO\
MP_Z'8W ?\<'[-ZRYM8D/Z!]M<#_;\<^W9Q_>AQ-'N6P<[<#GP^<#<%6;^V]X
M\_4VN+*'[>;QA\.#\[>''[8\;H +?/#^[]0\W\;-HT]GS?UWX!Y[WGSSD7M'
M L41*6(<@A'JD4D\(9DXCE138QD;QBA &\2PF0,+<$D4T3F'3>3>&&T<2\$'
M14-D49.U*O:]/<GX[IV" [N]^;:YTWR]5_VU_;;:^W/S[?85W^OVQO8EW304
MX(];-/L$\%@P_[R,P7*N@W5.,Y>BH]8IK:.]B%[/:T3N^<,83MMQ-UT>F[_;
M?LMO=L)6*ZO(4//@N8Y7:+]HO/DH;%0Q2H:(4PKQG*_E,#8H< E"4]%HK"Z/
MN>5'X#Y8;*G;;G>_9H,-/&A;&WD=WVJWAD,;M(#+HZ&VIR^L03"LJWX>*=E&
M#,-1<M,GLKF7+</4RD$Z<(;A^T/UWU/; _L![@B_C-]J?:N.H=&'_2IVLIV9
MTWZ'<91Q[F_]\<G+# _/ KG9)3RVO4]@C>1 5#9#1K^.C+Z1?5A'9"Y$E$W<
M7A9/VY[TX\OQ#[^-4[E;G;HCZXLNQZ;@-A-+9QV/K)U1JO?H!J/WUX?O70J<
M#=_D:IU3<?/[W[T8KY/OO:GQ=[[XN]=^]ZX$KPO\O??OW62RSO3]K_U>D^!=
MQ>?3RX+H>319KTM&GUB+&?_.%\]<6\[Q?*3UN4<X1LP\T6/$'D.P?PS5X]Y0
M<[X9:LYJ.ZO(6TA[/AN;RAAZFF,(3*S&T,1:U/@I5/^YE?O:(RN',Z_X_/SI
M'8Y%OLLOW[&[6N2[FO(M\W>UY7OM_"V[^>_:E[]_+Z"X;/FE97=_V=U__TT&
MXQ65RX<,6>X-H5QI3CGGVEIO6%+4^82I$CZOWE",V0T5D.B/%A?K&7:1%8N?
MYI+-,"OV>(=".\0!?=N"=K'&T=M6<ZO!&T>?R>[^NV_-\\WSYOX.;]*W5[)B
M#XX^'._NMX\^O-[Y!L]PUGR]@QOGG\[@.@%M9HVM!H'V0WO>ID9K:E^^\\(&
M3!Q*A"94%S37F@GD S',8DHI=VL;.3!=-A&4303/9A/!/4!G(O/$4>F9=SP)
MJCVGDBAB>* !"#A<IL8<$U3_(!DNH)LWZ*;*E3,OB-8**6()XA3[?#::1!QS
MPI/&RII\-MHZ640MRP*Z KKED-T]0'>O?)P"NOF";K(WGA.'A1$&>6?!H@M>
M(RVY0,$S:1-/V!F[ML'6%U+"LH"N@&XY9'</T(&':G%D&ON@.#$BGVH"WFRN
MZ*NY,*0&G0;0%8MN<:#C4V63(G$R>L2"-8@+(I #:PX%E??N@NQCD#7H: '=
M ^WH+*<XWJ$3-^$Y[*<X#/;6&__Z ]O)3;Y(Q*_S34L1^)72)T-Q/VP4%(D[
M%!IX7W="#*/QUSP]=K&WFX;)%;N343BK?AZYGL#34#_3%4V]XX)I:E'T">QL
M'A@RQA"D7&"6RTBY]&L;](5D=-V4:O&+,[4+&I\4&G\R;EK0N"QHG,1:B7%&
M.6(1XPXL<\ B,E90I*24D2A%#3,U&@5=%P6-!8T%C=>B\2<CK06-RX+&2716
M!D*$3P#$>@,P-1PY)QF*P82HM3))R*'5R-:O%J$J:"QH+&A\@-AL0>.RH'$2
MSR6)&!N=  \Z:L2Q3<A0 7Q,UF -V(R,#*U&N:X*&I<SI+O:Z;Q_=7.1F%;>
MP#\,ZL9OL>=;_7I7?5V$!AK:]9^K[DG-L)-<PZNL%ZZ^.GJ ^.ZLSMGI^%Y=
M,]&V7W6/C[N=H;:9+1$[7D6,X2][EC^\V>O9SJ=AK<6BB.Z@B)JOIB*[,7GM
M'7,H:,H0-P0CJX) 04@.&LE%*]+:!B%FO536+BD4!8ESB^L6)#XN$B<17<:<
ML9A[1%3@@$2G 8E)(($])4QI0SP#)'*\7K+*"A(+$N<6SRU(?%PD3B*YRGI!
MHS,(C$2!N(L4:9=/[8,!K[D+D0D#2*2T6(D%B06)\XOC%B0^+A(G$5PIG5-&
M:D2,QHAKGY#3(B"6'*44_  MLY7(=$'BLL9O5SLE]S^QWW\YCMU^/6SY0^BX
MTW:H7"[Y?W+:\X?UJ1/#4.Z@%VW_M'<VBND>Q\%A]S9EQ,KBXM(II9L/!9MO
M./>H<_1RJ(#>Y]'V*@^VW^/;R5![ET?:_FB@U4>$->IA5I307930WE3T-D5C
M;>(P(F+,T5O&D<4T(1&,(8((\+/<VH96UV2>/>@97RN_?%C@MYKP>[# ;8'?
M@N WB=-21R+E.B&#0WW$(<#/48TT*#)L-''$8K# ,;TFN:S0K]"OT._!8K2%
M?@NBWR0D2ZA2H*PP<EJ!Z>>#1#8(!G\X3Z(DA 0*II]8YP5^!7X%?O.+QA;X
M+0A^D^"K45QP2RQ2%FO$%2@HG0@(BGAAM([81[6V8<PZ+O!;NK#K:J?-ONIV
MZB?)6;(ANL$H EO6]YZB2GD*B;'# =>'YNVF+1APD].FBWZYBWZ9KA2K\M&I
M6-,<2*5Y>P88U]([!,+S6AJG'69K&W@A&WI7?FFOT' E:?@X.;&%A@]%PTF@
M%5,1B),4&4T\XMPP9).7B$;PFRC5A/F4:;B(C6J%AH6&RR&[IY .6VCX4#2<
M!%ZCHB(2R5&NR0BVH?#YR.B$J'%$2B=T$+'8AH6&A8;+E@E;:/A0-)Q$8J/T
M7!N;D/#2(&ZI1P93@U1P6NNDL8ZQV(9+'(U=[2386]2E#:WVZ>!61^:6-;\G
MKG:6H#+MUG"T7:FG4S307330=&W:E+RSN<!8BEXB3D)$-D:'+&?1&JU)8J(N
MI2-%*<!8$B(*')>W-FV!X\/ <1*Z-52H(+1'.,EZ@X!%.@B,A)284.F(#;R&
MHR&ESEB!8X'C\E:G+7!\&#C2J74M[F)2#C&6#]615B MJ47.1XX-%UYC7<-1
MD6L2R0H<"QP+')>D/FV!X\/ <1+8I8)('91"CF@*;K7&2&M@)4B04NHQUG1D
M.:H"QV4-[JYVJNUHTE>=.*CBZ+S!ZB37I<T86+9UQ,>3XW))[1_+LN3S=+3N
MS<=V_F1$^X?'=HZF6#FX\PYJ='>ZOBZE2HF8UT<)L8C3'(!1)J(0'?,.7A12
MK&V0=5:J!)5TD9(N\AW4_61\NJ!N/JB;Q)J#901+$9 0!#R&Q#&RV@J4I$U$
M::T)SF=:K.-2-K>@KJ#N.ZC[R6AS0=U\4$>G@B,F.<<,$BRJ?!ZN0LYRAPC'
M4:3 ,(ZX/HY]$<>:%=05U"V'[.Z!NI^,'1?4S0=UDSBP![-.4AX0UM@ASCA'
M-GH&1AY6*=FLH4Q&'2\9O@\5!/ZUSE>'OT/KR\:X5YNGQW OO_&O^L7A):[W
MZ\;%Y?7K%V_>2,GK&S/[!+=^\!]T8+O5B>AP^#LA(N-J_S".,VYOB-M6($=_
MVK8U05*W5X$T#ZL!7)=:>1)7_0@$"=5_3VUO$'O]*G8"?-F_3SMQV*%4OZBR
M6539SO3+#.>7B:E:'=\^S9<,QFUI?8D5C*OH!U4W93[-5G 8'-I!]=7VX<W4
MAS:[L_K27H1&PM?T8C@=\JZ5_X,VQ3X\V+>3V.G']>H>3WSCP][\K/';Z*$6
MFQ'+[K!TM]D9M,;=/=EZL3UJ^!^][O&K[O')Z:#NA]UTF>2;QS"*!T]]0:\=
M_WQ[]N%].'&4R\;1#GP^?#[8/_S<W'_#FZ^W16/KL-T\_G!X</[V\,.6QXVM
MMT<'[_].< _^,6 =;4H8)6XDXB8:9,#<1"08'1.S)%(++O;5];@*YG([#X=1
M(OQX[ ZZ,X?X]5]4,,SS\!L=]A>K$X!.S-,"7H5?1Y^KI\.G7K1Y4,+\Z.2W
M6[W*CO+MCVWO,XSU+[9].N\I<#&O+Z: S=.P#XJ@E4 I= 95IUXES@_Q*(\_
MB^@LFCP'6YW3^G&?+M'IT "]]#S#:4F-]4%[&8,%K 3KG&8N14>M4QH&\<-H
M@M:WZAAN?;CT2N!GI\ M'O2>&N!G,]N*!EB4!F@<;0OXWK/&^0YIGA_PQIN/
MR5,9B(^(,&\15QB,<T$T4M@PQ03&(>1S>6[:]O"4E<+-,V+I%<)5%5!=8?Z8
M]E.NCH\9*[_!5WUJ=6J_20"A1[^.W"8Q=')J!^)"871[(?:RLFC;DWY\.?[A
MM]#JG[3MV<M6I\9Z?=%E5PIN\]O75A@<OA1JG5%5$W^4I3+Z_N';9'VH#2ZY
M><,W&5EGC-W\_G<O?LQOYK>\^ ?).^.>ABD8KPTK/=Q'EZPEL[[LU, ^Z?9;
M>>R_K*<>*(31,",8NG5D87"ZKD8C^KHKK>MW,S]^&PU^//T5:S^81FO+;551
M<LEJG/HS/]=0\W%/G7%4"T$X!7LK&2Y]KET6HB6>?-1B;7S186\2>?D4D0-6
M?48V05>\M.VO]JR_]NM,CQT#5"Z)X4KO_FP7IC2_+JPE#G9(MU<C]N7PG)O\
ML=QX^_0:71WVLL'V/S^6.L%@7=<: -34JVSL=0;]?_UJ-ZX;4DOO7S1W][<K
M<[%=^U\SX; 'L&5G3=2]^"F7D7@;3[J@!SN?ML#<:'?[I[VX#[?YO0VVP2.;
MG<V]D=EY?'!^L+_SK7G\1GS8;[<;1V]H(YN@Q_\^;IRWCQM'?Q_M9A/T.-]G
MUNS\<-0\!'.2?MAJMW??OP/S]> KF*#PV8/SW?<'9\WW#0$F:.O@_(_4/-_&
MS:-/9\UAI)@TOWXD8')R!L:FL20BKB-&+C&/)-'Y^#/,B1G%^<'"B6$S^P:.
M.@WB\%(0S&WBACE+B%8N*.LBF*E5!,/N)+.Z=QK7-O:V7S>VF_M[U>X?U>_O
M]G::VWM[U69SJWJ]O?OZ[>9??^Z\JC;?;F_N70F07N\^7^=;7^NY_KBALP]F
M84Q)$KPUWG(&GJY73@@%5@FGQ.ETL2SRT$.VKCL-GE#_][/1J-U-OY_V80;U
M^_7T?ZXCMK$/K[WY2%,27@D%H]0PQ*G4R$H9$*7!8@-^$PO\LC ],Y0:QX+C
MC-N8C!!!41T5PXIQ02^/TN7'Y][F?[;WJM\/JM&$FIE/-[H=C^5D&+,NI+BG
MD\'7*;^MP7[Y3;Q.OO>F&'D^=[_VNW?5ZY**TN*YMEBNJWL[B(_5Q[=W/$N+
M[STJ^&U'Q1QVYERO%.:_3T<OQS+W+3-ZYM]+5UI#Q'SE.HH^K(9D_QC&8O>&
M"W1O1@MTVSD>>PMQ+S 4]=,?+4/SB0[-UK>J,5PF>-K#LNB@GSL;:BO[([U^
M7IUM#%>]^E=. EK2>3]G*:_4M,^K@!75+^I@3PZ8%!FOIHP9'LN8F"+CE9/Q
M7[&7GZ<6\:M#V_ETK^W\1<A++>0"ZV<BXP+KV\DXQ\&?FH!'I*ZNH?0/?);1
M.D5>35@NB9>&E8:5AI6&E8:5AI6&S3$"^8CUZ=1BCH+NYYR?ZL]HVX/#_V]I
M-[4_62DN]_)ED5V179'=RLNNW+_<?S'W7ZWSWQ9A@OUNW5GUZK[5@!=1A[[<
MO]R_W+_<O]Q_<?=?K5#&XHSQF_Y\M[ZWOFR&^N/)<KDD5\KMWZ=:X>4R69X2
M2B0ECE&NF'9*6.HE8V##^D3BC\IDR<O;3-_&+[%S&H<E3SJ#W(3WK<'AJ],^
M=%SL#4NB0-]M]OL1_@O[]MO2U#VYYW:^80G#HTWVX;C9:NYOGC=>OSL[.']S
MUG@/U[Q_=P[M$1^.ML\;^]OL8/\SN5S"L+$5C@_H#FEL-;Y^V/_W47-KY]O!
M_F'[PW[CVT&^'_S=V ^'N_M_I^;>5 U^0:DA,' 1BS(AKJ5 SB6&O#$F!J:B
M5G%MPY0*_"L6HBFU6A^&?IQ0CEFR5$C,/8Y.>L<DH=90FSB6/SH9MM!O\?2;
ME.7W2=(DA$41<X5X" D9KTS^57@5<1") _U,H5^AW[.AWR\WXF]8&NQA[;\\
M%*"S (73M1M&F7/V4QSFSNUT;JKF< $_1 O];D._2:5^80.WD6)DE8B()Q^0
M!N,/P> V/ ']>&!UI?XK^+NR/:B0;SQ[_G?9H%><_>+L/YRSKV(P0CL<&>-)
M&>N88$Q['QA7R:H?540MYN[B@3\YKP!;#5HZY5.\+0%SUS)D"*; ?Z*P\=1J
MEP_<T^40JF+O/A][]P[X<TEY1^&_H#D77&L3/#%*,ZRL%?B'IWD7_"T>?]\:
MK_"W&H&;'QFS4LL@$4T.9XL74$B80%0[R:71 FN= 5C"G06 !8 W^/L_9P*R
MXN8O"'NM"^Q1!1J):X:8EASQJ!RR7 :4X">OG=4ANGS0,BW8^REO?[5R$!\_
M=V(G;P3NU/5G;7MILQ1_4K=<;>*ST"U7C6OIP;CF@2CA%#<V.J8B)E%ZAAG\
MD$HBP;)IF=94(H%R1$@9%%+8:90K0R-+M$;1>D8L<81SN;9!Y=7SMQY>Q]QO
M2BTW(PO^5AQ_25%+A*=:4,Z=9PZ3;&*[Y WV(9*22;!\^)MD$BB=C&4BH2 2
M!OQIBZSD HE$#8R8F+#S:QN,\X*_@K]G@[\[IA+\I 584@D6C+])*D'RP>?S
M(1%WW"+.@\LG2R@$" PV"G#Y(P;KCZ^S^>82%/05]"V'[.Y@^6EIH]<I1$,T
M5T:9?,B*S@G8W!H:7%E47S[T31;5/0/N&9F!9P/BEC"4K71DM:%>A@!&O%[;
M$'012:0%?P5_RR&[N^04\:!"DMX+$7FP25LGK$H&"QPQ$ZHLJB\?_J87U9TU
MT5K%P.LU @#H(G*@P9!229JDP(H7 $ I2 %@ >"S >!=L^A_#H+%]5TX "?+
MZUH'YURDR'JF$&=<(0TL1-A;%2-+FG&:LXK657%^?PI^I3;!PZZOO^_VVN%K
M*\2J*IE;3U')W,'*QH)3I41D,E). W&1$2TI-\3 B]&7U?5E4S)GT]OTM16!
MTX0H9V!C8Y^0%5P@HG24FCE->%S;8*(DKI;$U8*_:_ G$HLNT&0,==Q+:HWD
MAG%,8O))4%Y6UY</?Y/5]2@CSB>3(Z]-0GEO/C*<2:19LHH934&":QN<7UU=
M*O@K^%M5_-TQQ/"3%F ),2P8?Y/5=8]]2%I0E()6@#\AD5$$_K#<NPBV(<5I
M;8.8>0<8"OH*^I9#=G=974]86BYY"$9Q&L'PT]0FA9,T3-!85M>7$'V3U75.
M:8K86P3FGT2<)(5<D$!"8*(/ECOKV-J&(E?)5RR_@K^"OY8RT20@'''><4:8
MEE&+F)R5,07F>%E=7S[\S6Q9#UXP)B52^0].F$%.*8.T<$&EK,!T6-O0K "P
M /#Y /"NJ^L_!\'B^BX<@)/5=1%$-!3LOA"Q0%PECNK%=L8MCC8P;@Q8@&3N
MJ>4K#[_5VKV^B!-T=GNV74[0*?<O]R_W+_<O]R]9:O/(4EO&$W2*E_; 82KK
M$^,D)0D^&H<?':>2&LTQ#<K;1$MZVI)Y:;O3I\A@+8T/GB'N$_AHD1FD(U:(
MB* D=L+*7/V J$44?UEY/ZW@;_7PQ[&GGKBHO/$\+_;'0+U52EJIA1_F9I3T
MM.7"WR0]+5<^<$DP%*R.B"NFD#')HD2Q2TY3[W"NKRBN'J10\%?P]^SP=VV(
M_B<-P%)6=C'0FR2E866D9EPB2PE #XP^9"1U*!!J";-1!)W6-J[+22O0*]![
M=M"[:O-%E?+2/B8N<6XQLUHRBBTF@7MM'"V):<N'OZG$M"2Q\I0BK[5!G J%
M-*8&F12B #)Z['@N^%=V9!7\%?Q=@S_".1$J&.(]XS1IA[54/!+M# ,[PI;$
MM.7#WW1BFK=@Z7DI1E4/M)5(<T>0PDJDA"EAT@  <0%@ 6 !X/5.[T\RL#B]
MB\+>)!W-)Z.9$1[)I&+>BFJ1380@1JBT&$QZ2W*LCZZ70Z-+3MK2K:67$U56
M5\-<-;%9I)XJ1D@R@C/,0*EX23758+EA9FU95%\R7=/8WQQ,%Q9SBB8:(\(D
M><2)3<@PYW*),6>TT)RGL+9!Z2)"K"M?7*P </4 &!CE8%M+0DS@PEF#!=C6
MF'GEE PAEF7U)01@<Q)C4(YPYB1&(!,)V-,>:4\,8D%Q$*$P*I>6I:R<JE(
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M/5_7 ?AR 'AJ59CS5*!OUU\<@ \*T.;L>>N.3K6&K>E4 (D-P6BDEE+'.!<
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MM)%!@C3 (>NCA %JP9A[SI([W]Q5;ZKC['L9[#M!&4K$3II;GUI0C3F35;2
ML17L^5V:ZK@RW!$6#YU][:FVF8!*GX!3!G"L!4J1B<'6-/=T<U<^D!1=&3H=
MG8Y'^LU:BS,V3"DP)B:63@'9XI3$28<[^\^+CH?.OA:.&'1"HBUPCC$ IV1
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MOY?#OQ-/;IZI ?WDYL7Y=W"H)F +DBJDM8X!IC+ ) E@;;/05&XSWY=)?JP
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MR=(R>HF1<FN'HP2OS>&U.1R %P X:J=6>J&.B'W$)=&TX I.0UO?='9G?H<
M/'/F<]\:EBSV144%S".":<F0 T_.W*BE#8!,#D 'X),!X!V+$]U3!7IQHJL#
M\*0 2\TAV1S0VM;WNV2$M5QET%%4%5EQCL.1;UXWH;PVD;/O$;+O+OY3[KV-
MG%*;%:U&FX4*8YJU=J;8W)U_6%@\<^=[G'&KM >3M&S=T08H886!2^KKZ*G:
MUA?W?8X>&CL=G8Z70N.8>TD35]!;L 24K?H_28J!,+2&[LX_+#J>N_/6&L7:
M$AC.K:-#6X)QJ^F;>*V&B;?B+/D6CQ(<CX[')X/'NU;UO9^ ],#Y^@P\^?1M
MRIJ\TL$B=T!3!FDV07EFSK)F,,O60/?UK4./G-^U0_^4C\S?MW>NIX ]' W>
M3,(86[6\L!E4Q0:-45&YDB5*Z0W\>=?@NUE_GIU;]^N1D1:I0L0:8=MGA[J$
M!'24NJ8=ZX@OSP]X@JPGR#H=+]854>,B6R>N7A$ER%31D,4*EV06WL"\=SKN
MB(YGOKYQJB&'#"5M)^[++""8%$JWE+CG7 K?TC%[T1&GH]/Q\O[$/>6C'Q^X
M%OC.S]SS%)X19DX#L%F&2H6!+-AH(:V'S+9=B==[#3GV''M/#GNOB\)<PK!D
MF4/;^HRSHFG"F6/D)0FUNZG_L-AXWHL7!Z^9S6"IR%:/),+2^PF6[D^T9GNM
M:6VQ\?V$UTCW=#HZ'?<Q=W=)>:J,;6#7F0RS+('8B&H;Q4J<"XQNZC\L.IZ;
M^K7C,.0 ' <"!F8PM X239=V'$M!;H;6^['XCJ+CT?%X.6:^IW[TF/EJY#M9
M^:7VWFQ!3_)L*VA.":I(@+(D(FLND[>^6.F"E>_<VX6?_S,D/KV%'G5_7\<^
MO3!-W^OV]K*)WD^;_'^[X[O] #_98^]7GWS\JV>??O;A=Y_BSU]?^T/0C=";
M?(X+G=QNYX9QFX,_?_U0I^"]7[SWI_'BC]]^\?4?QY>?=WMQZF/TL@/@WO(2
M?7P?W\?W\7U\[V:T=SWLW8R>S![!ZUNH,U&J-?"@-C#4H#;*NC5LH791#5XS
M:7>[!;\]3[PLFCO5L&45!04T*U!-%*P2]S6-D;D=CN1[!;Y'ZOR[R+\YC31C
MSH(EBK8Z),9)U(,.ZEXR:8?\.TNMQ$:YUU07\#!N&483C#$#Q3'$UL+&?:O,
M[/Q[9/Q[Z[I^LS;&\\>B[/_W;B?.%ZZWLW!Q;55(=*U*"1MS33&W5E"2S#!M
MOD%FF"]<UUZXSM*_*I.DMM:L:#( M1:0A %B$K)"D])M2X'@V0V/;.5R +X=
M .(H3#9;8EF"+RZU-ZO&D&.8RM;M#9*_'(!7W[DXR_#JK<=%.8$4>U[2/4RH
M<11(=4Z65-*4K:I5],,!3L"G0\ [%FVYIPSTHBW7)^ ITZM+2;GPA![+MGF;
M#*RD %;C3)U3+%8/1[QP/.JM%FUY]/![($E>N[N)WE;ET2XS=Q#:M9C6.3IW
M$FQIV.QH><1>.Q4.;A'N;YGYEW.+D JE//NVR; 6&+0>0$T8)"^-W=:7,.AP
MU&NTO7[TY<&<?X^/?QV#:M')<S3L84GLC8(E<FKK_S6Y1;A#_IU9A#(W4W?+
MC@@I R8TJ!,;2*HV";'J;7G8E!V #L G \ [[C/<4P3Z/L/5 7@2@+-JPRH(
M)=9- ,8,AIIA:L]*G>.:U\,QY9O7RV-[<5B'WR.$WQW4GR311JWVK8QEKV38
M0FY+Z,54J/?_J6FUJ[]W ;_SWBEI"?:VU%_&T0!KJR!U%N ^1BJE:^QSP>\J
M+I,#T &XC[F[ P"3%E'27JAL12M-1$)+TEO-F9#>I,B* _#JVW]G/CL%%%,B
MT)@%D.LB8*X,V33TN9:UPKS)/^\=Y01\.@2\8_Q[3QGH\>_U"7CRV9-P9$X,
ME"@"]A#!!F?(3:3'WF*DLF4:>0"\0Z/]*1_!]>XH#WR5N8/.#JE,7A%IH=HQ
MS&!C7> *4I?,#H'+<)M]=ZO,[\]M]KK"(QR9(,V,6SIK VFSP]005_ TK<ZM
M!0I>0V8_^HPN!^#C Z DC8T'3PJ,-2R)'22HJ'%;JING^^P[!."9SSZZM&38
M(?(@P* 9I(0,$0?KU+'$]@; [">:'( .P,O;#/<4@5ZO]5K8.^D^I3*C+;47
MU!;VFBK4;AE0!O9L5D<*AZ/<./8<>XZ]2X%OG"ULM8I2-\Q$BK-CPCK7_Z6H
MGV3?(P#/'':<*5!A!JIY.\6$!6SSVLM4TQ!TI-0/QYQ>WUQU #H '8"?-ZFS
MY]"M1$); 6_7B%-YY!A04G6'?8< /'?8T]+G-',!'E(!NU:0M&+@N4+?7-.P
MV'$1D*(3T GX9 AX1X?]GC+0'?;K$_#DL*_5BQ/5!I9U!<$#5Q#,O&+B-FNG
M5H*DO 7!KYL??I+]71OLWJ[D4;4K^>CC?WWVCQ^^][O?_^ZS9Q]_[%U+WMU,
MO/>+]_[/LW_^S4>??.R3\"XGX=4;\=Y[GWWZT<?_[F_$.YV,SSY]]J\?_>J1
M=%/R[D,^OH_OX_OX3WY\3WU^NZG/WGWHH>[[W<'YR&','(-H+@D#3^T2F.RV
MQRU/$\]YWMV^7_M>:3%JEIH$Z(6WC!>+H",DJ+VEG )I:N5P)"YN?+CQX0!\
M'8"EU<XYV@@YXNQ6"R:*U:CHJ&-Z^Z$] O LYSEBJR%NQ<1R'H!1%+1C!VP]
M#!FYQJVV(@4'H /0 7C9^+VG"/2<YVMA[Z3[3'$M1:V!6FF 8['/(E?HB;-J
M;TC%MJ,>-^+<<^XY]RXD/5.4T3/.R(A<J#;D(+.&/N-8@O -DI[G5\__9"_6
MW_77%Q\LL/:O7KSZN6O"Z\/Q+!]:0M <(D$P6DH0L8+0TH0CS&BVV,@8%AS?
MCYX1[71T.E[L[64V)<QL<RM>162-9(Y.EFJ3F(9G1.\0@><9T2L<SMNQN(6_
ML 0B]0J6NT#!,2S4F7GDPU'%BR$X 9V /Y(0?3^)Z''QU;AWRH,>;&NQVHY^
M] U^L]G2?L90&AJ/,C +WP;&WM3PZ61#[^XF>E^OI[?$O"ZR(V:UK&A;Y:JB
M(E*XK]6F31'B'-U\W]UB\X=S\SW8=EJ4"I24&9 Y0-64H<Z8J^6LM='AF(/W
MM;FBQG8 /AP #IY&-;=4S3 S:K'"NB)6E5)F;FZ^[Q" YP7'MHU6;@G2P E8
M*8*E,B%DF0&I!=&X .BM'1R 3PB =SQV?4\5Z,>NKP[ L])CC+G90%#L#;"U
M#FID(#4R2BR]83T<TP47WLN:._L>(?ONTM5UX*@TIR[9AQJ&S:4#VYPV^_J7
MKEYU;(?L.^_K%2O3Q (<!0'7-&X-716*:LZT,)AQB;^"+OX<@ [ 2V=O8@BU
M& LML9#+M)Q,PE9[.T0A2^ZQ[Q" W_/8U_)$33*L56KSV%<@K'7P4G]4*TY-
MMWVM2_2^7DY )^#EZ/>>*M ]]JMQ[^2QMY1B'"-L+08&8 X%E&:%WB?/J!AZ
MLL,Q7Z7@]J/GGA]K?[L6NW?T>JSKRZ73[8A+4M<TI6)LT73VDG&6$!M)9#?8
M=[?2_.>YP5[$1&)K$+>.D<B4P&+K4-$FUQ2':CL<A3V)U9-8'8"7#CG-Q#W,
MP)(RQJR5+(H8Y3#[#!/=8-\A ,\,=NDF/:J IB: A60!, U01BX8@XFE!<#H
MISP=@ [ 'SO=?B\1Z#L,U\+>2??EF%N/M4*MHP!.&4OR-8/!&,UB#ES*X<@W
MY-AS[#GV7M=]'#C3B+)X1IA'41L<U@LE>6JT&OQP^\-BXYGMWBCDN/X'EM$
MLS*LV:TP2\(1DLG<FGW%][GX"2>GH]/Q AUKB=07\T9N#35S'7DD*Z%SJTDC
MO8'Q[G3<$1W//?E.?50J&:*V 8B<P%(*T&:=D_LHN>0-CR5XS.QX=#Q>CIGO
MJ1\]9KX:^4ZN?.TU]RX&K6Y[A1(9:H\"1:>F%CEB38>C>M"\5U?>VX ]D@9@
M+S_#IQ_][I^???KK#W_SWJ\^^?AWWF_GL?6;\/%]?!_?QW^JXWMBXMM-3/1^
M.X\NMGY]ZS$QQ]Y8"[6"*LGFK%LRM5&78#8](W%O4?;FNIR<Z58&4P\9>K0
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M65^=425GSI":""#/!H;;K@.UDA"'#9;#,<4+77R]L8[#[Q'"[RY5;[64%E<
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MN0\!.ON<??N8NSN(OX"::[06<Z];FZT:R(1KJ229UX#NL>^0?6<>>U'+VG5
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MM;!WTGW:8TV3&N1:MB:#"X!KY<J@J7+:F@9Q;8=CO/'B'8X]Q]ZEXD45HZ7
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MZK:6*@VBRE-14M/(9<XZ:@EKT6GFUOZ#6H6^/;?V0XAUSJ6_<3TY@*4K"-,
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MOHHW:',\.AXOX''.*!KJ9*&"W:1&J5J+:(JCL>(;&/".QUWA\<R;GY;2HN
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MF2)+(=3D963VA])\[L]6DMX3#] 6%TFG9+ >E\[$$GJL%?-8H;=7:O1*C0[
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MI+ZMJYKKO]QG16S)HG0-,(C7RYV[0>V5(2R].FHO90H>CN@5;!^9JG$ OAT
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M'AAJC^8YRKO;T/SM7\YSE"4)2L(,0[;]3)X#9(0 Q2K7$CFUK(<CH1=Y\;.
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M>4@)(4D=BX#%2V"], )Z":P?G+T+RVU?J02]W/;M&7@RFJND0-H[Q$P&F/H
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M#T<,?@#9DS2=@/<0<$EGJAB5%]^0+:_')FAI@3 F&M;</MXE 4_V<4'I)$$
M.2= M D\+0&W,LA"H6GU<,Q(3L"714 _@/R8^PS7"4'?9[@9^4[V<1;*+6D%
MBW4 ;BV.M/0(O:8\<Y3):Y*.L;[Y\(3.;A]JES6/E!<\6LDT A8>&(4IS(8X
M8TMS])3=/][GPWWF'\_)<3., ^>E;9*LP*XE@LP2<E]0KGD]W(W]]-T+DS5.
MP$?RCZNU&<Q&J 6+!$[&#8=:$Z)<W3_>)P'/_..E037T-J#660 S!B C!@H!
MF3A8TWPXKMEU!#H"'8'WIP5?IP,]KKL=^$[^\9!:-YL8<ER*#U.;P$,FC(4_
M#6)1R ['%-_XKOY._6/OV?%"NG5\6XS[%U]^\>F__=1[=KRLFO4^OH_OX_OX
MKW5\SYQ[W,PY[]GQXH+J>U+FPAR2"H;"&:-EDJQLHL7ZND!:/65N?^$UGJ?,
M::H]YJQ@U#(@]0(ZD4$S99XU*,I6L=ZW%7U;T0EX'P')$*WFV9-&G&I2N>C,
M,::.-I4]96Z7!#SKV3'[FJ988#VNBX!3!2AP@<)"(8?0V;;S*5[9]:41T%/F
M'C-E[CHAZ-;*S<AW5G%E8@M4" 9R!!RY@\S:@;E+YU*[U$4^1$^9>WVR)I&-
MMFX$Y4G(K9/6U"R%;%R8JZ?,[?/A/J7,)5L8GK%!P#E68+<>;NJX5:TWL:5L
MNNA8#W=UU_2%R1HGX",1<.2*5D8:2]%H1;4IF&)*ZU'",JNGS.V2@.<E5TJP
M)(4AS;XBNX8-"#6N\"YG"]M4XE9UJGS8DLP1Z A\=0B\-ZZ[4@=Z7'<[\)U2
MYGHPU="VOK.+>9AR <9,D'/<EK1-_:W +B=/F7M%*7.[NXC>L^/UK3$?RFS)
MV&?7.B0G3#*T&VUGO8)8XM')'>3]K3;EW$'N0RQ:,AA;TU]L7$%:7\M.%LL!
MA6><AV.Z1<6!%U_=RP'X\@"X!%GJ/<]L>>*,HAR6/J/!2V>SLKF!O$L G@QD
MJI)S3AUTC XXK( VRZ <K6HDZ2T[ %\> +UCQR/N,UPI WV?X6;@._G',GD8
MT2)=Y 6^6A2(M )3QB MIK6<'8[H'3M>GZAI<VIH(7;>CJ=WU:UX4H[-9E$J
M'-T^WN6S?;*/J;=@?3W180H"\HKJ.)0.2^O,-G/MG,?A>!/WV$6- W ?<W=)
M5(<Q4"0J$@@M*JOI9!TDC?+4X>[Q+@%XYA[7EFV8)=!9#-#"5G<@5XBTUBM6
MZIW2X>BM:)V 3L#O">JN5($>U-V.>R?S.,22DAA!KA8 >Q#@.2J,6&U(U"4,
M5U27\TW,XQ=//C]U_+CFL??K>*DKS#W-SB5*S495AF%)I*T))@M+M#&*FEO'
MNUMK_N>?SZWC,2WRY 1CC 9+(1002A,,L6"WOM8>W9R36W2&>O%I2D[ ET=
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MI&(K%(NGHNTO;/WK>2H:2Z6Z)A!*B!&0<P1NP2#3FL9<M.695]3J,:OOUCD
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M3*91%PUCU0?D@#H!;T_ LT1/"1,[<H:Q6 A(J8$N\,$T12PCY$"Z$.AI\([
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M]_8Q=Q<(/^%(E;#W.BJ2+<Z12(A; ;.A.H/[[+LDX,EGCQ.34%2(/?.*?(V
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MT GH!+R'@%TSC3QL\$1&I<!48ZWK?T:-JSOLNR3@F</>:A 9U*"UK9@'TX9
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M4\Z\5$6*+;K9ODOXG<SVPD5P:\]A%K:6;9F J0^PTCF0:9.9-[/=&Q8Y 9V
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MTCC.6'(6;S^S3P*>N>W*2IBJ0&I8 2T6(.0&)8T4:\4EZNEP;.B;@([ UX/
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MMK1#'C/D>CC2+8["O/AJ;P[ EP? UDO'S"M0S1/)FA3E24NB<>J1]"%E=AR
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M-=:!O$*GK>_W4@_H=OLNZ7>RVS/WEE)M$+A-0%D(Y#X7_7+L-6*3.[L]LD?
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MQOJV<%]3.5,)T;;F"WZXR0GX>@AXX5;#E3K0MQIN3\"3VYXPY5+&A*7VVM*
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M:BL!]X> !=&E(<F:YXA!JI303"N^Q#KTF[Q/;QXEX/8)N S&F^"EM)2@YEP
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M]BO];B']UHFV.T^IVN9JSB@F<XLQ,5:;2\><C4;;=Y)^RVA[*4PIFPP.W?"
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MT &'FD!B-"8@]][= I#!;V/6I )2 ;D;MEO3>]Y01*KW? ,47-:HN.)]L87
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M#0#X0X]IIZI@^W;&QR6LFAGV8W%(//R!_KKM[7\ZN=P__C,ZV(+/)Q]Y&+)
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MPD#C"6]""+V7^8%X[Q-=X*?@2-;>N%L[>STI>1P(XK.,D"Q)N> J8'' F)#
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MGG<4>;[T,I]S&VB(ZT## ISEC4BG#V7=EEBPE8_'0*'CE+HJ3@2V=0I<&H1
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M:6F?CFD'N<[)UA#^M5&Y9IQ%VXXK'G3+*]H= .$M\@H&K?5D_&*!5@H-U-^
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M\ N2:.!G_GS)*")#[@[WG<V]=T^:A3_NJ+8Y+G_EI0:-;+PMV-U-!X)KDFW
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M_\FFW9& ^_4+@A2]8"L#R;])Z0!+B3-2JE*O. HHV1,>WL^78IC2+J]H 2L
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M5 9B/K0I9[@ 3IT<=)IV A> [\8. .@TII-,^H ^&T9/TDYZ#:1.X"7OX72
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M*+ AGH@.-G2T9[52B6Q\; 5WSDY!6NJV^D;ZWR?ICW H*AY5]3Q%[S2,+$Y
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M&:@<%58TL)!2M;+&LWT N"#"I!Q\>"W&I'IKT<FWH96PT L;T[\ZA;%"U&U
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M8F%X#8X=R8H,,;#QI;=S>OZ*(7.L]X+]GENZ>C2ZRI(Z<8E=94$5#*=BR!6
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M3L"E44AQ9*,^&;%WT.]A-BH?4AL^ROQL' 2A%V+K QB55PCW#U'BPBO/@"7
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MK>;/O'W68U@*MLMROEZN_#5:F+4:R^/BA"UG H;9,H&6";1,X%=F GK/;IG
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MC.)55D_^#5?/2P9#(A83'YN1 96&,/#$ASLFE*02N4PZ\%8O&N/)E6#=$KB
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MAU07WIT"YJ8BO!'>:O"N9K:U/8F.V$9L;\:VJ6T#$<0V8GLCMIM8IE&^RUY
MY&I+(KY$%Y:;(*8>N1S3<$)MEHA7(M?48Y%J8;X7X^$@"!T6B@? $D@4>*Y#
M9H25'Z9/:\+G3I ,/#;[PH.74HO?;\L+ >Z&KHHV>S(;]6Z[@"!)>216#[MJ
MIA]0+Z%>4EHOM:W2.]*@7L*TJ)KR815QTN/E4J,O0:(?$=DZ(KMIE*[V$=F(
M[&)*678;\JTRJD5(;"^F8%!EQR44/B5D";#]1"Y9:#,_IB-&1B&C,0M)/(8%
M\V,A) B)'\1DPJ@/?!@FWNR%-7F]GPX!6-3UR31TX67N&0T)G< "XXB,Z2TC
M \9\$C+;HU'D#EWFD#@ Y> /@W B?DW"$,@CKYR&+.*TBG.3@?.44/)XC[5V
M2+#YCBA]ADKR\#)DMVZ01-X]<7W;2QS@$3!43FV^\/DZ1O<5X(:E!3=.. LB
M%R0G&)*;JX/#T^/C*[7/MZTEN3S?I@/5[\:N/29W-.(J*),&QXUL+XA '"(V
MI2&H;F^E'(A_&(1['S53WB>32>(+Z8:W#IS$!IU-[;'+;N&5@RD+A1ZF'NQ;
MP5T\YH!L&K!I 97L8 (4D<H<] 2)Z(01N,(-'$+376 4$"<$(/MD< \D" -_
M1))I3+\*:%_?')\>7"G>'NT19&L ;%)+HIA]=?UD0@?ON%X_#(.Q__>(HYO1
MB!'J.^2S9PMN@]8Y##PW=J,ZYQCS1\!VN.;FZOCLT^]Z,TL'-50;)1'SOLYX
M=1D%H4LCS@[!)N/:(.Y<:B<T_,KB5#P-<C-V(ZG#*%"!>J#"@N$P@F^  !Y>
M?#DY>F_VP1;S0),YQ&&P7L<@.2W K_792 "!6P,@XS;_*ESN!7=@#40\F\JE
M%_!P<GAP=(R(*!H1KC_TW&^N0(23,*YPP4H+N>@Z8H<2MO9>R ; U4C 9. &
MD0N+ 27,]32+7:['#?)@>YIYFO!]_I5]@0U@_H<[UXG'\N1ZNIZ6973;L]8,
M#ZZD@RCPDIA]2+W31OX6B]?D?%/N&+%PV>E4C0?MYB+E\C_'X=Q='['W V#,
MU_=T"&^U3[T[>A^]V5MX^8GK9W=O=N#Q#ZCTO:08#HLCA>"<P^Q 6@;[!-;%
M0OXUOGBJWZ+).&3#?[[YP75:MC7H#ZQ>NVVV+-OI#?NMCNVTNDV'4=,V_VLV
MWGR\X9$'KOT.X9F W.@?>_3C*FCH;1;>@#TWI>(%"7CIJ.O+T/6:$EL',H-=
M9:=!*[%YAB[<'/XX3D)P>@C[-G5#&0+YQ 9A0L-[8C7,MD%^GN^K\/(1*)/J
MV$(:\"T73W2!:]QAE6S*N"G-8>!)$D>NPX1C^MEWN05['7/KJ [&;Y1XL0N>
M*'R?PI_<ZP5&\C^K9=SJP% @>CP.P =-.6<0<N X;AIU6&W&DCO7\XCG?N4>
MBF2GY.4P"47$<H&GR,H78J44GFV$T$C[X_NKY)/FN9XJ613)%^0C#P$L:E?8
M^SHR_$#GLID)9!#R6* /&E6ZIL*?$XR5.#"$K<P_Y??*K)MUHNVFF.!ACC2V
M(:3]43$75Z#^?F&P@+JN5#C<'S*.J&0>&]TV+-XRND\)BT]#D(+0Y2D&*39I
M='R&X.O?SVX^_X'QUA=P!68*AVLX_H='$]\>YS(5FG)!!_K_Z_/IYT.]86[H
M0.?-J8&EV/[EU?$?)]<W>K-%!ZYPC<.)?7CQ\XGB+6SU-U;V@- 7I[K#6@-"
M/\Q2Y4S\.BB;2&@9]DW6N;CQ/2J=LJ.?"\YZWAC*LL%I+E@D/])$LE$EV_^<
M)6$0V2[S[<>L?KE/SFW_MF$]P?8WR"7@AO^S$_A@;(+9_QX(*R.2?X+_P7-,
ML]OS'?M!#<ULHSXY_W+\RP&Y_GQ]<WRN^J1!_17;WF_'EZ<G%^=(YZ)+EJ9Y
M$8$_)BX/#[X36BD%_<W5R;GF#K(&K-B[N3K^<G*H^;:L :'), PFL-O>\<R[
MR^OAHQ@\-5G/,^5Q\"CF>Q,O\F+YW6&5/V=3WW<'0(?_B3U+A$1/KB^/KXX.
M3F'[/D<SJWB&UD(WRE38NZW,J76Q5%7?4+?U9B<95IAWJ6&UV<I[2H17ICU"
M=Y"(#$GZW4QL6<@>V')'!U=_')RJ/LFF HJVYO!*_F0B:VSGQG6F=].X+\\U
MB3RS+_G#<TYT>E\GY.3LYZO/L"GJK4.U8)4["!-PC=Q5I:]+_!IYP4!L@YFJ
MS;*23OK1P[C^\=7I\<$1LK%P-E(PX9,8;NZP=UL9, ZSX49N7C^2/WZ_.?E%
M;V9I8;?0@<M/.H7<]:(VFSM>7XY/M4^J:\&!01#&['_!)*?V1LR'N]D+Q1*B
M(H/( GQ^6A!N%,-""'7^3*)XPG4CK]Y%P^*E*Z#X[C-T(]Y],&*P#3GDKP24
M' NY'K,:N2,XJ5W(N>JQS%6; J.YZN/\#9D[&21AQ 0[^6F/)))UI[DPKJQ;
MI;EXKD%._%FU3IT\M'R%";KFI(\#B[L79TOHR =T1>E*>#46O)*TA;(7'+IA
M%,_>SVI8#>!/8'_E+Y![RT>='"V#QI>)-P%G(;PGO]Z#"P .NBA7VRIJ;+:?
M=)+2D(TL<S>XN+S^?*;Z@-$*B'5M0FV7'X:@OMP'/U_>7!U\.4'"%TWXB'GL
MFSNEHW=27SUP =(2P2ELCK$4-,&@Q5.155(XAS1TW."6PC; 2R?WR!G89X/
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M &[5+:N% $> 5Q7@O*A?UZ038ANQO1G;36UK!1#;B.V-V&[L>.I'Y:&M2:V
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MM,8XE&V=E_?4.MP_UO(U,6F\5D^EK)9ZYIV4#Y;QFUM&3^D2FI\H 59?OKG
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M*[)W<1/\68/ A^(_Y*1"G,SYD,A)C3EY..8YF(>#S'>[X:T8_+Z![ZFSRQ\
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M7[/(NLZ.T9I;&QW#*K9FX;&<!EH2FJN@@WG!G97+32P5W!U<7Q)@&XMB-TX
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M@+=8($U&P3N0I%G3%_@^W% D<>&J1 JCR->RD6OS_E,>':1%CO#"_.&#P(N
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MD/Y[Q(G!%IM#\IC.^UE,1Y2?N#Z?(LCE*RU*J3\<<B5J)5>-=0*('H@+_Y4
M\*Q>/;<.'EL23\EF_8C'O35-HSD?ZA2)[KDTG)\J!1 "IL1@)UXU8[;FG3(X
M#&2G**XH><,Z/\[ QNF1GACCJ^5W"OSWHX!_\_#BR\G1>[,/4N)&;K0\PHKW
MOGO/X%T3<5[5A1>>CTRWLXDG\KZ>"V2!!]US&1JZ*5F=@ EJ<U7.(L;_$50*
M:&-W"$#F@L@[[J5MJF -7T&3Y/4%*#3;G0IQB<>@QE8]7JY:=NF\Y\0**?CC
MJ>H3'COL 2STYYJQ/E<5<)\I*#&X,/VF*PNS;"%6_*U3!3*4JBYK_#?7O$+)
MP+=Y&  >,:6PQ)3VH&>!/T0V]$I8>F*/*QC0UT.@@,OY!(1)%39\SE>=>TN?
MAQUXVT';2V0\84&P :* "M@>IU+71BR.><?CJ1NXG"6Q.Y*MP^"S 2 HX$-V
M9#_E*85O!+>IKO"!1"2^"^0+P>T%SB*Q.V0G#A?1,0E\-PY">4!YY 4#KO[I
MU!7]QM*W%QV9X:<$&RA<5Q)/D#KF*I4_CO]_ GN*9%MVC[LQ\U=!&%39D-X&
M(9<WL;RG"3]H_H@W@<WM1$",M\W</+4TO9/G9UTV2UNZR,K7K>7.8P-.LR4P
MWZEG^K04)6IMIT1)J8O<4M-S<S #(W!FKG%H/,<$R$1J&8A=UB 'LRN\^[K8
M=.=3EP0R;@[_=?!0\\T%G*L]H6TXC[GL\J]^-JX-_ER:UV:B$X"3V*+U>117
M9)N=33I\HJ0)#;,D,ODM+M6=@I(WO.UJ$C[HI. 'X00>QZME)_+?>;]W>B_M
MG2#,KVGHAI%,T"RN+EH8G2C4==J?%0PH4#6>N)F3\'U1[%/ 4&Y&P4X0NH.$
M/Q7G_#USSE\3Y_SAG+\JS?ECZ7@<OI'PX13Y3834N(5[#D86Z<T]7U^$7X3R
M2JO@05==Q_ /<KJ&L/1]WK65F]A^7H7^[8>>978_1.3 ]Q.XZHJ)DY^@ICZ!
M7B1FX_V_EY6@< _ ZH!['8$;,/>=K7Y=>/?O*K4K'67E>%5ZJ0N?'(!9[Q&S
ME7<;?PYH*$;\'KG@X0G;&X33HS(Z$[)1 K]+2R6K4I2.HM$P"7=*1+EB?>;V
M HR$<]J7#WE0T C7AESX>:,B_L<9V.A6)XO 5(S@_TK /+$:!=-['FCK;4GT
M@V24@%5CM3.ZY]UC/K?'CH61.O<Q1:2 QTIMH7'AZ3(F()>;VD3PL@L+CRJE
M%2YN?CV^(B?GGRZNS@YN3B[.J_1R_#X'<C8!9^QE&/CPN\T6VX!4X$6O^(PG
MCFVQHYK;[ZA\2^3!:CJGTG2!2I4"^S&(?C!Q;>'=G,F R2<J]%657G,>JLSW
MQ)?QI&RN5Z8%>4Q L]=;SNQD;PD8OZ6ARS,W(K#! Q^BRU<6TAQ*5HN))7RR
M691%"6?!/N+";6UAJ<Z("'L1#VO,"">B<C-9DO&1+$623/FW_2%WQ>4DMUEZ
MA\;P*#<2,3P16QD&/*,1/=*:V07[U(_WWYN]7#F1R%\*STYQIY9;Y5;G@QH1
M,_'@?1XQ=>W'%[^8*VX9,BQQ,0LWGP4.\_85#P:N285R6P8L*'?HLIQ&F/ W
M@IT@#"(9JAZ+,1<VCR,##,&V"N]E<'?HL6]NFD1P&(_J"7\L#0#"@A,N:@G/
ML-2YA("C98]EDF,^;(/8L%31?#,W 5Z,-9Q'E'G&(1LIML*.1DE15U*ND^D4
M3.?#,7CK^HE)YB,(A\'CPV3HB ETI_F;!9"#+@]BGEV2,54GH=Y[F:A:0#!/
MVL-.8'M!Q".\:5I(I$%$;M05H0V14N.942X:V1 M$;B?T#_Y4-$LV,KW%QG;
MC'BY;)J6&\,KO>?I09[_H6+]S(\2D&'JL+]X=E)NBL,AXT4B;.%^*&-:R=C/
MF>H^G!ES^HA:&,#.$]=EK1);:9CR3JU1?D?*E26P^"X(O\)^QJ]ES!<9BC!)
M\^,BV\NF-,Q,O$RPN</#;H7OX[E?V=S,RQ(>N>3XA+%8_)L0//Z/(D@0N]D
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MC_:C@%)FQ&G.N!$O14H.$;? CR"8D="X9*40&!UQ)#F^'EBARL\.U/(UINE
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MQ(YE4 &8WLD&B=:HRO1/?FA]#4&3"'A^&M,,OF+Z,?W=8,<<4R30]JW?3\-
ME*]WV)B%V(D% Q\1 F??J.:N&VWMU<FP3;18)2E05[<WO<YMJXO"U.[<7ED-
MD)\\24O$<925!:4:&/^6-KJNU4FIYV@N,8\D&@0$#8Q%[W-DQ964.PF6BL\0
M]8AQ3SW5%E/H060U"!'L[S"_WAIA3KX/55!9UAS53W*?4U3<+Y+>>"H;?[)X
M[9BQ(WS$,TIYQ><$:-NBY<K,B#&\4H1'W)7@N)HE(D5U!\-EPA59H!E#X@73
MAL,QM'_^V^USTP-&@@M@Z8HL2  /I?7QP97C4/DWO]JUKB2)YN'(E1Z3,:-C
M,B\(7QR-"/O3B-D,@2TJA];?E%DBVP[/=W%%#N-X'$*Q>K#9$<Y$SG[@$-21
MCXL. L2=!1.(D@;Y!A]]'H7 IN@XF/OH.F"KY8,!RWX"03!^(2Q\9JAQZ]?V
MXXE+!0SJ@AV&*PY1/;;49 @SJ\R>]\D^XU2-Q(&)\\C]I7UDUN"/10$+M]D:
MD/1=#3UWP*@D9D_NC3E9L-=L.69#[5K7?I^.?A1B7_L&&3)MMM(>!7SI,9'-
M)!\S1U\+)W8LEYNS)[C+97Q%URX%'/G*E8+VA<G#7 0<Z$WPD3 QX$+DT3XR
M1X&C1AV\@>VSH_P%FH?<XG+B,!:IV!Q=A;\[VRU"676;3$U&%R0.T\:<9=?S
M*IF]E8$(D3F.Q (/I9%MGGDF%#PF!392'_9$\&9C"K'-A(OI_0NL!!YQ36[E
MAO5+OO-<'B?KB1J#N0>) 11Y6HV:<R"-U5'\S:_,=M*9Q\LN!N2JAH@*!$/X
M>1F54<++BS),JLJ$32*,.A"((@PVY[X[]ISEEV!L;?.0-;MC^D.XX2AD(S'0
M^4$T@)QF&'_=K/D))E/R8BD/,7 $^?8Q3'"Y>.CRXOY[D:VP!IZ'%IQ.1=S=
MYU3PAJF?N$WND#B*@4*J=4E-9=GH :+T1>R< LEK_$_NRSF!PJXX==D6 $D[
M>%AB:KLV!C<K9IH6*#U^!G'?,PP8<O\\'"@\=/! [25\S/P9T"IBJ2*<;G^[
M4C/BH:>%SU3XJ.AR&,*Q)J'D"TOJ1N ZPPE$#Q:D8(5S?J3[A&?B )Y)# /*
MC4[BJ'0#3I2A+2#4J(1BAL88C,]6Y2]F!V[PRD>\BZYD&3E;1A)9?>/87?2V
M/ \W1CON<L?$('\&N4FH*<!RP.E,VF#?):A]B*+-V<YL_T#F?NJ6C)$ ]J7_
M<UK)VICX#-< BX-__%&UV4@(F!^P;6",[4J21"]6BLNG&@M3;0[<*;?K=K=K
MY2AN5\-4;E?E=CUMMRL$C;5F4WJ(GHBKNK/HE$_1D69(,K6LC_46>="L1O/F
M8ZY<:*#RQ'4+!T+8E*XJ+"&FLX]1'9HP:9J!0+$O@%7$3MS[A<C^)OP6PG8U
MA*L%;6-@.Z)ILQ!S*QN%]7"OK\.)'?8A>^&-7((;;/#$GG_LP.;./'QQBCQL
M2@+>W72LC\UNS^I8#:U;;UE=[?:#9GV]:_;^ +_:7:?9:UKD*[[K6G"1,WRN
MN/VU\X8HT^8986@363\1R2OF:^-^NR9D#)!-51\,F%Z+;->6V60Y<9)$.T&4
M'!'P0@@T9?VE+0+U8IX53C())1M,!J$G]DP2=L7WV8\\+@GEN3URD48/<L%1
MB%DB(IN2DF?9>&=L6F?Q#MZR@3=WKU(++>E"7CMT0E+<DK8;,W'+CTQ<KF+S
MYG%\F:E])UO&D3WSW7?BE_?,TIZ-[,4[;X*+@3>M-@QEPW!=L52KZJ9X_E(3
M8JY+ZD6ZN-(6EJZ:1E'>O?8+VV]/NEI-Z]'E"[WXE(F]U+3-])Z=XK0KU9.D
M]D5I']Z.M_%VCM/]=_W&?6#3]*RW]/U .^@7*!/2VN@[WZ&I\@O0[,@MGM.?
M<!:]+!=)J!7DPJ!VP3<A)&?L<9AF^Z680M(%]Z8O-3[)Z7XX>^Y)E_553+FU
MTUZC0#"UUX"N\>%,^BO^U8+*F>_X^_$ZODI[.Z[_^:!K;8!Y0)N#;<C$M&I/
MSMU2QS=9;<WF!,D";=[#KAW>CSQGM( \.VR4P\Q6!*J>SJ'<!%%$%(ODCD6^
MV+^\<3A^S"1H"T/'MS_<0+MT8TQS)W.-MC-("GKS?QS'=0>#O&K*7Q!Y^KPH
M6L/Q! +J!2@Z[QTBA&G0[='XYK&7%H<[;(X4)LO0TIZ7S<)%K4:^Q-4E?'ZR
M954"UM-'L?@IL+A1+NJ5HN+PD^9P-?Z1>34U;?&%N!>C@ZGK>0/\EU<]CRMT
MU14]#_LKEYZ@Y:5 M6,?@8^GF*<C\+Q0JI8*%2,%/>\PPF55 IYP"BHFSX">
M=UY6''[2'*[&/S*O*CU/^?,>^_.80E=>T?*6D#XS:P<J3\>6=:T5C4+5,)6K
MXZ1='8K%MREYI;)N5!2'GS2'J_&5,R\#2EZ^G7F89)%9.^]9/1D\<QU&8//1
ML.Y&$P0]M1.P5*B:M8)YGD)$*P6J9E4ZE!LD1^.G)?O98]M,S44(CY*AY9J,
MMU@!M4_>> (>;4*G:0ER_ORYW!7LNYQ8DY>0RYWE8D*-3HK&CD5_R[ :4?$?
M]HVR'QX %"S (GQYCA/T"'7;F0XG/B KV^/9>_G74EFB-P&\C<D91\'$)K(2
MFML>81,F0KE&I*=9/*=VQG-J;8Y;8D.G[-F(S0QP=Z#9*O4T<?L;V_<@BC4;
M<:F+W\$]TG> YW^J["A0D>V@(M6C@(J81JJ@(N*[[#6=,T9BZ%K\CF 8%T^G
ML((<R1#D2((XI\,!SP5C4)$P!M;W3\W+9N^9,0D4I^\^Z25.<W\-O7LOD.QO
MPUEO%,]^FC_YI7/#</1A,'[UFT4?<%AP0S>T.--GF5&O0$T;\,X,*+7KD4@Y
MK&LG'(E^#>?VF5%Z;;\1:L,FM%>FCO@A-CF?PG=@'$ZGHBGOM>?W]L3USVY_
MC=P%WH;*53$" ?F C6HB6+/^U G78XLI<<K(I/<6)W.#.)FG+DZ/$'F5."EQ
M2EN<S/6GDYG'TVFC5-2*E7VD(IQ//'^XHV2LLW@-0^)Y*+')Q*3W%IOUIY"I
MFZ<B-=K.I]"+B,T)PXQQEM",HO%N,Y)T=H"W:C7=K-30I;(!=^N_FY&'RGKQ
MXGS+]6TW%W5C\T53KY;*!]Z[==1J5:]5S1UOS@J6$JS6R06EK.]G3 ;TYDWW
MD%A0_H 8\I1%TIP \+GC:@V^A6MG>!!XXG.QM;-?7,(\MV<SWHT;D2=ASZ,6
M!EK##FPT-K1[U[%#GWH5K/S[?MEI:8']0&T$H$M6O\\/$_E(1"''+XKATTX6
M^E<M.A?H[M4G)=!Y6]NX\/3L7]/)=+Q@-E0 /?8@R.@,W;&MI.GXTG15;REI
MRMO:)DC3E3URH+$9_-[R)C_N;=]5LG5\V6K5+Y5LY6UM$V2K9=^[(R55*4I5
MNV,IJ<K;VB9(53O>1ED)5WK"U; ^*.'*V]HF"%<#&C1B3J%TI^PC6MS]7&,O
MEBV^4!-+R C/P'9YFIYE&6(IO5.[9=YVRRML8-FV'S9XB3&B:+SG/\#SBZV-
M-<@KIFZ8_(X^W &]QP]W0A_F==;5]IWSB6TOZ'GIXH)3S(:N7!RGXJ"4:L6!
M2LK)14W!42KOCGE?5J6RV_QX4^_==:S'%0F'TB+;+]R.93L%V*?O9^C->>?.
MA+1;=MFHG9<*_,8'SX<RO "[:/=#Z%L.>D6?<I^H+3<,<^]JT#.;76 &("@=
M]^[0'@U$?T$4"/Z% +J2AA-V$S[/#H/A=,Y>K[\Y\?#%THJJ>K%:.2RMJ%S4
MRY5M:4=;<Y*V72R5]5)IUYN5C?8<2 K*'DJ@Y/7MIYON[8VH_J6_<&]]W9&;
MS)LU]-[-\#C/JG[_DA/+BNB?*L\R:]I]IUW#(;4'1+@B:P)9+Q?:6_^M=JW#
M_]]O6Y_WD?=L"?ESKW6^ %\.XP E7TII>387O2B_^N8Y+L://2A^*FRL,WG=
MGGOLDQG[Z-'% [0;I9TK1G\A2F:%,T^5I$IY3%%Y)'[MH/[0L*X^6QWM>KY7
MP$H1^E0WUWSIP(J'_XT\?'*4A'#4?#H:+:NX=<=A]P9LXHDZ[J,PLP*X.T*X
MN;8YW/SV?MI?L!_#8#SZ[1]02P,$%     @ CX#X4)]5=^\T&   ' (! !
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MO;@CA>"Z^S'$+NSFII]!6RAR+<^QG#EL %D?6%BBG*NU'S&]*EF4"OP(AF.
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M3=SJ72Q^W)#J((OOI==V5W^N:3?B+/ILM"<B"X,LLQS%0[,X88*#Y+AS37R
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M/6"T\@Y6_\6%>8WG T08?RZ5(48N<@QO<3K,U"HB0X;2^P7E%I$:JABEO$G
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M/',20PJ,T1A$/LHV^]X2?!V.V/'(7(T-1]T8O;X:<RNG<=K-UU])1[@7M/7
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M9>89//O:)YEXH[ARAA9"NE.N5I(@K2MB\<8XSGW2=VFPT$P)DSA3S_Q!EU3
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MM(%*>A?0!!Z8"\DT8=3V$$^64(VTU"#2M 9I-?XF:US;6#3!JJW/9;T L$G
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M>U!:&@AD/8' Q T:GYEK<L_P:$9W'V)+'B#+QS*Z>U%&>(/0LXFS)BMK/&K
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ME!I3B3D8^OX#7$W]L+*/H,_C7\NO-MBV@-S2VMX#\\-8W$VYL!OO.E/D\;?
ME= MYF2-82!K(HOR28'7G$[W6 *913P0_)/FWCT6^&.GWB[Z:T"Y.]:B8,;[
MG#ADE24HQ0JMGQ<P,6AKLLMD([3@T\.;ZLVU-^I0]!T:ZC/W83[=BU8]:U8_
MJ0TSD3Z^MLI\B5]P,/I<X[ESI%I;3B:  #]+)@FR0,PQUE]40.\X9_>5'>W^
MU--E1&,-K-TVNBKIWU"!M?CO\V^+&X$6A6IKG]*L<FV[=2V5LH5HA#8N%6,R
M>7#:,U&LS%[1NRY$SIM*V=8^\+#]?_&Q;ZX2/S )[KW7(&/PY 9:A("A]K(2
M-A:KBW%-&I_?07+HT;;XP/>CP>#5:/QG&.>>95(FJ1U(6<C'U86!%UR!"/4>
MT7BI;).L_A58CK^=':;KY>/K4/$V"#5=I:HQ:760/M&2L,[ID0Y\\KEF07+'
M C+FFA2//5S:X,':6*/=G439P#Z]2G.<-T-\>3&N[39FC?M[.4DLM<XCHJ<%
M^B!A!C70N<&]B9RK)OWE-H$Z'=4?+/(&]Z$+;/,XYNW!#;TLN8B6+&;&:F24
M$SA?(AG05GEG74(6FX23-Z(Z'4(<+O0&<;NKC<JSR'@T!7*.#)0PJ:8G%W"B
M1,GI?R$TR:Y<O>?OD?)U%;2]U2FBYPUR'[F P .O24ZD.2[(O^!)JFA<<+K)
M6;8&S[&ZK'9KK'0AW*>19(R),7J;.109%+T&GOS/+ (DF;RFPSP:W:3.\%$E
M&7>J]IWRAG<1?_.\T6W ?-=YPSMI:V,"Z3ZB;J[_6'32@5EPB=5#OV9<,L=!
M"T3MZ'A6V.2*]+'G#7>G]ETDW#9OV!K+HLP,T-;L(:\#A!(Y>-KIF"[.I.7B
MDB>0-[R3>-?G#>\BFZX#ZV=A?!X27DS[*0P6F1;1:S)*ZPR!V@VC* VQCJ/6
MF3-EHF1ZN2_ZZO#YBL]^JAH[6$X=OUV_8ZY 7N*7?L*K#)EHF4K>$7%J31RF
M!,Z%"-9+;5RQS*NPA=Y6??93U=O!<EH;)#C"Y<3;,!Z':?\+-KF4N//IS2XC
M-J]CZ1*BY")-RCX9CDISV@UKUT)K0PB<.;2;+B'N/*A9IO&UVQ=T3LKG"*EF
M'BG/ L0@,K!$0I0UVZW-$(EMP!V]'X,URA;N"JU>U"+OX"!:SL'&J"S3F17_
M$$EOCZ!NOG,N'=Q[81===6QUW&F9=*/]*&T'%V%P/7M<6RF8<AZR-+199R;!
M%4V'K V,JQ2*%=L8(SL\\H3(T5+81RWM^,<$R\7@3;]@SY(,O' (+B-975;7
M?$]-<M!T.D@F/$$][H9[#>ZXG3R;:7;KZHT]U=* .C=;K;TKRY+I90Q2"11
M>UT$98JBS8YV/)W(;+?6IIQT"])LAG6:=.E0%0VNZ%8FGR^#O S#&LU,9.27
MAU('UZ18+Z7(W8N2/!%R(8Q433K_; _Q6+<=S:V71EIY+'<BNV;YNF0SS]:
MEH%>OX !@D,%THDBR$AC/C<9K/G(BT=:L^7 $I%=M/9(TO.W@?RC1*0U%SK(
MT]]'D8^$@]R0X2@R E/%UNFDEFR-ZHUJU#$:B<DW&8']:+C7<8G(L:FWB_ZZ
M+M;>+2L]!AU=R+(6I"*HZ @I2@TE<\]U+29<=AV_F[J G92X?UW +AIHD(&[
M=D2E-4K&2,OU49/I6KL)&H,0DBR^UAOG-C&%QS8)^#AV51=::. 9;C&8=@N
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M.B4755:"K+N"*2+G6GFMC5,Q%US9/W^;AS;LP/OFJE&QYMYX%SQ8[169NEZ
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M.DJ?(F&$8D@[IN:1G&RK. 3'//A@LBW6:X--VE0^WCY%/F<Z3GR!9 BYXJ6
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M4D9S*8 9DH4L!5:D005S!G>!%+GW$B(\=:_XD>$/@<P*@NL@<UAP2-P/6-V
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M3GS.Z*\H=$J%1.RAR='9WK1GHWC1/I1G$T8J*DTH[0RGW\]^/3W3%#SPQ @
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M(0A<M;*31 <KRL$!KEXZ2A*5"DQKZJ0W/3;KU7'WL%$/$_.DDHPJ&\:X]Z2
M@KLL[242S&Z,!V<=F"P,R1YW'<D]8N+>D^0X#9I[X*MEH+IY6S/^B^:OALPJ
MOW?OT^5T,@NC- [+BX4V)IJS#80Q6UJB44F\59YH5FXE!6Y94#T8?#CR2^9N
MH)PJFLD%S8=QN+L.L,Q%4 'PQ2_-H;UA91<PA$L&ED9T#7*? ^_[H[YDM@;(
MIV)4]^K@_/QB,H;I]Y^+S3^_VN:7O0<-=\QF29RVK#2&+VV^>"!".ND@ZV17
MN\FMR5-8^XB7S&$MR57T21:Q*9C&T>0;S,+E.4Q_27/PD_/1[&)Q6WNY+S,!
MM%3SD\ MKN=1%'B,:-R<;<*=V;$^>V"/1[UD@FM+\B'1:IB%,T_3;SA/%"><
MGT[.KYKS70,3@E$AO"-)!EYJ$EGB<"DA A2++$L+C/4R<QYYR$LFMY[T'M*J
M!VV=T_F7R5<H<:\E&@LF62DD8=)((K44Q#$C2,[!TDRC\='VV3X?C/R2"1PH
MIX>LF2&LG5Y./Z?I<C_WQJ/CZR/1,I<:3EP3)[,FN!YD$,D("+P'8?<&?<E<
M;2^=AS39(33]-KJS25N3@Q2A!/TYSB8+CNKBT4CF4N5H-&>KA5D[6;H[YDLF
M:6O9/.3(;<O1;#H_^SB=Q,LP_S ]Q05Z%-)5-HX15&7IB%&J="3%?1:,-232
ME%A@2NA>W0%P_#L1-?QJ-9JV#L"A!]>K"+ZB@7,'S^QH'*\1+56\#Z@-(NR;
M:,5#-+N-KM<AZB'KE:1<,?KS.+BL7-0J&Z*$1 M-"B!6X6>.FA"#QKVD5Q+C
M<Z1^38A]A\QO(MS*\;X?P']'QVL9PTJ<NPR6$ZYY<;+0I?::1P)>I40SBUGW
M\53OC[J[7;JBF"=59%0YROY#@LOYTJZCVG,H9SV)EY*3#DT0*QS"XM)FM.V2
M5'U<SKMCOGBFMI5/Y;?JPQ3.[V@,EY&'5-J6NF*!4]#$F^2(M8(ZE1RN*'TL
MW_NCOG2N!LBH=O3\T_$2A%?"%94![S21D0IB 4VYH+0'*U4TM)?GOQSPQ7.T
ME60JA\S_.2E;]<\)SN=?EF@BC=QK1G@.ADCK:&DN2XE(/J8(AIK5NZ.=/#T<
M^:43-E!6E6/C_YQ<CF-YQV$<[T9QF762A6(W98W>+DZ40&GHK'S2B;D &?KL
M7&N&?_D<#I=:Y=CW2;H8!8C+M5HIB%D92AACY:JQ\,1SP4G.,BB:=6:K.3>=
M_-T?]:73-D!&E4/:IZ-2?WAT_<_1= 3+Q@G:\("+-4FE'I",%J>&<R.9&[!0
ME@;6YR1_W?@OG<$J<JL=Z)ZG<Y@N@3"E$L^T- ,S%EW/@*Z'H)0DFRT5*D8;
M>Q%X=] 7S]K6$JH<[/XT31?Y^Q*(\\G9$")1^**C45M,V2Q*0P#A:,X NI=W
M=F_0ET[5]A*J&/->V+5E6WV0/L<LY=9R37(JM0G@*L]=D'*H3%,J[5#[I!AV
M#O[2J1LNL0X7>U LY,WK7T^.WG^:CLZ_CKZ-IJ/Q<N?UPDN<AR&H1 I7:Y;*
M$L")-LF#1+\_FSXTKAO_I3-916X=9 ZKZ'+RYK_>GGXZ*O\>?_CA[7_BOQ_>
MX3=._]\OGW[]KZ/E#:(0-<) 3+ILQ-F4/!]FB<XNF,PC3]!G_^OWM)=.= .9
M=M ^+/*R6%76I<%::6GR.9#L#"JD =P@''Z0WB?/7 Q&]0E&/_J0ETYR/0EV
M<#LH;'/\X?WQFY-/J&;S+]_/OWY)XU&$^7*Q<=(+I\H)-Z!G))7#J0:?"5=:
M:H_VM'-](FV//N2E<UM/@AW<#@KLO'W_VYN?CDY_/?WTYOW[H_]\\_'=VP_O
M/YV\??]?1Y].WOSV]OC3<G4Q.BK'%C.FNEQ$C,3A9H)S%]2CH9<@]ZG%V_N!
M+YWS-I+MX']8/.CMZ<<W)Z^/WJ&*GMX@LHQ&P]G"C,>=A)H2JI*&@"N]=&1(
M2O4YYN@<_*7S.EQB'1P.2WS\]/.;D_=O?CWY<'K\]@VN-,MXL=:9L4R)3Z7U
M.-KWZ$O[8@:&<I'!R>!['59U#__2>:PAM0XF!\6(7A^=_-?1NS?_N4RFS0(?
M*7(I_UC.ITTB0+DDC*O$4O#>]RI_?G_4E\[; !EUT#4H3O3FY-V;H]?+)0"W
M:R$8;MY4E&:V'#PJCLM$J62C23$;U^=UNS?H2R=K>PEU<#4H4/3VEQ].?L5=
M=XG%19"H+8&X&"V10@5B&:)*-FOFLRUE+ON8,_>'?>E\#9%2QUG^H+#0;V_>
M'1^]OEF6 V-.6T-24A0W6._17';E4C0'*1B(H/NX&?<&?>EL;2^A#JX&17W^
MZ_]]>OO3C2V466)."4(I+4NR4&4O-23JA Y-!I?1WGF:JKMCOG2FMI9/!U'#
MXS0KERAI]E9!%NAU*D.DU_BZ.^I( "^#D";TNW31,?1+IVVHM#K8&Q2)^?#Q
M]-=?WGZZ25]$S\(87(UC\3ELPG>=9RB9/%()JPU^NP]O=P=]\8QM+:$.K@9%
M5G[]^.GDZ+>WUTBBCU''TBI8,H_OO,S$EVLAD>? '/"2@=J#JWN#OG2NMI=0
M!U>#HB#_"=-T/I\L$SZ2L#* (2&7M&!7+O,X)HE,,7KE.=A>9Q/W!GWI7&TO
MH0ZN!D4[WK[_[</_/7I_=/7O+V^6[SJ+QC+<.HDH]JHTN*$Z7)%)-C(K(X/S
MJ\T-U\4GNX9_Z?S5D%H'DX.B'1]//AR?O/WTYN/)C3</3@:9$MI"29=;X1 )
M:!T)SIA*=!*YM'U,QX<COW3^!LJJ@[I!D8^[V8Q1,I,XI^C5EQN/&DI+,>=)
ML#%PJE3PO6Z:'%#>Y[;2Z6!I4,SCY[<?3Y=G#(DFQ4W)H;(E=Q@" 2<XT=E:
MJ2P"84^U.[X_XDOG:$O9=&3$#PIR_-_W;]XL<60N38[ "2S2J#(M1T VD605
MSI F$T(?CNX,^=))VE8Z'2P-"F^@G?KK+TOW/7B7A+2*H$D:"9I!F5CD #^X
M* ,SW+ ^[O+=,5\Z3UO+IX.H0>&-TX]OW[]9G.PL Y@B.ZJ#)@8B@E%HVEC!
M'%&<F< #2]"K@-;JN"^=L$%RZB!M4%3CZ/5O1^^/W[Q>.NU*68MO.N':4-PQ
MJ2 ^:TZX#U)'+8WV??)M[X_ZT@D;(*,.N@8%-GYZ\_[-R=&[9:YARNBU>T.R
M+K<C#$]HW_C2%8Q&%4/(-O;9M.X-^M+)VEY"'5P-"FP<?WC_Z>CXT[LW[T_?
MG-Y]WU4 %DN3.#0_48$L&CZ6H2]1//? \'\F]]G$UHW_TAFL(K<.,H?=!OKU
MY*>WQS=Z91A$ 1JA>(7^GU>T?(8:)G#.-"7'>9_SYONCOG3B!LBH@ZZMPQME
M<C>M3GY*D\]3^/JEU.-?U)U(8*T7($@0MM29*3VLO.'$IB -*._ZM2SO58)C
M+8H_0V&>.A14O-2W '4UL[N0KI6^#ZC:U7G6HME]=9Y*;$U:B;IRB9[UX"#:
MK(751(!$8QQ2N:QO(L'70*!]!QZ]JQ?*_R,E>G9)_R82KDA[F%R.Y]/O9[^>
MEE97FB6NB"IE9Z1 6]Y%&XCP/&N?:7"LHPS3;"GF60JO/D^^_>-ZQ,*S67Y1
M:#9W:+Y]ZFYW]TKBGPR27>6Z/;^^?_OIS>O33T>?WIR^^:-L7+.;L >W*E)/
M<BKW51<IB8)[HIR4BG'J7:\$I;4/>,G<U9-<@TXD[R?C7V_J]8-+";VU<BN\
M1.LS6HZEYA P(QE3T7/?I"/1'0POF>>A(EU;#NA__V-%&N_PR\4/%M\OLSU)
M^6_EWU]/WMY(YO???W^%NO<J3"[^L9#(LMO@)"_[#\(XWD[^:)I@]@&-62CV
M*'HG>33W2U/T]F]>ISF,SF?W4<]&%U_/GPIUU'W^/VXE<%\RUR#N:<DN99'^
MF*=Q3/'O?QO%__C[2&5F:$9?"WUDZ6*$;-&CTU18*7+.X:PNE(&-B=9[)2C:
M]!9ME-D9U\H$ZQW1@9:8#J!?B<I,?#8 -F@PIH^%MFT#ST?!#3J21S\.QX?/
MZ?@+C#^GM^-3.$^S'[[?)^/,.N.S$+CYJBA*3 LM,H6+-_.:.:Z@G$;W.:?O
M][B]]>"KIP3WSO(;"+FBF;.4P4GZEL:7Z4<4SO$$32\(\W^.YE^.+V?SR46:
MOODCG%]&E,W1;(8O7XJ?X(\SI[U23 ()4H:2Q*6)M]'BS@XV4>YL]M#BO=@"
MZP$IU:X8:V!\W:SJ;\>X,:5WD]GL3%$1M:>.1.,8D1+EX(4T! T/3?'_FLH^
M%6HW5J(.+ >H)$,E7KEDX\/%L N@IZ!L!D62$*IDT0@"2@-![R JZKBVW&^U
MWQPVYVT$7+$JY%("MTB6B]=H?(D(KZ%.QK,?$LHD7?T>KEMI]LMH/)F.YM\7
M_4C2;'XTCO='>?,_EZ-20G;^98(_^8:_LK QSX0.3C-6:DI)G*HK=?@<2.(#
MS\(HP1F++9:7'<[Q@%3XN6M(Q4*;RZD>Q?^^O(+RXV1Z=%$$^N_%%,^BTT&8
MTI@E)H/KM&3$>U0VP[P12EECO&NANFL1':"BU9%^Q;*=M];=+.& 7U"-7Z.A
M=S[Y6D"^':,_'-"<.W/<NY2S(5JZA)/.HI3.TT0H2XU6VH;5%,]:MO>CN Y0
M16HR4?%P<0EO&0\YGESXT7@Q[ZOU\C.BQ,]FHWB]9AY-I\4D6*QZ2^L 5?YR
M//^0U_S)NQ'XT3DNF^S,1?1$+1J,W%I/)$/#P5G*28@T>JL5KJ!-G+T=S>\
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MG@<]B7 _9T)5>>VO,P-(V>W"<PTT HTF@B?9!'0KF2@UN S']97Z)"!FX.R
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M%'<XW:29;-("]2&4/X5E.)"!ASHQN/O,?437:M\'4TNKL O4?FS"H80]RO\
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MUG&"66WQQ]#U[7K*@$+:A6M+5&27SDK!7119\P31)5,BA.1B,N253%Z >)S
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M_S_B\4#^R^#9Q<O'+R (BB$,GM"X#Q2?EQ<4FA^4&/ST/O@YA$^<7^*0GJ6
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MBO6;F80_Q#7:;$RS$$'A(?CZO'Z<$+#6-Y\\<I]Z\HXPX/@0\BI+QO^#ZM4
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ML+]/O(PWS$>0;_&AAQ3/WT-@R54$'=?-[2<T0#,P:N#Q#'@<A1TTA]%!'F5
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MBSN(I1*(L!A]]%. A(C%[@_U+PP/WGSF6?A\]A-FOO!G\=W?;XH?P(OQ@$I
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MN029CH/C*Q,^(96%1R3-;UD'!;L-YG=[J2_<$GS"'0QA[6/_VW(]BP<TE&K
M%4(!>SH+I%TIYJK#-:H^Q[..FX6]6-4+UC*[&_%1U,3#QBS;LZR/(F/M?E3"
MXA8<:VX,2/8MJ'/P9I[T:<J-YC)T2(]'0BRJ84MHS20^\\!P>F&46GT_2COW
M8[E:DF*)7H[FI7V7TL6^"A(1@'$]\SJ=W,E1 ('=)C_H"J^Q-G>&^K2M3(<R
MHR^-\9TV9#UE""FSPT2;)EZK3W8=2GQ>VW,H6OFHHX5B,_N 005VF  V9THL
MF9<KR/U4;#H:(2:TNF!&YU0\\.CVCO^UYN%<G/:R2_=*KI'R5XO YH_OG<9>
MJ<K*<>PX,6U@I@*1&ETH&8Q1 =EG[/9(S#9LYAE]8^"F.LL\?T\ANDE".#K^
MY/L/OC$Q7G_8$E9,T0GP9B"\>HN+V8%<K8[L8ZQOIZ<8<I9+HP)_*+A5M+;F
M?GW6]!,2+G+-^^&3([>J#UW2O73_B 5T"-Z'G$NQ 2T-7DC4Q@6C)-$IG06$
M6(QC&;!UMHT^3<R(6^!K'6\[0DW37G/1":L*#G>WR/T3^2-36\R0=2S9[Z)(
MX(&F^X+_H B#'-<6N0,1N,\6S>YJ29E7SZX$0NP['I&&Y*LGQ+]4O2R?$-I5
M2W(WUOWJ_\GY 3=&9?0V.O1[J/)8:*Y6?V1KTN4+]?6IIL?[]C??NONGYB&H
M%(TP$\E\"LKW $N\B]HH82ECM!LG&X/8_GZOOGSQ"7$IN)^+#PI1[/;5_U#U
M:5B3_]*I$N<A?:H5Y-^W1%=W(($UL=#&/VQQ4Z8V)PY^#27E 4S3?F]NQ8JW
M\3S'&[C79HUW&[@/2/>^X&MB?6V+[1O3K'IIU@.#CGB 87P[/N<Y6Q+,^V@,
M6Y@!2V]83_.C?B^,#*&IA_S2MY)"TM,M=,OYHC,_3-7GW($8/P98%= &)!VQ
M%=.RU46>5:$B8KBZF(--]#_I;$GZW!EZ1^VQX8!P@Y,YJ3(_CKD:?6<]BTQ+
MCG:N_9.)D/Y^C <XR4)A?("+QFPE498Y^H58DHE4@7]"3 -+:_[,21>9Z(7E
MD)/(P:0ET49O[JC Y_.(I_@%::0GD$-?Q5&8:0;N**7 KD\GI1M>Z7ZJD'W<
MW$_\T:5C_[VS<%@9#C-M?O1NOA?[:]0".N+*E@Q@UM KV/M&N,(G_FVRXNF.
M*4,C>P#/18'WZI6E:/+%<?7BJ5_6]^^=3!O:/YIB%<;/Z0RX0%1'Z# 2M%A$
MUDG,.;I&[U8L"9G1(8.V=QQEZ]T%DW7WK[NY\:2@EGJ1TY%ZGL?=E>,O&/<O
MJU[_,#@'\=<HG<8<H(I)??'P!@J[6FZ4ZL1VA*8V,_4^3HWT#\O=/*OT;RO<
MXQ(/ $(SP7?L,W31%2(\FBR\P0XH'Z:9(N6"C9OO*AHS&N?;"3.+N]R5!>\>
MT=<5ANQ%#X<AZ6Y@VUF?Y0[#!>"45CC=?D0Z:)4VDF N3O^U ]EWPTS2S*!2
MIS&'D%/)(^-<]B T>=E(\#:_>Z?;TCQ' #1+$IQ^06Q.  ; \&R%VC<8"TY!
MM?)[((^R:64_9:Z&.3JFKD\F#?BKSW5+0?)5FXX<:4EZ_R4S9R!'CI\ J%;T
M(L$:OLF@2S+OTG<@R>90 -^/:X!V#]U7GQ+C#\8>9JBQ%Y0FKA>03OQ.= EY
M45]7NVM!Z_F@R]%*11X/I*XDR]6]12,&<XA:.#1LTXV5&K_-2CN%T.?>4]A/
MNY<W8%KF#WD_8/;T-Q@J*51H$KDV80/LE/P9G#>8BRP][!Q.M&._#SJK]Q?^
M0!!2\2I:!T=5;\O_?@-U.R%ILB):J/GOV[.N^A\'JVH3%]J-J?B-+;"^;7-
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M$9.JXS6-L+W!6F&*LK:OAR5S6-6-H_%W*RM%HD7O'L Z@$[F(81N >HUW4A
M'=6'(Z50D!O#.+H!E?"@S2_RWN)^0Z3L<,V\S\<FES&MLKK7[TU]M-#/Y(9X
M4AMBBZ=PP'%7+[K&1@E]CKM'CS'-/('<RX8 ^,4@,WCY>@LJ/;V$=D )IK]\
MW%!X_IA;_^YX1.T7/=L;Y;<O/)$PB'LF-K:M!>);+3&VK.QIL/QZAN!W?]?%
M!=AA5=$!B[N?HN]YT:=33E]4.14J#*TO=)6H[(\2/NUTRBN!3UVJPZ:[!M!%
MIDUS]Q!+0$UT"4$C,S@G( "WZ+UO#;M[^@6C]TW%L='"J)4D5.CF\Q^;1;T-
MC!R[Y5G-N"&MJ >\OS3?9O20$UXQI##*>7UWKV,/AVJPSL/$ANY41NKD/?$S
M%N^S#5)Q57!_O*_\L9&Q+M:@#93Q SJ!9K,YS AG'N1D=4#0X7VD/T1O307\
M/C<@AN8V:HB0\-+/?=<X&BJ:NGIK"A!2&3XFM&RBZ^QF[S7-EN'M,=<"R&#B
M7QD#G5U"%KV.,A-B6%'_Q/^")F/YVNT,HJAS3>D+GJU&MUY?3=O4U0W]FO18
M]2GJE  )PMG[O,V5*S3*\EE%-C=OG*2/,UO&&H"JN;X%N>1UI]KF*Z.D8/%Z
MRZA=D@.VWZ_D2Q7;7D 8;EZ".%I+_<^<//0,MF(S_5XO7AY'2=Z!R!^#\WLX
MA-TO=0LB_9RS,%CVF EVF78]O5CGV7\,S_SH MN(8UAUWD'2KY/CV&'5 -YA
M_'8E?/;&/864]<K'\5+%!S0]SYSZ&-;V,4YO\NFBW/&:SZ*N9\=^S^NN6$W]
M^@;3K@E=$!ZR?WDZ$R'YRM7&A4^_+FNWV3[;FJ(=R&7$3$4/@8X(T4$Q48#_
MF]E@/!_9I7T*P^M[/T)SK5C\WBOV:D.$@ISN1MNL>L&1_+' H2?SUS[D6,#E
M<)1'<$FL8B"9'ARY&4:][]??8OBB0JF"%GO?9/UB\HEN[\"6VR[=0]=$6;/2
M6>;F=UR<!_C$E*?-5=CF",!@Y Q="TVVX\YE+[8]4L_DE$!)YZ*9(=$=+I%7
M3YTN,E\5+)'F6('(\P2."&7;4\G2..(1PK7U'8C(>E-![#Z,*+WZZ4]W+^W*
M SWR#@T&7;UV/(LY2D87!^N.'C\XO8Q@*Z) SK5[A"TSPE0&*BH]O&H2VL2K
M5\T/,>Y4'V@UDS?/":&%:+QK?W=33T2\1D?E465FE@'R700?Z5IAF%F>P>IG
MLRSBTI!*5WFQ=O;;K!->V?WG'2!832X)+E(!1G\6CO@9#VFS9,'6[W2HTVLZ
MR8*!'M,]N/W?7.TB*H+T/=;RME/OW$*(7_WY0BPX9;]:!DFH\](='QL*H;<F
M;@Q'7(-+8JRA/:&B#1RK+D:0D?'ZZ].^[SHRNK8OP8(S6D/.UG5K^_/,=QAY
M7;U""&<;4F%[ (/SW'XZ+OXV1_WS!R_2:I,C46EQLND9KP8O/OCS,S'B"*",
MZ,/%'OW7L\A-%4DK0"D5^#7L Y5P* ]V"ME7W;YT<SWWQUF&K>?UY-K2]YJV
MNU/)MR6]<&P%9T8>53VE$KS2NK$ZG'8MQC?D=;? JQ<C]U]W[_DRJUJL0KX9
M-W,C#3L*T3XN$$AD=<,_%TGQL =PQ$,=NX!Q9M\.) 8%#R'/AE!"O]S-RZA@
M?$UO]Z5ZFL:%S*W?.U3N_=C-<H$;6%]P'.@^NRNU6*N<\[KM/K4F@TR_[KK1
MRI)F2TY<8<![AZUH.1V)!-';^2[>-Q1:W0WCBM3J!8<35<Q.Z+Z&%!NI"@@0
MRI*'&NB(&&TS:WBJMIE*.;%R7GVHR$EA]]2R\V+\8]W_[,D<YOW[Y]]7H!CC
M%]AAG!"!4H2L=TUG1[T8H<'B/53O*&GL0!!GLE0;FC_K%'RW?%IU@SDN#;+5
M7.#35#^2A64[ [Y1(-NZR_VTH%4/I)78EY/02.OH=:<,U[AJ:JY;XYDD>8LY
MYZ* !R\UM-534[_+<3:?/X#C48!NS48%2YGM"HPS\,R_G&Q<L"<RFMQ0TUD4
MH<;(BZUI.ZU]C6&3&7J#22K.)69=:LF24[9<2G!70^A$F\I=994RWP/=C/$>
M./VZ;#)7BSOC$3;./1A"KA^L2;[2WB#SH_'WDAT?2ML-J1XD4FM@$S>KDD-Z
M1X);-2+XT<9>[YK;IMK47OC8!T4P"^UN5*EDEA1F+)3XJR$?_MR+EJ;@FRLV
M$#0QX/"QNV(;OQFNWG7C7"'/M2:/Z?2&0H4D3R=&[%1]U.<@?='DW*9=E^*#
MKKIFN9_5#G[+KW]<, <,D6;<;K8GW9.[NYINW+5@V)"[P+HPBOK=$^U\L+RI
M]-4\V7.?F,74'W$X6V3ZB_/>HHJ@;7.\0';9C%5(4,B>[I"0T'VVU#0+9VOG
M3F<(!$+AN?C?_@N3_S7_U_R_G=++2)!S7,^8S6,B:T/P:>3]M]/D*38=.EJ?
M#,CG3*6:$H]5B?UIVI1;2O[61=5S(PVF*Q4^71@\TL2UOXB73NFB!)K,%&3&
MRGQW4.U 68T'UGS,R(#3PV3R0W3ZLEF&&)%[U66)$83]\]>MMIAN>VEB%\X-
MADWL)2MB_CUA4\:=QRFJYYM9,W8@KF/7RS_(!\0]#7KTNOCE.86K85Q6(S;O
M,=JJ-S_Y8L_ASRG<R"@<18_PA00_^LG,CZK8^,[W2^4 3KD!1S_BN96<R:IG
M""\:=XG%YC[_0ZOHA>\%@M6]R@J8C?S/PC:76U;H-<+@?=@RPERA3?H.!&/
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MO(_9]VU,U.ZNF@T#P-R'C#Q&[2;=!7I1?H-QC]U(WL9QI'?>SK.FIJ;U3A;
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M8!T;Z_O01C\S#G8$B+V&W8W=I?)&5<89=\P/!5J*P:CQQVHX!U@:Q\'%\P+
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M*Y+O%@D V2:29$3<I??$GWRV!T)Q,!-UFHX8*5T('RGK==H L6%7]X>Z0+?
M*.63P]@)7^5$4@H-=C))B2:+<CL3![<O:#?T+$"CFB:.I1N3=9+<IK-M'^4M
MO>PY%7C_MU#2Z[W)KW5S'S1N"K'\JC;[<2;+E\4,,-VNJCCM[VF=9/,IK4BJ
M_7 /,U0FC4V'FN550%DQR$0P2'-[^@APG>1V6*E<2&Y(A*&A<H9_ZS*LG_['
M#A>A/WJNLK@K".N(/$W_CF!P%AKK$+H^M#@,-2/RUT^,3V*2V:1O-#A[**).
MA9=^$&9P\1%\:[T,_3LL_QYR/AW!0ZN\7$H$A<"?-0F1PW"%UQ6C'OO=Z&;V
M\<6GBOV,6&)FT6O(EW6E,4:T<_0]3ZBU&UC*2X7*K"]R#<6].%06R#[T'.VJ
M;2O](9:4MV2\^'4X4:DDZUIR9'9=AUY?2:-G+9)D0?MR!'"$<;40^A#ROCYM
MAU4H(F>+;L$$.5<SU.*6-.9TA4=E<5^]XOOU'[VF#R88_&"4RDZI4!KZ".",
MC81616<1(1#R7?P6JZ]!6_.[W-#=%-K%6<M5X=<=+K(3.5:?;D0(O#"$N)V.
M'JCO <W'8:N5.ZTX.ZVY:.%8!^2Y"N_DQ)#,>C*RJ!L0?O=%52B>RQTK_:V"
MO:J;L;<H1,#M9S\K.83@U [EJ01'0*NJJ9R5>U8,K:JB&S_111-:^14^_*G&
M]VVQR9.*1F53-EUB,>L6Y\R\XY^.[9@1-23]3#G90_)5"W9,)*PZ,?4&,A/%
MYL'PS2UKAT+TUR'<:Q&%U]9 7H,TL5<N\1821OL%W5*YF1[ZG\P<>\3L:@\U
M*2?I(S[8*M#Z8B[UV2C\AM"G_+,314KZ%B\ZSZ3+U,9P3#A'\ADPBQI 9*K%
M4FF5R-<S/O/0=FP8L+RK34" 3]V"* :M+D,9#N,=G7<C=&6%WY8\U/MN!Z\=
MKW]#F^),/Q%!9WY$S&J>XP?91/$L-\^Q2C?(IE^J3]0>]HQ25)X8756*AB3(
M_ZYGYK']F"@]E?;VI;#;[R/ ?#:P%-()B@)Q-@DAAI#E%=Z\LY*$,QGGBC-6
M(4XG9[O._YAN-=9N+91^^_;<G2O;3%*AAS_(T[/5IXW:YY=61]R^+HIC_/76
MTCI@?4Z[X#*#KF[#YM_#*O@J 8'3VG%V1MKRB'6KG._96RX64X564Q"E)C[Z
M)(A-78#B_0K]K;JKMH*FN[G!L]-B+55:1I&:D;(X6#K[/EC>95+4<*6")T(
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M5$S VF2M^X?[3.,1(*?,BN>]>&9.65G#<,G"MZ%BT72_5!'#-CY[[]L AIC
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M?Q8'(A%_.[%:8#@0398Y!Y+QG0.)CV,/X']R']\F3<)^*^+_4<-]QX./"[@
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M+<Z\.(H^@](>1:N#<+NI]9];8@&W2;.N:W^,_D2O7_I0G.W;_/*:-9P_^Z9
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MYKA J$+ZPN76Q'7&W(>5=_]A56T.CY=EVBII:Q3;TZE[DX9 +HCM[66ELPW
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MQA)KE][E?DS<<_RWCV^D7&!*6^:GNS;*6:[_3SNK_T\=/)S9_P502P,$%
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M4IP->^UA6Z4?#]>W.D2,':YM)X7LJU\^$?MPJL^A(;QB;\>%UW6FZ+5Y#>O
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M[ 9F" _F?$X3V_W@HK/'TL71+B[UY$UL"U:<;0:YR"J75+9\1#=1G6YRJ^K
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M/(QXV&:AGM;ST%[6<VTR[E.MM,N1W=QC*;9.SZY6[!?;L"%5&+^D[9 5*A!
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M?,C00P=31]*J5.J,5^85Y8:\Z]TC;XI<N+=[4N2^TN*5TAC1O981'&"QEKI
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M_2-TD<^UO7;144P4+#:(A%$EY/WLCVA;MG53WI;BFR2:-(E9>X]F=VR^C=5
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MF)@WJT'LT?/AJW>,G(NZ7<=\WKZW()XSJ-IT3*"X>T_C@3WH?L5>2&68(YW
M U@UN/'*&>K#!HJ\HJO"/>9;J(ANV2B_3E?MM(15EU32H1L6\EU2*-W@WIR:
M9DW$]7:2SH')A,U-@6R+T?-HR>AMD\2D9!PJS<26JIM\Y<7M7>5!@G?D'#QL
M9:23W T2OJR#YZ]4A+NXA*OQMX/4<0JD:=B!@C27.=)$6![5V2/:AY&/!#OJ
M'BH-U<PH"M3:2]E(U#R9>:;OOR[9;9?+ =%K1;2SZ^)JHL5@E"6C+JFF%U*O
MBZOYLGVS6M4GO,'/.H5G?]#W4_X8W&:C6"N06>"S?.?*\$_*; ][3[0P-[U9
MS)]2-3P[RJ!WM39+?E3QZ:^^OW$NMMOM:Z;-YB=Y5F?=GH3[GKUL4X8=SV*9
M07[L*_ [V)";B=^E]31U\N"6<O>%36VV9RZ758Y[=: $:0_W%QV/5-\=N?W:
M7A(U[TH"H11L.8 'SN<=W3GV.5J&498S?>.,0W6JXR/OCV=)TB"UF[*RDU #
M<E-7K>",@9G?,["(M!\33;.:)2(1(E#"K9I=DI"G:[1)[)JRZ*^1T'-HJ$AL
M;]Z<?K@6L>95?JMM)ZF9F]2D&GJ#F<]O>R^J]N+8^L@Z; 2I>:2*P<[D7R1?
MS/6\J3@UYL.D5?MD@C543#^.*U?$: 4/> 2F]=0ZDY/K:RN_?A3ZZLK9G%T<
MV>@)'6#[_C@E4!]94TJ4@,YND>VS*]HU02';2O-S-/ ?8N)#0,9YW;@F"?:A
M2-U)XNQFIC3K,13'6'0;>&);FB$ A;/M:A2X-VH71BFEZM_N+-S;)J:P_\CA
M4J,'%\GX,9A,8E@CK$5C+6 (Y-7>5)(W.C8"%FUB2E0?#TQ&91ATC5_]FE2?
MVE/7]#I'WF=1;>2;H>Y=MO7GD._H:C^.(A&QS"-N,0_P-R:,A=!1LSS@ZAEZ
MN>WQP+DK.+'(I\NV<<[U9VU[]%T6GKDI97K1%T9'<LZ>S#QDBI1DL01\!Z82
M-[L%X=$#<!^ZBC#K-QESE:R\J=\DXHG-<\^9AKR)FN;G2*Z7B\UU8?8H[>GX
MN3G-N76]R.Y[F^,*"]A3' 52V4\Y"L.B-^Z*3D=IT)9O@_,IRD.?IARTW^<M
M_5HH.79RU^]W_&EM!RUCBI_![]!5QTK9^C9LI5,<N8_VK2NAJ%E7AKO;;"5;
M#C,8[RCZ@$,_9)ZXLHQ;*;W&32!1<P@50ASIS&&'.)8M9+XK;OO3+1H- R9F
M,<]M979-SXOK1.D_M+CP3G%O9[7UIT)3>LHAH<U(=4QGV)/MDT"&U7P&+ >Y
M!8:85FA<>_I*CG7ZWKF:6/_B1DO^')T@I3;_;U7I2RNW$2.2AJK%4) >>_)K
MQW?U'<70A['9N)N>MC*V"@^65:PKEF39XVH!._4='YT[;:XE'GM0(CJB''$N
M$9":O_HTBY[!]]-4A.E[G8I6G'E7'ME+\TN(!I__A#</X;(_D2M/MNU]XAWJ
MX+O_CTN$G9C<KYX /@9L66^R>9('B($MY=CJA(I)8X^[92;F11S+@>B=?A]&
M]9FTD7*WPEX&]\78[*4.ZN $V'('O9#6FPRR/'?Q@-^]1:[3:#)F!,&F<.@^
MVQ SFTB,QEQ%)?3Y$T9Z:1BQ0,,\]?K^Z)P;H\']3Z_#'S[IJ5HV>N]HX_=,
MG+5#='['34%@/G^?0FT&6S%:>X"SI7@F:V7U*<(41#[4/'/KW3>(-9Y='LZR
MJ)RSP.XY83K(OY]^[>!TBN:C=?_2F@\A?L0!WRMB_.W9&HO@CQ^E,ZLK_+ 8
MDP=H7N ^QLP2>GA 8<$CU*0HTA]%F?]KK</A^YN3N'7_=I9_TS8H.G'ODGQ?
MXQQ?#8411F?>#$?DAC0-1T2<DJ[*="L*U_XP^RFSVT8M\[)-3[B[[[VG/_*"
MFM,* Q O&SMT:\S=G5S1+F[]V%GJ!% " ,!NH-W>$I!QP!HCJWFR>2?G'"2&
MF.875,%<I@J1;:+UZ+WKH,/SI_IPP\=J&M-=:LU5S;1=C[]/4WRV=4YTM&-3
MR"U4@2;Q&F+)<<IX%RL'L0=BUI:#\W@,//AP=_6PB3V*[&5KD\[JLJZK- N4
M>%W8\=!3^/FM/E+/S0=L4?;"-5'-@G_?M&@8:!<R9&QO75M&HC<L/,4"Y[#0
MT7,\X,9\EQ%V#.ZMQ%1.LNV7,7Z4[ROC>' )V_+==6R"'^G0!4L&*<)RAB,@
M;1O\KA:>@+N_L'"U*[93*Q[U"YR>\9 />_* H8(43: @90$U/G4*ND<EC8S3
M7<G$.(J,;I,JW5X84G49KDYSZ;*K:I0XF'^G_XF>983X,T95P;RH%,/4]90_
M__ /XGL29(B%1?G9E\$6-\Q98NHI5>XCT']/,40ZPGQ@Y!?/<7T<Z6277#W
MUM9+&_J.WAZVRSHL[//;V9(?XUYXA&7%!H$M5B]XP'F*/,>:F]5L^D,A(J'9
MF",]K'@4BGOT\R:]\T3<);G5#P_4MMM7>F[O'/G:M-W216VOWK48;TN9XWS_
ML6&W@BUXS#<)0K4&-VN%]#O4>8D;?1V!!(@'W-F'_TA@V7_G 9\^'1=BQB/]
MA>:7.0I!"-_\@XM(,8>$HWW6\/P2'D!6\"EEX4[OV#P\@?F]<A#/ _XZV=H
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M<GTCQ[#I]3"LM$6CM6[UVVOXL6 &1SWDPM6A6AT!I^J'EQ8*,IU/+"RPNPJ
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M>RRFVG5!%76P/-.FFZ_3Z_K7^O&'>WTZKW"><U]$7V)OBDR%1;<QLUK1=3R
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M<I9P[.D,(^S*-&5Y$(^P$DD/Q$_,2GD  ')N0W6<([.Z7#Y;'L"/Y21S97A
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M_(Q=%O8_)CGS@\ (Q*HN\H9)^Z!!FPON75&&YG )WD1)0NKFZ,O/41W06F*
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MRW2]5M-D"TK*3M?2<?>"_QU%BG%MH_IA:TN_^-&T/V,4"[;J#7K]TEARC];
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M^0WQ[J[2,X$!=L?7A*!KRW*_T7#*\G[L/FRO%Z(-MUX"CLIWQECV3[+P/ B
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M^^&(><LS=)!;ZZW;;G8374'/(J00)Y;C; Y/?K\0<9_&%U3@+Z\X8(XA,XU
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M*(=@"A-RCJ B5)%$L:L!]L_\C;(=7H['J%KK9UB%Y70$',?T*49G7"8-8:O
ML=J-%<(<!,#9PS\!F(30!P8:(\;1A8MMR6SK.KWB_*$QHIE*G?K;,2.35RM&
M0PI;$:UF(Z,5^WJ.@S"6 XI^4#4GT^ZQ)#':G#3<!?@\RIUA0XCO<@K$&HZE
MF?J)'M6WFCSSLB&-9#'[XHUF>[')CV&O2'R)I=>G'='B+(YQH4NL[Z<7+H8-
M9]]3QB=:NE+(R3>UDUNZ%=RG+AF\ZFB<I+05G%YN:"_53BTUGW,4W!.2<],%
MVC)N(PMQ_0_:O]I!04#5_"N^?EP-MPT1+,&-NL&1!!98%B<__V)Q$'?@](@V
M=I4)$U0G;=D<*V<$8>H_[,[5QEJM^O&;IXX50T^.SUZQWCU)K"U[O?N:@GNL
M_V==Q<^04N',.ZQJB,P_;$:8 JR=!YP\;%U0.&5:AC&TE_17LA>W(<G;$,G+
MEE+4>FFG1=5S44?>!"0<*O7;UYXPOR36<QV9>Z) RSVW%MK(Y@$X]$1F)6!=
MCL$ T*5P2[M%":D^3:)!2Q1_@]:$9KV,D8_'[L"EF-\/;I,=(.O('V-<$=!G
M?@M.[38DRA#0A0X0@/V(>UASS-$/%P ?W.)OR\.+MUA^OTNY^MKN>2X9'T?3
M>$WK-73YSTE=31B4QKGIE(F\E"W^2-2O[-%J:FF;\OTD_E/>0M_TX+MFE/?G
MZ[8QT$,7GYU>@SJT_,-)."80S,=*;#^9!WY) LH%BX%<SQ%B!$*&?4U_&[*H
M1F=%;!GK95_5L(N2+1162E+:%Z.K?+3F(&GD?4E/?!EOFLY_T@Z('G,[,Q7:
MT3;Y2U$[]SU.G;&WR+O/8.AV%L]OOZ"*"YO);A_2(*7_]AJ")(ZRA?]MAH_?
MAC!=S&"<O7*LV__BL0\$S)M_%F5LGG^QI>_?VB11 *>4@7!&CB>_@ ]F)Q&:
MOC=5/^YDZ%*_-Q?')70=MJI7*PDN>7P:.XV[K=[>W+:IZF*4Y:/:*&].',(4
M4O!LA2.W", !@1&V=#1SD%/@ME@XZ)?BRC:I >)&@@9]K6K'0IA3SH=K:S_?
MZ=K;^CUE^<,CXNDQ4/OW#6U#6J'K.%"/W <DZ-'G.05=T*7L[.+W-1%P$%J5
M,'8W+HYW22"MRN[;/ GX?3;I^]ZK*NWQ8P4]IW(/[M;#RP$%_;?YN+LV .<J
M)*'Y+D'V%]*O;K_9AI*_6>Z-K6J;O]Y(#P37B#>'GW:_P_OJT4F3UM4+$C,@
MSH+ QV(Y SJ<,;;T-Z8;(%>.WJ2>3:9L *?97MKI6/5L<>_YP7/"04UM5T-N
M:"TOG;PJN^"=*15T>_BXW*AC':XOV!)*;V)"@$)6''<"SV/I2)$#PJBL#;$U
M+$]W3\(W=_RY)'04-=[7\I38Q-M[/CYYH^KGWS[N 55+PAKHNY)E$"N2.]US
MB /.5,I?.+GGM)YCF(/M$X^ =$IZE,TZZOMSC0E:]0O"Y&6Y_(IVUMXD(V'W
M!Z07=C[J,;<-YV#,7/H66QY4P2%+(,R2Z6ZT(*[4MSZ&Q1GZ,?+@)_C9K 6_
M=Z$^UZ<G6H2G^$]>*Y0ADMY:>:#[DW1VYT-8010<6TZ&F<18J*,K;U'KUX\&
MEJ/MF GMF1C#I6PHQB-[T%SYW.O*3Y$'3^*X\9?&/[:W_9C6D![(T][85!OY
M"&R!G-IMG*W/B@LGT,^0YZ,7C[4-XC.\BC6+9U/US>"RJBHV]-:_&X0]'5ES
MM,O+/L&>Z<$'_5XY/Y2Z&#^%'T'->;[ABH 24/ WKL^=*X?K.]ICL780/4O9
M&)90)7[EJK;96AP)&2->KFCASDX.%MVV6ONTFOE=75' 7KS+U$W82@ZYA1?&
M46CXC  !8)-U'%V_> FL1"U1SJ?',6YEG^9);[_&J5:M%%V>0/B-2::%/TK0
MZN<-/J@3F"L$_09?!Z>V0%H#IQ8K@(F<QBIRWREW$92M^) 6-[6S>D1@LCZ:
M3Y\,F+Y(2G;]>TB4J)"P9-)8$Q^E(]ET ZF].L96 =F#P%%.STYA(@XP$T 9
M8,<R_<BVMSK"L+@;A;%_]A5K_&)BO4N@RI:8:RUKWI:]\G%@][DSBWL_K@?&
M7IQP*F"1F-? ? C%CN ;%&C"C $JJE\B [P>/H1+M1+NGL;N(0(EW@D;;QV+
MEO,--;.($YH)]F$R*7VZ77HLR92/]:MA;$5.[5=EPT1"A&-=F$=K<VH+3O!$
MX_FS#4\+W&ILI$-25$IMW5VGBQ(R<@4@V 2,)=CA.'J,601L,6H64>LV+'5?
MML-X#U]DQ5G&[<]DF;T3O^H"%GVO_Q6A'#0_6AC>Z#>:MOG)3^^N>.5GD2T5
M"=)F?QA7.)= /X>3 QR<H&>V(?=.8Z+B%DF=39JMF4R9:*9\WD6%/.S>][V.
M:M!#]8-P8/\J6YH%AB@':X >XXK> TMZ,+#Q!-=O5@T0SG<Q5@HK/PFU& J3
M29$F)VML+Q[.VG3V>Q*ZN>=*[#X+S1P^=0Z.H<'L8B#8<BBN<!Q+E3OFNY%
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MYH2=[)IENC.&7Y9: :J,=*IX ;YJ_L3CVX9^FX91CRQB9WY($[%/+T_ZO?+
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MMIH/-F0)EA2Q_ZP8O_Q:EVMTW?%LPG3[X62+-]@^K,I.$LEY"'J .WL(#D-
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MA&ZY:NUX4)'V^_Q8?5LMKR3_\P>83Q*] NDZ.NI[^7H$P^'@@58ITYUZV#=
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M=UV'+1%V1^K=_-_<I33NXKA&7;YIA)-]DZ5F9:%O@,JC!4]SSEJQ3S!>P@$
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M/') (NON+^UI_]_DEO4L!_.(YK\X3?"@L!B;=XA^FLT[RQ2;\X77G1C7!>V
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M[2V'F K'SW=)*.J8T759OU7[2[/_,<6B_Z<T^U?%_JM>0\!J(0%D\81D  P
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M&K!A"LAO*QY,=5?&3?&N_-BYK:KG N[SF="VU<'R+B\>/9-XL0E0!Q3HY,H
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MZ/<KGGD7G6YOO*B@3?)T$"A%2F]<B=(TXL/"3DS<M#G'P(YC0* P/MT<;;;
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M8GH>I][@[Q"LH_R=S #PIF>(?7CPW]\H+JY'0V;#\*&['!\^,-P&D_6+J1.
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M^/S"Y<!1&Q%:@53^-Z7^V]Z]('X,MZ"  'R5/;>)A^ND_)0MAB7)R])=KF#
M"!_HK';AD9'<83UMSX:12&F#,''F"? #YO_<4?]0#WC^XSE<%<BT8=ISY>;W
M"Y^W<GX> '.\N,$MW":!U"9:GVI90,".N?9]0_97MI)Z:",^=_Q"C[0EYJWW
MV?VU*[3N]="O?Z%&H9R&_UX"0D/;93?H00W,[UJ[VV"9Y")1'C&)VPMWUO(!
M\L7BGYT2\_M+19O6Y&K5:)H$Z0?MVS#4]7.0V\]H/7S/G_#$K>GS_=$I1K%R
M^\L1+Q\]6SOG?U7X+T.1;O_SVILBW'Y^=D7X)>(ZX_ >,S?J/^SX7XSU7_NB
M%D%KI%K?1X&,P;&_#8L>7E;BB;@B9D.*_$W_L4;]1^C:B)WB4)>73H>Y*T7;
MZ7U[I7SJ5?/XH%J3L^'AG>3A-+PKT=@FM\!-K?'P-[#C;<0"YA'V?Y0[UL-#
M_SNYXS_S\D\L=$R-]JB8=@4K(K;LF_NVHV6;)[9N_O2LV>_&VK5K+[NGR MT
M\('&&Y 1']@3CY!A:%T%'V"LYP.QFDQO.!$5BT#>!BGFFCV0\'X>^>.QM238
MI<FDP&)&%"@)0W<@*O*!1[9TD"OM#;(4>EUVK:5P-Z"BJ0L.Q-]G2R7QL%8:
M= @M0OEY \(A!E&D<NW"Y0^*(A]*V-(J>;)H2<23HH?Y0$(>+!_?@%_1L?[]
M3I%()1^0\;'[#R5@X4?1IEP-9D6N&7EUH+M7^+/SC4.-7S2O;YZX^$!(K^A?
MOJM1L=9FHJ*LCEE%6!LSW6^^:)=0B'.V=TZZ:*>O(SAQ;LLO3\J_$7)B_8,U
MN+_I;O]OI:Q*6B^4]7?%7?XN9Q%"[+[S@7^CNSSX-SL:/'MT=3OX;[5'_X>2
M;UWW0J')GAY&=YC/UI%/?<+#(N4%!FM#BQ^]N JLN"W\?_/RPO_K]N\JL\>/
M<:Z2'+N.];VSK3@:9.[#75/M3UKH2$OQR%+-:I'RKK\7V?*I'$\W</ZX\\F-
M2E>=0R/*^?&=].-'AB^)?7@OL.01C0D"H]!R-:&1S%EZ5G,MIKGJZ6VS&Z<G
MZ=^6^E;"6#S(^.PZ][B18WS ZG$XD551A56#)ANH4D23B%$\&KK78=]MJ$V]
M\ORTA>!ZOZ-1;[^]<4G?;CZ/G[+@G(-;AV:;O3LA?4PC_AJL"6$8U#A8(RX8
M':NQB=D8Y KZI[S(<O=U2V^ZL.K(JK";V:&Z\:XXU\^B<DQM]BU>+G@:(_X5
MFF>'0'0Z5N-G9L2T?\1+@BVNLC>$7N5F'^CKH'[[A+C.&;?[]-X%K2H3-0+U
MMV3J+XBV4#RC$&/[.6R'.+X\)\"]QNF*MUK@C9H,)X,;)8^>&7HF (+.)#2"
M>;5RA'5#NI73TS24\,12MS=7DU?&W1 :^J#L@UU=UJCSUAE"2E7ZN;JPD[N$
M,J\,2(=*%Y>!M#K5OF)6*?L""S_E3./M(R#XIA\B9#%,FCM>.N[;61&?-^BL
M&_OP6,K3)7?OPZVD*U?4OC>HU(L.4I"U#3)!"E7V'>94[B9>KO46**!U9?]^
M16?7QJ$/%GWUF>%M=R5-,ZHLUFJ\L#\]_7*^$Q9;YMASU_%2$4?[1HU%E^6W
MF4A+:3>2I*%+H>#+;SK>WTJ?'=UHI[KZ4GJ'P>/ '"]'^8AB>V@:P:(]=)NC
M#F$;T>J4$-3@*IPP5Y]UJC @'P=5[F>]GK@7'_.]>IUW7:6?D993X))T^L[R
MCP,I,.[.[:\";".%.?MI=600=]QO@7\PE:8PP1Q=:+1%-;X9*S5QN3*NG(>X
M.I80CGWM7?9([4C?J>T!8FE&7>5)NA>TMZ<XN7#TP8;]L#8W$F*Q@MF[H5*.
MQFG,&I(Q=]/G$/-JK/A1J+O'M:Q_@?-8;R003T_QOYXUD"KQZOJ[[<>+7@@L
M+#6;).0*0<ZT6GL&IID/*/^J0W\V2[Y@G5\0K/0<'Q*LL>OKW':)MSH"G3I7
MMVN]PISB T-.M+3I<"9^'^\!)0"CT<!(6S69X6OW.+BBHL=.O<?KV\>@[8?O
MRKPO8.Z+JICVJ[[U^K8_2XDKD\WNXI5BSJ0!W#.LRFE)9OR^9"R8#*_O*3(/
M1BM?^ORS\&1P4+#B;7S@Y[ATG2-Q 5\?V4?<>& <_(,"Z9APY5T92!5OCGCN
M$M< JJ3A!P):T+)$-9HW3F:$:\O2I22&F-U9&+9EA#B/7=E6).3TK,QE6SK6
MR%WW$]6L:M_-JZ3>+IPUT1X)NU<)UHVX:%\52)_.P<A!:>R8GO'>NK6>D_?H
MW89/>F@]&0=S?S!H-J$ZA.@CN]O6FE9;/0B1*/K53_I UH!UN:=ZB9?HN&2R
M$"HJO%. 4&+FE$P@[C+?X>R"QI;5.@U[-F_*BLK\N8ZJNBWPOFF>X .A+X'_
MM+F2.C'1U]KG-#EYAQZGW/'1K$C!95?[<2P@T*[WAGJ-4A;08))FZE/9@$MP
M]]U86OHNR_/S(:<<\SM;^QQF79QKBI2E771.*6\76D6Q1!#[A ^4L?,X[HBS
MN1(-?A_23VX<,>V'E0@FC0:CY%1K9:;Q3:,OX\G?3^&F>((7=Y<TG-A_ XLA
MZX3N?RW6L4J\>JIX  ]+"'$VP0.'""_I]@V1^E[,K,0ZQ1&[QU E/2O9:B<O
MXP6!X%<@4!BU8<STX0!KBQZ@LE8"6"0GDU7K9(B"S#"J-&Q!W-=EI?]@^/[1
M25_-7O^R\OAHTJ43FFY^<NGV^\!&S'50G(0A8DJ@8N8.AF_L*&KUZ3B7?$),
MDU>!1T6$WG;5#8+.DJ9;!V4^TYCO;<8\-#EA7MXXN)FB7(#W<SR63<<E^&=N
M4-HX$39\U4:]817%C$*+NLS^_6W#%*_8RA/Y-P.*>M')!\3RFTU6_:(HDH2.
MCKQSR!R9Z=[R/.CG!T=_M;P0G)-!(LKTH.A$?PL?2$&+40*H\4L4!=B2>^ S
M49V>8O[(Q[990^_+H]>EE:8.)7LU@NZZ.#G\O"K7L4DHXP#DRHJGX]JPHC8L
M25IG\TYTBZ54GW5'P4^/7^'!6UV.RJ>;'F[P<!>6%?,+GHN!U]SJ"T\;TF>[
M087,CJ:56RS(E:849X:3(]0Y!>TK'$\,]SG4U[G_%='_7 PV$Y[9LWVY:$HM
MU6!Z%@7W45=3CE,A/4H#/B'7JF>V7"W'O]%:FDF-(1H]TCG%:5;]MIA3L_5R
M^(MW[W)/I&1DGG3;$W%<\!ZPDIFT;-M*81Y*4R9]Q)19-*5%42M-IEC^-*,M
MC)GGO#0:5AT)BN,^W90*AU4[30Z:#GJV!X0:[[K^XJ-<A?T=P9*C.%D$3IY$
M;SPG@C ,BR_1, />;9=G4ZQ,: XU]H\#CO;XQ7LYGO6/LYC?TVT;$!07$32C
MZRB:];VP^MW/ZP)LYU"*!B40CV3KU^--3K/7<646+>IJC1HJ/?$K[B6%(X:;
M5S5H*EF]&S.03I!4SP<8=2=Y9 SM.1^0I01A!OM'<RETRN!&O!3Q)*10Z!M8
MMQ[R9J"5;75?C-BALN5?/K=5'#3*W33]UO\K\:F$V(F+R_%TI>D=G(-P'\@,
ML6CY/2/N:J$]5X<L2(QXV3(JS]+Z:OWR@ME07LWQSO=206L]!U674P7W)OT^
M;K9H0L>VH 2Y>,B'7IR"D2SO>D$(:%D1R:VD?]OO[216_:HJ2K\RN^.V^Q[J
MVH1AG\-QYW:M2Z(6=Z1=Q3$/4U3A)C33&3WHW69MR4NL.7R)>91HRE2*X[JP
M3F&EA[RV9EFM^.2\J4IV.M=OH9ALTCY>F;XVI2M1)B\=6TXRAOM7J/%\X+2/
M!=L$TF0NV;%,FB6+!3I&=W#P<E#Y@K>:LR9>)-VT0R'G:^G^^5D!1?47):56
M"?M/TS2^VUVB3.6S>EK ,DRC.VLIE23M"\EY5K#T2O).^ZI0>O.JTX=", =S
MV^\[J[YP2%>VZCVIO$'K_OW^Q_\^IUG_VZ.S]_]Z*T04R]F"] _&!&"@#1'-
M\D=(RD<)!H>@@%$3N?V;0^C>U7%OL@]45UUHWH3=V5ZY9;-,:VAMUOGQA>-Y
M-:6EO2&Z/8N21\:C"1\NV)@=2]^C+7)$0TP[6@H@$2$./3.1<QAL &$IN!L$
M%J\X>]LC-LWSJ82R&3D:=/W2H'+E'S'.74.$N>)SUCVAA&/"=T8'II0^.O,!
M(E3:JB'+5(HO(GJ/%LL'#1G?/I$]:[[3B[TCF*"T[>N<P^YG[6O3-X;(V7SF
M;GG2\HAP86]9S]0#89L@_[,E=LJ?SCU[(- ^M?$;0,) PVP"LXTKGP=+?656
MY'&,H4GL%VL]KHXI1$6X7_QLWKVYIB.O*-5WO.GB@=_OR6S4VBKP?[5S76%-
M?D\Z%*E"0'J-4@2I*@)2)!::($9 :8HH13I1$0D2$D1Z25!^@((4*:(B1+K2
M B2 B(B"M" E04&E)8KADQ3V8_\W^SR[E[M[LWN3N^_,F3-S9M[W9&;^(9-5
M$CH$;1A5J4U$0(W0OPYHXU>KL&4H1QIT59)^ZGR;DSF3LQ='.H. ?KGXG7*!
M6'#^3<[[ KJUP&^3YSKQ9W=A2CX=AR6;$(79 :Q0\)"?<,4!/Y;VS_%.74;*
MW8UJ?;\+].*4VRVFD7$I'L7!+V?E'[[.'W3/55._E2PA(1M J"3./X,WRZVP
M0!^ [\PX"?'9O0T)*%$(XAHREOJ5O*%GZ-&D&K@S+ORR_H4F7;.J9-K4Z0=S
M*R</^!>?EG'1O/OH(6\%][%;Q*/Y8<'O!6-+:4>0(L'-!;A2[.CZ:I@?+K8X
MDM5_3N'OG_WQ< .,R?(V9#<&1&W=M[%7\?=4=8#NTB90+E<8A3\QIM4Z5I;5
MVSV2)V_Y<>@A)5)*VJT[LFN@MGR> $;OI#MXMHHD(]!VE+L_R.C2:9;1#R^O
MBS;5/4.:;*\*EV//>#J#<Y4/9:*[E._[/ 6]]YLI6V*4F0^HT'VH[JM&+!/T
M>2 EH!08)8%)U <?A9#XWOKTNY+#:%'9K_5:[RY[_:+\P=/>">U)SJ=]=Z&(
M*TX,+/58%5OA.<UGMS?;B<[VRL63?)2#HPO0K61=2[D)\[X:_8Z&?>&#>G6M
MYON4BCQD^!4Y;??.CJ[6+A&;ZY+-UAPX3_U3!?.#>M;4\[KF TN?/^/[%4V^
M V-+63#?@XK'<<DE#::K%QEG#<5#5#4 L^ H.H%&3$%[JQ;%4 F2P7?<LI3'
MLV=NWK_T^HU9^F73J43=Q;^Q<2#K?,(09'9G@#A.A1B I1@R$Q%9Q7N 4[0A
M0T?@!J/MG:MA:OGK^M",:H6GM@&OB]\6HK[%K=$\*VQO4W@YPS5 -(F[OR[G
M#&-_4N"SBXX*I\/7:US.1VGLJ?20.*%3I4H:*:D(VK)+V7A[RUO0L;FNH=DI
MCYF7K>=L39RY<(X7?T6;=^@_=JH_/@1@IIE[MR'WDBV#6:?086TM(Y:[6 [L
M Z.-PZ*H4>?[5^N:&*IYS0P3_)'5Q&3/FIKWC/6]#NZ^$5>.4SCWK20HZ//@
MB:RA41QBI\0EFT@ZPTHJV(JOG;$KHWH*E4$.MI2ZU-%>_>M+'$[40[\B2D,/
M]^EK8\3SS?&6)T'%FB.+']EVY92?LNXB_,SHYF4]%TADLBV_ZG%+W)A^;FYQ
M8:!L2967#1+)?W5?@GR/1H@ [PL<A.]5*501%)N%MJ<+]LQ-(FCK:5;JJ.$S
MG_0*J;5MN]T5*S>NZS68%-VHUS"P_2M/?W;X/0HRL33!EN&C,LL7$("6W K(
MTW?Y<=*:XBS(1 EL .L8U+LEG[09>M/827(UW&_LR%)0M/^N7S.??]T7C1?P
M*1G?TN;[I<L5W46UWX8$$@#3B[0_Q%5)6ISZ&:"%D0[&649@QL9TEJWQZ[8)
MPZ@ADV ]_4^IP2-]XT?#1H..)G1[+/"/80'MHKX&&H@9EE;L6+%LOEPTE@IF
MT[Y.80:2K&_4XYKQ0^Y,2WVSG&MB$LZ_I4O\]8SB^P]=.L<PG6#8> 1&9P^8
M)%MU9U@"^A"GF'AM;G*!-IS"CJD%\A?R4]H]59:2C(^N8U^UPP-E!F=#Y034
M,$/2P6IDRZ',7^_KM WLQ0 ;!IZZ#[1Y6:?N#W4:-H4[:K@R4/GC/HE3)[[8
MF7$^_73X\9GW[S+E>S=[?MGR$$:@XBBC;BY43I1J*!+<ZM&6/]2F&)5Y/68$
M&\?D>=,Q;%QY'):+I3N5I&)X@$I6#+;;P5*3_KN?8M"$)0!X)T69O,(7O49S
M89]J5[\&7?!XQ/O.LCG@K5CW8GL*TXQ3#9[GX#!@K-2W#>$3)$\+H5VI\+NJ
MASZQ$94S>7<;.\X&1VFVO"JJX''Y&4XMNV?EGZZ0:R] #'NA=,P",9I8CJA+
MAEI=*T#NW]OIG[595#>&OQESA =X EIX/S!*O^<"*GNF4SQX"]D+@W[Y4@)!
M&[VZ>#'NLL+^V#;-$>Y4Q+.7GI4I?G]3!;Y2HGE\0#[<;=>Y,[W-#(L$Z50#
M"29F:<-R'J;G+%R^1W\WVELB@#$%M/KJIB[-3%Z:G>O6;]\CZ$%02W>\D%LN
MKEPY^G *DHO__N<:D-/=*<'(>C+*]J8ZF5ZXFYYWSZ4.=TLSLI':K1P1=L=_
MZZ/@P!S=&H&#->6#VD^)>B$IFWVRJ@?'+6$,"V\Z(;E3\\?M#+$67&.HL'JZ
M6(1^O'I%?0SC9:K)VU<"@[)Z&-+3B]/=P;Q>E*[[-GOX=RJMR^[&0U0@*L\W
M_E?[TWB6_GUF5@BH1 [38S2LJ83BOK"9:,D7^/R,[^BZI0]--,Y*-PTR8!TS
M=:%0>5YYWHW8 \?!!#%6*!UX&HP?HQ6$T:=OD%.-B= 0YQF*8[SPM)Y_]76[
MO05DSDMLP' BO#E_994V/)6Q0$C)=Z$/9VQ4U7=F\BQ>K/M;]B8IU6)_^O$'
MY7[?;KD..[#'P1OB"UKP5#N88_F_T07),$ C9;4AT*2!X3.O=B* [ON!++0(
M/"KS?I^W9=R$6[EG6&C<KGK?1BU_&X(/33X'_005P<P17VU#<'\XL3W%HIP:
MC&I(:TE2V)H!&U$UB6H>]VQ,U?\T&V-P_U)A5);?S;[C3TZ:W%'\VL^6F> *
M^X]_F@5),6*^+MG3Q$8;R'FZ>IO[W>JV\#QCU66G^_9523);EV6(FJ8B^AB!
M+X"&A3->1>M]0['VB=;&WG:N=Y^\P>WIRFU)D)-M_MF5FRRTR=L[B 9#@*#!
M]SN&R=AKA"D_4K'2B/XMCA6)V4^WZ<A*RFKM%6L_$/A"QTY16R2]%"(-@<A+
M\S#S27A NV5%BI%"SK\L!B!8 6@CADF=7]7I9]X_O*"9*VMK5YOP$7\IVA6!
M0FT3^IEBI/%7<.HJENY(;$94P0#MP.[[-T+>MYR#I6[=!AP>'[RQ%&"_]UYQ
M[K*5%G" OMY;(M-^B-%R_J.OJA;]'].\K;,$Y4-I236?8[6: W4\R+U^.4'J
M2TGBUX7@13YTI,9!$@N\E-TGK)UU%I@=#-ZLZDR>N-B[&](\6_KTC(66;BB%
MCQ38!^?I/(QR[:.<?&T[AE:G*84[3!Y2$%V<;JN]\<'(VQMCA>V.8FL^P79K
M[-0])<#I'L@I"\>4'G?*.KD:*X .HG.3Y%OJ&;B2J-T3^VJOX(5^I]9$I!2<
MKXOD*RG0U&**QUN:+BRQI0=!!L729Y]I!HQ9UIA)+)0-HQ569/6EU*)P\H%)
M&M]4 [0X*A[*R?E7U+-O#,6ZY;_X<6<Q'UD;U)K;\2WW6RLB.";T\( TPSS9
M4_)S]KOS"?+*$B=D?J?T0@&M?+;4LBWG<:>Z)_<35K!=_^7WV;V-8TWK:;-&
M#(,<_H*DZ;?UE[Q]!FX/+%I_,CAC(Q]7I):E3JE[!GL$E\#LPWR>>^7.5I2D
M^HBA[ET<:R0H K190^CW![-MFK,YY2%;%;]/B2JO9>$>.O!T9WP0.?0M'<)!
M \&L4.X 5IZ-MI)C&W!*V8:UH?49.0%^53_!.XJ4'6K^2B%^:9-H&=R75#)H
M:37JBAG%-B-6:E@**+?1OI(F1/^Z* !U^ARA*&:"E/SYG.^R0ZFLO9\6NO?$
MKH0#%"$MWLZ= 24LMMDHT=\04#?(91C.[SGU9!G>8)>*5JI&F[0W90R:')[^
M*5O@]2*)*YBP9GWK@XKGO<"C\$LH)#.<\QCDGS*3W$D?R4[Y'U8ZXY9.\QWF
M<Z=4M4>H'7CKD5EXHU*L?ZX(.>!!=,PER A-T]=-O@NRCA%$8P!UUAFT12/0
MPCK&=O]H&4@M7/1O'F>;OK"+COCP>D8A:$!D.5M!7 '!+[)DI<:=AM6[]R!2
MP^E5-/=506J<G$]:C<U:2=SS%X5\-[O#DT8Y@Z>,)-2D#L=44$W=>WSH3H@D
M57D.F-1#X8"V81]Q:I-4?@:0*EUV@U()XAX&0Y;+6[?QFN-M*A5^W]+4WOQS
M,3M>.^!7,C]$C #LD^L1A5%(7*&T6!H>-WOV#0$SDC][>*Q3,\3T?G*X[>+F
MN8Y7>E_O]4Q/][PPWWM.&E(6#S^M34@DSD\;4J+[X4WN[)VIK2D9W/W+KC_O
M;*;8;"83FG2K]#7?WS8UE&DP4O5,(DR-/7S@^4^=F?%F^+^*.K\15;$1T,D%
MIM>X'AO.<N!^QO#2Q9A/A MZ)OI4=9I&BQ</7O<Z9%%+%S?*7% ?[W#HW)E0
M]!3;;8&1QW8CB'Y(*<S@G,1"2S.Q+7$694'>0WJSX>2KB6R8,1"X_?7A5^?!
M7HV,[KWQT!#Z-J07F3RK"]PID44;+60=WH:0#GMV?+GSIY(R$$+7UJS<P]=8
M"BDBX70_6)J">5B><Y?M-T^08)^F5ZWFTX==Z.N)Y>X,V[: !4>SL(VDX#V:
MK#.#^^QO_K(M-5,P*.] GP#C]C;(6A/:T1$,XLJC&)8,VO%C*9XY3(>FY5 K
M9J7&,%>Q&/6< 8;R.^*RGF]30FC;(PDJ]QWU$+/P^EPHVP3\&,L=QD*)_C-R
MS&-OZ#]#9A5'_QR#NXU7$IO3*A@"U<CGIYX/QJ(J'1PVY;+3 OBOI/@KN0=!
MY!>X(G.@_);]$/@\"",$C&X*-\/H=1OKLW@F-NYWE(IN.5V++0UGB@/EE<N4
M"1)B6HK:DJIOJ<^+H%W,DNISBW:LM/Z6,'#=+_NOCH/I^TG8@0U"%GR>D+XS
M8Z<,W%F$FC8$1>R_ CG*MV)^ 7/7CGZ*VDOL*RS!,S&P!*B4#Q 4Y%6S<=!6
MC%-P9G_2?HMHL[3,-JLP'LM[@NH05<= <)V;X#J>(4(C%&RW#5>X/:CKM"E;
M;^:@1LR/-YF \YH](0R(8^A2AWN)HA>!):H[?@,A%90?PS*HHZZZ*4U[UDWX
MOVI0]YN<6.QG*QX(#HX$=;XV$EX;7O[ C!U'>/FIE;>>3X=77K449[9Z";JJ
M3JW1X@HM@))_ GRTDJF0 4LS^C"SM?,-?8X,3U$\]ZNQ9=RW@"+TYVCXQ.9U
M>PUB@Z^SW<QK!=YK78(KNU"&&?#Y9R"&/8OG9=^&-YAF$L-]4A0#<>,;GD/4
MP6'IZ8J/,U)WP]5EIZ3)V9955_[N#1^065/\EK56578YN#6B1C.IM_?E_8MS
M)].'PU8J]-)?"FF>YN?K[C>FF[)E(KG"TZ "  ""-OY8@#"?,3>U1+I-!Y!=
M<@V JT>&;;K3-1_)A^\FSQHP__Z>_3+7KKWFT;YJH9OW6V@O#+U<L)A!+9)=
M)Q=KC*W>XE@@FA\L<KE;5-]DBK3+L :.K*/V3*-N+T38N!LMQ2%@KR$H%FZM
M'ZT$V6$?T7;8P*LJ[&83N9+.T /R+Z/OET-&IBUX9:E\UN2K'A.+T6SI:TL+
M+?'P*R634*YP%:/_<FN.%T!D2'5A]@!]OS_XQTZ+GF]DQ642'@^T!B9:2+&Z
M10/W43JBN:*C"X4E4Q8TK94X5C @UIM<3252C,[2O?\V*8E-I/PI=+S[S/,@
MGYB2Y@,9U^S:9UT!)R"P:'0XL$E',,, ;#3C(C,>(%!!/P9NDK$5RU8:8[Z-
M=\^*2QQ)C(C,U#'PQ$.D>J/<-B5FIONCPO>BOAUGO/[^SO8$X0,>,"^GMI#6
MP7#4+</51Y^8:)>I]%Z>5<5"35)>?O&PW7131:8V3E9(.M@")#OUZEU[)?J-
MUTOH("M49GL"P: E<H'!A>&[+>YY7.T1KJ2/T]/+P5,LFU+9UWDT-3-WG+I&
M.BE76^CK.<$GD]Q9;%UM%<-D8IZ#!YW-S/)$W,O3%<',\O,^.K]=,E\]Z%$8
M7KO6ZO)2<4;Y7:6\S"Y[U1:?_#FE#?S4^H(A6S%?O(&J5'3LB J4&3H:A8=>
MGLS.JEIN#7CL\L3.]>&:^[F6H)F[,XL*/!HY)8W$^0*8/#N2=1+4S9(KQ+X.
M%%T?!3)Z?41O'7.\U!K5_:8M[]W^/+0?_M! CHH51IMO>J?I]7^J#/$_%7C^
M,N6*"#/RF9A/Q/GOL,FY"Q.=6BB'J4;#7:BG@^1\=_.F>I X#1L4O>@-%!N4
MY8PVKC<?N2F^.>\_L9PK#9F\EKPH_;HEUQ]GLQN7E=WU2TC]&>'=,& >O0#O
M00JR53B/+0_1$*D4_:?/JS!C7)D)Y*TW3=IYBRHFE EGJ9G&@!8][8!4HVQI
M!;GBT#]NZ9"W]8QM2/P?F""!? S>1['FPD(CS9>S?SH;/TK=LSOARK1) G3H
M\0V?[#GZ29_I%*8!X,IRXLY$;T.DP42*3\;(WR//-9ET5 ,WD9*H=42=DSLB
M=KHG_W9?S#\(X=T5]H]\'D:^)4R)@$0[D"LB5OF32/?!4J+G-U>J6(>!6-?/
M.\0[&6.>T0>7[3PX7#4HD%&-X#UR[L>=\[]T,OZ><?FB[B@+3*SJ3*>>:OM3
MD ZN,\@$ 7/".K9['\8"'38&#S3,FFL^FU:%UJ5'5,LSC"N;TY[_%%Y8/2GK
M*?OQ='"HGIU]\O'=1"NDY@E5J_<$9F<*5\0U:AX)&&JQ)8FTRU4LB$DES9DZ
M)T'"TEFN)78%GRSML)661E\T'YN*/&BM/];[0LYZQER"Y[@"T5&[%#HX!^C"
M^GT$=E[KX?.%G4([?V+ZK\M-AEH=Y3QI/T5]2T ?J[J45LO6OQH>LXM9%?W\
M>%5<Q6U$F-H_#M)IZ62>["2"/:A#"KC"%:PO8E*=["6X HUCN0:#,!5ADL9O
MWI]:>/;UYPKZY>Q7?<_W)E-FP[<RZV181URT\DHY9>><_9(7UF;@I&+5D2BE
M(3^'CV$UM7\$W8FM+4W6#[[]<_5,IL"ENUU:1ZL;>1A:*X:L<&RW_C8DW(<'
M!(ITQ!R@M92)M'2F9AE2.3]1>5ND$Y_U5S>68Y_^$G[S^K,:SC%C^KG6ZX?$
M=55;7(SF%3*280AH3JPJ4->!_7CV'GPOMFYB58L6J@*C$5<VGZ%R;#)ZD >=
M[,B$R-BHV K$T^G H3;<YNH-.S[KFHZQ_'5=GJW[YVO;S:C+J[[39/=6L7\H
M20\.>\XYAF0=$9E#J=]_<V*-1Z$4FD.<3\36N6?!KR  S6&283Q,6D^L*L,I
M]T,3K5K-=MEQ>CG-P*G!+XO>KW&N67@7S5>8WWWB\W]X_[J/Y><:<X<%N>)?
M@/(:+[0K/<;)D7FM922<X#NNGSX3RKMI[Q=2+T#ZDH&:_LK?25:7ER=,.(!F
M?0<#]);Z0;.H*H _8Z!MK&JBYC(N*S?E]W -&)&H/+.FA](_=&.03T^$39@A
MOPAKX&Q<@ ';?@?.248@>2Y%E8]N3=S##E]8E;.G?Y4M6PR/=?E,2QC:I_O:
M_MIMX4;"WB5^MV_2/, $&+<;N3,^=? N0T#C:<D\$@=OFB/!!9>;K4S&:PTV
MX%*HQ9X^YM&*^XJF+,N1EXE'!8-%HOWX]K>QMB$IQ3MOQ,,[SM.Y!S..40)B
M"4%S#=$K??FF7%D&-NU6V@:3T9_Z%/7U]ZWO$9+^L?9?6QKWW[Q[<:66Q\IW
ME7.A+%X;5=6KJDB')T?!%(%AGX:1QCC5GM 9]_.?(]R48BV"L@?T1MY^U5%3
M:S#: X$\N*[[JW_GR24>.Y^U#6E$]#MBE=!83EWCJE&WCWC[R5% L+L!Y>KY
MVKRSFN_P?F+LURG+ #\S$S<6[CWGJ?-2C'#H5IO-OP::N_P114X7,NTY1=N0
M^>JY^LU$8P[2&M!D-#@ 2;L2"XZDQ;T$SLZR!CO:$C[C3:'*DMYE]6EBK7G:
MM;>S8,"!>D"4*_*<=8+[#EN_M#*XP%'OHP@D,7S[:57DN$B28OKEJ: MV2+^
MDD"6]:L\^XJ.T+1]=R\N^JK$4W!V/XZY?$*;4=?%>H^HJGP,>[F'1JUZ[:A[
M/M51-^Z'O+;2PTV_@5+H,!8P+^SO%**OLR5-:7,)?];E?C3?Z4_5I&_<D<V-
MO)-VXYGE9;71_=FG%"PJII0C5AN5=1Z$K@TG7SX$8!E:5(-<6HD(JLINHE%T
M=9_)3_.X%7>W:,F8*_!UB?K#?P0?1PU%&0L\KPPN6"RRPM<$O[KL=:G/[TU3
M:Y(_[KSZ+D\/B:XM10@[F],,GW^,K6M9O1JGQ99JXPJGT6&DK5NJ!QC^<F R
M[M0 ;@9'6,+GQ4P.C 13&VSOOZ2-&Z3KZ2)#$JP3!Q93%ZZ/;;71ET"4D,B5
M0A_[B)$!1$\[BHF2S(UK<\LF;3$70QU1;O)^JN]2JP$W7$Y%L)=XH3C^R8\\
MIMOM[WMFQT=D<$?S62]>0)Q7='K_14G^.[JN?NUT9+2!/MSS[X#^&.@4Q[<A
M080TV!XK\>7B0_?ZS+]Q"\/#G\R1^*;;O1I_Y?MI=_,K7W'_KL6V_<W2VZE9
M1(-?]*3WL[7YF%OI;)!9I,YB TJV#JVGP@!GCVU($HRA-+S2L--_P.#;AHCH
MPNBET.F?N@Q!KGH,)P_[O;]S+Y9JX\>5QI*1\/IACOPF&<K6?HGMB8<CGQ'(
M,"!KB>FYTX.V,]$M208/.&]#)-NY@_ -OSD).+VL#EP4PNDL(TI@::8E4X'<
MS%B:(%?:#4ZU^_]-_O\F_V]NLOJ_0-*0_RP"5<*6CN2*CW"*X>'#D]$T]Y42
M*G)*O:] ]<D"0:RS,+@Z1/%;13:ES=QD\[Q2ZM\[4"\(6W^G=WE[ZM\ 4$L#
M!!0    ( (^ ^%#_^*-(O9(  ..E   3    :FYJ+3(P,C P-C(X7V<R+FIP
M9^R\=U!34=0O&J37"-(1(@*B D:I"DA I(F(H/02E0Y"4*1)2!0ITIN HA 5
M$*1(+R(00@D@(M(A2 E5>J(8#J3PXO?N?>^/=V?>?7?F?G?FS=W,RG!R<C9K
MK;W*[W?.)H>3A_.@H]>,S8Q!+$=80'>8/Z##;9" @3OBG@?( \0<+(?3($/0
M$99_X]_KD7^#C?7?*SL;&RL;!SL'QW\()S<74S@Y.+AXN;AY_@WF;WR\/'S_
M#OY-\G]>>H2=E96=AY.#D^?_\SAL!PER';EVY#DKRTG0$4$65D&6PRX0A*DC
M^W^HQP+Z+X/E""L;.P<G4PU>Y@?JCS+59V5E*LW.U)AY-I)Y'L0FR"XD>\&
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M_P;0UR?4YZ1?,SN!CR!WP+VXFZTC[ F&RY=JFQ1DF].'KMPQ=58)/021;,'
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M018:OGR%-ZI&AY[=YS]5G"2O]G(IJX*VR L2Y'N(C20W,@38R":;J]2[2!%
MC5Q+$1RG:9'Z%\<VSX>!%V2*%I4>E-19#_)Q!P<5%BK[WPH>J*VSOG'*_@-?
MK[SM$Q J8PBNPAC#DFY)B\TW;F62)AC<,Z1;Q!EL,N,"[5IMT^C\<#U_<-V
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M]FZ:25?PLTYBE]*2Y\XHKON"3K]/^$^5_3(&CS\UT)71GL\%>) S%@U'_\+
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MB=IX!!J"NM+ 5\S*0D)"'@<7.J(P?L>/&HBGB,LFG35^<N?LTW90(.@M&(\
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MK+J$->723S<F$F9/<SQL=U.15:S', 1$)G2YJ:>1FLQL3$(&TU/L.K$@/46
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MUU<W!ML'4]%@F#>,HSB1QEJ*F([!CJR<<'8P-?F9'A':"<ZJQFVX%*$,D/(
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M=;G%'F\7/=8R\FLB]W'!2-^?^YXFKV[AB1X^N+F^3Q_W-0I@/BQL[I)*JU!
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M\2T@W9:%$%Z]B+DT#4#;"<5_9C5/W;HJ]%C^5\?)NX6GDT->JIPFPFS@X-8
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M,0HGQ*:%D/8C84JM,X"=<[0*PQI3JO$>&YHXO29;1P>]E:2E''V",<%K25I
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M,MKA]R?'W"VWSG7B$Y5V"^MJ=]D^ L+R7"!2GU3'/U46SIRC?J)Q 28=M)M
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MB()0<6S!N\RE]5MBOW T3CZKU!O;*[YP]^[7&)Z)CG8^)B_34<LE8QA[RO:
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M6\#@\#P)7DXT[[B9<>?%M'?%3O<([F(KD1Y6Y&70]T_2$4*#>P'\ 1)%[J<
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M#C7<H3($1W"/:!FUB +@Z0E8N@;?IX47ZR</4I7N!02$X-Y?+GWT-NU'A\)
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M(%F).B2VF:H.,V!CN:*O4](<7Y2B+-#0-K732&_\NZHJ%Z?H%+9D_,I&\]-
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MZ,6[JZIM?;CIV-*5WGML*>^1WNYYJZY/UH5FL4O5WODA.H"DLB+/#"J94H8
M5%P@6>+;9WO,[R:S'N'5[TUO:"5IBSR^O6'O&0=%X(.H9PK_<A:VJ2)Q RQ9
M 0_&[D.Y3,H\S#TYJCO7'F_E_KF%-[3S2JHM:94V9$S!!G+;HT@"5OB\%8GD
M2NJ5>HW5 3C7IXZ>'_I.OR\?C_S0Q[PP)U8HBGT<^\,G-6H"(GOU]*,>8A_L
M6P$/#6D8U7.QZQ0X11BDULN^,$_LG.>R]T)X7GH%_F=:I^.*W;58S_FMB(ME
M#MGW=)<HC^KSKX)]MTZE%,J4D3]T1*[4I&,!+^OM=B(OB7OZ(1XV,'8#E].5
M@&8-?'G7P4>@W48EMD"\GF$L0513_?('2*&JV.G3Z-*DT08 _E164P^6(JLI
M6M93N2@Q6F NP#BS;K4:EWUY79"-:?L2[=$A5:=LI%IYU!B*";U<@*BW3B.%
ME8_CY.-LQ8*%)4\@</U,L8;F;W+YN[JOJWP(4[S!$+5<\.O,$((81;("'<.H
MM6@XY>N23#V8^M:X#!.*T(O9,D^WCJU>R;W7J)_(KS-O5> 6_4Y25B(E9?<\
M>:<X&E;D"UZNV:X@BI"LP2E\$>&(G(7RL$/$8!MJN@N"Q/%YSVHZ;LJZX@TR
MO'T(F,+<GDS+MLSS(KIK\3;B<+F8:^>=B26$5K //]4/ [SXDB@RE!^V?E.4
M"Y[8^I&:I(>=#6?_-/Y=,Z+SE;V'D'!GJ54RB)T3S<&T8& W&N'TH6KV+<T=
M,QWBY?>-W8,(KXQ\JD0SWKY*7WKK(HYXLL\6RKM<U%RQ#<>Q@Y>4P]FW_^*M
M'>JF*$QVFTVVLVD-KP02[<SQSV;JP[ZY*[(FY3:=LHQS=[;.M+DEZ_&)7O$J
M0PX5(LTH1I(=8$=AK ;4>I=4&G*7B'<F?/_VQUA=*&LJ>;^(M>-@UYDYY(21
M6&87K-@**MR/M8M.9Y7^N.'I[LG<Y^GIS6&XDJICI6?5;06!0)9I+.[0Z/'\
M;_G?\K](%-?7E[XN[NYN&!8GGAF53>$UTQD6*X30=B)[B->I '>$.9Y YBAA
M!P'XLW"^3<!9]>7RYUQ )K#/_NP]!DT.,5GUHPCKDMR?Y\O][.8>O!LI1;>]
M:JZYV3&WOFXS:)UUA_!C<Z)"^(\[8L('F]FN75R,OOCO 8F>7J@PZ>Z4>Q&$
MPO>HBZOQX<WPN*H-LXXA5\BS6*8#*0FMB-GA$\C9$XA/T3SM:M$KOOX3"$9T
M@(\PY38VM3QM4EWB-K.$=4: .U&O<D*5^G_TER6_OO1Q;-]X-[W]!)(%S7/M
M4@&ZF%H>K&CLM=EG$'_NH=8J]D+ZX9@0@A]H.*F'5UM%/PN4>OC9TQO>KXHW
M*=(5T"9H=W/?O[CJ"\KQD;C'>[(Z2Z'G?8+>9^U))*X06ZV!C%7#>< )$2L4
M/H$(B0%NB)2B,;4J$B>0]E%Z\#VL'Y3U37OYUYHR'%=!3]YU1W=>E>\F)^*I
M65B.*/:[O1BHZ,5"/3+E#?)'OF(DCKD?CQU5^]O&DP0] 8PBJ@[M0O9W+-2>
MP%U]N+/#'5(SHB'S2RK4J(?G>YF^^=_7:/WTPNI5!L'ID-1'0Y.O49;CTPU4
M8D]O$%F&;2<'\VEFK :)L9-HJ\] P:NS*U\R5\W)>4$M%J+K3_L_?8X$%6KV
M:T9NR;B'6G17N\=Z4G"6)Y"U%%'<K'#%1RD8,1Y^ GD.<]*\1N5Z9LIGC3A1
M/%\?-$$CH+!&N,A-TPG/IXO&8P[V:*CA<X,M%Q9>E:+#\DM\VX66\A-B0]BT
MZV2].4CWT4R/:I2XEV<9K1'M01=(I464G+/A+Q#\+8-/R;@*L[">&K*$&:ST
MW^-[V.T-?(QE$VB'G^W5(/V)G#>1Z5?=AQ]<D=EC^)&TZWF$HGO/4D$7*-+I
MMF*P,T]\B.2Z8@#,$U+P5CD=Y_Y47591;6^T#]?UZY(G!7<97P%4BTV6KR0>
MF:J>0(:+L93,R"B[U4Z):3]0M>/WR GD2#;S!#*9_JLPB90""OTS$QD #&65
M(R- XV+PP]SCFG>_)IL*@@V"7?HSU E6*1%)1&M",+7*Z:3THQJ4^LKT\(*@
MP;T7L?SPE FOY"O;6;N/!"2C-;N'TG/1JE^1FKB%#/69/O6>R'<16[/P,'G+
M]"E_!&?+#4T/'C]I;I1KU.K![*+O1/WO3:E/</III@!O12/!!'YUSB=WS149
M1=^)%""X:P\%8GG,=.C_/Q'K85@S@L2+75;;CIN]3P>DYZS"A?2R([GA;:?F
M35''$:]/\<:3_MBCSWE'Q]7 I8;W-??/?6KA-RW%ZDV$^#IWS!ON*R$W9#Y_
M\N5-__"^)R@2X=SL.RPQ_IX$QQ6Q@)(Z[7A$"O*&2YE[L,)+WR A_=\78^B$
M;!8_6PFOS?:@&U$DOK[EFK[T!M":X B,AF*M;[^9V?N^T_#.[KL!U\*#M&C]
M"G4VS_T 0@6Y!>W./L^-H'P'QU:'73\EF1.$A:9ZGIK6'<PQ2@9 _#I'M:_*
MZH4)H72 H:?W6&2=$.I%C45_]!KI-P^RN^PKIRDAN"+^>A;[LAOB\77Q^\.2
M:K\:4Z*0X]_^8C'7"%OD#S"/RF'XH'QR?NI,@=BK+)W:K&U,X UUB-U0[,-K
M2KNHNRIKEF:(^F7@GF973$E<Q3E=K^),A#^,9]"I]F5L"(+7W$KBT-\;W4F-
MJ(/DI?^G;F@;6N^V\Y-H&37"-Z'6RYXT"[C7-CD#N\7K6Z;9;F+GQ,3O%.X(
M#YU /-"&:!=Y4#ZD^P22Z.NY L<@^A1#!:RSJU#S=UT^!KZWQ^=NR;5("BH$
M">8^9R9%%G==2PAECVO)47_XZ,\TRD=XNRM2_ 3B*Q%9Q.9WR/VXSZSOKG]Y
M5S_Y%RD7?P)IMH55P-E#D_LH<A-R2.,5!_]QBZF:AUQSV-^',LI*;W]]_G7K
MD_:;[R.4$+0+:KZ"D$U.:ZQ% ;Y#=4/EPPJ9Q+[P!*7?LU'M;\6\G*+5!LWP
M@]M^B(^(3T,DWG8"BEPS.=5S7Z00=AK<U.$FTIJW"NL1CS&FC\4D*6&J<QK+
M5^DKC^:3-:^,7_51[#<C_Z4G%'?^JMDSL NO_$B E8 & [+)B66"6KX+UBA7
M^&(69;L!75*_$[!Y?*D8K0(S9;Y4'/V_3#[CL>E(/J"O5VU)"XS')<L)Z$]=
M4$)XV,9VIUVZ$YZU\!K"(/8<(O;D'EI86PLI1\ZGG/> GJ7(@_ER\@934WF^
M^7:)AM<NQ&H,RW#HF.V:0L2B^"E8+'#G!)*$;H:EIQR_KO]%89UR\P4-.F1X
MUH;.K3%M#'%]U24N<G!51M]K7@3@IUP%$4EMAY?TB%/-%&/A/R2N[P?PY9;5
M=/]=UMXYRCZG^&XOE?F4VPWP61-!GHO_]AA0@"U6&/FH<'_%8+OL'2+4K1>A
MK%8H:M_WWF/TV[;H>N.S8Q;#OCU>NC(DXY>O XN)8FN981*9292:SRTHZ94O
M7+W+4N^&*HGFD6O'Z!ZO3%OHYZ-#CO4%X[30JD@#J4"$JTS#W>$H^>#YZ4O%
M281TCO^>W6(IIPR<GZRI579,504=U/;6)=H#;@K3SQ,(?2T^K_=T+6A M%E:
M I-[1^X*R/.0ICPT; ].^50',?X]@=B67,7&ZAZ/+Z.$0M5P;L^VD2$ L7_&
M]FOJ^VZ)3],-6[&YYY_CGX_^TJ4+HN-XK,M+&K'^=@+Y!"/Q./U[0%EI5:A-
M,]/S/NOT9=JM+I[6UPEKOUB *^-95R'(;L=HFB>].22G-*1TKVMMX;5+216(
M$-82F&E&'N76$N%[4=-C:/+5CO([W1M<09>\*CI6MF;,$""7G8-8.C9?YAGY
M]0G$'?H,U0CODX$G0T]WW&Z+>^4?#.>.SCMK$7U&5S-,0IU/5/2Y+DM9=DQ$
M&^51O^/6BLQ(ZJ.6KY?'5%SS?TV0M>+[5_"!HK;/LM^*!TZUN?^]3?58_X__
M] W\<9C[..;I"M]V%E"WAQL:9.<X8W<U0"@G^ZIG@?YRS%U&;M&(UQ'2*?4<
M;S(FD-;@^V5X#(*M$96$YOH+-HRQWZSW?$5L1<4:T%@&N;E>M#*0_0(9%D&?
MHA(0^[S%$*KI!#*X592P)++OU6 G1UCB_7;[I8GV5+"^7T\.P&^P^YAAY /#
M+T':[K\@6OCG77S?%+C6['LDNGZ,KFM<+#V!:.(9TMX]#KY?<FNR?QH4(1@?
M_5QKDV\XF%/-(BR26[LN4Q80W *#VEJMJAHJR6VA 7UGI\XV3SE*_M(<MJ-%
MEKHD=#._M0RMYK'^^Y6!]MFHPO/>E0=O39F'Y?+^?M]=JK$ #Z'I@ZZAP[A:
MBX#W:L%+>\=SXL6V<J>2+GVL?_X_ZL^_>S]&"1-@*Y&;9)&,8^^+V->*[1.+
MN@#L])?:>30M%V5T?YVUKS6"C' O&LM$[46-8AO9>U&8C16MO('Q9^&S1>ZP
MW;TJU]Z%W[,73A'V+\!D/AIHQM$I9C*JD%9FFZ)ZBYHV^E$_(E99M+6!$BU"
M(M*<G2<TZ.>\<(D7N\^PM'-V5/]S_ZH1E *>O8\$XW$LE&?,]C.SU<J>)"KN
M4ZRGW,JQ[T,#<,*BL7[&3,D^]XPZ[^Z^0GEH(\:$VZM#*+&7/EHO%PVFQZ,:
MY/M8)7&'O9UA*D+<-DU<\[=/"ZO^PANB>T04I$?".3P_U*QM3GNL;([DW&L9
MD2LO3%4I,0DQ^/N=?[J6Q^EN=G:)6+ZGY=1W9:)"<9*,DLY_UK^RW^WN[GC)
MN71UM::=NYA:FN]N+ZT?[5S/W0UAR?2X]6<<4]^K#07'@&8;D+N&RMR-:>B'
MWG^OI4H#/1KZCZ]7IMO[E_*Z'-U3K&6HI(]/D^%E]@].]MB=K=O<*=MN<T X
MI4.30C7%-@?N&SVJ\>Q*.L;L51?D5JR-DW@K*<SJ0<3[)#T8,X7/8U*^KXCU
MOMJ<$)-9M<-'RR6%$TBAD_A#"Y)8:T]D)7X@DHGH@NK1Z%*,&@Z9"GUVG7(1
M"#!.]N6ZUVWPG*G;^,7@;;G7D+E+<^>\"DHVVBAS*U[:1K&??YN-Y <^;/ ,
M/FX-6O>UC@@70['A[TIJ#KKE>+H.?Y@,KZASX GW+RMN)-NUF.GQ'DA^_>^J
M+2UG_I+/]&E$>"R)SE0K$V]>T!K[.S+ GS4EVT]S=VL=-0\=%-8"M?"S/44"
MI4#?EC;WI%?A>>^T6[HAHH8U$H]O^I_#:*6$9XMT:%_\ZO3\9_KY2\V\E\JW
M,4G9F0'N'M,6[<:1'VN"=H%UX\L7OLRP*=XR571WD)32EWLG<6!J8J/61 BN
M/SR!G";= .3[K]&\!Z$#F.!*)CU73X'&YV]$4T?8[A 5Z*Q@G"0GT&9%R.H
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M:-;Z(EK1$&HNTX]>?KTD.T."$S6JRQNOC;1I-VK%9GTVTM8Q+#7+FJ:5N73
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M+V<Z(F1@VIZ$6\*)9S(M/]<P3%&LJKIZ(891-(85I9!S/'P"H5,@=YY 5M2
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M #C4^\O33!'*?1(9EM -5@AVV]V=B1@_4(__,\00.'C( +!(3#H6Q1GP0LH
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M/NMB "A/F>R<[$GY]J\\>;4$XE7DJHN7RA0#\VI1:YF\ON:%<V9G HB\,RR
M:!8%?D>N.?E$/#D)'V)C68 V7L?YZ\![Q=67$)C;S&=6AOOG8]*_WMJ (?4_
MYVJO?908ZH]HTJ5+LA#+37=0 '("1=#Z3)WJ@YD_4;!<@4;-71#$:]?KX!9<
M'$?DJ1H!^F8\R)!GSY[V8%*TOXD@L;M'_R&1_UTJY_RMI8NH_DQ[ WH(YB,7
MW1K62_)WCJ'PM!<Z<BL]L4XO@%P7.V]_=2^1>X_, W%&M#X ^8#)7LC):Y 3
M9$V;G2;1.=M,\. M53?=J>;QKXWST2=>&\6\NG.I?2OKX P&W70)]XFPS]5E
MG5XR"MO>3&\>QQB6.HMZT+6(9G$?.F#F%W^E+P\XI:Q/TU:4;?,B[OQ]04L3
MHOX/:5@493JK\9P5'CLUT]MQ8=:/_+!M,CF_*?E4@^)[*F(0N0:IK3G(9 !.
M+E$5M@. <2!1I8TJ4D*O/G?;XXA919'P*"PF^S&"G::&_H,X0UP3[4J_E_LZ
M7P@NAB6F&9-X7@JQ1,YE67D[5+YC "2L]XL__HU/;O#<?Z5@?4C> =-_$?J^
M6?=>.\Y4BD?6#MV:^IOC[5)#LH1MY5:M8XK5_S24O\QRR3= *=L]DD=9CM,E
ML_:WP^I>?FK)0JF@!FIN6CL'4.)W+0W#9;#_U_B7:B*F4CUTLSBV,&=\[J)8
M*OB^BRU1GO0\?O;G@-Z)\SUG=5V')_Q*5R59MA!-(6O/0KS66^^I:!TVO;8M
M76ZVN.6FR?.\"&M]J(3^M48_2[4B++53$$H;]"'8VINR\[Z-J]UDP=_;X<?Z
MF3Q^(I,4$X//2<P5)%Z^?K+.B^-&W*NZ2R3Y5(N%92/_1(G0[N]UFIJ"F3S!
MP4^W>^4S4NW%JG0E3*2VP<W@?&^=HI@:QPC_&RVIDYNCEE)\'>./[L\R .4S
M+?D"K60%"Z?E.DK?<"/(8OJ0SH*]5X\1?ODS_1$FN H9N#8=0&FHVM6)WP%.
M, "DI%]T)<^5?*\M 53L.>3^: 'NR16QGC-AA^FK^MWJ*R-DDN:Q^-XOJA]B
MD0J9>X'3H:CJ.=]QIUXN$7*HOR$#8!.1M<Y\,G[B]_^I%R$G$:UNB+E\% %+
MY\HDN9+5T8^)=;&/,?C@8H>>G>4,7NYGR$:]DJ?- VQP#B/O20: B:Q3:3?(
M'*Z:S^! \ D&(%$F@6L /SB<+'%UH*!;'CB0G7B26D-[;R"(2MX?<U$=J;$Q
MN)@S:1(8_E'AR?A.'%;J\.1J_K%7 & EV>>;?]<#S\6O[T#^XO<%2;,FZM0$
MQ%8H$]4$B)>1N,CVNS_\OM+I#A9F'DI?P <S8Q2#.U,+(G*+F/?>!H*C,K_T
MKA;U>(<^IKA%7_T^?S;R;[;%_5=7C_.RJEM@BM+NV!IO#UDH_4_VERNF2$_(
MZJ7T7QB))FF"[0W;'9AQQ55/A5C5^\]JW3*74UC\US]6=M@61GW0&7'.YY^*
M2+6%;FJT_RJ-[[B6)!UJ4I 9-)U*P4Y!R%+!K39D:<I)LES7]M0/#%&\D?SB
M]O=6M\9SN._KAO7/P0U9AS:E*SHVJ ^>09,74CPR2!E!*R?*3B<J^.9%64M\
M X#8OT#:A&OO6ZG_7'LH![US)[-P>F-[G'[P0_4PU,+V^@FPU]/$B,>I&.Q3
M)M)A]4_]*]\L5@CB,U+O#3\8F0=G!$R<8P \P^ /#VP#[>D7!\:<!BY\!D"G
M&GC#M5;HP*3 >Z4TR*D"TL0[^VC1-3N3J]"&/<@(4CXO/3TE_M+9%Y$\7J:'
M\[A_1]\J/6L\[5AKV/T1O:NP\Q8W+-&JINUDR_#<W':]5]H5WGC;KC[!5L?=
MG+/2I(]L-HF:FW.@C93A);*QGECZO,$Y-#G!@6A4<%C;7&SBKTO\BF4'-;Q_
MFI_V#=^2(/==_J'/G;I&GL[#(!>$[YQ;Z(:8^,K@?A%9&;)-Z8_!:W8R *="
M2$9?$K/UU4[7]FLNWA);O$XUUF_@Y%95#16YB&YJQRWC/.4"\A\A8]&QY7'%
MJ];I4TS[J%61KFQN&JJ8QPQM%D2&..E=OK9@+R06R?KG])K+!F&'Q.262R_+
MRZJ5D8(\?$YF"XYK&K4+VX"%14-A@.M5U^.I[0NX6()H0H*W;JBR\I,S%^\G
M]JB5#_!SIJV&K&OKLZCC<C6(SMA$V'6E+ZJ5ADBET3./#RR/!J''4BVT%#KF
MW)![CD<Z5H8ZNZ>1DPXFFA/T\(JU^TSL"*&?J;DEU;P2D5GFX#@-9_N8VZ"/
M'=OB"*EJE] <.$>4>;%',;=HP_ES3;]>D_+92-<W]AT.+F>GOB3;$HOP,:W.
M4$HXKBA1:;?'[H6>2LOR$\"&E,]KWSVQH,X($\(0G7TH&)CI3@S'A9EJ\7I)
M2-1/PEMN%$0B-MX?VBYI;[V<V#SZ)#3<>H6:K[Z:776@V_*=)G..&'SVIVRQ
M&]NO3SNO@?FF:XMEC54;8?(]>AP4?WIOKGZ-_09<;GPE]1VT=LS?;3F"P^0E
MR/J!_MJO:F LAJ?I+C_Y8;>#1H'H9C:7A6S5[G@71KMS0;CBJ(56%E\4)DL1
M[D&387OGJOWR[N<1G!H#D&%"OS61ERWUI2W:Y)&UY<B;.?:?(WJA<Q'<+%]'
MFUP+[;N%?J8Z>ZD8E>B;N E57+SSR7KR-'3 :3/'(2!]2:K9.<E!OAOF30FC
M_Z"SSC(%,?_9X2675QX9V\Y/#G5XE'>\"*B$68(-1V/LK#D9.,<'K7](L>W0
M<@=NMHJ>XOG@+CGBO>K7SX)_-^EYI^V'+.U3A>%:J ,#((5]W:>U%:4:J^DH
M(*Q.NG>PL.(Q,ZN!K&PRPT.YR;HWZHG*\7N-SKK@:O-]S<PTUOG$\+2#([^)
M$$'Z$(A@U;AAO"'!3<LY'V['?0?*-]T>]TB<)T64YQ6B=CY83^X5%ZR=>'G>
MMA.2&(8DH3K08K.K%:(!3[%*YV(9@"^\.#[ZT1-^>Q1-SA"K3%=_N\1^TQK#
M:I]-Y;11B%KF/KA3JZBSK%?]1?N";X!L\P)B!I0U"+PPNQ\'W=JJ,5NIT;?8
M=DS(CG,P2XC[H[2M*U9UF1G,_J2-YC'9BJM4>LH!AT]C52;Y$R&_G;EFN[[>
MQ<61]&G6S\.6JD0_BR[Z[J/4())42N([:NL\Z 0YX9O.>JX$43TN.D T_YY?
MFI')T1M0O-4+[ -6K;//2?H/R P C@&(IDLMLUPA2G_190O7K?^VX_/H[-'O
M$=P 5[U+QSZP]Y;+5>;MC@0Q ))RU?GVWOE;=/?N:MOK1$D<*LY : TQH;-[
M)"]3T37\E('U#^Y"\ -5U:*4E/'(T-7=_(O]>@-A$H]Q%\TRS)@45"[NWP,
MC2GK7H1CW&V(RIU0?OB0PTRNPU"[#6A"1*H"(]M<+_K1%323#."G.+-3-SY_
M;AY1_C"D-F4B4_\U_4%=)+\"<W7DBL5230 \8?08Q'W0Q,=NTBU:IIXBP>=>
MHI?-Z+6UCLO&+Y:\+L-VWB&;!) 91924<K@M?A%>F2L2H@6:>0!4IM67+=+#
MC.DS(#L"(B87VK$FK$YITEED .JFAP5[[1%316@FC:?F(IS^*XYL2802^:[H
MN)33\H_"%]<SYLF0>FH8'9Z.M2T-23!*<!F4'BKXYB8<AR34+R.*?HUE.#GV
M>>I._C:Z<W.\]-.Z882!8QQI5]N%2&T BF;C#-"Q2_'[KFAL\8^+%8AN%"],
MFT#'_AR1V7F2<QGZD(]'%7P-T?"5+KG\E$T([9 D4A\?GZ,>="C966J3SOXD
M4#QUU<=+)STZY:%288F+,13*OIGAZ<B>SP",?1/OZ0R9[4 CZPY[T@P)5CV>
MGCF5+K0)-^ Z ^"+(,YW6QCZP;7)"7@0$!)ZV-S?&_!X:N+&S600+/@)^&?H
MTN=O0NK[VA#NP7:'"LF9S"<)U%G< 4KP[=*>BF!1S/[#629-E2;3_^[&#P$U
M_CN1M3?0(#Z2X"10LQK7O:,-G!,57[3<T7D55H)\0TR.]ZVW'BK2&>$_6S'3
M<?<3N]IOY@J6S=,U0GZ)A<C<RGYV?=4".;QG5[^+0[H$);.+[&1%='9V3K=/
M3ULPF6)FJHE01I",5&I8:OB0_*[>F3-">CJ%0%3V*@-0$;.D]=N)6)]I Y&>
M"(",_95.Q7_^&BU0L6/GE?O;V6/'POGB7?EOIUZ9^B>A.XF(UU/\6VIRV3\$
MVG$8\K4:E7IDDJA%J30:UQ5[-+<S',F>8;4#[$2_R#U+MOW$4ZW2."3S*D'1
M1+(-$Y&L/4[>>"?&RP88&TD_65KH&;;YUB"API/H//'[8V^"YW.Y-?*]2)YS
MSX^?8CW[S.O3<+JL"TB=%GBA4,LZJ7 [ C.'N$DNB=\%)D&.!H*C,\'E'A\=
MI]EM:2.]G#V/3?#:GU7>$<0 Y=W34L4[J[LKPTEV.S=VY*S29?V^,RE:Y=%X
M^8>X_6=-]D2S;A%P._+H\K:72%<=0B WV_W4HOVC>R67Q_U3P8"CX*,?_:,N
M:O=-*#J&2S5D6KQ;[;O&OM$H5>>SGD(RII[:(NF!Q$$>P63B/)?R3\)8>X]D
M?2WOQSMK-D]\?H4=7!%.UE%M3XE&3[)O8\>[22Z$[O4(BIX'Z#A,AXA5?VT4
MX6UYHWMJZT]K%M3)G?W]]NG3X;:?QH@Q$KYJ]46Q7@_N,0"!P* L^NK:FDPH
M;' 9\?@I#T=WE%90KHCW?N5^"6C+(#?%!MG3\H%I45U KW^EO/KWC='O,#/"
MKU1E\LUROM="#<<:2-#V#Z3NPL#=WFSO\%Y/A<TYDP?I[&;\\>P-*9&L^E?%
M2V'JH??79-$K8N--:BH!XMJPIK?;R X4DA1FPG2KR]W^?FSVZD>/&0(I+_)1
MB,9NHCM2O*6E>7CS#V;XR9_<4,> M%L+;Y&?9,K#9#8D"1IK.,'XOIGT8RU1
MQ=K>;%\-S (O?=D3CUMM*1#9\:+M2!9F*G!ZWU>_X[@'!]<T!H!0_C_>QG>;
M1BL;"]:!K6=H;9@++<KT&39B-^D+&4U1I_\"\L&L<<[&5\FM.!\.7$QT@(_?
MCDE5_5 >4?V=YAB/='[7]N]>G^PHSS=E'E.X\>]"\,JQI5FJ0 +I$BT3Y(.-
MW,>(P\ZY<V<3.4S)SPO)E\BY T&?<\&G'):'#,-Y&0"T7<?B#9G'V3="[L5X
M+N%U0K[.'7S>MD5>]@TWU2L'936/F4TN@;E&6H>ZMO'G-Y3N%M0E?DV#R'CK
M>GN/'\:0X&1SRC78A6&]B#DT'\QM&&;^WBS\1'>[#Z0S7+FBFOSHY<%H'7>Y
MV-AY[6CK I^?R?FAY[X0P>N?B"@2:@0QUYBK0F8C%I&B1JB.!2&V[5F1*T%N
M I5?DA[%#SXZ/RAV0]SF=NY]SJ4G9F)C4 ;@N#2YG&+1C.Z<G> CI8P5C2Z0
MU?&./I*W1F7J/7]L>A<7UMA/<2G<]$F?G]Z1ZZW&7;O(E(PUKQF UA\H@<_M
M*.[?1["(SRM["V.=QJ>CO]D4]@G(?5*;VI+O7"LQMX?D&9=>YU PD+F4[YAA
MH>9XQR0HJ:"ZP4>W,? Q[38Z$C37 N+'>$&>,0"5"Y@.;"2J6GTLJGH-PSOE
M*3CI%O=10=/?4(WO*Z(.ZBEYC\@9>@V4'BLUCRIKN0@?Q53%M$+C)83(RD0P
M?C,]CYS?=:<,+CJP.4'M[7+?'DJ_\R4:D6*6SOFM)/6JP+8R5>S5%08@,FP\
M\@JVPT=3@@%8WD]?(Y[P,+O00=&F_$IHSLD*7W./:- ?F"=L"'?KMH??#*]*
MK5-[DH4Q*P595QE4TQ)J.*:M2%IDR](UD<0T+*A=D3V\M_=KPN4O0^_=4Z:3
M358[X_8N?-V*I5]&"(<\KU"<B$JO5QGO:@<JA?J!FKK3AI]'];#+'YLS3CJ9
M0^&&21#@V9I;FRT"Y-"MM[[;-P*F_#ZM.T;K&S@W7T\Q@7QX6LN2>0+,I__;
MNED1@]W> ^GB?R(T=#Z>R?T!SAZEP#"@*TSX7N-Y]7]W)%14[9)3JW3Y2)/_
M=377"]$>[06Q1NR5N4*GAT4.UN:+UO<T7S3-"H6(L%T8B%/T]TS=]EQ:#0UI
M%OJ#-L)R,P#7!TL%M"7>G$W.KR\2-GWW-1^S1(,#0PJ%AI$*M=1F4#E\#69H
M& [MADST/#"A^A)&VT]?5/7249"G%P>J?M,M"D*6!#I5W(!+NZ3+#92+EA]6
M=&<[)!;_P#Y)E-_SI[,Z4X[])H.,F&RMGUR:=Q 67>[QBWRF'Z^GWIR?: *[
MNNP*E')'3F<^N1%O_ -!,$6095I**6XP9[!@R*Q9NH$XV65#:JQ"2,#9U#?:
MC!7K-W'RFL&Z>[&[*:VWLK)JZ#%NJ'KM9OG&!MYN+I*U3<HCG[TD_QD  - "
MV.)FE'RKGPY+&$=F8J0IHPW&!?JN39C&HLFA?2@+6<(N:TV_J_OW"]I@A"N5
MGC()FAE;7U/DMX3TR^P6_U=6HDJ;1YQ8!IZ"70[$@7@GV<J?I+$ PS3H@E83
MS_\ 5R!\,"<R& ]Z:2"7UCXY*7P.UARU6L&[J$?#+1M?:T9^.4Z;=5KJ8*ZH
MA##Y"RY4[S+>COMRR^CJ);W>4%V=M(/3OY+E5T,>QJX^>I-LFC60L59%=SVL
M*/T#*^)_.J*WSX,%FPY,[$-^, #& U1L9.D2)(&I2\U!D8A36S5]B&\STD3C
MR!IE_I Z,R)+W-15HCJA:GAS0UW4>_3MAAZ1O9\!<&>M>F^3%%__VXIE=2L>
MP@$#$[([MIG,(>. 1=$SZ-E!L,I2M!6U^[9W-GKB]R7M7(G+E>]$&N ED_JC
M6<$@/JMNUY"WUS;Y+/K"=%=KP];&\2VGZ%@@J\&Q$(DUW%8;@@WQR,Y+T-]Y
MU=\P0G<&XFQ.KUT-+_+7&ZH+=>XE:,\]Q.II,E'N%RVIZ1RQ:YZ43EAJ;_:;
MZ@[V[U6<C1O#2S2,7:Y.J&G/:#XWC!:]*?\,(,89WBG@UWIO2>B358(E.< A
M+.C@M-@3#=YW^38FO?B1M;4*S.7O< UZ&Z**9>,T$=W* %0S^4Z,I!71]GE!
MTJXHDUZ;BZ S-5&\O2*7[*VEI8<O24HMG7WU@(9&/$)/($F9! ?TAOI<SO6.
M!I?LH,PS.BI$MT^>7OO9XI(&YN4_;T*\379.U\N^2C9AF3@M87RZZZN;UFW=
M+"(V04(=++"6UVOQ1@-USU[QK3'OUZX#^,MG+.!TVV<FZ.O*/4_?)I^_G:-5
MWVN_7+,!W]A 9R^'3B2')O8^)7YBK[R3_&ID)6)C0G&Z*=.J#RY,52$@VGA8
M)D(XOMF,C1Y:9/N(UZ(\P\N<76A90L-R-Y+\I1*+2XY&L3#]Y)O +TM#>))%
MNH[:B(ZO9?R 5%GJ>LI!C4.-]W"@G,D/L,U4([01^I2I@GZV_2]VRO_C.&'S
MZ-YRQRD_5KT7=YN.,9\1?@3Q&)IPIA;%=<&<5_VK"<PQ[!>?#]>GQVK?68[Z
M]X_7VVMKFY<Y#H+<41-;W<!J:/(\(?CEN>WW";Q>#07%MVQN+XEF4WZ&LK_(
M,'C&"[*@<\#.$)2_08].A?!\"PM./P[1[_OY3+AB\>R3#*/-;N"5O\V*T?TA
M6\G+A$Y@*4Z<>,<A*#+"]=#PL%D1,5C/\LS;UQQ:]F#D\Y>P_6R(&Z@L8TH1
MZ@[C)2L2MDBA9$@!["S9_L,%5-[R:)N\1S3']VD7>]%CL.2.*DT_\&!#PT7T
MPN1("5[>M-Q>V]2\=J:\CKE H!*/@?SH?)&[>?E"!:D.4AEQTA-,L62?]5]=
M6$,(=-I +,01'Q.]0,#&E]WXHMG'V=OQRD KX$GWKCZW(2R0F#87G-#"M09T
M'_F@*1+0;YA1Q O?M!SS1O@21\ MJMKH^M5<#(XFV*ESXY G-N [5&&3[_'H
M3H5US*YDL>2K4('=WZ".^K+D(OG]3_KS4_WZJ#D&@&]1*R'ZTML-)=?-$4<S
MS.M&="><9Z<_GH1*1E1J-,]]S.[ <,]G6PT:N3A>T71R0+YG .SRA_UTDS5M
M8[PF:U'O/8-%1DL6?#;R?^,LA+%7$L86'UP1\WV7>T2=8N'X!G<Y3.[C&:>Q
MP6FK]3%CFB21$ZO8]6AO6L$IU*?\4'W:H/30_3+Q11>"D+R,&-?@Q>_?B8V1
MU([__4?E$".G0P ^3U?_H^[?H;/! ,35E"8%6SUUJT_S/]$_ KAO[6<A<(6=
MY=X)*_10Y3K_4RU7GNH].(:@ 5+\^66P^X$3_<= &")[EL",L(U8O7\_G)Y-
M[ID7?X@;:P,*P*X2-A-HA<4>+J(MPPH!ZWRD3Q_J0GD5E&7\+[IH+S:8]A.1
M\0&H8R'&UL2*ELU:$8-L_;VU&]EOKO/[2+[2S2D)V;*WI1]OWG26:*Z>7?A:
M"R03]D-K'(+'H+G=2YCU0"+"E%;?Y#XW%>%.BB;V89"S;1)RF9W^GBV27ROI
M_8T4MTS2A=K:I*BZE#_5]<C>>Q31/L[O!1%5A"4(,:8--;&*A="*])RA%\K?
M>]ZIBZMI2RD!+USFT5.X+AS WGKW4<8QT7KTOS77PWR.>;D+B=>Q[0:.+]+T
MY,O-YOJ"NVR-39H]?!9%_%<V%AV$B']N$F>^,P"RXUWJ "5\]Y<! WWZ[UDQ
MC#LR$G0&ID_1YHE-X7#L90!.3[3D<[VT#4LOG+KJ&GC13718P>?IJ8M@-:8B
M[U43.' S?SNO>LM%DBVI2-;VI955C!KN#J@!J1O?]"X_Y(<C)BP(9-N_W201
M_K+] 4%=DE/OSU"4,:O%N\R:S/-IU7>E/8WD;WR]#\^#8S'5,EU;"1B"'1>D
M'<.;L6\X5(TZ<2L+_#+KS\:7R)L^%9([O\0__BG[UC/FS?L\/B^+LHV1Q;B#
MXIC([L)4[B>0PS!'/.19R@I=9E2RKIIH&W.R)%G-^TQDO[;2RV=X\R]R)M5^
MP?,U\%=D,U(J67 >DR R]@W+"C,;0E/M<>.]:R(*G#.N]9PEOU\)_*B2^WS'
ME/?8O;$OWR8*=<:=P+4E!X6QQ7E+(5^#3-1J3+SYT>)E2,'D[9)J7SOW:ZD+
MR2)IJ46>1OI3OE"CF=0G@\V;FS!7B@<,3"MH^MM62I*)2"@K\E:X/RXB'#*P
M-7MML*P+]:1@U>A"_)5D[-.7Y]^9KJM: -"_'*A;3 :<5(DDRPNNKW-PTHJ,
MYT%[0JF8&_+HJ 4KRD.UEP6327?3IX*<XB:<F]6G/G1W6GZL?%SB&Y^0?F$Z
M-6E6US;(!&)^R$0KB!?LRG]G*G*EET]82Z4] ZQ=87-!4Y3A/08@6B'U>I*&
MQE 3R/NB,]@Y2R$O6*5#:T>J^_ZW[PI&1A'723;,F4#)^7C@1),OL4LW1_#&
M8Q-H?F+APNJ>Z,Y/U@BZW^5G3>H14S@(>PBT50)80RAZ&> 8 ;*HC#7V=O<6
MNIL$S^G12PV52O4SAQMWY5[ ^=7WLJ2;6-3VAW=)Y$@KMP:V=*_KG<;!E=7?
M^;ZM=M81+?:1/=Q+1 @.3KV9937@"CDV!WUQGV#<WB?@X_/PH.AMBV=%01=G
M)<;FX<&1;P" _*>\>'I@QP-Y?.F/&D]M"XN-NJ#9;%#!4W*8D.GI?".Y2_&5
M)O;2$V>9%)SOWO^V;NZG:$68!Z#C]%\BCD[+6:7D<%O[6VW>'L]K&S*%3GI$
MJX:>U7EEM*CU&-_<$K^K^G,(F(:?CVL=?IJUBKF[Z]V3"_=,=SWHY[5[[*JN
M98#<];Y+'0))MVC0^V8%$>X;CA007B9:0MY3K/QCJ?=;127$[U?</!'E-<V&
M3],IERN618#Q:F]W@;P>I#&2YL4[^,'M$ZG:@@/IST^V./U;M=AJ<@3>5Z.&
M8.6"X'&IM?,,_CED_W779O%F"T9KG=]V2TP;/W-,0,!8 UF%VNG49%FM\:7:
M9H$ > C+#J=4SN-<EU%@SX778_D#9H0(!6RD1\72/,_Z+#%[SAKW J\9^<3'
M)V$CQNI9:&WJH4^ZWWO49JWH,#NN=.^GDC)'\OO2^XM%+%4)YA'+U'#!%YWW
MO!NTLI[P.7ZZD'7P]SW^^Z5_DT2?T,L.QO$!\K.<Y,A.I3)U41-%J$]!_\2'
M%%,=,?_( F17^8"I96*:N;-*UYW$-(L^( C,O+=Y\MG#F21O[J]X)/E&=0Z/
MY2 #@.- =3J\K$6?&,Z _LFOZ2)O=$]<&IU[_4KU#^ --.A7@#A?VZ1T4315
MLV#*SI-TI@?JZNK.FGSQ_!4!2V9X>0\ B*O8+%<H7'#,G).6O;]BQ&W3G%YK
M(OTGU4$Z;ST(OZ/7#F3MYK.QLFRNV&KTP6A,C31#_+$!B G(G,9SXI8EK:@:
M=33417NDO 5;[(V:S#1?[%[HEIB5+KR$[N%_>.[(@?]PJA>9A72%AFH1A@40
M63: <]AC'. SY!PI9]O;FJD-FF]6MRN-?EH*3PN\>9YZ=24-=2LO*L.UQ-0T
M4:E@L7FD8&9["A_AL@Y5^_G;R3ETHO,J!6NG^ '3UF#L.DYD &)G/P>O-Q.]
M\>;(3N9/<):10&7>%1^V(?50/?=2J5HW6<XO![I*KPUKKSGY'.,T67.IN?^0
M.]M5/*KQ9P_OADU]?:@3,MC/'OE5:GC8YO4E+05%D^%\4Y77>VF6)CW[/HIP
MMY!$N*Z@!?_:R.MYKO.%%X9M'V4/_>&W- P4>VX8C&#!N&&2@.+0,\ 8.-O7
M^MKIN$"SYW\F#=?>.K+?I*\N-)>N;3UGRA<S: R<?SL0G:2S1D[>>]IM7J7(
ME0J\%I(*07_GN?:QQ<I@WD4"-SP?5QJ6L&X\D]GW&+.QB"S'T5GQ!E)>=@X:
M'^F_F\>IN=M,EF]E<(U\CJ).=::]KX%^AND1>GN\Q9X_J?$NZ_;TH>^^^<,
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M*RT360?)J=&$-RG!$VJ^L9%2%4EAA9F83PD>91J/W"GVIQ');:*\6J@9?U0
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M$04AK"YA4>XP)5N!>>WJD:JF0;6J2&/%#@'3TM9*R\<HQ<*[\KI]:M0H1,<
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M2))/?BK>@8S)I#<I]T7+V2A0+T,:WK)MS+#!JK;ZGR;KQ8[S7U8]2"IX;/2
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M/[';OX@]#A3@"N+585'-FD-+(_OQ C1[I1L]#W:OJ3VV2IM_TR+&$Z:E3G7
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MHFM'MPH^S?^=4;$^/@($K@:;_5)(STO/QF^=J'H"N]3C=*S9@X3YZ4UCXUE
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MD;J7R&<HRH2N,)ILVZ*#K"F RIUTIZG4I@7#+UYSXX/[<T%Y/6?#3(1;?HD
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MK0=7?/K[*A#%VKD;Y:.2=R!S)M-#6TU6B?W8YUC"-9@(<@!214HF>D.!XOS
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M^29OP-YB)7+'@TMIQP\]U):^!)<S_(KY@JR42*WN'GG0S@5HCEP@Q8+'8OL
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MSQ)K%(RS"/3%B! ?G([Y[/3E@X0[)6N.QVQY@Y:.%L[5AZ?[U2B=OR?_%G[
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MG1",?UT5F6?A]27D5:M7H.R^DB[;F5,*?COXI-*$RM[^JG]X07-+ICGF(T+
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MDSM7KA7-8[B)Y0(";6C# :@4'6)%L!LQ>]RP'PTI! @4"NLH^<BK 6!UFJZ
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MN20I\MG$69X2T]*2/->MP[X.=2#P_YL 4$L#!!0    ( (^ ^% 7=CA-NCP
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MCM6P_,E=R +".^@]IZ/%D<\M@E$9QZ;/%SVHY>8" !WN@* >NA9FD<$"#%D
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M^[10U!3U-=[L^*PINB+M>L@9QANX%_JKMA5%87$T%--:_F#U.PL0FNV7]_'
M95I:)-:4]J94JM3)"E:9G_38KG^Q,A>VE'5M=UI,AXB23_T-%6=-GRS5E?P?
M;CB:8/[3J4*R6?O=ZWUI_<X79M)K!E5?A\59(0Z$M:"%U1I4I^&CVE#%2+?<
M!PJ1DEN]<6^T5!TW<E4/?+30K*^K$JS3O8QU;;N(F2C-1IU_=A>[N.DVU?/@
M[M!SF@6X*O5#E")2/(;2Q6.#\W7./2AKTLZ0V[SQ.ENHJ_9&8L@#R\,5-\;U
MCQY[8-1V;25@++V*4#"8B6X:/Y; ^Z8_]5&5F</FK%G!#Z_ L65<,<3*1V]&
MW0A1AS OC;1"V^6(_CY3JO/;\NB*F[B&CH**5W[&,@;,G W=@HJ:-2O&L3_N
MHZ+02U"1(C]F"J76%$2TGOA\N_LS_S=,'7L/Y9\EGFY-[\$?6V&:*T.I#W]H
M922R,=?!*6QU\N\UF;;?*-R6XF\%#8C= Q476[_&>T4+A$CEAT@F(?,[)%O(
M%6KS/[H&<JF\0VU++E<1DGI/#S->:]!.A=+%-)V+90&+7-!L>=UW/ BKA_.9
M2LRKTY_0,P@GN@;]"3E1V K1Q[5VS,K("X5ON<N5'*)0C!)KN[/_A\50U?RB
MELJ5(QUS3MU2)OM\3TG<*C6^&''DH<&+%:2V9/7&R)88DX>3)DO7H4"3;$VI
MC>+/4?3K2(0'$"76C-7"[$!EX%OMS*A!E[E9@)?IF6AYC:4=O-?*9S6>/GU(
ML*;+#>DY%-&5R3DLH'6D;[@5.RE3F>98'2"0WG3TP]HSEU9])M>98+L<N@+C
M'C0 +O+GG9SGWC!RAH^.;6+0GJ&8YV!)AV128>%\7WMS_M6R0_NO&B3><_<\
M917]37;-"5V%6PPGFU KJ[Y<F)I-+P[%MHRF(4!?^R_58SDZFV=K/;A[A(>6
M2S6 S_Z;!L1[/IT%4>7&U6?.[!4Y7E0HHNC9'XA<7?%RWPJH:7*IOF0K4RV)
M<OA\;O>M:^<.S&N6ILZ.+BSY>X?JT>%0]?PV)BI,G 4T.S2)TYU MGRG[]@P
M%7(,9 H2TGOTU,'SD_:&TC#W=UF:+;&2J_:901(/7P8IM3=5!^=(V63\, B.
M=\I,DL76& U^?'&/J'.'EZW=1%9R%B(YO* _V;%O <[I/=SG<DT&07V)?>VC
M[9A;@/X6(;>V<F@F->C4,K+XLXWVT2]U6IG$GJ\^Q!YH=4AV46<4T)5)M'A?
M<7#Y<]]8JV/:-<%Z\PQ*J=]B[./VF&O[35WN)%_((8]<>^SBM:,\[%(WPI3V
MROME657VF"WA];&G-GIV:GJ8.D[Q=SXJYC]_Y)E587L5YE?MVC'WZC?I0CQ4
M+\K+%#([-8LBK2]%T:)3"7Q,43R)YC1QTB=SR[[T^B&/7;.B#U?<5Y\,:::D
MXU/G1EF *V+$K@7'B;Y,8&-V$<2K>)#6:R:Q6F<O"!WV.>N\++/8R='[!C43
MX7!4OK?RC4#$CNZ[N>$T';IFG[XLGN+K4--$X8I#7D[= W>F[*%-=!6VTW5&
MVSL^5DT"NZZ</@3P.FU[%SL=] R5GS/E>4KT(OLM09W$]PG)-TVJ_4FWBB_Z
M[<I/S,OO$I^H2@L,_E[ND=>K\+PWKKO$%E]L;I>6J5G@GNWM@"RI'GLWB'VU
M-IC<TA/#U*70"6\Q+2N\!E?(*RTZQ"%]>4LAS9A6G?4$K+KWVIEON=_"U2<F
M&A(^;=7$QI=\*EF;:^,?LZ"&UX!"M%/,T2S%Y->+'N 12G6#"HG &?7 >UC'
M(WTBJOI3H.GY=UVW#A6@#]> #Y*[#FA(+6.B,+PA:F3T>VH8&SG!/]OI@GR:
ML\O9V7&7\2XYBQ,#JY>#TBQ4&I+H-[S<POL:QMH);TS>PV7 ;,?!@*( ]]X&
MJRE=^&[4N^::S8_UQG7%CHNK-UZ[*EVJ<;U?+_?BUN/S'U,%LGI$[K5]CJ#R
M9YP]D9-Z0]5X:)ZKK'YA*93OYI/H72($[*7><[HE-8_2<E:&O!T9(OG!UX)5
M$T<17PU#I<_%:UKL>Q$??=[XIHE;MX61R++,#MLY/&Q+65\&@I]OA<PD<WQ9
M3S1\U3KD!,0MNRP9TNG1*HRA0A Q<_LR"YB<9P&Q85Z$1U9&:"U8?_@?L(PK
MACE!6#U;E4S;I<:,S6BR*R^&_W&_=*D!0E)Y*//4/M&/)+& F3P,Z+8%@2S"
M)00J QW(E@_"Y%!'?3F_RYP8T-/$KI;>32K+/VSQ?>GNAXR^IP\40CC6;CJ(
M/'XIK:+6B>&%>V*DH6 D6__:*4=0_<&<Z1.6I%DL$6EX'GQ.(@B!67,7L?T>
MO-8M)/DZ3_>LH$U.B4.VD\1(K&SHFY.7+\ZEC RW(*I,%@L+P[JAX@$=@:D*
M7&Q^[9,AN=GJNZ<IDB)V*MNEOC'9J3^L\^":LRE64-=U!\DU:+34];)(M%-;
M]RNE>IN!0]/')@J]%3YEQ'L%CUI8E.O*3%K9=-K@Z[Z:"U5>H_BF-[HL##6X
MU-R9]_^>/*I"U?L"OZ9J[$?QG\(E7%^7\C&027X.6K3ZSZL[=24TSJRP;Z_+
M]FN)W1FG97!__'-W.P10BF5A>B-A'\^^I/M37A=,F9;I.1<[@6*MC@-1RQN6
MNSJ4+%1>231Y"B)3>A\_;>W=;;Y4?@/L)KN15CI80 P68I3ZRMZ9@:.BKX2,
MT![>)9>^;GTWX'18FC'VF%M.2R!.AR/4?TW#E$;AB6*Q3<?#/MW)51NH)L0T
M 6 49R:>UGV.^&GHE=;30&U1%44_KFSNRGO '?][]G$'^BX>B;,1ULQ*19YP
MJNY+74R]$]@[[S%08#/<6=SO/[1+U:A,$*?B%SJ66E]3XM24VPD5AVR4CG;+
M:%Q%8&NR3%C/4%_G%$,-+V3Y0JNQ-L/45*[[R>[(NND'G?L2I"MW\1NNN112
MX,2Y^#"^D#W@K\O!5,IR23&*UCJIT9>'O8]*6J!N6E69)-.N:%6E&FN8"._J
M/IC&/_'A2]7U@FG%>?XQ#/5%-M61D=C@2SN#4C2KH?#UQ%0-ZB ;;@4]/-&:
MJ3Z:?]PP3?J6N>3)';IN5QX&P63I:$:*GA,T55.H"I-[#TT1[+.HZYNSK ''
M2,:)HAUMO2XN)E(3CGC)^S69/;4?323OGUPXKV1GAGH;ERX7>RNZ(D$(@S)Y
M,GISK<]N-2Y4,/2KELXMO)*EF3GR%.W<I6(R)J,"^S2K;ZG\/#A<] ,F 4=B
M$C [F?M]1G.28_1XR/OX+)JI-5E/AV+Y!CMS7@X^;.^B@5DBB0HS;14U2P=I
M[\J_QE#+*!,==*%,4B84)+&2ET8)20T72#]T5>7,)[[U3/$YGNST_7PXPB9Y
M2= LL:)5X5'B Y]AYB%F#X&]2=4TQ)#BU"(ZK.;[XI*],R+[:YGD69TSFM2T
M3I[G68,UT2AW58%V\RQ*]HI$9T&(/ 6SM($D?D^*(JK%C+[ ; ]1I?H>$%_O
M"C9^N+!=JR/#5^_QD![@]M:4\J9;8_A,T7#SE)=53X#B:GV@#RU^(FFS_JMT
M;[FA1'24 G]4\QV[MXEI3-IF077IYIT3'40T'HD@)8<+F5,0<?+#>@9%SA9%
M8*9#:/.-E=F]!>IR0M].U=I/)81^R$\,DDT;'F[%<>*NEB>Y[ 3C:0?X)4+.
M#^@Y<"WQ$Q-/;;91L906U\H!(0OL *FVTCXEY/%P-XKW\J)ZU"WMB&[JX%UQ
MWK/21OM?O:R[7KHY=,"B<3T5E].C>[AE"&][+M\R:_D'4GZ*YF3_+L@>XEO+
MQ_A=&3$06%7TL(#+QUG NKO-1O7?V]AW^@5I(1"EA TPWMU#SQBP -^N=6ZE
MO*;#M,O_Z%:VW_:K%DI^XW?O-%:VQ*T@7H/6])N%KZJ5,27"SH#&$$V<9]]Z
M^@]YHC\IF?X(PX\>N=7/ DP4K@S]$>Y%F#\NT-56=0ZC5VY#U1SNR,I'I3Q<
M5O+\^S](R0Y5)G\$\T'8'W<FJ9-<4%4<!IO*G V3Z$"O6EG2U>D1D)3E^L>(
MZ*N$KX4DDZ4+1/$P:;I+_\;.4M4 TP 5B:HRUZGVJ:%EV9;C^1E<MKSL.(Z4
MSWX/=^B+AG5C>)E"URK ; NDO^.PW)NCZF!,&U.A84AMND;!(2_)I\[]<+Z&
MG$9'U7&C@SN!X5 C5_)(H--H[:$;U.&SB4.*NXMH"MI=HS]]<).HN03<E>0(
M&0WP6RCM--^%]GJUV T?4V1U23(/2+O0OV_ -4Y=VN?@G?YG6U87^=[=]2K7
MFI?9 ?H2?:.9N^/?AVTG3S1EOVB5;RMH"KN3\F0F922USW3YTXJ<X/(GAUCY
MK+&\=+VC,H_&21S9C:-.!#2NZ&*;Z[7F4_Y(%0?MZAI:_1T]/#%ST8^FRX0"
MB>TUVA,=,PDD@ <V7C,G\A8V!1$FM[#R6YU[GU9XR"Z-HMYO=*J#OE0]4)LT
MAA0S26\P++G*E*R/F,:'P8;I5D&A;H5F;-NWV[],:2 HW7-;2\BULE&N*DY9
MN&UMKW?03;Q(Q<CA:I5SHUX<ZM.E F6=I-7 NXT(-.)(#OB*W(4GB(<(!)!7
MVH;%W$P'7/86CXZ>DZ,%U']X3:U\*GCED7*2D;B:5.7,=JV*5U>S]"ORQE&^
M-GU+RYJT$KN:NLHLV5X+'F7;Q$?DBZ]DDQX?*[EH._YP]E9-N67F^J?C<Q_S
M0T5Q\'FYCC!!)I[ R>0'\?@F];Y# =W6EAS?,R7A]PY63YA>,B#%[_RX]<:1
M+_SSM]/)GYX4/#*.%[\9B0P6$;YH]=R$7\;1SRPHE)!JT2OO?&VC0G#VU7X"
MAK!5PW *CA*V<GSR?S0U^W]<<?Z?[?^DDNOF/Q"2;1'QA@70,X[_4A7.3(AK
MJBE/1?^VFQ7O1Z G0Z/]Q&!O\M,?P)>VPB )[=IAU_\7=SO=@IQS? I-8QN'
M'/;6V>863AHWDX2"/!@(_WEPV-.9!<AQPZ>29Y/T.IA&&S@\5.CMZ#428<BB
MCT3] X;.^:^-A']%Z[^B]5_1^G]CM/K!I=#>_.&8M]&9;F7T6V#F2]"SW[KV
MZD&O@9QTSQ0[/YOW>N'=03WT$W+,G6M0'>A 0M!WI+& !^77*(J1>K!II7TU
M%'24YH3ML4M5Z@NVZI\K*L05#",CDZ8JX23C$$'('[K0;Q3+<& <L-H#WC6A
M"\TQD]ZVX$ !R(4")G]GZ LL($J";,%\L!*%)N?6L( II=][V+O@I'D8V1+S
M4Z>'FP403V/H1I 11-#$ MP;WUA]R1]-L%[T-3AW=V!P@25?%=S'8W+Q/EO&
M>:X3G=L:>YC"7LUJ/^6:1%A R]TQ:-;\WWK*K@ZF<_>^VC/53ZO6*#/7^O[Q
M:4VJS\H7^B@4L>F,7-SW&M".!7"]05,NHO'FS![$NE.("@N('(&#Q0R%/Z&$
MRA)N2G8.L;:,F5!CG@%]P1@'13K]U29$NQ_"C^)(!6BO\I^JOR1J7H31;6#D
M/MS;888HX9>^5'[F 9P9^H\V_LWH\+^9 3ZUQQVSMEI(@#%/_O.T@'H>1.:@
M>^K1MW%;AZ$/ :GHGH^8$/06^YH/4]*.>A>29PR21Z:9!;3]NJ5/A78"W8LD
MES/YH5R:*EG/_!/>R&?NVQ7  O3G&7U0LN"9>X?,6 #\0"@%^L3?70YZ([[^
M8,;[0D(%0T1"Q(2N6;ZX 5$B+!1I)R)90%QY'P*TPG#@OB?]TG?G#U_FON3?
M.QX<'Z;3"C<M6$ :__\-[K M#T=?\_WZSIC2E%AZ#;%'3V5/X\L27ZU6S-C-
MG*+*$O7WKN< O5T^ZX9_PD=%KSJ^MIG?V)6CJX4L@/!?\@*9MK_ ^HC- 6?-
MS61+VLU_(@"HD'KJ]=XR95)8  >TA.270N'$ 85$*Q1@_-"2%@%QZ=XA%&3+
M;?*_3A]@ ?^I<_[; 0I&7D\&%7L8>[R@T_99,O<U6OX)LS[C/\@"8EZ@F_71
MWW_H0<$0+HBF"*/Q?7 B!KX>D N=^#X6#L9MP/_3 +^G;\\HA81Y!JOP;>WA
M\!Z%1\"]X=R3XP;%L07)M),FU7J%EV9//ELUV1-4SO9;2-K\A!*#^P@QDR'P
M*^I))Y#_9O _=MD-?+OD_,0=U(K.WW'LY>0K L),[</6F;'(U4]SDA2M0JW]
MJ;WMHW?;F%ZSP[\E:OYO06HWKT97ZHE K)O\2H7[&]B_^.6//2Z9]-/2/YBA
M_;1?L9?K13<L36.&7:1-0X4%+!OQQVQ-_B-D(%[@R/GZ.]&]>Z!0$AHB_'+7
M'SY3=ON7__4F3AAE5Z7E7V_O#$/^EJSP/^)%6"KDT 00RN'3@9"NEDZ_G/A;
M1ZO!9]S<!+P>07^,;M7IA,]]LVR"T\.WJG_#S:+_;?= 70)<.BP <YLYCUZ%
MZH?=/Z <P:3K@U"IQ_5/=(G)WWHDYO]7#J' %LMIWLQ.'!]3X>P4OV38ES"1
MRBKD 7M;WZ6+:8=<-+;+';RK/"<^U13[>_**+*#_$\U"FI!94T>>(H94Y O<
MJQJK-GS7]$N4/M[\>HA_84#*[UW81O9PK]J'?R:@?CIA^,^#K%TQ9H.W&8$6
M-4/K\56Y?:L3BM6Y\'?R-YZGQU1PP-I++\A&\-@+#@T))RE].>C7_NQ D3C
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M)#N2)\J?(]NIZ[%RTMFRZFPN2;@4_"HLG/ V,!)'NAP2"KXE0:O4]W:2ZO2
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M!'_W=0FRP#O32G0K4^.LZB*2[G++[$-8: _U R.GX3BYD,D774U&WT^I2KQ
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MAJ((TQP$9"$,G5@[ ,DRH==ZD V!:8RDD4B_S F+M1P$46WZL"H'<3[0&\(
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M8'K \4\P0IV _[K_EV/1<L0&,H-5M(95O%;L4*S$K@ FH_7885X<!,.#$1@
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MBO1!D8&$17$8RG2[+?T'.;#)@'H)93:-.&(2!8;/PG7;OU+"77HK;,_>7<.
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MV$%J='1XS19*P8(4V.I0V7>G5G>X2*NX:&JSW+Y7;==46!FAY6I=',1UTG
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M[?4X_2L@**,9)NNE@2'_]6#L_W</QOYZH(ZP_K"[P,[ICX]4OCTSI4_#://
M6H @-"]LO K[PC8][+>.T<*.HQ?U9P &/\"6\6Q0&_OCHCJ3Q ^T&48L ^DH
M_+L/T$D#TWP.HG=]R7-9Y<L_\KD\[O=/P<-1;J15#:P,+-X;OQ5#K#D5R8I]
MQ4$\^.4VIR '!T-I%0B;I1_NJU@,-O*WB[*_'>)_6(.J^N,JU1QM@86[19K
M?0M\9@Y;2,X21$YBPN#T699FS?W=M/]C8$- 2>A$G"Q4;\U!K.WVM/[S)H[.
M@[B)K@'(;?FG+)NH$+,(>Z-$[[>N,7)BUQ F [IA:>"&M*8]]-#F _1[,Z_4
MP6<2@X1G. A= .43P'H<B+O(0;Q\ 7M_QO+9/W+\ORKY^T>#S4W38D7)Z+%#
M"V$^<&ZPT#7P]U8FI/D@6_$%K*[OHWK,<D/)2=@75V_^UC&86N9=X--")@?Q
M=3<\AWOQIN* /YEY 0.?4V(@>Z ;$):ZL*I*5X"KFOGZ0F<W_N _\ON_[KK_
MW^WD6>/[PS)9^Q]L#&A343B4S2J^[YWWRO5[6I]@3S2-_M8MJT%_6B-S6OB3
MF<?!\Y#Y'"J;-<QB-Y,6K:B&-E#B^N:53*-;_\CI<\#O$OZ/&P,7+;=R$).N
MIBQD >HR;1HR3B:T<A"5ZQFP-+%\Y&\W OZ^B/ZJ_D.5=8L )H/@#B(''&BB
M6JYNI0(?X<8UN0>NU2^ZIB__KU[^^E=9C/RO'5S_)^_@6O(FFC8B*R2CRD_K
M"@\'48%PUCY O*_R-2I*V[K6G#(2=N&BHKM@FU'R))JVOK.P"+WLC]^"HCU(
MY2!B7@B_?E6< E#@2*F_1)B9-Y( *'Q:'(2D*6L/ *JELN7S&KI8VV'=J3/<
M/SS^D #:,#^##<1S&S92.6C'03R4([ <70*'&'#"A+[$G.@1CL X,\]BU&O*
M]K_)18+'BIQ74P\>,A=;,9SM;B^Y0#N4K&Y\8O2*TEA57V7K\W3*'N?%]J_W
MO':?T5";+X:#3;%-M:@,DI]F!L)&]_NW6[1DK@</T%@#PP?DFB8!5N5)/VIU
M)^$<!Q'Y()&#Z*K&WP%6#RSBP0@[$HN5M]+!03PZ=%CM#0<1<1<:1RT[8F$M
M][T"%HV1M 742"L44PPKN4M'&%8-VBEDP4$8_0CN@2M&([1C,("#0.UFPRDU
M*70F>A9%&0>J<&Q)=!@>/.6!9"68LO2[&'#7RYJEE<$4-^[X>B/[G2![X6]^
MS^%O[0"&L,J=E%7=!0;@Y^&J;CQ$<8.VR42LUVD.0FB)70/,5+/4.8@&Y[/P
M_:)1U.V3A*6?>6-(Z!2**N\&+"WB25K0D<F9?]8F.##RD!:+^7K%E(-($OXO
M>_R]/8R&_M#2,*^OT-P@_KY<V\;<K] @<HNH;&"*ZGEHJWG\@-7]_6B5D/&<
MOPQ_[%'KDW[*R@-EC,-[[WPWT<HR6TN+7G6#Q%$L\0XHO@_6<2O\"_H=H &N
M)*'O@1XB9EU'(32D^:+[G[_VOE%N5IW=7XJ _'^6Z!O0?ZA^]VQP@(LPN-NT
M:79&1TL.VXO<HI5;&=D,P]4&9(#$@,K!IMNO#-8&A?_"^6K+HTEQ^VNJU'+"
M"S:_-[8;-AFI&K181&EV'531^;SD\2[_?&ALFL=/FV$-+\G59\_%!__*;7\*
M$!L8W8CP*7,0>#\C&-DNNB5Q$%MG8>*(?PRM HM\*L9^^#\'\U\%2=/1-F!Z
MS+(:Q7H"-!W^PD%,3Z'JT*R0MAY'M[\.YC]E#7WK;?3JROF?</?;A:0+E1%6
M5RT78*MOOWW'QNXO(_G/:7-"+A4*[F=FPS)%L(Z_68"PYYFP-S[)_;,6L?J]
M0:[\7VH/T3]@$J"1]!;/$E-LJ!ZKBBQ'$KDI+I(IMZ.\<F&-SJU6[IVYU?<(
M$'$<^E.8SU(""_0;W)Y4^UTW,3?174ET=)@97JE12: NJLN?M(TR?G\2FO7.
M<CSWG\JSXE2C5_^Y',Z?.?N#L:;\3&'[AV@J6\/9X3L9=]5\[UGYY* -P]O]
M>0O_(=KY_V0X&3/O0$0"#T#.()5R$%$<A,<"+NTQ_;J1;.6Y2O^3,K-6U0D/
M;]D?>7F_MTUQ3^RC?#U]\8O7%#Z@D]"T0/%P.'@$1&C%S9+629<"SY\ V=F.
M@2VJCY,=G-TPT8M<+-DG>08WD_43CB#M67*]*/)K?+E>@Z'^A'=\G7Z@%OEG
M"=704$<>2:F-:,PN;,T\OB=J1U5_T4]-:N(B>?<&] ZOBPZWB_P7]F)A/$X[
M]]QA8GWY.1I58C-O0>Y<?Z%(WHB_'4>=5SF685?>Z7LR063^5Z'>9X6 X4GS
MJ\Y;?B8J:I_\W-QB5%;^H8)0'KW6\NW0BS2=1.FL6^TS)L<W'-S^X)'G(G"J
M5\<1@(0W]%>@PV=W5'03KGWE("B7VX1'T7OW-"1N/9RD_(#'X/F+>,G[0DN,
M$G 5CI\UT(?F[,0FU$D% N1</!DGZ'X;C+8,.3R8'*Q;,XZ,$NB5+2#_>& E
M07D9N),_\JBQ^],C2?-=7_L8:;2N^73F'@R*G8_9D77I>QJ ,]!P?V.<Z_C.
M73W-MCZ1]S+B-NZ]WGUNKT]2.M-XFI6\6S,@"<EXH-^B/HZLRW88K* PX[3.
M]^M&X!JP<N\$O8#"2P*T$Y;JUCW/M%?4[V-_[IZ,&<;RLF1HDG.S-+<&/)>1
MQ/=K'8T9 K1?&3&9Q+*;+A6585=QOL"VY+-V./6FI+87PO$ ^3U0@6.)?6#P
M@!M)%:0Y-V<:!]%4)T1C?]X]L2 ,XNJ'4M/"4UTF=_=?2=D"6MLF?!(U.2LF
MA/1OODTPG2&45X7HX+Z&:A&_]$U (5KAT[1#=!G,,1G%+2)NDT^A;B^#Q0D/
M3"Y2#TNV":?66C0;2:Z_/G_@%:C5(J-<E/?2@['-SB/-:VZGV<WYG.-R)69Q
MC8J*^Y,-MIH5MUJ"NP+FYB>0803:>50,0#M1Z$!UF$673</1(?*5947#1Q1G
MW]6\IN?I>=<YNTMQG["KEY^?_/ I[.*W'CE6J=E#[KFNAQ",6T+;P72&4G?=
MCL"?Z#![H$5+YD>UY5>,$8;[56M>H,69=]5Q1<K]6STL-9J;_)T\M:_3]YRR
M-IR3#+IK.B_+= ;JK0AN' 2X6V]N_1VBC6NH<N'ZYXY&NM^KQSI;8U 4LQ^Z
MTV:'@U^F2CEX@V;H+Z)2C*4]7E^P-VR^:V OPYW;A##EHO55"X+#61;X7O3M
MOM'CTD& G.>T(69"*)4>0$UM8)\<:80$2H:PTH%]1\$K@)NWKU&GY?R@S6#B
MC[*;UXE;>,^+-TSM<KY_1K(9("?C*R19XK[K+Y_S!CHS^B,8H: TQ9.TK>MU
M#C[LIM%FCZI')[RT\LHW6"33Q<X<?[+%U5E6+R2B%74;ZL8O'F'Y<!!7L7!=
M>UEJTP@GFT<KZ\4T19+]T,"<@\ACKB'F@:M=X)Z\)F\9B.BD")OP*C1.XEDN
MC@!DET\KS2K(5]/&7RL/ADQXJ;JD=Q[Z=C%%EU\^5OC]_>A+;Z^_-&;*MAJI
M5="0H14X.;1[5=6CZT3'YN7!>ZXE:=_NA.L^:A5S?JIT^=U%N<0C"^C')-IY
M-=\)-'CH T.%-M0PM80Y_P)$7^BON<"(F*[LB:Q1_')EY6R^DZI@[%,?UE6"
MPW7NI2V,+G8>@4S@($J*&P1-(?XM5)P@:]- #3>E2^L<'?@XKSF^^LM0S43S
M SV_C.===934W=*=FT*L7>*-'?-FT$0. N(/R\7L9"=!PBP'4)#B$.S90BB_
M6489VT8F1;".=(KQ+MG%'[KZODY$?M;;6R##)7.34ECL_KLA0Q80_Z$7'H1*
ME3!-N)&DH00J-N^LIO]ZQD?-B]1X:],POLV=T"N-4YP/Z!!+2>E1./-]6M&U
M;/H;$E3G"]$F19!HY^#H3HFA=.[2T*\WD@?3"V8&&0FAVRO3YXB7[MW9?B\L
M_*)E#B)X2P$TR$'($9S1(Z84K;D*IAWK6 _+DT*(3QEB&&VEU^$IF2\[7X*)
M7PY.>1E1Q=+,QHD_#B&JKC#[$W5-W8]'G"(0W1Q@]_6RKM/14;]P7]7.@\?A
M)&]P$B>\>TMC(467@SHZS[?8^#?E-,5-)>,LR]P'*&%O%\T4ETI+/B5/(FFW
M#.M>OX%Z26]-PS%[I&;/8P?O:8R]CL2T>6U\6]NX-G=A1WHEG\Z*V[P>G8;9
M"&*KQA5HGS.4Z"FUONQ4,I*7V"X:'&!]YUH\HI5]054\)\-WL7[CN?91E>U(
M;:@>3[,U5)D@L+8IM@!5WO/G::Q 65OPZ-W"[RB)._(&3Q4?7.A-< J<YR[1
M^*:>L#'N28)2AM,*4?X=!R$&D0A56O7HK]R- ,T&&;LUT&.V_MXS&<M(C!W-
MS:Q;RO%ZAEA_;M2.E!$K]ZI1#UW:Z%&?O8DZX4=VQ3D_#$NL:83XTYE;9]$E
M>2Q98SI<U2/\ZHO AF5[,)NJ$CF_8U^<L_4'NGS<S^([!0-7A[]E[9X\+KK!
M?"/>%K8H;E9!JH*#>.!E<.6U0\<6]R3HB\Q5V\,A)0\KK5_SCJZ5Y>HO+QQ!
MW@MT:(*0=$*X-DD:M+P8SD&<')C;4=NG53BR;]2A/=1L\OR8G:W(G <[4(\E
MVF%"UXL@D)_BR[Z$3>@D^SF@0ITDPM<.<1"#ICN_ZW[,=@-3?^)OW1NJZ?[3
M^DD'0+-"@JHUI%)T#%8.^@QL-!#TG$#'HZ1_I?1AY0//,.9?E%9&[Y69O=CO
M$BL9_V7<L'?O$9<DYSW.GM6F=%0]BG9Q(8P@\!-2P^BQL^N0+#.Z=8++RA!:
ML!B2T4W*\TR7]!VV<S0.4FY^_(;+]N634<W%S*&-I:Q@YAE3@$( ]1L9@4,L
M3%'UF3*:I%4)S;5_]%A5E-"[:U'F$Y^)\PG]41/R'XL'TQ"K%HP@V(0OKJ,K
M2:QMQ#Y&&SL6*WN:JB4Z*[EO)L6)>Z#HLV!N8-BW^,T:WM^,O?=L\55]E^)Z
M[G3I:F3.T[,L$AW/&(4G:(!KZS[H($N+GC>_ M >4&WJ\=%&!J6T^#(_VM#1
MVC[OFAVOG9(F#V^>]/6YJ?N^8\%-1'S7+A?29Z ^GVB2?T>8V-A2A[3CNU^!
M(UI<A.&A3H2(^=3/_348Q-%H"^/1@ZO[6$K"!:CK0/B] ):8&R.+IM)H5M@[
M2T%_1$?N!:M:[C4\ZO%TTBB--^Y;MA4V%QW(#4IOF;(V#B6E,H\U</UJQGIA
MAY"TLVA0U7L.+JX\1T +IA$FD%[5P$0.KTQ(Y.W"OV"=LHQ8R5JP[&=5B;@'
MW/!#[=JMX(S8EKRI;9_7@XXDM^\:@6XL,8 A!-K ,RBR']78,'>S+AJ'&EX;
MZ>KVRXFY4ZU9L%7#,QAY_+%O^%D3<-RLC:L3X0K4FV,/0CUX7B/A&7]DR<\"
MBIW1'K"QF2$C'%*C3QV3\!QQM+^;(WC;95%S1^"5RK+XGS_M0BZ7C.BU-^6G
M9>CV$LBO]+"':*:-0 0@C17_:F],B1E9B!S7'X#$/21O60+?1I1S<L(2/6BK
M1XJ)8T2+IYNV(-M]NSI(M)M:3<A8H$IO;BH'&D555,7MI&O%8L3=?&A]#4([
MO2K]K<,E:_KE2G99S Y)=!B,NJI?06SHO<G6?B'<B1M&,EI@_^9@!U!5J'EE
MIF3>/#<-?0Q&\WS!V?9$,)8EVE\$5,)0HNT]&79;F-&7K0V\&W$? BZVPB ]
M- %+@KO:>1*HTLH2+2'<$);JH+UC6="&XO*Z:TYG$4)UN%]Z5'86.A+MG8@W
M^T6O2UCL<S.2?BGM)N?BU0%/<(*#:/<ED+-(C+V!>AR$N5;!<4@(QF*/-<!6
MJ%58F(/X?OLL7[?1@5Z 7*H@"EXR &A5$Z8?49'5<_;WQH &\=<LM0&,077"
M5[EZWA?5\[WU.Z8N=&S9H713=?\  &V& 06/ >@+?QX$#Q6"92=IFMEDG!PH
MBTXZ CZES=H_,0^@S)_;7Y^M*8[Y^B3[X:-\4>>$DP6*7,L!#PF3%_M0<TAA
MZ+[:8@RT*?,F!F:1/'VPW"$L"_#:AQI8OLW&X>EW_6X /44ZCS/(%N6XY#&7
M>%H)'TY/1;89@4W #A!$L =9*- IA52&:JS5;ZI#T85>2R11'!RQ=Z_TWIA.
M<#*M[5>.E+2PW1'M;KN=I+;SV$.#?-/&..9-H-X6N"P\\@"V?;T6J%K;U; 0
M21*H,P S,?M>!'90ZB)\<QW! ,?4#>-$VVL)#Q]]V'__C&W1RKC -3VV9G&B
MP47:EU:(?S/S9J D]>6CJ#HQ[)>T>38C =.X+S"O)5>W@L0%Z3ON$_CA*F<X
M62BE,E>Z@<MYHFO^*5VOA4 [Z\@-;4YFJL_><XJCJM;PH.*-5 (GSO<9P5[?
M!,5KBA('!P='JY52J[9]RMN?F'!,;_5V*I<WU$RH+([# ,PS+"?V?>!Z2A^2
M:M,@?4.KL&),H:W0"W.1,@M:.YP^JC$\6J_M6M?E(W4U]*STWM*-ENDHYP)Y
MBU-PO7^!\OQ&WW7QE]9#HZW5-')JP5>-C.=BS:AA2578&A46M#32A0$">19F
M+O:YH5+N:Y9S3Z^X%W]Z,,D\5?W\X5M%9[!]0Z/!O,E\/_=7K 9V%*A(;5P
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MGW;=LFE@T+MD%_.[=!!,5: /;OR_"0!02P,$%     @ CX#X4+(6H]?=.0
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M&-%S0LSPW><*%HS;2R+]U<QX):Z'LM[G4%>4[W!-QEG)ZF@3SP+/B9MNE[X
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M$VU"3?,N2KV]]L%VT[Z^UFFS?YC8N:T0M86E*0#==#^ 3'L*)%*>T H; -=
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M%E6/*]!0%_3 * W8VE'F"#Y8CU4S"4?[\W(QJ=H>7SF=^*7M+&M2*:@O/T6
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M]&UON+!B9*KAC/0#8X>7%5NY=WKO-+[\^7/2V T]?K9M:,Z&!@^%<X$R:%[
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M[&ON?N@GXBDWB]USV"N?FP5S/443]?IO^-]&_TW$SAK]/P!02P,$%     @
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M4Z-J"\0I^!7BZDH^"<X^#A+ F+<D)B-_W8H#I!CU<8"H"A:>.(OE !\NDCB
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M^C5VRN"@UT/I[RD\#WT?%:;NTW1;IFB,$LCX!+8^JI]^@[H<>W ?+?#> ?\
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MD'BRA2.W?WVYD(95O\XQ+9))[^W9 PL+9'-U=75WAZEPI;-O8MX %P$ V D
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MF>NT+YR99,8TZ*'3H/0Q_]M8_ E0#YR\_P^"0+4L)B@3^O0!BR9N<*=DU_6
M(?C%:0Y@,DSQ8HO)0'E&Z1P'$%YE-6!GZYB0J5HNGX76BT-,[?Y&7%W*GX"S
M3R.F=GEA5U?P) WV\6^S)17L73,,%!1:0: CU!QVO(2Z*7%L:P.$;?CF02+D
MCR<#B T%'!@#525&P;H9!TB!_9]J#SKVGQG%$2KO0@X'X-$%D;L&C'A8N8V2
M#L7S>]["J5$35@TEP1R@*+4LH3-/?_CD7\&=V6_T<?^/IU4N%Y4&//W<AOM4
M;@?6W%IC1F@4IWJ*EU8YW4Q8]AMSU!M4'B[[I2NQTO/G\.( D5"=XKD)A7?E
M/UPD1V2ZWN$M#;,V05?\U9H("I0+FUV(LXM&D#=X-3B U''X^7/(W^KG<X#P
MM]C>4?3O#\)(]D'<G^/V"^_ @'TWXL\QF<.60# ENMF)_9!U12"!:+>Y?NG^
M8?<L%/DG!>8_0^=P-&8RQ;S?@D:BN%_U<( 6UWA]TX950RBE&.UN_F9;1-N1
M,O.]1M7&;SFX'B_;/FZ0T#,H$?W87EEWXYGSRNB03=G[7E>OOX;$/V,O+)UY
M"FKRPP88D.>Z\!(<0&3>@ /@'[,WL"N\RB9!^#^#\Z^"H,VX"SLS85.'8#[!
MMNE_Y@ SWQ&-2.;]KO^T)'":R$WDQOKY)1P'V >G"5<0-S9LEB%;[KYYV][Q
M+Y'YYS#X?^D2S3Q9M,S&G&= )GTOERDQ]%>!^E<AL(-W+V2 (",(32ON_X?:
M V['[L:N&*./02W'/DCV%7LL4@ET_OT&>/@;4.UX#;4S"NL;&)DV=#BN91(&
M&B_!+QUP8/;L44ZVV5?Y%U&#?'QYOE4BL=!)UM+6ES%2_0OAW%VZVN*YYFV#
M,M4,'IW;^_)_)V9O[HK^#P*+8,%ZUB#+\$9Y.0_DLUYCM%$GV^BBH]ESUU&!
MK80K5.OZ Y\_GB';/[S[A;>DUT0<./??;W!]0];8+!92[=G\BPP-$$\O 3<*
M;"0C*/6>:EY77I94R1;L-.-Y)6 N="!9ZW670,ZMLHMV[M_QO#HX4-5K48B*
M.P..31,2)P5!@R(4SL;:S P,=*?.SM^8/?LAV]S_EUI]?.VKAEJ!X^GOG2_:
MC1=FUO=T(:DHB2@(<-MW4 GM4G8I+JCSIT!6CBNJ8__C5.?+7NBX%2ZF[)-\
MPX!4@R1DT>'TX!IZ$M)AO%-'S+3\I,X9:5>^]Y?,MHK<% +03QG<$  L@P)Q
M4%NTG]V.K-*(T.GA9=X&U501\969 G>N]NM^4CUE5C-423ITA^25M#?VH4:=
M^<->-6VIG=3ET<[I&:;4/*6S.2&4S@;=(8(;GH$--]3-[9Y2,=HZ[W1Q;705
MA5'2-@\@1+P1.N4<E42.4=W#(Y'GN>4,['2?KBN6#=LR4(6,FM]3]85X]2L'
MH%SJ@HTC#ZFV)(OHI^R-X#',?)$HA:O"DK/U>^+8&DR= >(E[/V:,BA:@FA^
MK>LR;OFO_6'P!\RCUV5&.8!3K30Y)LNA..>(SY(CP!H_WR7"^Y+=@:\<CL)>
M(XV<AR1</$\1$ITYW<^\0_&S]E#76FRUN-+7L?V1-L#].*RK 9 -.-Y,@"@F
M^2VV"L<4KZ?S@%M)5:0%K\L0Z6YK%*:R/JI,+\- 7/-P>D94^I5O*@/N:8*@
MG4/2>U'3L^+"\.#VF\3+:"%0EZPQ,DSNB33:@E;O^Y0>;2A-F3\F=;+JZGB7
MG[] N_P/MK+JBPIYQUCE%&>,"I48;1A(R31KQASJ50\ZIFA?FM%]H3_07?1D
MB+_JSN]QIP*DI:4?%Y##38 [ ?$,*Y28 RM&@56T:(28%04#L-SX'?EM>[(/
ME4EB+/"+V_I[#A[._^"^&K+$@PI0:VL4 UO9@FI3@5]33H"1TV\Q$CX<8&>#
MWYLYA#MU@RJ<(Y])4=>?^GFX-OVL<8%AC=2.D3M%O3EM!9H.ZZ6NBS0\4\R
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M+MUHXO__?8K_;H.+,_)_ 5!+ P04    " "/@/A0);^3SW]' 0 F2PT %
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M9RKVFW#BP='.1_!*.#!?R^M&C@>PM".\\Q :F,0VA-,F925>?X1T7/4^2>9
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M<4(HC)E G@P%HS&Q]LGW+]_4N,[4R$SO]1_+G:V"?@=:;EFFOM"?>>7#3!>
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MQ?&%YWEE0B#S.0RKSV7.U-PQ:>J!?K"C]?.P'9B/MP^;7/3MM#^N^V G35[
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MYRHF9W5R]V-6!>2\>3[TL*]I_GOE=E%12'#@!3"(S%Z9Y!1B@1/(%.$QP9Y
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MPJX"3(T3&J&!J*0&M!*[]!LL*\'ML]MVZI)V)AD#Z(&YQH@/-N377-.@7JL
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M%&N*2B)M0X4FQB'B(:>**6[E&;1L;VI^P&V1P6NPEEI_* 6WC]6RP;N=; 9
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M)?^LN%; ;35%[CR)^LV7:P6]O>2Y=I[:C*=7V1QWTR)D6MBAU0+JH1*:I*F
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MM<VDV_A.BG1V)>V%V=30_6X[C8]*9S-U*?_OLO01&XF?V/=1$DBS$<<"!CA
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M?Y[K7/GNMJJO+A:S,5\67]XB _>LMJYU.W/EQG!=SD#'5&=+.5V ZA14,+\
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MA;X %;%;+/S@!U.KE1\<A^ZW](,?'GNU'SQO/[?X@\\>_4E]7WPTNOYSA&G
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M'E&[4"@/&KKS!_B\\)T-6+W%\#J%OU\@SP:3SFB>U0#!:^1^D<M'E-,T5H)
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M3T7&1@[M,XX;2\JJ?7)50&,R U?S63F?3D3E 7YJ:D;>?Y>N_:V])\]R]VN
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M>Z_]D:!"(AHGL" 1TZO:A!B'L8 (QPHCR65>9*[IQ#Z*C&^_8:6_J4="&PO
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M&G"V5CH--U=R)H:?)3N_81#<>W8G^B,Z9S_C;#A#NA_^R@SJE9R-V:ZS<OZ
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MT;]YE(@1AF(*S0E_B"43L- ?'4.-15P@F>1YLJIJ\F#OD1Z39_7D;A<R>1B
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MF)A2(I_UP.)6+]QG3Q,V;3I-?7K[G?[/?'%E]MZK7@B(BB17.(.")MH7RX6
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MLW&V[=GK7)/FK($2&%02V[>X/P$RD3R-,AK"( ]BB$@L(,T##@F*2)RPA-'
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M5P%1MO8=?Z?2:H)^Q*:EF8"3W+^TPM9U*]-N$,=6=F)9?".ZF=[U?+5>EL;
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MYOSALT6Z]DNS*LK%Q5_.0L39YKN3C-/)YJG/XFJ]#&D]L2'(Z)4 SKT E:*
M4'P!&6*Q3J:D [O.;*5V1>1N)+_"]-/'Q9>?Z<&D >[K)U _ <;/Y/[?;KUT
M*YB'4?_K?#U=3W'U(<093H*4*0NCP9A80 45(":A(1;IHBR&1V4'H/[:2Z]3
M?U6QSY;IA\4RXY+LQOE;PS+=4O)US)[]QL^?PY(>!.G3=);/_[H:D"$TMUX,
M(<&M?HC>'W\@M@LNEYA?;]5S)W<;UM9D3G'SFP]5_>D*/H;P>?*>)(W5W#Z?
MA=7J37F_7J0_GGV=KB;:&[*<SA /I#_E4H:(Q%+$XHUQ)*2D;T/A' DEK.*&
MZ+,7;>& L_7J_#LW<?%=BL;#R1$:7K00=P>XN4K_B\5)F,XG$EDL+BH(,2=0
M&"-$RQ/8(J5''857N05@;I,R#E(&UO%B4('W )G%R<EBOF'@-SR)N)PHCXP+
MIR'S1!8W)/+*+ 9BP ?K?<I2F2:(N4G)N( Y5K4WD7*4G!\,%-I*X^)(J)"W
M-GG&?A*:_;Y8X^K%*9(7*,ZXD)GQI),%(>K^K&4F#YT9L)9[:\A5#,9_QXV\
M[_E[84!TCH'!!-@##,PU+M09%R@H0JL0SJK0]BM9@,!B F&-CMDZK9W;#P8[
MG[\7#.33@,'Q AP?!OJGG4QH93/Y7PX"B0"4Y8:<=8(V"TR@C(8$)O=!P>['
M[P4"]11 ,(#XQL< _XE?X\*=<5%-EB@E0DBN>N+6@/=<0,RDY:PX8X7O X([
MGK\7"O130,$0 NP!!M<,FM1G7(2<>3:>0[:!W&I2+_BD"G!KBM1>NI#8?C#8
M^?R]8&">!@R.%^"H,+@(QK^]FI?%\N0\_8>O*.*B^$HI'VJ6-W'F0$5!\940
MY.!PZ4/EB)4P5/9J)P7C^)##I"@&E.V(P6;EXOP$X0/][@1193)I!1POFIQ>
M&\$QLGA>123?AU:/'"(?>_6=(R>J!M#?8@!A=@*"_WD:EO3$V;=W^'FQ7$\X
M64\IA0=G':\L</ L>4"9$NKBE;=\0#S<>/W(!J(--(X1<2<H>8O+Z2+_.L\O
MPAHG,NFLG47(+)#YY%R10$C%AJ%R&HTAS ^(D6LO'R?^;(R0AXNW$WQ\6(;Y
M:EJ%<H9Q9JSP%#&#2T:!2C65ZYP +3SW/!8E& ZYK=QX_S@!:NLMYA@ACPR4
MK5A>3F?X^^DVM"J!W&=RO#+CEH2!CKB@+X/@"JWQEODA_(Z;[QTG9FT$C*.$
MV@4@WN'':3U>GJ]_#R<X21JEIA@-M%69 BTE(112*$\4A7LE4_!R,%!<?_<X
M46Q38!PAW"[ \6J>%DLR=!NA;$X-GR].Y^OEM^>+3+ZVR\9Y$T!B1E "D=QL
M1E\:I%".%Q1J""=D#U+V@HY]4M 93O1=(.E#^/HJDRRG9;HM^CJSEZ8$8[B+
MM!HT>>)&(&V@1@"3Y*-GEZ65PR5$[B!B+_2X)X6>(<3=!6Z>Y4SZ6)U]J.+A
MDZB2UD:K>D!H"/QD4&,-YE $12QI8FU'&<<#,;.#@+WPXI\47HX5<T]8>4Z?
MOEE^6/PYG_"<:\HY49R/"92MCAA/#%A1";TPPNKAO)E;K]\OR\:>(E >*..>
M8++94]\LWRX77Z;SA!//959&:Q"FYH1*5. 4Q7.621>R+(X"_Z&Q<H.&_0#S
M5/*R@TF[)]2\7:S68?9_II\W;EBV@L2A"V AJ2AM,@0M&'GUO'B;/5-ZL&+D
MG13LAYBGDJX=2-(CXZ7:QF=+#!NZO2?G7$0.,07RNDH1X%EA-?B+M(NJ*.,0
M5N7J._?#Q%-)T#Y8FB.CH%YNF;W]M)B?9X:RX:((YH%[84%QAA!LT)"20\$P
ML6+] $BX^=[]T/!4$K%'2;6+?>3YZ;+*;9L_GLX_UHWQ=#5QGCD52P:1LP<E
M)8>@<@'.C$%D%H,?XM#O/AKV0\K3RLP.(.TN4/-J3D\+:3W]@B_".IRQ-2DF
M:9%10):>^##(:[VL(]_;&^$%*H[#H68W#?NAYFFE;0>0=A>HJ><2R^?D>']<
M++]-4O8*O2))A$+Q?.(%G&,&LH](M#//40P&EFNOW@\C3RL_^W#9=@&-]R=A
M-OOE=$726*TFWJ 6$0V44(MM&1(C219@9ANEN<B&RY-<>_5^T'A:R=>'R[8+
M:/QZ@LN/M%?^9;GX<_WI^>+D<YA_FV3)1."!'&[ER-$*+D$P/@-+.CH==(IY
MN,.>G23L!Y6GE7<]7M9=0.;])YS-SJDOWAO:*2T@L4_.E2*7W'.*UX5W4?JH
M,0V7GK_ZYOU*UYY6OO7!DAT9%^\QG2Z)?B[BA^EZ1J&[*$Q[6<\0%)E!3;*(
M3 4*XGV27&@G,0V BIOOW0\33R6E>I141T;$AV6H'57>?SN)B]G$IAR]81HT
MEXPD0-0'1[NB<-9;-!Z3&*+XZ-I+]\/"4TF6/ER>G9B&7[^F3V'^$3>E,<8[
M+DHB_:&4H!P%6.1)TY8G7-"._O-AB$AVU[OW@\53R9<>+=TN'(HK-\3??R(Q
MKMZ<KFL#H8KXB50Z%:\3\&3)Z FCP'LGH?B8+28IK1XND+V/DOV0\U1RJP-+
MO@\<D1B78?9JGO'K_T#RH)@5+)<(.B+MDK46SQ=-GUGK0S:)J0'+&V^\?#^T
M/+'\ZA'R'?N8;IO5>SE=I3#[WQB6Y\7_ABL6ZZTTS-630FG!,\M :B.R")X0
M/T2D>]?[]X/)4TFH#B+E3JY87#+QDKZSFD@=BTSU$!I-HC"]N'KVI.K^&E/R
M)2HY1$ASQ^OWP\E32:H.(>.N8+*]4+1EP@1,Y($G,&AES0Y[<(J,)+.1JQBR
M&,:YO9. _:#R5)*LP\AY9+ \(P[RAHM9^#C),IIL*&;SQA.V [/@;#90BDO.
M:V&C*0, Y-I+]P/%4TFG/ER>@P'A7WZ^)4GBZX\']2"=KQ:S::[-97\)L]HW
M]?TGQ/7J.LU[]B6]ZUG']RK=B\HC^Y?>ZEGWIKR<SNEE4UK[B^UEO(L&F=J&
MC#P9D,QI4,IXB&&3!2G6U6N]WC9I\+</<<<VIWNV6I%L+UAUT7*E4G6M Q*K
M.8(SF@,/KAAGA(QR1^GA\:Q>)Z.3/H9#8>)FH[HC9#YJ%Y+K])_YX)=LD*.-
MCG,PKI!/94IM(YMKMX1D&;/6!M%DE>RD9EP$':/@G5@Y1M9=0.9Y6'UZ-L_U
MPZ__<3K]$F;$SNK9^GE8+K]-YQ__/<Q.<1*3K2GE!$+6#FW<.O*T1&W1)8Q.
M$AEG.ZYM#= 7<Q_J>H#443BXV2YS<)5T@;3?PO(/7-=N0&<YZRF>BVU"]"9I
MR0/4TI$;Z&E)AD@<:?+O'7,Q*M>DM?,]-(W;?7-X5 TE_@[Z]CY+J=Z-7;W#
MA+0\B*7?<7W."VWX*DJI09M DL',P,FHH$B1@^2JH-B1\AU@M[N'J'%;> Z/
MI<$4T(5A>C7_0G0OEM^(B4DH1A4"/%B9(BT%GL'5?C#*JU"*Q.#RCB3?\?"Y
M2L2XS3Z'A\N#!=P%/-XN\7.8YE^_?L;Y"FEC?K/^A,MK4II@,,4[%\"E;$&5
M.LVE< ?))RN2K1+:D?$['C5[T#9NS]#AP32T.KK V);\O^(LOUPLWY/#]_MB
M_38L*=!],5U]7JS"["_+Q>GG,_XV'$^L8HR;["A:X?6*G(L0?,JUQ]F&0Z;S
MCI*:H<*Z@V@=MV%I@_VOL;IZ\+&N+ZCH)*OU12X(0<&&%!!KIIT[Q133NN26
MV:=#+-G@!V"M4?00$3\<'XMUF VT*RX^XW+][>TLD#CFN4:JGVMNCI"_6DV2
MR2R)K&KIJJZ% 0ZBLQP(YL&:R++CC3;$^\CJ(:8;)/DTH/1[L#4IG9Z<SNK!
MP@LD(M)THQ/Z?(8;Y<SSLY-ZH>\_-]^_D_F),<ZI+#-DJVN;) I"@DX<&"VI
M$KS@WNZH%!LD]AN$@1[BQ&&2HV-H]' D^RV2Y_BQ4OIA,$#?R4\-@*3/J41:
ME[Q(3L(U 3P7##+W :,,EG:.1S6-G42<;0WCH9+O8(M]12J8?YS&&6X%1"S\
M^C7-3FMIYE\6B_SG=#:;I,!XELQ#"K'RQ OX[!B%.IEEGGSTEP6IP^8KOD]<
M#Z'G(*@:7!-=!)T7E'..Z!$3^&!JN7@-39(OP!1]PY&YE6Y'.<KQ&#H()XW#
MPT%P\B")=N" O3A[;6U">8(?PM<+F$]B0.4LQ39%;VX<86W<)#VXI!GF&#ES
M37:KNTGJ(0P<!"T#2;T+6W(E"??[8I[.8MH8"TL8!92$6/ONJWI=S0+7AIA@
M-IJTHP?.\>#92<TX;3\;X.9X67<!F2T'%*M&Y3(:0+VI\XT%'"/!& R<>95*
M%DT.7+:O'Z>W9[-RE(.DV8&+^WH:XG2V.8LF9WUS"^G38D9"7U7'??WM0C0&
ME<_:DDLE5"%TEP#.YP BEY*-1Z'DCDL:QZ-D7P+'S2PU+XQKHJ<NK- 5SF[F
M=HE@5-8E8+49@U)*0Y V0!V[SBQZ*U*3'.;=)(U;Z=0&!'<C[1A]=(&M]Y\6
MR_4'7)[\LE@N%W]2L+B:1!,-)J/!DUQ >:(_H"1[G9"5B'5>7I-X?0<MW:#I
M*$7?G&=_I,R[ ,YY?<W;\*T6UYP?$9E(VWM$#DS4,46%T;JB2!**T-GK5)AL
M= JWDYQQM[Q&\!E \KT@:'E*[[TEI0D!W[.L!<62T8&2(4*LOF(Q(BMD,GC?
MIAK\+HK&/?1HAZ,!Y#_^A-LM&^\PDH.Y>H?KT^6\;OYO28Z+JJ+:[ZSXDDL&
M+^D?542$P!U%'#(DEKGEF7_OSM)^;QKWC&)@G#00;A=VY]>3S[/%-\1WN#G\
MVX7_I&I>0I I)2M*PB+F:F=OVHIM<3FPV.8JP7<I&_>THI$=&E8?74#L;-E<
M9$TO69$Y\A+L9JJP "6<@E!\ &\<%S%[YG=U^QAL:[M-T;@'&VVWMB/EWP64
M=BR'$E)(Q2-13OZ=$F@@&N+!\I)5=(@R-XG/'FB/FIUS- +/D1+O(66YF'^L
M\>4+C.LKZ7=E9#8E<N""DQE-V578(SB9+&K&D.T:#3( ;G:2TTULUC!1=+P>
MNK!!MTX!KTBO'@4J'8-"I)619 +%C 2GZPBW:)(SSA:U:_1S@P/8ZW1U$[6U
M0]B0FND":M]U!DF65Y:2%W6VI*30U*=2._ D<-$1D\%'FY,D,]_$G3J,S&["
MPG9 ;*BW+G!YVZ.\PDUFZ)PW'$RH=?4&"\24!)2<8XR:*PQ-BI/N(ZJ;4+$=
MY@;320?E39N"B:O&^Y(3YH*3/,F:6_&@;**0A:L$4O/L2STIW=73;: *E9TD
M=1,SML/60/KHPG9=86-B3<PZY@QD?LDK( E!U+[4(2$Y.J+?J";E3E=HZ"9H
M?)03XH,DWD'L6)OM3M>U4*/*Y_EB7F=4X3Q55J(11G(*?J4N=6Z(]!7Y'*Q&
MH8WF-L0V+5;NIFG<BKE' =-0&NE@E[M'0M*J+#7IWGA%^[7% ,%Q!*VU==&2
ME&03'^K(>JEF=7>/ JV!]-'%+G>E2_BV^Y!VV9AH&01;Y[.ZRD%A=3*G<"YK
ME(2(5M;J*B%C-Z0;1L4[C-*#I=T%7J[<_]LX>W6BS1(_X7PU_8+;F.+U8E6S
M*&\*!1<3630OT@F@$)7</DP.G"NT[)*(B9::M;O&80YZ<7,?.L>N\FR"MI:Z
MZ@*,[W =IG/,OX;EO-:#7;N<6J9I2@&M".AT76#H.2TKLOB1DUL95&3%21\B
M:])_[/NDC9MG;02Y@372!<H^+#&L3I??KIAM9[@C,47R'C29[>PSU"[FP+(T
M/')+SD63U/UM4L9-DC9"T9$2[P(UMT5#%G=[L?1MO1]/"EJOE]-XNNG<]V%1
M4R44I! =],2/F\&UN%I/;'2!FR1!VU#3)IJ3J^ ,Z,1M"=;+V.86\##DCYM.
M;83.$33;08;C>Y'5Q&:7LR8O-@M.0;4)M%:CE&!34245ZYQL<JCT/<+V"R0&
M'R8Y5N;L>.4,!K9'Z*/_=J.#3[B>IC"[SL!Q3?6O/[A9A_U[Z'_<=ONN>$9F
MJ$AOZX&W 9]-I-TUQA20,&*;K-W':[=_L]1)JF3JD2DDQTV=6B3 L6@@22:B
MLZ&$W+[O61^WOP9'R'X-U0_10!<>W;/9;/%G7;HO%\L7B].X+J>SV_URKY1,
M*JY(8,[:REY$<(JX=;D:7)5U;I.9/8C*'ANL'X2+FTAKIJ(N$'B/]\"%,R[1
MMJY+G30>C2:I58 D&9#\2LVZ/ @8^^+TPXW:0+KHX'CI2E*:W)$WRXWH\B;L
M?HO+S>S0B=5)6:8+./(C0?%Z<458<DY%<J'XS(K$%O#:@[:Q-\]A8'#W0<$@
M.NG"?-V:2/OL=/UIL9S^)^:)%;YHXPMH1V98>:DH0(D1C"W1<58LMZXQP&[2
M-+8!:PVLHW30)Z!>K5:GQ(AW16=!T:[6.9& 8ITU:1DD9DVBQ9)(9(\"IBT]
MW6;Z!P72 V3?!8BN)9NWK$RXT8(Y(R F09YAD.081!&!%U?(-<6@=)-X> <M
MW2;XCP'/L3(?$#AMDE07[N=J4<[/PHY,3^U\Y)")J>_3/%!*:GOT?/&ZRPRH
MCAI-RF YUA97A5%D9NI@Z:()4_5.1I,&!G?0<_SI]!><G^)+6E2U_*P^\N_3
M]:?GIZLUO6YYT6>TAL'T_UR/X'.1$8NK-RMU';%C*#AEY--Q'4U1F'BCN9</
MH'5<OWL(#-T^O&ZKL!%CO=J5H(ZS6)WQ6/N9UL(/"B82B>_#8O/#B>/"&H.U
MB5BTM9\.>8"R]M,QQEIE7+S59GUGRX?OOVE<WWI(\#20;!<Y@=7Z3=GP4@^4
M</EEFG#UGAR!2<@HN3 ,M*IA9\8(,01.L:>1/(>4T39*!=Q%TKC^=0M+-)#X
M1S8X5[BHI-]8$5%DGA+7$'FLZ8N0P,F2 +TRV2IR_<(^MN;>EXSK/ ]M9H:3
M9P<69C//Y.UR4:;KB41T3"@+N20$E72=H*0]F&PP>J&5YJ:%2;E"P[B5*BUL
MR$,%/&*M207Y%;)O -Q*(C1& 2$Z#LHPK&U./5BI97+2F<3R'@;CSA>,>S]O
M:&,QC!P[*#QZCYNZJ;_@')=A5N?+Y)/I?%K%LYY^P;-Q@1.9>%0I9"!MUPMC
MUH'/28%EEG.!),7<Q"W9C[QQ;^^U,"\-U#)V?+071S<6DZ2-U:HD0%I=SY"M
M@"BS);^>OI9,2.;,'D;I(>\>]Q+?X#%4:^EWX/.\(Q41 74&_ N*%F>+S0"C
M,]8NTPOI/TZGF^XD9+[)[5]5OV]2BE'DW$L@V99Z/X@<O<0-4$R9&6<EL-3$
MOAU!\[A7 =MDB!Y'@2-;PB/8O+% N<]64/0!I9XK*L,I*&%H@4OM4?NHK8E[
MF,?!"!JY&'AHHSF.HKJUI!<,3J2TBE&< ]Z(6N\L.$3!!2T['[2SEKAI<NWP
M.W3M![\GEC0?3A-=FKT+5FZLF$P0R%9R$"K65CFU>"QY"S+Y(KTV*6;Y8--V
MQTOWP\^3R9NW$W@')NK5_ NNUEN&JM@N+OXD:X3/Q )J3>O :P8A>P<8DG1D
M;I/039K)W$70?J!Z4OGS060__M39ND;N8N7&XF!%"$',06%U,+20$IQC$CB)
M$8M4*&X6:.ZT1ON];3_$/)F\>@,1=V%_MER<9V*0EVAXB""SD_6^80:'%'\(
MK[BQ+"+')A7B-^C8#SM/*M-^C*1'=GEND'[ST%H7SNK,.2L\^6Y245!0*QP\
M,ZQH'J3=*[EU[TOVP\.32;L/)] .3,BF:\COBWF=O!W6F\O+55KG.#>Z&,<(
MYS;7FSK*9O#U,VDJSE5!TZ;,]GZR]@/4D\JU#ZB'/IR:<X;>[&3HQJ()&3W/
M,D(VOIK3(B :4<!)--9AB#JE/:S0(>_<#T-/)K?>3-P=V"B*(=?+T[0^71)?
MSS^%Y4?B(86HO*J7!F-B]68?(QX4@M4Q<4PJN]3D=N\N8O;#TE-+@Q\G\_$3
M/9?TIPW]G[>+8+U8;=.A(3$D[(,+]6!)DG0\8TB^/G*M,"%W^Q0G??=%^]5!
M/J5\](""[<"Z7'9).Z\*GLY/B;<S2[J8KW[!LECBE6[:OTWGB^6F*<S6$WPV
MS]>?LKU'\1NN/RWR9>BYFAA!XD59VP"RFH(7DD23$(PS,A7EN)1-W*E'Y'$_
MN#^I_'>O"!FYC.L1Q7+#?]&19\42P=QCM3!2@],Q (\Q.R:]P;*/Z1Z-@?W6
MR)/)\3\-('10YW8A@#.W_!><8ZW=3-R':+F%$'*].9 4>*<#$)5HO?)8?*.\
MW4YZ]H/G$SLM.%[RH^?Q=K)P,X--VX:QM 22K"=H@O[Q6&N!,:*2!H6*;F_3
M^)V7[8>3)W1&,+2 ._!N?\?UI6&=*)N]H^ -M/-U])7VX$391'&**9D==TV"
MYFM4[ >;)W4\\' IC^S#71!^O9_EMF?=#>0+*7SR J%$7;OZUH/52 :S*%53
MVT[=NKN[T[0<\,K]D/)D#@Y:";L#S^;\,OEYYYH+61&A6NM0P'-'\0QWM,'Z
M@)!4EI%,:0FAS1RZ.PC:#U)/ZNA@$-EWT:?C)B>_A-4T32)7.7,609;:PRTK
M"['VK+$1 P\J!#3L,2"TH6;<*_'#J/H[^#E<ZAWX.3>9>#&=G:XQ3Y3V2M;F
M608CL5$_<\PD$-+Q6%0)Q3:9$7<'/>->BG\4^#Q$\EU8G[_C].,GHOP9/31\
MQ-]/3R(NWY1M[YHWI^O5.LPWM=;G4E,N%F=0UN'7JM[Z+Q!D*E!'7PNI>5*A
MR8B 0PG=#W1/XJCS473UI-!X9JVEH^"S!!!!T +&FM%PDKC--M RE,&*)M>K
M#Z)RW+VS+60>B,_#M=?!7GL'<V>&_Q:/$\F"LQ(-&.\9U-Z_X%F=RF>C4CE:
M8O(Q[>1==(Z[-_< ST$TV % G\W7TUQYF7[!]YA.EYNQ"=O+4IBWAQ0GGT^W
MRGU3;KE%)[6;]$3DR%A.%(+;F&J7:@->>5V/XICTVHFHFC3J&H3Z_<#\I$I2
M'E^K@T&Y?0?"'8/?KG-Q5#/"74]OU9?PNYP,/S7C+"M79\C>>O<%=+-#+*8.
M5,GU;ENQH2;^R20FA2R:PF]=OQA\@,8^= Y[8""L*E[;",1Z/6"MK?,+=Q0G
M,G)89.*\-"E8.?S X#%F9PR.D_O/$0X1_A%%O^OA"LF_,WZ23/&T'N>GVAL6
M7^#VX^7FX&,QKAC(PN7::#%4+\/7(OJ,QL6469-!:,>3/G8?\<=#Z".KN0-G
M\BZ.7RZ6Y$7/MY-&TK</RS!?$7M5Y_.\^6JV0<!?PG1>I;.M@7F':196JVF9
MIG#^N^'K)'IKG,X*I"#G2)4B( 1"JK88T29O0WY4Z _)W+CF^[$!N^=Z&0T]
M':^H9U_"=%;/1(G56DI\Z>0_R_\XW5: 7:ALUQC&[4GJI=YB84&1'%@P2'IC
M'F(*"C!H8HMIPV.3O,,C\3?NIM/INAH30QTOK;_-2?2S.@+DKXM93>F<VY4W
M\RL26DY7]*,7F]+^K>XN!H=;$X7/(@"S05=?U(!+Y(MN1IPF83"K1]V@CF6H
MSTUI5/3NN<(>%4H=+ZG*\JW]^$)+-1WU[,WS5[3/UX*>-^52-A>"$%(Y%6,
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MU=>\*V X8RPXU(EK#T)J"ZJ>Z;L0%5EKZTN)J#AOLI_M3>'(7;D'!U@;U72
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MUU$)="%Q,O:UU35S%KS+$6)!R90MEN4F]NJ_3 _RA\!K:,5T43M\C^!>7]1
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MM^""C]$$YWAJ,I:W&4?#7BZ>PG8X& >CV!(/:WI__?YN<I%BP22Q=JGT)-O
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ME*0*4EKZH<V5U!ZT#MMSH0D&6VML%+!\[%S<^A9O;VJIN7"LL.Q!Y/H"//,
M7AD! 8.LI0E2BB;IY$[4#0N]X_EI_:MJ!(?N Z;NF'T*KA[\X;VM^$"^-S&7
M%S89S01X[CRH@JNGSPP*UN2\9Y[))AW^^F9DV$.] =:>1_-Q%3]2T[ON$%53
M9!?:<RY#%, $<:)2R!!4X,"MBYG'X+AITO_M6:I&!<HC0^:GUGA?[8T4C)N6
MXBM^N%<EUY&)VAF2E#(*/')B+WL3,ODZTC:Y:W^>K&%/_I'#<6_]C12/]4%
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MU!!8(O_;J(P1ZT.[)O=9/Z7LE,KC=D+%L^5-AZIH[)A;UTT8EWP(H2:(,9/
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M45O&9J4]SXHR8+W7V:"PZ,4N ]=^_)(6R]44WWW^<<])7'22M5#%(!.5DU@
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M=(L%3"*"EB&'E(RU#YM$CKA:IA^+/5=%<XSZ1N!6/FW"*O_7IO(4?:=_;G;
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M<?;W3S_\Y^)ROB)KS-.=KS[\<CU$)H+QJ#(X5AF\M"X0BO%@*+;V4OI N&Z
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MD8 C.GOJ'6U=V6EL7NS^N.I_%"5LJE2?%S_2C_D$-1<R6T^CHTFF4%8Z18/
M%;J<5-*F]._?7A1SV*!M2"R>:K.A.4OOC@P/SK*?-_1I_H3?Z3=6$QF9*(8B
M52%TJHUU*"A)64+2SIH2L<3<I-+\V/<.>[+:&\!Z-\%XX?7C9E>XO[@?"=<R
MAHFS+LM $\A&-*"\M.3-,0+/4LJHM8H^G :R9]X^[$;\4%#KRAQCOQ.^3\ 6
M!^_$=W11O-E+.KT]WF)<9[]27C2/@N< PLMZ]3<[")G"-;3*61699G].SHR#
MV;TUFF&A24O! GGQ;"($$S4$D;+G(=K@>MF#_1->*3\&5Z=<*3_&9&/+-&[*
M@M'*9%"2,\\IU6I.TE-.!;CQ%)9Z'J/OY>B[?27^*"YL'V7[1I7XQQABC&C:
M7[:L[311&V ::1@Z:?!..N!)9)=M]L[[L^!I# ?<'5BZ827^,6H?8U&V\YJI
M',BRA1RWXIJ!TUZ Q\@HN!7H'QY!OI*[8)T8[*6B[&.T-[Y=U_MIS>[&?TS9
M5499&RJWOS!5.Y1L,)XU9A=-.(,7>2S7Z[F=W-GZ=*)Q1K!2[6C-[@WJ>@YF
MF6OO&$[9LJKD9O7\G2<./BM>JR*]*KW<57Y2HA&YJE/MONC#""- TT^4_"^N
M<OZ4R1]6MI-]/TM7DN9*@9&%T3 8 BK,$*TU0:7,I!=]8.D)>89%4D?67G2O
M^H%CGXO5*J__L9RN\Z*4?1UU<13YH08;C:=(0-'BS4* R%+RS'FC&G5W/_#H
M89>K;D'0A?9&X#ZVI3_W=+(O(O0ZN4I-HW@%<8X2G,H,DHX>+8M6\U[V?YX2
M:-@CO'X<2"?*'P&(&AT*Y$ 3( 0$P4T]%J*%.EB=(.N21>2>,]D+M5]G15>C
M8%SH*8YN9Z:Q0>]Z,!\7L]G/BV7M$C+)VBECHZL9+;EC3VMQ2-K3Z((VM!87
MQ_I/W![+-=K NB40GD/:B589*<@FB5FNC42PS!E01AF*\E@!:8*VAGGARMF0
M-2(XG6KM!D@Z2O6MX?,M+Z>+]&F-RW5_Y:'!FYQS8N"MJ=75/D,(5E+P:'7A
M0@E6^B_B.Z8\]#P%>WV"J(WJ1[%'^0&OMJQMI)%[ YI$8411@8.)@4;B&(T)
M#:4<UKF$!C&47E+]IP0:4;5=QT#JQ 3'@\GOP#3/7VHT^+G7=6W7.SO]8[J^
M7&S6;W%U*28E1A0))22+&93%!,Y%"[G$$I+30LO^O=33\HVH^.X,J]^I!AHW
M_":E;I)Y1G!(-M6UW5+8B1$$Y;U<<%K:[;C"JO.4VITCK#I&]2>&53_-4[?%
MFX<K\#]L7_:^U%GR?K.>X55UW3?[M1]PFB8^>:VLI6'&7-FH/ 63I1(I!\%<
M%HGEAU5?+Q=SMI9F1#%8EWGA0.;JO]CS^H/Z3\!5_G__Z[\!4$L! A0#%
M  @ CX#X4#7330[)!P  7B0  !H              ( !     &$R,#(P,3 M
M<3)Q97AH:6)I=#,Q,6,N:'1M4$L! A0#%     @ CX#X4,O?;)#I!P  8"@
M !H              ( ! 0@  &$R,#(P,3 M<3)Q97AH:6)I=#,Q,F,N:'1M
M4$L! A0#%     @ CX#X4%> N?5Z!@  93P  !H              ( !(A
M &$R,#(P,3 M<3)Q97AH:6)I=#,R,6,N:'1M4$L! A0#%     @ CX#X4+>I
MCW]U!@  8SP  !H              ( !U!8  &$R,#(P,3 M<3)Q97AH:6)I
M=#,R,F,N:'1M4$L! A0#%     @ CX#X4%HX@,&?@@0 R9)/ !
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M,C R,# V,CA?9S$N:G!G4$L! A0#%     @ CX#X4-:M#)Q?.@  W$X  !0
M             ( !B"X& &IN:BTR,#(P,#8R.%]G,3 N:G!G4$L! A0#%
M  @ CX#X4+X*5[>,8@  &WL  !0              ( !&6D& &IN:BTR,#(P
M,#8R.%]G,3$N:G!G4$L! A0#%     @ CX#X4-6=)G6.<P  QHD  !0
M         ( !U\L& &IN:BTR,#(P,#8R.%]G,3(N:G!G4$L! A0#%     @
MCX#X4+KR'H>O6P  (7,  !0              ( !ES\' &IN:BTR,#(P,#8R
M.%]G,3,N:G!G4$L! A0#%     @ CX#X4/_XHTB]D@  XZ4  !,
M     ( !>)L' &IN:BTR,#(P,#8R.%]G,BYJ<&=02P$"% ,4    " "/@/A0
M,=)*1)R;  !KK@  $P              @ %F+@@ :FYJ+3(P,C P-C(X7V<S
M+FIP9U!+ 0(4 Q0    ( (^ ^% \,D@](XL  $&>   3              "
M 3/*" !J;FHM,C R,# V,CA?9S0N:G!G4$L! A0#%     @ CX#X4*V)*O6?
M0P  IE@  !,              ( !AU4) &IN:BTR,#(P,#8R.%]G-2YJ<&=0
M2P$"% ,4    " "/@/A0%W8X3;H\   P4   $P              @ %7F0D
M:FYJ+3(P,C P-C(X7V<V+FIP9U!+ 0(4 Q0    ( (^ ^%#M9[6X,D8  ,E<
M   3              "  4+6"0!J;FHM,C R,# V,CA?9S<N:G!G4$L! A0#
M%     @ CX#X4+(6H]?=.0  "TP  !,              ( !I1P* &IN:BTR
M,#(P,#8R.%]G."YJ<&=02P$"% ,4    " "/@/A01?<%O$U!  #/5P  $P
M            @ &S5@H :FYJ+3(P,C P-C(X7V<Y+FIP9U!+ 0(4 Q0    (
M (^ ^% EOY//?T<! "9+#0 4              "  3&8"@!J;FHM,C R,# V
M,CA?;&%B+GAM;%!+ 0(4 Q0    ( (^ ^% 6>%[6ALH  (/T"  4
M      "  >+?"P!J;FHM,C R,# V,CA?<')E+GAM;%!+!08     %P 7 /4%
(  ":J@P    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
